Citrus Sinensis ID: 003114
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 846 | 2.2.26 [Sep-21-2011] | |||||||
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.973 | 0.935 | 0.482 | 0.0 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.985 | 0.956 | 0.468 | 0.0 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.986 | 0.938 | 0.461 | 0.0 | |
| C0LGG6 | 876 | Probable LRR receptor-lik | no | no | 0.972 | 0.939 | 0.465 | 0.0 | |
| C0LGD9 | 871 | Probable LRR receptor-lik | no | no | 0.947 | 0.920 | 0.493 | 0.0 | |
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.962 | 0.928 | 0.484 | 0.0 | |
| O81069 | 884 | Probable leucine-rich rep | no | no | 0.978 | 0.936 | 0.466 | 0.0 | |
| C0LGD6 | 852 | Probable LRR receptor-lik | no | no | 0.925 | 0.919 | 0.483 | 0.0 | |
| C0LGG3 | 885 | Probable LRR receptor-lik | no | no | 0.966 | 0.924 | 0.472 | 0.0 | |
| Q9FZB8 | 871 | Probable LRR receptor-lik | no | no | 0.953 | 0.926 | 0.461 | 0.0 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 793 bits (2047), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/869 (48%), Positives = 558/869 (64%), Gaps = 45/869 (5%)
Query: 16 ALVALVHAQNQSG--------------------IKYISDTTFVDAGISKSVALAYQLESL 55
V LV AQ+QSG IKY+SD FV++G S+ +Q SL
Sbjct: 18 VFVLLVRAQDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIHSIDPEFQTSSL 77
Query: 56 HQPLWNLRSFPEGKRNCYNVK--LAKDVRYLIRASFAHGDYDGKGTVPEFDLHLGPNKWE 113
+ N+RSFPEG RNCY+VK K +YLIR F +G+YD G P+FDL+LG N W+
Sbjct: 78 EKQFQNVRSFPEGNRNCYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDLYLGFNIWD 137
Query: 114 SVILGNVSTIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRPLPNNTYITQSGSLNT 173
SV + N +TI+ KEIIH + S+ VCLV+ GTPF+SALE R L +NTY T SL
Sbjct: 138 SVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKSNTYETPYDSLIL 197
Query: 174 FIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQWQQITTPRTIDEDRYNDYQLPSIVMRSA 233
F R D+ + VRY+DDV+DR W P +P++ TID + +Q VM +A
Sbjct: 198 FKRWDLGGLGALPVRYKDDVFDRIWIPLRFPKYTIFNASLTIDSNNNEGFQPARFVMNTA 257
Query: 234 ATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELEELQANQSRQFNISFNGNHL-YGPVVPS 292
+P++ S+ ++ +D T K+++YMHFAE+ EL +N++R+F + N + P
Sbjct: 258 TSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVELPSNETREFKVLLNEKEINMSSFSPR 317
Query: 293 YRHTTTAYTTSALTGEKLQFSIHKTENSTLPPILNAIEFYLVQDFSQSETEQADVDAIMN 352
Y +T T + + ++G KL+F + +T STLPPI+NAIE Y V +F QS T+Q DVDAIM
Sbjct: 318 YLYTDTLFVQNPVSGPKLEFRLQQTPRSTLPPIINAIETYRVNEFLQSPTDQQDVDAIMR 377
Query: 353 IKSLYK-RKDWQGDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLT 411
IKS Y +K W GDPCAP + W + CSY DN+ PRI S+NLSS GLTG I SNLT
Sbjct: 378 IKSKYGVKKSWLGDPCAPVKYPWKDINCSYVDNESPRIISVNLSSSGLTGEIDAAFSNLT 437
Query: 412 MIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVD-- 469
++ LDLSNNSLTG +P+FL L L LNL GN L+G +P L+ERS + L +D
Sbjct: 438 LLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSNKKLILLRIDGN 497
Query: 470 --LCSSYPCK--ENNKKKNNFVFPVIASFASLLVVTLAISAIYWRHKRLRKDGS------ 519
LC S C+ + KKN ++ P++AS +L + LAI+ KR R+ GS
Sbjct: 498 PDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLAIALFLLYKKRHRRGGSGGVRAG 557
Query: 520 -LETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQF 578
L+T KR + Y+E+ K+TN+FE +LG+G FGKVYHG L+D+ +VAVK+LS SS QGY++F
Sbjct: 558 PLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKVYHGVLNDD-QVAVKILSESSAQGYKEF 616
Query: 579 EAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI 638
AEV LL VHHKNLT L GYC+EG ++ LIYE+MANG+L +YLS + VLSWE RL+I
Sbjct: 617 RAEVELLLRVHHKNLTALIGYCHEGKKMALIYEFMANGTLGDYLSGEKSYVLSWEERLQI 676
Query: 639 ATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698
+ +AAQGLEYLH GCKPP V RD+KPANIL+N++ QA++ADFGLS++ ++G + +T V
Sbjct: 677 SLDAAQGLEYLHNGCKPPIVQRDVKPANILINEKLQAKIADFGLSRSVALDGNNQDTTAV 736
Query: 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIA---NTEEHKHISQWVDFML 755
AGT GYLDPEY T +L+EKSD+YSFGVVLLE+++ +P IA T E+ HI+ VD ML
Sbjct: 737 AGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVVSGQPVIARSRTTAENIHITDRVDLML 796
Query: 756 AQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETAR 815
+ GDI+ IVDPKL D SAWK E+AM C S SS RP M+ VV ELKE ++ A
Sbjct: 797 STGDIRGIVDPKLGERFDAGSAWKITEVAMACASSSSKNRPTMSHVVAELKESVSRARA- 855
Query: 816 KEGHRFGSGDQSGRMMTLNLTSELAPLAR 844
G G+ + MT N S + P AR
Sbjct: 856 --GGGSGASSVTDPAMT-NFDSGMFPQAR 881
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 784 bits (2025), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/882 (46%), Positives = 568/882 (64%), Gaps = 48/882 (5%)
Query: 1 MEIFENFLFALLGGFALVALVHAQNQSG---------------------IKYISDTTFVD 39
M+ FL L+ + ++ V AQ+Q G I Y SD ++D
Sbjct: 1 MKSIHGFLLFLITAYVILESVQAQDQLGFISLDCGLVPKNATYTEKTTNITYKSDANYID 60
Query: 40 AGISKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDVRYLIRASFAHGDYDGKGT 99
+G+ ++ Y+ + L Q W +RSFPEG+RNCYN L RYLIRA+F +G+YDG
Sbjct: 61 SGLVGRISAEYKAQ-LQQQTWTVRSFPEGERNCYNFNLTAKSRYLIRATFTYGNYDGLRQ 119
Query: 100 VPEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRPL 159
VP+FD+H+GP+KW SV L V V E+IHV++ + ++CLV TG G PFIS+LE RPL
Sbjct: 120 VPKFDIHIGPSKWTSVKLDGVGNGAVLEMIHVLTQDRLQICLVKTGKGIPFISSLELRPL 179
Query: 160 PNNTYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQWQQITTPRTIDEDR 219
NNTY+TQSGSL F R+ S T +RY +D++DR W + I+T +D
Sbjct: 180 NNNTYLTQSGSLIGFARV-FFSATPTFIRYDEDIHDRVWVRQFGNGLKSISTDLLVDTS- 237
Query: 220 YNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELEELQANQSRQFNIS 279
N Y +P V ++A P N S+PL+ D ++ TS+ Y+YMHFAE++ L+ N R+FNI+
Sbjct: 238 -NPYDVPQAVAKTACVPSNASQPLIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREFNIT 296
Query: 280 FNG-NHLYGPVVPSYRHTTTAYTTSALTGEKLQFSIH--KTENSTLPPILNAIEFYLVQD 336
+NG ++Y + P +T + + L+ FS+ KT NSTLPP++N +E Y V D
Sbjct: 297 YNGGQNVYSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNSTLPPLINGLEIYKVLD 356
Query: 337 FSQSETEQADVDAIMNIKSLY---KRKDWQGDPCAPQAFLWNGLGCSYNDNDPPRITSLN 393
+ ET+Q +V A++NIK+ Y K+ WQGDPCAP+++ W GL CSY ++D PRI SLN
Sbjct: 357 LLELETDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPNSDQPRIISLN 416
Query: 394 LSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM-LTGPLP 452
L+ LTG I P +S LT + LDLS N L+G +PEF + ++ L+++NL+GN+ L +P
Sbjct: 417 LAENKLTGTITPEISKLTQLIELDLSKNDLSGEIPEFFADMKLLKLINLSGNLGLNSTIP 476
Query: 453 AGLVERSKNGSLSLSVDLCSSYPCKENNKKKNNFVFPVIASFASL--LVVTLAISAIYWR 510
+ +R + SL L + + K K + P++AS A + L+V LAI + R
Sbjct: 477 DSIQQRLDSKSLILILSKTVTKTVTLKGKSKKVPMIPIVASVAGVFALLVILAIFFVVRR 536
Query: 511 HKRLRKDG---SLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKML 567
G S+ TK+RR TY E+ K+TN+FE +LG+G FG VYHG L+D T+VAVKML
Sbjct: 537 KNGESNKGTNPSIITKERRITYPEVLKMTNNFERVLGKGGFGTVYHGNLED-TQVAVKML 595
Query: 568 SPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDS-N 626
S SS QGY++F+AEV LL VHH+NL L GYC++G+ + LIYEYMANG L+E +S
Sbjct: 596 SHSSAQGYKEFKAEVELLLRVHHRNLVGLVGYCDDGDNLALIYEYMANGDLKENMSGKRG 655
Query: 627 ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF 686
+VL+WE R++IA EAAQGLEYLH GC PP VHRD+K NILLN+++ A+LADFGLS++F
Sbjct: 656 GNVLTWENRMQIAVEAAQGLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSRSF 715
Query: 687 PIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKH 746
P++G SH+ST VAGT GYLDPEY +T L+EKSDVYSFGVVLLEI+T++P T E H
Sbjct: 716 PVDGESHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVTDKTRERTH 775
Query: 747 ISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806
I++WV ML +GDIK+I+DPKL GD D N AWK VE+A+ CV+ SS RP M VV EL
Sbjct: 776 INEWVGSMLTKGDIKSILDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVTELN 835
Query: 807 ECLAMETARKEG----HRFGSGDQSGRMMTLNLTSELAPLAR 844
EC+A+E AR++G H G D + + SE +P AR
Sbjct: 836 ECVALENARRQGREEMHTSGYVD-----FSRSSASEFSPGAR 872
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 770 bits (1989), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/899 (46%), Positives = 569/899 (63%), Gaps = 64/899 (7%)
Query: 1 MEIFENFLFALLGGFALVALVHAQNQSG---------------------IKYISDTTFVD 39
M+ FL L+ F ++ V AQNQ+G I Y SD ++D
Sbjct: 1 MKSLHWFLHLLIIAFTVLRSVEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSDVDYID 60
Query: 40 AGISKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDVRYLIRASFAHGDYDGKGT 99
+G+ + AY+ + Q +W +RSFP G+RNCYNV L + +YLIR +F +G+YDG
Sbjct: 61 SGLVGKINDAYKTQ-FQQQVWAVRSFPVGQRNCYNVNLTANNKYLIRGTFVYGNYDGLNQ 119
Query: 100 VPEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRPL 159
P FDLH+GPNKW SV + V+ + EIIHV+ +S VCLV TG TPFIS+LE RPL
Sbjct: 120 FPSFDLHIGPNKWSSVKILGVTNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPL 179
Query: 160 PNNTYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQWQQITTPRTIDEDR 219
N +Y+TQSGSL F R+ S ++ +RY +D++DR W + + I+T ID
Sbjct: 180 NNESYLTQSGSLMLFARVYFPSSSSSFIRYDEDIHDRVWNSFTDDETVWISTDLPIDTS- 238
Query: 220 YNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELEELQANQSRQFNIS 279
N Y +P VM++AA PKN SEP L+ +++T++ Y+YMHFAE++ L AN++R+FNI+
Sbjct: 239 -NSYDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREFNIT 297
Query: 280 FNGN-HLYGPVVPSYRHTTTAYTTSALTGEK--LQFSIHKTENSTLPPILNAIEFYLVQD 336
+NG + + P +T + A++ F+ T NSTLPP+LNA+E Y V D
Sbjct: 298 YNGGLRWFSYLRPPNLSISTIFNPRAVSSSNGIFNFTFAMTGNSTLPPLLNALEIYTVVD 357
Query: 337 FSQSETEQADVDAIMNIKSLY---KRKDWQGDPCAPQAFLWNGLGCSYNDNDPPRITSLN 393
Q ET + +V A+MNIK Y K+ WQGDPCAPQ + W GL CSY D++ RI SLN
Sbjct: 358 ILQLETNKDEVSAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYPDSEGSRIISLN 417
Query: 394 LSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN--MLTGPL 451
L+ LTG I +S LT++ LDLSNN L+G +P F ++++ L+++NL+GN + +
Sbjct: 418 LNGSELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNLTAI 477
Query: 452 PAGLVERSKNGSLSLSV-DLCSSYPCKENNKKKNNFVFPVIASFASLLVVTLAISAIYWR 510
P L +R + SL+L + + + P KE+ K + +A +LLV+ I +
Sbjct: 478 PDSLQQRVNSKSLTLILGENLTLTPKKESKKVPMVAIAASVAGVFALLVILAIFFVIKRK 537
Query: 511 HKRLRK--------------------DGSLETKKRRFTYAEITKITNDFETILGEGSFGK 550
+ + K + S+ T++R+ TY E+ K+TN+FE +LG+G FG
Sbjct: 538 NVKAHKSPGPPPLVTPGIVKSETRSSNPSIITRERKITYPEVLKMTNNFERVLGKGGFGT 597
Query: 551 VYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610
VYHG LD EVAVKMLS SS QGY++F+AEV LL VHH++L L GYC++G+ + LIY
Sbjct: 598 VYHGNLD-GAEVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIY 656
Query: 611 EYMANGSLEEYLSDS-NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL 669
EYMANG L E +S +VL+WE R++IA EAAQGLEYLH GC+PP VHRD+K NILL
Sbjct: 657 EYMANGDLRENMSGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCRPPMVHRDVKTTNILL 716
Query: 670 NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLL 729
N++ A+LADFGLS++FPI+G H+ST VAGT GYLDPEY +T L+EKSDVYSFGVVLL
Sbjct: 717 NERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLL 776
Query: 730 EIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVS 789
EI+T++P I T E HI+ WV FML +GDIK+IVDPKL GD D N AWK VE+A+ CV+
Sbjct: 777 EIVTNQPVIDKTRERPHINDWVGFMLTKGDIKSIVDPKLMGDYDTNGAWKIVELALACVN 836
Query: 790 HSSTPRPNMNRVVMELKECLAMETARKEG----HRFGSGDQSGRMMTLNLTSELAPLAR 844
SS RP M VVMEL +C+A+E AR++G + GS D S L+ TS+ AP AR
Sbjct: 837 PSSNRRPTMAHVVMELNDCVALENARRQGSEEMYSMGSVDYS-----LSSTSDFAPGAR 890
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 766 bits (1979), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/889 (46%), Positives = 566/889 (63%), Gaps = 66/889 (7%)
Query: 7 FLFALLGGFALVALVHAQNQSG---------------------IKYISDTTFVDAGISKS 45
FL L+ FA++ LV AQ+QSG I Y SD T++D+G+
Sbjct: 3 FLSFLIFVFAVLGLVQAQDQSGFISLDCGLVPTEITYVEKSTNITYRSDATYIDSGVPGK 62
Query: 46 VALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDVRYLIRASFAHGDYDGKGTVPEFDL 105
+ Y+ + Q +W LRSFPEG+RNCYN L +YLIR +F +G+YDG +P FDL
Sbjct: 63 INEVYRTQ-FQQQIWALRSFPEGQRNCYNFSLTAKRKYLIRGTFIYGNYDGLNQLPSFDL 121
Query: 106 HLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRPLPNNTYI 165
++GPNKW SV + V V E+IHV+ + ++CLV TG TPFIS+LE RPL NNTY+
Sbjct: 122 YIGPNKWTSVSIPGVRNGSVSEMIHVLRQDHLQICLVKTGETTPFISSLELRPLNNNTYV 181
Query: 166 TQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQWQQITTPRTIDEDRYNDYQL 225
T+SGSL R+ S T +RY +DV+DR W P+ + ++T ++D + Y +
Sbjct: 182 TKSGSLIVVARL-YFSPTPPFLRYDEDVHDRIWIPFLDNKNSLLSTELSVDTSNF--YNV 238
Query: 226 PSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELEELQANQSRQFNISFNGN-H 284
P V ++AA P N ++PL I+ +D TS+ Y+YMHFAE+E L+AN++R+FNI++NG +
Sbjct: 239 PQTVAKTAAVPLNATQPLKINWSLDDITSQSYIYMHFAEIENLEANETREFNITYNGGEN 298
Query: 285 LYGPVVPSYRHTTTAYTTSALTG--EKLQFSIHKTENSTLPPILNAIEFYLVQDFSQSET 342
+ P TT Y +A++ F+ T NST PP++N +E Y V + Q +T
Sbjct: 299 WFSYFRPPKFRITTVYNPAAVSSLDGNFNFTFSMTGNSTHPPLINGLEIYQVLELPQLDT 358
Query: 343 EQADVDAIMNIKSLY---KRKDWQGDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGL 399
Q +V A+MNIK++Y KR WQGDPCAP+ + W GL CSY + PP+I SLNLS L
Sbjct: 359 YQDEVSAMMNIKTIYGLSKRSSWQGDPCAPELYRWEGLNCSYPNFAPPQIISLNLSGSNL 418
Query: 400 TGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM-LTGPLPAGLVER 458
+G I +S LT + LDLSNN L+G +P S ++ L ++NL+GN L +P L +R
Sbjct: 419 SGTITSDISKLTHLRELDLSNNDLSGDIPFVFSDMKNLTLINLSGNKNLNRSVPETLQKR 478
Query: 459 SKNGSLSLSVDLCSSYPCKENNKKKNNFVFPVIASFASL--LVVTLAISAIYWRHKRLRK 516
N SL+L D E K N V + AS AS+ ++V LAI + R K+
Sbjct: 479 IDNKSLTLIRD--------ETGKNSTNVV-AIAASVASVFAVLVILAIVFVVIRKKQRTN 529
Query: 517 DGS--------------------LETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYL 556
+ S + TK+R+FTY+E+ K+T +FE +LG+G FG VYHG L
Sbjct: 530 EASGPRSFTTGTVKSDARSSSSSIITKERKFTYSEVLKMTKNFERVLGKGGFGTVYHGNL 589
Query: 557 DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616
DD T+VAVKMLS SS QGY++F+AEV LL VHH++L L GYC++G+ + LIYEYM G
Sbjct: 590 DD-TQVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMEKG 648
Query: 617 SLEEYLSDSNA-DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQA 675
L E +S ++ +VLSWE R++IA EAAQGLEYLH GC+PP VHRD+KP NILLN++ QA
Sbjct: 649 DLRENMSGKHSVNVLSWETRMQIAVEAAQGLEYLHNGCRPPMVHRDVKPTNILLNERSQA 708
Query: 676 RLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSR 735
+LADFGLS++FP++G SH+ T VAGT GYLDPEY +T L+EKSDVYSFGVVLLEI+T++
Sbjct: 709 KLADFGLSRSFPVDGESHVMTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQ 768
Query: 736 PAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPR 795
P + E HI++WV FML GDIK+IVDPKL+ D D N WK VE+A+ CV+ SS+ R
Sbjct: 769 PVMNKNRERPHINEWVMFMLTNGDIKSIVDPKLNEDYDTNGVWKVVELALACVNPSSSRR 828
Query: 796 PNMNRVVMELKECLAMETARKEGHRFGSGDQSGRMMTLNLTSELAPLAR 844
P M VVMEL ECLA+E RK+G + +S + + S+ +PLAR
Sbjct: 829 PTMPHVVMELNECLALEIERKQGSQATYIKESVE-FSPSSASDFSPLAR 876
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD9|Y1756_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07560 OS=Arabidopsis thaliana GN=At1g07560 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 765 bits (1975), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/835 (49%), Positives = 544/835 (65%), Gaps = 33/835 (3%)
Query: 29 IKYISDTTFVDAGISKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDVRYLIRAS 88
+ + SD F+ +G S + +E + +P LR FP+G RNCY + + + YLI A
Sbjct: 51 LTFTSDADFIKSGKSGKIQNVPGMEYI-KPYTVLRYFPDGVRNCYTLIVIQGTNYLIVAM 109
Query: 89 FAHGDYDGKGTVPEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTGAGT 148
F +G+YD T P+FDL+LGPN W +V L EIIH+ S S ++CLV TG T
Sbjct: 110 FTYGNYDNLNTHPKFDLYLGPNIWTTVDLQRNVNGTRAEIIHIPRSTSLQICLVKTGTTT 169
Query: 149 PFISALEFRPLPNNTYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQWQQ 208
P ISALE RPL NNTYI QSGSL T R+ L+ + + VRY +DV+DR W+P+ P+W+
Sbjct: 170 PLISALELRPLRNNTYIPQSGSLKTLFRVH-LTDSKETVRYPEDVHDRLWSPFFMPEWRL 228
Query: 209 ITTPRTIDEDRYNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELEEL 268
+ T T++ N Y +P V+ +AATP N S PL I E Y Y+H AE++ L
Sbjct: 229 LRTSLTVNTSDDNGYDIPEDVVVTAATPANVSSPLTISWNLETPDDLVYAYLHVAEIQSL 288
Query: 269 QANQSRQFNISFNGNHLYGPVVPSYRHTTTAYTTSALT--GEKLQFSIHKTENSTLPPIL 326
+ N +R+FNIS + YGPV P T + TS + G + KT STLPP+L
Sbjct: 289 RENDTREFNISAGQDVNYGPVSPDEFLVGTLFNTSPVKCEGGTCHLQLIKTPKSTLPPLL 348
Query: 327 NAIEFYLVQDFSQSETEQADVDAIMNIKSLY--KRKDWQGDPCAPQAFLWNGLGCSY-ND 383
NAIE ++ +F QSET DV AI +I++ Y R WQGDPC PQ LW+GL C Y N
Sbjct: 349 NAIEAFITVEFPQSETNANDVLAIKSIETSYGLSRISWQGDPCVPQQLLWDGLTCEYTNM 408
Query: 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443
+ PPRI SL+LSS LTG I P + NLT ++ LD SNN+LTG VPEFL+K++ L V+NL+
Sbjct: 409 STPPRIHSLDLSSSELTGIIVPEIQNLTELKKLDFSNNNLTGGVPEFLAKMKSLLVINLS 468
Query: 444 GNMLTGPLPAGLVERSKNGSLSLSV----DLCSSYPCKENNKKKNNFVFPVIASFASLLV 499
GN L+G +P L+ + KNG L L++ +LC S C NKKKN+ + PV+AS ASL
Sbjct: 469 GNNLSGSVPQALLNKVKNG-LKLNIQGNPNLCFSSSC---NKKKNSIMLPVVASLASLAA 524
Query: 500 VTLAISAIYWRHKRL---RK-----DGSLETKKRRFTYAEITKITNDFETILGEGSFGKV 551
+ I+ ++ KR RK S+ET K+R+TYAE+ +T FE +LG+G FG V
Sbjct: 525 IIAMIALLFVCIKRRSSSRKGPSPSQQSIETIKKRYTYAEVLAMTKKFERVLGKGGFGMV 584
Query: 552 YHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611
YHGY++ EVAVK+LSPSS QGY++F+ EV LL V+H NL +L GYC+E + + LIY+
Sbjct: 585 YHGYINGTEEVAVKLLSPSSAQGYKEFKTEVELLLRVYHTNLVSLVGYCDEKDHLALIYQ 644
Query: 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND 671
YM NG L+++ S S+ ++SW RL IA +AA GLEYLH+GCKP VHRD+K +NILL+D
Sbjct: 645 YMVNGDLKKHFSGSS--IISWVDRLNIAVDAASGLEYLHIGCKPLIVHRDVKSSNILLDD 702
Query: 672 QFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEI 731
Q QA+LADFGLS++FPI SH+ST VAGTFGYLD EY QT RL+EKSDVYSFGVVLLEI
Sbjct: 703 QLQAKLADFGLSRSFPIGDESHVSTLVAGTFGYLDHEYYQTNRLSEKSDVYSFGVVLLEI 762
Query: 732 ITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHS 791
IT++P I + + HI++WV ML +GDI NI+DPKL G D SAWKA+E+AM CV+ S
Sbjct: 763 ITNKPVIDHNRDMPHIAEWVKLMLTRGDISNIMDPKLQGVYDSGSAWKALELAMTCVNPS 822
Query: 792 STPRPNMNRVVMELKECLAMETARKEGHRFGSGDQSGRMMTLNLT--SELAPLAR 844
S RPNM+ VV ELKECL E R + R M +NL+ +++ P AR
Sbjct: 823 SLKRPNMSHVVHELKECLVSENNRTRDI------DTSRSMDINLSFGTDVNPKAR 871
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 762 bits (1967), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/861 (48%), Positives = 556/861 (64%), Gaps = 47/861 (5%)
Query: 6 NFLFALLGGFA----LVALVHAQNQSG--------------------IKYISDTTFVDAG 41
NF F L FA ++ LV AQ+QSG IKYISD FV++G
Sbjct: 3 NFNFLPLVSFASFVVVLVLVCAQDQSGFVSIDCGIPEDSSYYDEKTDIKYISDAAFVESG 62
Query: 42 ISKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVK--LAKDVRYLIRASFAHGDYDGKGT 99
S+ +Q ++L + +RSFPEGK+NCY+V+ K +YLIR F +G+YD G
Sbjct: 63 TIHSIDSKFQKKNLEKQFQKVRSFPEGKKNCYDVQPPQGKGFKYLIRTRFMYGNYDNLGK 122
Query: 100 VPEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRPL 159
P+FDL+LG N W+SV L N +TI+ KEII+ + S+ VCLV+ GTPF+S LE R L
Sbjct: 123 APDFDLYLGVNLWDSVTLENSTTIVTKEIIYTLRSDKVHVCLVDKERGTPFLSVLELRLL 182
Query: 160 PNNTYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQWQQITTPRTIDEDR 219
NN Y T S SL + R D+ + + RY+DD++DR W P +P + + T ID
Sbjct: 183 KNNIYETASDSLMLYRRWDLGATGDLPARYKDDIFDRFWMPLMFPNFLILNTSLMIDPTS 242
Query: 220 YNDYQLPSIVMRSAATPKNKS-EPLLIDLVHEDSTSKFYMYMHFAELEELQANQSRQFNI 278
N + PS+VM +A P N S E +++ D KFY+Y+HFAE+E+L +N++R+F++
Sbjct: 243 SNGFLPPSVVMSTAVAPMNSSIEQIMVYWEPRDPNWKFYIYIHFAEVEKLPSNETREFSV 302
Query: 279 SFNGNHLYGPVV--PSYRHTTTAYTTSALTGEKLQFSIHKTENSTLPPILNAIEFYLVQD 336
N + V PSY +T T Y + ++G L+F + + ST PPI+NAIE Y +
Sbjct: 303 FLNKEQIDTTSVFRPSYLYTDTLYVQNPVSGPFLEFVLRQGVKSTRPPIMNAIETYRTNE 362
Query: 337 FSQSETEQADVDAIMNIKSLYKRK-DWQGDPCAPQAFLWNGLGCSYNDNDPPRITSLNLS 395
F T+Q DVDAIM IK+ YK K +W GDPCAP + W G+ CSY N+PPRI S+NLS
Sbjct: 363 FLDLPTDQNDVDAIMKIKTKYKVKKNWLGDPCAPFGYPWQGINCSYTANNPPRIISVNLS 422
Query: 396 SRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGL 455
GLTG I P LT ++ LDLSNN LTG VP+FL+ L L LNL N LTG LP L
Sbjct: 423 FSGLTGQIDPVFITLTPLQKLDLSNNRLTGTVPDFLANLPDLTELNLEENKLTGILPEKL 482
Query: 456 VERSKNGSLSLSV----DLCSSYPCKENNKKKNNFVFPVIASFASLLVVTLAISAIYWRH 511
+ERSK+GSLSL V DLC S C+ ++ ++ P +AS L + LA+ + +W+
Sbjct: 483 LERSKDGSLSLRVGGNPDLCVSDSCRNKKTERKEYIIPSVASVTGLFFLLLALIS-FWQF 541
Query: 512 KRLR---KDGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLS 568
K+ + K G L+TK R + Y+EI +ITN+FE +LG+G FGKVY+G L +VA+KMLS
Sbjct: 542 KKRQQSVKTGPLDTK-RYYKYSEIVEITNNFERVLGQGGFGKVYYGVLR-GEQVAIKMLS 599
Query: 569 PSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNAD 628
SS QGY++F AEV LL VHHKNL L GYC+EG+Q+ LIYEY+ NG+L +YLS N+
Sbjct: 600 KSSAQGYKEFRAEVELLLRVHHKNLIALIGYCHEGDQMALIYEYIGNGTLGDYLSGKNSS 659
Query: 629 VLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688
+LSWE RL+I+ +AAQGLEYLH GCKPP VHRD+KP NIL+N++ QA++ADFGLS++F +
Sbjct: 660 ILSWEERLQISLDAAQGLEYLHNGCKPPIVHRDVKPTNILINEKLQAKIADFGLSRSFTL 719
Query: 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAI--ANTEEHKH 746
EG S +ST VAGT GYLDPE+ + +EKSDVYSFGVVLLE+IT +P I + TEE++H
Sbjct: 720 EGDSQVSTEVAGTIGYLDPEHYSMQQFSEKSDVYSFGVVLLEVITGQPVISRSRTEENRH 779
Query: 747 ISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806
IS V ML++GDIK+IVDPKL + AWK E+A+ C S S+ R M++VV ELK
Sbjct: 780 ISDRVSLMLSKGDIKSIVDPKLGERFNAGLAWKITEVALACASESTKTRLTMSQVVAELK 839
Query: 807 ECLAMETARKEGHRFGSGDQS 827
E L AR G SGD S
Sbjct: 840 ESLC--RARTSGD---SGDIS 855
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81069|Y2899_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g28990 OS=Arabidopsis thaliana GN=At2g28990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 752 bits (1941), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/892 (46%), Positives = 558/892 (62%), Gaps = 64/892 (7%)
Query: 6 NFLFALLGGFALVALVHAQNQ---------------------SGIKYISDTTFVDAGISK 44
+ L A++G F V ++ AQ+Q +G+ + SD+TF+ G
Sbjct: 4 HLLLAMIGTF--VVIIGAQDQEGFISLDCGLPSDESPYDDSFNGLTFTSDSTFIQTGKID 61
Query: 45 SVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDVRYLIRASFAHGDYDGKGTVPEFD 104
SV + +L + LR FPEGKRNCY++ + + YLI SF +G+YDG P FD
Sbjct: 62 SVDKDLNI-NLSKQYLTLRYFPEGKRNCYSLDVKRGTTYLIVVSFVYGNYDGLNRDPNFD 120
Query: 105 LHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRPLPNNTY 164
+HLGPNKW+ + L +EIIH SNS +CLV TG P ISA+E RPL NNTY
Sbjct: 121 IHLGPNKWKRIDLDGEKEGTREEIIHKARSNSLDICLVKTGETLPIISAIEIRPLRNNTY 180
Query: 165 ITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQWQQITTPRTIDEDRYNDYQ 224
+TQSGSL R+ LS ++ +RY DDV+DR W+P+ ITT I+ N Y+
Sbjct: 181 VTQSGSLMMSFRV-YLSNSDASIRYADDVHDRIWSPFNGSSHTHITTDLNINNS--NAYE 237
Query: 225 LPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELEELQANQSRQFNISFNGNH 284
+P ++++AA P+N S PL+I ++ Y+YMHFAE++ L+AN++RQF++ GN
Sbjct: 238 IPKNILQTAAIPRNASAPLIITWDPLPINAEVYLYMHFAEIQTLEANETRQFDVILRGNF 297
Query: 285 LYGPVVPSYRHTTTAYTTSALT--GEKLQFSIHKTENSTLPPILNAIEFYLVQDFSQSET 342
+ P+ T YT + E + KT NSTLPP++NAIE Y V +FSQ ET
Sbjct: 298 NHSGFSPTKLKVFTLYTEEPMKCGSEGCYLQLVKTPNSTLPPLINAIEAYSVIEFSQLET 357
Query: 343 EQADVDAIMNIKSLYK--RKDWQGDPCAPQAFLWNGLGCSYNDND-PPRITSLNLSSRGL 399
+DVDAI NIK+ YK + WQGDPC PQ W + C+Y D P I SL+LS GL
Sbjct: 358 SLSDVDAIKNIKNTYKLNKITWQGDPCLPQDLSWESIRCTYVDGSTSPTIISLDLSKSGL 417
Query: 400 TGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERS 459
G IP L N T ++ LDLSNNSLTGPVP FL+ ++ L ++NL+GN L+G +P L+++
Sbjct: 418 NGSIPQILQNFTQLQELDLSNNSLTGPVPIFLANMKTLSLINLSGNNLSGSVPQALLDKE 477
Query: 460 KNG---SLSLSVDLCSSYPCKENNKKKNNFVFPVIASFASLLVVTLAISAIYWRHKRL-- 514
K G L + DLC S C N +KKN F+ PVIAS ASL++V + ++ + K+
Sbjct: 478 KEGLVLKLEGNPDLCKSSFC--NTEKKNKFLLPVIASAASLVIVVVVVALFFVFRKKKAS 535
Query: 515 -------------------RKDGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGY 555
+ + S +KK RFTY+E+ ++TN+F+ LGEG FG VYHG+
Sbjct: 536 PSNLHAPPSMPVSNPGHNSQSESSFTSKKIRFTYSEVQEMTNNFDKALGEGGFGVVYHGF 595
Query: 556 LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615
++ +VAVK+LS SS QGY+ F+AEV LL VHH NL +L GYC+EG + LIYEYM N
Sbjct: 596 VNVIEQVAVKLLSQSSSQGYKHFKAEVELLMRVHHINLVSLVGYCDEGEHLALIYEYMPN 655
Query: 616 GSLEEYLSDSNAD-VLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ 674
G L+++LS + VLSWE RL+I +AA GLEYLH GC PP VHRDIK NILL+ Q
Sbjct: 656 GDLKQHLSGKHGGFVLSWESRLKIVLDAALGLEYLHTGCVPPMVHRDIKTTNILLDQHLQ 715
Query: 675 ARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITS 734
A+LADFGLS++FPI ++ST VAGT GYLDPEY QT LTEKSD+YSFG+VLLEII++
Sbjct: 716 AKLADFGLSRSFPIGNEKNVSTVVAGTPGYLDPEYYQTNWLTEKSDIYSFGIVLLEIISN 775
Query: 735 RPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTP 794
RP I + E HI +WV FM+ +GD+++I+DP LH D D+ S WKA+E+AM CVS SS
Sbjct: 776 RPIIQQSREKPHIVEWVSFMITKGDLRSIMDPNLHQDYDIGSVWKAIELAMSCVSLSSAR 835
Query: 795 RPNMNRVVMELKECLAMETAR-KEGHRFGSGDQSGRM-MTLNLTSELAPLAR 844
RPNM+RVV ELKECL ET+R EG S G M + ++ +E+ P AR
Sbjct: 836 RPNMSRVVNELKECLISETSRIGEGRDMES---KGSMEFSRDIYNEVIPQAR 884
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD6|Y1570_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g05700 OS=Arabidopsis thaliana GN=At1g05700 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 746 bits (1925), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/819 (48%), Positives = 544/819 (66%), Gaps = 36/819 (4%)
Query: 22 HAQNQSGIKYISDTTFVDAGISKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVK--LAK 79
+ + +GI Y+SD++FV+ G+SKS+ Q + L NLRSFPEG RNCY + K
Sbjct: 44 YKDDTTGINYVSDSSFVETGVSKSIPFTAQ-----RQLQNLRSFPEGSRNCYTLIPIQGK 98
Query: 80 DVRYLIRASFAHGDYDGKGTVPEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRV 139
+YLIRASF +G+YDG+ PEFDL LG N W++V+L N S+I+ KE++++ S + V
Sbjct: 99 GKKYLIRASFMYGNYDGENGSPEFDLFLGGNIWDTVLLSNGSSIVSKEVVYLSQSENIFV 158
Query: 140 CLVNTGAGTPFISALEFRPLPNN--TYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRS 197
CL N G GTPFIS LE R L N+ TY + +G+L R D+ S+ VRY DDVYDR
Sbjct: 159 CLGNKGKGTPFISTLELRFLGNDNTTYDSPNGALFFSRRWDLRSLMGSPVRYDDDVYDRI 218
Query: 198 WAPYAYPQWQQITTPRTIDEDRYNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFY 257
W P + ++I T + D N Y L S+VM +A TP N + P+ + L + D +++
Sbjct: 219 WIPRNFGYCREINTSLPVTSDN-NSYSLSSLVMSTAMTPINTTRPITMTLENSDPNVRYF 277
Query: 258 MYMHFAELEEL--QANQSRQFNISFNGNHLYGPVVPSYRHTTTAYTTSALTGEKLQFSIH 315
+YMHFAE+E+L + NQ+R+F+IS NG + P Y T T + + K+ FS+
Sbjct: 278 VYMHFAEVEDLSLKPNQTREFDISINGVTVAAGFSPKYLQTNTFFLNPE-SQSKIAFSLV 336
Query: 316 KTENSTLPPILNAIEFYLVQDFSQSETEQADVDAIMNIKSLYK-RKDWQGDPCAPQAFLW 374
+T STLPPI+NA+E Y+ FSQS T Q D DA+ ++K+ YK +K+W GDPC P ++W
Sbjct: 337 RTPKSTLPPIVNALEIYVANSFSQSLTNQEDGDAVTSLKTSYKVKKNWHGDPCLPNDYIW 396
Query: 375 NGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKL 434
GL CSY+ PPRITSLNLSS GLTG I SNLTMI+ LDLSNN LTG +PEFLSKL
Sbjct: 397 EGLNCSYDSLTPPRITSLNLSSSGLTGHISSSFSNLTMIQELDLSNNGLTGDIPEFLSKL 456
Query: 435 QYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVD----LCSSYPCKENNKKKNNFVFPV 490
++LRVLNL N LTG +P+ L+ERS GS SL + LC+ C+++N KK V P+
Sbjct: 457 KFLRVLNLENNTLTGSVPSELLERSNTGSFSLRLGENPGLCTEISCRKSNSKK--LVIPL 514
Query: 491 IASFASLLVVTLAISAIYWRHKRLRKDGSLET-----------KKRRFTYAEITKITNDF 539
+AS + L + L +S ++WR R R++ S+ + K FT+A++ K+TN+F
Sbjct: 515 VAS-FAALFILLLLSGVFWR-IRNRRNKSVNSAPQTSPMAKSENKLLFTFADVIKMTNNF 572
Query: 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGY 599
+LG+G FG VYHG+ D N +VAVK+LS +S QG+++F +EV +L VHH NLT L GY
Sbjct: 573 GQVLGKGGFGTVYHGFYD-NLQVAVKLLSETSAQGFKEFRSEVEVLVRVHHVNLTALIGY 631
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVH 659
+EG+Q+GLIYE+MANG++ ++L+ LSW RL+IA +AAQGLEYLH GCKPP VH
Sbjct: 632 FHEGDQMGLIYEFMANGNMADHLAGKYQHTLSWRQRLQIALDAAQGLEYLHCGCKPPIVH 691
Query: 660 RDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKS 719
RD+K +NILLN++ +A+LADFGLS++F E SH+ST VAGT GYLDP +T L EKS
Sbjct: 692 RDVKTSNILLNEKNRAKLADFGLSRSFHTESRSHVSTLVAGTPGYLDPLCFETNGLNEKS 751
Query: 720 DVYSFGVVLLEIITSRPAIANTEEHK-HISQWVDFML-AQGDIKNIVDPKLHGDIDVNSA 777
D+YSFGVVLLE+IT + I ++ + H+S WV +L + D+ N++D K+ D DVNS
Sbjct: 752 DIYSFGVVLLEMITGKTVIKESQTKRVHVSDWVISILRSTNDVNNVIDSKMAKDFDVNSV 811
Query: 778 WKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARK 816
WK VE+A+ VS + + RPNM +V L ECL E + K
Sbjct: 812 WKVVELALSSVSQNVSDRPNMPHIVRGLNECLQREESNK 850
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG3|Y5182_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51820 OS=Arabidopsis thaliana GN=At1g51820 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 743 bits (1919), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/867 (47%), Positives = 556/867 (64%), Gaps = 49/867 (5%)
Query: 14 GFALVALVHAQNQSGIKYISDTTFVDAGISKSVALAYQLESL-HQPLWNLRSFPEGKRNC 72
G +L+ + Q+G+ Y SD V +G K+ LA + E L +P LR FPEG RNC
Sbjct: 32 GLSLLESPYDAPQTGLTYTSDADLVASG--KTGRLAKEFEPLVDKPTLTLRYFPEGVRNC 89
Query: 73 YNVKLAKDVRYLIRASFAHGDYDGKGTVPEFDLHLGPNKWESVILGNVSTIIVKEIIHVI 132
YN+ + D YLI+A+F +G+YDG P F+L+LGPN W +V S ++EII V
Sbjct: 90 YNLNVTSDTNYLIKATFVYGNYDGLNVGPNFNLYLGPNLWTTV----SSNDTIEEIILVT 145
Query: 133 SSNSTRVCLVNTGAGTPFISALEFRPLPNNTYITQSGSLNTFIRMDVLSITNQVVRYRDD 192
SNS +VCLV TG PFI+ LE RP+ N Y+TQSGSL R +S ++ +R+ DD
Sbjct: 146 RSNSLQVCLVKTGISIPFINMLELRPMKKNMYVTQSGSLKYLFR-GYISNSSTRIRFPDD 204
Query: 193 VYDRSWAPYAYPQWQQITTPRTIDEDRYNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDS 252
VYDR W P W Q+TT ++ Y+LP VM AATP ++ L I E
Sbjct: 205 VYDRKWYPLFDDSWTQVTTNLKVNTSI--TYELPQSVMAKAATPIKANDTLNITWTVEPP 262
Query: 253 TSKFYMYMHFAELEELQANQSRQFNISFNGNHLYGPVVPSYRHTTTAYTTSA--LTGEKL 310
T++FY Y+H AE++ L+AN++R+FN++ NG + +GP P T + S G +
Sbjct: 263 TTQFYSYVHIAEIQALRANETREFNVTLNGEYTFGPFSPIPLKTASIVDLSPGQCDGGRC 322
Query: 311 QFSIHKTENSTLPPILNAIEFYLVQDFSQSETEQADVDAIMNIKSLY--KRKDWQGDPCA 368
+ KT STLPP+LNAIE + V DF Q ET + DV I N++ Y R WQGDPC
Sbjct: 323 ILQVVKTLKSTLPPLLNAIEAFTVIDFPQMETNENDVAGIKNVQGTYGLSRISWQGDPCV 382
Query: 369 PQAFLWNGLGCSYND-NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPV 427
P+ LW+GL C +D + PP ITSL+LSS GLTG I + NLT ++ LDLS+N+LTG V
Sbjct: 383 PKQLLWDGLNCKNSDISTPPIITSLDLSSSGLTGIITQAIKNLTHLQILDLSDNNLTGEV 442
Query: 428 PEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVD-----LCSSYPC---KEN 479
PEFL+ ++ L V+NL+GN L+G +P L+++ + L+V+ LC++ C KE+
Sbjct: 443 PEFLADIKSLLVINLSGNNLSGSVPPSLLQKK---GMKLNVEGNPHILCTTGSCVKKKED 499
Query: 480 NKKKNNFVFPVIASFASLLVVTLAISA-IYWRHKRLRK------------DGSLE----- 521
KK + + PV+AS AS+ V+ A+ + R KR K DG L
Sbjct: 500 GHKKKSVIVPVVASIASIAVLIGALVLFLILRKKRSPKVEGPPPSYMQASDGRLPRSSEP 559
Query: 522 ---TKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQF 578
TK RRF+Y+++ +TN+F+ ILG+G FG VYHG+++ +VAVK+LS SS QGY+QF
Sbjct: 560 AIVTKNRRFSYSQVVIMTNNFQRILGKGGFGMVYHGFVNGTEQVAVKILSHSSSQGYKQF 619
Query: 579 EAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDS-NADVLSWEGRLR 637
+AEV LL VHHKNL L GYC+EG+ + LIYEYMANG L+E++S + N +L+W RL+
Sbjct: 620 KAEVELLLRVHHKNLVGLVGYCDEGDNLALIYEYMANGDLKEHMSGTRNRFILNWGTRLK 679
Query: 638 IATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697
I E+AQGLEYLH GCKPP VHRD+K NILLN+ F+A+LADFGLS++F IEG +H+ST
Sbjct: 680 IVIESAQGLEYLHNGCKPPMVHRDVKTTNILLNEHFEAKLADFGLSRSFLIEGETHVSTV 739
Query: 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ 757
VAGT GYLDPEY +T LTEKSDVYSFG++LLEIIT+R I + E HI +WV ML +
Sbjct: 740 VAGTPGYLDPEYHRTNWLTEKSDVYSFGILLLEIITNRHVIDQSREKPHIGEWVGVMLTK 799
Query: 758 GDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARKE 817
GDI++I+DP L+ D D S WKAVE+AM C++HSS RP M++VV+EL ECLA E AR
Sbjct: 800 GDIQSIMDPSLNEDYDSGSVWKAVELAMSCLNHSSARRPTMSQVVIELNECLASENARGG 859
Query: 818 GHRFGSGDQSGRMMTLNLTSELAPLAR 844
R +S ++L +E++P AR
Sbjct: 860 ASR-DMESKSSIEVSLTFGTEVSPNAR 885
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 742 bits (1916), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/864 (46%), Positives = 551/864 (63%), Gaps = 57/864 (6%)
Query: 14 GFALVALVHAQNQSGIKYISDTTFVDAGISKSVALAYQLESLHQ-PLWNLRSFPEGKRNC 72
G ++ + ++ +G+ Y SD FV +G K + +LESL++ P LR FP+G RNC
Sbjct: 32 GLSIQGSPYKESSTGLTYTSDDGFVQSG--KIGKITKELESLYKKPERTLRYFPDGVRNC 89
Query: 73 YNVKLAKDVRYLIRASFAHGDYDGKGTVPEFDLHLGPNKWESVILGNVSTIIVKEIIHVI 132
+++ + + +YLI+ +F +G+YDG+ +P+FDL++GPN W +V N +KEI+HV
Sbjct: 90 FSLNVTRGTKYLIKPTFLYGNYDGRNVIPDFDLYIGPNMWITVNTDNT----IKEILHVS 145
Query: 133 SSNSTRVCLVNTGAGTPFISALEFRPLPNNTYITQSGSLNTFIRMDVLSITNQVVRYRDD 192
SN+ +VCLV TG P+I+ LE RPL ++ Y +SGSLN R+ S + Y DD
Sbjct: 146 KSNTLQVCLVKTGTSIPYINTLELRPLADDIYTNESGSLNYLFRV-YYSNLKGYIEYPDD 204
Query: 193 VYDRSWAP-YAYPQWQQITTPRTIDEDRYNDYQLPSIVMRSAATP-KNKSEPLLIDLVHE 250
V+DR W Y WQ +TT I+ NDY LP VM++A TP K + + E
Sbjct: 205 VHDRIWKQILPYQDWQILTTNLQINVS--NDYDLPQRVMKTAVTPIKASTTTMEFPWNLE 262
Query: 251 DSTSKFYMYMHFAELEELQANQSRQFNISFNGNHLYGPVVPSYRHTTTAYTTS--ALTGE 308
TS+FY+++HFAEL+ LQAN++R+FN+ NGN + P + T Y+T+ G
Sbjct: 263 PPTSQFYLFLHFAELQSLQANETREFNVVLNGNVTFKSYSPKFLEMQTVYSTAPKQCDGG 322
Query: 309 KLQFSIHKTENSTLPPILNAIEFYLVQDFSQSETEQADVDAIMNIKSLY--KRKDWQGDP 366
K + KT STLPP++NA+E Y V DF Q ET +V AI NI+S Y + WQGDP
Sbjct: 323 KCLLQLVKTSRSTLPPLINAMEAYTVLDFPQIETNVDEVIAIKNIQSTYGLSKTTWQGDP 382
Query: 367 CAPQAFLWNGLGCSYNDND-PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG 425
C P+ FLW+GL C+ +D+ PP ITSLNLSS GLTG I + NL ++ LDLSNN+L+G
Sbjct: 383 CVPKKFLWDGLNCNNSDDSTPPIITSLNLSSSGLTGIIVLTIQNLANLQELDLSNNNLSG 442
Query: 426 PVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSK-------NGSLSLSVDLCSSYPCKE 478
VPEFL+ ++ L V+NL+GN L+G +P L+E+ N L+ +V+ C + +E
Sbjct: 443 GVPEFLADMKSLLVINLSGNNLSGVVPQKLIEKKMLKLNIEGNPKLNCTVESCVNKD-EE 501
Query: 479 NNKKKNNFVFPVIASFASLLVVTLAISAIYWRHKR------------LRKDG-----SLE 521
++ + P++AS S++ T+A+ K L D ++
Sbjct: 502 GGRQIKSMTIPIVASIGSVVAFTVALMIFCVVRKNNPSNDEAPTSCMLPADSRSSEPTIV 561
Query: 522 TKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAE 581
TK ++FTYAE+ +TN+F+ ILG+G FG VY+G ++ +VAVKMLS SS QGY+QF+AE
Sbjct: 562 TKNKKFTYAEVLTMTNNFQKILGKGGFGIVYYGSVNGTEQVAVKMLSHSSAQGYKQFKAE 621
Query: 582 VILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDS-NADVLSWEGRLRIAT 640
V LL VHHKNL L GYC EG+++ LIYEYMANG L+E++S +L+W RL+IA
Sbjct: 622 VELLLRVHHKNLVGLVGYCEEGDKLALIYEYMANGDLDEHMSGKRGGSILNWGTRLKIAL 681
Query: 641 EAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAG 700
EAAQGLEYLH GCKP VHRD+K NILLN+ F +LADFGLS++FPIEG +H+ST VAG
Sbjct: 682 EAAQGLEYLHNGCKPLMVHRDVKTTNILLNEHFDTKLADFGLSRSFPIEGETHVSTVVAG 741
Query: 701 TFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDI 760
T GYLDPEY +T LTEKSDVYSFGVVLL +IT++P I E +HI++WV ML +GDI
Sbjct: 742 TIGYLDPEYYRTNWLTEKSDVYSFGVVLLVMITNQPVIDQNREKRHIAEWVGGMLTKGDI 801
Query: 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARKEGHR 820
K+I DP L GD + S WKAVE+AM C++ SS RP M++VV ELKECLA E++R+
Sbjct: 802 KSITDPNLLGDYNSGSVWKAVELAMSCMNPSSMTRPTMSQVVFELKECLASESSREVSMT 861
Query: 821 FGSGDQSGRMMTLNLTSELAPLAR 844
FG +E+AP+AR
Sbjct: 862 FG--------------TEVAPMAR 871
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 846 | ||||||
| 255549714 | 915 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.979 | 0.906 | 0.566 | 0.0 | |
| 255549706 | 886 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.994 | 0.949 | 0.548 | 0.0 | |
| 255549700 | 884 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.990 | 0.947 | 0.549 | 0.0 | |
| 255549716 | 892 | Nodulation receptor kinase precursor, pu | 0.969 | 0.919 | 0.557 | 0.0 | |
| 255549712 | 884 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.989 | 0.946 | 0.534 | 0.0 | |
| 255549708 | 883 | Nodulation receptor kinase precursor, pu | 0.982 | 0.941 | 0.526 | 0.0 | |
| 356522218 | 890 | PREDICTED: putative leucine-rich repeat | 0.992 | 0.943 | 0.534 | 0.0 | |
| 449448078 | 1804 | PREDICTED: uncharacterized protein LOC10 | 0.965 | 0.452 | 0.511 | 0.0 | |
| 449463629 | 877 | PREDICTED: putative leucine-rich repeat | 0.992 | 0.957 | 0.518 | 0.0 | |
| 449516792 | 877 | PREDICTED: putative leucine-rich repeat | 0.992 | 0.957 | 0.518 | 0.0 |
| >gi|255549714|ref|XP_002515908.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544813|gb|EEF46328.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 952 bits (2460), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/878 (56%), Positives = 618/878 (70%), Gaps = 49/878 (5%)
Query: 3 IFENFLFALLGGFALVALVHAQNQSG--------------------IKYISDTTFVDAGI 42
+ + + F LL AL+A+V AQ QSG I Y+SD F+D G
Sbjct: 32 MLKYYPFPLLSIIALLAVVQAQAQSGFISIDCGISENATYTDSTTSIDYVSDAAFIDTGK 91
Query: 43 SKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDVRYLIRASFAHGDYDGKGTVPE 102
SKS+A Y +++Q L N+RSF EG RNCY + L K +YLIRA F +G+YDG+ P
Sbjct: 92 SKSIAAEYTRYNINQQLQNVRSFAEGVRNCYKIGLKKGAKYLIRAEFLYGNYDGQNKAPI 151
Query: 103 FDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRPLPNN 162
FDL+LG +KWE+V N + II KEIIH+I+++ VCLVNTG+GTPF+S LE RP+ +
Sbjct: 152 FDLYLGSSKWETVDTINSTMIITKEIIHLINTSYIDVCLVNTGSGTPFMSKLELRPIRIS 211
Query: 163 TYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQWQQITTPRTIDEDRYND 222
Y T GSL F R DV S TN+ +RY DDVYDR W P + +W +I+T TID ND
Sbjct: 212 AYSTSLGSLARFSRSDVGSTTNRTLRYADDVYDRIWTPNHFFKWAEISTSETIDALAQND 271
Query: 223 YQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELEELQANQSRQFNISFNG 282
Y+ PSIVMR+A P N +EP+ + + ED+T +F +YMHFAE+ +L+AN+SRQFNIS NG
Sbjct: 272 YRPPSIVMRTAGIPANDNEPMTVSIDFEDTTFRFLVYMHFAEILKLEANESRQFNISLNG 331
Query: 283 NHLYGPVVPSYRHTTTAYTTSALTGEKLQFSIHKTENSTLPPILNAIEFYLVQDFSQSET 342
H +GP+ P Y +TTT ++ + L+G + +FSI+KTENSTLPP+LNAIE Y + D SQ ++
Sbjct: 332 EHWFGPLRPDYLYTTTVFSPTVLSGGQYEFSIYKTENSTLPPLLNAIEIYYILDLSQPQS 391
Query: 343 EQADVDAIMNIKSLYK-RKDWQGDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGLTG 401
Q DVDAI NIKS Y +++WQGDPCAPQA+LW GL CSY+ N PRI SLNLSS GLTG
Sbjct: 392 NQEDVDAITNIKSSYGIKRNWQGDPCAPQAYLWEGLNCSYSGNVMPRIISLNLSSSGLTG 451
Query: 402 GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKN 461
IP +S+LT +E LDLSNN LTG VP+FLS+L L VL LTGN L+G +P LVE+S+
Sbjct: 452 EIPSSISSLTSLESLDLSNNYLTGSVPDFLSQLPSLNVLILTGNRLSGSVPPSLVEKSEQ 511
Query: 462 GSLSLSV----DLCSSYPCKENNKKKNNFVFPVIASFASLLVVTLAISAIYWRHKRLRKD 517
L LSV +LC CK N+KKNN V PV+AS A +L++ A++AI + KR ++
Sbjct: 512 NLLVLSVGGNANLCLKSSCK--NEKKNNVVVPVVASIAGVLIIISALAAILYTRKRRKQQ 569
Query: 518 ----------GSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKML 567
G LE+K+R+FTY+EI ITN+FE +LG+G FG VYHGYLDD T+VAVK+L
Sbjct: 570 EEDTKTSNIYGPLESKERQFTYSEILNITNNFERVLGKGGFGTVYHGYLDD-TQVAVKIL 628
Query: 568 SPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNA 627
SP S QGY++F AEV LL VHH+NLT+L G+CNEG ++GLIYEYMANG LE LS N
Sbjct: 629 SPLSAQGYKEFHAEVKLLLRVHHRNLTSLVGFCNEGTKMGLIYEYMANGDLEHLLSGRNR 688
Query: 628 DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP 687
VL WE RL IA EAA+GLEYLH GCKPP VHRDIK ANILLNDQFQARLADFGLSK+FP
Sbjct: 689 HVLKWERRLDIAVEAAKGLEYLHNGCKPPIVHRDIKTANILLNDQFQARLADFGLSKSFP 748
Query: 688 IEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK-H 746
+EG +H+ST VAGT GYLDPEY T LTEKSDVYSFGVVLL+IIT RP IA +E H
Sbjct: 749 VEGGTHVSTVVAGTPGYLDPEYSMTNWLTEKSDVYSFGVVLLKIITGRPVIAVIDERSIH 808
Query: 747 ISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806
IS WV ++A GDIK ++DP L GD D+NS WKAVE+AM C S +S RP MN+VV EL
Sbjct: 809 ISHWVSSLVANGDIKTVIDPCLGGDFDINSVWKAVEVAMACTSPTSAGRPTMNQVVRELI 868
Query: 807 ECLAMETAR-KEGHRFGSGDQSGRMMTLNLTSELAPLA 843
E LA ETAR +EGH+ +S MMT E PLA
Sbjct: 869 ESLAEETARAEEGHK----TKSIVMMT-----ESTPLA 897
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549706|ref|XP_002515904.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544809|gb|EEF46324.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 946 bits (2446), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 485/884 (54%), Positives = 619/884 (70%), Gaps = 43/884 (4%)
Query: 3 IFENFLFALLGGFALVALVHAQNQSG--------------------IKYISDTTFVDAGI 42
I F G AL+ LVH Q+QSG + +ISD ++++ GI
Sbjct: 4 ILFQFFSKFFGVLALIVLVHCQDQSGFISLDCGLPGNTSYSDATTTLNFISDASYIEIGI 63
Query: 43 SKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDVRYLIRASFAHGDYDGKGTVPE 102
SKS+A + S+ +PLW +RSFP+G RNCYNV L KD YLIRA+F +G+YDG P
Sbjct: 64 SKSLAPEFSTNSIFRPLWYVRSFPQGSRNCYNVTLTKDTEYLIRATFMYGNYDGINQRPS 123
Query: 103 FDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRPLPNN 162
FDL+LGPNKW SV + N S + KEIIH VCLVNT +GTPFISALE RPL N
Sbjct: 124 FDLYLGPNKWVSVQILNGSIPVRKEIIHHPKRKYIHVCLVNTNSGTPFISALELRPLKNG 183
Query: 163 TYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQWQQITTPRTIDEDRYND 222
TY+++SGSL F R D+ SITNQ VRY DDVYDR W+P+ + +W I+T TID + N
Sbjct: 184 TYVSESGSLALFDRADISSITNQTVRYPDDVYDRRWSPFHFVEWTDISTTETIDLGKSNS 243
Query: 223 YQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELEELQANQSRQFNISFNG 282
YQLPS VMRSA TP+N S P+ + + ED T KFY Y HFAE+ +L ANQSR+FNI+ NG
Sbjct: 244 YQLPSTVMRSAGTPRNSSSPMEVTIAAEDPTLKFYAYFHFAEIVKLDANQSREFNITLNG 303
Query: 283 NHLYGPVVPSYRHTTTAYTTSALTGEKLQFSIHKTENSTLPPILNAIEFYLVQDFSQSET 342
+ YGP+ Y ++TT + A++G F I K STLPP+LNA+E Y + + Q ET
Sbjct: 304 DIWYGPITLHYLYSTTVSSGYAISGGTYDFQIFKVGGSTLPPLLNAVEVYYIVELLQLET 363
Query: 343 EQADVDAIMNIKSLYK-RKDWQGDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGLTG 401
+Q DV A++ IKS YK ++WQGDPCAPQ ++W GL C+Y+++ P I SL+LSS GLTG
Sbjct: 364 KQEDVYAMIKIKSTYKITRNWQGDPCAPQDYVWEGLKCNYSNSASPVIISLDLSSSGLTG 423
Query: 402 GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKN 461
+PP +NL +E LDLSNNSLTGPVP+FLS+L+ L+VL+LTGN LTG +P L +RS++
Sbjct: 424 DVPPVFANLKSLESLDLSNNSLTGPVPDFLSQLKSLKVLDLTGNKLTGIIPDDLFKRSQS 483
Query: 462 GSLSLSV----DLCSSYPCK---ENNKKKNNFVFPVIASFASLLVVTLAISAIYW---RH 511
G L LS +LC+S C + KK NNFV PV+AS A+LLV+ A++ I R
Sbjct: 484 GLLLLSFGGNPELCASVSCSNNNKKKKKNNNFVVPVVASIAALLVIVAALTIICCCRRRK 543
Query: 512 KRLRKDGSLETKK---------RRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEV 562
+++ ++ +TK+ RRFTY+E+ K+T +FE++LG G FG VY+GYL D EV
Sbjct: 544 QQVARNEEADTKETYEPREMRNRRFTYSEVLKLTKNFESVLGRGGFGTVYYGYLGD-IEV 602
Query: 563 AVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL 622
AVK+LS SS QGY++FEAEV LL VHHKNLTTL GYC+EG + LIYEYMANG+L ++L
Sbjct: 603 AVKVLSTSSVQGYKEFEAEVKLLLRVHHKNLTTLVGYCDEGGNMILIYEYMANGNLRQHL 662
Query: 623 SDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGL 682
S + D+LSWEGRL+IA E AQGLEYLH GCKPP VHRD+K ANILL+D+FQA+LADFGL
Sbjct: 663 SGEHPDILSWEGRLKIALETAQGLEYLHNGCKPPIVHRDVKTANILLDDKFQAKLADFGL 722
Query: 683 SKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTE 742
S+ FP EG +H+ST VAGT GYLDPEY LTEKSDVYSFGVVLLEIITSR I+ T
Sbjct: 723 SRMFPAEGGTHVSTIVAGTPGYLDPEYYVRNWLTEKSDVYSFGVVLLEIITSRSVISQTS 782
Query: 743 EHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVV 802
E H+SQWV ML +GDIKNIVD +L GD D N+AWKA E+AM CVS +ST RP+M++VV
Sbjct: 783 EKTHVSQWVKPMLERGDIKNIVDSRLCGDFDTNTAWKAAELAMACVSATSTERPSMSQVV 842
Query: 803 MELKECLAMETAR-KEGHRFGSGDQSGRMMTLN-LTSELAPLAR 844
MEL ECL E AR +EG+ + S +M++N L++ L+P +R
Sbjct: 843 MELSECLKTEMARTREGYCSAQSNSSAELMSVNVLSTVLSPRSR 886
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549700|ref|XP_002515901.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544806|gb|EEF46321.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 942 bits (2434), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 482/877 (54%), Positives = 613/877 (69%), Gaps = 39/877 (4%)
Query: 6 NFLFALLGGFALVALVHAQNQSG--------------------IKYISDTTFVDAGISKS 45
+FLF + L A V+AQ+QSG + YISD +F+D GI +
Sbjct: 9 DFLFRFIPVLFLTA-VYAQDQSGFISIDCGLPANSSYTDETTSLNYISDASFIDVGIITT 67
Query: 46 VALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDVRYLIRASFAHGDYDGKGTVPEFDL 105
+ S + ++RSFPEG RNC+NV+LAK+ +YLIRA FAHGDYDG +PEFDL
Sbjct: 68 ITPKVTTNSTDRQQLSVRSFPEGDRNCFNVELAKNTKYLIRAIFAHGDYDGSNELPEFDL 127
Query: 106 HLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRPLPNNTYI 165
HLGPNKW +V + N S ++KEIIH + N +CLVNT +G PFISALE RPL N TY+
Sbjct: 128 HLGPNKWVTVKILNASIPVIKEIIHTPTLNYIHICLVNTDSGMPFISALELRPLKNTTYV 187
Query: 166 TQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQWQQITTPRTIDEDRYNDYQL 225
QSG+L R+D+ S+TN+ VRY DDV+DR W P + +W ++TP T+D + D+Q
Sbjct: 188 AQSGALVKSTRLDLGSLTNKTVRYPDDVFDRIWTPDHFHKWTDLSTPDTVDAQNHIDFQP 247
Query: 226 PSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELEELQANQSRQFNISFNGNHL 285
PS+VMR+A P N SE + + +D+TS FY+YMHFAE+ ELQANQSR FNIS NG
Sbjct: 248 PSVVMRTANMPTNASENMEFYIDIDDTTSLFYVYMHFAEIVELQANQSRLFNISLNGTIW 307
Query: 286 YGPVVPSYRHTTTAYTTSALTGEKLQFSIHKTENSTLPPILNAIEFYLVQDFSQSETEQA 345
YGPV+P++ + T Y+ + G FS+ K E STLPP+LNAIE Y V D SQSET+Q
Sbjct: 308 YGPVIPNHLSSGTVYSQFPIIGGNNMFSLFKIEGSTLPPLLNAIEIYFVVDLSQSETDQD 367
Query: 346 DVDAIMNIKSLYK-RKDWQGDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGLTGGIP 404
DVDAIM IKS Y K+WQGDPCAPQA++W+GL CSY+D+DPP + SLNLSS GL G I
Sbjct: 368 DVDAIMKIKSTYGITKNWQGDPCAPQAYVWHGLNCSYSDDDPPTVKSLNLSSSGLRGEIV 427
Query: 405 PYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464
++NL +E LDLSNNSL+G +P+FLS++ L+VLNLTGN LTG +PA L ERS+ GSL
Sbjct: 428 SEIANLRSLELLDLSNNSLSGSLPDFLSRMTSLKVLNLTGNKLTGTIPADLFERSQQGSL 487
Query: 465 SLSV----DLCSSYPCKENNKKKNNFVFPVIASFASLLVVTLAISAIYWRHKRLRKDGS- 519
LSV +LC S C + K V + +F L + I ++ + + + +
Sbjct: 488 LLSVSGNPELCPSVSCTKKKKSVVVPVVASVVAFFILAAALVVILRYFFVRSQAKTNEAK 547
Query: 520 ----------LETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSP 569
+E+KKR+F+Y+EI KITN+F+ ILG+G FG VYHG L+D T+VAVK+LS
Sbjct: 548 ISYETNDEPLVESKKRQFSYSEILKITNNFDKILGKGGFGTVYHGTLNDGTQVAVKVLSL 607
Query: 570 SSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADV 629
SS QGY++F+AEV LL VHH+NLTTL GYCNEG +GLIYEYMANG+LE+YLSDS +
Sbjct: 608 SSAQGYKEFQAEVKLLLRVHHRNLTTLVGYCNEGTNLGLIYEYMANGNLEDYLSDSCLNT 667
Query: 630 LSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689
LSWE RLRIATEAAQGLEYLH GCKP VHRD+K NILLND+FQA+LADFGLS+ FP++
Sbjct: 668 LSWEIRLRIATEAAQGLEYLHNGCKPQIVHRDVKTTNILLNDKFQAKLADFGLSRIFPVD 727
Query: 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ 749
G +H+ST VAGT GYLDPEY LT+KSDV+SFGVVLLEIIT RPAIA T E HISQ
Sbjct: 728 GSTHISTVVAGTPGYLDPEYYVNNWLTDKSDVFSFGVVLLEIITGRPAIAQTRERTHISQ 787
Query: 750 WVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809
WV ML +GDI IVDP+L+GD ++NS WKA E+AMGCVS SS RP MN+ V+EL +CL
Sbjct: 788 WVSSMLEKGDIHGIVDPRLNGDFEINSVWKAAELAMGCVSASSARRPTMNQAVVELNDCL 847
Query: 810 AMETAR-KEGHRFGSGDQSG-RMMTLNLTSELAPLAR 844
+E R +EG S + + +MT+N+ +E +PLAR
Sbjct: 848 NIEMGRTREGQSSQSFNSNSIELMTVNVHTEASPLAR 884
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549716|ref|XP_002515909.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223544814|gb|EEF46329.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 935 bits (2417), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 491/881 (55%), Positives = 610/881 (69%), Gaps = 61/881 (6%)
Query: 19 ALVHAQNQSG--------------------IKYISDTTFVDAGISKSVALAYQLESLHQP 58
+VH Q+QSG + Y SD +F+D GISKS+A + ++L +
Sbjct: 18 CMVHGQDQSGFISLDCGLPANTTYTDETTSLNYNSDASFIDTGISKSLAPGFTTDNLRRQ 77
Query: 59 LWNLRSFPEGKRNCYNVKLAKDVRYLIRASFAHGDYDGKGTVPEFDLHLGPNKWESVILG 118
LW +RSFPEG RNCYN+ LAKD YLIRA+F +G+YDG +PEFDLH+GPNKW SV +
Sbjct: 78 LWYIRSFPEGDRNCYNLTLAKDTEYLIRATFMYGNYDGLNQLPEFDLHIGPNKWVSVKIL 137
Query: 119 NVSTIIVKEIIHVISSNSTR---VCLVNTGAGTPFISALEFRPLPNNTYITQSGSLNT-- 173
N ST + +EII I S ++ VCLV GTPFISALE RPL N TY+T+SGSL
Sbjct: 138 NASTSVTEEII--IGSPKSKYIHVCLVTKDTGTPFISALETRPLKNGTYVTESGSLGLAL 195
Query: 174 FIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQWQQITTPRTIDEDRYNDYQLPSIVMRSA 233
F R DV S+ N++VRY +DVYDR W PY + + I+T T+D D +ND+Q PSIVMRSA
Sbjct: 196 FTREDVGSLNNRIVRYPNDVYDRRWFPYHFKRGTDISTTLTVDLDDHNDFQPPSIVMRSA 255
Query: 234 ATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELEELQANQSRQFNISFNGNHLYGPVVPSY 293
N S PL ++ D+T K Y YMHFAE+ +L+ANQSRQFNIS NG YGPV P+Y
Sbjct: 256 VISINTSSPLEF-YINNDTTYKLYAYMHFAEIVKLEANQSRQFNISLNGKIWYGPVTPTY 314
Query: 294 RHTTTAYTTSALTGEKLQFSIHKTENSTLPPILNAIEFYLVQDFSQSETEQADVDAIMNI 353
+TTT Y+TSA+T +FS+ K E S LPP+LNAIE Y V D Q ET Q DV IMNI
Sbjct: 315 LYTTTVYSTSAITDGMYEFSLSKVEGSALPPLLNAIELYYVVDLLQPETNQRDVIGIMNI 374
Query: 354 KSLYK--RKDWQGDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLT 411
KS Y+ R +WQGDPCAP+ F+W GL C YN P I SLNLSS GL G I P ++NL
Sbjct: 375 KSTYRISRTNWQGDPCAPEDFVWEGLSCKYNVTSSPVIISLNLSSSGLHGEIAPDIANLK 434
Query: 412 MIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVD-- 469
+E LDLSNN+LT VP+FLS+LQ L+ LNLTGN L G +P L++R+ +G L+LSVD
Sbjct: 435 SLEILDLSNNNLTALVPDFLSQLQSLKFLNLTGNRLNGTIPDDLLKRADSG-LTLSVDGN 493
Query: 470 --LCSSYPCKENNKKKNN--FVFPVIASFASLLVVTLAISAIYWRHKRLRKDGS------ 519
LC S C + KKK N F+ PV+AS A+LLV+ + ++ I W KR ++ G+
Sbjct: 494 PELCKSVSCNKKKKKKKNTDFIVPVVASVAALLVIIVVLTTI-WYLKRRKQKGTYLHKYI 552
Query: 520 ---------------LETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEVAV 564
LE KR+FTY+++ KITN+F ++LG G FG VYHGYLDD EVAV
Sbjct: 553 LAGRTEAEAKKTHEPLELNKRQFTYSDVLKITNNFGSVLGRGGFGTVYHGYLDD-VEVAV 611
Query: 565 KMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSD 624
KMLSPSS QGY++F AEV LL VHHKNLTTL GYC+EGN +GLIYEYMANG+L+ +LS
Sbjct: 612 KMLSPSSVQGYKEFHAEVRLLLRVHHKNLTTLVGYCDEGNNMGLIYEYMANGNLKHHLSG 671
Query: 625 SN-ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLS 683
+ +LSWEGRL+IA EAAQGL+YLH GCKPP VHRD+K NILLND+FQA+LADFGLS
Sbjct: 672 CDHPSILSWEGRLQIALEAAQGLDYLHNGCKPPIVHRDVKTTNILLNDRFQAKLADFGLS 731
Query: 684 KTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE 743
+TFP+E SH+ST VAGT GYLDP+Y T LTEKSDVYS+GVVLLEIITSRP IA T +
Sbjct: 732 RTFPVEDGSHVSTVVAGTPGYLDPDYYVTNWLTEKSDVYSYGVVLLEIITSRPVIARTRD 791
Query: 744 HKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803
H+SQWV ML +GDIKNIVDP+L GD D NS WK E+AM C+S +S RP+M++VVM
Sbjct: 792 KTHVSQWVKAMLDKGDIKNIVDPRLRGDFDNNSVWKVTELAMACLSTTSGERPSMSQVVM 851
Query: 804 ELKECLAMETARKEGHRFGSGDQSGRMMTLNLTSELAPLAR 844
EL +CL E AR R S +++L+L + ++PLAR
Sbjct: 852 ELNDCLTTEMARAREGRSTQSSSSVEVISLHLHTGVSPLAR 892
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549712|ref|XP_002515907.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544812|gb|EEF46327.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 905 bits (2339), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/882 (53%), Positives = 599/882 (67%), Gaps = 45/882 (5%)
Query: 4 FENFLFALLGGFALVALVHAQNQSG--------------------IKYISDTTFVDAGIS 43
NFLF L AL LVH Q+QSG + Y+SD F+D GI
Sbjct: 7 LSNFLFRFLPILALAILVHCQDQSGFISIDCGLPANSSYTDATTGLNYVSDAAFIDTGII 66
Query: 44 KSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDVRYLIRASFAHGDYDGKGTVPEF 103
++A S+ + ++RSFPEG RNCY V+L + +YLIRA F + +YDG +P F
Sbjct: 67 NNLAPGLNTSSIDRQQLSVRSFPEGDRNCYQVELTRGTKYLIRAIFLYRNYDGLSKLPHF 126
Query: 104 DLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRPLPNNT 163
DLHLGPNKW +V + N + ++ EII+ N VCLVNTG GTPFISALE RPL N T
Sbjct: 127 DLHLGPNKWITVKILNATIPVITEIIYTPILNYIHVCLVNTGLGTPFISALELRPLKNTT 186
Query: 164 Y-ITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQWQQITTPRTIDEDRYND 222
Y I G+L F R+D S+TN+ VRY DDVYDR W P Y +W ++TP TID +ND
Sbjct: 187 YEIRSEGALAKFARLDFGSVTNKTVRYPDDVYDRIWTPDHYYKWTDLSTPETIDAQFHND 246
Query: 223 YQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELEELQANQSRQFNISFNG 282
+Q PSIVM +A P N SE + + +ED++ +FY YMHFAE+ +L+ANQSRQFNIS NG
Sbjct: 247 FQPPSIVMSTANVPTNASEDMQFFIDNEDTSLQFYFYMHFAEIVKLEANQSRQFNISLNG 306
Query: 283 NHLYGPVVPSYRHTTTAYTTSALTGEKLQFSIHKTENSTLPPILNAIEFYLVQDFSQSET 342
+GPV+P Y +T++ Y + FS+ K STLPP+LNAIE Y D SQS+T
Sbjct: 307 TIFFGPVIPDYLYTSSVYNGLPINAGSNVFSLFKIGGSTLPPLLNAIEIYFFVDLSQSQT 366
Query: 343 EQADVDAIMNIKSLYK-RKDWQGDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGLTG 401
+Q DVDAI IKS Y ++WQGD CAPQA++W GL CSY+DNDPP+ITSLNLSS GLTG
Sbjct: 367 DQDDVDAITKIKSTYGITRNWQGDACAPQAYVWQGLNCSYSDNDPPKITSLNLSSSGLTG 426
Query: 402 GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKN 461
I ++NL +E LDLSNNSL+GPVP+FLS++ L+VLNLTGN LTG +P L ER++
Sbjct: 427 EIVSDIANLKSLEFLDLSNNSLSGPVPDFLSQMPSLKVLNLTGNKLTGRIPVDLFERTQK 486
Query: 462 GSLSLSV----DLCSSYPCKENNKKKNNFVFPVIASFASLLVVTLAISAIYWRHKRLRK- 516
GSL LSV +LC S CK KK+ + PV+AS AS+ ++ A+ A+ R++ LR
Sbjct: 487 GSLLLSVSGNPELCPSVSCK---KKEKSIAVPVVASVASVFILAAAV-AVILRYRILRSV 542
Query: 517 ------------DGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEVAV 564
+ +E K ++FTY+E+ KITN+FE +LG+G FG VY+G L D T+VAV
Sbjct: 543 SETGETKLSHESNEPMELKNKQFTYSEVLKITNNFEKVLGKGGFGTVYYGTLADGTQVAV 602
Query: 565 KMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSD 624
K+LS SS QGY++F AEV LL VHH+NLTTL G C EG +GLIYEYMANG+LE+YLS
Sbjct: 603 KILSQSSVQGYKEFLAEVKLLMRVHHRNLTTLVGCCIEGTNMGLIYEYMANGNLEDYLSG 662
Query: 625 SNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSK 684
SN + LSWE RLRIA EA QGLEYLH GCK P VHRD+K NILLND+FQA+++DFGLS+
Sbjct: 663 SNLNTLSWEARLRIALEAGQGLEYLHGGCKLPIVHRDVKTTNILLNDKFQAKISDFGLSR 722
Query: 685 TFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEH 744
FP +G +H+ST VAGT GYLDPEY T LT+KSDVYSFGVVLLEIIT RP IA H
Sbjct: 723 IFPADGGTHVSTIVAGTPGYLDPEYYVTNWLTDKSDVYSFGVVLLEIITCRPVIAQNRNH 782
Query: 745 K--HISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVV 802
+ HISQWV M+ GD+ +I DP+L+G+ +VNS WK VE+AM C+S +S RP MN+VV
Sbjct: 783 ENSHISQWVSSMIENGDVNSIADPRLNGEYEVNSVWKIVELAMECLSTTSARRPTMNQVV 842
Query: 803 MELKECLAMETARKEGHRFGSGDQSGRMMTLNLTSELAPLAR 844
+EL ECL E AR + S ++T+N+ +E +PLAR
Sbjct: 843 IELNECLKTEMARTREGQSTQSYYSIELVTVNVDTESSPLAR 884
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549708|ref|XP_002515905.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223544810|gb|EEF46325.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 900 bits (2325), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/896 (52%), Positives = 599/896 (66%), Gaps = 65/896 (7%)
Query: 1 MEIFENFLFALLGGFALVALVHAQNQSG--------------------IKYISDTTFVDA 40
M +F F F L A+ LVH Q+QSG +KYISD F++
Sbjct: 1 MVLFCPFFFKFLCILAVRVLVHGQDQSGFISLDCGLQANSSYTDEKTGLKYISDAAFIET 60
Query: 41 GISKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDVRYLIRASFAHGDYDGKGTV 100
G++KS+A + L S +Q L +RSFP+G RNCY V+L K+ RYLIRA+F + +YDG +
Sbjct: 61 GVTKSIAPEF-LGSFNQQLRQVRSFPKGDRNCYKVELVKNTRYLIRATFLYANYDGLNKL 119
Query: 101 PEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRPLP 160
P FDLH+GPNKW +V + N +KEIIH + N+ VCLV TG TPFISALE RPL
Sbjct: 120 PAFDLHIGPNKWVNVQITNPLIYPIKEIIHAPTFNNIYVCLVRTGPWTPFISALEIRPLH 179
Query: 161 NNTYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQWQQITTPRTIDEDRY 220
N+TY+ QSGSL+ F R+DV S+TNQ +RY DDVYDR W P+ + + I+T I
Sbjct: 180 NSTYVAQSGSLSLFNRVDVGSLTNQTIRYPDDVYDRMWLPFHFDKGTDISTKENITSG-I 238
Query: 221 NDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELEELQANQSRQFNISF 280
+ +QLPS VM SA P N SE +++++ +D+T + Y+Y+HFAE+ L+ NQSR+FNIS
Sbjct: 239 DYFQLPSTVMNSATVPLNASEQIILNIDTQDNTFQAYVYIHFAEIVRLEPNQSRRFNISL 298
Query: 281 NGNHLYGPVVPSYRHTTTAYTTSALTGEKLQFSIHKTENSTLPPILNAIEFYLVQDFSQS 340
NG LYGPV P + TT Y+ SA+ G K FS + STLPP+LNA+E Y V D S
Sbjct: 299 NGKILYGPVTPKHLEATTVYSQSAIPGGKFLFSFYGVGGSTLPPLLNALELYSVVDLLHS 358
Query: 341 ETEQADVDAIMNIKSLYK-RKDWQGDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGL 399
ET Q DV+AI IKS Y ++WQGDPC+PQ + W+GL C+Y++ P ITSL+ SS GL
Sbjct: 359 ETNQVDVNAITKIKSTYGITRNWQGDPCSPQDYKWDGLNCTYSNTASPVITSLDFSSSGL 418
Query: 400 TGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERS 459
TG I P +SNL +E LDLSNNSLTGPVP+FLS+L L+ LNL GN LTG +PA L R
Sbjct: 419 TGEIDPDISNLKWLETLDLSNNSLTGPVPDFLSQLP-LKSLNLAGNNLTGTIPADLFNRW 477
Query: 460 KNGSLSLSV----DLCSSYPCKENNKKKNNFVFPVIASFASLLVVTLAISAIYWRHKRLR 515
++ L LSV LC+S C +NKK N PVI S +L V+ + I WR K+ +
Sbjct: 478 QSDLLFLSVSGNPQLCASVSCNSDNKK--NITVPVIISVTALFVIIAGSAIILWRLKKRK 535
Query: 516 KDGS-------------------------LETKKRRFTYAEITKITNDFETILGEGSFGK 550
+ G+ LE +KR+ Y EI +ITN+F+ ILG+G FG
Sbjct: 536 QQGTVPNGFCWVMIWPVVGKMEAEAKREPLELQKRQLRYFEIVQITNNFQRILGKGGFGT 595
Query: 551 VYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610
VYHG+LDD EVAVKMLSPSS QGY++F+ EV LL VHH+NLT+L GYC+EGN++ LIY
Sbjct: 596 VYHGHLDD-MEVAVKMLSPSSAQGYKEFQTEVKLLLRVHHRNLTSLVGYCDEGNKMALIY 654
Query: 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN 670
EYMANG+L + LSD N + LSWE RLRIA EAAQGLEYLH GCKPP +HRD+KP NILLN
Sbjct: 655 EYMANGNLRDNLSDGNGNFLSWEERLRIALEAAQGLEYLHNGCKPPIIHRDVKPTNILLN 714
Query: 671 DQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLE 730
++FQA+LADFGLS+ P+EG SH+ST VAGT GYLDPEY T LTEKSDV+SFGVVLLE
Sbjct: 715 NKFQAKLADFGLSRICPVEGGSHVSTIVAGTPGYLDPEYYATNWLTEKSDVFSFGVVLLE 774
Query: 731 IITSRPAIANTEEHK--HISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCV 788
IITS P I+ T + H+SQW M+ +GDI++IVDP+L D D+NS WK VE+AM CV
Sbjct: 775 IITSGPVISKTRDGDTTHLSQWFSSMVEKGDIQSIVDPRLGDDFDINSLWKVVELAMACV 834
Query: 789 SHSSTPRPNMNRVVMELKECLAMETARKEGHRFGSGDQSGRMMTLNLTSELAPLAR 844
S +S RP MN+VV+EL ECLA ET + EG S + + L +EL PLAR
Sbjct: 835 SATSAQRPTMNQVVIELSECLATETVKTEG-------TSSQSYSTVLHTELTPLAR 883
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356522218|ref|XP_003529744.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 899 bits (2323), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 478/894 (53%), Positives = 598/894 (66%), Gaps = 54/894 (6%)
Query: 1 MEIFENFLFALLGGFALVALVHAQNQSG--------------------IKYISDTTFVDA 40
M + FL+AL G V LV AQ+QSG I YISD F+DA
Sbjct: 1 MGMLLQFLYALFGVLTAVVLVQAQDQSGFTSIDCGLPEASSYNEKTTGIFYISDAKFIDA 60
Query: 41 GISKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDVRYLIRASFAHGDYDGKGTV 100
G+SKS++ A + L Q L +RSFP G+RNCY + + +YLIRA+F +G+YDG
Sbjct: 61 GVSKSISPAQKSTHLQQ-LAYVRSFPSGERNCYRINVTSGTKYLIRATFFYGNYDGLNQP 119
Query: 101 PEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRPLP 160
P+FDLHLG N W++V N S + EIIH S + + CLVNTG GTPFISA+E R L
Sbjct: 120 PQFDLHLGANIWDTVNFPNASLSEISEIIHTPSLDYIQPCLVNTGKGTPFISAIELRTLN 179
Query: 161 NNTYITQSG-SLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQWQQITTPRTIDEDR 219
N Y+T S SL + R D+ SITN RY DVYDR W P+ QW Q+++ + +
Sbjct: 180 NAFYVTASAESLAYYQRYDLGSITNLGYRYNYDVYDRIWVPHGLNQWTQLSSTLHLLDIF 239
Query: 220 YNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELEELQANQSRQFNIS 279
NDY+LP +VM +AATP N S P ++ KFY+YMHF+E+E L N++R FNI
Sbjct: 240 QNDYKLPEVVMSTAATPINASAPFQFYWGPDNVDDKFYIYMHFSEVEILAENETRTFNIF 299
Query: 280 FNGNHLYGPVVPSYRHTTTAYTTSALTGE-KLQFSIHKTENSTLPPILNAIEFYLVQDFS 338
NG YGP+ P Y T T Y SALTG + FS+ KT STLPPI+NA+E Y V DF
Sbjct: 300 MNGKLFYGPLTPGYLTTNTIYAKSALTGATRYLFSLAKTGTSTLPPIINAMEIYKVIDFP 359
Query: 339 QSETEQADVDAIMNIKSLYK-RKDWQGDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSR 397
QSETEQ DVDAI NIK+ Y ++WQGDPC P A++W GL CSY++ PRITSLNLSS
Sbjct: 360 QSETEQDDVDAITNIKNAYGVDRNWQGDPCGPVAYIWEGLNCSYDNT--PRITSLNLSSS 417
Query: 398 GLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVE 457
GLTG I ++S LTM+++LDLSNNSL+G +P+FL++LQ L+VLNL N LTGP+P GLVE
Sbjct: 418 GLTGQISSFISELTMLQYLDLSNNSLSGSLPDFLTQLQSLKVLNLVNNNLTGPVPGGLVE 477
Query: 458 RSKNGSLSLSV----DLCSSYPC--KENNKKKNN---------FVFPVIASFASLLV-VT 501
RSK GSLSLS+ +LC S PC + NNK+ + V P S A +LV V
Sbjct: 478 RSKEGSLSLSLGQNPNLCESDPCIQQSNNKQPDAANQNKNKNNIVIPAATSVAGILVLVI 537
Query: 502 LAISAIYWRHKRLRKDGS---------LETKKRRFTYAEITKITNDFETILGEGSFGKVY 552
+ ++AI K+ + G +K+R++++ E+ KIT+DF ILG G+FGKVY
Sbjct: 538 IVVTAIICGLKKRKPQGKATNTPSGSQFASKQRQYSFNELVKITDDFTRILGRGAFGKVY 597
Query: 553 HGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612
HG +DD T+VAVKMLSPS+ +GYEQF AEV LL VHH+NLT+L GYCNE N +GLIYEY
Sbjct: 598 HGIIDD-TQVAVKMLSPSAVRGYEQFLAEVKLLMRVHHRNLTSLVGYCNEENNMGLIYEY 656
Query: 613 MANGSLEEYLS--DSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN 670
MANG+L+E LS S A L+WE RL+IA +AAQGLEYLH GCKPP +HRD+K ANILLN
Sbjct: 657 MANGNLDEILSGKSSRAKFLTWEDRLQIALDAAQGLEYLHNGCKPPIIHRDVKCANILLN 716
Query: 671 DQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLE 730
+ FQA+LADFGLSK+FP +G S++ST VAGT GYLDPEY + RLTEKSDVYSFGVVLLE
Sbjct: 717 ENFQAKLADFGLSKSFPTDGGSYMSTVVAGTPGYLDPEYSISSRLTEKSDVYSFGVVLLE 776
Query: 731 IITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSH 790
++T +PAIA T E HISQWV FML GDIKNI D +L D D +S W+ VEI M VS
Sbjct: 777 MVTGKPAIAKTPEKTHISQWVKFMLPNGDIKNIADSRLQEDFDTSSVWRVVEIGMASVSI 836
Query: 791 SSTPRPNMNRVVMELKECLAMETARKEGHRFGSGDQSGRMMTLNLTSELAPLAR 844
S RP+M+ +V ELKECL E ARK R + S ++TLN T+EL P AR
Sbjct: 837 SPVKRPSMSNIVNELKECLTTELARKYSGRDTENNDSIELVTLNFTTELGPPAR 890
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449448078|ref|XP_004141793.1| PREDICTED: uncharacterized protein LOC101206211 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 880 bits (2275), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/876 (51%), Positives = 600/876 (68%), Gaps = 59/876 (6%)
Query: 21 VHAQNQSG--------------------IKYISDTTFVDAGISKSVALAYQLESLHQPLW 60
V AQ+QSG I Y+SD ++++G+S SVA Y + Q +
Sbjct: 936 VQAQDQSGFISLDCGTPEGTSYTETTTTIDYVSDAPYINSGVSGSVASVYG-NTFQQQMR 994
Query: 61 NLRSFPEGKRNCYNVKLAKDVRYLIRASFAHGDYDGKGTVPEFDLHLGPNKWESVILGNV 120
LRSFP+G RNCYNV + KD +YLIRASF +G+YDG ++P FDL++G + WE++ + V
Sbjct: 995 KLRSFPQGIRNCYNVSVKKDTKYLIRASFLYGNYDGLNSLPMFDLYIGNSLWETINVTKV 1054
Query: 121 STIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRPLPNNTYITQSGSLNTFIRMDVL 180
T ++K++IH+ SSN +CL+NTG G PFISALEFRPL N TY T +GSL+ R+DV
Sbjct: 1055 GTNVLKDLIHITSSNKVHICLINTGNGVPFISALEFRPLLNVTYQTAAGSLSLDYRLDVG 1114
Query: 181 SITNQVVRYRDDVYDRSWAPYAYPQWQQITTPRTIDEDRYNDYQLPSIVMRSAATPKNKS 240
S NQ R+ DVYDR WAP+ + +W Q++T RT+DE +N++Q PSIVM++A++ N S
Sbjct: 1115 STGNQTYRFPFDVYDRMWAPFNFKEWTQVSTNRTVDETDHNNHQPPSIVMQTASSRLNAS 1174
Query: 241 EPLLIDLVHEDSTSKFYMYMHFAELEELQANQSRQFNISFNGNHLYGPVVPSYRHTTTAY 300
+PL I EDS S++Y ++H AE+EEL+ NQSR FNI NG+ YGPV+PSY T T +
Sbjct: 1175 DPLEIWWDTEDS-SEYYAFIHVAEVEELRGNQSRGFNIMHNGDLFYGPVIPSYLSTLTIF 1233
Query: 301 TTSAL-TGEKLQFSIHKTENSTLPPILNAIEFYLVQDFSQSETEQADVDAIMNIKSLYK- 358
L ++ FS EN+TLPPI+NA E Y+V+D S+ E ++ DV+AI NIKS Y
Sbjct: 1234 GNKPLDAADRHTFSFTPIENATLPPIVNAFEVYIVKDISELEADKGDVEAITNIKSTYGV 1293
Query: 359 RKDWQGDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDL 418
+KDWQ DPC P + W+GL CS + PRI SLNLS+ GL G I Y+S+LTM++ LDL
Sbjct: 1294 KKDWQADPCMPMGYPWSGLNCS--NEAAPRIISLNLSASGLNGEISSYISSLTMLQTLDL 1351
Query: 419 SNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSV------DLCS 472
SNN+LTG VP+FLS L +L+ LNL N L+GP+PA L++RS +GSLSLSV + C+
Sbjct: 1352 SNNNLTGHVPDFLSSLSHLKTLNLGNNKLSGPIPAELLKRSNDGSLSLSVGGNQNLEGCA 1411
Query: 473 SYPCKENNKKKNNFVFPVIASFASLLVVTLAISAIYWRHKRLRKD--------------- 517
S PC +N +KKNN + P++AS LVV ++ +W K +K
Sbjct: 1412 SDPCPKNEEKKNNIIIPIVASIGGFLVVVTIVAITFWIIKSRKKQQGKNVVSVVDKSGTN 1471
Query: 518 ----GSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQ 573
SLE + R+FTY+E+ K+TN+F+ +LG+G FG+VY+G +D+ EVAVKMLS SS Q
Sbjct: 1472 SPLGTSLEVRSRQFTYSEVVKMTNNFKKVLGKGGFGEVYYGVIDE-IEVAVKMLSLSSSQ 1530
Query: 574 GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWE 633
GY QF+AEV LL VHH+NLT+L GY NE N +GLIYEYMANG L E+LS+ + ++SWE
Sbjct: 1531 GYRQFQAEVTLLMRVHHRNLTSLVGYLNEENHLGLIYEYMANGDLAEHLSERSVRIISWE 1590
Query: 634 GRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693
RLRIA +AAQGLEYLH GCKPP VHRD+K NILL D FQ +LADFGLSK+FP +G +H
Sbjct: 1591 DRLRIAMDAAQGLEYLHYGCKPPIVHRDVKTTNILLTDNFQGKLADFGLSKSFPTDGNTH 1650
Query: 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDF 753
+ST VAGT GYLDPEY + RLTEKSDVYSFG+ LLEII+ +P I+ T + HI++WV
Sbjct: 1651 MSTVVAGTPGYLDPEYYVSNRLTEKSDVYSFGIALLEIISCKPVISRTGDTPHIAKWVTS 1710
Query: 754 MLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMET 813
+LA GDI++IVDP+L G + NS WK VE+AM CV+ +S+ RP M+ VV ELK+CLA T
Sbjct: 1711 LLALGDIQSIVDPRLEGQYERNSVWKTVEVAMACVAANSSRRPTMSDVVAELKDCLA--T 1768
Query: 814 ARKEGHRFGSGDQSG----RMMTLNL-TSELAPLAR 844
A H GS + + R +++ + S+ +P+AR
Sbjct: 1769 ALSRNHENGSLESTNFGERRSISIGINASDSSPVAR 1804
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463629|ref|XP_004149534.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 877 bits (2265), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/881 (51%), Positives = 605/881 (68%), Gaps = 41/881 (4%)
Query: 1 MEIFENFLFALLGGFALVALVHAQNQSG--------------------IKYISDTTFVDA 40
ME + FL + A+ LV AQ+QSG IKYISD F +
Sbjct: 1 MEQIKYFLLQIFVVLAISFLVSAQDQSGFISIDCGISGNSSYKDSVTNIKYISDVNFTET 60
Query: 41 GISKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLA--KDVRYLIRASFAHGDYDGKG 98
GISKS++ + +L Q W +RSFPEG+RNCY +KLA K +YLIRASF +G YDG+G
Sbjct: 61 GISKSISSDFNTTTLPQQFWYVRSFPEGERNCYTIKLAQGKGFKYLIRASFMYGSYDGQG 120
Query: 99 TVPEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRP 158
T P FDL++G NKW +V++GN S II+KE++HV+ ++S +CLVNTG G+PFISALE R
Sbjct: 121 TAPVFDLYMGVNKWGTVVMGNESNIIIKEVVHVLPTSSICICLVNTGFGSPFISALELRL 180
Query: 159 LPNNTYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQWQQITTPRTIDED 218
L N +Y+T L R+DV S N+ VRY DD+ DR W PY + ++ + T T+D
Sbjct: 181 LKNASYVTDFDLLALHRRLDVGSTINRTVRYNDDISDRIWVPYNFLNYKIMNTSSTVDSG 240
Query: 219 RYNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELEELQANQSRQFNI 278
N Y LP IVM +A T N S+PL V ED ++++++++HFA+LE+LQANQ R+FNI
Sbjct: 241 GSNSYNLPGIVMSTAITTYNASDPLEFHWVPEDPSARYHIFLHFADLEKLQANQLREFNI 300
Query: 279 SFNGNHLYGPVVPSYRHTTTAYTTSALTGEKLQFSIHKTENSTLPPILNAIEFYLVQDFS 338
NGN+ +GP P Y +TT +TS ++GE + FS+ KT S LPPILNA+E YLV D
Sbjct: 301 YQNGNYFHGPFSPDYLQSTTLSSTSPMSGENIAFSLLKTNASNLPPILNALEIYLVLDTL 360
Query: 339 QSETEQADVDAIMNIKSLYK-RKDWQGDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSR 397
QS T++ D+ A+MNIKS Y RK+WQGDPC P++FLW+GL CSY+D P RIT+LNLSS
Sbjct: 361 QSRTDEQDITALMNIKSFYGVRKNWQGDPCQPKSFLWDGLICSYDDQIPNRITTLNLSSS 420
Query: 398 GLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVE 457
GL G I Y+S LT +++LDLSNN+L+GPVP+ LSKLQ L+VL+L N L G +P+ LVE
Sbjct: 421 GLVGEITTYVSELTTLQYLDLSNNNLSGPVPDSLSKLQSLKVLDLRDNPLLGSIPSELVE 480
Query: 458 RSKNGSLSLSV------DLCSSYPCKENNKKKNNFVFPVIASFASLLVVTLAISAIYWRH 511
RSKNGSLS+ V DLC+S C + K + +++SF LL T ++ I WR
Sbjct: 481 RSKNGSLSIRVGAGGNTDLCASSSCPKKKKSYVIMIVAIVSSFLVLLAAT-SVLIILWR- 538
Query: 512 KRLRKD-----GSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKM 566
KR RK G+LE KK++ +Y+EI +ITN+FE +GEG F KV+ G LDD ++VAVK+
Sbjct: 539 KRARKQPVIRLGTLEEKKQQLSYSEIRRITNNFERQIGEGGFAKVFLGNLDD-SQVAVKV 597
Query: 567 LSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSN 626
L SS QGY++FEAEV LL +HH+NLT+L GYC + + LIYEY+ NG+L+E+LS S
Sbjct: 598 LK-SSVQGYKEFEAEVKLLLRIHHRNLTSLVGYCCQKTNLVLIYEYINNGNLKEHLSGSK 656
Query: 627 ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF 686
VLSWE R+++A +AQGLEYLH GC+PP VHRD+K ANILLN++FQA++ADFGLSK+F
Sbjct: 657 GSVLSWEERMQVAVNSAQGLEYLHHGCRPPIVHRDVKSANILLNERFQAKIADFGLSKSF 716
Query: 687 PIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIA---NTEE 743
P E +H++T VAGT GYLDPEY T LTEKSDVYSFGV++LEI+TSRP + + +
Sbjct: 717 PTESRTHMTTVVAGTDGYLDPEYYATGWLTEKSDVYSFGVLVLEIVTSRPVLMIDRASSQ 776
Query: 744 HKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803
HISQWV ++ GDI++IVD K+ + D++SAWKAVEIAM C+S +S RPNM VV
Sbjct: 777 KYHISQWVMQLMKIGDIRSIVDQKVRENFDLSSAWKAVEIAMKCLSLNSIDRPNMKEVVS 836
Query: 804 ELKECLAMETARKEGHRFGSGDQSGRMMTLNLTSELAPLAR 844
EL ECLA+E ARK + +S + SE+ P AR
Sbjct: 837 ELSECLALEKARKRKNADTDMRKSNPVSRNFRESEVTPFAR 877
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449516792|ref|XP_004165430.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 875 bits (2262), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/881 (51%), Positives = 605/881 (68%), Gaps = 41/881 (4%)
Query: 1 MEIFENFLFALLGGFALVALVHAQNQSG--------------------IKYISDTTFVDA 40
ME + FL + A+ LV AQ+QSG IKYISD F +
Sbjct: 1 MEQIKYFLLQIFVVLAISFLVSAQDQSGFISIDCGISGNSSYKDSVTNIKYISDVNFTET 60
Query: 41 GISKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLA--KDVRYLIRASFAHGDYDGKG 98
GISKS++ + +L Q W +RSFPEG+RNCY +KLA K +YLIRASF +G YDG+G
Sbjct: 61 GISKSISSDFNTTTLPQQFWYVRSFPEGERNCYTIKLAQGKGFKYLIRASFMYGSYDGQG 120
Query: 99 TVPEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRP 158
T P FDL++G NKW +V++GN S II+KE++HV+ ++S +CLVNTG G+PFISALE R
Sbjct: 121 TAPVFDLYMGVNKWGTVVMGNESNIIIKEVVHVLPTSSICICLVNTGFGSPFISALELRL 180
Query: 159 LPNNTYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQWQQITTPRTIDED 218
L N +Y+T L R+DV S N+ VRY DD+ DR W PY + ++ + T T+D
Sbjct: 181 LKNASYVTDFDLLALHRRLDVGSTINRTVRYNDDISDRIWVPYNFLNYKIMNTSSTVDSG 240
Query: 219 RYNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELEELQANQSRQFNI 278
N Y LP IVM +A T N S+PL V ED ++++++++HFA+LE+LQANQ R+FNI
Sbjct: 241 GSNSYNLPGIVMSTAITTYNASDPLEFHWVPEDPSARYHIFLHFADLEKLQANQLREFNI 300
Query: 279 SFNGNHLYGPVVPSYRHTTTAYTTSALTGEKLQFSIHKTENSTLPPILNAIEFYLVQDFS 338
NGN+ +GP P Y +TT +TS ++GE + FS+ KT S LPPILNA+E YLV D
Sbjct: 301 YQNGNYFHGPFSPDYLQSTTLSSTSPMSGENIAFSLLKTNASNLPPILNALEVYLVLDTL 360
Query: 339 QSETEQADVDAIMNIKSLYK-RKDWQGDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSR 397
QS T++ D+ A+MNIKS Y RK+WQGDPC P++FLW+GL CSY+D P RIT+LNLSS
Sbjct: 361 QSRTDEQDITALMNIKSFYGVRKNWQGDPCQPKSFLWDGLICSYDDQIPNRITTLNLSSS 420
Query: 398 GLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVE 457
GL G I Y+S LT +++LDLSNN+L+GPVP+ LSKLQ L+VL+L N L G +P+ L+E
Sbjct: 421 GLVGEITTYVSELTTLQYLDLSNNNLSGPVPDSLSKLQSLKVLDLRDNPLLGSIPSELME 480
Query: 458 RSKNGSLSLSV------DLCSSYPCKENNKKKNNFVFPVIASFASLLVVTLAISAIYWRH 511
RSKNGSLS+ V DLC+S C + K + +++SF LL T ++ I WR
Sbjct: 481 RSKNGSLSIRVGAGGNTDLCASSSCPKKKKSYVIMIVAIVSSFLVLLAAT-SVLIILWR- 538
Query: 512 KRLRKD-----GSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKM 566
KR RK G+LE KK++ +Y+EI +ITN+FE +GEG F KV+ G LDD +VAVK+
Sbjct: 539 KRARKQPVIRLGTLEEKKQQLSYSEIRRITNNFERQIGEGGFAKVFLGNLDDG-QVAVKV 597
Query: 567 LSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSN 626
L SS QGY++FEAEV LL +HH+NLT+L GYC + + LIYEY+ NG+L+E+LS S
Sbjct: 598 LK-SSVQGYKEFEAEVKLLLRIHHRNLTSLVGYCCQKTNLVLIYEYINNGNLKEHLSGSK 656
Query: 627 ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF 686
A VLSWE R+++A +AQGLEYLH GC+PP VHRD+K ANILLN++FQA++ADFGLSK+F
Sbjct: 657 ASVLSWEERMQVAVNSAQGLEYLHHGCRPPIVHRDVKSANILLNERFQAKIADFGLSKSF 716
Query: 687 PIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIA---NTEE 743
P E +H++T VAGT GYLDPEY T LTEKSDVYSFGV++LEI+TSRP + + +
Sbjct: 717 PTESRTHMTTVVAGTDGYLDPEYYATGWLTEKSDVYSFGVLVLEIVTSRPVLMIDRASSQ 776
Query: 744 HKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803
HISQWV ++ GDI++IVD K+ + D++SAWKAVEIAM C+S +S RPNM VV
Sbjct: 777 KYHISQWVMQLMKIGDIRSIVDQKVRENFDLSSAWKAVEIAMKCLSLNSIDRPNMKEVVS 836
Query: 804 ELKECLAMETARKEGHRFGSGDQSGRMMTLNLTSELAPLAR 844
EL ECLA+E ARK + +S + SE+ P AR
Sbjct: 837 ELSECLALEKARKRKNADTDMRKSNPVSRNFRESEVTPFAR 877
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 846 | ||||||
| TAIR|locus:2017557 | 894 | IOS1 "IMPAIRED OOMYCETE SUSCEP | 0.576 | 0.545 | 0.442 | 8.1e-214 | |
| TAIR|locus:2047675 | 881 | AT2G19210 [Arabidopsis thalian | 0.958 | 0.920 | 0.486 | 3.4e-203 | |
| TAIR|locus:2055160 | 886 | AT2G14440 [Arabidopsis thalian | 0.522 | 0.498 | 0.496 | 1.1e-200 | |
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.898 | 0.867 | 0.507 | 3.3e-198 | |
| TAIR|locus:2078176 | 878 | MEE39 "maternal effect embryo | 0.966 | 0.931 | 0.462 | 3.5e-194 | |
| TAIR|locus:2059093 | 876 | FRK1 "FLG22-induced receptor-l | 0.957 | 0.924 | 0.468 | 2.8e-192 | |
| TAIR|locus:2195855 | 876 | AT1G51910 [Arabidopsis thalian | 0.923 | 0.891 | 0.474 | 3.6e-192 | |
| TAIR|locus:2066163 | 872 | AT2G29000 [Arabidopsis thalian | 0.956 | 0.927 | 0.463 | 1.1e-190 | |
| TAIR|locus:2078191 | 838 | AT3G46420 [Arabidopsis thalian | 0.554 | 0.559 | 0.422 | 3.2e-186 | |
| TAIR|locus:2078186 | 889 | AT3G46340 [Arabidopsis thalian | 0.575 | 0.547 | 0.414 | 2.3e-185 |
| TAIR|locus:2017557 IOS1 "IMPAIRED OOMYCETE SUSCEPTIBILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1112 (396.5 bits), Expect = 8.1e-214, Sum P(2) = 8.1e-214
Identities = 223/504 (44%), Positives = 320/504 (63%)
Query: 24 QNQSGIKYISDTTFVDAGISKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDVRY 83
+ + I YISD F++ G+ S+ Y+ + Q WNLRSFP+G RNCY + L Y
Sbjct: 44 EKTTNITYISDANFINTGVGGSIKQGYRTQ-FQQQTWNLRSFPQGIRNCYTLNLTIGDEY 102
Query: 84 LIRASFAHGDYDGKGTVPEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVN 143
LIRA+F HG YD K + +F+L+LGPN W +V N + + E+IH+++++ ++CLV
Sbjct: 103 LIRANFLHGGYDDKPST-QFELYLGPNLWSTVTTTNETEASIFEMIHILTTDRLQICLVK 161
Query: 144 TGAGTPFISALEFRPLPNNTYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAY 203
TG TPFISALE R L N TY+T+ GSL TFIR DV + NQ RY DV+DR W PY +
Sbjct: 162 TGNATPFISALELRKLMNTTYLTRQGSLQTFIRADVGATVNQGYRYGIDVFDRVWTPYNF 221
Query: 204 PQWQQITTPRTIDEDRYNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFA 263
W QI+T ++++ + NDYQ P I M +A+ P + + I LV + T +FY++MHFA
Sbjct: 222 GNWSQISTNQSVNIN--NDYQPPEIAMVTASVPTDPDAAMNISLVGVERTVQFYVFMHFA 279
Query: 264 ELEELQANQSRQFNISFNGNHLYGPVVP-SYRHXXXXXXXXXXXGEKLQ--FSIHKTENS 320
E++EL++N +R+FNI +N H+YGP P ++ Q FS+ +T NS
Sbjct: 280 EIQELKSNDTREFNIMYNNKHIYGPFRPLNFTTSSVFTPTEVVADANGQYIFSLQRTGNS 339
Query: 321 TLPPILNAIEFYLVQDFSQSETEQADVDAIMNIKSLY--KRKDWQGDPCAPQAFLWNGLG 378
TLPP+LNA+E Y V Q ET++ +VDA+MNIKS Y + DW+GDPC P + W+G+
Sbjct: 340 TLPPLLNAMEIYSVNLLPQQETDRKEVDAMMNIKSAYGVNKIDWEGDPCVPLDYKWSGVN 399
Query: 379 CSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLR 438
C+Y DN+ P+I SL+LS+ GLTG I ++S+LT +E LDLSNNSLTG VPEFL+ ++ L+
Sbjct: 400 CTYVDNETPKIISLDLSTSGLTGEILEFISDLTSLEVLDLSNNSLTGSVPEFLANMETLK 459
Query: 439 VLNLTGNMLTGPLPAGLVERSKNGSLSLSVD----LCSSYPCXXXXXXXXXFVF-PVIAS 493
++NL+GN L G +PA L+++ + GS++LS++ LCSS C V PV AS
Sbjct: 460 LINLSGNELNGSIPATLLDKERRGSITLSIEGNTGLCSSTSCATTKKKKKNTVIAPVAAS 519
Query: 494 FASLLVVTLAISA--IYWRHKRLR 515
S+ ++ I I R KR +
Sbjct: 520 LVSVFLIGAGIVTFLILKRKKRTK 543
|
|
| TAIR|locus:2047675 AT2G19210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1966 (697.1 bits), Expect = 3.4e-203, P = 3.4e-203
Identities = 407/836 (48%), Positives = 539/836 (64%)
Query: 29 IKYISDTTFVDAGISKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVK--LAKDVRYLIR 86
IKY+SD FV++G S+ +Q SL + N+RSFPEG RNCY+VK K +YLIR
Sbjct: 51 IKYVSDAAFVESGTIHSIDPEFQTSSLEKQFQNVRSFPEGNRNCYDVKPPQGKGFKYLIR 110
Query: 87 ASFAHGDYDGKGTVPEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTGA 146
F +G+YD G P+FDL+LG N W+SV + N +TI+ KEIIH + S+ VCLV+
Sbjct: 111 TRFMYGNYDNLGKAPDFDLYLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNR 170
Query: 147 GTPFISALEFRPLPNNTYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQW 206
GTPF+SALE R L +NTY T SL F R D+ + VRY+DDV+DR W P +P++
Sbjct: 171 GTPFLSALEIRLLKSNTYETPYDSLILFKRWDLGGLGALPVRYKDDVFDRIWIPLRFPKY 230
Query: 207 QQITTPRTIDEDRYNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELE 266
TID + +Q VM +A +P++ S+ ++ +D T K+++YMHFAE+
Sbjct: 231 TIFNASLTIDSNNNEGFQPARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVV 290
Query: 267 ELQANQSRQFNISFNGNHL-YGPVVPSYRHXXXXXXXXXXXGEKLQFSIHKTENSTLPPI 325
EL +N++R+F + N + P Y + G KL+F + +T STLPPI
Sbjct: 291 ELPSNETREFKVLLNEKEINMSSFSPRYLYTDTLFVQNPVSGPKLEFRLQQTPRSTLPPI 350
Query: 326 LNAIEFYLVQDFSQSETEQADVDAIMNIKSLYK-RKDWQGDPCAPQAFLWNGLGCSYNDN 384
+NAIE Y V +F QS T+Q DVDAIM IKS Y +K W GDPCAP + W + CSY DN
Sbjct: 351 INAIETYRVNEFLQSPTDQQDVDAIMRIKSKYGVKKSWLGDPCAPVKYPWKDINCSYVDN 410
Query: 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
+ PRI S+NLSS GLTG I SNLT++ LDLSNNSLTG +P+FL L L LNL G
Sbjct: 411 ESPRIISVNLSSSGLTGEIDAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEG 470
Query: 445 NMLTGPLPAGLVERSKNGSLSLSVD----LCSSYPCXXXXXXXXX--FVFPVIASFASLL 498
N L+G +P L+ERS + L +D LC S C ++ P++AS +L
Sbjct: 471 NKLSGAIPVKLLERSNKKLILLRIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVL 530
Query: 499 VVTLAISAIYWRHKRLRKDGS-------LETKKRRFTYAEITKITNDFETILGEGSFGKV 551
+ LAI+ KR R+ GS L+T KR + Y+E+ K+TN+FE +LG+G FGKV
Sbjct: 531 GLVLAIALFLLYKKRHRRGGSGGVRAGPLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKV 590
Query: 552 YHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611
YHG L+D+ +VAVK+LS SS QGY++F AEV LL VHHKNLT L GYC+EG ++ LIYE
Sbjct: 591 YHGVLNDD-QVAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYE 649
Query: 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND 671
+MANG+L +YLS + VLSWE RL+I+ +AAQGLEYLH GCKPP V RD+KPANIL+N+
Sbjct: 650 FMANGTLGDYLSGEKSYVLSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINE 709
Query: 672 QFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEI 731
+ QA++ADFGLS++ ++G + +T VAGT GYLDPEY T +L+EKSD+YSFGVVLLE+
Sbjct: 710 KLQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEV 769
Query: 732 ITSRPAIAN---TEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCV 788
++ +P IA T E+ HI+ VD ML+ GDI+ IVDPKL D SAWK E+AM C
Sbjct: 770 VSGQPVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMACA 829
Query: 789 SHSSTPRPNMNRVVMELKECLAMETARKEGHRFGSGDQSGRMMTLNLTSELAPLAR 844
S SS RP M+ VV ELKE ++ AR G G+ + MT N S + P AR
Sbjct: 830 SSSSKNRPTMSHVVAELKE--SVSRARAGGGS-GASSVTDPAMT-NFDSGMFPQAR 881
|
|
| TAIR|locus:2055160 AT2G14440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1093 (389.8 bits), Expect = 1.1e-200, Sum P(2) = 1.1e-200
Identities = 230/463 (49%), Positives = 311/463 (67%)
Query: 389 ITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
+ L+LS+ LTG IPP L NLTM+ LDLSNN+LTG VPEFL+ ++ L V++L GN L
Sbjct: 438 LRELDLSNNNLTGVIPPSLQNLTMLRELDLSNNNLTGEVPEFLATIKPLLVIHLRGNNLR 497
Query: 449 GPLPAGLVERSKNGSLSLSVDLCSSYPCXXXXXXXXXFVFPVIASFA--SLLVVTLAISA 506
G +P L +R N L L L + ++ ++AS + ++ ++ L +
Sbjct: 498 GSVPQALQDRENNDGLKL---LRGKHQ-------PKSWLVAIVASISCVAVTIIVLVLIF 547
Query: 507 IYWRHKR-LRK--DGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEVA 563
I+ R K RK SLE K RRF Y+E+ ++TN+FE +LG+G FG VYHG+L+ N +VA
Sbjct: 548 IFRRRKSSTRKVIRPSLEMKNRRFKYSEVKEMTNNFEVVLGKGGFGVVYHGFLN-NEQVA 606
Query: 564 VKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLS 623
VK+LS SS QGY++F+ EV LL VHH NL +L GYC++GN + LIYE+M NG+L+E+LS
Sbjct: 607 VKVLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDKGNDLALIYEFMENGNLKEHLS 666
Query: 624 DSNAD-VLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGL 682
VL+W GRL+IA E+A G+EYLH+GCKPP VHRD+K NILL +F+A+LADFGL
Sbjct: 667 GKRGGPVLNWPGRLKIAIESALGIEYLHIGCKPPMVHRDVKSTNILLGLRFEAKLADFGL 726
Query: 683 SKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTE 742
S++F + +H+ST VAGT GYLDPEY Q LTEKSDVYSFG+VLLEIIT +P I +
Sbjct: 727 SRSFLVGSQTHVSTNVAGTLGYLDPEYYQKNWLTEKSDVYSFGIVLLEIITGQPVIEQSR 786
Query: 743 EHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVV 802
+ +I +W MLA GDI++I+D LH D D +S+WKA+E+AM C++ SST RPNM RV
Sbjct: 787 DKSYIVEWAKSMLANGDIESIMDRNLHQDYDTSSSWKALELAMLCINPSSTLRPNMTRVA 846
Query: 803 MELKECLAM-ETARKEGHRFGSGDQSGRMMTLNLTSELAPLAR 844
EL ECL + ++ S SG T+ S++ P AR
Sbjct: 847 HELNECLEIYNLTKRRSQDQNSSKSSGH--TVTFISDI-PSAR 886
|
|
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1919 (680.6 bits), Expect = 3.3e-198, P = 3.3e-198
Identities = 398/784 (50%), Positives = 514/784 (65%)
Query: 79 KDVRYLIRASFAHGDYDGKGTVPEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTR 138
K +YLIR F +G+YDG PEFDL++G N WESV+L N + I+ KEII+ S+
Sbjct: 99 KGFKYLIRTRFMYGNYDGFSKTPEFDLYIGANLWESVVLINETAIMTKEIIYTPPSDHIH 158
Query: 139 VCLVNTGAGTPFISALEFRPLPNNTYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSW 198
VCLV+ GTPF+S LE R L N+TY T +L R D + TN +RY+DD YDR W
Sbjct: 159 VCLVDKNRGTPFLSVLEIRFLKNDTYDTPYEALMLGRRWDFGTATNLQIRYKDDFYDRIW 218
Query: 199 APYAYPQWQQITTPRTIDEDRYNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYM 258
PY P + + T TIDE +N ++ SIVMRSA P N+S PL + +D SKFY+
Sbjct: 219 MPYKSPYQKTLNTSLTIDETNHNGFRPASIVMRSAIAPGNESNPLKFNWAPDDPRSKFYI 278
Query: 259 YMHFAELEELQANQSRQFNISFNGNHLYGPVVPSYRHXXXXXXXXXXXGEKLQFSIHKTE 318
YMHFAE+ ELQ N++R+F+I N L P Y + + + +T
Sbjct: 279 YMHFAEVRELQRNETREFDIYINDVILAENFRPFYLFTDTRSTVDPVGRKMNEIVLQRTG 338
Query: 319 NSTLPPILNAIEFYLVQDFSQSETEQADVDAIMNIKSLYK-RKDWQGDPCAPQAFLWNGL 377
STLPPI+NAIE Y + +F Q T+Q DVDA+ IK Y+ +K+WQGDPC P W GL
Sbjct: 339 VSTLPPIINAIEIYQINEFLQLPTDQQDVDAMTKIKFKYRVKKNWQGDPCVPVDNSWEGL 398
Query: 378 GCSYNDNDP-PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQY 436
C ++DN+ P+ +LNLSS GLTG I P +NLT I LDLSNNSLTG VP+FL+ L
Sbjct: 399 ECLHSDNNTSPKSIALNLSSSGLTGQIDPAFANLTSINKLDLSNNSLTGKVPDFLASLPN 458
Query: 437 LRVLNLTGNMLTGPLPAGLVERSKNGSLSL----SVDLCSSYPCXXXXXXXXXFVFPVIA 492
L LNL GN LTG +PA L+E+SK+GSLSL + DLC S C ++ PV+A
Sbjct: 459 LTELNLEGNKLTGSIPAKLLEKSKDGSLSLRFGGNPDLCQSPSCQTTTKKKIGYIVPVVA 518
Query: 493 SFASLLVVTLAISAIYWRHKRLRKD-----------GSLETKKRRFTYAEITKITNDFET 541
S A LL+V A++ I+ KR R+ G L+T KR F Y+E+ ITN+FE
Sbjct: 519 SLAGLLIVLTALALIWHFKKRSRRGTISNKPLGVNTGPLDTAKRYFIYSEVVNITNNFER 578
Query: 542 ILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN 601
+LG+G FGKVYHG+L+ + +VAVK+LS S QGY++F AEV LL VHH NLT+L GYCN
Sbjct: 579 VLGKGGFGKVYHGFLNGD-QVAVKILSEESTQGYKEFRAEVELLMRVHHTNLTSLIGYCN 637
Query: 602 EGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRD 661
E N + LIYEYMANG+L +YLS ++ +LSWE RL+I+ +AAQGLEYLH GCKPP VHRD
Sbjct: 638 EDNHMALIYEYMANGNLGDYLSGKSSLILSWEERLQISLDAAQGLEYLHYGCKPPIVHRD 697
Query: 662 IKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDV 721
+KPANILLN+ QA++ADFGLS++FP+EG S +ST VAGT GYLDPEY T ++ EKSDV
Sbjct: 698 VKPANILLNENLQAKIADFGLSRSFPVEGSSQVSTVVAGTIGYLDPEYYATRQMNEKSDV 757
Query: 722 YSFGVVLLEIITSRPAIANTE-EHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKA 780
YSFGVVLLE+IT +PAI ++ E H+S V MLA GDIK IVD +L +V SAWK
Sbjct: 758 YSFGVVLLEVITGKPAIWHSRTESVHLSDQVGSMLANGDIKGIVDQRLGDRFEVGSAWKI 817
Query: 781 VEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARKEGHRFGSGDQSGRMMTLNLTSELA 840
E+A+ C S SS RP M++VVMELK+ + + H+ RM+T+NL +E+
Sbjct: 818 TELALACASESSEQRPTMSQVVMELKQSIFGRVNNRSDHK-----DPVRMVTMNLDTEMV 872
Query: 841 PLAR 844
P AR
Sbjct: 873 PRAR 876
|
|
| TAIR|locus:2078176 MEE39 "maternal effect embryo arrest 39" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1881 (667.2 bits), Expect = 3.5e-194, P = 3.5e-194
Identities = 388/839 (46%), Positives = 540/839 (64%)
Query: 22 HAQNQSGIKYISDTTFVDAGISKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDV 81
+ ++++GI++ SD F+ +G + + + E+L Q LR FP+G RNCY++++ +
Sbjct: 45 YIESETGIQFSSDENFIQSGKTGRIPKNLESENLKQYA-TLRYFPDGIRNCYDLRVEEGR 103
Query: 82 RYLIRASFAHGDYDGKGTVPEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCL 141
YLIRA+F +G++DG PEFD+H+GPNKW ++ L V VKEIIH+ SNS ++CL
Sbjct: 104 NYLIRATFFYGNFDGLNVSPEFDMHIGPNKWTTIDLQIVPDGTVKEIIHIPRSNSLQICL 163
Query: 142 VNTGAGTPFISALEFRPLPNNTYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPY 201
V TGA P ISALE RPL N+TYI +SGSL + RM LS ++RY DVYDRSW PY
Sbjct: 164 VKTGATIPMISALELRPLANDTYIAKSGSLKYYFRM-YLSNATVLLRYPKDVYDRSWVPY 222
Query: 202 AYPQWQQITTPRTIDEDRYNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMH 261
P+W QI+T + N Y P + ++ AATP N L + E+ + Y+YMH
Sbjct: 223 IQPEWNQISTTSNVSNK--NHYDPPQVALKMAATPTNLDAALTMVWRLENPDDQIYLYMH 280
Query: 262 FAELEELQANQSRQFNISFNGNHLYGP-VVPSYRHXXXXXXXXXXX--GEKLQFSIHKTE 318
F+E++ L+AN +R+F+I NG + V P Y G + + KT+
Sbjct: 281 FSEIQVLKANDTREFDIILNGETINTRGVTPKYLEIMTWLTTNPRQCNGGICRMQLTKTQ 340
Query: 319 NSTLPPILNAIEFYLVQDFSQSETEQADVDAIMNIKSLY--KRKDWQGDPCAPQAFLWNG 376
STLPP+LNA E Y V QS+T + +V AI NI++ Y R WQGDPC P+ FLW+G
Sbjct: 341 KSTLPPLLNAFEVYSVLQLPQSQTNEIEVVAIKNIRTTYGLSRISWQGDPCVPKQFLWDG 400
Query: 377 LGCSYND-NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQ 435
L C+ D + PPRI SLNLSS GL+G I NL +E LDLSNNSL+G VPEFL+ ++
Sbjct: 401 LNCNITDISAPPRIISLNLSSSGLSGTIVSNFQNLAHLESLDLSNNSLSGIVPEFLATMK 460
Query: 436 YLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSV----DLCSSYPCXXXXXXXXXF-VFPV 490
L V+NL+GN L+G +P L +R + G L L+V +LC S C V
Sbjct: 461 SLLVINLSGNKLSGAIPQALRDREREG-LKLNVLGNKELCLSSTCIDKPKKKVAVKVVAP 519
Query: 491 IASFASLLVVTLAISAIYWRHKRLRKDGSLETKKRRFTYAEITKITNDFETILGEGSFGK 550
+AS A+++VV L R + + ++TKK+RFTY+E+ ++T + + LGEG FG
Sbjct: 520 VASIAAIVVVILLFVFKKKMSSRNKPEPWIKTKKKRFTYSEVMEMTKNLQRPLGEGGFGV 579
Query: 551 VYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610
VYHG L+ + +VAVK+LS +S QGY++F+AEV LL VHH NL L GYC+E + LIY
Sbjct: 580 VYHGDLNGSEQVAVKLLSQTSAQGYKEFKAEVELLLRVHHINLVNLVGYCDEQDHFALIY 639
Query: 611 EYMANGSLEEYLSDSNA-DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL 669
EYM+NG L ++LS + VL+W RL+IA EAA GLEYLH GCKP VHRD+K NILL
Sbjct: 640 EYMSNGDLHQHLSGKHGGSVLNWGTRLQIAIEAALGLEYLHTGCKPAMVHRDVKSTNILL 699
Query: 670 NDQFQARLADFGLSKTFPIEG-VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVL 728
+++F+A++ADFGLS++F + G S +ST VAGT GYLDPEY T L+EKSDVYSFG++L
Sbjct: 700 DEEFKAKIADFGLSRSFQVGGDQSQVSTVVAGTLGYLDPEYYLTSELSEKSDVYSFGILL 759
Query: 729 LEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCV 788
LEIIT++ I T E+ +I++WV F++ +GD IVDPKLHG+ D +S W+A+E+AM C
Sbjct: 760 LEIITNQRVIDQTRENPNIAEWVTFVIKKGDTSQIVDPKLHGNYDTHSVWRALEVAMSCA 819
Query: 789 SHSSTPRPNMNRVVMELKECLAMETAR--KEGHRFGSGDQSGRM-MTLNLTSELAPLAR 844
+ SS RPNM++V++ LKECLA E R + SG S ++ +T+ +++ P AR
Sbjct: 820 NPSSVKRPNMSQVIINLKECLASENTRISRNNQNMDSGHSSDQLNVTVTFDTDVKPKAR 878
|
|
| TAIR|locus:2059093 FRK1 "FLG22-induced receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1863 (660.9 bits), Expect = 2.8e-192, P = 2.8e-192
Identities = 392/837 (46%), Positives = 533/837 (63%)
Query: 27 SGIKYISDTTFVDAGISKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKL--AKDVRYL 84
+GIKY+SD+ FVD+G +K +A +Q + L N+RSFP+ KR+CY+V K +YL
Sbjct: 48 TGIKYVSDSAFVDSGTTKRIAAQFQSSGFDRHLLNVRSFPQSKRSCYDVPTPRGKGFKYL 107
Query: 85 IRASFAHGDYDGKGTVPEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNT 144
IR F +G+YD G VPEFDL+LG N W+SV L + +TI+ KEII + ++ +VC+V+
Sbjct: 108 IRTRFMYGNYDDLGRVPEFDLYLGVNFWDSVKLDDATTILNKEIITIPLLDNVQVCVVDK 167
Query: 145 GAGTPFISALEFRPLPNNTYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAP-YAY 203
AGTPF+S LE R L N TY T +L R+D RY+DD+YDR W P
Sbjct: 168 NAGTPFLSVLEIRLLLNTTYETPYDALTLLRRLDYSKTGKLPSRYKDDIYDRIWTPRIVS 227
Query: 204 PQWQQITTPRTIDEDRYNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFA 263
+++ + T T+D+ N YQ S VM +A T +N+S L + D +KFY+YMHFA
Sbjct: 228 SEYKILNTSLTVDQFLNNGYQPASTVMSTAETARNESLYLTLSFRPPDPNAKFYVYMHFA 287
Query: 264 ELEELQANQSRQFNISFNGNHLYGPVVPSYRHXXXXXXXXXXXGEKLQFSIHKTENS-TL 322
E+E L++NQ+R+F+I N + + Y G + FS+ + L
Sbjct: 288 EIEVLKSNQTREFSIWLNEDVISPSFKLRYLLTDTFVTPDPVSGITINFSLLQPPGEFVL 347
Query: 323 PPILNAIEFYLVQDFSQSETEQADVDAIMNIKSLYK-RKDWQGDPCAPQAFLWNGLGCSY 381
PPI+NA+E Y V +F Q T DVDA+ IK+ Y+ +K+WQGDPC P + W G+ C
Sbjct: 348 PPIINALEVYQVNEFLQIPTHPQDVDAMRKIKATYRVKKNWQGDPCVPVDYSWEGIDCIQ 407
Query: 382 NDNDP-PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVL 440
+DN PR+ SLN+S L G I P SNLT I LDLS N+LTG +P FL+ L L L
Sbjct: 408 SDNTTNPRVVSLNISFSELRGQIDPAFSNLTSIRKLDLSGNTLTGEIPAFLANLPNLTEL 467
Query: 441 NLTGNMLTGPLPAGLVERSKNGSLSL----SVDLCSSYPCXXXXXXXXX-FVFPVIASFA 495
N+ GN LTG +P L ERSKNGSLSL + DLC S C ++ P++
Sbjct: 468 NVEGNKLTGIVPQRLHERSKNGSLSLRFGRNPDLCLSDSCSNTKKKNKNGYIIPLVV--V 525
Query: 496 SLLVVTLAISAIYWRHKRLR-------KDGSLETKKRRFTYAEITKITNDFETILGEGSF 548
++VV L A++ R K+ + ++G L+T KR F Y+E+ ITN+FE ++G+G F
Sbjct: 526 GIIVVLLTALALFRRFKKKQQRGTLGERNGPLKTAKRYFKYSEVVNITNNFERVIGKGGF 585
Query: 549 GKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGL 608
GKVYHG ++ +VAVK+LS S QGY++F AEV LL VHH NLT+L GYCNE N + L
Sbjct: 586 GKVYHGVINGE-QVAVKVLSEESAQGYKEFRAEVDLLMRVHHTNLTSLVGYCNEINHMVL 644
Query: 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANIL 668
IYEYMAN +L +YL+ + +LSWE RL+I+ +AAQGLEYLH GCKPP VHRD+KP NIL
Sbjct: 645 IYEYMANENLGDYLAGKRSFILSWEERLKISLDAAQGLEYLHNGCKPPIVHRDVKPTNIL 704
Query: 669 LNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVL 728
LN++ QA++ADFGLS++F +EG +ST VAG+ GYLDPEY T ++ EKSDVYS GVVL
Sbjct: 705 LNEKLQAKMADFGLSRSFSVEGSGQISTVVAGSIGYLDPEYYSTRQMNEKSDVYSLGVVL 764
Query: 729 LEIITSRPAIANTEEHK-HISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGC 787
LE+IT +PAIA+++ K HIS V +LA GDI+ IVD +L DV SAWK EIA+ C
Sbjct: 765 LEVITGQPAIASSKTEKVHISDHVRSILANGDIRGIVDQRLRERYDVGSAWKMSEIALAC 824
Query: 788 VSHSSTPRPNMNRVVMELKECLAMETARKEGHRFGSGDQSGRMMTLNLTSELAPLAR 844
H+S RP M++VVMELK+ + +E + D S +M+T+NL +E+ P AR
Sbjct: 825 TEHTSAQRPTMSQVVMELKQIVYGIVTDQENY-----DDSTKMLTVNLDTEMVPRAR 876
|
|
| TAIR|locus:2195855 AT1G51910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1862 (660.5 bits), Expect = 3.6e-192, P = 3.6e-192
Identities = 392/826 (47%), Positives = 534/826 (64%)
Query: 22 HAQNQSGIKYISDTTFVDAGISKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDV 81
+ + + I YISD ++D+G+++ ++ +Y+ + L Q W LRSFPEG+RNCYN L ++
Sbjct: 43 YTEQITNITYISDADYIDSGLTERISDSYKSQ-LQQQTWTLRSFPEGQRNCYNFNLKANL 101
Query: 82 RYLIRASFAHGDYDGKGTVPEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCL 141
+YLIR +F +G+YDG +P+FDLH+GPNKW SVIL V+ + EIIHV++ + +VCL
Sbjct: 102 KYLIRGTFVYGNYDGLNQMPKFDLHIGPNKWTSVILEGVANATIFEIIHVLTQDRLQVCL 161
Query: 142 VNTGAGTPFISALEFRPLPNNTYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPY 201
V TG TPFIS+LE RPL N+TY+TQ GSL +F R+ T +RY DD+YDR W P+
Sbjct: 162 VKTGQTTPFISSLELRPLNNDTYVTQGGSLMSFARI-YFPKTAYFLRYSDDLYDRVWVPF 220
Query: 202 AYPQWQQITTPRTIDEDRYNDYQLPSIVMRSAATPKNKSEPLLI--DLVHEDSTSKFYMY 259
+ + ++T +D N Y +P V SA P + PL I DL + ++ S Y+Y
Sbjct: 221 SQNETVSLSTNLPVDTSS-NSYNVPQNVANSAIIPAEATHPLNIWWDLQNINAPS--YVY 277
Query: 260 MHFAELEELQANQSRQFNISFNGNHLYGPVVPSYRHXXXXXXXXXXXGEK---LQFSIHK 316
MHFAE++ L+AN R+FNI++NG ++ + + F+
Sbjct: 278 MHFAEIQNLKANDIREFNITYNGGQVWESSIRPHNLSITTISSPTALNSSDGFFNFTFTM 337
Query: 317 TENSTLPPILNAIEFYLVQDFSQSETEQADVDAIMNIKSLY---KRKDWQGDPCAPQAFL 373
T STLPP++NA+E Y + + ET Q +V A+MNIK Y K+ WQGDPC+PQ +
Sbjct: 338 TTTSTLPPLINALEVYTLVENLLLETYQDEVSAMMNIKKTYGLSKKISWQGDPCSPQIYR 397
Query: 374 WNGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSK 433
W GL C Y D+D P ITSLNL + GLTG I +SNL + LDLS+N L+G +P+FL+
Sbjct: 398 WEGLNCLYLDSDQPLITSLNLRTSGLTGIITHDISNLIQLRELDLSDNDLSGEIPDFLAD 457
Query: 434 LQYLRVLNLTGN-MLTGPLPAGLVERSKNGSLSLSVDLCSSYPCXXXXXXXXXFVFPVIA 492
++ L ++NL GN L +P + R N SL L +D S FP++A
Sbjct: 458 MKMLTLVNLKGNPKLNLTVPDSIKHRINNKSLKLIIDENQS-------SEKHGIKFPLVA 510
Query: 493 SFASL--LVVTLAI---SAIYWRHKR------------LRKD-GSLETKKRRFTYAEITK 534
AS+ ++ LAI I+ R K+ +R S+ETK R+FTY+EI K
Sbjct: 511 ILASVAGVIALLAIFTICVIFKREKQGSGEAPTRVNTEIRSSYQSIETKDRKFTYSEILK 570
Query: 535 ITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNL 593
+TN+FE +LG+G +G+VY+G LDD TEVAVKML SS Q Y+ F+AEV LL VHH++L
Sbjct: 571 MTNNFERVLGKGGYGRVYYGKLDD-TEVAVKMLFHSSAEQDYKHFKAEVELLLRVHHRHL 629
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNAD-VLSWEGRLRIATEAAQGLEYLHLG 652
L GYC++G+ LIYEYMANG L+E +S + + VLSWE R++IA EAAQGLEYLH G
Sbjct: 630 VGLVGYCDDGDNFALIYEYMANGDLKENMSGNRSGHVLSWENRMQIAMEAAQGLEYLHNG 689
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
+PP VHRD+K NILLN+ +QA+LADFGLS++ P++G S++ST VAGT GYLDPE T
Sbjct: 690 SRPPMVHRDVKTTNILLNELYQAKLADFGLSRSSPVDGESYVSTIVAGTPGYLDPE---T 746
Query: 713 FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772
L+EK+DVYSFGVVLLEIIT++P I T E HI+ WV F L +GDI+NI+DPKL +
Sbjct: 747 NLLSEKTDVYSFGVVLLEIITNQPVIDTTREKAHITDWVGFKLMEGDIRNIIDPKLIKEF 806
Query: 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARKEG 818
D N WKAVE+A+ CV+ +S RP M VVMELKECL E ARK+G
Sbjct: 807 DTNGVWKAVELALSCVNPTSNHRPTMPHVVMELKECLDSEIARKQG 852
|
|
| TAIR|locus:2066163 AT2G29000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1848 (655.6 bits), Expect = 1.1e-190, P = 1.1e-190
Identities = 391/843 (46%), Positives = 541/843 (64%)
Query: 22 HAQNQSGIKYISDTTFVDAGISKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDV 81
+ ++ + + + SD F+ +GIS + ++P LR FP+G R+CY++ + +
Sbjct: 44 YTESTTSLVFTSDANFISSGISTKLPK----HDDYKPYNFLRYFPDGTRHCYDLSVKQGT 99
Query: 82 RYLIRASFAHGDYDGKGTVPEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCL 141
YLIRASF +G+YDG+ +P FDL++GPN W V ++ + +EIIH+ S S ++CL
Sbjct: 100 NYLIRASFVYGNYDGRNIMPRFDLYIGPNIWAVVSELDLYSP-EEEIIHMTKSTSLQICL 158
Query: 142 VNTGAGTPFISALEFRPLPNNTYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPY 201
V TG TPFIS LE RPL N+ YITQSGSL RM ++ T +RY DDVYDR W
Sbjct: 159 VKTGPTTPFISTLELRPLRNDNYITQSGSLKLMQRM-CMTETVSTLRYPDDVYDRLWYTD 217
Query: 202 AYPQWQQITTPRTIDEDRYNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMH 261
+ + + T +++ N ++LP +++RSAATP N SEP+ ++ S + Y+Y+H
Sbjct: 218 GIYETKAVKTALSVNST--NPFELPQVIIRSAATPVNSSEPITVEYGGYSSGDQVYLYLH 275
Query: 262 FAELEELQANQSRQFNISFNGNH---LYGPVVPSYRHXXXXXXXXXXXGEKLQFSIHKTE 318
FAE++ L+A+ +R+F+I + N Y P V S + + +T+
Sbjct: 276 FAEIQTLKASDNREFDIVWANNIKKLAYKPKV-SQIDTLLNTSPNKCDNTFCKAFLVRTQ 334
Query: 319 NSTLPPILNAIEFYLVQDFSQSETEQADVDAIMNIKSLYKRK--DWQGDPCAPQAFLWNG 376
STLPP+LNA E Y++ +F SET DV AI IK+ Y K WQGDPC P+ + W
Sbjct: 335 RSTLPPLLNAYEVYILVEFPYSETHPDDVVAIKKIKAAYGLKIISWQGDPCLPREYKWEY 394
Query: 377 LGCSYNDND-PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQ 435
+ CSY +N PPRI SL+LS+RGL G I P L NLT +E LDLS N L+G VPEFL+ ++
Sbjct: 395 IECSYTNNSIPPRIISLDLSNRGLKGIIEPVLQNLTQLEKLDLSINRLSGEVPEFLANMK 454
Query: 436 YLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSV----DLCSSYPCXXXXXXXXXFVFPVI 491
L +NL+ N L G +P L E+ KNG L L+ +LC C F +
Sbjct: 455 SLSNINLSWNNLKGLIPPALEEKRKNG-LKLNTQGNQNLCPGDECKRSIPK---FPVTTV 510
Query: 492 ASFASLL--VVTLAISAIYWRHK--RLRK-----DGSLETKKRRFTYAEITKITNDFETI 542
S +++L VV L I IY + K ++R + TKKRRFTY+E+ +TN FE +
Sbjct: 511 VSISAILLTVVVLLIVFIYKKKKTSKVRHRLPITKSEILTKKRRFTYSEVEAVTNKFERV 570
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE 602
+GEG FG VYHG+L+D +VAVK+LS SS QGY+QF+AEV LL VHH NL L GYCNE
Sbjct: 571 IGEGGFGIVYHGHLNDTEQVAVKLLSHSSTQGYKQFKAEVELLLRVHHTNLVNLVGYCNE 630
Query: 603 GNQIGLIYEYMANGSLEEYLS-DSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRD 661
+ + L+YEY ANG L+++LS +S++ L+W RL IATE AQGLEYLH+GC+PP +HRD
Sbjct: 631 EDHLALVYEYAANGDLKQHLSGESSSAALNWASRLGIATETAQGLEYLHIGCEPPMIHRD 690
Query: 662 IKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDV 721
+K NILL++ F A+LADFGLS++FP+ SH+ST VAGT GYLDPEY +T LTEKSDV
Sbjct: 691 VKTTNILLDEHFHAKLADFGLSRSFPVGVESHVSTNVAGTPGYLDPEYYRTNWLTEKSDV 750
Query: 722 YSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAV 781
YS G+VLLEIIT++P I E HI++WV ML +GDIK+I+DPKL+G+ D +S WKA+
Sbjct: 751 YSMGIVLLEIITNQPVIQQVREKPHIAEWVGLMLTKGDIKSIMDPKLNGEYDSSSVWKAL 810
Query: 782 EIAMGCVSHSSTPRPNMNRVVMELKECLAMETARKEGHRFGSGDQSGRMMTLNLTSELAP 841
E+AM CV+ SS RP M++V+ ELKECL E +RKEG R +S ++ + T+E+ P
Sbjct: 811 ELAMSCVNPSSGGRPTMSQVISELKECLIYENSRKEG-RSEVDSKSSIELSTSFTAEVTP 869
Query: 842 LAR 844
AR
Sbjct: 870 DAR 872
|
|
| TAIR|locus:2078191 AT3G46420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 961 (343.3 bits), Expect = 3.2e-186, Sum P(2) = 3.2e-186
Identities = 206/487 (42%), Positives = 295/487 (60%)
Query: 27 SGIKYISDTTFVDAGISKSVALAYQLESLHQPLWN-LRSFPEGKRNCYNVKLAKDVRYLI 85
+G+++ +D+ F++ G K + LE ++ LR FP+G RNCYN+ + + YLI
Sbjct: 49 TGLQFTTDSNFIETG--KLGRIQASLEPKYRKSQTTLRYFPDGIRNCYNLTVTQGTNYLI 106
Query: 86 RASFAHGDYDGKGTVPEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTG 145
RA +G+YDG P+FDL++GPN W ++ LG +EII++ SN VCLV TG
Sbjct: 107 RARAIYGNYDGLNIYPKFDLYIGPNFWVTIDLGKYVNGTWEEIIYIPKSNMLDVCLVKTG 166
Query: 146 AGTPFISALEFRPLPNNTYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQ 205
TP IS+L RPL N TYITQSG L T++R+ LS +N V+RY DDVYDR W Y P+
Sbjct: 167 PSTPLISSLVLRPLANATYITQSGWLKTYVRV-YLSDSNDVIRYPDDVYDRIWGSYFEPE 225
Query: 206 WQQITTPRTIDEDRYNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAEL 265
W++I+T T+ + + + P + +AA+P N S PL I V + + K Y+++HF+E+
Sbjct: 226 WKKIST--TLGVNSSSGFLPPLKALMTAASPANASAPLAIPGVLDFPSDKLYLFLHFSEI 283
Query: 266 EELQANQSRQFNISFNGNHLYGPVVPSYRHXXXXXXXXXXXGEKLQFSIH--KTENSTLP 323
+ L+AN++R+F I +N +Y P Y E+ + + KTE STLP
Sbjct: 284 QVLKANETREFEIFWNKKLVYNAYSPVYLQTKTIRNPSPVTCERGECILEMIKTERSTLP 343
Query: 324 PILNAIEFYLVQDFSQSETEQADVDAIMNIKSLY--KRKDWQGDPCAPQAFLWNGLGC-S 380
P+LNA+E + V +F Q ET+ +DV AI NIK++Y R WQGDPC PQ FLWNGL C S
Sbjct: 344 PLLNAVEVFTVVEFPQPETDASDVVAIKNIKAIYGLTRVTWQGDPCVPQQFLWNGLNCNS 403
Query: 381 YNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVL 440
+ PPRITSL+LSS GLTG I + NLT +E LDLSNN+LTG VP+FL+ +++L +
Sbjct: 404 METSTPPRITSLDLSSSGLTGSISVVIQNLTHLEKLDLSNNNLTGEVPDFLANMKFLVFI 463
Query: 441 NLTGNMLTGPLPAGLVERSKNGS---LSLSVDLCSSYPCXXXXXXXXXFVFPVIASFASL 497
NL+ N L G +P L +R G + +VD CSS C F ++A SL
Sbjct: 464 NLSKNNLNGSIPKALRDRENKGLKLIVDKNVDNCSSGSCTQKKK----FPLLIVALTVSL 519
Query: 498 LVVTLAI 504
++V+ +
Sbjct: 520 ILVSTVV 526
|
|
| TAIR|locus:2078186 AT3G46340 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 962 (343.7 bits), Expect = 2.3e-185, Sum P(2) = 2.3e-185
Identities = 208/502 (41%), Positives = 302/502 (60%)
Query: 27 SGIKYISDTTFVDAGISKSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDVRYLIR 86
+G+++ SD++F+ +G V +++ +L + LR FP+GKRNCYN+ + + Y+IR
Sbjct: 52 TGLRFSSDSSFIQSGKIGKVDKSFEATTLKSYM-TLRYFPDGKRNCYNLIVKQGKTYMIR 110
Query: 87 ASFAHGDYDGKGTVPEFDLHLGPNKWESVILGNVSTIIVKEIIHVISSNSTRVCLVNTGA 146
A+ +G+YDG P+FDL++G N W ++ G + +V+E+ ++ SNS VCLV T
Sbjct: 111 ATALYGNYDGLNISPKFDLYIGANFWTTLDAGEYLSGVVEEVNYIPRSNSLDVCLVKTDT 170
Query: 147 GTPFISALEFRPLPNNTYITQSGSLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQW 206
TPF+S LE RPL N++Y+T SGSL TF R LS + V+ Y +DV DR W P +W
Sbjct: 171 STPFLSLLELRPLDNDSYLTGSGSLKTFRRY-YLSNSESVIAYPEDVKDRIWEPTFDSEW 229
Query: 207 QQITTPRTIDEDRYNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELE 266
+QI T T+ + N Y +P V+ +AA P N S P + T + Y+Y+HF+E++
Sbjct: 230 KQIWT--TLKPNNSNGYLVPKNVLMTAAIPANDSAPFRFTEELDSPTDELYVYLHFSEVQ 287
Query: 267 ELQANQSRQFNISFNGNHLYGPVVPSYRHXXXXXXXXXXX--GEKLQFSIHKTENSTLPP 324
LQAN+SR+F+I ++G Y +P Y + G K + +T+NST PP
Sbjct: 288 SLQANESREFDILWSGEVAYEAFIPEYLNITTIQTNTPVTCPGGKCNLELKRTKNSTHPP 347
Query: 325 ILNAIEFYLVQDFSQSETEQADVDAIMNIKSLYK--RKDWQGDPCAPQAFLWNGLGCSYN 382
++NAIEFY V +F Q ET + DV AI +IK+ Y+ R WQGDPC PQ F+W GL C+
Sbjct: 348 LINAIEFYTVVNFPQLETNETDVVAIKDIKATYELNRITWQGDPCVPQKFIWEGLDCNSK 407
Query: 383 DN-DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLN 441
D PRITSLNLSS GLTG I + NLT ++ LDLSNN+LTG VPEFL+ ++ L +N
Sbjct: 408 DALTLPRITSLNLSSTGLTGNIAAGIQNLTHLDKLDLSNNNLTGGVPEFLASMKSLSFIN 467
Query: 442 LTGNMLTGPLPAGLVERSKNGSLSLSVDLCSSYPCXXXXXXXXXFVFPV--IASFASLLV 499
L+ N L G +P L++R K+G L LSVD C FPV +A +S +V
Sbjct: 468 LSKNNLNGSIPQALLKREKDG-LKLSVD--EQIRCFPGSCVITKKKFPVMIVALVSSAVV 524
Query: 500 VTLAISAIYWRHKRLRKDGSLE 521
V L + + + K+ +K +LE
Sbjct: 525 VILVVLVLIFVFKK-KKPSNLE 545
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00034228001 | SubName- Full=Chromosome chr9 scaffold_7, whole genome shotgun sequence; (853 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 846 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 1e-109 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-48 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-39 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-39 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-36 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-32 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-29 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-27 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-26 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-25 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-16 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.003 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 337 bits (866), Expect = e-109
Identities = 140/323 (43%), Positives = 190/323 (58%), Gaps = 20/323 (6%)
Query: 28 GIKYISDTTFVDAGISKSVALAYQLESLHQPLWNLRSFPEGKRNCYN--VKLAKDVRYLI 85
GI ++SD F+D G S +++ L +P LRSFP+GKRNCY V K +YLI
Sbjct: 17 GITWVSDAGFIDTGKSGNISKENSSSFLSKPYKTLRSFPDGKRNCYTLPVTPGKGTKYLI 76
Query: 86 RASFAHGDYDGKGTV---PEFDLHLGPNKWESVILGNVS-TIIVKE-IIHVISSNSTRVC 140
RA+F +G+YDG +V P FDL+LG N W +V L N S +VKE IIHV S++ VC
Sbjct: 77 RATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGDSVVKEYIIHVTKSDTLSVC 136
Query: 141 LVNTGAGTPFISALEFRPLPNNTYITQSGS--LNTFIRMDVLSITNQVVRYRDDVYDRSW 198
LVNTG GTPFISALE RPLP++ Y + GS L R++ + +RY DDVYDR W
Sbjct: 137 LVNTGTGTPFISALELRPLPDSLYPSSGGSQALKLVARLNFGG-SEGTIRYPDDVYDRIW 195
Query: 199 APY-AYPQWQQITTPRTIDED-RYNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKF 256
P+ + P W QI+T ++D Y PS V+++A TP N S PL D ++
Sbjct: 196 EPFFSSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAVTPTNASAPLNFTWDLVDPNFEY 255
Query: 257 YMYMHFAELEELQANQSRQFNISFNGNHLYGPVVPSYRHTTTA-----YTTSALTGEKLQ 311
Y+Y+HFAE++ L ++R+F+I NG +YG V P Y T T + + G L
Sbjct: 256 YVYLHFAEIQSL---ETREFDIYINGKTVYGDVSPKYLGTDTGALYLDFPVNVSGGGLLN 312
Query: 312 FSIHKTENSTLPPILNAIEFYLV 334
S+ T STLPP+LNA+E + V
Sbjct: 313 ISLVPTSGSTLPPLLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 2e-48
Identities = 73/194 (37%), Positives = 105/194 (54%), Gaps = 12/194 (6%)
Query: 543 LGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGY-EQFEAEVILLRTVHHKNLTTLYGYC 600
LGEG FG VY +VA+K++ E+ E+ +L+ ++H N+ LYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 601 NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPPRVH 659
+ N + L+ EY GSL++ L N LS + LRI + +GLEYLH G +H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL-KENEGKLSEDEILRILLQILEGLEYLHSNGI----IH 115
Query: 660 RDIKPANILL-NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE-YCQTFRLTE 717
RD+KP NILL +D + +LADFGLSK + L + GT Y+ PE +E
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSK--LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 718 KSDVYSFGVVLLEI 731
KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 5e-48
Identities = 71/202 (35%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 539 FETILGEGSFGKVYHGYLDDN-----TEVAVKML-SPSSRQGYEQFEAEVILLRTVHHKN 592
LGEG+FG+VY G L EVAVK L +S Q E+F E ++R + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-L 651
+ L G C E + ++ EYM G L YL N LS L A + A+G+EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQ 711
+HRD+ N L+ + +++DFGLS+ + + G ++ PE +
Sbjct: 122 NF----IHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKLPIRWMAPESLK 176
Query: 712 TFRLTEKSDVYSFGVVLLEIIT 733
+ T KSDV+SFGV+L EI T
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 6e-48
Identities = 68/207 (32%), Positives = 106/207 (51%), Gaps = 22/207 (10%)
Query: 539 FETILGEGSFGKVYHGYLDD-----NTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKN 592
LGEG+FG+VY G L T+VAVK L +S + E+F E +++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHL- 651
+ L G C +G + ++ EYM G L ++L + + L+ + L++A + A+G+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD----- 706
VHRD+ N L+ + +++DFGLS+ + G L
Sbjct: 122 NF----VHRDLAARNCLVTENLVVKISDFGLSRD-----IYEDDYYRKRGGGKLPIKWMA 172
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIIT 733
PE + + T KSDV+SFGV+L EI T
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 8e-48
Identities = 70/202 (34%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 539 FETILGEGSFGKVYHGYLDDN-----TEVAVKML-SPSSRQGYEQFEAEVILLRTVHHKN 592
LGEG+FG+VY G L EVAVK L +S Q E+F E ++R + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-L 651
+ L G C E + ++ EYM G L +YL + LS L A + A+G+EYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQ 711
+HRD+ N L+ + +++DFGLS+ + + G ++ PE +
Sbjct: 123 NF----IHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPESLK 177
Query: 712 TFRLTEKSDVYSFGVVLLEIIT 733
+ T KSDV+SFGV+L EI T
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 9e-47
Identities = 71/205 (34%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 542 ILGEGSFGKVYHGYLDDN----TEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTL 596
LGEG+FG+VY G L TEVAVK L S + + F E +++ + H N+ L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYL-------SDSNADVLSWEGRLRIATEAAQGLEYL 649
G C E + L+ EYM G L +YL LS + L A + A+G+EYL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 650 H-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE 708
VHRD+ N L+ + +++DFGLS+ + TG ++ PE
Sbjct: 122 ASKKF----VHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 709 YCQTFRLTEKSDVYSFGVVLLEIIT 733
+ T KSDV+SFGV+L EI T
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 71/200 (35%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYG 598
LG GSFG VY VAVK+L S + + E+ +LR + H N+ L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPPR 657
+ + + L+ EY G L +YLS LS + +IA + +GLEYLH G
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHSNGI---- 119
Query: 658 VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL-T 716
+HRD+KP NILL++ ++ADFGL+K S T GT Y+ PE
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 717 EKSDVYSFGVVLLEIITSRP 736
K DV+S GV+L E++T +P
Sbjct: 178 PKVDVWSLGVILYELLTGKP 197
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 5e-44
Identities = 66/199 (33%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGY-EQFEAEVILLRTVHHKNLTTLYGY 599
LGEGSFGKVY VA+K++ + E+ E+ +L+ + H N+ LY
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR-IATEAAQGLEYLH-LGCKPPR 657
+ +++ L+ EY G L + L LS E R + LEYLH G
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGR--LS-EDEARFYLRQILSALEYLHSKGI---- 118
Query: 658 VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTE 717
VHRD+KP NILL++ +LADFGL++ T GT Y+ PE +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 718 KSDVYSFGVVLLEIITSRP 736
D++S GV+L E++T +P
Sbjct: 176 AVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 2e-39
Identities = 71/245 (28%), Positives = 108/245 (44%), Gaps = 46/245 (18%)
Query: 542 ILGEGSFGKVYHGYLDDNTE-VAVK--MLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
+LG GSFG VY D E +AVK LS S + E E E+ +L ++ H N+ YG
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 599 YC--NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIAT------EAAQGLEYLH 650
E N + + EY++ GSL + +L G+L + +GL YLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSL--------SSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 651 LGCKPPR---VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDP 707
VHRDIK ANIL++ +LADFG +K + V GT ++ P
Sbjct: 119 ------SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 708 EYCQTFRLTEKSDVYSFGVVLLEIITSRP-------------AIANTEEHKHISQWV--- 751
E + +D++S G ++E+ T +P I ++ E I + +
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEE 232
Query: 752 --DFM 754
DF+
Sbjct: 233 AKDFL 237
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 3e-39
Identities = 123/447 (27%), Positives = 195/447 (43%), Gaps = 53/447 (11%)
Query: 58 PLWNLRSFP--EGKRNCYNVKLAKDVRYLIRASFAHGDYDGKGTVPEFDLHLGPNKWESV 115
PL LR FP +G NCYN+ Y +R F + P FD+ + + S+
Sbjct: 68 PLKTLRYFPLSDGPENCYNINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSL 127
Query: 116 ILG--NVSTIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRPLPNNTY-ITQSGSLN 172
G + + E + ++ S +C +TG G P I ++E + + Y S
Sbjct: 128 KSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILSIEILQVDDKAYNFGPSWGQG 187
Query: 173 TFIRMDV-LSITNQV----VRYRDDVY--DRSWAP---YAYPQWQQITTPRTIDEDRYND 222
+R LS Y D + DR W + Q I+T I +
Sbjct: 188 VILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAP 247
Query: 223 YQLPSIVMRSAATPKNKSEPLLIDLVHEDSTSKFYMYMHFAELEE-LQANQSRQFNISFN 281
P + +SA + ++P L + D + +++HFAE++ + A R F++ N
Sbjct: 248 NFYPESLYQSALVSTD-TQPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLIN 306
Query: 282 GNHLYGPV----VPSYRHTT-TAYTTSALTGEKLQFSIHKTENSTLPPILNAIEFYLVQD 336
G+ + V + R+T T A++G L + + + I+NAIE + +
Sbjct: 307 GDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQPKKGTH--AIINAIEVFEII- 363
Query: 337 FSQSETEQADVDAIMNIKS---LYKRKDWQGDPCAPQAFLWNGLGCSYND---------- 383
++S+T +V A+ +KS L R W GDPC PQ W+G C ++
Sbjct: 364 TAESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGL 423
Query: 384 ------------NDPPR---ITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVP 428
ND + + S+NLS + G IPP L ++T +E LDLS NS G +P
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 429 EFLSKLQYLRVLNLTGNMLTGPLPAGL 455
E L +L LR+LNL GN L+G +PA L
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 6e-39
Identities = 128/486 (26%), Positives = 215/486 (44%), Gaps = 67/486 (13%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L LS L+G IP LS+ + LDLS+N L+G +P S++ L L+L+ N
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 447 LTGPLPAGL--------VERSKN---GSL--------------SLSVDLCSS------YP 475
L+G +P L V S N GSL + ++DLC P
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618
Query: 476 CKENNKKKNNFVFPVIASFASLLVVTLAISA-IYWRHKR---LRK----DGSLETK---- 523
CK K + + F + + + LV+ L ++ R + L++ DG+ E +
Sbjct: 619 CKRVRKTPSWW-FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDS 677
Query: 524 --KRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDN-TEVAVKMLSPSSRQGYEQFEA 580
+ T +I + E ++ G G Y G N + VK ++ + +
Sbjct: 678 KVSKSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SS 732
Query: 581 EVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIAT 640
E+ + + H N+ L G C LI+EY+ +L E L + LSWE R +IA
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAI 787
Query: 641 EAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAG 700
A+ L +LH C P V ++ P I+++ + + L L + +S+
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS---- 842
Query: 701 TFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSR-PAIANTEEHKHISQWVDFMLAQGD 759
Y+ PE +T +TEKSD+Y FG++L+E++T + PA A H I +W + +
Sbjct: 843 --AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH 900
Query: 760 IKNIVDPKLHGDIDVNS--AWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARKE 817
+ +DP + GD+ VN + + +A+ C + T RP N V+ L+ ++
Sbjct: 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVT 960
Query: 818 GHRFGS 823
G +F S
Sbjct: 961 GLKFSS 966
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 66/239 (27%), Positives = 116/239 (48%), Gaps = 17/239 (7%)
Query: 538 DFETI--LGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLT 594
FE + +G+G FG+VY + EVA+K++ S++ E+ E+ +L+ H N+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR-IATEAAQGLEYLHLGC 653
YG + +++ ++ E+ + GSL++ L S L+ E ++ + E +GLEYLH
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLT-ESQIAYVCKELLKGLEYLH--- 115
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF 713
+HRDIK ANILL + +L DFGLS + + GT ++ PE
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGK 172
Query: 714 RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772
K+D++S G+ +E+ +P + K + F +A + +P+ D
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKAL-----FKIATNGPPGLRNPEKWSDE 226
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 31/204 (15%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE 602
LG G FG+V+ G + T+VAVK L P + E F E +++ + H L LY C+E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 603 GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDI 662
I ++ EYM+ GSL ++L L + +A + A+G+ YL +HRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129
Query: 663 KPANILLNDQFQARLADFGLSKT-------------FPIEGVSHLSTGVAGTFGYLDPEY 709
NIL+ + ++ADFGL++ FPI+ + PE
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTA--------------PEA 175
Query: 710 CQTFRLTEKSDVYSFGVVLLEIIT 733
R T KSDV+SFG++L EI+T
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 77/239 (32%), Positives = 114/239 (47%), Gaps = 44/239 (18%)
Query: 543 LGEGSFGKVYHGYL------DDNTEVAVKMLS-PSSRQGYEQFEAEVILLRTVHHKNLTT 595
LGEG+FGKV+ G +D VAVK L +S + FE E LL H+N+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYL------------SDSNADVLSWEGRLRIATEAA 643
YG C EG+ +++EYM +G L ++L DS L+ L+IA + A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 644 QGLEYL---HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT------FPIEGVSHL 694
G+ YL H VHRD+ N L+ ++ DFG+S+ + + G + L
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
++ PE + T +SDV+SFGVVL EI T +P ++N E + I+Q
Sbjct: 187 P------IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 5/203 (2%)
Query: 531 EITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH 590
EI + + LG G FG+V+ G ++ T VAVK L P + + F AE +++ + H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRH 60
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
L LY C I ++ E M GSL EYL L + +A + A G+ YL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
+HRD+ N+L+ + ++ADFGL++ E + G + PE
Sbjct: 121 ---AQNYIHRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEAA 176
Query: 711 QTFRLTEKSDVYSFGVVLLEIIT 733
R + KSDV+SFG++L EI+T
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (315), Expect = 4e-31
Identities = 80/269 (29%), Positives = 121/269 (44%), Gaps = 20/269 (7%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKMLSP---SSRQGYEQFEAEVILLRTV-HHKNLTTLYG 598
LGEGSFG+VY D VA+K+L+ S + E+F E+ +L ++ H N+ LY
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 599 YCNEGNQIGLIYEYMANGSLEEYL-SDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPR 657
+ + + L+ EY+ GSLE+ L LS L I + LEYLH
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGI--- 122
Query: 658 VHRDIKPANILLN-DQFQARLADFGLSKTFPIEGVS----HLSTGVAGTFGYLDPEY--- 709
+HRDIKP NILL+ D +L DFGL+K P G + L + GT GY+ PE
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 710 CQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769
+ SD++S G+ L E++T P + SQ + +L + L
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT--PSLASPLS 240
Query: 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNM 798
+ A ++ ++ R +
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 8e-30
Identities = 61/191 (31%), Positives = 101/191 (52%), Gaps = 5/191 (2%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE 602
LG G FG+V+ G + VA+K+L + F+ EV L+ + HK+L +L+ C+
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 603 GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDI 662
G + +I E M GSL +L VL + +A + A+G+ YL + +HRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 663 KPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVY 722
NIL+ + ++ADFGL++ I+ +LS+ + + PE + KSDV+
Sbjct: 131 AARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVW 188
Query: 723 SFGVVLLEIIT 733
SFG++L E+ T
Sbjct: 189 SFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 29/201 (14%)
Query: 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGY 599
TI G+G FG V G VAVK L S + F AE ++ T+ H NL L G
Sbjct: 12 ATI-GKGEFGDVMLGDYRGQK-VAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGV 68
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVH 659
+GN + ++ EYMA GSL +YL V++ +L A + +G+EYL + VH
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVH 125
Query: 660 RDIKPANILLNDQFQARLADFGLSKT---------FPIEGVSHLSTGVAGTFGYLDPEYC 710
RD+ N+L+++ A+++DFGL+K P++ + PE
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTA--------------PEAL 171
Query: 711 QTFRLTEKSDVYSFGVVLLEI 731
+ + + KSDV+SFG++L EI
Sbjct: 172 REKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 72/202 (35%), Positives = 110/202 (54%), Gaps = 17/202 (8%)
Query: 543 LGEGSFGKVY---HGYLDDNT--EVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTL 596
LGEG FGKV + L DNT +VAVK L+ S Q FE E+ +LRT+ H+N+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 597 YGYCNE--GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGC 653
G C + G + LI EY+ +GSL +YL + D ++ + L +++ +G++YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQRY 130
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI--EGVSHLSTGVAGTFGYLDPEYCQ 711
+HRD+ NIL+ + +++DFGL+K P + G + F Y PE +
Sbjct: 131 ----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLR 185
Query: 712 TFRLTEKSDVYSFGVVLLEIIT 733
T + + SDV+SFGV L E+ T
Sbjct: 186 TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 66/205 (32%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE 602
LG G FG+V+ GY +++T+VAVK L P + + F E L++T+ H L LY +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 603 GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDI 662
I +I EYMA GSL ++L + + + + A+G+ Y+ + +HRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129
Query: 663 KPANILLNDQFQARLADFGLSKTFPIEGVSHLS-TGVAGTFGYLDPEYCQTFRLTEKSDV 721
+ AN+L+++ ++ADFGL++ IE + + G + PE T KSDV
Sbjct: 130 RAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 722 YSFGVVLLEIIT----SRPAIANTE 742
+SFG++L EI+T P ++N++
Sbjct: 188 WSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 537 NDFETI--LGEGSFGKVYHG-YLDDNTEVAVKML-SPSSRQGYEQFEAEVILLRTVHHKN 592
+D E + LG+GS G VY + A+K + + +Q E+ LR+
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 593 LTTLYG-YCNEGNQIGLIYEYMANGSLEEYLSDSNA---DVLSWEGRLRIATEAAQGLEY 648
+ YG + EG +I ++ EYM GSL + L VL+ IA + +GL+Y
Sbjct: 61 VVKCYGAFYKEG-EISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDY 114
Query: 649 LHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA------GTF 702
LH +HRDIKP+N+L+N + + ++ADFG+SK L + GT
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKV--------LENTLDQCNTFVGTV 164
Query: 703 GYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSR 735
Y+ PE Q + +D++S G+ LLE +
Sbjct: 165 TYMSPERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 72/232 (31%), Positives = 104/232 (44%), Gaps = 44/232 (18%)
Query: 531 EITKITNDFETILGEGSFGKVYHGYL------DDNTEVAVKML----SPSSRQGYEQFEA 580
EI F LGEG+FGKVY G L T VA+K L P +Q + Q
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ--- 57
Query: 581 EVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL--------------SDSN 626
E L+ + H N+ L G C + +++EY+A+G L E+L ++
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 627 ADVLSWEGRLRIATEAAQGLEYL---HLGCKPPRVHRDIKPANILLNDQFQARLADFGLS 683
L L IA + A G+EYL H VHRD+ N L+ + +++DFGLS
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHF------VHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 684 KTFPIEGVSHLSTGVAGT----FGYLDPEYCQTFRLTEKSDVYSFGVVLLEI 731
+ + S V ++ PE + T +SD++SFGVVL EI
Sbjct: 172 R----DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 67/210 (31%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 543 LGEGSFGKVY---HGYLDDNTEVAVK--MLSPSSRQGYEQFEAEVILLRTVHHKNLTTLY 597
+G+GSFGKVY D +K LS S + E EV +L+ ++H N+ Y
Sbjct: 8 IGKGSFGKVYLVRR--KSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 598 GYCNEGNQIGLIYEYMANGSLEEYLSDSNAD--------VLSWEGRLRIATEAAQGLEYL 649
E ++ ++ EY G L + + + +L W + L+YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW------FVQLCLALKYL 119
Query: 650 HLGCKPPR--VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDP 707
H R +HRDIKP NI L +L DFG+SK V T V GT YL P
Sbjct: 120 H-----SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKT-VVGTPYYLSP 172
Query: 708 EYCQTFRLTEKSDVYSFGVVLLEIITSRPA 737
E CQ KSD++S G VL E+ T +
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 8e-28
Identities = 71/217 (32%), Positives = 113/217 (52%), Gaps = 12/217 (5%)
Query: 531 EITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH 590
E+ + T LG G FG+V+ GY + +T+VA+K L S E F AE L++ + H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-EAFLAEANLMKQLQH 60
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
L LY + I +I EYM NGSL ++L L+ + +A + A+G+ ++
Sbjct: 61 PRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS-TGVAGTFGYLDPEY 709
+ +HRD++ ANIL+++ ++ADFGL++ IE + + G + PE
Sbjct: 120 ---RKNYIHRDLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEA 174
Query: 710 CQTFRLTEKSDVYSFGVVLLEIIT----SRPAIANTE 742
T KSDV+SFG++L EI+T P + N E
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 542 ILGEGSFGKVYHGYLDDNTE--VAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLY 597
++G G+FG VY G L+ T VA+K +S + + E+ LL+ + H N+
Sbjct: 7 LIGRGAFGVVYKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 598 GYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRL------RIATEAAQGLEYLHL 651
G + + +I EY NGSL ++ G + QGL YLH
Sbjct: 66 GSIETSDSLYIILEYAENGSL--------RQIIKKFGPFPESLVAVYVYQVLQGLAYLH- 116
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQ 711
+ +HRDIK ANIL +LADFG++ + VS V GT ++ PE +
Sbjct: 117 --EQGVIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPEVIE 172
Query: 712 TFRLTEKSDVYSFGVVLLEIITSRP 736
+ SD++S G ++E++T P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-26
Identities = 72/217 (33%), Positives = 112/217 (51%), Gaps = 12/217 (5%)
Query: 531 EITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH 590
EI + + LG G FG+V+ G + NT+VAVK L P + E F E +++ + H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRH 60
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
L LY +E I ++ EYM+ GSL ++L D L + +A + A G+ Y+
Sbjct: 61 DKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS-TGVAGTFGYLDPEY 709
+ +HRD++ ANIL+ D ++ADFGL++ IE + + G + PE
Sbjct: 120 ---RMNYIHRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 174
Query: 710 CQTFRLTEKSDVYSFGVVLLEIITS----RPAIANTE 742
R T KSDV+SFG++L E++T P + N E
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE 211
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 538 DFETILGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTL 596
D LGEGS+G VY + + VA+K++ + ++ E+ +L+ +
Sbjct: 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIAT---EAAQGLEYLHLGC 653
YG + + ++ EY GS+ + + +N L+ E IA + +GLEYLH
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEE---EIAAILYQTLKGLEYLHSNK 119
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF 713
K +HRDIK NILLN++ QA+LADFG+S + V GT ++ PE Q
Sbjct: 120 K---IHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEI 174
Query: 714 RLTEKSDVYSFGVVLLEIITSRPAIAN 740
K+D++S G+ +E+ +P ++
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 70/217 (32%), Positives = 111/217 (51%), Gaps = 12/217 (5%)
Query: 531 EITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH 590
EI + + E LG+G FG+V+ G + T VA+K L P + E F E +++ + H
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRH 60
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
+ L LY +E I ++ EYM+ GSL ++L L + +A + A G+ Y+
Sbjct: 61 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS-TGVAGTFGYLDPEY 709
+ VHRD++ ANIL+ + ++ADFGL++ IE + + G + PE
Sbjct: 120 ---RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 174
Query: 710 CQTFRLTEKSDVYSFGVVLLEIITS----RPAIANTE 742
R T KSDV+SFG++L E+ T P + N E
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 211
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 10/211 (4%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE 602
LG G FG V+ G +VA+KM+ + + F E ++ + H NL LYG C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 603 GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDI 662
I ++ EYMANG L YL L E L + ++ + +EYL +HRD+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126
Query: 663 KPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVY 722
N L+ + +++DFGL++ + ++ S G + PE R + KSDV+
Sbjct: 127 AARNCLVGEDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185
Query: 723 SFGVVLLEIITS----RPAIANTEEHKHISQ 749
SFGV++ E+ + +N+E + +S
Sbjct: 186 SFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 542 ILGEGSFGKVYHGY---LDDNT--EVAVKML-SPSSRQGYEQFEAEVILLRTVHHKNLTT 595
+LG G+FG VY G + VA+K+L +S + ++ E ++ +V H ++
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL---HLG 652
L G C +Q+ LI + M G L +Y+ + + D + + L + A+G+ YL L
Sbjct: 74 LLGIC-LSSQVQLITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLEEKRL- 130
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
VHRD+ N+L+ ++ DFGL+K ++ + + G ++ E
Sbjct: 131 -----VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 713 FRLTEKSDVYSFGVVLLEIIT--SRP 736
T KSDV+S+GV + E++T ++P
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 64/196 (32%), Positives = 105/196 (53%), Gaps = 13/196 (6%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKM----LSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
+G+G+FG VY G L NTEVAVK L P ++ + Q EAE+ L+ H N+ L G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQ-EAEI--LKQYDHPNIVKLIG 59
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRV 658
C + I ++ E + GSL +L + L+ + L+++ +AA G+EYL +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLR-KKKNRLTVKKLLQMSLDAAAGMEYLESKNC---I 115
Query: 659 HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGT-FGYLDPEYCQTFRLTE 717
HRD+ N L+ + +++DFG+S+ G+ +S G+ + PE R T
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 718 KSDVYSFGVVLLEIIT 733
+SDV+S+G++L E +
Sbjct: 175 ESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 68/217 (31%), Positives = 113/217 (52%), Gaps = 12/217 (5%)
Query: 531 EITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH 590
EI + + + LG+G FG+V+ G + T+VA+K L P + E F E +++ + H
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRH 60
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
L LY +E I ++ E+M GSL ++L + + L + +A + A G+ Y+
Sbjct: 61 DKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS-TGVAGTFGYLDPEY 709
+ +HRD++ ANIL+ D ++ADFGL++ IE + + G + PE
Sbjct: 120 ---RMNYIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEA 174
Query: 710 CQTFRLTEKSDVYSFGVVLLEIITS----RPAIANTE 742
R T KSDV+SFG++L E++T P + N E
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE 211
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 72/205 (35%), Positives = 107/205 (52%), Gaps = 16/205 (7%)
Query: 539 FETILGEGSFGKV---YHGYLDDNTE--VAVKMLSPSSRQGYEQFEAEVILLRTVHHKNL 593
F LG+G+FG V + L DNT VAVK L S+ + FE E+ +L+++ H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 594 TTLYGYCNEG--NQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHL 651
G C + L+ EY+ GSL +YL + + L L A++ +G+EYL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYL-- 124
Query: 652 GCKPPR-VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST--GVAGTFGYLDPE 708
G K R VHRD+ NIL+ + + ++ DFGL+K P + + G + F Y PE
Sbjct: 125 GSK--RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PE 181
Query: 709 YCQTFRLTEKSDVYSFGVVLLEIIT 733
+ + SDV+SFGVVL E+ T
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 68/210 (32%), Positives = 107/210 (50%), Gaps = 16/210 (7%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKM-----LSPSSRQGYEQFEAEVILLRTVHHKNLTT 595
+LG+G+FG+VY Y +D E+AVK SP +++ E E+ LL+ + H+ +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKP 655
YG + + + EYM GS+++ L A L+ + + +G+EYLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYLH---SN 123
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG---VAGTFGYLDPEYCQT 712
VHRDIK ANIL + +L DFG SK ++ + TG V GT ++ PE
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKR--LQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 713 FRLTEKSDVYSFGVVLLEIITSRPAIANTE 742
K+DV+S G ++E++T +P A E
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 59/194 (30%), Positives = 100/194 (51%), Gaps = 12/194 (6%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGY---EQFEAEVILLRTVHHKNLTTLYGY 599
+G G FG V+ GY + +VA+K + R+G E F E ++ + H L LYG
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVH 659
C E + I L++E+M +G L +YL + S E L + + +G+ YL +H
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESSNV---IH 123
Query: 660 RDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKS 719
RD+ N L+ + +++DFG+++ F ++ STG + PE + + KS
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 720 DVYSFGVVLLEIIT 733
DV+SFGV++ E+ +
Sbjct: 183 DVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 6e-25
Identities = 73/233 (31%), Positives = 110/233 (47%), Gaps = 32/233 (13%)
Query: 543 LGEGSFGKVY----HGYL--DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTL 596
LGEG+FGKV+ H L D VAVK L +S + F+ E LL + H+++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADV-------------LSWEGRLRIATEAA 643
YG C EG + +++EYM +G L +L D L+ L IA++ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 644 QGLEY---LHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAG 700
G+ Y LH VHRD+ N L+ ++ DFG+S+ +
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 701 TFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
++ PE + T +SD++SFGVVL EI T +P ++NTE + I+Q
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 70/200 (35%), Positives = 109/200 (54%), Gaps = 13/200 (6%)
Query: 543 LGEGSFGKVYHGYLD---DNT--EVAVKMLSPSSRQGY-EQFEAEVILLRTVHHKNLTTL 596
LGEG FGKV D DNT +VAVK L P S + + E+ +LR ++H+N+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 597 YGYCNE--GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK 654
G C E GN I LI E++ +GSL+EYL N + ++ + +L+ A + +G++YL G +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLP-RNKNKINLKQQLKYAVQICKGMDYL--GSR 128
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPI-EGVSHLSTGVAGTFGYLDPEYCQTF 713
VHRD+ N+L+ + Q ++ DFGL+K + + + + PE
Sbjct: 129 Q-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 714 RLTEKSDVYSFGVVLLEIIT 733
+ SDV+SFGV L E++T
Sbjct: 188 KFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 61/192 (31%), Positives = 95/192 (49%), Gaps = 6/192 (3%)
Query: 543 LGEGSFGKVYHGYLDD-NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN 601
LG G +G+VY G + VAVK L + + E+F E +++ + H NL L G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 602 EGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRD 661
+I E+M G+L +YL + N ++ L +AT+ + +EYL K +HRD
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 129
Query: 662 IKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDV 721
+ N L+ + ++ADFGLS+ G + PE + + KSDV
Sbjct: 130 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 188
Query: 722 YSFGVVLLEIIT 733
++FGV+L EI T
Sbjct: 189 WAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYE-QFEAEVILLRTVHHKNLTTLYGY 599
LGEG+ G V L + + A+K ++ + Q E+ + ++ + YG
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 600 C--NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGR------LRIATEAAQGLEYLHL 651
+ IG+ EY GSL+ V GR +IA +GL YLH
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYKK----VKKRGGRIGEKVLGKIAESVLKGLSYLH- 122
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQ 711
+HRDIKP+NILL + Q +L DFG+S E V+ L+ GT Y+ PE Q
Sbjct: 123 --SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG----ELVNSLAGTFTGTSFYMAPERIQ 176
Query: 712 TFRLTEKSDVYSFGVVLLEIITSR 735
+ SDV+S G+ LLE+ +R
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 71/223 (31%), Positives = 101/223 (45%), Gaps = 23/223 (10%)
Query: 543 LGEGSFGKVY---HGYLDDNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTL 596
LG+GSFGKV D A+K+L R+ E E +L ++H + L
Sbjct: 1 LGKGSFGKVLLVRK--KDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR-IATEAAQGLEYLH-LGCK 654
+ ++ L+ EY G L +LS S E R R A E LEYLH LG
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLS--KEGRFS-EERARFYAAEIVLALEYLHSLGI- 114
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFR 714
++RD+KP NILL+ +L DFGL+K S +T GT YL PE
Sbjct: 115 ---IYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNT-FCGTPEYLAPEVLLGKG 169
Query: 715 LTEKSDVYSFGVVLLEIITSRP--AIANTEE--HKHISQWVDF 753
+ D +S GV+L E++T +P + +E K + + F
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF 212
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 537 NDFETI--LGEGSFG---KVYHGYLDDNTEVAVK-MLSPSSRQGYEQFEAEVILLRTVHH 590
+D E + LG G+ G KV H +AVK + + +Q E+ +L +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLH--RPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNS 58
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDS----NADVLSWEGRLRIATEAAQGL 646
+ YG I + EYM GSL++ L + +L +IA +GL
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGL 113
Query: 647 EYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
YLH K +HRD+KP+NIL+N + Q +L DFG+S + V+ L+ GT Y+
Sbjct: 114 TYLHEKHKI--IHRDVKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYMA 167
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIITSR 735
PE Q + KSD++S G+ L+E+ T R
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 70/203 (34%), Positives = 109/203 (53%), Gaps = 18/203 (8%)
Query: 542 ILGEGSFGKVYHGYLDDN----TEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKNLTTL 596
++G+G FG VYHG L D+ AVK L+ + + EQF E I+++ H N+ +L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 597 YGYC--NEGNQIGLIYEYMANGSLEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLG 652
G C +EG+ + ++ YM +G L ++ N V G + A+G+EYL
Sbjct: 62 LGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIG---FGLQVAKGMEYL--- 114
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSK-TFPIEGVS-HLSTGVAGTFGYLDPEYC 710
VHRD+ N +L++ F ++ADFGL++ + E S H TG ++ E
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 711 QTFRLTEKSDVYSFGVVLLEIIT 733
QT + T KSDV+SFGV+L E++T
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 31/221 (14%)
Query: 528 TYAEITKITNDFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLR 586
+ + ++ + E I GEG+ G+VY EVA+K + +Q E E+++++
Sbjct: 13 SEGDPRELYKNLEKI-GEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELIINEILIMK 70
Query: 587 TVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSW------EGRL-RIA 639
H N+ Y G+++ ++ EYM GSL D+++ E ++ +
Sbjct: 71 DCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL--------TDIITQNFVRMNEPQIAYVC 122
Query: 640 TEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFG----LSKTFPIEGVSHLS 695
E QGLEYLH +HRDIK NILL+ +LADFG L+K S +
Sbjct: 123 REVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK-----EKSKRN 174
Query: 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
+ V GT ++ PE + K D++S G++ +E+ P
Sbjct: 175 S-VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 540 ETILGEGSFGKVYHGYLDDNTE----VAVKMLSP-SSRQGYEQFEAEVILLRTVHHKNLT 594
E ++G G FG+V G L + VA+K L SS + F E ++ H N+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK 654
L G + + +I EYM NGSL+++L + N + + + A G++YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFG------YLDPE 708
VHRD+ NIL+N +++DFGLS+ S T G + PE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSR------RLEDSEATYTTKGGKIPIRWTAPE 178
Query: 709 YCQTFRLTEKSDVYSFGVVLLEIIT--SRP 736
+ T SDV+SFG+V+ E+++ RP
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 38/227 (16%)
Query: 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS--SRQGYEQF---EAEVILLRTVHHK 591
F I+GEGSF V + N E A+K+L ++ ++ E EV L R H
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLNGHP 62
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYL---SDSNADVLSWEGRLRIATEAAQGLEY 648
+ LY + + + EY NG L +Y+ + + A E LEY
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF-----YAAEILLALEY 117
Query: 649 LH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA-------- 699
LH G +HRD+KP NILL+ ++ DFG +K + G A
Sbjct: 118 LHSKGI----IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 700 ----------GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
GT Y+ PE + SD+++ G ++ +++T +P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 35/213 (16%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKM--LSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGY 599
+G G+FGKVY LD +AVK + + + ++ E+ +L + H NL YG
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRL-------RIATEAAQGLEYLHLG 652
++ + EY + G+LEE L GR+ + +GL YLH
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLE---------HGRILDEHVIRVYTLQLLEGLAYLH-- 116
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSK------TFPIEGVSHLSTGVAGTFGYLD 706
VHRDIKPANI L+ +L DFG + T E V L AGT Y+
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL----AGTPAYMA 171
Query: 707 PEYCQTFRLTEK---SDVYSFGVVLLEIITSRP 736
PE + +D++S G V+LE+ T +
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 3e-23
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 11/211 (5%)
Query: 538 DFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFEA--EVILLRTVHHKN 592
DFE + +G+GSFG V+ + V A+K + S E+ EA E +L +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG 652
+ Y + ++ ++ EY NG L + L L + R + GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH-- 118
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
+HRDIK N+ L+ ++ D G++K ++ + + GT YL PE C+
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFANTIVGTPYYLSPELCED 175
Query: 713 FRLTEKSDVYSFGVVLLEIITSR-PAIANTE 742
EKSDV++ GVVL E T + P AN +
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 71/224 (31%), Positives = 115/224 (51%), Gaps = 22/224 (9%)
Query: 540 ETILGEGSFGKVYHGYLD----DNTEVAVKMLSPSSRQGYEQ-FEAEVILLRTVHHKNLT 594
+ ++G G FG+V+ G L VA+K L P + Q F +E ++ H N+
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWE--GRLRIATEAAQGLEYLHLG 652
L G + +I EYM NG+L++YL D + + S++ G LR A G++YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL--- 123
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKT---FPIEGVSHLSTGVAGTFGYLDPEY 709
VHRD+ NIL+N + +++DFGLS+ P EG ++ ++G + PE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP-EG-TYTTSGGKIPIRWTAPEA 181
Query: 710 CQTFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
+ T SDV+SFG+V+ E+++ RP ++N E K I+
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND 225
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 7e-23
Identities = 70/202 (34%), Positives = 103/202 (50%), Gaps = 19/202 (9%)
Query: 543 LGEGSFGKV----YHGYLDDNTE-VAVKML-SPSSRQGYEQFEAEVILLRTVHHKNLTTL 596
LGEG FGKV Y D E VAVK L +Q ++ E+ +L+T++H+N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 597 YGYCNEGNQIG--LIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK 654
G C+E G LI EY+ GSL +YL L+ L A + +G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLH---S 125
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL---STGVAGTFGYLDPEYCQ 711
+HRD+ N+LL++ ++ DFGL+K P EG + G + F Y E +
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVREDGDSPVFWYA-VECLK 183
Query: 712 TFRLTEKSDVYSFGVVLLEIIT 733
+ + SDV+SFGV L E++T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 543 LGEGSFGKVYHGYL------DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTL 596
LGEG+FGKV+ D VAVK L +S + F E LL + H+++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNAD-VLSWEGR----------LRIATEAAQG 645
YG C EG+ + +++EYM +G L ++L D VL EG L IA + A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 646 LEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYL 705
+ YL VHRD+ N L+ + ++ DFG+S+ + ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 706 DPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
PE + T +SDV+S GVVL EI T
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 68/204 (33%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLS-----PSSRQGYEQFEAEVILLRTVHHKNLTTL 596
LG GSFG VY G LDD AVK +S + ++ +Q E E+ LL + H N+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAA-QGLEYLHLGCKP 655
G E + + + E + GSL + L + E +R+ T GLEYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGS---FPEPVIRLYTRQILLGLEYLH---DR 121
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST--GVAGTFGYLDPEYC-QT 712
VHRDIK ANIL++ +LADFG++K V S G+ ++ PE Q
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQ-----VVEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 713 FRLTEKSDVYSFGVVLLEIITSRP 736
+D++S G +LE+ T +P
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKP 200
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 2e-22
Identities = 70/218 (32%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 543 LGEGSFGKVYH----GYL--DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKNLTT 595
+G+G+FG+V+ G L + T VAVKML +S F+ E L+ H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYL--------------------SDSNADVLSWEGR 635
L G C G + L++EYMA G L E+L N LS +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 636 LRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695
L IA + A G+ YL + VHRD+ N L+ + ++ADFGLS+ S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
A ++ PE R T +SDV+++GVVL EI +
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-22
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE 602
LG G FG V +G +VA+KM+ S E E ++++ + H+ L LYG C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMK-LSHEKLVQLYGVCTK 70
Query: 603 GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDI 662
I ++ EYM+NG L YL + + L + + +G+ YL +HRD+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ-LLEMCKDVCEGMAYLE---SKQFIHRDL 126
Query: 663 KPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVY 722
N L++DQ +++DFGLS+ + ++ S G + PE + + KSDV+
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185
Query: 723 SFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
+FGV++ E+ + P N+E + +SQ
Sbjct: 186 AFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 542 ILGEGSFGKVYHGYLDDNTEVAVKM--LSPS----SRQGYEQFEAEVILLRTVHHKNLTT 595
+LG+G++G VY G + +AVK L S + + YE+ + EV LL+++ H N+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIAT-EAAQGLEYLHLGCK 654
G C + N I + E++ GS+ L+ E T + G+ YLH C
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLP---EPVFCKYTKQILDGVAYLHNNCV 123
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV----SHLSTGVAGTFGYLDPEYC 710
VHRDIK N++L +L DFG ++ G+ S++ + GT ++ PE
Sbjct: 124 ---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 711 QTFRLTEKSDVYSFGVVLLEIITSRPAIAN 740
KSD++S G + E+ T +P +A+
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLAS 210
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-22
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 541 TILGEGSFGKVYHGYL------DDNTEVAVKMLSPSSRQGYEQ-FEAEVILLRTVHHKNL 593
T LG G FG+V+ T V VK L + + + F E+ + R + HKN+
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADV-------LSWEGRLRIATEAAQGL 646
L G C E +I EY G L+++L + + LS + ++ + T+ A G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 647 EYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
++L VHRD+ N L++ Q + +++ LSK L + +L
Sbjct: 131 DHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLA 186
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIITS 734
PE Q + KSDV+SFGV++ E+ T
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQ 214
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 4e-22
Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLS--------PSS--RQGYEQFEAEVILLRTVHH 590
LGEG++G VY VA+K + PS+ R E+ LL+ + H
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR--------EISLLKELKH 57
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
N+ L + ++ L++EY L++YL D LS I + +GL Y H
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 651 LGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE- 708
R+ HRD+KP NIL+N +LADFGL++ F I + + V T Y PE
Sbjct: 116 SH----RILHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVV-TLWYRAPEI 169
Query: 709 YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
+ + D++S G + E+IT +P
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 8e-22
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 543 LGEGSFGKVYHGY------LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTL 596
LGEG+FGKV+ D VAVK L + + F+ E LL + H+++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADV--------------LSWEGRLRIATEA 642
YG C +G+ + +++EYM +G L ++L D L L IA++
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 643 AQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF 702
A G+ YL VHRD+ N L+ ++ DFG+S+ +
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 703 GYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
++ PE + T +SDV+SFGV+L EI T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 67/217 (30%), Positives = 112/217 (51%), Gaps = 12/217 (5%)
Query: 531 EITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH 590
EI + + E LG G FG+V+ + +T+VAVK + P S E F AE +++T+ H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH 60
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
L L+ + I +I E+MA GSL ++L + + + A+G+ ++
Sbjct: 61 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS-TGVAGTFGYLDPEY 709
+ +HRD++ ANIL++ ++ADFGL++ IE + + G + PE
Sbjct: 120 ---QRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEA 174
Query: 710 CQTFRLTEKSDVYSFGVVLLEIIT----SRPAIANTE 742
T KSDV+SFG++L+EI+T P ++N E
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 543 LGEGSFGKVYHGYL-----DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKNLTTL 596
LGE +FGK+Y G+L D VA+K L ++ Q + +F+ E L+ +HH N+ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYL------------SDSNADV---LSWEGRLRIATE 641
G + + +++EY+ G L E+L SD + V L L IA +
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 642 AAQGLEYL--HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699
A G+EYL H VH+D+ NIL+ +Q +++D GLS+ +
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
++ PE + + SD++SFGVVL EI +
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 73/274 (26%), Positives = 120/274 (43%), Gaps = 30/274 (10%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQ-GYEQFEAEVILLRTVHHKN 592
+D+E I +G G+ VY L +N +VA+K + Q ++ EV + +H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNA-DVLSWEGRLRIAT---EAAQGLEY 648
+ Y G+++ L+ Y++ GSL + + S L IAT E +GLEY
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD---EAIIATVLKEVLKGLEY 117
Query: 649 LHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF--PIEGVSHLSTGVAGTFGYLD 706
LH ++HRDIK NILL + ++ADFG+S + + + GT ++
Sbjct: 118 LH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 707 PEYCQTFR-LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765
PE + K+D++SFG+ +E+ T + K V + Q D
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-----VLMLTLQND-----P 224
Query: 766 PKLHGDIDVNSAWKAVE--IAMGCVSHSSTPRPN 797
P L D K+ I++ C+ + RP
Sbjct: 225 PSLETGADYKKYSKSFRKMISL-CLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 30/206 (14%)
Query: 543 LGEGSFGKVYHG-YLDDNTEVAVKMLS-PSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC 600
+G+GSFG+VY N VA+K++ + E + E+ L +T YG
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 601 NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR---IAT---EAAQGLEYLHLGCK 654
+G+++ +I EY GS D+L G+L IA E GLEYLH K
Sbjct: 69 LKGSKLWIIMEYCGGGSC--------LDLLK-PGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 655 PPRVHRDIKPANILLNDQFQARLADFG----LSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
+HRDIK ANILL+++ +LADFG L+ T S +T V GT ++ PE
Sbjct: 120 ---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-----SKRNTFV-GTPFWMAPEVI 170
Query: 711 QTFRLTEKSDVYSFGVVLLEIITSRP 736
+ EK+D++S G+ +E+ P
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 34/214 (15%)
Query: 543 LGEGSFGKVYHGYLDD------NTEVAVKMLSP--SSRQGYEQF-EAEVILLRTVHHKNL 593
LG+GSFG VY G T VA+K ++ S R+ E EA V+ HH +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH--V 71
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYL--------SDSNADVLSWEGRLRIATEAAQG 645
L G + G ++ E MA G L+ YL ++ + + +++A E A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 646 LEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT------FPIEGVSHLSTGVA 699
+ YL VHRD+ N ++ + ++ DFG+++ + G L
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV--- 185
Query: 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
++ PE + T KSDV+SFGVVL E+ T
Sbjct: 186 ---RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 38/213 (17%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQ---FEA--EVILLRTVHHKNLTTL 596
LGEG++ VY + VA+K + R+ + F A E+ LL+ + H N+ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 597 YG-YCNEGNQIGLIYEYMANGSLEEYLSD-----SNADVLSWEGRLRIATEAAQGLEYLH 650
+ ++ N I L++E+M LE+ + D + AD+ S+ +GLEYLH
Sbjct: 68 LDVFGHKSN-INLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT------LRGLEYLH 119
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE-- 708
+HRD+KP N+L+ +LADFGL+++F ++ V T Y PE
Sbjct: 120 ---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVV-TRWYRAPELL 174
Query: 709 -----YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
Y D++S G + E++ P
Sbjct: 175 FGARHY------GVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 8e-21
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSS-RQGYEQFEA-EVILLRTVHHKNLTTLYG 598
+GEG++G+VY VA+K + + ++G+ E+ LL+ + H N+ L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 599 YC--NEGNQIGLIYEYMA---NGSLEEYLSDSNADVLSWEGRLR-IATEAAQGLEYLHLG 652
I +++EYM G L+ + +V E +++ + +GL+YLH
Sbjct: 66 IVTSKGKGSIYMVFEYMDHDLTGLLD------SPEVKFTESQIKCYMKQLLEGLQYLH-S 118
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE---- 708
+HRDIK +NIL+N+ +LADFGL++ + + + V T Y PE
Sbjct: 119 NGI--LHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLG 175
Query: 709 ---YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
Y + D++S G +L E+ +P
Sbjct: 176 ATRY------GPEVDMWSVGCILAELFLGKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 18/212 (8%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKML-----SPSSRQGYEQFEAEVILLRTVHHKNLTT 595
+LG+G+FG+VY Y D E+AVK + SP + + E E+ LL+ + H+ +
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 596 LYGYCNEGNQ--IGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC 653
YG + + + + E+M GS+++ L A L+ + + +G+ YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLHSNM 126
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSK---TFPIEGVSHLSTGVAGTFGYLDPEYC 710
VHRDIK ANIL + +L DFG SK T + G S V GT ++ PE
Sbjct: 127 I---VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPYWMSPEVI 181
Query: 711 QTFRLTEKSDVYSFGVVLLEIITSRPAIANTE 742
K+D++S G ++E++T +P A E
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEA--EVILLRTVHHKNLTTLYG 598
++G G+FG V+ D V +K + E+ A E +L+ + H N+ Y
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRV 658
E + ++ EY G+L EY+ +L + L + L ++H +
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123
Query: 659 HRDIKPANILLND-QFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTE 717
HRD+K NILL+ + ++ DFG+SK I + V GT Y+ PE C+ +
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISK---ILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 718 KSDVYSFGVVLLEIITSRPA 737
KSD+++ G VL E+ + + A
Sbjct: 181 KSDIWALGCVLYELASLKRA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 13/210 (6%)
Query: 538 DFETI--LGEGSFGKVYH-GYLDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKN 592
D+E + +G+GSFG V D + K + + + +Q +EV +LR + H N
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 593 LTTLYGY-CNEGNQ-IGLIYEYMANGSLEEYLSDSNADVLSWEGR--LRIATEAAQGLEY 648
+ Y + NQ + ++ EY G L + + + E RI T+ L
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 649 LHLGCKP-PRV-HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
H P V HRD+KPANI L+ +L DFGL+K + S + GT Y+
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAKTYVGTPYYMS 178
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
PE EKSD++S G ++ E+ P
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSP 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 30/208 (14%)
Query: 538 DFETI--LGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLT 594
D+E I +G G++G VY + VA+K++ +E + E+ +L+ H N+
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV 63
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIA---TEAAQGLEYLHL 651
+G +++ ++ EY GSL++ + LS L+IA E +GL YLH
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLS---ELQIAYVCRETLKGLAYLHE 119
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA------GTFGYL 705
K +HRDIK ANILL + +LADFG+S + L+ +A GT ++
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFGVS--------AQLTATIAKRKSFIGTPYWM 168
Query: 706 DPEYCQ---TFRLTEKSDVYSFGVVLLE 730
PE K D+++ G+ +E
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 542 ILGEGSFGKVYHGYLD-DNTEVAVKM--LSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
+GEGSFGK+Y D+ +K L+ + E + EVILL + H N+ T +
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRV 658
E ++ ++ EY G L + ++ + S + L + + GL+++H +
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKIL 123
Query: 659 HRDIKPANILLNDQFQ-ARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTE 717
HRDIK NI L+ A+L DFG+++ + L+ GT YL PE CQ
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQNRPYNN 181
Query: 718 KSDVYSFGVVLLEIIT 733
K+D++S G VL E+ T
Sbjct: 182 KTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 20/208 (9%)
Query: 543 LGEGSFGKVYHGYLDDNTE--VAVKMLS-PSSRQGYEQFEAEVILLRTVHHKNLTTLYGY 599
+G+GSFG+V+ G +D+ T+ VA+K++ + E + E+ +L +T YG
Sbjct: 12 IGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIAT---EAAQGLEYLHLGCKPP 656
+G ++ +I EY+ GS + L D +IAT E +GL+YLH
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFD------EFQIATMLKEILKGLDYLH---SEK 121
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLT 716
++HRDIK AN+LL++Q +LADFG++ + + GT ++ PE Q
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAYD 179
Query: 717 EKSDVYSFGVVLLEIITSRPAIANTEEH 744
K+D++S G+ +E+ P N++ H
Sbjct: 180 SKADIWSLGITAIELAKGEP--PNSDMH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 5e-20
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKML-----SPSSRQGYEQFEAEVILLRTVHHKNLTT 595
+LG+G+FG+VY Y +D E+A K + SP + + E E+ LL+ + H+ +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 596 LYGYCNEGNQ--IGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC 653
YG + + + + EYM GS+++ L A L+ + + +G+ YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHSNM 126
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG---VAGTFGYLDPEYC 710
VHRDIK ANIL + +L DFG SK ++ + TG V GT ++ PE
Sbjct: 127 I---VHRDIKGANILRDSAGNVKLGDFGASKR--LQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 711 QTFRLTEKSDVYSFGVVLLEIITSRPAIANTE 742
K+DV+S G ++E++T +P A E
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 5e-20
Identities = 71/213 (33%), Positives = 106/213 (49%), Gaps = 20/213 (9%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKML--SPSSRQGYEQ---FEAEVILLRTVHHKNLTT 595
+LG G+FG+VY Y D E+AVK + P S++ ++ E E+ LL+ + H +
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 596 LYGYC---NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG 652
YG C E ++ + EYM GS+++ L A L+ R + QG+ YLH
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHSN 125
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG---VAGTFGYLDPEY 709
VHRDIK ANIL + +L DFG SK I+ + TG V GT ++ PE
Sbjct: 126 MI---VHRDIKGANILRDSAGNVKLGDFGASKR--IQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 710 CQTFRLTEKSDVYSFGVVLLEIITSRPAIANTE 742
K+DV+S ++E++T +P A E
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 32/222 (14%)
Query: 541 TILGEGSFGKVYHGY------LDDNTEVAVKMLSPSSRQG-YEQFEAEVILLRTVHHKNL 593
LGEG FGKV T VAVKML ++ +E LL+ V+H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSN----ADVLSWEGR-------------- 635
LYG C++ + LI EY GSL +L +S + + S R
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 636 ----LRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691
+ A + ++G++YL + VHRD+ N+L+ + + +++DFGLS+ E
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
+ ++ E T +SDV+SFGV+L EI+T
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 538 DFETI--LGEGSFGKVYH-GYLDDNTEVAVKMLSPSSRQGYEQFEA--EVILLRTVHHKN 592
DF+ + LG+GS+G VY L DN A+K + S E+ +A E+ +L +V+H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNA--DVLSWEGRLRIATEAAQGLEYLH 650
+ + +GN++ ++ EY G L + +S ++ + RI + +GL+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
+ +HRD+K ANILL ++ D G+SK +++ GT Y+ PE
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYMAPEVW 173
Query: 711 QTFRLTEKSDVYSFGVVLLEIITSRP 736
+ + KSD++S G +L E+ T P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAP 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 35/219 (15%)
Query: 539 FETILGEGSFGKVYHGYLDDN---TEVAVKMLSP-SSRQGYEQFEAEV-ILLRTVHHKNL 593
FE ++GEG+FG+V + + A+KML +S + F E+ +L + HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDS--------------NADVLSWEGRLRIA 639
L G C + + EY G+L ++L S A L+ + L+ A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 640 TEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699
++ A G++YL + +HRD+ N+L+ + +++ADFGLS+ + V
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY--------VK 174
Query: 700 GTFGYLDPEYCQTFRL-----TEKSDVYSFGVVLLEIIT 733
T G L + L T KSDV+SFGV+L EI++
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 62/202 (30%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 543 LGEGSFGKVYHG-YLDDNT---EVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLY 597
LG G+FG V G YL + EVAVK L G ++F E ++ + H + L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 598 GYCNEGNQIGLIYEYMANGSLEEYLSD----SNADVLSWEGRLRIATEAAQGLEYLHLGC 653
G C +G + L+ E G L +YL +D+ A + A G+ YL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE-SK 114
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF--GYLDPEYCQ 711
VHRD+ N+LL ++ QA+++DFG+S+ G + AG + + PE
Sbjct: 115 H--FVHRDLAARNVLLVNRHQAKISDFGMSRALGA-GSDYYRATTAGRWPLKWYAPECIN 171
Query: 712 TFRLTEKSDVYSFGVVLLEIIT 733
+ + KSDV+S+GV L E +
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 14/215 (6%)
Query: 542 ILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYE-QFEAEVILLRTVHHKNLTTLYGYC 600
+LG+G+FG+V+ G L D T VAVK Q + +F +E +L+ H N+ L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 601 NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHL-GCKPPRVH 659
+ I ++ E + G +L D L + ++ A +AA G+ YL C +H
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESKNC----IH 116
Query: 660 RDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGT-FGYLDPEYCQTFRLTEK 718
RD+ N L+ + +++DFG+S+ +G+ + S+G+ + PE R + +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQ-EDDGI-YSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 719 SDVYSFGVVLLEI----ITSRPAIANTEEHKHISQ 749
SDV+S+G++L E + P + N + + + +
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK 209
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 62/191 (32%), Positives = 97/191 (50%), Gaps = 12/191 (6%)
Query: 542 ILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN 601
+G+G FG V G +VAVK + + + F AE ++ + H NL L G
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 602 EGN-QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHR 660
E + ++ EYMA GSL +YL VL + L+ + + + +EYL VHR
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHR 126
Query: 661 DIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSD 720
D+ N+L+++ A+++DFGL+K E S TG + PE + + + KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKL-PVKWTAPEALREKKFSTKSD 181
Query: 721 VYSFGVVLLEI 731
V+SFG++L EI
Sbjct: 182 VWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 62/193 (32%), Positives = 100/193 (51%), Gaps = 14/193 (7%)
Query: 542 ILGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC 600
I+GEG FG V G Y +VAVK + + F E ++ +HHKNL L G
Sbjct: 13 IIGEGEFGAVLQGEYT--GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 601 NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHR 660
N + ++ E M+ G+L +L ++S L+ + + A+G+EYL VHR
Sbjct: 69 LH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124
Query: 661 DIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSD 720
D+ NIL+++ A+++DFGL++ GV + V T PE + + + KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGS-MGVDNSKLPVKWT----APEALKHKKFSSKSD 179
Query: 721 VYSFGVVLLEIIT 733
V+S+GV+L E+ +
Sbjct: 180 VWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 66/222 (29%), Positives = 111/222 (50%), Gaps = 22/222 (9%)
Query: 543 LGEGSFGKVYHGYLDDNTE-VAVKMLSPSSRQGYEQFEA-EVILLRTVHHKNLTTLYGYC 600
LGEG++ VY G E VA+K + + +G E+ L++ + H+N+ L+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 601 NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIAT------EAAQGLEYLHLGCK 654
+ N++ L++EYM + L++Y+ D++ G L T + +G+ + C
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYM-DTHGV----RGALDPNTVKSFTYQLLKGIAF----CH 117
Query: 655 PPRV-HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF 713
RV HRD+KP N+L+N + + +LADFGL++ F I V+ S V T Y P+
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP-VNTFSNEVV-TLWYRAPDVLLGS 175
Query: 714 RLTEKS-DVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFM 754
R S D++S G ++ E+IT RP T + + M
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIM 217
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 68/223 (30%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 542 ILGEGSFGKVYHGYL--DDNT--EVAVKM--LSPSSRQGYEQFEAEVILLRTVHHKNLTT 595
ILGEG FG V G L DD + +VAVK L + E+F +E ++ H N+
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 596 LYGYCNEGNQIG------LIYEYMANGSLEEYLSDS----NADVLSWEGRLRIATEAAQG 645
L G C E + + +I +M +G L +L S + L + L+ + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 646 LEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF--G 703
+EYL +HRD+ N +L + +ADFGLSK I + G
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKK--IYSGDYYRQGRIAKMPVK 180
Query: 704 YLDPEYCQTFRLTEKSDVYSFGVVLLEIIT----SRPAIANTE 742
++ E T KSDV++FGV + EI T P + N E
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE 223
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEA--EVILLRTVHHKNLTTLYGY 599
+GEG++G VY VA+K + A E+ LL+ ++H N+ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHL-GCKPPRV 658
+ L++E+M + L + + D L + QGL + H G +
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQR-GLPESLIKSYLYQLLQGLAFCHSHGI----L 120
Query: 659 HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH-LSTGVAGTFGYLDPEYCQTFRL-T 716
HRD+KP N+L+N + +LADFGL+++F G T T Y PE + +
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSF---GSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 717 EKSDVYSFGVVLLEIITSRP 736
D++S G + E+++ RP
Sbjct: 178 TPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 18/219 (8%)
Query: 543 LGEGSFGKVYHGYLD-DNTEVAVK----MLSPSSRQGYEQFEAEVILLRTVHHKNLTTLY 597
+G G+FG+V+ G L DNT VAVK L P + +F E +L+ H N+ L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK---AKFLQEARILKQYSHPNIVRLI 59
Query: 598 GYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPR 657
G C + I ++ E + G +L L + +++ AA G+EYL
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKHC--- 115
Query: 658 VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGT-FGYLDPEYCQTFRLT 716
+HRD+ N L+ ++ +++DFG+S+ +GV + G+ + PE R +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 717 EKSDVYSFGVVLLEIIT----SRPAIANTEEHKHISQWV 751
+SDV+SFG++L E + ++N + + I Q V
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV 213
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 56/194 (28%), Positives = 96/194 (49%), Gaps = 12/194 (6%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGY---EQFEAEVILLRTVHHKNLTTLYGY 599
LG G FG V+ G +VA+K + +G E F E ++ + H L LYG
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVH 659
C + + ++ E+M NG L YL LS + L + + +G+EYL + +H
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIH 123
Query: 660 RDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKS 719
RD+ N L++ +++DFG+++ + ++ S+G + PE + + KS
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 720 DVYSFGVVLLEIIT 733
DV+SFGV++ E+ T
Sbjct: 183 DVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 35/216 (16%)
Query: 542 ILGEGSFGKVYHGYLDDN---TEVAVKMLSP-SSRQGYEQFEAEV-ILLRTVHHKNLTTL 596
++GEG+FG+V + + + A+K + +S+ + F E+ +L + HH N+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDS--------------NADVLSWEGRLRIATEA 642
G C + L EY +G+L ++L S A LS + L A +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 643 AQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF 702
A+G++YL + +HRD+ NIL+ + + A++ADFGLS+ + V T
Sbjct: 122 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------VKKTM 170
Query: 703 GYLDPEYCQTFRL-----TEKSDVYSFGVVLLEIIT 733
G L + L T SDV+S+GV+L EI++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 35/219 (15%)
Query: 539 FETILGEGSFGKVYHGYLDDN---TEVAVK-MLSPSSRQGYEQFEAEV-ILLRTVHHKNL 593
F+ ++GEG+FG+V + + + A+K M +S+ + F E+ +L + HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYL--------------SDSNADVLSWEGRLRIA 639
L G C + L EY +G+L ++L ++S A LS + L A
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 640 TEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699
+ A+G++YL + +HRD+ NIL+ + + A++ADFGLS+ + V
Sbjct: 131 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------VK 179
Query: 700 GTFGYLDPEYCQTFRL-----TEKSDVYSFGVVLLEIIT 733
T G L + L T SDV+S+GV+L EI++
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 65/199 (32%), Positives = 89/199 (44%), Gaps = 17/199 (8%)
Query: 542 ILGEGSFGKVYHG-YLDDNTE---VAVKM----LSPSSRQGYEQFEAEVILLRTVHHKNL 593
+GEG FG VY G Y+ E VAVK SPS R E+F E ++R H ++
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR---EKFLQEAYIMRQFDHPHI 69
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC 653
L G E N + ++ E G L YL N L + + + + L YL
Sbjct: 70 VKLIGVITE-NPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLE--- 124
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF 713
VHRDI N+L++ +L DFGLS+ E S G ++ PE
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG-KLPIKWMAPESINFR 183
Query: 714 RLTEKSDVYSFGVVLLEII 732
R T SDV+ FGV + EI+
Sbjct: 184 RFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 543 LGEGSFGKVYHGYLDDNTEV--AVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLY-GY 599
LG+G+FGKVY T + A K++ S + E F E+ +L H N+ LY Y
Sbjct: 13 LGDGAFGKVYKAQ-HKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR-IATEAAQGLEYLHLGCKPPRV 658
E + ++ E+ G+L+ + L+ E ++R + + + L +LH +
Sbjct: 72 FYENK-LWILIEFCDGGALDS-IMLELERGLT-EPQIRYVCRQMLEALNFLH---SHKVI 125
Query: 659 HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY--CQTFRLT 716
HRD+K NILL +LADFG+S T + GT ++ PE C+TF+
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACETFKDN 183
Query: 717 E---KSDVYSFGVVLLEIITSRP 736
K+D++S G+ L+E+ P
Sbjct: 184 PYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 542 ILGEGSFGK-VYHGYLDDNTEVAVK---MLSPSSRQGYEQFEAEVILLRTVHHKNLTTLY 597
+LG+G+FG+ + +D++ V K + S ++ + E+++L + H N+ Y
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN-EIVILSLLQHPNIIAYY 65
Query: 598 GYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPR 657
+ + N + + EY G+L + + + E L + + Y+H K
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGI 122
Query: 658 VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTE 717
+HRDIK NI L +L DFG+SK E S T V GT Y+ PE CQ +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSE-YSMAET-VVGTPYYMSPELCQGVKYNF 180
Query: 718 KSDVYSFGVVLLEIITSRPAIANT 741
KSD+++ G VL E++T + T
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 58/200 (29%), Positives = 84/200 (42%), Gaps = 16/200 (8%)
Query: 543 LGEGSFGKV----YHGYLDDNTEVAVKMLSPSSRQG-YEQFEAEVILLRTVHHKNLTTLY 597
LG+GSFG V + VAVK L + F E ++ ++ H+NL LY
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 598 GYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPR 657
G + + ++ E GSL + L A + A G+ YL R
Sbjct: 63 GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES----KR 117
Query: 658 -VHRDIKPANILLNDQFQARLADFGLSKTFPIEG---VSHLSTGVAGTFGYLDPEYCQTF 713
+HRD+ NILL + ++ DFGL + P V V F + PE +T
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPESLRTR 175
Query: 714 RLTEKSDVYSFGVVLLEIIT 733
+ SDV+ FGV L E+ T
Sbjct: 176 TFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 540 ETILGEGSFGKVYHGYLD----DNTEVAVKMLSPSSRQGYEQ-----FEAEVILLRTVHH 590
E ++G G FG+V G L VA+K L + GY + F +E ++ H
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL----KAGYTEKQRRDFLSEASIMGQFDH 64
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL--SDSNADVLSWEGRLRIATEAAQGLEY 648
N+ L G + + ++ EYM NGSL+ +L D V+ G LR A G++Y
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKY 121
Query: 649 LH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE-GVSHLSTGVAGTFGYLD 706
L +G VHRD+ NIL+N +++DFGLS+ + ++ + G +
Sbjct: 122 LSDMG----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 177
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIIT--SRP 736
PE + T SDV+S+G+V+ E+++ RP
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 72/280 (25%), Positives = 127/280 (45%), Gaps = 29/280 (10%)
Query: 543 LGEGSFGKVYHGYLDDNTE--VAVKMLS-PSSRQGYEQFEAEVILLRTVHHKNLTTLYGY 599
+G+GSFG+V+ G +D+ T+ VA+K++ + E + E+ +L +T YG
Sbjct: 12 IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVH 659
+ ++ +I EY+ GS + L D LR E +GL+YLH ++H
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLDYLH---SEKKIH 124
Query: 660 RDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKS 719
RDIK AN+LL++ + +LADFG++ + GT ++ PE + K+
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 720 DVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWK 779
D++S G+ +E+ P + K V F++ + + P L G N +
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMK-----VLFLIPKNN-----PPTLEG----NYSKP 228
Query: 780 AVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARKEGH 819
E C++ + RP + LK + A+K +
Sbjct: 229 LKEFVEACLNKEPSFRPTAKEL---LKHKFIVRFAKKTSY 265
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 538 DFETI--LGEGSFG---KVYHGYLDDNTEVAVK-MLSPSSRQGYEQFEAEVILLRTVHHK 591
D ETI LG G+ G KV H + T +A K + + +Q E+ ++
Sbjct: 6 DLETISDLGAGNGGSVSKVKH--IPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSP 63
Query: 592 NLTTLYG-YCNEGNQIGLIYEYMANGSLEEYLSDS---NADVLSWEGRLRIATEAAQGLE 647
+ + YG + NE N I + E+M GSL+ ++L +IA +GL
Sbjct: 64 YIVSFYGAFLNENN-ICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLT 117
Query: 648 YLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDP 707
YL+ +HRDIKP+NIL+N + Q +L DFG+S E ++ ++ GT Y+ P
Sbjct: 118 YLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSG----ELINSIADTFVGTSTYMSP 171
Query: 708 EYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE 743
E Q + T KSDV+S G+ ++E+ + A +
Sbjct: 172 ERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 8e-18
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 539 FETILGEGSFGKVYH------GYLDDNTEVAVKMLSPSSRQGYEQ-FEAEV-ILLRTVHH 590
F LG G+FGKV D +VAVKML P++ + +E+ I+ +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
+N+ L G C G I +I EY G L +L L+ E L + + A+G+ +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 651 L-GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAG-TFGYLDPE 708
C +HRD+ N+LL ++ DFGL++ + +++ G A ++ PE
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLARDI-MNDSNYVVKGNARLPVKWMAPE 213
Query: 709 YCQTFRLTEKSDVYSFGVVLLEIIT 733
T +SDV+S+G++L EI +
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 543 LGEGSFGKVYHGYLDD------NTEVAVKML--SPSSRQGYEQF-EAEVILLRTVHHKNL 593
LG+GSFG VY G D T VAVK + S S R+ E EA V+ T HH +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--V 71
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGR--------LRIATEAAQG 645
L G ++G ++ E MA+G L+ YL + + GR +++A E A G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 646 LEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF--G 703
+ YL+ VHRD+ N ++ F ++ DFG+++ I + G G
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVR 186
Query: 704 YLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
++ PE + T SD++SFGVVL EI +
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 31/217 (14%)
Query: 543 LGEGSFGKVYHGY---LDDN-----TEVAVKML-SPSSRQGYEQFEAEVILLRTV-HHKN 592
LGEG FG+V LD T+VAVKML S ++ + +E+ +++ + HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYL--------------SDSNADVLSWEGRLRI 638
+ L G C + + +I EY + G+L EYL + + LS++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 639 ATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698
A + A+G+EYL +HRD+ N+L+ + ++ADFGL++ I + +
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD--IHHIDYYKKTT 200
Query: 699 AGTF--GYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
G ++ PE T +SDV+SFGV+L EI T
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 60/222 (27%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKMLSPSS---------RQGYEQFEAEVILLRTVHHK 591
++G GSFG VY G + E+ AVK + S R + E+ LL+ + H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRL--RIATEAAQGLEYL 649
N+ G + + + + EY+ GS+ L++ A +E L + +GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA----FEETLVRNFVRQILKGLNYL 122
Query: 650 HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG----VAGTFGYL 705
H +HRDIK ANIL++++ +++DFG+SK +S + G + G+ ++
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 706 DPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHI 747
PE + T K+D++S G +++E++T + + + + I
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 14/212 (6%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLS-PSSRQGYEQFEAEVILLRTVHH---KNLTTL 596
++G G++G VY G + VA+K+++ + + EV LL + N+T
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP 656
YG +G ++ +I EY GS+ + A ++ + I E L+Y+H K
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSV---RTLMKAGPIAEKYISVIIREVLVALKYIH---KVG 121
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLT 716
+HRDIK ANIL+ + +L DFG++ S + GT ++ PE +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ--NSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 717 E-KSDVYSFGVVLLEIITSRPAIANTEEHKHI 747
+ K+D++S G+ + E+ T P ++ + + +
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 75/233 (32%), Positives = 107/233 (45%), Gaps = 36/233 (15%)
Query: 534 KITNDFETILGEGSFGKVYHGYLDDNTE-VAVKMLSPSSRQGYEQFE---AEVILLRTVH 589
K+ D I G GSFG VY E VA+K +S S +Q E+++ EV L+ +
Sbjct: 15 KLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 590 HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGR----LRIAT---EA 642
H N T Y C + E+ A +E Y S +D+L + + IA A
Sbjct: 74 HPN-TIEYKGC-------YLREHTAWLVME-YCLGSASDILEVHKKPLQEVEIAAICHGA 124
Query: 643 AQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF 702
QGL YLH R+HRDIK NILL + +LADFG + VS ++ V GT
Sbjct: 125 LQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSFV-GTP 175
Query: 703 GYLDPEYCQTF---RLTEKSDVYSFGVVLLEIITSRPAIANTEEHK---HISQ 749
++ PE + K DV+S G+ +E+ +P + N HI+Q
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 58/196 (29%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 543 LGEGSFGKVYHGYLDDNTEV-AVKMLS-PSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC 600
+G+GSFG+VY G + EV A+K++ + E + E+ +L +T YG
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 601 NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHR 660
+G ++ +I EY+ GS + L + LR E +GL+YLH ++HR
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR---EILKGLDYLH---SERKIHR 125
Query: 661 DIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSD 720
DIK AN+LL++Q +LADFG++ + GT ++ PE + K+D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDFKAD 183
Query: 721 VYSFGVVLLEIITSRP 736
++S G+ +E+ P
Sbjct: 184 IWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 540 ETILGEGSFGKVYHGYLD----DNTEVAVKML-SPSSRQGYEQFEAEVILLRTVHHKNLT 594
E ++G G FG+V G L VA+K L S + + F +E ++ H N+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYL--SDSNADVLSWEGRLRIATEAAQGLEYLHLG 652
L G + + +I E+M NG+L+ +L +D V+ G LR A G++YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL--- 122
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAG---TFGYLDPEY 709
+ VHRD+ NIL+N +++DFGLS+ + T G + PE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 710 CQTFRLTEKSDVYSFGVVLLEIIT--SRP 736
+ T SDV+S+G+V+ E+++ RP
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 28/209 (13%)
Query: 543 LGEGSFGKVYHG---YLD-DNTEVAVKMLS---PSSRQGYEQFEAEVILLRTVHHKNLTT 595
LG G+FG+VY G D D E+ V + + S Q F E +++ +H+N+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYLSDS-----NADVLSWEGRLRIATEAAQGLEYL- 649
L G E ++ E MA G L+ +L ++ L+ + L A + A+G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 650 --HLGCKPPRVHRDIKPANILLND---QFQARLADFGLSKTFPIEGVSHLSTGVAGTF-- 702
H +HRDI N LL A++ADFG+++ I S+ G
Sbjct: 134 ENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARD--IYRASYYRKGGRAMLPI 185
Query: 703 GYLDPEYCQTFRLTEKSDVYSFGVVLLEI 731
++ PE T K+DV+SFGV+L EI
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 15/217 (6%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLS----PSSRQG--YEQFEAEVILLRTVHHKNLT 594
LG G+F Y + T +AVK ++ SS Q E E+ L+ ++H ++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK 654
+ G E + L E+MA GS+ LS A + + +GL YLH +
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLH---E 121
Query: 655 PPRVHRDIKPANILLNDQFQ-ARLADFGLSK--TFPIEGVSHLSTGVAGTFGYLDPEYCQ 711
+HRD+K AN+L++ Q R+ADFG + G + GT ++ PE +
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 712 TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHIS 748
+ DV+S G V++E+ T++P + H++
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA 218
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 543 LGEGSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTL-Y 597
LG+G FG+V + ++ A K L R+G + E +L V + + +L Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 598 GYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLEYLHLGCKPP 656
+ + + L+ M G L+ ++ + E R A + GLE+LH +
Sbjct: 61 AF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP-EARAIFYAAQIICGLEHLH---QRR 115
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLT 716
V+RD+KP N+LL+D R++D GL+ G AGT GY+ PE Q
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRAGTPGYMAPEVLQGEVYD 172
Query: 717 EKSDVYSFGVVLLEIITSR 735
D ++ G L E+I R
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 37/220 (16%)
Query: 542 ILGEGSFGKVYHGYL------DDNTEVAVKMLSPS-SRQGYEQFEAEVILLRTV-HHKNL 593
LGEG+FG+V ++ + VAVKML + + +E+ +++ + HKN+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSD--------SNADVLSWEGRL------RIA 639
L G C + + ++ EY A+G+L ++L S D E L A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 640 TEAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698
+ A+G+E+L C +HRD+ N+L+ + ++ADFGL++ + H+
Sbjct: 139 YQVARGMEFLASKKC----IHRDLAARNVLVTEDHVMKIADFGLAR-----DIHHIDYYR 189
Query: 699 AGTFGYLD-----PEYCQTFRLTEKSDVYSFGVVLLEIIT 733
T G L PE T +SDV+SFGV+L EI T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 42/228 (18%)
Query: 539 FETILGEGSFGKVY-------HGYLDDNTE----------VAVKML-SPSSRQGYEQFEA 580
F+ LGEG FG+V+ ++D + VAVKML +++ F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 581 EVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLS---------DSNADVLS 631
E+ ++ + N+ L C + + +I EYM NG L ++LS ++ +S
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 632 WEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT------ 685
+ + +AT+ A G++YL VHRD+ N L+ + ++ADFG+S+
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 686 FPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
+ I+G + L ++ E + T SDV++FGV L EI+T
Sbjct: 186 YRIQGRAVLP------IRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 51/164 (31%), Positives = 78/164 (47%), Gaps = 24/164 (14%)
Query: 536 TNDFE--TILGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHK 591
T FE ++GEG++GKVY + VA+K++ + E+ + E +LR +H
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHP 63
Query: 592 NLTTLYG------YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR------IA 639
N+ T YG +Q+ L+ E GS+ +D + RL+ I
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV----TDLVKGLRKKGKRLKEEWIAYIL 119
Query: 640 TEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLS 683
E +GL YLH + +HRDIK NILL + +L DFG+S
Sbjct: 120 RETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 24/227 (10%)
Query: 543 LGEGSFGKVYHGYLDDNT---EVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLY 597
LGEG FG V G L+ + +VAVK + + +R E F +E + ++ H N+ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 598 GYCNEGNQIG------LIYEYMANGSLEEYLSDSN----ADVLSWEGRLRIATEAAQGLE 647
G C + + +I +M +G L +L S L + ++ T+ A G+E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 648 YLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGT-FGYLD 706
YL +HRD+ N +LN+ +ADFGLSK G + +A ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAKMPVKWIA 182
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIITS----RPAIANTEEHKHISQ 749
E T KSDV+SFGV + EI T P + N+E + ++ Q
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 542 ILGEGSFGKVYHGYLDDNT-----EVAVKMLSPSSRQGYEQ---FEAEVILLRTVHHKNL 593
+L EG+FG++++G L D EV VK + + + Q E LL + H+N+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE--IQVTLLLQESCLLYGLSHQNI 70
Query: 594 TTLYGYCNEGNQIGLI-YEYMANGSLEEYLSDS------NADVLSWEGRLRIATEAAQGL 646
+ C E + + Y YM G+L+ +L N LS + + +A + A G+
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 647 EYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSK-TFPIEGVSH-LSTGVAGTFGY 704
YLH K +H+DI N +++++ Q ++ D LS+ FP++ H L +
Sbjct: 131 SYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD--YHCLGDNENRPVKW 185
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
+ E + SDV+SFGV+L E++T
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 543 LGEGSFGKVYHG--------YLDDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTV-HHKN 592
LGEG FG+V D VAVKML ++ + +E+ L++ + HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYL--------------SDSNADVLSWEGRLRI 638
+ L G C + + +I EY A G+L E+L + + LS++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 639 ATEAAQGLEYLHLG-CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697
A + A+G+EYL C +HRD+ N+L+ + ++ADFGL++ GV +
Sbjct: 140 AYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLAR-----GVHDIDYY 190
Query: 698 VAGTFG-----YLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
+ G ++ PE T +SDV+SFG+++ EI T
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 69/224 (30%), Positives = 102/224 (45%), Gaps = 42/224 (18%)
Query: 543 LGEGSFGKVY-------------HGYLDDN----TEVAVKMLSPS-SRQGYEQFEAEVIL 584
LGEG FG+V+ +DN VAVK+L P S E F EV +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 585 LRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDS---------NADVLSWEGR 635
L + N+ L G C + +I EYM NG L ++L N+ LS+
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 636 LRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT------FPIE 689
L +AT+ A G+ YL VHRD+ N L+ + ++ADFG+S+ + ++
Sbjct: 133 LYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
G + L ++ E + T KSDV++FGV L EI+T
Sbjct: 190 GRAPLP------IRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 68/234 (29%), Positives = 107/234 (45%), Gaps = 37/234 (15%)
Query: 542 ILGEGSFGKVYHGYLDD-------NTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKNL 593
LG G+FG+VY G D VAVK L ++ Q ++F E L+ +H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNAD-----VLSWEGRLRIATEAAQGLEY 648
L G C +I E M G L YL D+ + +L+ + L I + A+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 649 LHLGCKPPRVHRDIKPANILLNDQFQAR-----LADFGLSKT------FPIEGVSHLSTG 697
L + +HRD+ N L++++ + DFGL++ + EG L
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV- 177
Query: 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT----SRPAIANTEEHKHI 747
++ PE + T +SDV+SFGV++ EI+T PA+ N E +H+
Sbjct: 178 -----RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC 600
+LG+G++G VY L +A+K + + + E+ L + H+N+ G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 601 NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIAT-EAAQGLEYLHLGCKPPRVH 659
+E + E + GSL L + E + T + +GL+YLH VH
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVH 131
Query: 660 RDIKPANILLNDQFQA-RLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC-QTFR-LT 716
RDIK N+L+N +++DFG SK + G++ + GT Y+ PE + R
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKR--LAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189
Query: 717 EKSDVYSFGVVLLEIITSRP 736
+D++S G ++E+ T +P
Sbjct: 190 APADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 77/304 (25%), Positives = 127/304 (41%), Gaps = 52/304 (17%)
Query: 539 FETILGEGSFGKVYHGYLDDNTE---------------VAVKMLSPS-SRQGYEQFEAEV 582
+ LGEG FG+V+ + E VAVKML ++ F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 583 ILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSD----------SNADVLSW 632
++ + + N+ L G C + + +I EYM NG L ++LS +N +S
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 633 EGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT------F 686
L +A + A G++YL VHRD+ N L+ + + ++ADFG+S+ +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 687 PIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT---SRPAIANTEE 743
I+G + L ++ E + T SDV++FGV L E+ T +P ++E
Sbjct: 186 RIQGRAVLP------IRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239
Query: 744 HKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803
I +F QG + L ++ M C S RP N++
Sbjct: 240 QV-IENTGEFFRNQGRQIYLSQTPL-------CPSPVFKLMMRCWSRDIKDRPTFNKIHH 291
Query: 804 ELKE 807
L+E
Sbjct: 292 FLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 543 LGEGSFGKVYHGYL------DDNTEVAVKML--SPSSRQGYEQF-EAEVILLRTVHHKNL 593
LG+GSFG VY G + T VA+K + + S R+ E EA V+ HH +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--V 71
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGR--------LRIATEAAQG 645
L G ++G +I E M G L+ YL ++ + + +++A E A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 646 LEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFG-- 703
+ YL+ VHRD+ N ++ + F ++ DFG+++ I + G G
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDYYRKGGKGLLPVR 186
Query: 704 YLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
++ PE + T SDV+SFGVVL EI T
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 4e-16
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 543 LGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-------HKNLT 594
LG+G+FG VY + VA+K + ++ + +E E + LR V H N+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM----KKKFYSWE-ECMNLREVKSLRKLNEHPNIV 61
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR-IATEAAQGLEYLHLGC 653
L E +++ ++EYM G+L + + D S E +R I + QGL ++H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS-ESVIRSIIYQILQGLAHIH--- 116
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF 713
K HRD+KP N+L++ ++ADFGL++ I + V T Y PE
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYV-STRWYRAPEI--LL 171
Query: 714 RLTEKS---DVYSFGVVLLEIITSRP 736
R T S D+++ G ++ E+ T RP
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-16
Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 31/221 (14%)
Query: 543 LGEGSFGKVYH----GYLDDNTE----VAVKMLSP-SSRQGYEQFEAEVILLRTV-HHKN 592
LGEG FG+V G D VAVKML ++ + +E+ +++ + HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLS-------DSNADV-------LSWEGRLRI 638
+ L G C + + ++ EY + G+L EYL D + D L+++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 639 ATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698
A + A+G+EYL +HRD+ N+L+ + ++ADFGL++ + + +
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARD--VHNIDYYKKTT 194
Query: 699 AGTF--GYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPA 737
G ++ PE T +SDV+SFGV+L EI T +
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 32/286 (11%)
Query: 529 YAEITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKML---SPSSRQGYEQFEAEVILL 585
E I ++ E +Y G + N EV ++ + + E E+ L
Sbjct: 14 CIESDDIDKYTSVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNL 72
Query: 586 RTVHHKNLTTLYGY----CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATE 641
R + N+ +YG+ ++ ++ LI EY G L E L D D LS++ +L +A +
Sbjct: 73 RRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-DKEKD-LSFKTKLDMAID 130
Query: 642 AAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGT 701
+GL L+ P ++++ + L+ + ++ ++ GL K +++ V
Sbjct: 131 CCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV--- 185
Query: 702 FGYLDPEYCQTF--RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD 759
Y + T K D+YS GVVL EI T + N K I +
Sbjct: 186 --YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL-TTKEIYDLI-------- 234
Query: 760 IKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805
I KL +D K + A C SH S RPN+ ++ L
Sbjct: 235 INKNNSLKL--PLDCPLEIKCIVEA--CTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 30/227 (13%)
Query: 531 EITKITNDFETILGEGSFGKVYHGYL------DDNTEVAVKMLSPSSRQGY-EQFEAEVI 583
EI T F LGE FGKVY G+L + VA+K L + E+F+ E +
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 584 LLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL--SDSNADVLSWEGR------ 635
+ + H N+ L G + + +I+ Y ++ L E+L ++DV S +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 636 ------LRIATEAAQGLEYL---HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF 686
+ I T+ A G+E+L H+ VH+D+ N+L+ D+ +++D GL +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHV------VHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 687 PIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
L ++ PE + + SD++S+GVVL E+ +
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 69/231 (29%), Positives = 112/231 (48%), Gaps = 23/231 (9%)
Query: 513 RLRKDGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNT--EVAVKMLSPS 570
+LR S+ K+++T FE I G+G+ G VY +D T EVA+K ++
Sbjct: 7 KLRTIVSVGDPKKKYT---------RFEKI-GQGASGTVYTA-IDVATGQEVAIKQMNLQ 55
Query: 571 SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVL 630
+ E E++++R H N+ G+++ ++ EY+A GSL + ++++ D
Sbjct: 56 QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-- 113
Query: 631 SWEGRLR-IATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689
EG++ + E Q LE+LH +HRDIK NILL +L DFG E
Sbjct: 114 --EGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168
Query: 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIAN 740
S ST V GT ++ PE K D++S G++ +E++ P N
Sbjct: 169 Q-SKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 6e-16
Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 50/235 (21%)
Query: 539 FETILGEGSFGKVYHGYLDDNTE-----------------VAVKMLSP-SSRQGYEQFEA 580
F+ LGEG FG+V+ + + + VAVK+L P +++ F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 581 EVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNAD------------ 628
EV +L + N+ L G C + + + +I EYM NG L ++LS + D
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 629 -----VLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLS 683
+S+ L +A + A G++YL VHRD+ N L+ + ++ADFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 684 KT------FPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEII 732
+ + I+G + L ++ E + T SDV++FGV L EI+
Sbjct: 186 RNLYAGDYYRIQGRAVLP------IRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 7e-16
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 46/199 (23%)
Query: 550 KVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLI 609
KV +G +D V+ Q E+ +LR V+H N+ + + +I ++
Sbjct: 105 KVIYGNHED----TVR----------RQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150
Query: 610 YEYMANGSL-------EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDI 662
E+M GSL E++L+D +LS G+ YLH + VHRDI
Sbjct: 151 LEFMDGGSLEGTHIADEQFLADVARQILS-------------GIAYLH---RRHIVHRDI 194
Query: 663 KPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTE----- 717
KP+N+L+N ++ADFG+S+ + + ++ V GT Y+ PE T L
Sbjct: 195 KPSNLLINSAKNVKIADFGVSRILA-QTMDPCNSSV-GTIAYMSPERINT-DLNHGAYDG 251
Query: 718 -KSDVYSFGVVLLEIITSR 735
D++S GV +LE R
Sbjct: 252 YAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 525 RRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTE-----VAVKMLSP-SSRQGYEQF 578
R E+ K+ +LG G FG V+ G + VA+K + S RQ +++
Sbjct: 2 RILKETELRKLK-----LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEI 56
Query: 579 EAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI 638
++ + ++ H + L G C G + L+ + GSL +++ + D L + L
Sbjct: 57 TDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVR-QHRDSLDPQRLLNW 114
Query: 639 ATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698
+ A+G+ YL VHR++ NILL ++ADFG++ + + +
Sbjct: 115 CVQIAKGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171
Query: 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
++ E R T +SDV+S+GV + E+++
Sbjct: 172 KTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 68/217 (31%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 543 LGEGSFGKVYHGYLDDNTE-VAVKMLSPSSRQGYEQFE---AEVILLRTVHHKNLTTLYG 598
+G GSFG VY E VAVK +S S +Q E+++ EV L+ + H N G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRV 658
+ + L+ EY GS + L + E I A QGL YLH +
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVE-IAAITHGALQGLAYLHSHNM---I 143
Query: 659 HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF---RL 715
HRDIK NILL + Q +LADFG + S + GT ++ PE +
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILAMDEGQY 197
Query: 716 TEKSDVYSFGVVLLEIITSRPAIANTEEHK---HISQ 749
K DV+S G+ +E+ +P + N HI+Q
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 13/207 (6%)
Query: 538 DFETI--LGEGSFGKVYHGYLDDNTEVA-VKMLSPSSRQGYEQFEAEVILLRTVHHKNLT 594
DFE I +G G++G VY + E+A +K++ + + + E+I+++ H N+
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK 654
+G +++ + E+ GSL++ + LS ++ E QGL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLH---S 124
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFR 714
++HRDIK ANILL D +LADFG+S I GT ++ PE R
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 715 ---LTEKSDVYSFGVVLLEIITSRPAI 738
+ D+++ G+ +E+ +P +
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 543 LGEGSFGKVYHGYL--------DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTV-HHKN 592
LGEG FG+V + VAVKML ++ + +E+ +++ + HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLS-------DSNADV-------LSWEGRLRI 638
+ L G C + + +I EY + G+L EYL + + D+ ++++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 639 ATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698
+ A+G+EYL +HRD+ N+L+ + ++ADFGL++ + + +
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD--VNNIDYYKKTT 197
Query: 699 AGTF--GYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
G ++ PE T +SDV+SFGV++ EI T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 2e-15
Identities = 67/232 (28%), Positives = 113/232 (48%), Gaps = 23/232 (9%)
Query: 512 KRLRKDGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNT--EVAVKMLSP 569
++LR S+ K+++T FE I G+G+ G VY +D T EVA+K ++
Sbjct: 6 EKLRSIVSVGDPKKKYT---------RFEKI-GQGASGTVYTA-IDIATGQEVAIKQMNL 54
Query: 570 SSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADV 629
+ E E++++R + N+ G+++ ++ EY+A GSL + ++++ D
Sbjct: 55 QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD- 113
Query: 630 LSWEGRL-RIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688
EG++ + E Q L++LH +HRDIK NILL +L DFG
Sbjct: 114 ---EGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167
Query: 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIAN 740
E S ST V GT ++ PE K D++S G++ +E++ P N
Sbjct: 168 EQ-SKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 59/214 (27%), Positives = 109/214 (50%), Gaps = 23/214 (10%)
Query: 542 ILGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGY 599
++G G++G+VY G ++ A+K++ + + E+ + E+ +L+ HH+N+ T YG
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 600 CNEGN------QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC 653
+ N Q+ L+ E+ GS+ + + ++ + L E I E +GL +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 128
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY--CQ 711
+ +HRDIK N+LL + + +L DFG+S V +T + GT ++ PE C
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFI-GTPYWMAPEVIACD 186
Query: 712 -----TFRLTEKSDVYSFGVVLLEIITSRPAIAN 740
T+ KSD++S G+ +E+ P + +
Sbjct: 187 ENPDATYDF--KSDLWSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 539 FETILGEGSFGKVYHGY-LDDNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTL 596
++ ILG G+ G VY Y L +AVK++ + + +Q +E+ +L +
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP 656
YG N+I + E+M GSL+ Y VL RIA +GL YL K
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIPE-HVLG-----RIAVAVVKGLTYL-WSLKI- 116
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLT 716
+HRD+KP+N+L+N + Q +L DFG+S V+ ++ GT Y+ PE +
Sbjct: 117 -LHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYG 171
Query: 717 EKSDVYSFGVVLLEIITSR 735
SDV+S G+ +E+ R
Sbjct: 172 IHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 26/223 (11%)
Query: 538 DFETILGEGSFGKVYHGYLDDNTE-VAVKMLS-PSSRQGYEQFEA-EVILLRTVHHKNLT 594
D +GEG++G+VY D E VA+K + + ++G+ E+ +LR ++H+N+
Sbjct: 10 DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 595 TLY----------GYCNEGNQIGLIYEYMAN---GSLEEYLSDSNADVLSWEGRLRIATE 641
L + + L++EYM + G LE L + D + +
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-----SFMKQ 124
Query: 642 AAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGT 701
+GL Y H K +HRDIK +NILLN++ Q +LADFGL++ + S T T
Sbjct: 125 LLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLY-NSEESRPYTNKVIT 180
Query: 702 FGYLDPE-YCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE 743
Y PE R DV+S G +L E+ T +P +E
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTL- 596
++G+G+FGKV D ++ A+K ++ + E +L+ ++H L L
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLEYLHLGCKP 655
Y + +E N + L+ + + G L +LS S E +++ E LEYLH
Sbjct: 67 YSFQDEEN-MYLVVDLLLGGDLRYHLS--QKVKFS-EEQVKFWICEIVLALEYLH---SK 119
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL 715
+HRDIKP NILL++Q + DF ++ + L+T +GT GY+ PE
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTSTSGTPGYMAPEVLCRQGY 176
Query: 716 TEKSDVYSFGVVLLEIITSR 735
+ D +S GV E + +
Sbjct: 177 SVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 4e-15
Identities = 62/231 (26%), Positives = 109/231 (47%), Gaps = 21/231 (9%)
Query: 512 KRLRKDGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPS 570
++LR S+ K+++T FE I G+G+ G VY + EVA++ ++
Sbjct: 7 EKLRSIVSVGDPKKKYT---------RFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ 56
Query: 571 SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVL 630
+ E E++++R + N+ G+++ ++ EY+A GSL + ++++ D
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-- 114
Query: 631 SWEGRL-RIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689
EG++ + E Q LE+LH +HRDIK NILL +L DFG E
Sbjct: 115 --EGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIAN 740
+ + GT ++ PE K D++S G++ +E+I P N
Sbjct: 170 QSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 14/210 (6%)
Query: 543 LGEGSFGKVYHGY--LDDNTEVAVKMLSPSSRQGYEQFEA-EVILLRTVHHKNLTTLYGY 599
LGEG++ VY G L DN VA+K + +G EV LL+ + H N+ TL+
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVH 659
+ + L++EY+ + L++YL D + ++ + +GL Y H + +H
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCH---RRKVLH 127
Query: 660 RDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE-YCQTFRLTEK 718
RD+KP N+L+N++ + +LADFGL++ I ++ + V T Y P+ + + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYSTQ 185
Query: 719 SDVYSFGVVLLEIITSRPAI--ANTEEHKH 746
D++ G + E+ T RP + EE H
Sbjct: 186 IDMWGVGCIFYEMSTGRPLFPGSTVEEQLH 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 7e-15
Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 29/206 (14%)
Query: 542 ILGEGSFGKVYHGYL-------DDNTEVAVKMLSPSSRQGYEQFEA--EVILLRTVHHKN 592
+LG+GSFGKV+ L D A+K+L ++ + ++ E +L V+H
Sbjct: 3 VLGQGSFGKVF---LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPF 59
Query: 593 LTTL-YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLEYLH 650
+ L Y + EG ++ LI +++ G L LS +V+ E ++ E A L++LH
Sbjct: 60 IVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLH 115
Query: 651 -LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA--GTFGYLDP 707
LG ++RD+KP NILL+++ +L DFGLSK E + H + GT Y+ P
Sbjct: 116 SLGI----IYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAP 167
Query: 708 EYCQTFRLTEKSDVYSFGVVLLEIIT 733
E T+ +D +SFGV++ E++T
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKM--LSPSSRQGYEQ--------FEAEVILLRTVHH 590
++G+G++G+VY E+ AVK L + ++ +E+ L+ + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR------IATEAAQ 644
N+ G+ + + EY+ GS+ L GR + +
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSI--------GSCLRTYGRFEEQLVRFFTEQVLE 119
Query: 645 GLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704
GL YLH +HRD+K N+L++ +++DFG+SK + + + G+ +
Sbjct: 120 GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 705 LDPEYCQTFR--LTEKSDVYSFGVVLLEIITSRPAIANTE 742
+ PE ++ + K D++S G V+LE+ R ++ E
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 27/228 (11%)
Query: 542 ILGEGSFGKVYHGYL--DDNT--EVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTT 595
+LG+G FG V L +D + +VAVKML S E+F E ++ H N+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 596 LYGYCNEGNQIG------LIYEYMANGSLEEYLSDS----NADVLSWEGRLRIATEAAQG 645
L G G +I +M +G L +L S L + +R + A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 646 LEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF--G 703
+EYL +HRD+ N +LN+ +ADFGLSK I + G A
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKK--IYSGDYYRQGCASKLPVK 180
Query: 704 YLDPEYCQTFRLTEKSDVYSFGVVLLEII----TSRPAIANTEEHKHI 747
+L E T SDV++FGV + EI+ T + N+E + ++
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 541 TILGEGSFGKVYHGY-LDDNTEVAVKMLS-PSSRQGYEQFEA-EVILLRTV---HHKNLT 594
+GEG++G VY L+ VA+K + P S +G E+ LL+ + H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 595 TLYGYC-----NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL 649
L C + ++ L++E++ + L YLS L E + + +G+++L
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL 123
Query: 650 HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE- 708
H VHRD+KP NIL+ Q ++ADFGL++ + E L T V T Y PE
Sbjct: 124 HSHRI---VHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MAL-TSVVVTLWYRAPEV 177
Query: 709 -----YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
Y D++S G + E+ RP
Sbjct: 178 LLQSSYATPV------DMWSVGCIFAELFRRRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 540 ETILGEGSFGKVYHGYLD----DNTEVAVKML----SPSSRQGYEQFEAEVILLRTVHHK 591
E ILG G FG++ G L VA+ L S R+G F AE + L H
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG---FLAEALTLGQFDHS 66
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-H 650
N+ L G GN + ++ EYM+NG+L+ +L L + + A G++YL
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYLSE 125
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
+G VH+ + +L+N +++ F + E + +G + + PE
Sbjct: 126 MG----YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-WAAPEAI 180
Query: 711 QTFRLTEKSDVYSFGVVLLEIIT--SRP 736
Q + SDV+SFG+V+ E+++ RP
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 53/198 (26%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 542 ILGEGSFGKVYHGYLDDNTE-----VAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTT 595
+LG G+FG VY G E VA+K+L+ ++ + +F E +++ ++ H +L
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKP 655
L G C I L+ + M +G L +Y+ + ++ S + L + A+G+ YL +
Sbjct: 74 LLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGS-QLLLNWCVQIAKGMMYLE---ER 128
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL 715
VHRD+ N+L+ ++ DFGL++ + + + G ++ E +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 716 TEKSDVYSFGVVLLEIIT 733
T +SDV+S+GV + E++T
Sbjct: 189 THQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 38/217 (17%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPS----SRQGYEQFEAEVILLRTVH 589
+DFE I LG GSFG+V + + A+K+LS + +Q E E +L+++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 590 HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI------ATEAA 643
H L LYG + + + L+ EY+ G L +L S GR A +
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS--------GRFPEPVARFYAAQVV 111
Query: 644 QGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG---VA 699
LEYLH L V+RD+KP N+LL+ ++ DFG +K + +
Sbjct: 112 LALEYLHSLDI----VYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLC 159
Query: 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
GT YL PE + + D ++ G+++ E++ P
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 543 LGEGSFGKVYHGYLDDN-TEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN 601
+GEGS G V + +VAVKM+ +Q E EV+++R H+N+ +Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 602 EGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRD 661
G ++ ++ E++ G+L + +S + L+ E + Q L YLH +HRD
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLH---SQGVIHRD 142
Query: 662 IKPANILLNDQFQARLADFG----LSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTE 717
IK +ILL + +L+DFG +SK P + GT ++ PE
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKR------KSLVGTPYWMAPEVISRTPYGT 196
Query: 718 KSDVYSFGVVLLEIITSRP 736
+ D++S G++++E++ P
Sbjct: 197 EVDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 542 ILGEGSFGK---VYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
++GEGSFG+ V H D ++ P S E E +LL + H N+
Sbjct: 7 VVGEGSFGRALLVQH-VNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRV 658
+ ++ EY G L + + + + L+ + G++++H + +
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVL 122
Query: 659 HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEK 718
HRDIK NI L + +L DFG ++ ++ T V GT Y+ PE + K
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLT-SPGAYACTYV-GTPYYVPPEIWENMPYNNK 180
Query: 719 SDVYSFGVVLLEIITSR-PAIANTEEH 744
SD++S G +L E+ T + P AN+ ++
Sbjct: 181 SDIWSLGCILYELCTLKHPFQANSWKN 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 14/207 (6%)
Query: 537 NDFETI--LGEGSFGKVYHG-YLDDNTEVAVKML--SPSSRQGYEQFEAEVILLRTVHHK 591
N +E + +GEG++G V VA+K S + EV +LR + H+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH- 650
N+ L ++ L++EY+ +L E L +++ L + + Q + Y H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVER-TLLELL-EASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
+HRDIKP NIL+++ +L DFG ++ S L+ VA T Y PE
Sbjct: 119 HNI----IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELL 173
Query: 711 QTFRLTEKS-DVYSFGVVLLEIITSRP 736
K DV++ G ++ E++ P
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 543 LGEGSFGKVYHGYLDDNT--EVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC 600
+GEGS G V D +T +VAVK + +Q E EV+++R H N+ +Y
Sbjct: 27 IGEGSTGIVCIAT-DKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 601 NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIAT---EAAQGLEYLHLGCKPPR 657
G+++ ++ E++ G+L + ++ + + +IAT + L +LH
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVTHTRMN------EEQIATVCLAVLKALSFLH---AQGV 136
Query: 658 VHRDIKPANILLNDQFQARLADFG----LSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF 713
+HRDIK +ILL + +L+DFG +SK P + GT ++ PE
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR------KSLVGTPYWMAPEVISRL 190
Query: 714 RLTEKSDVYSFGVVLLEIITSRPAIAN 740
+ D++S G++++E++ P N
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 529 YAEITKITNDFETILGEGSFGK-VYHGYLDDNTEVAVKMLSPSSRQGYEQFEA--EVILL 585
Y ++ KI GEGSFGK + +D + +K ++ S E+ E+ EV +L
Sbjct: 2 YVKVKKI--------GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVL 53
Query: 586 RTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQG 645
+ H N+ E + ++ +Y G L + ++ + + L +
Sbjct: 54 SNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA 113
Query: 646 LEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYL 705
L+++H +HRDIK NI L +L DFG+++ + L+ GT YL
Sbjct: 114 LKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYL 168
Query: 706 DPEYCQTFRLTEKSDVYSFGVVLLEIITSRPA 737
PE C+ KSD+++ G VL E+ T + A
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEVAVKML-----SPSSRQGYEQFEAEVILLRTVH 589
+DFE I LG G+ G V + + + L P+ R Q E+ +L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN---QIIRELQVLHECN 61
Query: 590 HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL 649
+ YG +I + E+M GSL++ L ++ G++ IA +GL YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYL 119
Query: 650 HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY 709
K +HRD+KP+NIL+N + + +L DFG+S + ++ GT Y+ PE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 173
Query: 710 CQTFRLTEKSDVYSFGVVLLEIITSRPAI 738
Q + +SD++S G+ L+E+ R I
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEVAVKML-----SPSSRQGYEQFEAEVILLRTVH 589
+DFE I LG G+ G V+ + + + L P+ R Q E+ +L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN---QIIRELQVLHECN 61
Query: 590 HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL 649
+ YG +I + E+M GSL++ L + G++ IA +GL YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYL 119
Query: 650 HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY 709
K +HRD+KP+NIL+N + + +L DFG+S + ++ GT Y+ PE
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 173
Query: 710 CQTFRLTEKSDVYSFGVVLLEIITSRPAI 738
Q + +SD++S G+ L+E+ R I
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 59/234 (25%), Positives = 110/234 (47%), Gaps = 13/234 (5%)
Query: 543 LGEGSFGKVYHGYLDDNTE-VAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN 601
+GEGS G V + + + VAVK + +Q E EV+++R H+N+ +Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 602 EGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRD 661
G+++ ++ E++ G+L + ++ + ++ E + + L LH +HRD
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLH---AQGVIHRD 141
Query: 662 IKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDV 721
IK +ILL + +L+DFG E S + GT ++ PE + D+
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPEVDI 199
Query: 722 YSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNI--VDPKLHGDID 773
+S G++++E++ P N K + D + + +KN+ V P L G +D
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK--LKNLHKVSPSLKGFLD 251
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 56/214 (26%), Positives = 107/214 (50%), Gaps = 23/214 (10%)
Query: 542 ILGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGY 599
++G G++G+VY G ++ A+K++ + + E+ + E+ +L+ HH+N+ T YG
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 600 ------CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC 653
+Q+ L+ E+ GS+ + + ++ + L + I E +GL +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH- 140
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY--CQ 711
+HRDIK N+LL + + +L DFG+S V +T + GT ++ PE C
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFI-GTPYWMAPEVIACD 196
Query: 712 -----TFRLTEKSDVYSFGVVLLEIITSRPAIAN 740
T+ +SD++S G+ +E+ P + +
Sbjct: 197 ENPDATYDY--RSDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 18/213 (8%)
Query: 543 LGEGSFGKVYHGY--LDDNTEVAVKMLSPSSRQGYEQFEA-EVILLRTVHHKNLTTLYGY 599
LGEG++ V+ G L +N VA+K + +G EV LL+ + H N+ TL+
Sbjct: 13 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVH 659
+ + L++EY+ + L++YL D+ +++S + +GL Y H K +H
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILH 126
Query: 660 RDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKS 719
RD+KP N+L+N++ + +LADFGL++ + ++ + V T Y P+ TE S
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDV--LLGSTEYS 182
Query: 720 ---DVYSFGVVLLEIITSRPAI--ANTEEHKHI 747
D++ G +L E+ T RP + +E H+
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 60/231 (25%), Positives = 110/231 (47%), Gaps = 21/231 (9%)
Query: 512 KRLRKDGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPS 570
++LR S+ K+++T E +G+G+ G V+ + EVA+K ++
Sbjct: 6 EKLRTIVSIGDPKKKYTRYEK----------IGQGASGTVFTAIDVATGQEVAIKQINLQ 55
Query: 571 SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVL 630
+ E E+++++ + + N+ G+++ ++ EY+A GSL + ++++ D
Sbjct: 56 KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD-- 113
Query: 631 SWEGRL-RIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689
E ++ + E Q LE+LH +HRDIK N+LL +L DFG E
Sbjct: 114 --EAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168
Query: 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIAN 740
S ST V GT ++ PE K D++S G++ +E++ P N
Sbjct: 169 Q-SKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 43/219 (19%)
Query: 529 YAEITKITNDFETILGEGSFGKVYHGYLDDNTE-VAVKMLS--------PSSRQGYEQFE 579
Y ++ KI GEG++G V+ + E VA+K + PSS
Sbjct: 2 YEKLEKI--------GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------ 47
Query: 580 AEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNAD-----VLSWEG 634
E+ LL+ + HKN+ LY + ++ L++EY + L++Y N D V S+
Sbjct: 48 REICLLKELKHKNIVRLYDVLHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMF 106
Query: 635 RLRIATEAAQGLEYLHLGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693
+L +GL + C V HRD+KP N+L+N + +LADFGL++ F I V
Sbjct: 107 QL------LKGLAF----CHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-VRC 155
Query: 694 LSTGVAGTFGYLDPEYCQTFRLTEKS-DVYSFGVVLLEI 731
S V T Y P+ +L S D++S G + E+
Sbjct: 156 YSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 543 LGEGSFGKV-YHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN 601
+GEGS G V +VAVK + +Q E EV+++R HH+N+ +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 602 EGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRD 661
G+++ ++ E++ G+L + ++ + ++ E + + L YLH +HRD
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLH---NQGVIHRD 143
Query: 662 IKPANILLNDQFQARLADFG----LSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTE 717
IK +ILL + +L+DFG +SK P + GT ++ PE
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR------KSLVGTPYWMAPEVISRLPYGT 197
Query: 718 KSDVYSFGVVLLEIITSRPAIAN 740
+ D++S G++++E+I P N
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-14
Identities = 75/256 (29%), Positives = 107/256 (41%), Gaps = 38/256 (14%)
Query: 534 KITNDFETILGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFE---AEVILLRTVH 589
K+ D I G GSFG VY EV A+K +S S +Q E+++ EV L+ +
Sbjct: 25 KLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK 83
Query: 590 HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL 649
H N G + L+ EY GS + L + E I A QGL YL
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE-IAAITHGALQGLAYL 141
Query: 650 HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY 709
H +HRDIK NILL + Q +LADFG + ++ + GT ++ PE
Sbjct: 142 H---SHNMIHRDIKAGNILLTEPGQVKLADFGSAS------IASPANSFVGTPYWMAPEV 192
Query: 710 CQTF---RLTEKSDVYSFGVVLLEIITSRPAIANTEEHK---HISQ----------WVDF 753
+ K DV+S G+ +E+ +P + N HI+Q W D+
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY 252
Query: 754 MLAQGDIKNIVDPKLH 769
+N VD L
Sbjct: 253 F------RNFVDSCLQ 262
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 58/235 (24%), Positives = 93/235 (39%), Gaps = 46/235 (19%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKML--------SPSSRQGYEQ----FEA--EVILLRT 587
LGEG++GKV Y VA+K + RQ F E+ ++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 588 VHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEE------YLSDSNADVLSWEGRLRIATE 641
+ H+N+ L EG+ I L+ + MA L++ L++S + +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQ-------- 127
Query: 642 AAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH-------- 693
GL LH K +HRD+ PANI +N + ++ADFGL++ + S
Sbjct: 128 ILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 694 ----LSTGVAGTFGYLDPEYCQ-TFRLTEKSDVYSFGVVLLEIITSRPAIANTEE 743
T T Y PE + D++S G + E++T +P E
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239
|
Length = 335 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 29/209 (13%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVK------MLSPSSRQGYEQFEAEVILLRTVHH 590
E +G+G F VY L D VA+K M+ +RQ + E+ LL+ + H
Sbjct: 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLKQLDH 61
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRL-------RIATEAA 643
N+ E N++ ++ E G L + RL + +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ-----KRLIPERTIWKYFVQLC 116
Query: 644 QGLEYLHLGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF 702
LE++H R+ HRDIKPAN+ + +L D GL + F + + S + GT
Sbjct: 117 SALEHMH----SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 170
Query: 703 GYLDPEYCQTFRLTEKSDVYSFGVVLLEI 731
Y+ PE KSD++S G +L E+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 8e-14
Identities = 58/218 (26%), Positives = 89/218 (40%), Gaps = 34/218 (15%)
Query: 546 GSFGKVYHGYLDDNTE--VAVKMLSPSSRQGYEQFE---AEVILLRTVHHKNLTTLYGYC 600
G++G+V+ +T A+K++ + Q + E +L + LY Y
Sbjct: 4 GAYGRVFLA-KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YS 61
Query: 601 NEG-NQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LG 652
+G + L+ EY+ G L L + A R+ IA E LEYLH G
Sbjct: 62 FQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA-------RIYIA-EIVLALEYLHSNG 113
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSK------TFPIEGVSHLSTGVAGTFGYLD 706
+HRD+KP NIL++ +L DFGLSK + + GT Y+
Sbjct: 114 I----IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIITSRPAI-ANTEE 743
PE ++ D +S G +L E + P T E
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 54/198 (27%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 543 LGEGSFGKVYHGY--LDDNTEVAVKMLSPSSRQGYEQFEA-EVILLRTVHHKNLTTLYGY 599
LGEG++ V+ G L +N VA+K + +G EV LL+ + H N+ TL+
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVH 659
+ + L++EY+ + L++Y+ D +++S + +GL Y H + +H
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCH---RRKVLH 127
Query: 660 RDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE-YCQTFRLTEK 718
RD+KP N+L+N++ + +LADFGL++ + ++ + V T Y P+ + + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYSTQ 185
Query: 719 SDVYSFGVVLLEIITSRP 736
D++ G + E+ + RP
Sbjct: 186 IDMWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 44/215 (20%)
Query: 543 LGEGSFGKVYHGY--LDDNTEVAVKMLSPSSRQGYEQFEA--EVILLRTVHHKNLTTLYG 598
LGEGS+ VY G L VA+K + +G F A E LL+ + H N+ TL+
Sbjct: 13 LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHD 70
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSD-------SNADVLSWEGRLRIATEAAQGLEYLHL 651
+ + L++EY+ + L++Y+ D N + ++ LR GL Y H
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ-LLR-------GLAYCH- 120
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGL--SKTFPIEGVSHLSTGVAGTFGYLDP-- 707
+ +HRD+KP N+L++++ + +LADFGL +K+ P + S+ T Y P
Sbjct: 121 --QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV----TLWYRPPDV 174
Query: 708 -----EYCQTFRLTEKSDVYSFGVVLLEIITSRPA 737
EY + D++ G + E+ T RP
Sbjct: 175 LLGSTEY------STSLDMWGVGCIFYEMATGRPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 542 ILGEGSFGKVYHGYLDDNTE-----VAVKML-SPSSRQGYEQFEAEVILLRTVHHKNLTT 595
+LG G+FG VY G E VA+K L +S + ++ E ++ +V + ++
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL---HLG 652
L G C + + LI + M G L +Y+ + + D + + L + A+G+ YL L
Sbjct: 74 LLGICLT-STVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEERRL- 130
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
VHRD+ N+L+ ++ DFGL+K + + + G ++ E
Sbjct: 131 -----VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185
Query: 713 FRLTEKSDVYSFGVVLLEIIT--SRP 736
T +SDV+S+GV + E++T S+P
Sbjct: 186 RIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 52/224 (23%), Positives = 98/224 (43%), Gaps = 37/224 (16%)
Query: 538 DFETILGEGSFGKVYHGYL---DDNTEVAVKMLSPSSRQGYEQFEA----EVILLRTVHH 590
+ E +G G++G+VY D E A+K Q Y E+ LLR + H
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ-YTGISQSACREIALLRELKH 61
Query: 591 KNLTTLYGYC--NEGNQIGLIYEYMANGSLE--EYLSDSNADVLSWEGRLRIAT-EAAQG 645
+N+ +L + + L+++Y + + ++ + + ++ + G
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIP-PSMVKSLLWQILNG 120
Query: 646 LEYLHLGCKPPRVHRDIKPANILL----NDQFQARLADFGLSKTF--PIEGVSHLSTGVA 699
+ YLH +HRD+KPANIL+ ++ ++ D GL++ F P++ ++ L V
Sbjct: 121 VHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD-PVV 176
Query: 700 GTFGYLDPE-------YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
T Y PE Y T+ D+++ G + E++T P
Sbjct: 177 VTIWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTLEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEA--EVILLRTVHHKNLTTLYGY 599
+GEG+ G V+ + VA+K ++ +G +A E+ L+ H + L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPPRV 658
G+ L+ EYM L E L D + + + +G+ Y+H G +
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMHANGI----M 121
Query: 659 HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY---CQTFRL 715
HRD+KPAN+L++ ++ADFGL++ F E S VA T Y PE + +
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYGARKY-- 178
Query: 716 TEKSDVYSFGVVLLEIITSRP 736
D+++ G + E++ P
Sbjct: 179 DPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 34/216 (15%)
Query: 538 DFETI--LGEGSFG---KVYHGYLDDNTEVAVKML----SPSSRQGYEQFEAEVILLRTV 588
DFE + LG G+ G KV H +A K++ P+ R Q E+ +L
Sbjct: 2 DFEKLGELGAGNGGVVTKVLH--RPSGLIMARKLIHLEIKPAIRN---QIIRELKVLHEC 56
Query: 589 HHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRL------RIATEA 642
+ + YG +I + E+M GSL++ VL GR+ +I+
Sbjct: 57 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ--------VLKKAGRIPENILGKISIAV 108
Query: 643 AQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF 702
+GL YL K +HRD+KP+NIL+N + + +L DFG+S + + ++ GT
Sbjct: 109 LRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTR 162
Query: 703 GYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAI 738
Y+ PE Q T +SD++S G+ L+E+ R I
Sbjct: 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 543 LGEGSFGKVYHGYLDDNTE-VAVKMLSPSSRQGYEQFEA--EVILLRTVHHKNLTTLYGY 599
LGEGS+ VY G N + VA+K++S + +G F A E LL+ + H N+ L+
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHDI 71
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVH 659
+ + ++EYM + L +Y+ + + RL + +GL Y+H +H
Sbjct: 72 IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---GQHILH 126
Query: 660 RDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKS 719
RD+KP N+L++ + +LADFGL++ I ++ S V T Y P+ T+ S
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDV--LLGATDYS 182
Query: 720 ---DVYSFGVVLLEIITSRPAIANT 741
D++ G + +E++ +PA
Sbjct: 183 SALDIWGAGCIFIEMLQGQPAFPGV 207
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 7e-13
Identities = 63/234 (26%), Positives = 93/234 (39%), Gaps = 40/234 (17%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPSS--RQGYEQ-FEAEVILLRTVHH 590
+DFE I +G G+FG+V+ D +V A+K+L S ++ AE +L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
+ LY + + L+ EYM G L L + R IA E L+ +H
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIA-ELVLALDSVH 118
Query: 651 -LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS----------------- 692
LG +HRDIKP NIL++ +LADFGL K
Sbjct: 119 KLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 693 ----------HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
+ GT Y+ PE + + D +S GV+L E++ P
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 58/210 (27%), Positives = 84/210 (40%), Gaps = 27/210 (12%)
Query: 543 LGEGSFGKVYHG---YLDDNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYG 598
+G G FGKV G V VK L S+ F EV R ++H N+ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 599 YCNEGNQIGLIYEYMANGSLEEYL--------SDSNADVLSWEGRLRIATEAAQGLEYLH 650
C E L+ E+ G L+ YL + DVL R+A E A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL-----QRMACEVASGLLWLH 117
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
+ +H D+ N L ++ D+GL+ E A +L PE
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 711 QTF-------RLTEKSDVYSFGVVLLEIIT 733
+ T+KS+++S GV + E+ T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 19/211 (9%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEVA-VKMLSPSSRQGYEQFEAEVILLRTVHHKNL 593
+D+E I +G G++G VY E+A VK++ + + E+ +++ H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIA---TEAAQGLEYLH 650
+G ++ + EY GSL++ V L+IA E QGL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLAYLH 123
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
K +HRDIK ANILL D +LADFG++ I GT ++ PE
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKSFIGTPYWMAPEVA 178
Query: 711 QTFR---LTEKSDVYSFGVVLLEIITSRPAI 738
+ + D+++ G+ +E+ +P +
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 543 LGEGSFGKVYH------GYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTL 596
LG+G FG+V G L ++ K L R+GYE E +L VH + + +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK--KRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 597 YGYCNEGNQIGLIYEYMANGSLEE--YLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK 654
+ L+ M G L Y D + GLE+LH +
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---Q 115
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFR 714
++RD+KP N+LL++ R++D GL+ +G S + G AGT G++ PE Q
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVEL-KDGQSK-TKGYAGTPGFMAPELLQGEE 173
Query: 715 LTEKSDVYSFGVVLLEIITSR 735
D ++ GV L E+I +R
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 53/205 (25%), Positives = 79/205 (38%), Gaps = 19/205 (9%)
Query: 546 GSFGKVYHGYLDDNTE-VAVKMLSPSSRQGYEQFEAEVILLRTVHH-----KNLTTLYGY 599
G+FG VY + A+K+L S Q V R + + LY
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQV-TNVKAERAIMMIQGESPYVAKLYYS 65
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVH 659
+ + L+ EY+ G + W + E G+E LH + +H
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLH---QRGIIH 120
Query: 660 RDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKS 719
RDIKP N+L++ +L DFGLS+ + GT YL PE + S
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPETILGVGDDKMS 174
Query: 720 DVYSFGVVLLEIITS-RPAIANTEE 743
D +S G V+ E + P A T +
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 543 LGEGSFGKVYHGYLDDNTEV----AVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
LG+G+FGKVY N E A K++ S + E + E+ +L T +H + L G
Sbjct: 20 LGDGAFGKVYKA---KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRV 658
++ ++ E+ G+++ + + + + + ++ I + + L+YLH +
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQYLH---SMKII 132
Query: 659 HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST--GVAGTFGYLDPE--YCQTFR 714
HRD+K N+LL +LADFG+S + V L GT ++ PE C+T +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSA----KNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 715 LTE---KSDVYSFGVVLLEIITSRP 736
T K+D++S G+ L+E+ P
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 542 ILGEGSFGKVYHGYLDDNTE-----VAVKMLSP-SSRQGYEQFEAEVILLRTVHHKNLTT 595
+LG G+FG VY G + E VA+K+L +S + ++ E ++ V +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKP 655
L G C + + L+ + M G L +Y+ + N D + + L + A+G+ YL +
Sbjct: 74 LLGICLT-STVQLVTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLE---EV 128
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL 715
VHRD+ N+L+ ++ DFGL++ I+ + + G ++ E R
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 716 TEKSDVYSFGVVLLEIIT 733
T +SDV+S+GV + E++T
Sbjct: 189 THQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 20/224 (8%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLS-PSSRQGYEQFEA-EVILLRTVH---HKNLTTL 596
+G G++G VY VA+K + ++ G EV LL+ + H N+ L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 597 YGYC-----NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHL 651
C + ++ L++E++ + L YL L E + + +GL++LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS-TGVAGTFGYLDPEYC 710
C VHRD+KP NIL+ Q +LADFGL++ + ++ T V T Y PE
Sbjct: 127 NCI---VHRDLKPENILVTSGGQVKLADFGLARIYS----CQMALTPVVVTLWYRAPEVL 179
Query: 711 QTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFM 754
D++S G + E+ +P E + + D +
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 22/210 (10%)
Query: 543 LGEGSFGKVYHGYLDDNTE--VAVK---MLSPSSRQGYEQFEAEV--------ILLRTVH 589
LG G+FG VY +N + +A+K + +P+ + + + + I+ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 590 HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSD--SNADVLSWEGRLRIATEAAQGLE 647
H N+ Y E +++ ++ + + L E+ + + E I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 648 YLHLGCKPPR-VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
YLH K R VHRD+ P NI+L + + + DFGL+K + T V GT Y
Sbjct: 128 YLH---KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ---KQPESKLTSVVGTILYSC 181
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
PE + EK+DV++FG +L ++ T +P
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 63/209 (30%), Positives = 91/209 (43%), Gaps = 28/209 (13%)
Query: 541 TILGEGSFGKVYHG-YLDDNTEVAVKMLSPSS---RQGYEQFEAE-VILLRTVHHKNLTT 595
++G+GSFGKV + D AVK+L + ++ + AE +LL+ V H L
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 596 LYGYCNEGNQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIATEAAQGLEYL 649
L+ +++ + +Y+ G L E + A A E A L YL
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFY--------AAEIASALGYL 112
Query: 650 HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST--GVAGTFGYLDP 707
H ++RD+KP NILL+ Q L DFGL K EG+ H T GT YL P
Sbjct: 113 H---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLAP 165
Query: 708 EYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
E + D + G VL E++ P
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 38/212 (17%)
Query: 543 LGEGSFGKVYHG-YLDDNTEVAVKMLS--------PSS--RQGYEQFEAEVILLRTVHHK 591
+GEG++G VY VA+K + PS+ R E+ LL+ ++H
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR--------EISLLKELNHP 58
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ---GLEY 648
N+ L + N++ L++E++ + L++Y+ S L I + Q G+ Y
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGL---DPPLIKSYLYQLLQGIAY 114
Query: 649 LHLGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTF--PIEGVSHLSTGVAGTFGYL 705
C RV HRD+KP N+L++ + +LADFGL++ F P+ +H T Y
Sbjct: 115 ----CHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYR 166
Query: 706 DPEYCQTFRLTEKS-DVYSFGVVLLEIITSRP 736
PE R D++S G + E++ RP
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 543 LGEGSFGKVYHGYLDDNTE-VAVKMLS--------PSSRQGYEQFEAEVILLRTVHHKNL 593
+GEG++G VY E VA+K + PS+ E+ LL+ ++H N+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI------REISLLKELNHPNI 61
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC 653
L + N++ L++E++ + L++++ S + + QGL + C
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF----C 116
Query: 654 KPPRV-HRDIKPANILLNDQFQARLADFGLSKTF--PIEGVSHLSTGVAGTFGYLDPEY- 709
RV HRD+KP N+L+N + +LADFGL++ F P+ +H T Y PE
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 172
Query: 710 --CQTFRLTEKSDVYSFGVVLLEIITSR 735
C+ + + D++S G + E++T R
Sbjct: 173 LGCKYY--STAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 29/214 (13%)
Query: 538 DFETI--LGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQFEA--EVILLRTVHHKN 592
D+ I +GEG++G VY G VA+K + S + A E+ LL+ + H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-- 650
+ L + +++ LI+E+++ L++YL D L + +A YL+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSM-DLKKYL-----DSLPKGQYM----DAELVKSYLYQI 110
Query: 651 ----LGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTF--PIEGVSHLSTGVAGTFG 703
L C RV HRD+KP N+L++++ +LADFGL++ F P+ +H T
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV----TLW 166
Query: 704 YLDPE-YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
Y PE + R + D++S G + E+ T +P
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 538 DFETI--LGEGSFGKVYHGYLDDNTEV----AVKMLSPSS----RQGYEQFEAEVILLRT 587
D E I +G G+FG+V+ L + A+K+++ +Q + E +L+
Sbjct: 2 DLERIKTVGTGTFGRVH---LVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKE 57
Query: 588 VHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLE 647
V H + L+ ++ + ++ EY+ G L YL N+ S L A+E LE
Sbjct: 58 VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALE 115
Query: 648 YLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDP 707
YLH V+RD+KP NILL+ + +L DFG +K + + + GT YL P
Sbjct: 116 YLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKK-----LRDRTWTLCGTPEYLAP 167
Query: 708 EYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
E Q+ + D ++ G+++ E++ P
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFE---AEVILLRTVHHKNLTTLYG 598
+G GSFG VY + ++ VA+K +S S +Q E+++ EV L+ + H N G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRV 658
+ L+ EY GS + L + E + A QGL YLH +
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE-IAAVTHGALQGLAYLH---SHNMI 137
Query: 659 HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF---RL 715
HRD+K NILL++ +L DFG + + + GT ++ PE +
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANXFVGTPYWMAPEVILAMDEGQY 191
Query: 716 TEKSDVYSFGVVLLEIITSRPAIANTEEHK---HISQ 749
K DV+S G+ +E+ +P + N HI+Q
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFEAEV----ILLRTVHHKNLTTL 596
+LG+GSFGKV L EV A+K+L + + + IL H LT L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNA-DVLSWEGRLRI-ATEAAQGLEYLHLGCK 654
+ +++ + EY+ G L + S D E R R A E L +LH +
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD----EPRSRFYAAEVTLALMFLH---R 114
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFR 714
++RD+K NILL+ + +LADFG+ K + GV +T GT Y+ PE Q
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELE 172
Query: 715 LTEKSDVYSFGVVLLEIITSRPAI-ANTEE 743
D ++ GV++ E++ +P A+ E+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFEADNED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 60/196 (30%), Positives = 90/196 (45%), Gaps = 12/196 (6%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTL- 596
+LG+G FG+V + ++ A K L R+G E +L V+ + + L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP 656
Y Y + + L+ M G L+ ++ + E L A E GLE LH +
Sbjct: 67 YAY-ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---REN 122
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLT 716
V+RD+KP NILL+D R++D GL+ P EG G GT GY+ PE R T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIP-EG--ESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 717 EKSDVYSFGVVLLEII 732
D + G ++ E+I
Sbjct: 180 LSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 543 LGEGSFGKVYHGYLDDNTE--VAVKMLSPSSRQGYEQFEA--EVILLR---TVHHKNLTT 595
+GEG++GKV+ N VA+K + + + EV +LR T H N+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 596 LYGYC-----NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
L+ C + ++ L++E++ + L YL + E + + +GL++LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
VHRD+KP NIL+ Q +LADFGL++ + + T V T Y PE
Sbjct: 128 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVL 181
Query: 711 QTFRLTEKSDVYSFGVVLLEIITSRP 736
D++S G + E+ +P
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 543 LGEGSFGKVYHGYLDDNTEV--AVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC 600
LG+G+FGKVY + T V A K++ S + E + E+ +L + H N+ L
Sbjct: 13 LGDGAFGKVYKAQ-NKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 601 NEGNQIGLIYEYMANGS-------LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC 653
N + ++ E+ A G+ LE L++ V + + + L YLH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV--------VCKQTLEALNYLH--- 120
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLS--KTFPIEGVSHLSTGVAGTFGYLDPE--Y 709
+ +HRD+K NIL +LADFG+S T I+ GT ++ PE
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ----RRDSFIGTPYWMAPEVVM 176
Query: 710 CQTFR---LTEKSDVYSFGVVLLEIITSRP 736
C+T + K+DV+S G+ L+E+ P
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 22/224 (9%)
Query: 542 ILGEGSFGKVYHG-YLDDNTEVAVKMLSPSS---RQGYEQFEAEV-ILLRTVHHKNLTTL 596
++G+GSFGKV D + AVK+L + ++ AE +LL+ + H L L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLEYLHLGCKP 655
+ ++ + +Y+ G L +L + E R R A E A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL---EPRARFYAAEVASAIGYLH---SL 115
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV--SHLSTGVAGTFGYLDPEYCQTF 713
++RD+KP NILL+ Q L DFGL K EGV ++ GT YL PE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPEVLRKE 171
Query: 714 RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ 757
D + G VL E++ P + + +SQ D +L +
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYS----RDVSQMYDNILHK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 59/208 (28%), Positives = 86/208 (41%), Gaps = 18/208 (8%)
Query: 543 LGEGSFGKVYH-GYLDDNTEVAVKMLSPSSRQGYEQFE---AEVILLRTVHHKNLTTLYG 598
LG G FG+V N A+K + Q E +E +L +H + LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIA--TEAAQGLEYLH-LGCKP 655
+ I ++ EY G L L D + R IA A EYLH G
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLA---FEYLHNRGI-- 114
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL 715
++RD+KP N+LL+ +L DFG +K ++ T GT Y+ PE
Sbjct: 115 --IYRDLKPENLLLDSNGYVKLVDFGFAKK--LKSGQKTWTFC-GTPEYVAPEIILNKGY 169
Query: 716 TEKSDVYSFGVVLLEIITSRPAIANTEE 743
D +S G++L E++T RP +E
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 54/195 (27%), Positives = 98/195 (50%), Gaps = 14/195 (7%)
Query: 543 LGEGSFGKVYHGYL---DDNTEVAVKML-SPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
LG G+FG V G +VA+K+L + + + ++ E ++ + + + + G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRV 658
C E + L+ E + G L ++LS D ++ + + + + G++YL V
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLS-GKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117
Query: 659 HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF--GYLDPEYCQTFR-L 715
HRD+ N+LL +Q A+++DFGLSK + S+ AG + + PE C FR
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPE-CINFRKF 175
Query: 716 TEKSDVYSFGVVLLE 730
+ +SDV+S+G+ + E
Sbjct: 176 SSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 540 ETILGEGSFGKVYHG-YLDDNTEVAVK------MLSPSSRQGYEQFEAEVILLRTVHHKN 592
E +G G F +VY L D VA+K ++ +R + E+ LL+ ++H N
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQLNHPN 63
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLS--DSNADVLSWEGRLRIATEAAQGLEYLH 650
+ Y E N++ ++ E G L + ++ + + + LE++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 651 LGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY 709
RV HRDIKPAN+ + +L D GL + F + + S + GT Y+ PE
Sbjct: 124 ----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 710 CQTFRLTEKSDVYSFGVVLLEI 731
KSD++S G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 14/197 (7%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFEAEVILLRTV----HHKNLTTL 596
+LG+GSFGKV L E A+K L + E ++ R + H LT L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLEYLHLGCKP 655
+ + + EY+ G L ++ S + R R A E GL++LH K
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA---RARFYAAEIICGLQFLH---KK 115
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL 715
++RD+K N+LL+ ++ADFG+ K + G ST GT Y+ PE + +
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKAST-FCGTPDYIAPEILKGQKY 173
Query: 716 TEKSDVYSFGVVLLEII 732
E D +SFGV+L E++
Sbjct: 174 NESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 34/213 (15%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFE-AEVILLRTVHHKNLTTLY-- 597
+GEG++G V +VA+K +SP Q + Q E+ +LR H+N+ +
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDI 71
Query: 598 ----GYCNEGNQIGLIYEYMANGS----LEEYLSDSNADVLSWEGRLRIATEAAQGLEYL 649
+ + N + ++ E M ++LS+ + ++ LR GL+Y+
Sbjct: 72 IRPPSFESF-NDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ-ILR-------GLKYI 122
Query: 650 HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG-----VAGTFGY 704
H +HRD+KP+N+LLN ++ DFGL++ I H TG VA T Y
Sbjct: 123 H---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR---IADPEHDHTGFLTEYVA-TRWY 175
Query: 705 LDPEYCQTFRLTEKS-DVYSFGVVLLEIITSRP 736
PE + K+ D++S G +L E++++RP
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 540 ETILGEGSFGKVYHGYLDDN-TEVAVKMLSPSSRQGYEQFEAEVILLRTVH-HKNLTTLY 597
ETI G+G++GKV+ N ++ AVK+L P E+ EAE +L+ + H N+ Y
Sbjct: 24 ETI-GKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFY 81
Query: 598 GY-----CNEGNQIGLIYEYMANGSLEEYLSD--SNADVLSWEGRLRIATEAAQGLEYLH 650
G G+Q+ L+ E GS+ + + + + I EA GL++LH
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
+ +HRD+K NILL + +L DFG+S + GT ++ PE
Sbjct: 142 VN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTSVGTPFWMAPEVI 196
Query: 711 ---QTFRLT--EKSDVYSFGVVLLEIITSRPAIAN 740
Q T + DV+S G+ +E+ P +A+
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 540 ETILGEGSFGKVYH-GYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLY 597
ETI G+G++GKVY D + AVK+L P S E+ EAE +L+++ +H N+ Y
Sbjct: 28 ETI-GKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHPNVVKFY 85
Query: 598 GYCNE-----GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR------IATEAAQGL 646
G + G Q+ L+ E GS+ E + +L RL I A GL
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKG----LLICGQRLDEAMISYILYGALLGL 141
Query: 647 EYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
++LH +HRD+K NILL + +L DFG+S + +T V GT ++
Sbjct: 142 QHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR-NTSV-GTPFWMA 196
Query: 707 PEY--CQT---FRLTEKSDVYSFGVVLLEIITSRPAIAN 740
PE C+ + + DV+S G+ +E+ P + +
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-11
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 561 EVAVKML---SPSSRQGYEQFEAEVILLRTVHHKNLTTLY--GYCNEGNQIGLIYEYMAN 615
EVA+K+L +P +F E L ++H N+ L G G + ++EY+
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYVPG 63
Query: 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPPR--VHRDIKPANILL--- 669
+L +VL+ +G L L+ L L C + VHRD+KP NI++
Sbjct: 64 RTL--------REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQT 115
Query: 670 NDQFQARLADFGLSKTFP-----IEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSF 724
+ A++ DFG+ P +T V GT Y PE + +T SD+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 725 GVVLLEIITSRPAI--ANTEE--HKHISQWVDFMLAQ 757
G++ LE +T + + A+ E ++ +S VD L
Sbjct: 176 GLIFLECLTGQRVVQGASVAEILYQQLSP-VDVSLPP 211
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 62/203 (30%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 542 ILGEGSFGKVYHG-YLDDNTEVAVKMLSPSS----RQGYEQFEAEVILLRTVHHKNLTTL 596
++G+GSFGKV + + AVK+L + ++ +LL+ V H L L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLEYLHLGCKP 655
+ +++ + +Y+ G L +L + E R R A E A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFL---EPRARFYAAEIASALGYLH---SL 115
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST--GVAGTFGYLDPEYCQTF 713
V+RD+KP NILL+ Q L DFGL K E + H T GT YL PE
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 714 RLTEKSDVYSFGVVLLEIITSRP 736
D + G VL E++ P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 38/229 (16%)
Query: 536 TNDFETI--LGEGSFGKVYHG-YLDDNTEVAVK-MLSPSSRQGYEQFEA--EVILLRTVH 589
D+E + LGEG+FG+VY + VA+K +L + + G+ A E+ +L+ +
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFP-ITALREIKILKKLK 65
Query: 590 HKNLTTL----YGYC-NEGNQIGLIY---EYMA---NGSLEEYLSDSNADVLSWEGRLR- 637
H N+ L + G +Y YM +G LE N V E +++
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE------NPSVKLTESQIKC 119
Query: 638 IATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF---------PI 688
+ +G+ YLH + +HRDIK ANIL+++Q ++ADFGL++ +
Sbjct: 120 YMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 689 EGVSHLSTGVAGTFGYLDPEYC-QTFRLTEKSDVYSFGVVLLEIITSRP 736
G + T + T Y PE R T D++ G V E+ T RP
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 53/160 (33%), Positives = 74/160 (46%), Gaps = 11/160 (6%)
Query: 538 DFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPSS---RQGYEQFEAEVILLRTVHHK 591
F+ I LG+G G+V+ L ++ A+K+L R ++ E +L T+ H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH- 650
L TLY + L+ +Y G L L LS E A E LEYLH
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690
LG V+RD+KP NILL++ L+DF LSK +E
Sbjct: 122 LGI----VYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKMLSPSS---RQGYEQFEAEVILLRTVHHKN----L 593
I+G G FG+VY D ++ A+K L +QG E I+L V + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC 653
Y + + +++ I + M G L +LS V S + ATE GLE++H
Sbjct: 61 CMTYAF-HTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMH--- 114
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF 713
V+RD+KPANILL++ R++D GL+ F + H S GT GY+ PE Q
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV---GTHGYMAPEVLQKG 170
Query: 714 RLTEKS-DVYSFGVVLLEII 732
+ S D +S G +L +++
Sbjct: 171 TAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-11
Identities = 31/83 (37%), Positives = 49/83 (59%), Gaps = 5/83 (6%)
Query: 373 LWNGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLS 432
LW G+ C N+ R+ S++LS + ++G I + L I+ ++LSNN L+GP+P+ +
Sbjct: 59 LWQGITC----NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIF 114
Query: 433 KLQY-LRVLNLTGNMLTGPLPAG 454
LR LNL+ N TG +P G
Sbjct: 115 TTSSSLRYLNLSNNNFTGSIPRG 137
|
Length = 968 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 41/222 (18%)
Query: 542 ILGEGSFGKVYHGYLDDNTEVA----VKM------LSPSSRQGYEQFEAEVILLRTVHHK 591
+GEG++G VY + E+ V+M + SS + E+ LL + H
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-------EITLLLNLRHP 66
Query: 592 NLTTLYGYC--NEGNQIGLIYEY----MANGSLEEYLSDSNADVLSWEGRLR-IATEAAQ 644
N+ L + I L+ EY +A+ L D+ S E +++ + + +
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLAS------LLDNMPTPFS-ESQVKCLMLQLLR 119
Query: 645 GLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704
GL+YLH +HRD+K +N+LL D+ ++ADFGL++T+ + T T Y
Sbjct: 120 GLQYLHENFI---IHRDLKVSNLLLTDKGCLKIADFGLARTY--GLPAKPMTPKVVTLWY 174
Query: 705 LDPEY---CQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE 743
PE C T+ T D+++ G +L E++ +P + E
Sbjct: 175 RAPELLLGCTTY--TTAIDMWAVGCILAELLAHKPLLPGKSE 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 64/245 (26%), Positives = 105/245 (42%), Gaps = 42/245 (17%)
Query: 528 TYAEITKITNDFETILGEGSFGKVYHGYLDDNTE-VAVKMLSPSSRQGYEQFEA----EV 582
Y ++ KI G+G+FG+V+ + VA+K + + + E F E+
Sbjct: 13 KYEKLAKI--------GQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREI 62
Query: 583 ILLRTVHHKNLTTLYGYCNE----GN----QIGLIYEYMANGSLEEYLSDSNADVLSWEG 634
+L+ + H+N+ L C N L++E+ + L LS+ N +
Sbjct: 63 KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVK-FTLSE 120
Query: 635 RLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF--PIEGVS 692
++ GL Y+H +HRD+K ANIL+ +LADFGL++ F
Sbjct: 121 IKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177
Query: 693 HLSTGVAGTFGYLDPEYCQTFRLTEKS-----DVYSFGVVLLEIITSRPAI-ANTEEH-- 744
+ T T Y PE L E+ D++ G ++ E+ T P + NTE+H
Sbjct: 178 NRYTNRVVTLWYRPPE----LLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL 233
Query: 745 KHISQ 749
ISQ
Sbjct: 234 TLISQ 238
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTL- 596
+LG+G FG+V + ++ A K L R+G E +L V+ + + +L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 597 YGYCNEGNQIGLIYEYMANGSLE---EYLSDSNADVLSWEGR-LRIATEAAQGLEYLHLG 652
Y Y + + L+ M G L+ ++ ++ + EGR + A E GLE LH
Sbjct: 67 YAY-ETKDALCLVLTLMNGGDLKFHIYHMGEAGFE----EGRAVFYAAEICCGLEDLH-- 119
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
+ V+RD+KP NILL+D R++D GL+ P EG G GT GY+ PE +
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EG--QTIKGRVGTVGYMAPEVVKN 175
Query: 713 FRLTEKSDVYSFGVVLLEII 732
R T D ++ G +L E+I
Sbjct: 176 ERYTFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 540 ETILGEGSFGKVYHGY-LDDNTEVAVK------MLSPSSRQGYEQFEAEVILLRTVHHKN 592
E +G G F +VY L D VA+K M+ +RQ + E+ LL+ ++H N
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQLNHPN 63
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLS--DSNADVLSWEGRLRIATEAAQGLEYLH 650
+ E N++ ++ E G L + + ++ + + +E++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 651 LGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY 709
RV HRDIKPAN+ + +L D GL + F + + S + GT Y+ PE
Sbjct: 124 ----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 710 CQTFRLTEKSDVYSFGVVLLEI 731
KSD++S G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 16/196 (8%)
Query: 543 LGEGSFGKVYHGYLDDNTE-VAVKMLSPSSRQGYEQFEA--EVILLRTVHHKNLTTLYGY 599
LGEGS+ VY G N + VA+K++ +G F A E LL+ + H N+ L+
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDI 71
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVH 659
+ + L++EY+ + L +Y+ D + L E + +GL Y+H + +H
Sbjct: 72 IHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILH 126
Query: 660 RDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKS 719
RD+KP N+L++D + +LADFGL++ + SH + T Y P+ TE S
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVP--SHTYSNEVVTLWYRPPDV--LLGSTEYS 182
Query: 720 ---DVYSFGVVLLEII 732
D++ G + +E+I
Sbjct: 183 TCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 542 ILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEV-ILLRTVHHKNLTTL 596
++G+GSFGKV D AVK+L +R+ + AE +LL+ V H L L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLEYLHLGCKP 655
+ ++ + +++ G L +L + E R R A E A L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP---EPRARFYAAEIASALGYLH---SI 115
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH--LSTGVAGTFGYLDPEYCQTF 713
V+RD+KP NILL+ Q L DFGL K EG++ +T GT YL PE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK----EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 714 RLTEKSDVYSFGVVLLEIITSRPAIANTEEHK 745
D + G VL E++ P + +
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 33/218 (15%)
Query: 537 NDFETI--LGEGSFGKVYH-GYLDDNTEVAVKMLSPS-SRQGYEQFEAEV-ILLRTVHHK 591
+D E I LG G++G V ++ T +AVK + + + Q ++ ++ I +R+V
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDS-------NADVLSWEGRLRIATEAAQ 644
T YG + + E M + SL+++ D+L +IA +
Sbjct: 61 YTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVK 114
Query: 645 GLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS-TGVAGTFG 703
LEYLH +HRD+KP+N+L+N Q +L DFG+S V ++ T AG
Sbjct: 115 ALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYL----VDSVAKTIDAGCKP 168
Query: 704 YLDPEY------CQTFRLTEKSDVYSFGVVLLEIITSR 735
Y+ PE + + + KSDV+S G+ ++E+ T R
Sbjct: 169 YMAPERINPELNQKGYDV--KSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 48/148 (32%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 543 LGEGSFGKVYHGYLDDN---TEVAVKML-SPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
+G G FGKV G ++ +V VK L +S Q +F E R++ H NL G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 599 YCNEGNQIGLIYEYMANGSLEEYL-SDSNADVLSWEGRL--RIATEAAQGLEYLHLGCKP 655
C E L+ E+ G L+ YL S A++++ + R+A E A GL +LH K
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLS 683
+H D+ N LL ++ D+GLS
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 9e-11
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 542 ILGEGSFGKVYHGYLDDNTE-VAVKMLSPSSRQGYEQFEAEVILLRTV----HHKNLTTL 596
+LG+GSFGKV L E AVK L + E ++ R + + LT L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI------ATEAAQGLEYLH 650
Y + + E++ G L ++ D +GR + A E GL++LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQD--------KGRFDLYRATFYAAEIVCGLQFLH 113
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
++RD+K N++L+ ++ADFG+ K + G + ST GT Y+ PE
Sbjct: 114 ---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE-NVFGDNRAST-FCGTPDYIAPEIL 168
Query: 711 QTFRLTEKSDVYSFGVVLLEII 732
Q + T D +SFGV+L E++
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFEAEV----ILLRTVHHKNLTTL 596
+LG+GSFGKV L ++ + AVK+L + E + IL +H LT L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNA-DVLSWEGRLRI-ATEAAQGLEYLHLGCK 654
Y +++ + E++ G L ++ S D E R R A E L +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----EARARFYAAEITSALMFLH---D 114
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFR 714
++RD+K N+LL+ + +LADFG+ K G ++ GT Y+ PE Q
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEML 172
Query: 715 LTEKSDVYSFGVVLLEIITSR-PAIANTEE 743
D ++ GV+L E++ P A E+
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 12/194 (6%)
Query: 543 LGEGSFGKVYHGYLD---DNTEVAVKMLSPSSRQGY--EQFEAEVILLRTVHHKNLTTLY 597
LG G+FG V G VAVK+L + ++ E +++ + + + +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 598 GYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPR 657
G C E L+ E G L ++L N V + + + + G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQ-KNKHVTE-KNITELVHQVSMGMKYLE---ETNF 116
Query: 658 VHRDIKPANILLNDQFQARLADFGLSKTFPI-EGVSHLSTGVAGTFGYLDPEYCQTFRLT 716
VHRD+ N+LL Q A+++DFGLSK E T + PE ++ +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 717 EKSDVYSFGVVLLE 730
KSDV+SFGV++ E
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 31/208 (14%)
Query: 543 LGEGSFGKVYHG----YLDDN----TEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLT 594
LG+G+F K++ G D TEV +K+L S R E F ++ + HK+L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYLS-DSNADVLSWEGRLRIATEAAQGLEYLHLGC 653
YG C G++ ++ EY+ GSL+ YL + N +SW +L +A + A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE--- 117
Query: 654 KPPRVHRDIKPANILLNDQFQA--------RLADFGLSKT-FPIEGVSHLSTGVAGTFGY 704
H ++ N+LL + +L+D G+S T P E + V
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVP----- 172
Query: 705 LDPEYCQTFR-LTEKSDVYSFGVVLLEI 731
PE + + L+ +D +SFG L EI
Sbjct: 173 --PECIENPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 542 ILGEGSFGKVY-----HGYLDDNTEVAVKMLSPS----SRQGYEQFEAEVILLRTVHHKN 592
+LG+G +GKV+ G D A+K+L + +++ +AE +L V H
Sbjct: 3 VLGKGGYGKVFQVRKVTGA-DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSL-----EE--YLSDSNADVLSWEGRLRIATEAAQG 645
+ L G ++ LI EY++ G L E ++ D+ LS E +
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS---------EISLA 112
Query: 646 LEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG-VSHLSTGVAGTFGY 704
LE+LH + ++RD+KP NILL+ Q +L DFGL K EG V+H GT Y
Sbjct: 113 LEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEY 166
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHI 747
+ PE + D +S G ++ +++T P K I
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI 209
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 50/199 (25%), Positives = 91/199 (45%), Gaps = 11/199 (5%)
Query: 542 ILGEGSFGKVYH-GYLDDNTEVAVKMLSPSSRQGYEQFEA--EVILLRTVHHKNLTTLYG 598
++GEGS+G V + + VA+K S + A E+ +L+ + H+NL L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRV 658
++ L++E++ + L++ N L + + +G+E+ H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSH---NII 122
Query: 659 HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY-CQTFRLTE 717
HRDIKP NIL++ +L DFG ++T G + T T Y PE +
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELLVGDTKYGR 180
Query: 718 KSDVYSFGVVLLEIITSRP 736
D+++ G ++ E++T P
Sbjct: 181 AVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 20/208 (9%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTE-VAVKMLSPSSRQGYEQFE---AEVILLRTVHH 590
DF+ + +G+G +G+V+ D E VA+K + S + E +L T
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLEYL 649
+ L L + + L EY+ G L++ VLS E R E + ++ L
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLS-EDHARFYMAEMFEAVDAL 117
Query: 650 H-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE 708
H LG +HRD+KP N L++ +L DFGLSK G+ + V G+ Y+ PE
Sbjct: 118 HELG----YIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPE 168
Query: 709 YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
+ D +S G +L E + P
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 538 DFE--TILGEGSFGKVYHGYLDDNTEV-AVKMLSP---SSRQGYEQFEAEVILLRTVHHK 591
DFE ++G G+FG+V L + +V A+K+L+ R F E +L ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLS---DSNADVLS--WEGRLRIATEAAQGL 646
+TTL+ + N + L+ +Y G L LS D + ++ + + IA ++ L
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 647 EYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
Y VHRDIKP NIL++ RLADFG +G S V GT Y+
Sbjct: 122 HY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYIS 171
Query: 707 PEYCQTF-----RLTEKSDVYSFGVVLLEII 732
PE Q + + D +S GV + E++
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKMLSPSS---RQGYEQFEAEVILLRTVHHKN----L 593
I+G G FG+VY D ++ A+K L +QG E I+L V + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC 653
Y + + +++ I + M G L +LS V S A E GLE++H
Sbjct: 61 CMSYAF-HTPDKLSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMH--- 114
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF 713
V+RD+KPANILL++ R++D GL+ F + H S GT GY+ PE Q
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV---GTHGYMAPEVLQKG 170
Query: 714 RLTEKS-DVYSFGVVLLEII 732
+ S D +S G +L +++
Sbjct: 171 VAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 76/259 (29%), Positives = 118/259 (45%), Gaps = 45/259 (17%)
Query: 510 RHKRLRKDGSLETKKRRFTYAEITKITNDFETILGEGSFGKV---YHGYLDDNTEVAVKM 566
R KR S+E FT + K + + I G G+ G V Y L+ N VA+K
Sbjct: 3 RSKRDNNFYSVEIGDSTFT---VLKRYQNLKPI-GSGAQGIVCAAYDAILERN--VAIKK 56
Query: 567 LS-PSSRQGY-EQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEY--- 621
LS P Q + ++ E++L++ V+HKN+ IGL+ + SLEE+
Sbjct: 57 LSRPFQNQTHAKRAYRELVLMKCVNHKNI------------IGLLNVFTPQKSLEEFQDV 104
Query: 622 -----LSDSN-ADVLSWE-GRLRIATEAAQ---GLEYLHLGCKPPRVHRDIKPANILLND 671
L D+N V+ E R++ Q G+++LH +HRD+KP+NI++
Sbjct: 105 YIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 161
Query: 672 QFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEI 731
++ DFGL++T G S + T T Y PE E D++S G ++ E+
Sbjct: 162 DCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 732 ITSRPAIANTEEHKHISQW 750
I T+ HI QW
Sbjct: 219 IKGGVLFPGTD---HIDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 538 DFETI--LGEGSFGKVY----HGYLDDNTEVAVKMLSPSS----RQGYEQFEAEVILLRT 587
+FE + LG G++GKV+ G D A+K+L ++ + E E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 588 VHHKN-LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGL 646
V L TL+ ++ LI +Y+ G L +L S E R+ IA E L
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLAL 118
Query: 647 EYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYL 705
++LH LG ++RDIK NILL+ + L DFGLSK F + + GT Y+
Sbjct: 119 DHLHQLGI----IYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIEYM 173
Query: 706 DPEYCQTFRLTEKS--DVYSFGVVLLEIIT 733
PE + D +S GV+ E++T
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLY 597
+LG+G FG+V + ++ A K L R+G E +L V+ + + +L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL- 65
Query: 598 GYCNE-GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP 656
Y E + + L+ M G L+ ++ + + + A E GLE L +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RER 122
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLT 716
V+RD+KP NILL+D+ R++D GL+ P EG G GT GY+ PE + T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIP-EG--ETVRGRVGTVGYMAPEVINNEKYT 179
Query: 717 EKSDVYSFGVVLLEII 732
D + G ++ E+I
Sbjct: 180 FSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 37/221 (16%)
Query: 542 ILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVIL--------------LRT 587
+LG+G+FGKV + V+ + + + EVI+ L+
Sbjct: 2 LLGKGTFGKV----------ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN 51
Query: 588 VHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGL 646
H LT+L +++ + EY+ G L +LS V S E R R E L
Sbjct: 52 TRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER--VFS-EDRTRFYGAEIVSAL 108
Query: 647 EYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST--GVAGTFGY 704
+YLH G V+RD+K N++L+ ++ DFGL K EG++ +T GT Y
Sbjct: 109 DYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKTFCGTPEY 161
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK 745
L PE + D + GVV+ E++ R N + K
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 581 EVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIAT 640
E +LL+ V+H ++ + G ++ + + L YL+ + L + L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLT-KRSRPLPIDQALIIEK 164
Query: 641 EAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAG 700
+ +GL YLH +HRD+K NI +ND Q + D G ++ FP+ + L G+AG
Sbjct: 165 QILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFL--GLAG 218
Query: 701 TFGYLDPEYCQTFRLTEKSDVYSFGVVLLEII 732
T PE + K+D++S G+VL E++
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 53/219 (24%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 536 TNDFETILGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFEAEVILLRTVHHKN-- 592
+F +LG+GSFGKV E+ A+K+L + E ++ R + ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 593 --LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR------IATEAAQ 644
LT L+ +++ + EY+ G L ++ G+ + A E +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV--------GKFKEPQAVFYAAEISV 112
Query: 645 GLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704
GL +LH + ++RD+K N++L+ + ++ADFG+ K ++GV+ + GT Y
Sbjct: 113 GLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTPDY 167
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE 743
+ PE + D +++GV+L E++ +P +E
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEA----EVILLRTVHHKNLTTLYG 598
+GEG++G VY D T + + Q E + E+ LL+ + H N+ L
Sbjct: 10 IGEGTYGVVYKAR-DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ---GLEYLHLGCKP 655
+ ++ L++EY+ + L++++ DS+ D + RL I T Q G+ Y C
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHM-DSSPD-FAKNPRL-IKTYLYQILRGIAY----CHS 120
Query: 656 PRV-HRDIKPANILLNDQFQA-RLADFGLSKTF--PIEGVSHLSTGVAGTFGYLDPEYCQ 711
RV HRD+KP N+L++ + A +LADFGL++ F P+ +H T Y PE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPEILL 176
Query: 712 TFR-LTEKSDVYSFGVVLLEIITSRP 736
R + D++S G + E++ +P
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 8e-10
Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 46/220 (20%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEA-----EVILLRTVHHKNLTT 595
+G G++G V +VA+K +S + +A E+ LLR + H+N+
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLRHENIIG 63
Query: 596 LY-----GYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ------ 644
L + N + ++ E M +D + + S + + Q
Sbjct: 64 LLDILRPPSPEDFNDVYIVTELME--------TDLHKVIKS---PQPLTDDHIQYFLYQI 112
Query: 645 --GLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF--PIEGVSHLSTGVA 699
GL+YLH +HRD+KP+NIL+N ++ DFGL++ + L+ V
Sbjct: 113 LRGLKYLHSANV----IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 700 GTFGYLDPEY---CQTFRLTEKSDVYSFGVVLLEIITSRP 736
T Y PE + T+ D++S G + E++T +P
Sbjct: 169 -TRWYRAPELLLSSSRY--TKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 64/234 (27%), Positives = 96/234 (41%), Gaps = 52/234 (22%)
Query: 527 FTYAEITKITNDFETILGEGSFGKVY---HGYLDDNTEVAVKMLSPSSRQGYEQ----FE 579
FT ++ D I G G+FG V H T +AVK + S+ EQ +
Sbjct: 1 FTAEDLK----DLGEI-GRGAFGTVNKMLHK--PSGTIMAVKRIR-STVDEKEQKRLLMD 52
Query: 580 AEVILLRTVHHKNLTTLYG---------YCNEGNQIGLIYEYM-ANGSLEEYLSDSNADV 629
+V++ R+ + YG C E I L Y L+ + ++
Sbjct: 53 LDVVM-RSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVI---PEEI 108
Query: 630 LSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689
L G++ +AT A L YL K +HRD+KP+NILL+ +L DFG+S
Sbjct: 109 L---GKIAVATVKA--LNYLKEELKI--IHRDVKPSNILLDRNGNIKLCDFGIS------ 155
Query: 690 GVSHLSTGVAGTFG-----YLDPEYCQTFRLTE---KSDVYSFGVVLLEIITSR 735
L +A T Y+ PE +SDV+S G+ L E+ T +
Sbjct: 156 --GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 70/281 (24%), Positives = 104/281 (37%), Gaps = 107/281 (38%)
Query: 539 FETILGEGSFGKVYH----GYLDDNT--EVAVKMLSPSSRQG-YEQFEAEV-ILLRTVHH 590
LG G+FGKV G + VAVKML + Y+ E+ IL+ HH
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 591 KNLTTLYGYCNE-GNQIGLIYEYMANGSLEEYL--------------------------- 622
N+ L G C + G + +I EY G+L YL
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKK 130
Query: 623 --------SDSNA------------------------DVLSWEGRLRIATEAAQGLEYL- 649
S S+A + L+ E + + + A+G+E+L
Sbjct: 131 QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA 190
Query: 650 HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY 709
C +HRD+ NILL++ ++ DFGL++ Y DP+Y
Sbjct: 191 SRKC----IHRDLAARNILLSENNVVKICDFGLARDI-----------------YKDPDY 229
Query: 710 CQT--FRL---------------TEKSDVYSFGVVLLEIIT 733
+ RL T +SDV+SFGV+L EI +
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 27/208 (12%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKM------LSPSSRQGYEQFEAEVILLRTVHHKNLTTL 596
LG+G++G VY L T V + M L S + Q E+ +L +
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESK---FNQIIMELDILHKAVSPYIVDF 64
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRL-RIATEAAQGLEYLHLGCKP 655
YG + + EYM GSL++ + A E L RI +GL++L K
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL----KE 120
Query: 656 PR--VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY---- 709
+HRD+KP N+L+N Q +L DFG+S V+ L+ G Y+ PE
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL----VASLAKTNIGCQSYMAPERIKSG 176
Query: 710 --CQTFRLTEKSDVYSFGVVLLEIITSR 735
Q T +SDV+S G+ +LE+ R
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 45/148 (30%), Positives = 75/148 (50%), Gaps = 19/148 (12%)
Query: 546 GSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCN 601
G+FGKVY G +N+++ AVK++ + ++ Q +AE L + LY
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 602 EGNQIGLIYEYMANGSLEEYLS-----DSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP 656
N + L+ EY+ G ++ L D E ++ +E A L+YLH +
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDE-------EMAVKYISEVALALDYLH---RHG 124
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSK 684
+HRD+KP N+L++++ +L DFGLSK
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 37/94 (39%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 639 ATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698
A E GLE LH + V+RD+KP NILL+D R++D GL+ P EG G
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIP-EG--ETIRGR 161
Query: 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEII 732
GT GY+ PE + R T D + G ++ E+I
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 12/209 (5%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFEAEVILLRTV----HHKNLTTL 596
+LG+GSFGKV+ L + A+K L + E ++ R + H LT L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP 656
Y + + EY+ G L ++ + L A E GL++LH
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRA--TFYAAEIICGLQFLH---SKG 116
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLT 716
V+RD+K NILL+ ++ADFG+ K + G + T GT Y+ PE +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKE-NMLGDAKTCT-FCGTPDYIAPEILLGQKYN 174
Query: 717 EKSDVYSFGVVLLEIITSRPAIANTEEHK 745
D +SFGV+L E++ + +E +
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 538 DFE--TILGEGSFGKVYHGYLDDNTE-VAVKMLSPSSRQGYEQFE---AEVILLRTVHHK 591
DFE LG GSFG+V E A+K L +Q + E +L + H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNA---DVLSWEGRLRIATEAAQGLEY 648
+ + + N++ + E++ G L +L + DV + E EY
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-----YHAELVLAFEY 133
Query: 649 LHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE 708
LH ++RD+KP N+LL+++ ++ DFG +K V + + GT YL PE
Sbjct: 134 LH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK-----VPDRTFTLCGTPEYLAPE 185
Query: 709 YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
Q+ + D ++ GV+L E I P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 62/209 (29%), Positives = 91/209 (43%), Gaps = 31/209 (14%)
Query: 539 FETILGEGSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAEVILLRTVH---HK 591
+LG G FGKV E+ A+K L +R E E + T + H
Sbjct: 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLEYLH 650
L L+ + + + EY A G L ++ + DV S E R A GL+YLH
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHI---HTDVFS-EPRAVFYAACVVLGLQYLH 118
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST--GVAGTFGYLDPE 708
+ V+RD+K N+LL+ + ++ADFGL K EG+ GT +L PE
Sbjct: 119 ---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCGTPEFLAPE 171
Query: 709 YCQTFRLTEKS-----DVYSFGVVLLEII 732
LTE S D + GV++ E++
Sbjct: 172 V-----LTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 39/218 (17%)
Query: 538 DFETILGEGSF-GKVYHGYL--DDNTEVAVKM--LSPSSRQGYEQFEAEVILLRTVHHKN 592
+ T++G+ + H NT VAVK L S++ + + E+I R + H N
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIA---TEAAQGLEYL 649
+ +++ ++ MA GS E+ L + L L IA + L+Y+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYI 117
Query: 650 H-LGCKPPRVHRDIKPANILLNDQFQARLADF---------GLSKT----FPIEGVSHLS 695
H G +HR +K ++ILL+ + L+ G + FP V +L
Sbjct: 118 HSKGF----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 696 TGVAGTFGYLDPEYCQTFRL--TEKSDVYSFGVVLLEI 731
+L PE Q EKSD+YS G+ E+
Sbjct: 174 --------WLSPEVLQQNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-09
Identities = 63/260 (24%), Positives = 109/260 (41%), Gaps = 73/260 (28%)
Query: 527 FTYAEITKITNDF------ETILGEGSFGKVYHGYLDD-NTEVAVKMLSPSSRQGYEQFE 579
F E+ K + + +G G++G+V + +VA+K LS F+
Sbjct: 1 FYRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQ 53
Query: 580 A---------EVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEE----YL---- 622
+ E+ LL+ + H+N+ IGL+ + SLE+ YL
Sbjct: 54 SAIHAKRTYRELRLLKHMDHENV------------IGLLDVFTPASSLEDFQDVYLVTHL 101
Query: 623 --SDSNA----DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQAR 676
+D N LS + + + +GL+Y+H +HRD+KP+NI +N+ + +
Sbjct: 102 MGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELK 158
Query: 677 LADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE-------YCQTFRLTEKSDVYSFGVVLL 729
+ DFGL++ TG T Y PE Y QT D++S G ++
Sbjct: 159 ILDFGLARH-----TDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMA 207
Query: 730 EIITSRPAIANTEEHKHISQ 749
E++T + ++ HI Q
Sbjct: 208 ELLTGKTLFPGSD---HIDQ 224
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 26/218 (11%)
Query: 528 TYAEITKITNDFETILGEGSFGKVYHGY-LDDNTEVAVK-MLSPSS-----RQGYEQFEA 580
T EIT D + + G G+FG V VA+K ++ P S ++ Y
Sbjct: 4 TVFEITNRYVDLQPV-GMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR---- 58
Query: 581 EVILLRTVHHKNLTTLYG-YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIA 639
E+ LL+ + H+N+ +L + + I + E + L L+ + L +
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLT---SRPLEKQFIQYFL 114
Query: 640 TEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699
+ +GL+Y+H VHRD+KP+NIL+N+ ++ DFGL++ TG
Sbjct: 115 YQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYV 166
Query: 700 GTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRP 736
T Y PE T+ + + D++S G + E++ +P
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-09
Identities = 26/57 (45%), Positives = 38/57 (66%)
Query: 399 LTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGL 455
L+G IPP + +L + LDLS+NSL+G +PE + +LQ L +L+L N TG +P L
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL 328
|
Length = 968 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 30/96 (31%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 645 GLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSK---TFPIEGVSHLSTGVAGT 701
GL+Y+H +HRD+KP+N+L+N+ + R+ DFG+++ + P E ++ VA T
Sbjct: 119 GLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-T 174
Query: 702 FGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRP 736
Y PE + T D++S G + E++ R
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAEVILLRTV-HHKNLTTL 596
+LG+GSFGKV L E+ AVK+L E E +L H LT L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLEYLHLGCKP 655
+ +++ + EY+ G L ++ S E R R A E GL++LH +
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSG--RFD-EPRARFYAAEIVLGLQFLH---ER 115
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL 715
++RD+K N+LL+ + ++ADFG+ K + GV+ ++ GT Y+ PE
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPY 173
Query: 716 TEKSDVYSFGVVLLEIITSRP 736
D ++ GV+L E++ +
Sbjct: 174 GPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 27/219 (12%)
Query: 543 LGEGSFGKV---YHGYLDDNTEVAVKMLS-PSSRQGY-EQFEAEVILLRTVHHKNLTTLY 597
+G G+ G V Y LD N VA+K LS P Q + ++ E++L++ V+HKN+ +L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 598 GY------CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHL 651
E + L+ E M + + + + +S+ + + G+++LH
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLH- 136
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQ 711
+HRD+KP+NI++ ++ DFGL++T G S + T T Y PE
Sbjct: 137 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVIL 191
Query: 712 TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQW 750
E D++S G ++ E++ + + +I QW
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD---YIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 28/213 (13%)
Query: 538 DFE--TILGEGSFGKVY----HGYLDDNTEVAVKMLSPSS----RQGYEQFEAEVILLRT 587
+FE +LG G++GKV+ D A+K+L ++ + E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 588 VHHKN-LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSD----SNADVLSWEGRLRIATEA 642
V L TL+ ++ LI +Y++ G + +L S +V + G + +A
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA--- 117
Query: 643 AQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGT 701
LE+LH LG V+RDIK NILL+ + L DFGLSK F + + GT
Sbjct: 118 ---LEHLHKLGI----VYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGT 169
Query: 702 FGYLDPEYCQTFRLTEKS-DVYSFGVVLLEIIT 733
Y+ PE + K+ D +S G+++ E++T
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 51/160 (31%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 537 NDFETI--LGEGSFGKVYHGYL----DDNTEVAVKMLSPSSRQGYEQFE---AEVILLRT 587
+DFE+I +G G+FG+V L D A+K L S EQ AE +L
Sbjct: 1 DDFESIKVIGRGAFGEVR---LVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE 57
Query: 588 VHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEG-RLRIATEAAQGL 646
+ + LY + N + LI EY+ G + L D + E R IA E +
Sbjct: 58 ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIA-ETILAI 114
Query: 647 EYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF 686
+ +H K +HRDIKP N+LL+ + +L+DFGL
Sbjct: 115 DSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 47/229 (20%)
Query: 543 LGEGSFGKVYHGYLDD--NTEVAVKMLS------PSSRQGYEQFEAEVILLRTVHHKNLT 594
+G G+ G V Y D VA+K LS +++ Y + +L++ V+HKN+
Sbjct: 24 IGSGAQGIVCAAY-DTVTGQNVAIKKLSRPFQNVTHAKRAYREL----VLMKLVNHKNI- 77
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEY--------LSDSN-ADVLSWE-GRLRIATEAAQ 644
IGL+ + SLEE+ L D+N V+ + R++ Q
Sbjct: 78 -----------IGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQ 126
Query: 645 ---GLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGT 701
G+++LH +HRD+KP+NI++ ++ DFGL++T G S + T T
Sbjct: 127 MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVT 180
Query: 702 FGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQW 750
Y PE E D++S G ++ E+I T+ HI QW
Sbjct: 181 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD---HIDQW 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 539 FETILGEGSFGKV-YHGYLDDNTEVAVKMLS--PSSRQGYEQFEAEVILLRTVHHKNLTT 595
F ++G+GS+G+V + D + +K L+ +SR+ + E E LL + H N+
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 596 LYGYCNEGNQIGLIYEYMA---NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG 652
Y EG GL+Y M G L L + +L + + A L+YLH
Sbjct: 64 -YRESWEGED-GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH-- 119
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
+ +HRD+K N+ L ++ D G+++ +E +++ + GT Y+ PE
Sbjct: 120 -EKHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYMSPELFSN 176
Query: 713 FRLTEKSDVYSFGVVLLEIITSRPA 737
KSDV++ G + E+ T + A
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 537 NDFET--ILGEGSFGKVYHGYLDDNTE-VAVKML--SPSSRQGYEQFEAEVILLRTVHHK 591
N FE ++GEG++G V + E VA+K S + + E E+ +LRT+ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLE---EYLSDSNADVLSWEGRLRIATEAAQGLEY 648
N+ L ++ L++EY+ LE E + + ++ + Q ++
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE--------KVRSYIYQLIKA 112
Query: 649 LHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE 708
+H K VHRDIKP N+L++ +L DFG ++ EG + T T Y PE
Sbjct: 113 IHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPE 171
Query: 709 YCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE 743
+ D++S G +L E+ +P E
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 16/207 (7%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSP---SSRQGYEQFEAEVILLRTVHH 590
+DFE I +G G+FG+V + + A+K+L+ R F E +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
+ +TTL+ + N + L+ +Y G L LS + R IA E + +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA-EMVLAIHSIH 119
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
+ VHRDIKP N+LL+ RLADFG +G S V GT Y+ PE
Sbjct: 120 ---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEIL 175
Query: 711 QTF-----RLTEKSDVYSFGVVLLEII 732
Q + + D +S GV + E++
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 33/219 (15%)
Query: 529 YAEITKITNDFETILGEGSFGKVYHGYLDDNTE-VAVKMLSPSSRQGYEQFEA--EVILL 585
Y +++KI GEGS+G V+ + + VA+K S + A E+ +L
Sbjct: 3 YEKLSKI--------GEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRML 54
Query: 586 RTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQG 645
+ + H NL L ++ L++EY + L E + N + +I + Q
Sbjct: 55 KQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIKKIIWQTLQA 112
Query: 646 LEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704
+ + H C +HRD+KP NIL+ Q Q +L DFG ++ + G T T Y
Sbjct: 113 VNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWY 166
Query: 705 LDPE-------YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
PE Y DV++ G V E++T +P
Sbjct: 167 RAPELLVGDTQY------GPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 538 DFETILGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFEAEVILLRTVHHKN---- 592
+F +LG+GSFGKV E+ A+K+L + E ++ R +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR------IATEAAQGL 646
LT L+ +++ + EY+ G L + GR + A E A GL
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV--------GRFKEPHAVFYAAEIAIGL 114
Query: 647 EYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
+LH ++RD+K N++L+ + ++ADFG+ K +GV+ + GT Y+
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIA 169
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE 743
PE + D ++FGV+L E++ + +E
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 39/233 (16%)
Query: 543 LGEGSFGKVYHGYLDDNT--EVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC 600
+G G++G V LD T +VA+K L Y F++E+ R ++ L L
Sbjct: 23 VGSGAYGTVCSA-LDRRTGAKVAIKKL-------YRPFQSELFAKRA--YRELRLLKHMK 72
Query: 601 NEGNQIGLIYEYMANGSLEEY------LSDSNADVLSWEGRLRIATEAAQ--------GL 646
+E N IGL+ + + SL+ + + D+ +++ + Q GL
Sbjct: 73 HE-NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131
Query: 647 EYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
+Y+H +HRD+KP N+ +N+ + ++ DFGL++ E TG T Y
Sbjct: 132 KYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRA 183
Query: 707 PEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG 758
PE + T+ D++S G ++ E++T +P H H+ Q ++ M G
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG---HDHLDQLMEIMKVTG 233
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 66/240 (27%), Positives = 107/240 (44%), Gaps = 28/240 (11%)
Query: 511 HKRLRKDGSLETKKRRFTYA--EITKI---TNDFETI--LGEGSFGKVY---HGYLDDNT 560
LRK+ +++ R+ A +ITK+ DF+ I +G G+FG+V H
Sbjct: 12 IPALRKNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHK--SSKQ 69
Query: 561 EVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617
A+K+LS R F E ++ + + + L+ + + ++ EYM G
Sbjct: 70 VYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGD 129
Query: 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQAR 676
L +S N D+ R A E L+ +H +G +HRD+KP N+LL+ +
Sbjct: 130 LVNLMS--NYDIPEKWARFYTA-EVVLALDAIHSMGF----IHRDVKPDNMLLDKSGHLK 182
Query: 677 LADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLT----EKSDVYSFGVVLLEII 732
LADFG G+ T V GT Y+ PE ++ + D +S GV L E++
Sbjct: 183 LADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 40/220 (18%)
Query: 537 NDFETI--LGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQ----FEAEVILLRTVH 589
ND E + +G G+ G+VY + +AVK + + E + +V+L H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM-RRTGNKEENKRILMDLDVVLKS--H 71
Query: 590 H-KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNA----DVLSWEGRLRIATEAAQ 644
+ YGY + + + E M+ L++ L D+L G++ +A A
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDIL---GKMTVAIVKA- 126
Query: 645 GLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704
L YL K +HRD+KP+NILL+ +L DFG+S ++ + T AG Y
Sbjct: 127 -LHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISG-RLVDSKAK--TRSAGCAAY 180
Query: 705 LDPEYCQTFRLTEK---------SDVYSFGVVLLEIITSR 735
+ PE R+ +DV+S G+ L+E+ T +
Sbjct: 181 MAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 542 ILGEGSFGKVY-----HGYLDDNTEVAVKMLSPSS----RQGYEQFEAEVILLRTVHHKN 592
+LG G++GKV+ G+ D A+K+L ++ + E E +L +
Sbjct: 7 VLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 593 -LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSD----SNADVLSWEGRLRIATEAAQGLE 647
L TL+ ++ LI +Y+ G L +LS +V + G + +A LE
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLA------LE 119
Query: 648 YLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDP 707
+LH K ++RDIK NILL+ L DFGLSK F E + GT Y+ P
Sbjct: 120 HLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAYSFCGTIEYMAP 175
Query: 708 EYCQTFRLTEKS--DVYSFGVVLLEIIT-SRPAIANTEEHKH 746
+ + D +S GV++ E++T + P + E++
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 61/221 (27%), Positives = 91/221 (41%), Gaps = 37/221 (16%)
Query: 542 ILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVIL--------------LRT 587
+LG+G+FGKV + V+ + + EVI+ L+
Sbjct: 2 LLGKGTFGKV----------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 51
Query: 588 VHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGL 646
H LT L +++ + EY G L +LS V + E R R E L
Sbjct: 52 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFT-EERARFYGAEIVSAL 108
Query: 647 EYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST--GVAGTFGY 704
EYLH V+RDIK N++L+ ++ DFGL K EG+S +T GT Y
Sbjct: 109 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEY 161
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK 745
L PE + D + GVV+ E++ R N + +
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 64/249 (25%), Positives = 101/249 (40%), Gaps = 24/249 (9%)
Query: 537 NDFE--TILGEGSFGKVYHGYLDDNTE--VAVKMLSPSSRQGYE---QFEAEVILLRTVH 589
DF+ +++G G FG+V + T A+K++ S E FE E +L +
Sbjct: 1 KDFDVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 590 HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL 649
+ L + + + L+ EY G L L+ + +A E + +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-ELVLAIHSV 118
Query: 650 H-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE 708
H +G VHRDIKP N+L++ +LADFG + + S GT Y+ PE
Sbjct: 119 HQMG----YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPE 173
Query: 709 YCQTFRLTEKS------DVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKN 762
T K D +S GV+ E+I R K + ++F Q +K
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF---QRFLKF 230
Query: 763 IVDPKLHGD 771
DPK+ D
Sbjct: 231 PEDPKVSSD 239
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 65/238 (27%), Positives = 106/238 (44%), Gaps = 50/238 (21%)
Query: 562 VAVKMLS-PSSRQGY-EQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLE 619
VAVK LS P Q + ++ E++LL+ V+HKN+ I L+ + SLE
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI------------ISLLNVFTPQKSLE 96
Query: 620 EY--------LSDSN-ADVLSWE-GRLRIATEAAQ---GLEYLHLGCKPPRVHRDIKPAN 666
E+ L D+N V+ E R++ Q G+++LH +HRD+KP+N
Sbjct: 97 EFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSN 153
Query: 667 ILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGV 726
I++ ++ DFGL++T + + T T Y PE E D++S G
Sbjct: 154 IVVKSDCTLKILDFGLART---ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 210
Query: 727 VLLEIITSRPAIANTEEHKHISQW-----------VDFMLA-QGDIKNIVD--PKLHG 770
++ E++ T+ HI QW +FM Q ++N V+ P+ G
Sbjct: 211 IMGELVKGSVIFQGTD---HIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPG 265
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 537 NDFET--ILGEGSFGKVYHGYLDDNTEV-AVKMLSP---SSRQGYEQFEAEVILLRTVHH 590
+DFE ++G G+FG+V + + +V A+K+L+ R F E +L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
+ +T L+ + N + L+ +Y G L LS + R +A E ++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVLAIDSVH 119
Query: 651 -LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY 709
LG VHRDIKP N+LL+ RLADFG +G + V GT Y+ PE
Sbjct: 120 QLG----YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPEI 174
Query: 710 CQTF-----RLTEKSDVYSFGVVLLEII 732
Q R + D +S GV + E++
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 543 LGEGSFGKV------YHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTL 596
LG+G FG+V G + ++ K L S + E E+ L V+ + L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKP 655
+ L+ M G L+ ++ + L E + + + G+ +LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI-- 116
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL 715
V+RD+KP N+LL+DQ RL+D GL+ +G + T AGT GY+ PE +
Sbjct: 117 --VYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKT--ITQRAGTNGYMAPEILKEEPY 171
Query: 716 TEKSDVYSFGVVLLEIITSRPAIANTEE 743
+ D ++ G + E++ R + +E
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 543 LGEGSFGKVYHGYLDD-NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN 601
LG GS G V+ D + VAVK + + Q + E+ ++R + H N+ +Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 602 EGN-----QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR------IATEAAQGLEYLH 650
+G + E + ++EY+ A+VL +G L + +GL+Y+H
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE-QGPLSEEHARLFMYQLLRGLKYIH 131
Query: 651 LGCKPPRVHRDIKPANILLN-DQFQARLADFGLSKTFP--IEGVSHLSTGVAGTFGYLDP 707
+HRD+KPAN+ +N + ++ DFGL++ +LS G+ + Y P
Sbjct: 132 ---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRSP 187
Query: 708 EYC-QTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE 743
T+ D+++ G + E++T +P A E
Sbjct: 188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE 224
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 31/80 (38%), Positives = 45/80 (56%), Gaps = 1/80 (1%)
Query: 658 VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTE 717
+HRDIK ANILL +L DFG SK + + GT Y+ PE + ++
Sbjct: 165 IHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSK 224
Query: 718 KSDVYSFGVVLLEIIT-SRP 736
K+D++S GV+L E++T RP
Sbjct: 225 KADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 48/175 (27%), Positives = 83/175 (47%), Gaps = 10/175 (5%)
Query: 566 MLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDS 625
ML+ + Y + +E+ L H + + +++ LI EY + G L + +
Sbjct: 102 MLNDERQAAYAR--SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQR 159
Query: 626 NADVL---SWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGL 682
+ L +E L + + L+ +H +HRD+K ANI L +L DFG
Sbjct: 160 LKEHLPFQEYEVGL-LFYQIVLALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGF 215
Query: 683 SKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRP 736
SK + +++ GT YL PE + R ++K+D++S GV+L E++T RP
Sbjct: 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-08
Identities = 31/69 (44%), Positives = 41/69 (59%)
Query: 399 LTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVER 458
L+G IP + LT + HLDL N+LTGP+P L L+ L+ L L N L+GP+P +
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 459 SKNGSLSLS 467
K SL LS
Sbjct: 284 QKLISLDLS 292
|
Length = 968 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 67/278 (24%), Positives = 105/278 (37%), Gaps = 93/278 (33%)
Query: 539 FETILGEGSFGKVYH------GYLDDNTEVAVKMLSPSSRQG-YEQFEAEV-ILLRTVHH 590
F LG G+FGKV G D+ VAVKML S+ E +E+ IL H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 591 KNLTTLYG-------------YCNEGNQIGLIY---EYMAN------------------- 615
KN+ L G YC G+ + + E N
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNIT 161
Query: 616 --------------GSLEEYL--------SDSNADVLSWEGR-----------LRIATEA 642
+ Y+ S ++D E LR +++
Sbjct: 162 LEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQV 221
Query: 643 AQGLEYLHL-GCKPPRVHRDIKPANILLNDQFQARLADFGLSK------TFPIEGVSHLS 695
AQG+++L C +HRD+ N+LL D A++ DFGL++ + ++G + L
Sbjct: 222 AQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
++ PE T +SDV+S+G++L EI +
Sbjct: 278 V------KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 34/207 (16%)
Query: 543 LGEGSFGKVY---------HGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNL 593
LG+GSFG VY L E+ V L+P+ Q E LL + H +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV---QANQEAQLLSKLDHPAI 64
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSD--------SNADVLSWEGRLRIATEAAQG 645
+ E + +I EY L+ L + S V W +L + G
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------G 118
Query: 646 LEYLHLGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704
+ Y+H R+ HRD+K NI L + ++ DFG+S+ + G L+T GT Y
Sbjct: 119 VHYMHQ----RRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYY 171
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVLLEI 731
+ PE + KSD++S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-08
Identities = 32/77 (41%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 392 LNLSSRGLTGGIPP-YLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGP 450
LNLS+ TG IP + NL E LDLSNN L+G +P + L+VL+L GN+L G
Sbjct: 123 LNLSNNNFTGSIPRGSIPNL---ETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179
Query: 451 LPAGLVERSKNGSLSLS 467
+P L + L+L+
Sbjct: 180 IPNSLTNLTSLEFLTLA 196
|
Length = 968 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 542 ILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVIL--------------LRT 587
+LG+G+FGKV + VK + + + EVI+ L+
Sbjct: 2 LLGKGTFGKV----------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 51
Query: 588 VHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGL 646
H LT L +++ + EY G L +LS + + E R R E L
Sbjct: 52 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSAL 108
Query: 647 EYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST--GVAGTFGY 704
+YLH + V+RD+K N++L+ ++ DFGL K EG+ +T GT Y
Sbjct: 109 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFCGTPEY 162
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK 745
L PE + D + GVV+ E++ R N + K
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 26/236 (11%)
Query: 514 LRKDGSLETKKRRFTYAEITKITN------DFETI--LGEGSFGKVYHGYLDDNTEV-AV 564
LRK+ +++ R+ I KI + D+E + +G G+FG+V +V A+
Sbjct: 15 LRKNKNIDNFLNRYK-DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 73
Query: 565 KMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEY 621
K+LS R F E ++ + + L+ + + ++ EYM G L
Sbjct: 74 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL 133
Query: 622 LSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADF 680
+S N DV R A E L+ +H +G +HRD+KP N+LL+ +LADF
Sbjct: 134 MS--NYDVPEKWARFYTA-EVVLALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADF 186
Query: 681 GLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT----FRLTEKSDVYSFGVVLLEII 732
G EG+ T V GT Y+ PE ++ + D +S GV L E++
Sbjct: 187 GTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 22/205 (10%)
Query: 543 LGEGSFGKVYHGYLDDNTEVA---VKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYG 598
+G G FGKV + +T VA VK L + S + +F + R + H N+ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDS-----NADVLSWEGRLRIATEAAQGLEYLHLGC 653
C E L++EY G L+ YLS N+ +L + R+A E A G+ ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMH--- 116
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF 713
K +H D+ N L ++ D+G+ + E +L PE F
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 714 R-------LTEKSDVYSFGVVLLEI 731
T+ S+V++ GV L E+
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 538 DFETILGEGSFGKVYHGYLDDNTEV-AVKMLSPSS---RQGYEQFEAEVILLRTVHHKNL 593
D ++G G+FG+V + +V A+K+LS R F E ++ + +
Sbjct: 46 DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 105
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LG 652
L+ + + ++ EYM G L +S N DV + A E L+ +H +G
Sbjct: 106 VQLFCAFQDDKYLYMVMEYMPGGDLVNLMS--NYDVPEKWAKFYTA-EVVLALDAIHSMG 162
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
+HRD+KP N+LL+ +LADFG G+ T V GT Y+ PE ++
Sbjct: 163 L----IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKS 217
Query: 713 ----FRLTEKSDVYSFGVVLLEII 732
+ D +S GV L E++
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 8/96 (8%)
Query: 645 GLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF---PIEGVSHLSTGVAGT 701
GL+Y+H +HRD+KP N+L+N + ++ DFGL++ F P E ++ VA T
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-T 172
Query: 702 FGYLDPEYCQTFRLTEKS-DVYSFGVVLLEIITSRP 736
Y PE +F+ K+ DV+S G +L E++ +P
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 388 RITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNML 447
++ SL+LS L+G IP + L +E L L +N+ TG +P L+ L L+VL L N
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 448 TGPLPAGLVERSKNGSLSLSVD---------LCSS 473
+G +P L + + L LS + LCSS
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379
|
Length = 968 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 644 QGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSK-TFPIEGVSHLSTGVAGTF 702
+ L+Y+H HRD+KP NIL N + ++ DFGL++ F + T T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 703 GYLDPEYCQTF--RLTEKSDVYSFGVVLLEIITSRP 736
Y PE C +F + T D++S G + E++T +P
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 15/197 (7%)
Query: 543 LGEGSFGKVYHGYLDDNTEV-AVKMLSP----SSRQGYEQFEAEVILLRTVHHKN--LTT 595
+G+G+FG+VY D + A+K+LS + ++ IL+RT+ ++ +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKP 655
L + + L+ +YM+ G L +L + IA E LE+LH K
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQ-KEGRFSEDRAKFYIA-ELVLALEHLH---KY 115
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFR- 714
V+RD+KP NILL+ L DFGLSK + + GT YL PE +
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 715 LTEKSDVYSFGVVLLEI 731
T+ D +S GV++ E+
Sbjct: 174 YTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLY 597
+LG+G+FGKV + A+K+L ++ E +L+ H LT L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 598 GYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLEYLHLGCKPP 656
+++ + EY G L +LS V S E R R E L YLH C
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRER--VFS-EDRARFYGAEIVSALGYLH-SCDV- 116
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST--GVAGTFGYLDPEYCQTFR 714
V+RD+K N++L+ ++ DFGL K EG+S +T GT YL PE +
Sbjct: 117 -VYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 715 LTEKSDVYSFGVVLLEIITSRPAIANTEEHK 745
D + GVV+ E++ R N + K
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 60/198 (30%), Positives = 87/198 (43%), Gaps = 11/198 (5%)
Query: 543 LGEGSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYG 598
+G+GSFGKV D + A+K + + SR AE +L V+ + L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRV 658
++ L+ ++ G L +L LS R A E LE LH K +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLS-RARFYTA-ELLCALENLH---KFNVI 115
Query: 659 HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEK 718
+RD+KP NILL+ Q L DFGL K + + GT YL PE T+
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 719 SDVYSFGVVLLEIITSRP 736
D ++ GV+L E++T P
Sbjct: 174 VDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 53/220 (24%), Positives = 91/220 (41%), Gaps = 55/220 (25%)
Query: 543 LGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQFE-----AEVILLRTV-HHKNLTT 595
+GEG+F +V A+K + ++ ++ E E+ LR + H N+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM----KKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 596 LYG--YCNEGNQIGLIYEYMANGSLEEYLSD-----SNADVLSWEGRLRIATEAAQGLEY 648
L + + ++ L++E M + +L E + V S+ +L + L++
Sbjct: 63 LIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQL------LKSLDH 115
Query: 649 LHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE 708
+H + HRDIKP NIL+ D +LADFG + G+ Y E
Sbjct: 116 MH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR------------GIYSKPPY--TE 157
Query: 709 YCQT--FRLTE----------KSDVYSFGVVLLEIITSRP 736
Y T +R E K D+++ G V EI++ P
Sbjct: 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 538 DFETILGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFEAEVILLRTVHHKN---- 592
+F +LG+GSFGKV E+ A+K+L + E ++ R +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 62
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR------IATEAAQGL 646
LT L+ +++ + EY+ G L ++ G+ + A E A GL
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ--------VGKFKEPHAVFYAAEIAIGL 114
Query: 647 EYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
+LH ++RD+K N++L+ + ++ADFG+ K G + + GT Y+
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPDYIA 169
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
PE + D ++FGV+L E++ +P
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEA-EVILLRTVHHKNLTTLYG--Y 599
+G G++G VY D + L G E+ LLR + H N+ +L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 600 CNEGNQIGLIYEYMANG--SLEEYLSDSNAD---VLSWEGRLR-IATEAAQGLEYLHLGC 653
+ ++ L+++Y + + ++ S A+ V G ++ + + G+ YLH
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 654 KPPRVHRDIKPANILL----NDQFQARLADFGLSKTF--PIEGVSHLSTGVAGTFGYLDP 707
+HRD+KPANIL+ ++ + ++AD G ++ F P++ ++ L V TF Y P
Sbjct: 129 V---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP-VVVTFWYRAP 184
Query: 708 EYCQTFR-LTEKSDVYSFGVVLLEIITSRP 736
E R T+ D+++ G + E++TS P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 59/242 (24%), Positives = 106/242 (43%), Gaps = 29/242 (11%)
Query: 511 HKRLRKDGSLETKKR-RFTYAEITKITNDFETILGEGSFGKVYHG-YLDDN-TEVAVKML 567
HK+ D + E K++ + Y + +F LG GSFG+V Y +++ VA+K
Sbjct: 10 HKKKDSDSTKEPKRKNKMKYEDF-----NFIRTLGTGSFGRVILATYKNEDFPPVAIKRF 64
Query: 568 SPSSRQGYEQFE---AEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSD 624
S +Q + +E +L ++H LYG + + + L+ E++ G +L
Sbjct: 65 EKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR 124
Query: 625 SNA---DV-LSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADF 680
+ DV + ++ + E Q L V+RD+KP N+LL+ ++ DF
Sbjct: 125 NKRFPNDVGCFYAAQIVLIFEYLQSLNI---------VYRDLKPENLLLDKDGFIKMTDF 175
Query: 681 GLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIAN 740
G +K V + + GT Y+ PE + +D ++ G+ + EI+ P
Sbjct: 176 GFAKV-----VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230
Query: 741 TE 742
E
Sbjct: 231 NE 232
|
Length = 340 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 32/219 (14%)
Query: 537 NDFETI--LGEGSFGKVY---HGYLDDNTEVAVKMLSPSS---RQGYEQFEAEVILLRTV 588
DFETI + G++G VY H + A+K ++ + R +Q E +L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHK--ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA 58
Query: 589 HHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWE-GRLRIATEAAQGLE 647
+ + +++ + ++ EY+ G L N L + R+ A E LE
Sbjct: 59 ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK--NIGALPVDMARMYFA-ETVLALE 115
Query: 648 YLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG--------- 697
YLH G VHRD+KP N+L+ +L DFGLSK + ++L G
Sbjct: 116 YLHNYGI----VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 698 ----VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEII 732
V GT Y+ PE + D ++ G++L E +
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEA-EVILLRTVHHKNLTTLYG--Y 599
+G G++G VY D + L G E+ LLR + H N+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 600 CNEGNQIGLIYEYMANGSLEEYL-----SDSNADVLSWEGRL--RIATEAAQGLEYLHLG 652
+ ++ L+++Y A L + S +N + + + + G+ YLH
Sbjct: 69 SHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 653 CKPPRVHRDIKPANILL----NDQFQARLADFGLSKTF--PIEGVSHLSTGVAGTFGYLD 706
+HRD+KPANIL+ ++ + ++AD G ++ F P++ ++ L V TF Y
Sbjct: 128 WV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP-VVVTFWYRA 183
Query: 707 PEYCQTFR-LTEKSDVYSFGVVLLEIITSRP 736
PE R T+ D+++ G + E++TS P
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 60/224 (26%)
Query: 541 TILGEGSFGKVYHGYLDDNT--EVAVKMLSPS------SRQGYEQFEAEVILLRTVHHKN 592
T +G G++G V Y D +VAVK LS +R+ Y E+ LL+ + H+N
Sbjct: 21 TPVGSGAYGSVCSAY-DTRLRQKVAVKKLSRPFQSLIHARRTYR----ELRLLKHMKHEN 75
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEE----YL------SDSNADV----LSWEGRLRI 638
+ IGL+ + S+E YL +D N V LS E +
Sbjct: 76 V------------IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123
Query: 639 ATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698
+ +GL+Y+H +HRD+KP+N+ +N+ + R+ DFGL++ E TG
Sbjct: 124 IYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGY 175
Query: 699 AGTFGYLDPE-------YCQTFRLTEKSDVYSFGVVLLEIITSR 735
T Y PE Y QT D++S G ++ E++ +
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 18/165 (10%)
Query: 577 QFEAEVILLRTVHHKNLTTL--------YGYCNEGNQIGLIYEYMANGSLEEYLSDSNAD 628
Q E E++ L ++H+N+ + Y +Y +M + + + D
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD--WKDRP-- 264
Query: 629 VLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688
L + R I + +EY+H +HRDIK NI LN + L DFG + F
Sbjct: 265 -LLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319
Query: 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
E + G GT PE E +D++S G++LL++++
Sbjct: 320 EREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 59/217 (27%), Positives = 89/217 (41%), Gaps = 48/217 (22%)
Query: 543 LGEGSFGKVYHGYLDDN-----------TEVAVKMLSPSSRQGYEQFEAEVILLRTVHHK 591
LG+G+F +Y G L V +K+L R FE L+ + HK
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET-ASLMSQLSHK 61
Query: 592 NLTTLYGYC-NEGNQIGLIYEYMANGSLEEYLSDSNADV-LSWEGRLRIATEAAQGLEYL 649
+L LYG C + N + EY+ G L+ +L +V L W +L +A + A L YL
Sbjct: 62 HLVKLYGVCVRDENIMVE--EYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 650 H-LGCKPPRVHRDIKPANILL-------NDQFQARLADFG-----LSKTFPIEGVSHLST 696
VH ++ NIL+ +L+D G LS+ +E +
Sbjct: 118 EDKKL----VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP---- 169
Query: 697 GVAGTFGYLDPEYCQ--TFRLTEKSDVYSFGVVLLEI 731
++ PE + LT +D +SFG LLEI
Sbjct: 170 -------WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-07
Identities = 29/68 (42%), Positives = 40/68 (58%), Gaps = 3/68 (4%)
Query: 388 RITSLN---LSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
+TSLN L LTG IP L NL +++L L N L+GP+P + LQ L L+L+
Sbjct: 234 GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSD 293
Query: 445 NMLTGPLP 452
N L+G +P
Sbjct: 294 NSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 43/228 (18%)
Query: 541 TILGEGSFGKVYHGYLDDNT--EVAVKMLSPS------SRQGYEQFEAEVILLRTVHHKN 592
+ +G G++G V + D T VAVK LS +++ Y E+ LL+ + H+N
Sbjct: 23 SPVGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHEN 77
Query: 593 LTTLYGY------CNEGNQIGLIYEYMA----NGSLEEYLSDSNADVLSWEGRLRIATEA 642
+ L E N + L+ M N + L+D + L ++
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------I 129
Query: 643 AQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF 702
+GL+Y+H +HRD+KP+N+ +N+ + ++ DFGL++ E TG T
Sbjct: 130 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATR 181
Query: 703 GYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ 749
Y PE + + D++S G ++ E++T R T+ HI Q
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---HIDQ 226
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-07
Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 38/224 (16%)
Query: 542 ILGEGSFGKVYHGYLDD---NTEVAVKM----LSPSSRQGYEQFEAEVILLRTVHHKNLT 594
++G+G G+VY Y D + VA+K LS + ++F E + + H +
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLL-KKRFLREAKIAADLIHPGIV 65
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLE---------EYLSDSNADVLSWEGRLRIATEAAQG 645
+Y C++G+ + Y+ +L+ E LS A+ S L I +
Sbjct: 66 PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 646 LEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT------------FPIEGVSH 693
+EY+H +HRD+KP NILL + + D+G + + +
Sbjct: 126 IEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 694 LSTG----VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
S + GT Y+ PE +E +D+Y+ GV+L +++T
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 7e-07
Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 37/232 (15%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEV----AVKMLSPSSRQGYEQFEAEVILLRTVHH 590
N++E I +G G FG+V+ E A+ R+ Q EV ++R + H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEVNVMRELKH 71
Query: 591 KNLTTLYG-YCNEGNQ-IGLIYEYMANGSLEEYLSDSNADVLSWEGR--LRIATEAAQGL 646
KN+ + N+ NQ + ++ E+ G L + E + I + L
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 647 EYLHL---GCKPPRV-HRDIKPANILL-----------------NDQFQARLADFGLSKT 685
Y H G RV HRD+KP NI L N + A++ DFGLSK
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 686 FPIEGVSHLSTGVAGTFGYLDPEYC--QTFRLTEKSDVYSFGVVLLEIITSR 735
IE ++H GT Y PE +T +KSD+++ G ++ E+ + +
Sbjct: 192 IGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 1/98 (1%)
Query: 392 LNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPL 451
L+L L G IP L+NLT +E L L++N L G +P L +++ L+ + L N L+G +
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 452 PAGLVERSKNGSLSLSV-DLCSSYPCKENNKKKNNFVF 488
P + + L L +L P N K ++F
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLF 266
|
Length = 968 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 1e-06
Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 646 LEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF----PIEGVSHLSTGVAGT 701
L+Y+H G +HRD+KP+NILLN + +LADFGL+++ L+ VA T
Sbjct: 120 LKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA-T 175
Query: 702 FGYLDPE-YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
Y PE + R T+ D++S G +L E++ +P
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 33/211 (15%)
Query: 543 LGEGSFGKVYHGYL----DDNTE---------VAVKMLSPSSRQGYEQFEAEVILLRTVH 589
LG G+ ++Y G L DD + V +K+L PS R F ++R V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 590 HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL 649
HK++ LYG C + ++ E++ G L+ ++ +DVL+ + ++A + A L YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPWKFKVAKQLASALSYL 121
Query: 650 HLGCKPPRVHRDIKPANILLNDQ--------FQARLADFGLSKTFPIEGVSHLSTGVAGT 701
VH ++ NILL + F +L+D G+ PI +S
Sbjct: 122 E---DKDLVHGNVCTKNILLAREGIDGECGPF-IKLSDPGI----PITVLSRQEC--VER 171
Query: 702 FGYLDPEYCQTFR-LTEKSDVYSFGVVLLEI 731
++ PE + + L+ +D +SFG L EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 31/83 (37%), Positives = 41/83 (49%), Gaps = 1/83 (1%)
Query: 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
D P + L+L+ GG+P +E+LDLS N +G VP L L L L L+
Sbjct: 450 DMPSLQMLSLARNKFFGGLPD-SFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSE 508
Query: 445 NMLTGPLPAGLVERSKNGSLSLS 467
N L+G +P L K SL LS
Sbjct: 509 NKLSGEIPDELSSCKKLVSLDLS 531
|
Length = 968 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 35/211 (16%)
Query: 541 TILGEGSFGKVYHGYLDDNT--EVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
+G G++G V +D T +VA+K LS F++E+ R ++ LT L
Sbjct: 21 KQVGSGAYGSVCSA-IDKRTGEKVAIKKLS-------RPFQSEIFAKRA--YRELT-LLK 69
Query: 599 YCNEGNQIGLIYEYMANGSLEEY-------------LSDSNADVLSWEGRLRIATEAAQG 645
+ N IGL+ + + S +E+ L LS + + + G
Sbjct: 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 646 LEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYL 705
L+Y+H +HRD+KP N+ +N+ + ++ DFGL++ E TG T Y
Sbjct: 130 LKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYR 181
Query: 706 DPEYCQTF-RLTEKSDVYSFGVVLLEIITSR 735
PE + + D++S G ++ E++T +
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 60/257 (23%), Positives = 103/257 (40%), Gaps = 49/257 (19%)
Query: 537 NDFET--ILGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQ---FEAEVILLRTVHH 590
+DFE+ ++G G+FG+V D + A+K+L + EQ AE +L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
+ ++ + + LI E++ G + L D LS E E ++ +H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIH 118
Query: 651 -LGCKPPRVHRDIKPANILLNDQFQARLADFGLS-------KTFPIEGVSH--------- 693
LG +HRDIKP N+LL+ + +L+DFGL +T ++H
Sbjct: 119 QLGF----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 694 -----------------LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
L+ GT Y+ PE + D +S GV++ E++ P
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 737 AIAN---TEEHKHISQW 750
+ E ++ + W
Sbjct: 235 PFCSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 44/171 (25%), Positives = 73/171 (42%), Gaps = 26/171 (15%)
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRL-RIATEAAQGLEYLH 650
N+ L+ Y + + L+ ++ G L ++S ++ E + R A E L+ LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS-KFLNIP--EECVKRWAAEMVVALDALH 102
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFG----LSKTFPIEGVSHLSTGVAGTFGYLD 706
+ V RD+ P NILL+D+ +L F + + E V ++ Y
Sbjct: 103 ---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM---------YCA 150
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIIT------SRPAIANTEEHKHISQWV 751
PE TE D +S G +L E++T P+ NT +I +WV
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWV 201
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-06
Identities = 25/69 (36%), Positives = 38/69 (55%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
P + +L+LS+ L+G IP + + + ++ LDL N L G +P L+ L L L L N
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199
Query: 447 LTGPLPAGL 455
L G +P L
Sbjct: 200 LVGQIPREL 208
|
Length = 968 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 49/157 (31%), Positives = 73/157 (46%), Gaps = 13/157 (8%)
Query: 537 NDFETI--LGEGSFGKV-YHGYLDDNTEVAVKMLSPSSRQGYEQF---EAEVILLRTVHH 590
DF T+ +G+G+FG+V D A+K L S +Q +AE +L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWE-GRLRIATEAAQGLEYL 649
+ +LY + + LI E++ G L L D S + R +A E +E +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI--KYDTFSEDVTRFYMA-ECVLAIEAV 117
Query: 650 HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF 686
H K +HRDIKP NIL++ +L+DFGLS F
Sbjct: 118 H---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 644 QGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFG 703
+GL+YLH +HRDIKP N+L+N ++ DFGL++ + H++ V +
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 704 YLDPEYCQTFR-LTEKSDVYSFGVVLLEIITSR 735
Y PE R T D++S G + E++ R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-06
Identities = 36/96 (37%), Positives = 47/96 (48%), Gaps = 11/96 (11%)
Query: 387 PRITSLNLSSRGLTGGIPPYL---SNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443
PR+ L L S +G IP L +NLT+ LDLS N+LTG +PE L L L L
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTV---LDLSTNNLTGEIPEGLCSSGNLFKLILF 388
Query: 444 GNMLTGPLPAGL-----VERSKNGSLSLSVDLCSSY 474
N L G +P L + R + S S +L S +
Sbjct: 389 SNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424
|
Length = 968 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 61/256 (23%), Positives = 102/256 (39%), Gaps = 49/256 (19%)
Query: 538 DFET--ILGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQ---FEAEVILLRTVHHK 591
DFE+ ++G G+FG+V D V A+K+L + EQ AE +L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH- 650
+ ++ + + LI E++ G + L D L+ E E ++ +H
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQ 119
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLS-------KTFPIEGVSH---------- 693
LG +HRDIKP N+LL+ + +L+DFGL +T ++H
Sbjct: 120 LGF----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 694 ----------------LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPA 737
L+ GT Y+ PE + D +S GV++ E++ P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 738 IAN---TEEHKHISQW 750
+ E +K + W
Sbjct: 236 FCSETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 37/128 (28%), Positives = 65/128 (50%), Gaps = 11/128 (8%)
Query: 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLGCKPPRVHRDIKPANIL 668
Y+ + ++ LSD ++ L+ L + A+G+E+L C VHRD+ N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVL 269
Query: 669 LNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF---GYLDPEYCQTFRLTEKSDVYSFG 725
L ++ DFGL++ + +++S G TF ++ PE T SDV+S+G
Sbjct: 270 LAQGKIVKICDFGLARDI-MHDSNYVSKG--STFLPVKWMAPESIFDNLYTTLSDVWSYG 326
Query: 726 VVLLEIIT 733
++L EI +
Sbjct: 327 ILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 35/116 (30%), Positives = 59/116 (50%), Gaps = 5/116 (4%)
Query: 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLA 678
E D VL+ E + + + A+G+E+L +HRD+ NILL++ ++
Sbjct: 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKIC 221
Query: 679 DFGLSKTFPIEGVSHLSTGVAG-TFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
DFGL++ + ++ G A ++ PE T +SDV+SFGV+L EI +
Sbjct: 222 DFGLARDI-YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 27/99 (27%), Positives = 49/99 (49%), Gaps = 18/99 (18%)
Query: 645 GLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704
G+ +LH +HRD+K +N+LLN++ ++ DFGL++ + + + V T Y
Sbjct: 118 GVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVV-TLWY 172
Query: 705 LDPE-------YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
PE Y + D++S G + E++T +P
Sbjct: 173 RAPELLLGAKEY------STAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 45/158 (28%), Positives = 69/158 (43%), Gaps = 17/158 (10%)
Query: 581 EVILLRTVHHKNLTTLYGYCNEGNQIGLIY-EYMANGSLEEYLSDSN----ADVLSWEGR 635
E +LR ++H ++ L G LI Y + L YL+ D+L+
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAICDILA---- 186
Query: 636 LRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695
I + ++YLH + +HRDIK NI +N L DFG + FP++ ++
Sbjct: 187 --IERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKY 240
Query: 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
G AGT PE D++S G+VL E+ T
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 44/221 (19%)
Query: 542 ILGEGSFGKVYHGYLDDNTE--VAVKMLSPSSR---------------QGYEQFEAEVIL 584
+GEG++GKVY D NT VA+K Q + V L
Sbjct: 8 KIGEGTYGKVYKA-RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 585 LRTVHHKNLTTLYGYCNEGN-QIGLIYEYMANGSLEEYLSDSN----ADVLSWEGRLRIA 639
L H + G + L++EY+ + L++++ DSN L +
Sbjct: 67 LDVEHVEE--------KNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFM 116
Query: 640 TEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQA-RLADFGLSKTF--PIEGVSHLST 696
+ +G+ + H K +HRD+KP N+L++ Q ++AD GL + F P++ +H
Sbjct: 117 YQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 697 GVAGTFGYLDPEYCQTFR-LTEKSDVYSFGVVLLEIITSRP 736
T Y PE + D++S G + E+ +P
Sbjct: 174 ----TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 35/98 (35%), Positives = 48/98 (48%), Gaps = 8/98 (8%)
Query: 542 ILGEGSFGKVYHGYL------DDNTEVAVKMLSPSSRQGYEQ-FEAEV-ILLRTVHHKNL 593
ILG G+FGKV G +VAVKML P++R +Q +E+ I+ H N+
Sbjct: 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI 103
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLS 631
L G C + I +I EY G L YL + + LS
Sbjct: 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLS 141
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 36/128 (28%), Positives = 61/128 (47%), Gaps = 11/128 (8%)
Query: 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLGCKPPRVHRDIKPANIL 668
Y A + + LS+ + + + A G+E+L C VHRD+ N+L
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVL 271
Query: 669 LNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF---GYLDPEYCQTFRLTEKSDVYSFG 725
+ + ++ DFGL++ + +++S G TF ++ PE T SDV+SFG
Sbjct: 272 ICEGKLVKICDFGLARDI-MRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFG 328
Query: 726 VVLLEIIT 733
++L EI T
Sbjct: 329 ILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 34/206 (16%)
Query: 543 LGEGSFGKVY----HGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
L GS G+V+ HG + +V VK ++ G + E+ +L+T+ H+ + L
Sbjct: 100 LTPGSEGEVFVCTKHGD-EQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIH 153
Query: 599 YCNEGNQIGLI---YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKP 655
+ + ++ Y+ L Y+ S L E + I + L YLH
Sbjct: 154 AYRWKSTVCMVMPKYKC----DLFTYVDRSGP--LPLEQAITIQRRLLEALAYLH---GR 204
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE------Y 709
+HRD+K NI L++ A L DFG + + G +GT PE Y
Sbjct: 205 GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY 264
Query: 710 CQTFRLTEKSDVYSFGVVLLEIITSR 735
C K+D++S G+VL E+
Sbjct: 265 CA------KTDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 33/92 (35%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 539 FETILGEGSFGKVY----HGYL--DDNTEVAVKMLSPSSRQG-YEQFEAEVILLRTV-HH 590
F LG G+FGKV +G D VAVKML PS+ E +E+ +L + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL 622
N+ L G C G +I EY G L +L
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 52/191 (27%), Positives = 83/191 (43%), Gaps = 24/191 (12%)
Query: 560 TEVAVKM--LSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617
T V V++ L + + + + EV+L H N+ T + G+ + +I +MA GS
Sbjct: 26 TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS 85
Query: 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHL-GCKPPRVHRDIKPANILLNDQFQAR 676
L + +S I A +GL YLH G +HR+IK ++IL++
Sbjct: 86 ANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY----IHRNIKASHILISGDGLVS 141
Query: 677 LADFGLSKTFPI--EGVSH--------LSTGVAGTFGYLDPEYCQT--FRLTEKSDVYSF 724
L+ GLS + + G ST V +L PE + + KSD+YS
Sbjct: 142 LS--GLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELLRQDLYGYNVKSDIYSV 196
Query: 725 GVVLLEIITSR 735
G+ E+ T R
Sbjct: 197 GITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 641 EAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699
+ A+G+E+L C +HRD+ NILL++ ++ DFGL++ + ++ G A
Sbjct: 182 QVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGSA 236
Query: 700 G-TFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
++ PE T +SDV+SFGV+L EI +
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 56/226 (24%), Positives = 88/226 (38%), Gaps = 53/226 (23%)
Query: 530 AEITKITNDFETI----LGEGSFGKVY---HGYLDDNTEVAVKMLSPSSRQGYEQFEAEV 582
+E+ + + E + L +G FGKV H K++ + + E V
Sbjct: 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHK--PTQKLFVQKIIKAKN---FNAIEPMV 61
Query: 583 -ILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR---- 637
L++ + N LY LI +Y+ +G L + L EG+L
Sbjct: 62 HQLMK--DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK--------EGKLSEAEV 111
Query: 638 --IATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-QFQARLADFGLSKTFPIEGV-SH 693
I + + L LH K +H DIK N+L + + + L D+GL K I G S
Sbjct: 112 KKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK---IIGTPSC 165
Query: 694 LSTGVAGTFGYLDPE------YCQTFRLTEKSDVYSFGVVLLEIIT 733
GT Y PE Y +F D ++ GV+ E++T
Sbjct: 166 YD----GTLDYFSPEKIKGHNYDVSF------DWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 22/101 (21%)
Query: 645 GLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT------FPIEGVSHLSTGV 698
GL+Y+H +HRD+KP+N+LLN ++ DFGL++T F E V
Sbjct: 120 GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV------ 170
Query: 699 AGTFGYLDPEY---CQTFRLTEKSDVYSFGVVLLEIITSRP 736
T Y PE C + T DV+S G + E++ +P
Sbjct: 171 --TRWYRAPELLLNCSEY--TTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 32/88 (36%), Positives = 46/88 (52%), Gaps = 8/88 (9%)
Query: 543 LGEGSFGKVY----HG--YLDDNTEVAVKMLSPSSRQGYEQ-FEAEV-ILLRTVHHKNLT 594
LG G+FG+V HG + +VAVKML ++R +Q +E+ I+ H N+
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYL 622
L G C +G I +I EY G L +YL
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 50/181 (27%), Positives = 80/181 (44%), Gaps = 24/181 (13%)
Query: 562 VAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEY 621
V +K+L PS R F L+ V H +L ++G C G++ ++ E++ +G L+
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106
Query: 622 LSDSNADV-LSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADF 680
L V ++W ++ +A + A L YL VH ++ NILL ARL
Sbjct: 107 LRKEKGRVPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILL-----ARL--- 153
Query: 681 GLSK-TFPIEGVSHLSTGVAG--------TFGYLDPEYCQTF-RLTEKSDVYSFGVVLLE 730
GL++ T P +S ++ PE L+ +D +SFG LLE
Sbjct: 154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLE 213
Query: 731 I 731
I
Sbjct: 214 I 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 45/201 (22%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFE----AEVILLRTVHHKNLTTL 596
++G GS+ KV L + A+K++ E + + + + +H L L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP 656
+ +++ + EY+ G L ++ L E + E + L YLH +
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLH---ERG 116
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV--SHLSTGVAGTFGYLDPEYCQTFR 714
++RD+K N+LL+ + +L D+G+ K EG+ ++ GT Y+ PE +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 715 LTEKSDVYSFGVVLLEIITSR 735
D ++ GV++ E++ R
Sbjct: 173 YGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 4e-04
Identities = 27/61 (44%), Positives = 35/61 (57%), Gaps = 2/61 (3%)
Query: 388 RITSLNLSSRGLTGGIPP-YLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ SL+LS+ LT IP L ++ LDLS N+LT PE S L LR L+L+GN
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 447 L 447
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 542 ILGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFE----AEVILLRTVHHKNLTTL 596
++G GS+ KV L N ++ A+K++ E + + + + + L L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP 656
+ +++ L+ EY+ G L ++ L E A E L +LH +
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLH---ERG 116
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV--SHLSTGVAGTFGYLDPEYCQTFR 714
++RD+K N+LL+ +L D+G+ K EG+ ++ GT Y+ PE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK----EGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 715 LTEKSDVYSFGVVLLE---------IITSRPAIANTEEH 744
D ++ GV++ E IIT P + NTE++
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-NTEDY 210
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-04
Identities = 22/82 (26%), Positives = 38/82 (46%)
Query: 388 RITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNML 447
+ L L S L G IP L + + L +NS +G +P +KL + L+++ N L
Sbjct: 381 NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL 440
Query: 448 TGPLPAGLVERSKNGSLSLSVD 469
G + + + LSL+ +
Sbjct: 441 QGRINSRKWDMPSLQMLSLARN 462
|
Length = 968 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 63/272 (23%), Positives = 96/272 (35%), Gaps = 71/272 (26%)
Query: 539 FETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKN 592
F I LG G+FG+V +D A+K L R +AE +L ++
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG 652
+ LY + + + + +Y+ G D++S R+ I E L
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGG-----------DMMSLLIRMGIFPEDLARFYIAELT 111
Query: 653 C------KPPRVHRDIKPANILLNDQFQARLADFGLSKTF-------------------- 686
C K +HRDIKP NIL++ +L DFGL F
Sbjct: 112 CAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171
Query: 687 -------------------PIE---GVSH---LSTGVAGTFGYLDPEYCQTFRLTEKSDV 721
P+E H L+ + GT Y+ PE T+ D
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231
Query: 722 YSFGVVLLEIITSRP---AIANTEEHKHISQW 750
+S GV+L E++ +P A E + W
Sbjct: 232 WSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 65/276 (23%), Positives = 103/276 (37%), Gaps = 75/276 (27%)
Query: 539 FETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKN 592
F I +G G+FG+V +D N A+K L + R +AE +L ++
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSL----------EEYLSDSNADVLSWEGRLRIATEA 642
+ LY + + + + +Y+ G + EE L+ R IA E
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-----------RFYIA-EL 110
Query: 643 AQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF---------------- 686
+E +H K +HRDIKP NIL++ +L DFGL F
Sbjct: 111 TCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167
Query: 687 -----PIEGVSHLST--------------------GVAGTFGYLDPEYCQTFRLTEKSDV 721
P E S + + GT Y+ PE T+ D
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227
Query: 722 YSFGVVLLEIITSRPA-IANT--EEHKHISQWVDFM 754
+S GV+L E++ +P +A+T E + W +
Sbjct: 228 WSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-04
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGY- 599
I+G GSFG VY +D + +VA+K + Q + E+++++ ++H N+ L Y
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYY 128
Query: 600 ---CNEGNQ----IGLIYEYMANG--SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
C + N+ + ++ E++ ++ + +N + + +L + + + L Y+H
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL-YSYQLCRALAYIH 187
Query: 651 --LGCKPPRVHRDIKPANILLNDQFQA-RLADFGLSKTFPIEGVSHLSTGVAGTFGYLDP 707
C HRD+KP N+L++ +L DFG +K + G +S + F Y P
Sbjct: 188 SKFIC-----HRDLKPQNLLIDPNTHTLKLCDFGSAKNL-LAGQRSVSY-ICSRF-YRAP 239
Query: 708 E-YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
E T D++S G ++ E+I P
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 17/111 (15%)
Query: 630 LSWEGRLRIATEAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSK---- 684
L E L + + A+G+ +L C +HRD+ NILL ++ DFGL++
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRN 266
Query: 685 --TFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
+ ++G + L ++ PE T +SDV+S+G++L EI +
Sbjct: 267 DSNYVVKGNARLPV------KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 63/262 (24%), Positives = 100/262 (38%), Gaps = 61/262 (23%)
Query: 543 LGEGSFGKV-YHGYLDDNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYG 598
LG G+FG+V +D + A+K L +R +AE +L ++ + LY
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNA--DVLSWEGRLRIATEAAQGLEYLHLGCKPP 656
+ + + + +Y+ G + L +VL+ R IA E +E +H K
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA---RFYIA-ELTLAIESVH---KMG 121
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSKTFP-------IEGVSH---------------- 693
+HRDIKP NIL++ +L DFGL F + SH
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 694 ----------------------LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEI 731
L+ + GT Y+ PE T+ D +S GV+L E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 732 ITSRP---AIANTEEHKHISQW 750
+ +P A TE + W
Sbjct: 242 LVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.003
Identities = 33/146 (22%), Positives = 58/146 (39%), Gaps = 18/146 (12%)
Query: 542 ILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTT--LYGY 599
+L G +VY + + +K+ R+ E EV +L+ + K L +
Sbjct: 5 LLKGGLTNRVYL-LGTKDEDYVLKINPS--REKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRV- 658
L+ E++ +L+E + D IA + A+ L LH P V
Sbjct: 62 GESDGWSYLLMEWIEGETLDEVSEEEKED---------IAEQLAELLAKLHQ--LPLLVL 110
Query: 659 -HRDIKPANILLNDQFQARLADFGLS 683
H D+ P NIL++D + D+ +
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 32/115 (27%), Positives = 52/115 (45%), Gaps = 12/115 (10%)
Query: 543 LGEGSFGKVYHG--YLDDNTE----VAVKMLSP-SSRQGYEQFEAEV-ILLRTVHHKNLT 594
LG G+FG+V + D T VAVKML ++ + +E+ IL+ HH N+
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 595 TLYGYCNE-GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEY 648
L G C + G + +I E+ G+L YL + + ++ + QG
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTK---DARFRQGKSG 126
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 846 | |||
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.69 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.63 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.56 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.51 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.45 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.27 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.18 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.13 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.89 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.84 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.82 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.78 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.73 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.67 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.63 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.61 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.6 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.59 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.39 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.36 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.33 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.28 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.27 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.23 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.22 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.21 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.21 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.17 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.16 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.09 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.09 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.07 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.06 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.05 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.02 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.97 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.87 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.85 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 97.85 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 97.81 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.81 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.78 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.78 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 97.77 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.77 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.76 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.74 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.7 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.69 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.68 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.66 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 97.63 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 97.6 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.6 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.51 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 97.48 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 97.4 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.36 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.35 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.33 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.32 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.3 |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-80 Score=731.13 Aligned_cols=437 Identities=26% Similarity=0.434 Sum_probs=358.9
Q ss_pred CCCcEEecCccccccCccccccccccccccccCcceeecCC--CCCcceeeecccCCceeEEEEEeeeccCCCCCCCCee
Q 003114 26 QSGIKYISDTTFVDAGISKSVALAYQLESLHQPLWNLRSFP--EGKRNCYNVKLAKDVRYLIRASFAHGDYDGKGTVPEF 103 (846)
Q Consensus 26 ~~~~~~~~d~~~~~~g~~~~v~~~~~~~~~~~~~~~lr~fp--~~~~~cy~l~~~~~~~ylvr~~f~yg~~d~~~~~~~f 103 (846)
.+|++|++|.+|+. |....++.+ ....++|+|+|+|| +|++|||+||++++||||||++|+||||||.+++|.|
T Consensus 40 ~~~~~w~~D~~~~~-~~~~~~~~~---~~~~~~~~t~R~F~~~~g~~~cY~~~~~~~g~ylVRl~F~~~~y~~~~~~~~F 115 (623)
T PLN03150 40 PTNTLWYKDFAYTG-GIPANATRP---SFIAPPLKTLRYFPLSDGPENCYNINRVPKGHYSVRVFFGLVAEPNFDSEPLF 115 (623)
T ss_pred CCCCEEcCCccccc-CccccccCc---ccccchhhccccCCcccccccceEeeecCCCcEEEEEEeecCCcCCCCCCCce
Confidence 46999999999863 444433322 23567899999999 5899999999999999999999999999999999999
Q ss_pred eEeecCceeeEEeeC--CCcceEEEEEEEEecCCceEEEEeecCCCCcceeeeeeeecCCCcccccc---C--cceEEEE
Q 003114 104 DLHLGPNKWESVILG--NVSTIIVKEIIHVISSNSTRVCLVNTGAGTPFISALEFRPLPNNTYITQS---G--SLNTFIR 176 (846)
Q Consensus 104 d~~~~~~~w~~v~~~--~~~~~~~~e~~~~~~~~~~~vcl~~~~~~~Pfis~le~~~l~~~~Y~~~~---~--~~~~~~r 176 (846)
||++|+|+|.+|+.+ .++..+++|+|+++++++++|||+++++|+||||+||||||++++|.... . .|.++.|
T Consensus 116 dv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs~iEv~~l~~~~y~~~~~~~~~~~L~~~~R 195 (623)
T PLN03150 116 DVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILSIEILQVDDKAYNFGPSWGQGVILRTAKR 195 (623)
T ss_pred EEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCceeEEEEEEcCcccccccccccCceEEEEEEE
Confidence 999999999999863 23456889999999999999999999999999999999999999997332 2 4888999
Q ss_pred EeeeccCC-ceeecCCCCC--CCccccCCC---CCceeecccceeccCCCCCCCCcHHHHhhccccCCCCCceEEecccC
Q 003114 177 MDVLSITN-QVVRYRDDVY--DRSWAPYAY---PQWQQITTPRTIDEDRYNDYQLPSIVMRSAATPKNKSEPLLIDLVHE 250 (846)
Q Consensus 177 ~~~g~~~~-~~~rypdD~~--dR~W~~~~~---~~~~~~~t~~~~~~~~~~~~~~P~~v~~tA~t~~~~~~~l~~~~~~~ 250 (846)
.++|+... ..+|||||+| ||+|.|+.. +.|.++++..+|+.....+|.+|+.|||||.++.++...+.+.|+ +
T Consensus 196 ~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~~-v 274 (623)
T PLN03150 196 LSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQPDLSYTMD-V 274 (623)
T ss_pred EEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccccCCCccChHHHhhhhccccCCCCceEEEee-c
Confidence 99997643 3589999999 999998755 568899988887766566788999999999998876666666664 5
Q ss_pred CCCceEEEEEeeehhhc-cccccceEEEEEECCccccCCCC-----CCcceeeeEEeeeecCCccEEEEEecCCCCCchh
Q 003114 251 DSTSKFYMYMHFAELEE-LQANQSRQFNISFNGNHLYGPVV-----PSYRHTTTAYTTSALTGEKLQFSIHKTENSTLPP 324 (846)
Q Consensus 251 ~~~~~~~~~lhFae~~~-~~~~~~R~F~i~~n~~~~~~~~~-----p~~~~~~~~~~~~~~~~~~~~~~l~~t~~S~lpP 324 (846)
+++..|+|+|||||++. ....++|+|||++||+.+...+. +....+..........++.++|++.++.++ ||
T Consensus 275 ~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~~g~l~isl~p~~~s--~p 352 (623)
T PLN03150 275 DPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQPKKGT--HA 352 (623)
T ss_pred CCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceEEEeEEeecCCeEEEEEeeCCCC--cc
Confidence 78899999999999974 55668999999999998876543 222222222222233457899999998876 69
Q ss_pred HHHHHHHhhhccccCCccchhhHHHHHHHHhhcC---CCCCCCCCCCCCCCCceEEeecCCCC-CCCceEEEEcCCCCCc
Q 003114 325 ILNAIEFYLVQDFSQSETEQADVDAIMNIKSLYK---RKDWQGDPCAPQAFLWNGLGCSYNDN-DPPRITSLNLSSRGLT 400 (846)
Q Consensus 325 ~lna~ei~~~~~~~~~~~~~~d~~al~~~k~~~~---~~~W~~dpC~~~~~~w~gv~C~~~~~-~~~~l~~L~L~~n~l~ 400 (846)
+|||+|+|.+++. +..+.+.|+.||+++|..+. ..+|++|||+|..+.|.||.|+.... ....++.|+|++|+|+
T Consensus 353 ilNaiEI~~~~~~-~~~t~~~~~~aL~~~k~~~~~~~~~~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~ 431 (623)
T PLN03150 353 IINAIEVFEIITA-ESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLR 431 (623)
T ss_pred eeeeeeeeecccc-ccccCchHHHHHHHHHHhcCCcccCCCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCcc
Confidence 9999999999995 46889999999999999987 23899999999999999999974321 2235888888888888
Q ss_pred ccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCCcccc
Q 003114 401 GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVDL 470 (846)
Q Consensus 401 g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~nl 470 (846)
|.+|..|++|++|+.|+|++|+|+|.+|..+++|++|+.|||++|+|+|.+|+.++++++|+.|+|+.|.
T Consensus 432 g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~ 501 (623)
T PLN03150 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501 (623)
T ss_pred ccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCc
Confidence 8888888888888888888888888888888888888888888888888888888888888888877653
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-67 Score=578.44 Aligned_cols=309 Identities=41% Similarity=0.734 Sum_probs=266.8
Q ss_pred CCCCcEEecCccccccCccccccccc--cccccccCcceeecCCCCCcceeeeccc--CCceeEEEEEeeeccCCCCC--
Q 003114 25 NQSGIKYISDTTFVDAGISKSVALAY--QLESLHQPLWNLRSFPEGKRNCYNVKLA--KDVRYLIRASFAHGDYDGKG-- 98 (846)
Q Consensus 25 ~~~~~~~~~d~~~~~~g~~~~v~~~~--~~~~~~~~~~~lr~fp~~~~~cy~l~~~--~~~~ylvr~~f~yg~~d~~~-- 98 (846)
+.|||+|++|.+|+++|++++|++.. ......++|+|+|+||+|+||||+||+. +|+|||||+.|+||||||++
T Consensus 15 ~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~~yliRl~F~~gnyd~~~fs 94 (347)
T PF12819_consen 15 DSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGGKYLIRLHFYYGNYDGLNFS 94 (347)
T ss_pred CCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcCCCCccEEEeeccCCCCceEEEEEEeccccccccccc
Confidence 35699999999999999999994332 2356789999999999999999999987 57799999999999999985
Q ss_pred ---CCCeeeEeecCceeeEEeeCCCc-ceEEEE-EEEEecCCceEEEEeecCCCC-cceeeeeeeecCCCccc--cccC-
Q 003114 99 ---TVPEFDLHLGPNKWESVILGNVS-TIIVKE-IIHVISSNSTRVCLVNTGAGT-PFISALEFRPLPNNTYI--TQSG- 169 (846)
Q Consensus 99 ---~~~~fd~~~~~~~w~~v~~~~~~-~~~~~e-~~~~~~~~~~~vcl~~~~~~~-Pfis~le~~~l~~~~Y~--~~~~- 169 (846)
+||.|||++|+|.|++|+.+++. ..+++| +|+++++++++|||+++++|+ ||||+||||||++++|+ ...+
T Consensus 95 ~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~~lp~~ly~~~~~~~s 174 (347)
T PF12819_consen 95 VSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELRPLPDSLYPDTDANSS 174 (347)
T ss_pred cccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEEECCccceeccccCCC
Confidence 37889999999999999988732 368999 666666899999999999999 99999999999999995 2333
Q ss_pred -cceEEEEEeeeccCCceeecCCCCCCCccccCC-CCCceeecccceec-cCCCCCCCCcHHHHhhccccCCCCCceEEe
Q 003114 170 -SLNTFIRMDVLSITNQVVRYRDDVYDRSWAPYA-YPQWQQITTPRTID-EDRYNDYQLPSIVMRSAATPKNKSEPLLID 246 (846)
Q Consensus 170 -~~~~~~r~~~g~~~~~~~rypdD~~dR~W~~~~-~~~~~~~~t~~~~~-~~~~~~~~~P~~v~~tA~t~~~~~~~l~~~ 246 (846)
.|.++.|.++|..... +|||+|+|||+|+|+. .+.|..++|..+++ ....+.|.||..|||||+++.+.+.+++++
T Consensus 175 ~~L~~~~R~n~G~~~~~-iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~~~~P~~V~~TA~~~~~~s~~~nlt 253 (347)
T PF12819_consen 175 QALETVYRLNVGGSSSF-IRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNPYDAPSAVYQTARTPSNSSDPLNLT 253 (347)
T ss_pred ceeEEEEeecCCCcccc-cCCCCCcceeeccccccCccccccccceeeecccCCccCcChHHHHHhhhcccccccceEEE
Confidence 5999999999987653 9999999999999985 57899999988876 556778999999999999999888889999
Q ss_pred cccCCCCceEEEEEeeehhhccccc-cceEEEEEECCccccCCCCCCcceeeeE--Ee---eeecCCccEEEEEecCCCC
Q 003114 247 LVHEDSTSKFYMYMHFAELEELQAN-QSRQFNISFNGNHLYGPVVPSYRHTTTA--YT---TSALTGEKLQFSIHKTENS 320 (846)
Q Consensus 247 ~~~~~~~~~~~~~lhFae~~~~~~~-~~R~F~i~~n~~~~~~~~~p~~~~~~~~--~~---~~~~~~~~~~~~l~~t~~S 320 (846)
|..++++.+|||+|||||++.+..+ ++|+|||+|||+.+++++.|.++....+ |. .....++.++|+|.++.+|
T Consensus 254 w~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S 333 (347)
T PF12819_consen 254 WSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVNVPDSGFLNISLGPTPDS 333 (347)
T ss_pred eccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEEEecCCCEEEEEEEeCCCC
Confidence 9999999999999999999987544 4799999999999988999977766554 33 2234456789999999999
Q ss_pred CchhHHHHHHHhhh
Q 003114 321 TLPPILNAIEFYLV 334 (846)
Q Consensus 321 ~lpP~lna~ei~~~ 334 (846)
+|||||||+|||.+
T Consensus 334 ~lppiLNalEIy~v 347 (347)
T PF12819_consen 334 TLPPILNALEIYKV 347 (347)
T ss_pred CcCceeEeeeeEeC
Confidence 99999999999964
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-53 Score=469.14 Aligned_cols=288 Identities=49% Similarity=0.834 Sum_probs=254.9
Q ss_pred cccccCHHHHHHHHhhhh--hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEe
Q 003114 523 KKRRFTYAEITKITNDFE--TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC 600 (846)
Q Consensus 523 ~~~~~~~~el~~~t~~f~--~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 600 (846)
..+.|++.++.++|++|. +.||+|+||.||+|.+++++.||||++........++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 457799999999999997 699999999999999999999999988765543146699999999999999999999999
Q ss_pred ecCC-eeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEe
Q 003114 601 NEGN-QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLAD 679 (846)
Q Consensus 601 ~~~~-~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~D 679 (846)
.+.+ +.+||||||++|+|.++|+......++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 599999999999999999986643689999999999999999999999999999999999999999999999999
Q ss_pred ccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--ccccHHHHHHHHHhc
Q 003114 680 FGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTE--EHKHISQWVDFMLAQ 757 (846)
Q Consensus 680 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~--~~~~l~~~~~~~~~~ 757 (846)
||+|+..+.. .........||.+|+|||+...+..++|+|||||||+++||+||+++.+... ....+..|+...+.+
T Consensus 221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 9999765431 1111111189999999999999999999999999999999999999988653 455699999999999
Q ss_pred CCcccccCCCCC-CCCCh-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 758 GDIKNIVDPKLH-GDIDV-NSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 758 ~~~~~~~d~~L~-~~~~~-~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
+.+.+++|+.+. +.+.. +++.++.+++.+|++.+|++||+|.||+++|+.+...
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999997 56554 6889999999999999999999999999999765543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=504.80 Aligned_cols=413 Identities=26% Similarity=0.458 Sum_probs=309.1
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.++++.|+|++|+++|.+|..+++|++|+.|+|++|+++|.+|..|.++++|+.|||++|+++|.+|..+..++.|+.|+
T Consensus 498 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ 577 (968)
T PLN00113 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVN 577 (968)
T ss_pred hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEe
Confidence 35778889999999999999999999999999999999999999999999999999999999999999999999898888
Q ss_pred CccccC-------------------------CCC------CcccCCCCCCcccceeehhhhHHHHH-Hhhhheeeeeccc
Q 003114 466 LSVDLC-------------------------SSY------PCKENNKKKNNFVFPVIASFASLLVV-TLAISAIYWRHKR 513 (846)
Q Consensus 466 l~~nlc-------------------------~~~------pc~~~~~~~~~~~~~iv~~~~~ll~v-~l~i~~~~~~~kr 513 (846)
+++|.. +.. +|.... +.......+++.+++++++ ++++.++++++++
T Consensus 578 ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (968)
T PLN00113 578 ISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR-KTPSWWFYITCTLGAFLVLALVAFGFVFIRGRN 656 (968)
T ss_pred ccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc-ccceeeeehhHHHHHHHHHHHHHHHHHHHHhhh
Confidence 887642 211 121110 1111111111222222121 2222222222222
Q ss_pred cccCCcccc-------------cccccCHHHHHHHHhhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHH
Q 003114 514 LRKDGSLET-------------KKRRFTYAEITKITNDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFE 579 (846)
Q Consensus 514 ~~~~~~~~~-------------~~~~~~~~el~~~t~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~ 579 (846)
..+....+. ....++++++... ....+.||+|+||.||+|+. .++..||||++...... ..
T Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~ 731 (968)
T PLN00113 657 NLELKRVENEDGTWELQFFDSKVSKSITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PS 731 (968)
T ss_pred cccccccccccccccccccccccchhhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cH
Confidence 111111000 0122334444332 22346899999999999997 57899999998654322 23
Q ss_pred HHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeee
Q 003114 580 AEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVH 659 (846)
Q Consensus 580 ~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiH 659 (846)
+|++.+++++||||++++++|.+++..++||||+++|+|.++++. ++|.++.+++.|+|+||+|||+.++++|+|
T Consensus 732 ~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 806 (968)
T PLN00113 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVV 806 (968)
T ss_pred HHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeec
Confidence 568899999999999999999999999999999999999999963 899999999999999999999888889999
Q ss_pred cCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003114 660 RDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIA 739 (846)
Q Consensus 660 rDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~ 739 (846)
|||||+||++++++.+++. ||....... .....++..|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus 807 ~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 807 GNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred CCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 9999999999999988876 665543211 122367899999999999999999999999999999999999996
Q ss_pred Ccc-ccccHHHHHHHHHhcCCcccccCCCCCCC--CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhhh
Q 003114 740 NTE-EHKHISQWVDFMLAQGDIKNIVDPKLHGD--IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARK 816 (846)
Q Consensus 740 ~~~-~~~~l~~~~~~~~~~~~~~~~~d~~L~~~--~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~~ 816 (846)
... ....+.+|++...........+|+.+... ...++..++.+++.+|++.+|++||+|+||+++|+++.......+
T Consensus 880 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~~ 959 (968)
T PLN00113 880 AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCV 959 (968)
T ss_pred cccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccccc
Confidence 432 45567888887766666677778777543 345667788999999999999999999999999998775444433
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=392.77 Aligned_cols=256 Identities=34% Similarity=0.528 Sum_probs=213.4
Q ss_pred hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCch--hhHHHHHHHHHHHhcccccceeEeeEeecCC-eeeEeeecccCC
Q 003114 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQ--GYEQFEAEVILLRTVHHKNLTTLYGYCNEGN-QIGLIYEYMANG 616 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-~~~LV~Ey~~~g 616 (846)
.+.||+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4569999999999999975555999999865432 2568999999999999999999999999988 799999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCC-eeecCCCCCCEEECCCC-cEEEEeccCCccCCCCCcccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP-RVHRDIKPANILLNDQF-QARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-IiHrDlKp~NILld~~~-~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|.++++......+++..+++++.|||+||+||| +.+ ||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS 200 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence 9999998854455999999999999999999999 667 99999999999999997 99999999998653221 33
Q ss_pred cccccCCCcccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQ--TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~--~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
.+...||+.|||||++. ...+++|+|||||||++|||+||+.||.+....... ..+...+ .+...
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~----~~v~~~~---------~Rp~~ 267 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA----SAVVVGG---------LRPPI 267 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhcC---------CCCCC
Confidence 34478999999999999 668999999999999999999999999876652222 1222221 22222
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMET 813 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~ 813 (846)
+..+...+..++.+||..+|+.||++.+++..|+.+...-.
T Consensus 268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 33356688899999999999999999999999998876444
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=383.52 Aligned_cols=260 Identities=27% Similarity=0.454 Sum_probs=220.9
Q ss_pred HHHHhhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 533 TKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 533 ~~~t~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
......+.+.||+|.||.||.|.++....||+|.++..+. ..+.|.+|+++|++++|+|||+++|+|..++.++|||||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 3334456678999999999999999888999999987532 346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
|+.|+|.++|+......+...+.+.++.|||+||+||+ ++++|||||.++||||+++..+||+|||+|+.. .++..
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEY 358 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc-CCCce
Confidence 99999999999866667999999999999999999999 999999999999999999999999999999943 33334
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
....+..-+..|.|||.+...+++.|+|||||||+||||+| |+.|+......+.+.. + +...+-.
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-----l---------e~GyRlp 424 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-----L---------ERGYRLP 424 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-----H---------hccCcCC
Confidence 44445556788999999999999999999999999999998 7889887665443322 2 2222223
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
-+..++..+.+|+..||+.+|++|||++.+...|+++...
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 3556778899999999999999999999999999887643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=363.71 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=214.8
Q ss_pred cccCHHHHHHHHhhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeec
Q 003114 525 RRFTYAEITKITNDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE 602 (846)
Q Consensus 525 ~~~~~~el~~~t~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~ 602 (846)
..++..|++.. ..||+|..|+|||++++ +++-+|+|.+... +....+++.+|+++++..+||+||.++|.|..
T Consensus 74 ~~i~~~dle~~-----~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 74 NGISLSDLERL-----GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cccCHHHhhhh-----hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 34566666653 57999999999999986 6788999999544 45567899999999999999999999999998
Q ss_pred CC-eeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEecc
Q 003114 603 GN-QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFG 681 (846)
Q Consensus 603 ~~-~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFG 681 (846)
+. ...++||||++|+|++++...+. +++...-+|+.+|++||.|||+ +++||||||||+|||++..|++||||||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEecccc
Confidence 88 59999999999999999987644 8999999999999999999994 4899999999999999999999999999
Q ss_pred CCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cccccHHHHHHHHHhcCCc
Q 003114 682 LSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANT-EEHKHISQWVDFMLAQGDI 760 (846)
Q Consensus 682 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~-~~~~~l~~~~~~~~~~~~~ 760 (846)
.++.+-. .....+.||..|||||.+++..|+.++||||||+.++|+.+|+.|+... .......+.+.....+.
T Consensus 225 VS~~lvn----S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p-- 298 (364)
T KOG0581|consen 225 VSGILVN----SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP-- 298 (364)
T ss_pred ccHHhhh----hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC--
Confidence 9987632 2556788999999999999999999999999999999999999999865 22233334333333221
Q ss_pred ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 761 ~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.|.+... ....++..++..|++++|.+||+++|++++
T Consensus 299 ----pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 ----PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ----CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1222221 245678999999999999999999998764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.29 Aligned_cols=198 Identities=27% Similarity=0.504 Sum_probs=179.4
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.||+|+||+||+|++. ++.+||||.+... .++..+.+..|+.+|+.++|||||.+++++..++.++||||||+||
T Consensus 15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gG 94 (429)
T KOG0595|consen 15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGG 94 (429)
T ss_pred hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence 456999999999999975 6899999999876 5666777899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC------CcEEEEeccCCccCCCCC
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ------FQARLADFGLSKTFPIEG 690 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~------~~vkI~DFGla~~~~~~~ 690 (846)
+|.++++..+. +++.....++.|+|.||++|| +++||||||||+||||+.. -.+||+|||+|+.+..
T Consensus 95 DLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~-- 167 (429)
T KOG0595|consen 95 DLSDYIRRRGR--LPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP-- 167 (429)
T ss_pred CHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc--
Confidence 99999998764 899999999999999999999 9999999999999999754 5689999999998753
Q ss_pred cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK 745 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~ 745 (846)
.......+|++-|||||+++.++|+.|+|+||+|+++|||++|++||+.....+
T Consensus 168 -~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 168 -GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred -hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 345566899999999999999999999999999999999999999998655433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=376.11 Aligned_cols=246 Identities=22% Similarity=0.399 Sum_probs=209.4
Q ss_pred hhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 537 NDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+...+.||+|||+.||.++. ..|..||+|++.+. .....+...+|+++.+.++|||||+++++|++.++.|+|.|+
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLEL 99 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLEL 99 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEe
Confidence 44457899999999999997 89999999999763 344567789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
|++++|.++++..+ .+++.++..++.||+.||.||| +.+|+|||||..|+++++++++||+|||||..+.. ..
T Consensus 100 C~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~ 172 (592)
T KOG0575|consen 100 CHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DG 172 (592)
T ss_pred cCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecC--cc
Confidence 99999999998544 4999999999999999999999 99999999999999999999999999999998743 23
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
+.....+||+.|+|||++....++..+||||+|||+|-|+.|+|||+...-.+....+. ... ..+
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik----~~~---Y~~-------- 237 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK----LNE---YSM-------- 237 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH----hcC---ccc--------
Confidence 45566899999999999999999999999999999999999999998654333332211 111 111
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+.....+..+|+..+|+++|.+|||+++|+..
T Consensus 238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11223456799999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.21 Aligned_cols=250 Identities=22% Similarity=0.363 Sum_probs=203.5
Q ss_pred HhhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCch-------hhHHHHHHHHHHHhcccccceeEeeEeecCCeee
Q 003114 536 TNDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQ-------GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIG 607 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~-------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 607 (846)
.+-..+.||+|+||.|-+|.. ++|+.||||++++.... .....++|+++|++++|||||++++++...+..|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 344567899999999999985 57999999999764211 1223579999999999999999999999999999
Q ss_pred EeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC---CcEEEEeccCCc
Q 003114 608 LIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ---FQARLADFGLSK 684 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~---~~vkI~DFGla~ 684 (846)
+|||||+||+|.+.+-.++. +.+.....+++|++.|+.||| +.||+||||||+|||+..+ ..+||+|||+|+
T Consensus 253 mVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999987664 777788899999999999999 9999999999999999765 889999999999
Q ss_pred cCCCCCcccccccccCCCcccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcc
Q 003114 685 TFPIEGVSHLSTGVAGTFGYLDPEYCQTFR---LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIK 761 (846)
Q Consensus 685 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~ 761 (846)
... ........+||+.|.|||++.+.. +..++|+||+|||||-+++|.+||.+......+.+ .+..|+..
T Consensus 328 ~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e----QI~~G~y~ 400 (475)
T KOG0615|consen 328 VSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE----QILKGRYA 400 (475)
T ss_pred ccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH----HHhcCccc
Confidence 764 344566789999999999997664 33488999999999999999999987654443332 22222211
Q ss_pred cccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 762 NIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 762 ~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+.|. .-.+..++..+++.+|+..||++|||+.|+++
T Consensus 401 --f~p~----~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 401 --FGPL----QWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred --ccCh----hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1111 11234567889999999999999999999886
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=334.80 Aligned_cols=256 Identities=24% Similarity=0.382 Sum_probs=208.3
Q ss_pred HhhhhhhcCcCceEEEEEEE-EcCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEee-EeecCCe-eeEee
Q 003114 536 TNDFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYG-YCNEGNQ-IGLIY 610 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g-~~~~~~~-~~LV~ 610 (846)
...+.+.||+|.||+|||+. +.+|..||.|.++-. +.+..+....|+.+|++++|||||++++ -+.++.+ +.+||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 34556789999999999998 568999999998743 4456677889999999999999999998 4555555 89999
Q ss_pred ecccCCChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccCCCC--eeecCCCCCCEEECCCCcEEEEeccCCccC
Q 003114 611 EYMANGSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGCKPP--RVHRDIKPANILLNDQFQARLADFGLSKTF 686 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--IiHrDlKp~NILld~~~~vkI~DFGla~~~ 686 (846)
|||..|+|.++++..+ .+.+++...+++..|++.||.++|..- ++ |+||||||.||+++.+|.+||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999997533 556999999999999999999999321 44 999999999999999999999999999987
Q ss_pred CCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCC
Q 003114 687 PIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDP 766 (846)
Q Consensus 687 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 766 (846)
... .......+|||.||+||.+....|+.|+||||+||+++||..-++||.+. .+.+. ...+..++...+-
T Consensus 179 ~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L-~~KI~qgd~~~~p-- 249 (375)
T KOG0591|consen 179 SSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSL-CKKIEQGDYPPLP-- 249 (375)
T ss_pred cch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHH-HHHHHcCCCCCCc--
Confidence 432 33445678999999999999999999999999999999999999999865 23332 2334444322221
Q ss_pred CCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 767 KLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 767 ~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
......++.+|+..|+..||+.||+...+++.+..
T Consensus 250 ------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 ------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 12345678899999999999999997666655544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=380.67 Aligned_cols=258 Identities=29% Similarity=0.487 Sum_probs=221.1
Q ss_pred hhhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCCch-hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEe
Q 003114 537 NDFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSSRQ-GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV 609 (846)
..+.+.||+|+||+||+|+.. +.+.||||.++..... ..++|++|+++++.++|||||+|+|.|.+++..++|
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 345678999999999999853 3456999999977655 788999999999999999999999999999999999
Q ss_pred eecccCCChhhhhhcCC--------CCc----cChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEE
Q 003114 610 YEYMANGSLEEYLSDSN--------ADV----LSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARL 677 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~--------~~~----l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI 677 (846)
+|||..|+|.++|.... .+. ++..+.+.||.|||.||.||- +..+|||||.++|+||.++..|||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEe
Confidence 99999999999997543 222 888999999999999999999 999999999999999999999999
Q ss_pred EeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHh
Q 003114 678 ADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLA 756 (846)
Q Consensus 678 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~ 756 (846)
+|||+++..-..+..+......-+.+|||||.+...+++.++|||||||+|||+++ |+.||.+....+.+. .+.
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe-----~i~ 719 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE-----CIR 719 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH-----HHH
Confidence 99999998755555554445556789999999999999999999999999999997 899998777655443 244
Q ss_pred cCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 757 QGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 757 ~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
++++. .-++.++.++.+|+..||+.+|++||+++||-..|+...+.
T Consensus 720 ~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 720 AGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred cCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 44321 23567888999999999999999999999999999885543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=349.73 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=208.7
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCC---CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS---SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.|.++||+|+|++|++|+. ..++++|||++.+. .....+-...|-..|.+| +||.|++|+..|++...+|+|+||
T Consensus 76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~ 155 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY 155 (604)
T ss_pred chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence 5678999999999999995 47899999998754 122234466788889999 899999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.++|+..+. |++.....++.+|+.||+||| +.|||||||||+|||||+|+++||+|||.|+.++.....
T Consensus 156 A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 156 APNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred cCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 999999999998765 999999999999999999999 999999999999999999999999999999988543221
Q ss_pred ---------cc--cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcc
Q 003114 693 ---------HL--STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIK 761 (846)
Q Consensus 693 ---------~~--~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~ 761 (846)
.. ...++||..|.+||++.....+..+|+|+|||+||+|+.|++||....+.....+++..
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-------- 302 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-------- 302 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh--------
Confidence 11 14588999999999999999999999999999999999999999887765444443321
Q ss_pred cccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 762 NIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 762 ~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
|- .++......+.+|+.+.+..+|.+|++.+||.+.-
T Consensus 303 ---~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 303 ---DY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ---cc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11 12233335778999999999999999998887753
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=364.31 Aligned_cols=274 Identities=24% Similarity=0.428 Sum_probs=230.4
Q ss_pred cccCHHHHHHHHhhh-----------hhhcCcCceEEEEEEEEc----CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhc
Q 003114 525 RRFTYAEITKITNDF-----------ETILGEGSFGKVYHGYLD----DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTV 588 (846)
Q Consensus 525 ~~~~~~el~~~t~~f-----------~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l 588 (846)
..++|+|-.++-.+| +++||.|.||.|++|+++ ....||||.++... .+...+|..|+.+|.+.
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 456777655554444 468999999999999985 24569999998763 45567899999999999
Q ss_pred ccccceeEeeEeecCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEE
Q 003114 589 HHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANIL 668 (846)
Q Consensus 589 ~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NIL 668 (846)
.||||++|.|.....+..++|.|||++|+|+.+|+.+.++ +++.+..-++++||.||+||. +.++|||||.++|||
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNIL 763 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNIL 763 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhhee
Confidence 9999999999999999999999999999999999998876 999999999999999999999 999999999999999
Q ss_pred ECCCCcEEEEeccCCccCCCCC-cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccc
Q 003114 669 LNDQFQARLADFGLSKTFPIEG-VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKH 746 (846)
Q Consensus 669 ld~~~~vkI~DFGla~~~~~~~-~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~ 746 (846)
++.+..+|++|||+++.+..+. ......+-.-+.+|.|||.+...+++.++||||||||+||.++ |..||.+..+.+.
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV 843 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 843 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence 9999999999999999764332 1122222233578999999999999999999999999999885 8999988776665
Q ss_pred HHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhhh
Q 003114 747 ISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARK 816 (846)
Q Consensus 747 l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~~ 816 (846)
+..+ +...+-..+.+++..|.+|++.||+++-.+||.+.||+..|++++..-.+-+
T Consensus 844 IkaI--------------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk 899 (996)
T KOG0196|consen 844 IKAI--------------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLK 899 (996)
T ss_pred HHHH--------------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhc
Confidence 5442 2223334577899999999999999999999999999999999886555544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=327.59 Aligned_cols=256 Identities=20% Similarity=0.273 Sum_probs=205.4
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
..+|+|+||.|||++.+ +|+.||||++..+. +...+-..+|+.+|++++|+|+|.++..|.....+.||+|||+..
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT- 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT- 86 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH-
Confidence 46899999999999975 69999999997553 344566789999999999999999999999999999999999774
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
+.+-|.... ..++.....+++.|+++|+.|+| +.++|||||||+|||++.++.+||||||+|+.+.. ....-+.
T Consensus 87 vL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTD 160 (396)
T KOG0593|consen 87 VLHELERYP-NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYTD 160 (396)
T ss_pred HHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccchhhh
Confidence 444444332 34889999999999999999999 99999999999999999999999999999998753 2334455
Q ss_pred ccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHH-----------hcCC-----c
Q 003114 698 VAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFML-----------AQGD-----I 760 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~-----------~~~~-----~ 760 (846)
.+.|.+|+|||.+.+ .+|...+||||+||++.||++|.+.|.+.++-+.+..+.+.+- .... +
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l 240 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL 240 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence 678999999998877 6899999999999999999999999999887777766554321 1111 1
Q ss_pred ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 761 ~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+.-+++-.+..-.....-+++++..|++.||.+|++-+|++.
T Consensus 241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1121211111111223346789999999999999999999874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=351.01 Aligned_cols=258 Identities=25% Similarity=0.404 Sum_probs=203.4
Q ss_pred hhhhhhcCcCceEEEEEEEE------cCCcEEEEEEeCCCC-chhhHHHHHHHHHHHhc-ccccceeEeeEeecC-Ceee
Q 003114 537 NDFETILGEGSFGKVYHGYL------DDNTEVAVKMLSPSS-RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEG-NQIG 607 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~-~~~~ 607 (846)
..+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++..+ +||||++++++|... ...+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM 88 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence 34567899999999999974 235679999997543 23456788999999999 899999999988764 4688
Q ss_pred EeeecccCCChhhhhhcCC------------------------------------------------------------C
Q 003114 608 LIYEYMANGSLEEYLSDSN------------------------------------------------------------A 627 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~------------------------------------------------------------~ 627 (846)
+||||+++|+|.+++.... .
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 9999999999999987532 1
Q ss_pred CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccccCCCcccCc
Q 003114 628 DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDP 707 (846)
Q Consensus 628 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~AP 707 (846)
..+++..+.+++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++...............++..|+||
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 24778889999999999999999 899999999999999999999999999999865332222222234567889999
Q ss_pred cccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHh
Q 003114 708 EYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMG 786 (846)
Q Consensus 708 E~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~ 786 (846)
|++.+..++.++|||||||++|||++ |+.||........+. .. ...+.... .+......+.+++.+
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~---~~-~~~~~~~~---------~~~~~~~~l~~li~~ 312 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC---QR-LKDGTRMR---------APENATPEIYRIMLA 312 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HH-HhcCCCCC---------CCCCCCHHHHHHHHH
Confidence 99998899999999999999999997 999997654332221 11 12221110 111234568899999
Q ss_pred ccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 787 CVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 787 Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
|++.+|++||++.|+++.|++++.
T Consensus 313 cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 313 CWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=356.15 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=208.5
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||+|.||+||+|+|.+ .||||+++.. +....+.|++|+.++++-+|.||+=+.|||.++.. .+|+.+|+|
T Consensus 395 ~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG 471 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG 471 (678)
T ss_pred hccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence 345789999999999999854 6999999865 44567889999999999999999999999999887 999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
-+|+.+|+.... .|+..+.+.|+.|||+||.||| .++|||||||+.||++.+++.|||+|||++..-..-......
T Consensus 472 sSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~ 547 (678)
T KOG0193|consen 472 SSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL 547 (678)
T ss_pred chhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence 999999998764 3899999999999999999999 999999999999999999999999999998753222112222
Q ss_pred ccccCCCcccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 696 TGVAGTFGYLDPEYCQTF---RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~---~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
....|...|||||+++.. +++.++||||||||+|||+||..||.....+..+. ++..|.. -+.+. ..
T Consensus 548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif-----mVGrG~l----~pd~s-~~ 617 (678)
T KOG0193|consen 548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF-----MVGRGYL----MPDLS-KI 617 (678)
T ss_pred CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE-----Eeccccc----Cccch-hh
Confidence 334578899999998654 69999999999999999999999998433222111 1111111 01110 12
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
..++.+.+.+|+..||..++++||.+.+|+.+|++++.
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 34567789999999999999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=336.92 Aligned_cols=238 Identities=25% Similarity=0.354 Sum_probs=199.0
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.++||+|+||+||.++. ++++.+|+|++++.. ....+...+|..+|.+++||.||+++..|++++.++||+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 357899999999999985 468889999998653 3456678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
||.|..+|+..+. +++..+.-++.+|+.||.||| +++||||||||+|||||++|+++|+|||+++.... ....
T Consensus 109 GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~~~~ 181 (357)
T KOG0598|consen 109 GGELFYHLQREGR--FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--DGDA 181 (357)
T ss_pred CccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc--CCCc
Confidence 9999999987664 889989999999999999999 99999999999999999999999999999986422 2334
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
...++||+.|||||++.+..++..+|.||+|+++|||++|.+||...+. .++.+...... . ..-+.
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~----~~~~~~I~~~k-~--~~~p~------- 247 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV----KKMYDKILKGK-L--PLPPG------- 247 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH----HHHHHHHhcCc-C--CCCCc-------
Confidence 4558999999999999999999999999999999999999999986543 33333333322 0 00111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCC
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPN 797 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPs 797 (846)
-...+..+++...+..+|++|..
T Consensus 248 ~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 248 YLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred cCCHHHHHHHHHHhccCHHHhcC
Confidence 11235678899999999999963
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=346.54 Aligned_cols=249 Identities=28% Similarity=0.440 Sum_probs=209.7
Q ss_pred ccccCHHHHHHHHhhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecC
Q 003114 524 KRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG 603 (846)
Q Consensus 524 ~~~~~~~el~~~t~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 603 (846)
...+.+++|.+. +-||.|+.|.||+|+++ ++.||||+++. .-+.+++.|++++|+||+.+.|+|...
T Consensus 118 ~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 118 LWEIPFEEISEL-----EWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hccCCHHHhhhh-----hhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCC
Confidence 445666666553 45999999999999994 67899998753 234688999999999999999999999
Q ss_pred CeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCC
Q 003114 604 NQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLS 683 (846)
Q Consensus 604 ~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla 683 (846)
..+++|||||+.|-|++.|+.... +.......+..+||.||.||| .+.|||||||+-||||..+..+||+|||-+
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~~--itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGRP--ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred ceeEEeeeccccccHHHHHhccCc--cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccch
Confidence 999999999999999999998654 788888999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 003114 684 KTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNI 763 (846)
Q Consensus 684 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~ 763 (846)
+..... ...-.++||..|||||++.+.+.++|+||||||||||||+||.-||.+.+....+. .+
T Consensus 260 ~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw-------------GV 323 (904)
T KOG4721|consen 260 KELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW-------------GV 323 (904)
T ss_pred Hhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE-------------ec
Confidence 876322 23345789999999999999999999999999999999999999997654221110 11
Q ss_pred cCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 764 VDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 764 ~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
-...|.-..+..+++.+.-|+..||+..|..||++++++..|+
T Consensus 324 GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 324 GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 1122333456678889999999999999999999999999995
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=337.33 Aligned_cols=255 Identities=27% Similarity=0.392 Sum_probs=204.9
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCC--eeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN--QIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~~LV~Ey~~~ 615 (846)
..+.||+|+||.||++... +|...|||..........+.+++|+.+|.+++|||||+.+|.....+ .+.+.|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 3468999999999999975 48999999987664444677899999999999999999999854444 69999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-CCcEEEEeccCCccCCC-CCccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-QFQARLADFGLSKTFPI-EGVSH 693 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-~~~vkI~DFGla~~~~~-~~~~~ 693 (846)
|+|.+++...+. .+++..+.++..|+++||+||| +++|+||||||+|||++. ++.+||+|||+++.... .....
T Consensus 101 GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 101 GSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred CcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 999999998876 6999999999999999999999 999999999999999999 79999999999987643 11122
Q ss_pred ccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
......||+.|||||++..+ ....++||||+||++.||+||++||... .....++-......... ..
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~~~~~P---------~i 244 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGREDSLP---------EI 244 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhccCCCC---------CC
Confidence 33457899999999999853 3345999999999999999999999864 11122222222222111 22
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
+........+++.+|+..+|++|||++++++.---..
T Consensus 245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 2233456789999999999999999999998775544
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=374.44 Aligned_cols=264 Identities=28% Similarity=0.439 Sum_probs=221.1
Q ss_pred hhhhhhcCcCceEEEEEEEEc--CCc----EEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEe
Q 003114 537 NDFETILGEGSFGKVYHGYLD--DNT----EVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~--~g~----~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV 609 (846)
..+.+.||+|+||.||+|... ++. .||||.+++. +.+...+|.+|..+|++++|||||+++|.|.+....+++
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 344568999999999999964 333 4899999876 455678899999999999999999999999999999999
Q ss_pred eecccCCChhhhhhcCC-----CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCc
Q 003114 610 YEYMANGSLEEYLSDSN-----ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~ 684 (846)
+|||++|+|..+|++.. ...++....+.++.|||+|++||+ ++++|||||.++|+||+....|||+|||+|+
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 99999999999998863 345889999999999999999999 9999999999999999999999999999999
Q ss_pred cCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccc
Q 003114 685 TFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNI 763 (846)
Q Consensus 685 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~ 763 (846)
.+-..+.........-...|||||.++++.++.|+|||||||++||++| |..||...+..+.+.. +...++
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~----~~~ggR---- 922 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD----VLEGGR---- 922 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH----HHhCCc----
Confidence 6544433333333345678999999999999999999999999999998 7899987765544333 233331
Q ss_pred cCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhhhc
Q 003114 764 VDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARKE 817 (846)
Q Consensus 764 ~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~~~ 817 (846)
| +.+..++..+.+++..||+.+|++||++..+++++..+........-
T Consensus 923 ----L--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 923 ----L--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred ----c--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 1 23456778899999999999999999999999999988877666543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.84 Aligned_cols=260 Identities=23% Similarity=0.327 Sum_probs=210.5
Q ss_pred hhhhhhcCcCceEEEEEEE-EcCCcEEEEEEeCCCCch-hhHHHHHHHHHHHhcc-cccceeEeeEeecCC-eeeEeeec
Q 003114 537 NDFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQ-GYEQFEAEVILLRTVH-HKNLTTLYGYCNEGN-QIGLIYEY 612 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~-~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~-~~~LV~Ey 612 (846)
+...+.||.|.||.||+|+ ...|..||||+++..-.. ....-.+|++.|++++ ||||+++.+.+.+.+ .+++||||
T Consensus 12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~ 91 (538)
T KOG0661|consen 12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEF 91 (538)
T ss_pred HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHh
Confidence 3445789999999999999 457899999999765333 2223468999999998 999999999998877 99999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
|+ .+|+++++++ .+.+++..+..|+.||++||+|+| ++|+.|||+||+|||+..+..+||+|||+|+.+...
T Consensus 92 Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk--- 163 (538)
T KOG0661|consen 92 MD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK--- 163 (538)
T ss_pred hh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC---
Confidence 95 5999999988 667999999999999999999999 999999999999999999999999999999987433
Q ss_pred cccccccCCCcccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcc----------
Q 003114 693 HLSTGVAGTFGYLDPEYC-QTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIK---------- 761 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~-~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~---------- 761 (846)
..-+..+.|.+|+|||++ +..-|+.+.||||+|||++|+.+-++.|.+.++-+.+.++...+-......
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 234556789999999965 566799999999999999999999999999988887777655432221110
Q ss_pred -cccCCCCCC----CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 762 -NIVDPKLHG----DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 762 -~~~d~~L~~----~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.+.-|...+ ..-.....+.++++.+|+..||.+|||++|.+++
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000011111 0111255678899999999999999999998875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=338.97 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=206.9
Q ss_pred hhcCcCceEEEEEEE-EcCCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecC--CeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGY-LDDNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG--NQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~LV~Ey~~~ 615 (846)
+.||+|.||.||||+ ..+|+.||+|++.... .....-..+|+.+|++++||||++|.+...+. ..+|||+|||+.
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 469999999999999 5689999999997654 33445567899999999999999999988765 789999999976
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
+|.-++....- .++..++..++.|++.||+|+| ..+|+|||||.+|||||.+|.+||+|||||+.+.... ....
T Consensus 203 -DL~GLl~~p~v-kft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~-~~~~ 276 (560)
T KOG0600|consen 203 -DLSGLLSSPGV-KFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG-SAPY 276 (560)
T ss_pred -hhhhhhcCCCc-ccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCC-Cccc
Confidence 88888776543 3999999999999999999999 9999999999999999999999999999999775433 2335
Q ss_pred ccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC-------cc--cccC
Q 003114 696 TGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD-------IK--NIVD 765 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~-------~~--~~~d 765 (846)
+..+.|++|+|||++.+. .|+.++|+||.||||.||++|++.|.+..+.+.+..+++.+-.... +. ..+.
T Consensus 277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~k 356 (560)
T KOG0600|consen 277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFK 356 (560)
T ss_pred ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccC
Confidence 566789999999988765 6999999999999999999999999999988888877765432211 00 1111
Q ss_pred CCCCCCCC-------hHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 PKLHGDID-------VNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 ~~L~~~~~-------~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+.- .+. .......++|+..+|..||.+|.|+.++++
T Consensus 357 p~~--~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 357 PQQ--PYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCC--cccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 110 111 112245678999999999999999998875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.94 Aligned_cols=259 Identities=23% Similarity=0.362 Sum_probs=209.7
Q ss_pred hhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 537 NDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+++.+.||.|..++||+|+. ..++.||||++.-.. ....+.+++|+..|+.++||||++++..|..+..+++||.||.
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence 45567899999999999994 578999999997553 3346889999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|++.++++..-+..+++..+..|++++++||.||| .+|.||||||+.||||+++|.|||+|||.+..+...+....
T Consensus 108 ~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~ 184 (516)
T KOG0582|consen 108 GGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV 184 (516)
T ss_pred CCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence 999999999888778999999999999999999999 99999999999999999999999999998776644332111
Q ss_pred -c-ccccCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 695 -S-TGVAGTFGYLDPEYCQT--FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 695 -~-~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
. ....||+.|||||+++. ..|+.|+||||||+...||.+|+.||.....-+.+.. . -.+......-..+..
T Consensus 185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~---t--Lqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL---T--LQNDPPTLLTSGLDK 259 (516)
T ss_pred EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH---H--hcCCCCCcccccCCh
Confidence 1 45689999999998543 3699999999999999999999999987654333322 1 122222111111111
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+........+.+++..|+++||++|||++++++
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 112223346889999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.01 Aligned_cols=258 Identities=21% Similarity=0.323 Sum_probs=210.3
Q ss_pred hhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCch--hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 540 ETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQ--GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.||+|.||.||+|+. ++|+.||||+++..... ......+|++.|+.++|+||+.+++.|...+...||+|||+.
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t- 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT- 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-
Confidence 46899999999999995 58999999999865332 345678999999999999999999999999999999999964
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|+..+++.. ..++..+...++.++++|++||| ++.|+||||||.|+|++++|.+||+|||+|+.+...+ ....
T Consensus 86 dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~--~~~~ 159 (318)
T KOG0659|consen 86 DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN--RIQT 159 (318)
T ss_pred cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCC--cccc
Confidence 9999998765 35888999999999999999999 9999999999999999999999999999999886443 3333
Q ss_pred cccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC-----cccc-------
Q 003114 697 GVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD-----IKNI------- 763 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~-----~~~~------- 763 (846)
..+-|.+|+|||.+.+. .|+..+||||.|||+.||+-|.+-|.+..+-+.+..+++.+-.+.. ..++
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 44789999999988765 6999999999999999999999999988887777776654322110 0000
Q ss_pred -cCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 764 -VDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 764 -~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+.+......-.......++++..++..+|.+|++++|++++
T Consensus 240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00111111222344566899999999999999999998765
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=333.20 Aligned_cols=245 Identities=23% Similarity=0.419 Sum_probs=200.8
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchh---hHHHHHHHHHHHhcccccceeEeeEeec----CCeeeEeeecc
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQG---YEQFEAEVILLRTVHHKNLTTLYGYCNE----GNQIGLIYEYM 613 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~---~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~LV~Ey~ 613 (846)
..||+|++|.||+|.+ +|+.||||.++...... .+.+.+|+.++++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4699999999999998 68899999997653322 4678899999999999999999999866 45789999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCC-CCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK-PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
++|+|.+++.... .+++....+++.+++.||.||| + .+++||||||+|||+++++.+||+|||+++.+...
T Consensus 105 ~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--- 176 (283)
T PHA02988 105 TRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--- 176 (283)
T ss_pred CCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence 9999999998754 4899999999999999999999 5 47889999999999999999999999998865321
Q ss_pred cccccccCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQT--FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||......+ +.......+. . +
T Consensus 177 --~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~----~~~~i~~~~~-~----~---- 241 (283)
T PHA02988 177 --PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE----IYDLIINKNN-S----L---- 241 (283)
T ss_pred --cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhcCC-C----C----
Confidence 123457889999999876 679999999999999999999999998654322 2222222111 0 1
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
..+......+.+++.+||+.+|++|||++|+++.|+.+.
T Consensus 242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 112234457889999999999999999999999998864
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=335.61 Aligned_cols=261 Identities=26% Similarity=0.405 Sum_probs=203.2
Q ss_pred hhhhhhcCcCceEEEEEEEEcC-----------------CcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEee
Q 003114 537 NDFETILGEGSFGKVYHGYLDD-----------------NTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYG 598 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~-----------------g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g 598 (846)
..+.+.||+|+||.||++.+++ +..||+|.+.... .....++.+|+.++.+++||||+++++
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 86 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG 86 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 3456789999999999998642 3369999997653 334567899999999999999999999
Q ss_pred EeecCCeeeEeeecccCCChhhhhhcCC-----------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecC
Q 003114 599 YCNEGNQIGLIYEYMANGSLEEYLSDSN-----------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRD 661 (846)
Q Consensus 599 ~~~~~~~~~LV~Ey~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrD 661 (846)
++...+..++||||+++|+|.+++.... ...+++....+++.|++.||.||| +.+|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH~d 163 (304)
T cd05096 87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRD 163 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccccC
Confidence 9999999999999999999999986432 124788899999999999999999 88999999
Q ss_pred CCCCCEEECCCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 003114 662 IKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRPAIA 739 (846)
Q Consensus 662 lKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt--G~~p~~ 739 (846)
|||+|||+++++.+||+|||+++...............++..|+|||++....++.++|||||||+++||++ +..||.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 999999999999999999999986543322222334456789999999988889999999999999999987 566776
Q ss_pred CccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 740 NTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 740 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
.......+ ..+............ ...+......+.+++.+|++.+|++||||.||.+.|++
T Consensus 244 ~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 244 ELTDEQVI-ENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred cCCHHHHH-HHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 55433322 222222211110000 00112334578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=346.61 Aligned_cols=244 Identities=24% Similarity=0.420 Sum_probs=207.3
Q ss_pred hhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChh
Q 003114 541 TILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLE 619 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 619 (846)
+.||+|+.|.||.|+. .+++.||||++........+-+.+|+.+|+..+|+|||.+++.+..++++++|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 4699999999999984 578899999998776666677899999999999999999999998889999999999999999
Q ss_pred hhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccccc
Q 003114 620 EYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699 (846)
Q Consensus 620 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~ 699 (846)
+.+.... +++.++..|+.++++||+||| ..+|+|||||.+|||++.++.+||+|||++..+.... ......+
T Consensus 359 DvVt~~~---~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~KR~TmV 430 (550)
T KOG0578|consen 359 DVVTKTR---MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--SKRSTMV 430 (550)
T ss_pred hhhhccc---ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc--Ccccccc
Confidence 9998765 899999999999999999999 9999999999999999999999999999998775432 2445678
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHH
Q 003114 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWK 779 (846)
Q Consensus 700 gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~ 779 (846)
||+.|||||+.....|..|+||||||++++||+-|++||-....-..+. ++......++-.+. .....
T Consensus 431 GTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly-----LIa~ng~P~lk~~~-------klS~~ 498 (550)
T KOG0578|consen 431 GTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGTPKLKNPE-------KLSPE 498 (550)
T ss_pred CCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH-----HHhhcCCCCcCCcc-------ccCHH
Confidence 9999999999999999999999999999999999999998643322221 12222222222222 23346
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 780 AVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 780 l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+.+++.+||+.|+++||+++|+++.
T Consensus 499 ~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 499 LKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHHHHhhcchhcCCCHHHHhcC
Confidence 7899999999999999999999864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=345.51 Aligned_cols=256 Identities=26% Similarity=0.409 Sum_probs=204.3
Q ss_pred hhhhhhcCcCceEEEEEEEE------cCCcEEEEEEeCCCC-chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeE
Q 003114 537 NDFETILGEGSFGKVYHGYL------DDNTEVAVKMLSPSS-RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~L 608 (846)
..+.+.||+|+||.||+|+. +++..||||+++... ....+.+.+|+.+++.+ +||||++++++|..++..++
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 45568999999999999974 245689999997543 33456788999999999 89999999999999999999
Q ss_pred eeecccCCChhhhhhcCC--------------------------------------------------------------
Q 003114 609 IYEYMANGSLEEYLSDSN-------------------------------------------------------------- 626 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~-------------------------------------------------------------- 626 (846)
||||+++|+|.++++...
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 999999999999986432
Q ss_pred -----------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 627 -----------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 627 -----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
...+++..+.+++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++...........
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 124788899999999999999999 899999999999999999999999999999865432222222
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
....++..|+|||.+.+..++.++|||||||++|||++ |+.||........+.+++. .+... .. +.
T Consensus 274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~----~~~~~--~~-------~~ 340 (375)
T cd05104 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK----EGYRM--LS-------PE 340 (375)
T ss_pred CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH----hCccC--CC-------CC
Confidence 23345678999999999999999999999999999998 8899876544333333222 11100 00 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
....++.+++.+|++.+|++||++.||+++|++.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1234688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.64 Aligned_cols=250 Identities=36% Similarity=0.600 Sum_probs=198.4
Q ss_pred hhhhcCcCceEEEEEEEEc-----CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 539 FETILGEGSFGKVYHGYLD-----DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.+.||.|.||.||+|.+. .+..|+||.++... ....+++.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3467999999999999986 35779999997643 33478899999999999999999999999988889999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.+++.......+++.++.+|+.|+++||.||| +.+++|+||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999885556999999999999999999999 789999999999999999999999999999876322222
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
...........|+|||.+....++.++||||||+++|||++ |+.|+....... +.... .++....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~----~~~~~-~~~~~~~--------- 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE----IIEKL-KQGQRLP--------- 225 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH----HHHHH-HTTEETT---------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccc-cccccce---------
Confidence 23334457788999999999889999999999999999999 688987654322 22222 2221111
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
.+......+.+++..||..+|++||+|+++++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1122345688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=346.20 Aligned_cols=255 Identities=28% Similarity=0.419 Sum_probs=210.3
Q ss_pred hhhcCcCceEEEEEEEEcC--C---cEEEEEEeCC---CCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 540 ETILGEGSFGKVYHGYLDD--N---TEVAVKMLSP---SSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~--g---~~VAVK~l~~---~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
.+.||+|+||.||+|++.. + ..||||..+. ......+++.+|+++|++++|||||+++|++.....+++|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 4789999999999999753 2 2389999885 346677899999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
+|.||+|.++|+..+. .++..++++++.++|.||+||| ++++|||||.++|+|++.++.+||+|||+++.-. .
T Consensus 242 l~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~---~ 314 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS---Q 314 (474)
T ss_pred ecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCc---c
Confidence 9999999999998765 4999999999999999999999 9999999999999999999999999999987532 1
Q ss_pred ccccc-cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 692 SHLST-GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 692 ~~~~~-~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
..... ...-+..|+|||.+....++.++|||||||++||+++ |..||.+....... .+ +...+. .
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~-~k---I~~~~~---------r 381 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK-AK---IVKNGY---------R 381 (474)
T ss_pred eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH-HH---HHhcCc---------c
Confidence 11111 2235678999999999999999999999999999998 78899876543221 11 112211 1
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETA 814 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~ 814 (846)
-..+...+..+..+..+|+..+|++||+|.++.+.|+.+.....+
T Consensus 382 ~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 382 MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 112234556778888899999999999999999999998766554
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.64 Aligned_cols=254 Identities=23% Similarity=0.373 Sum_probs=204.0
Q ss_pred HhhhhhhcCcCceEEEEEEEEc----CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 536 TNDFETILGEGSFGKVYHGYLD----DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
...+.+.||+|+||.||+|.+. .+..||+|.++... ......+.+|+..+++++||||+++++++..++..++||
T Consensus 6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 85 (266)
T cd05064 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVT 85 (266)
T ss_pred HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEE
Confidence 3456688999999999999863 35689999998653 333457889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+++|+|.+++.... ..+++.+++.++.|++.||+||| +.+++||||||+||+++.++.+|++|||.+.......
T Consensus 86 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 86 EYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999997654 24899999999999999999999 8999999999999999999999999999876532211
Q ss_pred cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
........++..|+|||.+.+..++.++|||||||+++|+++ |+.||........+ .. ...+.. .
T Consensus 162 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~----~~-~~~~~~-----~--- 227 (266)
T cd05064 162 -IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI----KA-VEDGFR-----L--- 227 (266)
T ss_pred -hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH----HH-HHCCCC-----C---
Confidence 111112345678999999998999999999999999999875 99999765433221 11 111110 0
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
..+......+.+++.+|++.+|++||+++||.+.|+++
T Consensus 228 -~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11223445788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=342.95 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=203.7
Q ss_pred HhhhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeee
Q 003114 536 TNDFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIG 607 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 607 (846)
...+.+.||+|+||.||+|+.. ++..||+|++.... ......+.+|+.+++.+ +|+||++++++|...+..+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 3445688999999999998842 34579999997543 33446688999999999 8999999999999999999
Q ss_pred EeeecccCCChhhhhhcCC-------------------------------------------------------------
Q 003114 608 LIYEYMANGSLEEYLSDSN------------------------------------------------------------- 626 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~------------------------------------------------------------- 626 (846)
+||||+++|+|.+++....
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 9999999999999985421
Q ss_pred -------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccccc
Q 003114 627 -------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699 (846)
Q Consensus 627 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~ 699 (846)
...+++.++++++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++...............
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 123788889999999999999999 8999999999999999999999999999998653322222222334
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHH
Q 003114 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAW 778 (846)
Q Consensus 700 gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~ 778 (846)
++..|+|||++.+..++.++|||||||++|||++ |+.||........+... ...+. .+.. +.....
T Consensus 276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~----~~~~~-----~~~~----~~~~~~ 342 (374)
T cd05106 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM----VKRGY-----QMSR----PDFAPP 342 (374)
T ss_pred CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH----HHccc-----CccC----CCCCCH
Confidence 5678999999988899999999999999999997 99999765433222221 11110 0000 111235
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 779 KAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 779 ~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
.+.+++.+|++.+|++||++.+|+++|++++
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 6889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=335.80 Aligned_cols=270 Identities=24% Similarity=0.403 Sum_probs=224.4
Q ss_pred HHHHHHHHhhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCch-hhHHHHHHHHHHHhcccccceeEeeEeecCCeee
Q 003114 529 YAEITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQ-GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIG 607 (846)
Q Consensus 529 ~~el~~~t~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 607 (846)
..|.-....-|.+.||+|.||.|..+..+.+..||||+++..... ..++|.+|+++|.+++||||++++|.|..++.++
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 344444555678899999999999999988899999999987544 4589999999999999999999999999999999
Q ss_pred EeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCC
Q 003114 608 LIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP 687 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~ 687 (846)
+|+|||++|+|.+++.++....+.-....+|+.|||.||+||. +.+++||||.++|+|+|.++++||+|||.++.+-
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999999887655667778899999999999999 9999999999999999999999999999999776
Q ss_pred CCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 003114 688 IEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765 (846)
Q Consensus 688 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt--G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 765 (846)
..+..+.....+-+.+|||+|.+..++++.++|||+||+.+||+++ ...||....++..... ...+........
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven-~~~~~~~~~~~~--- 764 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN-AGEFFRDQGRQV--- 764 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh-hhhhcCCCCcce---
Confidence 6666666666777899999999999999999999999999999865 6889876654432221 111221111111
Q ss_pred CCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 766 PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 766 ~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
...-+..++.++.+++.+||..+-++||+++++...|.+.
T Consensus 765 ---~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 ---VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1112445677899999999999999999999999998763
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.03 Aligned_cols=254 Identities=27% Similarity=0.457 Sum_probs=207.5
Q ss_pred HhhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 536 TNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
...+.+.||+|++|.||+|...+++.||+|.++.... ..+++.+|+.++++++|+||+++++++...+..++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY 85 (261)
T ss_pred heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccC
Confidence 3455688999999999999988888999999976532 346788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++.......+++..+..++.+++.||.||| +.+|+||||||+||++++++.+||+|||+++...... ....
T Consensus 86 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 161 (261)
T cd05068 86 GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAR 161 (261)
T ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc-cccc
Confidence 99999998766556899999999999999999999 8899999999999999999999999999998764221 1111
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....+..|+|||+..+..++.++||||||++++||++ |+.||........+.. ....... ....
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~~~~~~~----------~~~~ 227 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ----VDQGYRM----------PCPP 227 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHcCCCC----------CCCC
Confidence 22233467999999998899999999999999999999 9999976543222211 1111100 1112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
.....+.+++.+|++.+|++||+++++++.|+++
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 2345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=333.17 Aligned_cols=242 Identities=27% Similarity=0.424 Sum_probs=208.7
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.||+|.||.||||+-+ +.+.||+|.+.+.. .+..+.+.+|+++++.++||||+.++++|+...+.++|.||+.|
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g- 85 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG- 85 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence 468999999999999965 67889999997653 44567799999999999999999999999999999999999976
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|..+|..... +++++...|+.+++.||.||| +.+|+|||+||+|||++.++.+|+||||+|+.+.. .....+
T Consensus 86 ~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vlt 158 (808)
T KOG0597|consen 86 DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVLT 158 (808)
T ss_pred hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--Cceeee
Confidence 99999987654 999999999999999999999 99999999999999999999999999999998643 355667
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
.+.||+-|||||+..++.|+..+|+||+||++|||++|++||-. ..+.+.++....+. -. .+...
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a----~si~~Lv~~I~~d~--------v~---~p~~~ 223 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA----RSITQLVKSILKDP--------VK---PPSTA 223 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH----HHHHHHHHHHhcCC--------CC---Ccccc
Confidence 78999999999999999999999999999999999999999964 33455555444332 11 11233
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
...+++++...+.+||..|.+..+++..
T Consensus 224 S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 224 SSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred cHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 4467899999999999999999998764
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.05 Aligned_cols=253 Identities=28% Similarity=0.485 Sum_probs=210.9
Q ss_pred hhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 537 NDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
..+.+.||.|+||.||+|...++..+|+|.+.........++.+|+.+++.++|+||+++++++...+..++||||++++
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG 87 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence 44568899999999999999889999999998776656678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.......+++.++.+++.+++.||.||| +.+|+||||||+||++++++.+||+|||++....... ....
T Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~--~~~~ 162 (261)
T cd05148 88 SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLSS 162 (261)
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc--cccc
Confidence 9999998766666899999999999999999999 8899999999999999999999999999998653321 1122
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
...++..|+|||......++.++||||||++++||++ |+.||......+.+.. ...... ...+..
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~----~~~~~~----------~~~~~~ 228 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ----ITAGYR----------MPCPAK 228 (261)
T ss_pred CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH----HHhCCc----------CCCCCC
Confidence 3346778999999988889999999999999999998 8999976543222211 111110 111223
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
....+.+++.+|++.+|++|||++++++.|+.+
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 229 CPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=336.23 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=205.3
Q ss_pred hhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCC----Cc-hhhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEe
Q 003114 537 NDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS----SR-QGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV 609 (846)
+.+.+.||+|.||.|+.|.. .++..||+|++... .. ...+.+.+|+.+++.++ ||||++++.++......++|
T Consensus 19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~iv 98 (370)
T KOG0583|consen 19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIV 98 (370)
T ss_pred eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEE
Confidence 44567899999999999985 47899999977654 12 23456778999999998 99999999999999999999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC-CcEEEEeccCCccCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ-FQARLADFGLSKTFPI 688 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-~~vkI~DFGla~~~~~ 688 (846)
|||+.+|+|.+++.+.+. +.+..+.+++.|++.|++||| +++|+||||||+|||++.+ +++||+|||++....
T Consensus 99 mEy~~gGdL~~~i~~~g~--l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 99 MEYCSGGDLFDYIVNKGR--LKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred EEecCCccHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999998443 888999999999999999999 9999999999999999999 999999999998763
Q ss_pred CCcccccccccCCCcccCccccccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--ccccc
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTFR-LT-EKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--IKNIV 764 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~~-~s-~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--~~~~~ 764 (846)
.........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||++......... +..+. +...+
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-----i~~~~~~~p~~~ 246 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-----IRKGEFKIPSYL 246 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-----HhcCCccCCCCc
Confidence 2334556789999999999999877 76 789999999999999999999987443222211 22221 11111
Q ss_pred CCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 765 DPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 765 d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
+ ..++..++.+|+..+|.+|+++.+|+ .-.-+.
T Consensus 247 ~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 247 L-----------SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred C-----------CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 0 45678999999999999999999998 444433
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=326.61 Aligned_cols=248 Identities=23% Similarity=0.308 Sum_probs=200.2
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++++++|+||+++.+++..++..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence 346799999999999996 578999999986542 2233467889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++...... ..
T Consensus 84 ~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~ 157 (285)
T cd05631 84 GGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ET 157 (285)
T ss_pred CCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---Ce
Confidence 999998887655445899999999999999999999 899999999999999999999999999999865322 12
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||................ .... ..+..
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~----------~~~~~ 226 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV-KEDQ----------EEYSE 226 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh-hccc----------ccCCc
Confidence 234568999999999999999999999999999999999999998655432222221111 1110 01122
Q ss_pred HHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPN-----MNRVVM 803 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPs-----m~eVl~ 803 (846)
.....+.+|+.+|++.+|++||+ ++++++
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 23346789999999999999997 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=320.40 Aligned_cols=252 Identities=27% Similarity=0.440 Sum_probs=205.8
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.+.||+|+||.||+|... .++.||+|.+.... ...+++.+|+++++.++|+||+++++++..++..++||||++++
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (263)
T cd05052 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 87 (263)
T ss_pred EEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence 44578999999999999975 58889999987543 34567889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.......+++..++.++.|+++||+||| +.+++||||||+||++++++.+||+|||++........ ....
T Consensus 88 ~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~ 163 (263)
T cd05052 88 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHA 163 (263)
T ss_pred cHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-eccC
Confidence 9999998766556899999999999999999999 88999999999999999999999999999986533211 1111
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
...++..|+|||.+.+..++.++|||||||+++||++ |..||......+ ...... .+ .....+..
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~~~~~~-~~---------~~~~~~~~ 229 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLE-KG---------YRMERPEG 229 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHH-CC---------CCCCCCCC
Confidence 2234668999999998899999999999999999998 899987543222 222111 11 11111223
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
....+.+++.+|++.+|++||++.++.++|+++
T Consensus 230 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 230 CPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=323.10 Aligned_cols=253 Identities=28% Similarity=0.490 Sum_probs=205.5
Q ss_pred hhhhhcCcCceEEEEEEEEcC-C-----cEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLDD-N-----TEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~-g-----~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
.+.+.||+|+||.||+|.... + ..||+|.+.... ......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence 445789999999999998643 2 579999987543 334567899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCC--------------CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEE
Q 003114 611 EYMANGSLEEYLSDSNA--------------DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQAR 676 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vk 676 (846)
||+++|+|.+++..... ..+++..++.++.|++.||.||| +.+++||||||+||++++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCcEE
Confidence 99999999999975421 45788999999999999999999 88999999999999999999999
Q ss_pred EEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHH
Q 003114 677 LADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFML 755 (846)
Q Consensus 677 I~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~ 755 (846)
|+|||+++...............+++.|+|||.+.+..++.++|||||||+++||++ |+.||......+ +... +
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-~~~~----i 239 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-VIEM----I 239 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH----H
Confidence 999999986543332233334456888999999988899999999999999999998 999997654322 2111 2
Q ss_pred hcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 756 AQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 756 ~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
..+... ..+......+.+|+.+|++.+|.+||+++||++.|++
T Consensus 240 ~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 RSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 122111 1123345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.32 Aligned_cols=262 Identities=27% Similarity=0.439 Sum_probs=205.6
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHh--cccccceeEeeEeecCC----eeeEeee
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRT--VHHKNLTTLYGYCNEGN----QIGLIYE 611 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~g~~~~~~----~~~LV~E 611 (846)
.+.++||+|+||.||||.++ ++.||||++..... +.|++|-.+.+. ++|+||+++++.-..+. +++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 34578999999999999995 48999999975543 566777666654 58999999999876655 8999999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccC------CCCeeecCCCCCCEEECCCCcEEEEeccCCcc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC------KPPRVHRDIKPANILLNDQFQARLADFGLSKT 685 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~IiHrDlKp~NILld~~~~vkI~DFGla~~ 685 (846)
|.++|+|.++|+.+- ++|....+|+..+++||+|||+.. +++|+|||||++||||.+|+++.|+|||+|..
T Consensus 289 fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 289 FHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999999764 899999999999999999999654 77899999999999999999999999999999
Q ss_pred CCCCCcccccccccCCCcccCccccccCC------CCchhhHHHHHHHHHHHHhCCCCCC--------C-----cccccc
Q 003114 686 FPIEGVSHLSTGVAGTFGYLDPEYCQTFR------LTEKSDVYSFGVVLLEIITSRPAIA--------N-----TEEHKH 746 (846)
Q Consensus 686 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~------~s~ksDVwS~Gvvl~ELltG~~p~~--------~-----~~~~~~ 746 (846)
+..........+.+||.+|||||++.+.. .-.+.||||+|.|||||+++-..++ . ...+..
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 87555555555688999999999997653 2247899999999999998643321 1 112233
Q ss_pred HHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 747 ISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 747 l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
+.+....+.+++.-..+-|.... ...+..+.+.+..||+.||+.|.|+.=|-+.+.++..
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 44433344444333333332221 2456678899999999999999999999888877553
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=319.66 Aligned_cols=251 Identities=28% Similarity=0.485 Sum_probs=205.6
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++..++..++||||+++++
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 9 KLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87 (261)
T ss_pred EEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence 34578999999999999988888999999875432 35678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++.......+++.+++.++.|++.||+||| +.+++||||||+||++++++.+||+|||++....... ......
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 163 (261)
T cd05072 88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREG 163 (261)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCc-eeccCC
Confidence 999998765556899999999999999999999 8899999999999999999999999999998653221 111223
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..++..|+|||+.....++.++|||||||++|||+| |+.||........... . ..+.. ... ....
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~-~~~~~-----~~~----~~~~ 229 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA----L-QRGYR-----MPR----MENC 229 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH----H-HcCCC-----CCC----CCCC
Confidence 346778999999988889999999999999999998 9999975443322111 1 11110 001 1123
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
...+.+++.+|+..+|++||+++++.+.|++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 230 PDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 3568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=321.42 Aligned_cols=256 Identities=29% Similarity=0.483 Sum_probs=206.9
Q ss_pred HHhhhhhhcCcCceEEEEEEEEcC------CcEEEEEEeCCCCch-hhHHHHHHHHHHHhcccccceeEeeEeecCCeee
Q 003114 535 ITNDFETILGEGSFGKVYHGYLDD------NTEVAVKMLSPSSRQ-GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIG 607 (846)
Q Consensus 535 ~t~~f~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 607 (846)
.+..+.+.||+|+||.||+|...+ +..||+|.++..... ..+.+.+|+++++.++|+||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 345566889999999999998643 478999999765444 4578999999999999999999999999999999
Q ss_pred EeeecccCCChhhhhhcCC------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcE
Q 003114 608 LIYEYMANGSLEEYLSDSN------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQA 675 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~v 675 (846)
+||||+++++|.+++.... ...+++.++..++.|++.|+.||| +.+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 9999999999999997543 234788999999999999999999 8899999999999999999999
Q ss_pred EEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHH
Q 003114 676 RLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFM 754 (846)
Q Consensus 676 kI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~ 754 (846)
||+|||+++...............++..|+|||++.+..++.++|||||||+++||++ |+.||......... . ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~-~---~~ 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI-E---CI 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-H---HH
Confidence 9999999976532222222233446788999999999999999999999999999998 99998765433221 1 11
Q ss_pred HhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 755 LAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 755 ~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
..+.... .+......+.+++.+|++.+|++||+++||++.|++
T Consensus 238 -~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 -TQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1221111 112234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=323.58 Aligned_cols=256 Identities=27% Similarity=0.472 Sum_probs=209.1
Q ss_pred hhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 539 FETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (291)
T cd05094 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEY 88 (291)
T ss_pred EeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEec
Confidence 4568999999999999842 3456899998876666667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCC--------------CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEE
Q 003114 613 MANGSLEEYLSDSNA--------------DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLA 678 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~ 678 (846)
+++++|.+++..... ..+++..+++++.|++.||+||| +.+|+||||||+||++++++.+||+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEEC
Confidence 999999999975431 24889999999999999999999 8999999999999999999999999
Q ss_pred eccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhc
Q 003114 679 DFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQ 757 (846)
Q Consensus 679 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~ 757 (846)
|||+++...............++..|+|||++.+..++.++|||||||+++||+| |+.||........+ .. ...
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~----~~-~~~ 240 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI----EC-ITQ 240 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HH-HhC
Confidence 9999976543322223334556788999999998899999999999999999999 99998765433211 11 122
Q ss_pred CCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 758 GDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 758 ~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
+..... .......+.+++.+|++.+|++||++++|+++|+++...
T Consensus 241 ~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 241 GRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 211111 112345788999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.31 Aligned_cols=258 Identities=28% Similarity=0.457 Sum_probs=208.9
Q ss_pred hhhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 537 NDFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
..+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++||
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 86 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 345678999999999999852 34568999998766666678999999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCC-----------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEe
Q 003114 611 EYMANGSLEEYLSDSN-----------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLAD 679 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~D 679 (846)
||+++++|.+++.... ...+++.+++.++.|++.||+||| +.+++||||||+||++++++.+||+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEecc
Confidence 9999999999997543 224899999999999999999999 89999999999999999999999999
Q ss_pred ccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcC
Q 003114 680 FGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQG 758 (846)
Q Consensus 680 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~ 758 (846)
||+++...............++..|+|||.+.+..++.++|||||||+++||++ |++||........+.. ...+
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~-----i~~~ 238 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC-----ITQG 238 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcC
Confidence 999986533222222233445778999999998899999999999999999998 8999876543332221 1222
Q ss_pred CcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 759 DIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 759 ~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
.... . .......+.+++.+|++.+|.+||+++||.+.|+++...
T Consensus 239 ~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 239 RVLQ-----R----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CcCC-----C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1111 1 112234689999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.90 Aligned_cols=248 Identities=25% Similarity=0.448 Sum_probs=201.4
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||.||++.++++..+|+|.+.... ...+++.+|+.++++++||||+++++++..++..++||||+++|+
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred EEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 3456799999999999999888899999986443 234678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.++++.... .+++..+..++.+++.||+||| +.+|+||||||+||++++++.+||+|||+++...... ......
T Consensus 86 L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~~~~ 160 (256)
T cd05114 86 LLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSG 160 (256)
T ss_pred HHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-eeccCC
Confidence 9999976443 4889999999999999999999 8999999999999999999999999999987653221 111122
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..++..|+|||.+....++.++||||||++++||++ |+.||......+.+. ....... ...+. ..
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~----~i~~~~~---~~~~~-------~~ 226 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE----MISRGFR---LYRPK-------LA 226 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHCCCC---CCCCC-------CC
Confidence 345678999999988889999999999999999999 899997654332222 1111111 11111 12
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
...+.+++.+|++.+|++||+++|+++.|
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 34688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.21 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=198.6
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
+.||+|+||.||+|... +++.+|+|.+.... ......+.+|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999974 78899999886543 33456789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~ 698 (846)
.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99997644 24889999999999999999999 899999999999999999999999999998764321111111112
Q ss_pred cCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHH
Q 003114 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSA 777 (846)
Q Consensus 699 ~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~ 777 (846)
..+..|+|||.+.+..++.++|||||||+++||++ |..||........ .. ..... .....+....
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-~~----~~~~~---------~~~~~~~~~~ 222 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-RE----AIEQG---------VRLPCPELCP 222 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-HH----HHHcC---------CCCCCcccCC
Confidence 33567999999998889999999999999999998 8888865432211 11 11111 0011122234
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 778 WKAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 778 ~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
..+.+++.+|++.+|++||+++||.++|+
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 57889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.28 Aligned_cols=253 Identities=25% Similarity=0.449 Sum_probs=204.8
Q ss_pred hhhhhcCcCceEEEEEEEEcC----CcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLDD----NTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|++.. ...||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 86 (266)
T cd05033 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEY 86 (266)
T ss_pred eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEc
Confidence 456789999999999999742 4579999987543 33456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++++|.+++..... .+++.++.+++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++........
T Consensus 87 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 87 MENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred CCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 999999999976543 4899999999999999999999 899999999999999999999999999999876422222
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.......++..|+|||.+.+..++.++||||||++++||++ |+.||....... + ..... .+... .
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-~---~~~~~-~~~~~---------~ 228 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-V---IKAVE-DGYRL---------P 228 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-H---HHHHH-cCCCC---------C
Confidence 22223345678999999998899999999999999999998 999986543222 1 11111 11100 0
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
........+.+++.+|++.+|++||+++||+++|+++
T Consensus 229 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1123345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=336.69 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=204.0
Q ss_pred hhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEe
Q 003114 538 DFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV 609 (846)
.+.+.||+|+||.||+|... .+..||||++..... ...+.+.+|+++++++. ||||++++++|.+....++|
T Consensus 40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv 119 (400)
T cd05105 40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYII 119 (400)
T ss_pred ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEE
Confidence 34578999999999999852 234699999975433 33467899999999996 99999999999999999999
Q ss_pred eecccCCChhhhhhcCC---------------------------------------------------------------
Q 003114 610 YEYMANGSLEEYLSDSN--------------------------------------------------------------- 626 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~--------------------------------------------------------------- 626 (846)
|||+++|+|.+++....
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (400)
T cd05105 120 TEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASK 199 (400)
T ss_pred EEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhh
Confidence 99999999999886431
Q ss_pred -------------------------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcE
Q 003114 627 -------------------------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQA 675 (846)
Q Consensus 627 -------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~v 675 (846)
...+++..+.+++.|++.||+||| +.+|+||||||+|||+++++.+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~~~ 276 (400)
T cd05105 200 YSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIV 276 (400)
T ss_pred hhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCCEE
Confidence 124778888999999999999999 8999999999999999999999
Q ss_pred EEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHH
Q 003114 676 RLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFM 754 (846)
Q Consensus 676 kI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~ 754 (846)
||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||........+.. .
T Consensus 277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~----~ 352 (400)
T cd05105 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN----K 352 (400)
T ss_pred EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH----H
Confidence 9999999986533222222233456788999999988889999999999999999997 8999875433222221 1
Q ss_pred HhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 755 LAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 755 ~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
...+.. . ..+......+.+++.+|++.+|++||++.+|.++|++++.
T Consensus 353 ~~~~~~-----~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 353 IKSGYR-----M----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HhcCCC-----C----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111110 0 1112334578899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=333.01 Aligned_cols=241 Identities=24% Similarity=0.328 Sum_probs=197.4
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.||+|+||.||+++.. +|+.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999864 78899999997532 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~ 153 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCccc
Confidence 9999997654 3899999999999999999999 899999999999999999999999999998753221 12233
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
...||+.|+|||.+.+..++.++||||+||+++||++|+.||...+..... .... .+. .. ++...
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~----~~~~-~~~------~~----~p~~~ 218 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELIL-MEE------IR----FPRTL 218 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH----HHHH-cCC------CC----CCCCC
Confidence 457999999999999989999999999999999999999999765432211 1111 111 11 11223
Q ss_pred HHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRP-----NMNRVVM 803 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~ 803 (846)
...+.+++.+|++.+|++|| +++++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 34678999999999999999 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=328.55 Aligned_cols=258 Identities=27% Similarity=0.430 Sum_probs=203.8
Q ss_pred hhhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhc-ccccceeEeeEeec-CCeee
Q 003114 537 NDFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNE-GNQIG 607 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~-~~~~~ 607 (846)
..+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++ +|+||++++++|.. +...+
T Consensus 9 ~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~ 88 (337)
T cd05054 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (337)
T ss_pred hhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEE
Confidence 455688999999999999742 34789999987543 33345678899999999 89999999998764 45788
Q ss_pred EeeecccCCChhhhhhcCC-----------------------------------------------------------CC
Q 003114 608 LIYEYMANGSLEEYLSDSN-----------------------------------------------------------AD 628 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~-----------------------------------------------------------~~ 628 (846)
+++||+++++|.+++.... ..
T Consensus 89 ~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (337)
T cd05054 89 VIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKE 168 (337)
T ss_pred EEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhc
Confidence 9999999999999986432 12
Q ss_pred ccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccccCCCcccCcc
Q 003114 629 VLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE 708 (846)
Q Consensus 629 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE 708 (846)
.++|..+.+++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.+.............++..|+|||
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 5889999999999999999999 8999999999999999999999999999998764322222223345677899999
Q ss_pred ccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhc
Q 003114 709 YCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGC 787 (846)
Q Consensus 709 ~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~C 787 (846)
++.+..++.++|||||||+++||++ |+.||......+.+.. ....+... ..+......+.+++.+|
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~~l~~~c 312 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR----RLKEGTRM---------RAPEYATPEIYSIMLDC 312 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHH----HHhccCCC---------CCCccCCHHHHHHHHHH
Confidence 9999999999999999999999998 9999976443332222 11111110 01112335688999999
Q ss_pred cCCCCCCCCCHHHHHHHHHHhhh
Q 003114 788 VSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 788 l~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
++.+|++||++.||+++|++++.
T Consensus 313 l~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 313 WHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=327.12 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=202.5
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCc----EEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNT----EVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
...+.||+|+||.||+|++. ++. .||+|.++... ....+++.+|+.+++.++||||++++++|... ...+|+|
T Consensus 10 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e 88 (316)
T cd05108 10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ 88 (316)
T ss_pred eeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeee
Confidence 34568999999999999864 333 48999987543 34456788999999999999999999999764 5679999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+++|+|.+++..... .+++..+++++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 89 ~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 89 LMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred cCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 9999999999987543 3889999999999999999999 89999999999999999999999999999987643322
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
........++..|+|||++.+..++.++|||||||++|||++ |+.||.+..... +.. ....+...
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~----~~~~~~~~--------- 230 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISS----ILEKGERL--------- 230 (316)
T ss_pred ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHH----HHhCCCCC---------
Confidence 222223345678999999999999999999999999999998 999997543221 111 11111100
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
..+......+.+++.+|+..+|++||++.+++..|..+....
T Consensus 231 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 001123346789999999999999999999999998875433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=329.32 Aligned_cols=239 Identities=26% Similarity=0.321 Sum_probs=194.1
Q ss_pred cCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 543 LGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 543 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
||+|+||.||+|+.. +++.||+|++... .......+.+|+.++++++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 6889999998643 233446678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~ 698 (846)
.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~ 153 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTF 153 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccccc
Confidence 99997654 3899999999999999999999 899999999999999999999999999999754221 1223345
Q ss_pred cCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHH
Q 003114 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAW 778 (846)
Q Consensus 699 ~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~ 778 (846)
.||+.|+|||.+.+..++.++||||+||+++||++|+.||....... ........ .. . .+.....
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~----~~~~~~~~-~~------~----~~~~~~~ 218 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE----MYRKILQE-PL------R----FPDGFDR 218 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH----HHHHHHcC-CC------C----CCCcCCH
Confidence 79999999999999899999999999999999999999997654322 22222211 10 1 1112234
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 779 KAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 779 ~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+.+++.+|++.+|++||++.++.+
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 6789999999999999986544333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.38 Aligned_cols=253 Identities=26% Similarity=0.470 Sum_probs=202.7
Q ss_pred hhhhhcCcCceEEEEEEEE-----cCCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 538 DFETILGEGSFGKVYHGYL-----DDNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
.+.+.||+|+||.||+|.. ..+..||+|.+.... ......+.+|+.+++.++||||+++++++..+...++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 87 (283)
T cd05090 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFE 87 (283)
T ss_pred eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEE
Confidence 4567899999999999984 246789999997543 3344678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCC---------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEE
Q 003114 612 YMANGSLEEYLSDSN---------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQAR 676 (846)
Q Consensus 612 y~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vk 676 (846)
|+++++|.+++.... ...+++.+.+.++.|++.||.||| +.+|+||||||+|||+++++.+|
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCcEE
Confidence 999999999985322 234788999999999999999999 88999999999999999999999
Q ss_pred EEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHH
Q 003114 677 LADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFML 755 (846)
Q Consensus 677 I~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~ 755 (846)
|+|||+++...............++..|+|||++.+..++.++|||||||+++||++ |..||....... +.+ ..
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~-~~~----~~ 239 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-VIE----MV 239 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHH----HH
Confidence 999999986543332233334456778999999988889999999999999999998 999986543221 111 11
Q ss_pred hcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 756 AQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 756 ~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
..+... ..+......+.+++.+|++.+|++||++.+|.++|+.
T Consensus 240 ~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111 0112234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.93 Aligned_cols=288 Identities=26% Similarity=0.411 Sum_probs=230.2
Q ss_pred HHHHHHhhhhhhcCcCceEEEEEEEEcC-CcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEe
Q 003114 531 EITKITNDFETILGEGSFGKVYHGYLDD-NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 531 el~~~t~~f~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV 609 (846)
|++.......++||.|.||.||.|.|+. .-.||||.++... ...++|.+|..+|+.++|||+|+|+|.|..+..+|+|
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 3333333346789999999999999975 5579999997654 4568999999999999999999999999999999999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
+|||..|+|.++|++.+...++....+.++.||+.||+||. .+++|||||.++|+|+.++..+||+|||+++.+..+
T Consensus 342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99999999999999988888888889999999999999999 999999999999999999999999999999987433
Q ss_pred CcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
......+..-...|.|||.+....++.|+|||+|||+|||+.| |..||.+.+.. + +..++ ....
T Consensus 419 -TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS----q-VY~LL---------Ekgy 483 (1157)
T KOG4278|consen 419 -TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----Q-VYGLL---------EKGY 483 (1157)
T ss_pred -ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH----H-HHHHH---------hccc
Confidence 2222333445678999999999999999999999999999998 78888765422 1 11122 2222
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhhhc-CCCCCCCCCCCccccccccC
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARKE-GHRFGSGDQSGRMMTLNLTS 837 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~~~-~~~~~~~~~~~~~~~~~~~~ 837 (846)
+-+.+..++.++.+|+..||+.+|.+||++.|+-+.+|.+.....-..+ ....+...-+++|+|+..-.
T Consensus 484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisdEV~keLgk~~~~~sv~~l~~lp 553 (1157)
T KOG4278|consen 484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISDEVQKELGKNNDKKSVVPLPRLP 553 (1157)
T ss_pred cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccHHHHHHHhhcccccccccccccc
Confidence 3334567888999999999999999999999999999988654332221 11223333356676654443
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=321.68 Aligned_cols=262 Identities=25% Similarity=0.424 Sum_probs=210.0
Q ss_pred HhhhhhhcCcCceEEEEEEEEc--------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCe
Q 003114 536 TNDFETILGEGSFGKVYHGYLD--------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQ 605 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 605 (846)
...+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.....
T Consensus 16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (304)
T cd05101 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 95 (304)
T ss_pred HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence 3445678999999999999741 24579999987542 34456789999999999 89999999999999999
Q ss_pred eeEeeecccCCChhhhhhcCC--------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC
Q 003114 606 IGLIYEYMANGSLEEYLSDSN--------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND 671 (846)
Q Consensus 606 ~~LV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~ 671 (846)
.++||||+++|+|.+++.... ...+++.+++.++.|++.||.||| +.+|+||||||+||++++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili~~ 172 (304)
T cd05101 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTE 172 (304)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEEcC
Confidence 999999999999999997642 234788899999999999999999 889999999999999999
Q ss_pred CCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHH
Q 003114 672 QFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQW 750 (846)
Q Consensus 672 ~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~ 750 (846)
++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||..... .++
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~ 248 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----EEL 248 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----HHH
Confidence 99999999999987643322222333456778999999988889999999999999999998 7888865432 222
Q ss_pred HHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 003114 751 VDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETA 814 (846)
Q Consensus 751 ~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~ 814 (846)
......... . .........+.+++.+|++.+|++||+|.||++.|++++.....
T Consensus 249 ~~~~~~~~~-~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 249 FKLLKEGHR-M---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred HHHHHcCCc-C---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 222221111 0 11123445788999999999999999999999999999987665
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=326.18 Aligned_cols=257 Identities=23% Similarity=0.319 Sum_probs=200.1
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
..+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (331)
T cd06649 9 RISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 88 (331)
T ss_pred EEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence 3467999999999999975 68889999987653 334567899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCC-CeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKP-PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
+|.+++.... .+++..+..++.|++.||.||| +. +|+||||||+|||+++++.+||+|||++...... ..
T Consensus 89 ~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~ 159 (331)
T cd06649 89 SLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA 159 (331)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc----cc
Confidence 9999997654 3889999999999999999999 54 6999999999999999999999999998765321 22
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcc--c-----------
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIK--N----------- 762 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~--~----------- 762 (846)
....|+..|+|||++.+..++.++|||||||++|||++|+.||......+ +..........+... .
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCcccccccc
Confidence 34568999999999998899999999999999999999999997544221 111111100000000 0
Q ss_pred ---------------------ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 763 ---------------------IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 763 ---------------------~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
+................+.+++.+|++.+|++|||++|+++.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000000011235688999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=328.65 Aligned_cols=241 Identities=25% Similarity=0.336 Sum_probs=196.8
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.||+|+||.||+++.. +|..||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999964 7899999999754 2234456778999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|..++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~ 153 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccc
Confidence 9999887654 3899999999999999999999 899999999999999999999999999998753221 12223
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .. +.. . ++...
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~----~~-~~~------~----~p~~~ 218 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI----LM-EEI------R----FPRTL 218 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH----hc-CCC------C----CCCCC
Confidence 457899999999999889999999999999999999999999765433222211 11 110 1 11123
Q ss_pred HHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRP-----NMNRVVM 803 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~ 803 (846)
...+.+++.+|++.+|++|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 34678999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=325.72 Aligned_cols=242 Identities=23% Similarity=0.372 Sum_probs=198.2
Q ss_pred hhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCc---hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 541 TILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSR---QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
..||+|+||.||.|+- ++|..+|+|++++... ...+..+.|-.+|....+|.||+|+..|++.+++||||||++||
T Consensus 147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGG 226 (550)
T KOG0605|consen 147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGG 226 (550)
T ss_pred eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCc
Confidence 5799999999999995 4799999999987743 34456788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC-------
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE------- 689 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~------- 689 (846)
++..+|...+. |++..+..++.+++.|++.+| +.|+|||||||+|+|||..|++||+||||+.-+...
T Consensus 227 D~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~ 301 (550)
T KOG0605|consen 227 DMMTLLMRKDT--LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYR 301 (550)
T ss_pred cHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhc
Confidence 99999988764 899999999999999999999 999999999999999999999999999998643110
Q ss_pred ---------------Ccc------cc-----------------cccccCCCcccCccccccCCCCchhhHHHHHHHHHHH
Q 003114 690 ---------------GVS------HL-----------------STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEI 731 (846)
Q Consensus 690 ---------------~~~------~~-----------------~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~EL 731 (846)
... .. ....+|||.|+|||++.+..|+..+|.||+|||+|||
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEm 381 (550)
T KOG0605|consen 302 LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEM 381 (550)
T ss_pred chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHH
Confidence 000 00 0124799999999999999999999999999999999
Q ss_pred HhCCCCCCCccccc---cHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCC---HHHHH
Q 003114 732 ITSRPAIANTEEHK---HISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPN---MNRVV 802 (846)
Q Consensus 732 ltG~~p~~~~~~~~---~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPs---m~eVl 802 (846)
+.|.+||......+ .+..|...+..+. ......+..+|+.+|+. +|++|.. ++||.
T Consensus 382 LvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 382 LVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 99999998765433 3444443332221 11122567899999999 9999986 44443
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.16 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=201.4
Q ss_pred hhhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEe
Q 003114 537 NDFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV 609 (846)
..+.+.||+|+||.||+|... .+..||+|++.... .....++.+|+.+++.++|+||+++++++..+...++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence 344678999999999999853 24679999986543 23445788999999999999999999999999999999
Q ss_pred eecccCCChhhhhhcCC--------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEecc
Q 003114 610 YEYMANGSLEEYLSDSN--------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFG 681 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFG 681 (846)
|||+++|+|.+++.... ...+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~dfg 164 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG 164 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEECCCC
Confidence 99999999999987532 123678889999999999999999 8899999999999999999999999999
Q ss_pred CCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCc
Q 003114 682 LSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDI 760 (846)
Q Consensus 682 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~ 760 (846)
+++...............++..|+|||++.+..++.++|||||||+++||++ |..||....... ...... .+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~----~~~~~~-~~~~ 239 (277)
T cd05062 165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ----VLRFVM-EGGL 239 (277)
T ss_pred CccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHH-cCCc
Confidence 9876533222222222345788999999998889999999999999999999 688887554322 122111 1111
Q ss_pred ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 761 ~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
.. .+......+.+++.+|++.+|++||++.|+++.|++
T Consensus 240 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 240 LD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11 112234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=319.29 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=202.7
Q ss_pred hhhhhhcCcCceEEEEEEEEcC---------------CcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEe
Q 003114 537 NDFETILGEGSFGKVYHGYLDD---------------NTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYC 600 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~---------------g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 600 (846)
..+.+.||+|+||.||++...+ ...||+|.++.. .......+.+|++++++++|+|++++++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 86 (295)
T cd05097 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVC 86 (295)
T ss_pred CeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence 4456789999999999987532 224899998764 333456789999999999999999999999
Q ss_pred ecCCeeeEeeecccCCChhhhhhcCC----------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC
Q 003114 601 NEGNQIGLIYEYMANGSLEEYLSDSN----------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN 670 (846)
Q Consensus 601 ~~~~~~~LV~Ey~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld 670 (846)
...+..++||||+++++|.+++.... ...+++..+++++.|++.||.||| +.+++||||||+||+++
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 87 VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVG 163 (295)
T ss_pred cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEEEc
Confidence 99999999999999999999986532 123688999999999999999999 89999999999999999
Q ss_pred CCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCccccccHH
Q 003114 671 DQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRPAIANTEEHKHIS 748 (846)
Q Consensus 671 ~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt--G~~p~~~~~~~~~l~ 748 (846)
+++.+||+|||++................++..|+|||......++.++|||||||+++||++ |..||........+.
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 243 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence 999999999999976543322222233445778999999988889999999999999999998 567776654433333
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 749 QWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 749 ~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
.........+..... .........+.+++.+|++.+|++||+|++|++.|++
T Consensus 244 ~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 244 NTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 222211111110001 0111233578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=331.81 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=204.0
Q ss_pred hhhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeE
Q 003114 537 NDFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~L 608 (846)
..+.+.||+|+||.||+|++. .++.||+|+++.... ...+.+.+|+.++.++. ||||++++++|...+..++
T Consensus 39 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~i 118 (401)
T cd05107 39 LVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYI 118 (401)
T ss_pred eehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEE
Confidence 345678999999999999863 346799999976532 23457889999999997 9999999999999999999
Q ss_pred eeecccCCChhhhhhcCCC-------------------------------------------------------------
Q 003114 609 IYEYMANGSLEEYLSDSNA------------------------------------------------------------- 627 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~------------------------------------------------------------- 627 (846)
|+||+++|+|.++++....
T Consensus 119 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (401)
T cd05107 119 ITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGT 198 (401)
T ss_pred EEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhh
Confidence 9999999999999965321
Q ss_pred -----------------------------------CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC
Q 003114 628 -----------------------------------DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ 672 (846)
Q Consensus 628 -----------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~ 672 (846)
..+++....+++.|++.||+||| +.+|+||||||+|||++++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeCC
Confidence 23677788999999999999999 8999999999999999999
Q ss_pred CcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHH
Q 003114 673 FQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWV 751 (846)
Q Consensus 673 ~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~ 751 (846)
+.+||+|||+++...............++..|+|||.+....++.++|||||||+++||++ |+.||......+.+..
T Consensus 276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~-- 353 (401)
T cd05107 276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN-- 353 (401)
T ss_pred CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH--
Confidence 9999999999986532221112223456788999999988889999999999999999998 8899875443222211
Q ss_pred HHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 752 DFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 752 ~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
....+. ....+......+.+++.+|+..+|++||+++||++.|++++
T Consensus 354 --~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 354 --AIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --HHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111111 00111223457889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=341.48 Aligned_cols=250 Identities=20% Similarity=0.296 Sum_probs=203.2
Q ss_pred hhhhhhcCcCceEEEEEEEEc-C-CcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 537 NDFETILGEGSFGKVYHGYLD-D-NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~-g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.+.||+|+||.||+|... + +..||+|.+..........+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 445678999999999999854 3 67889998766555555678889999999999999999999999999999999999
Q ss_pred CCChhhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 615 NGSLEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 615 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+|+|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988643 2335888999999999999999999 899999999999999999999999999999876433222
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
.......||++|+|||++.+..++.++|||||||+++||++|+.||....... ....... +... + .
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~----~~~~~~~-~~~~----~-----~ 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE----IMQQVLY-GKYD----P-----F 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHh-CCCC----C-----C
Confidence 23345679999999999999899999999999999999999999997654322 2222221 1111 0 1
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+......+.+++.+|+..+|++||++.+++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1122346889999999999999999999865
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=320.73 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=206.0
Q ss_pred hhhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeE
Q 003114 537 NDFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~L 608 (846)
..+.+.||+|+||.||++... .+..||+|+++... ....+.+.+|+.+++++ +|+||+++++++...+..++
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 445678999999999999742 34579999987553 33456788999999999 79999999999999999999
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
||||+.+|+|.++++......+++.++..++.+++.||.||| +.+|+|+||||+|||+++++.+|++|||+++....
T Consensus 117 v~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 999999999999998655455899999999999999999999 88999999999999999999999999999986643
Q ss_pred CCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCC
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
...........++..|+|||.+.+..++.++||||+||+++||++ |+.||............ ...+..
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~----~~~~~~------- 262 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL----IKEGYR------- 262 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH----HHcCCc-------
Confidence 322112223346778999999998889999999999999999998 99998765433322221 111110
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
..........+.+++.+|+..+|++||++.|+++.|++.
T Consensus 263 --~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 --MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 001112234788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=317.22 Aligned_cols=254 Identities=23% Similarity=0.401 Sum_probs=203.6
Q ss_pred hhhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCCch-hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEe
Q 003114 537 NDFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSSRQ-GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV 609 (846)
..+.+.||+|+||.||+|... ++..||+|+++..... ..+.+.+|+.++..++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 455678999999999999863 2478999999755433 345688999999999999999999999999999999
Q ss_pred eecccCCChhhhhhcCC--------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcE
Q 003114 610 YEYMANGSLEEYLSDSN--------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQA 675 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~v 675 (846)
+||+.+++|.+++.... ...+++..+.+++.|++.||.||| +.+|+||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence 99999999999985321 224788889999999999999999 8999999999999999999999
Q ss_pred EEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHH
Q 003114 676 RLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFM 754 (846)
Q Consensus 676 kI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~ 754 (846)
||+|||+++...............+++.|+|||.+....++.++|||||||+++||++ |..||...... ++....
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~~i 239 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----DVIEMI 239 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH
Confidence 9999999886543322222333456789999999988889999999999999999998 88888764432 222222
Q ss_pred HhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 755 LAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 755 ~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
. .+... ..+.+....+.+++..|++.+|++||++++|++.|+.
T Consensus 240 ~-~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 R-NRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H-cCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2 11111 1122345568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=324.09 Aligned_cols=241 Identities=25% Similarity=0.350 Sum_probs=197.5
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 84 (291)
T cd05612 5 RIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVP 84 (291)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCC
Confidence 4578999999999999975 68899999986432 2334568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----- 154 (291)
T cd05612 85 GGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----- 154 (291)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----
Confidence 999999997654 3889999999999999999999 899999999999999999999999999999865321
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....|++.|+|||.+.+..++.++|||||||+++||++|+.||....... ....... +.. . ++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----~~~~i~~-~~~------~----~~~ 219 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG----IYEKILA-GKL------E----FPR 219 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHh-CCc------C----CCc
Confidence 223568999999999998889999999999999999999999997654322 1222211 111 1 111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPN-----MNRVVME 804 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPs-----m~eVl~~ 804 (846)
.....+.+++.+|++.+|.+||+ ++|+++.
T Consensus 220 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 220 HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 12346789999999999999995 6666644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.28 Aligned_cols=259 Identities=20% Similarity=0.258 Sum_probs=198.6
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07848 5 VLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK 84 (287)
T ss_pred EEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCC
Confidence 4568999999999999985 67889999987542 23346678999999999999999999999999999999999998
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
+.+..+.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....... ....
T Consensus 85 ~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (287)
T cd07848 85 NMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANY 158 (287)
T ss_pred CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cccc
Confidence 7776554432 34889999999999999999999 8999999999999999999999999999998753221 1122
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHH-----------HHHhcCCccccc
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVD-----------FMLAQGDIKNIV 764 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~-----------~~~~~~~~~~~~ 764 (846)
....|++.|+|||++.+..++.++|||||||+++||++|++||......+.+..... ............
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 345689999999999988899999999999999999999999986543332222111 000000000110
Q ss_pred CCCCCCC------CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 765 DPKLHGD------IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 765 d~~L~~~------~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+..... ........+.+++.+|++.+|++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111000 00112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.23 Aligned_cols=243 Identities=27% Similarity=0.468 Sum_probs=206.1
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
+.||+|.||.||||... .++.||+|++.-. .....+.+++|+.+|..++++||.+++|.+..+..++++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 67999999999999964 6888999999755 445567899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~ 698 (846)
.+.++.... +++....-|++++..|+.||| ..+.+|||||+.|||+..+|.+|++|||.+..+... ......+
T Consensus 99 ~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~rr~tf 171 (467)
T KOG0201|consen 99 LDLLKSGNI--LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VKRRKTF 171 (467)
T ss_pred hhhhccCCC--CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech--hhccccc
Confidence 999987653 577888889999999999999 899999999999999999999999999999876432 2233668
Q ss_pred cCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHH
Q 003114 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAW 778 (846)
Q Consensus 699 ~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~ 778 (846)
.||+.|||||+++...|+.|+||||+|++.+||.+|.+|+........+.- +..-..|.|.+ ....
T Consensus 172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl----------Ipk~~PP~L~~----~~S~ 237 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL----------IPKSAPPRLDG----DFSP 237 (467)
T ss_pred cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe----------ccCCCCCcccc----ccCH
Confidence 899999999999988999999999999999999999999986554222111 12223344443 3445
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 779 KAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 779 ~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.+.+++..|++++|+.||++.++++.
T Consensus 238 ~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 238 PFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 68899999999999999999998763
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=312.07 Aligned_cols=251 Identities=29% Similarity=0.491 Sum_probs=203.2
Q ss_pred hhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 537 NDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
..+.+.||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++|||++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~ 85 (260)
T cd05070 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKG 85 (260)
T ss_pred hhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCC
Confidence 345678999999999999988888999999976433 34678999999999999999999998854 5688999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.++++......+++.++..++.+++.||+||| +.+|+||||||+||++++++.++|+|||++..+.... .....
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 161 (260)
T cd05070 86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQ 161 (260)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc-ccccc
Confidence 9999998765556899999999999999999999 8899999999999999999999999999997653321 11112
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
...++..|+|||+..+..++.++||||||++++||++ |++||......+.. .... .+. ....+..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~----~~~~-~~~---------~~~~~~~ 227 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL----EQVE-RGY---------RMPCPQD 227 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHH-cCC---------CCCCCCc
Confidence 2345678999999988889999999999999999999 89999764432212 1111 110 0111223
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
....+.+++.+|+..+|++|||+.++.+.|++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 34578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=313.20 Aligned_cols=254 Identities=28% Similarity=0.432 Sum_probs=199.3
Q ss_pred hhhhcCcCceEEEEEEEEcCC-c--EEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecC------Ceee
Q 003114 539 FETILGEGSFGKVYHGYLDDN-T--EVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG------NQIG 607 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~~g-~--~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~ 607 (846)
+.+.||+|+||.||+|...+. . .+|+|.++.. .....+.+.+|+.+++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 457899999999999997543 2 5899988754 334456788999999999999999999987432 3578
Q ss_pred EeeecccCCChhhhhhcC----CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCC
Q 003114 608 LIYEYMANGSLEEYLSDS----NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLS 683 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla 683 (846)
+|+||+++|+|.+++... ....+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 999999999999987432 2345889999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCccc
Q 003114 684 KTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKN 762 (846)
Q Consensus 684 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 762 (846)
+.+.............+++.|+|||+..+..++.++|||||||++|||++ |+.||...... +..... ..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~~-~~~~~~~ 234 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS----EIYDYL-RQGNRLK 234 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH-HcCCCCC
Confidence 87643222112223346778999999998899999999999999999999 78999754332 122222 2221111
Q ss_pred ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 763 IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 763 ~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
........+.+++.+|++.+|++|||+.++++.|++++
T Consensus 235 ---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 235 ---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11223456889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.69 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=201.2
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++..++||||+++++++..++..++||||++
T Consensus 5 ~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (333)
T cd05600 5 ILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVP 84 (333)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCC
Confidence 4568999999999999976 58899999997542 2334567889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..... .
T Consensus 85 g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~ 154 (333)
T cd05600 85 GGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----Y 154 (333)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----c
Confidence 999999997654 3889999999999999999999 89999999999999999999999999999976432 2
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+...... ... ..+..........
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~----~~~---~~~~~~~~~~~~~ 227 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK----YWK---ETLQRPVYDDPRF 227 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH----hcc---ccccCCCCCcccc
Confidence 334578999999999998899999999999999999999999997654332222111 100 0000000000011
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.....+.+++.+|+..+|++||+++|+++.
T Consensus 228 ~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 228 NLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.34 Aligned_cols=255 Identities=28% Similarity=0.430 Sum_probs=203.6
Q ss_pred hhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 539 FETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
+.+.||+|+||.||+|... ....+++|.+..... ...+++.+|+.+++.++||||+++++.+..++..++|+|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 4568999999999999853 235689998875533 345678899999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCC----------------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE
Q 003114 612 YMANGSLEEYLSDSN----------------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL 669 (846)
Q Consensus 612 y~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl 669 (846)
|+.+|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+|||+
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheEEE
Confidence 999999999986421 234789999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHH
Q 003114 670 NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHIS 748 (846)
Q Consensus 670 d~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~ 748 (846)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||....... +.
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~ 239 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-LF 239 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH-HH
Confidence 9999999999999986533322222233456778999999988889999999999999999998 999996543221 22
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 749 QWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 749 ~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
++ ...+. ....+......+.+++.+|++.+|++||++.|+++.|++++.
T Consensus 240 ~~----~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 240 NL----LKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HH----HhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 21 11110 111112234578899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=298.97 Aligned_cols=245 Identities=27% Similarity=0.397 Sum_probs=210.0
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
++.+.||+|.||.||.|+.+ ++-.||+|++.+.. ....+++.+|+++-..++||||+++++||.+....+|++||.
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 45689999999999999975 56779999997553 334578999999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
.+|+|...|++.....+++.....+..|+|.||.|+| .+++|||||||+|+|++..+..||+|||-+..-+ ..
T Consensus 105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~ 177 (281)
T KOG0580|consen 105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SN 177 (281)
T ss_pred CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC----CC
Confidence 9999999999877777999999999999999999999 9999999999999999999999999999886532 33
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.....+||..|.+||...+..++.++|+|++|++.+|++.|.+||......+...++.+. ++.+|
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--------~~~~p------- 242 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--------DLKFP------- 242 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--------cccCC-------
Confidence 445678999999999999999999999999999999999999999877654444433221 12222
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
........+++.+|+..+|.+|.+..||++.
T Consensus 243 ~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2233467899999999999999999998764
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=316.20 Aligned_cols=254 Identities=21% Similarity=0.328 Sum_probs=200.7
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCC-----eeeEeeecc
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN-----QIGLIYEYM 613 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-----~~~LV~Ey~ 613 (846)
.+++|.|+||.||+|.+. +++.||||+.-...+ --.+|+++|++++|||||+|+.+|.... ...+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 368999999999999965 578999999865533 2357899999999999999999885432 456899999
Q ss_pred cCCChhhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC-CcEEEEeccCCccCCCCC
Q 003114 614 ANGSLEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ-FQARLADFGLSKTFPIEG 690 (846)
Q Consensus 614 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-~~vkI~DFGla~~~~~~~ 690 (846)
+. +|.+.++.. ..+.++...+.-+..|+.+||.||| +.+|+||||||+|+|+|.+ +.+||||||.|+.+...
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~- 179 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG- 179 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC-
Confidence 86 999999852 2334777788889999999999999 8999999999999999966 99999999999987433
Q ss_pred cccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcC-------Ccc-
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG-------DIK- 761 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~-------~~~- 761 (846)
........|..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|.+.+..+.+.++++.+-.+. ...
T Consensus 180 --epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 180 --EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred --CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 223445678899999988765 699999999999999999999999999887778887776532211 111
Q ss_pred -cccCCCCCCC-----CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 762 -NIVDPKLHGD-----IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 762 -~~~d~~L~~~-----~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+...+.+... .......+.++++.+++..+|.+|.++.|++..
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 2222222211 233455678999999999999999999988753
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=312.77 Aligned_cols=253 Identities=28% Similarity=0.461 Sum_probs=204.4
Q ss_pred hhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 537 NDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
..+.+.||+|+||.||+|+.++...||+|++..... ..+++.+|+.+++.++|+||+++++++.+ ...++||||+++|
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~ 85 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 85 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCC
Confidence 456778999999999999987777899999975432 34578999999999999999999998754 5678999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.......+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||.++.+..... ....
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~~~ 161 (262)
T cd05071 86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQ 161 (262)
T ss_pred cHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-cccc
Confidence 9999998755556899999999999999999999 89999999999999999999999999999976543221 1122
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
...++..|+|||+..+..++.++|||||||+++||+| |+.||......... ... ..+. .. ....+
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~----~~~-~~~~-----~~----~~~~~ 227 (262)
T cd05071 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL----DQV-ERGY-----RM----PCPPE 227 (262)
T ss_pred CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH----HHH-hcCC-----CC----CCccc
Confidence 3446778999999988889999999999999999999 88888755432211 111 1110 00 11223
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
....+.+++.+|++.+|++||++.++.+.|++..
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 4567889999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=310.99 Aligned_cols=247 Identities=23% Similarity=0.403 Sum_probs=197.9
Q ss_pred hcCcCceEEEEEEEE---cCCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 542 ILGEGSFGKVYHGYL---DDNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~---~~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.||+|+||.||+|.+ +++..+|+|+++... ....+++.+|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 357889999986543 234567899999999999999999999886 45678999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc-cc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH-LS 695 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~-~~ 695 (846)
+|.+++.... .+++..+.+++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999997644 3889999999999999999999 8999999999999999999999999999998664322111 11
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
....++..|+|||.+....++.++|||||||+++||++ |+.||....... +... +..+... ..+.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~-i~~~~~~---------~~~~ 221 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE----VTQM-IESGERM---------ECPQ 221 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH-HHCCCCC---------CCCC
Confidence 22334678999999988889999999999999999998 999997654322 2222 2221111 1122
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
.....+.+++.+|++.+|++||++.+|++.|+++
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 2345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=312.09 Aligned_cols=254 Identities=29% Similarity=0.453 Sum_probs=206.2
Q ss_pred HHHhhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 534 KITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 534 ~~t~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
..+..+.+.||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 345566788999999999999998899999999875543 3467899999999999999999999874 45689999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++++|.+++.......+++.++..++.|++.||+||| +.+++||||||+||++++++.++|+|||++....... ..
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YT 158 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-cc
Confidence 9999999998766566899999999999999999999 8999999999999999999999999999997654221 11
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
......++..|+|||++....++.++||||||++++||++ |+.||........ ..... .+. .. ..
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~~~~-~~~-----~~----~~ 224 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV----IQNLE-RGY-----RM----PR 224 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH----HHHHH-cCC-----CC----CC
Confidence 2223446778999999988889999999999999999999 9999976543221 11111 110 00 11
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
.......+.+++.+|++.+|++||+++++.+.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11233568999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=307.91 Aligned_cols=247 Identities=24% Similarity=0.383 Sum_probs=200.2
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChh
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLE 619 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 619 (846)
++||+|+||.||+|...++..+|+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999876543 23446889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccccc
Q 003114 620 EYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699 (846)
Q Consensus 620 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~ 699 (846)
+++..... .+++..+..++.+++.+|.||| +.+++||||||+||++++++.+||+|||++...... .........
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKKD-ELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG-IYSSSGLKQ 155 (250)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccc-ccccCCCCC
Confidence 99876543 4789999999999999999999 899999999999999999999999999998754221 111112224
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHH
Q 003114 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAW 778 (846)
Q Consensus 700 gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~ 778 (846)
++..|+|||+..+..++.++||||||++++||++ |+.||......... .. ...+.. .........
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~----~~-~~~~~~---------~~~~~~~~~ 221 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR----EQ-VEKGYR---------MSCPQKCPD 221 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH----HH-HHcCCC---------CCCCCCCCH
Confidence 4678999999998899999999999999999998 99999755432211 11 111110 011122345
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 779 KAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 779 ~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
.+.+++.+|+..+|++||++.|++++|.
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 7889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.95 Aligned_cols=241 Identities=25% Similarity=0.349 Sum_probs=197.2
Q ss_pred hcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 542 ILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.||+|+||.||+++.. +++.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 6899999999999964 6899999999754 23345677889999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++..... ......
T Consensus 82 L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~ 154 (328)
T cd05593 82 LFFHLSRER--VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKT 154 (328)
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccccc
Confidence 999887654 3899999999999999999999 899999999999999999999999999998753211 122234
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSA 777 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~ 777 (846)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ...... +. ..+ +....
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~----~~~~~~-~~------~~~----p~~~~ 219 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILM-ED------IKF----PRTLS 219 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH----HHHhcc-CC------ccC----CCCCC
Confidence 5799999999999988999999999999999999999999976543221 111111 10 111 11223
Q ss_pred HHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 003114 778 WKAVEIAMGCVSHSSTPRP-----NMNRVVME 804 (846)
Q Consensus 778 ~~l~~L~~~Cl~~~P~~RP-----sm~eVl~~ 804 (846)
..+.+++.+|++.+|++|| ++.|+++.
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 4678999999999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=331.96 Aligned_cols=243 Identities=23% Similarity=0.369 Sum_probs=205.5
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+++.||+|+.|.|..|++ .+|+.+|||++.+.. ......+++|+.+|+.+.|||++++++.+.+..++|+|.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 456899999999999995 589999999997652 2234568999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|.|.+++-.+++ +++.++.+++.||+.|+.|+| ..+|+|||+||+|+|||..+++||+|||+|..-. ....
T Consensus 96 gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~gkl 167 (786)
T KOG0588|consen 96 GGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV---PGKL 167 (786)
T ss_pred CchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeeccc---CCcc
Confidence 9999999988775 899999999999999999999 9999999999999999999999999999997532 2344
Q ss_pred cccccCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQTFRLT-EKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s-~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
....||++.|.|||++.+.+|. .++||||+|||||-|+||+.||++......+ .. +..|.. +.+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LL----lK-V~~G~f----------~MP 232 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLL----LK-VQRGVF----------EMP 232 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHH----HH-HHcCcc----------cCC
Confidence 5567999999999999998875 6899999999999999999999854433322 22 222211 112
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.....+..+|+.+|+..||+.|.|++||.+.
T Consensus 233 s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 233 SNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 3334467899999999999999999999875
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=312.38 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=201.4
Q ss_pred hhhhcCcCceEEEEEEEEcC----CcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCe------e
Q 003114 539 FETILGEGSFGKVYHGYLDD----NTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQ------I 606 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~------~ 606 (846)
+.+.||+|+||.||+|.... +..||+|+++... ......+.+|+..++.++|+||+++++++...+. .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 45789999999999998642 3679999987542 3345678999999999999999999998866544 7
Q ss_pred eEeeecccCCChhhhhhcC----CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccC
Q 003114 607 GLIYEYMANGSLEEYLSDS----NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGL 682 (846)
Q Consensus 607 ~LV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGl 682 (846)
++|+||+++|+|.+++... ....+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCccc
Confidence 9999999999999998543 2335899999999999999999999 88999999999999999999999999999
Q ss_pred CccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcc
Q 003114 683 SKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIK 761 (846)
Q Consensus 683 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~ 761 (846)
++...............++..|+|||++.+..++.++|||||||+++||++ |.+||......+ +......... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~----~~~~~~~~~~-~ 234 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE----IYDYLRHGNR-L 234 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHcCCC-C
Confidence 987643322222222345678999999988889999999999999999999 889987544322 2222221111 1
Q ss_pred cccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 762 NIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 762 ~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
..+......+.+++.+|++.+|++||++.||++.|+++
T Consensus 235 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 235 ---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11223445789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=318.37 Aligned_cols=259 Identities=23% Similarity=0.376 Sum_probs=196.3
Q ss_pred hhhhhcCcCceEEEEEEEEc--CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhc---ccccceeEeeEee-----cCCe
Q 003114 538 DFETILGEGSFGKVYHGYLD--DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTV---HHKNLTTLYGYCN-----EGNQ 605 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~-----~~~~ 605 (846)
.+.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.+++.+ +||||++++++|. ....
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~ 83 (290)
T cd07862 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 83 (290)
T ss_pred ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCc
Confidence 34568999999999999863 46889999986542 22234556677777665 6999999999885 3456
Q ss_pred eeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCcc
Q 003114 606 IGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685 (846)
Q Consensus 606 ~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~ 685 (846)
.++||||+. ++|.+++.......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 84 LTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred EEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 899999996 69999998766556899999999999999999999 89999999999999999999999999999976
Q ss_pred CCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcC--Ccc--
Q 003114 686 FPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG--DIK-- 761 (846)
Q Consensus 686 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~--~~~-- 761 (846)
.... .......|++.|+|||.+....++.++|||||||++|||++|++||......+.+...+....... ...
T Consensus 160 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 160 YSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred ccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 5322 223345689999999999888899999999999999999999999987665444444332211000 000
Q ss_pred -----cccCCCCCC---CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 762 -----NIVDPKLHG---DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 762 -----~~~d~~L~~---~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+.+.-.. ....+....+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000000 000122345679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=319.09 Aligned_cols=255 Identities=25% Similarity=0.453 Sum_probs=204.3
Q ss_pred hhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCC-CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEe
Q 003114 538 DFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPS-SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV 609 (846)
.+.+.||+|+||.||++... ....+|+|.+... .......+.+|+.++.++ +|+||+++++++..++..++|
T Consensus 15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li 94 (293)
T cd05053 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV 94 (293)
T ss_pred EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence 34568999999999999864 2367999998754 233446688999999999 899999999999999999999
Q ss_pred eecccCCChhhhhhcC--------------CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcE
Q 003114 610 YEYMANGSLEEYLSDS--------------NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQA 675 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~v 675 (846)
|||+++|+|.++++.. ....+++..+++++.|++.||+||| +.+|+||||||+||++++++.+
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCCCeE
Confidence 9999999999999642 2345899999999999999999999 8999999999999999999999
Q ss_pred EEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHH
Q 003114 676 RLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFM 754 (846)
Q Consensus 676 kI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~ 754 (846)
||+|||+++.+.............++..|+|||...+..++.++|||||||++|||++ |..||........ ....
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----~~~~ 247 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL----FKLL 247 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH----HHHH
Confidence 9999999987643322222223345678999999988899999999999999999997 8999875442221 1111
Q ss_pred HhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 755 LAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 755 ~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
..+. ....+......+.+++.+|+..+|++|||++|+++.|++++
T Consensus 248 -~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 248 -KEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111 01112233457889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=310.93 Aligned_cols=248 Identities=27% Similarity=0.444 Sum_probs=200.6
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||.||+|..+++..+|+|.+..... ....+.+|+++++.++|+||+++++++...+..++|+||+++++
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred chhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 45678999999999999988778899999865432 23568889999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++..... .+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++...... ......
T Consensus 86 L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~~~ 160 (256)
T cd05059 86 LLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQG 160 (256)
T ss_pred HHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc-ccccCC
Confidence 9999976543 4899999999999999999999 8899999999999999999999999999987653211 111112
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||......+... .. ..+ ... ..+...
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~-~~~-----~~~----~~~~~~ 226 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE----SV-SAG-----YRL----YRPKLA 226 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH----HH-HcC-----CcC----CCCCCC
Confidence 234567999999998899999999999999999999 799997654332211 11 111 010 111123
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
...+.+++.+|+..+|++||+|.|+++.|
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 45789999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.38 Aligned_cols=231 Identities=26% Similarity=0.385 Sum_probs=192.4
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCch---hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQ---GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
...||.|+||.|..++.+ +|..+|+|++++..-. ..+...+|..+|+.+.||.++++.+.|.+.+..+|||||++|
T Consensus 49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G 128 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG 128 (355)
T ss_pred eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence 457999999999999976 6888999999876433 334466799999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|.|..+++..+. +++..+.-+|.+|+.||+||| +..|++|||||+|||+|.+|.+||+|||+|+.... ..
T Consensus 129 GElFS~Lrk~~r--F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-----rT 198 (355)
T KOG0616|consen 129 GELFSYLRKSGR--FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-----RT 198 (355)
T ss_pred ccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC-----cE
Confidence 999999998765 999999999999999999999 99999999999999999999999999999997632 24
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
...+||+.|+|||.++++.+..++|-|||||++|||+.|.+||........... +.++++ .++.-
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~K-----I~~~~v----------~fP~~ 263 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEK-----ILEGKV----------KFPSY 263 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHH-----HHhCcc----------cCCcc
Confidence 568999999999999999999999999999999999999999986654222111 112211 11111
Q ss_pred HHHHHHHHHHhccCCCCCCC
Q 003114 776 SAWKAVEIAMGCVSHSSTPR 795 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~R 795 (846)
....+.+|+...++.|-.+|
T Consensus 264 fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 264 FSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cCHHHHHHHHHHHhhhhHhh
Confidence 22245677777777777777
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=311.75 Aligned_cols=249 Identities=26% Similarity=0.426 Sum_probs=201.6
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||.||+|...++..+|+|.+..... ..+++.+|+.++++++||||+++++++...+..++||||+.+|+
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 44578999999999999988777899999875433 34678999999999999999999999999899999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++..... .+++.++++++.|++.||.||| +.+++|+||||+||++++++.+||+|||+++....... .....
T Consensus 86 l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~ 160 (256)
T cd05113 86 LLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVG 160 (256)
T ss_pred HHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecCC
Confidence 9999976543 4899999999999999999999 89999999999999999999999999999876533211 11222
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..++..|+|||...+..++.++|||||||++|||++ |+.||........ .......... ......
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~----~~~~~~~~~~----------~~~~~~ 226 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET----VEKVSQGLRL----------YRPHLA 226 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH----HHHHhcCCCC----------CCCCCC
Confidence 345678999999988889999999999999999999 9999875443221 1111111110 001112
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
...+.+++.+||+.+|.+||++.++++.|+
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 227 SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 357889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=316.24 Aligned_cols=251 Identities=28% Similarity=0.473 Sum_probs=203.4
Q ss_pred hhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 539 FETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+++++.++|+||+++++++..+...++++||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEec
Confidence 4578999999999999742 3567999998877666677899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCC-------------CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEe
Q 003114 613 MANGSLEEYLSDSNA-------------DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLAD 679 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~D 679 (846)
+++++|.+++..... ..+++..++.++.|++.|++||| +.+++||||||+|||+++++.+||+|
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEEECC
Confidence 999999999976432 34889999999999999999999 89999999999999999999999999
Q ss_pred ccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcC
Q 003114 680 FGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQG 758 (846)
Q Consensus 680 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~ 758 (846)
||+++...............+++.|+|||++.+..++.++|||||||+++||++ |++||......... .... .+
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~----~~~~-~~ 240 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI----ECIT-QG 240 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH----HHHH-cC
Confidence 999976533222222233345788999999998899999999999999999998 89998654432211 1111 11
Q ss_pred CcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 759 DIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 759 ~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
... ..+......+.+++.+|++.+|++||+++||.+.|+
T Consensus 241 ~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 241 REL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 100 011123346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=331.08 Aligned_cols=238 Identities=26% Similarity=0.387 Sum_probs=202.1
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.|..+||+|.||+|+++..+ +++.+|||++++. ..++.+..+.|..++... +||.++.++.+|+..+++++||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 34678999999999999986 6788999999876 345566777888888777 599999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+.||++..+.+. ..+++..+.-++..|+.||+||| +++||+||||.+|||||.+|.+||+|||+++.-. ...
T Consensus 451 ~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--~~g 522 (694)
T KOG0694|consen 451 VAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--GQG 522 (694)
T ss_pred cCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC--CCC
Confidence 999995544443 33899999999999999999999 9999999999999999999999999999999743 234
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
...+.++||+.|||||++.+..|+..+|-|||||+||||+.|+.||.+.++++....++. + +. .+
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~----d----~~-------~y 587 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN----D----EV-------RY 587 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc----C----CC-------CC
Confidence 466789999999999999999999999999999999999999999998877665443221 1 11 23
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
+.....+.++|+.+++.++|++|..+
T Consensus 588 P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 588 PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCcccHHHHHHHHHHhccCcccccCC
Confidence 34445678899999999999999987
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=319.21 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=206.4
Q ss_pred HhhhhhhcCcCceEEEEEEEEc--------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCe
Q 003114 536 TNDFETILGEGSFGKVYHGYLD--------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQ 605 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 605 (846)
...+.+.||+|+||.||+++.. +...+|+|.+.... .....++.+|+.+++.+ +|+||+++++++...+.
T Consensus 19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (307)
T cd05098 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 98 (307)
T ss_pred HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 3456688999999999999852 23569999997642 33456788899999999 79999999999999999
Q ss_pred eeEeeecccCCChhhhhhcCCC--------------CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC
Q 003114 606 IGLIYEYMANGSLEEYLSDSNA--------------DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND 671 (846)
Q Consensus 606 ~~LV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~ 671 (846)
.++||||+++|+|.+++..... ..+++.++++++.|++.||+||| +.+++||||||+||++++
T Consensus 99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTE 175 (307)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEcC
Confidence 9999999999999999976432 34889999999999999999999 899999999999999999
Q ss_pred CCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHH
Q 003114 672 QFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQW 750 (846)
Q Consensus 672 ~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~ 750 (846)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.||..... .+.
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----~~~ 251 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----EEL 251 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH----HHH
Confidence 99999999999876532221111222234568999999988889999999999999999998 8888865432 222
Q ss_pred HHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 751 VDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 751 ~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
.... ..+.. ...+......+.+++.+|+..+|++||+|.+|++.|++++...
T Consensus 252 ~~~~-~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 252 FKLL-KEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHH-HcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 2222 11111 0112233457889999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=316.15 Aligned_cols=266 Identities=26% Similarity=0.397 Sum_probs=202.3
Q ss_pred hhhhhcCcCceEEEEEEEE-----cCCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeec--CCeeeEe
Q 003114 538 DFETILGEGSFGKVYHGYL-----DDNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNE--GNQIGLI 609 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~LV 609 (846)
.+.+.||+|+||+||++.. .++..||+|.+..... .....+.+|+++++.++||||+++++++.. ....++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 3456899999999988653 3577899999876532 345678899999999999999999998765 3468899
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||+++++|.+++.... +++.++..++.|+++||.||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 87 ~e~~~~~~l~~~~~~~~---l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHHcC---CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999997643 899999999999999999999 889999999999999999999999999999866432
Q ss_pred Cccc-ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc-ccHHHHHHHHHhcCCcccccCCC
Q 003114 690 GVSH-LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEH-KHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 690 ~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
.... ......++..|+|||.+....++.++||||||++++||+||+.|+...... .....+...........+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 2111 112234566799999998888999999999999999999999998653311 00110000000001111122222
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
.....+......+.+++.+|++.+|++||++++|++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 222223334568899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=314.73 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=199.3
Q ss_pred hhhhcCcCceEEEEEEEEc-CCc----EEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 539 FETILGEGSFGKVYHGYLD-DNT----EVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.+.||+|+||.||+|.+. +++ .+++|.+.... .....++..|+..++.++||||+++++++.. ...++++||
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~ 89 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQL 89 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEe
Confidence 3468999999999999964 444 47888876443 2344677888889999999999999999864 557889999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.+++..... .+++..+..++.|++.||.||| +.+++||||||+|||+++++.+||+|||+++........
T Consensus 90 ~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 90 SPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred CCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 999999999976543 4899999999999999999999 889999999999999999999999999999865433222
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||....... +.++ ...+... ..+.
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~----~~~~~~~--~~~~---- 234 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDL----LEKGERL--AQPQ---- 234 (279)
T ss_pred cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH----HHCCCcC--CCCC----
Confidence 23334557789999999988889999999999999999998 999997654322 2221 2222111 1111
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
.....+.+++.+|+..+|++||++.|+.+.|+.+.
T Consensus 235 ---~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 235 ---ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred ---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 12345678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=308.70 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=203.0
Q ss_pred hhcCcCceEEEEEEEEcC--C--cEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLDD--N--TEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~--g--~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999999743 3 3689999987665 566789999999999999999999999888 889999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc-cc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS-HL 694 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~-~~ 694 (846)
++|.+++.......+++.....++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++.+...... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998765345899999999999999999999 899999999999999999999999999999876432211 11
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.....++..|+|||++.+..++.++|||||||+++||++ |+.||......+.... ........ ..+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~~~~~~~~---------~~~ 223 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK----IDKEGERL---------ERP 223 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhcCCcC---------CCC
Confidence 223457789999999998899999999999999999999 9999975543322221 11111100 011
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
......+.+++.+|++.+|++||++.+|++.|.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 123457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.66 Aligned_cols=242 Identities=23% Similarity=0.352 Sum_probs=197.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 100 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence 44678999999999999975 68899999986532 233456889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 101 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---- 171 (329)
T PTZ00263 101 VGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---- 171 (329)
T ss_pred CCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC----
Confidence 9999999998654 3788899999999999999999 899999999999999999999999999999865322
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ... +.++... .+
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~-i~~~~~~----------~p 235 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI----YEK-ILAGRLK----------FP 235 (329)
T ss_pred -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH----HHH-HhcCCcC----------CC
Confidence 1235689999999999998999999999999999999999999976443221 111 1122110 11
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPN-----MNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPs-----m~eVl~~ 804 (846)
......+.+++.+|++.+|++||+ ++++++.
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112245789999999999999997 5666643
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=302.83 Aligned_cols=254 Identities=19% Similarity=0.274 Sum_probs=205.2
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCch-h-hHHHHHHHHHHHhcccccceeEeeEeec--CCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQ-G-YEQFEAEVILLRTVHHKNLTTLYGYCNE--GNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-~-~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~LV~Ey~~~ 615 (846)
+.|++|.||.||+|+.+ +++.||+|+++..... + --...+|+.+|.+++|||||.+-..... -+.+++|||||+.
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 57999999999999975 6888999999865322 1 2245789999999999999999988743 4579999999976
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
+|..++..-+ +.+...+...+..|+++|++||| ...|+|||||++|+|+.+.|.+||+|||+|+.+... ....
T Consensus 162 -DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~k~~ 234 (419)
T KOG0663|consen 162 -DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--LKPY 234 (419)
T ss_pred -hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC--cccC
Confidence 8999998766 45888999999999999999999 999999999999999999999999999999987543 3344
Q ss_pred ccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC------
Q 003114 696 TGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL------ 768 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L------ 768 (846)
+..+.|.+|+|||.+.+. .|+...|+||+|||+.||+++++.|.+..+-+.+..+++.+-.+ .+.+-|..
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtP---te~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTP---SEAIWPGYSELPAV 311 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCC---ccccCCCccccchh
Confidence 567789999999988765 59999999999999999999999999999888888877654322 11111111
Q ss_pred -------------CCCCChH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 769 -------------HGDIDVN-SAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 769 -------------~~~~~~~-~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
...+... -.+.-.+|....+..||.+|.|++|.++.
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111111 12455788999999999999999987753
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=309.34 Aligned_cols=251 Identities=27% Similarity=0.464 Sum_probs=202.6
Q ss_pred hhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 537 NDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
..+.+.||+|++|.||+|..+.+..+|+|.+..... ..+.+.+|+.+++.++|+|++++++++.. +..++||||++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~ 85 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKG 85 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCC
Confidence 445678999999999999988777899998865432 34678899999999999999999998754 5688999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.++++......+++..+..++.+++.||.||| +.+++|+||||+||++++++.+||+|||+++...... .....
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~~~~~ 161 (260)
T cd05069 86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQ 161 (260)
T ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-ccccC
Confidence 9999998765556899999999999999999999 8899999999999999999999999999997653221 11122
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
...++..|+|||...+..++.++|||||||+++||++ |+.||......... .+ . ..+.. . .....
T Consensus 162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~---~-~~~~~-----~----~~~~~ 227 (260)
T cd05069 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL-EQ---V-ERGYR-----M----PCPQG 227 (260)
T ss_pred CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HH---H-HcCCC-----C----CCCcc
Confidence 2346778999999988889999999999999999999 89999765433221 11 1 11100 0 11123
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
....+.+++.+|+..+|++||++++|++.|++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 34578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=323.63 Aligned_cols=241 Identities=26% Similarity=0.392 Sum_probs=195.4
Q ss_pred hhcCcCceEEEEEEEE----cCCcEEEEEEeCCC----CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 541 TILGEGSFGKVYHGYL----DDNTEVAVKMLSPS----SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.||+|+||.||+++. ..++.||+|+++.. .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4699999999999985 35788999998753 223345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.+++..... +.+..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 154 (323)
T cd05584 82 LSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--G 154 (323)
T ss_pred CCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--C
Confidence 999999999976543 788888999999999999999 899999999999999999999999999998753221 1
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||........+ ..... +.. . .
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~----~~~~~-~~~------~----~ 219 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI----DKILK-GKL------N----L 219 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH----HHHHc-CCC------C----C
Confidence 2223457899999999999888999999999999999999999999865433222 11111 111 1 1
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRP-----NMNRVVM 803 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~ 803 (846)
+......+.+++.+|++.+|++|| +++++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 112234678999999999999999 7877766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.15 Aligned_cols=248 Identities=22% Similarity=0.288 Sum_probs=198.1
Q ss_pred cCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 543 LGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 543 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
||+|+||.||+++.. +|+.+|+|.+.... ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999965 68999999986432 12234556799999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~ 698 (846)
.+++.......+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++...... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence 99987666556899999999999999999999 899999999999999999999999999998765322 122335
Q ss_pred cCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHH
Q 003114 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAW 778 (846)
Q Consensus 699 ~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~ 778 (846)
.|+..|+|||++.+..++.++||||+||++|||++|+.||...........+....... .. ... ......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~----~~~-----~~~~~~ 224 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-EV----KFE-----HQNFTE 224 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-cc----ccc-----cccCCH
Confidence 68999999999988889999999999999999999999997544322222222221111 11 000 011234
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 779 KAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 779 ~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
.+.+++.+|++.+|++||+++|+++.+.
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 6789999999999999999988765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=314.89 Aligned_cols=258 Identities=21% Similarity=0.363 Sum_probs=197.9
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||++ |
T Consensus 9 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~ 87 (288)
T cd07871 9 KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-S 87 (288)
T ss_pred EeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-c
Confidence 3568999999999999975 68899999987543 2234567889999999999999999999999999999999997 4
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++..... .....
T Consensus 88 ~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~~~~~ 161 (288)
T cd07871 88 DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--TKTYS 161 (288)
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC--Ccccc
Confidence 9999887544 24788999999999999999999 899999999999999999999999999998754321 11223
Q ss_pred cccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc-----------CCccccc
Q 003114 697 GVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ-----------GDIKNIV 764 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~-----------~~~~~~~ 764 (846)
...+++.|+|||.+.+ ..++.++||||+||+++||++|++||......+.+....+..... .......
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence 3567899999998765 568999999999999999999999998765444333322211100 0000011
Q ss_pred CCCCCCCC----ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 765 DPKLHGDI----DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 765 d~~L~~~~----~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+...... ........++++.+|++.+|++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11110000 0112345789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=310.94 Aligned_cols=254 Identities=26% Similarity=0.446 Sum_probs=202.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-CC---cEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DN---TEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g---~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
...+.||+|+||.||+|+.. ++ ..+|+|.+.... ....+.+.+|++++++++|+|++++.+++...+..++||||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY 87 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence 34578999999999999975 33 369999987553 33456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++++|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+||++++++.+||+|||++.........
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 88 MENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 99999999997654 34899999999999999999999 889999999999999999999999999998765322111
Q ss_pred c-ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 693 H-LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 693 ~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
. .......+..|+|||++....++.++|||||||++|||++ |+.||....... +..........
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~----~~~~i~~~~~~---------- 229 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE----VMKAINDGFRL---------- 229 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH----HHHHHhcCCCC----------
Confidence 1 1111223467999999988889999999999999999997 999997544322 22222111110
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
....+....+.+++.+|++.+|++||+|.+|++.|++++
T Consensus 230 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 111233457889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=316.99 Aligned_cols=259 Identities=22% Similarity=0.329 Sum_probs=194.8
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++..++..++||||+.
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~- 86 (303)
T cd07869 8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH- 86 (303)
T ss_pred eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-
Confidence 34578999999999999976 688999999875432 223457789999999999999999999999999999999995
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 87 ~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~ 160 (303)
T cd07869 87 TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--SHTY 160 (303)
T ss_pred cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--CccC
Confidence 68888876543 34888999999999999999999 899999999999999999999999999998754221 1222
Q ss_pred ccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC---cc-----cccCC
Q 003114 696 TGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD---IK-----NIVDP 766 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~---~~-----~~~d~ 766 (846)
....|++.|+|||.+.+ ..++.++||||+||+++||++|+.||....+.....+.+........ .. ...++
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 34568899999998765 45889999999999999999999999865432211111111111000 00 00000
Q ss_pred C-CC--CCCCh-------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 767 K-LH--GDIDV-------NSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 767 ~-L~--~~~~~-------~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
. .. ..... .....+.+++.+|++.+|++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 00 00000 01235679999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=312.88 Aligned_cols=258 Identities=24% Similarity=0.396 Sum_probs=206.5
Q ss_pred HhhhhhhcCcCceEEEEEEEEcC-----CcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeec-CCeeeE
Q 003114 536 TNDFETILGEGSFGKVYHGYLDD-----NTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNE-GNQIGL 608 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~L 608 (846)
...+.+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.+++.++|+||+++++++.. +...++
T Consensus 7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 86 (280)
T cd05043 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFV 86 (280)
T ss_pred heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEE
Confidence 34456889999999999999765 6889999987543 3345678899999999999999999998765 577899
Q ss_pred eeecccCCChhhhhhcCCC------CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccC
Q 003114 609 IYEYMANGSLEEYLSDSNA------DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGL 682 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGl 682 (846)
++||+++++|.+++..... ..+++.+++.++.+++.||+||| +.+++||||||+||++++++.+||+|||+
T Consensus 87 ~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 87 LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred EEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 9999999999999876432 45899999999999999999999 89999999999999999999999999999
Q ss_pred CccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcc
Q 003114 683 SKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIK 761 (846)
Q Consensus 683 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~ 761 (846)
++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||...... ++...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~~~~~ 239 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF----EMAAYLKDGYRLA 239 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH----HHHHHHHcCCCCC
Confidence 986643322222233456778999999988889999999999999999999 99999754322 2222211111110
Q ss_pred cccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 762 NIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 762 ~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
........+.+++.+|+..+|++||++.|+++.|+++..
T Consensus 240 ----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 240 ----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 011233568899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.64 Aligned_cols=248 Identities=23% Similarity=0.416 Sum_probs=197.5
Q ss_pred hcCcCceEEEEEEEEc---CCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 542 ILGEGSFGKVYHGYLD---DNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++|+||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999863 455799999876533 334678999999999999999999998864 57899999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc-ccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH-LST 696 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~-~~~ 696 (846)
|.+++.... ..+++..+++++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.......... ...
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999997543 34899999999999999999999 8899999999999999999999999999997653322111 112
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
...++..|+|||.+....++.++|||||||++|||++ |+.||....... +... ...+.. ...+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~-~~~~~~---------~~~~~~ 222 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE----VMSF-IEQGKR---------LDCPAE 222 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH----HHHH-HHCCCC---------CCCCCC
Confidence 2234578999999988889999999999999999996 999997654322 1111 111111 111223
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
....+.+++.+|+..+|++||++.+|.+.|+..
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.94 Aligned_cols=252 Identities=29% Similarity=0.480 Sum_probs=206.2
Q ss_pred hhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 537 NDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
..+.+.||+|+||.||+|..+++..+|+|.+..... ..+++.+|+.++++++|+||+++++++......++||||++++
T Consensus 8 ~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 86 (261)
T cd05034 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKG 86 (261)
T ss_pred eeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCC
Confidence 345678999999999999988888999999975433 3467899999999999999999999999989999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.......+++..+..++.+++.|+.||| +.+++|+||||+||++++++.+||+|||+++.+.... .....
T Consensus 87 ~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~ 162 (261)
T cd05034 87 SLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTARE 162 (261)
T ss_pred CHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-hhhhh
Confidence 9999998766566899999999999999999999 8899999999999999999999999999987654211 11112
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
...++..|+|||.+.+..++.++||||+||+++||++ |+.||........+.. ...... ...+..
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~~~~~~----------~~~~~~ 228 (261)
T cd05034 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ----VERGYR----------MPRPPN 228 (261)
T ss_pred ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcCCC----------CCCCCC
Confidence 2234568999999998889999999999999999998 9999976543322222 111100 011112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
....+.+++.+|++.+|++||+++++.+.|+.
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 229 CPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 24578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.32 Aligned_cols=240 Identities=23% Similarity=0.323 Sum_probs=192.4
Q ss_pred cCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 543 LGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 543 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
||+|+||+||++... +++.+|+|.+.... ....+.+..|+.+++.++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 78899999986542 22345677899999999999999999999999999999999999999
Q ss_pred hhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 619 EEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 619 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
.+.+... ....+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++..+.... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 9887542 2335899999999999999999999 8999999999999999999999999999997653322 1223
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||.................. + .. ..+...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~--------~~--~~~~~~ 224 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN-D--------SV--TYPDKF 224 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc-c--------CC--CCcccC
Confidence 457899999999999999999999999999999999999999765433222222211111 0 00 112233
Q ss_pred HHHHHHHHHhccCCCCCCCCCH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
...+.+++.+|++.+|++||++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCC
Confidence 4567899999999999999944
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.03 Aligned_cols=249 Identities=31% Similarity=0.500 Sum_probs=205.6
Q ss_pred hhcCcCceEEEEEEEEcC----CcEEEEEEeCCCCch-hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLDD----NTEVAVKMLSPSSRQ-GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||.||+|.... +..|++|.+...... ..+.+.+|++.++.++|+||+++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 368999999999999754 788999999866443 367889999999999999999999999999999999999999
Q ss_pred CChhhhhhcCC-------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 616 GSLEEYLSDSN-------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 616 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
++|.+++.... ...+++.++..++.|+++||+||| +.+++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999998752 245899999999999999999999 89999999999999999999999999999987654
Q ss_pred CCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCC
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
...........++..|+|||.+....++.++||||+||+++||++ |+.||....... ....... +..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~-~~~------- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE----VLEYLRK-GYR------- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHHc-CCC-------
Confidence 332233444567889999999988889999999999999999999 599997664322 2222221 110
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
..........+.+++.+|++.+|++||++.|+++.|+
T Consensus 226 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 --LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111222457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.06 Aligned_cols=249 Identities=26% Similarity=0.449 Sum_probs=197.5
Q ss_pred hhcCcCceEEEEEEEEcC-Cc--EEEEEEeCCC-CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLDD-NT--EVAVKMLSPS-SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~-g~--~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
++||+|+||.||+|..++ +. .+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999753 43 4688888753 334456788999999999 899999999999999999999999999
Q ss_pred CChhhhhhcCC--------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEecc
Q 003114 616 GSLEEYLSDSN--------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFG 681 (846)
Q Consensus 616 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFG 681 (846)
|+|.+++.... ...+++.++..++.|++.||+||| +.+++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999997542 124789999999999999999999 8999999999999999999999999999
Q ss_pred CCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCc
Q 003114 682 LSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDI 760 (846)
Q Consensus 682 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~ 760 (846)
++..... .........+..|+|||++....++.++|||||||+++||++ |+.||....... ...........
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~----~~~~~~~~~~~ 230 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLPQGYRL 230 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH----HHHHHhCCCCC
Confidence 9863211 111111234567999999988889999999999999999997 999996543222 11111111000
Q ss_pred ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 761 ~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
.........+.+++.+|+..+|.+||++.|+++.|++++
T Consensus 231 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 ----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111123346789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=322.82 Aligned_cols=241 Identities=20% Similarity=0.303 Sum_probs=192.9
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 6789999999754 233445677888888776 899999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTT 153 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCcc
Confidence 99999887654 3899999999999999999999 899999999999999999999999999998753221 1222
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----ccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTE----EHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~----~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
....||..|+|||++.+..++.++|||||||+++||++|+.||.... .......+.......+.. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence 34678999999999999999999999999999999999999996321 111222333333322211 1
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
.+......+.+++.+|++.+|++||+.
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 122233467899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=320.69 Aligned_cols=238 Identities=26% Similarity=0.352 Sum_probs=190.6
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||.||+|+.. +++.||+|.++... ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999975 57889999987532 22334455666666654 899999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--~~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--EGKA 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC--CCcc
Confidence 99999997654 3889999999999999999999 899999999999999999999999999999754222 1233
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....||+.|+|||.+.+..++.++|||||||+++||++|+.||.......... .... .. + .++..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~----~i~~-~~------~----~~~~~ 218 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD----SILN-DR------P----HFPRW 218 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHc-CC------C----CCCCC
Confidence 44679999999999998889999999999999999999999998655432221 1111 10 1 11122
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNR 800 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~e 800 (846)
....+.+++.+|++.+|++||++.+
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChH
Confidence 3346789999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=320.03 Aligned_cols=258 Identities=22% Similarity=0.352 Sum_probs=198.8
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+++++.++|+||++++++|..++..++||||++
T Consensus 7 y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (333)
T cd06650 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (333)
T ss_pred hheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCC
Confidence 345678999999999999976 68889999887543 3345678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|.+++..... +++.....++.+++.||.|||+ ..+|+||||||+|||+++++.+||+|||++..+... .
T Consensus 87 ~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~ 158 (333)
T cd06650 87 GGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 158 (333)
T ss_pred CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----c
Confidence 9999999976543 7889999999999999999993 247999999999999999999999999998755221 2
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccc-c---------
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNI-V--------- 764 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~-~--------- 764 (846)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... +........ .+..... .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE-LELMFGCPV-EGDPAESETSPRPRPPGR 236 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH-HHHHhcCcc-cCCccccccCcccCCccc
Confidence 233568999999999998889999999999999999999999997543211 111110000 0000000 0
Q ss_pred -----CCC--------------CC---CCCC-hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 765 -----DPK--------------LH---GDID-VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 765 -----d~~--------------L~---~~~~-~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.+. .. .... .....++.+++.+|++.+|++||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000 00 0000 0122457899999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=337.51 Aligned_cols=257 Identities=22% Similarity=0.318 Sum_probs=210.0
Q ss_pred hhhhhcCcCceEEEEEEEEcCC-cEEEEEEeCCCCchhhHHHHHHHHHHHhcc-cccceeEeeE-eec------CCeeeE
Q 003114 538 DFETILGEGSFGKVYHGYLDDN-TEVAVKMLSPSSRQGYEQFEAEVILLRTVH-HKNLTTLYGY-CNE------GNQIGL 608 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g-~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~-~~~------~~~~~L 608 (846)
.+++.|.+|||+.||.|....+ .++|+|++-..+....+...+|+.+|++|+ |+|||.+++. ... .-+.+|
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 3467899999999999998765 999999998778888999999999999996 9999999993 211 246889
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
.||||++|.|-+++.......|++.++++|+.++++|+.+|| .++++|||||||.+||||+++++.||||||.+.....
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL 198 (738)
T ss_pred ehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence 999999999999998776666999999999999999999999 5588899999999999999999999999999875422
Q ss_pred CCcc--c-----ccccccCCCcccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcC
Q 003114 689 EGVS--H-----LSTGVAGTFGYLDPEYC---QTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG 758 (846)
Q Consensus 689 ~~~~--~-----~~~~~~gt~~Y~APE~~---~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~ 758 (846)
.... . ..-....|+.|+|||.+ .+...++|+|||++||+||-|+....||+....-.
T Consensus 199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------------- 265 (738)
T KOG1989|consen 199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------------- 265 (738)
T ss_pred CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------------
Confidence 1100 0 00123479999999976 56789999999999999999999999998653211
Q ss_pred CcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 759 DIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 759 ~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
+++-...-.-.......+.+||..||+.+|.+||++-||++.+-++....
T Consensus 266 ----Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 266 ----ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ----EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 12211111112356778999999999999999999999999998876443
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.39 Aligned_cols=262 Identities=26% Similarity=0.437 Sum_probs=200.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-----CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeec--CCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD-----DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE--GNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~LV~ 610 (846)
.+.+.||+|+||.||++..+ ++..||+|.+........+.+.+|+++++.++||||+++++++.. ....++|+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 34568999999999999852 578899999987766667789999999999999999999998743 45688999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+++++|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 87 e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 87 EYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EecCCCCHHHHHHhcCc-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 99999999999976532 4899999999999999999999 8999999999999999999999999999998764322
Q ss_pred cccc-cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC-------ccc
Q 003114 691 VSHL-STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD-------IKN 762 (846)
Q Consensus 691 ~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~-------~~~ 762 (846)
.... .....++..|+|||++.+..++.++|||||||+++||++|..++...... +......... +.+
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-----FMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-----hhhhcccccccccchHHHHH
Confidence 2111 11123445699999998888999999999999999999987765432210 0000000000 000
Q ss_pred ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 763 IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 763 ~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
.+...............+.+++.+|+..+|++|||++||+++|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0010000011223345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.84 Aligned_cols=254 Identities=23% Similarity=0.425 Sum_probs=202.7
Q ss_pred hhhhhhcCcCceEEEEEEEEcC-C---cEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 537 NDFETILGEGSFGKVYHGYLDD-N---TEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~-g---~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
.++.+.||+|+||.||+|.... + ..||+|.+... .....+++..|+.+++.++||||+++++++..+...++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 3456789999999999999752 3 36999998754 34456789999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+++++|.+++..... .+++.+++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 86 FMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred cCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 9999999999976543 4899999999999999999999 89999999999999999999999999999876533221
Q ss_pred cccccc-cc--CCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCC
Q 003114 692 SHLSTG-VA--GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 692 ~~~~~~-~~--gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
...... .. .+..|+|||++....++.++|||||||+++||++ |+.||......+ ...++. .....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-~~~~i~---~~~~~------- 230 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-VINAIE---QDYRL------- 230 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-HHHHHH---cCCcC-------
Confidence 111111 11 2457999999998899999999999999999886 999997654322 222211 11000
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
....+.+..+.+++.+|++.+|++||++++|+..|+++
T Consensus 231 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 ---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11123345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=329.15 Aligned_cols=243 Identities=23% Similarity=0.332 Sum_probs=197.9
Q ss_pred hhhhhhcCcCceEEEEEEEEcC--CcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 537 NDFETILGEGSFGKVYHGYLDD--NTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
..+.+.||+|+||.||+|...+ +..||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 4456789999999999998643 368999998643 22334568889999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+++|+|.+++..... +++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 112 y~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~--- 183 (340)
T PTZ00426 112 FVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--- 183 (340)
T ss_pred CCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC---
Confidence 9999999999986543 889999999999999999999 89999999999999999999999999999986532
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
......||+.|+|||++.+..++.++|||||||++|||++|++||........... +..+.. .
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~-----i~~~~~------~---- 246 (340)
T PTZ00426 184 --RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK-----ILEGII------Y---- 246 (340)
T ss_pred --CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH-----HhcCCC------C----
Confidence 12345789999999999988899999999999999999999999986543221111 111111 0
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRP-----NMNRVVME 804 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~~ 804 (846)
++......+.+++.+|++.+|++|+ +++|+++.
T Consensus 247 ~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111223567999999999999995 78887664
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=312.15 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=203.2
Q ss_pred hhhhhcCcCceEEEEEEEEcC------CcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLDD------NTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++|+||+++++++..+...++||
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 88 (277)
T cd05032 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVM 88 (277)
T ss_pred eEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEE
Confidence 345789999999999998642 3679999987553 334567889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCC--------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccC
Q 003114 611 EYMANGSLEEYLSDSN--------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGL 682 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGl 682 (846)
||+++|+|.+++.... ...+++..++.++.|++.||.||| +.+|+||||||+||++++++.+||+|||+
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~dfg~ 165 (277)
T cd05032 89 ELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGM 165 (277)
T ss_pred ecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECCccc
Confidence 9999999999996532 223788899999999999999999 89999999999999999999999999999
Q ss_pred CccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcc
Q 003114 683 SKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIK 761 (846)
Q Consensus 683 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~ 761 (846)
++...............++..|+|||.+.+..++.++|||||||+++||++ |+.||....... +.. ... .+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~---~~~-~~~~~ 240 (277)
T cd05032 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-VLK---FVI-DGGHL 240 (277)
T ss_pred chhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-HHH---HHh-cCCCC
Confidence 986543332222333456789999999988889999999999999999998 899987544322 112 111 11111
Q ss_pred cccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 762 NIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 762 ~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
. .+......+.+++.+|++.+|++|||+.++++.|++
T Consensus 241 ~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 241 D---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred C---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1 112234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.77 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=202.3
Q ss_pred hhhhhcCcCceEEEEEEEEcC-Cc--EEEEEEeCCC-CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLDD-NT--EVAVKMLSPS-SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~-g~--~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++......++|+||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 345789999999999998753 33 4788888743 334456788999999999 799999999999999999999999
Q ss_pred ccCCChhhhhhcCC--------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEE
Q 003114 613 MANGSLEEYLSDSN--------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLA 678 (846)
Q Consensus 613 ~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~ 678 (846)
+++++|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeEEEC
Confidence 99999999997542 124888999999999999999999 8999999999999999999999999
Q ss_pred eccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhc
Q 003114 679 DFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQ 757 (846)
Q Consensus 679 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~ 757 (846)
|||++...... ........+..|+|||+.....++.++|||||||+++||++ |+.||....... .......
T Consensus 162 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~----~~~~~~~- 233 (297)
T cd05089 162 DFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE----LYEKLPQ- 233 (297)
T ss_pred CcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHhc-
Confidence 99998643111 11111223567999999988889999999999999999997 999997654322 1111111
Q ss_pred CCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 003114 758 GDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETA 814 (846)
Q Consensus 758 ~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~ 814 (846)
+ .....+......+.+++.+|++.+|.+||++.++++.|++++....+
T Consensus 234 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 234 G---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred C---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1 01111122335688999999999999999999999999988865533
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.29 Aligned_cols=247 Identities=24% Similarity=0.389 Sum_probs=203.5
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|++|.||+|..+ +++.|++|.+... .....+.+.+|+++++.++||||+++++++..++..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08529 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN 83 (256)
T ss_pred EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence 4568999999999999975 6889999998643 344567788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.++++......+++..+.+++.+++.||.||| +.+++||||||+||++++++.+||+|||+++.+.... ...
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--~~~ 158 (256)
T cd08529 84 GDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFA 158 (256)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--chh
Confidence 99999998765556899999999999999999999 8999999999999999999999999999988654321 122
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....|+..|+|||+..+..++.++|||||||+++||++|+.||.......... . ...+... .....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~-~~~~~~~---------~~~~~ 224 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL----K-IIRGVFP---------PVSQM 224 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH----H-HHcCCCC---------CCccc
Confidence 33468889999999998889999999999999999999999997655322111 1 1111111 11112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
....+.+++.+|++.+|++||++.++++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 34568899999999999999999998763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.70 Aligned_cols=247 Identities=28% Similarity=0.459 Sum_probs=204.5
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||.|+||.||+|... ++.||+|.+..... ..+++.+|+.+++.++|+||+++++++......++||||+++++
T Consensus 9 ~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 9 KLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred cceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 45678999999999999875 78999999976644 45788999999999999999999999998999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++.......+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||.++...... ..
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~ 158 (256)
T cd05039 87 LVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DS 158 (256)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc-----cc
Confidence 999998766556999999999999999999999 8999999999999999999999999999998653211 12
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..++..|+|||++.+..++.++||||||++++||++ |+.||....... +.. ....+.. ...+...
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~----~~~~~~~---------~~~~~~~ 224 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVP----HVEKGYR---------MEAPEGC 224 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-HHH----HHhcCCC---------CCCccCC
Confidence 334668999999988889999999999999999997 999987553222 111 1111110 0111223
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
...+.+++.+|+..+|++||+++|++++|+.+
T Consensus 225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 225 PPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 45788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.04 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=204.2
Q ss_pred hhhhhcCcCceEEEEEEEEcC-----------------CcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeE
Q 003114 538 DFETILGEGSFGKVYHGYLDD-----------------NTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGY 599 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~-----------------g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~ 599 (846)
.+.+.||+|+||.||++...+ +..||+|.+.... ....+.+.+|+.++++++||||++++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 87 (296)
T cd05051 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGV 87 (296)
T ss_pred cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 456789999999999998642 2458999987653 3445678999999999999999999999
Q ss_pred eecCCeeeEeeecccCCChhhhhhcCC---------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC
Q 003114 600 CNEGNQIGLIYEYMANGSLEEYLSDSN---------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN 670 (846)
Q Consensus 600 ~~~~~~~~LV~Ey~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld 670 (846)
+..++..++|+||+++++|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||+++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Nili~ 164 (296)
T cd05051 88 CTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVG 164 (296)
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhceeec
Confidence 999999999999999999999997654 125899999999999999999999 88999999999999999
Q ss_pred CCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCccccccHH
Q 003114 671 DQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRPAIANTEEHKHIS 748 (846)
Q Consensus 671 ~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt--G~~p~~~~~~~~~l~ 748 (846)
+++.++|+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||........+
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~- 243 (296)
T cd05051 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI- 243 (296)
T ss_pred CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH-
Confidence 999999999999986543322223334556789999999988889999999999999999998 67787654432221
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 749 QWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 749 ~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
................ .........+.+++.+|++.+|++||++.||++.|++
T Consensus 244 ~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 244 ENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111111111111111 1112234578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=307.79 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=194.3
Q ss_pred hcCcCceEEEEEEEEcC---CcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 542 ILGEGSFGKVYHGYLDD---NTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 45789998876532 334578889999999999999999999999999999999999999
Q ss_pred hhhhhhcCC---CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 618 LEEYLSDSN---ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 618 L~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
|.++++... ....++..+.+++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999997533 224677788899999999999999 89999999999999999999999999999975433222222
Q ss_pred cccccCCCcccCccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCC
Q 003114 695 STGVAGTFGYLDPEYCQTF-------RLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDP 766 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~-------~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 766 (846)
.....++..|+|||++... .++.++|||||||+++||++ |+.||......+.... ... +......++
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~ 233 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY----TVR-EQQLKLPKP 233 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH----Hhh-cccCCCCCC
Confidence 2335578889999987642 35789999999999999996 9999976543322111 111 111222223
Q ss_pred CCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 767 KLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 767 ~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
.+.. .....+.+++..|+ .+|++|||++||++.|+
T Consensus 234 ~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 234 RLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 3221 12335678889998 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=322.86 Aligned_cols=243 Identities=23% Similarity=0.355 Sum_probs=190.8
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+++++.++|+||+++++++..++..++||||+++|+
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 158 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence 467999999999999965 689999999965433 345678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+.. ...+..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.+... ......
T Consensus 159 L~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~ 227 (353)
T PLN00034 159 LEGTH------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDPCNS 227 (353)
T ss_pred ccccc------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--cccccc
Confidence 86532 2456778899999999999999 899999999999999999999999999999865321 112234
Q ss_pred ccCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 698 VAGTFGYLDPEYCQT-----FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~-----~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
..||..|+|||++.. ...+.++|||||||++|||++|+.||....... ............ .+ ..
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~------~~----~~ 296 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASLMCAICMSQ------PP----EA 296 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhccC------CC----CC
Confidence 578999999998743 234568999999999999999999997433222 111111111100 01 11
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.......+.+++.+||+.+|++||+++|+++.
T Consensus 297 ~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 297 PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12234568899999999999999999999874
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.85 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=199.4
Q ss_pred hhhhcCcCceEEEEEEEEcC------CcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 539 FETILGEGSFGKVYHGYLDD------NTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
+.+.||+|++|.||+|.+.+ +..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEe
Confidence 34789999999999999753 5678999886543 3334568899999999999999999999999899999999
Q ss_pred cccCCChhhhhhcCCC-----CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC---cEEEEeccCC
Q 003114 612 YMANGSLEEYLSDSNA-----DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF---QARLADFGLS 683 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~---~vkI~DFGla 683 (846)
|+++++|.+++..... ..+++..+++++.|++.||+||| +.+++||||||+||+++.++ .+||+|||++
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEeccCccc
Confidence 9999999999976532 25899999999999999999999 88999999999999998654 6999999999
Q ss_pred ccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCccc
Q 003114 684 KTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKN 762 (846)
Q Consensus 684 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 762 (846)
+................+..|+|||++.+..++.++|||||||+++||++ |+.||....... ..........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~----~~~~~~~~~~--- 239 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE----VMEFVTGGGR--- 239 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHcCCc---
Confidence 86532221111222234568999999998899999999999999999997 999997654322 2222221111
Q ss_pred ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 763 IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 763 ~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
...+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 240 -------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 -------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1112233457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=321.47 Aligned_cols=242 Identities=26% Similarity=0.375 Sum_probs=195.3
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999975 57899999987532 23345567788888866 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|...+.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTT 153 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccC--Cccc
Confidence 99999987654 3889999999999999999999 899999999999999999999999999998754221 1223
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........... .... . ...+ ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~----i~~~-~---~~~p-------~~ 218 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES----ILHD-D---VLYP-------VW 218 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH----HHcC-C---CCCC-------CC
Confidence 345689999999999988999999999999999999999999986654332222 1111 1 1111 11
Q ss_pred HHHHHHHHHHhccCCCCCCCC-------CHHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRP-------NMNRVVME 804 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RP-------sm~eVl~~ 804 (846)
....+.+++.+|++.+|++|| +++++++.
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 234678999999999999999 67777644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.80 Aligned_cols=253 Identities=24% Similarity=0.408 Sum_probs=200.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCc----EEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNT----EVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
.+.+.||+|+||+||+|++. +++ .||+|+++... ....+.+.+|+.+++.++|+||+++++++.. ...++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~ 88 (279)
T cd05109 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQ 88 (279)
T ss_pred eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEE
Confidence 34578999999999999853 444 48999987543 3345678899999999999999999999875 45779999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+++|+|.++++.... .+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 89 ~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 89 LMPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred cCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 9999999999976542 4899999999999999999999 89999999999999999999999999999987643222
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
........++..|+|||...+..++.++|||||||++|||++ |+.||...... .+..++. .+....
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~----~~~~~~-------- 231 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-EIPDLLE----KGERLP-------- 231 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHH----CCCcCC--------
Confidence 222222345678999999988899999999999999999998 89998754322 2222221 111100
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
........+.+++.+|++.+|++||++.++++.|+++.
T Consensus 232 -~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 232 -QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred -CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11123456889999999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=312.57 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=202.2
Q ss_pred hhhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEe
Q 003114 537 NDFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV 609 (846)
..+.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++|+||+++++++..+...++|
T Consensus 8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (288)
T cd05061 8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 87 (288)
T ss_pred ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 344678999999999999753 24579999886543 23345678899999999999999999999999999999
Q ss_pred eecccCCChhhhhhcCC--------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEecc
Q 003114 610 YEYMANGSLEEYLSDSN--------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFG 681 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFG 681 (846)
|||+++|+|.++++... ...+++..+.+++.|++.||.||| +++|+||||||+||++++++.+||+|||
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~Dfg 164 (288)
T cd05061 88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG 164 (288)
T ss_pred EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEECcCC
Confidence 99999999999997532 123567788899999999999999 8999999999999999999999999999
Q ss_pred CCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCc
Q 003114 682 LSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDI 760 (846)
Q Consensus 682 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~ 760 (846)
+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.||......+ +.......+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~----~~~~~~~~~~- 239 (288)
T cd05061 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ----VLKFVMDGGY- 239 (288)
T ss_pred ccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHcCCC-
Confidence 9986533222222222345678999999998889999999999999999998 788887544322 2222221111
Q ss_pred ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 761 ~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
.. .+......+.+++.+|++.+|++||++.++++.|++.+
T Consensus 240 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 240 LD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 10 11223457899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=321.32 Aligned_cols=246 Identities=19% Similarity=0.303 Sum_probs=196.9
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||.||+++.. +++.||+|+++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999975 6889999999753 223345678899999888 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTT 153 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCcc
Confidence 99999887654 3899999999999999999999 899999999999999999999999999998743211 1223
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccc----cccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE----HKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~----~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
....||+.|+|||++.+..++.++|||||||++|||++|+.||+.... ......+.......+... +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~--- 224 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------I--- 224 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------C---
Confidence 346789999999999998999999999999999999999999964221 112223333333332211 1
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCC------HHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPN------MNRVVM 803 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPs------m~eVl~ 803 (846)
+......+.+++.+|++.+|++||+ ++++++
T Consensus 225 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 -PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1122346789999999999999998 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=325.30 Aligned_cols=242 Identities=24% Similarity=0.343 Sum_probs=196.1
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.||+|+||.||++... +++.||+|++... .......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999864 7899999999753 2233456778999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCC-CCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK-PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
+|.+++.... .+++..+..++.|++.||.||| + .+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATM 153 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cccc
Confidence 9999887654 3899999999999999999999 6 79999999999999999999999999998753221 1122
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... .+.. .+ +..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~----~~~i~-~~~~------~~----p~~ 218 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELIL-MEEI------RF----PRT 218 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH----HHHHh-cCCC------CC----CCC
Confidence 345699999999999988999999999999999999999999976543221 11111 1110 11 112
Q ss_pred HHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRP-----NMNRVVME 804 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~~ 804 (846)
....+.+++.+|++.+|++|+ +++++++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 234678999999999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.79 Aligned_cols=248 Identities=24% Similarity=0.309 Sum_probs=199.1
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc---hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR---QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
..+.||+|+||.||++... +++.||+|++..... .....+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05605 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccC
Confidence 3467999999999999964 688999999865422 223456789999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|.+++.......+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++....... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~ 157 (285)
T cd05605 84 GGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---T 157 (285)
T ss_pred CCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC---c
Confidence 999999887655455899999999999999999999 8899999999999999999999999999987653221 1
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||...........+... +.... ..+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~----------~~~~~ 226 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR-VKEDQ----------EEYSE 226 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-hhhcc----------cccCc
Confidence 23346899999999998888999999999999999999999999865433222222111 11110 11122
Q ss_pred HHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRP-----NMNRVVM 803 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~ 803 (846)
.....+.+++.+|+..+|++|| +++++++
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 2345678999999999999999 6666644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=321.65 Aligned_cols=249 Identities=26% Similarity=0.318 Sum_probs=197.2
Q ss_pred hhhhcCcCceEEEEEEEE----cCCcEEEEEEeCCCC----chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEe
Q 003114 539 FETILGEGSFGKVYHGYL----DDNTEVAVKMLSPSS----RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV 609 (846)
+.+.||+|+||.||+++. .+++.||+|++.+.. ....+.+.+|+.+++.+ +|+||+++++++..++..++|
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (332)
T cd05614 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLI 83 (332)
T ss_pred EEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEE
Confidence 457899999999999885 367899999986431 22345678899999999 599999999999999999999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 84 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 84 LDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 99999999999997654 3889999999999999999999 899999999999999999999999999999865322
Q ss_pred CcccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
. ........||+.|+|||.+.+. .++.++|||||||+++||++|+.||................... ++.+
T Consensus 159 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------~~~~ 230 (332)
T cd05614 159 E-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC-------DPPF 230 (332)
T ss_pred C-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC-------CCCC
Confidence 2 1222345799999999998765 47889999999999999999999997554333333322222211 1111
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRP-----NMNRVVME 804 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~~ 804 (846)
+......+.+++.+|++.+|++|| +++++++.
T Consensus 231 ----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 231 ----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 112234678999999999999999 66677653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=313.13 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=199.0
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCc--------------hhhHHHHHHHHHHHhcccccceeEeeEeec
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSR--------------QGYEQFEAEVILLRTVHHKNLTTLYGYCNE 602 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--------------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~ 602 (846)
.+...||+|.||.|-+|+. .+++.||||++.+... ...+...+|+.+|++++|||||+|+.+..+
T Consensus 100 ~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDD 179 (576)
T KOG0585|consen 100 ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDD 179 (576)
T ss_pred ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecC
Confidence 3456799999999999995 4789999999965311 123578899999999999999999999865
Q ss_pred --CCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEec
Q 003114 603 --GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADF 680 (846)
Q Consensus 603 --~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DF 680 (846)
.+.+|||+|||..|.+...=..... ++..++.+++.+++.||+||| .++||||||||+|+||+++|++||+||
T Consensus 180 P~s~~~YlVley~s~G~v~w~p~d~~e--ls~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 180 PESDKLYLVLEYCSKGEVKWCPPDKPE--LSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred cccCceEEEEEeccCCccccCCCCccc--ccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEEeecc
Confidence 5689999999998887654333222 899999999999999999999 999999999999999999999999999
Q ss_pred cCCccCCCC---CcccccccccCCCcccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHH
Q 003114 681 GLSKTFPIE---GVSHLSTGVAGTFGYLDPEYCQTFR----LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDF 753 (846)
Q Consensus 681 Gla~~~~~~---~~~~~~~~~~gt~~Y~APE~~~~~~----~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~ 753 (846)
|.+...+.. +.........||+.|+|||...+.. .+.+.||||+||+||-|+.|+.||-+..+.+....++
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv-- 332 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV-- 332 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh--
Confidence 999866322 2222334478999999999887632 4578999999999999999999997655433322221
Q ss_pred HHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 754 MLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 754 ~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
...|.-....+....+.+|+.++|++||+.|.+..+|....--
T Consensus 333 -----------n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 333 -----------NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred -----------cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 2222212222455678899999999999999999999877633
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=321.82 Aligned_cols=236 Identities=26% Similarity=0.363 Sum_probs=191.9
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||.||+|+.+ +++.||+|++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999975 6889999998753 223345667788888776 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTT 153 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcc
Confidence 99999987654 3889999999999999999999 899999999999999999999999999998753221 1223
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .... .+.. .. +..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~----~~i~-~~~~---~~-------~~~ 218 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF----EAIL-NDEV---VY-------PTW 218 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH----HHHh-cCCC---CC-------CCC
Confidence 3457999999999999889999999999999999999999999865533222 2111 1111 01 111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
....+.+++.+|++.+|++||++
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCC
Confidence 23467899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=321.69 Aligned_cols=259 Identities=21% Similarity=0.346 Sum_probs=194.2
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecC-----CeeeEee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG-----NQIGLIY 610 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~~LV~ 610 (846)
+.+.||+|+||.||+|+.. ++..||+|++... ......++.+|+.+++.++||||+++++++... ...++||
T Consensus 4 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~ 83 (338)
T cd07859 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83 (338)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEE
Confidence 4578999999999999965 6899999998743 223345688999999999999999999987533 3589999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+. ++|.+++.... .+++..+..++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 84 e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 84 ELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred ecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 9995 68999887654 3899999999999999999999 8999999999999999999999999999997643221
Q ss_pred c-ccccccccCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHh-----------
Q 003114 691 V-SHLSTGVAGTFGYLDPEYCQT--FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLA----------- 756 (846)
Q Consensus 691 ~-~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~----------- 756 (846)
. ........||..|+|||++.+ ..++.++|||||||+++||++|++||........+.. +.....
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL-ITDLLGTPSPETISRVR 236 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH-HHHHhCCCCHHHHHHhh
Confidence 1 112234578999999998865 5789999999999999999999999976543222111 100000
Q ss_pred cCCccccc---CCCCCCCC---ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 757 QGDIKNIV---DPKLHGDI---DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 757 ~~~~~~~~---d~~L~~~~---~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.......+ .+...... .......+.+++.+|++.+|++||+++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 00000000 01123457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=305.78 Aligned_cols=247 Identities=27% Similarity=0.411 Sum_probs=200.2
Q ss_pred hhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEe-ecCCeeeEeeecccC
Q 003114 537 NDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC-NEGNQIGLIYEYMAN 615 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~-~~~~~~~LV~Ey~~~ 615 (846)
..+.+.||+|+||.||++... +..+|+|.++... ..+.+.+|+.++++++|+|++++++++ ..++..++|+||+++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred CeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 344578999999999999874 7789999986543 245788999999999999999999975 455678999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.++++......+++..+++++.+++.||+||| +.+++||||||+||++++++.+||+|||+++..... .
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-----~ 156 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----Q 156 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc-----C
Confidence 99999998766556899999999999999999999 899999999999999999999999999998754321 1
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
....++..|+|||++.+..++.++|||||||+++||++ |+.||..... .+...... .+... ....
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~~-~~~~~---------~~~~ 222 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRVE-KGYKM---------DAPD 222 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHh-cCCCC---------CCCC
Confidence 22345678999999998889999999999999999997 9999875432 22222211 11111 1112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
.....+.+++.+|++.+|++|||+.++++.|+++
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 3345788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=306.74 Aligned_cols=249 Identities=22% Similarity=0.405 Sum_probs=211.0
Q ss_pred HHHHhhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeE
Q 003114 533 TKITNDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 533 ~~~t~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L 608 (846)
.+-.+++.+.||+|.||.|-+|+. ..|+.||||.+++. +.++.-.+++|+++|..++||||+.++..|.+.+.+.+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 345567778999999999999985 68999999999765 34455678899999999999999999999999999999
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
||||..+|.|++++.+.+. +++.++..+..||+.|+.|+| +.+++|||||.+|||+|+++++||+|||++..+..
T Consensus 131 vMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999998765 999999999999999999999 99999999999999999999999999999987743
Q ss_pred CCcccccccccCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCC
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLT-EKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s-~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
. .....++|++-|.+||...+.+|. +.+|-||+||+||-|+.|-.||++.+....+.+ +..|...+-
T Consensus 206 ~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQ-----Is~GaYrEP---- 273 (668)
T KOG0611|consen 206 K---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQ-----ISRGAYREP---- 273 (668)
T ss_pred c---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHH-----hhcccccCC----
Confidence 3 345678999999999999998874 789999999999999999999987654332222 223322221
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
..+....-|+.+|+..+|++|-|+.+|...-
T Consensus 274 -------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 -------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1222456789999999999999999997653
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=319.46 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=218.0
Q ss_pred hhhhhhcCcCceEEEEEEEEc---CC--cEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 537 NDFETILGEGSFGKVYHGYLD---DN--TEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~---~g--~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
....++||.|-||.||+|... .| ..||||..+.. ..+..+.|.+|..+|++++||||++++|.|.+ ...++||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 344678999999999999853 33 34899998874 55667889999999999999999999999987 5689999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
|.++-|.|.++|+.++. .++......++.|+..+|.||| +.+++||||.++|||+.....+|++|||+++.+....
T Consensus 470 EL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred ecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999999999987764 3888999999999999999999 9999999999999999999999999999999875443
Q ss_pred cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
. +..+...-+..|||||.+.-.+++.++|||.|||.+||++. |..||.+-...+.+ -.+...-+
T Consensus 546 y-YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--------------~~iEnGeR 610 (974)
T KOG4257|consen 546 Y-YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--------------GHIENGER 610 (974)
T ss_pred h-hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--------------EEecCCCC
Confidence 3 33334556789999999999999999999999999999875 89999865433322 11222223
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhhh
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARK 816 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~~ 816 (846)
...+..++..+..|..+||..+|.+||++.|+...|+++++.|..-.
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~ 657 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINS 657 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhh
Confidence 34466788899999999999999999999999999999998766544
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=320.55 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=201.4
Q ss_pred HhhhhhhcCcCceEEEEEEEE------cCCcEEEEEEeCCCC-chhhHHHHHHHHHHHhc-ccccceeEeeEeec-CCee
Q 003114 536 TNDFETILGEGSFGKVYHGYL------DDNTEVAVKMLSPSS-RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNE-GNQI 606 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~-~~~~ 606 (846)
...+.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+||+++++++.. +...
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 87 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence 345678899999999999973 356789999997543 33446788999999999 68999999998765 4567
Q ss_pred eEeeecccCCChhhhhhcCC------------------------------------------------------------
Q 003114 607 GLIYEYMANGSLEEYLSDSN------------------------------------------------------------ 626 (846)
Q Consensus 607 ~LV~Ey~~~gsL~~~l~~~~------------------------------------------------------------ 626 (846)
++||||+++|+|.+++....
T Consensus 88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (343)
T cd05103 88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE 167 (343)
T ss_pred EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence 89999999999999986432
Q ss_pred -----CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccccCC
Q 003114 627 -----ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGT 701 (846)
Q Consensus 627 -----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt 701 (846)
...+++.++.+++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++...............++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 123678888999999999999999 899999999999999999999999999999865322221122223456
Q ss_pred CcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHH
Q 003114 702 FGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKA 780 (846)
Q Consensus 702 ~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l 780 (846)
..|+|||.+.+..++.++|||||||+++||++ |..||........+.. ....+..... +. .....+
T Consensus 245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~~~~~~~--~~-------~~~~~~ 311 (343)
T cd05103 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR----RLKEGTRMRA--PD-------YTTPEM 311 (343)
T ss_pred cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH----HHhccCCCCC--CC-------CCCHHH
Confidence 78999999988889999999999999999997 8999876433222111 1222211100 11 112357
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 781 VEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 781 ~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
.+++.+|++.+|++||++.||++.|+.+++
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=304.35 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=198.6
Q ss_pred hhcCcCceEEEEEEEEc-C---CcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD-D---NTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~---g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||.||+|+.. . +..+|+|.+..... ...+++.+|+.+++.++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36999999999999853 2 26899999876543 34567899999999999999999999876 4568999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc-c
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH-L 694 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~-~ 694 (846)
|+|.+++.... .+++..+..++.|++.||+||| ..+++||||||+||++++++.+||+|||+++......... .
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999998765 4899999999999999999999 8899999999999999999999999999998664322111 1
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.....++..|+|||...+..++.++|||||||+++||++ |++||....... +..++ ..+... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-~~~~~----~~~~~~---------~~~ 220 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-VIAML----ESGERL---------PRP 220 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-HHHHH----HcCCcC---------CCC
Confidence 112224568999999998899999999999999999998 999997654322 22221 111110 111
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
......+.+++.+|+..+|++||++.++++.|+++
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 22345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=314.53 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=203.4
Q ss_pred hhhhhcCcCceEEEEEEEEc--------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeee
Q 003114 538 DFETILGEGSFGKVYHGYLD--------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIG 607 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 607 (846)
.+.+.||+|+||.||+++.. ....+|+|.++... ......+.+|+.+++++ +||||+++++++..++..+
T Consensus 15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (314)
T cd05099 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLY 94 (314)
T ss_pred eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceE
Confidence 45678999999999999742 24568999987543 33456788999999999 6999999999999999999
Q ss_pred EeeecccCCChhhhhhcCC--------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC
Q 003114 608 LIYEYMANGSLEEYLSDSN--------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF 673 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~ 673 (846)
+|+||+++|+|.+++.... ...+++.++.+++.|++.||.||| +.+|+||||||+|||+++++
T Consensus 95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDN 171 (314)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEcCCC
Confidence 9999999999999997542 234889999999999999999999 89999999999999999999
Q ss_pred cEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHH
Q 003114 674 QARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVD 752 (846)
Q Consensus 674 ~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~ 752 (846)
.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ...
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----~~~ 247 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE----LFK 247 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH----HHH
Confidence 999999999986543222111222234567999999988889999999999999999999 888986543222 111
Q ss_pred HHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 753 FMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 753 ~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
.. ..+... .........+.+++.+|+..+|++||++.|+++.|+++...
T Consensus 248 ~~-~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 248 LL-REGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HH-HcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 11 111111 11223345788999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.80 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=204.8
Q ss_pred HHhhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 535 ITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 535 ~t~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
....+.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|+.+++.++|+||+++.+++.. ...+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 3445668899999999999998888889999887543 234678899999999999999999999887 77899999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+++|.+++.......+++..+..++.+++.||.||| +.+++||||||+||+++.++.+||+|||++....... ...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~ 159 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTA 159 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC-ccc
Confidence 999999998765556899999999999999999999 8899999999999999999999999999997653221 111
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.....++..|+|||++....++.++|+|||||+++||++ |+.||....... +..+ ...+... ...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~~~~----~~~~~~~---------~~~ 225 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRA----LERGYRM---------PRP 225 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-HHHH----HhCCCCC---------CCc
Confidence 223345678999999988889999999999999999999 899997644322 1111 1111110 111
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=305.58 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=191.9
Q ss_pred hcCcCceEEEEEEEEcC---CcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 542 ILGEGSFGKVYHGYLDD---NTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+..++.++|+||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3468888876543 3334568899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCC---CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 618 LEEYLSDSNA---DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 618 L~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
|.+++..... ...++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999976542 23567888999999999999999 89999999999999999999999999999875433222222
Q ss_pred cccccCCCcccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCC
Q 003114 695 STGVAGTFGYLDPEYCQT-------FRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDP 766 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~-------~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 766 (846)
.....++..|+|||+... ..++.++|||||||++|||++ |+.||........+.. ..... .....++
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~----~~~~~-~~~~~~~ 233 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ----VVREQ-DIKLPKP 233 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH----Hhhcc-CccCCCC
Confidence 233456778999998643 357889999999999999999 7888876543332222 12221 1122222
Q ss_pred CCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 767 KLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 767 ~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
.+. ......+.+++..|+ .+|++||+++||++.|
T Consensus 234 ~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 234 QLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 222 223345667788888 5999999999999987
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=311.44 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=201.5
Q ss_pred hhhhhcCcCceEEEEEEEEc-----------------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeE
Q 003114 538 DFETILGEGSFGKVYHGYLD-----------------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGY 599 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-----------------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~ 599 (846)
.+.+.||+|+||.||++... +...+|+|++.... ....+.+.+|+.+++.++|+||++++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~ 87 (296)
T cd05095 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAV 87 (296)
T ss_pred eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 45678999999999998642 23468999997543 3345678999999999999999999999
Q ss_pred eecCCeeeEeeecccCCChhhhhhcCCC---------CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC
Q 003114 600 CNEGNQIGLIYEYMANGSLEEYLSDSNA---------DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN 670 (846)
Q Consensus 600 ~~~~~~~~LV~Ey~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld 670 (846)
+..++..++||||+++|+|.+++..... ..+++.++.+++.|++.||+||| +.+++||||||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Nili~ 164 (296)
T cd05095 88 CITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVG 164 (296)
T ss_pred EecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheEEEc
Confidence 9999999999999999999999976431 24778899999999999999999 88999999999999999
Q ss_pred CCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCccccccHH
Q 003114 671 DQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRPAIANTEEHKHIS 748 (846)
Q Consensus 671 ~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt--G~~p~~~~~~~~~l~ 748 (846)
+++.++|+|||+++.+.............++..|+|||......++.++|||||||++|||++ |..||......+.+.
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 244 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE 244 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 999999999999986533322222223345678999999888889999999999999999998 678886544333222
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 749 QWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 749 ~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
.. ........... ..+ .+......+.+++.+|++.+|++||+|.||++.|++
T Consensus 245 ~~-~~~~~~~~~~~-~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 245 NT-GEFFRDQGRQV-YLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH-HHHHhhccccc-cCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 11111111000 001 111234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.87 Aligned_cols=249 Identities=28% Similarity=0.459 Sum_probs=198.8
Q ss_pred hcCcCceEEEEEEEEcC-------CcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 542 ILGEGSFGKVYHGYLDD-------NTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.||+|+||.||+|+..+ +..+|+|.+.... .....++.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 68999999999998643 2578999886543 234567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCC-----CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC-----cEEEEeccCC
Q 003114 614 ANGSLEEYLSDSN-----ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF-----QARLADFGLS 683 (846)
Q Consensus 614 ~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-----~vkI~DFGla 683 (846)
++++|.+++.... ...+++.+++.++.|++.||+||| +.+++|+||||+||+++.+. .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999997532 234789999999999999999999 88999999999999999877 8999999999
Q ss_pred ccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCccc
Q 003114 684 KTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKN 762 (846)
Q Consensus 684 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 762 (846)
+...............++..|+|||++.+..++.++|||||||+++||++ |+.||....... . ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-~---~~~~~~~~~~-- 232 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-V---LQHVTAGGRL-- 232 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-H---HHHHhcCCcc--
Confidence 76543222222223345778999999998899999999999999999998 999997543322 1 1111111100
Q ss_pred ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 763 IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 763 ~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
.........+.+++.+|+..+|++||++++|.+.|++
T Consensus 233 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 233 --------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1112234578899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=302.72 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=200.6
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCch-hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChh
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQ-GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLE 619 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 619 (846)
+.||+|+||.||++...+++.||+|.+...... ..+.+.+|+.++++++|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999877999999998765443 5568899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccccc
Q 003114 620 EYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699 (846)
Q Consensus 620 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~ 699 (846)
+++..... .+++..+..++.+++.||+||| +.+++||||||+||++++++.+||+|||+++...............
T Consensus 81 ~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKKN-RLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 99976433 4789999999999999999999 8899999999999999999999999999997653221111111223
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHH
Q 003114 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAW 778 (846)
Q Consensus 700 gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~ 778 (846)
++..|+|||.+.+..++.++|+|||||+++||+| |..||......... . . ...+. ....+.....
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-~---~-~~~~~---------~~~~~~~~~~ 222 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-E---R-IESGY---------RMPAPQLCPE 222 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-H---H-HhcCC---------CCCCCccCCH
Confidence 4667999999988889999999999999999999 78888655432211 1 1 11110 0011122345
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 779 KAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 779 ~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
.+.+++.+|+..+|++||+++|+++.|+
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 7889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=305.74 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=205.4
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||++.. .+++.+|||.+... .....+++.+|+.+++.++|+||+++++++..++..+++|||+
T Consensus 5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08229 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA 84 (267)
T ss_pred hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEec
Confidence 4467899999999999996 47899999988653 2234467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 614 ANGSLEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 614 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
++++|.+++... ....+++..+++++.++++||.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 85 DAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred CCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 999999998742 2345899999999999999999999 8999999999999999999999999999987653321
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.......|+..|+|||.+.+..++.++||||||++++||++|+.||...... ...+.+.... ...+.+.
T Consensus 161 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~------~~~~~~~-- 229 (267)
T cd08229 161 -TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQ------CDYPPLP-- 229 (267)
T ss_pred -cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhc------CCCCCCC--
Confidence 1122356888999999998888999999999999999999999999654321 1222221111 1111111
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
.......+.+++.+|++.+|++||||.+|+++++++
T Consensus 230 -~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 230 -SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 112345788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=336.58 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=201.1
Q ss_pred hhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCC--------e
Q 003114 537 NDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN--------Q 605 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--------~ 605 (846)
+.+.+.||+|+||.||+|+. .+++.||||++... .......+.+|+..+..++|+||++++..+...+ .
T Consensus 34 Y~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~ 113 (496)
T PTZ00283 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLM 113 (496)
T ss_pred EEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceE
Confidence 34567899999999999985 47899999998654 3344567889999999999999999988764322 3
Q ss_pred eeEeeecccCCChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCC
Q 003114 606 IGLIYEYMANGSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLS 683 (846)
Q Consensus 606 ~~LV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla 683 (846)
.++||||+++|+|.++++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 114 i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred EEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 689999999999999997532 345889999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 003114 684 KTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNI 763 (846)
Q Consensus 684 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~ 763 (846)
+.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...... +++..... +...
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~----~~~~~~~~-~~~~-- 263 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME----EVMHKTLA-GRYD-- 263 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHhc-CCCC--
Confidence 8764322222334567999999999999989999999999999999999999999764432 22222221 1111
Q ss_pred cCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 764 VDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 764 ~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
..+......+.+++.+|++.+|++||++.++++.
T Consensus 264 -------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 -------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1112234568899999999999999999999764
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=306.74 Aligned_cols=257 Identities=21% Similarity=0.336 Sum_probs=202.5
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCC--CCchhhHHHHHHHHHHHhcccccceeEeeEeec-----CCeeeEeeec
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSP--SSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE-----GNQIGLIYEY 612 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-----~~~~~LV~Ey 612 (846)
+.||+|+||.|..+... +|+.||||++.. ......++..+|+++|+.++|+||+.+.+.+.- -+..++|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 57999999999999964 789999999973 345566788999999999999999999998754 4579999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
| +-+|.+.++.+.. ++......++.|+++||+|+| +.+|+|||+||+|+|++.+...||+|||+|+........
T Consensus 108 M-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 108 M-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred H-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 9 5699999987654 888899999999999999999 999999999999999999999999999999987543233
Q ss_pred cccccccCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc----------CCcc
Q 003114 693 HLSTGVAGTFGYLDPEYCQ-TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ----------GDIK 761 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~----------~~~~ 761 (846)
...+..+.|.+|.|||.+. ...|+...||||.|||+.||++|++.|.+.+...++..+....-.. ....
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 3446677899999999765 4579999999999999999999999999877555544433321110 0000
Q ss_pred cccC------C-CCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 762 NIVD------P-KLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 762 ~~~d------~-~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
..+. + .+..-++ ......++|+.+|+..||.+|+|++|.++.
T Consensus 262 ~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 0 0000011 122456799999999999999999998764
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.17 Aligned_cols=253 Identities=24% Similarity=0.434 Sum_probs=202.2
Q ss_pred hhhhhcCcCceEEEEEEEEc----CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD----DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|... .+..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (267)
T cd05066 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY 86 (267)
T ss_pred EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 45678999999999999863 23469999987543 33456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++++|.+++..... .+++.++.+++.|++.||.||| +.+++||||||+||+++.++.++|+|||++..+......
T Consensus 87 ~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 87 MENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred CCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 999999999976543 4899999999999999999999 899999999999999999999999999999876432211
Q ss_pred c-ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 693 H-LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 693 ~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
. ......++..|+|||++.+..++.++|||||||+++|+++ |+.||......+ ... ... ++. ..
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-~~~---~~~-~~~-----~~---- 228 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-VIK---AIE-EGY-----RL---- 228 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-HHH---HHh-CCC-----cC----
Confidence 1 1112234568999999998889999999999999999886 999997654322 111 111 110 00
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
.........+.+++.+|++.+|++||+|.++++.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=314.93 Aligned_cols=256 Identities=27% Similarity=0.463 Sum_probs=201.6
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCc--EEEEEEeCCC-CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNT--EVAVKMLSPS-SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~--~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|... ++. .+|+|.+... .....+.+.+|++++.++ +|+||+++++++..++..++|+||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 45678999999999999974 444 4678877643 334456788999999999 899999999999999999999999
Q ss_pred ccCCChhhhhhcCC--------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEE
Q 003114 613 MANGSLEEYLSDSN--------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLA 678 (846)
Q Consensus 613 ~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~ 678 (846)
+++++|.++++... ...+++.+++.++.|++.||+||| +.+++||||||+|||+++++.+||+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcEEeC
Confidence 99999999997543 124789999999999999999999 8999999999999999999999999
Q ss_pred eccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhc
Q 003114 679 DFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQ 757 (846)
Q Consensus 679 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~ 757 (846)
|||+++.... ........++..|+|||++....++.++|||||||+++||+| |+.||......+ ...... .
T Consensus 167 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~-~ 238 (303)
T cd05088 167 DFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLP-Q 238 (303)
T ss_pred ccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH----HHHHHh-c
Confidence 9999864311 111111234667999999988889999999999999999998 999996544322 111111 1
Q ss_pred CCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 003114 758 GDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMET 813 (846)
Q Consensus 758 ~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~ 813 (846)
+ ............+.+++.+|++.+|++||++++++++|++++..+.
T Consensus 239 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 239 G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred C---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 1 0001111233467899999999999999999999999998775554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.16 Aligned_cols=237 Identities=24% Similarity=0.350 Sum_probs=189.8
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHH---HhcccccceeEeeEeecCCeeeEeee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILL---RTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l---~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
+.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++ +.++||||+++++++..++..++|||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 3568999999999999965 68999999997532 22334566666554 56689999999999999999999999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+++|+|...++.. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-- 154 (324)
T cd05589 83 YAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-- 154 (324)
T ss_pred CCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC--
Confidence 99999999888653 4899999999999999999999 899999999999999999999999999998753221
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||........... .... .. .
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~----i~~~-~~------~---- 219 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS----IVND-EV------R---- 219 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhC-CC------C----
Confidence 2223346799999999999998999999999999999999999999986554332222 1111 10 0
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
.+......+.+++.+|++.+|++||++
T Consensus 220 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 220 YPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 111223467899999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=303.38 Aligned_cols=251 Identities=27% Similarity=0.469 Sum_probs=195.6
Q ss_pred hhcCcCceEEEEEEEEc----CCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEee-cCCeeeEeeeccc
Q 003114 541 TILGEGSFGKVYHGYLD----DNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCN-EGNQIGLIYEYMA 614 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~-~~~~~~LV~Ey~~ 614 (846)
+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 2457999998643 3344567889999999999999999999775 4556889999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc--
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS-- 692 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~-- 692 (846)
+|+|.+++..... .+++..+..++.|++.||.||| +.+++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999976543 3677888999999999999999 889999999999999999999999999999765322111
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITS-RPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG-~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.......++..|+|||.+....++.++|||||||+++||++| .+||...... ............ .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~----~~~~~~~~~~~~------~---- 222 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF----DITVYLLQGRRL------L---- 222 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHhcCCCC------C----
Confidence 111233467789999999888999999999999999999995 5666543322 222222211110 0
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
.+...+..+.+++.+|+..+|++||++.||++.|+++.
T Consensus 223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 01122346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=324.55 Aligned_cols=238 Identities=25% Similarity=0.353 Sum_probs=193.6
Q ss_pred hhcCcCceEEEEEEEE----cCCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 541 TILGEGSFGKVYHGYL----DDNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.||+|+||.||+++. .+|+.+|+|++..... .....+..|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999875 3678999999975422 233457789999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~ 154 (318)
T cd05582 82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKK 154 (318)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCc
Confidence 999999997654 3899999999999999999999 899999999999999999999999999998764322 122
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||.......... .... ... ..+.
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~----~i~~-~~~----------~~p~ 219 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT----MILK-AKL----------GMPQ 219 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH----HHHc-CCC----------CCCC
Confidence 334578999999999998889999999999999999999999997654322221 1111 110 0111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNR 800 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~e 800 (846)
.....+.+++.+|++.+|++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 22346789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.55 Aligned_cols=241 Identities=24% Similarity=0.326 Sum_probs=195.1
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||.||+++.. +++.||+|++.... ......+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999975 57899999997532 23345667888888887 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|..++.... .+++.++..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTT 153 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcc
Confidence 99999987654 3899999999999999999999 899999999999999999999999999998753211 1122
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....|+..|+|||++.+..++.++|||||||+++||++|+.||......... .... .... .++..
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~----~~i~-~~~~----------~~~~~ 218 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF----QSIL-EDEV----------RYPRW 218 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH----HHHH-cCCC----------CCCCc
Confidence 3356899999999999999999999999999999999999999765432211 1111 1111 01112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNM-----NRVVM 803 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm-----~eVl~ 803 (846)
....+.+++.+|++.+|++||++ .++++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 33567899999999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=317.59 Aligned_cols=264 Identities=26% Similarity=0.439 Sum_probs=208.3
Q ss_pred HHHhhhhhhcCcCceEEEEEEEEc--------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhc-ccccceeEeeEeecC
Q 003114 534 KITNDFETILGEGSFGKVYHGYLD--------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEG 603 (846)
Q Consensus 534 ~~t~~f~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~ 603 (846)
.....+.+.||+|+||.||+++.. ....||+|.+.... ....+++.+|+.+++++ +||||++++++|..+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 344566788999999999999742 12368999887543 33456789999999999 799999999999999
Q ss_pred CeeeEeeecccCCChhhhhhcCC--------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE
Q 003114 604 NQIGLIYEYMANGSLEEYLSDSN--------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL 669 (846)
Q Consensus 604 ~~~~LV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl 669 (846)
+..++++||+++|+|.+++.... ...+++.++++++.|++.||+||| +.+|+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence 99999999999999999997532 234788999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHH
Q 003114 670 NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHIS 748 (846)
Q Consensus 670 d~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~ 748 (846)
++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.||......
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---- 243 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---- 243 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH----
Confidence 9999999999999986533221112222334568999999998889999999999999999998 88888754322
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 003114 749 QWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETA 814 (846)
Q Consensus 749 ~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~ 814 (846)
++...... +... .........+.+++.+|++.+|++||++.|+++.|+++......
T Consensus 244 ~~~~~~~~-~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 244 ELFKLLKE-GHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred HHHHHHHc-CCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 22222221 1111 11122345788999999999999999999999999998865543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=304.86 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=204.6
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|+++++.++||||+++++++...+..++|+||+
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence 34578999999999999964 7899999987643 2334456889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 614 ANGSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 614 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
++|+|.+++.... ...+++..+..++.|+++||.||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 9999999886422 334788999999999999999999 8999999999999999999999999999988653221
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+.......+ .+..
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~------~~~~--- 228 (267)
T cd08228 161 -TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFSLCQKIEQCD------YPPL--- 228 (267)
T ss_pred -HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc--cHHHHHHHHhcCC------CCCC---
Confidence 112234688899999999888899999999999999999999999864332 1222222221111 1111
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1122345688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=321.81 Aligned_cols=238 Identities=28% Similarity=0.364 Sum_probs=190.0
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHH-HHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVI-LLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||+||+|+.. +++.||+|++.... ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999975 78999999986532 122234444444 56789999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTT 153 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCcc
Confidence 99999987654 3889999999999999999999 899999999999999999999999999998753211 2223
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....||+.|+|||++.+..++.++|||||||+++||++|+.||......+. ....... . ..+.. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~-~------~~~~~----~ 218 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM----YDNILNK-P------LRLKP----N 218 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH----HHHHHcC-C------CCCCC----C
Confidence 345789999999999998999999999999999999999999976543222 2222211 1 11111 1
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNR 800 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~e 800 (846)
....+.+++.+|++.+|++||++++
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 219 ISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred CCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 2346789999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.10 Aligned_cols=239 Identities=26% Similarity=0.354 Sum_probs=191.3
Q ss_pred hcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccCC
Q 003114 542 ILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++... +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 6899999999999975 57899999987542 22334566677777764 8999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 82 ~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (316)
T cd05619 82 DLMFHIQSCH--KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTC 154 (316)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCcee
Confidence 9999997643 3889999999999999999999 899999999999999999999999999998753211 11223
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
...||..|+|||++.+..++.++|||||||++|||++|+.||........ ...... .. +.. +...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~----~~~i~~-~~------~~~----~~~~ 219 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL----FQSIRM-DN------PCY----PRWL 219 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHh-CC------CCC----CccC
Confidence 45689999999999988999999999999999999999999976543221 111111 11 111 1112
Q ss_pred HHHHHHHHHhccCCCCCCCCCHH-HHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMN-RVV 802 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~-eVl 802 (846)
...+.+++.+|++.+|++||++. ++.
T Consensus 220 ~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 220 TREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 34678999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=300.72 Aligned_cols=258 Identities=22% Similarity=0.334 Sum_probs=206.3
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhccccc-ceeEeeEeecCC------eeeEee
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKN-LTTLYGYCNEGN------QIGLIY 610 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~------~~~LV~ 610 (846)
++||+|+||+||+|+.. +|+.||+|++.-... .......+|+.+|++++|+| |+++++++...+ ..++|+
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 46999999999999964 789999999976543 23456789999999999999 999999998877 789999
Q ss_pred ecccCCChhhhhhcCCC--CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 611 EYMANGSLEEYLSDSNA--DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
||++ -+|.+++..... +.++...+..++.|+++||+||| +++|+||||||+|||++++|.+||+|||+|+.+..
T Consensus 97 e~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 97 EFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLARAFSI 172 (323)
T ss_pred Eeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence 9995 599999987653 35777889999999999999999 99999999999999999999999999999996542
Q ss_pred CCcccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--ccccc-
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--IKNIV- 764 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--~~~~~- 764 (846)
. ....+...+|..|+|||++.+. .|+...||||+||++.||+++++.|.+..+.+.+..+.+.+-.++. ...+.
T Consensus 173 p--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~ 250 (323)
T KOG0594|consen 173 P--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS 250 (323)
T ss_pred C--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence 2 2224556789999999988776 6999999999999999999999999998887777776665432211 11100
Q ss_pred CCCCCCCC---------ChH---HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 765 DPKLHGDI---------DVN---SAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 765 d~~L~~~~---------~~~---~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
-+.....+ ... ......+++.+|++.+|.+|.|++.++++
T Consensus 251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00110000 000 11357899999999999999999998876
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=306.54 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=203.5
Q ss_pred hhhhhhcCcCceEEEEEEEEcC----CcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 537 NDFETILGEGSFGKVYHGYLDD----NTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
..+.+.||+|+||.||+|...+ ...||+|...... ....+.+.+|+.+++.++||||+++++++.. +..++|||
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e 86 (270)
T cd05056 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME 86 (270)
T ss_pred ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEE
Confidence 3456789999999999998643 2468999887654 4455688999999999999999999999875 45789999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+++|+|.+++..... .+++..+..++.+++.||+||| +.+++||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 161 (270)
T cd05056 87 LAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES- 161 (270)
T ss_pred cCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc-
Confidence 9999999999976543 4899999999999999999999 8999999999999999999999999999987654321
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
........++..|+|||.+....++.++|||||||+++||++ |+.||......+.... ...+...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-----~~~~~~~--------- 227 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR-----IENGERL--------- 227 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-----HHcCCcC---------
Confidence 112223345578999999988889999999999999999986 9999976554322211 1111100
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
.........+.+++.+|+..+|++||++.++++.|+++...
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01122345788999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=324.92 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=193.3
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.+++..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 467999999999999864 68899999996532 23445688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc----
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV---- 691 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~---- 691 (846)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 86 g~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 86 GDMMSLLIRME--VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999997654 3888899999999999999999 89999999999999999999999999999764311000
Q ss_pred -----------------------------------------ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHH
Q 003114 692 -----------------------------------------SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLE 730 (846)
Q Consensus 692 -----------------------------------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~E 730 (846)
........||+.|+|||.+.+..++.++|||||||+++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 000123469999999999998889999999999999999
Q ss_pred HHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHh--ccCCCCCCCCCHHHHHHH
Q 003114 731 IITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMG--CVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 731 LltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~--Cl~~~P~~RPsm~eVl~~ 804 (846)
|++|+.||........... ......... + +. ......++.+++.+ |+..+|..||+++|+++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~----i~~~~~~~~-~-~~-----~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLK----VINWENTLH-I-PP-----QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHhCCCCCcCCCHHHHHHH----HHccccccC-C-CC-----CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999976543322211 111000000 0 00 01122345667766 666677779999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.09 Aligned_cols=240 Identities=25% Similarity=0.342 Sum_probs=192.1
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||.||+|+.. +++.||+|.++... ....+....|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999975 68899999997532 22334566777777654 899999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRA 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCce
Confidence 99999987654 3889999999999999999999 899999999999999999999999999998743211 1223
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....||+.|+|||++.+..++.++||||+||+++||++|+.||........ ..... .+ .+.+ +..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~----~~~~~-~~------~~~~----~~~ 218 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL----FESIR-VD------TPHY----PRW 218 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHH-hC------CCCC----CCC
Confidence 346789999999999998999999999999999999999999976543321 11111 11 0111 111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMN-RVV 802 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~-eVl 802 (846)
...++.+++.+|++.+|++||++. ++.
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 234678999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.53 Aligned_cols=252 Identities=23% Similarity=0.390 Sum_probs=199.8
Q ss_pred hhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 537 NDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
..+.+.||+|+||.||+|+. .+++.||+|++..........+++|+.++++++||||+++++++..++..++|+||+++
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~ 90 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG 90 (267)
T ss_pred cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence 44567899999999999996 47889999999766555556788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.++++... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++....... ...
T Consensus 91 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~ 163 (267)
T cd06646 91 GSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKR 163 (267)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc--ccc
Confidence 99999987644 3889999999999999999999 8899999999999999999999999999998653221 112
Q ss_pred ccccCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 696 TGVAGTFGYLDPEYCQ---TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
....|+..|+|||.+. ...++.++|||||||+++||++|+.||...........+ ... ....+.+..
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-----~~~---~~~~~~~~~-- 233 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-----SKS---NFQPPKLKD-- 233 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-----ecC---CCCCCCCcc--
Confidence 2346888999999874 345788999999999999999999998644322111110 000 011111111
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
.......+.+++.+|+..+|++||+++++++.|
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 112335788999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=310.15 Aligned_cols=253 Identities=29% Similarity=0.470 Sum_probs=201.4
Q ss_pred hhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
.+.+.||+|+||.||++... ++..||+|++.... ....+++.+|+.++++++||||+++++++..+...++|+
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (288)
T cd05050 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87 (288)
T ss_pred eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEE
Confidence 34578999999999999863 46789999987553 334567889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCC--------------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC
Q 003114 611 EYMANGSLEEYLSDSN--------------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN 670 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld 670 (846)
||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+++||||||+||+++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~nil~~ 164 (288)
T cd05050 88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVG 164 (288)
T ss_pred ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhheEec
Confidence 9999999999997432 124788899999999999999999 88999999999999999
Q ss_pred CCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHH
Q 003114 671 DQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQ 749 (846)
Q Consensus 671 ~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~ 749 (846)
+++.+||+|||++..+..............+..|+|||.+.+..++.++|||||||+++||++ |..||...... +
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~----~ 240 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE----E 240 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----H
Confidence 999999999999876532222122222345677999999988899999999999999999997 88888654322 2
Q ss_pred HHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 750 WVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 750 ~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
+... ...+.... .+......+.+++.+|++.+|++||++.|+++.|++
T Consensus 241 ~~~~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYY-VRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHH-HhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 2222 22222111 111234578899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=322.05 Aligned_cols=250 Identities=20% Similarity=0.331 Sum_probs=192.3
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||+||++... +++.||+|++.... ......+.+|+.++..++|+||+++++.+.++...++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 3468999999999999865 68899999997532 2334567889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc--
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS-- 692 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~-- 692 (846)
+|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 85 gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 85 GGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 999999998654 3899999999999999999999 899999999999999999999999999998754321100
Q ss_pred -------------------------------cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 003114 693 -------------------------------HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANT 741 (846)
Q Consensus 693 -------------------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~ 741 (846)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0112357999999999999989999999999999999999999999765
Q ss_pred cccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhcc--CCCCCCCCCHHHHHHH
Q 003114 742 EEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCV--SHSSTPRPNMNRVVME 804 (846)
Q Consensus 742 ~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl--~~~P~~RPsm~eVl~~ 804 (846)
........ .... .....+.+.. . ....+.+++.+++ ..++..||+++||++.
T Consensus 240 ~~~~~~~~----i~~~-~~~~~~p~~~--~----~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 240 TPQETYKK----VMNW-KETLIFPPEV--P----ISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CHHHHHHH----HHcC-cCcccCCCcC--C----CCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 43322211 1111 0001111111 1 1123455555533 2344567999999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.61 Aligned_cols=239 Identities=24% Similarity=0.352 Sum_probs=192.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccc-cceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHK-NLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~Hp-nIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|+.. +++.||+|++... .....+.+..|..++..++|+ +|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 34578999999999999975 5788999998753 223445677899999999764 688899999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++..... .
T Consensus 83 ~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~ 155 (324)
T cd05587 83 VNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--G 155 (324)
T ss_pred CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC--C
Confidence 999999999976543 889999999999999999999 899999999999999999999999999998753211 1
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||........... .. ... . .+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~----i~-~~~------~----~~ 220 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS----IM-EHN------V----SY 220 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HH-cCC------C----CC
Confidence 122345689999999999998999999999999999999999999986554332222 11 111 0 11
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
+......+.+++.+|+..+|++|++.
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11223467899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=324.94 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=196.2
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..++||||+++++++..++..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence 3478999999999999975 68999999997532 2334567889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc-
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH- 693 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~- 693 (846)
+|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 85 ~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 85 GGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 999999997654 3899999999999999999999 8999999999999999999999999999987543211000
Q ss_pred -----------------------------------ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003114 694 -----------------------------------LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAI 738 (846)
Q Consensus 694 -----------------------------------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~ 738 (846)
......||+.|+|||++....++.++|||||||+++||++|++||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 011246999999999999889999999999999999999999999
Q ss_pred CCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCC---HHHHHHH
Q 003114 739 ANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPN---MNRVVME 804 (846)
Q Consensus 739 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPs---m~eVl~~ 804 (846)
........... ...... ...-+. .......+.+++.+|+. +|.+|++ ++|+++.
T Consensus 240 ~~~~~~~~~~~----i~~~~~--~~~~~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 240 CSDNPQETYRK----IINWKE--TLQFPD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCHHHHHHH----HHcCCC--ccCCCC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 86553322211 111110 000000 01123456788888886 8999998 8887663
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=322.84 Aligned_cols=249 Identities=21% Similarity=0.282 Sum_probs=198.5
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+++..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (330)
T cd05601 5 VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQP 84 (330)
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCC
Confidence 4578999999999999965 78899999997542 2344668899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..+..... ..
T Consensus 85 ~~~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~ 159 (330)
T cd05601 85 GGDLLSLLNRYED-QFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VN 159 (330)
T ss_pred CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-ee
Confidence 9999999987532 4899999999999999999999 89999999999999999999999999999986543221 12
Q ss_pred cccccCCCcccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 695 STGVAGTFGYLDPEYCQ------TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~------~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||........... .......... +
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~----i~~~~~~~~~--~-- 231 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN----IMNFQRFLKF--P-- 231 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHH----HHcCCCccCC--C--
Confidence 23356899999999886 45678999999999999999999999976543322221 2111111100 0
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
........+.+++..|+. +|++||+++++++.
T Consensus 232 ---~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 232 ---EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ---CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 011233467788999997 99999999998853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=324.13 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=201.0
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++..++|+||+++++++.+++..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (350)
T cd05573 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMP 84 (350)
T ss_pred EEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCC
Confidence 4568999999999999975 68999999997532 2345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC----
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG---- 690 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~---- 690 (846)
+++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 85 GGDLMNLLIRKD--VFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 999999998763 4899999999999999999999 8999999999999999999999999999998654322
Q ss_pred -----------------------cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccH
Q 003114 691 -----------------------VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHI 747 (846)
Q Consensus 691 -----------------------~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l 747 (846)
.........||+.|+|||.+.+..++.++|||||||+++||++|+.||.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 001223456899999999999999999999999999999999999999865532222
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 003114 748 SQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPN-MNRVVME 804 (846)
Q Consensus 748 ~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPs-m~eVl~~ 804 (846)
.. ..... ....-+. .......+.+++.+|+. +|++||+ ++|+++.
T Consensus 240 ~~----i~~~~--~~~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 240 NK----IINWK--ESLRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH----HhccC--CcccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 11100 0000000 11134567899999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=321.41 Aligned_cols=243 Identities=28% Similarity=0.351 Sum_probs=192.5
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHH-HHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVI-LLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||.||+|+.. +|+.+|+|++... .....+.+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36899999999999964 7899999998653 2223344555554 56778999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTT 153 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCc
Confidence 99999887654 3889999999999999999999 899999999999999999999999999998753211 1223
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....||+.|+|||.+.+..++.++|||||||+++||++|++||........ ....... .. .+. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~----~~~~~~~-~~------~~~----~~ 218 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM----YDNILHK-PL------VLR----PG 218 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH----HHHHHcC-Cc------cCC----CC
Confidence 345799999999999999999999999999999999999999976543222 2222211 10 111 12
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
....+.+++.+|++.+|++||++++.++.+
T Consensus 219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 219 ASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred CCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 234677899999999999999987544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.82 Aligned_cols=245 Identities=28% Similarity=0.371 Sum_probs=192.2
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHH-HHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEV-ILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei-~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36899999999999975 67789999986532 12223334443 456788999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.+++..... +.+.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~ 153 (325)
T cd05602 81 GELFYHLQRERC--FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTT 153 (325)
T ss_pred CcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCc
Confidence 999999976543 778888899999999999999 899999999999999999999999999998754221 1223
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....||+.|+|||++.+..++.++||||+||++|||++|++||......... ...... .. .+ ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----~~i~~~-~~------~~----~~~ 218 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY----DNILNK-PL------QL----KPN 218 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH----HHHHhC-Cc------CC----CCC
Confidence 3467999999999999999999999999999999999999999765433222 111111 10 01 112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
....+.+++.+|++.+|.+||++.+.+.++.+
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 219 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 23467899999999999999998865544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=302.91 Aligned_cols=248 Identities=28% Similarity=0.433 Sum_probs=198.9
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC-----chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS-----RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
..+.||+|++|.||++.. ++++.+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++|+||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 357899999999999986 468999999986432 12345688899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++++|.+++.... .+++..+.+++.+++.||.||| +.+|+||||||+||++++++.++|+|||+++........
T Consensus 86 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 86 MPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred CCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 99999999997654 3788999999999999999999 899999999999999999999999999998765322111
Q ss_pred c-ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 693 H-LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 693 ~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
. ......++..|+|||.+.+..++.++||||+|+++|||++|+.||........... ...... ...
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~---------~~~ 227 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPT---------NPQ 227 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccCC---------CCC
Confidence 1 11234578899999999998899999999999999999999999975433221111 111110 011
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.+......+.+++.+|+..+|++||++.|+++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 122234467899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=307.36 Aligned_cols=239 Identities=24% Similarity=0.382 Sum_probs=188.9
Q ss_pred hcCcCceEEEEEEEEcC-------------------------CcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeE
Q 003114 542 ILGEGSFGKVYHGYLDD-------------------------NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTL 596 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~~-------------------------g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l 596 (846)
.||+|+||.||+|.+.. ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999998521 13589999876655555678889999999999999999
Q ss_pred eeEeecCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC---
Q 003114 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF--- 673 (846)
Q Consensus 597 ~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~--- 673 (846)
+++|..+...++||||+++|+|..++..... .+++..+.+++.|+++||+||| +.+|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG-RVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999875433 4889999999999999999999 89999999999999997543
Q ss_pred ----cEEEEeccCCccCCCCCcccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCccccccH
Q 003114 674 ----QARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEII-TSRPAIANTEEHKHI 747 (846)
Q Consensus 674 ----~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELl-tG~~p~~~~~~~~~l 747 (846)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||........
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 4899999988643211 12356788999998865 56899999999999999995 79999976443221
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 748 SQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 748 ~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
..+.. ... .+.. .....+.+++.+|++.+|++||++++|++.|+
T Consensus 231 ~~~~~---~~~--------~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERFYE---KKH--------RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHH---hcc--------CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111 000 0111 11235789999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.92 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=206.0
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++..++..++||||+
T Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (267)
T cd08224 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecC
Confidence 45678999999999999976 8899999988643 2233567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 614 ANGSLEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 614 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
++++|.+++... ....+++.++..++.++++||.||| +.+|+||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 85 DAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred CCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 999999998653 2345889999999999999999999 8999999999999999999999999999987653221
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.......++..|+|||.+.+..++.++|||||||+++||++|+.||.... ..+.++...... +.... .
T Consensus 161 -~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~-----~--- 228 (267)
T cd08224 161 -TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCKKIEK-CDYPP-----L--- 228 (267)
T ss_pred -cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC--ccHHHHHhhhhc-CCCCC-----C---
Confidence 11223457889999999988889999999999999999999999986443 222222222111 11110 0
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
........+.+++.+|+..+|++||++.+|+++|+++
T Consensus 229 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0113345788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=303.81 Aligned_cols=239 Identities=24% Similarity=0.403 Sum_probs=190.3
Q ss_pred hhcCcCceEEEEEEEEcC-------------CcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeee
Q 003114 541 TILGEGSFGKVYHGYLDD-------------NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIG 607 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~-------------g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 607 (846)
+.||+|+||.||+|++.. ...|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998532 2358999987665555667889999999999999999999999999999
Q ss_pred EeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc-------EEEEec
Q 003114 608 LIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ-------ARLADF 680 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~-------vkI~DF 680 (846)
+||||+++|+|..++..... .+++..+++++.|+++||+||| +.+|+||||||+|||++.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999998875433 4899999999999999999999 899999999999999986654 899999
Q ss_pred cCCccCCCCCcccccccccCCCcccCccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCccccccHHHHHHHHHhcC
Q 003114 681 GLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQ-TFRLTEKSDVYSFGVVLLEII-TSRPAIANTEEHKHISQWVDFMLAQG 758 (846)
Q Consensus 681 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwS~Gvvl~ELl-tG~~p~~~~~~~~~l~~~~~~~~~~~ 758 (846)
|++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......+. .. .. .+
T Consensus 157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~-~~-~~ 224 (262)
T cd05077 157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ER-FY-EG 224 (262)
T ss_pred CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HH-HH-hc
Confidence 998754221 2245788899999886 466899999999999999998 58888765432111 01 11 11
Q ss_pred CcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 759 DIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 759 ~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
.. . . .......+.+++.+|++.+|++||++++|++.+
T Consensus 225 ~~-~-----~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QC-M-----L----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred Cc-c-----C----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 10 0 0 111234678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=320.05 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=212.5
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCe-eeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQ-IGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~-~~LV~Ey~ 613 (846)
...+.+|+|+||.++..+.+ +++.+++|.+.-. +....+...+|+.++++++|||||.+.+.+.+++. .++||+|+
T Consensus 7 e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~ 86 (426)
T KOG0589|consen 7 EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYC 86 (426)
T ss_pred hhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeec
Confidence 34578999999999998865 6778999988643 33444578899999999999999999999988888 99999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
+||+|.+.+...+...++++...+++.|++.|+.||| +..|+|||||+.||+++.+..|||.|||+|+.+.... .
T Consensus 87 eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~ 161 (426)
T KOG0589|consen 87 EGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--S 161 (426)
T ss_pred CCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch--h
Confidence 9999999999888778999999999999999999999 9999999999999999999999999999999875432 3
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
......||+.|+.||.+.+.+|..|+||||+||+++||++-+++|...+....+.+..+.. ....+
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~--------------~~Plp 227 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL--------------YSPLP 227 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc--------------CCCCC
Confidence 4566889999999999999999999999999999999999999998776554444433221 11223
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
......+..++..|+..+|+.||++.+++.+
T Consensus 228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 3445578899999999999999999999987
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=301.26 Aligned_cols=248 Identities=27% Similarity=0.508 Sum_probs=200.7
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||.||++.+.++..+|+|.+..... ...++.+|++++++++|||++++++++......++|+||+++++
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 34578999999999999987788999999875432 23578899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++..... .+++..+..++.+++.|++||| +.+++||||||+||+++.++.+||+|||+++...... ......
T Consensus 86 L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~ 160 (256)
T cd05112 86 LSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTG 160 (256)
T ss_pred HHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-ccccCC
Confidence 9999976543 3789999999999999999999 8899999999999999999999999999987653221 111122
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..++.+|+|||.+.+..++.++||||||+++|||++ |+.||........ .... ..+ .....+.. .
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~----~~~~-~~~--~~~~~~~~-------~ 226 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV----VETI-NAG--FRLYKPRL-------A 226 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH----HHHH-hCC--CCCCCCCC-------C
Confidence 335678999999988889999999999999999998 9999975443221 2211 111 01111221 2
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
...+.+++.+|++.+|++||+++|++++|
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 35788999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=313.77 Aligned_cols=257 Identities=18% Similarity=0.265 Sum_probs=196.5
Q ss_pred hhhhcCcC--ceEEEEEEEE-cCCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 539 FETILGEG--SFGKVYHGYL-DDNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 539 f~~~LG~G--~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
+.++||+| +|++||++.. .+|+.||+|++.... ....+.+++|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 7899999986 478999999997542 233456788999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc-
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS- 692 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~- 692 (846)
++|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999997655455899999999999999999999 899999999999999999999999999865443211110
Q ss_pred ----cccccccCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC-
Q 003114 693 ----HLSTGVAGTFGYLDPEYCQT--FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD- 765 (846)
Q Consensus 693 ----~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d- 765 (846)
.......++..|+|||++.+ ..++.++|||||||+++||++|+.||.............. +......+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~~ 233 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-----GTVPCLLDT 233 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc-----CCccccccc
Confidence 11122356778999999875 4588999999999999999999999976443222111110 11111000
Q ss_pred ------------------CCCC-----------------CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 ------------------PKLH-----------------GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 ------------------~~L~-----------------~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.... ..........+.+++.+|++.+|++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 0011122346889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=315.99 Aligned_cols=238 Identities=24% Similarity=0.343 Sum_probs=191.9
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|..++..+ +|++|+++++++...+..++||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (323)
T cd05616 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (323)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCC
Confidence 4568999999999999975 57899999987542 22334566777777777 5899999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|+|.+.+..... +++.++..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++..... ..
T Consensus 84 ~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--~~ 156 (323)
T cd05616 84 NGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--GV 156 (323)
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC--CC
Confidence 99999999876543 889999999999999999999 899999999999999999999999999998754221 11
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
......||+.|+|||++.+..++.++|||||||++|||+||+.||........... .. .... .++
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~----i~-~~~~----------~~p 221 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IM-EHNV----------AYP 221 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH----HH-hCCC----------CCC
Confidence 22345789999999999999999999999999999999999999986554332222 11 1111 111
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
......+.+++.+|++.+|++|++.
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 2234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.96 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=192.4
Q ss_pred hcCcCceEEEEEEEEcCC---cEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 542 ILGEGSFGKVYHGYLDDN---TEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~~g---~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999985433 346677766543 3345688999999999999999999999999999999999999999
Q ss_pred hhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 618 LEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 618 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|.++++... ....++.....++.|++.||+||| +.+++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997643 234667778899999999999999 889999999999999999999999999998643222111222
Q ss_pred ccccCCCcccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCC
Q 003114 696 TGVAGTFGYLDPEYCQT-------FRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~-------~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
....++..|+|||++.. ..++.++|||||||++|||++ |..||....+.+.+. ....+ ......++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~ 233 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN----HVIKD-QQVKLFKPQ 233 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHhh-cccccCCCc
Confidence 34567889999998743 245789999999999999997 577886544332222 22222 223334444
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
+...+ ...+.+++..|+ .+|++||+++||++.|.
T Consensus 234 ~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 43322 245677888999 57999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=308.82 Aligned_cols=244 Identities=23% Similarity=0.375 Sum_probs=199.9
Q ss_pred hhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 540 ETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
.+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+++++|
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L 104 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence 46799999999999986 47889999999876555567789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~ 698 (846)
.+++... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....... ......
T Consensus 105 ~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~ 176 (296)
T cd06654 105 TDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTM 176 (296)
T ss_pred HHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--cccCcc
Confidence 9998653 3788999999999999999999 8999999999999999999999999999987643221 112334
Q ss_pred cCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHH
Q 003114 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAW 778 (846)
Q Consensus 699 ~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~ 778 (846)
.|++.|+|||.+.+..++.++|||||||+++||++|+.||........+.. ....+ .. .+ ........
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~----~~~~~-~~-----~~--~~~~~~~~ 244 (296)
T cd06654 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL----IATNG-TP-----EL--QNPEKLSA 244 (296)
T ss_pred cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH----HhcCC-CC-----CC--CCccccCH
Confidence 688899999999888899999999999999999999999976543222211 11111 00 11 01122335
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 779 KAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 779 ~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+.+++.+|+..+|++||++.|+++
T Consensus 245 ~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 245 IFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHHHHHHHCcCCcccCcCHHHHhh
Confidence 6789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.94 Aligned_cols=259 Identities=27% Similarity=0.447 Sum_probs=202.2
Q ss_pred hhhhhhcCcCceEEEEEEEE-----cCCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecC--CeeeE
Q 003114 537 NDFETILGEGSFGKVYHGYL-----DDNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG--NQIGL 608 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~L 608 (846)
....+.||+|+||.||.++. .++..||+|.++... ....+.+.+|+.+++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 34456799999999999984 357889999987553 33456789999999999999999999998764 56899
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
||||+++++|.+++..... .+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++.+..
T Consensus 86 v~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 9999999999999976532 4899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCcc-cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------ccccHHHHHHHHHh
Q 003114 689 EGVS-HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTE-----------EHKHISQWVDFMLA 756 (846)
Q Consensus 689 ~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~-----------~~~~l~~~~~~~~~ 756 (846)
.... .......++..|+|||.+.+..++.++|||||||+++||++++.|..... .......++.. ..
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-LE 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH-HH
Confidence 2211 11223456778999999988889999999999999999999877653211 11111122211 11
Q ss_pred cCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 757 QGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 757 ~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
.+.. ..........+.+++.+|++.+|++||+++++++.|++++
T Consensus 241 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 241 EGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred cCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 1110 0111224457899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=309.99 Aligned_cols=257 Identities=22% Similarity=0.406 Sum_probs=201.5
Q ss_pred hhhcCcCceEEEEEEEEc-CCc----EEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 540 ETILGEGSFGKVYHGYLD-DNT----EVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.||+|+||.||+|... ++. .||+|.+..... ....++.+|+.+++.++||||++++++|... ...+++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 457999999999999863 443 478998875533 3344688999999999999999999998754 467999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|+|.+++..... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++.........
T Consensus 91 ~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 166 (303)
T cd05110 91 PHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166 (303)
T ss_pred CCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCccccc
Confidence 99999999876542 3889999999999999999999 8999999999999999999999999999998764332222
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ...+++ ..+... ..
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-~~~~~~----~~~~~~---------~~ 232 (303)
T cd05110 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-EIPDLL----EKGERL---------PQ 232 (303)
T ss_pred ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH----HCCCCC---------CC
Confidence 2233446778999999998899999999999999999997 89998754321 122222 111100 00
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhh
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETAR 815 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~ 815 (846)
.......+.+++..|+..+|++||+++++++.|+++...+...
T Consensus 233 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 275 (303)
T cd05110 233 PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRY 275 (303)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhh
Confidence 1123346789999999999999999999999999876554433
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.83 Aligned_cols=237 Identities=26% Similarity=0.365 Sum_probs=188.8
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHH-HHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEV-ILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei-~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||.||+|+.. +++.||+|++.... ......+.+|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 68899999986532 12233444554 467889999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.+.+.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (321)
T cd05603 81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETT 153 (321)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcc
Confidence 99998887543 3788889999999999999999 899999999999999999999999999998753211 2223
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+... ........ .. ..+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~-~~----------~~~~~ 218 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ----MYDNILHK-PL----------QLPGG 218 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH----HHHHHhcC-CC----------CCCCC
Confidence 34578999999999998889999999999999999999999997654322 22222111 10 11122
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMN 799 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~ 799 (846)
....+.+++.+|++.+|++||+..
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 334678999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.58 Aligned_cols=257 Identities=27% Similarity=0.474 Sum_probs=204.0
Q ss_pred hhhhhcCcCceEEEEEEEEc-----CCcEEEEEEeCCCCch-hhHHHHHHHHHHHhcccccceeEeeEeec--CCeeeEe
Q 003114 538 DFETILGEGSFGKVYHGYLD-----DNTEVAVKMLSPSSRQ-GYEQFEAEVILLRTVHHKNLTTLYGYCNE--GNQIGLI 609 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~LV 609 (846)
.+.+.||+|+||.||+|+++ .+..+|+|.+...... ..+.+.+|+++++.++|+||+++++++.. +...++|
T Consensus 7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05038 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86 (284)
T ss_pred hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEE
Confidence 34568999999999999864 3678999999866543 56789999999999999999999999877 6679999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||+++++|.+++..... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 87 ~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 87 MEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred EecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 999999999999986553 4899999999999999999999 889999999999999999999999999999876422
Q ss_pred Ccc-cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc-----------cHHHHHHHHHhc
Q 003114 690 GVS-HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK-----------HISQWVDFMLAQ 757 (846)
Q Consensus 690 ~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~-----------~l~~~~~~~~~~ 757 (846)
... .......++..|+|||...+..++.++||||||++++||++|+.|+....... ....+.... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 241 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL-KE 241 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH-Hc
Confidence 111 11122345667999999988899999999999999999999999886532211 111111111 11
Q ss_pred CCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 758 GDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 758 ~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
+. ....+......+.+++.+|++.+|++||+|.||+++|+++
T Consensus 242 ~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 242 GE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 10 1111122346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=321.54 Aligned_cols=249 Identities=21% Similarity=0.325 Sum_probs=196.8
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 46 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05596 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYM 125 (370)
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCC
Confidence 34578999999999999975 6889999998643 2223345778999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........ .
T Consensus 126 ~gg~L~~~l~~~~---l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~ 198 (370)
T cd05596 126 PGGDLVNLMSNYD---IPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-V 198 (370)
T ss_pred CCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-c
Confidence 9999999987643 778888899999999999999 89999999999999999999999999999976532211 1
Q ss_pred ccccccCCCcccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTF----RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........... ...... ....+
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~~~~--~~~~~--- 269 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK----IMDHKN--SLTFP--- 269 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH----HHcCCC--cCCCC---
Confidence 22345799999999988653 478899999999999999999999986543322211 111110 00000
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTP--RPNMNRVVME 804 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~--RPsm~eVl~~ 804 (846)
........+.+++.+|++.+|++ ||+++|+++.
T Consensus 270 --~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 270 --DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 01123456789999999999987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=307.00 Aligned_cols=243 Identities=25% Similarity=0.339 Sum_probs=196.4
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.||+|+||+||+|... +++.+|+|.+.... ......+.+|+.+++.++|+||+++.+.+..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 357999999999999975 68899999986542 22234577899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++.......+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++...... ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~---~~~ 158 (285)
T cd05632 85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ESI 158 (285)
T ss_pred ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC---Ccc
Confidence 99999987655556999999999999999999999 899999999999999999999999999998764321 112
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....|+..|+|||++.+..++.++|+|||||+++||++|+.||...........+..... ... .. +...
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~-~~~--~~--------~~~~ 227 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVL-ETE--EV--------YSAK 227 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhh-ccc--cc--------cCcc
Confidence 335689999999999888999999999999999999999999986544332222222111 110 01 1112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMN 799 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~ 799 (846)
....+.+++..|++.+|++||++.
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCc
Confidence 234678999999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=320.73 Aligned_cols=254 Identities=20% Similarity=0.221 Sum_probs=192.6
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.+.||+|+||.||++... +++.||+|... .+.+.+|+.++++++||||+++++++..+...++|+|++.
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~- 166 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK- 166 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence 344578999999999999964 68899999753 2356789999999999999999999999999999999995
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 167 ~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~ 240 (391)
T PHA03212 167 TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NANKY 240 (391)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-ccccc
Confidence 78988887654 3889999999999999999999 889999999999999999999999999999753221 11222
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccc-------cccHHHHHHHHHhc-CC--------
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE-------HKHISQWVDFMLAQ-GD-------- 759 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~-------~~~l~~~~~~~~~~-~~-------- 759 (846)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ...+...+...... ..
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 345799999999999988999999999999999999999987643221 11111111110000 00
Q ss_pred cccc---------cCCCCCCCC--ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 760 IKNI---------VDPKLHGDI--DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 760 ~~~~---------~d~~L~~~~--~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+. ..+...... .......+.+++.+|++.+|++|||++|+++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 000000000 0123456889999999999999999999875
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=323.92 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=193.8
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.++...++||||++
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 3468999999999999864 78899999986432 2344668889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc--
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS-- 692 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~-- 692 (846)
+|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 85 gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 85 GGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 999999997654 3888899999999999999999 899999999999999999999999999999643210000
Q ss_pred -------------------------------------------cccccccCCCcccCccccccCCCCchhhHHHHHHHHH
Q 003114 693 -------------------------------------------HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLL 729 (846)
Q Consensus 693 -------------------------------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ 729 (846)
.......||+.|+|||++.+..++.++|||||||+++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 0001246999999999999889999999999999999
Q ss_pred HHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCC---CCHHHHHHH
Q 003114 730 EIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPR---PNMNRVVME 804 (846)
Q Consensus 730 ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~R---Psm~eVl~~ 804 (846)
||++|++||........... ...... .+.-+. .......+.+++.+|+. +|.+| +++.|+++.
T Consensus 240 elltG~~Pf~~~~~~~~~~~----i~~~~~--~~~~p~-----~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRK----IINWRE--TLYFPD-----DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHH----HHccCC--ccCCCC-----CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999976543322211 111100 000010 01123457788999997 66665 589888775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=301.80 Aligned_cols=238 Identities=25% Similarity=0.414 Sum_probs=190.9
Q ss_pred hhcCcCceEEEEEEEEcCCc-----------EEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEe
Q 003114 541 TILGEGSFGKVYHGYLDDNT-----------EVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~-----------~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV 609 (846)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999976432 5788877655433 5788999999999999999999999988 778999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC-------cEEEEeccC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF-------QARLADFGL 682 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-------~vkI~DFGl 682 (846)
+||+++|+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999986543 4889999999999999999999 89999999999999999887 799999999
Q ss_pred CccCCCCCcccccccccCCCcccCccccccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCC
Q 003114 683 SKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF--RLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGD 759 (846)
Q Consensus 683 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~ 759 (846)
+..... .....++..|+|||++... .++.++|||||||++|||++ |..|+........ ..+ ......
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-~~~---~~~~~~ 224 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-ERF---YQDQHR 224 (259)
T ss_pred cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-HHH---HhcCCC
Confidence 986532 1233466789999998876 78999999999999999999 5777765432211 111 111100
Q ss_pred cccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 760 IKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 760 ~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
+ .......+.+++.+|+..+|++||++.||++.|+
T Consensus 225 --------~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 225 --------L----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --------C----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0011157889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=301.15 Aligned_cols=247 Identities=21% Similarity=0.353 Sum_probs=202.0
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||+|+||.||++... ++..+|+|.++.. .....+.+.+|+.+++.++|+||+++++.+..++..++||||+++|
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 83 (255)
T cd08219 4 VLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG 83 (255)
T ss_pred EEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence 4578999999999999965 6889999998643 3345567889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.......+++.....++.|++.||.||| +.+|+|+||||+||++++++.++++|||++...... .....
T Consensus 84 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~~~ 158 (255)
T cd08219 84 DLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAYAC 158 (255)
T ss_pred cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--ccccc
Confidence 9999987655556889999999999999999999 899999999999999999999999999998765322 11223
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
...|+..|+|||++.+..++.++||||||+++++|++|+.||........ .... ..+.... + +...
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~----~~~~-~~~~~~~-----~----~~~~ 224 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL----ILKV-CQGSYKP-----L----PSHY 224 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH----HHHH-hcCCCCC-----C----Cccc
Confidence 45688899999999988899999999999999999999999975432221 1111 1121111 1 1122
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
...+.+++.+|++.+|++||++.|++..
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 3467899999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.48 Aligned_cols=254 Identities=23% Similarity=0.408 Sum_probs=203.2
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCc----EEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNT----EVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
.+.+.||+|+||.||+|... ++. .+|+|.+..... ....++.+|+.++++++|+||+++++++.. ...++|+|
T Consensus 10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 88 (279)
T cd05057 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQ 88 (279)
T ss_pred EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEe
Confidence 44578999999999999864 333 589998876543 345678899999999999999999999987 78899999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+++|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 89 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 89 LMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred cCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 9999999999987543 3899999999999999999999 89999999999999999999999999999987643322
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
........++..|+|||.+....++.++|+|||||+++|+++ |+.||...... ++..... .+.. .
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~-~~~~--~------- 230 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV----EIPDLLE-KGER--L------- 230 (279)
T ss_pred ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHHHh-CCCC--C-------
Confidence 222222334678999999988889999999999999999998 99999765422 2222221 1110 0
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
..+..+...+.+++.+|+..+|++||++.++++.|+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0111233467899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=314.82 Aligned_cols=242 Identities=20% Similarity=0.295 Sum_probs=193.0
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 67889999997542 23345678899998888 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT 153 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCce
Confidence 99999887654 3899999999999999999999 899999999999999999999999999998753211 1223
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccc--cccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE--HKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
....||+.|+|||++.+..++.++|||||||+++||++|+.||..... .....++........... .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----------IP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----------CC
Confidence 346799999999999999999999999999999999999999964322 111222222222222111 11
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMN 799 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~ 799 (846)
......+.+++.+|++.+|++||++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 12234578999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.71 Aligned_cols=250 Identities=22% Similarity=0.388 Sum_probs=199.2
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
..+.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++.+..++..++|+||+++
T Consensus 11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 90 (267)
T cd06645 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG 90 (267)
T ss_pred HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence 345678999999999999864 6889999999766555556788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++.... .+++.+...++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++...... ....
T Consensus 91 ~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~~ 163 (267)
T cd06645 91 GSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKR 163 (267)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cccc
Confidence 99999987654 3899999999999999999999 889999999999999999999999999998765321 1122
Q ss_pred ccccCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 696 TGVAGTFGYLDPEYCQ---TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
....|+..|+|||++. ...++.++|||||||+++||++|+.||........+... . .... ..+.+...
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~----~-~~~~---~~~~~~~~- 234 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM----T-KSNF---QPPKLKDK- 234 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh----h-ccCC---CCCccccc-
Confidence 3456899999999874 445889999999999999999999998654332221111 1 1110 01111110
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
......+.+++.+|+..+|++||++++|++
T Consensus 235 -~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 235 -MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 112345789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=320.99 Aligned_cols=259 Identities=22% Similarity=0.343 Sum_probs=209.2
Q ss_pred HhhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-c-----ccceeEeeEeecCCeeeE
Q 003114 536 TNDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-H-----KNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H-----pnIv~l~g~~~~~~~~~L 608 (846)
++.+.+.||+|.||.|-||.. ++++.||||+++.... -..+...|+.+|..++ | -|+|++++||...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 456678999999999999985 5799999999986533 3466788999999997 4 379999999999999999
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC--CcEEEEeccCCccC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ--FQARLADFGLSKTF 686 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~--~~vkI~DFGla~~~ 686 (846)
|+|.+. .+|.++|+.++...++......|+.||+.||.+|| +.+|||+||||+||||.+. ..+||+|||.++..
T Consensus 266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999994 59999999999888999999999999999999999 9999999999999999743 47999999999865
Q ss_pred CCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHH-------HhcC-
Q 003114 687 PIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFM-------LAQG- 758 (846)
Q Consensus 687 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~-------~~~~- 758 (846)
... . .....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.++.+.+..++... +..+
T Consensus 342 ~q~----v-ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQR----V-YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CCc----c-eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 322 1 14456788999999999999999999999999999999999999988887776665432 1110
Q ss_pred CcccccCC--------------------------------CCCC--------CCChHHHHHHHHHHHhccCCCCCCCCCH
Q 003114 759 DIKNIVDP--------------------------------KLHG--------DIDVNSAWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 759 ~~~~~~d~--------------------------------~L~~--------~~~~~~~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
+....++. .... ......-..+++++.+|+..||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 11111111 0000 0111334567899999999999999999
Q ss_pred HHHHHH
Q 003114 799 NRVVME 804 (846)
Q Consensus 799 ~eVl~~ 804 (846)
.|+++.
T Consensus 497 ~qal~H 502 (586)
T KOG0667|consen 497 AQALNH 502 (586)
T ss_pred HHHhcC
Confidence 998764
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=323.40 Aligned_cols=247 Identities=22% Similarity=0.316 Sum_probs=190.6
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++|+||+++++.+.+++..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g 85 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence 467999999999999964 68889999987542 23345688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc----
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV---- 691 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~---- 691 (846)
|+|.+++.... .+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 86 g~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 86 GDMMSLLIRMG--IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999997654 3788889999999999999999 89999999999999999999999999999753310000
Q ss_pred -----------------------------------------ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHH
Q 003114 692 -----------------------------------------SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLE 730 (846)
Q Consensus 692 -----------------------------------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~E 730 (846)
........||+.|+|||++.+..++.++||||+||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 001123468999999999998899999999999999999
Q ss_pred HHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 003114 731 IITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPN---MNRVVM 803 (846)
Q Consensus 731 LltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPs---m~eVl~ 803 (846)
|++|++||............ .... .....+. .........+++.+|+ .+|++|++ +.|+++
T Consensus 241 lltG~~Pf~~~~~~~~~~~i----~~~~--~~~~~p~-----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKV----INWQ--TSLHIPP-----QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHH----HccC--CCcCCCC-----cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 99999999865433222211 1100 0000010 0112234556666655 49999997 777664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=318.88 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=196.4
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCC-----eeeEee
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN-----QIGLIY 610 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-----~~~LV~ 610 (846)
..+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.+++.++|+||+++++++...+ ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 356899999999999996 47899999998653 2334567889999999999999999999998766 789999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+. ++|.+.+.... .+++..+..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 84 e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 84 ELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred eccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 9996 58888876543 4899999999999999999999 8999999999999999999999999999997643221
Q ss_pred cccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHH----------------
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDF---------------- 753 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~---------------- 753 (846)
........++..|+|||.+.+. .++.++||||+||+++||++|+.||........+......
T Consensus 158 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 158 -SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred -cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 1222334678999999988764 4789999999999999999999999866543322222111
Q ss_pred --HHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 754 --MLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 754 --~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
............+.+ ..........+.+++.+|++.+|++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000000 00111224567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.06 Aligned_cols=258 Identities=23% Similarity=0.343 Sum_probs=194.8
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhc---ccccceeEeeEeec-----CCeee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--QGYEQFEAEVILLRTV---HHKNLTTLYGYCNE-----GNQIG 607 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~-----~~~~~ 607 (846)
+.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++.. ....+
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~ 83 (288)
T cd07863 4 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVT 83 (288)
T ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEE
Confidence 4567999999999999975 688999999875422 1223456677776665 69999999998754 34589
Q ss_pred EeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCC
Q 003114 608 LIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP 687 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~ 687 (846)
+||||+. ++|.+++.......+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 84 LVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred EEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 9999997 58999987765556899999999999999999999 8999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--cc----
Q 003114 688 IEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--IK---- 761 (846)
Q Consensus 688 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--~~---- 761 (846)
.. .......|+..|+|||++.+..++.++||||+||+++||++|++||........+.+.......... ..
T Consensus 160 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 160 CQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred Cc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 21 1223356789999999998888999999999999999999999999766544444333322111000 00
Q ss_pred ---cccCCCCCC---CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 762 ---NIVDPKLHG---DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 762 ---~~~d~~L~~---~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+.+.... ....+....+.+++.+|++.||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 001123356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=327.60 Aligned_cols=256 Identities=20% Similarity=0.325 Sum_probs=191.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecC--------CeeeE
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG--------NQIGL 608 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--------~~~~L 608 (846)
.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++... ...++
T Consensus 69 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 34578999999999999974 68899999885432 2345799999999999999999876321 24678
Q ss_pred eeecccCCChhhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC-cEEEEeccCCcc
Q 003114 609 IYEYMANGSLEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF-QARLADFGLSKT 685 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-~vkI~DFGla~~ 685 (846)
||||+++ +|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus 145 vmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 145 VMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 9999974 777776532 2345899999999999999999999 89999999999999999664 799999999986
Q ss_pred CCCCCcccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc-------
Q 003114 686 FPIEGVSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ------- 757 (846)
Q Consensus 686 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~------- 757 (846)
+... .......||+.|+|||++.+. .++.++|||||||++|||++|++||.+....+.+...++.....
T Consensus 221 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 221 LLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred ccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 5322 122335689999999987654 68999999999999999999999998765544444433221100
Q ss_pred --CCc-----ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 758 --GDI-----KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 758 --~~~-----~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
... ..+....+...++.....++.+++.+||+.+|++|||+.|+++.
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000 00001111111122234578899999999999999999998854
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=313.82 Aligned_cols=239 Identities=23% Similarity=0.371 Sum_probs=192.3
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|..+++.+. |++|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 45678999999999999965 68899999987532 223455777888888885 57788899999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.+++..... +++.++..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-- 155 (323)
T cd05615 83 VNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-- 155 (323)
T ss_pred CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC--
Confidence 999999999876543 899999999999999999999 8999999999999999999999999999987542221
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
.......||+.|+|||++.+..++.++||||+||+++||++|+.||......... ..... ... .+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~----~~i~~-~~~----------~~ 220 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF----QSIME-HNV----------SY 220 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHHh-CCC----------CC
Confidence 1223456899999999999888999999999999999999999999865433222 11111 111 11
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
+......+.+++.+|++.+|++|++.
T Consensus 221 p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11223467899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.54 Aligned_cols=244 Identities=26% Similarity=0.434 Sum_probs=199.3
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++|+||++++
T Consensus 8 ~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06642 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred HHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCC
Confidence 3467999999999999865 67889999987543 344567899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++... .+++..+..++.+++.|+.||| +.+++|+||+|+||++++++.++|+|||++..+.... ....
T Consensus 88 ~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~ 159 (277)
T cd06642 88 SALDLLKPG---PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRN 159 (277)
T ss_pred cHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhhh
Confidence 999998653 3889999999999999999999 8999999999999999999999999999997653221 1122
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
...++..|+|||++.+..++.++|||||||+++||++|+.|+......... . ....+ ..+.+ ....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----~-~~~~~-----~~~~~----~~~~ 225 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL----F-LIPKN-----SPPTL----EGQY 225 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH----h-hhhcC-----CCCCC----Cccc
Confidence 345788999999999888999999999999999999999998654322211 1 11111 11111 2233
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
...+.+++.+|++.+|++||+|.+|++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 4578899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=305.25 Aligned_cols=240 Identities=25% Similarity=0.421 Sum_probs=191.5
Q ss_pred hhcCcCceEEEEEEEEcC--------CcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 541 TILGEGSFGKVYHGYLDD--------NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.||+|+||.||+|.... ..++|+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998632 234888888766555567889999999999999999999999998999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc--------EEEEeccCCc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ--------ARLADFGLSK 684 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~--------vkI~DFGla~ 684 (846)
+++|+|.++++.... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999986543 4899999999999999999999 899999999999999987765 6999999886
Q ss_pred cCCCCCcccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCC-CCCCCccccccHHHHHHHHHhcCCccc
Q 003114 685 TFPIEGVSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSR-PAIANTEEHKHISQWVDFMLAQGDIKN 762 (846)
Q Consensus 685 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~-~p~~~~~~~~~l~~~~~~~~~~~~~~~ 762 (846)
.... .....++..|+|||++.+. .++.++|||||||++|||++|. +|+........ ........
T Consensus 157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~----~~~~~~~~---- 222 (258)
T cd05078 157 TVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK----LQFYEDRH---- 222 (258)
T ss_pred ccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH----HHHHHccc----
Confidence 5422 1234578889999998764 5799999999999999999995 55544332211 11111100
Q ss_pred ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 763 IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 763 ~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
..+.....++.+++.+|++.+|++|||++++++.|+
T Consensus 223 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 --------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111122346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=301.40 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=198.7
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++..++..++|+||+++++
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~ 88 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 88 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence 3467999999999999976 577889999977666666788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|..++.... ..+++..+..++.|+++||.||| +.+++||||||+||+++.++.+||+|||++...... ......
T Consensus 89 l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~ 162 (282)
T cd06643 89 VDAVMLELE-RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDS 162 (282)
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc--cccccc
Confidence 999886533 34899999999999999999999 899999999999999999999999999998764321 122234
Q ss_pred ccCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 698 VAGTFGYLDPEYCQ-----TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 698 ~~gt~~Y~APE~~~-----~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
..++..|+|||++. +..++.++|||||||++|||++|++||............. .... .....
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~----~~~~-~~~~~------- 230 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA----KSEP-PTLAQ------- 230 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh----hcCC-CCCCC-------
Confidence 56889999999874 3457789999999999999999999997654332222211 1111 11111
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+......+.+++.+|++.+|++||++.++++.
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11223468899999999999999999988653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=301.89 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=199.1
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhH--HHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYE--QFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~--~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|+||+||+++.. +++.+|+|++......... ...+|+.++++++||||+++++++......++||||+++
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 82 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG 82 (260)
T ss_dssp EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccc
Confidence 4568999999999999976 5668999999877544322 345699999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++.... .+++..+..++.|+++||.+|| +.+|+|+||||+||++++++.++|+|||.+... .......
T Consensus 83 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~ 155 (260)
T PF00069_consen 83 GSLQDYLQKNK--PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENF 155 (260)
T ss_dssp EBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEB
T ss_pred ccccccccccc--cccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--ccccccc
Confidence 99999998333 3899999999999999999999 889999999999999999999999999998754 1122334
Q ss_pred ccccCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 696 TGVAGTFGYLDPEYCQ-TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~-~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
....++..|+|||.+. +...+.++||||+|+++++|++|+.||.............+...... ..... ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~--~~~ 227 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL------PSSSQ--QSR 227 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH------HHHTT--SHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc------ccccc--ccc
Confidence 4567899999999998 88899999999999999999999999987632222221111111000 00000 000
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.....+.+++.+|++.+|++||++.++++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11268899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.08 Aligned_cols=246 Identities=27% Similarity=0.438 Sum_probs=201.0
Q ss_pred hhhhhcCcCceEEEEEEEEcC-CcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 538 DFETILGEGSFGKVYHGYLDD-NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.+.||+|+||.||+|+..+ +..+++|.+..... .+++.+|++++++++|+||+++++++..+...++++||++++
T Consensus 6 ~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 83 (256)
T cd06612 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG 83 (256)
T ss_pred hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence 445789999999999999864 78999999875533 578999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.... ..+++..+..++.|++.||.||| +.+++||||+|+||++++++.+||+|||++....... ....
T Consensus 84 ~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~ 157 (256)
T cd06612 84 SVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AKRN 157 (256)
T ss_pred cHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--cccc
Confidence 9999997544 34899999999999999999999 8899999999999999999999999999998654321 1223
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
...++..|+|||++.+..++.++|||||||+++||++|++||............ .. ...+.+. .+...
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-----~~-----~~~~~~~--~~~~~ 225 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-----PN-----KPPPTLS--DPEKW 225 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-----cc-----CCCCCCC--chhhc
Confidence 345788999999999889999999999999999999999999765433221110 00 0001111 11223
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
...+.+++.+|++.+|++||+++||++
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 346889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.96 Aligned_cols=246 Identities=23% Similarity=0.378 Sum_probs=195.8
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChh
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLE 619 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 619 (846)
..||+|+||.||+|+.. ++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 57999999999999964 67889999998776666778999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCC-ccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-CCcEEEEeccCCccCCCCCccccccc
Q 003114 620 EYLSDSNAD-VLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-QFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 620 ~~l~~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
+++...... ..++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||++....... .....
T Consensus 94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 168 (268)
T cd06624 94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PCTET 168 (268)
T ss_pred HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC--Ccccc
Confidence 999864321 1278888899999999999999 899999999999999976 6799999999987653221 12223
Q ss_pred ccCCCcccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 698 VAGTFGYLDPEYCQTF--RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~--~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
..|+..|+|||++... .++.++||||||++++||++|++||........ ..+...... ..+ ..+..
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-~~~~~~~~~-------~~~----~~~~~ 236 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-AMFKVGMFK-------IHP----EIPES 236 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-hHhhhhhhc-------cCC----CCCcc
Confidence 4578999999998654 378999999999999999999999975432111 111110000 001 11222
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
....+.+++.+|++.+|++||++.|+++
T Consensus 237 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 237 LSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 3456889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.94 Aligned_cols=247 Identities=26% Similarity=0.461 Sum_probs=199.0
Q ss_pred hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCC------chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSS------RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|+++++.++|+||+++++++.+.+..++|+||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 46799999999999998889999999986432 123356889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC---
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG--- 690 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~--- 690 (846)
++++|.+++.... .+++..+..++.|++.||+||| +.+|+|+||||+||++++++.+||+|||++.......
T Consensus 85 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 85 PGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999997654 3789999999999999999999 8899999999999999999999999999987642211
Q ss_pred -cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 691 -VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 691 -~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
.........|+..|+|||++.+..++.++|||||||+++||++|+.||...+........ ...... .+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~---~~~~~~-----~~~~- 230 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI---GAHRGL-----MPRL- 230 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh---hhccCC-----CCCC-
Confidence 111223356889999999999888999999999999999999999999764432221111 111011 1111
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+......+.+++.+|++.+|++||++.|+++
T Consensus 231 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 231 ---PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1223456789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.12 Aligned_cols=246 Identities=24% Similarity=0.450 Sum_probs=194.7
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeecC------CeeeEee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEG------NQIGLIY 610 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~------~~~~LV~ 610 (846)
..+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++++ +|+||+++++++... ...++||
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 88 (272)
T cd06637 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 88 (272)
T ss_pred HHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEE
Confidence 3567999999999999965 68889999986543 3345788899999998 799999999998642 4689999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+++++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 89 e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~- 164 (272)
T cd06637 89 EFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT- 164 (272)
T ss_pred EcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCceecccc-
Confidence 9999999999998765556899999999999999999999 889999999999999999999999999998765321
Q ss_pred cccccccccCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQ-----TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 765 (846)
........|+..|+|||++. ...++.++|||||||++|||++|+.||......... .. ..... .
T Consensus 165 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~---~~--~~~~~-----~ 233 (272)
T cd06637 165 -VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---FL--IPRNP-----A 233 (272)
T ss_pred -cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH---HH--HhcCC-----C
Confidence 12233456889999999875 345788999999999999999999999654322111 11 11111 1
Q ss_pred CCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 ~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+.+. .......+.+++.+|+..+|.+||++.|+++
T Consensus 234 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 234 PRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1111 1123346889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.40 Aligned_cols=249 Identities=30% Similarity=0.512 Sum_probs=202.0
Q ss_pred hhhhcCcCceEEEEEEEEcC-----CcEEEEEEeCCCCch-hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 539 FETILGEGSFGKVYHGYLDD-----NTEVAVKMLSPSSRQ-GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.+.||.|+||.||++...+ +..||+|.+...... ..+.+.+|+..++.++|+||+++++++...+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45689999999999999753 478999999765443 567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++++|.+++.......+++.++..++.|++.||+||| +.+++||||||+||++++++.++|+|||+++........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 99999999998765444899999999999999999999 889999999999999999999999999999876433211
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
. .....++..|+|||.+.+..++.++||||+|++++||++ |++||...... ......... ... .
T Consensus 160 ~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~----~~~~~~~~~-~~~---------~ 224 (258)
T smart00219 160 K-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE----EVLEYLKKG-YRL---------P 224 (258)
T ss_pred c-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHhcC-CCC---------C
Confidence 1 112336789999999988889999999999999999998 78888753322 212222111 111 0
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
........+.+++.+|+..+|++|||+.|+++.|
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1112345788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=316.68 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=208.9
Q ss_pred hhhhcCcCceEEEEEEEEc--CC--cEEEEEEeCCCCch-hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 539 FETILGEGSFGKVYHGYLD--DN--TEVAVKMLSPSSRQ-GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~--~g--~~VAVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.-+.||+|.||.|++|.|+ .| ..||||.++..... ....|.+|+.+|.+|+|+|+++|+|...+ ....||+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3478999999999999985 34 35899999876544 67889999999999999999999999987 7789999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
+.|+|.+.|++.....|-......++.|||.||.||. .++.|||||.++|+||-....+||+||||.+.+......+
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 9999999999865566888888999999999999999 9999999999999999999999999999999886544433
Q ss_pred -ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 694 -LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 694 -~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
+.....-.+.|+|||.+...+++.++|||+|||.+|||+| |..||-+-.....+. .+|..-+-.
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~--------------~iD~~erLp 335 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK--------------NIDAGERLP 335 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH--------------hccccccCC
Confidence 3333456788999999999999999999999999999998 688997655332221 122222223
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
-+..+.+.+.+++..||..+|++||++..|.+.+
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 3567888999999999999999999999998544
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=300.08 Aligned_cols=246 Identities=24% Similarity=0.443 Sum_probs=198.3
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCch---------hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeE
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQ---------GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L 608 (846)
+...||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 4568999999999999864 6889999988654221 22567889999999999999999999999999999
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
|+||+++++|.+++.... .+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 84 FLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 999999999999997654 3888999999999999999999 88999999999999999999999999999987642
Q ss_pred CCcc----cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 003114 689 EGVS----HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIV 764 (846)
Q Consensus 689 ~~~~----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~ 764 (846)
.... .......|+..|+|||.+.+..++.++||||+||+++||++|+.||........+.. .. . ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~-~-----~~ 228 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK----IG-E-----NA 228 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHH----Hh-c-----cC
Confidence 2111 111234578899999999888899999999999999999999999976543222111 11 1 11
Q ss_pred CCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 765 DPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 765 d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+. .+......+.+++.+|++.+|++||++.||++
T Consensus 229 ~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 SPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111 12233457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=319.25 Aligned_cols=249 Identities=22% Similarity=0.312 Sum_probs=194.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 46 ~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05621 46 DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYM 125 (370)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCC
Confidence 34568999999999999975 5788999998642 2223456788999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 126 ~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~~ 198 (370)
T cd05621 126 PGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MV 198 (370)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-ce
Confidence 999999999754 3788899999999999999999 8999999999999999999999999999998653221 11
Q ss_pred ccccccCCCcccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFR----LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~----~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||........... ......... .
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~----i~~~~~~~~-----~- 268 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK----IMDHKNSLN-----F- 268 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCcccC-----C-
Confidence 223467999999999986543 78899999999999999999999976543322222 111111000 0
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTP--RPNMNRVVME 804 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~--RPsm~eVl~~ 804 (846)
.........+.+++..|+...+.+ ||++.|+++.
T Consensus 269 -p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 -PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 001122345678888888755543 8899998876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.17 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=197.8
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.++++++|+|++++++.+..++..++||||+++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 467999999999999965 68899999986542 22234577899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++.......+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++....... ..
T Consensus 85 ~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~ 158 (285)
T cd05630 85 GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TI 158 (285)
T ss_pred CcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---cc
Confidence 99999997655556899999999999999999999 8999999999999999999999999999987543221 12
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....|+..|+|||++.+..++.++|||||||+++||++|+.||...........+ ....... . .. +...
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~-~~~~~~~--~----~~----~~~~ 227 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-ERLVKEV--Q----EE----YSEK 227 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH-Hhhhhhh--h----hh----cCcc
Confidence 2346899999999999889999999999999999999999999764322111111 1111100 0 00 1112
Q ss_pred HHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPN-----MNRVVM 803 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPs-----m~eVl~ 803 (846)
....+.+++..|++.+|++||| ++|+++
T Consensus 228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 2345789999999999999999 777766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.43 Aligned_cols=245 Identities=26% Similarity=0.425 Sum_probs=203.8
Q ss_pred hcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChhh
Q 003114 542 ILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEE 620 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 620 (846)
+||+|.||+||.|+.. +...+|||-+........+.+.+|+.+.+.++|.|||+++|.|.+++.+-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999965 566799999988777777889999999999999999999999999999999999999999999
Q ss_pred hhhcCCCC-ccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC-CCCcEEEEeccCCccCCCCCcccccccc
Q 003114 621 YLSDSNAD-VLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN-DQFQARLADFGLSKTFPIEGVSHLSTGV 698 (846)
Q Consensus 621 ~l~~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld-~~~~vkI~DFGla~~~~~~~~~~~~~~~ 698 (846)
+|+..-+. .-++.++-.+.+||++||+||| +..|||||||-+|||++ -.|.+||+|||-++.+. +.......+
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhc--cCCcccccc
Confidence 99865432 1267777888999999999999 89999999999999996 57899999999998863 344455667
Q ss_pred cCCCcccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 699 AGTFGYLDPEYCQTF--RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 699 ~gt~~Y~APE~~~~~--~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
-||..|||||++..+ .|..++|||||||.+.||.||+|||-........ +.+-|- -......+.+.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA------MFkVGm------yKvHP~iPeel 804 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA------MFKVGM------YKVHPPIPEEL 804 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh------hhhhcc------eecCCCCcHHH
Confidence 899999999999765 4899999999999999999999999754432211 111110 01123446666
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+...++++|..++|.+||+++++++
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 778889999999999999999999875
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=336.49 Aligned_cols=258 Identities=22% Similarity=0.319 Sum_probs=202.4
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+|+.. +++.||+|++.... ....+++.+|+.++++++||||+++++++.+++..++||||++
T Consensus 6 Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~e 85 (932)
T PRK13184 6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIE 85 (932)
T ss_pred EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence 3568999999999999975 68999999997542 2334678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCC---------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCcc
Q 003114 615 NGSLEEYLSDSN---------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685 (846)
Q Consensus 615 ~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~ 685 (846)
+|+|.+++.... ...+++..+++++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecCccee
Confidence 999999986421 223567788999999999999999 88999999999999999999999999999986
Q ss_pred CCCCCc----------------ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHH
Q 003114 686 FPIEGV----------------SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ 749 (846)
Q Consensus 686 ~~~~~~----------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~ 749 (846)
...... ........||+.|+|||++.+..++.++|||||||+++||+||+.||...........
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~ 242 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh
Confidence 521110 0111234699999999999999999999999999999999999999976432211100
Q ss_pred HHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhhh
Q 003114 750 WVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRP-NMNRVVMELKECLAM 811 (846)
Q Consensus 750 ~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RP-sm~eVl~~L~~~l~~ 811 (846)
.. ..++.-.. ...+....+.+++.+|++.+|++|| +++++.+.|+..+..
T Consensus 243 --------~~---i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 243 --------DV---ILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred --------hh---ccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 00110000 0112335678999999999999995 788888888887654
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=296.93 Aligned_cols=248 Identities=21% Similarity=0.356 Sum_probs=200.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeec-CCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNE-GNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~LV~Ey~ 613 (846)
.+.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++|+|++++++.+.. ....++||||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence 34578999999999999965 57889999986432 3345678899999999999999999988764 44688999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++++|.+++.......+++.++..++.+++.|+++|| +.+++||||||+||+++.++.++|+|||++...... ..
T Consensus 83 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~ 157 (257)
T cd08223 83 EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CD 157 (257)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEeccc--CC
Confidence 9999999998765556899999999999999999999 899999999999999999999999999999765322 12
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
......+++.|+|||...+..++.++||||+||+++||++|+.||...+.. .+..... .+... ..+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~----~~~~~~~-~~~~~---------~~~ 223 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN----SLVYRII-EGKLP---------PMP 223 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHH-hcCCC---------CCc
Confidence 223456889999999999989999999999999999999999999754432 2222221 12111 111
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
......+.+++.+|++.+|++||++.++++.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 2234568899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=322.72 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=193.1
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++.++|+||+++++.+.+++..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 3468999999999999964 68899999986532 2234567889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC----
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG---- 690 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~---- 690 (846)
+|+|.+++.... .+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..+....
T Consensus 85 ~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 85 GGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 999999997654 3788888999999999999999 8999999999999999999999999999975331000
Q ss_pred -------------------------------------cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh
Q 003114 691 -------------------------------------VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733 (846)
Q Consensus 691 -------------------------------------~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt 733 (846)
.........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 0001123469999999999999999999999999999999999
Q ss_pred CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCC---CHHHHHHH
Q 003114 734 SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRP---NMNRVVME 804 (846)
Q Consensus 734 G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RP---sm~eVl~~ 804 (846)
|+.||........... ..... .....+. .......+.+++.+|+ .+|++|+ ++.|+++.
T Consensus 240 G~~Pf~~~~~~~~~~~----i~~~~--~~~~~~~-----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 240 GQPPFLADTPAETQLK----VINWE--TTLHIPS-----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCCHHHHHHH----HhccC--ccccCCC-----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999986553322111 11100 0000010 1112234566777765 4999999 78888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.51 Aligned_cols=244 Identities=27% Similarity=0.405 Sum_probs=195.3
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||+|+||.||+|.. .+++.||+|.+... .....+++.+|+.++++++||||+++++++...+..++||||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 456899999999999986 47889999998654 3334567889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|..+. .+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++...... ...
T Consensus 85 ~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~ 151 (279)
T cd06619 85 SLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAK 151 (279)
T ss_pred ChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----ccc
Confidence 997652 2678888999999999999999 899999999999999999999999999999765321 223
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc---cHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK---HISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~---~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
...|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....+......+. .+.+. .
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~---~ 222 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVLP---V 222 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCCC---C
Confidence 4578999999999998889999999999999999999999997533211 1112222111111 11111 1
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
......+.+++.+|++.+|++||+++|+++.
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1123467899999999999999999998875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=319.73 Aligned_cols=257 Identities=20% Similarity=0.263 Sum_probs=196.9
Q ss_pred HhhhhhhcCcCceEEEEEEEEc---CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 536 TNDFETILGEGSFGKVYHGYLD---DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.+.||+|+||.||++... .+..||+|.+... +...+|+.++++++||||+++++++......++|||+
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 3455678999999999999753 3578999988643 3456899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+. ++|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 168 ~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 168 YK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred cC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 95 6888888543 34899999999999999999999 899999999999999999999999999999866443333
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc---cHHHHHHHHHhcCCcc--c-----
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK---HISQWVDFMLAQGDIK--N----- 762 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~---~l~~~~~~~~~~~~~~--~----- 762 (846)
.......||+.|+|||++....++.++|||||||++|||++|+.||....... .+...++... ..... .
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~-~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ-VHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhc-cCccccCCccchh
Confidence 33345679999999999998899999999999999999999999997644222 1222111110 00000 0
Q ss_pred ------ccCCCCCCCCC-------hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 763 ------IVDPKLHGDID-------VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 763 ------~~d~~L~~~~~-------~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.+.......+. ......+.+++.+|+..+|++||++.|++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0123457789999999999999999998865
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=298.05 Aligned_cols=244 Identities=25% Similarity=0.428 Sum_probs=197.9
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||.||++.. .++.||+|.++... ..+.+.+|+.+++.++|||++++++++... ..++||||+++++
T Consensus 9 ~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~ 84 (254)
T cd05083 9 TLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN 84 (254)
T ss_pred eeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence 4567899999999999975 67789999986543 235788999999999999999999998764 4789999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++.......+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++...... ...
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~ 156 (254)
T cd05083 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDN 156 (254)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----CCC
Confidence 999998766556899999999999999999999 899999999999999999999999999998754211 122
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
...+..|+|||.+.+..++.++|||||||+++||++ |++||......+ +.... ..+.. .......
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~~~-~~~~~---------~~~~~~~ 222 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE----VKECV-EKGYR---------MEPPEGC 222 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH----HHHHH-hCCCC---------CCCCCcC
Confidence 334568999999988889999999999999999997 999997654322 22211 11110 0111223
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
...+.+++.+|++.+|++||+++++++.|++
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 4578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=296.67 Aligned_cols=248 Identities=25% Similarity=0.327 Sum_probs=208.2
Q ss_pred hhhcCcCceEEEEEEEEcC-CcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 540 ETILGEGSFGKVYHGYLDD-NTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.||+|.-|+||++++.+ +..+|+|++.+.. .....+.+.|-++|+.++||.+..|++.++.++..++|||||+|
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG 161 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG 161 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence 3579999999999999864 5889999998753 33455677899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC------
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE------ 689 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~------ 689 (846)
|+|..+++.+..+.+++..+.-++.+++-||+||| ..|||.|||||+||||-++|++.|+||.|+......
T Consensus 162 GdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s 238 (459)
T KOG0610|consen 162 GDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS 238 (459)
T ss_pred ccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence 99999999999888999999999999999999999 999999999999999999999999999998654210
Q ss_pred --------------------------C-c---------------------ccccccccCCCcccCccccccCCCCchhhH
Q 003114 690 --------------------------G-V---------------------SHLSTGVAGTFGYLDPEYCQTFRLTEKSDV 721 (846)
Q Consensus 690 --------------------------~-~---------------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDV 721 (846)
. . ......++||-.|+|||++.+...+.++|-
T Consensus 239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDW 318 (459)
T KOG0610|consen 239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDW 318 (459)
T ss_pred CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhH
Confidence 0 0 011123579999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCC----
Q 003114 722 YSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPN---- 797 (846)
Q Consensus 722 wS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPs---- 797 (846)
|+|||++|||+.|..||.+....+.+...+. +.+.-.........+.+|+.+.+.+||++|..
T Consensus 319 WtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-------------~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rG 385 (459)
T KOG0610|consen 319 WTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-------------QPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRG 385 (459)
T ss_pred HHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-------------CCCcCCCCCcchhHHHHHHHHHhccChhhhhccccc
Confidence 9999999999999999998877666555432 22221112244567889999999999999998
Q ss_pred HHHHHH
Q 003114 798 MNRVVM 803 (846)
Q Consensus 798 m~eVl~ 803 (846)
+.||.+
T Consensus 386 A~eIK~ 391 (459)
T KOG0610|consen 386 AAEIKR 391 (459)
T ss_pred hHHhhc
Confidence 666654
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=298.18 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=198.4
Q ss_pred hhhhcCcCceEEEEEEEEcC--CcEEEEEEeCCC----------CchhhHHHHHHHHHHHh-cccccceeEeeEeecCCe
Q 003114 539 FETILGEGSFGKVYHGYLDD--NTEVAVKMLSPS----------SRQGYEQFEAEVILLRT-VHHKNLTTLYGYCNEGNQ 605 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~----------~~~~~~~~~~Ei~~l~~-l~HpnIv~l~g~~~~~~~ 605 (846)
+.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++..++.
T Consensus 4 ~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 83 (269)
T cd08528 4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR 83 (269)
T ss_pred hhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCe
Confidence 45679999999999999765 678999987532 12234456778887765 799999999999999999
Q ss_pred eeEeeecccCCChhhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCC
Q 003114 606 IGLIYEYMANGSLEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLS 683 (846)
Q Consensus 606 ~~LV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla 683 (846)
.++||||+++++|.+++... ....+++..+++++.|++.||.|||+ ..+++|+||||+||++++++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecccce
Confidence 99999999999999988542 23458899999999999999999993 267999999999999999999999999999
Q ss_pred ccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 003114 684 KTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNI 763 (846)
Q Consensus 684 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~ 763 (846)
....... ......|+..|+|||.+.+..++.++||||||+++|||++|++||........ ...... +...
T Consensus 162 ~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~----~~~~~~-~~~~-- 231 (269)
T cd08528 162 KQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL----ATKIVE-AVYE-- 231 (269)
T ss_pred eeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH----HHHHhh-ccCC--
Confidence 8653322 23345688999999999988899999999999999999999999975443221 111111 1111
Q ss_pred cCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 764 VDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 764 ~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
+.. .......+.+++.+|++.+|++||++.||.+++++
T Consensus 232 --~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 232 --PLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred --cCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 100 11223568899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=286.86 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=207.1
Q ss_pred hhhhhhcCcCceEEEEEEE-EcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecC-----CeeeEee
Q 003114 537 NDFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG-----NQIGLIY 610 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~~LV~ 610 (846)
+.+.+.||+|||+-||.++ +.++..+|+|++.-.+.++.+..++|++..++++|||++++++++..+ ...++++
T Consensus 23 yri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~ 102 (302)
T KOG2345|consen 23 YRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLL 102 (302)
T ss_pred EEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEe
Confidence 3456789999999999998 668889999999877777788899999999999999999999987543 3599999
Q ss_pred ecccCCChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 611 EYMANGSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
.|...|+|.+.++... +..+++.+.++|+.++++||++||.. .++++||||||.|||+.+.+.++|.|||.+...+.
T Consensus 103 Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i 181 (302)
T KOG2345|consen 103 PYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPI 181 (302)
T ss_pred ehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccce
Confidence 9999999999997654 45799999999999999999999932 34599999999999999999999999999986542
Q ss_pred CCcccc-------cccccCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcC
Q 003114 689 EGVSHL-------STGVAGTFGYLDPEYCQ---TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG 758 (846)
Q Consensus 689 ~~~~~~-------~~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~ 758 (846)
.-.... ......|.-|.|||.+. +...++++|||||||+||+|+.|..||+..-+. .+
T Consensus 182 ~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~------------Gg 249 (302)
T KOG2345|consen 182 QIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ------------GG 249 (302)
T ss_pred EeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc------------CC
Confidence 211111 11235788999999875 456889999999999999999999999743211 11
Q ss_pred Ccc-cccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 759 DIK-NIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 759 ~~~-~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
.+. .+....+.-.-.....+.+.+++.+|++.||.+||++.+++..++.++
T Consensus 250 SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111 111112211112225668999999999999999999999999998764
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=303.30 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=202.8
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
..+.+.||+|+||+||++... +++.+|+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||++
T Consensus 7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (284)
T cd06620 7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD 86 (284)
T ss_pred HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCC
Confidence 345578999999999999965 68899999886543 3445778999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+++|.+++...+ .+++..+..++.+++.||.|||+ ..+++||||||+||++++++.++|+|||++...... .
T Consensus 87 ~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~ 158 (284)
T cd06620 87 CGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----I 158 (284)
T ss_pred CCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----c
Confidence 999999987654 38999999999999999999993 258999999999999999999999999998654211 1
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc-------ccHHHHHHHHHhcCCcccccCCC
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEH-------KHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~-------~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
.....|+..|+|||++.+..++.++|||||||+++||++|+.||...... ..+..+......+. .+.
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 232 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPR 232 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCC
Confidence 22356899999999998888999999999999999999999999864432 11222333222211 111
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
+. .......+.+++.+|++.+|++||+++||+++.
T Consensus 233 ~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 233 LP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11 112345688999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=296.84 Aligned_cols=250 Identities=23% Similarity=0.412 Sum_probs=203.0
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.+.||+|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++..++..+++|||++++
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~ 85 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85 (262)
T ss_pred EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence 34578999999999999974 67889999998766556788999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.... ..+++.++..++.|++.||.||| +.+|+|+||||+||++++++.+||+|||++...... .....
T Consensus 86 ~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~~~~ 159 (262)
T cd06613 86 SLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IAKRK 159 (262)
T ss_pred cHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhh--hhccc
Confidence 9999987653 23889999999999999999999 899999999999999999999999999998765321 11223
Q ss_pred cccCCCcccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 697 GVAGTFGYLDPEYCQTF---RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~---~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
...++..|+|||..... .++.++|||||||+++||++|++||............. ... ...+.+. ..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~-----~~~---~~~~~~~--~~ 229 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS-----KSN---FPPPKLK--DK 229 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hcc---CCCcccc--ch
Confidence 35678899999998776 78999999999999999999999997654332222111 110 0011111 12
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
......+.+++.+|+..+|.+||++++|+.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 233457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.86 Aligned_cols=261 Identities=24% Similarity=0.382 Sum_probs=199.8
Q ss_pred hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHH--hcccccceeEeeEeecC----CeeeEeeecc
Q 003114 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLR--TVHHKNLTTLYGYCNEG----NQIGLIYEYM 613 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~--~l~HpnIv~l~g~~~~~----~~~~LV~Ey~ 613 (846)
.+.||+|.||+||+|++ .|+.||||++...+. +...+|.++++ .++|+||+.+++.-..+ .+++||++|.
T Consensus 216 ~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 46799999999999999 578999999976544 34555555555 56999999999876443 3689999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhc-----cCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHL-----GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
+.|||.|+|... .++....++++..+|.||+|||. +.++.|.|||||++|||+..++.+.|+|+|||.....
T Consensus 292 e~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~ 368 (513)
T KOG2052|consen 292 EHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 368 (513)
T ss_pred cCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecc
Confidence 999999999874 48999999999999999999993 4478899999999999999999999999999987654
Q ss_pred CC--cccccccccCCCcccCccccccCC------CCchhhHHHHHHHHHHHHhC----------CCCCCCccccccHHHH
Q 003114 689 EG--VSHLSTGVAGTFGYLDPEYCQTFR------LTEKSDVYSFGVVLLEIITS----------RPAIANTEEHKHISQW 750 (846)
Q Consensus 689 ~~--~~~~~~~~~gt~~Y~APE~~~~~~------~s~ksDVwS~Gvvl~ELltG----------~~p~~~~~~~~~l~~~ 750 (846)
.. ........+||.+|||||++...- .-..+||||||.|+||+.-. ++||.+.-..+.-.+-
T Consensus 369 ~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ee 448 (513)
T KOG2052|consen 369 DTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEE 448 (513)
T ss_pred cCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHH
Confidence 32 223344578999999999986532 23479999999999998752 3566433221111111
Q ss_pred HHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 751 VDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 751 ~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
++.++-..++...++.++. +.+.+..+.+++..||..+|.-|.|+-.|.+.|.++.+
T Consensus 449 MrkVVCv~~~RP~ipnrW~---s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 449 MRKVVCVQKLRPNIPNRWK---SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HhcceeecccCCCCCcccc---cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 2222222233333333332 45677889999999999999999999999999988774
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=305.59 Aligned_cols=254 Identities=25% Similarity=0.358 Sum_probs=197.9
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||+|+||.||++... ++..+|+|.+.... ....+++.+|++++++++||||+++++++..++..++|+||++++
T Consensus 5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 3567999999999999965 67889999887543 334466889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.++++... .+++..+..++.|+++||.|||+ ..+++||||||+|||+++++.+||+|||++...... ...
T Consensus 85 ~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~ 156 (308)
T cd06615 85 SLDQVLKKAG--RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 156 (308)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc----ccc
Confidence 9999997653 38899999999999999999993 258999999999999999999999999998754321 123
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCccc--------------
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKN-------------- 762 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~-------------- 762 (846)
...|+..|+|||.+.+..++.++|||||||+++||++|+.||...... ....+............
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccCCCCCccc
Confidence 456889999999998888999999999999999999999998654321 11111111000000000
Q ss_pred ----------cc---CCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 763 ----------IV---DPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 763 ----------~~---d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.. .+.+. .......+.+++.+|+..+|++||+++||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hhhHHHHHHHHhcCCCccCc---CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00000 00123458899999999999999999998876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=307.14 Aligned_cols=196 Identities=25% Similarity=0.379 Sum_probs=160.6
Q ss_pred hhcCcCceEEEEEEEEc---CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeec--CCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD---DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE--GNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~LV~Ey~~~ 615 (846)
+.||+|+||.||+|+.. +++.+|+|.+..... ...+.+|+.++++++||||+++++++.. +...++|+||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 57999999999999864 467899999875432 2457889999999999999999998843 567899999985
Q ss_pred CChhhhhhcCC-------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE----CCCCcEEEEeccCCc
Q 003114 616 GSLEEYLSDSN-------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL----NDQFQARLADFGLSK 684 (846)
Q Consensus 616 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl----d~~~~vkI~DFGla~ 684 (846)
++|.+++.... ...+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 58888775321 234888999999999999999999 8999999999999999 456789999999998
Q ss_pred cCCCCCc-ccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 003114 685 TFPIEGV-SHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTE 742 (846)
Q Consensus 685 ~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~ 742 (846)
....... ........||+.|+|||++.+. .++.++||||+||+++||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 6533211 1122345789999999988764 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=298.36 Aligned_cols=253 Identities=27% Similarity=0.400 Sum_probs=198.1
Q ss_pred hhhhcCcCceEEEEEEEEc----CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCC------ee
Q 003114 539 FETILGEGSFGKVYHGYLD----DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN------QI 606 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------~~ 606 (846)
+.+.||+|+||.||+|.+. .++.||+|++... .....+++.+|+.+++.++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4568999999999999863 3688999998754 3344567889999999999999999999875432 24
Q ss_pred eEeeecccCCChhhhhhcCC----CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccC
Q 003114 607 GLIYEYMANGSLEEYLSDSN----ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGL 682 (846)
Q Consensus 607 ~LV~Ey~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGl 682 (846)
++++||+++|+|.+++.... ...+++....+++.|++.||+||| +.+|+||||||+||++++++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcccc
Confidence 78899999999998875322 224788899999999999999999 88999999999999999999999999999
Q ss_pred CccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcc
Q 003114 683 SKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIK 761 (846)
Q Consensus 683 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~ 761 (846)
++...............++..|++||.+....++.++|||||||++|||++ |++||....... +.. .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~-~~~---~~~~~~~~~ 235 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-IYN---YLIKGNRLK 235 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH-HHH---HHHcCCcCC
Confidence 986643322222223345678999999988889999999999999999999 889987544321 222 111111111
Q ss_pred cccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 762 NIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 762 ~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 236 ----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 ----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0112345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=286.50 Aligned_cols=247 Identities=25% Similarity=0.393 Sum_probs=201.8
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-----c---hhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeE
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-----R---QGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~L 608 (846)
-+++||.|..++|.++..+ +|.+.|+|++.... . ...+.-.+|+.+|+++ .||+|+++.++++.+...++
T Consensus 21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~Fl 100 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFL 100 (411)
T ss_pred hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhh
Confidence 3578999999999998865 78899999985321 1 1233456799999998 79999999999999999999
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
|+|.|+.|.|.++|...-. +++....+|+.|+..|++||| ...|+||||||+|||+|++.++||+|||+++.+..
T Consensus 101 VFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 101 VFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 9999999999999987654 899999999999999999999 99999999999999999999999999999998753
Q ss_pred CCcccccccccCCCcccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCccc
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQ------TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKN 762 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~------~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 762 (846)
.......+||++|+|||.+. ...|+..+|+|++||++|-|+.|-+||.....-- +..++.+|.. +
T Consensus 176 ---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml-----MLR~ImeGky-q 246 (411)
T KOG0599|consen 176 ---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML-----MLRMIMEGKY-Q 246 (411)
T ss_pred ---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-----HHHHHHhccc-c
Confidence 34556689999999999874 3458899999999999999999999997543221 2223333332 2
Q ss_pred ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 763 IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 763 ~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+-.|++. +......+|+.+|++.||++|.|.+|+++.
T Consensus 247 F~speWa-----dis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 247 FRSPEWA-----DISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cCCcchh-----hccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 2223332 233467899999999999999999999864
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.65 Aligned_cols=259 Identities=24% Similarity=0.336 Sum_probs=196.4
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|++|.||+|+.. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (285)
T cd07861 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS- 82 (285)
T ss_pred EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence 3467999999999999975 68899999986542 2234678899999999999999999999999999999999997
Q ss_pred CChhhhhhcCC-CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 616 GSLEEYLSDSN-ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 616 gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
++|.+++.... ...+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++...... ...
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~ 157 (285)
T cd07861 83 MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRV 157 (285)
T ss_pred CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--ccc
Confidence 68988886543 245899999999999999999999 899999999999999999999999999998754322 112
Q ss_pred cccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcC-----------Cccc
Q 003114 695 STGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG-----------DIKN 762 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~-----------~~~~ 762 (846)
.....+++.|+|||.+.+. .++.++|||||||+++||+||++||....+...+........... ....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 2234568899999987654 578999999999999999999999986544333222221110000 0000
Q ss_pred ccCCCCCC---CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 763 IVDPKLHG---DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 763 ~~d~~L~~---~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.++..... ........++.+++.+|++.+|++|||+++|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 000112346779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.59 Aligned_cols=258 Identities=21% Similarity=0.371 Sum_probs=195.6
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
..+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 10 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 88 (309)
T cd07872 10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK- 88 (309)
T ss_pred EEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-
Confidence 3467999999999999975 67889999987543 22334677899999999999999999999999999999999975
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++..... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++...... ....
T Consensus 89 ~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~ 162 (309)
T cd07872 89 DLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTYS 162 (309)
T ss_pred CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--cccc
Confidence 88888866542 4788999999999999999999 8999999999999999999999999999987543221 1222
Q ss_pred cccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--------cccccC--
Q 003114 697 GVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--------IKNIVD-- 765 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--------~~~~~d-- 765 (846)
...++..|+|||.+.+ ..++.++||||+||+++||+||++||......+.+....+....... ..+..+
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence 3467899999998764 46899999999999999999999999866543333222221100000 000000
Q ss_pred -CCCCC----CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 -PKLHG----DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 -~~L~~----~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+.... .........+.+++.+|++.+|++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 000112345789999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=324.17 Aligned_cols=251 Identities=24% Similarity=0.424 Sum_probs=212.2
Q ss_pred hhhcCcCceEEEEEEEE-cCC----cEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 540 ETILGEGSFGKVYHGYL-DDN----TEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~-~~g----~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.++||+|+||+||||.+ .+| .+||+|++... ..+..+++.+|+.+|.+++|||+++|+|+|..+. ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 46899999999999986 333 46899998654 4556789999999999999999999999998766 88999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
+.|+|.++++.++.. +.....+.+..|||+||.||| +++++||||.++|||+..-..+||.|||+++.+..++.+.
T Consensus 780 P~G~LlDyvr~hr~~-igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDN-IGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred ccchHHHHHHHhhcc-ccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 999999999987643 888899999999999999999 9999999999999999999999999999999987776666
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
......-.+.|||-|.+....++.++|||||||.+||++| |..|+++...++ +.+ .++.+ .+-.-
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-I~d----lle~g---------eRLsq 921 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-IPD----LLEKG---------ERLSQ 921 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-hhH----HHhcc---------ccCCC
Confidence 6666667789999999999999999999999999999998 899998765322 111 11111 11122
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
+.-+...+..++.+||..|+..||+++++..++.+..
T Consensus 922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 922 PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 4456678889999999999999999999999987753
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=300.24 Aligned_cols=248 Identities=21% Similarity=0.340 Sum_probs=198.7
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.+.||+|+||.||+|+.. +++.+++|.+........+.+.+|+.+++.++|+||+++++.+..++..++||||++++
T Consensus 15 ~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 94 (292)
T cd06644 15 EIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGG 94 (292)
T ss_pred hhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCC
Confidence 34567999999999999975 58899999998777667788999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|..++.... ..+++..+..++.|++.+|.||| +.+++||||||+||+++.++.+||+|||++...... .....
T Consensus 95 ~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 168 (292)
T cd06644 95 AVDAIMLELD-RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRD 168 (292)
T ss_pred cHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--ccccc
Confidence 9998876543 24899999999999999999999 899999999999999999999999999998754221 11123
Q ss_pred cccCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 697 GVAGTFGYLDPEYCQ-----TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
...++..|+|||++. ...++.++|||||||++|||++|++||........... ..... ......
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~------ 237 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK----IAKSE-PPTLSQ------ 237 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHH----HhcCC-CccCCC------
Confidence 345788999999874 34568899999999999999999999975443221111 11111 111100
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+......+.+++.+|+..+|++||+++|+++
T Consensus 238 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 238 -PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1122346789999999999999999999865
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=298.67 Aligned_cols=245 Identities=27% Similarity=0.454 Sum_probs=200.7
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (274)
T cd06609 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG 83 (274)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence 34567999999999999965 68899999987543 34456788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++... .+++..+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||+++...... ...
T Consensus 84 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~ 155 (274)
T cd06609 84 GSCLDLLKPG---KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKR 155 (274)
T ss_pred CcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--ccc
Confidence 9999999865 4899999999999999999999 8999999999999999999999999999998764321 222
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....++..|+|||++.+..++.++|||||||++|||+||+.||......... .. ...+.. +.+... .
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~----~~-~~~~~~-----~~~~~~---~ 222 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL----FL-IPKNNP-----PSLEGN---K 222 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH----HH-hhhcCC-----CCCccc---c
Confidence 3456788999999999888999999999999999999999999754422211 11 111111 111111 0
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
....+.+++.+|+..+|++||+++++++
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 3346789999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=299.50 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=200.1
Q ss_pred hhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCCch-hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 540 ETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSSRQ-GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 457999999999999964 3457999988765443 457799999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCC-------CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCcc
Q 003114 613 MANGSLEEYLSDSNA-------DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~ 685 (846)
+++|+|.++++.... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.++++|||++..
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcccccccc
Confidence 999999999976551 25899999999999999999999 88999999999999999999999999999875
Q ss_pred CCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCccccc
Q 003114 686 FPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIV 764 (846)
Q Consensus 686 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~ 764 (846)
..... ........++..|+|||.+.+...+.++||||||++++||++ |..||........ +.. ...+.....
T Consensus 167 ~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~----~~~-~~~~~~~~~- 239 (275)
T cd05046 167 VYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV----LNR-LQAGKLELP- 239 (275)
T ss_pred cCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH----HHH-HHcCCcCCC-
Confidence 42211 112223356778999999988889999999999999999999 7888865433221 111 111111110
Q ss_pred CCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 765 DPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 765 d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
........+.+++.+|++.+|++||++.|+++.|+
T Consensus 240 -------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 240 -------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11123457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=295.99 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=203.2
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||.|+||.||.++. +++..+++|.+... +....+++.+|+.++++++|+||+++++++.+.+..+++|||+++
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (256)
T cd08221 4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG 83 (256)
T ss_pred EeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCC
Confidence 456899999999999985 46889999987644 344556788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++.......+++.++..++.|++.||.||| +.+++||||||+||++++++.+||+|||++........ ..
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~ 158 (256)
T cd08221 84 GTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MA 158 (256)
T ss_pred CcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cc
Confidence 99999998765556899999999999999999999 88999999999999999999999999999986533221 22
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....++..|+|||...+..++.++||||||++++||++|+.||......+ ...... .+..... ...
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----~~~~~~-~~~~~~~---------~~~ 224 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN----LVVKIV-QGNYTPV---------VSV 224 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHH-cCCCCCC---------ccc
Confidence 34568899999999988888999999999999999999999997644322 222222 1111111 112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
....+.+++.+|+..+|++||+++|+++.+
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 225 YSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 334688999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.68 Aligned_cols=244 Identities=24% Similarity=0.409 Sum_probs=200.8
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
..+.||.|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++.++...++||||++++
T Consensus 8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06640 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence 3467999999999999975 68899999987543 345567889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++... .+++.+...++.+++.||+||| +.+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 88 ~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 159 (277)
T cd06640 88 SALDLLRAG---PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRN 159 (277)
T ss_pred cHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--cccc
Confidence 999998753 3788999999999999999999 8999999999999999999999999999997653322 1223
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
...++..|+|||++.+..++.++|||||||+++||++|+.||......... .. ...+ .........
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----~~-~~~~---------~~~~~~~~~ 225 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----FL-IPKN---------NPPTLTGEF 225 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----hh-hhcC---------CCCCCchhh
Confidence 345788999999998888999999999999999999999999754322111 11 1111 111223345
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
...+.+++.+|++.+|++||+++++++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 6678899999999999999999999766
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=303.65 Aligned_cols=244 Identities=20% Similarity=0.358 Sum_probs=200.4
Q ss_pred hhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 540 ETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 45799999999999985 57899999999766555567788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~ 698 (846)
.+++... .+++.++..++.+++.||+||| +.+++||||||+||+++.++.+||+|||++....... ......
T Consensus 104 ~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~ 175 (296)
T cd06655 104 TDVVTET---CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRSTM 175 (296)
T ss_pred HHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccc--ccCCCc
Confidence 9998754 3899999999999999999999 8999999999999999999999999999987653321 122334
Q ss_pred cCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHH
Q 003114 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAW 778 (846)
Q Consensus 699 ~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~ 778 (846)
.++..|+|||.+.+..++.++|||||||++|||++|+.||...+.......+ .. ........ ......
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~----~~-~~~~~~~~-------~~~~~~ 243 (296)
T cd06655 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----AT-NGTPELQN-------PEKLSP 243 (296)
T ss_pred CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hh-cCCcccCC-------cccCCH
Confidence 6888999999999888999999999999999999999999776543322211 11 11111101 112234
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 779 KAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 779 ~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+.+++.+|+..+|++||++.++++
T Consensus 244 ~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 244 IFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHHHHHHhhcChhhCCCHHHHhh
Confidence 6788999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=303.40 Aligned_cols=245 Identities=22% Similarity=0.378 Sum_probs=199.8
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+++++
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (297)
T cd06656 23 RFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (297)
T ss_pred eeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCC
Confidence 456799999999999996 4789999999976655556778899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++... .+++.++..++.+++.||.||| +.+++||||||+||+++.++.++|+|||++....... .....
T Consensus 103 L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 174 (297)
T cd06656 103 LTDVVTET---CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRST 174 (297)
T ss_pred HHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc--cCcCc
Confidence 99998653 3788999999999999999999 8999999999999999999999999999987653221 12233
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSA 777 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~ 777 (846)
..+++.|+|||...+..++.++|||||||++++|++|+.||........+.. ....+ .+.+ .......
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~----~~~~~------~~~~--~~~~~~~ 242 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNG------TPEL--QNPERLS 242 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee----eccCC------CCCC--CCccccC
Confidence 4688899999999988899999999999999999999999976443221110 00000 0000 0111223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 778 WKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 778 ~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+.+++.+|+..+|++||+++++++
T Consensus 243 ~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 243 AVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 45789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=320.72 Aligned_cols=254 Identities=20% Similarity=0.243 Sum_probs=191.5
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
.+.||+|+||.||++... .++.||||... ...+.+|+.++++++|+||+++++++..++..++|||++. ++|
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDL 246 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence 467999999999999975 57889999643 2346789999999999999999999999999999999994 789
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~ 698 (846)
.+++..... .+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..............
T Consensus 247 ~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 322 (461)
T PHA03211 247 YTYLGARLR-PLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322 (461)
T ss_pred HHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccccc
Confidence 888865432 4899999999999999999999 899999999999999999999999999999865432222223346
Q ss_pred cCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccc-------cccHHHHHHHHHhc-CCcccccCCCC--
Q 003114 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE-------HKHISQWVDFMLAQ-GDIKNIVDPKL-- 768 (846)
Q Consensus 699 ~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~-------~~~l~~~~~~~~~~-~~~~~~~d~~L-- 768 (846)
.||..|+|||++.+..++.++|||||||++|||++|..++-.... ...+.+.++..... ..........+
T Consensus 323 ~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~ 402 (461)
T PHA03211 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVS 402 (461)
T ss_pred CCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHH
Confidence 799999999999999999999999999999999998765432211 11122222211100 00000000000
Q ss_pred ----------CCCCC-------hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 769 ----------HGDID-------VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 769 ----------~~~~~-------~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
..... ......+.+|+.+|++.||++|||+.|+++.
T Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 403 QYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 0111257789999999999999999999864
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=298.94 Aligned_cols=249 Identities=23% Similarity=0.359 Sum_probs=200.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.+.||.|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++.+..+...++||||++++
T Consensus 8 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (280)
T cd06611 8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGG 87 (280)
T ss_pred HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCC
Confidence 44577999999999999975 68899999998766666678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++..... .+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++...... .....
T Consensus 88 ~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~~~~ 161 (280)
T cd06611 88 ALDSIMLELER-GLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQKRD 161 (280)
T ss_pred cHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc--ccccc
Confidence 99999876442 4899999999999999999999 889999999999999999999999999988754321 11223
Q ss_pred cccCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 697 GVAGTFGYLDPEYCQ-----TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
...++..|+|||.+. ...++.++|||||||++|||++|++||...+....+..+ . .+... .+.
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~----~-~~~~~-----~~~-- 229 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI----L-KSEPP-----TLD-- 229 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH----h-cCCCC-----CcC--
Confidence 346889999999874 345778999999999999999999999765433322221 1 11111 110
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.+......+.+++.+|++.+|++||++.+|++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 011223467899999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=297.60 Aligned_cols=251 Identities=21% Similarity=0.384 Sum_probs=197.1
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc----------hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeE
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR----------QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~----------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L 608 (846)
.+.||+|+||.||+|... +++.+|+|.++.... ...+.+.+|+.+++.++|+|++++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 467999999999999854 688999998853211 113467889999999999999999999999999999
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
|+||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+|||+++....
T Consensus 86 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 86 FLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred EEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999999998763 4889999999999999999999 88999999999999999999999999999976532
Q ss_pred CCcccccccccCCCcccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCC
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTFR--LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDP 766 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 766 (846)
...........|+..|+|||.+.... ++.++||||||++++||++|+.||........+ .. .. .......+++
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~-~~-~~~~~~~~~~ 235 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM---FK-LG-NKRSAPPIPP 235 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH---HH-hh-ccccCCcCCc
Confidence 21122223456889999999887654 789999999999999999999999654322211 11 11 1111111111
Q ss_pred CCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 767 KLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 767 ~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.. .......+.+++.+|+..+|++||++++|++.
T Consensus 236 ~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 236 DV----SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11 12234578899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=295.85 Aligned_cols=244 Identities=27% Similarity=0.401 Sum_probs=199.1
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-----chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-----RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
..+.||+|++|.||+|... ++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++..+...++|+||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 3467999999999999976 78999999986533 23456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++++|.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 84 VPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 99999999997654 3889999999999999999999 8899999999999999999999999999987653222
Q ss_pred cccccccCCCcccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFR-LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
......|+..|+|||.+.... ++.++|+|||||+++||++|+.||...........+ ....... .
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~---------~ 222 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI----GRSKELP---------P 222 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH----HhcccCC---------C
Confidence 223456889999999987766 899999999999999999999999765432222111 1111111 1
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+......+.+++.+|++.+|++||+++++++
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11123356789999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=289.07 Aligned_cols=247 Identities=24% Similarity=0.355 Sum_probs=201.1
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
.+.+.||+|.|+.||++.. .+|+.+|+|++... +..+.+++++|+.+.+.++||||++|.....+....++|+|+|.
T Consensus 14 ~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~ 93 (355)
T KOG0033|consen 14 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 93 (355)
T ss_pred hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEeccc
Confidence 4457899999999999875 47899999887532 34467889999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC---CCCcEEEEeccCCccCCCCCc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN---DQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld---~~~~vkI~DFGla~~~~~~~~ 691 (846)
|++|..-|-.. ..+++..+-..+.||+.+|.|+| ..+|||||+||+|+|+. ..--+|++|||+|..+. .
T Consensus 94 G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~ 165 (355)
T KOG0033|consen 94 GGELFEDIVAR--EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---D 165 (355)
T ss_pred chHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC---C
Confidence 99998766544 24778888899999999999999 99999999999999995 34468999999999875 3
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.....+.+||++|||||++...+++..+|||+.||+|+-|+.|.+||.+.+.+....++. .+. .-+++.-..
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~-----~g~--yd~~~~~w~- 237 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK-----AGA--YDYPSPEWD- 237 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh-----ccc--cCCCCcccC-
Confidence 445567889999999999999999999999999999999999999998765444333222 221 112221111
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.......+|+.+|+..||.+|.|+.|.++
T Consensus 238 ---~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 238 ---TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ---cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 22345678999999999999999988764
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=295.66 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=201.9
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|+||.||++... +++.+|+|.+... .....+++.+|+.++++++||||+++++++...+..++|+||+++
T Consensus 4 ~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08218 4 KVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83 (256)
T ss_pred EEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCC
Confidence 4568999999999999864 6889999998643 233456789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++.......+++.++++++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~ 158 (256)
T cd08218 84 GDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--ELA 158 (256)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hhh
Confidence 99999998765555889999999999999999999 8899999999999999999999999999997653221 112
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....|+..|+|||+..+...+.++|||||||+++||++|+.||....... .+...... .... .+..
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----~~~~~~~~-~~~~---------~~~~ 224 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN----LVLKIIRG-SYPP---------VSSH 224 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH----HHHHHhcC-CCCC---------Cccc
Confidence 23457889999999998889999999999999999999999997544322 22222211 1111 1122
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
....+.+++.+|++.+|++||+|+||++.
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 225 YSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 34568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=295.91 Aligned_cols=246 Identities=28% Similarity=0.455 Sum_probs=191.6
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-----chhhHHHHHHHHHHHhcccccceeEeeEeec--CCeeeEee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-----RQGYEQFEAEVILLRTVHHKNLTTLYGYCNE--GNQIGLIY 610 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~LV~ 610 (846)
..+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.. +...++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 3578999999999999864 68899999886432 2234568889999999999999999998865 46788999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+++++|.+++..... +++.....++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 86 e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 86 EYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred eCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 99999999999976543 789999999999999999999 8899999999999999999999999999987653211
Q ss_pred c-ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 691 V-SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 691 ~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
. ........++..|+|||++.+..++.++|||||||+++||++|+.||........+. ...... ..+.+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~----~~~~~~-----~~~~~- 230 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF----KIATQP-----TNPQL- 230 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH----HHhcCC-----CCCCC-
Confidence 1 111123458889999999998889999999999999999999999997543222111 111111 11111
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+......+.+++ +|+..+|++||+|+||++
T Consensus 231 ---~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 231 ---PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 112223445555 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=311.01 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=193.4
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecC------CeeeEe
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG------NQIGLI 609 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~LV 609 (846)
..+.||+|+||.||++... .++.||+|++... .....+.+.+|+.+++.++||||+++++++... ...++|
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEE
Confidence 3468999999999999864 6889999999754 233446678899999999999999999987543 357999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||+++ +|.+.+.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~- 171 (355)
T cd07874 101 MELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT- 171 (355)
T ss_pred hhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCCC-
Confidence 999965 67766653 2788899999999999999999 89999999999999999999999999999976432
Q ss_pred CcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHH----------------
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDF---------------- 753 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~---------------- 753 (846)
........||..|+|||.+.+..++.++|||||||+++||++|+.||...+........+..
T Consensus 172 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 172 --SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred --ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 22223456899999999999889999999999999999999999999765432222211111
Q ss_pred --HHhc-CCcccccCCCC-----C---CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 754 --MLAQ-GDIKNIVDPKL-----H---GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 754 --~~~~-~~~~~~~d~~L-----~---~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.... ........+.. . ..........+.+++.+|++.+|++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 00000000000 0 00111223567899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.39 Aligned_cols=258 Identities=23% Similarity=0.306 Sum_probs=198.3
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++|+|++++++++..+...++||||+++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (286)
T cd07847 5 KLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84 (286)
T ss_pred eeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCc
Confidence 4467999999999999976 68899999886442 22345678999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
+.|..++.... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........ ..
T Consensus 85 ~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 157 (286)
T cd07847 85 TVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DY 157 (286)
T ss_pred cHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cc
Confidence 98888776543 3899999999999999999999 89999999999999999999999999999987643221 12
Q ss_pred ccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHh----------cC-Ccccc
Q 003114 696 TGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLA----------QG-DIKNI 763 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~----------~~-~~~~~ 763 (846)
....++..|+|||.+.+ ..++.++|||||||+++||++|++||......+.+..+...... .. .....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 23457888999998865 45789999999999999999999999866544333332221100 00 00000
Q ss_pred cCCCCCCCCC-----hHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 764 VDPKLHGDID-----VNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 764 ~d~~L~~~~~-----~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+....... ......+.+++.+|++.+|++||++.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0111100000 112356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=315.11 Aligned_cols=250 Identities=21% Similarity=0.304 Sum_probs=194.6
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 46 ~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (371)
T cd05622 46 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 125 (371)
T ss_pred EEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 34578999999999999975 6788999998642 2223455788999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|+|.+++.... ++...+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 126 ~gg~L~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-~~ 198 (371)
T cd05622 126 PGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MV 198 (371)
T ss_pred CCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-cc
Confidence 9999999997543 788888999999999999999 8999999999999999999999999999998653322 12
Q ss_pred ccccccCCCcccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFR----LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~----~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
......||+.|+|||++.... ++.++|||||||++|||++|+.||......... .............+
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~---- 270 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY----SKIMNHKNSLTFPD---- 270 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCcccCCC----
Confidence 223467999999999987543 789999999999999999999999865433222 22221111111111
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTP--RPNMNRVVMEL 805 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~--RPsm~eVl~~L 805 (846)
.......+.+++..|+...+.+ ||+++|+++..
T Consensus 271 ---~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 271 ---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ---cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1123346778889999844433 77888888753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=310.71 Aligned_cols=255 Identities=21% Similarity=0.292 Sum_probs=192.4
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecC------CeeeEe
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG------NQIGLI 609 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~LV 609 (846)
..+.||+|+||.||++... +|..||+|++... .......+.+|+.+++.++||||+++++++... ...++|
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 104 (359)
T cd07876 25 QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104 (359)
T ss_pred EEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEE
Confidence 3578999999999999864 6899999999643 233456778999999999999999999988543 357999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||+++ +|.+.+.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~- 175 (359)
T cd07876 105 MELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT- 175 (359)
T ss_pred EeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcccccc-
Confidence 999965 66666643 2788889999999999999999 89999999999999999999999999999975422
Q ss_pred CcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHH----------------
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDF---------------- 753 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~---------------- 753 (846)
........||+.|+|||.+.+..++.++||||+||++|||++|+.||...+...........
T Consensus 176 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 176 --NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred --CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 12223456899999999999999999999999999999999999999865432221111110
Q ss_pred --HHhcC-Cc-----ccccCCCCCC---CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 754 --MLAQG-DI-----KNIVDPKLHG---DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 754 --~~~~~-~~-----~~~~d~~L~~---~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
..... .. .+........ .........+.+++.+|++.+|++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 00 0000000000 0011123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=315.85 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=192.4
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.||+|+||.||++... +++.||+|++... .......+.+|+.++..++|+||+++++.+..++..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 468999999999999975 6889999999643 223345678899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc---
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS--- 692 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~--- 692 (846)
|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 86 g~L~~~l~~~~~--l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 86 GDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred ccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999999976543 889999999999999999999 999999999999999999999999999998754221100
Q ss_pred ------------------------------cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 003114 693 ------------------------------HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTE 742 (846)
Q Consensus 693 ------------------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~ 742 (846)
.......||+.|+|||++.+..++.++|||||||+++||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 00123469999999999999999999999999999999999999997654
Q ss_pred ccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCC---HHHHHHH
Q 003114 743 EHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPN---MNRVVME 804 (846)
Q Consensus 743 ~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPs---m~eVl~~ 804 (846)
..... ....... ....+.+.. .....+.+++.+|+. +|++|++ ++|+++.
T Consensus 241 ~~~~~----~~i~~~~-~~~~~p~~~------~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 241 PQETY----RKVMNWK-ETLVFPPEV------PISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred HHHHH----HHHHcCC-CceecCCCC------CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 33221 1111110 000111110 122356677777664 9999996 4555443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=299.04 Aligned_cols=260 Identities=21% Similarity=0.315 Sum_probs=200.5
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++..+...++|+||+ +
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~ 82 (286)
T cd07832 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-P 82 (286)
T ss_pred EEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-C
Confidence 4567999999999999974 78999999987553 334567899999999999999999999999999999999999 9
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++.... ..+++.++..++.|+++||+||| +.+++|+||||+||++++++.++|+|||++........ ...
T Consensus 83 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (286)
T cd07832 83 SDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY 157 (286)
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence 99999987654 45899999999999999999999 88999999999999999999999999999987643221 122
Q ss_pred ccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC-----cccc------
Q 003114 696 TGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD-----IKNI------ 763 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~-----~~~~------ 763 (846)
....|+..|+|||.+.+. .++.++||||+||+++||++|+++|....+...+............ ..+.
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 345688999999988654 4689999999999999999998888765443322222111100000 0000
Q ss_pred cCCCCC----CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 764 VDPKLH----GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 764 ~d~~L~----~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
..+.-. .....+....+.+++.+|++.+|++||+++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 00011234678899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=302.02 Aligned_cols=255 Identities=22% Similarity=0.349 Sum_probs=196.8
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|+||+++
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (286)
T cd07846 5 NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH 84 (286)
T ss_pred EeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCc
Confidence 4468999999999999986 588999998865322 2345688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.++..... .+++.++..++.|+++||.||| +.+++||||+|+||++++++.++|+|||++....... ...
T Consensus 85 ~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07846 85 TVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVY 157 (286)
T ss_pred cHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--ccc
Confidence 99988776543 3899999999999999999999 8899999999999999999999999999987653322 222
Q ss_pred ccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcc----------c--
Q 003114 696 TGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIK----------N-- 762 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~----------~-- 762 (846)
....++..|+|||++.+ ..++.++|||||||+++||++|++||......+........ .+... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKC---LGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH---hCCCchhhHHHhccchHh
Confidence 33457889999998865 45788999999999999999999999755432222111110 00000 0
Q ss_pred --ccCCCCCCC-----CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 763 --IVDPKLHGD-----IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 763 --~~d~~L~~~-----~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
...+..... ........+.+++.+|++.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000100000 01123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=303.65 Aligned_cols=196 Identities=26% Similarity=0.384 Sum_probs=159.8
Q ss_pred hhcCcCceEEEEEEEEc---CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEee--cCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD---DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN--EGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~~LV~Ey~~~ 615 (846)
..||+|+||.||+|+.. ++..||+|.+..... ...+.+|+.++++++||||+++++++. .+...++|+||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 47999999999999965 457899999875432 245788999999999999999999884 4567899999986
Q ss_pred CChhhhhhcC-------CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE----CCCCcEEEEeccCCc
Q 003114 616 GSLEEYLSDS-------NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL----NDQFQARLADFGLSK 684 (846)
Q Consensus 616 gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl----d~~~~vkI~DFGla~ 684 (846)
++|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+|||+ ++++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 4787776432 1234888999999999999999999 8999999999999999 566799999999998
Q ss_pred cCCCCCcc-cccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 003114 685 TFPIEGVS-HLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTE 742 (846)
Q Consensus 685 ~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~ 742 (846)
........ .......||+.|+|||.+.+. .++.++|||||||+++||+||++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 65332111 122345689999999988764 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=310.85 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=194.1
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecC------CeeeE
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG------NQIGL 608 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~L 608 (846)
.+.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++... ...++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~l 106 (364)
T cd07875 27 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106 (364)
T ss_pred eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEE
Confidence 34568999999999999964 6889999999753 233446678899999999999999999987543 35799
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 107 v~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 107 VMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred EEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 9999964 77777753 2788899999999999999999 89999999999999999999999999999976432
Q ss_pred CCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHH--------------
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFM-------------- 754 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~-------------- 754 (846)
........||..|+|||++.+..++.++|||||||+++||++|+.||...+........+...
T Consensus 179 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 179 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred ---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 122234568999999999999999999999999999999999999998665433322222110
Q ss_pred ----HhcC-Ccc-----cccCCCC---CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 755 ----LAQG-DIK-----NIVDPKL---HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 755 ----~~~~-~~~-----~~~d~~L---~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.... ... ......+ ...........+.+++.+|++.+|++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 000 0000000 000111123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=309.08 Aligned_cols=252 Identities=23% Similarity=0.304 Sum_probs=192.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY 83 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence 34578999999999999975 6889999998642 2223456888999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++....... ..
T Consensus 84 ~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (331)
T cd05597 84 VGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TV 158 (331)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Cc
Confidence 9999999997543 24889999999999999999999 8999999999999999999999999999987653221 11
Q ss_pred ccccccCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQT-----FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+. ............ +.+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~----~~~i~~~~~~~~-~~~~- 232 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET----YGKIMNHKEHFQ-FPPD- 232 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH----HHHHHcCCCccc-CCCc-
Confidence 2223468999999999863 4578899999999999999999999976443222 121211111001 0111
Q ss_pred CCCCChHHHHHHHHHHHhccCC--CCCCCCCHHHHHHH
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSH--SSTPRPNMNRVVME 804 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~--~P~~RPsm~eVl~~ 804 (846)
.......+.+++.+|+.. ++..||+++++++.
T Consensus 233 ----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 233 ----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111234566777776644 44458899888876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=302.27 Aligned_cols=258 Identities=23% Similarity=0.365 Sum_probs=195.7
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++|+||++ +
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~ 88 (301)
T cd07873 10 KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 88 (301)
T ss_pred EeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-c
Confidence 3467999999999999875 67899999987543 2234567789999999999999999999999999999999997 5
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++..... .+++..+..++.|+++||.||| +.+|+||||||+||++++++.+||+|||++....... ....
T Consensus 89 ~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~ 162 (301)
T cd07873 89 DLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYS 162 (301)
T ss_pred CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--Cccc
Confidence 89988876533 4889999999999999999999 8999999999999999999999999999987543221 1222
Q ss_pred cccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc--CCcccccC--------
Q 003114 697 GVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ--GDIKNIVD-------- 765 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~--~~~~~~~d-------- 765 (846)
...+++.|+|||.+.+. .++.++|||||||+++||++|++||......+.+.......... .....+.+
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence 34578899999987653 57889999999999999999999998655332222211111000 00000000
Q ss_pred -CCCCCC----CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 -PKLHGD----IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 -~~L~~~----~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+..... ........+.+++.+|++.+|++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 110000 01122346789999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.63 Aligned_cols=253 Identities=24% Similarity=0.392 Sum_probs=203.5
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|++.++.++|+||+++++.+..++..++|+|++++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 34568999999999999964 67889999987543 33567889999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCC-CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc--
Q 003114 616 GSLEEYLSDSNA-DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS-- 692 (846)
Q Consensus 616 gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~-- 692 (846)
++|.++++.... ..+++.....++.|++.||.||| +.+++||||||+||++++++.+||+|||++..+......
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 84 GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 999999976543 45899999999999999999999 899999999999999999999999999998766433222
Q ss_pred cccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.......|+..|+|||++... ..+.++|||||||+++||++|+.||..........+... .. .+.+...
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~----~~------~~~~~~~ 230 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ----ND------PPSLETG 230 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc----CC------CCCcCCc
Confidence 122334688999999998776 789999999999999999999999976544332222211 11 1111111
Q ss_pred C-ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 772 I-DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 772 ~-~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
. .......+.+++.+|+..+|++||+++|+++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1 1123456789999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.02 Aligned_cols=245 Identities=23% Similarity=0.387 Sum_probs=199.9
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+++++.++|||++++++.+..++..++|+||+++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08220 4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPG 83 (256)
T ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCC
Confidence 4568999999999999864 7888999998654 233456788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC-CcEEEEeccCCccCCCCCcccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ-FQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-~~vkI~DFGla~~~~~~~~~~~ 694 (846)
++|.+++.......+++..+.+++.++++||+||| +.+++||||||+||+++++ +.+||+|||++...... ..
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---~~ 157 (256)
T cd08220 84 GTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---SK 157 (256)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---cc
Confidence 99999998765556899999999999999999999 8999999999999999854 56899999999865332 12
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....++..|+|||.+.+...+.++||||||+++++|++|+.||........ +...... ....+ ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~----~~~~~~~-~~~~~---------~~ 223 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL----VLKIMSG-TFAPI---------SD 223 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH----HHHHHhc-CCCCC---------CC
Confidence 2235678899999999988899999999999999999999999976543222 2211111 11111 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.....+.+++.+|++.+|++|||++|+++
T Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 23346889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=303.79 Aligned_cols=244 Identities=22% Similarity=0.380 Sum_probs=198.4
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChh
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLE 619 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 619 (846)
..||+|+||.||++... ++..||+|.+........+.+.+|+..++.++|+||+++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 46899999999999864 68899999987665556677899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccccc
Q 003114 620 EYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699 (846)
Q Consensus 620 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~ 699 (846)
+++... .+++.++..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++....... .......
T Consensus 108 ~~~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~ 179 (292)
T cd06658 108 DIVTHT---RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLV 179 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceee
Confidence 988643 3789999999999999999999 8899999999999999999999999999987543221 1122346
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHH
Q 003114 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWK 779 (846)
Q Consensus 700 gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~ 779 (846)
|+..|+|||...+..++.++|||||||+++||++|+.||........+.. .. . ...+.+.. .......
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----~~-~-----~~~~~~~~--~~~~~~~ 247 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR----IR-D-----NLPPRVKD--SHKVSSV 247 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HH-h-----cCCCcccc--ccccCHH
Confidence 88999999999888899999999999999999999999976443222211 11 1 11111111 1112335
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 780 AVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 780 l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+.+++.+|+..+|++|||++|+++.
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhC
Confidence 7789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.06 Aligned_cols=259 Identities=23% Similarity=0.311 Sum_probs=199.0
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCch-----hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQ-----GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.+.||+|++|.||+|... +++.||+|.+...... ....+..|+++++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (298)
T cd07841 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF 83 (298)
T ss_pred eeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcc
Confidence 3467999999999999975 6899999999755322 334567899999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+ +|+|.+++.... ..+++..+.+++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 156 (298)
T cd07841 84 M-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-- 156 (298)
T ss_pred c-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--
Confidence 9 899999997654 34899999999999999999999 8999999999999999999999999999998664321
Q ss_pred cccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc--------CCcccc
Q 003114 693 HLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ--------GDIKNI 763 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~--------~~~~~~ 763 (846)
.......++..|+|||.+.+ ..++.++|||||||+++||++|.++|........+.......... ......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence 12223356788999998754 457899999999999999999988887654433222222111000 000011
Q ss_pred cCCCCCCCCC-----hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 764 VDPKLHGDID-----VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 764 ~d~~L~~~~~-----~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.........+ ......+.+++.+|++.+|++||+++||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1100001111 1234678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=308.06 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=209.2
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCch---hhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEeee
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQ---GYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E 611 (846)
+.+.+.||+|.||.||+++.+ +|+.+|+|.+.+.... ......+|+.+|+++. |||||.+.+.+......++|||
T Consensus 37 Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmE 116 (382)
T KOG0032|consen 37 YELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVME 116 (382)
T ss_pred EEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEE
Confidence 445578999999999999976 4999999999765432 4468999999999998 9999999999999999999999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC----CCcEEEEeccCCccCC
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND----QFQARLADFGLSKTFP 687 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~----~~~vkI~DFGla~~~~ 687 (846)
++.||.|.+.+... . +++..+..++.|++.+++||| +.+|+||||||+|+|+.. ++.+|++|||++....
T Consensus 117 L~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 117 LCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred ecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999999999877 2 899999999999999999999 899999999999999963 3579999999998764
Q ss_pred CCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCC
Q 003114 688 IEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 688 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
. .......+||+.|+|||++....++..+||||.||++|.|++|.+||....+...... +..++. ++-++.
T Consensus 191 ~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~-----i~~~~~-~f~~~~ 261 (382)
T KOG0032|consen 191 P---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA-----ILRGDF-DFTSEP 261 (382)
T ss_pred C---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-----HHcCCC-CCCCCC
Confidence 3 4556678999999999999999999999999999999999999999987765444332 222222 222222
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+ ......+.+++..|+..+|.+|+++.++++.
T Consensus 262 w-----~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 262 W-----DDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred c-----cccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 2 1234567899999999999999999999983
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=312.59 Aligned_cols=236 Identities=25% Similarity=0.311 Sum_probs=184.0
Q ss_pred cCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhc---ccccceeEeeEeecCCeeeEeeecccC
Q 003114 543 LGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTV---HHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 543 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
||+|+||+||+|+.. +++.||+|++.... .........|..++... +||||+++++.+......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 68999999986432 12223344566666555 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~ 153 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTT 153 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCCc
Confidence 99999987654 3889999999999999999999 899999999999999999999999999998754221 1223
Q ss_pred ccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 696 TGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
....||..|+|||.+.+. .++.++||||+||++|||++|+.||........ .+.. ..+.. .+.. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~----~~~i-~~~~~------~~~~---~ 219 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM----YRNI-AFGKV------RFPK---N 219 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH----HHHH-HcCCC------CCCC---c
Confidence 346799999999988754 489999999999999999999999976543221 1111 11111 0100 0
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMN 799 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~ 799 (846)
.....+.+++.+|++.+|++||++.
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 1234567899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=302.80 Aligned_cols=244 Identities=23% Similarity=0.358 Sum_probs=198.6
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChh
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLE 619 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 619 (846)
..||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 36999999999999864 68999999987655445567889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccccc
Q 003114 620 EYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699 (846)
Q Consensus 620 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~ 699 (846)
+++... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++....... .......
T Consensus 107 ~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~ 178 (297)
T cd06659 107 DIVSQT---RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLV 178 (297)
T ss_pred HHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccccee
Confidence 988653 3889999999999999999999 8899999999999999999999999999987553221 1223356
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHH
Q 003114 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWK 779 (846)
Q Consensus 700 gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~ 779 (846)
|+..|+|||++.+..++.++|||||||+++||++|+.||........+.. . ...... .+. ........
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~-~~~~~~-----~~~--~~~~~~~~ 246 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR----L-RDSPPP-----KLK--NAHKISPV 246 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----H-hccCCC-----Ccc--ccCCCCHH
Confidence 88999999999988899999999999999999999999975543322211 1 111100 000 01112345
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 780 AVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 780 l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+.+++.+|++.+|++||+++++++.
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhC
Confidence 7899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=320.49 Aligned_cols=254 Identities=20% Similarity=0.324 Sum_probs=187.8
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccc------cceeEeeEeecC-CeeeEe
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHK------NLTTLYGYCNEG-NQIGLI 609 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~Hp------nIv~l~g~~~~~-~~~~LV 609 (846)
.+.+.||+|+||+||+|... .++.||||+++.... ..+....|+.+++.++|. +++++++++..+ .+.++|
T Consensus 132 ~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv 210 (467)
T PTZ00284 132 KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV 210 (467)
T ss_pred EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence 34578999999999999964 678899999964322 234556677777777554 588898888654 578899
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCC-CCeeecCCCCCCEEECCCC---------------
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK-PPRVHRDIKPANILLNDQF--------------- 673 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~IiHrDlKp~NILld~~~--------------- 673 (846)
||++ +++|.+++.... .+++..+..|+.|++.||+||| . .+|+||||||+|||++.++
T Consensus 211 ~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 211 MPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred Eecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 9988 778999887654 3899999999999999999999 6 5999999999999998665
Q ss_pred -cEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHH
Q 003114 674 -QARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVD 752 (846)
Q Consensus 674 -~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~ 752 (846)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+.+..+.+
T Consensus 285 ~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 285 CRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred ceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 49999999876421 223346799999999999999999999999999999999999999987654333322211
Q ss_pred HHH-------h-------------cCCcccccCCCC----CCC---CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 753 FML-------A-------------QGDIKNIVDPKL----HGD---IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 753 ~~~-------~-------------~~~~~~~~d~~L----~~~---~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
... . .+......++.. ... ........+.+|+.+||+.||++|||++|+++
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 100 0 000000000000 000 00011245779999999999999999999986
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=296.20 Aligned_cols=250 Identities=24% Similarity=0.401 Sum_probs=197.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
++.+.||+|+||.||++... +++.||+|.+... ......++.+|+.++++++|+||+++++.+...+..++|+||+++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence 45578999999999999976 7899999988754 333456788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCC-CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 616 GSLEEYLSDSN-ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 616 gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
++|.+++.... ...+++..+..++.+++.||.|||+ +.+|+||||||+||+++.++.+||+|||++..+... .
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~ 157 (286)
T cd06622 84 GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----L 157 (286)
T ss_pred CCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC----c
Confidence 99999987642 2358999999999999999999993 358999999999999999999999999998765321 2
Q ss_pred cccccCCCcccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 695 STGVAGTFGYLDPEYCQTF------RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~------~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
.....++..|+|||.+.+. .++.++|||||||+++||++|+.||........... ..... .+.. +.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~-~~~~-----~~- 229 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ-LSAIV-DGDP-----PT- 229 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH-HHHHh-hcCC-----CC-
Confidence 2234578899999988554 358899999999999999999999975432221111 11111 1111 11
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
........+.+++.+|++.+|++||++++++..
T Consensus 230 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 230 ---LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 122234567899999999999999999988863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=292.70 Aligned_cols=249 Identities=26% Similarity=0.389 Sum_probs=201.5
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
++.+.||+|++|.||++... +++.+|+|.+.... ....+++.+|++++++++||||+++++.+..++..++|+||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 34568999999999999976 68899999987653 34456788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCC-CCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK-PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
++|.+++.... ..+++....+++.|++.||+||| + .+++|+||||+||++++++.++|+|||.+.......
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---- 155 (265)
T cd06605 84 GSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---- 155 (265)
T ss_pred CcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----
Confidence 99999998654 34888999999999999999999 7 899999999999999999999999999987552211
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccc-cccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE-HKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.....++..|+|||.+.+..++.++||||||+++++|++|+.||..... .....+.++....... +.+..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~--- 226 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP------PRLPS--- 226 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC------CCCCh---
Confidence 1125688899999999988999999999999999999999999975431 2222333332222110 11111
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
......+.+++.+|+..+|++||++.|++.
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 113456889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.12 Aligned_cols=239 Identities=28% Similarity=0.407 Sum_probs=198.6
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc---hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR---QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.||.|+||.||.|+.. +.+.||||++.-..+ ..+..+.+|+.+|++++|||++.+.|++..+...+||||||- |
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence 35999999999999964 677899999976543 345678999999999999999999999999999999999994 6
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+-.+++.-.+ +++.+.++..|+.+.++||.||| +.+.||||||+.|||+++.|.|||+|||.|....+ ..
T Consensus 111 SAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------An 180 (948)
T KOG0577|consen 111 SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------AN 180 (948)
T ss_pred cHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc------hh
Confidence 7788776544 34888999999999999999999 99999999999999999999999999999876532 34
Q ss_pred cccCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 697 GVAGTFGYLDPEYCQ---TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~---~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.++|||.|||||++. .+.|+-|+||||+||...||...+||+.+...-..+..+.. .. .|.|. .
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ-----Ne-----sPtLq---s 247 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-----NE-----SPTLQ---S 247 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh-----cC-----CCCCC---C
Confidence 578999999999874 46799999999999999999999999877655444433222 11 23332 2
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+....+.+++..|+++-|.+|||..++++
T Consensus 248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 248 NEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 345567889999999999999999887654
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=300.81 Aligned_cols=252 Identities=26% Similarity=0.339 Sum_probs=200.9
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc---hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR---QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+++++.++|+||+++++.+..+...++||||+++
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 467999999999999975 589999999976532 2456788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc---
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS--- 692 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~--- 692 (846)
++|.+++.......+++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+|||++.........
T Consensus 86 ~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (316)
T cd05574 86 GELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162 (316)
T ss_pred CCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccccc
Confidence 99999998665556899999999999999999999 899999999999999999999999999998754321100
Q ss_pred ------------------------cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHH
Q 003114 693 ------------------------HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHIS 748 (846)
Q Consensus 693 ------------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~ 748 (846)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||...+....+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~ 242 (316)
T cd05574 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS 242 (316)
T ss_pred ccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHH
Confidence 01112457889999999998889999999999999999999999997655433222
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 749 QWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 749 ~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
.. . .... .. .........+.+++.+|+..+|++||++...++++..
T Consensus 243 ~~----~-~~~~------~~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 243 NI----L-KKEV------TF--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH----h-cCCc------cC--CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 21 1 1110 00 0011134678999999999999999995555444433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=298.17 Aligned_cols=247 Identities=24% Similarity=0.397 Sum_probs=192.8
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEee-----cCCeeeEeeec
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCN-----EGNQIGLIYEY 612 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~-----~~~~~~LV~Ey 612 (846)
.+.||+|+||.||++... +++.+|+|++..... ...++.+|+.+++.+ +||||+++++++. .++..++||||
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 101 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence 468999999999999874 678999998865322 235678899999999 6999999999873 45678999999
Q ss_pred ccCCChhhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 613 MANGSLEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 613 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
+++++|.+++... ....+++..+..++.|+++||.||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 178 (286)
T cd06638 102 CNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178 (286)
T ss_pred cCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence 9999999988642 2335888999999999999999999 8999999999999999999999999999987653221
Q ss_pred cccccccccCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQT-----FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 765 (846)
.......|+..|+|||++.. ..++.++||||+||++|||++|+.||........+..+ .........+
T Consensus 179 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~ 251 (286)
T cd06638 179 --LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI-----PRNPPPTLHQ 251 (286)
T ss_pred --CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc-----cccCCCcccC
Confidence 12233468999999998753 44788999999999999999999999765432222111 0111111111
Q ss_pred CCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 766 PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 766 ~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+. .....+.+++.+|++.+|++||+++||++.
T Consensus 252 ~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 252 PE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11 123468899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=297.07 Aligned_cols=257 Identities=20% Similarity=0.318 Sum_probs=197.8
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.||.|++|.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 467999999999999975 68899999987542 2233578899999999999999999999999999999999995 6
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.......+++..+..++.|++.||+||| +.+++||||+|+||++++++.+||+|||++....... ....
T Consensus 84 ~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~ 158 (284)
T cd07860 84 DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYT 158 (284)
T ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--cccc
Confidence 8999987765556899999999999999999999 8899999999999999999999999999987653221 1122
Q ss_pred cccCCCcccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC---------------c
Q 003114 697 GVAGTFGYLDPEYCQTFR-LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD---------------I 760 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~-~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~---------------~ 760 (846)
...++..|+|||...+.. ++.++|||||||+++||+||+.||....+...+.+.......... .
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 345688999999876644 688999999999999999999999766544444333321111000 0
Q ss_pred ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 761 ~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.......+. .........+.+++.+|++.+|++||+++|+++
T Consensus 239 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 239 PKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred ccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000 000112245678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=289.86 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=200.6
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEee--cCCeeeEeeecc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCN--EGNQIGLIYEYM 613 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~~LV~Ey~ 613 (846)
+.+.||.|+||.||++... +++.+|+|.+... .....+++.+|+++++.++|+||+++++++. .+...+++|||+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~ 83 (265)
T cd08217 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83 (265)
T ss_pred eeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence 4467999999999999864 6789999998643 3344567889999999999999999999775 345689999999
Q ss_pred cCCChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccC--CCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 614 ANGSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGC--KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 614 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
++++|.+++.... ...+++..++.++.+++.||.|||..+ +.+++|+||||+||++++++.+||+|||++......
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 84 EGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred cCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 9999999997532 345899999999999999999999554 778999999999999999999999999999876432
Q ss_pred CcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
. .......++..|+|||.+....++.++||||||+++++|++|+.||....... + ... ...+..
T Consensus 164 ~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~---~~~-~~~~~~--------- 227 (265)
T cd08217 164 S--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-L---ASK-IKEGKF--------- 227 (265)
T ss_pred c--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-H---HHH-HhcCCC---------
Confidence 2 11233568899999999998889999999999999999999999998654221 1 111 111111
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
...+......+.+++.+|++.+|++||++++|++.
T Consensus 228 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11222334578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=306.43 Aligned_cols=251 Identities=22% Similarity=0.276 Sum_probs=192.6
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+++.+ +++.+|+|++.+. .......+.+|+.++..++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~ 84 (332)
T cd05623 5 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYV 84 (332)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccC
Confidence 4578999999999999976 5778999998642 12233457889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++....... ...
T Consensus 85 ~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~~~ 159 (332)
T cd05623 85 GGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQ 159 (332)
T ss_pred CCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-cce
Confidence 9999999976432 3889999999999999999999 8999999999999999999999999999987653221 122
Q ss_pred cccccCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQ-----TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...+.... ........... .+...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~-~~p~~-- 232 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET----YGKIMNHKERF-QFPAQ-- 232 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH----HHHHhCCCccc-cCCCc--
Confidence 23457999999999886 34678999999999999999999999976543222 22222111000 00000
Q ss_pred CCCChHHHHHHHHHHHhccCCC--CCCCCCHHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHS--STPRPNMNRVVME 804 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~--P~~RPsm~eVl~~ 804 (846)
.......+.+++.+|+..+ +..|++++|+++.
T Consensus 233 ---~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 233 ---VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1122345677788877544 4447899998776
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=307.03 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=193.2
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+++.. +++.||+|.+... .......+.+|..++..++|+||+++++++..++..++||||++
T Consensus 5 i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~ 84 (331)
T cd05624 5 IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYV 84 (331)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 4568999999999999975 6788999998653 22234557889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 85 gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 159 (331)
T cd05624 85 GGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ 159 (331)
T ss_pred CCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence 9999999986432 4888999999999999999999 8999999999999999999999999999997653322 112
Q ss_pred cccccCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQT-----FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.. ........ .-.+.+.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~----~~i~~~~~-~~~~p~~~- 233 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY----GKIMNHEE-RFQFPSHI- 233 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH----HHHHcCCC-cccCCCcc-
Confidence 233569999999998875 46788999999999999999999999764432221 11111110 00011111
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTP--RPNMNRVVME 804 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~--RPsm~eVl~~ 804 (846)
.+....+.+++.+|+...+++ |++++++++.
T Consensus 234 ----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 234 ----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 122346778888888765544 5678887654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=300.23 Aligned_cols=252 Identities=20% Similarity=0.282 Sum_probs=199.1
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (305)
T cd05609 5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVE 84 (305)
T ss_pred EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 3468999999999999975 57889999987553 2334567899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC----
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG---- 690 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~---- 690 (846)
+++|.+++.... .+++..+..++.+++.||.||| +.+++||||||+||+++.++.+||+|||+++......
T Consensus 85 g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 85 GGDCATLLKNIG--ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 999999997654 3889999999999999999999 8899999999999999999999999999986421100
Q ss_pred ---------cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcc
Q 003114 691 ---------VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIK 761 (846)
Q Consensus 691 ---------~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~ 761 (846)
.........++..|+|||.+....++.++|+|||||+++||++|+.||.+.... ++........ .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----~~~~~~~~~~-~- 233 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----ELFGQVISDD-I- 233 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcc-c-
Confidence 000111245788999999998888999999999999999999999999754332 2222222111 0
Q ss_pred cccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 762 NIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 762 ~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
..+... ......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 234 --~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 234 --EWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --CCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111111 1223467899999999999999998777776655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=297.17 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=197.8
Q ss_pred HHHHHHHhhh--hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeecC--
Q 003114 530 AEITKITNDF--ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEG-- 603 (846)
Q Consensus 530 ~el~~~t~~f--~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~-- 603 (846)
.++.++++++ .+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.+++++ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 3444444444 468999999999999974 688999999865432 345678899999998 899999999998643
Q ss_pred ---CeeeEeeecccCCChhhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEE
Q 003114 604 ---NQIGLIYEYMANGSLEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLA 678 (846)
Q Consensus 604 ---~~~~LV~Ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~ 678 (846)
+..++|+||+++++|.++++.. ....+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEe
Confidence 4689999999999999988642 2345899999999999999999999 8899999999999999999999999
Q ss_pred eccCCccCCCCCcccccccccCCCcccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHH
Q 003114 679 DFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF-----RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDF 753 (846)
Q Consensus 679 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~ 753 (846)
|||++....... .......|+..|+|||.+... .++.++|||||||+++||++|++||........+.++.
T Consensus 171 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~-- 246 (291)
T cd06639 171 DFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP-- 246 (291)
T ss_pred ecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh--
Confidence 999987653221 112234688899999987543 36889999999999999999999997654333332211
Q ss_pred HHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 754 MLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 754 ~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
........+ ..+....+.+++.+|++.+|++||++.|+++
T Consensus 247 ---~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 247 ---RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ---cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111111 1122346889999999999999999999876
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=291.20 Aligned_cols=249 Identities=23% Similarity=0.416 Sum_probs=198.6
Q ss_pred hhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC------chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 540 ETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS------RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.||+|++|.||+|.. .+++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+++..++|+||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 46799999999999986 578999999987432 12346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC-cEEEEeccCCccCCCCCc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF-QARLADFGLSKTFPIEGV 691 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-~vkI~DFGla~~~~~~~~ 691 (846)
+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++ .+||+|||++..+.....
T Consensus 85 ~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 85 MAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred cCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 99999999997654 3889999999999999999999 88999999999999998775 699999999877643211
Q ss_pred c--cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 692 S--HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 692 ~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
. .......++..|+|||.+.+..++.++||||+|++++||++|+.||...........+.. ...... .
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~---------~ 229 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK-IASATT---------A 229 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHH-HhccCC---------C
Confidence 1 112234678899999999888899999999999999999999999975443222221111 111100 1
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
...+......+.+++.+|+..+|++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 230 PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1122233457889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=295.43 Aligned_cols=258 Identities=21% Similarity=0.325 Sum_probs=198.8
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
..+.||.|++|.||+|... +|+.||+|++.... ....+.+.+|+++++.++|||++++++++..++..+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 3467999999999999965 79999999987543 2233568889999999999999999999999999999999995
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++.......+++..+..++.|+++||+||| +.+++||||+|+||++++++.++|+|||+++...... ...
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~ 156 (283)
T cd07835 82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--RTY 156 (283)
T ss_pred cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--ccc
Confidence 69999987766456899999999999999999999 8899999999999999999999999999997653221 111
Q ss_pred ccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--------ccc----
Q 003114 696 TGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--------IKN---- 762 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--------~~~---- 762 (846)
....++..|+|||++.+. .++.++||||||+++|||++|++||...+....+.+.++....... ..+
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 223568899999987654 5789999999999999999999999766544333333222110000 000
Q ss_pred ---ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 763 ---IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 763 ---~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
...... ..........+.+++.+|++.+|++||+++|+++
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 0011122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=290.48 Aligned_cols=245 Identities=27% Similarity=0.408 Sum_probs=192.2
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-----chhhHHHHHHHHHHHhcccccceeEeeEeecC--CeeeEeee
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-----RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG--NQIGLIYE 611 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~LV~E 611 (846)
.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 568999999999999974 68999999875321 22345788899999999999999999988663 56789999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+++++|.+++..... +++....+++.|++.||+||| +.+++|+||||+||++++++.++|+|||+++.......
T Consensus 87 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 87 HMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred ecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 9999999999876543 788889999999999999999 88999999999999999999999999999876532111
Q ss_pred c-cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 692 S-HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 692 ~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
. .......|+..|+|||.+.+..++.++|||||||++|||++|+.||........+.+ ..... .. .
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~-----~~----~ 228 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQP-----TN----P 228 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH----HhcCC-----CC----C
Confidence 1 112234588899999999888899999999999999999999999975432221111 11111 01 1
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+......+.+++.+|+. +|++||+++||++
T Consensus 229 ~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 229 VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1222334567788888985 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=291.31 Aligned_cols=245 Identities=25% Similarity=0.437 Sum_probs=199.5
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+.++++++||||+++++++..+...++||||+++
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 86 (277)
T ss_pred hhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCC
Confidence 34567999999999999864 68899999986543 33456788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++... .+++..+..++.+++.|+.||| +.+++|+||||+||+++.++.++|+|||++....... ...
T Consensus 87 ~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06641 87 GSALDLLEPG---PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhh
Confidence 9999998753 3889999999999999999999 8999999999999999999999999999987653321 112
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....++..|+|||.+.+...+.++|||||||+++||++|+.||....... +.... .... .+.+ ...
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~~-~~~~-----~~~~----~~~ 224 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK----VLFLI-PKNN-----PPTL----EGN 224 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH----HHHHH-hcCC-----CCCC----Ccc
Confidence 23467889999999988889999999999999999999999997543221 11111 1111 1111 122
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
....+.+++.+|++.+|++||++.++++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 34567899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=288.72 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=203.7
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+..+.+++|+||+++++++..++..++|+||++++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06623 5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG 84 (264)
T ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence 4578999999999999976 589999999876644 45678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCC-CCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK-PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
+|.+++... ..+++..+..++.|+++|+.||| + .+++||||+|+||+++.++.++|+|||++........ ..
T Consensus 85 ~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~~ 157 (264)
T cd06623 85 SLADLLKKV--GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--QC 157 (264)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC--cc
Confidence 999999865 34899999999999999999999 8 9999999999999999999999999999986643221 11
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....++..|+|||.+.+..++.++||||||++++||++|+.||....... ..+....... ... +.+ +..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~-~~~-----~~~----~~~ 226 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-FFELMQAICD-GPP-----PSL----PAE 226 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC-HHHHHHHHhc-CCC-----CCC----Ccc
Confidence 23467889999999998889999999999999999999999997664211 1121222211 111 111 112
Q ss_pred -HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 776 -SAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 776 -~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
....+.+++.+|+..+|++||++.|+++.
T Consensus 227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 34578999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=300.42 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=196.5
Q ss_pred hhcCcC--ceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEG--SFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G--~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+| +||+||+++.. +++.||+|++.... ....+.+++|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456776 99999999974 78999999987542 33456788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc--
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH-- 693 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~-- 693 (846)
++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999998765556899999999999999999999 8899999999999999999999999998654321111100
Q ss_pred ---ccccccCCCcccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHH---------------
Q 003114 694 ---LSTGVAGTFGYLDPEYCQTF--RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDF--------------- 753 (846)
Q Consensus 694 ---~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~--------------- 753 (846)
......++..|+|||++.+. .++.++|||||||+++||++|+.||...............
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 01112345679999998763 4789999999999999999999999765433222211110
Q ss_pred -----------------HHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 754 -----------------MLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 754 -----------------~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
....+......+..+...........+.+++.+|++.+|++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000000001111112222223345678999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=306.26 Aligned_cols=188 Identities=26% Similarity=0.375 Sum_probs=160.1
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++|+||+++++++..+...++|+|++.
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 140 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS- 140 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-
Confidence 344578999999999999975 5678999975432 23568999999999999999999999999999999994
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++.... ..+++..+.+++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++.... ....
T Consensus 141 ~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~~~ 213 (357)
T PHA03209 141 SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---APAF 213 (357)
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cccc
Confidence 68888886543 34899999999999999999999 88999999999999999999999999999874321 1122
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAI 738 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~ 738 (846)
....||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 3456899999999999989999999999999999999865444
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=289.02 Aligned_cols=249 Identities=26% Similarity=0.408 Sum_probs=199.5
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
..+.||+|+||.||+|... +++.|++|.+..... ...+.+.+|+.+++.++|+||+++++++...+..++|+||+++
T Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCC
Confidence 3468999999999999965 788999999876543 3667899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc-
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL- 694 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~- 694 (846)
++|.+++.... .+++..+..++.++++||.||| +.+|+|+||+|+||++++++.+||+|||++...........
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 84 GTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 99999998654 3788999999999999999999 89999999999999999999999999999987643322111
Q ss_pred -cccccCCCcccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 695 -STGVAGTFGYLDPEYCQTFR---LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 695 -~~~~~gt~~Y~APE~~~~~~---~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
.....++..|+|||++.... .+.++||||||++++||++|+.||...+....... . ...+. .+.+..
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~---~-~~~~~-----~~~~~~ 229 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF---H-VGAGH-----KPPIPD 229 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH---H-HhcCC-----CCCCCc
Confidence 12356788999999988766 88999999999999999999999975432211111 1 11111 111111
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.......+.+++.+|++.+|++||++.|++.
T Consensus 230 --~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 --SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1112446789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=305.28 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=191.8
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecC------CeeeEe
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG------NQIGLI 609 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~LV 609 (846)
..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++... ...+++
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 98 (343)
T cd07878 19 NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLV 98 (343)
T ss_pred hheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEE
Confidence 346899999999999986 468899999987542 22345677899999999999999999887532 457899
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
+|++ +++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 99 ~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~- 170 (343)
T cd07878 99 TNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD- 170 (343)
T ss_pred eecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccceecCC-
Confidence 9988 78998887643 3899999999999999999999 89999999999999999999999999999986532
Q ss_pred CcccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC---
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD--- 765 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d--- 765 (846)
......||+.|+|||.+.+ ..++.++|||||||+++||++|+.||........+..+....... ..+...
T Consensus 171 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 244 (343)
T cd07878 171 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP--SPEVLKKIS 244 (343)
T ss_pred ----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC--CHHHHHhcc
Confidence 1234568999999999876 568999999999999999999999997654333333322211000 000000
Q ss_pred --------CCCCCCCC--------hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 766 --------PKLHGDID--------VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 766 --------~~L~~~~~--------~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
..+. ..+ ......+.+++.+|++.+|++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 245 SEHARKYIQSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhhHHHHhhccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000 0112346799999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.87 Aligned_cols=260 Identities=20% Similarity=0.296 Sum_probs=199.3
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
++.+.||+|+||.||+|..+ +++.||+|.++.. .....+.+.+|+++++.++|+||+++++++..++..++|+||++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 83 (288)
T cd07833 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE 83 (288)
T ss_pred eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCC
Confidence 34568999999999999976 6889999998653 23345678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
++.+..+..... .+++.++..++.+++.||.||| +.+++||||+|+||++++++.+||+|||++........ ..
T Consensus 84 ~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (288)
T cd07833 84 RTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SP 157 (288)
T ss_pred CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-cc
Confidence 877776655433 3889999999999999999999 88999999999999999999999999999887643321 12
Q ss_pred cccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHH-----------hcCCcc-
Q 003114 695 STGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFML-----------AQGDIK- 761 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~-----------~~~~~~- 761 (846)
.....++..|+|||++.+. .++.++||||||++++||++|++||......+.+........ ......
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 2335678899999999887 789999999999999999999999976543332222111000 000000
Q ss_pred ----cccCCCC-CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 762 ----NIVDPKL-HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 762 ----~~~d~~L-~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+..++.. ...++.....++.+++.+|+..+|++||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000 00011122567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=294.26 Aligned_cols=259 Identities=18% Similarity=0.246 Sum_probs=197.3
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeecC--CeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNEG--NQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|... +++.+|+|.++.... .....+.+|+.++++++||||+++++++... ...++|+||
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~ 87 (293)
T cd07843 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEY 87 (293)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehh
Confidence 34578999999999999976 688999999875432 2234567899999999999999999998777 899999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
++ ++|.+++..... .+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||++.......
T Consensus 88 ~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 160 (293)
T cd07843 88 VE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-- 160 (293)
T ss_pred cC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc--
Confidence 97 599998876543 5899999999999999999999 8899999999999999999999999999998764321
Q ss_pred cccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc--------------
Q 003114 693 HLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ-------------- 757 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~-------------- 757 (846)
.......++..|+|||.+.+. ..+.++|+||+|++++||++|++||........+..........
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 122334578899999988654 46899999999999999999999998655433332222111000
Q ss_pred --CCcccccCCCCCCCCChH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 758 --GDIKNIVDPKLHGDIDVN-SAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 758 --~~~~~~~d~~L~~~~~~~-~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..........+...++.. ....+.+++.+|++.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000001111111111111 2456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=290.66 Aligned_cols=244 Identities=24% Similarity=0.413 Sum_probs=197.3
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcc---cccceeEeeEeecCCeeeEeeecc
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVH---HKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
+.+.||+|+||.||+|.. .+++.+|+|.+... .....+++.+|+.+++.++ |||++++++++..+...++||||+
T Consensus 5 ~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06917 5 RLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA 84 (277)
T ss_pred hhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecC
Confidence 346799999999999996 47899999998754 3344567889999999997 999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++++|.+++... .+++.....++.+++.||.||| +.+|+||||+|+||++++++.++|+|||++..+.... .
T Consensus 85 ~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06917 85 EGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--S 156 (277)
T ss_pred CCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--c
Confidence 999999998754 4899999999999999999999 8999999999999999999999999999998764332 2
Q ss_pred ccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
......|+..|+|||.+.+. .++.++|||||||++|||++|+.||....... +... . .....+.+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~----~~~~-~-----~~~~~~~~~~~- 225 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR----AMML-I-----PKSKPPRLEDN- 225 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh----hhhc-c-----ccCCCCCCCcc-
Confidence 22334688899999988654 46899999999999999999999997543221 1110 0 01111222111
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.....+.+++.+|++.+|++||++.|+++
T Consensus 226 --~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 226 --GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred --cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 13457889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=295.90 Aligned_cols=257 Identities=20% Similarity=0.327 Sum_probs=192.6
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|+||.||+|+.. +|+.+|+|.+.... ......+.+|+.++++++|+||+++++++.+....++|+||++
T Consensus 4 ~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 82 (284)
T cd07839 4 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD- 82 (284)
T ss_pred eEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-
Confidence 4467999999999999975 68899999986432 2223567889999999999999999999999999999999996
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++..... .+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 83 ~~l~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 156 (284)
T cd07839 83 QDLKKYFDSCNG-DIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCY 156 (284)
T ss_pred CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CCc
Confidence 588888765432 4899999999999999999999 8999999999999999999999999999997653221 112
Q ss_pred ccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccc-cccHHHHHHHHHhcCC------cccccCC-
Q 003114 696 TGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEE-HKHISQWVDFMLAQGD------IKNIVDP- 766 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~-~~~l~~~~~~~~~~~~------~~~~~d~- 766 (846)
....++..|+|||.+.+. .++.++|||||||+++||+||+.|+..... ...+....+. ..... ..+..+.
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL-LGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHH-hCCCChHHhHHhhhccccc
Confidence 234578899999988664 478999999999999999999888643332 2222111111 00000 0000000
Q ss_pred ---CCCC-----CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 767 ---KLHG-----DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 767 ---~L~~-----~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.... .........+.+++.+|++.+|.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 001122356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=283.55 Aligned_cols=245 Identities=26% Similarity=0.453 Sum_probs=202.5
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
.+.||+|++|.||++... +++.+++|++........+.+.+|++.++.++|+|++++++++..+...++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 467999999999999976 6889999999876555667899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~ 698 (846)
.+++.... ..+++..+..++.+++.||.+|| +.+++||||+|+||++++++.++|+|||.+........ ....
T Consensus 85 ~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~ 157 (253)
T cd05122 85 KDLLKSTN-QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTM 157 (253)
T ss_pred HHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccce
Confidence 99998764 34899999999999999999999 89999999999999999999999999999886643221 3345
Q ss_pred cCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHH
Q 003114 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAW 778 (846)
Q Consensus 699 ~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~ 778 (846)
.++..|+|||.+.....+.++||||||++++||++|+.||...+....+.. ... .......++ .....
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~-------~~~~~ 225 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK----IAT-NGPPGLRNP-------EKWSD 225 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH----HHh-cCCCCcCcc-------cccCH
Confidence 688999999999888899999999999999999999999976542222211 111 111111111 11135
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 779 KAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 779 ~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+.+++.+|++.+|++|||+.|+++
T Consensus 226 ~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 226 EFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhc
Confidence 6889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=294.14 Aligned_cols=258 Identities=22% Similarity=0.344 Sum_probs=192.9
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++..++..++||||+. +
T Consensus 9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07844 9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-T 87 (291)
T ss_pred EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-C
Confidence 3468999999999999975 688999999875432 223456789999999999999999999999999999999997 4
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++..... .+++.....++.|+++||.||| +.+|+||||||+||++++++.+||+|||+++...... ....
T Consensus 88 ~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~ 161 (291)
T cd07844 88 DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--KTYS 161 (291)
T ss_pred CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--cccc
Confidence 99998876543 5889999999999999999999 8899999999999999999999999999987542211 1112
Q ss_pred cccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccc-ccHHHHHHHHHh--cCCc------ccccC-
Q 003114 697 GVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEH-KHISQWVDFMLA--QGDI------KNIVD- 765 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~-~~l~~~~~~~~~--~~~~------~~~~d- 765 (846)
...++..|+|||.+.+ ..++.++||||+||+++||++|+.||...... +.+....+.... +... .+...
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY 241 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc
Confidence 2346788999998865 45889999999999999999999999755421 111111110000 0000 00000
Q ss_pred -------CCCCCCC-ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 -------PKLHGDI-DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 -------~~L~~~~-~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+.... .......+.+++.+|++.+|++||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 0111256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=293.40 Aligned_cols=246 Identities=24% Similarity=0.463 Sum_probs=193.9
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEee------cCCeeeEee
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCN------EGNQIGLIY 610 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~------~~~~~~LV~ 610 (846)
+.+.||+|+||.||+|.. ++++.+|+|.+.... ....++..|+.+++++ +|+||+++++++. .....+++|
T Consensus 20 ~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 98 (282)
T cd06636 20 LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVM 98 (282)
T ss_pred hheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEE
Confidence 346899999999999997 468899999986543 2345688899999998 7999999999984 346789999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+++|+|.+++.......+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++......
T Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~- 174 (282)
T cd06636 99 EFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT- 174 (282)
T ss_pred EeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcc-
Confidence 9999999999998765556888889999999999999999 889999999999999999999999999998754321
Q ss_pred cccccccccCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQ-----TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 765 (846)
........|+..|+|||.+. ...++.++|||||||++|||++|+.||........+.. .... ..
T Consensus 175 -~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-----~~~~-----~~ 243 (282)
T cd06636 175 -VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-----IPRN-----PP 243 (282)
T ss_pred -ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-----HhhC-----CC
Confidence 11223356889999999875 34678899999999999999999999965432221111 0000 01
Q ss_pred CCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 ~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+.+. .......+.+++.+|++.+|.+||++.|+++
T Consensus 244 ~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 244 PKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1111 1123457889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.30 Aligned_cols=246 Identities=22% Similarity=0.366 Sum_probs=209.4
Q ss_pred HhhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 536 TNDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+++++.||+|.|+.|-+|++ -+|..||||++.+..- .....+.+|+..|+.++|||||+|+........+|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 356678899999999999985 4899999999987643 3456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE-CCCCcEEEEeccCCccCCCCCc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL-NDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl-d~~~~vkI~DFGla~~~~~~~~ 691 (846)
=++|+|.++|.++.. .+.+..+.++..||+.|+.|+| +..+|||||||+||.+ ..-|-+||.|||++-.+..
T Consensus 99 GD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P--- 171 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP--- 171 (864)
T ss_pred cCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCC---
Confidence 999999999987653 4899999999999999999999 9999999999999976 5678999999999987643
Q ss_pred ccccccccCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLT-EKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s-~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
.......+|++.|.|||.+.+..|+ +++||||+|||||.|++|++||+...+.+.+..++ |...
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm-------------DCKY-- 236 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM-------------DCKY-- 236 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh-------------cccc--
Confidence 3455667999999999999998877 57999999999999999999999877666554433 2221
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+.....+..+|+..|+..+|++|-+.+||+.
T Consensus 237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 224445667889999999999999999888754
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=312.38 Aligned_cols=242 Identities=28% Similarity=0.501 Sum_probs=195.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEE---EEEeCC-CCchhhHHHHHHHHHHHhcccccceeEeeEeecCC--eeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVA---VKMLSP-SSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN--QIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VA---VK~l~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~~LV~ 610 (846)
.|.++||+|+|-+||||... +|.+|| ||.-.. .++...+.|..|+.+|+.|+|+||++++.++.+.. .+.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45678999999999999964 688886 332221 24455688999999999999999999999886654 488999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-CCcEEEEeccCCccCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-QFQARLADFGLSKTFPIE 689 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-~~~vkI~DFGla~~~~~~ 689 (846)
|.|..|+|..++++.+. .+.+...+|++||++||.|||.. .++|||||||-+||+|+. .|.|||+|.|||......
T Consensus 123 EL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999999998765 78889999999999999999954 789999999999999985 589999999999876432
Q ss_pred CcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc---CCcccccCC
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ---GDIKNIVDP 766 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~---~~~~~~~d~ 766 (846)
+ ...+.|||.|||||... ..|.+.+||||||+.++||+|+..||..-. +..++.+.+... ..+..+-||
T Consensus 200 ---~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~---n~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 200 ---H-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT---NPAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred ---c-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC---CHHHHHHHHHcCCCHHHhhccCCH
Confidence 2 23378999999999877 689999999999999999999999997443 334444433322 222333333
Q ss_pred CCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 767 KLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 767 ~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
++.+++.+|+.. .++|||+.|+++
T Consensus 272 ------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 ------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 467999999999 999999999875
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=289.92 Aligned_cols=246 Identities=23% Similarity=0.354 Sum_probs=198.5
Q ss_pred cCcCceEEEEEEEEc-CCcEEEEEEeCCCCc---hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 543 LGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR---QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 543 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
||.|+||.||+++.. +++.+++|.+..... ...+.+.+|+.++++++|+||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 489999999875533 3456788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc------c
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV------S 692 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~------~ 692 (846)
.+++.... .+++..+.+++.|++.||.||| +.+++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99998654 4899999999999999999999 89999999999999999999999999999875432211 1
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
.......++..|+|||.......+.++||||||++++||++|+.||........ ...... +.... + .
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~-~~~~~---~-----~ 222 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI----FQNILN-GKIEW---P-----E 222 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhc-CCcCC---C-----c
Confidence 122335578899999999888899999999999999999999999976543322 221111 11110 0 0
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
.......+.+++.+|++.+|++||++.++.+.|+
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0012457789999999999999999977766664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=296.39 Aligned_cols=247 Identities=23% Similarity=0.383 Sum_probs=200.2
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.+.||+|+||.||++.. .++..||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (293)
T cd06647 22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGG 101 (293)
T ss_pred eeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCC
Confidence 3456799999999999985 468899999987655555677889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++... .+++.++..++.+++.||.||| +.+++||||||+||+++.++.+||+|||++....... ....
T Consensus 102 ~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--~~~~ 173 (293)
T cd06647 102 SLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRS 173 (293)
T ss_pred cHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--cccc
Confidence 999999764 3788999999999999999999 8999999999999999999999999999887653322 1223
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
...+++.|+|||.+....++.++|||||||++|||++|+.||........+.. ....+. +.. ......
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~----~~~~~~------~~~--~~~~~~ 241 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNGT------PEL--QNPEKL 241 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee----hhcCCC------CCC--CCcccc
Confidence 34688899999999888899999999999999999999999976543221111 000100 000 011123
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
...+.+++.+|+..+|++||++.+++.+
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3467899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=293.32 Aligned_cols=246 Identities=24% Similarity=0.391 Sum_probs=201.3
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
+.+.||+|++|.||+|..+ ++..+++|++..... ..+.+.+|++.++.++|+|++++++++...+..++|+||+++++
T Consensus 23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 101 (286)
T cd06614 23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS 101 (286)
T ss_pred HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence 3467999999999999986 688999999976544 45678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++.... ..+++..+..++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++....... .....
T Consensus 102 L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~ 175 (286)
T cd06614 102 LTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKRNS 175 (286)
T ss_pred HHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--hhhcc
Confidence 999998765 35899999999999999999999 8999999999999999999999999999887553221 11223
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSA 777 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~ 777 (846)
..++..|+|||.+.+..++.++|||||||+++||++|+.||...........+ . ........+ .....
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~----~-~~~~~~~~~-------~~~~~ 243 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI----T-TKGIPPLKN-------PEKWS 243 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----H-hcCCCCCcc-------hhhCC
Confidence 45788999999998888999999999999999999999999755433222111 1 111111111 11133
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 778 WKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 778 ~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+.+++.+|++.+|.+||++.+|++
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 244 PEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhh
Confidence 56889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=291.83 Aligned_cols=243 Identities=22% Similarity=0.353 Sum_probs=198.0
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChh
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLE 619 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 619 (846)
+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+||+++++++..++..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 58999999999999964 78899999987655555567889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccccc
Q 003114 620 EYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699 (846)
Q Consensus 620 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~ 699 (846)
+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||.+....... .......
T Consensus 105 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~ 176 (285)
T cd06648 105 DIVTHT---RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKSLV 176 (285)
T ss_pred HHHHhC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--ccccccc
Confidence 998872 3889999999999999999999 8999999999999999999999999999887543221 1122345
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHH
Q 003114 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWK 779 (846)
Q Consensus 700 gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~ 779 (846)
|+..|+|||...+..++.++|||||||+++||++|+.||...... ........ ... +.+.. .......
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~----~~~~~~~~-~~~-----~~~~~--~~~~~~~ 244 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL----QAMKRIRD-NLP-----PKLKN--LHKVSPR 244 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH----HHHHHHHh-cCC-----CCCcc--cccCCHH
Confidence 889999999998888999999999999999999999998754322 11221111 111 11110 1113347
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHH
Q 003114 780 AVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 780 l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+.+++.+|++.+|++||++.++++
T Consensus 245 l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 245 LRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHcccChhhCcCHHHHcc
Confidence 889999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=289.87 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=196.6
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeec--CCeeeEeeecccC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNE--GNQIGLIYEYMAN 615 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~LV~Ey~~~ 615 (846)
.+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||+++++++.. ....++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 467999999999999975 688899999875432 345678999999999999999999998854 3478999999999
Q ss_pred CChhhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 616 GSLEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 616 gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|.+++... ....+++.....++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~---- 158 (287)
T cd06621 86 GSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS---- 158 (287)
T ss_pred CCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccccc----
Confidence 9999887542 2344788999999999999999999 899999999999999999999999999998754321
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccc-cccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE-HKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
......++..|+|||.+.+..++.++||||+||++|||++|+.||..... .....+....... .......+ .. ..
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~--~~ 234 (287)
T cd06621 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKD-EP--GN 234 (287)
T ss_pred ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhcc-CC--CC
Confidence 11234578889999999988999999999999999999999999986532 1111122221111 11111100 00 00
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.......+.+++.+|++.+|++|||+.||++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1123457889999999999999999999887
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=289.87 Aligned_cols=247 Identities=28% Similarity=0.422 Sum_probs=199.9
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+..+...++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (257)
T cd08225 4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG 83 (257)
T ss_pred EEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCC
Confidence 4567999999999999975 58899999986532 23346788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC-cEEEEeccCCccCCCCCcccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF-QARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-~vkI~DFGla~~~~~~~~~~~ 694 (846)
++|.+++.......+++..+..++.++++||.||| +.+++|+||||+||++++++ .+||+|||.+...... ...
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~~ 158 (257)
T cd08225 84 GDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--MEL 158 (257)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCC--ccc
Confidence 99999998765556899999999999999999999 88999999999999999875 5699999998765322 112
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....|++.|+|||+..+..++.++||||||++++||++|+.||...... +++..... +..... ..
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-~~~~~~---------~~ 224 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH----QLVLKICQ-GYFAPI---------SP 224 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHhc-ccCCCC---------CC
Confidence 22345889999999998888999999999999999999999999754322 22222221 111111 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.....+.+++.+|+..+|++||+++|+++.
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 223468899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=289.47 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=195.8
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeecC------CeeeEe
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEG------NQIGLI 609 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~------~~~~LV 609 (846)
.+.+.||+|++|.||+|... +++.+++|++..... ..+++.+|+.+++++ +|+||+++++++... ...++|
T Consensus 9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence 34578999999999999975 678899999876543 346789999999999 799999999998654 458999
Q ss_pred eecccCCChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCC
Q 003114 610 YEYMANGSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP 687 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~ 687 (846)
|||+++++|.+++.... ...+++..+..++.|++.||.||| +.+++||||+|+||++++++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 99999999999987543 345899999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCcccccccccCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCccc
Q 003114 688 IEGVSHLSTGVAGTFGYLDPEYCQT-----FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKN 762 (846)
Q Consensus 688 ~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 762 (846)
.. ........|+..|+|||.+.. ..++.++|||||||+++||++|+.||........+.+. .....
T Consensus 165 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~-- 235 (275)
T cd06608 165 ST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI-----PRNPP-- 235 (275)
T ss_pred cc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh-----hccCC--
Confidence 21 122233568899999998753 34778999999999999999999999754332222221 11111
Q ss_pred ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 763 IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 763 ~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+.+. ........+.+++.+|+..+|++|||+.|+++
T Consensus 236 ---~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 236 ---PTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ---CCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 11123457889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=293.50 Aligned_cols=243 Identities=28% Similarity=0.393 Sum_probs=194.2
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
...+.||+|+||.||+|... +++.||+|.+.... ....+++.+|+++++.++||||++++++|..++..++|+||+
T Consensus 18 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 97 (307)
T cd06607 18 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC 97 (307)
T ss_pred hhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhh
Confidence 34567999999999999975 68899999986432 233456889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
. |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||+|+||++++++.+||+|||++......
T Consensus 98 ~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 98 L-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred C-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 6 67777775433 24899999999999999999999 889999999999999999999999999998754321
Q ss_pred ccccccCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQ---TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
....++..|+|||.+. ...++.++||||||+++|||++|++||........+.. ...... +.+.
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~-----~~~~~~-----~~~~- 235 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----IAQNDS-----PTLS- 235 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH-----HhcCCC-----CCCC-
Confidence 2345788999999874 45688999999999999999999999976543222111 111110 1111
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.......+.+++.+|+..+|++||++.+|+..
T Consensus 236 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 236 --SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11234578899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=290.94 Aligned_cols=246 Identities=24% Similarity=0.299 Sum_probs=194.9
Q ss_pred cCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 543 LGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 543 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
||+|+||+||++... +++.+|+|.+.... ......+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999864 68899999986532 22344567899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~ 698 (846)
.+++.......+++..+..++.|++.||.||| +.+++||||+|+||++++++.+||+|||++..... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence 99998766556899999999999999999999 89999999999999999999999999999876532 1122234
Q ss_pred cCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHH
Q 003114 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAW 778 (846)
Q Consensus 699 ~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~ 778 (846)
.++..|+|||.+.+..++.++||||+||+++||++|+.||................. .. .. ..+.....
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~------~~----~~~~~~~~ 223 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-EM------AV----EYPDKFSP 223 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-cc------cc----cCCccCCH
Confidence 578899999999888899999999999999999999999976543222111111100 00 00 11122344
Q ss_pred HHHHHHHhccCCCCCCCCCHHH-HHHHH
Q 003114 779 KAVEIAMGCVSHSSTPRPNMNR-VVMEL 805 (846)
Q Consensus 779 ~l~~L~~~Cl~~~P~~RPsm~e-Vl~~L 805 (846)
.+.+++.+|++.+|++||+..+ ..+.|
T Consensus 224 ~~~~li~~~l~~~p~~R~~~~~~~~~~l 251 (277)
T cd05577 224 EAKDLCEALLQKDPEKRLGCRGGSADEV 251 (277)
T ss_pred HHHHHHHHHccCChhHccCCCcccHHHH
Confidence 6789999999999999995555 44444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=283.61 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=202.7
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeecC--CeeeEeeeccc
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNEG--NQIGLIYEYMA 614 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~LV~Ey~~ 614 (846)
.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+..+++++|+||+++++.+... ...++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 467999999999999976 789999999876543 4567889999999999999999999999888 89999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+++|.+++.... .+++..+..++.++++||+||| +.+++|+||+|+||+++.++.++|+|||.+...........
T Consensus 85 ~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 85 GGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999998765 5899999999999999999999 89999999999999999999999999999987644322112
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....++..|+|||.......+.++||||||+++++|++|+.||....... ........ .......+.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~---------~~~~~~~~~ 227 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM---AALYKIGS---------SGEPPEIPE 227 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHhccc---------cCCCcCCCc
Confidence 334568889999999988889999999999999999999999997655111 11111110 011111222
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.....+.+++.+|++.+|++||++.|+++
T Consensus 228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 228 HLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 23467889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=292.87 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=192.6
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEeeecccCC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 467999999999999965 68999999987543 334567889999999996 99999999999999999999999864
Q ss_pred Chhhhh---hcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 617 SLEEYL---SDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 617 sL~~~l---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
+|.++. .......+++.....++.+++.||+|||+ +.+++||||||+||+++.++.+||+|||+++..... .
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~---~ 162 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS---I 162 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC---C
Confidence 555433 32333458999999999999999999993 358999999999999999999999999998765322 1
Q ss_pred ccccccCCCcccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTF---RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~---~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
......|+..|+|||.+.+. .++.++|||||||+++||++|+.||..... ...-...... + ..+.+..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~-~-----~~~~~~~ 233 (288)
T cd06616 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVK-G-----DPPILSN 233 (288)
T ss_pred ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhcC-C-----CCCcCCC
Confidence 12234578899999998765 689999999999999999999999975431 1111111111 1 1122222
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.........+.+++.+|++.+|++||++++|++.
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2222345578899999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=292.02 Aligned_cols=259 Identities=22% Similarity=0.309 Sum_probs=197.4
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecC--CeeeEeeecc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG--NQIGLIYEYM 613 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~LV~Ey~ 613 (846)
+.+.||+|++|.||+|+.. +++.+|+|++.... ......+.+|+.+++.++|+|++++++++... +..++|+||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 3467999999999999976 58899999998653 33345688999999999999999999999887 8999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++ +|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||++++++.+||+|||++........ .
T Consensus 83 ~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (287)
T cd07840 83 DH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-A 156 (287)
T ss_pred cc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-c
Confidence 74 8998887653 34899999999999999999999 88999999999999999999999999999986643221 1
Q ss_pred ccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc--CCcccccC-----
Q 003114 694 LSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ--GDIKNIVD----- 765 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~--~~~~~~~d----- 765 (846)
......++..|+|||.+.+ ..++.++||||||++++||++|+.||........+.......... .......+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 2233456788999997664 457899999999999999999999997655433322222211000 00000000
Q ss_pred ---------CCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 ---------PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 ---------~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+...........+++++.+|+..+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000001112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=293.30 Aligned_cols=239 Identities=26% Similarity=0.375 Sum_probs=195.6
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 5 ~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (290)
T cd05580 5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP 84 (290)
T ss_pred EEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCC
Confidence 4578999999999999975 68999999986532 2334668899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+++|.+++.... .+++..+..++.|++.||.||| +.+|+||||+|+||++++++.+||+|||++......
T Consensus 85 ~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----- 154 (290)
T cd05580 85 GGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----- 154 (290)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----
Confidence 999999997764 4889999999999999999999 899999999999999999999999999999865322
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....+++.|+|||.+.+...+.++||||||++++||++|+.||.......... ... .+.. .+ +.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~-~~~~------~~----~~ 219 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE----KIL-EGKV------RF----PS 219 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHh-cCCc------cC----Cc
Confidence 234568899999999988888999999999999999999999997654221111 111 1111 11 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCC-----CHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRP-----NMNRVV 802 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl 802 (846)
.....+.+++.+|+..+|.+|| +++|++
T Consensus 220 ~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 220 FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred cCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 2235678999999999999999 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=295.18 Aligned_cols=260 Identities=19% Similarity=0.247 Sum_probs=194.7
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
+.+|.|+++.||++.. +++.||+|++... .....+.+.+|+.+++.++|+||+++++++...+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4455566666666555 6899999998754 344567899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc-----cc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV-----SH 693 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~-----~~ 693 (846)
.+++.......+++.....++.|+++||+||| +.+|+||||||+||+++.++.+||+|||.+..+..... ..
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 99998765556889999999999999999999 88999999999999999999999999998875532211 11
Q ss_pred ccccccCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHH----hcC-------Cc
Q 003114 694 LSTGVAGTFGYLDPEYCQT--FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFML----AQG-------DI 760 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~----~~~-------~~ 760 (846)
......++..|+|||.+.. ..++.++|||||||+++||++|+.||........+.+-..... ... ..
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 1223457788999999865 3588999999999999999999999986543322221111000 000 00
Q ss_pred cc----ccCCCCC----CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 761 KN----IVDPKLH----GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 761 ~~----~~d~~L~----~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.. ..++... ..........+.+++.+||+.+|++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00 0000000 00112233567899999999999999999998874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=287.05 Aligned_cols=237 Identities=23% Similarity=0.302 Sum_probs=193.5
Q ss_pred cCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 543 LGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 543 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
||.|++|.||+++.. +++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 48899999987542 23446788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~ 698 (846)
.+++..... +++..+..++.|+++||+||| +.+++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDRGL--FDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhcCC--CCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 999976543 889999999999999999999 8999999999999999999999999999998664321 22234
Q ss_pred cCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHH
Q 003114 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAW 778 (846)
Q Consensus 699 ~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~ 778 (846)
.++..|+|||.+.+..++.++|+||+|+++|||++|+.||....+. ..+......... ....++.....
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~---------~~~~~~~~~~~ 221 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKGN---------GKLEFPNYIDK 221 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhccC---------CCCCCCcccCH
Confidence 6788999999998888999999999999999999999999765421 122222222101 01111222245
Q ss_pred HHHHHHHhccCCCCCCCCCH
Q 003114 779 KAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 779 ~l~~L~~~Cl~~~P~~RPsm 798 (846)
.+.+++.+|++.+|++||++
T Consensus 222 ~~~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLGN 241 (262)
T ss_pred HHHHHHHHHccCChhhCcCC
Confidence 78999999999999999993
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=327.87 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=193.8
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeec--CCeeeEeee
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE--GNQIGLIYE 611 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~LV~E 611 (846)
+.+.+.||+|+||+||+++.. .+..+|+|.+... .......+..|+.+++.++||||+++++++.. ...+++|||
T Consensus 15 YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVME 94 (1021)
T PTZ00266 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILME 94 (1021)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEe
Confidence 445678999999999999975 5778999998654 23345678899999999999999999998744 457899999
Q ss_pred cccCCChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccC----CCCeeecCCCCCCEEECC--------------
Q 003114 612 YMANGSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGC----KPPRVHRDIKPANILLND-------------- 671 (846)
Q Consensus 612 y~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~IiHrDlKp~NILld~-------------- 671 (846)
|+++|+|.++|.... ...+++..++.|+.||+.||.|||... ..+|+||||||+||||+.
T Consensus 95 Y~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n 174 (1021)
T PTZ00266 95 FCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174 (1021)
T ss_pred CCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccc
Confidence 999999999997532 235899999999999999999999422 146999999999999964
Q ss_pred ---CCcEEEEeccCCccCCCCCcccccccccCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccc
Q 003114 672 ---QFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT--FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKH 746 (846)
Q Consensus 672 ---~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~ 746 (846)
...+||+|||++..+... .......||+.|+|||++.. ..++.++|||||||++|||+||+.||.......
T Consensus 175 ~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~- 250 (1021)
T PTZ00266 175 LNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS- 250 (1021)
T ss_pred cCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH-
Confidence 345899999999865322 12234578999999998854 458899999999999999999999997544322
Q ss_pred HHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 747 ISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 747 l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.++..+. .+ +.+. .......+.+|+..||..+|.+||++.|++.
T Consensus 251 --qli~~lk-~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 251 --QLISELK-RG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred --HHHHHHh-cC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 2222221 11 1110 0112346889999999999999999999984
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=289.80 Aligned_cols=258 Identities=23% Similarity=0.320 Sum_probs=198.1
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhc---ccccceeEeeEeecCCe-----ee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--QGYEQFEAEVILLRTV---HHKNLTTLYGYCNEGNQ-----IG 607 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~~~~-----~~ 607 (846)
+.+.||+|+||.||+|+.+ +++.+|+|.+..... .....+.+|+.+++++ +|+|++++++++...+. .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 3467999999999999986 489999999974322 2234566777777666 59999999999987776 99
Q ss_pred EeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCC
Q 003114 608 LIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP 687 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~ 687 (846)
++|||+. ++|.+++.......+++..+..++.|+++||.||| +.+++|+||||+||++++++.+||+|||++..+.
T Consensus 83 l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 83 LVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred EEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999997 58999887655445899999999999999999999 8899999999999999999999999999997753
Q ss_pred CCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccc----
Q 003114 688 IEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNI---- 763 (846)
Q Consensus 688 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~---- 763 (846)
... ......++..|+|||.+.+..++.++|||||||+++||++|++||......+.+..+.............
T Consensus 159 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 159 FEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred CCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 221 1223457889999999998899999999999999999999999998766555554444322211110000
Q ss_pred -----cCCCCCC---CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 764 -----VDPKLHG---DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 764 -----~d~~L~~---~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
....... ....+....+.+++.+|++.+|++||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000 001123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=291.98 Aligned_cols=257 Identities=21% Similarity=0.300 Sum_probs=194.6
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++++++..+...++||||++
T Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 84 (294)
T PLN00009 6 KVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD- 84 (294)
T ss_pred EEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-
Confidence 3467999999999999975 788999999865422 234568889999999999999999999999999999999995
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-CCcEEEEeccCCccCCCCCcccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-QFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
++|.+++.......+++.....++.|++.||+||| +.+++||||||+||+++. ++.+||+|||++...... ...
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--~~~ 159 (294)
T PLN00009 85 LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--VRT 159 (294)
T ss_pred ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--ccc
Confidence 58888886655544678888899999999999999 889999999999999985 567999999999764322 111
Q ss_pred cccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC--------
Q 003114 695 STGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD-------- 765 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d-------- 765 (846)
.....++..|+|||++.+. .++.++||||+||+++||+||++||......+.+.+..... ... .....+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~ 237 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRIL-GTP-NEETWPGVTSLPDY 237 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCC-Chhhccccccchhh
Confidence 2234578899999988654 57899999999999999999999997655433333221110 000 000000
Q ss_pred ----CCCCC----CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 ----PKLHG----DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 ----~~L~~----~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+.... .........+.+++.+|++.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 001122345789999999999999999999986
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=291.81 Aligned_cols=244 Identities=27% Similarity=0.370 Sum_probs=195.0
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
...+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|+.+++.++|+|++++++++..++..++||||+
T Consensus 28 ~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 107 (317)
T cd06635 28 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC 107 (317)
T ss_pred hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCC
Confidence 34567999999999999964 68899999986432 233457888999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
. |+|.+.+.... ..+++.++..++.+++.||.||| +.+|+||||+|+||+++.++.+||+|||++.....
T Consensus 108 ~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 108 L-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred C-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 6 58887776443 34899999999999999999999 89999999999999999999999999999875422
Q ss_pred ccccccCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQ---TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
.....|+..|+|||++. ...++.++|||||||+++||++|+.||........+..+.. .+. +..
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----~~~------~~~-- 244 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NES------PTL-- 244 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh----ccC------CCC--
Confidence 12346788999999873 45688999999999999999999999876543322222211 111 000
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
........+.+++.+|++.+|++||++.+|++.+
T Consensus 245 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 245 -QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred -CCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0112334688999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=291.93 Aligned_cols=243 Identities=22% Similarity=0.367 Sum_probs=197.3
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChh
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLE 619 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 619 (846)
..||+|+||.||++..+ ++..||+|++..........+.+|+.+++.++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999874 78999999987655555677899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccccc
Q 003114 620 EYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699 (846)
Q Consensus 620 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~ 699 (846)
+++... .+++.....++.|++.||+||| +.+++||||||+||++++++.++|+|||++....... .......
T Consensus 106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 177 (292)
T cd06657 106 DIVTHT---RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV 177 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence 987643 3789999999999999999999 8899999999999999999999999999987653221 1123346
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHH
Q 003114 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWK 779 (846)
Q Consensus 700 gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~ 779 (846)
|+..|+|||...+..++.++|+||+||+++||++|+.||........... . ... ..+.+.. .......
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-~----~~~-----~~~~~~~--~~~~~~~ 245 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-I----RDN-----LPPKLKN--LHKVSPS 245 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-H----Hhh-----CCcccCC--cccCCHH
Confidence 88999999999888889999999999999999999999975443222111 1 111 0111110 0112335
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHH
Q 003114 780 AVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 780 l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+.+++.+|++.+|.+||++.++++
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc
Confidence 778999999999999999999877
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=294.09 Aligned_cols=261 Identities=20% Similarity=0.288 Sum_probs=194.4
Q ss_pred hhhhcCcCceEEEEEEEEc---CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecC--CeeeEee
Q 003114 539 FETILGEGSFGKVYHGYLD---DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG--NQIGLIY 610 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~LV~ 610 (846)
+.+.||+|+||.||+|... .++.||+|.+.... ....+.+.+|+.+++.++||||+++++++... ...++||
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 83 (316)
T cd07842 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF 83 (316)
T ss_pred EEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEE
Confidence 4567999999999999975 47899999998633 33346678899999999999999999999887 8899999
Q ss_pred ecccCCChhhhhhcCC---CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC----CCcEEEEeccCC
Q 003114 611 EYMANGSLEEYLSDSN---ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND----QFQARLADFGLS 683 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~----~~~vkI~DFGla 683 (846)
||+++ +|.+++.... ...+++.....++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||++
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99975 7777665332 225888999999999999999999 899999999999999999 999999999999
Q ss_pred ccCCCCCc-ccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccc---------cHHHHHH
Q 003114 684 KTFPIEGV-SHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHK---------HISQWVD 752 (846)
Q Consensus 684 ~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~---------~l~~~~~ 752 (846)
+....... ........++..|+|||.+.+. .++.++|||||||+++||++|++||....... .+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86533221 1122345678999999987654 57899999999999999999999997654322 1111111
Q ss_pred HHHhc-----------CCcccccCCCCCCCCC---------h--HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 753 FMLAQ-----------GDIKNIVDPKLHGDID---------V--NSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 753 ~~~~~-----------~~~~~~~d~~L~~~~~---------~--~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+... .......+......++ . .....+.+++.+|++.+|++|||+.|+++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11000 0000000000000001 0 23346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=289.14 Aligned_cols=245 Identities=25% Similarity=0.360 Sum_probs=189.0
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHH-HHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVIL-LRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~-l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|+||.||+++.. +|+.||+|.+.... .....++..|+.. ++..+||||+++++++..++..++||||++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~- 83 (283)
T cd06617 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD- 83 (283)
T ss_pred EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-
Confidence 3467999999999999975 68999999987542 2233455556654 666799999999999999999999999996
Q ss_pred CChhhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCC-CeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 616 GSLEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKP-PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 616 gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
|+|.+++... ....+++..+..++.|++.||+||| +. +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--- 157 (283)
T cd06617 84 TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--- 157 (283)
T ss_pred ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccccc---
Confidence 6888887643 2345899999999999999999999 65 8999999999999999999999999998765321
Q ss_pred cccccccCCCcccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccc-ccHHHHHHHHHhcCCcccccCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQT----FRLTEKSDVYSFGVVLLEIITSRPAIANTEEH-KHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~----~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
.......++..|+|||.+.+ ..++.++|+|||||+++||++|+.||...... +.+.. .... .. +.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~-~~-----~~ 227 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ----VVEE-PS-----PQ 227 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH----HHhc-CC-----CC
Confidence 11223467889999998764 45688999999999999999999999653221 11111 1111 11 11
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+. .......+.+++.+|+..+|++||+++++++
T Consensus 228 ~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 0112346889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=288.39 Aligned_cols=258 Identities=21% Similarity=0.307 Sum_probs=191.6
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++|+||+++++++..++..++|+||+. +
T Consensus 9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07870 9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-T 87 (291)
T ss_pred EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence 3467999999999999864 688999999865432 223467789999999999999999999999999999999995 6
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||+++...... ....
T Consensus 88 ~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~ 161 (291)
T cd07870 88 DLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--QTYS 161 (291)
T ss_pred CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC--CCCC
Confidence 7877765443 24788889999999999999999 8899999999999999999999999999987542221 1123
Q ss_pred cccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccc-ccHHHHHHHHH-----------h-cCCccc
Q 003114 697 GVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEH-KHISQWVDFML-----------A-QGDIKN 762 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~-~~l~~~~~~~~-----------~-~~~~~~ 762 (846)
...++..|+|||.+.+. .++.++|||||||+++||++|+.||...... +.+.+.+.... . .....+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 34578899999988754 5788999999999999999999999754421 11111110000 0 000000
Q ss_pred ccCCCCCCCC-----ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 763 IVDPKLHGDI-----DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 763 ~~d~~L~~~~-----~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.......... .......+.+++.+|+..+|++|||++|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 0112356779999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=289.25 Aligned_cols=242 Identities=26% Similarity=0.352 Sum_probs=186.3
Q ss_pred hcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc---hhhHHHHHHHHHHH---hcccccceeEeeEeecCCeeeEeeeccc
Q 003114 542 ILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR---QGYEQFEAEVILLR---TVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~~l~---~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+||+|+||.||++... +++.+|+|.+..... .....+.+|..+++ ..+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 688999998865321 11223344444333 3479999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||+++++.++|+|||++...... .
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~ 151 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----C
Confidence 999999987654 3899999999999999999999 899999999999999999999999999998754321 1
Q ss_pred cccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.....|+..|+|||.+.+ ..++.++||||+||+++||++|+.||....... ... ....... ....+ +
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~-~~~~~~~------~~~~~----~ 219 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHE-IDRMTLT------VNVEL----P 219 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-HHH-HHHHhhc------CCcCC----c
Confidence 223468999999998864 568899999999999999999999997543221 111 1111100 11111 2
Q ss_pred hHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRP-----NMNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~~ 804 (846)
......+.+++.+|+..+|++|| +++|+++.
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 22345788999999999999999 58877664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=284.41 Aligned_cols=243 Identities=23% Similarity=0.303 Sum_probs=189.8
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCch---hhHHHHHHHHH-HHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQ---GYEQFEAEVIL-LRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~~~~Ei~~-l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||.||+|... +++.||+|.+...... ....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 35899999999999874 6889999998754321 22234445444 3455899999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++.... .+++..+.+++.|++.||.||| +.+++||||+|+||++++++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 99999997654 3889999999999999999999 88999999999999999999999999999875422 2
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....++..|+|||.+.+..++.++||||||++++||++|..||........... .. .+... ..+ .....
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~-~~~~~--~~~----~~~~~ 219 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN----IL-SRRIN--WPE----EVKEF 219 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HH-hcccC--CCC----ccccc
Confidence 234578899999999888889999999999999999999999976543222111 11 11110 000 11112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
....+.+++.+|++.+|++||++.++.+.|
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 345788999999999999999887665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=287.65 Aligned_cols=256 Identities=22% Similarity=0.274 Sum_probs=191.3
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcc-cccceeEeeEeecC--CeeeEeeecc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVH-HKNLTTLYGYCNEG--NQIGLIYEYM 613 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~--~~~~LV~Ey~ 613 (846)
+.+.||+|+||.||+|... +++.+|+|+++... ........+|+..+.++. |+|++++++++.++ +..++|+||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 3467999999999999964 68899999987542 222234457888888885 99999999999877 8899999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
+ |+|.+.+.... ..+++.++..++.|++.||+||| +.+++||||||+||+++. +.+||+|||+++......
T Consensus 83 ~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--- 153 (282)
T cd07831 83 D-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--- 153 (282)
T ss_pred C-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC---
Confidence 6 58888887643 34899999999999999999999 889999999999999999 999999999998653221
Q ss_pred ccccccCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHH----------HHhcCCccc
Q 003114 694 LSTGVAGTFGYLDPEYCQ-TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDF----------MLAQGDIKN 762 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~----------~~~~~~~~~ 762 (846)
......++..|+|||.+. +..++.++||||+||+++||++|++||...+..+.+...... .........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 112345788999999764 455788999999999999999999999765433222111110 000000001
Q ss_pred ccCCCCCC----CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 763 IVDPKLHG----DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 763 ~~d~~L~~----~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
...+...+ .........+.+++.+|++.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00010000 001123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=286.52 Aligned_cols=244 Identities=23% Similarity=0.293 Sum_probs=199.2
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||.|+||.||+|... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++..+...++|+||++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (258)
T cd05578 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLL 83 (258)
T ss_pred EEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCC
Confidence 4568999999999999976 68999999997542 2446788999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+++|.+++... ..+++..+..++.|+++||.||| +.+++|+||||+||++++++.++|+|||++....... .
T Consensus 84 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~ 155 (258)
T cd05578 84 GGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---L 155 (258)
T ss_pred CCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---c
Confidence 99999999765 34889999999999999999999 8899999999999999999999999999988654321 2
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....|+..|+|||.+.+..++.++|+||+|+++++|++|+.||...... .... ....... .. ...+.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~-~~~~~~~--~~--------~~~~~ 223 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQ-IRAKQET--AD--------VLYPA 223 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHH-HHHHhcc--cc--------ccCcc
Confidence 23456888999999998888999999999999999999999999865432 1111 1111111 00 11122
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNM--NRVV 802 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm--~eVl 802 (846)
.....+.+++.+|++.+|.+||++ +|+.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 234678899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=276.89 Aligned_cols=263 Identities=20% Similarity=0.351 Sum_probs=203.7
Q ss_pred cCHHHHHHHHhhhhhhcCcCceEEEEEEE-EcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeecCC
Q 003114 527 FTYAEITKITNDFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGN 604 (846)
Q Consensus 527 ~~~~el~~~t~~f~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 604 (846)
-+++|+-+.|. +.||+|+++.|-.+. +.+|.++|||++.+..........+|++++.+. .|+||++|+++|+++.
T Consensus 73 g~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 73 GKFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred chHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 35777777775 589999999999887 789999999999988777788899999999998 5999999999999999
Q ss_pred eeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC---cEEEEecc
Q 003114 605 QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF---QARLADFG 681 (846)
Q Consensus 605 ~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~---~vkI~DFG 681 (846)
.+|||||.|.||+|.+.|++..- +++.++.++.++|+.||.||| .++|.|||+||+|||..+.. -+||+||.
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred eEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence 99999999999999999987654 999999999999999999999 99999999999999996543 47999999
Q ss_pred CCccCCCCC-----cccccccccCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCccc------cc
Q 003114 682 LSKTFPIEG-----VSHLSTGVAGTFGYLDPEYCQ-----TFRLTEKSDVYSFGVVLLEIITSRPAIANTEE------HK 745 (846)
Q Consensus 682 la~~~~~~~-----~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~------~~ 745 (846)
+..-+...+ ........+|+..|||||+.. ...|+.++|.||+|||+|-|+.|.+||.+.-. ..
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 876542211 112223467899999999753 34689999999999999999999999975321 11
Q ss_pred cHHHHHHH----HHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 746 HISQWVDF----MLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 746 ~l~~~~~~----~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
...+-.+. -+.+|. -++-|+.+. ....+..+++...+..++.+|.++.+++.
T Consensus 305 e~Cr~CQ~~LFesIQEGk-YeFPdkdWa-----hIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEGK-YEFPDKDWA-----HISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHHHHHHHHhccC-CcCChhhhH-----HhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11111111 122221 112222221 12234567777888899999999988877
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=295.06 Aligned_cols=261 Identities=22% Similarity=0.351 Sum_probs=196.0
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhc-ccccceeEeeEeec--CCeeeEee
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNE--GNQIGLIY 610 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~--~~~~~LV~ 610 (846)
..+.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +|+||+++++++.. +...++||
T Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07852 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF 88 (337)
T ss_pred HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence 344578999999999999975 6889999988543 233345677899999999 99999999998864 34689999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||++ ++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++.......
T Consensus 89 e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 89 EYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred cccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 9997 5999988764 4889999999999999999999 8999999999999999999999999999998764332
Q ss_pred cc---cccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHH----------h
Q 003114 691 VS---HLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFML----------A 756 (846)
Q Consensus 691 ~~---~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~----------~ 756 (846)
.. .......|+..|+|||.+.+ ..++.++||||||++++||++|++||................. .
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 21 12233568899999998754 4578899999999999999999999976543332222111100 0
Q ss_pred cCCcccccC----CCC--CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 757 QGDIKNIVD----PKL--HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 757 ~~~~~~~~d----~~L--~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
......+++ ... ...........+.+++.+|++.+|++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000110 000 000011134578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=296.97 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=193.0
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecC------CeeeEee
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG------NQIGLIY 610 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~LV~ 610 (846)
.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+.++++++|+||+++++++... ...++||
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 100 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence 468999999999999964 7899999998643 233445677899999999999999999987543 3579999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+. ++|.+.+... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 101 e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~- 171 (353)
T cd07850 101 ELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS- 171 (353)
T ss_pred eccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC-
Confidence 9995 5888887643 788899999999999999999 889999999999999999999999999999865322
Q ss_pred cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHH-----------------
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDF----------------- 753 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~----------------- 753 (846)
.......++..|+|||.+.+..++.++|||||||++++|++|+.||...+...........
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred --CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 1123345788999999999999999999999999999999999999765432211111110
Q ss_pred -HHhcCC------cccccCCCCC----CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 754 -MLAQGD------IKNIVDPKLH----GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 754 -~~~~~~------~~~~~d~~L~----~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
...... ..+.....+. ..........+.+++.+|++.+|++||++.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0011111110 00011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=318.11 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=208.5
Q ss_pred hhhhhcCcCceEEEEEEEEc--------CCcEEEEEEeCCC-CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeee
Q 003114 538 DFETILGEGSFGKVYHGYLD--------DNTEVAVKMLSPS-SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIG 607 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 607 (846)
.+.+.||+|.||.|++|... ....||||.++.. .....+.+..|+++|+.+ +|+||+.++|+|..++..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 44568999999999999853 1456999999865 335667899999999999 6999999999999999999
Q ss_pred EeeecccCCChhhhhhcCC------C--------CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC
Q 003114 608 LIYEYMANGSLEEYLSDSN------A--------DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF 673 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~------~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~ 673 (846)
+|.||++.|+|.++++... . ..++....+.++.|||.|++||+ +.+++||||.++|||+.++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCC
Confidence 9999999999999998765 0 13888899999999999999999 99999999999999999999
Q ss_pred cEEEEeccCCccCCCCCcccccccc-cCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHH
Q 003114 674 QARLADFGLSKTFPIEGVSHLSTGV-AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWV 751 (846)
Q Consensus 674 ~vkI~DFGla~~~~~~~~~~~~~~~-~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~ 751 (846)
.+||+|||+++.............. .-...|||||.+....++.|+|||||||+||||+| |..||.+......+.+
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~-- 533 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE-- 533 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH--
Confidence 9999999999976443333212111 13567999999999999999999999999999998 6889976332222222
Q ss_pred HHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 752 DFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 752 ~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
.+++|.- -..+..+..++.+++..||+.+|++||++.|+++.++..+.
T Consensus 534 --~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 534 --FLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred --HHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 3333321 12233456688899999999999999999999999999654
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=289.72 Aligned_cols=259 Identities=19% Similarity=0.276 Sum_probs=193.0
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcc-cccceeEeeEeecCCe-----eeEe
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQ-----IGLI 609 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~-----~~LV 609 (846)
..+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++ |+||+++++++...+. .++|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 3467999999999999975 689999998865422 23456888999999995 6999999999876655 8999
Q ss_pred eecccCCChhhhhhcCC---CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-CCcEEEEeccCCcc
Q 003114 610 YEYMANGSLEEYLSDSN---ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-QFQARLADFGLSKT 685 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-~~~vkI~DFGla~~ 685 (846)
|||+++ +|.+++.... ...+++..+..++.|+++||.||| +.+|+||||||+||+++. ++.+||+|||+++.
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 999985 8988886533 235899999999999999999999 899999999999999998 89999999999876
Q ss_pred CCCCCcccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--ccc
Q 003114 686 FPIEGVSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--IKN 762 (846)
Q Consensus 686 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--~~~ 762 (846)
+.... .......+++.|+|||.+.+ ..++.++||||||++++||++|++||........+............ ...
T Consensus 161 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 161 FSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred cCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 53211 11122356788999998765 45789999999999999999999999765543333332221110000 000
Q ss_pred ccC-------CCCCC----CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 763 IVD-------PKLHG----DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 763 ~~d-------~~L~~----~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+ +.... .........+.+++.+|+..+|++||+++|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 00000 001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=280.68 Aligned_cols=244 Identities=26% Similarity=0.416 Sum_probs=200.6
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|++|.||++... +++.+++|.+..... ...+.+.+|++++++++|+|++++++++..++..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (254)
T cd06627 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83 (254)
T ss_pred eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCC
Confidence 4568999999999999865 678999999976654 4567889999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++........ ..
T Consensus 84 ~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 156 (254)
T cd06627 84 GSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DD 156 (254)
T ss_pred CcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--cc
Confidence 99999997653 4899999999999999999999 89999999999999999999999999999987643221 12
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....++..|+|||...+...+.++||||+|++++||++|+.||........... .. .... +. .+..
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~----~~-~~~~-----~~----~~~~ 222 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR----IV-QDDH-----PP----LPEG 222 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----Hh-ccCC-----CC----CCCC
Confidence 335678899999999888889999999999999999999999975542221111 11 1110 11 1112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
....+.+++.+|+..+|++||++.|++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 2457789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=280.81 Aligned_cols=246 Identities=27% Similarity=0.408 Sum_probs=202.7
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||.|+||.||++... ++..+++|++..... ...+.+.+|+++++.++|+|++++++.+..++..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 3467999999999999975 688999999976533 4567788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 616 GSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 616 gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|.+++.... ...+++.++..++.+++.||.||| +.+++|+||+|+||++++++.++|+|||.+....... .
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 158 (258)
T cd08215 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--D 158 (258)
T ss_pred CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc--c
Confidence 99999998753 356899999999999999999999 8899999999999999999999999999997653322 1
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
......|++.|+|||......++.++||||+|+++++|++|+.||...... +........ ... ..+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~~-~~~---------~~~ 224 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL----ELALKILKG-QYP---------PIP 224 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH----HHHHHHhcC-CCC---------CCC
Confidence 223346888999999998888999999999999999999999999765422 222222211 111 111
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
......+.+++.+|+..+|++||++.|+++
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 225 SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 133457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=287.21 Aligned_cols=259 Identities=22% Similarity=0.367 Sum_probs=197.2
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|+.++++++|+||+++++++...+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 82 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK- 82 (284)
T ss_pred EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence 3568999999999999975 688999999876533 2345677899999999999999999999999999999999985
Q ss_pred ChhhhhhcCC-CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 617 SLEEYLSDSN-ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 617 sL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
+|.+++.... ...+++..+.+++.|++.||.||| +.+++||||||+||++++++.++|+|||++...... ....
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~ 157 (284)
T cd07836 83 DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VNTF 157 (284)
T ss_pred cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cccc
Confidence 8988886544 235899999999999999999999 889999999999999999999999999999754321 1112
Q ss_pred ccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--cccccC-CCCCCC
Q 003114 696 TGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--IKNIVD-PKLHGD 771 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--~~~~~d-~~L~~~ 771 (846)
....++..|++||.+.+. .++.++|||||||+++||++|++||......+.............. ...+.+ +.+...
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 234578899999987653 5789999999999999999999999876544333322221100000 000000 000000
Q ss_pred -----------CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 772 -----------IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 772 -----------~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
........+.+++.+|++.+|.+||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01122346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=290.79 Aligned_cols=255 Identities=17% Similarity=0.216 Sum_probs=181.4
Q ss_pred hhhhhhcCcCceEEEEEEEEcC----CcEEEEEEeCCCCchhh-----------HHHHHHHHHHHhcccccceeEeeEee
Q 003114 537 NDFETILGEGSFGKVYHGYLDD----NTEVAVKMLSPSSRQGY-----------EQFEAEVILLRTVHHKNLTTLYGYCN 601 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~~~~-----------~~~~~Ei~~l~~l~HpnIv~l~g~~~ 601 (846)
..+.+.||+|+||.||+|...+ +..+|+|+......... .....+...+..+.|+|++++++++.
T Consensus 14 y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 93 (294)
T PHA02882 14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGS 93 (294)
T ss_pred eEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeee
Confidence 4456789999999999999754 34566665433221110 01122334455678999999998765
Q ss_pred cCC----eeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEE
Q 003114 602 EGN----QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARL 677 (846)
Q Consensus 602 ~~~----~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI 677 (846)
... ..++++|++. .++.+.+.... ..++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|
T Consensus 94 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 94 FKRCRMYYRFILLEKLV-ENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EecCCceEEEEEEehhc-cCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEEE
Confidence 433 3467777764 36666665432 2567888999999999999999 889999999999999999999999
Q ss_pred EeccCCccCCCCCcc-----cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHH
Q 003114 678 ADFGLSKTFPIEGVS-----HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVD 752 (846)
Q Consensus 678 ~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~ 752 (846)
+|||+++.+...... .......||+.|+|||...+..++.++|||||||+++||++|+.||........+..-..
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 999999876322111 112234699999999999999999999999999999999999999987643222211111
Q ss_pred -HHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 753 -FMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 753 -~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
.... .+....+. .......+.+++..|+..+|++||++.++++.|
T Consensus 248 ~~~~~-----~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 248 CDFIK-----RLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHH-----Hhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0100 00001110 112245788999999999999999999999876
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-33 Score=283.89 Aligned_cols=246 Identities=23% Similarity=0.383 Sum_probs=204.6
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
+.+.||+|+||.|||+.++ .|+.+|+|++...+ +.+++.+|+.++++++.|++|+++|.+.....+++|||||..|+
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 3468999999999999975 78999999986543 46789999999999999999999999988899999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
+.+.++..+ +++.+.++..++.+.++||+||| ...-||||||+.|||++-+|.+|++|||.|..+.. .-.....
T Consensus 115 iSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRNT 188 (502)
T KOG0574|consen 115 ISDIMRARR-KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRNT 188 (502)
T ss_pred HHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhCc
Confidence 999998765 45999999999999999999999 77889999999999999999999999999976532 2223345
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSA 777 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~ 777 (846)
+.||+.|||||+++.-.|..++||||+|+...||..|++||.+...-..+. ++.......+.. ++...
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-----MIPT~PPPTF~K-------PE~WS 256 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-----MIPTKPPPTFKK-------PEEWS 256 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-----eccCCCCCCCCC-------hHhhh
Confidence 789999999999999999999999999999999999999998765432221 111111111111 33345
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 778 WKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 778 ~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.++-+++..|+-++|++|-|+-++++.
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 577899999999999999999888764
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=287.96 Aligned_cols=260 Identities=25% Similarity=0.326 Sum_probs=195.8
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCC---------
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN--------- 604 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--------- 604 (846)
..+.+.||+|+||.||+|... +++.||+|.++... ......+.+|+++++.++||||+++++++.+..
T Consensus 9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 88 (302)
T cd07864 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK 88 (302)
T ss_pred hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence 344678999999999999975 68899999987542 223356778999999999999999999987654
Q ss_pred -eeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCC
Q 003114 605 -QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLS 683 (846)
Q Consensus 605 -~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla 683 (846)
..++|+||+++ +|.+.+.... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++
T Consensus 89 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 89 GAFYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred CcEEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999976 7777776543 34899999999999999999999 889999999999999999999999999999
Q ss_pred ccCCCCCcccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--c
Q 003114 684 KTFPIEGVSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--I 760 (846)
Q Consensus 684 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--~ 760 (846)
........ .......++..|+|||.+.+ ..++.++|||||||+++||++|++||........+....+....... .
T Consensus 164 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 164 RLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred ccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 86543221 12223346778999998764 35789999999999999999999999866544443333322111100 0
Q ss_pred cccc--------CC------CCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 761 KNIV--------DP------KLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 761 ~~~~--------d~------~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+. ++ .+... .......+.+++.+|++.+|++||+++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 00 00000 0112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=291.97 Aligned_cols=249 Identities=21% Similarity=0.364 Sum_probs=203.7
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCC--CCchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeeccc
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSP--SSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~--~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
...+.||.||.+.||++.-.+.+-+|+|++.. .+.+....|.+|+.+|.++ .|.+||+|++|-..++.+++||||=
T Consensus 364 eilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G- 442 (677)
T KOG0596|consen 364 EILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG- 442 (677)
T ss_pred hHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-
Confidence 34467999999999999998888888888753 3555677899999999999 5999999999999999999999976
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+.+|..+|+........| .+..+..|++.++.++| ..+|||.||||.|+|+-. |.+||+|||.|..++.+...-.
T Consensus 443 d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~ 517 (677)
T KOG0596|consen 443 DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIV 517 (677)
T ss_pred cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCcccccee
Confidence 569999999887655556 77889999999999999 999999999999999865 5899999999999887766666
Q ss_pred cccccCCCcccCccccccC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 003114 695 STGVAGTFGYLDPEYCQTF-----------RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNI 763 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~-----------~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~ 763 (846)
....+||+.||+||.+... +.+.++||||+|||||+|+.|++||.... ..|.+ +..+
T Consensus 518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~aK-------l~aI 585 (677)
T KOG0596|consen 518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIAK-------LHAI 585 (677)
T ss_pred eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHHH-------HHhh
Confidence 7778999999999987432 36789999999999999999999996432 12222 2334
Q ss_pred cCCCCCCCCC-hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 764 VDPKLHGDID-VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 764 ~d~~L~~~~~-~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.||...-+++ ....+++++++..||..||++||+..|+++.
T Consensus 586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 5554432222 1223449999999999999999999999863
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=280.86 Aligned_cols=244 Identities=26% Similarity=0.368 Sum_probs=200.1
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|++|.||+++.. +++.+++|.+.... .....++.+|+++++.++|+||+++++++..+...++|+||+++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd08530 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPF 83 (256)
T ss_pred EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence 4567999999999999864 67899999987542 33456778899999999999999999999999999999999999
Q ss_pred CChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 616 GSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 616 gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|.+++.... ...+++..+..++.+++.||.||| +.+++|+||+|+||++++++.+|++|||++......
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---- 156 (256)
T cd08530 84 GDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---- 156 (256)
T ss_pred CCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC----
Confidence 99999987632 245899999999999999999999 899999999999999999999999999999876432
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
......++..|+|||...+..++.++|+||+|++++||++|+.||...+..... .. ...+... ...
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~----~~-~~~~~~~---------~~~ 222 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR----YK-VQRGKYP---------PIP 222 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HH-HhcCCCC---------CCc
Confidence 222345788999999999888999999999999999999999999765532211 11 1111111 112
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
......+.+++.+|+..+|++||++.|+++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 234456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=287.74 Aligned_cols=252 Identities=25% Similarity=0.298 Sum_probs=198.5
Q ss_pred hhhhcCcCceEEEEEEEE----cCCcEEEEEEeCCCC----chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEe
Q 003114 539 FETILGEGSFGKVYHGYL----DDNTEVAVKMLSPSS----RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV 609 (846)
+.+.||+|++|.||+++. .+++.||||.+.... ....+.+.+|+.++.++ +||||+++++.+..+...++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 456899999999999984 357889999986432 22345678899999999 699999999999999999999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||+++|+|.+++.... .+++.....++.|+++||.||| +.+++||||||+||+++.++.++|+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 84 LDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 99999999999987643 3889999999999999999999 899999999999999999999999999998765332
Q ss_pred CcccccccccCCCcccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCC
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTFR--LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
. ........|+..|+|||...+.. .+.++||||||++++||++|+.||...........+.+...... +.
T Consensus 159 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------~~ 230 (288)
T cd05583 159 E-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK-------PP 230 (288)
T ss_pred c-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC-------CC
Confidence 1 11222346889999999987655 78899999999999999999999964432222223222222111 11
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
. +......+.+++.+|++.+|++|||++++.+.|+.
T Consensus 231 ~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 231 F----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred C----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1 11123467899999999999999999988887754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=285.61 Aligned_cols=257 Identities=21% Similarity=0.283 Sum_probs=199.1
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.||+|++|.||++... +++.+++|.+..... .....+.+|+.++++++|+||+++++++..+...++|+||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 457999999999999975 788999999875533 2456788899999999999999999999999999999999975
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.... ..+++..+..++.+++.||.||| +.+|+|+||||+||++++++.+||+|||.+....... ....
T Consensus 83 ~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 83 DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 8888887654 34899999999999999999999 8999999999999999999999999999987764332 1222
Q ss_pred cccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc--CCcccccC------CC
Q 003114 697 GVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ--GDIKNIVD------PK 767 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~--~~~~~~~d------~~ 767 (846)
...++..|+|||.+.+. ..+.++||||+|+++++|+||+.||...+..+.+.......... .......+ ..
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 34578889999988776 78999999999999999999999997665433322222111000 00000000 00
Q ss_pred CC-------CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 768 LH-------GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 768 L~-------~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.. .........++.+++.+|++.+|.+||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 0011123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=304.15 Aligned_cols=267 Identities=26% Similarity=0.385 Sum_probs=207.2
Q ss_pred hhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecC------CeeeEeee
Q 003114 540 ETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG------NQIGLIYE 611 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~LV~E 611 (846)
.+.||+|+||.||+|+. ..|+.||||.++... ....+...+|+++|++++|+|||++.+.-... ....+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 46899999999999995 589999999998753 33456678999999999999999999976543 46789999
Q ss_pred cccCCChhhhhhcCC-CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC--CCC--cEEEEeccCCccC
Q 003114 612 YMANGSLEEYLSDSN-ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN--DQF--QARLADFGLSKTF 686 (846)
Q Consensus 612 y~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld--~~~--~vkI~DFGla~~~ 686 (846)
||.+|+|...+.... ...|++.+.+.++.+++.||.||| +.+|+||||||.||++- .+| .-||+|||.|+.+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999999997643 456999999999999999999999 99999999999999983 333 4699999999987
Q ss_pred CCCCcccccccccCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHH--HHHHHHhcCCcccc
Q 003114 687 PIEGVSHLSTGVAGTFGYLDPEYCQ-TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ--WVDFMLAQGDIKNI 763 (846)
Q Consensus 687 ~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~--~~~~~~~~~~~~~~ 763 (846)
... .......||..|.+||... .+.++..+|.|||||++||++||..||..........+ |......+..+.-.
T Consensus 175 ~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 175 DDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred CCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 433 3667789999999999988 48899999999999999999999999976554433222 22222222222222
Q ss_pred cCCCCCCC------------CChHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHHHhhhhh
Q 003114 764 VDPKLHGD------------IDVNSAWKAVEIAMGCVSHSSTPRP--NMNRVVMELKECLAME 812 (846)
Q Consensus 764 ~d~~L~~~------------~~~~~~~~l~~L~~~Cl~~~P~~RP--sm~eVl~~L~~~l~~e 812 (846)
.++...+. ........+-+....++..+|++|- ...+....+..++...
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 22222211 1222344566778888888999999 8888888887777544
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=285.79 Aligned_cols=258 Identities=23% Similarity=0.336 Sum_probs=196.6
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|++|.||+|+.. +++.|++|++..... .......+|+..+++++ |+|++++++++..++..++||||+ +
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 4567999999999999975 578899999865422 22334567899999998 999999999999999999999999 8
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.+.+.......+++.++..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||++....... ..
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---~~ 155 (283)
T cd07830 82 GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---PY 155 (283)
T ss_pred CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---Cc
Confidence 89999998766456899999999999999999999 8899999999999999999999999999997653221 12
Q ss_pred ccccCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHH------------HHHHHHhcCCccc
Q 003114 696 TGVAGTFGYLDPEYCQ-TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ------------WVDFMLAQGDIKN 762 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~-~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~------------~~~~~~~~~~~~~ 762 (846)
....++..|+|||.+. ...++.++|+||||++++||++|++||......+.... |............
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 2345788999999774 44578999999999999999999999976543332221 1111111111111
Q ss_pred ccCCCCC---CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 763 IVDPKLH---GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 763 ~~d~~L~---~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+..... ..........+.+++.+|++.+|++||+++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 1000000 0000112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=280.71 Aligned_cols=247 Identities=27% Similarity=0.401 Sum_probs=194.6
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC-----CchhhHHHHHHHHHHHhcccccceeEeeEeecC--CeeeEe
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS-----SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG--NQIGLI 609 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~LV 609 (846)
.+.+.||+|+||.||+|... ++..||+|.+... .....+.+++|++++++++|+||+++++++.+. ...++|
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 34578999999999999964 6899999987532 223456788999999999999999999998653 568899
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
+||+++++|.+++..... +++....+++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 85 VEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEeCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 999999999999976543 788999999999999999999 889999999999999999999999999999865321
Q ss_pred Cc-ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 690 GV-SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 690 ~~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
.. ........++..|+|||++.+..++.++|||||||+++||++|+.||........+.+ ..... .
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~---------~ 226 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK----IATQP---------T 226 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH----HHcCC---------C
Confidence 11 1112235688999999999888899999999999999999999999976433222211 11111 1
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
....+......+.+++.+|+. +|..||+..+++.
T Consensus 227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111222334568899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=292.73 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=194.7
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchh--------------hHHHHHHHHHHHhcccccceeEeeEeecCC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQG--------------YEQFEAEVILLRTVHHKNLTTLYGYCNEGN 604 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~--------------~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~ 604 (846)
.+.||+|+||.||+|... +++.||+|.+....... ...+.+|+++++.++|+||+++++++..++
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 457999999999999965 68999999986542211 124678999999999999999999999999
Q ss_pred eeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCc
Q 003114 605 QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 605 ~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~ 684 (846)
..++||||+. |+|.+++.... .+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCcccee
Confidence 9999999996 69999987643 3889999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCc------------ccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHH
Q 003114 685 TFPIEGV------------SHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWV 751 (846)
Q Consensus 685 ~~~~~~~------------~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~ 751 (846)
....... ........++..|+|||.+.+. .++.++||||+||+++||++|++||......+.+....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 6541110 1111223467889999988764 46899999999999999999999998765444333222
Q ss_pred HHHHhcCC--ccccc--------CCCCCC---CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 752 DFMLAQGD--IKNIV--------DPKLHG---DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 752 ~~~~~~~~--~~~~~--------d~~L~~---~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
........ ..... ...... .........+.+++.+|++.+|++||+++|++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 21111000 00000 000000 000122456789999999999999999999875
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=298.98 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=207.8
Q ss_pred hhcCcCceEEEEEEEEcC-CcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChh
Q 003114 541 TILGEGSFGKVYHGYLDD-NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLE 619 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 619 (846)
..||.|+||.||+|..++ +...|.|++...+....+.+.-|+++|..+.||+||+|++.|...+.+++..|||.||-..
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD 117 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD 117 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence 458999999999998753 4456789998888888899999999999999999999999998889999999999999998
Q ss_pred hhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccccc
Q 003114 620 EYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699 (846)
Q Consensus 620 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~ 699 (846)
..+-+-+ ..+.+.++.-++++++.||.||| +.+|||||||+.|||++-+|.++|+|||.+.... ........+.
T Consensus 118 aimlEL~-r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRDsFI 191 (1187)
T KOG0579|consen 118 AIMLELG-RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRDSFI 191 (1187)
T ss_pred HHHHHhc-cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHhhhcccc
Confidence 8876654 35999999999999999999999 9999999999999999999999999999876432 1223345678
Q ss_pred CCCcccCcccc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 700 GTFGYLDPEYC-----QTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 700 gt~~Y~APE~~-----~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
||+.|||||+. ...+|+.++||||||+.|.||..+.+|-........+.. +.......++.|.
T Consensus 192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK-----iaKSePPTLlqPS------- 259 (1187)
T KOG0579|consen 192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK-----IAKSEPPTLLQPS------- 259 (1187)
T ss_pred CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH-----HhhcCCCcccCcc-------
Confidence 99999999976 456799999999999999999999999865544333322 2222223333322
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH-----------HHHHhhhhhhhh
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVM-----------ELKECLAMETAR 815 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~-----------~L~~~l~~e~~~ 815 (846)
.....+.+++.+|+.++|..||++.++++ ++.++++...++
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ireLlAEakAe 311 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIRELLAEAKAE 311 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchHHHHHHHHHHHH
Confidence 23346779999999999999999999875 456665544443
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=283.80 Aligned_cols=241 Identities=26% Similarity=0.339 Sum_probs=186.3
Q ss_pred hcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc---hhhHHHHHHHH---HHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 542 ILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR---QGYEQFEAEVI---LLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~---~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+||+|+||.||++... +++.||+|.+..... .....+..|.. .++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 688999999865422 11122334433 3444579999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...... .
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~ 151 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----C
Confidence 999999887643 4899999999999999999999 889999999999999999999999999998765322 1
Q ss_pred cccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.....|+..|+|||.+.+. .++.++||||+||+++||++|+.||......... . ....... .+..+ +
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-~-~~~~~~~------~~~~~----~ 219 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-E-IDRMTLT------MAVEL----P 219 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-H-HHHHhhc------cCCCC----C
Confidence 1234689999999998754 6899999999999999999999999765322111 1 1111110 11111 1
Q ss_pred hHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRP-----NMNRVVM 803 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~ 803 (846)
......+.+++.+|+..+|++|| ++.++++
T Consensus 220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 12235788999999999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=290.70 Aligned_cols=242 Identities=26% Similarity=0.339 Sum_probs=199.3
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
++||+|+||.||-++.. +|+.+|.|.+.+. .+........|-.+|.+++.+.||.+-..|...+.+++|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 68999999999999864 7888999887543 2334456778999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.-+|.+.+...+++..+.-++.+|+.||++|| +.+||.||+||+|||+|++|+++|+|.|+|..++.. ....
T Consensus 271 DLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g---~~~~ 344 (591)
T KOG0986|consen 271 DLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG---KPIR 344 (591)
T ss_pred ceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC---Cccc
Confidence 9999999888778999999999999999999999 999999999999999999999999999999987543 2334
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
+.+||.+|||||++++..|+...|-||+||++|||+.|+.||....+...-.+ +.....+ | ...++...
T Consensus 345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE-vdrr~~~-------~---~~ey~~kF 413 (591)
T KOG0986|consen 345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE-VDRRTLE-------D---PEEYSDKF 413 (591)
T ss_pred cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH-HHHHHhc-------c---hhhccccc
Confidence 45899999999999999999999999999999999999999976543221111 1111111 1 11233344
Q ss_pred HHHHHHHHHhccCCCCCCCCCHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMN 799 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~ 799 (846)
..+...|....+.++|++|..-+
T Consensus 414 S~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 414 SEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred CHHHHHHHHHHHccCHHHhccCC
Confidence 45677888888999999987544
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=287.51 Aligned_cols=258 Identities=22% Similarity=0.321 Sum_probs=190.8
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCC--------ee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN--------QI 606 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--------~~ 606 (846)
.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+ ..
T Consensus 15 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 94 (310)
T cd07865 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSF 94 (310)
T ss_pred EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceE
Confidence 34568999999999999975 68899999886432 222345678999999999999999999886543 45
Q ss_pred eEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccC
Q 003114 607 GLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF 686 (846)
Q Consensus 607 ~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~ 686 (846)
++||||+. ++|.+.+.... ..+++.++..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++..+
T Consensus 95 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 95 YLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred EEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 99999996 58888886543 24899999999999999999999 889999999999999999999999999999865
Q ss_pred CCCCcc--cccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 003114 687 PIEGVS--HLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNI 763 (846)
Q Consensus 687 ~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~ 763 (846)
...... .......++..|+|||.+.+. .++.++||||||++++||++|++||........+.. +.... +.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~-~~~~~--~~~~~~ 246 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL-ISQLC--GSITPE 246 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHh--CCCChh
Confidence 332211 122334578899999987654 478899999999999999999999976543322211 11111 000000
Q ss_pred ----------cCC-CCCCCC---------ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 764 ----------VDP-KLHGDI---------DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 764 ----------~d~-~L~~~~---------~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+. ...... .......+.+++.+|+..+|++||+++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 000000 0001235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=284.88 Aligned_cols=248 Identities=25% Similarity=0.320 Sum_probs=195.1
Q ss_pred hhhhcCcCceEEEEEEEE----cCCcEEEEEEeCCCC----chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEe
Q 003114 539 FETILGEGSFGKVYHGYL----DDNTEVAVKMLSPSS----RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV 609 (846)
+.+.||+|+||.||+++. .+|..||+|++.... ....+.+.+|+.+++++ +|+||+++++++..+...++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 356799999999999986 368899999987532 22345678899999999 599999999999999999999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
+||+++++|.+++.... .+++.....++.|++.||.||| +.+++||||||+|||+++++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 84 LDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999997654 3788899999999999999999 899999999999999999999999999999765332
Q ss_pred CcccccccccCCCcccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCC
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTF--RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
. ........|+..|+|||.+... .++.++||||||++++||++|+.||...........+........ +.
T Consensus 159 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~ 230 (290)
T cd05613 159 E-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-------PP 230 (290)
T ss_pred c-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-------CC
Confidence 1 1122235688999999988653 467899999999999999999999975443333333333322211 11
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRP-----NMNRVVM 803 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~ 803 (846)
++......+.+++.+|++.+|++|| +.+++..
T Consensus 231 ----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 231 ----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1122334678999999999999997 5555544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=287.33 Aligned_cols=258 Identities=21% Similarity=0.282 Sum_probs=192.7
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeecC--CeeeEeeecc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNEG--NQIGLIYEYM 613 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~LV~Ey~ 613 (846)
+.+.||+|+||.||+|... +|+.||+|.++.... .....+.+|+.++++++|+||+++++++... +..++||||+
T Consensus 11 ~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (309)
T cd07845 11 KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC 90 (309)
T ss_pred EeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecC
Confidence 3467999999999999975 689999999864422 2223566899999999999999999998654 5689999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
+ ++|.+++.... ..+++.++..++.|+++||+||| +.+++||||||+||++++++.+||+|||++....... .
T Consensus 91 ~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~--~ 163 (309)
T cd07845 91 E-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA--K 163 (309)
T ss_pred C-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc--C
Confidence 6 58888887643 34899999999999999999999 8899999999999999999999999999998764321 1
Q ss_pred ccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcC-Cc-c--------c
Q 003114 694 LSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG-DI-K--------N 762 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~-~~-~--------~ 762 (846)
......++..|+|||.+.+ ..++.++||||+||++|||++|++||........+........... .. . .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 1222345788999998865 4578999999999999999999999986654433332222110000 00 0 0
Q ss_pred cc--CCCCCCCCC---hHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 763 IV--DPKLHGDID---VNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 763 ~~--d~~L~~~~~---~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+ ......... ......+.+++.+|++.+|++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 000000000 012356779999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=296.34 Aligned_cols=258 Identities=23% Similarity=0.362 Sum_probs=193.1
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecC-----CeeeEeee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG-----NQIGLIYE 611 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~~LV~E 611 (846)
+.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.++++++|+||+++++++... ...++|+|
T Consensus 9 i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 88 (336)
T cd07849 9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQE 88 (336)
T ss_pred EEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEeh
Confidence 4578999999999999864 78999999987532 33445678899999999999999999886543 35899999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+. ++|.+.+... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 89 LME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred hcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 996 4888877643 3899999999999999999999 89999999999999999999999999999876532211
Q ss_pred -ccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC---cccccCC
Q 003114 692 -SHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD---IKNIVDP 766 (846)
Q Consensus 692 -~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~---~~~~~d~ 766 (846)
........|+..|+|||.+.+ ..++.++||||+||+++||++|++||...+.......+.. ...... ...+.+.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILG-VLGTPSQEDLNCIISL 240 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HcCCCCHHHHHHhhch
Confidence 111233568899999998654 5689999999999999999999999976543222222211 111000 0000000
Q ss_pred C-------C--CCCC-----ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 767 K-------L--HGDI-----DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 767 ~-------L--~~~~-----~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
. . .... .......+.+++.+|++.+|++||++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 0000 01123468899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=286.25 Aligned_cols=243 Identities=26% Similarity=0.363 Sum_probs=193.1
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
..+.||+|+||.||+|+.. ++..+|+|.+... .....+++.+|+++++.++|+|++++++++..+...++|+||+.
T Consensus 19 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 98 (308)
T cd06634 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (308)
T ss_pred HHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC
Confidence 3467999999999999965 6788999998642 22344567889999999999999999999999999999999996
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
|+|.+.+.... ..+++.++..++.+++.||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 99 -~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------ 167 (308)
T cd06634 99 -GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167 (308)
T ss_pred -CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC------
Confidence 68888775443 34889999999999999999999 88999999999999999999999999999876432
Q ss_pred cccccCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQ---TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.....++..|+|||.+. ...++.++|||||||+++||++|+.||........+..+. .+.. +...
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~~~-----~~~~-- 235 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-----QNES-----PALQ-- 235 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh-----hcCC-----CCcC--
Confidence 12345788999999874 3467889999999999999999999986544322222211 1111 1110
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
.......+.+++.+|++.+|++||++.++++.-
T Consensus 236 -~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 236 -SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 112334678999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=286.81 Aligned_cols=248 Identities=21% Similarity=0.334 Sum_probs=191.3
Q ss_pred hhhhhcCcCceEEEEEEEEcC-CcEEEEEEeCCCC-chhhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEeeeccc
Q 003114 538 DFETILGEGSFGKVYHGYLDD-NTEVAVKMLSPSS-RQGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
.+.+.||+|+||.||+|..++ ++.||||.++... .....++..|+.++.+.. |+||+++++++..+...++||||+.
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 345789999999999999864 8899999997543 233455667777676664 9999999999999999999999985
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCC-CCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK-PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|.+++..... .+++..+..++.++++||.||| + .+|+||||+|+||++++++.+||+|||++..+....
T Consensus 98 -~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~--- 169 (296)
T cd06618 98 -TCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK--- 169 (296)
T ss_pred -cCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC---
Confidence 577777655332 5899999999999999999999 5 589999999999999999999999999987653221
Q ss_pred ccccccCCCcccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFR----LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~----~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
......++..|+|||.+.+.. ++.++||||||++++||++|+.||....... +......... ... +.
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~-~~~-----~~ 240 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF---EVLTKILQEE-PPS-----LP 240 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH---HHHHHHhcCC-CCC-----CC
Confidence 112335788999999987554 7889999999999999999999997533221 1111112111 111 10
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
........+.+++.+|+..+|++||+++++++.
T Consensus 241 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 241 --PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011234568899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=283.00 Aligned_cols=257 Identities=24% Similarity=0.317 Sum_probs=197.8
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.||+|++|.||+|+.. +++.+|+|.+.... ....+.+..|+.+++.++|+|++++++++...+..++|+||++ +
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 457999999999999976 58999999998653 3334677889999999999999999999999999999999997 5
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.... ..+++..+.+++.+++.||.||| +.+|+||||+|+||++++++.+||+|||+++....... ...
T Consensus 83 ~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~ 156 (282)
T cd07829 83 DLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYT 156 (282)
T ss_pred CHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccC
Confidence 9999998763 24899999999999999999999 88999999999999999999999999999976533211 222
Q ss_pred cccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc--------CCc---cccc
Q 003114 697 GVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ--------GDI---KNIV 764 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~--------~~~---~~~~ 764 (846)
...++..|+|||.+.+. .++.++|||||||+++||++|++||........+.......... ... ...+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 33457789999988766 78999999999999999999999997655333322222111000 000 0000
Q ss_pred CCCCCC---CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 765 DPKLHG---DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 765 d~~L~~---~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
...... .........+.+++.+|+..+|++||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000 000112457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=283.64 Aligned_cols=245 Identities=24% Similarity=0.398 Sum_probs=198.8
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEeeecc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++ |+||+++++++..++..++||||+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd05581 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYA 84 (280)
T ss_pred EeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCC
Confidence 4567999999999999975 7899999998753 2233467888999999998 999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc-
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS- 692 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~- 692 (846)
++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++++|||++.........
T Consensus 85 ~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 85 PNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 9999999998764 4999999999999999999999 899999999999999999999999999998866432211
Q ss_pred -----------------cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHH
Q 003114 693 -----------------HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFML 755 (846)
Q Consensus 693 -----------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~ 755 (846)
.......++..|+|||......++.++||||||++++|+++|+.||........... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~ 235 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK----IL 235 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----HH
Confidence 122234578899999999888899999999999999999999999986653221111 11
Q ss_pred hcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 003114 756 AQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNM----NRVVM 803 (846)
Q Consensus 756 ~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm----~eVl~ 803 (846)
.. ....+......+.+++.+|++.+|++||++ +|+++
T Consensus 236 ~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 KL-----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred hc-----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 10 001112224568899999999999999999 66543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=284.58 Aligned_cols=240 Identities=28% Similarity=0.376 Sum_probs=191.4
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.||+|+||.||+|+.. +++.|++|++.... ....+.+.+|+++++.++|||++++++++.+++..++||||+. |
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 105 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G 105 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence 46999999999999964 68899999986432 2334567889999999999999999999999999999999995 5
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.... ..+++.++..++.|++.||.||| +.+++||||||+||++++++.+||+|||++..... ..
T Consensus 106 ~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~ 175 (313)
T cd06633 106 SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------AN 175 (313)
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC------CC
Confidence 7888776543 34899999999999999999999 88999999999999999999999999999864321 22
Q ss_pred cccCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 697 GVAGTFGYLDPEYCQ---TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~---~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
...|+..|+|||++. ...++.++|||||||+++||++|++||........+.. .... ...... .
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~--------~ 242 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQN-DSPTLQ--------S 242 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhc-CCCCCC--------c
Confidence 356888999999874 45688899999999999999999999876543222211 1111 111111 1
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
......+.+++.+|++.+|++||++.++++.
T Consensus 243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122457899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=278.92 Aligned_cols=233 Identities=22% Similarity=0.305 Sum_probs=183.8
Q ss_pred cCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccCCChhh
Q 003114 543 LGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMANGSLEE 620 (846)
Q Consensus 543 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 620 (846)
||+|+||.||++... ++..+|+|.+....... .|+.....+ +|+||+++++++...+..++||||+++++|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 599999999999864 67889999986542211 122222222 79999999999999999999999999999999
Q ss_pred hhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC-cEEEEeccCCccCCCCCccccccccc
Q 003114 621 YLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF-QARLADFGLSKTFPIEGVSHLSTGVA 699 (846)
Q Consensus 621 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-~vkI~DFGla~~~~~~~~~~~~~~~~ 699 (846)
++.... .+++.++..++.|+++||.||| +.+++||||||+||+++.++ .++|+|||+++..... ....
T Consensus 99 ~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~ 167 (267)
T PHA03390 99 LLKKEG--KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYD 167 (267)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCC
Confidence 998764 4899999999999999999999 88999999999999999988 9999999998765321 2345
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc-cHHHHHHHHHhcCCcccccCCCCCCCCChHHHH
Q 003114 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK-HISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAW 778 (846)
Q Consensus 700 gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~ 778 (846)
++..|+|||++.+..++.++|||||||+++||++|+.||....... ....+.... .... . .......
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~------~----~~~~~~~ 235 (267)
T PHA03390 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKL------P----FIKNVSK 235 (267)
T ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccC------C----cccccCH
Confidence 7899999999998889999999999999999999999998543322 222322221 1100 0 0112334
Q ss_pred HHHHHHHhccCCCCCCCCC-HHHHHH
Q 003114 779 KAVEIAMGCVSHSSTPRPN-MNRVVM 803 (846)
Q Consensus 779 ~l~~L~~~Cl~~~P~~RPs-m~eVl~ 803 (846)
.+.+++.+|++.+|.+||+ ++|+++
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhc
Confidence 6789999999999999995 688764
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=292.67 Aligned_cols=260 Identities=17% Similarity=0.296 Sum_probs=195.2
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEee----cCCeeeEeee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCN----EGNQIGLIYE 611 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~----~~~~~~LV~E 611 (846)
+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++. .....++|+|
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence 3568999999999999965 68999999987542 234466788999999999999999998875 3457899999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+. ++|.+++..... +++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 89 ~~~-~~l~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 89 LME-SDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred hhh-hhHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 995 689999876543 899999999999999999999 88999999999999999999999999999976533221
Q ss_pred c--cccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHH----------hcC
Q 003114 692 S--HLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFML----------AQG 758 (846)
Q Consensus 692 ~--~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~----------~~~ 758 (846)
. .......|+..|+|||.+.+ ..++.++|||||||+++||++|++||...+....+..+....- ...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 1 11233568899999998765 4688999999999999999999999976543222211111100 000
Q ss_pred CcccccCC-CCCCCC-----ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 759 DIKNIVDP-KLHGDI-----DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 759 ~~~~~~d~-~L~~~~-----~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.+.+..+. ...... .......+.+++.+|++.+|++||++.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000 000000 11234678999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=274.58 Aligned_cols=236 Identities=28% Similarity=0.358 Sum_probs=194.2
Q ss_pred cCcCceEEEEEEEEc-CCcEEEEEEeCCCCc---hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 543 LGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR---QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 543 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
||+|+||.||++... +++.+|+|.+..... .....+..|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 588999999875432 2456788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~ 698 (846)
.+++.... .+++.....++.|+++||.||| +.+++|+||||+||++++++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 99998654 3899999999999999999999 8999999999999999999999999999987653221 223345
Q ss_pred cCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHH
Q 003114 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAW 778 (846)
Q Consensus 699 ~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~ 778 (846)
.++..|+|||...+...+.++|+||||++++||++|+.||...+... ....... .. . ..+.....
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~-~~------~----~~~~~~~~ 218 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE----IYEKILK-DP------L----RFPEFLSP 218 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHhc-CC------C----CCCCCCCH
Confidence 68889999999988888999999999999999999999997654321 1121111 10 0 11112245
Q ss_pred HHHHHHHhccCCCCCCCCCHHH
Q 003114 779 KAVEIAMGCVSHSSTPRPNMNR 800 (846)
Q Consensus 779 ~l~~L~~~Cl~~~P~~RPsm~e 800 (846)
.+.+++.+|+..+|++||++.+
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCccc
Confidence 7789999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=285.54 Aligned_cols=260 Identities=22% Similarity=0.283 Sum_probs=190.7
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeecC--------Ceee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNEG--------NQIG 607 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--------~~~~ 607 (846)
+.+.||+|+||.||+|... +++.+|+|++..... .....+.+|+++++.++|+||+++++++... ...+
T Consensus 12 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 91 (311)
T cd07866 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91 (311)
T ss_pred EEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEE
Confidence 4567999999999999975 688999999864322 2234567899999999999999999887443 3579
Q ss_pred EeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCC
Q 003114 608 LIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP 687 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~ 687 (846)
+|+||+.+ +|.+.+.... ..+++.++..++.|+++||.||| +.+|+||||||+||++++++.+||+|||+++...
T Consensus 92 lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 92 MVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred EEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 99999964 7777776543 24899999999999999999999 8899999999999999999999999999998653
Q ss_pred CCCcc---------cccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc
Q 003114 688 IEGVS---------HLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ 757 (846)
Q Consensus 688 ~~~~~---------~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~ 757 (846)
..... .......+++.|+|||.+.+ ..++.++|||||||+++||++|++||...........+.......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 22111 11123456888999998765 458899999999999999999999997655433333222211000
Q ss_pred --------CCcccccC----CCCCCCC---ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 758 --------GDIKNIVD----PKLHGDI---DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 758 --------~~~~~~~d----~~L~~~~---~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+....+ ....... .......+.+++.+|++.+|++|||+.|++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00011110 0000000 0112246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=322.19 Aligned_cols=245 Identities=26% Similarity=0.379 Sum_probs=197.6
Q ss_pred hhcCcCceEEEEEEE-EcCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 541 TILGEGSFGKVYHGY-LDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
..||.|.||.||-|. .++|.-.|+|-+... .....+...+|+.++..++|||+|+.+|.-.+.+..++.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 479999999999998 567888999987643 34556788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC--ccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG--VSHLS 695 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~--~~~~~ 695 (846)
|.+.+..... .++.....+..|++.|+.||| +.+||||||||.||+|+.+|.+|.+|||.|..+.... .....
T Consensus 1321 La~ll~~gri--~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1321 LASLLEHGRI--EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred HHHHHHhcch--hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 9999986543 566666778899999999999 9999999999999999999999999999998874331 11222
Q ss_pred ccccCCCcccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 696 TGVAGTFGYLDPEYCQTF---RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~---~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
...+||+.|||||++.+. ....+.||||+|||++||+||+.||...+..-.+.- .+..|...+ +
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy----~V~~gh~Pq---------~ 1462 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY----HVAAGHKPQ---------I 1462 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh----HHhccCCCC---------C
Confidence 356899999999998654 356789999999999999999999987664433221 223333222 2
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+......-.+++.+|+..||++|.++.|+++
T Consensus 1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 2223334568999999999999988876554
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=307.71 Aligned_cols=263 Identities=20% Similarity=0.279 Sum_probs=183.3
Q ss_pred hhhhhhcCcCceEEEEEEEEcC--CcEEEEEEe--------------C---CCCchhhHHHHHHHHHHHhcccccceeEe
Q 003114 537 NDFETILGEGSFGKVYHGYLDD--NTEVAVKML--------------S---PSSRQGYEQFEAEVILLRTVHHKNLTTLY 597 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~--g~~VAVK~l--------------~---~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~ 597 (846)
+.+.+.||+|+||+||++.++. +...+.|.+ . .........+++|+.++++++||||++++
T Consensus 150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 229 (501)
T PHA03210 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIE 229 (501)
T ss_pred cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEe
Confidence 4456789999999999987542 222222211 0 11122345688999999999999999999
Q ss_pred eEeecCCeeeEeeecccCCChhhhhhcCC---CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc
Q 003114 598 GYCNEGNQIGLIYEYMANGSLEEYLSDSN---ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ 674 (846)
Q Consensus 598 g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~ 674 (846)
+++...+..++|+|++. ++|.+++.... .......+...++.|++.||+||| +.+|+||||||+|||++.++.
T Consensus 230 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 230 EILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred EEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCC
Confidence 99999999999999984 57777765432 112335567789999999999999 899999999999999999999
Q ss_pred EEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCcc--ccccHHHHH
Q 003114 675 ARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPA-IANTE--EHKHISQWV 751 (846)
Q Consensus 675 vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p-~~~~~--~~~~l~~~~ 751 (846)
+||+|||+++.+.... ........||..|+|||++.+..++.++|||||||++|||++|+.+ +.... ....+.+.+
T Consensus 306 vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 306 IVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred EEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 9999999998764321 2222346799999999999999999999999999999999998754 43221 112222222
Q ss_pred HHHHh-cCCcc-------cccCC-CCC---CCC-----ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 752 DFMLA-QGDIK-------NIVDP-KLH---GDI-----DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 752 ~~~~~-~~~~~-------~~~d~-~L~---~~~-----~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
..... .+... +.++. ... ... .......+.+++.+|++.||++|||+.|+++.
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11100 00000 00000 000 000 00112346678899999999999999999874
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=289.74 Aligned_cols=258 Identities=22% Similarity=0.356 Sum_probs=195.0
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecC-----CeeeEeee
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG-----NQIGLIYE 611 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~~LV~E 611 (846)
.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|+.+++.++|+||+++++++... ...++|+|
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 467999999999999964 6899999998753 233345677899999999999999999987543 35899999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+. ++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 162 (337)
T cd07858 90 LMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG- 162 (337)
T ss_pred CCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence 995 68998887654 3899999999999999999999 8899999999999999999999999999998653321
Q ss_pred ccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc-----------CC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ-----------GD 759 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~-----------~~ 759 (846)
.......++..|+|||.+.. ..++.++|||||||+++||++|++||...+....+...... ... ..
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITEL-LGSPSEEDLGFIRNEK 240 (337)
T ss_pred -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH-hCCCChHHhhhcCchh
Confidence 22233457889999998764 46889999999999999999999999765422211111110 000 00
Q ss_pred c-------ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHH
Q 003114 760 I-------KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME--LKE 807 (846)
Q Consensus 760 ~-------~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~--L~~ 807 (846)
. ....++.... ........+.+++.+|++.+|++||+++|+++. ++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 241 ARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0 0000000000 011234567899999999999999999999877 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=288.99 Aligned_cols=266 Identities=21% Similarity=0.330 Sum_probs=202.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCC-----eeeEe
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN-----QIGLI 609 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-----~~~LV 609 (846)
.+.+.||.|++|.||+|+.. +++.+|+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..++|
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 34578999999999999975 58999999987643 444567899999999999999999999987765 78999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||++ ++|.+++.... .+++..+..++.+++.||+||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 83 ~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 83 TELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred ecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99997 58999887654 4899999999999999999999 889999999999999999999999999999876432
Q ss_pred Ccc-cccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc----------
Q 003114 690 GVS-HLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ---------- 757 (846)
Q Consensus 690 ~~~-~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~---------- 757 (846)
... .......++..|+|||.+.+. .++.++||||||+++++|++|++||........+.......-..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 210 112334578899999999887 78999999999999999999999997665433222211110000
Q ss_pred CCcccccC---CCCC---CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHhh
Q 003114 758 GDIKNIVD---PKLH---GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME--LKECL 809 (846)
Q Consensus 758 ~~~~~~~d---~~L~---~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~--L~~~l 809 (846)
......+. ..-. ..........+.+++.+|++.+|++||+++++++. +++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00000000 0000 00011124567899999999999999999999975 55533
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=276.82 Aligned_cols=246 Identities=24% Similarity=0.331 Sum_probs=192.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC-----CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS-----SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
.+.+.||+|+||.||+++.. .+..+++|.++.. ......++..|+.+++.++||||+++++++.+.+..++|+|
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE 82 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence 34578999999999999865 3455666665432 22233457789999999999999999999999999999999
Q ss_pred cccCCChhhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 612 YMANGSLEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 612 y~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|+++++|.+++... ....+++..++.++.|++.||.||| +.+++|+||||+||++++ +.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 99999999988652 2345899999999999999999999 899999999999999986 46999999998765322
Q ss_pred CcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
........|+..|+|||...+..++.++|+||||+++++|++|+.||...... ....... .+. .+.
T Consensus 159 --~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----~~~~~~~-~~~-----~~~-- 224 (260)
T cd08222 159 --CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL----SVVLRIV-EGP-----TPS-- 224 (260)
T ss_pred --cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHH-cCC-----CCC--
Confidence 12223355788999999998888899999999999999999999999654322 2222111 111 111
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+......+.+++.+|+..+|++||++.|+++
T Consensus 225 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 --LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 12233457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=264.44 Aligned_cols=247 Identities=22% Similarity=0.363 Sum_probs=193.3
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEeeecccCC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
...||.|..|.|++++.. .|..+|||.+... ++...+++...+.++.+-+ +|.||+.+|||..+....+.||.|.-
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 356999999999999975 6889999999765 4555677777777777665 89999999999999999999999843
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
-++.+++.-. +++++.-.=++...+++||.||.+ +++|+|||+||+|||+|+.|++|+||||++-.+-. +...+
T Consensus 176 C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkAht 249 (391)
T KOG0983|consen 176 CAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKAHT 249 (391)
T ss_pred HHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec---ccccc
Confidence 4444544333 347888888899999999999996 77999999999999999999999999999987632 23334
Q ss_pred cccCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 697 GVAGTFGYLDPEYCQT---FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~---~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
..+|-+.|||||.+.- .+|+.++||||||+.++||.||+.||.+.+.+.... ..+..++ .|.|.+..
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l---tkvln~e------PP~L~~~~- 319 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL---TKVLNEE------PPLLPGHM- 319 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH---HHHHhcC------CCCCCccc-
Confidence 5678899999998853 468999999999999999999999998765332221 1222221 13333221
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.....+.+++..|+.+|+.+||...++++.
T Consensus 320 -gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 320 -GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 134467899999999999999999988764
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=287.82 Aligned_cols=259 Identities=22% Similarity=0.336 Sum_probs=192.2
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecC------CeeeEee
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG------NQIGLIY 610 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~LV~ 610 (846)
.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++|+||+++++++... ...++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 468999999999999964 78999999986532 22345678999999999999999999988654 3468999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+. .+|.+++. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 100 e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-- 169 (342)
T cd07879 100 PYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-- 169 (342)
T ss_pred cccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC--
Confidence 9996 47776653 23889999999999999999999 88999999999999999999999999999875422
Q ss_pred cccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHH----------HhcCC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFM----------LAQGD 759 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~----------~~~~~ 759 (846)
......++..|+|||.+.+ ..++.++|||||||+++||++|+.||........+....... .....
T Consensus 170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 170 ---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred ---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 1223467889999998866 468899999999999999999999998654322222211100 00000
Q ss_pred cccccC--CC-CCCCC---ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHhhhh
Q 003114 760 IKNIVD--PK-LHGDI---DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME--LKECLAM 811 (846)
Q Consensus 760 ~~~~~d--~~-L~~~~---~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~--L~~~l~~ 811 (846)
.....+ +. ..... .......+.+++.+|++.+|++||+++|++.. +++....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 000000 00 00000 01123457899999999999999999999955 7766543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=284.33 Aligned_cols=253 Identities=21% Similarity=0.310 Sum_probs=191.6
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeec-CCeeeEeeecccC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE-GNQIGLIYEYMAN 615 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~LV~Ey~~~ 615 (846)
.+.||.|+||.||++... +++.||+|++... .....+.+.+|+++++.++||||+++++++.. +...++|+||+ +
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~ 93 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G 93 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence 478999999999999865 7899999988643 22334678889999999999999999998865 56789999998 5
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.++++.. .+++.....++.|++.||.||| +.+|+||||||+||++++++.+||+|||++..... ..
T Consensus 94 ~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-----~~ 162 (328)
T cd07856 94 TDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-----QM 162 (328)
T ss_pred cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----Cc
Confidence 6899888753 3788888899999999999999 89999999999999999999999999999875422 11
Q ss_pred ccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHH-----------HHHHhcCCcccc
Q 003114 696 TGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWV-----------DFMLAQGDIKNI 763 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~-----------~~~~~~~~~~~~ 763 (846)
....++..|+|||.+.+ ..++.++|||||||+++||++|++||...........+. ............
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 23457888999998765 568999999999999999999999997654322221111 111111000000
Q ss_pred cCCCCCCCCC-----hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 764 VDPKLHGDID-----VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 764 ~d~~L~~~~~-----~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
..-......+ ......+.+++.+|++.+|++||++.+++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000001111 1123578899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=284.72 Aligned_cols=258 Identities=24% Similarity=0.334 Sum_probs=190.1
Q ss_pred hhhhcCcCceEEEEEEEEc-C--CcEEEEEEeCCC--CchhhHHHHHHHHHHHhc-ccccceeEeeEeec----CCeeeE
Q 003114 539 FETILGEGSFGKVYHGYLD-D--NTEVAVKMLSPS--SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNE----GNQIGL 608 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~--g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~----~~~~~L 608 (846)
+.+.||+|+||.||++... . +..||+|.+... .....+.+.+|+.+++++ +||||+++++.+.. ....++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 83 (332)
T cd07857 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYL 83 (332)
T ss_pred EEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEE
Confidence 4567999999999999965 3 778999998743 222345678899999999 59999999987532 245788
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
++||+. ++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 84 YEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 899885 68999886543 4899999999999999999999 89999999999999999999999999999986543
Q ss_pred CCcc--cccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHH-----------
Q 003114 689 EGVS--HLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFM----------- 754 (846)
Q Consensus 689 ~~~~--~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~----------- 754 (846)
.... .......|+..|+|||.+.+ ..++.++||||+||++++|++|++||...+....+...+...
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 2211 11233568999999998765 468999999999999999999999997654322222111110
Q ss_pred HhcCC------cccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 755 LAQGD------IKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 755 ~~~~~------~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+.. ....-...+ ..........+.+++.+|++.+|++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 000000000 0001112356889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=289.83 Aligned_cols=242 Identities=22% Similarity=0.384 Sum_probs=201.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
.+...||+|.|+.|..|+.. ++.+||+|.+.+.. ......+.+|+++|..++|||||+++.+......+++||||+.
T Consensus 59 ~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~ 138 (596)
T KOG0586|consen 59 VIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYAS 138 (596)
T ss_pred eeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEecc
Confidence 34568999999999999964 79999999998764 3344568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|.+.+++.+++. ..+..+..+..|+..+++||| ++.|+|||||++||||+.+.++||+|||++..+. ....
T Consensus 139 ~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~~~~ 210 (596)
T KOG0586|consen 139 GGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---YGLM 210 (596)
T ss_pred CchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec---cccc
Confidence 9999999998775 556888899999999999999 9999999999999999999999999999998774 3455
Q ss_pred cccccCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~-s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
....+|++.|.|||++++.++ .+++|+||+|+++|-|+.|..||++..-.+ .-++.+.+.+.
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-----------------Lr~rvl~gk~r 273 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-----------------LRPRVLRGKYR 273 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-----------------ccchheeeeec
Confidence 667899999999999998875 579999999999999999999998654221 11112222111
Q ss_pred h--HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 774 V--NSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 774 ~--~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
. -...+.-+++.+++..+|.+|++++++.+.
T Consensus 274 Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 274 IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1 111244588899999999999999998764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=285.81 Aligned_cols=262 Identities=21% Similarity=0.332 Sum_probs=194.2
Q ss_pred HHHHHHHhhh--hhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecC-
Q 003114 530 AEITKITNDF--ETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG- 603 (846)
Q Consensus 530 ~el~~~t~~f--~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~- 603 (846)
.++..+++++ .+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 3444444444 36799999999999985 478899999987532 22345678899999999999999999987543
Q ss_pred -----CeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEE
Q 003114 604 -----NQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLA 678 (846)
Q Consensus 604 -----~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~ 678 (846)
...+++++++ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEe
Confidence 3467888877 78999888653 3889999999999999999999 8999999999999999999999999
Q ss_pred eccCCccCCCCCcccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc
Q 003114 679 DFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ 757 (846)
Q Consensus 679 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~ 757 (846)
|||+++.... ......++..|+|||.+.+ ..++.++|||||||+++||++|++||........+..........
T Consensus 163 dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 163 DFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred cccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999875422 1233467889999998766 468899999999999999999999997554333222221111000
Q ss_pred ----------CC-------cccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 758 ----------GD-------IKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 758 ----------~~-------~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.. .......... .........+.+++.+|++.+|.+||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 0000000000 0000123467899999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=270.05 Aligned_cols=237 Identities=25% Similarity=0.335 Sum_probs=194.3
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
+|.++||+|.||.|..++.+ .++.+|+|++++.- +.....-..|-.+|+..+||.+..|-..|+..+.+++||||.
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 45679999999999999976 68899999998763 333344566889999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
.||.|.-+|.... .+++....-+-.+|+.||.||| +.+||.||||.+|.|+|.+|++||+|||+++.-- ....
T Consensus 251 nGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~g~ 323 (516)
T KOG0690|consen 251 NGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KYGD 323 (516)
T ss_pred cCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc--cccc
Confidence 9999998887654 4888888888999999999999 8999999999999999999999999999998632 2344
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
....++||+.|+|||++....|...+|-|.+|||+|||++|+.||-..+.+ .+.+.+. .. ++. ++
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-kLFeLIl--~e-----d~k-------FP 388 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-KLFELIL--ME-----DLK-------FP 388 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-HHHHHHH--hh-----hcc-------CC
Confidence 566789999999999999999999999999999999999999999866543 3333221 11 111 11
Q ss_pred hHHHHHHHHHHHhccCCCCCCCC
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRP 796 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RP 796 (846)
.....+...|....+.++|.+|.
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhc
Confidence 11223456778888999999997
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=305.64 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=188.8
Q ss_pred HHhhhh--hhcCcCceEEEEEEEEc-CCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeec--------
Q 003114 535 ITNDFE--TILGEGSFGKVYHGYLD-DNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE-------- 602 (846)
Q Consensus 535 ~t~~f~--~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-------- 602 (846)
...+|+ ++||+||||.|||++.+ ||+.+|||++.-. +......+.+|+.+|++++|||||+++..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 444565 47999999999999976 8999999999754 44456778899999999999999988752200
Q ss_pred -----------------------------------------------C--------------------------------
Q 003114 603 -----------------------------------------------G-------------------------------- 603 (846)
Q Consensus 603 -----------------------------------------------~-------------------------------- 603 (846)
.
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred --------------------------------CeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhc
Q 003114 604 --------------------------------NQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHL 651 (846)
Q Consensus 604 --------------------------------~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 651 (846)
..+|+=||||+.-.|.++++.+.... .....+++..+|+.||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH- 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH- 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH-
Confidence 01456699999888888887665311 35677899999999999999
Q ss_pred cCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCC----------------CCCcccccccccCCCcccCccccccC--
Q 003114 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP----------------IEGVSHLSTGVAGTFGYLDPEYCQTF-- 713 (846)
Q Consensus 652 ~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~----------------~~~~~~~~~~~~gt~~Y~APE~~~~~-- 713 (846)
+.+||||||||.||++|++..|||+|||+|+... ........++.+||.-|+|||++.+.
T Consensus 715 --~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 715 --DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred --hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 8999999999999999999999999999998721 00111234567899999999998765
Q ss_pred -CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCC
Q 003114 714 -RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSS 792 (846)
Q Consensus 714 -~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P 792 (846)
+|+.|+|+||+|||++||+. ||...-+.... -..++.+.+..- ..+....+..-..++.++++.||
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~i----L~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASI----LTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHHH----HHhcccCCCCCC------cccccccchHHHHHHHHHhcCCC
Confidence 49999999999999999994 35543332211 112334433332 11222333445789999999999
Q ss_pred CCCCCHHHHHH
Q 003114 793 TPRPNMNRVVM 803 (846)
Q Consensus 793 ~~RPsm~eVl~ 803 (846)
.+|||+.|++.
T Consensus 860 ~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 860 SKRPTATELLN 870 (1351)
T ss_pred ccCCCHHHHhh
Confidence 99999999875
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=288.42 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=191.0
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecC-------------
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG------------- 603 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------------- 603 (846)
.+.+.||.|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 8 ~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (342)
T cd07854 8 MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTE 87 (342)
T ss_pred EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccc
Confidence 34568999999999999964 6889999999776666667889999999999999999999766543
Q ss_pred -CeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC-CCCcEEEEecc
Q 003114 604 -NQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN-DQFQARLADFG 681 (846)
Q Consensus 604 -~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld-~~~~vkI~DFG 681 (846)
...++|+||++ ++|.+++... .+++.....++.|++.||.||| +.+|+||||||+||+++ +++.+||+|||
T Consensus 88 ~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 88 LNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 35789999997 5898888643 3889999999999999999999 88999999999999997 56688999999
Q ss_pred CCccCCCCCcc-cccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc--
Q 003114 682 LSKTFPIEGVS-HLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ-- 757 (846)
Q Consensus 682 la~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~-- 757 (846)
+++........ .......++..|+|||.+.. ..++.++|||||||+++||++|+.||...................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 99765321111 11122357889999997654 568889999999999999999999997654332222211110000
Q ss_pred ---CC----ccc-ccCCCCCCC-----CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 758 ---GD----IKN-IVDPKLHGD-----IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 758 ---~~----~~~-~~d~~L~~~-----~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.. ... ......... .......++.+++.+|++.+|++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00 000 000000000 00112346789999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=267.32 Aligned_cols=259 Identities=24% Similarity=0.323 Sum_probs=194.1
Q ss_pred hhhhcCcCceEEEEEEEEc---C--CcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeec-CCeeeEee
Q 003114 539 FETILGEGSFGKVYHGYLD---D--NTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNE-GNQIGLIY 610 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~---~--g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~LV~ 610 (846)
....||+|.||.||||.-. + ...+|+|+++.+.. .......+|+.+++.++|||++.|...+.+ +...+|++
T Consensus 28 ~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~f 107 (438)
T KOG0666|consen 28 GIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLF 107 (438)
T ss_pred ccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEe
Confidence 3457999999999999643 2 33789999976532 233567899999999999999999998866 78899999
Q ss_pred ecccCCChhhhhhcCC---CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC----CcEEEEeccCC
Q 003114 611 EYMANGSLEEYLSDSN---ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ----FQARLADFGLS 683 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~----~~vkI~DFGla 683 (846)
||.+. +|.+.|+.+. .+.++......|+.||+.|+.||| +.-|+||||||.|||+..+ |.|||+|+|++
T Consensus 108 dYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 108 DYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred hhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 99976 8998886543 356888899999999999999999 8999999999999999877 99999999999
Q ss_pred ccCCCCCc-ccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccc---------ccHHHHHH
Q 003114 684 KTFPIEGV-SHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEH---------KHISQWVD 752 (846)
Q Consensus 684 ~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~---------~~l~~~~~ 752 (846)
+.+...-. -.....++.|..|+|||.+.+. .|+.+.|||+.|||+.||+|-++.|.+.++. +.+.+++.
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~ 263 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE 263 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH
Confidence 98753321 1233456789999999988876 4899999999999999999999999765421 22333222
Q ss_pred HHHhcCCcccccCCCCCC--C-------C-----Ch---H--------HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 753 FMLAQGDIKNIVDPKLHG--D-------I-----DV---N--------SAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 753 ~~~~~~~~~~~~d~~L~~--~-------~-----~~---~--------~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.+ |...+-.-|.+.. + + +. . .....++|..+++..||.+|.|.++.++.
T Consensus 264 vL---G~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 264 VL---GTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred Hc---CCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 11 1111111111100 0 0 00 0 00125689999999999999999988764
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=283.04 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=189.9
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCC------eeeEee
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN------QIGLIY 610 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------~~~LV~ 610 (846)
.+.||+|+||.||++... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.... ..++||
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 467999999999999854 7899999998643 2233456889999999999999999999886543 468999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+ +++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++.....
T Consensus 100 e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~-- 170 (343)
T cd07880 100 PFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS-- 170 (343)
T ss_pred ecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccccccc--
Confidence 999 77998888643 3899999999999999999999 89999999999999999999999999999976432
Q ss_pred cccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHH----------HhcCC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFM----------LAQGD 759 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~----------~~~~~ 759 (846)
......+++.|+|||.+.+ ..++.++|+||+||++++|++|++||................ +....
T Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07880 171 ---EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247 (343)
T ss_pred ---CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence 1223457889999998875 458899999999999999999999997654322222211100 00000
Q ss_pred -------cccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 760 -------IKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 760 -------~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
........+ ..........+.+++.+|++.+|++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 248 AKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 0001122345789999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=266.92 Aligned_cols=246 Identities=21% Similarity=0.290 Sum_probs=198.3
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeec----CCeeeEeeeccc
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNE----GNQIGLIYEYMA 614 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~----~~~~~LV~Ey~~ 614 (846)
++||-|-.|.|-.+..+ +++.+|+|++... ...++|+++--.. .|||||.+++.+.+ ...+++|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 68999999999988865 7888999998654 3457888876665 69999999998754 456889999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC---CCCcEEEEeccCCccCCCCCc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN---DQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld---~~~~vkI~DFGla~~~~~~~~ 691 (846)
||.|.+.+++++.+.+++.++..|+.||+.|+.||| +.+|.||||||+|+|.. .|..+||+|||+|+....
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--- 216 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--- 216 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCC---
Confidence 999999999999888999999999999999999999 99999999999999996 456799999999986432
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||-.... ..+..-++..+..+.. ++-++++
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~aispgMk~rI~~gqy-~FP~pEW--- 291 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKRRIRTGQY-EFPEPEW--- 291 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccCChhHHhHhhccCc-cCCChhH---
Confidence 2334456789999999999999999999999999999999999999975543 2233333333333321 1112222
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
....+...+++..++..+|++|.|+.|+...
T Consensus 292 --s~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 292 --SCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred --hHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1234566789999999999999999998753
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=286.81 Aligned_cols=252 Identities=21% Similarity=0.344 Sum_probs=191.2
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCe------eeEee
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQ------IGLIY 610 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~------~~LV~ 610 (846)
.+.||+|++|.||+|+.. +++.||+|++... .....+.+.+|+.+++.++|+|++++++++...+. .++|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 468999999999999975 6789999998653 22334567789999999999999999987765544 89999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+ +++|.+++... .+++..+..++.|+++||.||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 100 e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 100 HLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred ecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 998 67999988753 4899999999999999999999 889999999999999999999999999999765321
Q ss_pred cccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc----------CC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ----------GD 759 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~----------~~ 759 (846)
.....++..|+|||.+.+ ..++.++|||||||+++||++|+.||........+..+....... ..
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 233467889999998765 367899999999999999999999997654332222211110000 00
Q ss_pred cccccC---CCCCCCC---ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 760 IKNIVD---PKLHGDI---DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 760 ~~~~~d---~~L~~~~---~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
....+. ..-...+ .......+.+++.+|++.+|++|||+.||++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000 0000000 0112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=241.24 Aligned_cols=256 Identities=21% Similarity=0.341 Sum_probs=199.2
Q ss_pred hhcCcCceEEEEEEEE-cCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 541 TILGEGSFGKVYHGYL-DDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
+.||+|.||+|+||+. +.++.||+|.++-. +...-....+|+-+++.++|+|||++++....++...+|+|||. .+
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qd 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QD 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HH
Confidence 5699999999999994 56888999998644 33334567899999999999999999999999999999999995 58
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|..+....++. ++......++.|+++||.++| ++++.|||+||+|.|++.+|+.|++|||+++.+... ..-.+.
T Consensus 87 lkkyfdslng~-~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip--vrcysa 160 (292)
T KOG0662|consen 87 LKKYFDSLNGD-LDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYSA 160 (292)
T ss_pred HHHHHHhcCCc-CCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eEeeec
Confidence 88888766543 888889999999999999999 999999999999999999999999999999976432 112233
Q ss_pred ccCCCcccCccccccCC-CCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcC--C---cccccCCCCCC
Q 003114 698 VAGTFGYLDPEYCQTFR-LTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQG--D---IKNIVDPKLHG 770 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~-~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~--~---~~~~~d~~L~~ 770 (846)
...|..|.+|.++.+.+ |+...|+||-||++.|+.. |++.|.+.+-.+.+.++++..-... . +..+-|-....
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 46789999999988765 8899999999999999985 7888888887777777766542221 1 11222222222
Q ss_pred CCChHH-H--------HHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 771 DIDVNS-A--------WKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 771 ~~~~~~-~--------~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.++..- . ..=.++.+..+.-+|.+|.++++.++
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 221111 1 11246778888889999999887654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=262.71 Aligned_cols=238 Identities=27% Similarity=0.411 Sum_probs=195.7
Q ss_pred ceEEEEEEEEc-CCcEEEEEEeCCCCchh-hHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChhhhhhc
Q 003114 547 SFGKVYHGYLD-DNTEVAVKMLSPSSRQG-YEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSD 624 (846)
Q Consensus 547 ~fG~Vykg~~~-~g~~VAVK~l~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~ 624 (846)
+||.||+|... +++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48999999998765544 67899999999999999999999999999999999999999999999976
Q ss_pred CCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccccCCCcc
Q 003114 625 SNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704 (846)
Q Consensus 625 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y 704 (846)
... +++..+..++.++++++.||| +.+++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 554 889999999999999999999 8899999999999999999999999999998764321 23345678899
Q ss_pred cCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHH
Q 003114 705 LDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIA 784 (846)
Q Consensus 705 ~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~ 784 (846)
++||......++.++||||||++++||++|+.||........+.++.. .+.... .. ........+.+++
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~----~~~~~~-~~------~~~~~~~~~~~~i 221 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG----KPKPPF-PP------PEWKISPEAKDLI 221 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh----ccCCCC-cc------ccccCCHHHHHHH
Confidence 999999888899999999999999999999999976433333322221 111000 00 0000335788999
Q ss_pred HhccCCCCCCCCCHHHHHH
Q 003114 785 MGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 785 ~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+|+..+|++||++.++++
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHccCCchhccCHHHHhh
Confidence 9999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=271.47 Aligned_cols=253 Identities=26% Similarity=0.372 Sum_probs=209.4
Q ss_pred hhhcCcCceEEEEEEEEc------CCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeec-CCeeeEeee
Q 003114 540 ETILGEGSFGKVYHGYLD------DNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE-GNQIGLIYE 611 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~LV~E 611 (846)
..++-+|.||.||+|.|. +.+.|.+|.++.. +.-....+..|..++..+.|||+.++.+.+.+ ....+++|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 457899999999999764 3455778877654 33455678889999999999999999998855 567888899
Q ss_pred cccCCChhhhhhc------CCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCcc
Q 003114 612 YMANGSLEEYLSD------SNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685 (846)
Q Consensus 612 y~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~ 685 (846)
++.-|+|..++.. +..+.++..+...++.|++.|++||| +.++||.||.++|+++|+..++||+|=.+++.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhccc
Confidence 9999999999972 23556888889999999999999999 99999999999999999999999999999998
Q ss_pred CCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCccccc
Q 003114 686 FPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIV 764 (846)
Q Consensus 686 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~ 764 (846)
+-..+..........+..||+||.+++..++..+|||||||++|||+| |+.|+...+..+.. ..+++|
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-----~ylkdG------ 514 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-----HYLKDG------ 514 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-----HHHhcc------
Confidence 876666666666667889999999999999999999999999999998 89999876644321 222222
Q ss_pred CCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 765 DPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 765 d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
.++. -+.+++.++..++.-||...|++||+++|++.-|.+.-
T Consensus 515 -yRla--QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 515 -YRLA--QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred -ceec--CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 1121 24467889999999999999999999999999998754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-31 Score=282.20 Aligned_cols=244 Identities=24% Similarity=0.379 Sum_probs=192.9
Q ss_pred hhhcCcCceEEEEEEEE-cCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 540 ETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+++||.|.||+||-|++ ++|+.||||++.+. ..+...++++|+.+|++++||.||.+-..|+..+..++|||.+.|-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 47899999999999996 48999999999764 2334478999999999999999999999999999999999999654
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC---CcEEEEeccCCccCCCCCccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ---FQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~---~~vkI~DFGla~~~~~~~~~~ 693 (846)
-|+-.|.... ..+++.....++.||+.||.||| -++|+|+||||+|||+.+. .++||||||+|+.++.. .
T Consensus 649 MLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---s 721 (888)
T KOG4236|consen 649 MLEMILSSEK-GRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---S 721 (888)
T ss_pred HHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchh---h
Confidence 4444444433 34888888889999999999999 8999999999999999643 58999999999987543 3
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
....++||+.|+|||+++.+.|...-|+||.||++|--++|-.||...++ +.+-++ . ..-++.+.-..
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---IndQIQ----N--AaFMyPp~PW~--- 789 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---INDQIQ----N--AAFMYPPNPWS--- 789 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---hhHHhh----c--cccccCCCchh---
Confidence 34567899999999999999999999999999999999999999975443 222111 0 11111221111
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+.....++++...++..-++|-+.++-+.
T Consensus 790 -eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 790 -EISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred -hcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 22335678888888888888888876543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=265.97 Aligned_cols=221 Identities=23% Similarity=0.213 Sum_probs=176.9
Q ss_pred CceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChhhhhhc
Q 003114 546 GSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSD 624 (846)
Q Consensus 546 G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~ 624 (846)
|.+|.||+++.. +++.+|+|++.... .+..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999964 78899999997653 233455555566799999999999999999999999999999999876
Q ss_pred CCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccccCCCcc
Q 003114 625 SNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704 (846)
Q Consensus 625 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y 704 (846)
... +++..+..++.|++.||.||| +.+|+||||||+||+++.++.++++|||.+..... ......++..|
T Consensus 79 ~~~--l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y 148 (237)
T cd05576 79 FLN--IPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMY 148 (237)
T ss_pred hcC--CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccc
Confidence 543 899999999999999999999 89999999999999999999999999998765422 12234567789
Q ss_pred cCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHH
Q 003114 705 LDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIA 784 (846)
Q Consensus 705 ~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~ 784 (846)
+|||......++.++||||+||+++||++|+.|+....... ....... .+......+.+++
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~~~~----~~~~~~~~~~~li 209 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHTTLN----IPEWVSEEARSLL 209 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------ccccccC----CcccCCHHHHHHH
Confidence 99999988889999999999999999999998875321100 0000001 1112234678999
Q ss_pred HhccCCCCCCCCCHHH
Q 003114 785 MGCVSHSSTPRPNMNR 800 (846)
Q Consensus 785 ~~Cl~~~P~~RPsm~e 800 (846)
.+|++.+|++||++.+
T Consensus 210 ~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 210 QQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHccCCHHHhcCCCc
Confidence 9999999999999744
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=302.90 Aligned_cols=141 Identities=30% Similarity=0.474 Sum_probs=126.7
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++|+||+++++.+......++||||+.
T Consensus 8 i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~ 87 (669)
T cd05610 8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLI 87 (669)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCC
Confidence 3568999999999999976 68899999997542 2334678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~ 684 (846)
+++|.+++.... .+++..+++++.||+.||+||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 88 g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 88 GGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999997654 3788999999999999999999 8899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=272.79 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=197.1
Q ss_pred HHHhhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeE
Q 003114 534 KITNDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 534 ~~t~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~L 608 (846)
....+|..+||+|+||.|-+|..+ ..+.+|||++++.- .++.+--..|-.+|... +-|.+++++.+|+.-+.+++
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 334577889999999999999865 45668999998652 22223334566777766 56789999999999999999
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
||||+.||+|--.+++-+. +.+..+.-+|.+||-||-+|| +++||.||||.+||++|.+|++||+|||+++.--.
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999988887654 888899999999999999999 99999999999999999999999999999985322
Q ss_pred CCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
. ......++||+.|+|||.+..++|+..+|-|||||+||||+.|++||++.++++....+... .
T Consensus 503 ~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-------------n- 566 (683)
T KOG0696|consen 503 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-------------N- 566 (683)
T ss_pred C--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-------------c-
Confidence 1 23345689999999999999999999999999999999999999999988877655443221 1
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCC
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPN 797 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPs 797 (846)
-.++..-..+.+.+....+.+.|.+|..
T Consensus 567 -vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 -VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1234444556778888889999988863
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=282.43 Aligned_cols=236 Identities=26% Similarity=0.345 Sum_probs=190.6
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+...+|.|+|+.|-++.. .+++..+||++.+... +-.+|+.++... +||||+++.+.+.++.+.++|||.+.+
T Consensus 325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred ccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 4456799999999999885 4788999999976622 335566555555 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE-CCCCcEEEEeccCCccCCCCCcccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL-NDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl-d~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+-|.+.+..... +. .++..|+.+++.++.||| +++++||||||+|||+ ++.++++|+|||.++.....
T Consensus 401 ~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----- 469 (612)
T KOG0603|consen 401 GELLRRIRSKPE--FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----- 469 (612)
T ss_pred cHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----
Confidence 988887776542 22 677789999999999999 8999999999999999 68999999999999876432
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
....+-|..|.|||++....+++++|+||||++||+|++|+.||.....+..+.. .+..+. +..
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~----~i~~~~------------~s~ 533 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT----RIQMPK------------FSE 533 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH----hhcCCc------------ccc
Confidence 3334668899999999999999999999999999999999999987654422211 222221 123
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.......+|+.+|++.+|.+||+|.++...
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 334567899999999999999999998653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=261.82 Aligned_cols=261 Identities=22% Similarity=0.298 Sum_probs=195.5
Q ss_pred cccCHHHHHHHHhhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc-hhhHHHHHHHHHH-HhcccccceeEeeEee
Q 003114 525 RRFTYAEITKITNDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR-QGYEQFEAEVILL-RTVHHKNLTTLYGYCN 601 (846)
Q Consensus 525 ~~~~~~el~~~t~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l-~~l~HpnIv~l~g~~~ 601 (846)
..|+-++++.. ..||.|+||+|+|-.++ .|+..|||+++.... ...+++..|.+.. +.-+.||||+++|.+-
T Consensus 59 ~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 59 HTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 34554455442 46999999999998875 799999999986543 5567788887754 4457999999999999
Q ss_pred cCCeeeEeeecccCCChhhhh---hcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEE
Q 003114 602 EGNQIGLIYEYMANGSLEEYL---SDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLA 678 (846)
Q Consensus 602 ~~~~~~LV~Ey~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~ 678 (846)
.++..++.||.|. .+|..+- ..-....+++.-.-.|....++||.||.+ ...|||||+||+|||++..|.+|||
T Consensus 134 ~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 134 SEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred cCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeee
Confidence 9999999999994 4665543 22233347777777888889999999986 6789999999999999999999999
Q ss_pred eccCCccCCCCCcccccccccCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHh
Q 003114 679 DFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT--FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLA 756 (846)
Q Consensus 679 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~ 756 (846)
|||.+..+. .+...+..+|-..|||||.+.. ..++.++||||+|+.|+|+.||+.|+..-+. +.+-+..+.
T Consensus 211 DFGIcGqLv---~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv- 283 (361)
T KOG1006|consen 211 DFGICGQLV---DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVV- 283 (361)
T ss_pred cccchHhHH---HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHH-
Confidence 999987652 1233445678889999998853 3589999999999999999999999976442 222222222
Q ss_pred cCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 757 QGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 757 ~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.|+...+..+ ..+.+....++.++-.|+.++-+.||...++.+.
T Consensus 284 ~gdpp~l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 284 IGDPPILLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCCCCeecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2222221111 1123345678899999999999999999887653
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=267.09 Aligned_cols=251 Identities=26% Similarity=0.435 Sum_probs=192.9
Q ss_pred hhhcCcCceEEEEEEE-EcCCcEEEEEEeCCCCc-------hhhHHHHHHHHHHHhcccccceeEeeEee-cCCeeeEee
Q 003114 540 ETILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSR-------QGYEQFEAEVILLRTVHHKNLTTLYGYCN-EGNQIGLIY 610 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~-------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~-~~~~~~LV~ 610 (846)
.++||+|||+.||||. +...+.||||+-..... ...+...+|..+-+.+.||-||++++|+. +.+.++-|+
T Consensus 468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL 547 (775)
T KOG1151|consen 468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL 547 (775)
T ss_pred HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence 4689999999999998 56788899998643211 12234678999999999999999999985 456789999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC---CCCcEEEEeccCCccCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN---DQFQARLADFGLSKTFP 687 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld---~~~~vkI~DFGla~~~~ 687 (846)
|||+|.+|.-+|+.+.. +++.++..|+.||+.||.||.+ .+++|||-||||.|||+- ..|.+||+|||+++.+.
T Consensus 548 EYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMd 624 (775)
T KOG1151|consen 548 EYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMD 624 (775)
T ss_pred eecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchhhhcc
Confidence 99999999999988764 8999999999999999999984 478999999999999994 45889999999999885
Q ss_pred CCCcc-----cccccccCCCcccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcC
Q 003114 688 IEGVS-----HLSTGVAGTFGYLDPEYCQTF----RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG 758 (846)
Q Consensus 688 ~~~~~-----~~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~ 758 (846)
.+... ...+..+||.+|++||.+.-. +.+.|+||||.|||+|+.+.|+.||........+.+.-. .+...
T Consensus 625 ddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT-IlkAt 703 (775)
T KOG1151|consen 625 DDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT-ILKAT 703 (775)
T ss_pred CCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc-hhcce
Confidence 44332 233456899999999987533 588999999999999999999999987654444333111 11111
Q ss_pred CcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 003114 759 DIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVV 802 (846)
Q Consensus 759 ~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl 802 (846)
.+.--..| ....+...++.+|++.--++|....++.
T Consensus 704 EVqFP~KP--------vVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 704 EVQFPPKP--------VVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred eccCCCCC--------ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11111111 1223456889999999999998876653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=282.43 Aligned_cols=248 Identities=26% Similarity=0.450 Sum_probs=203.2
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEee-----cCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCN-----EGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~-----~~~~~~LV~ 610 (846)
.|.+.||.|.+|.||+++. ++++.+|+|++..... ..++++.|.++++.. .|||++.++|++. .+++++|||
T Consensus 22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM 100 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM 100 (953)
T ss_pred EEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence 4568999999999999994 5788899999876543 347788899999888 6999999999884 367899999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
|||.+|+..|+++...+..+.|..+..|+..++.|+.+|| ...++|||||-.|||++.++.+|++|||++..+..
T Consensus 101 EfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds-- 175 (953)
T KOG0587|consen 101 EFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS-- 175 (953)
T ss_pred eccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeeec--
Confidence 9999999999999887778999999999999999999999 89999999999999999999999999999986532
Q ss_pred cccccccccCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQT-----FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 765 (846)
.........||+.|||||++.- ..|+..+|+||+|++..||.-|.+|+.+......+.. +...-.
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~----------IpRNPP 245 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----------IPRNPP 245 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc----------CCCCCC
Confidence 2233345679999999998853 3578899999999999999999999976654332211 111111
Q ss_pred CCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 ~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
|.|+ -+..-..++.+++..|+.++-+.||++.++++
T Consensus 246 PkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 246 PKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cccc--chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 2222 23455678899999999999999999988764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=291.91 Aligned_cols=248 Identities=22% Similarity=0.283 Sum_probs=198.1
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.++||+|+||.|..++.+ .++.+|+|++++. ......-|.+|-.+|...+.+-|+.++..|.+.+++|+|||||+
T Consensus 79 ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~p 158 (1317)
T KOG0612|consen 79 ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMP 158 (1317)
T ss_pred HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEeccc
Confidence 3578999999999999975 5778899999863 34456779999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
||+|-.++.... .+++..+..++..|+-||.-|| +.|+|||||||+|||||.+|++||+|||.+-.+..++ ...
T Consensus 159 GGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-~V~ 232 (1317)
T KOG0612|consen 159 GGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-TVR 232 (1317)
T ss_pred CchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCCCC-cEE
Confidence 999999999877 4889999999999999999999 9999999999999999999999999999988775443 334
Q ss_pred cccccCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQT-----FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
+...+|||.|++||+++. +.|+..+|-||+||++|||+.|..||-...-.+....++. .... +.
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~---hk~~--------l~ 301 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMN---HKES--------LS 301 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhc---hhhh--------cC
Confidence 455789999999998853 5689999999999999999999999965443222222221 1111 10
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCC---HHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPN---MNRVVME 804 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPs---m~eVl~~ 804 (846)
-.-..+......+|+.+.+. +|+.|.. ++++...
T Consensus 302 FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 302 FPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred CCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 00012234456677776665 7788887 7777553
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=282.21 Aligned_cols=253 Identities=17% Similarity=0.260 Sum_probs=164.8
Q ss_pred hhhhhcCcCceEEEEEEEEc-C----CcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeE------eecCCee
Q 003114 538 DFETILGEGSFGKVYHGYLD-D----NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGY------CNEGNQI 606 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~----g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~------~~~~~~~ 606 (846)
.+.+.||+|+||.||+|++. + +..||+|++...... +....| .+....+.++..++.. +..+...
T Consensus 135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence 34578999999999999975 4 689999998643321 111111 1122222222222211 2456789
Q ss_pred eEeeecccCCChhhhhhcCCCC------------------ccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEE
Q 003114 607 GLIYEYMANGSLEEYLSDSNAD------------------VLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANIL 668 (846)
Q Consensus 607 ~LV~Ey~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NIL 668 (846)
++|+||+.+++|.+++...... ......+..++.|++.||+||| +.+|+||||||+|||
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NIL 287 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNII 287 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHEE
Confidence 9999999999999998754311 0112345579999999999999 889999999999999
Q ss_pred ECC-CCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccC----------------------CCCchhhHHHHH
Q 003114 669 LND-QFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF----------------------RLTEKSDVYSFG 725 (846)
Q Consensus 669 ld~-~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----------------------~~s~ksDVwS~G 725 (846)
+++ ++.+||+|||+++.+... .........+++.|+|||.+... .++.++||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 985 689999999999865322 22333456789999999965321 234567999999
Q ss_pred HHHHHHHhCCCCCCCccc---------cccHHHHHHHHHhcCCcccccCCCCCCCCC--hHHHHHHHHHHHhccCCCCCC
Q 003114 726 VVLLEIITSRPAIANTEE---------HKHISQWVDFMLAQGDIKNIVDPKLHGDID--VNSAWKAVEIAMGCVSHSSTP 794 (846)
Q Consensus 726 vvl~ELltG~~p~~~~~~---------~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~--~~~~~~l~~L~~~Cl~~~P~~ 794 (846)
|++|||+++..+++.... ......|....... ..+.+...+. ........+|+.+|++.+|++
T Consensus 367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999998766542210 01112222111100 0000000000 001123458999999999999
Q ss_pred CCCHHHHHHH
Q 003114 795 RPNMNRVVME 804 (846)
Q Consensus 795 RPsm~eVl~~ 804 (846)
|||++|+++.
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-29 Score=263.97 Aligned_cols=264 Identities=20% Similarity=0.319 Sum_probs=203.8
Q ss_pred HHHHHHHHhhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-c-cc----ceeEeeEee
Q 003114 529 YAEITKITNDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-H-KN----LTTLYGYCN 601 (846)
Q Consensus 529 ~~el~~~t~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H-pn----Iv~l~g~~~ 601 (846)
..|.....+.+...+|+|.||.|-.+... .+..||||+++...+ ..+..+-|+++|+++. + |+ +|.+.+||.
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 33444455556678999999999998864 478899999975432 2355677999999993 2 32 788889999
Q ss_pred cCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC----------
Q 003114 602 EGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND---------- 671 (846)
Q Consensus 602 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~---------- 671 (846)
-.++.++|+|.+ |-|+.+++.+++..+++...+..|+.|+++++++|| +.+++|.||||+|||+-+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccC
Confidence 999999999998 569999999988888999999999999999999999 999999999999999831
Q ss_pred ----------CCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 003114 672 ----------QFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANT 741 (846)
Q Consensus 672 ----------~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~ 741 (846)
+..+||+|||.|..-... .+.++.|..|.|||++.+-.++.++||||+||||.|+.||...|...
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 346899999999753221 25567899999999999999999999999999999999999999876
Q ss_pred cccccHHHHHHHHHhc-----------------CCc-----------ccccCCCC--CC--CCChHHHHHHHHHHHhccC
Q 003114 742 EEHKHISQWVDFMLAQ-----------------GDI-----------KNIVDPKL--HG--DIDVNSAWKAVEIAMGCVS 789 (846)
Q Consensus 742 ~~~~~l~~~~~~~~~~-----------------~~~-----------~~~~d~~L--~~--~~~~~~~~~l~~L~~~Cl~ 789 (846)
++.+++ ..++..+.+ +.+ ....++.. .. .-...+..++++|+.+|+.
T Consensus 313 en~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 313 ENLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CcHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 655554 222222111 100 00001000 00 0122356789999999999
Q ss_pred CCCCCCCCHHHHHH
Q 003114 790 HSSTPRPNMNRVVM 803 (846)
Q Consensus 790 ~~P~~RPsm~eVl~ 803 (846)
.||.+|+|+.|++.
T Consensus 392 fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 392 FDPARRITLREALS 405 (415)
T ss_pred cCccccccHHHHhc
Confidence 99999999999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=270.86 Aligned_cols=236 Identities=21% Similarity=0.307 Sum_probs=196.7
Q ss_pred hhcCcCceEEEEEEEEcCCc-EEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 541 TILGEGSFGKVYHGYLDDNT-EVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~-~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
..||-|+||.|=+.+.+... .+|+|++++. .....+....|-.+|...+.|.||+++-.|.++...|+.||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 36999999999999876433 4788887654 3334455678999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
.|...+++.+. ++......++..+++|++||| .++||.|||||+|.++|.+|-+||.|||+|+.+. ......
T Consensus 506 ElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~g~KTw 577 (732)
T KOG0614|consen 506 ELWTILRDRGS--FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---SGRKTW 577 (732)
T ss_pred hhhhhhhhcCC--cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhc---cCCcee
Confidence 99999998765 888999999999999999999 9999999999999999999999999999999874 345566
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
.++||+.|.|||.+.++..+.++|.||+|++++||++|.+||.+.+.......+.+-. |. -.++...
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi----------d~---i~~Pr~I 644 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI----------DK---IEFPRRI 644 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh----------hh---hhccccc
Confidence 7899999999999999999999999999999999999999999876433222221111 10 1223344
Q ss_pred HHHHHHHHHhccCCCCCCCCC
Q 003114 777 AWKAVEIAMGCVSHSSTPRPN 797 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPs 797 (846)
.+...+++.+.+..+|.+|..
T Consensus 645 ~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 645 TKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred chhHHHHHHHHHhcCcHhhhc
Confidence 456678999999999999986
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-29 Score=250.56 Aligned_cols=255 Identities=23% Similarity=0.357 Sum_probs=192.2
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeec--------CCeeeEe
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE--------GNQIGLI 609 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--------~~~~~LV 609 (846)
..||+|.||.||+|+.+ .|+.||+|++-.. ...--....+|+.+|..++|+|++.++..|.. ...+++|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 46999999999999965 5778898875322 12222456789999999999999999998743 2358999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|++|+. +|.-+|.+... .++..++.+++.++..||.|+| ...|+|||+||.|+|++.++.+||+|||+++.+...
T Consensus 103 f~~ceh-DLaGlLsn~~v-r~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~ 177 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRKV-RFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARAFSTS 177 (376)
T ss_pred HHHhhh-hHHHHhcCccc-cccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence 999975 88888876643 3888999999999999999999 999999999999999999999999999999876433
Q ss_pred Cc--ccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCC
Q 003114 690 GV--SHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDP 766 (846)
Q Consensus 690 ~~--~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 766 (846)
.. ....+..+.|..|++||.+.+ ..++++.|||+-|||+.||+||.+.+.+..+...+..+.... |.+..-+-|
T Consensus 178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc---Gs~tkevWP 254 (376)
T KOG0669|consen 178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC---GSITKEVWP 254 (376)
T ss_pred cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh---ccCCcccCC
Confidence 22 222334567999999998765 469999999999999999999999999877665554332211 111100000
Q ss_pred C--------------C-CCCC--ChHHH------HHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 767 K--------------L-HGDI--DVNSA------WKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 767 ~--------------L-~~~~--~~~~~------~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
. + .+.+ -.+.. ...++|+..++..||.+|++.++++.
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 0 1 0000 01111 25678999999999999999988764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-29 Score=282.21 Aligned_cols=242 Identities=28% Similarity=0.414 Sum_probs=188.0
Q ss_pred hhhcCcCceEE-EEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 540 ETILGEGSFGK-VYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 540 ~~~LG~G~fG~-Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
++++|.|+.|+ ||+|.. +|++||||++-... .+-.++|+..|+.- .|||||++++.-.+....|+..|.|. .+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS 588 (903)
T ss_pred HHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence 46899999986 799998 57899999986443 34568899999988 69999999999999999999999995 69
Q ss_pred hhhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-----CCcEEEEeccCCccCCCCC
Q 003114 618 LEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-----QFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 618 L~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-----~~~vkI~DFGla~~~~~~~ 690 (846)
|++++... ......-...+.+..|+++||++|| +.+||||||||+||||+. ...++|+|||+++.+....
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 99999874 1111122445788999999999999 899999999999999975 3579999999999986443
Q ss_pred cc-cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 691 VS-HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITS-RPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 691 ~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG-~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
.+ ....+..||-||+|||.+....-+.++||||+|||+|+.++| .+||.+.-+.+. ..+.....+.. |
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-----NIl~~~~~L~~-----L 735 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-----NILTGNYTLVH-----L 735 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-----hhhcCccceee-----e
Confidence 22 224567899999999999988888899999999999999987 899976543221 00000000000 0
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.. ..++ ...+|+.+|++++|..||++.+|+.
T Consensus 736 ~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 EP--LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred cc--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 1111 6679999999999999999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=273.92 Aligned_cols=252 Identities=19% Similarity=0.263 Sum_probs=174.3
Q ss_pred hhhhcCcCceEEEEEEEE-----------------cCCcEEEEEEeCCCCchhhHH--------------HHHHHHHHHh
Q 003114 539 FETILGEGSFGKVYHGYL-----------------DDNTEVAVKMLSPSSRQGYEQ--------------FEAEVILLRT 587 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-----------------~~g~~VAVK~l~~~~~~~~~~--------------~~~Ei~~l~~ 587 (846)
+.++||+|+||.||+|.+ .+++.||||++........++ ...|+..+.+
T Consensus 149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 357899999999999964 245679999987543322222 3346667777
Q ss_pred cccccc-----eeEeeEeec--------CCeeeEeeecccCCChhhhhhcCCC----------------------CccCh
Q 003114 588 VHHKNL-----TTLYGYCNE--------GNQIGLIYEYMANGSLEEYLSDSNA----------------------DVLSW 632 (846)
Q Consensus 588 l~HpnI-----v~l~g~~~~--------~~~~~LV~Ey~~~gsL~~~l~~~~~----------------------~~l~~ 632 (846)
++|.++ ++++++|.. .+..+|||||+++++|.++++.... ..+++
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 766554 677887753 3568999999999999999874321 12467
Q ss_pred HHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccccCCCcccCcccccc
Q 003114 633 EGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712 (846)
Q Consensus 633 ~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 712 (846)
..+..++.|++.+|.||| +.+|+||||||+|||++.++.+||+|||+++...... ........+++.|+|||.+..
T Consensus 309 ~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred HHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChhhhcC
Confidence 788899999999999999 8899999999999999999999999999997653221 111112335789999998753
Q ss_pred CC----------------------CCchhhHHHHHHHHHHHHhCCC-CCCCccc--------cccHHHHHHHHHhcCCcc
Q 003114 713 FR----------------------LTEKSDVYSFGVVLLEIITSRP-AIANTEE--------HKHISQWVDFMLAQGDIK 761 (846)
Q Consensus 713 ~~----------------------~s~ksDVwS~Gvvl~ELltG~~-p~~~~~~--------~~~l~~~~~~~~~~~~~~ 761 (846)
.. ...+.||||+||+++||++|.. |+..... ...+..|... ....
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~~~~-- 460 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--KGQK-- 460 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--cccC--
Confidence 22 1235799999999999999975 6653211 1122223221 1111
Q ss_pred cccCCCCCCCCChHHHHHHHHHHHhccCCCC---CCCCCHHHHHHH
Q 003114 762 NIVDPKLHGDIDVNSAWKAVEIAMGCVSHSS---TPRPNMNRVVME 804 (846)
Q Consensus 762 ~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P---~~RPsm~eVl~~ 804 (846)
.+-.. .........+++.+|+..+| .+|+|++|++++
T Consensus 461 --~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 --YDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --CCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 01000 01123456788888998765 789999998753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=232.31 Aligned_cols=210 Identities=34% Similarity=0.574 Sum_probs=183.7
Q ss_pred cCcCceEEEEEEEEcC-CcEEEEEEeCCCCch-hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChhh
Q 003114 543 LGEGSFGKVYHGYLDD-NTEVAVKMLSPSSRQ-GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEE 620 (846)
Q Consensus 543 LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 620 (846)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999999866443 34678999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-CCcEEEEeccCCccCCCCCccccccccc
Q 003114 621 YLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-QFQARLADFGLSKTFPIEGVSHLSTGVA 699 (846)
Q Consensus 621 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-~~~vkI~DFGla~~~~~~~~~~~~~~~~ 699 (846)
++.... ..+++..+..++.++++++.+|| +.+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 998653 24889999999999999999999 889999999999999999 89999999999986543211 123345
Q ss_pred CCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHH
Q 003114 700 GTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAW 778 (846)
Q Consensus 700 gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~ 778 (846)
+...|++||..... ..+.+.|+|++|+++++| .
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------~ 188 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------P 188 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------H
Confidence 77889999998877 788999999999999999 3
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 779 KAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 779 ~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.+.+++..|++.+|++||++.++++.
T Consensus 189 ~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 189 ELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 57899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=229.50 Aligned_cols=196 Identities=27% Similarity=0.364 Sum_probs=161.2
Q ss_pred hhcCcCceEEEEEEEE-cCCcEEEEEEeCCC-CchhhHHHHHHHHHHHh-cccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 541 TILGEGSFGKVYHGYL-DDNTEVAVKMLSPS-SRQGYEQFEAEVILLRT-VHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~-l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
+.||+|++|.|-+-++ .+|+..|+|.+... ..+..++...|+.+..+ ..+|.+|.++|........++.||.|+ -|
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tS 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TS 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hh
Confidence 4699999999988885 58999999999765 34455667777776554 479999999999888899999999995 47
Q ss_pred hhhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 618 LEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 618 L~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|..+-++- .+..+++...=+|+..++.||.|||+ +..+||||+||+|||++.+|++||||||.+-.+... -..
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS---iAk 205 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS---IAK 205 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh---hHH
Confidence 87765432 24458888889999999999999996 678999999999999999999999999999766321 122
Q ss_pred ccccCCCcccCccccc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 003114 696 TGVAGTFGYLDPEYCQ----TFRLTEKSDVYSFGVVLLEIITSRPAIANTE 742 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~----~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~ 742 (846)
+-..|-..|||||.+. ...|+.|+||||+|+.+.||.+++.||+...
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 2245777899999874 3468999999999999999999999998654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=257.16 Aligned_cols=197 Identities=26% Similarity=0.398 Sum_probs=167.5
Q ss_pred hhcCcCceEEEEEEE-EcCCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 541 TILGEGSFGKVYHGY-LDDNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.||-|+||+|.+++ .++...+|.|.+++.+ +......++|-.+|.....+-||+|+..|.+++.+|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 359999999999987 4566778999987653 223345678999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCC---------
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP--------- 687 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~--------- 687 (846)
++-.+|-..+- +.+..+..++.++..|+++.| +.|+|||||||+|||||.+|++||+||||+.-+.
T Consensus 715 DmMSLLIrmgI--FeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 715 DMMSLLIRMGI--FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred cHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 99999877653 788888889999999999999 9999999999999999999999999999986431
Q ss_pred CCCcc-------------------------------cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 003114 688 IEGVS-------------------------------HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736 (846)
Q Consensus 688 ~~~~~-------------------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~ 736 (846)
..+-. ......+||+.|+|||++....++..+|-||.||||+||+.|++
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~ 869 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP 869 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence 00000 00112469999999999999999999999999999999999999
Q ss_pred CCCCcc
Q 003114 737 AIANTE 742 (846)
Q Consensus 737 p~~~~~ 742 (846)
||....
T Consensus 870 pf~~~t 875 (1034)
T KOG0608|consen 870 PFLADT 875 (1034)
T ss_pred CccCCC
Confidence 997654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=240.72 Aligned_cols=241 Identities=20% Similarity=0.311 Sum_probs=191.2
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeeccc
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
..+||+|+|+.|..+++. +.+.+|+|++++. .....+-.+.|-.+..+. +||.+|.++.+|..+..+++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 468999999999999975 5677899998754 233344566777777666 79999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
||+|.-+++.... ++++.+..+..+|.-||.||| +.+||.||||..|||+|..|++|++|+|.++.-- .....
T Consensus 335 ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l--~~gd~ 407 (593)
T KOG0695|consen 335 GGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--GPGDT 407 (593)
T ss_pred Ccceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC--CCCcc
Confidence 9999877766543 899999999999999999999 9999999999999999999999999999998632 23445
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---ccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTE---EHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~---~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.+.++||+.|+|||.+.+..|...+|-|++||+++||+.|+.||+-.. .+..-..+.-+++.+..+. -|
T Consensus 408 tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir---ip----- 479 (593)
T KOG0695|consen 408 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR---IP----- 479 (593)
T ss_pred cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---cc-----
Confidence 667899999999999999999999999999999999999999997422 2223333333344333211 11
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCC
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPN 797 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPs 797 (846)
.....+...+...-+++||.+|..
T Consensus 480 --rslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 480 --RSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --ceeehhhHHHHHHhhcCCcHHhcC
Confidence 111224456777888899988853
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=240.28 Aligned_cols=259 Identities=20% Similarity=0.332 Sum_probs=190.3
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecC-----CeeeEeee
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG-----NQIGLIYE 611 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~~LV~E 611 (846)
++-||.|+||.||..... +|+.||.|++... +-...+.+.+|+++|...+|.|++..++...-. .++++++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 467999999999999864 7999999998643 334567889999999999999999988865432 35788899
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
.|. .+|...|-. ++.++.....-++.||++||+||| +.+|.||||||.|.|+++|...||+|||+++.-..++.
T Consensus 138 LmQ-SDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 138 LMQ-SDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHH-hhhhheecc--CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 885 477777654 345888888889999999999999 99999999999999999999999999999986543332
Q ss_pred ccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHH----------HhcCCc
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFM----------LAQGDI 760 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~----------~~~~~~ 760 (846)
.+ .+..+.|-.|.|||.+++. .|+.+.||||.||++.||+..+-.|.....-+.+.-+...+ --+|.-
T Consensus 212 ~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 212 LN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 22 2334568889999998876 58999999999999999999998887655333332221110 000100
Q ss_pred ccccCCCCC-----CCC----ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 761 KNIVDPKLH-----GDI----DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 761 ~~~~d~~L~-----~~~----~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
..++....+ --+ ......+-+.+.+.++..+|..|.+..+.+..+
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 011111111 000 111223456788889999999999988877665
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=227.34 Aligned_cols=252 Identities=17% Similarity=0.326 Sum_probs=191.7
Q ss_pred hhhhhcCcCceEEEEEEE-EcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-cccceeEeeEeec--CCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-HKNLTTLYGYCNE--GNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~--~~~~~LV~Ey~ 613 (846)
.+.+.+|+|.+++|+.|. ..+++.++||++++... +.+.+|+.+|+.++ ||||+++++...+ +....||+||+
T Consensus 41 eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v 117 (338)
T KOG0668|consen 41 EIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYV 117 (338)
T ss_pred HHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhh
Confidence 345689999999999998 56788999999986543 67899999999996 9999999998865 45688999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-CCcEEEEeccCCccCCCCCcc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-QFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-~~~vkI~DFGla~~~~~~~~~ 692 (846)
++.+...+-.. ++...+...+.++++||.|+| +.||+|||+||.|+++|. ....+|+|+|+|..+......
T Consensus 118 ~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 118 NNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred ccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCcee
Confidence 99877766543 777888899999999999999 999999999999999995 567999999999877543221
Q ss_pred cccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-cccccHHHHHHHHHhcC------Cccccc
Q 003114 693 HLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANT-EEHKHISQWVDFMLAQG------DIKNIV 764 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~-~~~~~l~~~~~~~~~~~------~~~~~~ 764 (846)
...+.+..|.-||.+..- .++-.-|+|||||++..|+..+.||-.. +..+.++++++.+-.++ ...-.+
T Consensus 190 ---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 190 ---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 123456678899987654 5788999999999999999999998643 34555665554321110 001112
Q ss_pred CCCCCC---C-------------CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 765 DPKLHG---D-------------IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 765 d~~L~~---~-------------~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
||+... . ...-...+.++++.+.+..|-++|||++|...
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 322211 0 00011256789999999999999999999765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=228.21 Aligned_cols=197 Identities=35% Similarity=0.507 Sum_probs=171.8
Q ss_pred hhhhcCcCceEEEEEEEEcC-CcEEEEEEeCCCCch-hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLDD-NTEVAVKMLSPSSRQ-GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 34679999999999999865 889999999876554 5678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++...... +++.....++.+++.++.+|| +.+++|+|++|+||+++.++.++|+|||.+....... .....
T Consensus 83 ~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (225)
T smart00221 83 DLFDYLRKKGGK-LSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALLK 157 (225)
T ss_pred CHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccccc
Confidence 999999875432 788999999999999999999 8899999999999999999999999999998764332 01223
Q ss_pred cccCCCcccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003114 697 GVAGTFGYLDPEYC-QTFRLTEKSDVYSFGVVLLEIITSRPAIAN 740 (846)
Q Consensus 697 ~~~gt~~Y~APE~~-~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~ 740 (846)
...++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 35677889999988 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-26 Score=234.66 Aligned_cols=248 Identities=23% Similarity=0.298 Sum_probs=189.0
Q ss_pred hcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeec------CCeeeEeeec
Q 003114 542 ILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE------GNQIGLIYEY 612 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~------~~~~~LV~Ey 612 (846)
.+|.|.- .|-.+... .+++||+|++... .....+...+|..++..+.|+||++++.++.- -.+.++|||+
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 4677776 45455432 5789999988643 33445678899999999999999999998843 3468999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
| .++|.+.+.. .++-.....|..|++.|++||| +.+|+||||||+||++..++.+||.|||+|+.- +..
T Consensus 103 m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e---~~~ 171 (369)
T KOG0665|consen 103 M-DANLCQVILM----ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE---DTD 171 (369)
T ss_pred h-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhccc---Ccc
Confidence 9 4699988873 2677888999999999999999 999999999999999999999999999999853 333
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcc-----------
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIK----------- 761 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~----------- 761 (846)
-..+....|..|.|||++.+..+.+.+||||.||++.||++|+..|.+. .++.+|-+....-|...
T Consensus 172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~---d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK---DHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc---hHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 4566678899999999998888999999999999999999999988743 34455544322211110
Q ss_pred ----------------cccCCC-CCCC--CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 762 ----------------NIVDPK-LHGD--IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 762 ----------------~~~d~~-L~~~--~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+.+... .... .+.-......+++.+|+..+|++|.+++++++.
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111111 1100 111223456789999999999999999998864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=232.95 Aligned_cols=257 Identities=21% Similarity=0.303 Sum_probs=190.7
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-----c---ccceeEeeEee----cCC
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-----H---KNLTTLYGYCN----EGN 604 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-----H---pnIv~l~g~~~----~~~ 604 (846)
-..++||=|.|++||++.. .+.+.||+|+.+... ...+....|+++|++++ | ..||+|+++|. .+.
T Consensus 81 ~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~ 159 (590)
T KOG1290|consen 81 HVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQ 159 (590)
T ss_pred EEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCc
Confidence 3456899999999999985 467889999986432 23456788999999984 3 35999999985 467
Q ss_pred eeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC-----------C
Q 003114 605 QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ-----------F 673 (846)
Q Consensus 605 ~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-----------~ 673 (846)
+.+||+|++ |-+|..+|.....+.++.....+|++||+.||.|||. +.+|||.||||+|||+..+ +
T Consensus 160 HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~ 236 (590)
T KOG1290|consen 160 HVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCSTEIDPAKDAREAG 236 (590)
T ss_pred EEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeeccccchhhhhhhhc
Confidence 999999999 6799999998888889999999999999999999997 4599999999999999321 0
Q ss_pred --------------------------------------------------------------------------------
Q 003114 674 -------------------------------------------------------------------------------- 673 (846)
Q Consensus 674 -------------------------------------------------------------------------------- 673 (846)
T Consensus 237 e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v 316 (590)
T KOG1290|consen 237 EATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTV 316 (590)
T ss_pred cccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccch
Confidence
Q ss_pred ---------------------------------------------------------------------------cEEEE
Q 003114 674 ---------------------------------------------------------------------------QARLA 678 (846)
Q Consensus 674 ---------------------------------------------------------------------------~vkI~ 678 (846)
.+||+
T Consensus 317 ~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIa 396 (590)
T KOG1290|consen 317 ERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIA 396 (590)
T ss_pred hhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEe
Confidence 01111
Q ss_pred eccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCc------cccccHHHHHH
Q 003114 679 DFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANT------EEHKHISQWVD 752 (846)
Q Consensus 679 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~------~~~~~l~~~~~ 752 (846)
|||-|+-.. ...+....|..|+|||++.+..|+..+||||++|+++||+||...|+.. .+++++..++.
T Consensus 397 DlGNACW~~-----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~E 471 (590)
T KOG1290|consen 397 DLGNACWVH-----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIME 471 (590)
T ss_pred eccchhhhh-----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHH
Confidence 111111000 0001123567899999999999999999999999999999999888642 25556665554
Q ss_pred HH-------HhcCC-cccccCCC--------CC-----------CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 753 FM-------LAQGD-IKNIVDPK--------LH-----------GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 753 ~~-------~~~~~-~~~~~d~~--------L~-----------~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+ ...|. ..++++.. |+ -.++.+++.++.+++.-|++.+|++|||+.+.++
T Consensus 472 LLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 472 LLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 32 11221 22333321 11 1346778899999999999999999999999885
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=245.56 Aligned_cols=190 Identities=24% Similarity=0.343 Sum_probs=163.6
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--------hhhHHHHHHHHHHHhcc---cccceeEeeEeecCCeeeE
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--------QGYEQFEAEVILLRTVH---HKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--------~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~L 608 (846)
+.+|.|+||.|+.|.++ +..+|+||.+.+..- ........|+.+|..++ |+||++++++|++++.++|
T Consensus 567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl 646 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL 646 (772)
T ss_pred eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence 56999999999999986 567799999876421 11223567999999997 9999999999999999999
Q ss_pred eeeccc-CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCC
Q 003114 609 IYEYMA-NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP 687 (846)
Q Consensus 609 V~Ey~~-~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~ 687 (846)
+||-.. +.+|.++|..+.. +++.++..|.+||+.|+++|| +.+|||||||-+||.++.+|.+||+|||.+....
T Consensus 647 ~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred EecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccchhhhc
Confidence 999874 4599999987765 899999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCcccccccccCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCC
Q 003114 688 IEGVSHLSTGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRPAIA 739 (846)
Q Consensus 688 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwS~Gvvl~ELltG~~p~~ 739 (846)
. .....+.||.+|.|||++.+.+| ...-|||++|++||-++....||-
T Consensus 722 s----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 722 S----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred C----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 2 23345789999999999998876 456899999999999999888874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-26 Score=251.26 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=200.1
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
...+|.|.+|.|||++.. .++..|+|+++-.-....+-.++|+.+++..+||||+.++|.+...+..+++||||.+|+|
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggsl 99 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSL 99 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence 357999999999999964 7889999999877777778889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~ 698 (846)
++.-+.... +++.++..++++.++|++||| +.+=+|||||-.|||+++.+.+|++|||.+..+.. .-.....+
T Consensus 100 Qdiy~~Tgp--lselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~Krksf 172 (829)
T KOG0576|consen 100 QDIYHVTGP--LSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIAKRKSF 172 (829)
T ss_pred cceeeeccc--chhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh--hhhhhhcc
Confidence 998876654 899999999999999999999 89999999999999999999999999999876532 23334567
Q ss_pred cCCCcccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 699 AGTFGYLDPEYC---QTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 699 ~gt~~Y~APE~~---~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
.||+.|||||+. ....|..++|||+.|+...|+---++|..+......+. .+- ...++|--..+ ...
T Consensus 173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~----LmT-----kS~~qpp~lkD-k~k 242 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF----LMT-----KSGFQPPTLKD-KTK 242 (829)
T ss_pred cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH----Hhh-----ccCCCCCcccC-Ccc
Confidence 899999999975 45568999999999999999999998865433222111 111 11222211111 112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
-...+-+++..|+.++|++||+++.++.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee
Confidence 3345679999999999999999987654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-25 Score=241.37 Aligned_cols=269 Identities=20% Similarity=0.242 Sum_probs=206.5
Q ss_pred ccCHHHHHHHHhhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc------cccceeEee
Q 003114 526 RFTYAEITKITNDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH------HKNLTTLYG 598 (846)
Q Consensus 526 ~~~~~el~~~t~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~------HpnIv~l~g 598 (846)
++.+.|+....+......|+|-|++|.+|... .|..||||++..... ..+.=..|+++|+++. .-+.++++-
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 34566777777777778999999999999964 588999999986533 3355678999999995 247899999
Q ss_pred EeecCCeeeEeeecccCCChhhhhhcCC-CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC-CcEE
Q 003114 599 YCNEGNQIGLIYEYMANGSLEEYLSDSN-ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ-FQAR 676 (846)
Q Consensus 599 ~~~~~~~~~LV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-~~vk 676 (846)
.|...+++|||+|-+. .+|.++|+..+ .-.|.......++.|+.-||..|. ..+|+|.||||.|||+++. ..+|
T Consensus 502 ~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceee
Confidence 9999999999999884 59999998765 335888889999999999999999 8899999999999999865 5689
Q ss_pred EEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHH----
Q 003114 677 LADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVD---- 752 (846)
Q Consensus 677 I~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~---- 752 (846)
|||||.|....... .+-...+..|.|||++.+..|+...|+||.||.||||.||+-.|.+......+.-.+.
T Consensus 578 LCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 578 LCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 99999997653322 1223345679999999999999999999999999999999999987665544433322
Q ss_pred ---HHHhcCCc-ccccCCCC--------------------------------CC--CCC---hHHHHHHHHHHHhccCCC
Q 003114 753 ---FMLAQGDI-KNIVDPKL--------------------------------HG--DID---VNSAWKAVEIAMGCVSHS 791 (846)
Q Consensus 753 ---~~~~~~~~-~~~~d~~L--------------------------------~~--~~~---~~~~~~l~~L~~~Cl~~~ 791 (846)
.++..+.+ .+-+|..+ .+ .++ ......+.+|+..|+..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 12222221 11122211 00 012 223456778999999999
Q ss_pred CCCCCCHHHHHH
Q 003114 792 STPRPNMNRVVM 803 (846)
Q Consensus 792 P~~RPsm~eVl~ 803 (846)
|++|.|..|.++
T Consensus 734 P~KRit~nqAL~ 745 (752)
T KOG0670|consen 734 PEKRITVNQALK 745 (752)
T ss_pred hhhcCCHHHHhc
Confidence 999999998875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=210.18 Aligned_cols=249 Identities=19% Similarity=0.340 Sum_probs=185.0
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEee-EeecCCeeeEeeecc
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYG-YCNEGNQIGLIYEYM 613 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g-~~~~~~~~~LV~Ey~ 613 (846)
+++.+.||+|.||.+-+++++ ..+.+++|.+.... ...++|.+|...--.+ .|.||+.-++ .|+..+.+.+++||+
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 455678999999999999976 57789999886542 2347788888655455 6899998876 467778899999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC--CCCcEEEEeccCCccCCCCCc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN--DQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld--~~~~vkI~DFGla~~~~~~~~ 691 (846)
+.|+|.+-+...+ +.+....+++.|++.||.||| ++.+||||||.+|||+- +...+|+||||+.+...
T Consensus 105 P~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g---- 174 (378)
T KOG1345|consen 105 PRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG---- 174 (378)
T ss_pred ccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC----
Confidence 9999999887754 778888999999999999999 99999999999999993 44589999999987542
Q ss_pred ccccccccCCCcccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCcc-ccccHHHHHHHHHhcCCcccccC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTF-----RLTEKSDVYSFGVVLLEIITSRPAIANTE-EHKHISQWVDFMLAQGDIKNIVD 765 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~-----~~s~ksDVwS~Gvvl~ELltG~~p~~~~~-~~~~l~~~~~~~~~~~~~~~~~d 765 (846)
.......-+..|.+||..... ...+.+|||.||++++.++||++||+... .+....+|.+-..+.. . .-
T Consensus 175 -~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~--~--~~ 249 (378)
T KOG1345|consen 175 -TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN--P--AL 249 (378)
T ss_pred -ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC--c--cC
Confidence 122233456679999976543 35678999999999999999999998543 3444555554322211 1 11
Q ss_pred CCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 766 PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 766 ~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
|.....+ ..++..+..+-+.+++++|--..++.++.
T Consensus 250 P~~F~~f----s~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 250 PKKFNPF----SEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred chhhccc----CHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 1111112 23566777888999999996555555544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-23 Score=206.28 Aligned_cols=167 Identities=22% Similarity=0.207 Sum_probs=126.9
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.++++..+ ..+++.++..++.|++.||.||| +.+ ||+|||+++++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc------
Confidence 68999998643 34999999999999999999999 444 999999999999999 9998765321
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccc-HHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKH-ISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
...|++.|+|||++.+..++.++|||||||++|||+||+.||........ +..+..... .. ++.-. ....
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~------~~~~~-~~~~ 133 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP-AD------DPRDR-SNLE 133 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc-cC------Ccccc-ccHH
Confidence 12588999999999999999999999999999999999999975443222 222221111 10 00000 0111
Q ss_pred HHH--HHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 775 NSA--WKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 775 ~~~--~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
... ..+.+++.+|+..+|++||++.|+++.+..+.
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 122 25899999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-24 Score=261.11 Aligned_cols=196 Identities=16% Similarity=0.209 Sum_probs=140.3
Q ss_pred hccc-ccceeEeeEe-------ecCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCee
Q 003114 587 TVHH-KNLTTLYGYC-------NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRV 658 (846)
Q Consensus 587 ~l~H-pnIv~l~g~~-------~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~Ii 658 (846)
.++| +||++++++| .+.+.+.+++|++ +++|.++|.... ..+++.+++.++.||++||+||| +++|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAH---SQGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 4556 6888888887 2334677888987 669999997543 34899999999999999999999 89999
Q ss_pred ecCCCCCCEEECCC-------------------CcEEEEeccCCccCCCCCc--------------ccccccccCCCccc
Q 003114 659 HRDIKPANILLNDQ-------------------FQARLADFGLSKTFPIEGV--------------SHLSTGVAGTFGYL 705 (846)
Q Consensus 659 HrDlKp~NILld~~-------------------~~vkI~DFGla~~~~~~~~--------------~~~~~~~~gt~~Y~ 705 (846)
||||||+||||+.. +.+|++|||+++....... ........||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 4556666666653210000 00011235788999
Q ss_pred CccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHH
Q 003114 706 DPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAM 785 (846)
Q Consensus 706 APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~ 785 (846)
|||++.+..++.++|||||||+||||++|.+|+..... .+..+... ...+.. ........+++.
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~---------~~~~~~-----~~~~~~~~~~~~ 246 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR---------VLPPQI-----LLNWPKEASFCL 246 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh---------hcChhh-----hhcCHHHHHHHH
Confidence 99999999999999999999999999999988653211 11111110 111111 011224567888
Q ss_pred hccCCCCCCCCCHHHHHH
Q 003114 786 GCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 786 ~Cl~~~P~~RPsm~eVl~ 803 (846)
+|++++|.+||+|.||++
T Consensus 247 ~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 247 WLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HhCCCChhhCcChHHHhh
Confidence 999999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=210.52 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=194.8
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
++..+|.+...|+.|+|+++.+ .+++|++... +....+.|.+|.-.|+...||||++++|.|....+..++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 4556788999999999999654 5666776543 334457799999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|+..+++...-..+..++.+++.++|+|+.|||+- ++-|.---|.++.|++|++.+++|+=-. + ..+...
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad-~------kfsfqe 343 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMAD-T------KFSFQE 343 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheeccc-c------eeeeec
Confidence 9999999998776788899999999999999999942 3344455688999999999999886111 1 112222
Q ss_pred ccccCCCcccCccccccCCC---CchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 696 TGVAGTFGYLDPEYCQTFRL---TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~---s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
.+..-.+.||+||.++.++- -+++|+|||++++|||.|...||.+-..-+.-.+.. -+.|+...
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-------------leglrv~i 410 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-------------LEGLRVHI 410 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-------------hccccccC
Confidence 33445788999999987653 457999999999999999999998765433222211 12233334
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
+......+.+|+.-|+..||.+||.++.|+-.||+++
T Consensus 411 ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 4445557788999999999999999999999998864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.3e-23 Score=219.43 Aligned_cols=255 Identities=23% Similarity=0.333 Sum_probs=191.3
Q ss_pred hhhcCcCceEEEEEEEEc----CCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeeccc
Q 003114 540 ETILGEGSFGKVYHGYLD----DNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
.++||+|.|++||++.+. ..+.||+|.+...+.. ..+.+|++.|..+ .+.||+++.+++..+++..+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 468999999999999853 4678999999876554 4688999999998 58999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC-CcEEEEeccCCccCC------
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ-FQARLADFGLSKTFP------ 687 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-~~vkI~DFGla~~~~------ 687 (846)
.-...++... ++..++..++..+.+||.++| ..+||||||||+|+|.+.. +.-.|.|||+|....
T Consensus 119 H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~ 190 (418)
T KOG1167|consen 119 HDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE 190 (418)
T ss_pred ccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence 9998888876 667888999999999999999 9999999999999999854 567899999997210
Q ss_pred -----------C-C----------------Cc--------ccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHH
Q 003114 688 -----------I-E----------------GV--------SHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLE 730 (846)
Q Consensus 688 -----------~-~----------------~~--------~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~E 730 (846)
. . +. .......+||+||.|||++... ..+.++||||.|||++-
T Consensus 191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls 270 (418)
T KOG1167|consen 191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS 270 (418)
T ss_pred hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence 0 0 00 0011135699999999988654 57889999999999999
Q ss_pred HHhCCCCCCCcc-ccccHHHHHHH---------HHhcCC--ccc---------------ccC-CCCCC-C--------CC
Q 003114 731 IITSRPAIANTE-EHKHISQWVDF---------MLAQGD--IKN---------------IVD-PKLHG-D--------ID 773 (846)
Q Consensus 731 LltG~~p~~~~~-~~~~l~~~~~~---------~~~~~~--~~~---------------~~d-~~L~~-~--------~~ 773 (846)
+++++.||-... +-..+.+.+.. ....|. +.+ -++ ..+.. . ..
T Consensus 271 lls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~ 350 (418)
T KOG1167|consen 271 LLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS 350 (418)
T ss_pred hhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence 999999986543 33333333321 111122 100 000 00000 0 00
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.-....++++..+|+..+|.+|.|++|.++.
T Consensus 351 d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 351 DVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 1112357899999999999999999998764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-20 Score=207.07 Aligned_cols=262 Identities=21% Similarity=0.232 Sum_probs=198.5
Q ss_pred hhhhhhcCcCceEEEEEEEEcCC--cEEEEEEeCCCCchhhHHHHHHHHHHHhccc----ccceeEeeEe-ecCCeeeEe
Q 003114 537 NDFETILGEGSFGKVYHGYLDDN--TEVAVKMLSPSSRQGYEQFEAEVILLRTVHH----KNLTTLYGYC-NEGNQIGLI 609 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~g--~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~H----pnIv~l~g~~-~~~~~~~LV 609 (846)
..+.+.||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ..+...++|
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV 99 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV 99 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence 34567899999999999997553 5789888876543332367888888888863 5788888888 577788999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC-----CcEEEEeccCCc
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ-----FQARLADFGLSK 684 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-----~~vkI~DFGla~ 684 (846)
|+.+ |.+|.++......+.++..+.++|+.|++.+|++|| +.+++||||||.|+++... ..+.|.|||+++
T Consensus 100 M~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 100 MSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred Eecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9988 789999887666667999999999999999999999 9999999999999999754 469999999999
Q ss_pred --cCCCCCcc-----cc-cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHh
Q 003114 685 --TFPIEGVS-----HL-STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLA 756 (846)
Q Consensus 685 --~~~~~~~~-----~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~ 756 (846)
.+...... .. .....||..|.+++...+...+.+.|+||++.++.|+..|..||..........+.......
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 43222111 11 23456999999999999999999999999999999999999999765543332222221111
Q ss_pred cCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 757 QGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 757 ~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
. .... ........+.++...+-..+..++|....+...|+++...+
T Consensus 256 ~-----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 256 L-----LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred h-----cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1 1110 11122345556666666689999999999999988877554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-21 Score=210.89 Aligned_cols=160 Identities=20% Similarity=0.193 Sum_probs=124.5
Q ss_pred hhhhhcCcCceEEEEEEEEc--CCcEEEEEEeCCC-----CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD--DNTEVAVKMLSPS-----SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
.+.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+++|++++|+|+++.+..+ +..++||
T Consensus 21 ~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~~LVm 97 (365)
T PRK09188 21 VETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKDGLVR 97 (365)
T ss_pred eEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCcEEEE
Confidence 44578999999999999875 5777899987533 122356689999999999999998643322 4579999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCC-CCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDI-KPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDl-Kp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
||+++++|... ... . ...++.+++++|.||| +.+|+|||| ||+|||++.++.+||+|||+++.+...
T Consensus 98 E~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 98 GWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred EccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 99999999732 111 1 1467889999999999 899999999 999999999999999999999977543
Q ss_pred Ccccc------cccccCCCcccCcccccc
Q 003114 690 GVSHL------STGVAGTFGYLDPEYCQT 712 (846)
Q Consensus 690 ~~~~~------~~~~~gt~~Y~APE~~~~ 712 (846)
..... .....+++.|+|||++..
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 32211 135678899999998854
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-19 Score=193.84 Aligned_cols=258 Identities=30% Similarity=0.439 Sum_probs=196.4
Q ss_pred hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCch---hhHHHHHHHHHHHhcccc-cceeEeeEeecCCeeeEeeecccC
Q 003114 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQ---GYEQFEAEVILLRTVHHK-NLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~---~~~~~~~Ei~~l~~l~Hp-nIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......+++++++.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 457899999999999987 78899998765332 367889999999999988 799999999777778999999999
Q ss_pred CChhhhhhcCCC-CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC-cEEEEeccCCccCCCCCccc
Q 003114 616 GSLEEYLSDSNA-DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF-QARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 616 gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-~vkI~DFGla~~~~~~~~~~ 693 (846)
+++.+++..... ..+.......++.+++.++.|+| +.+++|||+||+||+++... .++++|||.++.........
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 83 GSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred CcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence 999977765532 14888899999999999999999 88899999999999999988 79999999998654332221
Q ss_pred ----ccccccCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCC
Q 003114 694 ----LSTGVAGTFGYLDPEYCQT---FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDP 766 (846)
Q Consensus 694 ----~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 766 (846)
......|+..|+|||.... .......|+||+|++++++++|+.|+.................... .. ....
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~-~~~~ 237 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP-TP-SLAS 237 (384)
T ss_pred cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC-Cc-cccc
Confidence 3456789999999999987 5789999999999999999999999765543101111111111111 11 0000
Q ss_pred CCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 767 KLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 767 ~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.............+.+++..|+..+|..|.++.+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11100001223467789999999999999999987765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-20 Score=219.07 Aligned_cols=253 Identities=19% Similarity=0.207 Sum_probs=185.7
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeC----CC-Cc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLS----PS-SR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~----~~-~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
.+.++|.|++|.|+..... .....+.|... .. .. .....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4568999999977776632 33333333322 11 11 112226667788888999999888888777776666799
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
||++ +|..++.... .+...++..+..|+..|++|+| ..+|.|||+|++|++++.++.+||+|||.+..+.....
T Consensus 402 ~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 9999998763 2788889999999999999999 99999999999999999999999999999887644333
Q ss_pred c--cccccccCCCcccCccccccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 692 S--HLSTGVAGTFGYLDPEYCQTFRLTE-KSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 692 ~--~~~~~~~gt~~Y~APE~~~~~~~s~-ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
. ....+++|+-.|+|||.+....|.+ ..||||.|+++..|.+|+.||......+... ......+ +..+..-
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~~---~~~~~~~ 549 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYSD---QRNIFEG 549 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhcccc---ccccccC
Confidence 3 6667789999999999999988876 5899999999999999999997655332211 0000000 0000000
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
........+.....++.++++.+|.+|-|+++|++
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00011223345678999999999999999999875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=201.93 Aligned_cols=218 Identities=23% Similarity=0.362 Sum_probs=166.4
Q ss_pred HHhcccccceeEeeEeecCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCe-eecCCC
Q 003114 585 LRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPR-VHRDIK 663 (846)
Q Consensus 585 l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~I-iHrDlK 663 (846)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.... ..++|.....++++++.||.||| ..+| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeec
Confidence 457899999999999999999999999999999999998854 34999999999999999999999 4444 999999
Q ss_pred CCCEEECCCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccC-------CCCchhhHHHHHHHHHHHHhCCC
Q 003114 664 PANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF-------RLTEKSDVYSFGVVLLEIITSRP 736 (846)
Q Consensus 664 p~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-------~~s~ksDVwS~Gvvl~ELltG~~ 736 (846)
+.|+++|..+.+||+|||+.................-..-|.|||.+... ..+.++||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998765321111111112234569999988763 15778999999999999999999
Q ss_pred CCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 737 AIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 737 p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
||+.........+.+..+.. .-...+-|.+.... +....+..++..||..+|++||++++|-..++.+..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99875533332344443322 11222233322111 333478999999999999999999999998877654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.6e-18 Score=178.22 Aligned_cols=265 Identities=18% Similarity=0.264 Sum_probs=197.2
Q ss_pred hhhhcCcCceEEEEEEE-EcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.++||+|.||..+.|+ +-++++||||.-...+.. -++..|....+.+ ..++|-..+.+-.++.+-.||+|.+ |.
T Consensus 32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP 108 (449)
T KOG1165|consen 32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP 108 (449)
T ss_pred eccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence 45689999999999998 568999999986544332 5678888888888 4689988888888899999999998 88
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-----CCcEEEEeccCCccCCCCCc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-----QFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-----~~~vkI~DFGla~~~~~~~~ 691 (846)
+|+++..-.+.+ ++..+...+|.|++.-++|+| ++..|.|||||+|+||.. ...+.|+|||+|+.+.....
T Consensus 109 SLEDLFD~CgR~-FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 109 SLEDLFDLCGRR-FSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred CHHHHHHHhcCc-ccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 999998766643 899999999999999999999 999999999999999963 34689999999998743221
Q ss_pred -----ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCC
Q 003114 692 -----SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDP 766 (846)
Q Consensus 692 -----~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 766 (846)
........||.+||+=....+...+.+.|+-|+|-|+++.+-|..||.+-.....-.++-+ +.+..-..-++
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK--IGe~Kr~T~i~- 261 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK--IGETKRSTPIE- 261 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH--hccccccCCHH-
Confidence 1122345699999999999999999999999999999999999999998665443333221 11111111111
Q ss_pred CCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhhhc
Q 003114 767 KLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARKE 817 (846)
Q Consensus 767 ~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~~~ 817 (846)
.|...+ +.++..-+.-.-..+=.+-|..+=+...+.+++.......+
T Consensus 262 ~Lc~g~----P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~D 308 (449)
T KOG1165|consen 262 VLCEGF----PEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDD 308 (449)
T ss_pred HHHhcC----HHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccc
Confidence 112222 22333333333344567778888887777777765555443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-19 Score=211.53 Aligned_cols=245 Identities=20% Similarity=0.259 Sum_probs=181.3
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCC-chhhHHHH---HHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSS-RQGYEQFE---AEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-~~~~~~~~---~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||.+.|=+|.+|+.++|. |+||++-+.. .-..+.|. +|++ ...++|||.+++.-.-......+||-+|+
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 34578999999999999998887 8999986554 22334444 4444 55669999999988877778889999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccC--CCCCc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF--PIEGV 691 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~--~~~~~ 691 (846)
.. +|+|.+..++. +...+...|+.|++.||..+| +.+|+|||||.+|||++.-.-+.|+||..-+.. +.++.
T Consensus 104 kh-nLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 104 KH-NLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred hh-hhhhhhccchH--HHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 65 99999987654 888889999999999999999 999999999999999999999999999765532 22222
Q ss_pred c---cccccccCCCcccCccccccC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHh
Q 003114 692 S---HLSTGVAGTFGYLDPEYCQTF----------R-LTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLA 756 (846)
Q Consensus 692 ~---~~~~~~~gt~~Y~APE~~~~~----------~-~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~ 756 (846)
. ........-..|+|||.+... . .+++-||||.||+++||++ |+++|.-.. +.. ....
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~a---Yr~~ 250 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLA---YRSG 250 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHh---Hhcc
Confidence 2 111222233469999976431 2 6788999999999999987 688885321 111 1100
Q ss_pred cCC-----cccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 757 QGD-----IKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 757 ~~~-----~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
... ++++-|+ .+.+++..|++.+|++|.++++.++.-.+..
T Consensus 251 ~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 251 NADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred CccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 000 1112222 4679999999999999999999999855443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-18 Score=173.99 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=186.2
Q ss_pred hhhhhcCcCceEEEEEEE-EcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhccc-ccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH-KNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
...+.||.|+||.+|.|. ..+|.+||||+-+..... .++..|..+.+.++| ..|-.+..|..+..+-.+|||.+ |
T Consensus 18 ~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-G 94 (341)
T KOG1163|consen 18 KLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-G 94 (341)
T ss_pred EEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-C
Confidence 445689999999999998 578999999997654332 467788999999975 56777777888889999999988 8
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC---CCcEEEEeccCCccCCCCCc-
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND---QFQARLADFGLSKTFPIEGV- 691 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~---~~~vkI~DFGla~~~~~~~~- 691 (846)
.+|+++..-.... ++..+.+-++-|++.-++|+| .+++|||||||+|+|..- ...+.++|||+++.+.....
T Consensus 95 PsLEdLfnfC~R~-ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 95 PSLEDLFNFCSRR-FTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred ccHHHHHHHHhhh-hhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 8999998766543 888999999999999999999 899999999999999963 35789999999998743211
Q ss_pred ----ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCC
Q 003114 692 ----SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 692 ----~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
........||..|.+-....+...+.+.|+-|+|.+|....-|..||++.........+- .+.+......+. .
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE--kI~EkK~s~~ie-~ 247 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE--KISEKKMSTPIE-V 247 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH--HHHHhhcCCCHH-H
Confidence 122334569999998888777788899999999999999999999999866443333322 222222222111 1
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
|...+ +.++...+.-|-..-=++-|...=+.+.+
T Consensus 248 LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 248 LCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred HhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 11122 23344445555555555666654443333
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.6e-19 Score=177.68 Aligned_cols=138 Identities=18% Similarity=0.148 Sum_probs=107.4
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCch--h------------------------hHHHHHHHHHHHhcccccce
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQ--G------------------------YEQFEAEVILLRTVHHKNLT 594 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--~------------------------~~~~~~Ei~~l~~l~HpnIv 594 (846)
..||+|+||.||+|...+|+.||||+++..... . ......|+..+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999888999999999754211 0 01224599999999888764
Q ss_pred eEeeEeecCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHH-hccCCCCeeecCCCCCCEEECCCC
Q 003114 595 TLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQF 673 (846)
Q Consensus 595 ~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~IiHrDlKp~NILld~~~ 673 (846)
....+.. ...++||||++++++....... ..++......++.|++.+|.++ | +.+|+||||||+|||+++ +
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~~-~ 154 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYHD-G 154 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEEC-C
Confidence 3333222 2238999999988776543322 2488899999999999999999 6 789999999999999984 7
Q ss_pred cEEEEeccCCccC
Q 003114 674 QARLADFGLSKTF 686 (846)
Q Consensus 674 ~vkI~DFGla~~~ 686 (846)
.++|+|||++...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-18 Score=178.82 Aligned_cols=166 Identities=15% Similarity=0.159 Sum_probs=127.7
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHH---------HHHHHHHHHhcccccceeEeeEeecC-----
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQ---------FEAEVILLRTVHHKNLTTLYGYCNEG----- 603 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~---------~~~Ei~~l~~l~HpnIv~l~g~~~~~----- 603 (846)
...+++|.|+||.||.... ++..+|+|.+.+......+. +++|+..+.++.|++|..+..++...
T Consensus 34 ~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~ 112 (232)
T PRK10359 34 KTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTL 112 (232)
T ss_pred EEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccc
Confidence 3457899999999999655 57789999997653332222 68899999999999999998885432
Q ss_pred ---CeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEec
Q 003114 604 ---NQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADF 680 (846)
Q Consensus 604 ---~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DF 680 (846)
...++||||++|.+|.++.. ++. ....+++.++..+| ..+++|||+||+||++++++ ++|+||
T Consensus 113 ~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 113 RYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred cccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 35889999999999988732 222 24568999999999 99999999999999999988 999999
Q ss_pred cCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHH
Q 003114 681 GLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEII 732 (846)
Q Consensus 681 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELl 732 (846)
|........... ..+.....+..++|+||||+.+....
T Consensus 179 g~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988654211100 11334445667999999999987765
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.7e-18 Score=171.29 Aligned_cols=138 Identities=20% Similarity=0.212 Sum_probs=109.4
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCch--------------------------hhHHHHHHHHHHHhcccccce
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQ--------------------------GYEQFEAEVILLRTVHHKNLT 594 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--------------------------~~~~~~~Ei~~l~~l~HpnIv 594 (846)
..||+|++|.||+|...+|+.||||+++..... ....+..|...+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 579999999999999878999999998764211 011235788999999999875
Q ss_pred eEeeEeecCCeeeEeeecccCCChhhh-hhcCCCCccChHHHHHHHHHHHHHHHHHhccCC-CCeeecCCCCCCEEECCC
Q 003114 595 TLYGYCNEGNQIGLIYEYMANGSLEEY-LSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK-PPRVHRDIKPANILLNDQ 672 (846)
Q Consensus 595 ~l~g~~~~~~~~~LV~Ey~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~IiHrDlKp~NILld~~ 672 (846)
....+... ..++||||++++++... +.. ..++.....+++.+++.++.++| . .+|+||||||+||+++ +
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence 44443332 24899999998855433 332 23677889999999999999999 7 8999999999999999 7
Q ss_pred CcEEEEeccCCccCC
Q 003114 673 FQARLADFGLSKTFP 687 (846)
Q Consensus 673 ~~vkI~DFGla~~~~ 687 (846)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-17 Score=196.39 Aligned_cols=252 Identities=20% Similarity=0.190 Sum_probs=181.3
Q ss_pred HHHHHHhhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc---cccceeEeeEeecCCeee
Q 003114 531 EITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH---HKNLTTLYGYCNEGNQIG 607 (846)
Q Consensus 531 el~~~t~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~ 607 (846)
++......+.+.||+|+||+||+|...+|+.||+|+-++.+.... ---.+++.+|+ -+.|..+...+.-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 444444556788999999999999988899999999888765531 11222333443 233444444445566778
Q ss_pred EeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC-------CCCcEEEEec
Q 003114 608 LIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN-------DQFQARLADF 680 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld-------~~~~vkI~DF 680 (846)
||+||.+.|+|.+++... +.++|...+.++.|+++.+++|| ..+||||||||+|+||. +...++|+||
T Consensus 771 lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 999999999999999844 44899999999999999999999 99999999999999993 3456899999
Q ss_pred cCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCc
Q 003114 681 GLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDI 760 (846)
Q Consensus 681 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 760 (846)
|.+-.+..-.........++|-++-.+|...++.++-++|.|.++-+++-|+.|+.. + ...| -
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~--------------q--~~~g-~ 908 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM--------------E--VKNG-S 908 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH--------------H--hcCC-c
Confidence 999776433333455667889999999999999999999999999999999999631 1 1111 1
Q ss_pred ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 761 ~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
...++..+......+... ++...+|+.+-..=|...++...+++.+.
T Consensus 909 ~~~~~~~~~Ry~~~~~W~---~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 909 SWMVKTNFPRYWKRDMWN---KFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred ceeccccchhhhhHHHHH---HHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 122222222212222222 34444455555555777788888877664
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.8e-17 Score=163.31 Aligned_cols=187 Identities=18% Similarity=0.159 Sum_probs=139.9
Q ss_pred hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCch----hhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEeeeccc
Q 003114 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQ----GYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~----~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
...|++|+||+||.+.. .+.+++.+.+...... ....+.+|+++|++++ |+++.+++++ +..+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46799999999997665 6778887777654331 1235889999999995 5889999886 34689999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCC-CCCCEEECCCCcEEEEeccCCccCCCCCcc-
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDI-KPANILLNDQFQARLADFGLSKTFPIEGVS- 692 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDl-Kp~NILld~~~~vkI~DFGla~~~~~~~~~- 692 (846)
|.+|.+.+.. ....++.+++++|+++| +.+|+|||| ||+|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~---------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 82 GAAMYQRPPR---------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred CccHHhhhhh---------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9998764321 11357789999999999 999999999 799999999999999999999865432210
Q ss_pred -----cc-----cccccCCCcccCccccccC-CCC-chhhHHHHHHHHHHHHhCCCCCCCccc
Q 003114 693 -----HL-----STGVAGTFGYLDPEYCQTF-RLT-EKSDVYSFGVVLLEIITSRPAIANTEE 743 (846)
Q Consensus 693 -----~~-----~~~~~gt~~Y~APE~~~~~-~~s-~ksDVwS~Gvvl~ELltG~~p~~~~~~ 743 (846)
.. ......++.|++|+...-. ..+ ...+-++-|.-+|.++|++.+.....+
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 00 0112367888888854322 223 567889999999999999988755443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.4e-18 Score=188.81 Aligned_cols=225 Identities=26% Similarity=0.304 Sum_probs=175.2
Q ss_pred hcCcCceEEEEEEE----EcCCcEEEEEEeCCCCchh--hHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEeeeccc
Q 003114 542 ILGEGSFGKVYHGY----LDDNTEVAVKMLSPSSRQG--YEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 542 ~LG~G~fG~Vykg~----~~~g~~VAVK~l~~~~~~~--~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
.+|+|.||.|+.++ .+.|..+|+|++++..... ......|..++..++ ||.+|++...+..+...+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999765 3457778998887543221 114456778888887 9999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|.|...+..... ++..........++-+++++| +.+|+|||+|++||+++.+|.+++.|||+++..-....
T Consensus 81 gg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM--FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred cchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 9999988876553 666777778888999999999 99999999999999999999999999999986532211
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.+||..|||||++. .....+|-||||++++||+||-.||.. +.++.....+ -..+.
T Consensus 153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~-----------~~~p~ 208 (612)
T KOG0603|consen 153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAE-----------LEMPR 208 (612)
T ss_pred ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhc-----------cCCch
Confidence 18999999999988 578899999999999999999999976 1122222111 11223
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
+.......++..+...+|..|.-.
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 333345577777778888888755
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=167.93 Aligned_cols=228 Identities=20% Similarity=0.258 Sum_probs=147.4
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhccc----------ccceeEeeE------
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHH----------KNLTTLYGY------ 599 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H----------pnIv~l~g~------ 599 (846)
.+.||.|+++.||.++.. +|+++|+|++... .....+++++|......+.+ -.++-.++.
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 468999999999999986 5899999997533 33456777777766655322 112211111
Q ss_pred ---eecC---C-----eeeEeeecccCCChhhhhhc---CC--CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCC
Q 003114 600 ---CNEG---N-----QIGLIYEYMANGSLEEYLSD---SN--ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIK 663 (846)
Q Consensus 600 ---~~~~---~-----~~~LV~Ey~~~gsL~~~l~~---~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlK 663 (846)
+... . ..+++|+-+ .++|.+++.. .. ...+....++.+..|+++.+++|| ..+++|+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecccc
Confidence 1111 1 235677766 4688887643 11 123555667788899999999999 9999999999
Q ss_pred CCCEEECCCCcEEEEeccCCccCCCCCcccccccccCCCcccCcccccc--------CCCCchhhHHHHHHHHHHHHhCC
Q 003114 664 PANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT--------FRLTEKSDVYSFGVVLLEIITSR 735 (846)
Q Consensus 664 p~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~s~ksDVwS~Gvvl~ELltG~ 735 (846)
|+|++++.+|.++|+||+....... .... ...+..|.+||.... ..++.+.|.|++|+++|.|++|.
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGT---RYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTE---EEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCc---eeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 9999999999999999987765421 1111 234577999997643 25789999999999999999999
Q ss_pred CCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCC
Q 003114 736 PAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPR 795 (846)
Q Consensus 736 ~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~R 795 (846)
.||+........ .| .+. .+.+.++.+..|+..+++.+|++|
T Consensus 248 lPf~~~~~~~~~-~~----------------~f~--~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADP-EW----------------DFS--RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTS-GG----------------GGT--TSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccc-cc----------------cch--hcCCcCHHHHHHHHHHccCCcccC
Confidence 999865432210 00 111 122566788899999999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=162.03 Aligned_cols=134 Identities=17% Similarity=0.274 Sum_probs=105.4
Q ss_pred hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-----ccccceeEeeEeecCC---e-eeEee
Q 003114 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-----HHKNLTTLYGYCNEGN---Q-IGLIY 610 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~l~g~~~~~~---~-~~LV~ 610 (846)
.+.||+|+||.||. +......+||++........+++.+|+.+++.+ .||||++++|++..+. . ..+|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 35799999999996 433333479988765444567899999999999 5799999999998763 3 34789
Q ss_pred ec--ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHH-HHHhccCCCCeeecCCCCCCEEECC----CCcEEEEeccCC
Q 003114 611 EY--MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGL-EYLHLGCKPPRVHRDIKPANILLND----QFQARLADFGLS 683 (846)
Q Consensus 611 Ey--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~IiHrDlKp~NILld~----~~~vkI~DFGla 683 (846)
|| +.+|+|.+++.+.. +++. ..++.+++.++ +||| +.+|+||||||+|||++. +..++|+||+-+
T Consensus 85 e~~G~~~~tL~~~l~~~~---~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 85 DFDGKPSITLTEFAEQCR---YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cCCCCcchhHHHHHHccc---ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 99 55799999997632 5544 35677888777 9999 999999999999999973 348999995444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.2e-16 Score=158.37 Aligned_cols=134 Identities=18% Similarity=0.329 Sum_probs=113.6
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCch--------hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQ--------GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.||+|++|.||+|.. .|..+++|+....... ....+.+|+.++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999988 6778999987643211 123577899999999999988777777777788999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~ 685 (846)
++|++|.+++.... + .+..++.+++.+|.++| +.+++|||++|+|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986532 2 78899999999999999 89999999999999999 78899999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-15 Score=154.95 Aligned_cols=130 Identities=24% Similarity=0.355 Sum_probs=107.2
Q ss_pred hcCcCceEEEEEEEEcCCcEEEEEEeCCCCc--------hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 542 ILGEGSFGKVYHGYLDDNTEVAVKMLSPSSR--------QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.||+|+||.||+|.+ ++..|++|+...... ....++.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 568899998654321 11255778999999999987665555556666778999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCcc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~ 685 (846)
++++|.+.+..... .++.+++.+|.+|| +.+++|||+||+||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998765321 78999999999999 89999999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.3e-15 Score=175.17 Aligned_cols=88 Identities=43% Similarity=0.711 Sum_probs=79.2
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCccccccc-CCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVER-SKNGSL 464 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l-~~l~~l 464 (846)
..+|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|..+..+ .++..+
T Consensus 441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l 520 (623)
T PLN03150 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520 (623)
T ss_pred CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceE
Confidence 3478999999999999999999999999999999999999999999999999999999999999999998864 355667
Q ss_pred CCccc--cCCC
Q 003114 465 SLSVD--LCSS 473 (846)
Q Consensus 465 ~l~~n--lc~~ 473 (846)
++..| +|+.
T Consensus 521 ~~~~N~~lc~~ 531 (623)
T PLN03150 521 NFTDNAGLCGI 531 (623)
T ss_pred EecCCccccCC
Confidence 77766 5764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-15 Score=158.31 Aligned_cols=139 Identities=18% Similarity=0.180 Sum_probs=107.6
Q ss_pred hhhhhcCcCceEEEEEEE--EcCCcEEEEEEeCCCCch------------------------hhHHHHHHHHHHHhcccc
Q 003114 538 DFETILGEGSFGKVYHGY--LDDNTEVAVKMLSPSSRQ------------------------GYEQFEAEVILLRTVHHK 591 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~--~~~g~~VAVK~l~~~~~~------------------------~~~~~~~Ei~~l~~l~Hp 591 (846)
.+.+.||+|++|.||+|. ..+|+.||+|++...... ....+..|+..+.++.+.
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~ 110 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA 110 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 345789999999999998 568999999998743210 112356899999999764
Q ss_pred c--ceeEeeEeecCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCC-eeecCCCCCCEE
Q 003114 592 N--LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP-RVHRDIKPANIL 668 (846)
Q Consensus 592 n--Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-IiHrDlKp~NIL 668 (846)
. +.+++++ ...++||||+++++|........ .+...+...++.|++.++.+|| ..+ |+||||||+||+
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIl 181 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNIL 181 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEE
Confidence 3 3344433 23479999999988877653322 2555667899999999999999 888 999999999999
Q ss_pred ECCCCcEEEEeccCCccC
Q 003114 669 LNDQFQARLADFGLSKTF 686 (846)
Q Consensus 669 ld~~~~vkI~DFGla~~~ 686 (846)
++ ++.++|+|||.+...
T Consensus 182 i~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EE-CCCEEEEEChhhhcc
Confidence 99 889999999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.5e-15 Score=152.79 Aligned_cols=135 Identities=18% Similarity=0.206 Sum_probs=106.9
Q ss_pred hhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCch----------------------hhHHHHHHHHHHHhccccc--
Q 003114 537 NDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQ----------------------GYEQFEAEVILLRTVHHKN-- 592 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~----------------------~~~~~~~Ei~~l~~l~Hpn-- 592 (846)
..+.+.||+|+||.||++...+|+.||||++...... .......|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 3446789999999999999888999999987543210 1123567888899998874
Q ss_pred ceeEeeEeecCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC
Q 003114 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ 672 (846)
Q Consensus 593 Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~ 672 (846)
+...++. ...++||||+++++|.+.... .....++.+++.++.++| +.+|+||||||+||+++++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCC
Confidence 4444432 345899999999999876431 234678899999999999 8999999999999999999
Q ss_pred CcEEEEeccCCccC
Q 003114 673 FQARLADFGLSKTF 686 (846)
Q Consensus 673 ~~vkI~DFGla~~~ 686 (846)
+.++|+|||.+...
T Consensus 162 ~~~~liDfg~~~~~ 175 (198)
T cd05144 162 EKIYIIDWPQMVST 175 (198)
T ss_pred CcEEEEECCccccC
Confidence 99999999999755
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.3e-15 Score=174.23 Aligned_cols=131 Identities=22% Similarity=0.346 Sum_probs=108.2
Q ss_pred hhhcCcCceEEEEEEEEcCCcEEEEEE-eCCC-Cc------hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 540 ETILGEGSFGKVYHGYLDDNTEVAVKM-LSPS-SR------QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~g~~VAVK~-l~~~-~~------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
.+.||+|+||.||+|.+.+.. +++|+ ..+. .. ...+.+.+|+++++.++|++++....++......++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 578999999999999886544 34443 2221 11 123467899999999999999988888877778899999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCcc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~ 685 (846)
|+++++|.+++. .+..++.+++++|.+|| +.+++||||||+|||+ +++.++|+|||+++.
T Consensus 417 ~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 417 YIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999875 35678999999999999 8999999999999999 677999999999975
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.6e-14 Score=153.19 Aligned_cols=199 Identities=21% Similarity=0.254 Sum_probs=140.1
Q ss_pred ccccceeEeeEeec---------------------------CCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHH
Q 003114 589 HHKNLTTLYGYCNE---------------------------GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATE 641 (846)
Q Consensus 589 ~HpnIv~l~g~~~~---------------------------~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 641 (846)
+|||||++.++|.+ +...++||.-.. .+|.+++..+. .+...+.-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 69999998876632 345788988774 48999987654 456677778999
Q ss_pred HHHHHHHHhccCCCCeeecCCCCCCEEE--CCCC--cEEEEeccCCccCCCCCc----ccccccccCCCcccCccccccC
Q 003114 642 AAQGLEYLHLGCKPPRVHRDIKPANILL--NDQF--QARLADFGLSKTFPIEGV----SHLSTGVAGTFGYLDPEYCQTF 713 (846)
Q Consensus 642 ia~gL~yLH~~~~~~IiHrDlKp~NILl--d~~~--~vkI~DFGla~~~~~~~~----~~~~~~~~gt~~Y~APE~~~~~ 713 (846)
+++|+.||| +++|.|||+|++|||+ |+|. ...|+|||++-.....+- ..-.-...|.-.-||||+....
T Consensus 350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999 9999999999999998 4443 578899998754322111 1111123467778999987643
Q ss_pred C------CCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhc
Q 003114 714 R------LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGC 787 (846)
Q Consensus 714 ~------~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~C 787 (846)
+ .-.|+|.|+.|-+.||+++...||-...+.. + + .....+---| ..+......+.+++...
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L-~-------~r~Yqe~qLP----alp~~vpp~~rqlV~~l 493 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-L-D-------TRTYQESQLP----ALPSRVPPVARQLVFDL 493 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-e-c-------hhhhhhhhCC----CCcccCChHHHHHHHHH
Confidence 2 3468999999999999999999996532211 0 0 0001111112 22334555678999999
Q ss_pred cCCCCCCCCCHHHHHHHHHH
Q 003114 788 VSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 788 l~~~P~~RPsm~eVl~~L~~ 807 (846)
++.+|++|++..-....|+=
T Consensus 494 L~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 494 LKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred hcCCccccCCccHHHhHHHH
Confidence 99999999998776666643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.1e-15 Score=165.39 Aligned_cols=173 Identities=25% Similarity=0.401 Sum_probs=127.8
Q ss_pred CeeeEeeecccCCChhhhhhcCC-CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccC
Q 003114 604 NQIGLIYEYMANGSLEEYLSDSN-ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGL 682 (846)
Q Consensus 604 ~~~~LV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGl 682 (846)
.+.++.|++|+..+|.+||.... ....++.....++.|++.|++| ++.+|+|+||.||+...+.++||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 35789999999999999997433 4557888899999999999998 6789999999999999999999999999
Q ss_pred CccCCCCC----cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCccccccHHHHHHHHHhc
Q 003114 683 SKTFPIEG----VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITS-RPAIANTEEHKHISQWVDFMLAQ 757 (846)
Q Consensus 683 a~~~~~~~----~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG-~~p~~~~~~~~~l~~~~~~~~~~ 757 (846)
........ .....+...||..||+||.+.+..|+.|+||||+|++|+||+.- ..++...... .-++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~--------~d~r~ 474 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL--------TDIRD 474 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh--------hhhhc
Confidence 87664332 12233456799999999999999999999999999999999972 2222111000 00111
Q ss_pred CCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHH
Q 003114 758 GDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMN 799 (846)
Q Consensus 758 ~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~ 799 (846)
+ .++|....+++ .=..+..+++.+.|.+||+..
T Consensus 475 g----~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 475 G----IIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred C----CCChHHhhcCc-----HHHHHHHHhcCCCcccCchHH
Confidence 1 12212211222 224788999999999999433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-13 Score=133.47 Aligned_cols=133 Identities=23% Similarity=0.242 Sum_probs=113.5
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhccc--ccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH--KNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
+.||+|.++.||++..++ ..+++|....... ...+.+|+..++.++| ..+.+++++...++..++++||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 468999999999999865 7899999866543 4678899999999977 4899999988888899999999998877
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCcc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~ 685 (846)
..+ +......++.++++++++||.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 81 ~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 654 4566778899999999999954446899999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.7e-14 Score=141.15 Aligned_cols=135 Identities=20% Similarity=0.241 Sum_probs=97.0
Q ss_pred hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCch--hhHH----------------------HHHHHHHHHhccccc--c
Q 003114 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQ--GYEQ----------------------FEAEVILLRTVHHKN--L 593 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--~~~~----------------------~~~Ei~~l~~l~Hpn--I 593 (846)
.+.||+|+||.||+|...+++.||||++...... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3579999999999999888999999998754221 1111 134555555554433 3
Q ss_pred eeEeeEeecCCeeeEeeecccCCChhh-hhhcCCCCccChHHHHHHHHHHHHHHHHHhccCC-CCeeecCCCCCCEEECC
Q 003114 594 TTLYGYCNEGNQIGLIYEYMANGSLEE-YLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK-PPRVHRDIKPANILLND 671 (846)
Q Consensus 594 v~l~g~~~~~~~~~LV~Ey~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~IiHrDlKp~NILld~ 671 (846)
.+.+++ ...++||||++++.+.. .+.... .. .+...++.+++.++.++| . .+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-
Confidence 334433 23589999999854322 121111 11 567789999999999999 7 8999999999999999
Q ss_pred CCcEEEEeccCCccC
Q 003114 672 QFQARLADFGLSKTF 686 (846)
Q Consensus 672 ~~~vkI~DFGla~~~ 686 (846)
++.++++|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.4e-14 Score=170.32 Aligned_cols=205 Identities=21% Similarity=0.294 Sum_probs=140.4
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChh
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLE 619 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 619 (846)
+.|-.|++|.||..+++ ..+++|+|+ .+++- +.+- ++.....|.+| |+-.
T Consensus 89 klisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv---------------------gDc~ 139 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV---------------------GDCA 139 (1205)
T ss_pred EeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee---------------------chhh
Confidence 57889999999999976 466778743 32211 0000 22222333322 4555
Q ss_pred hhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC---------
Q 003114 620 EYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG--------- 690 (846)
Q Consensus 620 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~--------- 690 (846)
..++..+. ++. +++.+++||| ..+|+|||+||+|.+|+.-|.+|+.|||+++......
T Consensus 140 tllk~~g~--lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 140 TLLKNIGP--LPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred hhcccCCC--Ccc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 55555443 222 2278899999 9999999999999999999999999999987532110
Q ss_pred ----cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCC
Q 003114 691 ----VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDP 766 (846)
Q Consensus 691 ----~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 766 (846)
..-....++||+.|+|||++..+.|...+|-|++|+|+||.+-|..||.+...++.+...+...+ ...+- |
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i---~wpE~-d- 281 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI---EWPEE-D- 281 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc---ccccc-C-
Confidence 01112346899999999999999999999999999999999999999987765554444332111 01111 2
Q ss_pred CCCCCCChHHHHHHHHHHHhccCCCCCCCCCHH
Q 003114 767 KLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMN 799 (846)
Q Consensus 767 ~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~ 799 (846)
.....+..+++.+.++.+|.+|--..
T Consensus 282 -------ea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 282 -------EALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred -------cCCCHHHHHHHHHHHHhChHhhcccc
Confidence 22334677888899999999997444
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.8e-13 Score=140.28 Aligned_cols=134 Identities=18% Similarity=0.166 Sum_probs=104.6
Q ss_pred hhcC-cCceEEEEEEEEcCCcEEEEEEeCCCC-------------chhhHHHHHHHHHHHhcccccc--eeEeeEeecCC
Q 003114 541 TILG-EGSFGKVYHGYLDDNTEVAVKMLSPSS-------------RQGYEQFEAEVILLRTVHHKNL--TTLYGYCNEGN 604 (846)
Q Consensus 541 ~~LG-~G~fG~Vykg~~~~g~~VAVK~l~~~~-------------~~~~~~~~~Ei~~l~~l~HpnI--v~l~g~~~~~~ 604 (846)
.+|| .|+.|+||+.... +..++||.+.... ......+.+|+.++..++|+++ .+.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4688 8999999999885 6788998875311 1223467889999999998885 66776643322
Q ss_pred ----eeeEeeecccC-CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEe
Q 003114 605 ----QIGLIYEYMAN-GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLAD 679 (846)
Q Consensus 605 ----~~~LV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~D 679 (846)
..++|+|++++ .+|.+++.... ++.. .+.+++.+|.+|| +.+|+||||||+|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~---l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAP---LSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCC---CCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 23599999997 69998886532 3433 3568999999999 99999999999999999988999999
Q ss_pred ccCCcc
Q 003114 680 FGLSKT 685 (846)
Q Consensus 680 FGla~~ 685 (846)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.5e-14 Score=165.59 Aligned_cols=252 Identities=22% Similarity=0.294 Sum_probs=188.0
Q ss_pred hhhhhcCcCceEEEEEEEEcC--CcEEEEEEeCCCC--chhhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLDD--NTEVAVKMLSPSS--RQGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++...+.+..+++.+|
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 334569999999998877533 4456777665443 223344455776666675 99999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC-cEEEEeccCCccCCC-CC
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF-QARLADFGLSKTFPI-EG 690 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-~vkI~DFGla~~~~~-~~ 690 (846)
..++++.+.+........+....-.+..|+..++.|+|. ..++.|+|+||+|.+++..+ ..+++|||+|..+.. .+
T Consensus 103 s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g 180 (601)
T KOG0590|consen 103 SDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG 180 (601)
T ss_pred ccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence 999999998842222236667778899999999999995 57899999999999999999 999999999998876 56
Q ss_pred cccccccccC-CCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccc-cHHHHHHHHHhcCCcccccCCC
Q 003114 691 VSHLSTGVAG-TFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHK-HISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 691 ~~~~~~~~~g-t~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
........+| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++...... ....|.... +.. ...
T Consensus 181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~----~~~ 253 (601)
T KOG0590|consen 181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---GRF----TQL 253 (601)
T ss_pred cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---ccc----ccC
Confidence 6666666788 9999999988774 45678999999999999999999998765332 122222211 000 000
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVV 802 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl 802 (846)
... .......++..+++..+|..|.+.+++.
T Consensus 254 ~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 254 PWN----SISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccc----cCChhhhhcccccccCCchhcccccccc
Confidence 111 1123456778888889999999988764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.9e-12 Score=146.46 Aligned_cols=140 Identities=21% Similarity=0.244 Sum_probs=99.3
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhH----------------------------------------HHHH
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYE----------------------------------------QFEA 580 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~----------------------------------------~~~~ 580 (846)
+.||.|++|.||+|++.+|+.||||+.++....... .|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 469999999999999999999999998764211100 1334
Q ss_pred HHHHHHhcc----cccceeEeeEe-ecCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHH-HHHHHhccCC
Q 003114 581 EVILLRTVH----HKNLTTLYGYC-NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ-GLEYLHLGCK 654 (846)
Q Consensus 581 Ei~~l~~l~----HpnIv~l~g~~-~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~~ 654 (846)
|+..+.+++ |.+-+.+-..+ ......+|||||++|++|.+........ . .+.+++..++. .+..+| .
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~---~~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-L---DRKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-C---CHHHHHHHHHHHHHHHHH---h
Confidence 454444442 22222222222 2244579999999999999876542211 2 34556666666 467888 8
Q ss_pred CCeeecCCCCCCEEECCCCcEEEEeccCCccCC
Q 003114 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFP 687 (846)
Q Consensus 655 ~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~ 687 (846)
.+++|+|+||.||++++++.+++.|||++..+.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 899999999999999999999999999997653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.4e-12 Score=131.06 Aligned_cols=202 Identities=21% Similarity=0.316 Sum_probs=139.5
Q ss_pred HHHHhcccccceeEeeEeecC-----CeeeEeeecccCCChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccCCC
Q 003114 583 ILLRTVHHKNLTTLYGYCNEG-----NQIGLIYEYMANGSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGCKP 655 (846)
Q Consensus 583 ~~l~~l~HpnIv~l~g~~~~~-----~~~~LV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 655 (846)
..|-++-|.|||+++.|+.+. ....++.|||+-|+|.++|++.. ...+....-.+++.||..||.||| .|.+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCC
Confidence 345566799999999987553 45789999999999999998643 344667777899999999999999 5799
Q ss_pred CeeecCCCCCCEEECCCCcEEEEeccCCccCC-C--CCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHH
Q 003114 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFP-I--EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEII 732 (846)
Q Consensus 656 ~IiHrDlKp~NILld~~~~vkI~DFGla~~~~-~--~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELl 732 (846)
+|+|+++..+-|++..++-+||.- +.-.... . ...........+-++|.|||+-.....+-.+|||+||+-.+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 999999999999999998888742 1111110 0 00011112234678999999988888889999999999999998
Q ss_pred hCCCCCCCc-cccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 733 TSRPAIANT-EEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 733 tG~~p~~~~-~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
-+..--... .....-...... + ......+ -...+..|++..|..||+|++++..
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~------i-~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANV------I-IGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhhhhh------e-eeccCcc-----------ccCcCcccccCCCCCCcchhhhhcC
Confidence 875432211 111000000000 0 0001111 1256678999999999999998654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.7e-11 Score=155.13 Aligned_cols=138 Identities=30% Similarity=0.569 Sum_probs=94.6
Q ss_pred hHHHHHHHhhhccccCCccchhhHHHHHHHHhhcC-----CCCCC-CCCCCCCCCCceEEeecCCCCCCCceEEEEcCCC
Q 003114 324 PILNAIEFYLVQDFSQSETEQADVDAIMNIKSLYK-----RKDWQ-GDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSR 397 (846)
Q Consensus 324 P~lna~ei~~~~~~~~~~~~~~d~~al~~~k~~~~-----~~~W~-~dpC~~~~~~w~gv~C~~~~~~~~~l~~L~L~~n 397 (846)
|.+-.+-++..... ..+.++|..||++||+.+. ..+|+ ++.|| .|.||+|+. ..+++.|+|++|
T Consensus 10 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c----~w~gv~c~~----~~~v~~L~L~~~ 79 (968)
T PLN00113 10 PYLIFMLFFLFLNF--SMLHAEELELLLSFKSSINDPLKYLSNWNSSADVC----LWQGITCNN----SSRVVSIDLSGK 79 (968)
T ss_pred ChHHHHHHHHHHHc--cCCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC----cCcceecCC----CCcEEEEEecCC
Confidence 44444444444432 3447799999999999885 45785 33443 799999974 347888888888
Q ss_pred CCcccCCccccCCCCCCeEeccCCCCCCCCCchhc-ccCccccccccCccCC----------------------CCCccc
Q 003114 398 GLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLS-KLQYLRVLNLTGNMLT----------------------GPLPAG 454 (846)
Q Consensus 398 ~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~-~l~~L~~L~Ls~N~l~----------------------g~iP~~ 454 (846)
+++|.+|+.|..|++|+.|+|++|+++|.+|..+. ++++|++|+|++|+++ |.+|..
T Consensus 80 ~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~ 159 (968)
T PLN00113 80 NISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPND 159 (968)
T ss_pred CccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChH
Confidence 88888877788888888888888888777776554 5666666666555555 455556
Q ss_pred ccccCCCCCCCCccccC
Q 003114 455 LVERSKNGSLSLSVDLC 471 (846)
Q Consensus 455 ~~~l~~l~~l~l~~nlc 471 (846)
++++++|+.|+++.|..
T Consensus 160 ~~~l~~L~~L~L~~n~l 176 (968)
T PLN00113 160 IGSFSSLKVLDLGGNVL 176 (968)
T ss_pred HhcCCCCCEEECccCcc
Confidence 66677777777766643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.1e-10 Score=115.73 Aligned_cols=127 Identities=20% Similarity=0.217 Sum_probs=95.4
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChhh
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEE 620 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 620 (846)
+.|+.|.++.||++... +..+++|....... ....+..|+..++.+.+.++++-+-.+. ....++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-CCCCeEEEEecCCCcccc
Confidence 35789999999999875 77899999765432 2245688999999987766654333332 234579999999988765
Q ss_pred hhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCC-----eeecCCCCCCEEECCCCcEEEEeccCCc
Q 003114 621 YLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP-----RVHRDIKPANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 621 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----IiHrDlKp~NILld~~~~vkI~DFGla~ 684 (846)
. . . ....++.+++++|..|| ..+ ++|||++|+||+++ ++.++++|||.+.
T Consensus 81 ~-~------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 81 E-D------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred c-c------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 3 0 1 11345678999999999 555 59999999999999 5689999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1e-09 Score=125.17 Aligned_cols=166 Identities=18% Similarity=0.163 Sum_probs=128.4
Q ss_pred EcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChhhhhhcCCCCccChHHH
Q 003114 556 LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGR 635 (846)
Q Consensus 556 ~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~ 635 (846)
..++.+|.|+..+...........+.++.|+.++||||++++.....++..|+|+|-+ ..|..++++.. ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHHH
Confidence 4478899999887766655667888899999999999999999999999999999988 36777776633 4555
Q ss_pred HHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCC
Q 003114 636 LRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL 715 (846)
Q Consensus 636 ~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~ 715 (846)
...+.||+.||.|||+ +.+++|++|...-|++++.|+.||++|.++......+ .......---.|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~--~~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN--APAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC--cccccchhhhcccChhhcCccc-
Confidence 6678999999999986 6689999999999999999999999999886542211 1111111122356666543322
Q ss_pred CchhhHHHHHHHHHHHHhC
Q 003114 716 TEKSDVYSFGVVLLEIITS 734 (846)
Q Consensus 716 s~ksDVwS~Gvvl~ELltG 734 (846)
-..|.|.|||+++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 357999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.9e-11 Score=135.59 Aligned_cols=138 Identities=17% Similarity=0.196 Sum_probs=88.9
Q ss_pred hhcCcCceEEEEEEEEcC-CcEEEEEEeCCCCchh----------------------------------hHH------HH
Q 003114 541 TILGEGSFGKVYHGYLDD-NTEVAVKMLSPSSRQG----------------------------------YEQ------FE 579 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~----------------------------------~~~------~~ 579 (846)
+.||.|++|.||+|++++ |++||||+.++.-... .+. +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 479999999999999987 9999999997652110 111 23
Q ss_pred HHHHHHHhcc----cccceeEeeEeec-CCeeeEeeecccCCChhhhh--hcCCCCccChHHHHHHHHHHHHH-HHHHhc
Q 003114 580 AEVILLRTVH----HKNLTTLYGYCNE-GNQIGLIYEYMANGSLEEYL--SDSNADVLSWEGRLRIATEAAQG-LEYLHL 651 (846)
Q Consensus 580 ~Ei~~l~~l~----HpnIv~l~g~~~~-~~~~~LV~Ey~~~gsL~~~l--~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~ 651 (846)
+|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.+.+.- ...+ .+ +..++...+.. +..++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d---~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TD---MKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CC---HHHHHHHHHHHHHHHHH-
Confidence 3333333332 2232332222222 44578999999999998742 2221 11 11222222221 23334
Q ss_pred cCCCCeeecCCCCCCEEECCCC----cEEEEeccCCccCC
Q 003114 652 GCKPPRVHRDIKPANILLNDQF----QARLADFGLSKTFP 687 (846)
Q Consensus 652 ~~~~~IiHrDlKp~NILld~~~----~vkI~DFGla~~~~ 687 (846)
..+++|+|+||.||+++.++ .+++.|||++..+.
T Consensus 278 --~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 --RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred --hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 67999999999999999888 99999999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.3e-10 Score=131.50 Aligned_cols=251 Identities=21% Similarity=0.204 Sum_probs=176.6
Q ss_pred HHHHhhhhhhcCc--CceEEEEEEEE---cCCcEEEEEEeCC--CCchhhHHHHHHHHHHHhc-ccccceeEeeEeecCC
Q 003114 533 TKITNDFETILGE--GSFGKVYHGYL---DDNTEVAVKMLSP--SSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGN 604 (846)
Q Consensus 533 ~~~t~~f~~~LG~--G~fG~Vykg~~---~~g~~VAVK~l~~--~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 604 (846)
......+.+.+|. |.+|.||++.. .++..+|+|+-+. ........-.+|+....++ .|+|.++....+..++
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3334455677899 99999999987 3677889988432 2223333345566666666 4999999888888899
Q ss_pred eeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHH----HHHHHhccCCCCeeecCCCCCCEEECCC-CcEEEEe
Q 003114 605 QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ----GLEYLHLGCKPPRVHRDIKPANILLNDQ-FQARLAD 679 (846)
Q Consensus 605 ~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~IiHrDlKp~NILld~~-~~vkI~D 679 (846)
..++-+|++. .+|.++.+.... .++....+.+..+..+ |+.++| ...++|-|+||.||++..+ ...++.|
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred cceeeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCC
Confidence 9999999985 688887765432 3566677777777777 999999 9999999999999999998 8999999
Q ss_pred ccCCccCCCCCccccc---ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHh
Q 003114 680 FGLSKTFPIEGVSHLS---TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLA 756 (846)
Q Consensus 680 FGla~~~~~~~~~~~~---~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~ 756 (846)
||+...+...+..... ....|...|++||..++ .++...|+|++|.+++|..++..+...... ..|.. .+
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----~~W~~--~r 339 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN----SSWSQ--LR 339 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC----CCccc--cc
Confidence 9999887554432211 22357788999998776 578899999999999999998765543311 11211 00
Q ss_pred cCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 757 QGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 757 ~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+ . +..++...-...+...+..+++.+|..|++.+++..
T Consensus 340 ~~-----~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QG-----Y---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cc-----c---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 10 0 111111111223444788899999999998876643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.3e-09 Score=109.85 Aligned_cols=142 Identities=20% Similarity=0.227 Sum_probs=110.7
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccc--cceeEeeEeecCC---eeeEeeeccc
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHK--NLTTLYGYCNEGN---QIGLIYEYMA 614 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~Hp--nIv~l~g~~~~~~---~~~LV~Ey~~ 614 (846)
+.|+.|..+.||++...+|..+++|....... .....+..|+++++.+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 35899999999999987778999999765432 2346788999999999764 4566777776542 5689999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccC-----------------------------------------
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC----------------------------------------- 653 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 653 (846)
+.++.+.+.. ..++..++..++.+++++|..||...
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876642 23677778888889999999988421
Q ss_pred ------------CCCeeecCCCCCCEEECC--CCcEEEEeccCCcc
Q 003114 654 ------------KPPRVHRDIKPANILLND--QFQARLADFGLSKT 685 (846)
Q Consensus 654 ------------~~~IiHrDlKp~NILld~--~~~vkI~DFGla~~ 685 (846)
...++|+|+++.||++++ ++.+.|.||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.3e-08 Score=101.32 Aligned_cols=135 Identities=18% Similarity=0.168 Sum_probs=96.6
Q ss_pred hhcCcCceEEEEEEEEcC-------CcEEEEEEeCCCC----------------------chhhHHH----HHHHHHHHh
Q 003114 541 TILGEGSFGKVYHGYLDD-------NTEVAVKMLSPSS----------------------RQGYEQF----EAEVILLRT 587 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~~~----------------------~~~~~~~----~~Ei~~l~~ 587 (846)
..||.|-=+.||.|.-.+ +..+|||+.+... ....+.+ ++|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 4799999874310 0112233 379999998
Q ss_pred cccc--cceeEeeEeecCCeeeEeeecccCCChh-hhhhcCCCCccChHHHHHHHHHHHHHHHHH-hccCCCCeeecCCC
Q 003114 588 VHHK--NLTTLYGYCNEGNQIGLIYEYMANGSLE-EYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLGCKPPRVHRDIK 663 (846)
Q Consensus 588 l~Hp--nIv~l~g~~~~~~~~~LV~Ey~~~gsL~-~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~IiHrDlK 663 (846)
+... ++-+.+++ ..-++||||+.+..+. ..+++. .++..+...+..+++.+|..| | +.+++||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 8543 44455544 4568999999765432 223221 144455677889999999999 7 8899999999
Q ss_pred CCCEEECCCCcEEEEeccCCccC
Q 003114 664 PANILLNDQFQARLADFGLSKTF 686 (846)
Q Consensus 664 p~NILld~~~~vkI~DFGla~~~ 686 (846)
+.||++++ +.+.|+|||.+...
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeC
Confidence 99999974 67999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.8e-08 Score=97.55 Aligned_cols=130 Identities=22% Similarity=0.291 Sum_probs=101.5
Q ss_pred hcCcCceEEEEEEEEcCCcEEEEEEeCCCCc---h-----hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 542 ILGEGSFGKVYHGYLDDNTEVAVKMLSPSSR---Q-----GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~---~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+++|+=+.+|.+.+. |.++++|.-.+... . ....-.+|+.++.+++--.|-...-+..+.....++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999774 34466665433311 1 1234567999999988767666666777778889999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCcc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~ 685 (846)
+|..|.+.+... +..++..+-.-+.-|| ..+|+||||.++||++..+. +.++|||++..
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888765 2457777888888999 99999999999999998875 99999999963
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.1e-08 Score=96.76 Aligned_cols=141 Identities=19% Similarity=0.258 Sum_probs=104.5
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEe-CCC-------CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKML-SPS-------SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l-~~~-------~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
..+-+|+-+.|+++.+. |+...||.. .+. ..-..+...+|+..|.+++--.|.-..-++.+...-.++|||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 56889999999999985 555555543 222 112345677899999998766665555566666777899999
Q ss_pred ccC-CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC---cEEEEeccCCcc
Q 003114 613 MAN-GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF---QARLADFGLSKT 685 (846)
Q Consensus 613 ~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~---~vkI~DFGla~~ 685 (846)
+++ .++.+++...-...........++..+-+.+.-|| ...||||||..+||++.+++ .+.+.|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 976 37888886654333333444788899999999999 99999999999999996544 458999999863
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=9.4e-10 Score=105.21 Aligned_cols=85 Identities=35% Similarity=0.464 Sum_probs=80.4
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
..+++.|.||+|+|+ .+|+.+++|.+|+.|+|++|++. .+|.+++.|++|+.|+++-|++. .+|.+|+.++.|+.|+
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 457899999999999 99999999999999999999999 89999999999999999999999 8999999999999999
Q ss_pred CccccCCC
Q 003114 466 LSVDLCSS 473 (846)
Q Consensus 466 l~~nlc~~ 473 (846)
|.+|....
T Consensus 109 ltynnl~e 116 (264)
T KOG0617|consen 109 LTYNNLNE 116 (264)
T ss_pred cccccccc
Confidence 99987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.73 E-value=7.6e-09 Score=117.32 Aligned_cols=240 Identities=21% Similarity=0.242 Sum_probs=167.6
Q ss_pred hhcCcCceEEEEEEEE--cCCcEEEEEEeCCCCchhhH--HHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYL--DDNTEVAVKMLSPSSRQGYE--QFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~--~~g~~VAVK~l~~~~~~~~~--~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
..||.|.|+.|++... .++..+++|........... .-..|+.+...+ .|.++++...-+...++.++=-|||++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 4699999999998774 36778888887654332222 224566666655 588888877766666777799999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC-CcEEEEeccCCccCCCCCcccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ-FQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+++...+.. ...++...++++..+++.++.++| ++.++|+|+||+||++..+ +..++.|||.+..+....
T Consensus 351 ~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~---- 421 (524)
T KOG0601|consen 351 GSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS---- 421 (524)
T ss_pred cchhhhhHH--HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccceec----
Confidence 988766622 234778888999999999999999 9999999999999999876 888999999986532111
Q ss_pred cccccCCCcc-cCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 695 STGVAGTFGY-LDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 695 ~~~~~gt~~Y-~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
......+..| .+|+......+..+.|++|||.-+.|.+++.+.-.... +|.. +..+.+ +.+ +
T Consensus 422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------~~~~--i~~~~~-----p~~----~ 484 (524)
T KOG0601|consen 422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------QSLT--IRSGDT-----PNL----P 484 (524)
T ss_pred ccccccccccccchhhccccccccccccccccccccccccCcccCcccc------ccee--eecccc-----cCC----C
Confidence 1111223334 36666677788999999999999999999975432211 1111 111111 111 1
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~ 807 (846)
..- ..+..++..+..+++..||.+.+.....+.
T Consensus 485 ~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 485 GLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred chH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111 456678888999999999999887665543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.4e-07 Score=99.00 Aligned_cols=139 Identities=16% Similarity=0.104 Sum_probs=99.7
Q ss_pred cCcCceEEEEEEEEcCCcEEEEEEeCCCCch-hhH----------HHHHHHHHHHhcccccc--eeEeeEeec-----CC
Q 003114 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQ-GYE----------QFEAEVILLRTVHHKNL--TTLYGYCNE-----GN 604 (846)
Q Consensus 543 LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-~~~----------~~~~Ei~~l~~l~HpnI--v~l~g~~~~-----~~ 604 (846)
+-.-....|.+..+ +|+.+.||........ ..+ .+.+|...+.++...+| .+.+++... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333445667666 5778999977543311 111 37788988888854443 344555432 23
Q ss_pred eeeEeeecccCC-ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-------CCcEE
Q 003114 605 QIGLIYEYMANG-SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-------QFQAR 676 (846)
Q Consensus 605 ~~~LV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-------~~~vk 676 (846)
.-++|+|++++. +|.+++........+...+..++.+++..+.-|| ..+|+|+|++++|||++. +..+.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEE
Confidence 578999999886 8999886432233456677889999999999999 999999999999999975 57899
Q ss_pred EEeccCCcc
Q 003114 677 LADFGLSKT 685 (846)
Q Consensus 677 I~DFGla~~ 685 (846)
++||+.++.
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998853
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.2e-08 Score=83.42 Aligned_cols=61 Identities=48% Similarity=0.610 Sum_probs=54.7
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNML 447 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l 447 (846)
++|+.|+|++|+|+..-+..|..+++|++|+|++|+|+..-|..|.+|++|+.|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4789999999999955556899999999999999999977778999999999999999986
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=9e-09 Score=122.22 Aligned_cols=195 Identities=24% Similarity=0.304 Sum_probs=134.4
Q ss_pred cccccceeEeeEeecCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCE
Q 003114 588 VHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANI 667 (846)
Q Consensus 588 l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NI 667 (846)
.+||-++....-+.......||++|..+++|...++..+. .+..-.......+.++++||| ...+.|+|++|.|.
T Consensus 861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~ 935 (1205)
T KOG0606|consen 861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSL 935 (1205)
T ss_pred CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccc---cchhhcccccccch
Confidence 3445555554445566778999999999999999987663 444445556667888999999 77799999999999
Q ss_pred EECCCCcEEEEeccCCccCCCC-------------------------C----cccccccccCCCcccCccccccCCCCch
Q 003114 668 LLNDQFQARLADFGLSKTFPIE-------------------------G----VSHLSTGVAGTFGYLDPEYCQTFRLTEK 718 (846)
Q Consensus 668 Lld~~~~vkI~DFGla~~~~~~-------------------------~----~~~~~~~~~gt~~Y~APE~~~~~~~s~k 718 (846)
|...++..+++|||........ . .........||+.|.+||...+......
T Consensus 936 l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ 1015 (1205)
T KOG0606|consen 936 LIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA 1015 (1205)
T ss_pred hhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc
Confidence 9999999999999844322100 0 0011223568999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCH
Q 003114 719 SDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 719 sDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
+|.|+.|+.++|.++|.+||......... +.. ..+.+.- . ...........+++...+..+|.+|-.|
T Consensus 1016 ad~~~~g~~l~e~l~g~pp~na~tpq~~f----~ni-~~~~~~~-----p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1016 ADWWSSGVCLFEVLTGIPPFNAETPQQIF----ENI-LNRDIPW-----P--EGPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred chhhhhhhhhhhhhcCCCCCCCcchhhhh----hcc-ccCCCCC-----C--CCccccChhhhhhhhhhhccCchhccCc
Confidence 99999999999999999999865433221 111 1111110 0 1111222334456666667777777666
Q ss_pred H
Q 003114 799 N 799 (846)
Q Consensus 799 ~ 799 (846)
.
T Consensus 1084 ~ 1084 (1205)
T KOG0606|consen 1084 K 1084 (1205)
T ss_pred c
Confidence 5
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=4e-07 Score=91.92 Aligned_cols=125 Identities=28% Similarity=0.338 Sum_probs=82.3
Q ss_pred EEEEEEEcCCcEEEEEEeCCCC--------------c------------hhhHHHHHHHHHHHhccccc--ceeEeeEee
Q 003114 550 KVYHGYLDDNTEVAVKMLSPSS--------------R------------QGYEQFEAEVILLRTVHHKN--LTTLYGYCN 601 (846)
Q Consensus 550 ~Vykg~~~~g~~VAVK~l~~~~--------------~------------~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~~~ 601 (846)
.||.|...+|..+|+|+.+... . ......++|.+.|.++..-+ +-+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999999999999874320 0 01234678999999997664 44555442
Q ss_pred cCCeeeEeeeccc--CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHH-HhccCCCCeeecCCCCCCEEECCCCcEEEE
Q 003114 602 EGNQIGLIYEYMA--NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEY-LHLGCKPPRVHRDIKPANILLNDQFQARLA 678 (846)
Q Consensus 602 ~~~~~~LV~Ey~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~IiHrDlKp~NILld~~~~vkI~ 678 (846)
.-.+||||++ +..+..+... . ++......++.+++..+.. +| ..+|+|||+.+.||+++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-D---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-G---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhc-c---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEE
Confidence 3479999998 5445443332 1 2234556677788885555 57 8899999999999999988 99999
Q ss_pred eccCCccC
Q 003114 679 DFGLSKTF 686 (846)
Q Consensus 679 DFGla~~~ 686 (846)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.5e-06 Score=94.52 Aligned_cols=266 Identities=18% Similarity=0.209 Sum_probs=161.1
Q ss_pred hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEe-------ecCCeeeEeee
Q 003114 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYC-------NEGNQIGLIYE 611 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~-------~~~~~~~LV~E 611 (846)
...||+|+-+.+|-.-. -...+.|+..........+. ++.|... .||-+-.-+.|= ..+....+.|.
T Consensus 16 gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 45799999999985321 12234577665544332222 2223333 565433212221 12233677788
Q ss_pred cccCC-Chhhhhhc----CCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccC
Q 003114 612 YMANG-SLEEYLSD----SNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF 686 (846)
Q Consensus 612 y~~~g-sL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~ 686 (846)
.+.+. .+..+.+. ..-...+|...++.+..+|.+.+-|| ..+.+-||+.++|+|+.+++.+.+.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeec
Confidence 77664 22222221 11234899999999999999999999 889999999999999999999999986543321
Q ss_pred CCCCcccccccccCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCccccccHHHHHHHHHhcCCc
Q 003114 687 PIEGVSHLSTGVAGTFGYLDPEYCQ-----TFRLTEKSDVYSFGVVLLEIITS-RPAIANTEEHKHISQWVDFMLAQGDI 760 (846)
Q Consensus 687 ~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~Gvvl~ELltG-~~p~~~~~~~~~l~~~~~~~~~~~~~ 760 (846)
.........+|...|.+||... +..-+...|-|.+||++++++.| ++||.+.........-...-+..+..
T Consensus 168 ---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 168 ---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred ---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 2223334457889999999654 34567889999999999999887 99997643111000000001112222
Q ss_pred ccccCCC--CCC---CCChH-HHHHHHHHHHhccCCC--CCCCCCHHHHHHHHHHhhhhhhhhh
Q 003114 761 KNIVDPK--LHG---DIDVN-SAWKAVEIAMGCVSHS--STPRPNMNRVVMELKECLAMETARK 816 (846)
Q Consensus 761 ~~~~d~~--L~~---~~~~~-~~~~l~~L~~~Cl~~~--P~~RPsm~eVl~~L~~~l~~e~~~~ 816 (846)
...-|.. ++. ..+-+ -...+.-+..+|.... +.-|||.+..+..|.++.+.-..+.
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~ 308 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCT 308 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence 1111111 110 11111 1234556778888655 5789999999999887665555443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.5e-06 Score=96.86 Aligned_cols=168 Identities=15% Similarity=0.199 Sum_probs=128.7
Q ss_pred eEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEee----cCCeeeEeeecccC-CChhhh
Q 003114 548 FGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN----EGNQIGLIYEYMAN-GSLEEY 621 (846)
Q Consensus 548 fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~----~~~~~~LV~Ey~~~-gsL~~~ 621 (846)
..+.||+... +|..+++|+++............-++.++++.|.|+|++...+. .+..+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3568999854 89999999995443333334456678899999999999999875 34578999999986 477776
Q ss_pred hhcCC-------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 622 LSDSN-------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 622 l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
--... +...++...+.++.|+..||.++| +.|...+-|.+++||++.+.+++|+..|..-.+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 53221 224677889999999999999999 88999999999999999999999998887765533
Q ss_pred CCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPA 737 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p 737 (846)
+. + |-+.. -.+-|.=.||.+++-|.||..-
T Consensus 446 d~---------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DP---------T-------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC---------C-------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 21 0 11111 2367899999999999999643
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.9e-08 Score=95.19 Aligned_cols=84 Identities=26% Similarity=0.344 Sum_probs=70.6
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCC-CCcccccccCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG-PLPAGLVERSKNGSLS 465 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g-~iP~~~~~l~~l~~l~ 465 (846)
.+++.|+|++|++. .+|.+++.|++|++|+++-|+|. .+|..|+.++.|+.|||++|+++. .+|..|+-+..|..|+
T Consensus 56 ~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlraly 133 (264)
T KOG0617|consen 56 KNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALY 133 (264)
T ss_pred hhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHH
Confidence 46788888889888 88888899999999999988888 788888999999999998888864 5688888888888888
Q ss_pred CccccCC
Q 003114 466 LSVDLCS 472 (846)
Q Consensus 466 l~~nlc~ 472 (846)
|+.|-..
T Consensus 134 l~dndfe 140 (264)
T KOG0617|consen 134 LGDNDFE 140 (264)
T ss_pred hcCCCcc
Confidence 8877654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.2e-06 Score=99.06 Aligned_cols=143 Identities=21% Similarity=0.288 Sum_probs=92.2
Q ss_pred hhh-hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchh------------------------------hHH---------
Q 003114 538 DFE-TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQG------------------------------YEQ--------- 577 (846)
Q Consensus 538 ~f~-~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~------------------------------~~~--------- 577 (846)
+|+ +-|+.++-|.||+|++++|+.||||+.++.-... .++
T Consensus 127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 343 5689999999999999999999999986532110 011
Q ss_pred -HHHHHHHHHhcc-----cccceeEeeEeecCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHH-HHHHh
Q 003114 578 -FEAEVILLRTVH-----HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQG-LEYLH 650 (846)
Q Consensus 578 -~~~Ei~~l~~l~-----HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g-L~yLH 650 (846)
+..|...+.+++ .+++.--.-|.+-.....|+|||++|-.+.+...-.. ...+ +..++..++++ +..+-
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q~~ 282 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQLL 282 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHHHH
Confidence 223333333332 2232211122233456789999999998888743222 2244 23333333333 22222
Q ss_pred ccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCC
Q 003114 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP 687 (846)
Q Consensus 651 ~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~ 687 (846)
..+++|+|.+|.||+++.++.+.+.|||+...+.
T Consensus 283 ---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 283 ---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ---hcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 5689999999999999999999999999988764
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.33 E-value=7.6e-08 Score=107.89 Aligned_cols=135 Identities=24% Similarity=0.304 Sum_probs=105.0
Q ss_pred CCCchhHHHHHHHhhhccccCCccchhhHHHHHHHHhhcC--CCCCCC---CCCCCCCCCceEEeecCCCCCCCceEEEE
Q 003114 319 NSTLPPILNAIEFYLVQDFSQSETEQADVDAIMNIKSLYK--RKDWQG---DPCAPQAFLWNGLGCSYNDNDPPRITSLN 393 (846)
Q Consensus 319 ~S~lpP~lna~ei~~~~~~~~~~~~~~d~~al~~~k~~~~--~~~W~~---dpC~~~~~~w~gv~C~~~~~~~~~l~~L~ 393 (846)
-+.+||.|..+..+.-++++ ....+.-.++|..+...-. +++-.- .-|.. .| .+++.||
T Consensus 211 l~N~Ptsld~l~NL~dvDlS-~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~---~W------------~~lEtLN 274 (1255)
T KOG0444|consen 211 LDNIPTSLDDLHNLRDVDLS-ENNLPIVPECLYKLRNLRRLNLSGNKITELNMTEG---EW------------ENLETLN 274 (1255)
T ss_pred hhcCCCchhhhhhhhhcccc-ccCCCcchHHHhhhhhhheeccCcCceeeeeccHH---HH------------hhhhhhc
Confidence 35578999999999999988 4566677778887776533 222110 11211 23 3788999
Q ss_pred cCCCCCcccCCccccCCCCCCeEeccCCCCCC-CCCchhcccCccccccccCccCCCCCcccccccCCCCCCCCccccC
Q 003114 394 LSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG-PVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVDLC 471 (846)
Q Consensus 394 L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g-~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~nlc 471 (846)
||+|+|+ .+|..+++|++|+.|++.+|+|+- -||+.++.|.+|+.+.+++|.|. .+|++++.+.+|+.|.|+.|-.
T Consensus 275 lSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrL 351 (1255)
T KOG0444|consen 275 LSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRL 351 (1255)
T ss_pred cccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccce
Confidence 9999999 999999999999999999999863 48999999999999999999998 8899999888888888877643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.28 E-value=9e-06 Score=82.84 Aligned_cols=138 Identities=17% Similarity=0.168 Sum_probs=104.0
Q ss_pred cCcCceEEEEEEEEcCCcEEEEEEeCCC---C---chhhHHHHHHHHHHHhccccc--ceeEeeEeec-----CCeeeEe
Q 003114 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPS---S---RQGYEQFEAEVILLRTVHHKN--LTTLYGYCNE-----GNQIGLI 609 (846)
Q Consensus 543 LG~G~fG~Vykg~~~~g~~VAVK~l~~~---~---~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~~~~-----~~~~~LV 609 (846)
-|+||-+-|++-.+++. .+-+|+-... + +.....|.+|...+.++...+ +.+.+ ++.. .....||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46789999999777544 6888876521 1 334567999999999996433 33444 3321 2347899
Q ss_pred eecccC-CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc--EEEEeccCCcc
Q 003114 610 YEYMAN-GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ--ARLADFGLSKT 685 (846)
Q Consensus 610 ~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~--vkI~DFGla~~ 685 (846)
+|-+++ .+|.+++.+......+..++..++.++++.+.-|| ..++.|+|+.++||+++.++. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998864 48999987655444677888899999999999999 999999999999999986666 99999976653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=5.2e-06 Score=86.46 Aligned_cols=133 Identities=20% Similarity=0.200 Sum_probs=96.0
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCC--------------------C--chhhHHHHHHHHHHHhcccc--cc
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPS--------------------S--RQGYEQFEAEVILLRTVHHK--NL 593 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--------------------~--~~~~~~~~~Ei~~l~~l~Hp--nI 593 (846)
.+.+.||-|-=+.||.|..++|.++|||.=+.. + .......++|.+.|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 455789999999999999999999999963211 0 01223467899999998654 55
Q ss_pred eeEeeEeecCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC
Q 003114 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF 673 (846)
Q Consensus 594 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~ 673 (846)
-+.+++ +.-.+|||++++-.|...- ++....-.++..|+.-+.-+- ..+|||||+.+-||+++++|
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence 555554 4458999999986665543 122233345555555555555 67899999999999999999
Q ss_pred cEEEEeccCCc
Q 003114 674 QARLADFGLSK 684 (846)
Q Consensus 674 ~vkI~DFGla~ 684 (846)
.+.++||--+.
T Consensus 240 ~~~vIDwPQ~v 250 (304)
T COG0478 240 DIVVIDWPQAV 250 (304)
T ss_pred CEEEEeCcccc
Confidence 99999996554
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.8e-07 Score=105.08 Aligned_cols=152 Identities=22% Similarity=0.268 Sum_probs=103.0
Q ss_pred HHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc-------cccccccCCCcccCccccc
Q 003114 639 ATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS-------HLSTGVAGTFGYLDPEYCQ 711 (846)
Q Consensus 639 ~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~-------~~~~~~~gt~~Y~APE~~~ 711 (846)
+.+++.|+.|+|. +.++||++|.|++|.++.++..||+.|+.+......... .......-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3456699999995 789999999999999999999999999987654321110 0011123456799999999
Q ss_pred cCCCCchhhHHHHHHHHHHHH-hCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCC
Q 003114 712 TFRLTEKSDVYSFGVVLLEII-TSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSH 790 (846)
Q Consensus 712 ~~~~s~ksDVwS~Gvvl~ELl-tG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~ 790 (846)
....+.++|+||+||+++-+. .|+..+..... ......... ..+-.. ..+..+.+.++.+=+.+.+..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~~---------~~~~~~-~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSRN---------LLNAGA-FGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCC-cchhhhhhc---------cccccc-ccccccCcHHHHHHHHHHhcC
Confidence 988899999999999999999 55555543321 111110000 001111 112234456778888899999
Q ss_pred CCCCCCCHHHHHH
Q 003114 791 SSTPRPNMNRVVM 803 (846)
Q Consensus 791 ~P~~RPsm~eVl~ 803 (846)
++..||++.++..
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999998776543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.22 E-value=8.5e-06 Score=83.98 Aligned_cols=105 Identities=20% Similarity=0.214 Sum_probs=82.9
Q ss_pred HHHHHHHHHHHhccccc--ceeEeeEeecC----CeeeEeeecccCC-ChhhhhhcCCCCccChHHHHHHHHHHHHHHHH
Q 003114 576 EQFEAEVILLRTVHHKN--LTTLYGYCNEG----NQIGLIYEYMANG-SLEEYLSDSNADVLSWEGRLRIATEAAQGLEY 648 (846)
Q Consensus 576 ~~~~~Ei~~l~~l~Hpn--Iv~l~g~~~~~----~~~~LV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y 648 (846)
....+|...+..+.... ..+.+++.... ...++|+|++++. +|.+++..... .+......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 45778888887775433 44555655442 2458999999884 89999886433 5566778899999999999
Q ss_pred HhccCCCCeeecCCCCCCEEECCCC---cEEEEeccCCcc
Q 003114 649 LHLGCKPPRVHRDIKPANILLNDQF---QARLADFGLSKT 685 (846)
Q Consensus 649 LH~~~~~~IiHrDlKp~NILld~~~---~vkI~DFGla~~ 685 (846)
|| ..+|+|+|++++|||++.+. .+.++||+.++.
T Consensus 134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99 99999999999999999876 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=4e-07 Score=97.89 Aligned_cols=96 Identities=25% Similarity=0.314 Sum_probs=80.6
Q ss_pred EEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCcccccccc-CccCC
Q 003114 376 GLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT-GNMLT 448 (846)
Q Consensus 376 gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls-~N~l~ 448 (846)
-|.|+..+ +.|+..+.|+|..|+|+-.-|.+|+.|++|+.||||+|+|+-+-|++|..|++|..|-|- +|+|+
T Consensus 50 ~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~ 129 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT 129 (498)
T ss_pred eEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh
Confidence 38898753 678899999999999994444579999999999999999999899999999998766554 59999
Q ss_pred CCCcc-cccccCCCCCCCCccccCC
Q 003114 449 GPLPA-GLVERSKNGSLSLSVDLCS 472 (846)
Q Consensus 449 g~iP~-~~~~l~~l~~l~l~~nlc~ 472 (846)
.+|. .|..|..++.|.++-|.|.
T Consensus 130 -~l~k~~F~gL~slqrLllNan~i~ 153 (498)
T KOG4237|consen 130 -DLPKGAFGGLSSLQRLLLNANHIN 153 (498)
T ss_pred -hhhhhHhhhHHHHHHHhcChhhhc
Confidence 7776 5778888888888877664
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.8e-07 Score=75.28 Aligned_cols=60 Identities=37% Similarity=0.409 Sum_probs=53.8
Q ss_pred CCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCCcccc
Q 003114 411 TMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVDL 470 (846)
Q Consensus 411 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~nl 470 (846)
++|+.|+|++|+|+..-+..|.++++|++|+|++|+|+..-|..|..+++|+.|++++|.
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 579999999999996555799999999999999999996666789999999999999874
|
... |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1e-06 Score=99.03 Aligned_cols=167 Identities=22% Similarity=0.317 Sum_probs=91.5
Q ss_pred EEECCccccCCCCCCcceeeeEEeeeecCCccEEEEEecCCCCCchhHHHHHHHhhhccccCCc--cchhhHHHHHHHHh
Q 003114 278 ISFNGNHLYGPVVPSYRHTTTAYTTSALTGEKLQFSIHKTENSTLPPILNAIEFYLVQDFSQSE--TEQADVDAIMNIKS 355 (846)
Q Consensus 278 i~~n~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~l~~t~~S~lpP~lna~ei~~~~~~~~~~--~~~~d~~al~~~k~ 355 (846)
|.+.|+.++|..-|.....-+.. .=++|..|.-.-+|.=|.++..+..+.++... +.-.|...|-.+++
T Consensus 12 vDfsgNDFsg~~FP~~v~qMt~~---------~WLkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRs 82 (1255)
T KOG0444|consen 12 VDFSGNDFSGDRFPHDVEQMTQM---------TWLKLNRTKLEQVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRS 82 (1255)
T ss_pred ccccCCcCCCCcCchhHHHhhhe---------eEEEechhhhhhChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHH
Confidence 45567777776666544332211 12455566666677777666555544444322 22223333333443
Q ss_pred hcCCCC-C--CCCCCCCCCCCceEEeecCCCCCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCc-hh
Q 003114 356 LYKRKD-W--QGDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPE-FL 431 (846)
Q Consensus 356 ~~~~~~-W--~~dpC~~~~~~w~gv~C~~~~~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~-~~ 431 (846)
.....+ - +|-|- + .-....|+.||||+|+|+ ..|..+-.-+++-.|+||+|+|. +||. -|
T Consensus 83 v~~R~N~LKnsGiP~------------d--iF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lf 146 (1255)
T KOG0444|consen 83 VIVRDNNLKNSGIPT------------D--IFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLF 146 (1255)
T ss_pred HhhhccccccCCCCc------------h--hcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHH
Confidence 332111 0 12111 0 012235666777777776 66766666667777777777776 5553 34
Q ss_pred cccCccccccccCccCCCCCcccccccCCCCCCCCcccc
Q 003114 432 SKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVDL 470 (846)
Q Consensus 432 ~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~nl 470 (846)
.+|+.|-+||||+|+|. .+|+.+..|..|++|.|++|.
T Consensus 147 inLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NP 184 (1255)
T KOG0444|consen 147 INLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNP 184 (1255)
T ss_pred HhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCCh
Confidence 66666777777777776 666666666666666666653
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.3e-06 Score=86.86 Aligned_cols=82 Identities=30% Similarity=0.379 Sum_probs=37.6
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchh-cccCccccccccCccCCCCCc--ccccccCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFL-SKLQYLRVLNLTGNMLTGPLP--AGLVERSKNGS 463 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~-~~l~~L~~L~Ls~N~l~g~iP--~~~~~l~~l~~ 463 (846)
.+++.|+|++|+|+ .++ .+..|++|+.|+|++|+|+ .+++.+ ..+++|+.|+|++|+|.. +- ..+..+++|+.
T Consensus 42 ~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~ 117 (175)
T PF14580_consen 42 DKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLRV 117 (175)
T ss_dssp TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--E
T ss_pred cCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCcce
Confidence 57889999999998 454 5788899999999999998 565555 468899999999999873 32 35667888888
Q ss_pred CCCccccCC
Q 003114 464 LSLSVDLCS 472 (846)
Q Consensus 464 l~l~~nlc~ 472 (846)
|++.+|.+.
T Consensus 118 L~L~~NPv~ 126 (175)
T PF14580_consen 118 LSLEGNPVC 126 (175)
T ss_dssp EE-TT-GGG
T ss_pred eeccCCccc
Confidence 888888663
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.3e-06 Score=94.22 Aligned_cols=84 Identities=27% Similarity=0.364 Sum_probs=67.9
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCC----------------------CCCC-chhcccCcccccccc
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLT----------------------GPVP-EFLSKLQYLRVLNLT 443 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~----------------------g~iP-~~~~~l~~L~~L~Ls 443 (846)
++++.|+|++|-|. .+|.+++.+..|+.||||+|+|. |.+| +.+.+|.+|..|||.
T Consensus 435 ~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~ 513 (565)
T KOG0472|consen 435 QKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQ 513 (565)
T ss_pred hcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccC
Confidence 46777888888887 88888888888888888877664 1233 338888999999999
Q ss_pred CccCCCCCcccccccCCCCCCCCccccCC
Q 003114 444 GNMLTGPLPAGLVERSKNGSLSLSVDLCS 472 (846)
Q Consensus 444 ~N~l~g~iP~~~~~l~~l~~l~l~~nlc~ 472 (846)
+|.|. .||..++++.+|++|.+.+|...
T Consensus 514 nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 514 NNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred CCchh-hCChhhccccceeEEEecCCccC
Confidence 99998 89999999999999999988775
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.2e-05 Score=79.99 Aligned_cols=138 Identities=18% Similarity=0.313 Sum_probs=84.8
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccc--eeEeeEeecCCeeeEeeecccCCC-
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNL--TTLYGYCNEGNQIGLIYEYMANGS- 617 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnI--v~l~g~~~~~~~~~LV~Ey~~~gs- 617 (846)
+.||+|..+.||+. .+..+++|...... ......+|.++++.+..-.+ .+.+++...++...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 24567788876543 23456889999999865443 566777777777889999998863
Q ss_pred hhhhh---------------------hcCCCCccChHHHHH-HHH----------HHHH-HHHHHhc-cCCCCeeecCCC
Q 003114 618 LEEYL---------------------SDSNADVLSWEGRLR-IAT----------EAAQ-GLEYLHL-GCKPPRVHRDIK 663 (846)
Q Consensus 618 L~~~l---------------------~~~~~~~l~~~~~~~-i~~----------~ia~-gL~yLH~-~~~~~IiHrDlK 663 (846)
+.+.+ +.-............ +.. .+.. ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 22111 111101111111100 000 0111 1122211 113457899999
Q ss_pred CCCEEECCCCcEEEEeccCCc
Q 003114 664 PANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 664 p~NILld~~~~vkI~DFGla~ 684 (846)
|.||++++++ +.|.||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.9e-06 Score=95.29 Aligned_cols=108 Identities=29% Similarity=0.390 Sum_probs=89.4
Q ss_pred CCCCCCCCceE--EeecCC-----------CCCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhc
Q 003114 366 PCAPQAFLWNG--LGCSYN-----------DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLS 432 (846)
Q Consensus 366 pC~~~~~~w~g--v~C~~~-----------~~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~ 432 (846)
+| |..|...+ ..|+.. +..++..+.|||++|.|+..-+..|-+|++|+.++|.+|.|+ .||....
T Consensus 45 ~c-pa~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~ 122 (873)
T KOG4194|consen 45 EC-PATCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGH 122 (873)
T ss_pred cC-CCcCCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccc
Confidence 55 55565555 567764 234567789999999999888888999999999999999999 8999666
Q ss_pred ccCccccccccCccCCCCCcccccccCCCCCCCCccccCCCCC
Q 003114 433 KLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVDLCSSYP 475 (846)
Q Consensus 433 ~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~nlc~~~p 475 (846)
...+|+.|+|.+|.|+..-.+++.-++.|++|+|+.|+....+
T Consensus 123 ~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~ 165 (873)
T KOG4194|consen 123 ESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIP 165 (873)
T ss_pred cccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhccc
Confidence 6677999999999999555678999999999999999887643
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.6e-06 Score=93.52 Aligned_cols=78 Identities=26% Similarity=0.346 Sum_probs=45.0
Q ss_pred eEEEEcCCCCCcccCCcccc-CCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCCc
Q 003114 389 ITSLNLSSRGLTGGIPPYLS-NLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLS 467 (846)
Q Consensus 389 l~~L~L~~n~l~g~ip~~~~-~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~ 467 (846)
+.+|+++.|+|. .+|.+.+ +|.+|..|||..|+|+ +.|+++.-|++|.+||||+|.|+ .+|.+++++ .|..|.+.
T Consensus 230 L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~le 305 (565)
T KOG0472|consen 230 LKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALE 305 (565)
T ss_pred HHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhc
Confidence 445555555555 5555433 5666666666666665 55666666666666666666666 455566665 55555555
Q ss_pred ccc
Q 003114 468 VDL 470 (846)
Q Consensus 468 ~nl 470 (846)
+|.
T Consensus 306 GNP 308 (565)
T KOG0472|consen 306 GNP 308 (565)
T ss_pred CCc
Confidence 553
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.5e-06 Score=86.57 Aligned_cols=85 Identities=33% Similarity=0.452 Sum_probs=30.1
Q ss_pred CCCCceEEEEcCCCCCcccCCcccc-CCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCccccc-ccCCC
Q 003114 384 NDPPRITSLNLSSRGLTGGIPPYLS-NLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLV-ERSKN 461 (846)
Q Consensus 384 ~~~~~l~~L~L~~n~l~g~ip~~~~-~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~-~l~~l 461 (846)
.++.+++.|+|.+|+|+ .|. .++ .|++|+.||||+|.|+ .++ .+..|+.|+.|+|++|+|+ .+++.+. .+++|
T Consensus 16 ~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L 90 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNL 90 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT-
T ss_pred ccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcC
Confidence 34457899999999999 554 566 6899999999999999 565 4889999999999999999 6766664 68999
Q ss_pred CCCCCccccCCC
Q 003114 462 GSLSLSVDLCSS 473 (846)
Q Consensus 462 ~~l~l~~nlc~~ 473 (846)
+.|++++|....
T Consensus 91 ~~L~L~~N~I~~ 102 (175)
T PF14580_consen 91 QELYLSNNKISD 102 (175)
T ss_dssp -EEE-TTS---S
T ss_pred CEEECcCCcCCC
Confidence 999999986643
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.6e-06 Score=102.10 Aligned_cols=79 Identities=32% Similarity=0.464 Sum_probs=56.5
Q ss_pred CceEEEEcCCCCCcccCCcc-ccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~-~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.+|+.|+|++|+|. .+|.+ +.+|..|+.|+||+|+|+ .||+.+.++..|++|...+|+|. ..| .+.+++.|+.+|
T Consensus 383 ~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lD 458 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLD 458 (1081)
T ss_pred cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEe
Confidence 47888888888887 66664 788888888888888888 77777777766666666666666 556 555666555555
Q ss_pred Cccc
Q 003114 466 LSVD 469 (846)
Q Consensus 466 l~~n 469 (846)
++.|
T Consensus 459 lS~N 462 (1081)
T KOG0618|consen 459 LSCN 462 (1081)
T ss_pred cccc
Confidence 5554
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.97 E-value=4e-06 Score=63.46 Aligned_cols=37 Identities=46% Similarity=0.633 Sum_probs=24.0
Q ss_pred CCCCeEeccCCCCCCCCCchhcccCccccccccCccCC
Q 003114 411 TMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448 (846)
Q Consensus 411 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~ 448 (846)
++|++|+|++|+|+ .+|..|++|++|+.|+|++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 35666777777776 56666777777777777777766
|
... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00011 Score=84.87 Aligned_cols=139 Identities=20% Similarity=0.208 Sum_probs=86.9
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchh-------------------------------hHH------HHHHHH
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQG-------------------------------YEQ------FEAEVI 583 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~-------------------------------~~~------~~~Ei~ 583 (846)
+-||.-+.|.||+|++++|+.||||+-++.-+.. .+. |.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5699999999999999999999999876531110 011 223333
Q ss_pred HHH----hccccccee---EeeE-eecCCeeeEeeecccCCChhhhh--hcCCCCccChHHHHHHHHHHHHHHHHHhccC
Q 003114 584 LLR----TVHHKNLTT---LYGY-CNEGNQIGLIYEYMANGSLEEYL--SDSNADVLSWEGRLRIATEAAQGLEYLHLGC 653 (846)
Q Consensus 584 ~l~----~l~HpnIv~---l~g~-~~~~~~~~LV~Ey~~~gsL~~~l--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 653 (846)
-.. .++|-+... +=.. ..-.....|+||||+|..+.+.- .+.+ ++... ++..+.++.. +.-.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~---i~~~l~~~~~--~qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPHD---ILNKLVEAYL--EQIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC---CCHHH---HHHHHHHHHH--HHHH
Confidence 222 223444111 1111 22245689999999998776653 3332 44443 3333333322 1112
Q ss_pred CCCeeecCCCCCCEEECC----CCcEEEEeccCCccCC
Q 003114 654 KPPRVHRDIKPANILLND----QFQARLADFGLSKTFP 687 (846)
Q Consensus 654 ~~~IiHrDlKp~NILld~----~~~vkI~DFGla~~~~ 687 (846)
..|++|+|-+|.||++.. ++++.+.|||+...+.
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 457999999999999983 6789999999988653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.85 E-value=9.7e-05 Score=76.74 Aligned_cols=141 Identities=21% Similarity=0.261 Sum_probs=84.3
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhccccc--ceeEeeEee---cCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKN--LTTLYGYCN---EGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~~~---~~~~~~LV~Ey~~~ 615 (846)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+.... +.+++.++. .....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 357889999999999877 69999997655 44567888999988886443 445665442 23457899999998
Q ss_pred CChhh----------------hh---hcC--CCCccChHH---------HHHH------------HHHHHH-HHHHHhc-
Q 003114 616 GSLEE----------------YL---SDS--NADVLSWEG---------RLRI------------ATEAAQ-GLEYLHL- 651 (846)
Q Consensus 616 gsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~- 651 (846)
..+.. .+ +.. ......+.. .... ...+.+ .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87777 11 111 000111110 0000 111222 2333331
Q ss_pred ---cCCCCeeecCCCCCCEEEC-CCCcEEEEeccCCc
Q 003114 652 ---GCKPPRVHRDIKPANILLN-DQFQARLADFGLSK 684 (846)
Q Consensus 652 ---~~~~~IiHrDlKp~NILld-~~~~vkI~DFGla~ 684 (846)
.....++|+|+.++||+++ +++.+.|.||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2356799999999999999 66667899998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.85 E-value=3.7e-06 Score=94.46 Aligned_cols=85 Identities=28% Similarity=0.252 Sum_probs=69.0
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
.+++.|+|..|+++..-..++-+|++|+.||||+|.|...-+++++-+++|+.||||+|+|+-.-|.+|..|+.|+.|.|
T Consensus 269 ~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 269 EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred cccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 36788888888888666667888888888888888888777888888888888888888888555667778888888888
Q ss_pred ccccC
Q 003114 467 SVDLC 471 (846)
Q Consensus 467 ~~nlc 471 (846)
+.|..
T Consensus 349 s~Nsi 353 (873)
T KOG4194|consen 349 SHNSI 353 (873)
T ss_pred cccch
Confidence 77754
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=97.81 E-value=6.9e-06 Score=82.15 Aligned_cols=103 Identities=17% Similarity=0.267 Sum_probs=54.8
Q ss_pred EEEEeeeccCCceeecCCCCCCCccccCCC---CCceeeccc--c--eeccCCCCCCCCcHHHHhhccccCCCCCceEEe
Q 003114 174 FIRMDVLSITNQVVRYRDDVYDRSWAPYAY---PQWQQITTP--R--TIDEDRYNDYQLPSIVMRSAATPKNKSEPLLID 246 (846)
Q Consensus 174 ~~r~~~g~~~~~~~rypdD~~dR~W~~~~~---~~~~~~~t~--~--~~~~~~~~~~~~P~~v~~tA~t~~~~~~~l~~~ 246 (846)
+.|.|.|+. .| +|..+..|+++.. ..|.-..+. . ............+..++||+-.+.+ .+.+.
T Consensus 2 ~~~IN~Gg~-----~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~---~f~Y~ 72 (174)
T PF11721_consen 2 VLRINAGGP-----AY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS---SFSYD 72 (174)
T ss_dssp EEEEEETSS-----SE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SS---SEEEE
T ss_pred EEEEECCCC-----cc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCC---ceEEE
Confidence 568888865 34 8999999998643 334111110 0 0011112224567799999977332 24444
Q ss_pred cccCCCCceEEEEEeeehhhcccc------ccceEEEEEECCccccC
Q 003114 247 LVHEDSTSKFYMYMHFAELEELQA------NQSRQFNISFNGNHLYG 287 (846)
Q Consensus 247 ~~~~~~~~~~~~~lhFae~~~~~~------~~~R~F~i~~n~~~~~~ 287 (846)
.+ ..++-.|-|-|||||+.. .. .++|+|||++||+.+..
T Consensus 73 ip-~~~~G~Y~V~L~FaE~~~-~~~~~~~~~G~RvFdV~v~g~~vl~ 117 (174)
T PF11721_consen 73 IP-VVPNGTYTVRLHFAELYF-GASGGASGPGQRVFDVYVNGETVLK 117 (174)
T ss_dssp EE---S-EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEE
T ss_pred Ee-cCCCcEEEEEEEeccccc-cccccccCCCceEEEEEecceEEEe
Confidence 32 367778999999999975 33 67999999999998754
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.0002 Score=75.61 Aligned_cols=137 Identities=17% Similarity=0.122 Sum_probs=83.3
Q ss_pred CcCce-EEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEeeecccCCChhhh
Q 003114 544 GEGSF-GKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEY 621 (846)
Q Consensus 544 G~G~f-G~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~ 621 (846)
-.|.+ ..||+...+ +..+.+|+..... .....+|+++++.+. +--+.+++++...++..++|||+++|.+|.+.
T Consensus 7 ~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 7 TEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 34444 789998764 4678888876543 345678998888884 33355677777666678999999998877643
Q ss_pred h-------------------hcCCCC--ccCh--HHHHHHHH--------------------HHHHHHHHHhc----cCC
Q 003114 622 L-------------------SDSNAD--VLSW--EGRLRIAT--------------------EAAQGLEYLHL----GCK 654 (846)
Q Consensus 622 l-------------------~~~~~~--~l~~--~~~~~i~~--------------------~ia~gL~yLH~----~~~ 654 (846)
. +..... .+.. ..+..... .+...+..|-. ...
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 111100 0100 00000000 01111122210 113
Q ss_pred CCeeecCCCCCCEEECCCCcEEEEeccCCc
Q 003114 655 PPRVHRDIKPANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 655 ~~IiHrDlKp~NILld~~~~vkI~DFGla~ 684 (846)
..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 558999999999999998888999999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00013 Score=74.65 Aligned_cols=127 Identities=17% Similarity=0.176 Sum_probs=79.4
Q ss_pred cCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHH---------HHHHHHHHhcccc---cceeEeeEe-----ecCCe
Q 003114 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQF---------EAEVILLRTVHHK---NLTTLYGYC-----NEGNQ 605 (846)
Q Consensus 543 LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~---------~~Ei~~l~~l~Hp---nIv~l~g~~-----~~~~~ 605 (846)
+-......|.+-.. +|..+++|..+.......+.| .+++..+..++.. ....++... .-...
T Consensus 39 ~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~ 117 (229)
T PF06176_consen 39 FKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSS 117 (229)
T ss_pred ecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeE
Confidence 33333344444434 567788888776544332322 2334444444322 223322222 22345
Q ss_pred eeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCc
Q 003114 606 IGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 606 ~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~ 684 (846)
.+++|||++|..|.+... ++. .++..+++++.-|| +.|+.|||.+|+|+++++++ +++.||+..+
T Consensus 118 ~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 118 YVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred EEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 679999999988776542 222 24566778899999 99999999999999999664 9999998664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00038 Score=71.01 Aligned_cols=131 Identities=23% Similarity=0.455 Sum_probs=94.0
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCC----------------chhhHHHHHHHHHHHhcc------cccceeEee
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSS----------------RQGYEQFEAEVILLRTVH------HKNLTTLYG 598 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----------------~~~~~~~~~Ei~~l~~l~------HpnIv~l~g 598 (846)
..||+|+.-.||. ++++....||+..... ....++..+|+.....+. +..|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 5799999999986 4556677889887665 223566777777666665 778999999
Q ss_pred EeecCCeeeEeeecccCC------ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC
Q 003114 599 YCNEGNQIGLIYEYMANG------SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ 672 (846)
Q Consensus 599 ~~~~~~~~~LV~Ey~~~g------sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~ 672 (846)
+...+....+|+|.+.+. +|.+++.+.. ++. ...+.+.++ .+||- +..|+.+|++|+||++..+
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEEEEec
Confidence 999999999999998542 7888885543 444 334444444 34555 6679999999999999532
Q ss_pred ---C-cEEEEe-ccCC
Q 003114 673 ---F-QARLAD-FGLS 683 (846)
Q Consensus 673 ---~-~vkI~D-FGla 683 (846)
. .+.|+| ||..
T Consensus 155 ~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGEK 170 (199)
T ss_pred CCCceEEEEEeCCCCc
Confidence 2 577777 4544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=97.77 E-value=9.4e-05 Score=89.80 Aligned_cols=57 Identities=5% Similarity=0.080 Sum_probs=36.5
Q ss_pred ecCCCCCchhHHHHHHHh----------------hhccccCCccchhhHHHHHHHHhhcC----CCC----CCC--CCCC
Q 003114 315 HKTENSTLPPILNAIEFY----------------LVQDFSQSETEQADVDAIMNIKSLYK----RKD----WQG--DPCA 368 (846)
Q Consensus 315 ~~t~~S~lpP~lna~ei~----------------~~~~~~~~~~~~~d~~al~~~k~~~~----~~~----W~~--dpC~ 368 (846)
...+.+..||-+..-|-. .-+-+...+|.+.+...++++.+.+. ..+ |+| |+|.
T Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~ 96 (754)
T PRK15370 17 SNEASTEVPLKEEIWNKISAFFSSEHQVEAQNCIAYLCHPPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCI 96 (754)
T ss_pred hhhhccCCCchhHHHHHHHHHhccchHHHHHHHHHHHhCCCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccc
Confidence 344555666766653322 23445556789999999999998876 334 865 6785
Q ss_pred CCC
Q 003114 369 PQA 371 (846)
Q Consensus 369 ~~~ 371 (846)
-..
T Consensus 97 ~~~ 99 (754)
T PRK15370 97 LSE 99 (754)
T ss_pred cCC
Confidence 433
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.77 E-value=4.7e-06 Score=77.62 Aligned_cols=83 Identities=28% Similarity=0.318 Sum_probs=69.0
Q ss_pred CCceEEEEcCCCCCcccCCccccCC-CCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNL-TMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L-~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
..+|+.++|++|++. ..|+.|... +.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|.-+..|.++..|
T Consensus 52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~L 128 (177)
T KOG4579|consen 52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDML 128 (177)
T ss_pred CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHh
Confidence 357888899999998 777776554 58899999999999 89999999999999999999998 678888888888888
Q ss_pred CCccccC
Q 003114 465 SLSVDLC 471 (846)
Q Consensus 465 ~l~~nlc 471 (846)
+...|.-
T Consensus 129 ds~~na~ 135 (177)
T KOG4579|consen 129 DSPENAR 135 (177)
T ss_pred cCCCCcc
Confidence 7766643
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.76 E-value=6.8e-06 Score=88.67 Aligned_cols=87 Identities=22% Similarity=0.220 Sum_probs=80.1
Q ss_pred CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCC
Q 003114 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGS 463 (846)
Q Consensus 384 ~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~ 463 (846)
...++|+.|+|++|+|++.-+.+|..+.+|+.|+|..|+|.-.--..|.+|..|+.|+|.+|+|+-.-|..|..+..|..
T Consensus 271 ~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~ 350 (498)
T KOG4237|consen 271 KKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLST 350 (498)
T ss_pred hhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeee
Confidence 56789999999999999999999999999999999999998666678999999999999999999888999999999999
Q ss_pred CCCcccc
Q 003114 464 LSLSVDL 470 (846)
Q Consensus 464 l~l~~nl 470 (846)
|.+-.|.
T Consensus 351 l~l~~Np 357 (498)
T KOG4237|consen 351 LNLLSNP 357 (498)
T ss_pred eehccCc
Confidence 9887774
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.74 E-value=9.7e-05 Score=74.87 Aligned_cols=103 Identities=27% Similarity=0.311 Sum_probs=82.3
Q ss_pred HHHHHHHHhccc-ccceeEeeEeecCCeeeEeeecccCCChhhhhhc-CCCCccChHHHHHHHHHHHHHHHHHhccCCCC
Q 003114 579 EAEVILLRTVHH-KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSD-SNADVLSWEGRLRIATEAAQGLEYLHLGCKPP 656 (846)
Q Consensus 579 ~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 656 (846)
..|..+++.+.+ +++.+++|+|-. ++|.||...+++...-.. ..--.-+|..|.+||.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888876 699999999965 789999987766422100 00012689999999999999999999766667
Q ss_pred eeecCCCCCCEEECCCCcEEEEeccCCcc
Q 003114 657 RVHRDIKPANILLNDQFQARLADFGLSKT 685 (846)
Q Consensus 657 IiHrDlKp~NILld~~~~vkI~DFGla~~ 685 (846)
+.-.|++++|+-+++++.+|+.|.+.+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00037 Score=72.23 Aligned_cols=135 Identities=19% Similarity=0.193 Sum_probs=88.9
Q ss_pred hcCcCceEEEEEEEEcCCcEEEEEEeCCCCchh-------------------h-----HHHHHHHHHHHhcccc--ccee
Q 003114 542 ILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQG-------------------Y-----EQFEAEVILLRTVHHK--NLTT 595 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~-------------------~-----~~~~~Ei~~l~~l~Hp--nIv~ 595 (846)
.|..|.-+.||+|.-.++..+|||+.+...... . .-.++|+..|.++... .+-+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 577788889999998889999999986432110 0 0123455555555322 2223
Q ss_pred EeeEeecCCeeeEeeecccCC-ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc
Q 003114 596 LYGYCNEGNQIGLIYEYMANG-SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ 674 (846)
Q Consensus 596 l~g~~~~~~~~~LV~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~ 674 (846)
-+++. +-.|||||+... .-.-.|++-. +...+...+..++++.+.-|-. ..++||+||..=|||+. ++.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~---~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKDVP---LELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcccCC---cCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCe
Confidence 33332 237999999543 2222232222 2233566777788888887762 47999999999999999 789
Q ss_pred EEEEeccCCccC
Q 003114 675 ARLADFGLSKTF 686 (846)
Q Consensus 675 vkI~DFGla~~~ 686 (846)
+.|+|+|-|...
T Consensus 205 p~iID~~QaV~~ 216 (268)
T COG1718 205 PYIIDVSQAVTI 216 (268)
T ss_pred EEEEECcccccc
Confidence 999999988654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0003 Score=69.08 Aligned_cols=127 Identities=20% Similarity=0.214 Sum_probs=87.9
Q ss_pred hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChh
Q 003114 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLE 619 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 619 (846)
.+.||+|.+|.||+|.+. |.++|+|+-...++. ..++.|+++|..+.-.++.+=+-.+.. ..+.|||+.|-.|.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L~ 100 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcchh
Confidence 467999999999999995 458999988766553 678999999999988777654433322 23459999988888
Q ss_pred hhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCC-CCCEEECCCCcEEEEeccCCc
Q 003114 620 EYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIK-PANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 620 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlK-p~NILld~~~~vkI~DFGla~ 684 (846)
++-... +-... ..++..---|. ..+|-|+.|. |...++-.+..+.|+||..|+
T Consensus 101 ~~~~~~-----~rk~l----~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 101 KLEIGG-----DRKHL----LRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhcc-----cHHHH----HHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 765432 11222 23334433344 6788899886 444444444489999999886
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.68 E-value=2.3e-05 Score=59.32 Aligned_cols=37 Identities=43% Similarity=0.708 Sum_probs=33.0
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLT 424 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~ 424 (846)
++|+.|+|++|+|+ .+|+.|++|++|+.|+|++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 36899999999999 78989999999999999999998
|
... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=1.3e-05 Score=91.48 Aligned_cols=182 Identities=19% Similarity=0.152 Sum_probs=131.9
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhccccc-ceeEeeEeecCCeeeEeeecccCC-Ch
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKN-LTTLYGYCNEGNQIGLIYEYMANG-SL 618 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~~~~LV~Ey~~~g-sL 618 (846)
+-+++|+.+.++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..+....++++++..+ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 346889999999987544444446655433 34556889999999999 666667677778899999999877 22
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~ 698 (846)
....... ...+...+...+...-.++++++| +-.=+|+| ||+..+ ...|..||+....+.... .....
T Consensus 323 ~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~ 390 (829)
T KOG0576|consen 323 ALEMTVS-EIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTA 390 (829)
T ss_pred cccCChh-hHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc---ccccC
Confidence 2222111 112444555567777788999999 54457888 777666 578999999887664321 34456
Q ss_pred cCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003114 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIA 739 (846)
Q Consensus 699 ~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~ 739 (846)
.+++.++|||..+...+..+.|+|+.|+--.+|.-|-+|-.
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 78999999999999999999999999987778877776643
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.63 E-value=1.6e-05 Score=93.97 Aligned_cols=85 Identities=32% Similarity=0.485 Sum_probs=73.5
Q ss_pred ceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCCc
Q 003114 388 RITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLS 467 (846)
Q Consensus 388 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~ 467 (846)
+|..|||++|+++ ..|..+..+.+|+.|+++.|-+. ..|.+.+++++|++|+|.+|.+. .+|.++..+.+|+.|+++
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 5888999988887 88888888999999999999888 78888888899999999998888 889999999999999998
Q ss_pred cccCCCCC
Q 003114 468 VDLCSSYP 475 (846)
Q Consensus 468 ~nlc~~~p 475 (846)
+|..+..|
T Consensus 123 ~N~f~~~P 130 (1081)
T KOG0618|consen 123 FNHFGPIP 130 (1081)
T ss_pred hhccCCCc
Confidence 88776643
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0001 Score=73.77 Aligned_cols=128 Identities=18% Similarity=0.266 Sum_probs=66.6
Q ss_pred cCCCCcEEecCccccccCcc-----------ccccccccccccccCcceeecCCCCCcceeeecccCCceeEEEEEe---
Q 003114 24 QNQSGIKYISDTTFVDAGIS-----------KSVALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDVRYLIRASF--- 89 (846)
Q Consensus 24 ~~~~~~~~~~d~~~~~~g~~-----------~~v~~~~~~~~~~~~~~~lr~fp~~~~~cy~l~~~~~~~ylvr~~f--- 89 (846)
.+..|+.|.+|..|..++.. ...........-.+.|+|-|+=|. ...|.+|+.+.|.|-||+.|
T Consensus 13 ~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~--~f~Y~ip~~~~G~Y~V~L~FaE~ 90 (174)
T PF11721_consen 13 TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS--SFSYDIPVVPNGTYTVRLHFAEL 90 (174)
T ss_dssp EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SS--SEEEEEE--S-EEEEEEEEEE-S
T ss_pred cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCC--ceEEEEecCCCcEEEEEEEeccc
Confidence 57789999999999755441 011111111223356889999333 67999999999999999999
Q ss_pred eeccCCCCCCCC---eeeEeecCce-eeEEeeCCC-c--c-eEEEEE-EEEecCCceEEEEee-----------cCCCCc
Q 003114 90 AHGDYDGKGTVP---EFDLHLGPNK-WESVILGNV-S--T-IIVKEI-IHVISSNSTRVCLVN-----------TGAGTP 149 (846)
Q Consensus 90 ~yg~~d~~~~~~---~fd~~~~~~~-w~~v~~~~~-~--~-~~~~e~-~~~~~~~~~~vcl~~-----------~~~~~P 149 (846)
+++. ++....| +||+.++|+. ...+++-.. + . ....+. -+.+.+..+.++|.. ...|.|
T Consensus 91 ~~~~-~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~~~~~i~~~~~~~~p 169 (174)
T PF11721_consen 91 YFGA-SGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGKGTLCIPFIGSYGNP 169 (174)
T ss_dssp SS---------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--SEEEEEEESSSSSS
T ss_pred cccc-cccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCCCcEEeeccccCCCc
Confidence 3433 3333333 7999999963 222221111 1 1 233333 223478889999986 455668
Q ss_pred ceeee
Q 003114 150 FISAL 154 (846)
Q Consensus 150 fis~l 154 (846)
.||+|
T Consensus 170 ~IsaI 174 (174)
T PF11721_consen 170 LISAI 174 (174)
T ss_dssp SEEEE
T ss_pred EEeeC
Confidence 88886
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.60 E-value=1.1e-05 Score=83.87 Aligned_cols=58 Identities=33% Similarity=0.476 Sum_probs=37.2
Q ss_pred ceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCC
Q 003114 388 RITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448 (846)
Q Consensus 388 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~ 448 (846)
.++.||||+|.|+ .|..+..-++.++.|+||+|.|. .+-. +..|.+|+.||||+|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls 342 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA 342 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH
Confidence 3566666666666 66666666666666666666666 3333 666666666666666665
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.001 Score=82.83 Aligned_cols=78 Identities=18% Similarity=0.348 Sum_probs=56.3
Q ss_pred hhcCcCceEEEEEEEEcCC---cEEEEEEeCCCC-chhhHHHHHHHHHHHhcc-cccc--eeEeeEeecC---CeeeEee
Q 003114 541 TILGEGSFGKVYHGYLDDN---TEVAVKMLSPSS-RQGYEQFEAEVILLRTVH-HKNL--TTLYGYCNEG---NQIGLIY 610 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g---~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~-HpnI--v~l~g~~~~~---~~~~LV~ 610 (846)
+.++.|.+..+|+....++ ..+++|+..... ......+.+|+.+++.+. |.++ .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 4578999999999887654 367777764332 123356889999999995 6664 7778887664 4678999
Q ss_pred ecccCCCh
Q 003114 611 EYMANGSL 618 (846)
Q Consensus 611 Ey~~~gsL 618 (846)
||+++..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99987643
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=97.48 E-value=8.8e-05 Score=89.75 Aligned_cols=78 Identities=28% Similarity=0.352 Sum_probs=61.5
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
..|+.|+|++|+|+ .+|.. .++|+.|+|++|+|+ .+|..+ .+|+.|+|++|+|+ .+|.+++++++|..|++
T Consensus 382 ~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdL 452 (788)
T PRK15387 382 SGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 452 (788)
T ss_pred cccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEEC
Confidence 46788888888888 46653 357888888888888 477643 46788999999998 78999999999999999
Q ss_pred ccccCCC
Q 003114 467 SVDLCSS 473 (846)
Q Consensus 467 ~~nlc~~ 473 (846)
++|....
T Consensus 453 s~N~Ls~ 459 (788)
T PRK15387 453 EGNPLSE 459 (788)
T ss_pred CCCCCCc
Confidence 9886653
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.40 E-value=3.2e-05 Score=87.04 Aligned_cols=89 Identities=26% Similarity=0.369 Sum_probs=64.6
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
..+.+..||.+.|++. ++|+.++.|++|+.|.+..|++. .+|.++..| .|..||+|.|+++ .||-.|.+|+.|+.|
T Consensus 164 ~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l 239 (722)
T KOG0532|consen 164 LLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVL 239 (722)
T ss_pred cchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheee
Confidence 3345566666666666 66666666666666666666666 566666644 4778888999988 889999999999999
Q ss_pred CCccccCCCCCcc
Q 003114 465 SLSVDLCSSYPCK 477 (846)
Q Consensus 465 ~l~~nlc~~~pc~ 477 (846)
.|.+|...+.|..
T Consensus 240 ~LenNPLqSPPAq 252 (722)
T KOG0532|consen 240 QLENNPLQSPPAQ 252 (722)
T ss_pred eeccCCCCCChHH
Confidence 9999988776643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0011 Score=70.79 Aligned_cols=136 Identities=15% Similarity=0.105 Sum_probs=78.7
Q ss_pred cCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhccccccee-EeeEeecCCeeeEeeecccCCChhhh
Q 003114 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTT-LYGYCNEGNQIGLIYEYMANGSLEEY 621 (846)
Q Consensus 543 LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~-l~g~~~~~~~~~LV~Ey~~~gsL~~~ 621 (846)
+..|-...+|+... ++..+++|........-.-...+|..+++.+....+++ +++.+. -.+|+||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45678889998874 56678888765443221124578888998886544433 333322 3689999998765421
Q ss_pred -----------------hhcCC--CCccChHHHH-HHH---------HHHHHHHHHHhc-----cCCCCeeecCCCCCCE
Q 003114 622 -----------------LSDSN--ADVLSWEGRL-RIA---------TEAAQGLEYLHL-----GCKPPRVHRDIKPANI 667 (846)
Q Consensus 622 -----------------l~~~~--~~~l~~~~~~-~i~---------~~ia~gL~yLH~-----~~~~~IiHrDlKp~NI 667 (846)
++... ...++...++ ... ..+...+..+.. .....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 12111 1111211111 110 011111222211 1134589999999999
Q ss_pred EECCCCcEEEEeccCCc
Q 003114 668 LLNDQFQARLADFGLSK 684 (846)
Q Consensus 668 Lld~~~~vkI~DFGla~ 684 (846)
++++++ +.+.||..+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999877 7899999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0017 Score=68.05 Aligned_cols=72 Identities=21% Similarity=0.314 Sum_probs=48.4
Q ss_pred hcCcCceEEEEEEEEcC--CcEEEEEEeCCCCchhhHHHHHHHHHHHhccccccee-EeeEeecCCeeeEeeecccCCCh
Q 003114 542 ILGEGSFGKVYHGYLDD--NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTT-LYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~-l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
.|..|-...+|+....+ +..+++|+....... .....+|+.+++.+...++++ +++.+. -.++|||++|.++
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 46778888999998764 678899977654322 233457888888886544443 333332 2489999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0032 Score=68.78 Aligned_cols=75 Identities=16% Similarity=0.151 Sum_probs=55.2
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhccc---ccceeEeeEeec---CCeeeEeeeccc
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH---KNLTTLYGYCNE---GNQIGLIYEYMA 614 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~H---pnIv~l~g~~~~---~~~~~LV~Ey~~ 614 (846)
+.||.|..+.||+....++ .+.+|..+... ....+..|.+.|+.+.. -.+.+++++|.. .+..++|||+++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 20 ECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 4699999999999877666 46667754311 22578899999988853 357778887754 366899999999
Q ss_pred CCCh
Q 003114 615 NGSL 618 (846)
Q Consensus 615 ~gsL 618 (846)
++++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0019 Score=65.60 Aligned_cols=125 Identities=25% Similarity=0.360 Sum_probs=87.3
Q ss_pred HHhhhhhhcCcCce-EEEEEEEEcCCcEEEEEEeCC---CCc------------------hhhHHHHHHHHHHHhcc---
Q 003114 535 ITNDFETILGEGSF-GKVYHGYLDDNTEVAVKMLSP---SSR------------------QGYEQFEAEVILLRTVH--- 589 (846)
Q Consensus 535 ~t~~f~~~LG~G~f-G~Vykg~~~~g~~VAVK~l~~---~~~------------------~~~~~~~~Ei~~l~~l~--- 589 (846)
...+|.+.||.|.- |.|||+++ +|+.+|+|++.. ... .....|..|+....+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 34456688999999 99999999 466999999321 100 11235778888877774
Q ss_pred cccc--eeEeeEeecC------------------CeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHH
Q 003114 590 HKNL--TTLYGYCNEG------------------NQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL 649 (846)
Q Consensus 590 HpnI--v~l~g~~~~~------------------~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL 649 (846)
+.++ |+.+||..-. ....+|.||++... .+ ..+-+.+|.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~----~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PL----QIRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------cc----chhHHHHHHHHHHHH
Confidence 4566 8999987221 12456777765432 12 223445677778889
Q ss_pred hccCCCCeeecCCCCCCEEECCCCcEEEEeccCC
Q 003114 650 HLGCKPPRVHRDIKPANILLNDQFQARLADFGLS 683 (846)
Q Consensus 650 H~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla 683 (846)
| ..+|+-+|+|+.|.. .-||+|||.+
T Consensus 181 ~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 H---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred H---HCCeeeccCcccccc-----CCEEEecccC
Confidence 9 999999999999986 5689999864
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.30 E-value=7.8e-05 Score=77.81 Aligned_cols=92 Identities=25% Similarity=0.267 Sum_probs=70.1
Q ss_pred eEEeecCC-CCCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcc
Q 003114 375 NGLGCSYN-DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPA 453 (846)
Q Consensus 375 ~gv~C~~~-~~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~ 453 (846)
+-++|.+. -...|.++.|+||+|+|. .+.. +..|.+|+.||||+|.|+ .+-..-..|-+.+.|.|+.|.|.. -+
T Consensus 294 N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~--LS 368 (490)
T KOG1259|consen 294 NLITQIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET--LS 368 (490)
T ss_pred cchhhhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhh--hh
Confidence 44556542 135689999999999998 4444 899999999999999998 555555667788899999998862 24
Q ss_pred cccccCCCCCCCCccccC
Q 003114 454 GLVERSKNGSLSLSVDLC 471 (846)
Q Consensus 454 ~~~~l~~l~~l~l~~nlc 471 (846)
++..+-+|..|+++.|..
T Consensus 369 GL~KLYSLvnLDl~~N~I 386 (490)
T KOG1259|consen 369 GLRKLYSLVNLDLSSNQI 386 (490)
T ss_pred hhHhhhhheeccccccch
Confidence 567777788888887753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 846 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-53 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-53 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-50 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-42 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-42 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-41 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-39 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-25 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-23 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-23 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-21 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-21 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-21 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-21 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-21 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-21 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-21 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-21 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-21 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-15 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-15 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-15 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-15 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-06 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-06 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 9e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 5e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 7e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-04 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-04 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-04 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 455 bits (1172), Expect = e-155
Identities = 123/302 (40%), Positives = 179/302 (59%), Gaps = 9/302 (2%)
Query: 517 DGSLETKKRRFTYAEITKITNDF--ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQG 574
+ + R ++ + TN+F + ++G G FGKVY G L D +VA+K +P S QG
Sbjct: 19 SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG 78
Query: 575 YEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADV--LSW 632
E+FE E+ L H +L +L G+C+E N++ LIY+YM NG+L+ +L S+ +SW
Sbjct: 79 IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSW 138
Query: 633 EGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692
E RL I AA+GL YLH +HRD+K NILL++ F ++ DFG+SK +
Sbjct: 139 EQRLEICIGAARGLHYLHTRAI---IHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195
Query: 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANT--EEHKHISQW 750
HLST V GT GY+DPEY RLTEKSDVYSFGVVL E++ +R AI + E ++++W
Sbjct: 196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255
Query: 751 VDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810
G ++ IVDP L I S K + A+ C++ SS RP+M V+ +L+ L
Sbjct: 256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
Query: 811 ME 812
++
Sbjct: 316 LQ 317
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 374 bits (962), Expect = e-123
Identities = 112/291 (38%), Positives = 167/291 (57%), Gaps = 10/291 (3%)
Query: 525 RRFTYAEITKITNDF--ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYE-QFEAE 581
+RF+ E+ +++F + ILG G FGKVY G L D T VAVK L QG E QF+ E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 582 VILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNAD--VLSWEGRLRIA 639
V ++ H+NL L G+C + L+Y YMANGS+ L + L W R RIA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 640 TEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699
+A+GL YLH C P +HRD+K ANILL+++F+A + DFGL+K +H++T V
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVR 196
Query: 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAI----ANTEEHKHISQWVDFML 755
GT G++ PEY T + +EK+DV+ +GV+LLE+IT + A ++ + WV +L
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 756 AQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806
+ ++ +VD L G+ + +++A+ C S RP M+ VV L+
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 372 bits (957), Expect = e-123
Identities = 105/304 (34%), Positives = 169/304 (55%), Gaps = 20/304 (6%)
Query: 521 ETKKRRFTYAEITKITNDF--------ETILGEGSFGKVYHGYLDDNTEVAVKMLS---- 568
+T+ F++ E+ +TN+F +GEG FG VY GY+++ T VAVK L+
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVD 67
Query: 569 PSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSD-SNA 627
++ + +QF+ E+ ++ H+NL L G+ ++G+ + L+Y YM NGSL + LS
Sbjct: 68 ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 628 DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP 687
LSW R +IA AA G+ +LH + +HRDIK ANILL++ F A+++DFGL++
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 688 IEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHI 747
+ +++ + GT Y+ PE +T KSD+YSFGVVLLEIIT PA+ E + +
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243
Query: 748 SQWVDFMLA-QGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806
+ + + I++ +D K+ D D S +A C+ RP++ +V L+
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 807 ECLA 810
E A
Sbjct: 303 EMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 1e-79
Identities = 76/317 (23%), Positives = 126/317 (39%), Gaps = 31/317 (9%)
Query: 522 TKKRRFTYAEITKITNDFE--TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFE 579
+ + + + + G FG V+ L N VAVK+ +Q ++ E
Sbjct: 9 SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQ-NE 66
Query: 580 AEVILLRTVHHKNLTTLYGYCNEGNQIG----LIYEYMANGSLEEYLSDSNADVLSWEGR 635
EV L + H+N+ G G + LI + GSL ++L + V+SW
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNEL 123
Query: 636 LRIATEAAQGLEYLH-------LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688
IA A+GL YLH G KP HRDIK N+LL + A +ADFGL+ F
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 689 EGVSHLSTGVAGTFGYLDPEYCQ-----TFRLTEKSDVYSFGVVLLEIITSRPAIANTEE 743
+ + G GT Y+ PE + + D+Y+ G+VL E+ + A +
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 744 HKHI--SQWVDFMLAQGDIKNIV-----DPKLHGDIDVNSAWKAV-EIAMGCVSHSSTPR 795
+ + + + D++ +V P L ++ + E C H + R
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 796 PNMNRVVMELKECLAME 812
+ V + + +
Sbjct: 304 LSAGCVGERITQMQRLT 320
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 8e-62
Identities = 73/328 (22%), Positives = 116/328 (35%), Gaps = 42/328 (12%)
Query: 527 FTYAEITKITNDFE--TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVIL 584
+E + ++ + ++G G +G VY G LD VAVK+ S ++RQ + E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQNFIN-EKNIYR 60
Query: 585 LRTVHHKNLTTLYGYCNEGNQIG-----LIYEYMANGSLEEYLSDSNADVLSWEGRLRIA 639
+ + H N+ G L+ EY NGSL +YLS W R+A
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLA 117
Query: 640 TEAAQGLEYLH------LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF------P 687
+GL YLH KP HRD+ N+L+ + ++DFGLS
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 688 IEGVSHLSTGVAGTFGYLDPEY-------CQTFRLTEKSDVYSFGVVLLEIITSRPAIAN 740
+ + GT Y+ PE ++ D+Y+ G++ EI +
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 741 TEEHKHI----SQWVDFMLAQGDIKNIVD-----PKLHGDIDVNSAWKAV--EIAMGCVS 789
E V D++ +V PK NS E C
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297
Query: 790 HSSTPRPNMNRVVMELKECLAMETARKE 817
+ R + E + + K
Sbjct: 298 QDAEARLTAQXAEERMAELMMIWERNKS 325
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 4e-60
Identities = 67/201 (33%), Positives = 109/201 (54%), Gaps = 7/201 (3%)
Query: 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTT 595
+ + +G GSFG V+ ++VAVK+L + +F EV +++ + H N+
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYLSDSNA-DVLSWEGRLRIATEAAQGLEYLHLGCK 654
G + + ++ EY++ GSL L S A + L RL +A + A+G+ YLH
Sbjct: 99 FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRN 157
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFR 714
PP VHR++K N+L++ ++ ++ DFGLS+ +S S AGT ++ PE +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEP 215
Query: 715 LTEKSDVYSFGVVLLEIITSR 735
EKSDVYSFGV+L E+ T +
Sbjct: 216 SNEKSDVYSFGVILWELATLQ 236
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 4e-59
Identities = 67/213 (31%), Positives = 111/213 (52%), Gaps = 24/213 (11%)
Query: 538 DFETILGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQG-------YEQFEAEVILLRTVH 589
++E +G+G FG V+ G + D + VA+K L +G +++F+ EV ++ ++
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 590 HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL 649
H N+ LYG + ++ + E++ G L L D A + W +LR+ + A G+EY+
Sbjct: 82 HPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYM 138
Query: 650 HLGCKPPRVHRDIKPANILL-----NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704
PP VHRD++ NI L N A++ADFGLS+ H +G+ G F +
Sbjct: 139 Q-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQW 192
Query: 705 LDPE--YCQTFRLTEKSDVYSFGVVLLEIITSR 735
+ PE + TEK+D YSF ++L I+T
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-58
Identities = 46/203 (22%), Positives = 85/203 (41%), Gaps = 16/203 (7%)
Query: 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTT 595
+F T L E G+++ G ++ VK+L S + F E LR H N+
Sbjct: 13 NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 596 LYGYCNE--GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC 653
+ G C LI +M GSL L + V+ ++ A + A+G+ +LH
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TL 130
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE---YC 710
+P + ++++++ AR++ + +F S G ++ PE
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKK 183
Query: 711 QTFRLTEKSDVYSFGVVLLEIIT 733
+D++SF V+L E++T
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVT 206
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-58
Identities = 72/303 (23%), Positives = 120/303 (39%), Gaps = 33/303 (10%)
Query: 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
+G+G +G+V+ G +VAVK+ + E E+ + H+N+
Sbjct: 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIA 98
Query: 599 YCNEGN----QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH---- 650
+G Q+ LI +Y NGSL +YL + L + L++A + GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 651 -LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG--VSHLSTGVAGTFGYLDP 707
KP HRD+K NIL+ +AD GL+ F + V GT Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 708 E------YCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK-HISQWVDFMLAQGDI 760
E F+ +D+YSFG++L E+ + EE++ V + D+
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 761 KNIVD--------PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812
+ IV P + ++ C +H+ R RV L + +
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMG--KLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
Query: 813 TAR 815
+
Sbjct: 334 DIK 336
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-56
Identities = 68/279 (24%), Positives = 116/279 (41%), Gaps = 30/279 (10%)
Query: 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLY 597
+ E ++G G+FG V +VA+K + S + + F E+ L V+H N+ LY
Sbjct: 11 EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLY 67
Query: 598 GYCNEGNQIGLIYEYMANGSLEEYL-SDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP 656
G C N + L+ EY GSL L + + + +QG+ YLH
Sbjct: 68 GACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 657 RVHRDIKPANILLNDQFQ-ARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL 715
+HRD+KP N+LL ++ DFG + + T G+ ++ PE +
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEGSNY 180
Query: 716 TEKSDVYSFGVVLLEIITSR-PAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI-- 772
+EK DV+S+G++L E+IT R P + + I V +
Sbjct: 181 SEKCDVFSWGIILWEVITRRKP-------------FDEIGGPAFRIMWAVHNGTRPPLIK 227
Query: 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811
++ + + C S + RP+M +V + +
Sbjct: 228 NLPKPIE--SLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 4e-56
Identities = 68/293 (23%), Positives = 113/293 (38%), Gaps = 29/293 (9%)
Query: 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
+G+G +G+V+ G VAVK+ S + E E+ + H+N+
Sbjct: 12 LLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK-SWFRETELYNTVMLRHENILGFIA 69
Query: 599 YCNEGN----QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH---- 650
Q+ LI Y GSL +YL + L LRI A GL +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 651 -LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL--STGVAGTFGYLDP 707
KP HRD+K NIL+ Q +AD GL+ + GT Y+ P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 708 E------YCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK-HISQWVDFMLAQGDI 760
E F ++ D+++FG+VL E+ + E++K V + D+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 761 KNIVD-----PKLHGDIDVNSAWKAV-EIAMGCVSHSSTPRPNMNRVVMELKE 807
+ +V P + + ++ ++ C + + R R+ L +
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 5e-56
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPS----SRQGYEQFEAEVILLRTVHHKNL 593
E I+G G FGKVY + EVAVK Q E E L + H N+
Sbjct: 10 TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC 653
L G C + + L+ E+ G L LS + + + A + A+G+ YLH
Sbjct: 69 IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEA 125
Query: 654 KPPRVHRDIKPANILLNDQFQAR--------LADFGLSKTFPIEGVSHLSTGVAGTFGYL 705
P +HRD+K +NIL+ + + + DFGL++ E AG + ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWM 181
Query: 706 DPEYCQTFRLTEKSDVYSFGVVLLEIITSR 735
PE + ++ SDV+S+GV+L E++T
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 8e-56
Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 21/274 (7%)
Query: 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTL 596
+G GSFG VY G + +VAVKML+ + + Q + F+ EV +LR H N+
Sbjct: 28 VGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP 656
GY + ++ ++ SL +L S + + IA + A+G++YLH
Sbjct: 86 MGYSTAPQ-LAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE---YCQTF 713
+HRD+K NI L++ ++ DFGL+ SH ++G+ ++ PE +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 714 RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773
+ +SDVY+FG+VL E++T + +N I + V D+ + +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS-------N 253
Query: 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807
K + C+ RP+ R++ E++E
Sbjct: 254 CPKRMK--RLMAECLKKKRDERPSFPRILAEIEE 285
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 5e-55
Identities = 71/298 (23%), Positives = 124/298 (41%), Gaps = 29/298 (9%)
Query: 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
+ +G+G FG+V+ G EVAVK+ S + EAE+ + H+N+
Sbjct: 46 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIA 103
Query: 599 YCNEGN----QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH---- 650
N+ N Q+ L+ +Y +GSL +YL+ ++ EG +++A A GL +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 651 -LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP--IEGVSHLSTGVAGTFGYLDP 707
KP HRD+K NIL+ +AD GL+ + + GT Y+ P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 708 E------YCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKH-ISQWVDFMLAQGDI 760
E + F +++D+Y+ G+V EI E+++ V + ++
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280
Query: 761 KNIVD-----PKLHGDIDVNSAWKAV-EIAMGCVSHSSTPRPNMNRVVMELKECLAME 812
+ +V P + A + + +I C + R R+ L + E
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-54
Identities = 57/284 (20%), Positives = 111/284 (39%), Gaps = 34/284 (11%)
Query: 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTT 595
+ ++G+G FG+VYHG + EVA++++ + + F+ EV+ R H+N+
Sbjct: 36 EIGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKP 655
G C + +I +L + D+ VL +IA E +G+ YLH
Sbjct: 94 FMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AK 149
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS---TGVAGTFGYLDPEYCQT 712
+H+D+K N+ D + + DFGL + G +L PE +
Sbjct: 150 GILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 713 FRL---------TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNI 763
++ SDV++ G + E+ ++ + + + G N+
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-----AEAIIWQMGTGMKPNL 263
Query: 764 VDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807
I + +I + C + RP +++ L++
Sbjct: 264 S------QIGMGKEIS--DILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 6e-51
Identities = 63/285 (22%), Positives = 109/285 (38%), Gaps = 35/285 (12%)
Query: 539 FETILGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLY 597
+LG+G FG+ + + + +K L + F EV ++R + H N+
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 598 GYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPP 656
G + ++ I EY+ G+L + ++ W R+ A + A G+ YLH +
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMNI--- 129
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSK------------TFPIEGVSHLSTGVAGTFGY 704
+HRD+ N L+ + +ADFGL++ + V G +
Sbjct: 130 -IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIV 764
+ PE EK DV+SFG+VL EII A D++ D V
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA------------DPDYLPRTMDFGLNV 236
Query: 765 DPKLHGDI--DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807
L + ++ I + C RP+ ++ L+
Sbjct: 237 RGFLDRYCPPNCPPSFF--PITVRCCDLDPEKRPSFVKLEHWLET 279
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 61/267 (22%), Positives = 111/267 (41%), Gaps = 21/267 (7%)
Query: 510 RHKRLRKDGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGY-LDDNTEVAVK--M 566
+ +R ++ +E + + F+ +G GSF VY G + EVA
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 567 LSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGY----CNEGNQIGLIYEYMANGSLEEYL 622
++ ++F+ E +L+ + H N+ Y I L+ E M +G+L+ YL
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 623 SDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF-QARLADFG 681
+ + + +GL++LH PP +HRD+K NI + ++ D G
Sbjct: 121 KRFKV--MKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177
Query: 682 LSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANT 741
L+ ++ S V GT ++ PE + + E DVY+FG+ +LE+ TS +
Sbjct: 178 LAT---LKRASFAKA-VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232
Query: 742 EEHKHISQWVDFMLAQGDIKNIVDPKL 768
+ I + +K K+
Sbjct: 233 QNAAQI-----YRRVTSGVKPASFDKV 254
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-41
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKNLTTL 596
+G G+FG+V+ G L DNT VAVK +F E +L+ H N+ L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKP 655
G C + I ++ E + G +L + L + L++ +AA G+EYL C
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKCC-- 234
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY--LDPEYCQTF 713
+HRD+ N L+ ++ +++DFG+S+ + ++G PE
Sbjct: 235 --IHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 714 RLTEKSDVYSFGVVLLEIIT 733
R + +SDV+SFG++L E +
Sbjct: 291 RYSSESDVWSFGILLWETFS 310
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-40
Identities = 69/230 (30%), Positives = 111/230 (48%), Gaps = 20/230 (8%)
Query: 518 GSLETKKRRFTYAEITKITND---FETILGEGSFGKVYHGYLD-----DNTEVAVKMLSP 569
G + ++K+ T + T LGEG FGKV D +VAVK L P
Sbjct: 1 GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP 60
Query: 570 -SSRQGYEQFEAEVILLRTVHHKNLTTLYGYC--NEGNQIGLIYEYMANGSLEEYLSDSN 626
S + E+ +LR ++H+N+ G C + GN I LI E++ +GSL+EYL N
Sbjct: 61 ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KN 119
Query: 627 ADVLSWEGRLRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685
+ ++ + +L+ A + +G++YL VHRD+ N+L+ + Q ++ DFGL+K
Sbjct: 120 KNKINLKQQLKYAVQICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKA 175
Query: 686 FPIEGVSHLSTGVAGTF--GYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
+ + + PE + SDV+SFGV L E++T
Sbjct: 176 IE-TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 4e-39
Identities = 78/312 (25%), Positives = 128/312 (41%), Gaps = 32/312 (10%)
Query: 458 RSKNGSLSLSV---DLCSSYPCKENNKKK----NNFVFPVIASF-------ASLLVVTLA 503
S G S+S+ Y + K + F +A A L+ TL
Sbjct: 135 ESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLH 194
Query: 504 ISAIYWRHKRLRKDGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHG-YLDDNTEV 562
A + K +IT + LG G +G+VY G + + V
Sbjct: 195 YPAPKRNKPTIYGVS-PNYDKWEMERTDIT-----MKHKLGGGQYGEVYEGVWKKYSLTV 248
Query: 563 AVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL 622
AVK L + + E+F E +++ + H NL L G C +I E+M G+L +YL
Sbjct: 249 AVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 307
Query: 623 SDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFG 681
+ N +S L +AT+ + +EYL +HR++ N L+ + ++ADFG
Sbjct: 308 RECNRQEVSAVVLLYMATQISSAMEYLEKKNF----IHRNLAARNCLVGENHLVKVADFG 363
Query: 682 LSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSR----PA 737
LS+ G + PE + + KSDV++FGV+L EI T P
Sbjct: 364 LSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422
Query: 738 IANTEEHKHISQ 749
I ++ ++ + +
Sbjct: 423 IDLSQVYELLEK 434
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-38
Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
E LG+G FG+V+ G + T VA+K L P + E F E +++ + H+ L LY
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPPR 657
+E I ++ EYM+ GSL ++L L + +A + A G+ Y+ +
Sbjct: 247 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---- 301
Query: 658 VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTE 717
VHRD++ ANIL+ + ++ADFGL++ + G + PE R T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 718 KSDVYSFGVVLLEIITSR----PAIANTEEHKHISQ 749
KSDV+SFG++L E+ T P + N E + +
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 38/230 (16%)
Query: 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLY 597
+ LG G +G+VY G + VAVK L + + E+F E +++ + H NL L
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 75
Query: 598 GYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLGCKPP 656
G C +I E+M G+L +YL + N +S L +AT+ + +EYL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 132
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSKT-------------FPIEGVSHLSTGVAGTFG 703
+HRD+ N L+ + ++ADFGLS+ FPI+
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------------- 177
Query: 704 YLDPEYCQTFRLTEKSDVYSFGVVLLEIITSR----PAIANTEEHKHISQ 749
+ PE + + KSDV++FGV+L EI T P I ++ ++ + +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 28/211 (13%)
Query: 539 FETILGEGSFGKVYHGYLD-----DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNL 593
F LG+G+FG V D VAVK L S+ + FE E+ +L+++ H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 594 TTLYGYCNEGNQ--IGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH- 650
G C + + LI EY+ GSL +YL + + + L+ ++ +G+EYL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG--------VAGTF 702
+HRD+ NIL+ ++ + ++ DFGL+K P + A
Sbjct: 133 KRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA--- 185
Query: 703 GYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
PE + + SDV+SFGVVL E+ T
Sbjct: 186 ----PESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 7e-38
Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 46/231 (19%)
Query: 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
+G+G FG V G +VAVK + + + F AE ++ + H NL L G
Sbjct: 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 81
Query: 599 YC-NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLGCKPP 656
E + ++ EYMA GSL +YL VL + L+ + + + +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 138
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSK---------TFPI-----EGVSHLSTGVAGTF 702
VHRD+ N+L+++ A+++DFGL+K P+ E + F
Sbjct: 139 -VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE------KKF 191
Query: 703 GYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
+ KSDV+SFG++L EI + P I + + +
Sbjct: 192 -------------STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 8e-38
Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
E LG+G FG+V+ G + T VA+K L P + E F E +++ + H+ L LY
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPPR 657
+E I ++ EYM+ GSL ++L L + +A + A G+ Y+ +
Sbjct: 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---- 384
Query: 658 VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTE 717
VHRD++ ANIL+ + ++ADFGL++ + G + PE R T
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 718 KSDVYSFGVVLLEIITSR----PAIANTEEHKHISQ 749
KSDV+SFG++L E+ T P + N E + +
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 38/229 (16%)
Query: 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
LG G FG V G +VAVKM+ S ++F E + + H L YG
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYG 70
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLGCKPPR 657
C++ I ++ EY++NG L YL S+ L L + + +G+ +L
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESHQF---- 125
Query: 658 VHRDIKPANILLNDQFQARLADFGLSKT-------------FPIEGVSHLSTGVAGTFGY 704
+HRD+ N L++ +++DFG+++ FP++ +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA------------ 173
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
PE F+ + KSDV++FG+++ E+ + P N+E +SQ
Sbjct: 174 --PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 38/229 (16%)
Query: 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
F +G G FG V+ GY + +VA+K + + E F E ++ + H L LYG
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYG 70
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLGCKPPR 657
C E I L+ E+M +G L +YL + + + E L + + +G+ YL
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEACV---- 125
Query: 658 VHRDIKPANILLNDQFQARLADFGLSKT-------------FPIEGVSHLSTGVAGTFGY 704
+HRD+ N L+ + +++DFG+++ FP++ S
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS------------ 173
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
PE R + KSDV+SFGV++ E+ + P +N+E + IS
Sbjct: 174 --PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 539 FETILGEGSFGKVYHGYLD-----DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNL 593
F LG+G+FG V D VAVK L S+ + FE E+ +L+++ H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 594 TTLYGYCNEGNQ--IGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH- 650
G C + + LI EY+ GSL +YL + + + L+ ++ +G+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYL----- 705
+HRD+ NIL+ ++ + ++ DFGL+K P + + G
Sbjct: 164 KRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWY 215
Query: 706 DPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
PE + + SDV+SFGVVL E+ T
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 67/229 (29%), Positives = 103/229 (44%), Gaps = 38/229 (16%)
Query: 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
F LG G FG V +G +VA+KM+ S ++F E ++ + H+ L LYG
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYG 86
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLGCKPPR 657
C + I +I EYMANG L YL + L + + + +EYL
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQF---- 141
Query: 658 VHRDIKPANILLNDQFQARLADFGLSKT-------------FPIEGVSHLSTGVAGTFGY 704
+HRD+ N L+NDQ +++DFGLS+ FP+
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP------------ 189
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
PE + + KSD+++FGV++ EI + P N+E +HI+Q
Sbjct: 190 --PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-37
Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 36/226 (15%)
Query: 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
+G+G FG V G +VAVK + + + F AE ++ + H NL L G
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 253
Query: 599 YC-NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLGCKPP 656
E + ++ EYMA GSL +YL VL + L+ + + + +EYL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 310
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSKT---------FPIEGVSHLSTGVAGTFGYLDP 707
VHRD+ N+L+++ A+++DFGL+K P++ + P
Sbjct: 311 -VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--------------WTAP 355
Query: 708 EYCQTFRLTEKSDVYSFGVVLLEIITSR----PAIANTEEHKHISQ 749
E + + + KSDV+SFG++L EI + P I + + +
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 73/234 (31%), Positives = 116/234 (49%), Gaps = 48/234 (20%)
Query: 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
LG G FG+V+ GY + +T+VAVK L S + F AE L++ + H+ L LY
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA 75
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLGCKPPR 657
+ I +I EYM NGSL ++L + L+ L +A + A+G+ ++
Sbjct: 76 VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---- 130
Query: 658 VHRDIKPANILLNDQFQARLADFGLSKT-------------FPI-----EGVSHLSTGVA 699
+HRD++ ANIL++D ++ADFGL++ FPI E +++
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY------ 184
Query: 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
GTF T KSDV+SFG++L EI+T P + N E +++ +
Sbjct: 185 GTF-------------TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-37
Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 17/222 (7%)
Query: 539 FETILGEGSFGKVYHGYLDD-----NTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKN 592
+LG G+FG VY G VA+K L +S + ++ E ++ +V + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HL 651
+ L G C + + LI + M G L +Y+ + + D + + L + A+G+ YL
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQ 711
VHRD+ N+L+ ++ DFGL+K E + + G ++ E
Sbjct: 137 RL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 712 TFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
T +SDV+S+GV + E++T S+P I +E + +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 539 FETILGEGSFGKVYHGYLDDNTE-----VAVKMLSP-SSRQGYEQFEAEVILLRTVHHKN 592
LGEG FGKV D + VAVK L + Q ++ E+ +LRT++H++
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 593 LTTLYGYC--NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
+ G C + L+ EY+ GSL +YL + + L A + +G+ YLH
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH 151
Query: 651 -LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYL---- 705
+HRD+ N+LL++ ++ DFGL+K P + G
Sbjct: 152 AQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFW 203
Query: 706 -DPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
PE + ++ SDV+SFGV L E++T
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 30/216 (13%)
Query: 539 FETILGEGSFGKVYHGYLDD----NTEVAVKMLSP--SSRQGYEQFEAEVILLRTVHHKN 592
ILGEG FG V G L + +VAVK + SS++ E+F +E ++ H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 593 LTTLYGYCNEGNQIG-----LIYEYMANGSLEEYL----SDSNADVLSWEGRLRIATEAA 643
+ L G C E + G +I +M G L YL ++ + + L+ + A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 644 QGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF 702
G+EYL + +HRD+ N +L D +ADFGLSK + G
Sbjct: 158 LGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGDYYRQGRI 208
Query: 703 GYL-----DPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
+ E T KSDV++FGV + EI T
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 539 FETILGEGSFGKVYHGYLDD----NTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKNL 593
+ ++G+G FG VYHG D + A+K LS + Q E F E +L+R ++H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 594 TTLYGYCNEGNQIGLI-YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HL 651
L G + + YM +G L +++ + + + + + A+G+EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGMEYLAEQ 143
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYL-----D 706
VHRD+ N +L++ F ++ADFGL++ I + S L
Sbjct: 144 KF----VHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQ-QHRHARLPVKWTA 196
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIIT 733
E QT+R T KSDV+SFGV+L E++T
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 53/225 (23%)
Query: 539 FETILGEGSFGKVYHGYL--------DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH 590
F LG+G+F K++ G TEV +K+L + R E F ++ + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL- 649
K+L YG C G++ L+ E++ GSL+ YL N + ++ +L +A + A + +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLE 130
Query: 650 --HLGCKPPRVHRDIKPANILLNDQFQAR--------LADFGLSKT--------FPIEGV 691
L +H ++ NILL + + L+D G+S T I V
Sbjct: 131 ENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV 184
Query: 692 SHLSTGVAGTFGYLDPE---YCQTFRLTEKSDVYSFGVVLLEIIT 733
PE + +D +SFG L EI +
Sbjct: 185 P--------------PECIENPKNL--NLATDKWSFGTTLWEICS 213
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 539 FETILGEGSFGKVYHGYLD-----DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNL 593
+ + LG+G+FG V D VAVK L S F+ E+ +L+ +H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 594 TTLYGYCNEGNQ--IGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH- 650
G + + L+ EY+ +G L ++L + L L +++ +G+EYL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLGS 145
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYL----- 705
C VHRD+ NIL+ + ++ADFGL+K P++ V G
Sbjct: 146 RRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWY 197
Query: 706 DPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
PE + +SDV+SFGVVL E+ T
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 58/214 (27%), Positives = 87/214 (40%), Gaps = 25/214 (11%)
Query: 539 FETILGEGSFGKVYHGYLDDN----TEVAVKMLSP--SSRQGYEQFEAEVILLRTVHHKN 592
+LG+G FG V L +VAVKML + E+F E ++ H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 593 LTTLYGYCNEG------NQIGLIYEYMANGSLEEYL----SDSNADVLSWEGRLRIATEA 642
+ L G +I +M +G L +L N L + +R +
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 643 AQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGT 701
A G+EYL +HRD+ N +L + +ADFGLS+ I + G A
Sbjct: 147 ACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSR--KIYSGDYYRQGCASK 200
Query: 702 F--GYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
+L E T SDV++FGV + EI+T
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 539 FETILGEGSFGKVYHGYL----DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKNL 593
E I+G G G+V +G L + VA+K L + + F +E ++ H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLG 652
L G G ++ EYM NGSL+ +L ++ + + + G+ YL LG
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV--------AGTFGY 704
VHRD+ N+L++ +++DFGLS+ + + +T A
Sbjct: 172 Y----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA----- 222
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
PE + SDV+SFGVV+ E++ RP + N + + +
Sbjct: 223 --PEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 540 ETILGEGSFGKVYHGYL---DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKNLTT 595
+ LG G+FG V G +VA+K+L + + E+ E ++ + + +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLGCK 654
L G C + + L+ E G L ++L + + + + + G++YL
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLEEKNF- 131
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF--GYLDPEYCQT 712
VHRD+ N+LL ++ A+++DFGLSK + S+ + AG + + PE
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINF 187
Query: 713 FRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
+ + +SDV+S+GV + E ++ +P + E I Q
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 70/241 (29%), Positives = 108/241 (44%), Gaps = 39/241 (16%)
Query: 539 FETILGEGSFGKVYHGYL------DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKN 592
+ LGEG+FGKV+ D VAVK L + + F+ E LL + H++
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGR--------------LRI 638
+ YG C +G+ + +++EYM +G L ++L D + L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 639 ATEAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697
A++ A G+ YL VHRD+ N L+ ++ DFG+S+ V
Sbjct: 139 ASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRD-----VYSTDYY 189
Query: 698 VAGTFGYL-----DPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHIS 748
G L PE + T +SDV+SFGV+L EI T +P ++NTE + I+
Sbjct: 190 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 249
Query: 749 Q 749
Q
Sbjct: 250 Q 250
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 531 EITKITNDFETILGEGSFGKVYHGYLDDN----TEVAVKMLSP-SSRQGYEQFEAEVILL 585
+ + F ++G G FG VYHG L DN AVK L+ + QF E I++
Sbjct: 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80
Query: 586 RTVHHKNLTTLYGYC-NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ 644
+ H N+ +L G C ++ YM +G L ++ + + + + + A+
Sbjct: 81 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAK 139
Query: 645 GLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFG 703
G++YL VHRD+ N +L+++F ++ADFGL++ + + S T
Sbjct: 140 GMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVH-NKTGA 192
Query: 704 YL-----DPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
L E QT + T KSDV+SFGV+L E++T
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 30/216 (13%)
Query: 539 FETILGEGSFGKVYHGYL------DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHK 591
LG+GSFG VY G + T VA+K ++ +S + +F E +++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYL--------SDSNADVLSWEGRLRIATEAA 643
++ L G ++G +I E M G L+ YL ++ S +++A E A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 644 QGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF 702
G+ YL+ VHRD+ N ++ + F ++ DFG+++ + G
Sbjct: 149 DGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRD-----IYETDYYRKGGK 199
Query: 703 GYL-----DPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
G L PE + T SDV+SFGVVL EI T
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 539 FETILGEGSFGKVYHGYLDD-----NTEVAVKML-SPSSRQGYEQFEAEVILLRTVHHKN 592
+LG G FG V+ G V +K++ S RQ ++ ++ + ++ H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-L 651
+ L G C G+ + L+ +Y+ GSL +++ + L + L + A+G+ YL
Sbjct: 77 IVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQ 711
G VHR++ N+LL Q ++ADFG++ P + L + ++ E
Sbjct: 135 GM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 712 TFRLTEKSDVYSFGVVLLEIIT 733
+ T +SDV+S+GV + E++T
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-36
Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 38/229 (16%)
Query: 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
E LG G FG+V+ + +T+VAVK + P S E F AE +++T+ H L L+
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 250
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLGCKPPR 657
+ I +I E+MA GSL ++L + + + A+G+ ++
Sbjct: 251 VVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---- 305
Query: 658 VHRDIKPANILLNDQFQARLADFGLSKT-------------FPIEGVSHLSTGVAGTFGY 704
+HRD++ ANIL++ ++ADFGL++ FPI+ +
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA------------ 353
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
PE T KSDV+SFG++L+EI+T P ++N E + + +
Sbjct: 354 --PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-36
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 12/207 (5%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKM--LSPSSRQGYEQFEAEVILLRTVHHK 591
+ + +GEGSFGK +D + +K +S S + E+ EV +L + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHL 651
N+ E + ++ +Y G L + ++ + + L + L+++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH- 142
Query: 652 GCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
++ HRDIK NI L +L DFG+++ V + GT YL PE C
Sbjct: 143 ---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACI-GTPYYLSPEIC 197
Query: 711 QTFRLTEKSDVYSFGVVLLEIITSRPA 737
+ KSD+++ G VL E+ T + A
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-36
Identities = 72/240 (30%), Positives = 107/240 (44%), Gaps = 38/240 (15%)
Query: 539 FETILGEGSFGKVYHGYL------DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKN 592
+ LGEG+FGKV+ D VAVK L +S + F+ E LL + H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGR-------------LRIA 639
+ +G C EG + +++EYM +G L +L D G L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 640 TEAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698
++ A G+ YL L VHRD+ N L+ ++ DFG+S+ +
Sbjct: 165 SQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYYR 215
Query: 699 AGTFGYL-----DPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
G L PE + T +SDV+SFGVVL EI T +P ++NTE I+Q
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 20/222 (9%)
Query: 540 ETILGEGSFGKVYHGYL---DDNTEVAVKMLSP--SSRQGYEQFEAEVILLRTVHHKNLT 594
+ LG G+FG V GY VAVK+L + ++ AE +++ + + +
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLGC 653
+ G C E L+ E G L +YL + + + + + + + G++YL
Sbjct: 82 RMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF--GYLDPEYCQ 711
VHRD+ N+LL Q A+++DFGLSK + ++ G + + PE
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYKAQTHGKWPVKWYAPECIN 193
Query: 712 TFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
++ + KSDV+SFGV++ E + +P + +E + +
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 531 EITKITNDFETILGEGSFGKVYHGYLDDN----TEVAVKMLSP-SSRQGYEQFEAEVILL 585
+ + F ++G G FG VYHG L DN AVK L+ + QF E I++
Sbjct: 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144
Query: 586 RTVHHKNLTTLYGYC-NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ 644
+ H N+ +L G C ++ YM +G L ++ + + + + + A+
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAK 203
Query: 645 GLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFG 703
G+++L VHRD+ N +L+++F ++ADFGL++ + S T
Sbjct: 204 GMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEFDSVH-NKTGA 256
Query: 704 YL-----DPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
L E QT + T KSDV+SFGV+L E++T
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 60/214 (28%), Positives = 89/214 (41%), Gaps = 39/214 (18%)
Query: 539 FETILGEGSFGKVYHGYL----DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKNL 593
ILGEG FG+VY G + VAVK + E+F +E ++++ + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLG 652
L G E +I E G L YL N + L + + + + + YL +
Sbjct: 76 VKLIGII-EEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKT-------------FPIEGVSHLSTGVA 699
C VHRDI NIL+ +L DFGLS+ PI+ +S
Sbjct: 134 C----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS------- 182
Query: 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
PE R T SDV+ F V + EI++
Sbjct: 183 -------PESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 539 FETILGEGSFGKVYHGYLDD-----NTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKN 592
+LG G+FG VY G VA+K L +S + ++ E ++ +V + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HL 651
+ L G C + + LI + M G L +Y+ + + D + + L + A+G+ YL
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQ 711
VHRD+ N+L+ ++ DFGL+K E + + G ++ E
Sbjct: 137 RL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 712 TFRLTEKSDVYSFGVVLLEIIT 733
T +SDV+S+GV + E++T
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMT 214
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 56/214 (26%), Positives = 83/214 (38%), Gaps = 39/214 (18%)
Query: 539 FETILGEGSFGKVYHGYL----DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKNL 593
+GEG FG V+ G + VA+K +S E+F E + +R H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLG 652
L G N + +I E G L +L L + A + + L YL
Sbjct: 79 VKLIGVI-TENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKT-------------FPIEGVSHLSTGVA 699
VHRDI N+L++ +L DFGLS+ PI+
Sbjct: 137 F----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK---------- 182
Query: 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
++ PE R T SDV+ FGV + EI+
Sbjct: 183 ----WMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-35
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 539 FETILGEGSFGKVYHGYL-----DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKN 592
+ ++G G FG+VY G L VA+K L + + F E ++ H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HL 651
+ L G ++ + +I EYM NG+L+++L S + + A G++YL ++
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP-IEGVSHLSTG-------VAGTFG 703
VHRD+ NIL+N +++DFGLS+ ++ ++G A
Sbjct: 167 NY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA---- 218
Query: 704 YLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
PE + T SDV+SFG+V+ E++T
Sbjct: 219 ---PEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 58/207 (28%), Positives = 85/207 (41%), Gaps = 21/207 (10%)
Query: 539 FETILGEGSFGKVYHGYL----DDNTEVAVKMLSP---SSRQGYEQFEAEVILLRTVHHK 591
LG+GSFG V G VAVK L P S + + F EV + ++ H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-- 649
NL LYG + ++ E GSL + L + R A + A+G+ YL
Sbjct: 82 NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 650 -HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY--LD 706
+HRD+ N+LL + ++ DFGL + P H +
Sbjct: 140 KRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQND-DHYVMQEHRKVPFAWCA 192
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIIT 733
PE +T + SD + FGV L E+ T
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 36/222 (16%)
Query: 539 FETILGEGSFGKVYHGYL------DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHK 591
F LGE FGKVY G+L + VA+K L + E+F E +L + H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGR--------------LR 637
N+ L G + + +I+ Y ++G L E+L + +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 638 IATEAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696
+ + A G+EYL VH+D+ N+L+ D+ +++D GL + V
Sbjct: 133 LVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADY 183
Query: 697 GVAGTFGYL-----DPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
L PE + + SD++S+GVVL E+ +
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 10/200 (5%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC 600
+LG+G++G VY G L + +A+K + + + E+ L + + HKN+ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 601 NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIAT-EAAQGLEYLHLGCKPPRVH 659
+E I + E + GSL L + E + T + +GL+YLH VH
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI---VH 145
Query: 660 RDIKPANILLNDQF-QARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL--T 716
RDIK N+L+N +++DFG SK + G++ + GT Y+ PE
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 717 EKSDVYSFGVVLLEIITSRP 736
+ +D++S G ++E+ T +P
Sbjct: 204 KAADIWSLGCTIIEMATGKP 223
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 16/222 (7%)
Query: 539 FETILGEGSFGKVYHGYL----DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKNL 593
+ ++G G FG+V G L VA+K L + + F E ++ H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLG 652
L G + + ++ EYM NGSL+ +L + + + + A G++YL +G
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP-IEGVSHLSTGVAGTFGYLDPEYCQ 711
VHRD+ NIL+N +++DFGL + ++ + G + PE
Sbjct: 168 Y----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 712 TFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
+ T SDV+S+G+VL E+++ RP ++N + K + +
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 13/209 (6%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVK---MLSPSSRQGYEQFEAEVILLRTVHH 590
+F +G G F +VY L D VA+K + + E+ LL+ ++H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSD--SNADVLSWEGRLRIATEAAQGLEY 648
N+ Y E N++ ++ E G L + ++ + + LE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 649 LHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE 708
+H +HRDIKPAN+ + +L D GL + F + + V GT Y+ PE
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLV-GTPYYMSPE 206
Query: 709 YCQTFRLTEKSDVYSFGVVLLEIITSRPA 737
KSD++S G +L E+ +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 13/212 (6%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKM--LSPSSRQGYEQFEAEVILLRTVHHK 591
D+E + +G GS+G+ D + K + + +EV LLR + H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 592 NLTTLYG--YCNEGNQIGLIYEYMANGSLEEYLSDS--NADVLSWEGRLRIATEAAQGLE 647
N+ Y + ++ EY G L ++ L E LR+ T+ L+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 648 YLHLGCKPPR--VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYL 705
H +HRD+KPAN+ L+ + +L DFGL++ S T V GT Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKTFV-GTPYYM 183
Query: 706 DPEYCQTFRLTEKSDVYSFGVVLLEIITSRPA 737
PE EKSD++S G +L E+ P
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 50/221 (22%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 533 TKITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH 589
+ DF+ I +G G FG+V+ D +K + ++ E+ E EV L +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLD 62
Query: 590 HKNLTTLYGY----------------CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWE 633
H N+ G ++ + + E+ G+LE+++ + L
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 634 GRLRIATEAAQGLEYLHLGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692
L + + +G++Y+H ++ +RD+KP+NI L D Q ++ DFGL + ++
Sbjct: 123 LALELFEQITKGVDYIH----SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--LKNDG 176
Query: 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
+ GT Y+ PE + ++ D+Y+ G++L E++
Sbjct: 177 KRTRSK-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 63/236 (26%), Positives = 97/236 (41%), Gaps = 34/236 (14%)
Query: 539 FETILGEGSFGKVYHGYL------DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHK 591
LG G+FG+VY G + +VAVK L S Q F E +++ +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYL-----SDSNADVLSWEGRLRIATEAAQGL 646
N+ G + ++ E MA G L+ +L S L+ L +A + A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 647 EYL-HLGCKPPRVHRDIKPANILLNDQFQARL---ADFGLSKTFPIEGVSHLSTGVAGTF 702
+YL +HRDI N LL R+ DFG+++ + S G
Sbjct: 154 QYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGC 204
Query: 703 GYL-----DPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
L PE T K+D +SFGV+L EI + P + +N E + ++
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 47/246 (19%), Positives = 88/246 (35%), Gaps = 30/246 (12%)
Query: 511 HKRLRKDGSLETKKRRFTYAEITKITNDFETI--LGEGSFGKVYHGYLDDNTEVAVKM-- 566
H ++ + ++ + + +G G KV+ + A+K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 61
Query: 567 LSPSSRQGYEQFEAEVILLRTVHHKNLT--TLYGYCNEGNQIGLIYEYMANGSLEEYLSD 624
L + Q + + E+ L + + LY Y I ++ E N L +L
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK 120
Query: 625 SNADVLSWEGRLRIATEAAQGLEYLHLGCKPPR---VHRDIKPANILLNDQFQARLADFG 681
+ + R + + +H + VH D+KPAN L+ D +L DFG
Sbjct: 121 KKS--IDPWERKSYWKNMLEAVHTIH------QHGIVHSDLKPANFLIVDG-MLKLIDFG 171
Query: 682 LSKTFPIEGVSHLSTGVAGTFGYLDPE-----------YCQTFRLTEKSDVYSFGVVLLE 730
++ + S + GT Y+ PE +++ KSDV+S G +L
Sbjct: 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 731 IITSRP 736
+ +
Sbjct: 232 MTYGKT 237
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-33
Identities = 49/201 (24%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 540 ETILGEGSFGKVYHGYL---DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKNLTT 595
+ LG G+FG V G +VA+K+L + + E+ E ++ + + +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLGCK 654
L G C + + L+ E G L ++L + + + + + G++YL
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLEEKNF- 457
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY--LDPEYCQT 712
VHR++ N+LL ++ A+++DFGLSK + S+ + AG + PE
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINF 513
Query: 713 FRLTEKSDVYSFGVVLLEIIT 733
+ + +SDV+S+GV + E ++
Sbjct: 514 RKFSSRSDVWSYGVTMWEALS 534
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 55/213 (25%), Positives = 83/213 (38%), Gaps = 22/213 (10%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC- 600
LGEG F V L D A+K + +Q E+ + E + R +H N+ L YC
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 601 ---NEGNQIGLIYEYMANGSLEEYLSD--SNADVLSWEGR-LRIATEAAQGLEYLHLGCK 654
++ L+ + G+L + + L+ E + L + +GLE +H
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT-EDQILWLLLGICRGLEAIH---A 152
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA-------GTFGYLDP 707
HRD+KP NILL D+ Q L D G I T Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 708 EYCQTFR---LTEKSDVYSFGVVLLEIITSRPA 737
E + E++DV+S G VL ++
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 66/240 (27%), Positives = 112/240 (46%), Gaps = 41/240 (17%)
Query: 539 FETILGEGSFGKVYHGYLDDN---TEVAVKMLSP-SSRQGYEQFEAEVILLRTV-HHKNL 593
F+ ++GEG+FG+V + + + A+K + +S+ + F E+ +L + HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYL--------------SDSNADVLSWEGRLRIA 639
L G C + L EY +G+L ++L ++S A LS + L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 640 TEAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698
+ A+G++YL +HRD+ NIL+ + + A++ADFGLS+ V
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSRG--------QEVYV 196
Query: 699 AGTFGYL-----DPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEEHKHISQ 749
T G L E T SDV+S+GV+L EI++ P + E ++ + Q
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 44/230 (19%)
Query: 539 FETILGEGSFGKVYHGYL------DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHK 591
LGEG FGKV T VAVKML +S +E +L+ V+H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYL----------------------SDSNADV 629
++ LYG C++ + LI EY GSL +L +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 630 LSWEGRLRIATEAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688
L+ + A + +QG++YL + VHRD+ NIL+ + + +++DFGLS+
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSR---- 198
Query: 689 EGVSHLSTGVAGTFGYL-----DPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
V + V + G + E T +SDV+SFGV+L EI+T
Sbjct: 199 -DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 53/219 (24%), Positives = 84/219 (38%), Gaps = 17/219 (7%)
Query: 538 DFETI--LGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQFEA---EVILLRTVHHK 591
F+ + LG GS+G+V+ +D AVK R ++ + H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR-IATEAAQGLEYLH 650
L EG + L E SL+++ A L E ++ + L +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGA-SLP-EAQVWGYLRDTLLALAHLH 174
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
VH D+KPANI L + + +L DFGL + G Y+ PE
Sbjct: 175 ---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-GDPRYMAPELL 228
Query: 711 QTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ 749
Q +DV+S G+ +LE+ + E + + Q
Sbjct: 229 QG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ 266
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 68/306 (22%), Positives = 118/306 (38%), Gaps = 44/306 (14%)
Query: 479 NNKKKNNFVFPVIASFASLLVVTLAISAIYWRHKRLRKDGSLETKKRRFTYAEITKITND 538
++ +++ P + + + + ++ +LR + + +A T +D
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISD 64
Query: 539 ----------FETILGEGSFGKVYHGYL------DDNTEVAVKMLSP-SSRQGYEQFEAE 581
LG G+FG+VY G + +VAVK L S Q F E
Sbjct: 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 124
Query: 582 VILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL-----SDSNADVLSWEGRL 636
+++ +H+N+ G + ++ E MA G L+ +L S L+ L
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184
Query: 637 RIATEAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARL---ADFGLSKTFPIEGVS 692
+A + A G +YL +HRDI N LL R+ DFG+++ +
Sbjct: 185 HVARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIY 235
Query: 693 HLSTGVAGTFGYL-----DPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRP--AIANTEE 743
G L PE T K+D +SFGV+L EI + P + +N E
Sbjct: 236 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295
Query: 744 HKHISQ 749
+ ++
Sbjct: 296 LEFVTS 301
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 39/225 (17%)
Query: 539 FETILGEGSFGKVYHGYL------DDNTEVAVKMLSPS-SRQGYEQFEAEVILLRTV-HH 590
F LG G+FGKV D VAVKML PS E +E+ +L + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL----------------SDSNADVLSWEG 634
N+ L G C G +I EY G L +L + + L E
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 635 RLRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693
L + + A+G+ +L C +HRD+ NILL ++ DFGL++ + +
Sbjct: 147 LLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR-----DIKN 197
Query: 694 LSTGVAGTFGYL-----DPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
S V L PE T +SDV+S+G+ L E+ +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 43/227 (18%)
Query: 539 FETILGEGSFGKVYHGYL--------DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTV- 588
LGEG+FG+V + VAVKML ++ + +E+ +++ +
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 589 HHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL--------------SDSNADVLSWEG 634
HKN+ L G C + + +I EY + G+L EYL + + ++++
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 635 RLRIATEAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693
+ + A+G+EYL C +HRD+ N+L+ + ++ADFGL++ +++
Sbjct: 159 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR-----DINN 209
Query: 694 LSTGVAGTFGYL-----DPE--YCQTFRLTEKSDVYSFGVVLLEIIT 733
+ T G L PE + + + T +SDV+SFGV++ EI T
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-33
Identities = 60/227 (26%), Positives = 107/227 (47%), Gaps = 43/227 (18%)
Query: 539 FETILGEGSFGKVYHGYL--------DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTV- 588
LGEG FG+V + VAVKML ++ + +E+ +++ +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 589 HHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL--------------SDSNADVLSWEG 634
HKN+ L G C + + +I EY + G+L EYL + + ++++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 635 RLRIATEAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693
+ + A+G+EYL C +HRD+ N+L+ + ++ADFGL++ +++
Sbjct: 205 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR-----DINN 255
Query: 694 LSTGVAGTFGYL-----DPE--YCQTFRLTEKSDVYSFGVVLLEIIT 733
+ T G L PE + + + T +SDV+SFGV++ EI T
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 300
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-33
Identities = 56/204 (27%), Positives = 81/204 (39%), Gaps = 19/204 (9%)
Query: 539 FETILGEGSFGKVYHGYL----DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHKNL 593
+GEG FG V+ G + VA+K +S E+F E + +R H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LG 652
L G N + +I E G L +L L + A + + L YL
Sbjct: 454 VKLIGVI-TENPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG---VAGTFGYLDPEY 709
VHRDI N+L++ +L DFGLS+ S G + PE
Sbjct: 512 F----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APES 563
Query: 710 CQTFRLTEKSDVYSFGVVLLEIIT 733
R T SDV+ FGV + EI+
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILM 587
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-33
Identities = 64/230 (27%), Positives = 96/230 (41%), Gaps = 44/230 (19%)
Query: 539 FETILGEGSFGKVYHGYL------DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTVHHK 591
+ +GEG+FG+V+ + T VAVKML +S F+ E L+ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGR---------------- 635
N+ L G C G + L++EYMA G L E+L + +
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 636 ------LRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688
L IA + A G+ YL VHRD+ N L+ + ++ADFGLS+
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSRN--- 223
Query: 689 EGVSHLSTGVAGTFGYL-----DPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
+ A + PE R T +SDV+++GVVL EI +
Sbjct: 224 --IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 38/224 (16%)
Query: 539 FETILGEGSFGKVYHGYL------DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTV-HH 590
LG G+FG+V VAVKML ++ + +E+ +L + HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 591 KNLTTLYGYC-NEGNQIGLIYEYMANGSLEEYL--------------SDSNADVLSWEGR 635
N+ L G C G + +I E+ G+L YL D D L+ E
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 636 LRIATEAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694
+ + + A+G+E+L C +HRD+ NILL+++ ++ DFGL++ +
Sbjct: 151 ICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLAR-----DIYKD 201
Query: 695 STGVAGTFGYL-----DPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
V L PE T +SDV+SFGV+L EI +
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 34/226 (15%)
Query: 534 KITNDFETI--LGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH 590
+ +DFE I LG+G+FG+V D+ A+K + + + +EV+LL +++H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNH 61
Query: 591 KNLTTLYG-YCNEGNQIGL---------IY---EYMANGSLEEYLSDSNADVLSWEGRLR 637
+ + Y + N + ++ EY NG+L + + N + + R
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRDEYWR 120
Query: 638 IATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF----------- 686
+ + + L Y+H +HRD+KP NI +++ ++ DFGL+K
Sbjct: 121 LFRQILEALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 687 -PIEGVSHLSTGVAGTFGYLDPEYCQ-TFRLTEKSDVYSFGVVLLE 730
+ G S T GT Y+ E T EK D+YS G++ E
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-33
Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 39/223 (17%)
Query: 539 FETILGEGSFGKVYHGYL------DDNTEVAVKMLSPS-SRQGYEQFEAEVILLRTV-HH 590
F LG G+FGKV D +VAVKML + E +E+ ++ + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL------------SDSNADVLSWEGRLRI 638
+N+ L G C G + +I EY G L +L S L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 639 ATEAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697
+++ AQG+ +L C +HRD+ N+LL + A++ DFGL++ + + S
Sbjct: 170 SSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNY 220
Query: 698 VAGTFGYL-----DPE--YCQTFRLTEKSDVYSFGVVLLEIIT 733
+ L PE + + T +SDV+S+G++L EI +
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVY--TVQSDVWSYGILLWEIFS 261
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 54/242 (22%), Positives = 94/242 (38%), Gaps = 33/242 (13%)
Query: 510 RHKRLRKDGSLETKKRRFTYAEITKITNDF--ETILGEGSFGKVYHGY-LDDNTEVAVK- 565
+ +G L T+K + E + + + +G GSFG+V+ + AVK
Sbjct: 31 GPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK 90
Query: 566 -MLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSD 624
L + E++ + + LYG EG + + E + GSL
Sbjct: 91 VRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL------ 137
Query: 625 SNADVLSWEGRLR------IATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ-FQARL 677
++ G L +A +GLEYLH +H D+K N+LL+ +A L
Sbjct: 138 --GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI---LHGDVKADNVLLSSDGSRAAL 192
Query: 678 ADFGLSKTFPIEGVSHLSTG---VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITS 734
DFG + +G+ + GT ++ PE K D++S ++L ++
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252
Query: 735 RP 736
Sbjct: 253 CH 254
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 39/225 (17%)
Query: 539 FETILGEGSFGKVYHGYL--------DDNTEVAVKMLSP-SSRQGYEQFEAEVILLRTV- 588
LGEG+FG+V + T+VAVKML ++ + +E+ +++ +
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 589 HHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL--------------SDSNADVLSWEG 634
HKN+ L G C + + +I EY + G+L EYL S + + LS +
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 635 RLRIATEAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693
+ A + A+G+EYL C +HRD+ N+L+ + ++ADFGL++ + H
Sbjct: 193 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR-----DIHH 243
Query: 694 LSTGVAGTFGYL-----DPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
+ T G L PE T +SDV+SFGV+L EI T
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 50/227 (22%), Positives = 92/227 (40%), Gaps = 34/227 (14%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEVAVKMLS-----------------PSSRQGYEQ 577
ND+ I L +G F K+ DN A+K S + Y+
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 578 FEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRL- 636
F+ E+ ++ + ++ T G +++ +IYEYM N S+ ++ ++ +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 637 -----RIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691
I Y+H + HRD+KP+NIL++ + +L+DFG S+
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV---- 203
Query: 692 SHLSTGVAGTFGYLDPEYCQTFRLT--EKSDVYSFGVVLLEIITSRP 736
G GT+ ++ PE+ K D++S G+ L + +
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-32
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 532 ITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HH 590
+ KI+ + +LG G+ G + + + DN +VAVK + P + + EV LLR H
Sbjct: 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEH 77
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
N+ + + + E A +L+EY+ + L E + + GL +LH
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLH 135
Query: 651 -LGCKPPRVHRDIKPANILL-----NDQFQARLADFGLSKTFPIEGVS-HLSTGVAGTFG 703
L VHRD+KP NIL+ + + +A ++DFGL K + S +GV GT G
Sbjct: 136 SLNI----VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 704 YLDPEYCQ---TFRLTEKSDVYSFGVVLLEIIT 733
++ PE T D++S G V +I+
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 46/212 (21%), Positives = 80/212 (37%), Gaps = 28/212 (13%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKM--LSPSSRQGYEQFEAEVILLRTVHHKNLT--TLYG 598
+G G KV+ + A+K L + Q + + E+ L + + LY
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPR- 657
Y I ++ E N L +L + + R + + +H +
Sbjct: 77 YEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIH------QH 127
Query: 658 --VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE------- 708
VH D+KPAN L+ D +L DFG++ + S + GT Y+ PE
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 709 ----YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
+++ KSDV+S G +L + +
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 30/224 (13%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLS-PSSRQGYEQFEAEVILLRTVHHKN 592
DFE I LG G FG V+ D+ A+K + P+ E+ EV L + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 593 LTTLYGYCNEGNQI---------GLIY---EYMANGSLEEYLSDSNADVLSWEGR-LRIA 639
+ + E N +Y + +L+++++ L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 640 TEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSK----------TFPIE 689
+ A+ +E+LH +HRD+KP+NI ++ DFGL
Sbjct: 125 LQIAEAVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
TG GT Y+ PE + K D++S G++L E++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 44/230 (19%)
Query: 539 FETILGEGSFGKVYHGYL------DDNTEVAVKMLSPS-SRQGYEQFEAEVILLRTV-HH 590
F +LG G+FGKV + + +VAVKML E +E+ ++ + H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL---------------------SDSNADV 629
+N+ L G C I LI+EY G L YL + + +V
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 630 LSWEGRLRIATEAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688
L++E L A + A+G+E+L C VHRD+ N+L+ ++ DFGL++
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLAR---- 220
Query: 689 EGVSHLSTGVAGTFGYL-----DPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
+ S V L PE T KSDV+S+G++L EI +
Sbjct: 221 -DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 63/249 (25%), Positives = 108/249 (43%), Gaps = 29/249 (11%)
Query: 511 HKRLRKDGSLETKKRRFTYAEITKITNDFETI--LGEGSFGKVYHG-YLDDNTEVAVK-M 566
+R R + L K++ + +DFE I LG G+ G V+ + +A K +
Sbjct: 12 QQRKRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI 66
Query: 567 LSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSN 626
Q E+ +L + + YG +I + E+M GSL+
Sbjct: 67 HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD------- 119
Query: 627 ADVLSWEGRL------RIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADF 680
VL GR+ +++ +GL YL K +HRD+KP+NIL+N + + +L DF
Sbjct: 120 -QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDF 176
Query: 681 GLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIAN 740
G+S + ++ GT Y+ PE Q + +SD++S G+ L+E+ R I
Sbjct: 177 GVSGQL----IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232
Query: 741 TEEHKHISQ 749
+ +
Sbjct: 233 PDAKELELM 241
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 45/212 (21%), Positives = 79/212 (37%), Gaps = 28/212 (13%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKM--LSPSSRQGYEQFEAEVILLRTVHHKNLT--TLYG 598
+G G KV+ + A+K L + Q + + E+ L + + LY
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPR- 657
Y I ++ E N L +L + + R + + +H +
Sbjct: 124 YEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIH------QH 174
Query: 658 --VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE------- 708
VH D+KPAN L+ D +L DFG++ + S + G Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 709 ----YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
+++ KSDV+S G +L + +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 537 NDFETI--LGEGSFGKVYHG-YLDDNTEVAVK-MLSPSSRQGYEQFEAEV-ILLRTVHHK 591
+D E I LG G++G V ++ +AVK + + + Q ++ ++ I +RTV
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRL------RIATEAAQG 645
T YG + + E M + SL+++ V+ + +IA +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY----KQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 646 LEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA-----G 700
LE+LH +HRD+KP+N+L+N Q ++ DFG+S +L VA G
Sbjct: 122 LEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG--------YLVDDVAKDIDAG 171
Query: 701 TFGYLDPE----YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
Y+ PE + KSD++S G+ ++E+ R
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 211
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 50/218 (22%), Positives = 85/218 (38%), Gaps = 24/218 (11%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEV-ILLRTVHHKNLTTLYGYC 600
L EG F VY + E A+K L + + EV + + H N+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 601 -------NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGR-LRIATEAAQGLEYLHLG 652
+ G L+ + G L E+L + L+I + + ++++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-R 154
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTF---PIEGVSHLSTGVA-------GTF 702
KPP +HRD+K N+LL++Q +L DFG + T P S + T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 703 GYLDPEYCQTFR---LTEKSDVYSFGVVLLEIITSRPA 737
Y PE + + EK D+++ G +L + +
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 47/245 (19%), Positives = 94/245 (38%), Gaps = 37/245 (15%)
Query: 533 TKITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVK--MLSPSSRQGYEQFEAEVILLRT 587
++ T +F + +G G FG V+ D A+K + + EV
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 588 V-HHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSW-EGRLR-IATEAAQ 644
+ H ++ + E + + + EY GSL + +S++ + + E L+ + + +
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 645 GLEYLHLGCKPPRVHRDIKPANILLN-------------------DQFQARLADFGLSKT 685
GL Y+H VH DIKP+NI ++ ++ ++ D G
Sbjct: 127 GLRYIHSMSL---VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 686 FPIEGVSHLSTGVAGTFGYLDPEYCQ-TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEH 744
+S G +L E Q + K+D+++ + ++ + P N ++
Sbjct: 184 -----ISSPQV-EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237
Query: 745 KHISQ 749
I Q
Sbjct: 238 HEIRQ 242
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 36/228 (15%)
Query: 522 TKKRRFTYAEITKITNDFETI--LGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGY--- 575
+KKR++ DFE LG+G FG VY +A+K+L + +
Sbjct: 1 SKKRQWA-------LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE 53
Query: 576 EQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGR 635
Q EV + + H N+ LYGY ++ ++ LI EY G++ L +
Sbjct: 54 HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK--------LSK 105
Query: 636 L------RIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688
TE A L Y H +HRDIKP N+LL + ++ADFG S P
Sbjct: 106 FDEQRTATYITELANALSYCHSKRV----IHRDIKPENLLLGSAGELKIADFGWSVHAP- 160
Query: 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
S T + GT YL PE + EK D++S GV+ E + +P
Sbjct: 161 ---SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 39/228 (17%), Positives = 71/228 (31%), Gaps = 25/228 (10%)
Query: 531 EITKITNDFETI--LGEGSFGKVYHGYLDDNTE------VAVKMLSPSSRQGYEQFEAEV 582
E + LGEG+F +VY D + +K+ P++ + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 583 ILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL---SDSNADVLSWEGRLRIA 639
L+ Y N L+ E + G+L + ++ V+ + A
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 640 TEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQA-----------RLADFGLSKTFPI 688
+E +H +H DIKP N +L + F L D G S +
Sbjct: 179 MRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
+ T T G+ E + D + + ++
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 60/241 (24%), Positives = 107/241 (44%), Gaps = 34/241 (14%)
Query: 512 KRLRKDGSLETKKRRFTYAEITKITN---DFETI--LGEGSFGKVYHGY-LDDNTEVAVK 565
+ G + ++ + + + ++ +GEGS G V +VAVK
Sbjct: 17 NLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVK 76
Query: 566 MLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDS 625
M+ +Q E EV+++R H N+ +Y G ++ ++ E++ G+L
Sbjct: 77 MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL------- 129
Query: 626 NADVLSWEGRLR---IAT---EAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLAD 679
D++S + RL IAT Q L YLH +HRDIK +ILL + +L+D
Sbjct: 130 -TDIVS-QVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSD 184
Query: 680 FG----LSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSR 735
FG +SK V + + GT ++ PE + D++S G++++E++
Sbjct: 185 FGFCAQISKD-----VPKRKS-LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
Query: 736 P 736
P
Sbjct: 239 P 239
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 29/205 (14%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN 601
+G+G+ G VY + EVA++ ++ + E E++++R + N+
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 602 EGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR---IAT---EAAQGLEYLHLGCKP 655
G+++ ++ EY+A GSL DV++ E + IA E Q LE+LH
Sbjct: 88 VGDELWVVMEYLAGGSL--------TDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQV- 137
Query: 656 PRVHRDIKPANILLNDQFQARLADFG----LSKTFPIEGVSHLSTGVAGTFGYLDPEYCQ 711
+HRDIK NILL +L DFG ++ S ST + GT ++ PE
Sbjct: 138 --IHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRST-MVGTPYWMAPEVVT 189
Query: 712 TFRLTEKSDVYSFGVVLLEIITSRP 736
K D++S G++ +E+I P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 20/213 (9%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSP-SSRQGYEQFEAEV-ILLRTVHHK 591
D + + +G G++G V +AVK + + +Q ++ +++R+
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSW--EGRL-RIATEAAQGLEY 648
+ YG + E M+ S +++ + + E L +I + L +
Sbjct: 82 YIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 649 LHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS-TGVAGTFGYLDP 707
L K +HRDIKP+NILL+ +L DFG+S V ++ T AG Y+ P
Sbjct: 141 LKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMAP 194
Query: 708 EYCQTFRL----TEKSDVYSFGVVLLEIITSRP 736
E +SDV+S G+ L E+ T R
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 51/237 (21%), Positives = 101/237 (42%), Gaps = 30/237 (12%)
Query: 514 LRKDGSLETKKRRFTYAEITKITNDFETI--LGEGSFGKVYHG-YLDDNTEVAVK-MLSP 569
++ G L +R+ ND E + +G G+ G+V+ + +AVK M
Sbjct: 7 GKQTGYLTIGGQRYQAEI-----NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61
Query: 570 SSRQGYEQFEAEV-ILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNA- 627
+++ ++ ++ ++L++ + +G + + E M + +
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPI 121
Query: 628 --DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685
+L ++ + L YL +HRD+KP+NILL+++ Q +L DFG+S
Sbjct: 122 PERILG-----KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR 174
Query: 686 FPIEGVSHLS-TGVAGTFGYLDPEYCQTFRLTE-----KSDVYSFGVVLLEIITSRP 736
V + AG Y+ PE T+ ++DV+S G+ L+E+ T +
Sbjct: 175 L----VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-29
Identities = 55/226 (24%), Positives = 87/226 (38%), Gaps = 37/226 (16%)
Query: 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEV-ILLRTVHHKNLTTL 596
E ILG GS G V VAVK + + E+ +L + H N+
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRY 74
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYL-----SDSNADVLSWEGRLRIATEAAQGLEYLH- 650
Y + + E N +L++ + SD N + + + + A G+ +LH
Sbjct: 75 YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 651 LGCKPPRVHRDIKPANILL-------------NDQFQARLADFGLSKTFPIEGVSHLST- 696
L +HRD+KP NIL+ + + ++DFGL K S +
Sbjct: 134 LKI----IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 697 -GVAGTFGYLDPE-------YCQTFRLTEKSDVYSFGVVLLEIITS 734
+GT G+ PE RLT D++S G V I++
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 56/240 (23%), Positives = 102/240 (42%), Gaps = 45/240 (18%)
Query: 521 ETKKRRFTYAEITKITN---DFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQG 574
K R Y + + + +E + LG+G+FGKVY + A K++ S +
Sbjct: 2 MRKSRE--YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE 59
Query: 575 YEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVL-SWE 633
E + E+ +L T H + L G ++ ++ E+ G++ ++ +
Sbjct: 60 LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV--------DAIMLELD 111
Query: 634 GRLR---IAT---EAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP 687
L I + + L +LH +HRD+K N+L+ + RLADFG+S
Sbjct: 112 RGLTEPQIQVVCRQMLEALNFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVS---- 164
Query: 688 IEGVSHLSTGVA------GTFGYLDPE--YCQTFRLT---EKSDVYSFGVVLLEIITSRP 736
+ + GT ++ PE C+T + T K+D++S G+ L+E+ P
Sbjct: 165 ----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 25/213 (11%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLS-PSSRQGYEQFEAEVILLRTVHHKNLTTLYGY 599
ILG+G+ V+ G A+K+ + S + + E +L+ ++HKN+ L+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 600 --CNEGNQIGLIYEYMANGSLEEYLSD-SNADVLSWEGRLRIATEAAQGLEYLH-LGCKP 655
LI E+ GSL L + SNA L L + + G+ +L G
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI-- 133
Query: 656 PRVHRDIKPANILLNDQFQAR----LADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQ 711
VHR+IKP NI+ + L DFG ++ E + + GT YL P+ +
Sbjct: 134 --VHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVS-LYGTEEYLHPDMYE 188
Query: 712 TFRL--------TEKSDVYSFGVVLLEIITSRP 736
L D++S GV T
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 537 NDFETI--LGEGSFGKVYHG-YLDDNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHH 590
+DF+ LG+G FG VY + +A+K+L S Q E+ + + H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRL------RIATEAAQ 644
N+ +Y Y ++ +I L+ E+ G L + L GR E A
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK--------HGRFDEQRSATFMEELAD 125
Query: 645 GLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFG 703
L Y H +HRDIKP N+L+ + + ++ADFG S P S + GT
Sbjct: 126 ALHYCHERKV----IHRDIKPENLLMGYKGELKIADFGWSVHAP----SLRRRTMCGTLD 177
Query: 704 YLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
YL PE + EK D++ GV+ E + P
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLS-PSSRQGYEQFEAEVILLRTVHHKN 592
+D+E +G G+ V Y +VA+K ++ + ++ E+ + HH N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR---IAT---EAAQGL 646
+ + Y +++ L+ + ++ GS+ + + A G L IAT E +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 647 EYLHLGCKPPRVHRDIKPANILLNDQFQARLADFG----LSKTFPIEGVSHLSTGVAGTF 702
EYLH K ++HRD+K NILL + ++ADFG L+ I T GT
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT-FVGTP 190
Query: 703 GYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRP 736
++ PE + R K+D++SFG+ +E+ T
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-28
Identities = 41/206 (19%), Positives = 75/206 (36%), Gaps = 19/206 (9%)
Query: 544 GEGSFGKVYHGY-LDDNTEVAVKM--LSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC 600
G V V V+ L S + + E+ + + +H N+
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 601 NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIAT---EAAQGLEYLHLGCKPPR 657
N++ ++ +MA GS ++ + D ++ E IA + L+Y+H
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMN-ELA--IAYILQGVLKALDYIH---HMGY 149
Query: 658 VHRDIKPANILLNDQFQARLADFGLSKTFPIEG-----VSHLSTGVAGTFGYLDPEYCQT 712
VHR +K ++IL++ + L+ + + G V +L PE Q
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 713 FRL--TEKSDVYSFGVVLLEIITSRP 736
KSD+YS G+ E+
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGHV 235
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 537 NDFET--ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGY---EQFEAEVILLRTVHH 590
DF+ +LG+GSF VY + EVA+KM+ + ++ + EV + + H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
++ LY Y + N + L+ E NG + YL + E R + G+ YLH
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLH 129
Query: 651 LGCKPPR--VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE 708
+HRD+ +N+LL ++ADFGL+ T T + GT Y+ PE
Sbjct: 130 S-----HGILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYT-LCGTPNYISPE 182
Query: 709 YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
+SDV+S G + ++ RP
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRP 210
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 26/236 (11%), Positives = 52/236 (22%), Gaps = 48/236 (20%)
Query: 539 FETILGEGSFGKVYHGY-LDDNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLT 594
L G V+ ++ + A+K+ + SR E+ + ++
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125
Query: 595 TLYGYCNEGNQIG--------------------------LIYEYMANGSLEEYLS----- 623
L+ + LE S
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV 184
Query: 624 DSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGL 682
+ + + L G VH P N+ + + L D
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKGL----VHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 683 SKTFPIEGVSHLSTGVAGTFGYLDPEY--CQTFRLTEKSDVYSFGVVLLEIITSRP 736
V + Y E+ T T + + G+ + +
Sbjct: 241 LWK-----VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 31/223 (13%)
Query: 543 LGEGSFGKVYHGYLDDNT---EVAVKMLSP--SSRQGY-EQFEAEVILLRTVHHKNLTTL 596
+G G G VY D VA+K++S SS + + + E + ++ +
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP 656
+ + Q+ + + L L L+ + I + L+ H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAH------ 151
Query: 657 R---VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF 713
HRD+KP NIL++ A L DFG++ E ++ L GT Y+ PE
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSES 210
Query: 714 RLTEKSDVYSFGVVLLEIITSRP-------AIANTEEHKHISQ 749
T ++D+Y+ VL E +T P ++ HI+Q
Sbjct: 211 HATYRADIYALTCVLYECLTGSPPYQGDQLSVM----GAHINQ 249
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 22/202 (10%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQG-YEQFEAEVILLRTVHHKNLTTLYGYC 600
+G+GSFG+V+ G VA+K++ + E + E+ +L +T YG
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 601 NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR---IAT---EAAQGLEYLHLGCK 654
+ ++ +I EY+ GS D+L G L IAT E +GL+YLH
Sbjct: 90 LKDTKLWIIMEYLGGGSA--------LDLLE-PGPLDETQIATILREILKGLDYLH---S 137
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFR 714
++HRDIK AN+LL++ + +LADFG++ + GT ++ PE +
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIKQSA 195
Query: 715 LTEKSDVYSFGVVLLEIITSRP 736
K+D++S G+ +E+ P
Sbjct: 196 YDSKADIWSLGITAIELARGEP 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-28
Identities = 47/203 (23%), Positives = 78/203 (38%), Gaps = 25/203 (12%)
Query: 543 LGEGSFGKVYHGY---LDDNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYG 598
+ G G +Y ++ V +K L S + AE L V H ++ ++
Sbjct: 88 IAHGGLGWIYLALDRNVNGRP-VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 599 YCNEGNQIG-----LIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC 653
+ ++ G ++ EY+ SL+ L + E L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLH--- 199
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF 713
V+ D+KP NI+L ++ Q +L D G G + GT G+ PE +T
Sbjct: 200 SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY------LYGTPGFQAPEIVRT- 251
Query: 714 RLTEKSDVYSFGVVLLEIITSRP 736
T +D+Y+ G L + P
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLP 274
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 543 LGEGSFGKVYHGYLDD---NTEVAVKMLSP---SSRQGYEQFEAEVILLRTVHHKNLTTL 596
LG G VY D N +VA+K + + ++FE EV + H+N+ ++
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKP 655
E + L+ EY+ +L EY+ LS + + + G+++ H +
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMRI-- 132
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG-VAGTFGYLDPEYCQTFR 714
VHRDIKP NIL++ ++ DFG++K + S T V GT Y PE +
Sbjct: 133 --VHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 715 LTEKSDVYSFGVVLLEIITSRP--------AIANTEEHKHISQ 749
E +D+YS G+VL E++ P +IA KHI
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA----IKHIQD 227
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 36/229 (15%)
Query: 543 LGEGSFGKVYHGYLDDNT---EVAVKMLSP---SSRQGYEQFEAEVILLRTVHHKNLTTL 596
LG G +V+ D +VAVK+L Y +F E ++H + +
Sbjct: 20 LGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 597 YGYCNEGNQIGLIY----EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG 652
Y G + EY+ +L + + ++ + + + +A Q L + H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSH-- 133
Query: 653 CKPPR---VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG-VAGTFGYLDPE 708
+ +HRD+KPANI+++ ++ DFG+++ G S T V GT YL PE
Sbjct: 134 ----QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 709 YCQTFRLTEKSDVYSFGVVLLEIITSRP--------AIANTEEHKHISQ 749
+ + +SDVYS G VL E++T P ++A ++H+ +
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA----YQHVRE 234
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 25/213 (11%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLS-PSSRQGYEQFEAEVILLRTVHHKNLTTLYGY 599
ILG+G+ V+ G A+K+ + S + + E +L+ ++HKN+ L+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 600 --CNEGNQIGLIYEYMANGSLEEYLSD-SNADVLSWEGRLRIATEAAQGLEYLH-LGCKP 655
LI E+ GSL L + SNA L L + + G+ +L G
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI-- 133
Query: 656 PRVHRDIKPANILL----NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQ 711
VHR+IKP NI+ + Q +L DFG ++ E + + GT YL P+ +
Sbjct: 134 --VHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVS-LYGTEEYLHPDMYE 188
Query: 712 TFRL--------TEKSDVYSFGVVLLEIITSRP 736
L D++S GV T
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-27
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 18/211 (8%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKMLS-PSSRQGYEQFEAEVILLRTVHHKNLTT 595
+ + LG G FG V D +VA+K S + E++ E+ +++ ++H N+ +
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 596 LY------GYCNEGNQIGLIYEYMANGSLEEYLSD-SNADVLSWEGRLRIATEAAQGLEY 648
+ L EY G L +YL+ N L + ++ + L Y
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 649 LHLGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYL 705
LH + +HRD+KP NI+L + ++ D G +K + V GT YL
Sbjct: 137 LH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFV-GTLQYL 190
Query: 706 DPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
PE + + T D +SFG + E IT
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 23/202 (11%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN 601
LGEGS+G VY + VA+K + S ++ E+ +++ ++ YG
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 602 EGNQIGLIYEYMANGSLEEYLSDSNADVLSW-EGRLR---IAT---EAAQGLEYLHLGCK 654
+ + ++ EY GS+ +D++ L IAT +GLEYLH
Sbjct: 95 KNTDLWIVMEYCGAGSV--------SDIIRLRNKTLTEDEIATILQSTLKGLEYLH---F 143
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFR 714
++HRDIK NILLN + A+LADFG++ + ++ +T + GT ++ PE Q
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL-TDTMAKRNTVI-GTPFWMAPEVIQEIG 201
Query: 715 LTEKSDVYSFGVVLLEIITSRP 736
+D++S G+ +E+ +P
Sbjct: 202 YNCVADIWSLGITAIEMAEGKP 223
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 27/219 (12%)
Query: 536 TNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHK 591
FE + +G G++G+VY G + A+K++ + E+ + E+ +L+ HH+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 592 NLTTLYG------YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIAT---EA 642
N+ T YG +Q+ L+ E+ GS+ + + ++ + L E IA E
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK-EEW--IAYICREI 138
Query: 643 AQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF 702
+GL +LH +HRDIK N+LL + + +L DFG+S ++ GT
Sbjct: 139 LRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGTP 193
Query: 703 GYLDPEYCQTFRLTE-----KSDVYSFGVVLLEIITSRP 736
++ PE + KSD++S G+ +E+ P
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 45/204 (22%), Positives = 86/204 (42%), Gaps = 23/204 (11%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGY---EQFEAEVILLRTVHHKNLTTLYG 598
LG+G F K + D A K++ S E+ E+ + R++ H+++ +G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRL------RIATEAAQGLEYLHLG 652
+ + + + ++ E SL E L + G +YLH
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRR--------KALTEPEARYYLRQIVLGCQYLH-- 132
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
+ +HRD+K N+ LN+ + ++ DFGL+ +G + GT Y+ PE
Sbjct: 133 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKV-LCGTPNYIAPEVLSK 189
Query: 713 FRLTEKSDVYSFGVVLLEIITSRP 736
+ + DV+S G ++ ++ +P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKP 213
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 45/204 (22%), Positives = 86/204 (42%), Gaps = 23/204 (11%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGY---EQFEAEVILLRTVHHKNLTTLYG 598
LG+G F K + D A K++ S E+ E+ + R++ H+++ +G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRL------RIATEAAQGLEYLHLG 652
+ + + + ++ E SL E L + G +YLH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKR--------RKALTEPEARYYLRQIVLGCQYLH-- 158
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
+ +HRD+K N+ LN+ + ++ DFGL+ +G + GT Y+ PE
Sbjct: 159 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKV-LCGTPNYIAPEVLSK 215
Query: 713 FRLTEKSDVYSFGVVLLEIITSRP 736
+ + DV+S G ++ ++ +P
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKP 239
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 42/213 (19%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFE---AEVILLRTVHHKNLTTLYG 598
+G GSFG VY + ++ VA+K +S S +Q E+++ EV L+ + H N G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLR---IAT---EAAQGLEYLHLG 652
+ L+ EY + + + + L+ IA A QGL YLH
Sbjct: 122 CYLREHTAWLVMEYCLGSASD--------LLEVHKKPLQEVEIAAVTHGALQGLAYLH-- 171
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLS------KTFPIEGVSHLSTGVAGTFGYLD 706
+HRD+K NILL++ +L DFG + +F GT ++
Sbjct: 172 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF------------VGTPYWMA 218
Query: 707 PE---YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
PE + K DV+S G+ +E+ +P
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-26
Identities = 31/236 (13%), Positives = 66/236 (27%), Gaps = 46/236 (19%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPS---SRQGYEQFEAEVILLRT---------- 587
+LG+ + V + + +Q + EV+ LR
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 588 ------------VHHKNLTTLYGYCNEGNQIGLIYEYM----ANGSLEEYLSDSNADV-- 629
V + + + ++ + +L+ + +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 630 ---LSWEGRLRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685
L RL++ + + L LH G VH ++P +I+L+ + L F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGL----VHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 686 FPIEGVSHLSTGVAGTFGYLDPEYC-----QTFRLTEKSDVYSFGVVLLEIITSRP 736
VS + G +T D ++ G+ + I +
Sbjct: 261 DGASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 40/291 (13%), Positives = 84/291 (28%), Gaps = 66/291 (22%)
Query: 493 SFASLLVVTLAISAIYWRHKRLRKDGSLETKKRRFTYAEITKITNDFETILGEGSFGKVY 552
S +S W + + S ++ R T T+LG+
Sbjct: 40 SEYMQSAADSLVSTSLWNTGQPFRVESELGERPR---------TLVRGTVLGQEDPYAYL 90
Query: 553 HGY-LDDNTEVAVKMLS----------------------------PSSRQGYEQFEAEVI 583
+ V + + + +F
Sbjct: 91 EATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150
Query: 584 LLRTVHHKNLTTLYGYCNEGNQIGLIYEYM-ANGSLEEYLSD-----SNADVLSWEGRLR 637
L++ K + + + + + Y +L+ + S L RL+
Sbjct: 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 210
Query: 638 IATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696
+ + + L LH G VH ++P +I+L+ + L F +G +S+
Sbjct: 211 LTLQVIRLLASLHHYGL----VHTYLRPVDIVLDQRGGVFLTGFEHLVR---DGARVVSS 263
Query: 697 GVAGTFGYLDPEY-----------CQTFRLTEKSDVYSFGVVLLEIITSRP 736
+ G+ PE + +T D ++ G+V+ I +
Sbjct: 264 ---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 58/227 (25%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLS--------------------------PSSRQGY 575
+G+GS+G V Y +DNT A+K+LS R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 576 EQFEAEVILLRTVHHKNLTTLY---GYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSW 632
EQ E+ +L+ + H N+ L NE + + +++E + G + E +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNE-DHLYMVFELVNQGPVMEVPTL-------- 131
Query: 633 EGRLRIATEA-------AQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSK 684
L +A +G+EYLH +HRDIKP+N+L+ + ++ADFG+S
Sbjct: 132 -KPLSED-QARFYFQDLIKGIEYLHYQKI----IHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 685 TFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLT---EKSDVYSFGVVL 728
F + LS GT ++ PE R + DV++ GV L
Sbjct: 186 EF-KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 56/205 (27%), Positives = 83/205 (40%), Gaps = 33/205 (16%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLS----PSSRQGYEQFEAEVILLRTVHHKNLTTLY 597
LGEGS+GKV + AVK+L G + E+ LLR + HKN+ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 598 G--YCNEGNQIGLIYEYMANGSLE--EYLSDSNADVLSWEGRLRIATEAAQ-------GL 646
Y E ++ ++ EY G E + + E R + +A GL
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVP---------EKRFPVC-QAHGYFCQLIDGL 122
Query: 647 EYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYL 705
EYLH G VH+DIKP N+LL +++ G+++ G+ +
Sbjct: 123 EYLHSQGI----VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 706 DPEYCQTFRLTE--KSDVYSFGVVL 728
PE K D++S GV L
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTL 203
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 60/267 (22%), Positives = 92/267 (34%), Gaps = 57/267 (21%)
Query: 515 RKDGSLETKKRRFTYAEITKITNDFET--ILGEGSFGKVYHGY-LDDNTEVAVKM----- 566
S + F + ++ + +G+GS+G V A+K+
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63
Query: 567 LSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSN 626
+ + + E+ + EV L++ +HH N+ LY + I L+ E G L + L+
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 627 ADVLSWEGRLRIAT-------------------------------EAA-------QGLEY 648
D + T + L Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 649 LH-LGCKPPRVHRDIKPANILLNDQFQARL--ADFGLSKTFPI--EGVSHLSTGVAGTFG 703
LH G HRDIKP N L + + DFGLSK F G + T AGT
Sbjct: 184 LHNQGI----CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239
Query: 704 YLDPEYCQTFRL--TEKSDVYSFGVVL 728
++ PE T K D +S GV+L
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 34/202 (16%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQG-YEQFEAEVILLRTVHHKNLTTLYGYC 600
LGEG++G+V VAVK++ E + E+ + + ++H+N+ YG+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 601 NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ-------GLEYLH-LG 652
EGN L EY + G L + + + +A + G+ YLH +G
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPD--------IGMPEP-DAQRFFHQLMAGVVYLHGIG 125
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE---- 708
HRDIKP N+LL+++ +++DFGL+ F L + GT Y+ PE
Sbjct: 126 I----THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 709 --YCQTFRLTEKSDVYSFGVVL 728
+ E DV+S G+VL
Sbjct: 182 REF-----HAEPVDVWSCGIVL 198
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-24
Identities = 59/240 (24%), Positives = 100/240 (41%), Gaps = 31/240 (12%)
Query: 512 KRLRKDGSLETKKRRFTYAEITKITNDFET--ILGEGSFGKVYHGY-LDDNTEVAVKMLS 568
+ L G L+ F ++ ++ ++ LG G++G+V + E A+K++
Sbjct: 12 ENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR 71
Query: 569 PS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL------EE 620
+ S + EV +L+ + H N+ LY + + L+ E G L
Sbjct: 72 KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM 131
Query: 621 YLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQ---FQAR 676
++ +A I + G+ YLH VHRD+KP N+LL + +
Sbjct: 132 KFNEVDA--------AVIIKQVLSGVTYLHKHNI----VHRDLKPENLLLESKEKDALIK 179
Query: 677 LADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
+ DFGLS F GT Y+ PE + + EK DV+S GV+L ++ P
Sbjct: 180 IVDFGLSAVF---ENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYP 235
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 48/202 (23%), Positives = 84/202 (41%), Gaps = 27/202 (13%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTL 596
F +LG G+F +V+ A+K + S E E+ +L+ + H+N+ TL
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 597 YGYCNEGNQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
L+ + ++ G L ++ +A + + ++YLH
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS--------LVIQQVLSAVKYLH 123
Query: 651 -LGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
G VHRD+KP N+L + + + DFGLSK + + + GT GY+
Sbjct: 124 ENGI----VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVA 175
Query: 707 PEYCQTFRLTEKSDVYSFGVVL 728
PE ++ D +S GV+
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVIT 197
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 36/203 (17%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQG-YEQFEAEVILLRTVHHKNLTTLYGYC 600
LGEG++G+V VAVK++ E + E+ + + ++H+N+ YG+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 601 NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ-------GLEYLH-LG 652
EGN L EY + G L + + + +A + G+ YLH +G
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPD--------IGMPEP-DAQRFFHQLMAGVVYLHGIG 125
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTF-PIEGVSHLSTGVAGTFGYLDPE--- 708
HRDIKP N+LL+++ +++DFGL+ F L+ GT Y+ PE
Sbjct: 126 I----THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180
Query: 709 ---YCQTFRLTEKSDVYSFGVVL 728
+ E DV+S G+VL
Sbjct: 181 RREF-----HAEPVDVWSCGIVL 198
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 48/207 (23%), Positives = 81/207 (39%), Gaps = 37/207 (17%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTL 596
E +G GS+G+V A K + + ++F+ E+ +++++ H N+ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 597 YGYCNEGNQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
Y + I L+ E G L + +S+A RI + + Y H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA--------ARIMKDVLSAVAYCH 123
Query: 651 -LGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
L HRD+KP N L + +L DFGL+ F + GT Y+
Sbjct: 124 KLNV----AHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRTKVGTPYYVS 176
Query: 707 PE-----YCQTFRLTEKSDVYSFGVVL 728
P+ Y + D +S GV++
Sbjct: 177 PQVLEGLY------GPECDEWSAGVMM 197
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 64/218 (29%), Positives = 93/218 (42%), Gaps = 40/218 (18%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKMLS---PSSRQGYEQFEAEVILLRTVHHKNL 593
+ +LG+GSFG+V E AVK++S + E EV LL+ + H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIATEAAQGLE 647
LY + + L+ E G L + S+ +A RI + G+
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA--------ARIIRQVLSGIT 140
Query: 648 YLH-LGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFG 703
Y+H VHRD+KP N+LL + R+ DFGLS F S GT
Sbjct: 141 YMHKNKI----VHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAY 193
Query: 704 YLDPE-----YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
Y+ PE Y EK DV+S GV+L +++ P
Sbjct: 194 YIAPEVLHGTY------DEKCDVWSTGVILYILLSGCP 225
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 17/230 (7%)
Query: 516 KDGSLETKKRRFTYAEITKIT-NDFE--TILGEGSFGKVYHGYLDDNTEV-AVKMLSPS- 570
D + ++ + E +T N F +LG+G FG+V + ++ A K L
Sbjct: 162 LDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR 221
Query: 571 --SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE-GNQIGLIYEYMANGSLEEYLSDSNA 627
R+G E +L V+ + + +L Y E + + L+ M G L+ ++
Sbjct: 222 IKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQ 280
Query: 628 DVLSWEGRLRI-ATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF 686
E R A E GLE LH + V+RD+KP NILL+D R++D GL+
Sbjct: 281 AGFP-EARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336
Query: 687 PIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
P EG + G GT GY+ PE + R T D ++ G +L E+I +
Sbjct: 337 P-EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 533 TKITNDFET--ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH 589
+ T+ +E +G GS+ N E AVK++ S R E+ E ILLR
Sbjct: 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQ 74
Query: 590 HKNLTTLYGYCNEGNQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIATEAA 643
H N+ TL ++G + ++ E M G L +++ S+ A + L T+
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LFTITKT- 128
Query: 644 QGLEYLH-LGCKPPRVHRDIKPANILL----NDQFQARLADFGLSKTFPIEGVSHLSTGV 698
+EYLH G VHRD+KP+NIL + R+ DFG +K E L
Sbjct: 129 --VEYLHAQGV----VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTP 180
Query: 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVL 728
T ++ PE + D++S GV+L
Sbjct: 181 CYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKML--SPSSRQGYEQFEAEVILLRTVHHKNLT 594
LG+G+F V + E A ++ S + +++ E E + R + H N+
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 595 TLYGYCNEGNQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIATEAAQGLEY 648
L+ +E LI++ + G L EY S+++A ++ EA + +
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILEA---VLH 125
Query: 649 LH-LGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704
H +G VHR++KP N+LL +LADFGL+ E G AGT GY
Sbjct: 126 CHQMGV----VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGY 179
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVL 728
L PE + + D+++ GV+L
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTT 595
F+ LG G+FG V+ E +K ++ S+ EQ EAE+ +L+++ H N+
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRL------RIATEAAQGLEYL 649
++ + + + ++ E G L E + + A L + + L Y
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQAR----GKALSEGYVAELMKQMMNALAYF 140
Query: 650 H-LGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYL 705
H VH+D+KP NIL + ++ DFGL++ F ST AGT Y+
Sbjct: 141 HSQHV----VHKDLKPENILFQDTSPHSPIKIIDFGLAELF---KSDEHSTNAAGTALYM 193
Query: 706 DPEYCQTFRLTEKSDVYSFGVVL 728
PE + +T K D++S GVV+
Sbjct: 194 APEVFKR-DVTFKCDIWSAGVVM 215
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 56/208 (26%), Positives = 85/208 (40%), Gaps = 15/208 (7%)
Query: 537 NDFETI--LGEGSFGKVYHG-YLDDNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHH 590
DF+ LGEGSF V L + E A+K+L E ++ + H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLEYL 649
LY + ++ Y NG L +Y+ E R E LEYL
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFD-ETCTRFYTAEIVSALEYL 146
Query: 650 H-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE 708
H G +HRD+KP NILLN+ ++ DFG +K E + GT Y+ PE
Sbjct: 147 HGKGI----IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
Query: 709 YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
+ SD+++ G ++ +++ P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 59/249 (23%), Positives = 98/249 (39%), Gaps = 52/249 (20%)
Query: 519 SLETKKRRFTYAEITKITNDFET--ILGEGSFGKVYHGY-LDDNTEVAVKMLS------- 568
+ + + KI + LG G++G+V + ++E A+K++
Sbjct: 18 GIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKG 77
Query: 569 ------PSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL---- 618
+ + +E+ E+ LL+++ H N+ L+ + L+ E+ G L
Sbjct: 78 RYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI 137
Query: 619 --EEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILL---NDQ 672
+ +A I + G+ YLH VHRDIKP NILL N
Sbjct: 138 INRHKFDECDA--------ANIMKQILSGICYLHKHNI----VHRDIKPENILLENKNSL 185
Query: 673 FQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE-----YCQTFRLTEKSDVYSFGVV 727
++ DFGLS F + GT Y+ PE Y EK DV+S GV+
Sbjct: 186 LNIKIVDFGLSSFF---SKDYKLRDRLGTAYYIAPEVLKKKY------NEKCDVWSCGVI 236
Query: 728 LLEIITSRP 736
+ ++ P
Sbjct: 237 MYILLCGYP 245
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 18/232 (7%)
Query: 516 KDGSLETKKRRFTYAEITKIT-NDFE--TILGEGSFGKVYHGYLDDNTEV-AVKMLSPS- 570
D + ++ + E + + F +LG G FG+V+ + ++ A K L+
Sbjct: 163 LDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR 222
Query: 571 --SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE-GNQIGLIYEYMANGSLEEYLS--DS 625
R+GY+ E +L VH + + +L Y E + L+ M G + ++ D
Sbjct: 223 LKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDE 281
Query: 626 NADVLSWEGRLRI-ATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSK 684
+ E R + GLE+LH + ++RD+KP N+LL+D R++D GL+
Sbjct: 282 DNPGFQ-EPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 685 TFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
+ G AGT G++ PE D ++ GV L E+I +R
Sbjct: 338 ELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKML--SPSSRQGYEQFEAEVILLRTVHHKNLT 594
D + LG+G+F V E A K++ S + +++ E E + R + H N+
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 595 TLYGYCNEGNQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIATEAAQGLEY 648
L+ E + L+++ + G L E+ S+++A ++ E+ + Y
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILES---IAY 120
Query: 649 LH-LGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704
H G VHR++KP N+LL +LADFGL+ + G AGT GY
Sbjct: 121 CHSNGI----VHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DS--EAWHGFAGTPGY 173
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVL 728
L PE + ++ D+++ GV+L
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVIL 197
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 56/215 (26%), Positives = 82/215 (38%), Gaps = 39/215 (18%)
Query: 538 DFETILGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQG---------YEQFEAEV-ILLR 586
+ + ILG G V + E AVK++ + E EV IL +
Sbjct: 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 587 TVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIAT 640
H N+ L L+++ M G L + LS+ + +R
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-----MRALL 134
Query: 641 EAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699
E + LH L VHRD+KP NILL+D +L DFG S + L V
Sbjct: 135 EV---ICALHKLNI----VHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLRE-VC 184
Query: 700 GTFGYLDPE------YCQTFRLTEKSDVYSFGVVL 728
GT YL PE ++ D++S GV++
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 58/233 (24%), Positives = 104/233 (44%), Gaps = 30/233 (12%)
Query: 511 HKRLRKDGSLETKKRRFTYAEITKITNDFET--ILGEGSFGKVYHGY-LDDNTEVAVKML 567
H G + F TK +++++ LG+G+F V E A K++
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 568 --SPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL------E 619
S + +++ E E + R + H N+ L+ E + L+++ + G L
Sbjct: 63 NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122
Query: 620 EYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQA--- 675
E+ S+++A ++ E+ + Y H G VHR++KP N+LL + +
Sbjct: 123 EFYSEADASHC-----IQQILES---IAYCHSNGI----VHRNLKPENLLLASKAKGAAV 170
Query: 676 RLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVL 728
+LADFGL+ + G AGT GYL PE + ++ D+++ GV+L
Sbjct: 171 KLADFGLAIEVN-DS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 4e-22
Identities = 39/239 (16%), Positives = 83/239 (34%), Gaps = 21/239 (8%)
Query: 512 KRLRKDGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEVA-----VKM 566
KR+R +++ + + ++ + + +
Sbjct: 37 KRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTD 96
Query: 567 LSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSN 626
SS + ++ + KN + + + + +L+++++
Sbjct: 97 WPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156
Query: 627 A-DVLSWEGRLRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSK 684
+ + L I + A+ +E+LH G +HRD+KP+NI ++ DFGL
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLHSKGL----MHRDLKPSNIFFTMDDVVKVGDFGLVT 212
Query: 685 ----------TFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT 733
TG GT Y+ PE + K D++S G++L E++
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 21/93 (22%), Positives = 32/93 (34%), Gaps = 4/93 (4%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLS-PSSRQGYEQFEAEVILLRTVHHKN 592
DFE I +G G FG V+ D+ A+K + P+ E+ EV L + H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDS 625
+ + E E +E
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 34/201 (16%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGY 599
+G+G+F KV + EVA+K++ + + ++ EV +++ ++H N+ L+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 600 CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRL------RIATEAAQGLEYLHLGC 653
+ LI EY + G + +YL GR+ + ++Y H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAH--------GRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE----- 708
VHRD+K N+LL+ ++ADFG S F + G L G Y PE
Sbjct: 135 I---VHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFC-GAPPYAAPELFQGK 188
Query: 709 -YCQTFRLTEKSDVYSFGVVL 728
Y + DV+S GV+L
Sbjct: 189 KYDGP-----EVDVWSLGVIL 204
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 59/209 (28%), Positives = 89/209 (42%), Gaps = 39/209 (18%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQG--YEQFEAEVILLRTVHHKNLT 594
+ +LG+GSFG+V E AVK+++ +S + EV LL+ + H N+
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 595 TLYGYCNEGNQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIATEAAQGLEY 648
L+ + + ++ E G L + S+ +A RI + G+ Y
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIKQVFSGITY 136
Query: 649 LH-LGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704
+H VHRD+KP NILL ++ DFGLS F + GT Y
Sbjct: 137 MHKHNI----VHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYY 189
Query: 705 LDPE-----YCQTFRLTEKSDVYSFGVVL 728
+ PE Y EK DV+S GV+L
Sbjct: 190 IAPEVLRGTY------DEKCDVWSAGVIL 212
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 44/212 (20%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPS--------SRQGYEQFEAEVILLRTVHHKN 592
LG G+ G+V + +VA+K++S E E+ +L+ ++H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAA--------- 643
+ + + + ++ E M G L + + + RL EA
Sbjct: 77 IIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN--------KRL---KEATCKLYFYQML 124
Query: 644 QGLEYLH-LGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGVSHLSTGVA 699
++YLH G +HRD+KP N+LL + ++ DFG SK G + L +
Sbjct: 125 LAVQYLHENGI----IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLC 177
Query: 700 GTFGYLDPE---YCQTFRLTEKSDVYSFGVVL 728
GT YL PE T D +S GV+L
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-22
Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 39/209 (18%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLT 594
+ +LG+GSFG+V E AVK+++ + + EV LL+ + H N+
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 595 TLYGYCNEGNQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIATEAAQGLEY 648
L+ + + ++ E G L + S+ +A RI + G+ Y
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIKQVFSGITY 136
Query: 649 LH-LGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704
+H VHRD+KP NILL ++ DFGLS F + GT Y
Sbjct: 137 MHKHNI----VHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYY 189
Query: 705 LDPE-----YCQTFRLTEKSDVYSFGVVL 728
+ PE Y EK DV+S GV+L
Sbjct: 190 IAPEVLRGTY------DEKCDVWSAGVIL 212
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 51/236 (21%), Positives = 86/236 (36%), Gaps = 32/236 (13%)
Query: 511 HKRLRKDGSLETKKRRFTYAEITKITNDFE---TILGEGSFGKVYHGY-LDDNTEVAVKM 566
H ++ + + N + LG G F V E A K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKF 61
Query: 567 L--SPSSRQGYEQFEAEV-ILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLS 623
L + + E+ +L + L+ ++I LI EY A G +
Sbjct: 62 LKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL 121
Query: 624 DSNADVLSWEGRLRIATEAA-------QGLEYLH-LGCKPPRVHRDIKPANILLNDQFQA 675
A+++S E + +G+ YLH VH D+KP NILL+ +
Sbjct: 122 PELAEMVS-E------NDVIRLIKQILEGVYYLHQNNI----VHLDLKPQNILLSSIYPL 170
Query: 676 ---RLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVL 728
++ DFG+S+ L + GT YL PE +T +D+++ G++
Sbjct: 171 GDIKIVDFGMSRKI--GHACELRE-IMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 44/211 (20%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPS--------SRQGYEQFEAEVILLRTVHHKNL 593
LG G+ G+V + +VA++++S E E+ +L+ ++H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAA---------Q 644
+ + + ++ E M G L + + + RL EA
Sbjct: 203 IKIKNFFDA-EDYYIVLELMEGGELFDKVVGN--------KRL---KEATCKLYFYQMLL 250
Query: 645 GLEYLH-LGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGVSHLSTGVAG 700
++YLH G +HRD+KP N+LL + ++ DFG SK G + L + G
Sbjct: 251 AVQYLHENGI----IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCG 303
Query: 701 TFGYLDPE---YCQTFRLTEKSDVYSFGVVL 728
T YL PE T D +S GV+L
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 37/203 (18%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYG 598
LG G+FGKV G +VAVK+L+ S + + E+ L+ H ++ LY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ-------GLEYLHL 651
+ ++ EY++ G L +Y+ GR+ EA + ++Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKH--------GRVEEM-EARRLFQQILSAVDYCH- 128
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE--- 708
+ VHRD+KP N+LL+ A++ADFGLS L T G+ Y PE
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRT-SCGSPNYAAPEVIS 183
Query: 709 ---YCQTFRLTEKSDVYSFGVVL 728
Y + D++S GV+L
Sbjct: 184 GRLYAGP-----EVDIWSCGVIL 201
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 57/235 (24%), Positives = 98/235 (41%), Gaps = 43/235 (18%)
Query: 518 GSLETKKRRFT--YAEITKITNDFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQG 574
GS ++ RF Y ++ + +LGEG+ +V L + E AVK++
Sbjct: 1 GSTDSFSGRFEDVY-QLQE------DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI 53
Query: 575 YEQFEAEV-ILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL------EEYLSDSNA 627
+ EV +L + H+N+ L + E ++ L++E M GS+ + ++ A
Sbjct: 54 RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA 113
Query: 628 DVLSWEGRLRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQA---RLADFGLS 683
V+ ++ A L++LH G HRD+KP NIL Q ++ DF L
Sbjct: 114 SVV-----VQDVASA---LDFLHNKGI----AHRDLKPENILCEHPNQVSPVKICDFDLG 161
Query: 684 KTFPIEGVSHLSTG-----VAGTFGYLDPEYCQTFRLTEKS-----DVYSFGVVL 728
+ G + G+ Y+ PE + F D++S GV+L
Sbjct: 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 43/210 (20%), Positives = 81/210 (38%), Gaps = 32/210 (15%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKM-----LSPSSRQGYEQFEAEVILLRTVHHK 591
+ ++G+G F V + + AVK+ + S E + E + + H
Sbjct: 27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYL--SDSNADVLSWEGRLRIATEAA------ 643
++ L + + +++E+M L + V S E A+
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS-E------AVASHYMRQI 139
Query: 644 -QGLEYLH-LGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGVSHLSTGV 698
+ L Y H +HRD+KP +LL + +L FG++ G+ ++ G
Sbjct: 140 LEALRYCHDNNI----IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGR 193
Query: 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVL 728
GT ++ PE + + DV+ GV+L
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 54/202 (26%), Positives = 78/202 (38%), Gaps = 37/202 (18%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN 601
+G G+FG VAVK + E + E+I R++ H N+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 602 EGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ-------GLEYLHLGCK 654
+ +I EY + G L E + ++ GR EA G+ Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERICNA--------GRFSED-EARFFFQQLLSGVSYCH---S 134
Query: 655 PPRVHRDIKPANILLNDQFQARL--ADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE---- 708
HRD+K N LL+ RL DFG SK+ + + V GT Y+ PE
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV-GTPAYIAPEVLLR 191
Query: 709 --YCQTFRLTEKSDVYSFGVVL 728
Y + +DV+S GV L
Sbjct: 192 QEYD-----GKIADVWSCGVTL 208
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 41/204 (20%), Positives = 80/204 (39%), Gaps = 30/204 (14%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTL 596
D LG G+FG V+ K ++ + E+ ++ +HH L L
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAA---------QGLE 647
+ + ++ LI E+++ G L + ++ + + +EA +GL+
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM----------SEAEVINYMRQACEGLK 163
Query: 648 YLH-LGCKPPRVHRDIKPANILLNDQFQARL--ADFGLSKTFPIEGVSHLSTGVAGTFGY 704
++H VH DIKP NI+ + + + DFGL+ + T +
Sbjct: 164 HMHEHSI----VHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKV-TTATAEF 216
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVL 728
PE + +D+++ GV+
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 44/217 (20%)
Query: 538 DFETILGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQG--------YEQFEAEV-ILLRT 587
D + ++G G V + E AVK++ ++ + E E IL +
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 588 VHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAA---- 643
H ++ TL + + L+++ M G L +YL++ L +E
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--------VAL---SEKETRSI 205
Query: 644 -----QGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697
+ + +LH VHRD+KP NILL+D Q RL+DFG S
Sbjct: 206 MRSLLEAVSFLHANNI----VHRDLKPENILLDDNMQIRLSDFGFSCHL---EPGEKLRE 258
Query: 698 VAGTFGYLDPE------YCQTFRLTEKSDVYSFGVVL 728
+ GT GYL PE ++ D+++ GV+L
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-21
Identities = 47/204 (23%), Positives = 82/204 (40%), Gaps = 30/204 (14%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTL 596
D LG G+FG V+ A K + E E+ + + H L L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAA---------QGLE 647
+ + N++ +IYE+M+ G L E ++D + ++ +E +GL
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEH-------NKM---SEDEAVEYMRQVCKGLC 269
Query: 648 YLH-LGCKPPRVHRDIKPANILLNDQFQARL--ADFGLSKTFPIEGVSHLSTGVAGTFGY 704
++H VH D+KP NI+ + L DFGL+ + + GT +
Sbjct: 270 HMHENNY----VHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKV-TTGTAEF 322
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVL 728
PE + + +D++S GV+
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 7e-21
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 537 NDFE--TILGEGSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAEVILLRTVHH 590
NDF I+G G FG+VY D ++ A+K L +QG E I+L V
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 591 KN---LTTLYGYCNE-GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQG 645
+ + + Y +++ I + M G L +LS V S E +R A E G
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFS-EADMRFYAAEIILG 304
Query: 646 LEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYL 705
LE++H V+RD+KPANILL++ R++D GL+ + GT GY+
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYM 357
Query: 706 DPEYCQTFRLTEKS-DVYSFGVVLLEIITSRP 736
PE Q + S D +S G +L +++
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 50/199 (25%), Positives = 81/199 (40%), Gaps = 29/199 (14%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEV-ILLRTVHHKNLTTLYGY 599
LGEGSF N AVK++S + E+ L H N+ L+
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRME---ANTQKEITALKLCEGHPNIVKLHEV 74
Query: 600 CNEGNQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LG 652
++ L+ E + G L +++ S++ A I + + ++H +G
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS--------YIMRKLVSAVSHMHDVG 126
Query: 653 CKPPRVHRDIKPANILLNDQFQA---RLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY 709
VHRD+KP N+L D+ ++ DFG ++ P + L T T Y PE
Sbjct: 127 V----VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKT-PCFTLHYAAPEL 180
Query: 710 CQTFRLTEKSDVYSFGVVL 728
E D++S GV+L
Sbjct: 181 LNQNGYDESCDLWSLGVIL 199
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 54/202 (26%), Positives = 83/202 (41%), Gaps = 28/202 (13%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTL 596
+ E+ LG G+ VY A+K+L + E+ +L + H N+ L
Sbjct: 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 597 YGYCNEGNQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
+I L+ E + G L + Y S+ +A ++ EA + YLH
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-----VKQILEA---VAYLH 165
Query: 651 -LGCKPPRVHRDIKPANILLNDQFQA---RLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
G VHRD+KP N+L ++ADFGLSK L V GT GY
Sbjct: 166 ENGI----VHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCA 218
Query: 707 PEYCQTFRLTEKSDVYSFGVVL 728
PE + + D++S G++
Sbjct: 219 PEILRGCAYGPEVDMWSVGIIT 240
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 49/205 (23%), Positives = 82/205 (40%), Gaps = 35/205 (17%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKML------SPSSRQGYEQFEAEVILLRTVHHK--NL 593
LG G FG VY G + DN VA+K + + EV+LL+ V +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 594 TTLYGYCNEGNQIGLIYEYMAN-GSLEEYLSDSNADVLSWEGRL------RIATEAAQGL 646
L + + LI E L +++++ G L + + +
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--------GALQEELARSFFWQVLEAV 162
Query: 647 EYLH-LGCKPPRVHRDIKPANILLN-DQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704
+ H G +HRDIK NIL++ ++ + +L DFG + + GT Y
Sbjct: 163 RHCHNCGV----LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTD-FDGTRVY 214
Query: 705 LDPEYCQTFRLT-EKSDVYSFGVVL 728
PE+ + R + V+S G++L
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILL 239
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 524 KRRFTYAEITKITNDFE----TILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQF 578
R A+ + + + ILG G FG+V+ ++A K++ + E+
Sbjct: 74 DHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV 133
Query: 579 EAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI 638
+ E+ ++ + H NL LY N I L+ EY+ G L + + D + ++ +
Sbjct: 134 KNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI-LF 192
Query: 639 ATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARL--ADFGLSKTFPIEGVSHLS 695
+ +G+ ++H + +H D+KP NIL ++ ++ DFGL++ + + L
Sbjct: 193 MKQICEGIRHMHQMYI----LHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLK 246
Query: 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVL 728
GT +L PE ++ +D++S GV+
Sbjct: 247 V-NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 54/209 (25%), Positives = 80/209 (38%), Gaps = 33/209 (15%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKMLS------PSSRQGYEQFEAEVILLRTVHH 590
D LG G F V E A K + E+ E EV +LR V H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIATEAAQ 644
N+ TL+ + LI E ++ G L +E LS+ A ++ +
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD--- 126
Query: 645 GLEYLH-LGCKPPRVHRDIKPANILL----NDQFQARLADFGLSKTFPIEGVSHLSTGVA 699
G+ YLH H D+KP NI+L +L DFGL+ +
Sbjct: 127 GVNYLHTKKI----AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIF 179
Query: 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVL 728
GT ++ PE L ++D++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 61/237 (25%), Positives = 94/237 (39%), Gaps = 31/237 (13%)
Query: 516 KDGSLETKKRRFTYAEITKITNDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPS-- 570
+ + K+ R +DFE + +G G+F +V + +V A+K+++
Sbjct: 47 EPIVVRLKEVRLQ-------RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM 99
Query: 571 -SRQGYEQFEAEVILLRTVHHKNLTTLYGYC-NEGNQIGLIYEYMANGSLEEYLSDSNAD 628
R F E +L + +T L+ + + N + L+ EY G L LS +
Sbjct: 100 LKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKF-GE 157
Query: 629 VLSWEGRLRI-ATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF 686
+ R E ++ +H LG VHRDIKP NILL+ RLADFG
Sbjct: 158 RIP-AEMARFYLAEIVMAIDSVHRLGY----VHRDIKPDNILLDRCGHIRLADFGSCLKL 212
Query: 687 PIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVY-------SFGVVLLEIITSRP 736
+G V GT YL PE Q + Y + GV E+ +
Sbjct: 213 RADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 20/213 (9%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAEVILLRTVHH 590
DFE + +G G+FG+V L + +V A+K+L+ R F E +L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLEYL 649
K +TTL+ + N + L+ +Y G L LS D L E R E ++ +
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS-KFEDRLP-EEMARFYLAEMVIAIDSV 191
Query: 650 H-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE 708
H L VHRDIKP NIL++ RLADFG +G S V GT Y+ PE
Sbjct: 192 HQLHY----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPE 246
Query: 709 YCQTFRLTEKS-----DVYSFGVVLLEIITSRP 736
Q + D +S GV + E++
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 38/203 (18%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYG 598
LGEGSFGKV +VA+K +S + + E E+ L+ + H ++ LY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ-------GLEYLHL 651
I ++ EY A G L +Y+ + + R+ E + +EY H
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYIVE--------KKRMTED-EGRRFFQQIICAIEYCH- 125
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE--- 708
+ VHRD+KP N+LL+D ++ADFGLS L T G+ Y PE
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKT-SCGSPNYAAPEVIN 180
Query: 709 ---YCQTFRLTEKSDVYSFGVVL 728
Y + DV+S G+VL
Sbjct: 181 GKLYAGP-----EVDVWSCGIVL 198
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 25/201 (12%), Positives = 55/201 (27%), Gaps = 46/201 (22%)
Query: 543 LGEGSFGKVYHGY---LDDNTEVAVKMLSP---SSRQGYEQFEAEVILLRTVHHKNLTTL 596
G + + LD +VA+ + P ++ + + L + + +
Sbjct: 39 HGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKP 655
+ ++ E++ GSL+E S G +R A + H G
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAHRAGV-- 150
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL 715
P+ + ++ LA +
Sbjct: 151 --ALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA------- 179
Query: 716 TEKSDVYSFGVVLLEIITSRP 736
+ D+ G L ++ +R
Sbjct: 180 NPQDDIRGIGASLYALLVNRW 200
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 37/203 (18%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYG 598
LG G+FGKV G +VAVK+L+ S + E+ L+ H ++ LY
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ-------GLEYLHL 651
+ + I ++ EY++ G L +Y+ + GRL E+ + G++Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKN--------GRLDEK-ESRRLFQQILSGVDYCH- 133
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE--- 708
+ VHRD+KP N+LL+ A++ADFGLS L T G+ Y PE
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSC-GSPNYAAPEVIS 188
Query: 709 ---YCQTFRLTEKSDVYSFGVVL 728
Y + D++S GV+L
Sbjct: 189 GRLYAGP-----EVDIWSSGVIL 206
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 5e-20
Identities = 54/209 (25%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVK------MLSPSSRQGYEQFEAEVILLRTVHH 590
+ LG G F V E A K + S E+ E EV +LR + H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIATEAAQ 644
N+ TL+ + LI E ++ G L +E L++ A L+ +
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD--- 119
Query: 645 GLEYLH-LGCKPPRVHRDIKPANILLNDQFQA----RLADFGLSKTFPIEGVSHLSTGVA 699
G+ YLH H D+KP NI+L D+ +L DFG++ E + +
Sbjct: 120 GVHYLHSKRI----AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKN-IF 172
Query: 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVL 728
GT ++ PE L ++D++S GV+
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-20
Identities = 54/209 (25%), Positives = 78/209 (37%), Gaps = 33/209 (15%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKMLS------PSSRQGYEQFEAEVILLRTVHH 590
D LG G F V E A K + E+ E EV +LR V H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIATEAAQ 644
N+ TL+ + LI E ++ G L +E LS+ A +
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA--------TSFIKQILD 126
Query: 645 GLEYLH-LGCKPPRVHRDIKPANILL----NDQFQARLADFGLSKTFPIEGVSHLSTGVA 699
G+ YLH H D+KP NI+L +L DFGL+ +
Sbjct: 127 GVNYLHTKKI----AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIF 179
Query: 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVL 728
GT ++ PE L ++D++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 50/207 (24%), Positives = 76/207 (36%), Gaps = 39/207 (18%)
Query: 543 LGEGSFGKVYHG-YLDDNTEVAVKML--------SPSSRQGYEQFEAEVILLRTVHHKNL 593
LG G+FG V+ + N EV VK + + E+ +L V H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRL------RIATEAAQGLE 647
+ L+ E +G L+ + + RL I + +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-LDLF------AFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 648 YLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDP 707
YL L +HRDIK NI++ + F +L DFG + E T GT Y P
Sbjct: 145 YLRLKDI---IHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIEYCAP 198
Query: 708 E------YCQTFRLTEKSDVYSFGVVL 728
E Y + +++S GV L
Sbjct: 199 EVLMGNPY-----RGPELEMWSLGVTL 220
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 46/230 (20%), Positives = 83/230 (36%), Gaps = 24/230 (10%)
Query: 510 RHKRLRKDG-SLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGY-LDDNTEVAVKML 567
H G + + +T + +LG G GKV + + A+K+L
Sbjct: 3 HHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL 62
Query: 568 SPSSRQGYEQFEAEV-ILLRTVHHKNLTTLYG-YCNEGNQIGLIY---EYMANGSLEEYL 622
S + EV + ++ + Y N + + E M G L +
Sbjct: 63 YDSPK-----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI 117
Query: 623 SDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQA---RLA 678
+ + I + +++LH HRD+KP N+L + + +L
Sbjct: 118 QERGDQAFTEREAAEIMRDIGTAIQFLHSHNI----AHRDVKPENLLYTSKEKDAVLKLT 173
Query: 679 DFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVL 728
DFG +K + L T T Y+ PE + + D++S GV++
Sbjct: 174 DFGFAKETT-QNA--LQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 35/204 (17%), Positives = 75/204 (36%), Gaps = 31/204 (15%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTL 596
LG G FG V+ K + + E+ +L H+N+ L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAA---------QGLE 647
+ ++ +I+E+++ + E ++ S ++ E + L+
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFEL----------NEREIVSYVHQVCEALQ 116
Query: 648 YLH-LGCKPPRVHRDIKPANILLNDQFQARL--ADFGLSKTFPIEGVSHLSTGVAGTFGY 704
+LH H DI+P NI+ + + + +FG ++ + + Y
Sbjct: 117 FLHSHNI----GHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLF-TAPEY 169
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVL 728
PE Q ++ +D++S G ++
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 53/209 (25%), Positives = 81/209 (38%), Gaps = 33/209 (15%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVK------MLSPSSRQGYEQFEAEVILLRTVHH 590
D LG G F V + A K S E E EV +L+ + H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSL------EEYLSDSNADVLSWEGRLRIATEAAQ 644
N+ TL+ + LI E +A G L +E L++ A L+
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILNG-- 126
Query: 645 GLEYLH-LGCKPPRVHRDIKPANILL----NDQFQARLADFGLSKTFPIEGVSHLSTGVA 699
+ YLH L H D+KP NI+L + + ++ DFGL+ G +
Sbjct: 127 -VYYLHSLQI----AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEF--KNIF 178
Query: 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVL 728
GT ++ PE L ++D++S GV+
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-19
Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 26/240 (10%)
Query: 514 LRKDGSLETKKRRF--TYAEITKIT---NDFETI--LGEGSFGKVYHGYLDDNTEV-AVK 565
LRK+ +++ R+ T +I + D+E + +G G+FG+V +V A+K
Sbjct: 41 LRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK 100
Query: 566 MLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL 622
+LS R F E ++ + + L+ + + ++ EYM G L +
Sbjct: 101 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 623 SDSNADVLSWEGRLRI-ATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADF 680
S+ + E R E L+ +H +G +HRD+KP N+LL+ +LADF
Sbjct: 161 SNYDVP----EKWARFYTAEVVLALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADF 212
Query: 681 GLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT----FRLTEKSDVYSFGVVLLEIITSRP 736
G EG+ T V GT Y+ PE ++ + D +S GV L E++
Sbjct: 213 GTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 51/207 (24%), Positives = 80/207 (38%), Gaps = 37/207 (17%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKML------SPSSRQGYEQFEAEVILLRTVH----HK 591
LG+G FG V+ G+ L D +VA+K++ S EV LL V H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGS-LEEYLSDSNADVLSWEGRL------RIATEAAQ 644
+ L + L+ E L +Y+++ G L +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--------GPLGEGPSRCFFGQVVA 150
Query: 645 GLEYLH-LGCKPPRVHRDIKPANILLN-DQFQARLADFGLSKTFPIEGVSHLSTGVAGTF 702
+++ H G VHRDIK NIL++ + A+L DFG + GT
Sbjct: 151 AIQHCHSRGV----VHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTD-FDGTR 202
Query: 703 GYLDPEYCQTFRLT-EKSDVYSFGVVL 728
Y PE+ + + V+S G++L
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILL 229
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 22/82 (26%), Positives = 45/82 (54%), Gaps = 1/82 (1%)
Query: 387 PRITSLNLSSR-GLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
P + L + L G IPP ++ LT + +L +++ +++G +P+FLS+++ L L+ + N
Sbjct: 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135
Query: 446 MLTGPLPAGLVERSKNGSLSLS 467
L+G LP + ++
Sbjct: 136 ALSGTLPPSISSLPNLVGITFD 157
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 23/85 (27%), Positives = 41/85 (48%), Gaps = 7/85 (8%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++ L ++ ++G IP +LS + + LD S N+L+G +P +S L L + GN
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 447 LTGPLPAGLVERSKNGSL-SLSVDL 470
++G +P GS L +
Sbjct: 161 ISGAIPDSY------GSFSKLFTSM 179
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 5e-17
Identities = 19/68 (27%), Positives = 35/68 (51%), Gaps = 1/68 (1%)
Query: 389 ITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
++L+ L + + + LDL NN + G +P+ L++L++L LN++ N L
Sbjct: 223 TQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 449 GPLPAGLV 456
G +P G
Sbjct: 282 GEIPQGGN 289
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 21/64 (32%), Positives = 30/64 (46%), Gaps = 1/64 (1%)
Query: 389 ITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
TS+ +S LTG IPP +NL + +DLS N L G + + ++L N L
Sbjct: 176 FTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 449 GPLP 452
L
Sbjct: 235 FDLG 238
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 20/79 (25%), Positives = 36/79 (45%), Gaps = 1/79 (1%)
Query: 389 ITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
+ ++LS L G + + + L+ NSL + + + + L L+L N +
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIY 257
Query: 449 GPLPAGLVERSKNGSLSLS 467
G LP GL + SL++S
Sbjct: 258 GTLPQGLTQLKFLHSLNVS 276
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 6e-14
Identities = 18/82 (21%), Positives = 34/82 (41%), Gaps = 2/82 (2%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLT-MIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
P + + ++G IP + + + + +S N LTG +P + L L ++L+ N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN 207
Query: 446 MLTGPLPAGLVERSKNGSLSLS 467
ML G + L+
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLA 229
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 22/71 (30%), Positives = 34/71 (47%), Gaps = 3/71 (4%)
Query: 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
+ L+L + + G +P L+ L + L++S N+L G +P+ LQ V
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYAN 300
Query: 445 N-MLTG-PLPA 453
N L G PLPA
Sbjct: 301 NKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 2e-09
Identities = 22/79 (27%), Positives = 37/79 (46%), Gaps = 7/79 (8%)
Query: 384 NDPPRITSLNLSS----RGLTGGIPPYLSNLTMIEHLDLSNNSLTG--PVPEFLSKLQYL 437
+P ++S ++ R G + + + +LDLS +L P+P L+ L YL
Sbjct: 19 GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78
Query: 438 RVLNLTG-NMLTGPLPAGL 455
L + G N L GP+P +
Sbjct: 79 NFLYIGGINNLVGPIPPAI 97
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-18
Identities = 24/66 (36%), Positives = 39/66 (59%)
Query: 389 ITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
+ LNL ++G IP + +L + LDLS+N L G +P+ +S L L ++L+ N L+
Sbjct: 658 LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
Query: 449 GPLPAG 454
GP+P
Sbjct: 718 GPIPEM 723
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-17
Identities = 31/72 (43%), Positives = 38/72 (52%)
Query: 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443
N + L L + G TG IPP LSN + + L LS N L+G +P L L LR L L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 444 GNMLTGPLPAGL 455
NML G +P L
Sbjct: 451 LNMLEGEIPQEL 462
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-17
Identities = 28/69 (40%), Positives = 42/69 (60%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ +L L LTG IP LSN T + + LSNN LTG +P+++ +L+ L +L L+ N
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 447 LTGPLPAGL 455
+G +PA L
Sbjct: 526 FSGNIPAEL 534
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-17
Identities = 27/69 (39%), Positives = 39/69 (56%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ SL+LS L+G IP L +L+ + L L N L G +P+ L ++ L L L N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 447 LTGPLPAGL 455
LTG +P+GL
Sbjct: 478 LTGEIPSGL 486
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-16
Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 16/98 (16%)
Query: 361 DWQG--DPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGLTGG---IPPYLSNLTMIEH 415
DW +PC ++G+ C ++TS++LSS+ L G + L +LT +E
Sbjct: 32 DWSSNKNPCT-----FDGVTC-----RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81
Query: 416 LDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPA 453
L LSN+ + G V F L L+L+ N L+GP+
Sbjct: 82 LFLSNSHINGSVSGFKC-SASLTSLDLSRNSLSGPVTT 118
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-16
Identities = 24/81 (29%), Positives = 39/81 (48%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
N++SR G P N + LD+S N L+G +P+ + + YL +LNL N
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 447 LTGPLPAGLVERSKNGSLSLS 467
++G +P + + L LS
Sbjct: 668 ISGSIPDEVGDLRGLNILDLS 688
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-16
Identities = 21/79 (26%), Positives = 44/79 (55%)
Query: 389 ITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
+ L++S L+G IP + ++ + L+L +N ++G +P+ + L+ L +L+L+ N L
Sbjct: 634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLD 693
Query: 449 GPLPAGLVERSKNGSLSLS 467
G +P + + + LS
Sbjct: 694 GRIPQAMSALTMLTEIDLS 712
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-16
Identities = 24/82 (29%), Positives = 39/82 (47%), Gaps = 3/82 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L++S L+G +S T ++ L++S+N GP+P L+ L+ L+L N
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENK 280
Query: 447 LTGPLPAGLVERSKN-GSLSLS 467
TG +P L L LS
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLS 302
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-16
Identities = 24/69 (34%), Positives = 34/69 (49%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++ L L L G IP L + +E L L N LTG +P LS L ++L+ N
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501
Query: 447 LTGPLPAGL 455
LTG +P +
Sbjct: 502 LTGEIPKWI 510
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-15
Identities = 22/67 (32%), Positives = 39/67 (58%), Gaps = 1/67 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L++SS + GIP +L + + ++HLD+S N L+G +S L++LN++ N
Sbjct: 200 VNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ 258
Query: 447 LTGPLPA 453
GP+P
Sbjct: 259 FVGPIPP 265
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-15
Identities = 27/83 (32%), Positives = 37/83 (44%), Gaps = 2/83 (2%)
Query: 387 PRITSLNLSSRGLTGGIPPYLS-NLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ L+L+ TG IP +LS + LDLS N G VP F L L L+ N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 446 MLTGPLPAGLVERSKN-GSLSLS 467
+G LP + + + L LS
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLS 351
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-15
Identities = 30/86 (34%), Positives = 42/86 (48%), Gaps = 2/86 (2%)
Query: 384 NDPPRITSLNLSSRGLTGGIPPYLSN--LTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLN 441
N + +L+LSS +G I P L ++ L L NN TG +P LS L L+
Sbjct: 365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH 424
Query: 442 LTGNMLTGPLPAGLVERSKNGSLSLS 467
L+ N L+G +P+ L SK L L
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLW 450
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-15
Identities = 17/69 (24%), Positives = 35/69 (50%), Gaps = 3/69 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L +S ++G + +S +E LD+S+N+ + +P L L+ L+++GN
Sbjct: 178 GELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNK 234
Query: 447 LTGPLPAGL 455
L+G +
Sbjct: 235 LSGDFSRAI 243
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 8e-15
Identities = 28/115 (24%), Positives = 45/115 (39%), Gaps = 7/115 (6%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG 449
++LS+ LTG IP ++ L + L LSNNS +G +P L + L L+L N+ G
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 450 PLPAGLVERSK-------NGSLSLSVDLCSSYPCKENNKKKNNFVFPVIASFASL 497
+PA + ++S G + + F L
Sbjct: 553 TIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-14
Identities = 25/82 (30%), Positives = 41/82 (50%), Gaps = 3/82 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPY--LSNLTMIEHLDLSNNSLTGPVP-EFLSKLQYLRVLNLT 443
+TSL+LS L+G + L + + ++ L++S+N+L P KL L VL+L+
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159
Query: 444 GNMLTGPLPAGLVERSKNGSLS 465
N ++G G V G L
Sbjct: 160 ANSISGANVVGWVLSDGCGELK 181
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-14
Identities = 29/85 (34%), Positives = 43/85 (50%), Gaps = 4/85 (4%)
Query: 387 PRITSLNLSSRGLTGGIPP-YLSNLTMIEHLDLSNNSLTGPVPEFLSKL-QYLRVLNLTG 444
+ SL LSS +G +P L + ++ LDLS N +G +PE L+ L L L+L+
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 445 NMLTGPLPAGLVERSKNG--SLSLS 467
N +GP+ L + KN L L
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQ 402
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-13
Identities = 25/84 (29%), Positives = 36/84 (42%), Gaps = 4/84 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEF--LSKLQYLRVLNLTG 444
+ SL LS+ + G + + LDLS NSL+GPV L L+ LN++
Sbjct: 77 TGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSS 135
Query: 445 NMLTGPLPAGLVERSKN-GSLSLS 467
N L P + + L LS
Sbjct: 136 NTLDFPGKVSGGLKLNSLEVLDLS 159
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-13
Identities = 19/72 (26%), Positives = 30/72 (41%), Gaps = 4/72 (5%)
Query: 387 PRITSLNLSSRGLTGGIP-PYLSNLTMIEHLDLSNNSLTGPVPE---FLSKLQYLRVLNL 442
+ LN+SS L L +E LDLS NS++G L+ L +
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI 185
Query: 443 TGNMLTGPLPAG 454
+GN ++G +
Sbjct: 186 SGNKISGDVDVS 197
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-12
Identities = 10/65 (15%), Positives = 24/65 (36%)
Query: 391 SLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGP 450
+ G L+ L+ ++++ G + L+++ NML+G
Sbjct: 588 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 647
Query: 451 LPAGL 455
+P +
Sbjct: 648 IPKEI 652
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-11
Identities = 16/81 (19%), Positives = 28/81 (34%), Gaps = 4/81 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L LS+ +G IP L + + LDL+ N G +P + K + N
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANF 569
Query: 447 LTGPLPAGLVERSKNGSLSLS 467
+ G + +
Sbjct: 570 IAGKRYVYIKNDGMKKECHGA 590
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-09
Identities = 15/79 (18%), Positives = 27/79 (34%), Gaps = 2/79 (2%)
Query: 391 SLNLSSRGLTGGIPPYLSNLTMIEHLDLSNN--SLTGPVPEFLSKLQYLRVLNLTGNMLT 448
S +++ + G Y+ N M + + N G E L++L N+T +
Sbjct: 562 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG 621
Query: 449 GPLPAGLVERSKNGSLSLS 467
G L +S
Sbjct: 622 GHTSPTFDNNGSMMFLDMS 640
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 12/83 (14%), Positives = 29/83 (34%), Gaps = 6/83 (7%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L+L++ G IP + + ++ N + G ++ + + GN+
Sbjct: 538 RSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNL 593
Query: 447 --LTGPLPAGLVERSKNGSLSLS 467
G L S +++
Sbjct: 594 LEFQGIRSEQLNRLSTRNPCNIT 616
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 48/229 (20%), Positives = 88/229 (38%), Gaps = 41/229 (17%)
Query: 521 ETKKRRFTYAEITKITNDFET---ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYE 576
+ + + I +D++ +LG G GKV + + A+KML +
Sbjct: 45 QFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK---- 100
Query: 577 QFEAEV-ILLRTVHHKNLTTLYG-YCNEGNQIGLIY---EYMANGSL--------EEYLS 623
EV + R ++ + Y N + E + G L ++ +
Sbjct: 101 -ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 159
Query: 624 DSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQA---RLAD 679
+ A + ++ EA ++YLH + HRD+KP N+L + +L D
Sbjct: 160 EREASEI-----MKSIGEA---IQYLHSINI----AHRDVKPENLLYTSKRPNAILKLTD 207
Query: 680 FGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVL 728
FG +K L+T T Y+ PE + + D++S GV++
Sbjct: 208 FGFAKETTSHNS--LTT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFE---AEVILLRTVHH 590
+ FE + +G+GSFGKV +D ++ A+K ++ + E+ +++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 591 KNLTTLYGYC--NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLE 647
L L+ Y +E + + ++ + + G L +L + E +++ E L+
Sbjct: 75 PFLVNLW-YSFQDEED-MFMVVDLLLGGDLRYHLQQNV--HFK-EETVKLFICELVMALD 129
Query: 648 YLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
YL +HRD+KP NILL++ + DF ++ P E T +AGT Y+
Sbjct: 130 YLQNQRI----IHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMA 182
Query: 707 PEYCQTFRLTEKS---DVYSFGVVLLEIITSRP 736
PE + + S D +S GV E++ R
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 61/250 (24%), Positives = 107/250 (42%), Gaps = 58/250 (23%)
Query: 510 RHKRLRKDGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLS- 568
H +L + Y ++ K+ GEG++G VY VA+K +
Sbjct: 4 HHHHSSGRENLYFQGLMEKYQKLEKV--------GEGTYGVVYKAKDSQGRIVALKRIRL 55
Query: 569 -------PSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLE 619
PS+ R E+ LL+ +HH N+ +L + + L++E+M L+
Sbjct: 56 DAEDEGIPSTAIR--------EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLK 106
Query: 620 EYLSDSN-----ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRV-HRDIKPANILLNDQF 673
+ L ++ + + + +L +G+ + H R+ HRD+KP N+L+N
Sbjct: 107 KVLDENKTGLQDSQIKIYLYQL------LRGVAHCHQH----RILHRDLKPQNLLINSDG 156
Query: 674 QARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE-------YCQTFRLTEKSDVYSFGV 726
+LADFGL++ F I V + V T Y P+ Y + D++S G
Sbjct: 157 ALKLADFGLARAFGIP-VRSYTHEVV-TLWYRAPDVLMGSKKY------STSVDIWSIGC 208
Query: 727 VLLEIITSRP 736
+ E+IT +P
Sbjct: 209 IFAEMITGKP 218
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 25/172 (14%)
Query: 531 EITKITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQ---FEA--EV 582
++ +E + LGEG F VY + N VA+K + R + A E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 583 ILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSN-----ADVLSWEGRLR 637
LL+ + H N+ L + I L++++M LE + D++ + + ++
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMT- 121
Query: 638 IATEAAQGLEYLHLGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTFPI 688
QGLEYLH + HRD+KP N+LL++ +LADFGL+K+F
Sbjct: 122 -----LQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 9e-18
Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 48/223 (21%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEVAVKMLS--------PSS--RQGYEQFEAEVIL 584
+ + +GEG++G VY + A+K + PS+ R E+ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR--------EISI 53
Query: 585 LRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ 644
L+ + H N+ LY + ++ L++E++ + L++ L + S + Q
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVT----AKSFLLQ 108
Query: 645 ---GLEYLHLGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAG 700
G+ Y H RV HRD+KP N+L+N + + ++ADFGL++ F I V + +
Sbjct: 109 LLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIV- 162
Query: 701 TFGYLDPE-------YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
T Y P+ Y + D++S G + E++ P
Sbjct: 163 TLWYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGTP 199
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 39/164 (23%), Positives = 66/164 (40%), Gaps = 16/164 (9%)
Query: 535 ITNDFETI--LGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQFEA----EVILLRT 587
+ +E I +GEGS+G V+ D VA+K S + E+ +L+
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD--PVIKKIALREIRMLKQ 58
Query: 588 VHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLE 647
+ H NL L ++ L++EY + ++ L D + I + Q +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL-DRYQRGVPEHLVKSITWQTLQAVN 116
Query: 648 YLHLGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTFPIEG 690
+ H HRD+KP NIL+ +L DFG ++
Sbjct: 117 FCHKH----NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 50/217 (23%)
Query: 543 LGEGSFGKVYHGYLDDNTE-VAVKMLS-------PSS--RQGYEQFEAEVILLRTVHHKN 592
LGEG++ VY G VA+K + P + R EV LL+ + H N
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR--------EVSLLKDLKHAN 61
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSN-----ADVLSWEGRLRIATEAAQGLE 647
+ TL+ + + L++EY+ + L++YL D +V + +L +GL
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQL------LRGLA 114
Query: 648 YLHLGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
Y H +V HRD+KP N+L+N++ + +LADFGL++ I V T Y
Sbjct: 115 YCHR----QKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYDNEVV-TLWYRP 168
Query: 707 PE-------YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
P+ Y + + D++ G + E+ T RP
Sbjct: 169 PDILLGSTDY------STQIDMWGVGCIFYEMATGRP 199
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 51/227 (22%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTE--VAVKMLS-------PSS--RQGYEQFEAEVI 583
+ F+ + LG G++ VY G L+ T VA+K + PS+ R E+
Sbjct: 5 SQFKQLEKLGNGTYATVYKG-LNKTTGVYVALKEVKLDSEEGTPSTAIR--------EIS 55
Query: 584 LLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAA 643
L++ + H+N+ LY + N++ L++E+M + L++Y+ V + L +
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRT--VGNTPRGLELNLVKY 112
Query: 644 ------QGLEYLHLGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696
QGL + H ++ HRD+KP N+L+N + Q +L DFGL++ F I V+ S+
Sbjct: 113 FQWQLLQGLAFCHEN----KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-VNTFSS 167
Query: 697 GVAGTFGYLDPE-------YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
V T Y P+ Y + D++S G +L E+IT +P
Sbjct: 168 EVV-TLWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGKP 207
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFE---AEVILLRTVHH 590
N+FE + LG+G+FGKV A+K+L ++ E +L+ H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 591 KNLTTLYGYC-NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLEY 648
LT L Y +++ + EY G L +LS V S E R R E L+Y
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS--RERVFS-EDRARFYGAEIVSALDY 263
Query: 649 LHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA--GTFGYLD 706
LH + V+RD+K N++L+ ++ DFGL K EG+ +T GT YL
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFCGTPEYLA 317
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
PE + D + GVV+ E++ R
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 5e-17
Identities = 67/216 (31%), Positives = 111/216 (51%), Gaps = 31/216 (14%)
Query: 537 NDFETI--LGEGSFGKVY---HGYLDDNTEV-AVKMLSPSSRQGYEQFE--AEVILLRTV 588
+ FE + LG+GSFGKV+ D ++ A+K+L ++ + ++ E +L V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 589 HHKNLTTLYGYC--NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQG 645
+H + L+ Y EG + LI +++ G L LS + + E ++ E A
Sbjct: 84 NHPFIVKLH-YAFQTEGK-LYLILDFLRGGDLFTRLS--KEVMFT-EEDVKFYLAELALA 138
Query: 646 LEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF-G 703
L++LH LG ++RD+KP NILL+++ +L DFGLSK E + H A +F G
Sbjct: 139 LDHLHSLGI----IYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKK--AYSFCG 188
Query: 704 ---YLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
Y+ PE T+ +D +SFGV++ E++T
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 41/162 (25%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEA----EVILLRTVH 589
+E + +GEGS+G V D VA+K S + + E+ LL+ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD--KMVKKIAMREIKLLKQLR 82
Query: 590 HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL 649
H+NL L C + + L++E++ + ++ + L + + L ++ + + G+ +
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL-ELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 650 HL-GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690
H +HRDIKP NIL++ +L DFG ++T G
Sbjct: 141 HSHNI----IHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFE---AEVILLRTVHH 590
+ F+ I LG GSFG+V ++ A+K+L +Q E E +L+ V+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLEYL 649
L L + + + ++ EY+A G + +L S E R A + EYL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFS-EPHARFYAAQIVLTFEYL 157
Query: 650 H-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE 708
H L ++RD+KP N+L++ Q ++ DFG +K V + + GT L PE
Sbjct: 158 HSLDL----IYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPE 208
Query: 709 YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
+ + D ++ GV++ E+ P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 46/163 (28%), Positives = 80/163 (49%), Gaps = 36/163 (22%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLS--------PSS--RQGYEQFEAEVILLRTVHHK 591
+GEG++G V+ + + VA+K + PSS R E+ LL+ + HK
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR--------EICLLKELKHK 61
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSN-----ADVLSWEGRLRIATEAAQGL 646
N+ L+ + ++ L++E+ + L++Y N V S+ +L +GL
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQL------LKGL 114
Query: 647 EYLHLGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTFPI 688
+ H V HRD+KP N+L+N + +LA+FGL++ F I
Sbjct: 115 GFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 50/225 (22%)
Query: 543 LGEGSFGKVY---HGYLDDNTEVAVKMLS----PSSRQGYEQFEAEVILLRTVHHKNLTT 595
+G G++G VY D+ + A+K + S E+ LLR + H N+ +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVIS 82
Query: 596 LYGYCNE--GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAA--------QG 645
L ++ L+++Y + L + + + + +++ G
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEH-DLWHII-KFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 646 LEYLHLGCKPPRV-HRDIKPANILLNDQFQAR----LADFGLSKTF--PIEGVSHLSTGV 698
+ YLH V HRD+KPANIL+ + R +AD G ++ F P++ ++ L V
Sbjct: 141 IHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 699 AGTFGYLDPE-------YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
TF Y PE Y T+ D+++ G + E++TS P
Sbjct: 197 V-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSEP 234
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 27/217 (12%)
Query: 537 NDFETI--LGEGSFGKVY---HGYLDDNTEV-AVKMLSPSS-RQGYEQFE---AE-VILL 585
+FE + LG G++GKV+ D ++ A+K+L ++ Q + E E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 586 RTVHHKNLTTLYGYC--NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEA 642
L TL+ Y E + LI +Y+ G L +LS + + E ++I E
Sbjct: 114 HIRQSPFLVTLH-YAFQTETK-LHLILDYINGGELFTHLS--QRERFT-EHEVQIYVGEI 168
Query: 643 AQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGT 701
LE+LH LG ++RDIK NILL+ L DFGLSK F + GT
Sbjct: 169 VLALEHLHKLGI----IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGT 223
Query: 702 FGYLDPEYCQTFRL--TEKSDVYSFGVVLLEIITSRP 736
Y+ P+ + + D +S GV++ E++T
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 68/222 (30%), Positives = 98/222 (44%), Gaps = 38/222 (17%)
Query: 534 KIT-NDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFE---AEVILLR 586
K+T NDF+ + LG+G+FGKV A+K+L ++ E +L+
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 587 TVHHKNLTTLYGYC-NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQ 644
H LT L Y +++ + EY G L +LS V + E R R E
Sbjct: 61 NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS--RERVFT-EERARFYGAEIVS 116
Query: 645 GLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF- 702
LEYLH V+RDIK N++L+ ++ DFGL K EG+S +T TF
Sbjct: 117 ALEYLHSRDV----VYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGAT--MKTFC 166
Query: 703 G---YLDPEYCQTFRLTEKS-----DVYSFGVVLLEIITSRP 736
G YL PE L + D + GVV+ E++ R
Sbjct: 167 GTPEYLAPEV-----LEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 30/215 (13%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFE---AE-VILLRTVH 589
DF LG+GSFGKV+ + A+K L + E E +L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 590 HKNLTTLYGYC--NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGL 646
H LT ++ + N + + EY+ G L ++ + R A E GL
Sbjct: 77 HPFLTHMF-CTFQTKEN-LFFVMEYLNGGDLMYHIQ--SCHKFD-LSRATFYAAEIILGL 131
Query: 647 EYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF-G- 703
++LH G V+RD+K NILL+ ++ADFG+ K E + + TF G
Sbjct: 132 QFLHSKGI----VYRDLKLDNILLDKDGHIKIADFGMCK----ENMLGDAK--TNTFCGT 181
Query: 704 --YLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
Y+ PE + D +SFGV+L E++ +
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 68/215 (31%), Positives = 94/215 (43%), Gaps = 30/215 (13%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFE---AE-VILLRTVH 589
+DF + +G+GSFGKV AVK+L + ++ + +E +LL+ V
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 590 HKNLTTLYGYC--NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGL 646
H L L+ + + + +Y+ G L +L E R R A E A L
Sbjct: 98 HPFLVGLH-FSFQTADK-LYFVLDYINGGELFYHLQ--RERCFL-EPRARFYAAEIASAL 152
Query: 647 EYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF-G- 703
YLH L V+RD+KP NILL+ Q L DFGL K E + H ST TF G
Sbjct: 153 GYLHSLNI----VYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNST--TSTFCGT 202
Query: 704 --YLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
YL PE D + G VL E++ P
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 6e-16
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 33/218 (15%)
Query: 537 NDFETI--LGEGSFGKVY---HGYLDDNTEV-AVKMLSPSS----RQGYEQFEAEVILLR 586
FE + LG+G +GKV+ + ++ A+K+L + + +AE +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 587 TVHHKNLTTLYGYC--NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAA 643
V H + L Y G + LI EY++ G L L + E E +
Sbjct: 77 EVKHPFIVDLI-YAFQTGGK-LYLILEYLSGGELFMQLE--REGIFM-EDTACFYLAEIS 131
Query: 644 QGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF 702
L +LH G ++RD+KP NI+LN Q +L DFGL K E + + TF
Sbjct: 132 MALGHLHQKGI----IYRDLKPENIMLNHQGHVKLTDFGLCK----ESIHDGTV--THTF 181
Query: 703 -G---YLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
G Y+ PE D +S G ++ +++T P
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 49/226 (21%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQ----FEA--EVILLRT 587
+ + I LGEG++G+VY N VA+K + R +E+ A EV LL+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI----RLEHEEEGVPGTAIREVSLLKE 89
Query: 588 VHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSD----SNADVLSWEGRLRIATEAA 643
+ H+N+ L + +++ LI+EY N L++Y+ S + S+ +L
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL------I 142
Query: 644 QGLEYLHLGCKPPRV-HRDIKPANILLNDQFQAR-----LADFGLSKTFPIEGVSHLSTG 697
G+ + H R HRD+KP N+LL+ + + DFGL++ F I + +
Sbjct: 143 NGVNFCHS----RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-IRQFTHE 197
Query: 698 VAGTFGYLDPE-------YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
+ T Y PE Y + D++S + E++ P
Sbjct: 198 II-TLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKTP 236
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 8e-16
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPSSRQGYEQFE---AEVILLRTVHH 590
DF+ + LG GSFG+V+ N A+K+L +Q E E ++L V H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLEYL 649
+ ++G + QI +I +Y+ G L L + + A E LEYL
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR--KSQRFP-NPVAKFYAAEVCLALEYL 122
Query: 650 H-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE 708
H ++RD+KP NILL+ ++ DFG +K T + GT Y+ PE
Sbjct: 123 HSKDI----IYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYT-LCGTPDYIAPE 173
Query: 709 YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
T + D +SFG+++ E++
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 60/253 (23%), Positives = 101/253 (39%), Gaps = 49/253 (19%)
Query: 523 KKRRFTYAEITK----ITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGY 575
+ F EI + ++ + +G G+ G V Y VA+K LS
Sbjct: 7 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS------- 59
Query: 576 EQFEA---------EVILLRTVHHKNLTTLY------GYCNEGNQIGLIYEYMA---NGS 617
F+ E++L++ V+HKN+ L E + ++ E M
Sbjct: 60 RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV 119
Query: 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARL 677
++ L L ++ L G+++LH +HRD+KP+NI++ ++
Sbjct: 120 IQMELDHERMSYLLYQM-LC-------GIKHLHSAGI---IHRDLKPSNIVVKSDCTLKI 168
Query: 678 ADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPA 737
DFGL++T G S + T T Y PE E D++S G ++ E+I
Sbjct: 169 LDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVL 225
Query: 738 IANTEEHKHISQW 750
T+ HI QW
Sbjct: 226 FPGTD---HIDQW 235
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 51/238 (21%), Positives = 83/238 (34%), Gaps = 31/238 (13%)
Query: 522 TKKRRFTYAEITK----ITNDFETI--LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGY 575
K ++ + + + + GS+G V G + VA+K + + G
Sbjct: 3 QAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGR 62
Query: 576 EQ--FEA---------EVILLRTVHHKNLTTLY-----GYCNEGNQIGLIYEYMANGSLE 619
E+ LL HH N+ L +++ L+ E M L
Sbjct: 63 TVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLA 121
Query: 620 EYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLAD 679
+ + V+S + GL LH VHRD+ P NILL D + D
Sbjct: 122 QVIH-DQRIVISPQHIQYFMYHILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICD 177
Query: 680 FGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRP 736
F L++ T Y PE F+ T+ D++S G V+ E+ +
Sbjct: 178 FNLARED---TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.1 bits (197), Expect = 1e-15
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAE-VILLRTVH 589
DF + LG+GSFGKV E+ AVK+L E E +L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 590 HKNLTTLYGYC-NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLE 647
LT L+ C +++ + EY+ G L ++ E A E A GL
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFK-EPHAVFYAAEIAIGLF 456
Query: 648 YLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF-G--- 703
+L ++RD+K N++L+ + ++ADFG+ K E + T TF G
Sbjct: 457 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVT--TKTFCGTPD 507
Query: 704 YLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
Y+ PE + D ++FGV+L E++ +
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 25/217 (11%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLS-PSSRQGYEQFEA----EVILLR-- 586
+ +E + +G G++G VY VA+K + P+ G EV LLR
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 587 -TVHHKNLTTLY-----GYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIAT 640
H N+ L + ++ L++E++ L YL + L E +
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 127
Query: 641 EAAQGLEYLHLGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699
+ +GL++LH + HRD+KP NIL+ +LADFGL++ + T V
Sbjct: 128 QFLRGLDFLHAN----CIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVV 180
Query: 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
T Y PE D++S G + E+ +P
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 40/220 (18%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAE-VILLRTVH 589
DF+ + +G GS+ KV L + A+K++ + + + E + + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 590 HKNLTTLYGYC--NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGL 646
H L L+ C E + + EY+ G L ++ L E R + E + L
Sbjct: 69 HPFLVGLH-SCFQTESR-LFFVIEYVNGGDLMFHMQ--RQRKLP-EEHARFYSAEISLAL 123
Query: 647 EYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF-G- 703
YLH G ++RD+K N+LL+ + +L D+G+ K EG+ T TF G
Sbjct: 124 NYLHERGI----IYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDT--TSTFCGT 173
Query: 704 --YLDPEYCQTFRLTEKS-----DVYSFGVVLLEIITSRP 736
Y+ PE L + D ++ GV++ E++ R
Sbjct: 174 PNYIAPEI-----LRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 56/245 (22%), Positives = 97/245 (39%), Gaps = 50/245 (20%)
Query: 519 SLETKKRRFTYAEITKITNDFE--------TILGEGSFGKVYHGY-LDDNTEVAVKMLSP 569
S +F E+ + F +G G+ G V Y + VA+K LS
Sbjct: 40 SKSKVDNQFYSVEVGD--STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS- 96
Query: 570 SSRQGYEQFEA---------EVILLRTVHHKNLTTLY------GYCNEGNQIGLIYEYMA 614
F+ E++L++ V+HKN+ +L E + L+ E M
Sbjct: 97 ------RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD 150
Query: 615 ---NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND 671
++ L L ++ L G+++LH +HRD+KP+NI++
Sbjct: 151 ANLCQVIQMELDHERMSYLLYQM-LC-------GIKHLHSAGI---IHRDLKPSNIVVKS 199
Query: 672 QFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEI 731
++ DFGL++T G S + T T Y PE E D++S G ++ E+
Sbjct: 200 DCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
Query: 732 ITSRP 736
+ +
Sbjct: 257 VRHKI 261
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 28/214 (13%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAE-VILLRTVH 589
DF + LG+GSFGKV E+ AVK+L E E +L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 590 HKNLTTLYGYC-NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGLE 647
LT L+ C +++ + EY+ G L ++ E A E A GL
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGRFK-EPHAVFYAAEIAIGLF 135
Query: 648 YLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF-G-- 703
+L G ++RD+K N++L+ + ++ADFG+ K E + T TF G
Sbjct: 136 FLQSKGI----IYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVT--TKTFCGTP 185
Query: 704 -YLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
Y+ PE + D ++FGV+L E++ +
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 40/220 (18%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAE-VILLRTVH 589
DF+ + +G GS+ KV L + A++++ + + + E + + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 590 HKNLTTLYGYC--NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGL 646
H L L+ C E + + EY+ G L ++ L E R + E + L
Sbjct: 112 HPFLVGLH-SCFQTESR-LFFVIEYVNGGDLMFHMQ--RQRKLP-EEHARFYSAEISLAL 166
Query: 647 EYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF-G- 703
YLH G ++RD+K N+LL+ + +L D+G+ K EG+ T TF G
Sbjct: 167 NYLHERGI----IYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDT--TSTFCGT 216
Query: 704 --YLDPEYCQTFRLTEKS-----DVYSFGVVLLEIITSRP 736
Y+ PE L + D ++ GV++ E++ R
Sbjct: 217 PNYIAPEI-----LRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 40/220 (18%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEV-AVKMLSPS---SRQGYEQFEAE-VILLRTVH 589
++FE I LG+GSFGKV + + ++ AVK+L E E IL +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 590 HKNLTTLYGYC--NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI-ATEAAQGL 646
H LT L+ C + + E++ G L ++ + E R R A E L
Sbjct: 83 HPFLTQLF-CCFQTPDR-LFFVMEFVNGGDLMFHIQ--KSRRFD-EARARFYAAEIISAL 137
Query: 647 EYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF-G- 703
+LH G ++RD+K N+LL+ + +LADFG+ K EG+ + T TF G
Sbjct: 138 MFLHDKGI----IYRDLKLDNVLLDHEGHCKLADFGMCK----EGICNGVT--TATFCGT 187
Query: 704 --YLDPEYCQTFRLTEKS-----DVYSFGVVLLEIITSRP 736
Y+ PE L E D ++ GV+L E++
Sbjct: 188 PDYIAPEI-----LQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 39/158 (24%), Positives = 60/158 (37%), Gaps = 28/158 (17%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN 601
+G G+FG++ G L N VA+K+ SR E + + +Y +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYR-FYKQLGSGDGIPQVYYFGP 75
Query: 602 EGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGR-------LRIATEAAQGLEYLH-LGC 653
G Y M E L S D+ R L IA + +EY+H
Sbjct: 76 CGK-----YNAMV----LELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 654 KPPRVHRDIKPANILL-----NDQFQARLADFGLSKTF 686
++RD+KP N L+ Q + DF L+K +
Sbjct: 127 ----IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTE--VAVKMLS--------PSS--RQGYEQFEAEV 582
+E + +GEG++GKV+ N VA+K + P S R EV
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR--------EV 62
Query: 583 ILLR---TVHHKNLTTLY-----GYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEG 634
+LR T H N+ L+ + ++ L++E++ + L YL + E
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTET 121
Query: 635 RLRIATEAAQGLEYLHLGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693
+ + +GL++LH RV HRD+KP NIL+ Q +LADFGL++ + +
Sbjct: 122 IKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MA 175
Query: 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
L++ V T Y PE D++S G + E+ +P
Sbjct: 176 LTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 41/215 (19%)
Query: 542 ILGEGSFGKVYHGYLDDNTEVAVK-MLSPSSRQGYEQFEAEVILLRTVHHKNLTTLY--- 597
++G GSFG V+ L ++ EVA+K +L + E+ ++R V H N+ L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-----RELQIMRIVKHPNVVDLKAFF 101
Query: 598 ---GYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ--------GL 646
G + + L+ EY+ ++ + + + + L
Sbjct: 102 YSNGDKKDEVFLNLVLEYV-PETVYRASRHY------AKLKQTMPMLLIKLYMYQLLRSL 154
Query: 647 EYLHLGCKPPRV-HRDIKPANILLN-DQFQARLADFGLSKTF-PIEG-VSHLSTGVAGTF 702
Y+H + HRDIKP N+LL+ +L DFG +K E VS++ +
Sbjct: 155 AYIHSI----GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY---- 206
Query: 703 GYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRP 736
Y PE T D++S G V+ E++ +P
Sbjct: 207 -YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 51/241 (21%), Positives = 99/241 (41%), Gaps = 49/241 (20%)
Query: 522 TKKRRFTYAEITK----ITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQG 574
+K+ F ++ K + + + +G G++G V +VA+K LS
Sbjct: 5 IRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS------ 58
Query: 575 YEQFEA---------EVILLRTVHHKNLTTLY------GYCNEGNQIGLIYEYMA---NG 616
F++ E++LL+ + H+N+ L L+ +M
Sbjct: 59 -RPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQK 117
Query: 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQAR 676
+ S+ L ++ L+ GL+Y+H VHRD+KP N+ +N+ + +
Sbjct: 118 IMGLKFSEEKIQYLVYQ-MLK-------GLKYIHSAGV---VHRDLKPGNLAVNEDCELK 166
Query: 677 LADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSR 735
+ DFGL++ TG T Y PE ++ + D++S G ++ E++T +
Sbjct: 167 ILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
Query: 736 P 736
Sbjct: 222 T 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 6e-14
Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 51/231 (22%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTE--VAVKMLSPSSRQGYEQ----FEA--EVILLR 586
+ +E + +G+G+FG+V+ T VA+K + E+ A E+ +L+
Sbjct: 17 SKYEKLAKIGQGTFGEVFKA-RHRKTGQKVALKKV----LMENEKEGFPITALREIKILQ 71
Query: 587 TVHHKNLTTLYG--------YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRI 638
+ H+N+ L Y I L++++ + L LS+ E I
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSE----I 126
Query: 639 ATEAAQ---GLEYLHLGCKPPRV-HRDIKPANILLNDQFQARLADFGLSKTF--PIEGVS 692
GL Y+H ++ HRD+K AN+L+ +LADFGL++ F
Sbjct: 127 KRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 693 HLSTGVAGTFGYLDPE-------YCQTFRLTEKSDVYSFGVVLLEIITSRP 736
+ T T Y PE Y D++ G ++ E+ T P
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRSP 227
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 35/172 (20%), Positives = 61/172 (35%), Gaps = 28/172 (16%)
Query: 543 LGEGSFGKVYHGY---------LDDNTEVAVKMLSPSSRQGYEQFE----------AEVI 583
+ G +Y + ++K+ + R EQ +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 584 LLRTVHHKNLTTLYGY-CNEGNQIGLIYEYMANG-SLEEYLSDSNADVLSWEGRLRIATE 641
L + + T G+ ++ L+ + G SL+ L S VLS L++A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 642 AAQGLEYLHLGCKPPRVHRDIKPANILL--NDQFQARLADFGLSKTFPIEGV 691
LE+LH + VH ++ NI + DQ Q LA +G + + G
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 39/150 (26%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 543 LGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH-KNLTTLYGYC 600
+G GSFG +Y G + EVA+K+ ++ + Q E + + + + T+
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 601 NEGNQIGLIYEYMANG-SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVH 659
EG+ ++ E + G SLE+ + + S + L +A + +EY+H +H
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLF-NFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 128
Query: 660 RDIKPANILL---NDQFQARLADFGLSKTF 686
RD+KP N L+ + DFGL+K +
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 38/173 (21%), Positives = 66/173 (38%), Gaps = 38/173 (21%)
Query: 533 TKITNDFETI---LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEV-ILLRT 587
I +D++ LG G GKV + + A+KML + EV + R
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRA 67
Query: 588 VHHKNLTTLYG-YCNEGNQIGLIY---EYMANGSL--------EEYLSDSNADVLSWEGR 635
++ + Y N + E + G L ++ ++ A +
Sbjct: 68 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI----- 122
Query: 636 LRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQA---RLADFGLSK 684
++ EA ++YLH + HRD+KP N+L + +L DFG +K
Sbjct: 123 MKSIGEA---IQYLHSINI----AHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 60/240 (25%), Positives = 96/240 (40%), Gaps = 48/240 (20%)
Query: 517 DGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGY 575
G + + +Y + I G GSFG VY L D VA+K + R
Sbjct: 44 PGQGPDRPQEVSYTDTKVI--------GNGSFGVVYQAKLCDSGELVAIKKVLQDKR--- 92
Query: 576 EQFEA-EVILLRTVHHKNLTTLYGY------CNEGNQIGLIYEYMANGSLEEYLSDSNAD 628
F+ E+ ++R + H N+ L + + + L+ +Y+ E +
Sbjct: 93 --FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARH 145
Query: 629 VLSWEGRLRIAT------EAAQGLEYLH-LGCKPPRVHRDIKPANILLN-DQFQARLADF 680
+ L + + + L Y+H G HRDIKP N+LL+ D +L DF
Sbjct: 146 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI----CHRDIKPQNLLLDPDTAVLKLCDF 201
Query: 681 GLSKTFPIEG---VSHLSTGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRP 736
G +K + G VS++ + Y PE T DV+S G VL E++ +P
Sbjct: 202 GSAKQL-VRGEPNVSYICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 51/236 (21%), Positives = 98/236 (41%), Gaps = 42/236 (17%)
Query: 524 KRRFTYAEITK----ITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYE 576
+ F E+TK + + + +G G++G V +VA+K L
Sbjct: 8 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------R 60
Query: 577 QFEA---------EVILLRTVHHKNLTTLY------GYCNEGNQIGLIYEYMANGSLEEY 621
F++ E+ LL+ + H+N+ L ++ L+ +M L +
Sbjct: 61 PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKL 119
Query: 622 LSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFG 681
+ + L + + + +GL Y+H +HRD+KP N+ +N+ + ++ DFG
Sbjct: 120 MK---HEKLGEDRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFG 173
Query: 682 LSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRP 736
L++ TG T Y PE + T+ D++S G ++ E+IT +
Sbjct: 174 LAR-----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 40/153 (26%), Positives = 66/153 (43%), Gaps = 18/153 (11%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH-KNLTTLYGYC 600
+GEGSFG ++ G L +N +VA+K S Q E + + + +Y +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 601 NEGNQIGLIYEYMANG-SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH-LGCKPPRV 658
EG L+ + + G SLE+ L D S + A + ++ +H V
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLL-DLCGRKFSVKTVAMAAKQMLARVQSIHEKSL----V 128
Query: 659 HRDIKPANILL-----NDQFQARLADFGLSKTF 686
+RDIKP N L+ + + DFG+ K +
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEA---------EVILLRTVHHKN 592
+GEG++G V Y + VA+K +SP FE E+ +L H+N
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIKILLRFRHEN 86
Query: 593 LTTLY-----GYCNEGNQIGLIYEYM----ANGSLEEYLSDSNADVLSWEGRLRIATEAA 643
+ + + + ++ + M ++LS+ + ++ LR
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ-ILR------ 139
Query: 644 QGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSK-TFPIEGVSHLSTGVAGTF 702
GL+Y+H +HRD+KP+N+LLN ++ DFGL++ P + T T
Sbjct: 140 -GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 703 GYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRP 736
Y PE + T+ D++S G +L E++++RP
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-12
Identities = 24/158 (15%), Positives = 43/158 (27%), Gaps = 30/158 (18%)
Query: 337 FSQSETEQADVDAIMNIKSLYKR-----KDWQ----GDPC------APQAFLWNGLG--C 379
+ T+ A V ++ + Y + K+ G WN
Sbjct: 8 KDNALTDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD 67
Query: 380 SYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGP----VPE 429
+ N R+T L+L G +G +P + LT +E L L ++ P+
Sbjct: 68 MWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPK 127
Query: 430 FLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLS 467
+S + L
Sbjct: 128 GISANMSDEQKQKMRMHYQKTFVDYD---PREDFSDLI 162
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-12
Identities = 19/81 (23%), Positives = 32/81 (39%), Gaps = 4/81 (4%)
Query: 389 ITSLNLSSRGLTGG-IPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNML 447
I + + L + L + + L+ N L G +P F L LNL N +
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQI 365
Query: 448 TGPLPAGLVERSKN-GSLSLS 467
T +PA ++ +LS +
Sbjct: 366 TE-IPANFCGFTEQVENLSFA 385
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 7/76 (9%), Positives = 21/76 (27%), Gaps = 3/76 (3%)
Query: 392 LNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPL 451
+ P ++ + L + +N + + + L++ N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISV---LDIKDNPNISID 603
Query: 452 PAGLVERSKNGSLSLS 467
+ + + G L
Sbjct: 604 LSYVCPYIEAGMYMLF 619
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-10
Identities = 11/66 (16%), Positives = 22/66 (33%)
Query: 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443
N + N NL + +++ N +P FL L ++++N+
Sbjct: 222 NICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281
Query: 444 GNMLTG 449
N
Sbjct: 282 CNRGIS 287
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 17/76 (22%), Positives = 31/76 (40%), Gaps = 8/76 (10%)
Query: 387 PRITSLNLSSRGLTG-------GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRV 439
+++++ S + + P + ++LSNN ++ E S L
Sbjct: 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSS 461
Query: 440 LNLTGNMLTGPLPAGL 455
+NL GNMLT +P
Sbjct: 462 INLMGNMLTE-IPKNS 476
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 6e-10
Identities = 13/69 (18%), Positives = 24/69 (34%), Gaps = 2/69 (2%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++ L L G P + + L+L+ N +T F + + L+ N
Sbjct: 330 KKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNK 388
Query: 447 LTGPLPAGL 455
L +P
Sbjct: 389 LKY-IPNIF 396
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 9/80 (11%), Positives = 22/80 (27%), Gaps = 1/80 (1%)
Query: 388 RITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNML 447
+ ++S I + +N++T V + + +L LR + +
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218
Query: 448 TGPLPAGLVERSKNGSLSLS 467
E +
Sbjct: 219 VAENICEAWENENSEYAQQY 238
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 19/76 (25%), Positives = 30/76 (39%), Gaps = 9/76 (11%)
Query: 387 PRITSLNLSSRGLTGG--------IPPYLSNLTMIEHLDLSNNSL-TGPVPEFLSKLQYL 437
P + +N++ G I+ + + N+L T PV L K++ L
Sbjct: 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKL 332
Query: 438 RVLNLTGNMLTGPLPA 453
+L N L G LPA
Sbjct: 333 GMLECLYNQLEGKLPA 348
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 16/73 (21%), Positives = 27/73 (36%), Gaps = 8/73 (10%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG-------PVPEFLSKLQYLRVLNL 442
+S+NLS+ ++ S + + ++L N LT E L ++L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 443 TGNMLTGPLPAGL 455
N LT L
Sbjct: 496 RFNKLTK-LSDDF 507
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 17/77 (22%), Positives = 28/77 (36%), Gaps = 10/77 (12%)
Query: 387 PRITSLNLSSRGLTGGIPP--YLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVL---- 440
+TS++L LT + + L + +DLS NS + P L+
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545
Query: 441 --NLTGNMLTGPLPAGL 455
+ GN P G+
Sbjct: 546 QRDAQGNRTLREWPEGI 562
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 12/75 (16%), Positives = 26/75 (34%), Gaps = 8/75 (10%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSN------NSLTGPVPEFLSKLQYLRVL 440
P + ++LS + P N + ++ + N N PE ++ L L
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571
Query: 441 NLTGNMLTGPLPAGL 455
+ N + + +
Sbjct: 572 QIGSNDIRK-VNEKI 585
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 11/85 (12%), Positives = 21/85 (24%), Gaps = 20/85 (23%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGP-------------------VPEF 430
T + S +T + + LT + + N+
Sbjct: 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK 244
Query: 431 LSKLQYLRVLNLTGNMLTGPLPAGL 455
L+ L + + LP L
Sbjct: 245 WDNLKDLTDVEVYNCPNLTKLPTFL 269
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 16/91 (17%), Positives = 36/91 (39%), Gaps = 12/91 (13%)
Query: 387 PRITSLNLSSRGLTGGIPPYLS--NLTMIEHLDLSNNSLTG-------PVPEFLSKLQYL 437
++ +L+ + L IP +++++ +D S N + P+ K +
Sbjct: 377 EQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
Query: 438 RVLNLTGNMLTGPLPAGLVERSKN-GSLSLS 467
+NL+ N ++ P L S++L
Sbjct: 436 SSINLSNNQISK-FPKELFSTGSPLSSINLM 465
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 6/89 (6%), Positives = 21/89 (23%), Gaps = 9/89 (10%)
Query: 375 NGLGCSYNDNDPPRITSL------NLSSRGLTGGIPPYLSNLTM--IEHLDLSNNSLTGP 426
+G + P I++ Y + ++++
Sbjct: 115 HGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174
Query: 427 VPEFLSKLQYLRVLNLTGNMLTGPLPAGL 455
+ + + N +T + +
Sbjct: 175 IKKSSRITLKDTQIGQLSNNITF-VSKAV 202
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 9/62 (14%), Positives = 19/62 (30%), Gaps = 3/62 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
P +T L + S + + I LD+ +N ++ + L +
Sbjct: 566 PSLTQLQIGSNDIRK-VNE--KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
Query: 447 LT 448
Sbjct: 623 TQ 624
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 37/121 (30%), Positives = 58/121 (47%), Gaps = 15/121 (12%)
Query: 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYL-HLGCKPPRVHRDIKPANILLNDQFQARL 677
EE D D L+ E + + + A+G+E+L C +HRD+ NILL+++ ++
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKI 234
Query: 678 ADFGLSKTFPIEGVSHLSTGVAGTFGYLD-----PEYCQTFRLTEKSDVYSFGVVLLEII 732
DFGL++ + V L PE T +SDV+SFGV+L EI
Sbjct: 235 CDFGLARD-----IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
Query: 733 T 733
+
Sbjct: 290 S 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 9/93 (9%)
Query: 539 FETILGEGSFGKVYHGYL------DDNTEVAVKML-SPSSRQGYEQFEAEVILLRTV-HH 590
LG G+FG+V VAVKML ++ + +E+ +L + HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 591 KNLTTLYGYCN-EGNQIGLIYEYMANGSLEEYL 622
N+ L G C G + +I E+ G+L YL
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 27/165 (16%), Positives = 55/165 (33%), Gaps = 24/165 (14%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKMLS--PSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC 600
+G+G FG +Y ++ + V E+ + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 601 NEGNQIGL--IYEYMANGSLE--------EYLSDSNADVLSWEGR-------LRIATEAA 643
+ +G+ + + + + + L+++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRIL 162
Query: 644 QGLEYLHLGCKPPRVHRDIKPANILLN--DQFQARLADFGLSKTF 686
LEY+H + VH DIK +N+LLN + Q L D+GL+ +
Sbjct: 163 DILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-12
Identities = 19/83 (22%), Positives = 27/83 (32%), Gaps = 6/83 (7%)
Query: 379 CSYN------DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLS 432
C DN P +L+LS L + ++ LDLS +
Sbjct: 14 CMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73
Query: 433 KLQYLRVLNLTGNMLTGPLPAGL 455
L +L L LTGN +
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAF 96
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-12
Identities = 15/66 (22%), Positives = 30/66 (45%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+T L+LS L P ++L+ ++ L++S+N+ L L+VL+ + N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 447 LTGPLP 452
+
Sbjct: 530 IMTSKK 535
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 15/67 (22%), Positives = 24/67 (35%), Gaps = 1/67 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ L ++ P + L + LDLS L P + L L+VLN++ N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504
Query: 446 MLTGPLP 452
Sbjct: 505 NFFSLDT 511
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 16/83 (19%), Positives = 28/83 (33%), Gaps = 2/83 (2%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
++ L+ L +L + +LD+S+ + L L VL + GN
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
Query: 446 MLTGPLPAGLVERSKN-GSLSLS 467
+ +N L LS
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLS 478
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 6e-11
Identities = 19/85 (22%), Positives = 37/85 (43%), Gaps = 1/85 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG-PVPEFLSKLQYLRVLNLTGN 445
+ L L + +L ++ L++++N + +PE+ S L L L+L+ N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 446 MLTGPLPAGLVERSKNGSLSLSVDL 470
+ L + L+LS+DL
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDL 184
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 13/69 (18%), Positives = 23/69 (33%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
P + L+LS + +L+ + L L+ N + S L L+ L
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 447 LTGPLPAGL 455
L +
Sbjct: 112 LASLENFPI 120
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 11/63 (17%), Positives = 26/63 (41%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+++L L+ + S L+ ++ L +L + L+ L+ LN+ N+
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 447 LTG 449
+
Sbjct: 136 IQS 138
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-09
Identities = 15/64 (23%), Positives = 21/64 (32%), Gaps = 1/64 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQY-LRVLNLTGN 445
+ LN+S L ++ LD S N + + L L LNLT N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 446 MLTG 449
Sbjct: 554 DFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 23/86 (26%), Positives = 40/86 (46%), Gaps = 6/86 (6%)
Query: 387 PRITSLNLSSRGLTGG-IPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRV----LN 441
+ LN++ + +P Y SNLT +EHLDLS+N + L L + + L+
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 442 LTGNMLTGPLPAGLVERSKNGSLSLS 467
L+ N + + G + + L+L
Sbjct: 184 LSLNPMNF-IQPGAFKEIRLHKLTLR 208
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 26/99 (26%), Positives = 43/99 (43%), Gaps = 4/99 (4%)
Query: 372 FLWNGLGCSYNDNDPPRITSLNLSSRGLT--GGIPPYLSNLTMIEHLDLSNNSLTGPVPE 429
F N G ++++ D P + L+LS GL+ G T +++LDLS N +
Sbjct: 332 FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN 391
Query: 430 FLSKLQYLRVLNLTGNMLTGPLPAGLVERSKN-GSLSLS 467
FL L+ L L+ + L + +N L +S
Sbjct: 392 FLG-LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 19/76 (25%), Positives = 32/76 (42%), Gaps = 3/76 (3%)
Query: 377 LGCSYNDNDPPRITSL-NLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLT--GPVPEFLSK 433
+ C + ++ SL L+ GG +L +E LDLS N L+ G +
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 434 LQYLRVLNLTGNMLTG 449
L+ L+L+ N +
Sbjct: 372 TTSLKYLDLSFNGVIT 387
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 19/116 (16%), Positives = 36/116 (31%), Gaps = 15/116 (12%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLT----MIEHLDLSNNSLTGPVPEFLSKLQYLRVLNL 442
+ L+LSS + L L + LDLS N + P +++ L L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTL 207
Query: 443 TGNMLTGPLPAGLVER-SKNGSLSLSVDLCSSYPCKENNKKKNNFVFPVIASFASL 497
N + + ++ + L + + N ++ L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE---------GNLEKFDKSALEGL 254
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 12/59 (20%), Positives = 20/59 (33%), Gaps = 2/59 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
++S +L S + S +HL+L N L L+ L + G
Sbjct: 282 TNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 10/69 (14%), Positives = 21/69 (30%), Gaps = 5/69 (7%)
Query: 388 RITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVP-EFLSKLQYLRVLNLTGNM 446
R+ L+ I + LT + L + ++ + Q+L ++N
Sbjct: 263 RLAYLDYYL----DDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ 318
Query: 447 LTGPLPAGL 455
L
Sbjct: 319 FPTLKLKSL 327
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 16/65 (24%), Positives = 22/65 (33%), Gaps = 2/65 (3%)
Query: 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPE-FLSKLQYLRVLNLTG 444
P SL+LS + I P + L L NN + V + + L L V L
Sbjct: 176 PLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234
Query: 445 NMLTG 449
Sbjct: 235 GEFRN 239
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 68.9 bits (168), Expect = 3e-12
Identities = 41/149 (27%), Positives = 74/149 (49%), Gaps = 12/149 (8%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-HKNLTTLYGYC 600
+G GSFG++Y G + N EVA+K+ + ++ + Q E + R + + + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 601 NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHR 660
EG+ L+ + + SLE+ + + LS + L +A + +E++H +HR
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHR 127
Query: 661 DIKPANILL---NDQFQARLADFGLSKTF 686
DIKP N L+ Q + DFGL+K +
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 53/226 (23%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEA---------EVILLRTVHHK 591
+LGEG++G V VA+K + P F+ E+ +L+ H+
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHE 69
Query: 592 NLTTLY-----GYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGR-------LRIA 639
N+ T++ N++ +I E M L +S +LS + LR
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIS---TQMLSDDHIQYFIYQTLR-- 123
Query: 640 TEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA 699
++ LH +HRD+KP+N+L+N ++ DFGL++ +
Sbjct: 124 -----AVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 700 GTFG--------YLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRP 736
+ Y PE T + DV+S G +L E+ RP
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 47/232 (20%), Positives = 104/232 (44%), Gaps = 30/232 (12%)
Query: 521 ETKKRRFTYAEITKIT----NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQ 573
+ R + E + +D++ + LG G + +V+ + +N +V VK+L P ++
Sbjct: 16 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK 75
Query: 574 GYEQFEAEVILLRTV-HHKNLTTLYG--YCNEGNQIGLIYEYMANGSLEEYLSD-SNADV 629
++ E+ +L + N+ TL L++E++ N ++ ++ D+
Sbjct: 76 KIKR---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI 132
Query: 630 LSWEGRLRIATEAAQGLEYLHLGCKPPRV-HRDIKPANILLN-DQFQARLADFGLSKTFP 687
E + L+Y H + HRD+KP N++++ + + RL D+GL++ +
Sbjct: 133 RF------YMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY- 181
Query: 688 IEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKS-DVYSFGVVLLEIITSRPAI 738
+ VA + + PE +++ + S D++S G +L +I +
Sbjct: 182 -HPGQEYNVRVA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 6e-12
Identities = 33/202 (16%), Positives = 63/202 (31%), Gaps = 55/202 (27%)
Query: 536 TNDFETI--LGEGSFGKVYHGYLDDNTEVAVKML--------SPSSRQGYEQFEAEVILL 585
T + +GEG FG+V+ D+T VA+K++ + S ++ +E+ E+I+
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 586 RTVH---------HKNLTTLYGYC------------------------------NEGNQI 606
+ + + L + +Q+
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 607 GLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPAN 666
++ E+ G L + S I + L HRD+ N
Sbjct: 138 FIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 667 ILLNDQFQARLADFGLSKTFPI 688
+LL +L K+ I
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTI 214
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 38/164 (23%), Positives = 64/164 (39%), Gaps = 25/164 (15%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN 601
+G G FG +Y + + + A ++ Q +E+ + V K+ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVK-VEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 602 EGNQIGLIYEYMANGSLE-----------EYLSDSNADVLSWEGR------LRIATEAAQ 644
+ + +G I + +G E E L + G L++
Sbjct: 104 QLDYLG-IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLD 162
Query: 645 GLEYLHLGCKPPRVHRDIKPANILL--NDQFQARLADFGLSKTF 686
LEY+H + VH DIK AN+LL + Q LAD+GLS +
Sbjct: 163 VLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 55/246 (22%), Positives = 92/246 (37%), Gaps = 43/246 (17%)
Query: 517 DGSLETKKRRFTYAEIT-KITNDFETI--LGEGSFGKVYHGYL-DDNTEVAVK--MLSPS 570
GS+ + E + K + F+ G+G+FG V G VA+K + P
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 571 SRQGYEQFEAEVI-LLRTVHHKNLTTLYGY-----CNEGNQI--GLIYEYM--------- 613
+ E +++ L +HH N+ L Y + I ++ EY+
Sbjct: 62 ----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCR 117
Query: 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRV-HRDIKPANILLNDQ 672
+ V ++ +R + LHL V HRDIKP N+L+N+
Sbjct: 118 NYYRRQVAPPPILIKVFLFQ-LIR-------SIGCLHLPSV--NVCHRDIKPHNVLVNEA 167
Query: 673 -FQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLE 730
+L DFG +K S + + Y PE + T D++S G + E
Sbjct: 168 DGTLKLCDFGSAKKL---SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAE 224
Query: 731 IITSRP 736
++ P
Sbjct: 225 MMLGEP 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 52/228 (22%), Positives = 93/228 (40%), Gaps = 55/228 (24%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEA-----EVILLRTVHHKNLTT 595
LG G G V+ D + VA+K + + Q E+ ++R + H N+
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ-----SVKHALREIKIIRRLDHDNIVK 72
Query: 596 LY--------------GYCNEGNQIGLIYEYM---------ANGSLEEYLSDSNADVLSW 632
++ G E N + ++ EYM L + +A + +
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-----LLEEHARLFMY 127
Query: 633 EGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF-QARLADFGLSKTF--PIE 689
+ LR GL+Y+H +HRD+KPAN+ +N + ++ DFGL++
Sbjct: 128 Q-LLR-------GLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 690 GVSHLSTGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRP 736
HLS G+ T Y P + T+ D+++ G + E++T +
Sbjct: 177 HKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-11
Identities = 28/96 (29%), Positives = 40/96 (41%), Gaps = 8/96 (8%)
Query: 379 CSYN------DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLS 432
CS+ D+ P IT LNL+ L + + + LD+ N+++ PE
Sbjct: 11 CSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQ 70
Query: 433 KLQYLRVLNLTGNMLTGPLPAGLVERSKN-GSLSLS 467
KL L+VLNL N L+ L N L L
Sbjct: 71 KLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLM 105
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 16/66 (24%), Positives = 26/66 (39%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ LNL S G +L ++ +DL N+L + L+ LNL N+
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595
Query: 447 LTGPLP 452
+T
Sbjct: 596 ITSVEK 601
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-10
Identities = 23/114 (20%), Positives = 41/114 (35%), Gaps = 13/114 (11%)
Query: 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443
+T L+L S + + LDLS+N L+ +L+ L+ L L+
Sbjct: 94 AFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLS 153
Query: 444 GNMLTGPLPAGLVERSKNGSLSLSVDLCSSYPCKENNKKKNNFVFPVIASFASL 497
N + L + ++ N SL ++L S N F ++
Sbjct: 154 NNKIQA-LKSEELDIFANSSL-KKLELSS-----------NQIKEFSPGCFHAI 194
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-10
Identities = 17/80 (21%), Positives = 28/80 (35%), Gaps = 2/80 (2%)
Query: 387 PRITSLNLSSRGLTGGIPPYLS--NLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
+ L LS+ + L + ++ L+LS+N + P + L L L
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204
Query: 445 NMLTGPLPAGLVERSKNGSL 464
L L L N S+
Sbjct: 205 VQLGPSLTEKLCLELANTSI 224
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-10
Identities = 16/79 (20%), Positives = 29/79 (36%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+T L+LS L + L +E+ L N++ L L +R LNL +
Sbjct: 248 TNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSF 307
Query: 447 LTGPLPAGLVERSKNGSLS 465
+ + + + S
Sbjct: 308 TKQSISLASLPKIDDFSFQ 326
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 20/81 (24%), Positives = 31/81 (38%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
P + LNL L+ + T + L L +NS+ K + L L+L+ N
Sbjct: 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132
Query: 447 LTGPLPAGLVERSKNGSLSLS 467
L+ V+ L LS
Sbjct: 133 LSSTKLGTQVQLENLQELLLS 153
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 11/64 (17%), Positives = 19/64 (29%), Gaps = 1/64 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ L+L + + L I + LS N + + L+ L L
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464
Query: 446 MLTG 449
L
Sbjct: 465 ALKN 468
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 19/82 (23%), Positives = 37/82 (45%), Gaps = 2/82 (2%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++TSL++ ++ P L M++ L+L +N L+ + + L L+L N
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 447 LTGPLPAGLVERSKN-GSLSLS 467
+ + + KN +L LS
Sbjct: 109 IQK-IKNNPFVKQKNLITLDLS 129
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-09
Identities = 23/104 (22%), Positives = 36/104 (34%), Gaps = 2/104 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNL--TMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
I +L+LS+ L+ L T + LDLS N+L + + L L L
Sbjct: 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEY 281
Query: 445 NMLTGPLPAGLVERSKNGSLSLSVDLCSSYPCKENNKKKNNFVF 488
N + L L+L + K ++F F
Sbjct: 282 NNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 23/90 (25%), Positives = 36/90 (40%), Gaps = 10/90 (11%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLT--------GPVPEFLSKLQYLR 438
+T L+LS+ + L L +E LDL +N+L G FL L +L
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539
Query: 439 VLNLTGNMLTGPLPAGLVERSKN-GSLSLS 467
+LNL N +P + + + L
Sbjct: 540 ILNLESNGFDE-IPVEVFKDLFELKIIDLG 568
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 19/64 (29%), Positives = 27/64 (42%), Gaps = 2/64 (3%)
Query: 387 PRITSLNLSSRGLTG--GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
P + L L L P L + LDLSNN++ + L L+ L +L+L
Sbjct: 454 PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQH 513
Query: 445 NMLT 448
N L
Sbjct: 514 NNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 15/84 (17%), Positives = 30/84 (35%), Gaps = 4/84 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG--PVPEFLSKLQYLRVLNLTG 444
I + LS + + ++ L L +L P L+ L +L+L+
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 445 NMLTGPLPAGLVERSKN-GSLSLS 467
N + + ++E + L L
Sbjct: 490 NNIAN-INDDMLEGLEKLEILDLQ 512
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-08
Identities = 18/89 (20%), Positives = 33/89 (37%), Gaps = 8/89 (8%)
Query: 387 PRITSLNLSS--------RGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLR 438
++ L+L GG +L L+ + L+L +N E L L+
Sbjct: 504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563
Query: 439 VLNLTGNMLTGPLPAGLVERSKNGSLSLS 467
+++L N L + + SL+L
Sbjct: 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQ 592
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 7e-08
Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 3/62 (4%)
Query: 388 RITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNML 447
+ S LT +P L T I L+L++N L ++ L L++ N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 448 TG 449
+
Sbjct: 62 SK 63
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 18/73 (24%), Positives = 33/73 (45%), Gaps = 6/73 (8%)
Query: 387 PRITSLNLSS-----RGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLN 441
+ L+LS+ R LT L++ + + L+L+ N ++ + S L +L VL+
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAH-SPLHILNLTKNKISKIESDAFSWLGHLEVLD 411
Query: 442 LTGNMLTGPLPAG 454
L N + L
Sbjct: 412 LGLNEIGQELTGQ 424
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 15/77 (19%), Positives = 29/77 (37%), Gaps = 1/77 (1%)
Query: 389 ITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
T ++S L L +EHL++ +N + G + L L+ L+L+ + +
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366
Query: 449 -GPLPAGLVERSKNGSL 464
L + L
Sbjct: 367 LRTLTNETFVSLAHSPL 383
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 15/70 (21%), Positives = 26/70 (37%), Gaps = 3/70 (4%)
Query: 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLS---KLQYLRVLNL 442
+ L LSS + P + + L L+N L + E L +R L+L
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229
Query: 443 TGNMLTGPLP 452
+ + L+
Sbjct: 230 SNSQLSTTSN 239
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-07
Identities = 18/74 (24%), Positives = 30/74 (40%), Gaps = 5/74 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLS---NLTMIEHLDLSNNSLTGPVPEFLSKLQY--LRVLN 441
R+ L L++ L + L T I +L LSN+ L+ L++ L +L+
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 442 LTGNMLTGPLPAGL 455
L+ N L
Sbjct: 255 LSYNNLNVVGNDSF 268
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 9e-06
Identities = 18/70 (25%), Positives = 29/70 (41%), Gaps = 4/70 (5%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNN--SLTGPVPEFLSKLQ--YLRVLNL 442
+ LN+ + G + L +++L LSN+ SL E L L +LNL
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 443 TGNMLTGPLP 452
T N ++
Sbjct: 389 TKNKISKIES 398
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHK------NLT 594
++G+GSFG+V Y + VA+KM+ + ++ + Q E+ +L + + N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK 654
+ N I + +E ++ +L E + + S + A Q L+ LH K
Sbjct: 163 HMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---K 218
Query: 655 PPRVHRDIKPANILLNDQFQA--RLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
+H D+KP NILL Q ++ ++ DFG S + + + T + F Y PE
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQ---RVYTYIQSRF-YRAPEVILG 273
Query: 713 FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHIS 748
R D++S G +L E++T P + +E ++
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA 309
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 40/232 (17%), Positives = 83/232 (35%), Gaps = 50/232 (21%)
Query: 514 LRKDGSLETKKRRFTYAEITK--ITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLS 568
+ + + + I + +++ +G GS+G VY Y + VA+K ++
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 569 PSSRQGYEQFEA---------EVILLRTVHHKNLTTLY-----GYCNEGNQIGLIYEYM- 613
FE E+ +L + + LY + +++ ++ E
Sbjct: 61 RM-------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD 113
Query: 614 --------ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPA 665
+L++ + + + L G ++H +HRD+KPA
Sbjct: 114 SDLKKLFKTP----IFLTEEHIKTILYN-LLL-------GENFIHESGI---IHRDLKPA 158
Query: 666 NILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTE 717
N LLN ++ DFGL++T E +++ + +LT
Sbjct: 159 NCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 46/216 (21%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEA---------EVILLRTVHHKN 592
+G G++G V + VAVK LS F++ E+ LL+ + H+N
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELRLLKHMKHEN 89
Query: 593 LTTLY------GYCNEGNQIGLIYEYMANGSLEEY-----LSDSNADVLSWEGRLRIATE 641
+ L E N + L+ M L L+D + L ++ LR
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQ-ILR---- 143
Query: 642 AAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGT 701
GL+Y+H +HRD+KP+N+ +N+ + ++ DFGL++ + TG T
Sbjct: 144 ---GLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARH-----TADEMTGYVAT 192
Query: 702 FGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRP 736
Y PE + + D++S G ++ E++T R
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 35/202 (17%), Positives = 66/202 (32%), Gaps = 16/202 (7%)
Query: 290 VPSYRHTTTAYTTSALTGEKLQ-FSIHKTENSTLPPILNAIEFYLVQDFSQSETEQA--D 346
+P+ + AYTT + +G K + I N + ET + D
Sbjct: 211 LPAGTYQVVAYTTYSQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKD 270
Query: 347 VDAIMNIKSLYKRKDWQGDPCAPQAFL----WNGLG--CSYND------NDPPRITSLNL 394
A+ I K+W+ + WN + D ++ R+T L+L
Sbjct: 271 YKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSL 330
Query: 395 SSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAG 454
+ G G +P + LT ++ L +S T F + + + +
Sbjct: 331 AGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKM 390
Query: 455 LVERSKN-GSLSLSVDLCSSYP 475
++ + L D + P
Sbjct: 391 FLDYDQRLNLSDLLQDAINRNP 412
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 4e-10
Identities = 18/90 (20%), Positives = 30/90 (33%), Gaps = 8/90 (8%)
Query: 373 LWNGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLT-------G 425
+ CS +D +++ LS + + + I + LSNN +T
Sbjct: 659 EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLK 718
Query: 426 PVPEFLSKLQYLRVLNLTGNMLTGPLPAGL 455
P L ++L N LT L
Sbjct: 719 PKDGNYKNTYLLTTIDLRFNKLTS-LSDDF 747
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 9e-10
Identities = 14/63 (22%), Positives = 21/63 (33%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG 449
N SNL + ++L N +P+FL L L+ LN+ N
Sbjct: 470 EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
Query: 450 PLP 452
Sbjct: 530 AAQ 532
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 9e-09
Identities = 15/91 (16%), Positives = 33/91 (36%), Gaps = 10/91 (10%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGP---------VPEFLSKLQYL 437
+T + L + +P +L +L ++ L+++ N + + +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 438 RVLNLTGNMLTG-PLPAGLVERSKNGSLSLS 467
++ + N L P A L + K G L
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCV 581
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 13/84 (15%), Positives = 27/84 (32%), Gaps = 3/84 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYL-SNLTMIEHLDLSNNSLTG-PVPEFLSKLQYLRVLNLTG 444
++T L L + IP + +E L S+N L P + + ++ +
Sbjct: 595 VKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSY 653
Query: 445 NMLTGPLPAGLVERSKNGSLSLSV 468
N + ++ S
Sbjct: 654 NKIGSEGRNISCSMDDYKGINAST 677
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 12/79 (15%), Positives = 29/79 (36%), Gaps = 5/79 (6%)
Query: 392 LNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN-MLTGP 450
+ + P ++ + L + +N + V E L L +L++ N ++
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISID 843
Query: 451 LPAGLVERSKNGSLSLSVD 469
+ + + + G L D
Sbjct: 844 VTS-VCPYIEAGMYVLLYD 861
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 9/67 (13%), Positives = 21/67 (31%), Gaps = 5/67 (7%)
Query: 387 PRITSLNLSSRGLTG-----GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLN 441
+ S++ S + + LS N + E + + +
Sbjct: 644 YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703
Query: 442 LTGNMLT 448
L+ N++T
Sbjct: 704 LSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 10/75 (13%), Positives = 27/75 (36%), Gaps = 8/75 (10%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDL------SNNSLTGPVPEFLSKLQYLRVL 440
P ++++++S + P N + ++ + N + P ++ L L
Sbjct: 753 PYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811
Query: 441 NLTGNMLTGPLPAGL 455
+ N + + L
Sbjct: 812 QIGSNDIRK-VDEKL 825
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 16/84 (19%), Positives = 26/84 (30%), Gaps = 7/84 (8%)
Query: 387 PRITSLNLSSRGLTGGIPPY--LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
P+I + L P L + + LD +N + + F L L L
Sbjct: 548 PKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVRH-LEAF-GTNVKLTDLKLDY 604
Query: 445 NMLTGPLPAGLVERSKN-GSLSLS 467
N + +P + L S
Sbjct: 605 NQIEE-IPEDFCAFTDQVEGLGFS 627
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 14/77 (18%), Positives = 29/77 (37%), Gaps = 10/77 (12%)
Query: 387 PRITSLNLSSRGLTGGIPP--YLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNL-- 442
+T+++L LT + + L + ++D+S N + P L+ +
Sbjct: 728 YLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRH 785
Query: 443 ----TGNMLTGPLPAGL 455
GN + P G+
Sbjct: 786 QRDAEGNRILRQWPTGI 802
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 14/92 (15%), Positives = 28/92 (30%), Gaps = 10/92 (10%)
Query: 384 NDPPRITSLNLSSRGLTGGIPPY--LSNLTMIEHLDLSNNSLTGPVPEFLSKLQY----- 436
++ L S L IP ++ ++ +D S N + +
Sbjct: 616 AFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674
Query: 437 LRVLNLTGNMLTGPLPAGLVERSKN-GSLSLS 467
+ L+ N + P L ++ LS
Sbjct: 675 ASTVTLSYNEIQK-FPTELFATGSPISTIILS 705
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 11/82 (13%), Positives = 23/82 (28%), Gaps = 3/82 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++ L+ + + L L N + +F + + L + N
Sbjct: 573 VKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNK 630
Query: 447 LTGPLPAGLVERSKN-GSLSLS 467
L + GS+ S
Sbjct: 631 LKYIPNIFNAKSVYVMGSVDFS 652
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 14/85 (16%), Positives = 25/85 (29%), Gaps = 20/85 (23%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGP-------------------VPEF 430
T + + +T I + LT ++ + +N+ T
Sbjct: 428 TQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELS 486
Query: 431 LSKLQYLRVLNLTGNMLTGPLPAGL 455
S L+ L + L LP L
Sbjct: 487 WSNLKDLTDVELYNCPNMTQLPDFL 511
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 9e-04
Identities = 8/88 (9%), Positives = 26/88 (29%), Gaps = 7/88 (7%)
Query: 386 PPRITSLNLSSRGLT-----GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVL 440
R+ +L + I + N +T + + + +L L+++
Sbjct: 395 DQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQII 453
Query: 441 NLTGNMLTG-PLPAGLVERSKNGSLSLS 467
+ T + + + + +
Sbjct: 454 YFANSPFTYDNIAVDWEDANSDYAKQYE 481
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 48/238 (20%), Positives = 79/238 (33%), Gaps = 54/238 (22%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGY- 599
LG GSFG V + ++ A+K + R E+ +++ + H N+ L Y
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYF 69
Query: 600 --CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGR--------------------LR 637
+ N + +N L+
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129
Query: 638 IATEAAQ----------------GLEYLH-LGCKPPRVHRDIKPANILLN-DQFQARLAD 679
+ + + ++H LG HRDIKP N+L+N +L D
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI----CHRDIKPQNLLVNSKDNTLKLCD 185
Query: 680 FGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRP 736
FG +K I ++ + F Y PE T D++S G V E+I +P
Sbjct: 186 FGSAKKL-IPSEPSVAY-ICSRF-YRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 52/238 (21%), Positives = 93/238 (39%), Gaps = 33/238 (13%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH----------- 589
LG G F V+ + +NT VA+K++ + E E E+ LL+ V+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 590 HKNLTTLYGY----CNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQG 645
++ L + G + +++E + +L + + +I+ + G
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 646 LEYLHLGCKPPRVHRDIKPANILLND------QFQARLADFGLSKTFPIEGVSHLSTGVA 699
L+Y+H C +H DIKP N+L+ Q ++AD G + + T
Sbjct: 144 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACW----YDEHYTNSI 196
Query: 700 GTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ 757
T Y PE +D++S ++ E+IT E H + D +AQ
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD--DDHIAQ 252
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-10
Identities = 18/96 (18%), Positives = 24/96 (25%), Gaps = 8/96 (8%)
Query: 379 CSYN------DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLS 432
C P L S L S L + LDL+ + +
Sbjct: 19 CENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQ 78
Query: 433 KLQYLRVLNLTGNMLTGPLPAGLVERSKN-GSLSLS 467
L L LT N L + + K L
Sbjct: 79 SQHRLDTLVLTANPLIF-MAETALSGPKALKHLFFI 113
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 19/84 (22%), Positives = 31/84 (36%), Gaps = 4/84 (4%)
Query: 387 PRITSLNLSS---RGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443
P + LNL L L +E L LS L+ + L+ + ++L+
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508
Query: 444 GNMLTGPLPAGLVERSKNGSLSLS 467
N LT + K L+L+
Sbjct: 509 HNRLTS-SSIEALSHLKGIYLNLA 531
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 13/63 (20%), Positives = 24/63 (38%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
R+ +L L++ L LS ++HL ++ L + L L L N
Sbjct: 81 HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 447 LTG 449
++
Sbjct: 141 ISS 143
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 19/75 (25%), Positives = 32/75 (42%), Gaps = 1/75 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L+L++ L+ +P L L+ ++ L LS N S L L++ GN
Sbjct: 278 SGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNT 336
Query: 447 LTGPLPAGLVERSKN 461
L G +E +N
Sbjct: 337 KRLELGTGCLENLEN 351
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 17/86 (19%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443
+ P + L G++ L N +E L L +N ++ + L+VL+
Sbjct: 102 SGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQ 161
Query: 444 GNMLTGPLPAGLV--ERSKNGSLSLS 467
N + + +++ N SL+L+
Sbjct: 162 NNAIHYLSKEDMSSLQQATNLSLNLN 187
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 27/81 (33%), Positives = 43/81 (53%), Gaps = 1/81 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
R+ L LS L+ ++L M+ H+DLS+N LT E LS L+ + LNL N
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH 534
Query: 447 LTGPLPAGLVERSKNGSLSLS 467
++ LP+ L S+ +++L
Sbjct: 535 ISIILPSLLPILSQQRTINLR 555
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 17/64 (26%), Positives = 29/64 (45%), Gaps = 1/64 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
P++ L+L+ L NL +++ L+LS++ L + L L+ LNL GN
Sbjct: 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGN 459
Query: 446 MLTG 449
Sbjct: 460 HFPK 463
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 15/82 (18%), Positives = 29/82 (35%), Gaps = 2/82 (2%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+T L+L+ + + ++ L L+ N L LS + L+ L
Sbjct: 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG 116
Query: 447 LTGPLPAGLVERSKN-GSLSLS 467
++ + + K SL L
Sbjct: 117 ISS-IDFIPLHNQKTLESLYLG 137
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 16/69 (23%), Positives = 24/69 (34%), Gaps = 3/69 (4%)
Query: 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG---PVPEFLSKLQYLRVL 440
+ + LNLS L L ++HL+L N L L L +L
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481
Query: 441 NLTGNMLTG 449
L+ L+
Sbjct: 482 VLSFCDLSS 490
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 15/71 (21%), Positives = 25/71 (35%), Gaps = 2/71 (2%)
Query: 387 PRITSLNLSSRGLT--GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
+ L+LS + L NL+ ++ L+LS N E + L +L+L
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 445 NMLTGPLPAGL 455
L
Sbjct: 410 TRLKVKDAQSP 420
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 14/64 (21%), Positives = 25/64 (39%), Gaps = 1/64 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPV-PEFLSKLQYLRVLNLTGN 445
+ L LS+ SN + HL + N+ + L L+ LR L+L+ +
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360
Query: 446 MLTG 449
+
Sbjct: 361 DIET 364
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 18/59 (30%), Positives = 30/59 (50%), Gaps = 1/59 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ ++LS LT LS+L I +L+L++N ++ +P L L R +NL N
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQN 557
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 12/75 (16%), Positives = 27/75 (36%), Gaps = 5/75 (6%)
Query: 384 NDPPRITSLNLSS---RGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVL 440
+ + ++ + L ++ +E ++L + L+ L
Sbjct: 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEMS-VESINLQKHYFFNISSNTFHCFSGLQEL 283
Query: 441 NLTGNMLTGPLPAGL 455
+LT L+ LP+GL
Sbjct: 284 DLTATHLSE-LPSGL 297
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 10/70 (14%), Positives = 16/70 (22%), Gaps = 4/70 (5%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSN--LTMIEHLDLSNNSLTGPVPEFLSKLQ--YLRVLNL 442
SLN I L N + + + P L + +NL
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261
Query: 443 TGNMLTGPLP 452
+
Sbjct: 262 QKHYFFNISS 271
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 50/216 (23%), Positives = 96/216 (44%), Gaps = 17/216 (7%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV------HHKNLT 594
++G+GSFG+V Y + VA+K++ + + Q + EV LL + +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIK-NKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK 654
L + N + L++E ++ +L + L ++N +S + A + L +L +
Sbjct: 120 HLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-E 177
Query: 655 PPRVHRDIKPANILLNDQFQA--RLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
+H D+KP NILL + ++ ++ DFG S + + + F Y PE
Sbjct: 178 LSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQ---RIYQYIQSRF-YRSPEVLLG 232
Query: 713 FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHIS 748
D++S G +L+E+ T P + E ++
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 268
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 42/236 (17%), Positives = 83/236 (35%), Gaps = 56/236 (23%)
Query: 515 RKDGSLETKKRRFTYAEIT-KITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPS 570
RK +I + +E +G GS+G V Y + VA+K +
Sbjct: 30 RKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-- 87
Query: 571 SRQGYEQFEA---------EVILLRTVHHKNLTTLY-----GYCNEGNQIGLIYEYM--- 613
FE E+ +L ++H ++ + + +++ ++ E
Sbjct: 88 -----RVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD 142
Query: 614 ------ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRV-HRDIKPAN 666
YL++ + L + L G++Y+H + HRD+KPAN
Sbjct: 143 FKKLFRTP----VYLTELHIKTLLYN-LLV-------GVKYVHSA----GILHRDLKPAN 186
Query: 667 ILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFR-----LTE 717
L+N ++ DFGL++T + ++ ++ + LT
Sbjct: 187 CLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 21/96 (21%), Positives = 34/96 (35%), Gaps = 8/96 (8%)
Query: 379 CSYN------DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLS 432
C D+ P +++LS L SN + ++ LDLS + +
Sbjct: 18 CMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWH 77
Query: 433 KLQYLRVLNLTGNMLTGPLPAGLVERSKN-GSLSLS 467
L +L L LTGN + G + +L
Sbjct: 78 GLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAV 112
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 14/70 (20%), Positives = 28/70 (40%)
Query: 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443
+ +T L+LS L L ++ L++S+N+L ++L L L+ +
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529
Query: 444 GNMLTGPLPA 453
N +
Sbjct: 530 FNRIETSKGI 539
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-09
Identities = 14/64 (21%), Positives = 24/64 (37%), Gaps = 1/64 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ +L ++ +N T + LDLS L L L++LN++ N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 446 MLTG 449
L
Sbjct: 508 NLLF 511
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 8e-09
Identities = 16/85 (18%), Positives = 37/85 (43%), Gaps = 1/85 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG-PVPEFLSKLQYLRVLNLTGN 445
+ +L L + L ++ L++++N + +P + S L L ++L+ N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163
Query: 446 MLTGPLPAGLVERSKNGSLSLSVDL 470
+ L +N ++LS+D+
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDM 188
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 9e-09
Identities = 17/68 (25%), Positives = 29/68 (42%), Gaps = 1/68 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+++L L+ + P S LT +E+L L + +L L+ LN+ N
Sbjct: 80 HHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF 139
Query: 447 LTG-PLPA 453
+ LPA
Sbjct: 140 IHSCKLPA 147
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 15/62 (24%), Positives = 23/62 (37%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
R+ LN+S L + + L + LD S N + + L NLT N
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
Query: 447 LT 448
+
Sbjct: 557 VA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 15/83 (18%), Positives = 26/83 (31%), Gaps = 2/83 (2%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ L+ L +L + +LD+S + L L L + GN
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
Query: 446 MLTGPLPAGLVERSKN-GSLSLS 467
+ + + N L LS
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLS 481
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 12/67 (17%), Positives = 24/67 (35%), Gaps = 2/67 (2%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG-PVPEFLSKLQYLRVLNLTGN 445
+ L+LS G + L ++HLD +++L L+ L L+++
Sbjct: 376 NSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 446 MLTGPLP 452
Sbjct: 435 NTKIDFD 441
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 15/82 (18%), Positives = 28/82 (34%), Gaps = 2/82 (2%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L+LS + L + +L L+ N + P S L L L
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 447 LTGPLPAGLVERSKN-GSLSLS 467
L L + + + L+++
Sbjct: 116 LAS-LESFPIGQLITLKKLNVA 136
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 20/86 (23%), Positives = 36/86 (41%), Gaps = 6/86 (6%)
Query: 387 PRITSLNLSSRGLTG-GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLR----VLN 441
+ LN++ + +P Y SNLT + H+DLS N + L L+ L+
Sbjct: 128 ITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLD 187
Query: 442 LTGNMLTGPLPAGLVERSKNGSLSLS 467
++ N + + + K L+L
Sbjct: 188 MSLNPIDF-IQDQAFQGIKLHELTLR 212
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 21/96 (21%), Positives = 34/96 (35%), Gaps = 4/96 (4%)
Query: 375 NGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTM--IEHLDLSNNSLTGPVPEFLS 432
N S+ P ++ L+LS L+ S+L + HLDLS N
Sbjct: 338 NKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-SANFM 396
Query: 433 KLQYLRVLNLTGNMLTGPLPAGLVERSKN-GSLSLS 467
L+ L+ L+ + L + L +S
Sbjct: 397 GLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 8e-04
Identities = 9/66 (13%), Positives = 21/66 (31%), Gaps = 5/66 (7%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+++++L+ + + + L + L L L+ L LT N
Sbjct: 285 ANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKS---LTLTMNK 339
Query: 447 LTGPLP 452
+
Sbjct: 340 GSISFK 345
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 8e-09
Identities = 24/75 (32%), Positives = 33/75 (44%), Gaps = 6/75 (8%)
Query: 383 DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNL 442
D + L L++ GL+ +P +L E L S NSLT +PE L+ L V N
Sbjct: 67 DCLDRQAHELELNNLGLSS-LPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNN 121
Query: 443 TGNMLTGPLPAGLVE 457
L+ LP L
Sbjct: 122 NLKALSD-LPPLLEY 135
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 17/63 (26%), Positives = 31/63 (49%), Gaps = 6/63 (9%)
Query: 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
PP + L +S+ L +P L N + ++ +D+ NNSL +P+ L++ + N
Sbjct: 130 PPLLEYLGVSNNQLEK-LPE-LQNSSFLKIIDVDNNSLKK-LPDLPPSLEF---IAAGNN 183
Query: 446 MLT 448
L
Sbjct: 184 QLE 186
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 19/70 (27%), Positives = 30/70 (42%), Gaps = 9/70 (12%)
Query: 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
PP + LN SS + + +L E L++SNN L +P +L+ L + N
Sbjct: 296 PPNLYYLNASSNEIRS-LCDLPPSL---EELNVSNNKLIE-LPALPPRLE---RLIASFN 347
Query: 446 MLTGPLPAGL 455
L +P
Sbjct: 348 HLAE-VPELP 356
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 19/84 (22%), Positives = 30/84 (35%), Gaps = 9/84 (10%)
Query: 377 LGCSYN-----DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFL 431
+ N + P + S+ + L P L NL + + NN L +P+
Sbjct: 200 IYADNNSLKKLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKT-LPDLP 256
Query: 432 SKLQYLRVLNLTGNMLTGPLPAGL 455
L+ L V + L LP L
Sbjct: 257 PSLEALNVRDNYLTDLP-ELPQSL 279
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 16/79 (20%), Positives = 28/79 (35%), Gaps = 11/79 (13%)
Query: 377 LGCSYND-----NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFL 431
+ N + PP + + + L P L NL + + NNSL +P+
Sbjct: 158 IDVDNNSLKKLPDLPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK-LPDLP 214
Query: 432 SKLQYLRVLNLTGNMLTGP 450
L+ + N+L
Sbjct: 215 LSLES---IVAGNNILEEL 230
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 18/100 (18%), Positives = 34/100 (34%), Gaps = 24/100 (24%)
Query: 377 LGCSYND-----NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGP----- 426
L + PP + SL S LT +P +L + + + +L+
Sbjct: 76 LELNNLGLSSLPELPPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLE 134
Query: 427 -----------VPEFLSKLQYLRVLNLTGNMLTGPLPAGL 455
+PE +L+++++ N L LP
Sbjct: 135 YLGVSNNQLEKLPEL-QNSSFLKIIDVDNNSLKK-LPDLP 172
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 26/101 (25%), Positives = 38/101 (37%), Gaps = 28/101 (27%)
Query: 377 LGCSYN-----DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFL 431
+ N + PP + +LN+ LT +P +LT LD+S N +G + E
Sbjct: 242 IYADNNLLKTLPDLPPSLEALNVRDNYLTD-LPELPQSLT---FLDVSENIFSG-LSELP 296
Query: 432 SKLQY-----------------LRVLNLTGNMLTGPLPAGL 455
L Y L LN++ N L LPA
Sbjct: 297 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP 336
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 52/240 (21%), Positives = 97/240 (40%), Gaps = 71/240 (29%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEA---------EVILLRTVH-H 590
LG+G++G V+ VAVK + + F+ E+++L + H
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIMILTELSGH 68
Query: 591 KNLTTLYG--YCNEGNQIGLIYEYMANGSLEEYLSD----SNADVLSWEGR-------LR 637
+N+ L + + L+++YM +D A++L + ++
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYME--------TDLHAVIRANILEPVHKQYVVYQLIK 120
Query: 638 IATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697
++YLH G +HRD+KP+NILLN + ++ADFGLS++F +
Sbjct: 121 -------VIKYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 698 VAGTFGYLDPEYCQTFRLTE---------------------KSDVYSFGVVLLEIITSRP 736
++ + + Q LT+ D++S G +L EI+ +P
Sbjct: 171 LSINENTENFDDDQPI-LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 21/68 (30%), Positives = 29/68 (42%), Gaps = 11/68 (16%)
Query: 386 PPRITSLNLSS---RGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNL 442
P ++ SLNLS + + G+P L LDLS N L P +L + L+L
Sbjct: 252 PSQLNSLNLSFTGLKQVPKGLPAKL------SVLDLSYNRLDR-NP-SPDELPQVGNLSL 303
Query: 443 TGNMLTGP 450
GN
Sbjct: 304 KGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 22/85 (25%), Positives = 32/85 (37%), Gaps = 5/85 (5%)
Query: 375 NGLGCSYNDNDPPRITSLNLSSRGLT---GGIPPYLSNLTMIEHLDLSNNSLTG-PVPEF 430
GL + P + L L + G+ G + ++ LDLS+NSL
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 431 LSKLQYLRVLNLTGNMLTGPLPAGL 455
L LNL+ L +P GL
Sbjct: 249 CDWPSQLNSLNLSFTGLKQ-VPKGL 272
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 19/89 (21%), Positives = 29/89 (32%), Gaps = 7/89 (7%)
Query: 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGP-------VPEFLSKLQYLR 438
P + L+++ + + LDLS+N G P LQ L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 439 VLNLTGNMLTGPLPAGLVERSKNGSLSLS 467
+ N +G A R + L LS
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLS 236
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 19/89 (21%), Positives = 34/89 (38%), Gaps = 8/89 (8%)
Query: 387 PRITSLNLSSRGLTGGIPPYLS----NLTMIEHLDLSNN---SLTGPVPEFLSKLQYLRV 439
P +++L+LS G + ++ L L N + +G + L+
Sbjct: 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQG 232
Query: 440 LNLTGNMLTGPLPAGLVERSKN-GSLSLS 467
L+L+ N L A + SL+LS
Sbjct: 233 LDLSHNSLRDAAGAPSCDWPSQLNSLNLS 261
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 2e-08
Identities = 30/188 (15%), Positives = 62/188 (32%), Gaps = 4/188 (2%)
Query: 261 HFAELEELQANQSRQFNISFNGNHLYGPVVPSYRHTTTAYTTSALTGEKLQFSIHKTENS 320
H + ++ ++ + + + + + + E
Sbjct: 316 HTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQ 375
Query: 321 TLPPILNAIEFYLVQDFSQSETEQADVDAIMNIKSLYKRKDWQGDPCAPQAFLWNGLGCS 380
L P ++ + + + + +L K D L S
Sbjct: 376 ELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTL-KAVDPMRAAYLDDLRSKFLLENS 434
Query: 381 YNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVL 440
+ + L+L+ + LT + +L L ++ HLDLS+N L +P L+ L+ L VL
Sbjct: 435 VLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVL 491
Query: 441 NLTGNMLT 448
+ N L
Sbjct: 492 QASDNALE 499
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 21/62 (33%), Positives = 31/62 (50%), Gaps = 3/62 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+T L+LS L +PP L+ L +E L S+N+L V ++ L L+ L L N
Sbjct: 463 LLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN-VDG-VANLPRLQELLLCNNR 519
Query: 447 LT 448
L
Sbjct: 520 LQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 18/63 (28%), Positives = 26/63 (41%), Gaps = 3/63 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG-PVPEFLSKLQYLRVLNLTGN 445
+ L S L + ++NL ++ L L NN L + L L +LNL GN
Sbjct: 486 RCLEVLQASDNALEN-VDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
Query: 446 MLT 448
L
Sbjct: 544 SLC 546
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 22/96 (22%), Positives = 31/96 (32%), Gaps = 8/96 (8%)
Query: 379 CSYN------DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLS 432
C DN P +L+LS L + ++ LDLS +
Sbjct: 14 CMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73
Query: 433 KLQYLRVLNLTGNMLTGPLPAGLVERSKN-GSLSLS 467
L +L L LTGN + L G + L
Sbjct: 74 SLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAV 108
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 12/71 (16%), Positives = 25/71 (35%), Gaps = 3/71 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPY--LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
++ L+ L + + +L + +LD+S+ + L L VL + G
Sbjct: 396 EQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 445 NMLTGPLPAGL 455
N +
Sbjct: 455 NSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 17/78 (21%), Positives = 31/78 (39%), Gaps = 3/78 (3%)
Query: 379 CSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG-PVPEFLSKLQYL 437
CS +D + L+LS G+ + L +EHLD +++L L+ L
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 438 RVLNLTGNMLTGPLPAGL 455
L+++ G+
Sbjct: 424 IYLDISHTHTRV-AFNGI 440
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 19/76 (25%), Positives = 31/76 (40%), Gaps = 2/76 (2%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ L ++ P + L + LDLS L P + L L+VLN+ N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504
Query: 446 MLTGPLPAGLVERSKN 461
L +P G+ +R +
Sbjct: 505 QLKS-VPDGIFDRLTS 519
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 19/88 (21%), Positives = 38/88 (43%), Gaps = 1/88 (1%)
Query: 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLT-GPVPEFLSKLQYLRVLNL 442
+ + L L + +L ++ L++++N + +PE+ S L L L+L
Sbjct: 97 SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156
Query: 443 TGNMLTGPLPAGLVERSKNGSLSLSVDL 470
+ N + L + L+LS+DL
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 14/71 (19%), Positives = 28/71 (39%), Gaps = 4/71 (5%)
Query: 386 PPRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPV-PEFLSKLQYLRVLNLT 443
+ L++S + L+ +E L ++ NS P+ ++L+ L L+L+
Sbjct: 420 LRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 444 GNMLTGPLPAG 454
L L
Sbjct: 479 QCQLEQ-LSPT 488
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 11/62 (17%), Positives = 26/62 (41%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+++L L+ + S L+ ++ L +L + L+ L+ LN+ N+
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 447 LT 448
+
Sbjct: 136 IQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 17/83 (20%), Positives = 30/83 (36%), Gaps = 4/83 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
P + L+LS + I +L+ + L L+ N + S L L+ L
Sbjct: 52 PELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 446 MLTGPLPAGLVERSKN-GSLSLS 467
L L + K L+++
Sbjct: 111 NLAS-LENFPIGHLKTLKELNVA 132
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 14/60 (23%), Positives = 29/60 (48%), Gaps = 2/60 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+T L+LS L + P ++L+ ++ L++++N L +L L+ + L N
Sbjct: 470 RNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 58/275 (21%), Positives = 95/275 (34%), Gaps = 28/275 (10%)
Query: 387 PRITSLNLSSRGLT-GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRV----LN 441
+ LN++ + +P Y SNLT +EHLDLS+N + L L + + L+
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 442 LTGNMLTGPLPAGLVERSKNGSLSLSVDLCSSYPCKENNKKKNNFVFPVIASFASLLVVT 501
L+ N + + G + + L+L NN N + I A L V
Sbjct: 184 LSLNPMNF-IQPGAFKEIRLHKLTLR-----------NNFDSLNVMKTCIQGLAGLEVHR 231
Query: 502 LAISAIYWRHKRLRKDGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNTE 561
L + + D S T E D+ F + +
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291
Query: 562 VAVKMLSPSSRQGYEQF----EAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617
V ++ + S Q + T+ K+L L N+ G + + S
Sbjct: 292 VTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT---FTSNKGGNAFSEVDLPS 348
Query: 618 LEE-YLSDSNADVLSWEGRLRIATEAAQGLEYLHL 651
LE LS + LS++G + L+YL L
Sbjct: 349 LEFLDLSRNG---LSFKGCCSQSDFGTTSLKYLDL 380
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 16/66 (24%), Positives = 27/66 (40%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
R ++ L + + ++ LDLS N L+ L+ L +LNL+ N+
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 447 LTGPLP 452
L L
Sbjct: 70 LYETLD 75
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 18/82 (21%), Positives = 34/82 (41%), Gaps = 3/82 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++ +L+LSS L + P + + + L NN L + + L Q L +L GN
Sbjct: 191 AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNG 248
Query: 447 L-TGPLPAGLVERSKNGSLSLS 467
G L + + +++
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 16/62 (25%), Positives = 27/62 (43%), Gaps = 7/62 (11%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++ LNLSS L L +L+ + LDL+NN + L + L+ N
Sbjct: 58 TKLELLNLSSNVLYE-TLD-LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNN 110
Query: 447 LT 448
++
Sbjct: 111 IS 112
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 9/47 (19%), Positives = 20/47 (42%)
Query: 402 GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
I N + ++++SL + ++ L+L+GN L+
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS 47
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 16/82 (19%), Positives = 31/82 (37%), Gaps = 4/82 (4%)
Query: 387 PRITSLNLSSRGLTG-GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
R+ L+L + ++ +EHL+L N + V + L+ L+L+ N
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSN 201
Query: 446 MLTGPLPAGLVERSKNGSLSLS 467
L + + +SL
Sbjct: 202 KLAF-MGPEFQSAAGVTWISLR 222
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 10/62 (16%), Positives = 24/62 (38%), Gaps = 3/62 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
P I +L+ ++ ++ ++ L+NN +T ++ L+L N
Sbjct: 99 PSIETLHAANNNISRVSCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 447 LT 448
+
Sbjct: 156 ID 157
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 3e-08
Identities = 76/504 (15%), Positives = 152/504 (30%), Gaps = 142/504 (28%)
Query: 306 TGEKLQFSIHKTENSTLPPILNAIEFYLVQDFSQSETEQADVDAIMNIKSLYKRKD---W 362
TGE Q+ + ++ + VQD +S + ++D I+ K W
Sbjct: 11 TGE-HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFW 69
Query: 363 ----QGDPCAPQAFLWNGLGCSYN---------DNDPPRITSLNLSSRG-LTGGIPPYLS 408
+ + Q F+ L +Y P +T + + R L +
Sbjct: 70 TLLSKQEEMV-QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAK 128
Query: 409 -NLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLS 467
N++ ++ L + L +L+ + + + G +L G +G K ++
Sbjct: 129 YNVSRLQPY----LKLR----QALLELRPAKNVLIDG-VL-G---SG-----KT---WVA 167
Query: 468 VDLCSSYPCKENNKKKNNFVFPVI-ASFASLLVVTLAISAIYWRHKRLRKDGSLETKKRR 526
+D+C SY K + F + + + + + ++ + + +
Sbjct: 168 LDVCLSY------KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSS 221
Query: 527 FTYAEITKITNDFETILGEGSFGKVY-HGY--LDD--NTEVAVKMLSPSSRQGYEQFEAE 581
I I + +L K Y + L + N + + S +
Sbjct: 222 NIKLRIHSIQAELRRLLKS----KPYENCLLVLLNVQNAKA-WNAFNLSCK--------- 267
Query: 582 VILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATE 641
IL LTT + ++LS + +S + T
Sbjct: 268 -IL--------LTT------------------RFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 642 AAQGLEYL--HLGCKP---PRVHRDIKPANILLNDQFQARLADF-GLSKTFPIEGVSHLS 695
+ L +L C+P PR P + D + L+
Sbjct: 301 -DEVKSLLLKYLDCRPQDLPREVLTTNP---RRLSIIAESIRDGLATWDNWKHVNCDKLT 356
Query: 696 TGVAGTFGYLDPEYCQTFRLTEKSDVY-SFGV---------VLLEIITSRPAIANTEEHK 745
T + + L+P E ++ V +LL +I
Sbjct: 357 TIIESSLNVLEPA--------EYRKMFDRLSVFPPSAHIPTILLSLI------------- 395
Query: 746 HISQWVDFMLAQGDIKNIVDPKLH 769
W D + + D+ +V+ KLH
Sbjct: 396 ----WFD--VIKSDVMVVVN-KLH 412
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 3e-07
Identities = 77/643 (11%), Positives = 169/643 (26%), Gaps = 191/643 (29%)
Query: 149 PFISALEFRPLPNNT----------YITQSGSLNTFIR--MDVL--SITNQVVRYRDDVY 194
F+ + + + + +I S + L V ++ ++V
Sbjct: 28 AFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVL 87
Query: 195 DRSWAPYAYPQWQQITTPRTIDEDRYNDYQLPSIVMRSAATPKNKSEPLLIDLVHEDSTS 254
++ + + ++ Y + + N S + +
Sbjct: 88 RINY-KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQ---- 142
Query: 255 KFYMYMHFAELEELQANQSRQFNISFNGNHLYGPVVPSYRHTTTAYTTSALTGEKLQFSI 314
L EL+ + N+ +G G + + +
Sbjct: 143 ---------ALLELRPAK----NVLIDGVLGSG--------------KTWVALDVCLS-- 173
Query: 315 HKTENSTLPPILNAIEFYLVQDFSQSETEQADVDAIMNIKSLYKRKDWQGDPCAPQAFLW 374
+K + + I F+L + + + ++ L + D
Sbjct: 174 YKVQ-CKMD---FKI-FWL--NLKNCNS---PETVLEMLQKLLYQIDPNWTS-------- 215
Query: 375 NGLGCSYNDNDPPRITSLNLSSRGLTGGIPPY---------LSNLTMIEHLDLS------ 419
++ N RI S+ R L PY + N +LS
Sbjct: 216 ---RSDHSSNIKLRIHSIQAELRRLLKS-KPYENCLLVLLNVQNAKAWNAFNLSCKILLT 271
Query: 420 --NNSLTGPVPEFLSKLQYLRV-LNLTGNMLTGPLPAGLVERSKNGSLS-LSVDLCSSYP 475
+T +FLS + L+ LT L+ + + L ++ ++ P
Sbjct: 272 TRFKQVT----DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP 327
Query: 476 CKENNKKKNNFVFPVIASFASLLVVTLAISAIYWRH---KRLRK--DGSLET-----KKR 525
++ A + LA W+H +L + SL ++
Sbjct: 328 R-------------RLSIIAESIRDGLATW-DNWKHVNCDKLTTIIESSLNVLEPAEYRK 373
Query: 526 RFTYAEI----TKITNDFETIL-GEGSFGKVYHGYLDDNTEVAVKMLSPS--SRQGYE-- 576
F + I +++ + D V K+ S +Q E
Sbjct: 374 MFDRLSVFPPSAHIPTILLSLIWFDVIK--------SDVMVVVNKLHKYSLVEKQPKEST 425
Query: 577 ------QFEAEV-ILLRTVHHKNLTTLY----GYCNEGNQI----GLIYEY----MANGS 617
E +V + H+++ Y + ++ Y + + N
Sbjct: 426 ISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIE 485
Query: 618 LEE--------YLSDSNADVLSW-EGRLRIATEAAQGLEYL------------HLGCKPP 656
E +L + E ++R + A + ++ P
Sbjct: 486 HPERMTLFRMVFLD------FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDP 539
Query: 657 RVHR---DI-----KPANILLNDQFQARLADFGLSKTFPIEGV 691
+ R I K L+ ++ L L E +
Sbjct: 540 KYERLVNAILDFLPKIEENLICSKY-TDLLRIALM--AEDEAI 579
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 13/58 (22%), Positives = 28/58 (48%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNML 447
L + + +T P LS LT + LD+S+++ + ++ L + ++L+ N
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 17/78 (21%), Positives = 33/78 (42%), Gaps = 2/78 (2%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG 449
L +++ T P +S L+ +E L + +T LS L L +L+++ +
Sbjct: 69 KDLTINNIHATN-YNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 450 PLPAGLVERSKNGSLSLS 467
+ + K S+ LS
Sbjct: 127 SILTKINTLPKVNSIDLS 144
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 1/62 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+T L++S I ++ L + +DLS N L L L+ LN+ +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPELKSLNIQFDG 170
Query: 447 LT 448
+
Sbjct: 171 VH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 16/79 (20%), Positives = 31/79 (39%), Gaps = 4/79 (5%)
Query: 389 ITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
+T + L++ +T + + I+ L ++N T +S L L L + G +T
Sbjct: 46 LTYITLANINVTD-LTG-IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVT 101
Query: 449 GPLPAGLVERSKNGSLSLS 467
L + L +S
Sbjct: 102 SDKIPNLSGLTSLTLLDIS 120
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 13/63 (20%), Positives = 25/63 (39%), Gaps = 3/63 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
P++ S++LS G I P L L ++ L++ + + + L L
Sbjct: 136 PKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQT 192
Query: 447 LTG 449
+ G
Sbjct: 193 IGG 195
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 18/69 (26%), Positives = 29/69 (42%), Gaps = 3/69 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
P +L L S L P L+ ++H+ + L +P+ + + L L L N
Sbjct: 81 PGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNP 138
Query: 447 LTGPLPAGL 455
L LPA +
Sbjct: 139 LRA-LPASI 146
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 17/67 (25%), Positives = 29/67 (43%), Gaps = 4/67 (5%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG-NMLT 448
SL L G+ +P ++NL ++ L + N+ L+ + + L L L+L G L
Sbjct: 186 QSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALR 243
Query: 449 GPLPAGL 455
P
Sbjct: 244 N-YPPIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 17/87 (19%), Positives = 34/87 (39%), Gaps = 2/87 (2%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSN-NSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
L+L PP ++ L L + ++L +P + +L L L+L G +
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNL 290
Query: 449 GPLPAGLVERSKNGSLSLSVDLCSSYP 475
LP+ + + N + + L +
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQAQLD 317
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 18/67 (26%), Positives = 30/67 (44%), Gaps = 4/67 (5%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG-NMLT 448
+ + + GL +P + +E L L+ N L +P ++ L LR L++ LT
Sbjct: 107 QHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELT 164
Query: 449 GPLPAGL 455
LP L
Sbjct: 165 E-LPEPL 170
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 16/67 (23%), Positives = 27/67 (40%), Gaps = 3/67 (4%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG-NMLT 448
SL + + L+ + P + +L +E LDL + P L+ L L + L
Sbjct: 209 KSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267
Query: 449 GPLPAGL 455
LP +
Sbjct: 268 T-LPLDI 273
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 11/63 (17%), Positives = 23/63 (36%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG 449
L L +P + LT +E LDL +P +++L ++ + ++
Sbjct: 256 KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315
Query: 450 PLP 452
Sbjct: 316 LDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 15/75 (20%), Positives = 26/75 (34%), Gaps = 11/75 (14%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLS-NNSLT--------GPVPEFLSKLQYLRVL 440
+L L+ L +P +++L + L + LT L L+ L
Sbjct: 130 ETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188
Query: 441 NLTGNMLTGPLPAGL 455
L + LPA +
Sbjct: 189 RLEWTGIRS-LPASI 202
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 1e-07
Identities = 19/63 (30%), Positives = 31/63 (49%), Gaps = 2/63 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++ LN+ S ++ I L+NL+ + L L+NN L E + L L L L+ N
Sbjct: 265 TKLKMLNVGSNQISD-ISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 447 LTG 449
+T
Sbjct: 323 ITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 7e-07
Identities = 15/64 (23%), Positives = 33/64 (51%), Gaps = 4/64 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
R+ SL + + +T + P L+NL+ + L++ N ++ + L L++LN+ N
Sbjct: 221 TRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQ 276
Query: 447 LTGP 450
++
Sbjct: 277 ISDI 280
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 9e-07
Identities = 16/63 (25%), Positives = 27/63 (42%), Gaps = 3/63 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L L+ ++ I P L+NLT + L+L N LS + L L +T +
Sbjct: 110 TNLRELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESK 166
Query: 447 LTG 449
+
Sbjct: 167 VKD 169
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 1e-06
Identities = 19/67 (28%), Positives = 31/67 (46%), Gaps = 4/67 (5%)
Query: 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443
+ IT L ++ + I + LT +E+L+L+ N +T P LS L L L +
Sbjct: 41 EELESITKLVVAGEKVAS-IQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIG 96
Query: 444 GNMLTGP 450
N +T
Sbjct: 97 TNKITDI 103
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 2e-06
Identities = 20/66 (30%), Positives = 30/66 (45%), Gaps = 4/66 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ LNL+ +T I P LSNL + +L + N +T L L LR L L +
Sbjct: 66 TNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDN 121
Query: 447 LTGPLP 452
++ P
Sbjct: 122 ISDISP 127
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 2e-06
Identities = 16/81 (19%), Positives = 35/81 (43%), Gaps = 4/81 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++T L + + ++ + +LT ++ L++ +N ++ L+ L L L L N
Sbjct: 243 SQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQ 298
Query: 447 LTGPLPAGLVERSKNGSLSLS 467
L + + +L LS
Sbjct: 299 LGNEDMEVIGGLTNLTTLFLS 319
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 14/62 (22%), Positives = 26/62 (41%), Gaps = 2/62 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++ SL L++ L + LT + L LS N +T P L+ L + + +
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344
Query: 447 LT 448
+
Sbjct: 345 IK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 4e-06
Identities = 16/67 (23%), Positives = 30/67 (44%), Gaps = 4/67 (5%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++T+L + + +T L NLT + L L+ ++++ L+ L + LNL N
Sbjct: 88 VKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANH 143
Query: 447 LTGPLPA 453
L
Sbjct: 144 NLSDLSP 150
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 5e-06
Identities = 16/71 (22%), Positives = 23/71 (32%), Gaps = 4/71 (5%)
Query: 382 NDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLN 441
D D L +T L I L ++ + + + L L LN
Sbjct: 17 PDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASI--QGIEYLTNLEYLN 72
Query: 442 LTGNMLTGPLP 452
L GN +T P
Sbjct: 73 LNGNQITDISP 83
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 14/64 (21%), Positives = 26/64 (40%), Gaps = 4/64 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ +T I P ++N+T + L + NN +T L+ L L L + N
Sbjct: 199 TSLHYFTAYVNQITD-ITP-VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQ 254
Query: 447 LTGP 450
++
Sbjct: 255 ISDI 258
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 5e-05
Identities = 13/63 (20%), Positives = 25/63 (39%), Gaps = 4/63 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L ++ + + P ++NLT + L L+ N + L+ L L N
Sbjct: 155 TGLNYLTVTESKVKD-VTP-IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQ 210
Query: 447 LTG 449
+T
Sbjct: 211 ITD 213
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 9e-05
Identities = 10/59 (16%), Positives = 20/59 (33%), Gaps = 4/59 (6%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
+L + P ++L L S+T V +L+ + L + G +
Sbjct: 3 ATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 18/82 (21%), Positives = 34/82 (41%), Gaps = 3/82 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++ +L+LSS L + P + + + L NN L + + L Q L +L GN
Sbjct: 191 AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNG 248
Query: 447 LT-GPLPAGLVERSKNGSLSLS 467
G L + + +++
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 16/66 (24%), Positives = 27/66 (40%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
R ++ L + + ++ LDLS N L+ L+ L +LNL+ N+
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 447 LTGPLP 452
L L
Sbjct: 70 LYETLD 75
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 12/67 (17%), Positives = 26/67 (38%), Gaps = 2/67 (2%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG-PVPEFLSKLQYLRVLNLTGNMLT 448
++ L++ +T + +++LDL N + E + L LNL N +
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 449 GPLPAGL 455
+ +
Sbjct: 183 D-VKGQV 188
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 14/81 (17%), Positives = 25/81 (30%), Gaps = 4/81 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ LNL + + ++ LDLS+N L + + ++L N
Sbjct: 169 DTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNK 225
Query: 447 LTGPLPAGLVERSKNGSLSLS 467
L + L L
Sbjct: 226 LVL-IEKALRFSQNLEHFDLR 245
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 16/62 (25%), Positives = 27/62 (43%), Gaps = 7/62 (11%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++ LNLSS L L +L+ + LDL+NN + L + L+ N
Sbjct: 58 TKLELLNLSSNVLYE-TLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN 110
Query: 447 LT 448
++
Sbjct: 111 IS 112
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 10/53 (18%), Positives = 22/53 (41%), Gaps = 1/53 (1%)
Query: 402 GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAG 454
I N + ++++SL + ++ L+L+GN L+ + A
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ-ISAA 52
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 10/62 (16%), Positives = 24/62 (38%), Gaps = 3/62 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
P I +L+ ++ ++ ++ L+NN +T ++ L+L N
Sbjct: 99 PSIETLHAANNNISRVSCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 447 LT 448
+
Sbjct: 156 ID 157
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 53/281 (18%), Positives = 96/281 (34%), Gaps = 79/281 (28%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN 601
LG G F V+ + + VA+K++ S+ E E+ LL++V + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSD-PNDPNREM 102
Query: 602 -------------EGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEY 648
G I +++E + + L +++ SN L +I + QGL+Y
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161
Query: 649 LHLGCKPPRVHRDIKPANILLN-------------------------------------- 670
LH C+ +H DIKP NILL+
Sbjct: 162 LHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219
Query: 671 -----------DQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKS 719
++ + ++AD G + V T T Y E +
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNACW-----VHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274
Query: 720 DVYSFGVVLLEIITSRP---AIANTEEHK---HISQWVDFM 754
D++S + E+ T + E + HI+ ++ +
Sbjct: 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 24/77 (31%), Positives = 31/77 (40%), Gaps = 10/77 (12%)
Query: 377 LGCSYN-----DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFL 431
L S N P + L +S LT +P S L L + N LT +PE L
Sbjct: 226 LIVSGNRLTSLPVLPSELKELMVSGNRLTS-LPMLPSGLL---SLSVYRNQLTR-LPESL 280
Query: 432 SKLQYLRVLNLTGNMLT 448
L +NL GN L+
Sbjct: 281 IHLSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 25/84 (29%), Positives = 34/84 (40%), Gaps = 14/84 (16%)
Query: 377 LGCSYND-----NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFL 431
L S N P + L + LT +P S L L +S N LT +P
Sbjct: 186 LSVSDNQLASLPTLPSELYKLWAYNNRLTS-LPALPSGLK---ELIVSGNRLTS-LPVLP 240
Query: 432 SKLQYLRVLNLTGNMLTGPLPAGL 455
S+L+ L ++GN LT LP
Sbjct: 241 SELKE---LMVSGNRLTS-LPMLP 260
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 25/84 (29%), Positives = 32/84 (38%), Gaps = 14/84 (16%)
Query: 377 LGCSYN-----DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFL 431
L S N P + L + LT +P S L L +S+N L +P
Sbjct: 146 LSVSDNQLASLPALPSELCKLWAYNNQLTS-LPMLPSGLQ---ELSVSDNQLAS-LPTLP 200
Query: 432 SKLQYLRVLNLTGNMLTGPLPAGL 455
S+L L N N LT LPA
Sbjct: 201 SELYKLWAYN---NRLT-SLPALP 220
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 20/81 (24%), Positives = 27/81 (33%), Gaps = 11/81 (13%)
Query: 377 LGCSYND--NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKL 434
P + L + LT +P L L +S+N L +P S+L
Sbjct: 109 FSNPLTHLPALPSGLCKLWIFGNQLTS-LPVLPPGLQ---ELSVSDNQLAS-LPALPSEL 163
Query: 435 QYLRVLNLTGNMLTGPLPAGL 455
L N N LT LP
Sbjct: 164 CKLWAYN---NQLTS-LPMLP 180
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 21/84 (25%), Positives = 27/84 (32%), Gaps = 14/84 (16%)
Query: 377 LGCSYN-----DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFL 431
L N PP + +L +S LT +P L + L P
Sbjct: 66 LVIPDNNLTSLPALPPELRTLEVSGNQLTS-LPVLPPGLLELSIFSNPLTHL----PALP 120
Query: 432 SKLQYLRVLNLTGNMLTGPLPAGL 455
S L L + GN LT LP
Sbjct: 121 SGLCK---LWIFGNQLTS-LPVLP 140
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 17/70 (24%), Positives = 29/70 (41%), Gaps = 1/70 (1%)
Query: 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
P L+L + ++ +E L+L+ N ++ P + L LR L L N
Sbjct: 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90
Query: 446 MLTGPLPAGL 455
L +P G+
Sbjct: 91 RLKL-IPLGV 99
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 15/62 (24%), Positives = 27/62 (43%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
R+ L +S + P + L +++ +LT + L YLR LNL+ N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNP 259
Query: 447 LT 448
++
Sbjct: 260 IS 261
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 18/82 (21%), Positives = 32/82 (39%), Gaps = 2/82 (2%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ L L LT IP LS+L + L L + ++ +L L+VL ++
Sbjct: 152 NSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210
Query: 446 MLTGPLPAGLVERSKNGSLSLS 467
+ + SLS++
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSIT 232
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 16/63 (25%), Positives = 26/63 (41%), Gaps = 2/63 (3%)
Query: 387 PRITSLNLSSRGLTGGIPP-YLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ +L L S L IP + L+ + LD+S N + + L L+ L + N
Sbjct: 80 FNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDN 138
Query: 446 MLT 448
L
Sbjct: 139 DLV 141
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 17/63 (26%), Positives = 31/63 (49%), Gaps = 2/63 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+TSL+++ LT +P + +L + L+LS N ++ L +L L+ + L G
Sbjct: 224 LNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282
Query: 446 MLT 448
L
Sbjct: 283 QLA 285
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 14/63 (22%), Positives = 27/63 (42%), Gaps = 2/63 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
P + L L+ ++ + P +NL + L L +N L + L L L+++ N
Sbjct: 56 PHLEELELNENIVSA-VEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISEN 114
Query: 446 MLT 448
+
Sbjct: 115 KIV 117
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 19/63 (30%), Positives = 24/63 (38%), Gaps = 2/63 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ SL + L I S L +E L L +LT E LS L L VL L
Sbjct: 128 YNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL 186
Query: 446 MLT 448
+
Sbjct: 187 NIN 189
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 25/83 (30%), Positives = 35/83 (42%), Gaps = 4/83 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ LNLS ++ I L L ++ + L L P L YLRVLN++GN
Sbjct: 248 VYLRFLNLSYNPIST-IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306
Query: 446 MLTGPLPAGLVERSKN-GSLSLS 467
LT L + N +L L
Sbjct: 307 QLTT-LEESVFHSVGNLETLILD 328
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 15/63 (23%), Positives = 27/63 (42%), Gaps = 2/63 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYL-SNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+T L++S + + Y+ +L ++ L++ +N L S L L L L
Sbjct: 104 SNLTKLDISENKIVI-LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKC 162
Query: 446 MLT 448
LT
Sbjct: 163 NLT 165
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 17/83 (20%), Positives = 29/83 (34%), Gaps = 4/83 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ L L + I Y L ++ L++S+ + L L++T
Sbjct: 176 HGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234
Query: 446 MLTGPLPAGLVERSKN-GSLSLS 467
LT +P V L+LS
Sbjct: 235 NLTA-VPYLAVRHLVYLRFLNLS 256
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 21/71 (29%), Positives = 30/71 (42%), Gaps = 3/71 (4%)
Query: 386 PPRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
PP L+L + +T I NL + L L NN ++ P + L L L L+
Sbjct: 51 PPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109
Query: 445 NMLTGPLPAGL 455
N L LP +
Sbjct: 110 NQLKE-LPEKM 119
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 14/75 (18%), Positives = 32/75 (42%), Gaps = 8/75 (10%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG------PVPEFLSKLQYLRVL 440
P + L+L++ L +P L++ I+ + L NN+++ P + +K +
Sbjct: 240 PHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 298
Query: 441 NLTGNMLT-GPLPAG 454
+L N + +
Sbjct: 299 SLFSNPVQYWEIQPS 313
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 24/83 (28%), Positives = 37/83 (44%), Gaps = 3/83 (3%)
Query: 386 PPRITSLNLSSRGLTGGIPP-YLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
PP +T L+L +T + L L + L LS NS++ L+ +LR L+L
Sbjct: 191 PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 249
Query: 445 NMLTGPLPAGLVERSKNGSLSLS 467
N L +P GL + + L
Sbjct: 250 NKLVK-VPGGLADHKYIQVVYLH 271
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 12/73 (16%), Positives = 26/73 (35%), Gaps = 5/73 (6%)
Query: 386 PPRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPV--PEFLSKLQYLRVLNL 442
P + L + +T + + L + ++L N L ++ L + +
Sbjct: 120 PKTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178
Query: 443 TGNMLTGPLPAGL 455
+T +P GL
Sbjct: 179 ADTNITT-IPQGL 190
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 16/84 (19%), Positives = 29/84 (34%), Gaps = 9/84 (10%)
Query: 379 CSYN------DNDPPRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFL 431
+ SL+LS +T I L ++ L L ++ + +
Sbjct: 12 GRSRSFTSIPSGLTAAMKSLDLSFNKITY-IGHGDLRACANLQVLILKSSRINTIEGDAF 70
Query: 432 SKLQYLRVLNLTGNMLTGPLPAGL 455
L L L+L+ N L+ L +
Sbjct: 71 YSLGSLEHLDLSDNHLSS-LSSSW 93
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 17/74 (22%), Positives = 30/74 (40%), Gaps = 4/74 (5%)
Query: 384 NDPPRITSLNLSSRGLT--GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLN 441
P + +L LS L L L + LD+S N+ P+P+ + +R LN
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLN 416
Query: 442 LTGNMLTGPLPAGL 455
L+ + + +
Sbjct: 417 LSSTGIRV-VKTCI 429
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 17/62 (27%), Positives = 25/62 (40%), Gaps = 3/62 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ SR T IP L+ ++ LDLS N +T L L+VL L +
Sbjct: 5 DASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 447 LT 448
+
Sbjct: 62 IN 63
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 17/74 (22%), Positives = 27/74 (36%), Gaps = 7/74 (9%)
Query: 377 LGCSYN-----DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFL 431
L S N PR+ L +S L +P S ++ + +S N L
Sbjct: 436 LDVSNNNLDSFSLFLPRLQELYISRNKLKT-LPDA-SLFPVLLVMKISRNQLKSVPDGIF 493
Query: 432 SKLQYLRVLNLTGN 445
+L L+ + L N
Sbjct: 494 DRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 23/69 (33%), Positives = 34/69 (49%), Gaps = 8/69 (11%)
Query: 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
P ++ LNLSS G+ + + +E LD+SNN+L FL +LQ L ++ N
Sbjct: 409 PEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDS-FSLFLPRLQ---ELYISRN 461
Query: 446 MLTGPLPAG 454
L LP
Sbjct: 462 KLKT-LPDA 469
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 12/60 (20%), Positives = 26/60 (43%)
Query: 389 ITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
I L++ L + S L ++ + + N+ + F L+ L L+L+ N++
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 20/63 (31%), Positives = 28/63 (44%), Gaps = 2/63 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ L L S + I +L +EHLDLS+N L+ + L L+ LNL GN
Sbjct: 50 ANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGN 108
Query: 446 MLT 448
Sbjct: 109 PYQ 111
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 19/92 (20%), Positives = 32/92 (34%), Gaps = 15/92 (16%)
Query: 377 LGCSYN------DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG-PVPE 429
L S P + L++S+ L +L L L +S N L P
Sbjct: 415 LNLSSTGIRVVKTCIPQTLEVLDVSNNNLDS-FSLFLPRLQ---ELYISRNKLKTLPDAS 470
Query: 430 FLSKLQYLRVLNLTGNMLTGPLPAGLVERSKN 461
L + ++ N L +P G+ +R +
Sbjct: 471 LFPVLLVM---KISRNQLKS-VPDGIFDRLTS 498
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 10/63 (15%), Positives = 23/63 (36%), Gaps = 1/63 (1%)
Query: 387 PRITSLNLSSRGLTGGIPP-YLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ +L + + I + LT + L++ SL + L ++ + L L +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 446 MLT 448
Sbjct: 183 ESA 185
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 13/64 (20%), Positives = 21/64 (32%), Gaps = 2/64 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ L + + L L ++ I HL L + + F L +R L L
Sbjct: 148 TSLNELEIKALSLRN-YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 446 MLTG 449
L
Sbjct: 207 NLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 12/65 (18%), Positives = 24/65 (36%), Gaps = 3/65 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLT---GPVPEFLSKLQYLRVLNLT 443
++ + + + + + +L +E LDLS N + L+ L L+
Sbjct: 310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369
Query: 444 GNMLT 448
N L
Sbjct: 370 QNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 12/64 (18%), Positives = 21/64 (32%), Gaps = 2/64 (3%)
Query: 387 PRITSLNLSSRGLTG-GIPPYLSNLTMIEHLDLS-NNSLTGPVPEFLSKLQYLRVLNLTG 444
+ LNL G+ NLT ++ L + + + + L L L +
Sbjct: 98 SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157
Query: 445 NMLT 448
L
Sbjct: 158 LSLR 161
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 9e-04
Identities = 14/69 (20%), Positives = 26/69 (37%), Gaps = 5/69 (7%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+TSL++S +P + L+LS+ + L+ VL+++ N
Sbjct: 387 KNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLE---VLDVSNNN 442
Query: 447 LTGPLPAGL 455
L L
Sbjct: 443 LDS-FSLFL 450
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 8e-07
Identities = 16/78 (20%), Positives = 30/78 (38%), Gaps = 4/78 (5%)
Query: 375 NGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKL 434
+ + + D ++T+L G+ + L + ++ SNN LT P L L
Sbjct: 34 TNVTDTVSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNL 89
Query: 435 QYLRVLNLTGNMLTGPLP 452
L + + N + P
Sbjct: 90 TKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 17/63 (26%), Positives = 29/63 (46%), Gaps = 4/63 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ SL ++ ++ I P L LT ++ L L+ N L L+ L L L+L N
Sbjct: 199 TNLESLIATNNQISD-ITP-LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQ 254
Query: 447 LTG 449
++
Sbjct: 255 ISN 257
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 4/61 (6%)
Query: 389 ITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
+T +N S+ LT I P L NLT + + ++NN + P L+ L L L L N +T
Sbjct: 70 LTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT 125
Query: 449 G 449
Sbjct: 126 D 126
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 18/64 (28%), Positives = 31/64 (48%), Gaps = 4/64 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+T+L L+ L I P +SNL + +L L N+++ P +S L L+ L N
Sbjct: 287 TALTNLELNENQLED-ISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK 342
Query: 447 LTGP 450
++
Sbjct: 343 VSDV 346
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 20/66 (30%), Positives = 31/66 (46%), Gaps = 4/66 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+T L+L++ ++ + P LS LT + L L N ++ P L+ L L L L N
Sbjct: 243 TNLTDLDLANNQISN-LAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 298
Query: 447 LTGPLP 452
L P
Sbjct: 299 LEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 8e-06
Identities = 20/66 (30%), Positives = 34/66 (51%), Gaps = 4/66 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++T L L + ++ I P L+ LT + +L+L+ N L P +S L+ L L L N
Sbjct: 265 TKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNN 320
Query: 447 LTGPLP 452
++ P
Sbjct: 321 ISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 17/64 (26%), Positives = 31/64 (48%), Gaps = 4/64 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++ + +++ + I P L+NLT + L L NN +T + L L L L L+ N
Sbjct: 90 TKLVDILMNNNQIAD-ITP-LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNT 145
Query: 447 LTGP 450
++
Sbjct: 146 ISDI 149
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 18/64 (28%), Positives = 29/64 (45%), Gaps = 4/64 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L++SS ++ L+ LT +E L +NN ++ L L L L+L GN
Sbjct: 177 TTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDI--TPLGILTNLDELSLNGNQ 232
Query: 447 LTGP 450
L
Sbjct: 233 LKDI 236
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 15/66 (22%), Positives = 29/66 (43%), Gaps = 4/66 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+T L L ++ P +S+LT ++ L NN ++ L+ L + L+ N
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQ 364
Query: 447 LTGPLP 452
++ P
Sbjct: 365 ISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 19/63 (30%), Positives = 33/63 (52%), Gaps = 5/63 (7%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L+ ++ +T P L+NLT +E LD+S+N ++ L+KL L L T N
Sbjct: 156 TSLQQLSFGNQ-VTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQ 210
Query: 447 LTG 449
++
Sbjct: 211 ISD 213
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 23/64 (35%), Positives = 35/64 (54%), Gaps = 5/64 (7%)
Query: 389 ITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
+T L L + +T I P L NLT + L+LS+N+++ LS L L+ L+ GN +T
Sbjct: 114 LTGLTLFNNQITD-IDP-LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVT 168
Query: 449 GPLP 452
P
Sbjct: 169 DLKP 172
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 17/64 (26%), Positives = 29/64 (45%), Gaps = 5/64 (7%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L LSS ++ LS LT ++ L N +T P L+ L L L+++ N
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ-VTDLKP--LANLTTLERLDISSNK 188
Query: 447 LTGP 450
++
Sbjct: 189 VSDI 192
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 9e-07
Identities = 21/84 (25%), Positives = 31/84 (36%), Gaps = 3/84 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
++ L L S+ I NL + LDL ++ + P+ L +L L L
Sbjct: 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107
Query: 446 MLT-GPLPAGLVERSKN-GSLSLS 467
L+ L G K L LS
Sbjct: 108 GLSDAVLKDGYFRNLKALTRLDLS 131
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 25/115 (21%), Positives = 40/115 (34%), Gaps = 13/115 (11%)
Query: 384 NDPPRITSLNLSSRGLTGGIPPYL-----SNLTMIEHLDLSNNSLTGPVPEFLSKLQYLR 438
++ P + L L L L L+ ++ L L++N L P S L LR
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507
Query: 439 VLNLTGNMLTGPLPAGLVERSKNGSLSLS------VDLCSSYPCKENNKKKNNFV 487
L+L N LT L + + L +S + + N F+
Sbjct: 508 GLSLNSNRLTV-LSHNDLPANLE-ILDISRNQLLAPNPDVFVSLSVLDITHNKFI 560
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 7e-06
Identities = 16/65 (24%), Positives = 27/65 (41%), Gaps = 3/65 (4%)
Query: 387 PRITSLNLSSRGLTGGIPP--YLSNLTMIEHLDLSNNSLTG-PVPEFLSKLQYLRVLNLT 443
+ L L GL+ + Y NL + LDLS N + + KL L+ ++ +
Sbjct: 97 FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS 156
Query: 444 GNMLT 448
N +
Sbjct: 157 SNQIF 161
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 8e-06
Identities = 15/77 (19%), Positives = 22/77 (28%), Gaps = 5/77 (6%)
Query: 392 LNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPL 451
LT +P L+ L LS N + L+ L++L L +
Sbjct: 9 AFYRFCNLTQ-VPQVLNTTE---RLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 452 PAGLVERSKN-GSLSLS 467
N L L
Sbjct: 65 DKEAFRNLPNLRILDLG 81
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 16/63 (25%), Positives = 26/63 (41%), Gaps = 2/63 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ LNLS L + L + ++DL N + + L+ L+ L+L N
Sbjct: 314 DNLQVLNLSYNLLGE-LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDN 372
Query: 446 MLT 448
LT
Sbjct: 373 ALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 16/61 (26%), Positives = 28/61 (45%), Gaps = 2/61 (3%)
Query: 389 ITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNML 447
+ L+LS + + L ++ L+L+ N + E L L+VLNL+ N+L
Sbjct: 268 VRHLDLSHGFVFS-LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 448 T 448
Sbjct: 327 G 327
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 19/88 (21%), Positives = 29/88 (32%), Gaps = 2/88 (2%)
Query: 383 DNDPPRITSLNLSSRGLTG-GIPPYLSNLTMIEHLDLSNNSLTG-PVPEFLSKLQYLRVL 440
++LS L I +L + ++ L L+ N + + S+ L L
Sbjct: 397 PKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQL 456
Query: 441 NLTGNMLTGPLPAGLVERSKNGSLSLSV 468
L NML L G L V
Sbjct: 457 FLGENMLQLAWETELCWDVFEGLSHLQV 484
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 16/74 (21%), Positives = 28/74 (37%), Gaps = 3/74 (4%)
Query: 387 PRITSLNLSSRGLTG-GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQ--YLRVLNLT 443
+T L+LS + + P L ++ +D S+N + L LQ L +L
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 444 GNMLTGPLPAGLVE 457
N L + +
Sbjct: 183 ANSLYSRVSVDWGK 196
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 13/63 (20%), Positives = 23/63 (36%), Gaps = 2/63 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ LNL+ + I L ++ L+LS N L L + ++L N
Sbjct: 290 KDLKVLNLAYNKINK-IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 446 MLT 448
+
Sbjct: 349 HIA 351
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 17/71 (23%), Positives = 31/71 (43%), Gaps = 3/71 (4%)
Query: 386 PPRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
P T L+L + ++ + L + L L NN ++ + S L+ L+ L ++
Sbjct: 53 SPDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111
Query: 445 NMLTGPLPAGL 455
N L +P L
Sbjct: 112 NHLVE-IPPNL 121
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 21/71 (29%), Positives = 31/71 (43%), Gaps = 3/71 (4%)
Query: 386 PPRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
P + L+L + I L + + L L +N + LS L LR L+L
Sbjct: 192 PETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDN 250
Query: 445 NMLTGPLPAGL 455
N L+ +PAGL
Sbjct: 251 NKLSR-VPAGL 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 16/68 (23%), Positives = 32/68 (47%), Gaps = 7/68 (10%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG-PVPEF-----LSKLQYLRVL 440
P + L+L + L+ +P L +L +++ + L N++T V +F K Y +
Sbjct: 241 PTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299
Query: 441 NLTGNMLT 448
+L N +
Sbjct: 300 SLFNNPVP 307
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 56/244 (22%), Positives = 97/244 (39%), Gaps = 55/244 (22%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGY-EQFEAEVILLRTV-----HHKNLT 594
+G+G+FG+V +D+ AVK++ + + Y + E +L+ + ++ N+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR--NIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK 654
+G + + LI+E + SL E ++ +N + E E + L YL K
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---K 155
Query: 655 PPRVHRDIKPANILLNDQFQA-------------------------RLADFGLSKTFPIE 689
H D+KP NILL+D + +L DFG TF +
Sbjct: 156 MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-CATFKSD 214
Query: 690 GVSHLSTGVAGTFGYLDPE------YCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE 743
+ + + Y PE + SD++SFG VL E+ T E
Sbjct: 215 ---YHGSIINTRQ-YRAPEVILNLGWDV------SSDMWSFGCVLAELYTGSLLFRTHEH 264
Query: 744 HKHI 747
+H+
Sbjct: 265 MEHL 268
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 17/78 (21%), Positives = 30/78 (38%), Gaps = 11/78 (14%)
Query: 377 LGCSYNDNDP------PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEF 430
D +TSL+ + +T + + LT + L ++N++T +
Sbjct: 26 AAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITT-LD-- 80
Query: 431 LSKLQYLRVLNLTGNMLT 448
LS+ L L N LT
Sbjct: 81 LSQNTNLTYLACDSNKLT 98
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 20/79 (25%), Positives = 31/79 (39%), Gaps = 13/79 (16%)
Query: 377 LGCSYND-------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPE 429
L C + +T L +S +T + LS T + +L +N LT +
Sbjct: 47 LDCHNSSITDMTGIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD- 101
Query: 430 FLSKLQYLRVLNLTGNMLT 448
++ L L LN N LT
Sbjct: 102 -VTPLTKLTYLNCDTNKLT 119
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 17/79 (21%), Positives = 34/79 (43%), Gaps = 13/79 (16%)
Query: 377 LGCSYNDN-------DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPE 429
L C N ++T+L+ S +T + +S ++ L+ N++T +
Sbjct: 153 LDCHLNKKITKLDVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITK-LD- 207
Query: 430 FLSKLQYLRVLNLTGNMLT 448
L++ L L+ + N LT
Sbjct: 208 -LNQNIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 15/81 (18%), Positives = 25/81 (30%), Gaps = 17/81 (20%)
Query: 377 LGCSYNDNDPPRITSLNLSS---------RGLTGGIPPYLSNLTMIEHLDLSNNSLTGPV 427
L C + ++L+ G +++ T + LD +T
Sbjct: 259 LHCIQT-----DLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT--- 310
Query: 428 PEFLSKLQYLRVLNLTGNMLT 448
LS+ L L L LT
Sbjct: 311 ELDLSQNPKLVYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 17/78 (21%), Positives = 31/78 (39%), Gaps = 11/78 (14%)
Query: 377 LGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEF 430
L C+ N + ++T L+ ++ T + LD S N +T +
Sbjct: 132 LNCARNTLTEIDVSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITE-LD-- 186
Query: 431 LSKLQYLRVLNLTGNMLT 448
+S+ + L LN N +T
Sbjct: 187 VSQNKLLNRLNCDTNNIT 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 23/78 (29%), Positives = 34/78 (43%), Gaps = 12/78 (15%)
Query: 377 LGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEF 430
L C N+ N ++T L+ SS LT I ++ LT + + D S N LT +
Sbjct: 196 LNCDTNNITKLDLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLT-ELD-- 249
Query: 431 LSKLQYLRVLNLTGNMLT 448
+S L L L+ L
Sbjct: 250 VSTLSKLTTLHCIQTDLL 267
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 16/62 (25%), Positives = 26/62 (41%), Gaps = 2/62 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
R+ L +S+ L + Y + ++ LDLS+N L V + L L L N
Sbjct: 278 QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNS 335
Query: 447 LT 448
+
Sbjct: 336 IV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 9/70 (12%), Positives = 25/70 (35%), Gaps = 3/70 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ + + +P L + +E L+L++ + + ++ L + N
Sbjct: 51 NNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109
Query: 446 MLTGPLPAGL 455
+ LP +
Sbjct: 110 AIRY-LPPHV 118
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 18/62 (29%), Positives = 26/62 (41%), Gaps = 2/62 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+T L L LT +L N + +DLS N L + K+Q L L ++ N
Sbjct: 232 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 289
Query: 447 LT 448
L
Sbjct: 290 LV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 18/70 (25%), Positives = 30/70 (42%), Gaps = 3/70 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
++ LNL+ + I Y + I+ L + N++ P + L VL L N
Sbjct: 75 RQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 133
Query: 446 MLTGPLPAGL 455
L+ LP G+
Sbjct: 134 DLSS-LPRGI 142
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 8/69 (11%), Positives = 24/69 (34%), Gaps = 2/69 (2%)
Query: 382 NDNDPPRITSLNLSSRGLTGGIPPYLSNLTM--IEHLDLSNNSLTGPVPEFLSKLQYLRV 439
+ N ++ T + ++T+ + + N+++ L + + +
Sbjct: 20 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 79
Query: 440 LNLTGNMLT 448
LNL +
Sbjct: 80 LNLNDLQIE 88
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 18/63 (28%), Positives = 28/63 (44%), Gaps = 2/63 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYL-SNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
P +T L L L+ +P + N + L +SNN+L + L+ L L+ N
Sbjct: 123 PLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 181
Query: 446 MLT 448
LT
Sbjct: 182 RLT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 16/59 (27%), Positives = 26/59 (44%), Gaps = 4/59 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
P + L+LS L + +E+L L +NS+ + LS L+ L L+ N
Sbjct: 301 PTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHN 355
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 56/239 (23%), Positives = 90/239 (37%), Gaps = 49/239 (20%)
Query: 542 ILGEGSFGKVYHGY--LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHK------NL 593
LGEG+FGKV ++VA+K++ + E E+ +L+ + K
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY-REAARLEINVLKKIKEKDKENKFLC 84
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC 653
+ + N + + +E + + E+L ++N +A + L +LH
Sbjct: 85 VLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH--- 140
Query: 654 KPPRVHRDIKPANILLNDQFQA-------------------RLADFGLSKTFPIEGVSHL 694
+ H D+KP NIL + R+ADFG S TF E H
Sbjct: 141 ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATFDHE---HH 196
Query: 695 STGVAGTFGYLDPE------YCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHI 747
+T VA Y PE + Q DV+S G +L E E +H+
Sbjct: 197 TTIVATRH-YRPPEVILELGWAQ------PCDVWSIGCILFEYYRGFTLFQTHENREHL 248
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 6e-06
Identities = 17/60 (28%), Positives = 28/60 (46%), Gaps = 1/60 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGP-VPEFLSKLQYLRVLNLTGN 445
++ L LS ++GG+ + HL+LS N + E L KL+ L+ L+L
Sbjct: 64 NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 18/64 (28%), Positives = 31/64 (48%), Gaps = 6/64 (9%)
Query: 387 PRITSLNLSSRGLT--GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
+ L+ + GLT +P L ++ L+LS+N ++G + K L LNL+G
Sbjct: 42 EELEFLSTINVGLTSIANLP----KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSG 97
Query: 445 NMLT 448
N +
Sbjct: 98 NKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 8e-04
Identities = 24/88 (27%), Positives = 35/88 (39%), Gaps = 5/88 (5%)
Query: 382 NDNDPPRITSLNLSSRGLT-GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVL 440
+ P + L L + G + +E L N LT L KL L+ L
Sbjct: 12 RNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKL 69
Query: 441 NLTGNMLTGPLPAGLVERSKN-GSLSLS 467
L+ N ++G L L E+ N L+LS
Sbjct: 70 ELSDNRVSGGLE-VLAEKCPNLTHLNLS 96
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 16/62 (25%), Positives = 26/62 (41%), Gaps = 2/62 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
R+ L +S+ L + Y + ++ LDLS+N L V + L L L N
Sbjct: 272 QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNS 329
Query: 447 LT 448
+
Sbjct: 330 IV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 18/70 (25%), Positives = 30/70 (42%), Gaps = 3/70 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
++ LNL+ + I Y + I+ L + N++ P + L VL L N
Sbjct: 69 RQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 127
Query: 446 MLTGPLPAGL 455
L+ LP G+
Sbjct: 128 DLSS-LPRGI 136
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 12/95 (12%), Positives = 31/95 (32%), Gaps = 4/95 (4%)
Query: 375 NGLGCSYNDNDPPRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSK 433
+ + D + + + +P L + +E L+L++ + +
Sbjct: 33 QDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAY 91
Query: 434 LQYLRVLNLTGNMLTGPLPAGLVERSKN-GSLSLS 467
++ L + N + LP + + L L
Sbjct: 92 AHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLE 125
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 18/62 (29%), Positives = 26/62 (41%), Gaps = 2/62 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+T L L LT +L N + +DLS N L + K+Q L L ++ N
Sbjct: 226 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283
Query: 447 LT 448
L
Sbjct: 284 LV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 18/63 (28%), Positives = 28/63 (44%), Gaps = 2/63 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYL-SNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
P +T L L L+ +P + N + L +SNN+L + L+ L L+ N
Sbjct: 117 PLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 175
Query: 446 MLT 448
LT
Sbjct: 176 RLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 8/69 (11%), Positives = 24/69 (34%), Gaps = 2/69 (2%)
Query: 382 NDNDPPRITSLNLSSRGLTGGIPPYLSNLTM--IEHLDLSNNSLTGPVPEFLSKLQYLRV 439
+ N ++ T + ++T+ + + N+++ L + + +
Sbjct: 14 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 73
Query: 440 LNLTGNMLT 448
LNL +
Sbjct: 74 LNLNDLQIE 82
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 13/63 (20%), Positives = 24/63 (38%), Gaps = 2/63 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
I L + + +PP+ N+ ++ L L N L+ L L+++ N
Sbjct: 93 HTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN 151
Query: 446 MLT 448
L
Sbjct: 152 NLE 154
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 16/62 (25%), Positives = 26/62 (41%), Gaps = 4/62 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
P + L+LS L + +E+L L +NS+ + LS L+ L L+ N
Sbjct: 295 PTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHND 350
Query: 447 LT 448
Sbjct: 351 WD 352
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 6/77 (7%)
Query: 386 PPRITSLNLSSRGLTGGIPPYL-SNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
I LNLSS LTG + L + LDL NN + +P+ ++ LQ L+ LN+
Sbjct: 427 AESILVLNLSSNMLTGSVFRCLPPKVK---VLDLHNNRIMS-IPKDVTHLQALQELNVAS 482
Query: 445 NMLTGPLPAGLVERSKN 461
N L +P G+ +R +
Sbjct: 483 NQLKS-VPDGVFDRLTS 498
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 9e-05
Identities = 19/68 (27%), Positives = 30/68 (44%), Gaps = 10/68 (14%)
Query: 390 TSLNLSSRGLT---GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ ++ S+R LT +P + L LS NS++ +S L LRVL L+ N
Sbjct: 34 SMVDYSNRNLTHVPKDLP------PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNR 87
Query: 447 LTGPLPAG 454
+ L
Sbjct: 88 IRS-LDFH 94
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 17/71 (23%), Positives = 34/71 (47%), Gaps = 1/71 (1%)
Query: 375 NGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKL 434
N L S PP++ L+L + + IP +++L ++ L++++N L +L
Sbjct: 438 NMLTGSVFRCLPPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRL 496
Query: 435 QYLRVLNLTGN 445
L+ + L N
Sbjct: 497 TSLQYIWLHDN 507
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 5/79 (6%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG 449
++ S GL +P LS T L++S N ++ + L LR+L ++ N +
Sbjct: 3 FLVDRSKNGLI-HVPKDLSQKT--TILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 450 PLPAGLVERSKN-GSLSLS 467
L + + ++ L LS
Sbjct: 60 -LDISVFKFNQELEYLDLS 77
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 4/76 (5%)
Query: 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ SLN+SS LT I L I+ LDL +N + +P+ + KL+ L+ LN+ N
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASN 454
Query: 446 MLTGPLPAGLVERSKN 461
L +P G+ +R +
Sbjct: 455 QLKS-VPDGIFDRLTS 469
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 16/76 (21%), Positives = 30/76 (39%), Gaps = 6/76 (7%)
Query: 379 CSYN------DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLS 432
S N + + T LN+S ++ + +L+ + L +S+N +
Sbjct: 7 RSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFK 66
Query: 433 KLQYLRVLNLTGNMLT 448
Q L L+L+ N L
Sbjct: 67 FNQELEYLDLSHNKLV 82
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 16/71 (22%), Positives = 32/71 (45%), Gaps = 2/71 (2%)
Query: 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLT--GPVPEFLSKLQYLRVLNLT 443
L+ S+ LT + +LT +E L L N L + E ++++ L+ L+++
Sbjct: 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDIS 382
Query: 444 GNMLTGPLPAG 454
N ++ G
Sbjct: 383 QNSVSYDEKKG 393
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 26/175 (14%), Positives = 52/175 (29%), Gaps = 13/175 (7%)
Query: 390 TSLNLSSRGLTG-GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
L+LS I N++ ++ L LS L ++ L +VL + G
Sbjct: 93 KHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG 152
Query: 449 GPLPAGLVERSKNGSLSLSVDLCSSYPCKENNKKKNNFVFPVIASFASLLVVTLAISAIY 508
++ SL + NK+ + + + + A+L + +
Sbjct: 153 EKEDPEGLQDFNTESLHIVFP---------TNKEFHFILDVSVKTVANLELSNIKCVLED 203
Query: 509 WRHKRLRKDGSLETKK---RRFTYAEITKITNDFETILGEGSFGKVYHGYLDDNT 560
+ + T I N F IL V++ + +
Sbjct: 204 NKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK 258
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 20/60 (33%), Positives = 29/60 (48%), Gaps = 1/60 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVP-EFLSKLQYLRVLNLTGN 445
P++ L LS + GG+ L + HL+LS N L E L KL+ L+ L+L
Sbjct: 71 PKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 18/69 (26%), Positives = 26/69 (37%), Gaps = 3/69 (4%)
Query: 382 NDNDPPRITSLNLSSRGLT-GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVL 440
+ P + L L + G I + +E L L N L L KL L+ L
Sbjct: 19 RNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKL 76
Query: 441 NLTGNMLTG 449
L+ N + G
Sbjct: 77 ELSENRIFG 85
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 9e-04
Identities = 20/62 (32%), Positives = 30/62 (48%), Gaps = 2/62 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L+L + GL + L L ++ L+LS N + G + KL L LNL+GN
Sbjct: 49 VNLEFLSLINVGLIS-VSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNK 106
Query: 447 LT 448
L
Sbjct: 107 LK 108
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 9e-06
Identities = 20/71 (28%), Positives = 27/71 (38%), Gaps = 3/71 (4%)
Query: 386 PPRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
P LNL + I +L +E L L NS+ + L L L L
Sbjct: 74 PSNTRYLNLMENNIQM-IQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132
Query: 445 NMLTGPLPAGL 455
N LT +P+G
Sbjct: 133 NWLTV-IPSGA 142
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 13/62 (20%), Positives = 28/62 (45%), Gaps = 2/62 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ L + + ++ I L + L+L++N+L+ + + L+YL L+L N
Sbjct: 242 SSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
Query: 446 ML 447
Sbjct: 301 PW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 19/83 (22%), Positives = 30/83 (36%), Gaps = 4/83 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ L +S I P L+ ++ L + N+ ++ L L LNL N
Sbjct: 218 VGLEELEMSGNHFPE-IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHN 276
Query: 446 MLTGPLPAGLVERSKN-GSLSLS 467
L+ LP L + L L
Sbjct: 277 NLSS-LPHDLFTPLRYLVELHLH 298
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 2/62 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ LNL + P L+ L +E L++S N P L L+ L + +
Sbjct: 196 FNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 447 LT 448
++
Sbjct: 254 VS 255
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 14/74 (18%), Positives = 26/74 (35%), Gaps = 6/74 (8%)
Query: 386 PPRITSLNLSSRGLTGGIPPYLSNLT----MIEHLDLSNNSLTGPVPEFLSKLQYLRVLN 441
P + +L++S+ L +P N +T +PE + L +
Sbjct: 179 PESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTII 236
Query: 442 LTGNMLTGPLPAGL 455
L N L+ + L
Sbjct: 237 LEDNPLSSRIRESL 250
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 23/84 (27%), Positives = 36/84 (42%), Gaps = 14/84 (16%)
Query: 377 LGCSYND-----NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFL 431
L N P + L++ + LT +P + L E+++ NN LT +PE
Sbjct: 105 LDACDNRLSTLPELPASLKHLDVDNNQLTM-LPELPALL---EYINADNNQLTM-LPELP 159
Query: 432 SKLQYLRVLNLTGNMLTGPLPAGL 455
+ L VL++ N LT LP
Sbjct: 160 TSL---EVLSVRNNQLTF-LPELP 179
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 24/84 (28%), Positives = 36/84 (42%), Gaps = 14/84 (16%)
Query: 377 LGCSYND-----NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFL 431
L + N P + L+ L+ +P ++L HLD+ NN LT +PE
Sbjct: 85 LEITQNALISLPELPASLEYLDACDNRLST-LPELPASLK---HLDVDNNQLTM-LPELP 139
Query: 432 SKLQYLRVLNLTGNMLTGPLPAGL 455
+ L+Y +N N LT LP
Sbjct: 140 ALLEY---INADNNQLTM-LPELP 159
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 19/70 (27%), Positives = 25/70 (35%), Gaps = 3/70 (4%)
Query: 386 PPRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
LNL + I +L +E L LS N + + L L L L
Sbjct: 63 STNTRLLNLHENQIQI-IKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121
Query: 445 NMLTGPLPAG 454
N LT +P G
Sbjct: 122 NRLTT-IPNG 130
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 12/62 (19%), Positives = 26/62 (41%), Gaps = 2/62 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ L + + I NL + ++L++N+LT + + L +L ++L N
Sbjct: 231 MHLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
Query: 446 ML 447
Sbjct: 290 PW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 17/62 (27%), Positives = 28/62 (45%), Gaps = 2/62 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ LNL+ L P L+ L ++ LDLS N L+ P L +L+ L + +
Sbjct: 185 SNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242
Query: 447 LT 448
+
Sbjct: 243 IQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 20/83 (24%), Positives = 32/83 (38%), Gaps = 4/83 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
++ L+LS L+ I P L ++ L + + + LQ L +NL N
Sbjct: 207 IKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265
Query: 446 MLTGPLPAGLVERSKN-GSLSLS 467
LT LP L + + L
Sbjct: 266 NLTL-LPHDLFTPLHHLERIHLH 287
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 16/70 (22%), Positives = 26/70 (37%), Gaps = 3/70 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ L LS + I + L + L+L +N LT L L+ L L N
Sbjct: 88 RHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNN 146
Query: 446 MLTGPLPAGL 455
+ +P+
Sbjct: 147 PIES-IPSYA 155
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 13/80 (16%), Positives = 31/80 (38%), Gaps = 7/80 (8%)
Query: 379 CSYNDNDPPRITSLNLSSRGLT---GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQ 435
++ + + + +LS + + + ++L L L+ N + L
Sbjct: 267 FTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLE---QLTLAQNEINKIDDNAFWGLT 323
Query: 436 YLRVLNLTGNMLTGPLPAGL 455
+L LNL+ N L + + +
Sbjct: 324 HLLKLNLSQNFLGS-IDSRM 342
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 18/90 (20%), Positives = 32/90 (35%), Gaps = 18/90 (20%)
Query: 365 DPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLT 424
DP + CS + +RGL +P +++ ++DLS NS+
Sbjct: 2 DPGTSE--------CSVIG------YNAICINRGLHQ-VPELPAHVN---YVDLSLNSIA 43
Query: 425 GPVPEFLSKLQYLRVLNLTGNMLTGPLPAG 454
S+LQ L+ L + +
Sbjct: 44 ELNETSFSRLQDLQFLKVEQQTPGLVIRNN 73
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 15/71 (21%), Positives = 21/71 (29%), Gaps = 2/71 (2%)
Query: 387 PRITSLNLSSRGLTGGIPPYL-SNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ L + + I L+ + L L N + L L VL LT
Sbjct: 54 QDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQC 113
Query: 446 MLTG-PLPAGL 455
L G L
Sbjct: 114 NLDGAVLSGNF 124
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 17/65 (26%), Positives = 29/65 (44%), Gaps = 3/65 (4%)
Query: 387 PRITSLNLSSRGLTGGIPP--YLSNLTMIEHLDLSNNSLTGPVPE-FLSKLQYLRVLNLT 443
+ L L+ L G + + LT +E L L +N++ P F ++ VL+LT
Sbjct: 103 ANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLT 162
Query: 444 GNMLT 448
N +
Sbjct: 163 FNKVK 167
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 15/63 (23%), Positives = 31/63 (49%), Gaps = 2/63 (3%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+T L+LS L + P ++L+ ++ L++S+N+ L L+VL+ + N
Sbjct: 175 RNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233
Query: 446 MLT 448
+
Sbjct: 234 HIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 16/69 (23%), Positives = 25/69 (36%), Gaps = 2/69 (2%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ L ++ P + L + LDLS L P + L L+VLN++ N
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 209
Query: 446 MLTGPLPAG 454
L
Sbjct: 210 NFFS-LDTF 217
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 14/70 (20%), Positives = 27/70 (38%), Gaps = 3/70 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG-PVPEFLSKLQYLRVLNLTGN 445
+ L+LS G+ + L +EHLD +++L L+ L L+++
Sbjct: 78 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 446 MLTGPLPAGL 455
G+
Sbjct: 137 HTRV-AFNGI 145
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 19/62 (30%), Positives = 27/62 (43%), Gaps = 9/62 (14%)
Query: 390 TSLNLSSRGLT---GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
T + +S+GLT GIP L+L +N L KL L L+L+ N
Sbjct: 10 TEIRCNSKGLTSVPTGIPSSA------TRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG 63
Query: 447 LT 448
L+
Sbjct: 64 LS 65
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 12/71 (16%), Positives = 25/71 (35%), Gaps = 3/71 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPY--LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
++ L+ L + + +L + +LD+S+ + L L VL + G
Sbjct: 101 EQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 159
Query: 445 NMLTGPLPAGL 455
N +
Sbjct: 160 NSFQENFLPDI 170
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 24/71 (33%), Positives = 33/71 (46%), Gaps = 3/71 (4%)
Query: 386 PPRITSLNLSSRGLTGGIPP-YLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
P IT + L + IPP S + +DLSNN ++ P+ L+ L L L G
Sbjct: 31 PETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89
Query: 445 NMLTGPLPAGL 455
N +T LP L
Sbjct: 90 NKITE-LPKSL 99
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 16/59 (27%), Positives = 28/59 (47%), Gaps = 3/59 (5%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
L+ + + LS L +HL LS N++ LS ++ LR+L+L N++
Sbjct: 28 VELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE--KISSLSGMENLRILSLGRNLIK 83
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 5e-05
Identities = 17/91 (18%), Positives = 38/91 (41%), Gaps = 12/91 (13%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSN---LTMIEHLDLSNNSLTG----PVPEFLSKLQYLRV 439
P + L + + L +E +D+S LT + + + K+++L+
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311
Query: 440 LNLTGNMLTGPLPAGLVERSKNGSLSLSVDL 470
+N+ N L+ + L + SL + +D+
Sbjct: 312 INMKYNYLSDEMKKELQK-----SLPMKIDV 337
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 24/113 (21%), Positives = 39/113 (34%), Gaps = 17/113 (15%)
Query: 365 DPCAPQAFLWNGLGCSYNDN--------DPPRITSLNLSSRGLTGGIPPY-LSNLTMIEH 415
D C P +GL C+ + +T L + ++ + L L + +
Sbjct: 3 DACCPHGS--SGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 416 LDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSV 468
L + + L P+ L LNL+ N L L V+ LSL
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQ-----GLSLQE 107
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 50/240 (20%), Positives = 89/240 (37%), Gaps = 51/240 (21%)
Query: 542 ILGEGSFGKVYHGY--LDDNTEVAVKMLSPSSRQGY-EQFEAEVILLRTVHHK------N 592
LGEG+FGKV VAVK++ + Y E +E+ +L ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVK--NVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG 652
+ + I +++E + S +++ ++ + ++A + + + +LH
Sbjct: 79 CVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH-- 135
Query: 653 CKPPRVHRDIKPANILLNDQFQA-------------------RLADFGLSKTFPIEGVSH 693
H D+KP NIL ++ DFG S T+ E H
Sbjct: 136 -SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SATYDDE---H 190
Query: 694 LSTGVAGTFGYLDPE------YCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHI 747
ST V+ Y PE + Q DV+S G +L+E + +H+
Sbjct: 191 HSTLVSTRH-YRAPEVILALGWSQ------PCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 14/60 (23%), Positives = 26/60 (43%), Gaps = 1/60 (1%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVP-EFLSKLQYLRVLNLTGN 445
R+ +L +++ + L + L L+NNSL + L+ L+ L L + N
Sbjct: 64 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 18/72 (25%), Positives = 26/72 (36%), Gaps = 10/72 (13%)
Query: 387 PRITSLNLSSRGLT---GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443
R SS L G+ + + LDLSNN +T L + L+ L LT
Sbjct: 31 DRNGICKGSSGSLNSIPSGLTEAV------KSLDLSNNRITYISNSDLQRCVNLQALVLT 84
Query: 444 GNMLTGPLPAGL 455
N + +
Sbjct: 85 SNGINT-IEEDS 95
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 16/81 (19%), Positives = 35/81 (43%), Gaps = 5/81 (6%)
Query: 388 RITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNML 447
+ + + S L+ G L ++ +++ SL V + L+++ L L + N L
Sbjct: 233 DLDTFHFSE--LSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
Query: 448 TGPLPAGLVERSKN-GSLSLS 467
+P G+ +R + + L
Sbjct: 290 KS-VPDGIFDRLTSLQKIWLH 309
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 20/71 (28%), Positives = 29/71 (40%), Gaps = 4/71 (5%)
Query: 386 PPRITSLNLSSRGLTGGIPP--YLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443
P L+LS L+ + + LT + L LS+N L E + LR L+L+
Sbjct: 38 PSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96
Query: 444 GNMLTGPLPAG 454
N L L
Sbjct: 97 SNHLHT-LDEF 106
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 20/69 (28%), Positives = 27/69 (39%), Gaps = 3/69 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ SL LS L I + + +LDLS+N L S LQ L VL L N
Sbjct: 64 TNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNN 122
Query: 446 MLTGPLPAG 454
+ +
Sbjct: 123 HIVV-VDRN 130
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 14/67 (20%), Positives = 28/67 (41%), Gaps = 7/67 (10%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPE----FLSKLQYLRVLN 441
+ L L + + + ++ ++ L LS N ++ P +KL L +L+
Sbjct: 112 QALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLD 169
Query: 442 LTGNMLT 448
L+ N L
Sbjct: 170 LSSNKLK 176
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 12/70 (17%), Positives = 22/70 (31%), Gaps = 2/70 (2%)
Query: 386 PPRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
P + L ++ +P + L L +N L + L L L+L+
Sbjct: 31 PAASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89
Query: 445 NMLTGPLPAG 454
N +
Sbjct: 90 NAQLRSVDPA 99
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 14/69 (20%), Positives = 22/69 (31%), Gaps = 3/69 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+ L L L +P +L + HL L N ++ L L L L N
Sbjct: 129 AALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 446 MLTGPLPAG 454
+ +
Sbjct: 188 RVAH-VHPH 195
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 19/83 (22%), Positives = 30/83 (36%), Gaps = 4/83 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
+T L L ++ +P L ++ L L N + P L L L L N
Sbjct: 153 GNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 446 MLTGPLPAGLVERSKN-GSLSLS 467
L+ LP + + L L+
Sbjct: 212 NLSA-LPTEALAPLRALQYLRLN 233
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 18/69 (26%), Positives = 31/69 (44%), Gaps = 3/69 (4%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
R+ +L+L GL + P L +++L L +N+L + L L L L GN
Sbjct: 105 GRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163
Query: 446 MLTGPLPAG 454
++ +P
Sbjct: 164 RISS-VPER 171
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 23/71 (32%), Positives = 30/71 (42%), Gaps = 4/71 (5%)
Query: 387 PRITSLNLSSRGLTGGIPPY-LSNLTMIEHLDLSNNS-LTGPVPEFLSKLQYLRVLNLTG 444
+T L L S L I + L ++E LDLS+N+ L P L L L+L
Sbjct: 56 RNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114
Query: 445 NMLTGPLPAGL 455
L L GL
Sbjct: 115 CGLQE-LGPGL 124
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 18/61 (29%), Positives = 23/61 (37%), Gaps = 11/61 (18%)
Query: 390 TSLNLSSRGLTG-----GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
T ++ RGLT P L L+ N+LT P L L LR +L
Sbjct: 11 TLVDCGRRGLTWASLPTAFP------VDTTELVLTGNNLTALPPGLLDALPALRTAHLGA 64
Query: 445 N 445
N
Sbjct: 65 N 65
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 25/69 (36%), Positives = 32/69 (46%), Gaps = 2/69 (2%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
P + +L+LS L +P L + LD+S N LT L L L+ L L GN
Sbjct: 77 PVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135
Query: 447 LTGPLPAGL 455
L LP GL
Sbjct: 136 LKT-LPPGL 143
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 17/62 (27%), Positives = 19/62 (30%), Gaps = 9/62 (14%)
Query: 390 TSLNLSSRGLT---GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+N R LT +P L LS N L L L LNL
Sbjct: 13 LEVNCDKRNLTALPPDLPKDT------TILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 447 LT 448
LT
Sbjct: 67 LT 68
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 22/82 (26%), Positives = 29/82 (35%), Gaps = 3/82 (3%)
Query: 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
P T L+LS L L T + L+L LT + L L L+L+ N
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHN 87
Query: 446 MLTGPLPAGLVERSKNGSLSLS 467
L LP L +S
Sbjct: 88 QLQS-LPLLGQTLPALTVLDVS 108
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 20/62 (32%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++ SL+L G++ I L +L +E L L NN +T LS+L L L+L N
Sbjct: 109 KKLKSLSLEHNGISD-ING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQ 164
Query: 447 LT 448
++
Sbjct: 165 IS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 14/67 (20%), Positives = 27/67 (40%), Gaps = 4/67 (5%)
Query: 382 NDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLN 441
D+ NL + +T + + L I+ + +N+ + + + L + L
Sbjct: 16 PDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--SVQGIQYLPNVTKLF 71
Query: 442 LTGNMLT 448
L GN LT
Sbjct: 72 LNGNKLT 78
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 13/72 (18%), Positives = 24/72 (33%), Gaps = 4/72 (5%)
Query: 386 PPRITSLNLSSRGLTGGIPP--YLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443
P L L++ T + L + ++ SNN +T + + LT
Sbjct: 31 PQYTAELRLNNNEFTV-LEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89
Query: 444 GNMLTGPLPAGL 455
N L + +
Sbjct: 90 SNRLEN-VQHKM 100
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 20/62 (32%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
++ SL+L G++ I L +L +E L L NN +T LS+L L L+L N
Sbjct: 112 KKLKSLSLEHNGISD-ING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQ 167
Query: 447 LT 448
++
Sbjct: 168 IS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 14/67 (20%), Positives = 28/67 (41%), Gaps = 4/67 (5%)
Query: 382 NDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLN 441
+D+ NL + +T + + L I+ + +N+ + + + L + L
Sbjct: 19 SDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--SVQGIQYLPNVTKLF 74
Query: 442 LTGNMLT 448
L GN LT
Sbjct: 75 LNGNKLT 81
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 22/80 (27%), Positives = 28/80 (35%), Gaps = 14/80 (17%)
Query: 378 GCSYNDNDPPRITSLNLSSRGLT---GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKL 434
GC+ N+ ++ + L GIP E LDL + L L
Sbjct: 9 GCTCNEGK----KEVDCQGKSLDSVPSGIP------ADTEKLDLQSTGLATLSDATFRGL 58
Query: 435 QYLRVLNLTGNMLTGPLPAG 454
L LNL N L L AG
Sbjct: 59 TKLTWLNLDYNQLQT-LSAG 77
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 15/62 (24%), Positives = 27/62 (43%), Gaps = 4/62 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L L +T I P L+ LT +++L + N ++ L+ L L L N
Sbjct: 129 SNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADDNK 184
Query: 447 LT 448
++
Sbjct: 185 IS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 20/62 (32%), Positives = 30/62 (48%), Gaps = 4/62 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L L +T + P L NLT I L+LS N L ++ LQ ++ L+LT
Sbjct: 63 NNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQ 118
Query: 447 LT 448
+T
Sbjct: 119 IT 120
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 12/62 (19%), Positives = 30/62 (48%), Gaps = 4/62 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L++ + ++ + P L+NL+ + L +N ++ L+ L L ++L N
Sbjct: 151 TNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQ 206
Query: 447 LT 448
++
Sbjct: 207 IS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 9e-04
Identities = 16/62 (25%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
I +L+L+S +T + P L+ L+ ++ L L N +T L+ L L+ L++
Sbjct: 107 QSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQIT--NISPLAGLTNLQYLSIGNAQ 162
Query: 447 LT 448
++
Sbjct: 163 VS 164
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 27/79 (34%), Positives = 37/79 (46%), Gaps = 14/79 (17%)
Query: 379 CSYNDNDPPRITSLNLSSRGLT---GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQ 435
CS N+N S++ SS+ LT IP + LDL +N L+ + +L
Sbjct: 12 CSCNNN----KNSVDCSSKKLTAIPSNIP------ADTKKLDLQSNKLSSLPSKAFHRLT 61
Query: 436 YLRVLNLTGNMLTGPLPAG 454
LR+L L N L LPAG
Sbjct: 62 KLRLLYLNDNKLQT-LPAG 79
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 16/62 (25%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ L++ + L I L L+ +E LDL N +T L++L+ + ++LTG
Sbjct: 128 KNLEILSIRNNKLKS-IVM-LGFLSKLEVLDLHGNEIT--NTGGLTRLKKVNWIDLTGQK 183
Query: 447 LT 448
Sbjct: 184 CV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 10/67 (14%), Positives = 27/67 (40%), Gaps = 4/67 (5%)
Query: 382 NDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLN 441
D NL + +T + L+ +++ + N+++ + L+ L+
Sbjct: 14 PDPGLANAVKQNLGKQSVTD-LVS-QKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELH 69
Query: 442 LTGNMLT 448
L+ N ++
Sbjct: 70 LSHNQIS 76
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 12/68 (17%), Positives = 21/68 (30%), Gaps = 10/68 (14%)
Query: 390 TSLNLSSRGLT---GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446
+ +P ++LDLS N L L+VL+L+
Sbjct: 10 ITYQCMELNFYKIPDNLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 447 LTGPLPAG 454
+ + G
Sbjct: 64 IQT-IEDG 70
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 846 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.69 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.6 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.54 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.51 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.46 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.36 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.32 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.27 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.27 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.24 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.23 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.23 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.23 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.17 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.16 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.15 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.1 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.08 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.02 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.0 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.0 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 98.99 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 98.99 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 98.98 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 98.96 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 98.95 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 98.94 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 98.91 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.91 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.91 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.88 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 98.87 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 98.87 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.87 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.87 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 98.87 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.86 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 98.86 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 98.86 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.85 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.84 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.83 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.83 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.82 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.81 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.81 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 98.81 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.79 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.79 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.78 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 98.78 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 98.78 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 98.77 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.77 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.75 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 98.74 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 98.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.74 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.71 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.71 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 98.71 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 98.71 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 98.7 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.69 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.69 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 98.69 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.69 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.68 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.68 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.65 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 98.65 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.65 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.64 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 98.63 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.63 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 98.63 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.61 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.6 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.58 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.58 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.58 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.56 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.56 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.55 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.55 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.55 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.54 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.53 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.53 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.51 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.51 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.5 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.49 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.49 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.48 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.48 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.47 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.46 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.45 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.45 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.43 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.4 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.4 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.35 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.34 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.34 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.31 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.31 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.3 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.29 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.29 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.28 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.26 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.25 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.23 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.23 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.22 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.2 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.2 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.2 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.15 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.13 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.12 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.11 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.11 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.11 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.08 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.07 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.07 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.05 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.05 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.04 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.03 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.0 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.0 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.96 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 97.88 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.86 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 97.79 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 97.75 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.7 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 97.64 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.62 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.61 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.52 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.48 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.21 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.16 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.12 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.09 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.91 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 96.87 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 96.83 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 96.68 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.66 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.65 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.64 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.59 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.54 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.5 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.31 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.27 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.26 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.12 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.06 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 96.02 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.97 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.93 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.65 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 95.53 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 95.5 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.12 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.92 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 93.08 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.52 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 91.42 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 91.13 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 90.24 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.13 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 84.26 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 83.99 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 80.08 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=444.75 Aligned_cols=255 Identities=28% Similarity=0.458 Sum_probs=207.9
Q ss_pred hhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 539 FETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.+.||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+++..++||||
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578999999999999874 4788999999987777778999999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCC-------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEe
Q 003114 613 MANGSLEEYLSDSN-------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLAD 679 (846)
Q Consensus 613 ~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~D 679 (846)
|++|+|.++++... ...++|.++++|+.|+|+||+||| +++||||||||+||||++++.+||+|
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEEEcc
Confidence 99999999997643 235999999999999999999999 88999999999999999999999999
Q ss_pred ccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcC
Q 003114 680 FGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQG 758 (846)
Q Consensus 680 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~ 758 (846)
||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||......+.+ ..+. .+
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~----~~i~-~g 276 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI----DCIT-QG 276 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH----HHHH-HT
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH----HHHH-cC
Confidence 999987654444444456789999999999999999999999999999999999 89999876543322 2222 22
Q ss_pred CcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 759 DIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 759 ~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
.. ...+......+.+|+.+||+.+|++||||+||+++|+.+.+
T Consensus 277 ~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 277 RE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp CC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11 01123345678899999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=448.62 Aligned_cols=262 Identities=24% Similarity=0.398 Sum_probs=216.8
Q ss_pred HHHHHHhhhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecC
Q 003114 531 EITKITNDFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG 603 (846)
Q Consensus 531 el~~~t~~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 603 (846)
|+...+..|.+.||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 344445567789999999999999973 46789999997553 33457899999999999999999999999999
Q ss_pred CeeeEeeecccCCChhhhhhcCC--------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE
Q 003114 604 NQIGLIYEYMANGSLEEYLSDSN--------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL 669 (846)
Q Consensus 604 ~~~~LV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl 669 (846)
+..++|||||++|+|.++|.... ...++|.++++|+.|||+||+||| +.+||||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEE
Confidence 99999999999999999996532 235899999999999999999999 8899999999999999
Q ss_pred CCCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHH
Q 003114 670 NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHIS 748 (846)
Q Consensus 670 d~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~ 748 (846)
++++.+||+|||+++.....+.........||+.|||||++.+..++.++|||||||++|||+| |++||.+....+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--- 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--- 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999987654433444556789999999999999999999999999999999998 899998765432
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 749 QWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 749 ~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
.+.. +..+... ..+.+++..+.+|+.+||+.+|++||||+||++.|+...
T Consensus 256 -~~~~-i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 256 -VVEM-IRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp -HHHH-HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -HHHH-HHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 2222 2222211 123345567899999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=441.28 Aligned_cols=257 Identities=28% Similarity=0.467 Sum_probs=215.3
Q ss_pred hhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 538 DFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
.+.+.||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+++..++|||
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 95 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 95 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 34678999999999999864 477899999988777777899999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCC-----------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEec
Q 003114 612 YMANGSLEEYLSDSN-----------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADF 680 (846)
Q Consensus 612 y~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DF 680 (846)
||++|+|.++|+... ...++|.++++|+.|+|+||+||| +++|+||||||+|||+++++.+||+||
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEECCc
Confidence 999999999997642 346999999999999999999999 889999999999999999999999999
Q ss_pred cCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCC
Q 003114 681 GLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGD 759 (846)
Q Consensus 681 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~ 759 (846)
|+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||......+. +.... .+.
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~----~~~i~-~~~ 247 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV----IECIT-QGR 247 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----HHHHH-HTC
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHH-cCC
Confidence 99987644333333444679999999999999999999999999999999999 8999987654332 22222 222
Q ss_pred cccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 760 IKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 760 ~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
.. ..+...+.++.+|+.+||+.+|++||||+||.+.|+++...
T Consensus 248 ~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 248 VL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11 11233456789999999999999999999999999987643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=434.36 Aligned_cols=256 Identities=27% Similarity=0.475 Sum_probs=203.8
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||+|+||+||+|++++ .||||+++.. +....++|.+|+.++++++|||||+++|+|.+ +..++|||||++
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g 115 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG 115 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred EEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence 356789999999999998754 6999998754 34456789999999999999999999999865 568999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.++|+.... .++|.++++|+.|+|+||+||| +++||||||||+||||++++.+||+|||+|+...........
T Consensus 116 GsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 116 SSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp CBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred CCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 999999976543 4999999999999999999999 889999999999999999999999999999876443334444
Q ss_pred ccccCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 696 TGVAGTFGYLDPEYCQT---FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~---~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
...+||+.|||||++.+ ..++.++|||||||++|||+||+.||.+......+.. ....+. ..|.+. ..
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~----~~~~~~----~~p~~~-~~ 262 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF----MVGRGY----ASPDLS-KL 262 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH----HHHTTC----CCCCST-TS
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH----HHhcCC----CCCCcc-cc
Confidence 56789999999999864 3589999999999999999999999986554333322 222221 111111 12
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
..++...+.+|+.+||+.+|++||||.||++.|+.+.
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 2345567889999999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=418.70 Aligned_cols=265 Identities=25% Similarity=0.372 Sum_probs=201.6
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCC----eeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN----QIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~LV~Ey~ 613 (846)
.+.+.||+|+||+||+|++ +|+.||||+++..... ...++.|+..+.+++|||||+++++|.+++ ..+||||||
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 3467899999999999998 5899999999754322 233456777778899999999999997653 689999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhcc-----CCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG-----CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
++|+|.++++... ++|..+.+++.|+++||+|||+. ..++|+||||||+|||+++++.+||+|||+++....
T Consensus 84 ~~gsL~~~l~~~~---l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 84 EHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp TTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCCcHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 9999999998653 89999999999999999999943 134999999999999999999999999999987643
Q ss_pred CCcc--cccccccCCCcccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCcccc-----------ccHHH
Q 003114 689 EGVS--HLSTGVAGTFGYLDPEYCQTF------RLTEKSDVYSFGVVLLEIITSRPAIANTEEH-----------KHISQ 749 (846)
Q Consensus 689 ~~~~--~~~~~~~gt~~Y~APE~~~~~------~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~-----------~~l~~ 749 (846)
.... ......+||+.|||||++.+. .++.++|||||||++|||+||++|+...... .....
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 3221 122346799999999998754 4678999999999999999998877533211 11222
Q ss_pred HHHHHHhcCCcccccCCCCCCC-CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 750 WVDFMLAQGDIKNIVDPKLHGD-IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 750 ~~~~~~~~~~~~~~~d~~L~~~-~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
+... ..++ ..+|.+... ...+....+.+|+.+||+.+|++||||.||++.|+++.+.+
T Consensus 241 ~~~~-~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 241 MRKV-VCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHH-HTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHH-Hhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 2222 2111 122222211 12345678899999999999999999999999999876543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=426.69 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=213.9
Q ss_pred hhhhhhcCcCceEEEEEEEEcC------CcEEEEEEeCCCCc-hhhHHHHHHHHHHHhccc-ccceeEeeEeec-CCeee
Q 003114 537 NDFETILGEGSFGKVYHGYLDD------NTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHH-KNLTTLYGYCNE-GNQIG 607 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~-~~~~~ 607 (846)
..+.+.||+|+||+||+|++.. ++.||||++..... ...+++.+|+.+|.+++| ||||+++|+|.+ ++..+
T Consensus 66 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~ 145 (353)
T 4ase_A 66 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 145 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred eEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEE
Confidence 3456789999999999998642 35799999986543 345679999999999965 899999999966 46789
Q ss_pred EeeecccCCChhhhhhcCC--------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC
Q 003114 608 LIYEYMANGSLEEYLSDSN--------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF 673 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~ 673 (846)
+|||||++|+|.++|+... ...++|.+++.++.|||+||+||| +++||||||||+|||+++++
T Consensus 146 iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp EEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceeeCCCC
Confidence 9999999999999997542 234899999999999999999999 89999999999999999999
Q ss_pred cEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHH
Q 003114 674 QARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVD 752 (846)
Q Consensus 674 ~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~ 752 (846)
.+||+|||+|+.+.............||+.|||||++.+..++.++|||||||++|||+| |+.||.+......+..
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~--- 299 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR--- 299 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH---
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH---
Confidence 999999999997754444444455779999999999999999999999999999999998 8999987654333322
Q ss_pred HHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 753 FMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 753 ~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
.+.++... ..+.....++.+++.+||+.+|++||||.||+++|+++++..
T Consensus 300 -~i~~g~~~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 300 -RLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp -HHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -HHHcCCCC---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 22222111 112233457889999999999999999999999999998654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=417.44 Aligned_cols=254 Identities=20% Similarity=0.255 Sum_probs=208.8
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
.+.||+|+||.||+|+.. +|+.||||+++.... ..+|+.+++.++|||||++++++.+++..++|||||++|+|
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 467999999999999975 689999999975432 24799999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC-cEEEEeccCCccCCCCCccc---c
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF-QARLADFGLSKTFPIEGVSH---L 694 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-~vkI~DFGla~~~~~~~~~~---~ 694 (846)
.++++..+. +++..+..++.|++.||+||| +++||||||||+|||++.++ .+||+|||+|+.+....... .
T Consensus 138 ~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 138 GQLIKQMGC--LPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp HHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred HHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 999987653 999999999999999999999 89999999999999999987 69999999998764332211 2
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
....+||+.|||||++.+..++.++||||+||++|||+||++||........+..... ...... ..+.
T Consensus 213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~~~~~~--------~~~~ 280 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS----EPPPIR--------EIPP 280 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH----SCCGGG--------GSCT
T ss_pred CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc----CCCCch--------hcCc
Confidence 2346799999999999999999999999999999999999999987665554443222 111000 1122
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhh
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETAR 815 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~ 815 (846)
.....+.+++.+||+.||++|||+.|+++.|.+.+....+.
T Consensus 281 ~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l 321 (336)
T 4g3f_A 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321 (336)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSS
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhc
Confidence 33456889999999999999999999999998887655443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=418.80 Aligned_cols=244 Identities=22% Similarity=0.348 Sum_probs=205.8
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++..++|||||++|+|
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999975 7999999999766555567789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGV 698 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~ 698 (846)
.+++... .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.+... .......
T Consensus 159 ~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~ 230 (346)
T 4fih_A 159 TDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSL 230 (346)
T ss_dssp HHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBCCC
T ss_pred HHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC--CCccccc
Confidence 9999764 3899999999999999999999 899999999999999999999999999999876432 2234557
Q ss_pred cCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHH
Q 003114 699 AGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAW 778 (846)
Q Consensus 699 ~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~ 778 (846)
+||+.|||||++.+..|+.++||||+||++|||++|++||.+....+.+.. .. .+. .+.+. .......
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~----i~-~~~-----~~~~~--~~~~~s~ 298 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM----IR-DNL-----PPRLK--NLHKVSP 298 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HH-HSS-----CCCCS--CGGGSCH
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH----HH-cCC-----CCCCC--ccccCCH
Confidence 899999999999999999999999999999999999999986554332222 11 111 11111 1122345
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 779 KAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 779 ~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+.+++.+||+.||++|||++|+++
T Consensus 299 ~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 299 SLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 7889999999999999999998865
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=421.41 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=202.3
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
.+.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.+|++++|||||++++++.+++..++|||||+
T Consensus 27 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~ 106 (350)
T 4b9d_A 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE 106 (350)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 44578999999999999975 7999999999754 33456789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|.++|...+...+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.+.. ....
T Consensus 107 gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~ 181 (350)
T 4b9d_A 107 GGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVEL 181 (350)
T ss_dssp TCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--HHHH
T ss_pred CCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC--Cccc
Confidence 999999998776666899999999999999999999 89999999999999999999999999999987532 1222
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
....+||+.|||||++.+..++.++||||+||++|||+||++||........+. ..... ... .+ ..
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~----~i~~~-~~~-----~~----~~ 247 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL----KIISG-SFP-----PV----SL 247 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHT-CCC-----CC----CT
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH----HHHcC-CCC-----CC----Cc
Confidence 345679999999999999999999999999999999999999998765433222 22222 111 11 12
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.....+.+|+.+||+.||++|||++|+++
T Consensus 248 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 23356889999999999999999999976
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=409.71 Aligned_cols=244 Identities=25% Similarity=0.432 Sum_probs=197.6
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeec----CCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE----GNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~LV~ 610 (846)
.+++.||+|+||+||+|... ++..||+|++... .....+.|.+|+.++++++|||||++++++.. ++..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34567999999999999975 6889999999643 33455779999999999999999999999854 45689999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCC--eeecCCCCCCEEECC-CCcEEEEeccCCccCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP--RVHRDIKPANILLND-QFQARLADFGLSKTFP 687 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--IiHrDlKp~NILld~-~~~vkI~DFGla~~~~ 687 (846)
|||++|+|.++++.... +++..+..++.||+.||+||| +++ |+||||||+|||+++ ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999987543 899999999999999999999 666 999999999999984 7999999999998542
Q ss_pred CCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCC
Q 003114 688 IEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 688 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
. ......+||+.|||||++.+ +++.++|||||||++|||+||++||........+. .. +..+.....+++
T Consensus 184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~---~~-i~~~~~~~~~~~- 253 (290)
T 3fpq_A 184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY---RR-VTSGVKPASFDK- 253 (290)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---HH-HTTTCCCGGGGG-
T ss_pred C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHH---HH-HHcCCCCCCCCc-
Confidence 2 23345689999999998865 69999999999999999999999997654333222 22 222211111111
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
....++.+++.+||+.+|++|||++|+++
T Consensus 254 -------~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 254 -------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12236789999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=412.31 Aligned_cols=246 Identities=23% Similarity=0.351 Sum_probs=208.4
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.+.+.||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 455689999999999999974 7899999999753 223456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
|++|+|.+++...+. +++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+.+......
T Consensus 114 ~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 114 AKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 999999999987654 999999999999999999999 899999999999999999999999999999987544444
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
......+||+.|||||++.+..++.++||||+||++|||+||++||...+....+.. ... +.. .+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~----i~~-~~~------~~---- 253 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK----IIK-LEY------DF---- 253 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHH-TCC------CC----
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHc-CCC------CC----
Confidence 455667899999999999999999999999999999999999999987654333222 222 211 11
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVV 802 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl 802 (846)
+.....++.+++.+|++.||++|||++|+.
T Consensus 254 p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 112234678999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=419.82 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=206.4
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
+.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++.+++|||||++|+
T Consensus 155 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~ 234 (423)
T 4fie_A 155 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 234 (423)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence 3467999999999999975 699999999987666666789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.++++... +++.++..++.||+.||+||| +++||||||||+||||+.++.+||+|||+|+.+... ......
T Consensus 235 L~~~i~~~~---l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~ 306 (423)
T 4fie_A 235 LTDIVTHTR---MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKS 306 (423)
T ss_dssp HHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS--CCCBCC
T ss_pred HHHHHhccC---CCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCC--Cccccc
Confidence 999997643 899999999999999999999 899999999999999999999999999999876432 223455
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSA 777 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~ 777 (846)
.+||+.|||||++.+..|+.++|||||||++|||++|++||.+......+.. .. .+. .+.+. ......
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~----i~-~~~-----~~~~~--~~~~~s 374 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM----IR-DNL-----PPRLK--NLHKVS 374 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HH-HSC-----CCCCS--CTTSSC
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH----HH-cCC-----CCCCc--ccccCC
Confidence 7899999999999999999999999999999999999999986554332222 11 111 11111 011223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 778 WKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 778 ~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+.+|+.+||+.||++|||+.|+++
T Consensus 375 ~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 375 PSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 46889999999999999999998865
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=395.66 Aligned_cols=243 Identities=25% Similarity=0.388 Sum_probs=190.0
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.+.+.||+|+||+||+|+.. +|+.||+|++.+.. ....+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 94 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 94 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 445678999999999999964 79999999996542 23356789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+ +|+|.+++...+. +++.++..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+|+.... .
T Consensus 95 ~-~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~ 165 (275)
T 3hyh_A 95 A-GNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---G 165 (275)
T ss_dssp C-CEEHHHHHHHSCS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred C-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCC---C
Confidence 9 6899999987654 999999999999999999999 89999999999999999999999999999986532 2
Q ss_pred cccccccCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
......+||+.|+|||++.+..+ +.++||||+||++|||+||+.||....... ..+... .+.. .+
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~----~~~~i~-~~~~------~~--- 231 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV----LFKNIS-NGVY------TL--- 231 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHH-HTCC------CC---
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHH-cCCC------CC---
Confidence 23345689999999999998876 579999999999999999999997654332 222222 2211 11
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+......+.+++.+|++.||++|||++|+++
T Consensus 232 -p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 -PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1122346789999999999999999999876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=401.28 Aligned_cols=240 Identities=25% Similarity=0.321 Sum_probs=193.5
Q ss_pred hhhhhhcCcCceEEEEEEEEc----CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 537 NDFETILGEGSFGKVYHGYLD----DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
+++.+.||+|+||+||+|+.. .++.||+|+++... ......+.+|+.+|++++|||||++++++.+++..++||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 455689999999999999862 46789999997542 223456889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
|||++|+|.+++..... +++.++..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 106 Ey~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 179 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH- 179 (304)
T ss_dssp CCCTTCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EcCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC-
Confidence 99999999999987653 999999999999999999999 899999999999999999999999999999865322
Q ss_pred cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
.......+||+.|||||++.+..++.++||||+||++|||+||++||.+.+..+.+.. ... +.. .
T Consensus 180 -~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~----i~~-~~~------~--- 244 (304)
T 3ubd_A 180 -EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM----ILK-AKL------G--- 244 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHH-CCC------C---
T ss_pred -CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHH----HHc-CCC------C---
Confidence 2233457899999999999999999999999999999999999999987654433322 222 111 1
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCH
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
++......+.+++.+||+.||++|||+
T Consensus 245 -~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 245 -MPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 112233467899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=386.55 Aligned_cols=247 Identities=21% Similarity=0.324 Sum_probs=185.5
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCC-----------
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN----------- 604 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----------- 604 (846)
++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 8 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~ 87 (299)
T 4g31_A 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87 (299)
T ss_dssp EEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------C
T ss_pred EEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCC
Confidence 34578999999999999975 78999999997543 334567899999999999999999999886533
Q ss_pred -eeeEeeecccCCChhhhhhcCCC-CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccC
Q 003114 605 -QIGLIYEYMANGSLEEYLSDSNA-DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGL 682 (846)
Q Consensus 605 -~~~LV~Ey~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGl 682 (846)
..++|||||++|+|.+++..... ...++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 88 ~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp EEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred cEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 47899999999999999986543 23556678899999999999999 89999999999999999999999999999
Q ss_pred CccCCCCCcc----------cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHH
Q 003114 683 SKTFPIEGVS----------HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVD 752 (846)
Q Consensus 683 a~~~~~~~~~----------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~ 752 (846)
|+.+...... ......+||+.|||||++.+..++.++|||||||++|||++ ||....+. ... ..
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--~~~-~~ 238 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--VRT-LT 238 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--HHH-HH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--HHH-HH
Confidence 9876432211 12234679999999999999999999999999999999996 77543221 111 11
Q ss_pred HHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 753 FMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 753 ~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
. ......... ..+....+.+++.+||+.+|++|||+.|+++
T Consensus 239 ~-~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 239 D-VRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H-HHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-HhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 111111111 1122234678999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=378.77 Aligned_cols=270 Identities=44% Similarity=0.731 Sum_probs=238.8
Q ss_pred hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChh
Q 003114 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLE 619 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 619 (846)
.+.||+|+||.||+|+..+++.||+|++........+.+.+|+.+++.++||||+++++++..++..++||||+++|+|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 46899999999999998889999999998777777788999999999999999999999999999999999999999999
Q ss_pred hhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 620 EYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 620 ~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
+++.... ...+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.............
T Consensus 124 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 200 (321)
T 2qkw_B 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200 (321)
T ss_dssp GGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCC
T ss_pred HHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccc
Confidence 9997654 235899999999999999999999 88999999999999999999999999999986543333333445
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--ccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTE--EHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~--~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.... +......|.......+.+...+++.+......+
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (321)
T 2qkw_B 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280 (321)
T ss_dssp CEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHH
T ss_pred cCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHH
Confidence 568999999999998899999999999999999999999997644 334566777777777788888888888778888
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
....+.+++.+|++.+|++|||+.||++.|++++...
T Consensus 281 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 281 SLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp HHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 8999999999999999999999999999999987543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=376.81 Aligned_cols=284 Identities=39% Similarity=0.667 Sum_probs=244.9
Q ss_pred ccccCHHHHHHHHhhh--hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEe
Q 003114 524 KRRFTYAEITKITNDF--ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYC 600 (846)
Q Consensus 524 ~~~~~~~el~~~t~~f--~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 600 (846)
...+++.++...+.++ .+.||+|+||.||+|+..+++.||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 4567888888887777 478999999999999988899999999976532 2334689999999999999999999999
Q ss_pred ecCCeeeEeeecccCCChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEE
Q 003114 601 NEGNQIGLIYEYMANGSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLA 678 (846)
Q Consensus 601 ~~~~~~~LV~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~ 678 (846)
..++..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||..+..+|+||||||+|||+++++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998754 3348999999999999999999994444499999999999999999999999
Q ss_pred eccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC----ccccccHHHHHHHH
Q 003114 679 DFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIAN----TEEHKHISQWVDFM 754 (846)
Q Consensus 679 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~----~~~~~~l~~~~~~~ 754 (846)
|||+++..... .........||+.|+|||.+.+..++.++|||||||+++||++|+.||.. .........|+...
T Consensus 177 Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCcc-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 99999876432 22233445699999999999888999999999999999999999999973 33455677888877
Q ss_pred HhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 755 LAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 755 ~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
..........+..+......+....+.+++.+|++.+|++|||++||+++|++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 788888888888888888889999999999999999999999999999999873
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=383.73 Aligned_cols=258 Identities=18% Similarity=0.297 Sum_probs=202.3
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeec------CCeeeE
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNE------GNQIGL 608 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~------~~~~~L 608 (846)
.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.. .+..++
T Consensus 57 ~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~i 136 (398)
T 4b99_A 57 EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 136 (398)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEE
Confidence 44578999999999999975 79999999997543 3345678899999999999999999998753 467899
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
|||||+ |+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 137 vmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 137 VLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 999995 68999998754 4999999999999999999999 89999999999999999999999999999987643
Q ss_pred CC--cccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 003114 689 EG--VSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765 (846)
Q Consensus 689 ~~--~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 765 (846)
.. ........+||+.|+|||++.+. .++.++||||+||+++||++|++||.+.+....+..+....... .....
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p---~~~~~ 287 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP---SPAVI 287 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC---CGGGT
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC---ChHHh
Confidence 21 12234457899999999998775 46999999999999999999999998876655555444322111 10000
Q ss_pred CC------------CCC--CCC-----hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 766 PK------------LHG--DID-----VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 766 ~~------------L~~--~~~-----~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.. +.. ..+ ......+++|+.+||..||++|||++|+++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 000 000 0123467899999999999999999998763
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=376.85 Aligned_cols=256 Identities=22% Similarity=0.332 Sum_probs=193.6
Q ss_pred hhhhhcCcCceEEEEEEEEc----CCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD----DNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||+||+|+.+ .++.||+|++..... ..++.+|+++|+.+ +||||+++++++.++++.++||||
T Consensus 24 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~ 101 (361)
T 4f9c_A 24 KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY 101 (361)
T ss_dssp EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence 34578999999999999853 467899999976543 35678999999988 699999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC-CcEEEEeccCCccCCCCCc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ-FQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-~~vkI~DFGla~~~~~~~~ 691 (846)
+++|+|.++++. +++.++..++.|++.||+||| +.+|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 102 ~~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 102 LEHESFLDILNS-----LSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp CCCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred CCcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 999999999853 889999999999999999999 8999999999999999876 7999999999986532211
Q ss_pred --------------------------ccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-c
Q 003114 692 --------------------------SHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTE-E 743 (846)
Q Consensus 692 --------------------------~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~-~ 743 (846)
.......+||+.|+|||++.+. .++.++||||+||+++||++|+.||.... +
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 0112345799999999998775 58999999999999999999999996544 3
Q ss_pred cccHHHHHHHHHhc---------C-------Cc--------------ccccCCCCCC---------CCChHHHHHHHHHH
Q 003114 744 HKHISQWVDFMLAQ---------G-------DI--------------KNIVDPKLHG---------DIDVNSAWKAVEIA 784 (846)
Q Consensus 744 ~~~l~~~~~~~~~~---------~-------~~--------------~~~~d~~L~~---------~~~~~~~~~l~~L~ 784 (846)
...+..+....-.. + .. .....+.+.. ........+.++|+
T Consensus 254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl 333 (361)
T 4f9c_A 254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL 333 (361)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence 33333322210000 0 00 0000000000 00111234678999
Q ss_pred HhccCCCCCCCCCHHHHHH
Q 003114 785 MGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 785 ~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+|++.||++|||++|+++
T Consensus 334 ~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 334 DKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHTCSCTTTSCCHHHHHT
T ss_pred HHHCcCChhHCcCHHHHhc
Confidence 9999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=360.21 Aligned_cols=282 Identities=37% Similarity=0.656 Sum_probs=235.0
Q ss_pred cccccCHHHHHHHHhhhh--------hhcCcCceEEEEEEEEcCCcEEEEEEeCCC----CchhhHHHHHHHHHHHhccc
Q 003114 523 KKRRFTYAEITKITNDFE--------TILGEGSFGKVYHGYLDDNTEVAVKMLSPS----SRQGYEQFEAEVILLRTVHH 590 (846)
Q Consensus 523 ~~~~~~~~el~~~t~~f~--------~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----~~~~~~~~~~Ei~~l~~l~H 590 (846)
....|++.++.+++.+|. +.||+|+||.||+|.. +++.||+|++... .....+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 346789999999999986 4599999999999987 6889999998753 23345678999999999999
Q ss_pred ccceeEeeEeecCCeeeEeeecccCCChhhhhhcCC-CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE
Q 003114 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSN-ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL 669 (846)
Q Consensus 591 pnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl 669 (846)
|||+++++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||.||| +.+|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence 999999999999999999999999999999997543 345899999999999999999999 8899999999999999
Q ss_pred CCCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHH
Q 003114 670 NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ 749 (846)
Q Consensus 670 d~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~ 749 (846)
++++.+||+|||+++...............||+.|+|||.+.+ .++.++|||||||+++||++|++||........+..
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 9999999999999987644333333445679999999998865 589999999999999999999999987766555555
Q ss_pred HHHHHHhcC-CcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 750 WVDFMLAQG-DIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 750 ~~~~~~~~~-~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
+........ .+...+++.+. .........+.+++.+|++.+|++||+++||++.|+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 554443322 23444554442 3456677889999999999999999999999999998753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=395.97 Aligned_cols=249 Identities=20% Similarity=0.324 Sum_probs=207.3
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+.+|+.++|||||++++++.+++..++|||||++
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 345678999999999999975 7899999999877666677899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC--CcEEEEeccCCccCCCCCccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ--FQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~--~~vkI~DFGla~~~~~~~~~~ 693 (846)
|+|.+++..... .+++.++..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+++.+... .
T Consensus 239 g~L~~~i~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~---~ 311 (573)
T 3uto_A 239 GELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---Q 311 (573)
T ss_dssp CBHHHHHTCTTS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT---S
T ss_pred CcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC---C
Confidence 999999975433 4899999999999999999999 8999999999999999854 89999999999876432 2
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.....+||+.|||||++.+..++.++||||+||++|||++|++||.+....+.+.. .. .... .+++...
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~----i~-~~~~--~~~~~~~---- 380 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN----VK-SCDW--NMDDSAF---- 380 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HH-TTCC--CCCSGGG----
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH----HH-hCCC--CCCcccc----
Confidence 33456899999999999999999999999999999999999999987654433322 11 1111 0111111
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
......+.+|+.+||+.||++|||+.|+++
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112346789999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=368.54 Aligned_cols=260 Identities=26% Similarity=0.449 Sum_probs=214.0
Q ss_pred hhhhhcCcCceEEEEEEEEc--------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeee
Q 003114 538 DFETILGEGSFGKVYHGYLD--------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIG 607 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 607 (846)
.+.+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|+.+++.+ +||||++++++|...+..+
T Consensus 84 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 163 (370)
T 2psq_A 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 163 (370)
T ss_dssp EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCE
T ss_pred EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEE
Confidence 34578999999999999862 35579999997653 34457799999999999 8999999999999999999
Q ss_pred EeeecccCCChhhhhhcCCC--------------CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC
Q 003114 608 LIYEYMANGSLEEYLSDSNA--------------DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF 673 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~ 673 (846)
+||||+++|+|.+++..... ..+++.+++.++.|++.||+||| +.+|+||||||+|||++.++
T Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENN 240 (370)
T ss_dssp EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTC
T ss_pred EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEECCCC
Confidence 99999999999999986532 34889999999999999999999 88999999999999999999
Q ss_pred cEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHH
Q 003114 674 QARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVD 752 (846)
Q Consensus 674 ~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~ 752 (846)
.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......... .
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~-~--- 316 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-K--- 316 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-H---
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-H---
Confidence 999999999987644333333344567889999999999999999999999999999999 99999876543322 1
Q ss_pred HHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 003114 753 FMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETA 814 (846)
Q Consensus 753 ~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~ 814 (846)
.+..+.. ...+......+.+++.+|++.+|++||++.|+++.|++++.....
T Consensus 317 -~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 317 -LLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp -HHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -HHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 1122211 111223445788999999999999999999999999999876543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=388.86 Aligned_cols=245 Identities=23% Similarity=0.333 Sum_probs=196.0
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhH---HHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYE---QFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~---~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
.+.+.||+|+||.||+|+.. +|+.||+|++.+.. ..... ....++.+++.++|||||++++++.+.+.+++||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm 271 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence 34578999999999999975 68999999996431 11112 2334466777889999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
|||+||+|.++|...+. +++..+..++.||+.||+||| +.+||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 272 Ey~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~- 345 (689)
T 3v5w_A 272 DLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 345 (689)
T ss_dssp CCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCCC-
Confidence 99999999999987654 999999999999999999999 999999999999999999999999999999876432
Q ss_pred cccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
.....+||+.|||||++.. ..++.++|+||+||++|||++|++||....... ..+........ .. .
T Consensus 346 ---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~-~~------~-- 412 (689)
T 3v5w_A 346 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTM-AV------E-- 412 (689)
T ss_dssp ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHC-CC------C--
T ss_pred ---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCC-CC------C--
Confidence 2345689999999999864 579999999999999999999999997644322 22222222221 11 1
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPN-----MNRVVM 803 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPs-----m~eVl~ 803 (846)
++......+.+|+.+|++.||++|++ ++||.+
T Consensus 413 --~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 413 --LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11222346789999999999999998 566654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=359.54 Aligned_cols=260 Identities=27% Similarity=0.392 Sum_probs=206.4
Q ss_pred hhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCC----eeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN----QIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+|+.. ++.||||++..... .....+.|+.++++++||||+++++++..+. ..++||||++
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~ 105 (322)
T 3soc_A 28 LLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE 105 (322)
T ss_dssp EEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred hhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCC
Confidence 4578999999999999875 78999999975433 3345677999999999999999999987643 4799999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCC----------CeeecCCCCCCEEECCCCcEEEEeccCCc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKP----------PRVHRDIKPANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------~IiHrDlKp~NILld~~~~vkI~DFGla~ 684 (846)
+|+|.++++... +++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 106 KGSLSDFLKANV---VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp TCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 999999997643 899999999999999999999 77 99999999999999999999999999998
Q ss_pred cCCCCCcccccccccCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCccccc------------cH
Q 003114 685 TFPIEGVSHLSTGVAGTFGYLDPEYCQT-----FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK------------HI 747 (846)
Q Consensus 685 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~------------~l 747 (846)
...............||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... ..
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence 7654333333444679999999999876 356678999999999999999999997643221 12
Q ss_pred HHHHHHHHhcCCcccccCCCCCCC-CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 748 SQWVDFMLAQGDIKNIVDPKLHGD-IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 748 ~~~~~~~~~~~~~~~~~d~~L~~~-~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
..+........ ..+.+... ........+.+++.+||+.+|++|||++||++.|+++...
T Consensus 260 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 260 EDMQEVVVHKK-----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHTTSC-----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhccc-----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 22222221111 11111111 1224556799999999999999999999999999998654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.90 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=210.2
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
+.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||+++|+
T Consensus 14 ~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 93 (310)
T 3s95_A 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT 93 (310)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred ccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCc
Confidence 4578999999999999975 689999999987777777889999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc----
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH---- 693 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~---- 693 (846)
|.+++..... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 94 L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 169 (310)
T 3s95_A 94 LRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169 (310)
T ss_dssp HHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----------
T ss_pred HHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccc
Confidence 9999987543 4899999999999999999999 8899999999999999999999999999998763322111
Q ss_pred --------ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc-----cHHHHHHHHHhcCCc
Q 003114 694 --------LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK-----HISQWVDFMLAQGDI 760 (846)
Q Consensus 694 --------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~-----~l~~~~~~~~~~~~~ 760 (846)
......||+.|+|||.+.+..++.++|||||||++|||++|..|+....... ....... .
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~----~--- 242 (310)
T 3s95_A 170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD----R--- 242 (310)
T ss_dssp ----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----H---
T ss_pred cccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----c---
Confidence 1114579999999999999999999999999999999999999987543211 1111111 0
Q ss_pred ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 003114 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMET 813 (846)
Q Consensus 761 ~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~ 813 (846)
.. +......+.+++.+|++.+|++|||+.|+++.|+++.....
T Consensus 243 ------~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 243 ------YC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp ------TC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ------cC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00 11122357899999999999999999999999998875443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=354.39 Aligned_cols=258 Identities=28% Similarity=0.454 Sum_probs=202.1
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||+|+||.||+|+. +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||||+++
T Consensus 40 ~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 3p86_A 40 NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118 (309)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTT
T ss_pred eeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCC
Confidence 3457899999999999987 68899999997653 33456789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCC-CccChHHHHHHHHHHHHHHHHHhccCCCC--eeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 616 GSLEEYLSDSNA-DVLSWEGRLRIATEAAQGLEYLHLGCKPP--RVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 616 gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
|+|.+++..... ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 119 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~ 193 (309)
T 3p86_A 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST--F 193 (309)
T ss_dssp CBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred CcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc--c
Confidence 999999987542 34899999999999999999999 778 999999999999999999999999999754321 1
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ........ ...
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~----~~~~~~~~---------~~~ 260 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA----AVGFKCKR---------LEI 260 (309)
T ss_dssp --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH----HHHHSCCC---------CCC
T ss_pred cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcCCC---------CCC
Confidence 22334679999999999999999999999999999999999999998665433221 11111110 111
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETA 814 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~ 814 (846)
+......+.+++.+|++.+|++|||+.|+++.|++++....+
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 223345688999999999999999999999999998865444
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=358.17 Aligned_cols=256 Identities=24% Similarity=0.405 Sum_probs=208.6
Q ss_pred hhhhhcCcCceEEEEEEEEc----CCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD----DNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|+.. .+..||||++... .....+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 52 ~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 131 (325)
T 3kul_A 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEY 131 (325)
T ss_dssp EEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEEC
T ss_pred EEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeC
Confidence 34578999999999999974 3556999999865 344557799999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc-
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV- 691 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~- 691 (846)
+++|+|.++++.... .+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 132 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 132 MENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp CTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred CCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 999999999976543 4899999999999999999999 88999999999999999999999999999987643221
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........... ..... ..
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~----~~~~~----------~~ 273 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS----VEEGY----------RL 273 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH----HHTTC----------CC
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----HHcCC----------CC
Confidence 122233456788999999998899999999999999999999 9999976654332221 11111 11
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
..+......+.+++.+|++.+|++||++.||++.|++++..
T Consensus 274 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 11223445788999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=351.42 Aligned_cols=261 Identities=22% Similarity=0.323 Sum_probs=214.3
Q ss_pred ccccCHHHHHHHHhhh------------hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhccc
Q 003114 524 KRRFTYAEITKITNDF------------ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH 590 (846)
Q Consensus 524 ~~~~~~~el~~~t~~f------------~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~H 590 (846)
...++++++..++... .+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+++.++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 3567888888877642 357999999999999986 799999999987666666789999999999999
Q ss_pred ccceeEeeEeecCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC
Q 003114 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN 670 (846)
Q Consensus 591 pnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld 670 (846)
|||+++++++..++..++||||+++++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||++
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLT 175 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEC
Confidence 99999999999999999999999999999998753 3899999999999999999999 88999999999999999
Q ss_pred CCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHH
Q 003114 671 DQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQW 750 (846)
Q Consensus 671 ~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~ 750 (846)
.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||+++||++|+.||.........
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~--- 250 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM--- 250 (321)
T ss_dssp TTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---
T ss_pred CCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 99999999999998764321 2234467999999999999999999999999999999999999999765433222
Q ss_pred HHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 751 VDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 751 ~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
..... .. .+.+. ........+.+++.+|++.+|++|||++|+++.
T Consensus 251 -~~~~~-~~-----~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 251 -KRLRD-SP-----PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp -HHHHH-SS-----CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HHHhc-CC-----CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 11 11111 112234568899999999999999999999763
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=349.52 Aligned_cols=245 Identities=22% Similarity=0.358 Sum_probs=205.2
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
+.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++..++..++||||+++|+
T Consensus 24 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (297)
T 3fxz_A 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (297)
T ss_dssp CCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred eeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCC
Confidence 346899999999999996 5789999999976655556778999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++.... +++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....... .....
T Consensus 104 L~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 175 (297)
T 3fxz_A 104 LTDVVTETC---MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRST 175 (297)
T ss_dssp HHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBCC
T ss_pred HHHHHhhcC---CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--cccCC
Confidence 999998653 889999999999999999999 8899999999999999999999999999998764322 22345
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSA 777 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~ 777 (846)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||........+... ...+.. . + ..+....
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----~~~~~~-~-----~--~~~~~~~ 243 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI----ATNGTP-E-----L--QNPEKLS 243 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHHCSC-C-----C--SCGGGSC
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhCCCC-C-----C--CCccccC
Confidence 67999999999999999999999999999999999999999865543322221 111111 1 0 1122334
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 778 WKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 778 ~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+.+++.+|++.+|++|||++|+++
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 244 AIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhh
Confidence 56889999999999999999999976
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.75 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=210.2
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||.||+|+..++..||+|++...... .+++.+|+.++++++||||+++++++.+++..++||||+++++
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 345789999999999999988999999999865433 3678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..... .......
T Consensus 92 L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 166 (269)
T 4hcu_A 92 LSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTG 166 (269)
T ss_dssp HHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHSTTS
T ss_pred HHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc-ccccccC
Confidence 9999976543 4899999999999999999999 889999999999999999999999999999865321 1222334
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..+++.|+|||.+.+..++.++||||+|++++||++ |+.||........... ..... .. ..+...
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~----~~~~~---~~-------~~~~~~ 232 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----ISTGF---RL-------YKPRLA 232 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHTTC---CC-------CCCTTS
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH----HhcCc---cC-------CCCCcC
Confidence 557788999999998999999999999999999999 9999986554332222 21110 01 111122
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
...+.+++.+|++.+|++||+++|+++.|+++.+
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 233 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 3568899999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=362.78 Aligned_cols=264 Identities=27% Similarity=0.440 Sum_probs=216.6
Q ss_pred hhhhhcCcCceEEEEEEEEc--------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeee
Q 003114 538 DFETILGEGSFGKVYHGYLD--------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIG 607 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 607 (846)
.+.+.||+|+||.||+|+.. .+..||||++.... ....+++.+|+++++++ +||||+++++++..++..+
T Consensus 72 ~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 151 (382)
T 3tt0_A 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 151 (382)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred EeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceE
Confidence 44578999999999999862 23579999997653 34457789999999999 9999999999999999999
Q ss_pred EeeecccCCChhhhhhcCCC--------------CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC
Q 003114 608 LIYEYMANGSLEEYLSDSNA--------------DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF 673 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~ 673 (846)
+||||+++|+|.+++..... ..+++.+++.++.|++.||+||| +.+|+||||||+|||+++++
T Consensus 152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~ 228 (382)
T 3tt0_A 152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDN 228 (382)
T ss_dssp EEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTC
T ss_pred EEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEcCCC
Confidence 99999999999999986542 35899999999999999999999 88999999999999999999
Q ss_pred cEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHH
Q 003114 674 QARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVD 752 (846)
Q Consensus 674 ~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~ 752 (846)
.+||+|||+++...............+|+.|+|||++.+..++.++|||||||+++||++ |+.||....... ...
T Consensus 229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~----~~~ 304 (382)
T 3tt0_A 229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----LFK 304 (382)
T ss_dssp CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHH
T ss_pred cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH
Confidence 999999999987654333334445567899999999999999999999999999999999 999997654332 222
Q ss_pred HHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhhhcC
Q 003114 753 FMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARKEG 818 (846)
Q Consensus 753 ~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~~~~ 818 (846)
... .+... ..+......+.+++.+|++.+|++||+++||++.|++++........+
T Consensus 305 ~~~-~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 360 (382)
T 3tt0_A 305 LLK-EGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG 360 (382)
T ss_dssp HHH-TTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC--
T ss_pred HHH-cCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCC
Confidence 222 22111 112233457889999999999999999999999999999877665543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=366.26 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=208.2
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||+|+||.||+|+.. +++.||||+++... ....+++.+|+.++++++||||+++++++..++..++||||+++
T Consensus 117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 196 (377)
T 3cbl_A 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 196 (377)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence 34578999999999999986 78999999997653 33445788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.++++... ..+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++...........
T Consensus 197 g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 197 GDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp CBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 99999998654 24899999999999999999999 889999999999999999999999999999864322111111
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
....++..|+|||.+....++.++|||||||++|||+| |+.||........ . .....+.. ...+.
T Consensus 273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-~----~~~~~~~~---------~~~~~ 338 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-R----EFVEKGGR---------LPCPE 338 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-H----HHHHTTCC---------CCCCT
T ss_pred CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-H----HHHHcCCC---------CCCCC
Confidence 22345778999999998899999999999999999998 9999986543321 1 11222210 11122
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
.....+.+++.+||+.+|++|||+++|++.|+++..
T Consensus 339 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 339 LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 334578899999999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=344.90 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=208.2
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||.||+|...++..||+|++...... .+++.+|++++++++||||+++++++.+++..++||||+++++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 105 (283)
T 3gen_A 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 105 (283)
T ss_dssp EEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred HhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence 345789999999999999998889999999865433 3678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++..... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..... .......
T Consensus 106 L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 180 (283)
T 3gen_A 106 LLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVG 180 (283)
T ss_dssp HHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH-HHHSTTS
T ss_pred HHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccc-ccccccC
Confidence 9999986433 3899999999999999999999 889999999999999999999999999999865322 1122233
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..+|+.|+|||.+.+..++.++||||+|++++||+| |+.||........... .. .+. ....+...
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~-~~~---------~~~~~~~~ 246 (283)
T 3gen_A 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IA-QGL---------RLYRPHLA 246 (283)
T ss_dssp TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HH-TTC---------CCCCCTTC
T ss_pred CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH----Hh-ccc---------CCCCCCcC
Confidence 457788999999998899999999999999999998 9999986654332221 11 110 00111122
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
...+.+++.+|++.+|++|||++|+++.|++++..|
T Consensus 247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 247 SEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 357889999999999999999999999999988654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=360.15 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=210.2
Q ss_pred hhhhhcCcCceEEEEEEEE------cCCcEEEEEEeCCCC-chhhHHHHHHHHHHHhc-ccccceeEeeEeecCC-eeeE
Q 003114 538 DFETILGEGSFGKVYHGYL------DDNTEVAVKMLSPSS-RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGN-QIGL 608 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~-~~~L 608 (846)
.+.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++.++ +||||+++++++.+.+ ..++
T Consensus 25 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~i 104 (359)
T 3vhe_A 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 104 (359)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEE
T ss_pred eeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEE
Confidence 3457899999999999984 245789999998653 33456799999999999 8999999999987754 4899
Q ss_pred eeecccCCChhhhhhcCCC-------------------------------------------------------------
Q 003114 609 IYEYMANGSLEEYLSDSNA------------------------------------------------------------- 627 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~------------------------------------------------------------- 627 (846)
||||+++|+|.+++.....
T Consensus 105 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (359)
T 3vhe_A 105 IVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED 184 (359)
T ss_dssp EEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------C
T ss_pred EEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccc
Confidence 9999999999999976542
Q ss_pred ---CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccccccCCCcc
Q 003114 628 ---DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704 (846)
Q Consensus 628 ---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y 704 (846)
..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...............||+.|
T Consensus 185 ~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 261 (359)
T 3vhe_A 185 LYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261 (359)
T ss_dssp TTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred hhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence 12889999999999999999999 889999999999999999999999999999876444333344456789999
Q ss_pred cCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHH
Q 003114 705 LDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEI 783 (846)
Q Consensus 705 ~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L 783 (846)
+|||++.+..++.++|||||||+++||+| |+.||........+...+ ..+... ..+......+.++
T Consensus 262 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~----~~~~~~---------~~~~~~~~~l~~l 328 (359)
T 3vhe_A 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----KEGTRM---------RAPDYTTPEMYQT 328 (359)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH----HHTCCC---------CCCTTCCHHHHHH
T ss_pred EChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH----HcCCCC---------CCCCCCCHHHHHH
Confidence 99999999999999999999999999998 999998765443332222 121111 1112233468899
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 784 AMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 784 ~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
+.+|++.+|++|||+.||+++|++++...
T Consensus 329 i~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999988643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=363.84 Aligned_cols=258 Identities=23% Similarity=0.421 Sum_probs=199.6
Q ss_pred hhhhhcCcCceEEEEEEEEc----CCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD----DNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|+.. ++..||||+++.. .....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 48 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 127 (373)
T 2qol_A 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 127 (373)
T ss_dssp CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeC
Confidence 44578999999999999875 5778999999765 334556799999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.++++... ..+++.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 128 ~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 128 MENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp CTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 99999999998654 34899999999999999999999 889999999999999999999999999999876432211
Q ss_pred -cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 693 -HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 693 -~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
.......+++.|+|||++.+..++.++|||||||++|||++ |+.||......... ... ..+. ..
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~----~~i-~~~~---------~~ 269 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----KAV-DEGY---------RL 269 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH----HHH-HTTE---------EC
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHH-HcCC---------CC
Confidence 11222345778999999999999999999999999999998 99999765433221 111 1110 01
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMET 813 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~ 813 (846)
.........+.+++.+|++.+|++||++.||+++|++++....
T Consensus 270 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 1122345678999999999999999999999999999876443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=341.78 Aligned_cols=253 Identities=23% Similarity=0.409 Sum_probs=209.9
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||.||+|+..++..||+|++...... .+++.+|+.++++++||||+++++++..++..++||||+++++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (268)
T 3sxs_A 11 TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC 89 (268)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence 445789999999999999998889999999765433 3678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 90 L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~ 164 (268)
T 3sxs_A 90 LLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSSVG 164 (268)
T ss_dssp HHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEECCS
T ss_pred HHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hhcccC
Confidence 999997653 34899999999999999999999 8899999999999999999999999999998664332 222334
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..+|+.|+|||.+.+..++.++||||+|++++||++ |+.||........... .. .+. .... +...
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~-~~~--~~~~-------~~~~ 230 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----VS-QGH--RLYR-------PHLA 230 (268)
T ss_dssp CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HH-TTC--CCCC-------CTTS
T ss_pred CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH----HH-cCC--CCCC-------CCcC
Confidence 556788999999998889999999999999999999 9999986554332221 11 111 1111 1112
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
...+.+++.+|++.+|++|||+.|+++.|+++..
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 231 SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 3468899999999999999999999999988754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=348.66 Aligned_cols=256 Identities=28% Similarity=0.414 Sum_probs=211.5
Q ss_pred hhhhhcCcCceEEEEEEEE------cCCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYL------DDNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 105 (314)
T 2ivs_A 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV 105 (314)
T ss_dssp EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEE
Confidence 3457899999999999986 245789999997653 345577899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCC----------------------CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEE
Q 003114 611 EYMANGSLEEYLSDSNA----------------------DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANIL 668 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NIL 668 (846)
||+++|+|.+++..... ..+++.+++.++.|++.||.||| +.+|+||||||+||+
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~NIl 182 (314)
T 2ivs_A 106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNIL 182 (314)
T ss_dssp ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEE
T ss_pred eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccchheEE
Confidence 99999999999986532 34889999999999999999999 889999999999999
Q ss_pred ECCCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccH
Q 003114 669 LNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHI 747 (846)
Q Consensus 669 ld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l 747 (846)
+++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||+++||++ |+.||........
T Consensus 183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 261 (314)
T 2ivs_A 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL- 261 (314)
T ss_dssp EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999987644333333344567889999999998899999999999999999999 9999986654332
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 748 SQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 748 ~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
... ...+.. ...+......+.+++.+|++.+|++||++.|+++.|++++.
T Consensus 262 ~~~----~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 262 FNL----LKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp HHH----HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----hhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 221 112111 11122334578899999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=347.93 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=206.5
Q ss_pred hhhhhhcCcCceEEEEEEEE-----cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeec--CCeeeEe
Q 003114 537 NDFETILGEGSFGKVYHGYL-----DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE--GNQIGLI 609 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~LV 609 (846)
..+.+.||+|+||.||+|++ .+++.||||++........+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 91 (295)
T 3ugc_A 12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 91 (295)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEE
T ss_pred hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEE
Confidence 34567899999999999985 3688999999988777777889999999999999999999999854 3568999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||+++|+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 92 MEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp EECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred EEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 999999999999987543 4899999999999999999999 899999999999999999999999999999876432
Q ss_pred Ccc-cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc-----------ccHHHHHHHHHhc
Q 003114 690 GVS-HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEH-----------KHISQWVDFMLAQ 757 (846)
Q Consensus 690 ~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~-----------~~l~~~~~~~~~~ 757 (846)
... .......++..|+|||.+.+..++.++|||||||+++||+||..|+...... .............
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc
Confidence 211 2223345778899999999999999999999999999999999998653211 0011111111111
Q ss_pred CCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 758 GDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 758 ~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
+ .....+......+.+++.+|++.+|++|||++|+++.|+++..
T Consensus 248 ~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 248 N---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp T---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1 1111223345678999999999999999999999999999764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.00 Aligned_cols=244 Identities=21% Similarity=0.385 Sum_probs=203.5
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 18 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 97 (328)
T 3fe3_A 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS 97 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence 3457899999999999997 58999999999654 33455678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 98 ~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~---~~ 169 (328)
T 3fe3_A 98 GGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GK 169 (328)
T ss_dssp TCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS---CG
T ss_pred CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC---Cc
Confidence 9999999976543 899999999999999999999 889999999999999999999999999999865432 23
Q ss_pred cccccCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQTFRLT-EKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s-~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.....||+.|+|||.+.+..+. .++||||+||+++||++|+.||.+..... ....... +... .+
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~-~~~~----------~p 234 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE----LRERVLR-GKYR----------IP 234 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHH-CCCC----------CC
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHh-CCCC----------CC
Confidence 3456799999999999888765 79999999999999999999998655332 2222222 1110 11
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
......+.+++.+|+..+|++|||++|+++.
T Consensus 235 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1223467899999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=348.73 Aligned_cols=259 Identities=25% Similarity=0.409 Sum_probs=213.9
Q ss_pred hhhhhhcCcCceEEEEEEEE------cCCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeE
Q 003114 537 NDFETILGEGSFGKVYHGYL------DDNTEVAVKMLSPSSR-QGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~L 608 (846)
..+.+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++..++..++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 104 (313)
T 1t46_A 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (313)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEE
Confidence 34567899999999999985 3567899999986543 3457789999999999 99999999999999999999
Q ss_pred eeecccCCChhhhhhcCCCC----------------ccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC
Q 003114 609 IYEYMANGSLEEYLSDSNAD----------------VLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ 672 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~ 672 (846)
||||+++|+|.+++...... .+++..++.++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHG 181 (313)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETT
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEcCC
Confidence 99999999999999865422 4899999999999999999999 8899999999999999999
Q ss_pred CcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHH
Q 003114 673 FQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWV 751 (846)
Q Consensus 673 ~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~ 751 (846)
+.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||+++||+| |+.||............+
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 261 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHh
Confidence 9999999999987654433333344567889999999999999999999999999999999 999998765443333322
Q ss_pred HHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 752 DFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 752 ~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
. .+. . . .........+.+++.+|++.+|++|||+.|+++.|++++..
T Consensus 262 ~----~~~-~----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 262 K----EGF-R----M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp H----HTC-C----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c----cCC-C----C----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 2 111 0 0 11122345788999999999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=370.75 Aligned_cols=253 Identities=27% Similarity=0.440 Sum_probs=209.7
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||.||+|.++++..||||+++.... ..+.+.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 191 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~ 268 (454)
T 1qcf_A 191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS 268 (454)
T ss_dssp EEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred EEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence 44578999999999999998899999999986543 4578999999999999999999999987 567899999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.++++......+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 269 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~~ 344 (454)
T 1qcf_A 269 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-EYTAREG 344 (454)
T ss_dssp HHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH-HHHTTCS
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC-ceeccCC
Confidence 999998654445889999999999999999999 889999999999999999999999999999875321 1122233
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..++..|+|||.+....++.++|||||||++|||+| |+.||......+.+ ......... ..+...
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~----~~i~~~~~~----------~~~~~~ 410 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI----RALERGYRM----------PRPENC 410 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH----HHHHHTCCC----------CCCTTS
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcCCCC----------CCCCCC
Confidence 456789999999998899999999999999999999 99999865543322 222211111 112234
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
...+.+++.+||+.+|++|||+++|++.|+++..
T Consensus 411 ~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 411 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 4678899999999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=352.80 Aligned_cols=258 Identities=28% Similarity=0.419 Sum_probs=209.1
Q ss_pred hhhhhcCcCceEEEEEEEE------cCCcEEEEEEeCCC-CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEe
Q 003114 538 DFETILGEGSFGKVYHGYL------DDNTEVAVKMLSPS-SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV 609 (846)
.+.+.||+|+||.||+|+. .++..||+|++... .....+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 48 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 127 (344)
T 1rjb_A 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127 (344)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEE
Confidence 4457899999999999996 24568999999754 233457789999999999 899999999999999999999
Q ss_pred eecccCCChhhhhhcCCC---------------------CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEE
Q 003114 610 YEYMANGSLEEYLSDSNA---------------------DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANIL 668 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NIL 668 (846)
|||+++|+|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||+|||
T Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl 204 (344)
T 1rjb_A 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVL 204 (344)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEE
T ss_pred EecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEE
Confidence 999999999999986542 23789999999999999999999 889999999999999
Q ss_pred ECCCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccH
Q 003114 669 LNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHI 747 (846)
Q Consensus 669 ld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l 747 (846)
++.++.+||+|||++................||+.|+|||.+.+..++.++|||||||+++||+| |+.||........+
T Consensus 205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 284 (344)
T 1rjb_A 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284 (344)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHH
Confidence 99999999999999987644333333344567889999999998899999999999999999998 99999876544333
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 748 SQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 748 ~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
...+ ..+. ....+......+.+++.+|++.+|++||++.|+++.|+.++..
T Consensus 285 ~~~~----~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 285 YKLI----QNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp HHHH----HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHH----hcCC---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 3322 2211 1111222345788999999999999999999999999997754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.65 Aligned_cols=259 Identities=25% Similarity=0.364 Sum_probs=199.7
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHh--cccccceeEeeEeec----CCeeeEeee
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRT--VHHKNLTTLYGYCNE----GNQIGLIYE 611 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~g~~~~----~~~~~LV~E 611 (846)
.+.+.||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++.. ....++|||
T Consensus 11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 11 TLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred EEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 3457899999999999998 6889999999654 23455666666666 799999999998643 356899999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccC-----CCCeeecCCCCCCEEECCCCcEEEEeccCCccC
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC-----KPPRVHRDIKPANILLNDQFQARLADFGLSKTF 686 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~ 686 (846)
|+++|+|.++++.. .+++..+++++.|++.||+|||... +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 87 YHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163 (301)
T ss_dssp CCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred hccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence 99999999999653 4899999999999999999999432 678999999999999999999999999999765
Q ss_pred CCCCcc--cccccccCCCcccCccccccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCccccc-cH
Q 003114 687 PIEGVS--HLSTGVAGTFGYLDPEYCQTF------RLTEKSDVYSFGVVLLEIITS----------RPAIANTEEHK-HI 747 (846)
Q Consensus 687 ~~~~~~--~~~~~~~gt~~Y~APE~~~~~------~~s~ksDVwS~Gvvl~ELltG----------~~p~~~~~~~~-~l 747 (846)
...... .......||+.|+|||.+.+. .++.++|||||||++|||+|| +.||....... ..
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~ 243 (301)
T 3q4u_A 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243 (301)
T ss_dssp ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred ccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch
Confidence 332211 112335799999999998876 455799999999999999999 88886543222 22
Q ss_pred HHHHHHHHhcCCcccccCCCCCC-CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 748 SQWVDFMLAQGDIKNIVDPKLHG-DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 748 ~~~~~~~~~~~~~~~~~d~~L~~-~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
............ .+.+.. .........+.+++.+|++.+|++|||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 244 EDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 222222211111 111111 11234667899999999999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=346.89 Aligned_cols=261 Identities=23% Similarity=0.382 Sum_probs=206.8
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 93 (294)
T 4eqm_A 14 KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI 93 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCC
Confidence 34578999999999999965 7899999998543 2344567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 94 ~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 167 (294)
T 4eqm_A 94 EGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LT 167 (294)
T ss_dssp CSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc-cc
Confidence 9999999998764 3899999999999999999999 8899999999999999999999999999998653221 22
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
......||+.|+|||.+.+..++.++||||+||++|||++|+.||........... .... ..... .. ...
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~----~~~~-~~~~~-~~----~~~ 237 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK----HIQD-SVPNV-TT----DVR 237 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH----HHSS-CCCCH-HH----HSC
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH----Hhhc-cCCCc-ch----hcc
Confidence 23345799999999999999999999999999999999999999986553322111 1111 11110 00 111
Q ss_pred hHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhhhhhh
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRP-NMNRVVMELKECLAMETA 814 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RP-sm~eVl~~L~~~l~~e~~ 814 (846)
.+....+.+++.+|++.+|++|| +++++.+.|++++....+
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 22345788999999999999999 999999999987754433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=364.95 Aligned_cols=248 Identities=26% Similarity=0.421 Sum_probs=206.8
Q ss_pred hhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCC-eeeEeeecccCCC
Q 003114 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN-QIGLIYEYMANGS 617 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-~~~LV~Ey~~~gs 617 (846)
+.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.++++++||||+++++++.+.+ ..++||||+++|+
T Consensus 197 ~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~ 273 (450)
T 1k9a_A 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273 (450)
T ss_dssp EEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred EEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence 4578999999999999985 7799999998654 4578999999999999999999999987654 7999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++.......+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 274 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~ 345 (450)
T 1k9a_A 274 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDT 345 (450)
T ss_dssp HHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccC
Confidence 999998776555899999999999999999999 889999999999999999999999999999854221 122
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..++..|+|||.+.+..++.++|||||||++|||+| |+.||......+.... +..+. ....+...
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-----i~~~~---------~~~~p~~~ 411 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGY---------KMDAPDGC 411 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-----HHTTC---------CCCCCTTC
T ss_pred CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCC---------CCCCCCcC
Confidence 357889999999999999999999999999999998 9999987654432221 11221 11122334
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
...+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 412 PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 56788999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=354.12 Aligned_cols=255 Identities=29% Similarity=0.452 Sum_probs=209.1
Q ss_pred hhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 539 FETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
+.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 130 (343)
T 1luf_A 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130 (343)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEe
Confidence 4578999999999999974 34789999998653 3445779999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCC----------------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE
Q 003114 612 YMANGSLEEYLSDSN----------------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL 669 (846)
Q Consensus 612 y~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl 669 (846)
|+++|+|.+++.... ...+++.+++.++.|+++||.||| +.+|+||||||+|||+
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~ 207 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLV 207 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEE
Confidence 999999999997643 145899999999999999999999 8899999999999999
Q ss_pred CCCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHH
Q 003114 670 NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHIS 748 (846)
Q Consensus 670 d~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~ 748 (846)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-- 285 (343)
T 1luf_A 208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV-- 285 (343)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--
T ss_pred CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHH--
Confidence 9999999999999986543322233344568899999999998899999999999999999999 9999976543322
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 749 QWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 749 ~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
... +..+.... .+......+.+++.+|++.+|++||++.||++.|+++..
T Consensus 286 --~~~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 286 --IYY-VRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp --HHH-HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --HHH-HhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 221 22222111 122334578899999999999999999999999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=360.64 Aligned_cols=260 Identities=26% Similarity=0.400 Sum_probs=210.7
Q ss_pred hhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
.+.+.||+|+||.||+|++. +++.||||++... ......++.+|+.++++++||||+++++++..+...++||
T Consensus 74 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 153 (367)
T 3l9p_A 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 153 (367)
T ss_dssp EEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEE
Confidence 44678999999999999953 4678999999754 3445567889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCC-----CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC---cEEEEeccC
Q 003114 611 EYMANGSLEEYLSDSN-----ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF---QARLADFGL 682 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~---~vkI~DFGl 682 (846)
||+++|+|.+++.... ...+++.+++.++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+
T Consensus 154 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 154 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp ECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 9999999999997643 234899999999999999999999 88999999999999999554 599999999
Q ss_pred CccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcc
Q 003114 683 SKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIK 761 (846)
Q Consensus 683 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~ 761 (846)
++...............||+.|+|||.+.+..++.++|||||||+++||++ |+.||........ .........
T Consensus 231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~----~~~i~~~~~-- 304 (367)
T 3l9p_A 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV----LEFVTSGGR-- 304 (367)
T ss_dssp HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----HHHHHTTCC--
T ss_pred ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHcCCC--
Confidence 975432222233334568899999999999999999999999999999998 9999986554322 222222111
Q ss_pred cccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 003114 762 NIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETA 814 (846)
Q Consensus 762 ~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~ 814 (846)
...+......+.+++.+|++.+|++||++.||++.|+.+......
T Consensus 305 --------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 305 --------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred --------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 111223345688999999999999999999999999998765443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=352.78 Aligned_cols=255 Identities=24% Similarity=0.391 Sum_probs=201.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCc----EEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNT----EVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
.+.+.||+|+||.||+|+.. +++ +||+|.+... .....+++.+|+.++++++||||++++++|..+. .++|+|
T Consensus 18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e 96 (327)
T 3poz_A 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQ 96 (327)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEE
T ss_pred ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEE
Confidence 34578999999999999964 444 3688888644 3345578999999999999999999999998755 779999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+++|+|.+++..... .+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 97 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 97 LMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp CCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred ecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 9999999999987543 4899999999999999999999 88999999999999999999999999999987654433
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
........+|+.|+|||.+.+..++.++|||||||++|||+| |+.||....... +... ...+. ..
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~----~~~~~---------~~ 238 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSI----LEKGE---------RL 238 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHH----HHTTC---------CC
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-HHHH----HHcCC---------CC
Confidence 333444567889999999999999999999999999999999 999998765433 2221 11111 11
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
..+......+.+++.+|++.+|++||+++|+++.|+++...
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11223445788999999999999999999999999988654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=372.99 Aligned_cols=255 Identities=26% Similarity=0.435 Sum_probs=213.6
Q ss_pred hhhhhhcCcCceEEEEEEEEcC-CcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 537 NDFETILGEGSFGKVYHGYLDD-NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
..+.+.||+|+||.||+|++.. +..||||+++.... ..+++.+|+.++++++||||++++++|...+..++||||+++
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~ 300 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 300 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCC
Confidence 3456789999999999999874 88999999976543 357899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.+++.......+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 301 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~ 376 (495)
T 1opk_A 301 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 376 (495)
T ss_dssp CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC-CEECC
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCC-ceeec
Confidence 99999998766666999999999999999999999 889999999999999999999999999999876432 22223
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
....++..|+|||.+....++.++|||||||++|||+| |+.||....... +.+. +..+ .....+.
T Consensus 377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-~~~~----~~~~---------~~~~~~~ 442 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYEL----LEKD---------YRMERPE 442 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHH----HHTT---------CCCCCCT
T ss_pred CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-HHHH----HHcC---------CCCCCCC
Confidence 34556789999999998899999999999999999999 999998765433 2221 1111 1111223
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
.....+.+|+.+||+.+|++|||+.||++.|++++.
T Consensus 443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 345678899999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=342.90 Aligned_cols=266 Identities=20% Similarity=0.274 Sum_probs=211.7
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCC--eeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN--QIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 91 (319)
T 4euu_A 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91 (319)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred EEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCC
Confidence 34578999999999999976 58999999997543 233567889999999999999999999987654 789999999
Q ss_pred cCCChhhhhhcCCC-CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE----CCCCcEEEEeccCCccCCC
Q 003114 614 ANGSLEEYLSDSNA-DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL----NDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 614 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl----d~~~~vkI~DFGla~~~~~ 688 (846)
++++|.+++..... ..+++.+++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++....
T Consensus 92 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp TTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred CCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 99999999987543 33899999999999999999999 8899999999999999 8888999999999987643
Q ss_pred CCcccccccccCCCcccCccccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCc
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQ--------TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDI 760 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~--------~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 760 (846)
. .......||+.|+|||.+. +..++.++|||||||++|||++|+.||..........+.+.........
T Consensus 169 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~ 245 (319)
T 4euu_A 169 D---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (319)
T ss_dssp T---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred C---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence 2 2223456999999999886 5678999999999999999999999997654433333334433332211
Q ss_pred ---cccc---------CCC--CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 761 ---KNIV---------DPK--LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 761 ---~~~~---------d~~--L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
..+. .+. ............+.+++.+|++.||++|||++|+++...+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1000 001 112334566778899999999999999999999999987643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.35 Aligned_cols=248 Identities=22% Similarity=0.350 Sum_probs=205.0
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecC--CeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG--NQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|+.+ ++.||+|++.... ....+.+.+|+.++++++||||+++++++... +..++||||+
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 91 (271)
T 3kmu_A 13 NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM 91 (271)
T ss_dssp EEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECC
T ss_pred HHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeeccc
Confidence 34578999999999999985 8899999997653 34456799999999999999999999999877 7889999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCC--eeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP--RVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
++|+|.+++.......+++..++.++.|++.||.||| +.+ |+||||||+||++++++.++|+|||++....
T Consensus 92 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~---- 164 (271)
T 3kmu_A 92 PYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ---- 164 (271)
T ss_dssp TTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS----
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec----
Confidence 9999999998876656999999999999999999999 777 9999999999999999999999999876432
Q ss_pred ccccccccCCCcccCccccccCCCCc---hhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTE---KSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~---ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
.....||+.|+|||.+.+...+. ++|||||||++|||++|+.||.......... .....+.. +
T Consensus 165 ---~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~-----~-- 230 (271)
T 3kmu_A 165 ---SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM----KVALEGLR-----P-- 230 (271)
T ss_dssp ---CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH----HHHHSCCC-----C--
T ss_pred ---ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH----HHHhcCCC-----C--
Confidence 12356899999999988765444 8999999999999999999998655433222 22222111 1
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
..+......+.+++.+|++.+|++|||++|+++.|+++.
T Consensus 231 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 231 --TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 112233457889999999999999999999999999865
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.14 Aligned_cols=258 Identities=25% Similarity=0.375 Sum_probs=196.8
Q ss_pred hhhhhhcCcCceEEEEEEEEcCC----cEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCee----
Q 003114 537 NDFETILGEGSFGKVYHGYLDDN----TEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQI---- 606 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~g----~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~---- 606 (846)
..+.+.||+|+||.||+|+.... ..||||++... .....+.+.+|+.++++++||||+++++++......
T Consensus 25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (323)
T 3qup_A 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP 104 (323)
T ss_dssp CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence 34467899999999999996533 27999999764 344567899999999999999999999999876655
Q ss_pred --eEeeecccCCChhhhhhcCC----CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEec
Q 003114 607 --GLIYEYMANGSLEEYLSDSN----ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADF 680 (846)
Q Consensus 607 --~LV~Ey~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DF 680 (846)
++||||+++|+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+||
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEEeec
Confidence 99999999999999996533 224899999999999999999999 889999999999999999999999999
Q ss_pred cCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCC
Q 003114 681 GLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGD 759 (846)
Q Consensus 681 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~ 759 (846)
|+++...............+++.|+|||.+.+..++.++|||||||+++||++ |+.||........... ......
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~----~~~~~~ 257 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY----LIGGNR 257 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH----HHTTCC
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH----HhcCCC
Confidence 99987644333333334567889999999999999999999999999999999 9999987654433222 111111
Q ss_pred cccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 760 IKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 760 ~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
..........+.+++.+|++.+|++|||+.|+++.|++++.-
T Consensus 258 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 258 ----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp ----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 011223345788999999999999999999999999998753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=347.10 Aligned_cols=261 Identities=26% Similarity=0.442 Sum_probs=212.5
Q ss_pred hhhhhhcCcCceEEEEEEEEc--------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCee
Q 003114 537 NDFETILGEGSFGKVYHGYLD--------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQI 606 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 606 (846)
..+.+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 116 (334)
T 2pvf_A 37 LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 116 (334)
T ss_dssp EEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCC
T ss_pred eEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCce
Confidence 344678999999999999863 46789999997653 34567789999999999 899999999999999999
Q ss_pred eEeeecccCCChhhhhhcCCC--------------CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC
Q 003114 607 GLIYEYMANGSLEEYLSDSNA--------------DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ 672 (846)
Q Consensus 607 ~LV~Ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~ 672 (846)
++||||+++|+|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 117 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTEN 193 (334)
T ss_dssp EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTT
T ss_pred EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEEcCC
Confidence 999999999999999986542 24889999999999999999999 8899999999999999999
Q ss_pred CcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHH
Q 003114 673 FQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWV 751 (846)
Q Consensus 673 ~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~ 751 (846)
+.+||+|||+++...............+++.|+|||.+.+..++.++|||||||+++||++ |+.||....... ..
T Consensus 194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~ 269 (334)
T 2pvf_A 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LF 269 (334)
T ss_dssp CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HH
T ss_pred CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH----HH
Confidence 9999999999987644333333344567889999999988889999999999999999999 999997654332 22
Q ss_pred HHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 003114 752 DFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETA 814 (846)
Q Consensus 752 ~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~ 814 (846)
.... .+... ..+......+.+++.+|++.+|++||++.|+++.|++++.....
T Consensus 270 ~~~~-~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 270 KLLK-EGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHH-HTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHh-cCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 2222 11111 11223345788999999999999999999999999999876554
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=348.67 Aligned_cols=248 Identities=24% Similarity=0.399 Sum_probs=201.3
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||+++|
T Consensus 11 i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 90 (323)
T 3tki_A 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 90 (323)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCC
Confidence 4578999999999999976 789999999865432 23467889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+..........
T Consensus 91 ~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 91 ELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp EGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred cHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 99999976543 899999999999999999999 8999999999999999999999999999998764333334445
Q ss_pred cccCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccccc-HHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 697 GVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRPAIANTEEHKH-ISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~-s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
...||+.|+|||++.+..+ +.++|||||||+++||++|+.||........ ...|. .... ... ...
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~----~~~~---~~~------~~~ 232 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----EKKT---YLN------PWK 232 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH----TTCT---TST------TGG
T ss_pred CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----cccc---cCC------ccc
Confidence 5789999999999987765 7899999999999999999999986554322 11211 1110 000 012
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.....+.+++.+|++.+|++|||++|+++.
T Consensus 233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 233 KIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 234567899999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=367.55 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=205.0
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||.||+|.++++..||||+++.... ..+++.+|+.++++++||||+++++++.+ +..++||||+++|+
T Consensus 187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gs 264 (452)
T 1fmk_A 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 264 (452)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred eeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCC
Confidence 34578999999999999998888999999986543 34679999999999999999999999876 67899999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++.......+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++..... .......
T Consensus 265 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~ 340 (452)
T 1fmk_A 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQG 340 (452)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCC-ceecccC
Confidence 999998654445899999999999999999999 889999999999999999999999999999865422 1122233
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..++..|+|||.+....++.++|||||||++|||++ |+.||......+.+ .... .+. ....+...
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~----~~i~-~~~---------~~~~~~~~ 406 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL----DQVE-RGY---------RMPCPPEC 406 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHHH-TTC---------CCCCCTTS
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH----HHHH-cCC---------CCCCCCCC
Confidence 457889999999998899999999999999999999 99999865433222 2221 211 11112234
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
...+.+++.+|++.+|++|||+++|++.|+++...
T Consensus 407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 56788999999999999999999999999987643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=337.59 Aligned_cols=247 Identities=26% Similarity=0.452 Sum_probs=192.5
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCc----hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSR----QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|... ++.||||++..... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (271)
T 3dtc_A 10 TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA 88 (271)
T ss_dssp EEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECC
T ss_pred eeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcC
Confidence 34578999999999999975 88999999875422 23467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCC---eeecCCCCCCEEECC--------CCcEEEEeccC
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP---RVHRDIKPANILLND--------QFQARLADFGL 682 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~---IiHrDlKp~NILld~--------~~~vkI~DFGl 682 (846)
++++|.+++... .+++..+..++.|++.||.||| +.+ |+||||||+||+++. ++.+||+|||+
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 89 RGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp TTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred CCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999643 4899999999999999999999 555 999999999999986 77899999999
Q ss_pred CccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCccc
Q 003114 683 SKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKN 762 (846)
Q Consensus 683 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 762 (846)
++..... ......||+.|+|||.+.+..++.++||||||++++||++|+.||........... .... .
T Consensus 163 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~-~--- 230 (271)
T 3dtc_A 163 AREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG----VAMN-K--- 230 (271)
T ss_dssp -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH----HHTS-C---
T ss_pred ccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh----hhcC-C---
Confidence 9865322 12245689999999999998999999999999999999999999986553322211 1111 1
Q ss_pred ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 763 IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 763 ~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
.....+......+.+++.+|++.+|++|||++|++++|+++
T Consensus 231 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 -----LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11112223445788999999999999999999999999863
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=339.16 Aligned_cols=257 Identities=24% Similarity=0.356 Sum_probs=198.7
Q ss_pred hhhhhhcCcCceEEEEEEEEcC----CcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 537 NDFETILGEGSFGKVYHGYLDD----NTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
..+.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..++|||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 95 (281)
T 1mp8_A 17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 95 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEe
Confidence 3456789999999999999743 4569999987643 344567899999999999999999999985 467889999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 170 (281)
T 1mp8_A 96 LCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST- 170 (281)
T ss_dssp CCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCccc-
Confidence 999999999998654 24899999999999999999999 8899999999999999999999999999998764321
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
........+++.|+|||.+....++.++|||||||+++||++ |+.||........... .. .+...
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~----i~-~~~~~--------- 236 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IE-NGERL--------- 236 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH----HH-TTCCC---------
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH----HH-cCCCC---------
Confidence 112233456789999999998899999999999999999997 9999987654433222 11 11110
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMET 813 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~ 813 (846)
..+......+.+++.+|++.+|++||++.|+++.|++++..+.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 237 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1122334578899999999999999999999999999887654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=335.51 Aligned_cols=253 Identities=26% Similarity=0.441 Sum_probs=209.4
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||.||+|...++..||+|++...... .+.+.+|+.+++.++||||+++++++..++..++||||+++++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred eeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 345789999999999999988899999999865433 3678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..... .......
T Consensus 90 L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~ 164 (267)
T 3t9t_A 90 LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTG 164 (267)
T ss_dssp HHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHSTTS
T ss_pred HHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc-ccccccc
Confidence 999998654 34899999999999999999999 889999999999999999999999999999865321 1122234
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..++..|+|||.+.+..++.++||||+|++++||++ |+.||........ ..... .+.. . ..+...
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~i~-~~~~--~-------~~~~~~ 230 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----VEDIS-TGFR--L-------YKPRLA 230 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHH-TTCC--C-------CCCTTS
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH----HHHHh-cCCc--C-------CCCccC
Confidence 557889999999998899999999999999999999 8999986543322 22221 1110 0 111123
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
...+.+++.+|++.+|++||+++|+++.|+++.+
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 231 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3568899999999999999999999999999764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=346.41 Aligned_cols=259 Identities=23% Similarity=0.372 Sum_probs=201.5
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcE----EEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTE----VAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~----VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
.+.+.||+|+||.||+|+.. +++. ||+|.+... .....+.+.+|+.+++.++||||+++++++..+. .++|+|
T Consensus 18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~ 96 (327)
T 3lzb_A 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQ 96 (327)
T ss_dssp EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEEC
T ss_pred eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEE
Confidence 34578999999999999964 4443 578877644 3445678999999999999999999999998755 789999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+++|+|.+++..... .+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 97 ~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 97 LMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp CCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred ecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 9999999999987543 4899999999999999999999 88999999999999999999999999999987644333
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........ ... ...+. ..
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~~~----~~~~~---------~~ 238 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSI----LEKGE---------RL 238 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHH----HHTTC---------CC
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-HHH----HHcCC---------CC
Confidence 333344567889999999999999999999999999999999 9999987654432 221 11111 11
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhh
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETAR 815 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~ 815 (846)
..+......+.+++.+|++.+|++||+++|+++.|+++.......
T Consensus 239 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 283 (327)
T 3lzb_A 239 PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRY 283 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCce
Confidence 112233457889999999999999999999999999987654433
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=343.33 Aligned_cols=258 Identities=20% Similarity=0.317 Sum_probs=202.1
Q ss_pred hhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||+|+||+||+|+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 25 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~- 103 (311)
T 3niz_A 25 KLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103 (311)
T ss_dssp EEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-
T ss_pred hhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-
Confidence 356899999999999999889999999997543 22346788999999999999999999999999999999999974
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+.+..... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 104 ~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~ 177 (311)
T 3niz_A 104 DLKKVLDENKT-GLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP--VRSYT 177 (311)
T ss_dssp EHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC--CC---
T ss_pred CHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC--ccccc
Confidence 88888876543 4899999999999999999999 889999999999999999999999999999875322 22233
Q ss_pred cccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCc--ccc------cCCC
Q 003114 697 GVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDI--KNI------VDPK 767 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~--~~~------~d~~ 767 (846)
...||+.|+|||.+.+ ..++.++||||+||+++||++|++||........+............. ... .+..
T Consensus 178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (311)
T 3niz_A 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257 (311)
T ss_dssp CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCC
T ss_pred CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcc
Confidence 4578999999998876 568999999999999999999999998877666555544432211100 000 0000
Q ss_pred C--CCCC-----ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 768 L--HGDI-----DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 768 L--~~~~-----~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
. .... ......++.+++.+|++.+|++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 0000 1112346789999999999999999999876
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=341.73 Aligned_cols=257 Identities=28% Similarity=0.503 Sum_probs=196.3
Q ss_pred hhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 537 NDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
..+.+.||+|+||.||+|+..+ .||+|+++... ....+.+.+|+.++++++||||+++++++. ....++||||++
T Consensus 26 y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~ 102 (289)
T 3og7_A 26 ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCE 102 (289)
T ss_dssp CEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCC
T ss_pred eeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEEecC
Confidence 4456789999999999998643 59999997543 345577999999999999999999999764 456899999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 103 GSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp EEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred CCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 999999997654 34899999999999999999999 88999999999999999999999999999986543222333
Q ss_pred cccccCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQ---TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.....||+.|+|||.+. ...++.++|||||||+++||++|+.||........+.+.+. .+....... .
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~-----~ 249 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG----RGSLSPDLS-----K 249 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH----HTSCCCCTT-----S
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc----ccccCcchh-----h
Confidence 34567999999999886 56788999999999999999999999987654443333222 222111111 1
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
........+.+++.+|++.+|++||++.|++++|+++.
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 12234467899999999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=336.58 Aligned_cols=258 Identities=22% Similarity=0.409 Sum_probs=210.8
Q ss_pred hhcCcCceEEEEEEEEc---CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 541 TILGEGSFGKVYHGYLD---DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.+++.++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 37999999999999853 67889999998753 34567799999999999999999999999 456789999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc-ccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS-HLS 695 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~-~~~ 695 (846)
+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++........ ...
T Consensus 95 ~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 170 (287)
T 1u59_A 95 PLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170 (287)
T ss_dssp EHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred CHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecc
Confidence 9999997543 34899999999999999999999 889999999999999999999999999999876433221 122
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
....+|+.|+|||.+.+..++.++|||||||+++||++ |+.||......... .. +..+.. ...+.
T Consensus 171 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----~~-i~~~~~---------~~~~~ 236 (287)
T 1u59_A 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM----AF-IEQGKR---------MECPP 236 (287)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH----HH-HHTTCC---------CCCCT
T ss_pred ccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH----HH-HhcCCc---------CCCCC
Confidence 33457899999999988889999999999999999998 99999765543221 11 112111 11122
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhhhc
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARKE 817 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~~~ 817 (846)
.....+.+++.+|++.+|++||++.|+++.|++++........
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 3445788999999999999999999999999999877666443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=352.75 Aligned_cols=271 Identities=17% Similarity=0.231 Sum_probs=208.7
Q ss_pred hhhhhhcCcCceEEEEEEEEcC------CcEEEEEEeCCCCchhh-----------HHHHHHHHHHHhcccccceeEeeE
Q 003114 537 NDFETILGEGSFGKVYHGYLDD------NTEVAVKMLSPSSRQGY-----------EQFEAEVILLRTVHHKNLTTLYGY 599 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~~~~-----------~~~~~Ei~~l~~l~HpnIv~l~g~ 599 (846)
..+.+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..++.++||||++++++
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 116 (364)
T 3op5_A 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116 (364)
T ss_dssp EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence 3446789999999999999764 47899999876542211 123345556777789999999999
Q ss_pred eecC----CeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC--CCC
Q 003114 600 CNEG----NQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN--DQF 673 (846)
Q Consensus 600 ~~~~----~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld--~~~ 673 (846)
+... ...++||||+ +++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++ .++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSCTT
T ss_pred eeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCCCC
Confidence 8664 5589999999 999999998753 34999999999999999999999 88999999999999999 889
Q ss_pred cEEEEeccCCccCCCCCcc-----cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHH
Q 003114 674 QARLADFGLSKTFPIEGVS-----HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHIS 748 (846)
Q Consensus 674 ~vkI~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~ 748 (846)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 9999999999876432111 11133559999999999999999999999999999999999999998644333333
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhhh
Q 003114 749 QWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARK 816 (846)
Q Consensus 749 ~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~~ 816 (846)
.+...... ..+.+++++.+.. ......+.+++..|++.+|++||++++|++.|++++.......
T Consensus 272 ~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 272 RDSKIRYR-ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp HHHHHHHH-HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHhh-hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 33332222 2233444433321 1234578899999999999999999999999999887655433
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=339.70 Aligned_cols=259 Identities=26% Similarity=0.414 Sum_probs=215.7
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
..+.+.||+|+||.||+|... ++..||+|++.... ...+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 15 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 93 (288)
T 3kfa_A 15 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 93 (288)
T ss_dssp EEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred eeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCC
Confidence 344578999999999999986 48889999997643 3457789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++.......+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....... ....
T Consensus 94 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~ 169 (288)
T 3kfa_A 94 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAH 169 (288)
T ss_dssp EEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SEEE
T ss_pred CcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-cccc
Confidence 99999998876667999999999999999999999 8899999999999999999999999999998764322 2233
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
....+++.|+|||.+.+..++.++||||||++++||++ |+.||........... + ... .....+.
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-~----~~~---------~~~~~~~ 235 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-L----EKD---------YRMERPE 235 (288)
T ss_dssp TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-H----HTT---------CCCCCCT
T ss_pred cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-H----hcc---------CCCCCCC
Confidence 34557889999999998999999999999999999999 9999987654332211 1 111 1111122
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETA 814 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~ 814 (846)
.....+.+++.+|++.+|++||++.|+++.|++++.....
T Consensus 236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~ 275 (288)
T 3kfa_A 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275 (288)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 3345788999999999999999999999999998876544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=347.56 Aligned_cols=257 Identities=24% Similarity=0.408 Sum_probs=201.9
Q ss_pred hhhhhhcCcCceEEEEEEEEcC-C-------cEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeE
Q 003114 537 NDFETILGEGSFGKVYHGYLDD-N-------TEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~-g-------~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L 608 (846)
..+.+.||+|+||.||+|+... + ..||+|++........+.+.+|+.++++++||||+++++++..++..++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL 89 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence 3456789999999999998653 3 4799999987766677889999999999999999999999999999999
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc--------EEEEec
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ--------ARLADF 680 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~--------vkI~DF 680 (846)
||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +||+||
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 90 VQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred EEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 999999999999998754 33899999999999999999999 889999999999999998877 999999
Q ss_pred cCCccCCCCCcccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCC-CCCCCccccccHHHHHHHHHhcC
Q 003114 681 GLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSR-PAIANTEEHKHISQWVDFMLAQG 758 (846)
Q Consensus 681 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~-~p~~~~~~~~~l~~~~~~~~~~~ 758 (846)
|++..... .....|++.|+|||.+.+ ..++.++|||||||+++||++|. +|+....... ... ......
T Consensus 166 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~---~~~~~~ 235 (289)
T 4fvq_A 166 GISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQ---FYEDRH 235 (289)
T ss_dssp CSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHH---HHHTTC
T ss_pred cccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHH---HhhccC
Confidence 99875421 123457889999999887 67999999999999999999964 5554433221 111 111111
Q ss_pred CcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhhhcCC
Q 003114 759 DIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARKEGH 819 (846)
Q Consensus 759 ~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~~~~~ 819 (846)
..... ....+.+++.+|++.+|++|||++|+++.|++++....+...++
T Consensus 236 ~~~~~------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~~ 284 (289)
T 4fvq_A 236 QLPAP------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSH 284 (289)
T ss_dssp CCCCC------------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----------
T ss_pred CCCCC------------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCCcc
Confidence 11111 12246799999999999999999999999999998777655433
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=337.53 Aligned_cols=254 Identities=29% Similarity=0.459 Sum_probs=209.0
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||.||+|...++..||+|++..... ..+.+.+|+++++.++||||+++++++.. +..++||||+++++
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~ 93 (279)
T 1qpc_A 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGS 93 (279)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCB
T ss_pred hheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCC
Confidence 44578999999999999998888999999976543 34678999999999999999999999874 56899999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++.......+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++...... ......
T Consensus 94 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 169 (279)
T 1qpc_A 94 LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREG 169 (279)
T ss_dssp HHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTT
T ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cccccC
Confidence 999998654335899999999999999999999 8899999999999999999999999999998764322 222334
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..++..|+|||.+.+..++.++||||||++++||++ |+.||........ ..... .+. . ...+...
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----~~~~~-~~~-----~----~~~~~~~ 235 (279)
T 1qpc_A 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV----IQNLE-RGY-----R----MVRPDNC 235 (279)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----HHHHH-TTC-----C----CCCCTTC
T ss_pred CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH----HHHHh-ccc-----C----CCCcccc
Confidence 557889999999998889999999999999999999 8999976543322 22221 111 0 0111233
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
...+.+++.+|++.+|++|||++++++.|+++...
T Consensus 236 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 45788999999999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=345.71 Aligned_cols=245 Identities=25% Similarity=0.357 Sum_probs=202.8
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|+.. +|+.||+|++++. .....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~ 87 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 34578999999999999975 6899999999753 2234467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 88 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~ 160 (337)
T 1o6l_A 88 NGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GA 160 (337)
T ss_dssp TTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--TC
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC--CC
Confidence 9999999997654 3899999999999999999999 889999999999999999999999999999864222 22
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....... .. . ++
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~-~~------~----~p 225 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----FELILME-EI------R----FP 225 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHC-CC------C----CC
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH----HHHHHcC-CC------C----CC
Confidence 33456799999999999999999999999999999999999999976543322 2222221 11 1 11
Q ss_pred hHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRP-----NMNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~~ 804 (846)
......+.+++.+|++.+|++|| +++||++.
T Consensus 226 ~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 22334678999999999999999 88888764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=343.87 Aligned_cols=248 Identities=22% Similarity=0.338 Sum_probs=203.3
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCch------hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEe
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQ------GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV 609 (846)
+.+.+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 92 (326)
T 2y0a_A 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 92 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 455678999999999999975 6899999998654321 356789999999999999999999999999999999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC----cEEEEeccCCcc
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF----QARLADFGLSKT 685 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~----~vkI~DFGla~~ 685 (846)
|||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus 93 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 93 LELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 99999999999997654 4899999999999999999999 89999999999999999887 899999999987
Q ss_pred CCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 003114 686 FPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765 (846)
Q Consensus 686 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 765 (846)
.... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||........+... ... ..
T Consensus 168 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~----~~~-~~----- 234 (326)
T 2y0a_A 168 IDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----SAV-NY----- 234 (326)
T ss_dssp CCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH----HHT-CC-----
T ss_pred CCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH----Hhc-CC-----
Confidence 6322 2233457999999999999889999999999999999999999999765543322221 111 00
Q ss_pred CCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 ~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.............+.+++.+|++.+|++|||+.|+++
T Consensus 235 -~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 -EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000112346789999999999999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=345.90 Aligned_cols=256 Identities=23% Similarity=0.391 Sum_probs=203.4
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcE----EEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTE----VAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~----VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.+.||+|+||.||+|+.. +++. ||+|.+.... ....+.+.+|+.+++.++||||+++++++. ++..++||||
T Consensus 17 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 95 (325)
T 3kex_A 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQY 95 (325)
T ss_dssp EEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEEC
T ss_pred eeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEe
Confidence 3568999999999999964 4443 8888886443 334466788999999999999999999986 4568899999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 96 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 171 (325)
T 3kex_A 96 LPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171 (325)
T ss_dssp CTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred CCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence 99999999998653 34899999999999999999999 889999999999999999999999999999987554444
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.......|+..|+|||.+.+..++.++|||||||++|||+| |+.||........ ... ...+... ..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~----~~~~~~~--~~------ 238 (325)
T 3kex_A 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-PDL----LEKGERL--AQ------ 238 (325)
T ss_dssp CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-HHH----HHTTCBC--CC------
T ss_pred ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-HHH----HHcCCCC--CC------
Confidence 44455678889999999999999999999999999999999 9999987553322 111 1111110 00
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMET 813 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~ 813 (846)
+......+.+++.+|++.+|++||+++|+++.|+++.....
T Consensus 239 -~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~ 279 (325)
T 3kex_A 239 -PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279 (325)
T ss_dssp -CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred -CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 11122246789999999999999999999999999865443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=351.11 Aligned_cols=251 Identities=21% Similarity=0.297 Sum_probs=202.3
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
.+.||+|+||.||+|... +|+.||+|++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 357999999999999974 6899999999877666678899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE--CCCCcEEEEeccCCccCCCCCcccccc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL--NDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl--d~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+ ++++.+||+|||+++.+.... ...
T Consensus 174 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~ 246 (373)
T 2x4f_A 174 FDRIIDES-YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLK 246 (373)
T ss_dssp HHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCC
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccc
Confidence 99987643 24899999999999999999999 8899999999999999 677899999999998764322 223
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
...||+.|+|||++....++.++|||||||+++||++|+.||........+..+.. .... ..+.. ....
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~----~~~~---~~~~~----~~~~ 315 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA----CRWD---LEDEE----FQDI 315 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----TCCC---SCSGG----GTTS
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----ccCC---CChhh----hccC
Confidence 45699999999999988999999999999999999999999987665443333222 1110 00000 0122
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHh
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVM--ELKEC 808 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~--~L~~~ 808 (846)
...+.+++.+|++.+|++||++.|+++ .+++.
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 357889999999999999999999987 45443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=350.22 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=202.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCch------hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQ------GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
.+.+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 15 ~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 94 (361)
T 2yab_A 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLIL 94 (361)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEE
Confidence 44678999999999999975 6899999999754322 3467899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC----cEEEEeccCCccC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF----QARLADFGLSKTF 686 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~----~vkI~DFGla~~~ 686 (846)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||+++++ .+||+|||+++..
T Consensus 95 e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 95 ELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp ECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 9999999999997654 4899999999999999999999 88999999999999998776 7999999999876
Q ss_pred CCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCC
Q 003114 687 PIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDP 766 (846)
Q Consensus 687 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 766 (846)
... .......||+.|+|||++.+..++.++||||+||++|||++|++||........+.. .. .+.. .+++
T Consensus 170 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~----i~-~~~~--~~~~ 239 (361)
T 2yab_A 170 EDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN----IT-AVSY--DFDE 239 (361)
T ss_dssp CTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HH-TTCC--CCCH
T ss_pred CCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HH-hcCC--CCCc
Confidence 432 223446799999999999998999999999999999999999999987654332222 11 1110 0010
Q ss_pred CCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 767 KLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 767 ~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
... ......+.+++.+|+..+|++|||+.|+++
T Consensus 240 ~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 240 EFF----SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 112346789999999999999999999885
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=343.89 Aligned_cols=261 Identities=17% Similarity=0.211 Sum_probs=208.1
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++.+ +||||+++++++..++..++||||+ ++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (330)
T 2izr_A 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP 89 (330)
T ss_dssp EEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence 457899999999999996 5789999999875432 34688999999999 9999999999999999999999999 99
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc-----EEEEeccCCccCCCCCc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ-----ARLADFGLSKTFPIEGV 691 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~-----vkI~DFGla~~~~~~~~ 691 (846)
+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+++.+.....
T Consensus 90 ~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~ 165 (330)
T 2izr_A 90 SLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165 (330)
T ss_dssp BHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred CHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence 9999998653 34999999999999999999999 889999999999999998887 99999999987643222
Q ss_pred cc-----ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCC
Q 003114 692 SH-----LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDP 766 (846)
Q Consensus 692 ~~-----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 766 (846)
.. ......||+.|+|||.+.+..++.++|||||||+++||++|+.||........ .+.......... ... ..
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~~~~~-~~~-~~ 242 (330)
T 2izr_A 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIGDTKR-ATP-IE 242 (330)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHHHHHH-HSC-HH
T ss_pred CccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHHhhhc-cCC-HH
Confidence 11 12456799999999999999999999999999999999999999987543322 121111111000 000 00
Q ss_pred CCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 003114 767 KLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETA 814 (846)
Q Consensus 767 ~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~ 814 (846)
.+ ....+ .+.+++..|++.+|.+||++++|.+.|+++......
T Consensus 243 ~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 243 VL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 00 01123 788999999999999999999999999987755443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=347.35 Aligned_cols=260 Identities=25% Similarity=0.398 Sum_probs=211.5
Q ss_pred hhhhhcCcCceEEEEEEEEcC------CcEEEEEEeCCCC-chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEe
Q 003114 538 DFETILGEGSFGKVYHGYLDD------NTEVAVKMLSPSS-RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV 609 (846)
.+.+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..++..++|
T Consensus 49 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 128 (333)
T 2i1m_A 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 128 (333)
T ss_dssp EEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEE
Confidence 345789999999999999742 2479999997653 34456789999999999 899999999999999999999
Q ss_pred eecccCCChhhhhhcCC------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEE
Q 003114 610 YEYMANGSLEEYLSDSN------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARL 677 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI 677 (846)
|||+++|+|.+++.... ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 129 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp EECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGGEEEB
T ss_pred EecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCCeEEE
Confidence 99999999999997542 234789999999999999999999 889999999999999999999999
Q ss_pred EeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHh
Q 003114 678 ADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLA 756 (846)
Q Consensus 678 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~ 756 (846)
+|||+++...............+|+.|+|||.+.+..++.++|||||||+++||+| |+.||............+.
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~---- 281 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK---- 281 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH----
T ss_pred CccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh----
Confidence 99999986643333333344567889999999998899999999999999999998 9999987654443333222
Q ss_pred cCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 003114 757 QGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMET 813 (846)
Q Consensus 757 ~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~ 813 (846)
.+.. . ..+......+.+++.+|++.+|++|||+.||++.|+++.....
T Consensus 282 ~~~~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 282 DGYQ-----M----AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp HTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cCCC-----C----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 1110 0 0111224578899999999999999999999999999876543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=342.02 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=210.3
Q ss_pred hhhhhcCcCceEEEEEEEE------cCCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhc-ccccceeEeeEeecCC-eeeE
Q 003114 538 DFETILGEGSFGKVYHGYL------DDNTEVAVKMLSPSSR-QGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGN-QIGL 608 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~-~~~L 608 (846)
.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++...+ ..++
T Consensus 30 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~l 109 (316)
T 2xir_A 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 109 (316)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred eeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEE
Confidence 3457899999999999985 3467899999976543 3456789999999999 7999999999987654 5899
Q ss_pred eeecccCCChhhhhhcCCCC--------------ccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc
Q 003114 609 IYEYMANGSLEEYLSDSNAD--------------VLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ 674 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~--------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~ 674 (846)
||||+++|+|.+++...... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~ 186 (316)
T 2xir_A 110 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNV 186 (316)
T ss_dssp EEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCC
Confidence 99999999999999875432 2889999999999999999999 889999999999999999999
Q ss_pred EEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHH
Q 003114 675 ARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDF 753 (846)
Q Consensus 675 vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~ 753 (846)
+||+|||+++...............||+.|+|||.+.+..++.++|||||||+++||+| |+.||........+...
T Consensus 187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~--- 263 (316)
T 2xir_A 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--- 263 (316)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH---
T ss_pred EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH---
Confidence 99999999987644333333344567899999999999999999999999999999998 99999765543332221
Q ss_pred HHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 754 MLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 754 ~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
...+... . .+......+.+++.+|++.+|++|||+.||++.|+++++..
T Consensus 264 -~~~~~~~-----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 264 -LKEGTRM-----R----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp -HHHTCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -hccCccC-----C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1121111 1 11123346889999999999999999999999999988654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=340.34 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=199.3
Q ss_pred HhhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHh--cccccceeEeeEeecC----CeeeEe
Q 003114 536 TNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRT--VHHKNLTTLYGYCNEG----NQIGLI 609 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~g~~~~~----~~~~LV 609 (846)
...+.+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++.. ++||||+++++++... ...++|
T Consensus 38 ~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 113 (337)
T 3mdy_A 38 QIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113 (337)
T ss_dssp HCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred ceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence 4455689999999999999985 8999999986432 2334445555544 4999999999998876 789999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCC--------CeeecCCCCCCEEECCCCcEEEEecc
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKP--------PRVHRDIKPANILLNDQFQARLADFG 681 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~--------~IiHrDlKp~NILld~~~~vkI~DFG 681 (846)
|||+++|+|.++++.. .+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||+|||
T Consensus 114 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 114 TDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp ECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 9999999999999764 3899999999999999999999 66 99999999999999999999999999
Q ss_pred CCccCCCCCcc--cccccccCCCcccCccccccCCCCch------hhHHHHHHHHHHHHhC----------CCCCCCccc
Q 003114 682 LSKTFPIEGVS--HLSTGVAGTFGYLDPEYCQTFRLTEK------SDVYSFGVVLLEIITS----------RPAIANTEE 743 (846)
Q Consensus 682 la~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~s~k------sDVwS~Gvvl~ELltG----------~~p~~~~~~ 743 (846)
+++.+...... .......||+.|+|||.+.+.....+ +|||||||++|||+|| +.||.....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 99765432211 11234579999999999987766554 9999999999999999 666654432
Q ss_pred cccHHHHHHHHHhcCCcccccCCCCCCCC-ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 744 HKHISQWVDFMLAQGDIKNIVDPKLHGDI-DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 744 ~~~l~~~~~~~~~~~~~~~~~d~~L~~~~-~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
................. .+...... ..+....+.+++.+|++.+|++|||+.||++.|+++.+.
T Consensus 268 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 268 SDPSYEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp SSCCHHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCchhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 22222222222221111 11111111 225677899999999999999999999999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.31 Aligned_cols=249 Identities=30% Similarity=0.539 Sum_probs=200.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchh-------hHHHHHHHHHHHhcccccceeEeeEeecCCeeeEe
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQG-------YEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~-------~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV 609 (846)
.+.+.||+|+||.||+|+.. +++.||+|++....... .+.+.+|+.++++++||||+++++++.+.. ++|
T Consensus 22 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv 99 (287)
T 4f0f_A 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMV 99 (287)
T ss_dssp EEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEE
T ss_pred eehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEE
Confidence 44578999999999999974 78999999986543221 267899999999999999999999997665 699
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCC--eeecCCCCCCEEECCCCc-----EEEEeccC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP--RVHRDIKPANILLNDQFQ-----ARLADFGL 682 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--IiHrDlKp~NILld~~~~-----vkI~DFGl 682 (846)
|||+++|+|.+.+.... ..+++..+..++.|++.||+||| +.+ |+||||||+|||++.++. +||+|||+
T Consensus 100 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 100 MEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp EECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred EEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 99999999999887654 34899999999999999999999 778 999999999999988776 99999999
Q ss_pred CccCCCCCcccccccccCCCcccCcccc--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCc
Q 003114 683 SKTFPIEGVSHLSTGVAGTFGYLDPEYC--QTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDI 760 (846)
Q Consensus 683 a~~~~~~~~~~~~~~~~gt~~Y~APE~~--~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 760 (846)
++.... ......||+.|+|||.+ ....++.++||||+||++|||++|+.||........ .........+.
T Consensus 176 ~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~- 247 (287)
T 4f0f_A 176 SQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI--KFINMIREEGL- 247 (287)
T ss_dssp CBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH--HHHHHHHHSCC-
T ss_pred cccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH--HHHHHHhccCC-
Confidence 975422 23446799999999998 445678999999999999999999999976543321 11222222111
Q ss_pred ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 761 ~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
....+......+.+++.+|++.+|++|||++|+++.|+++
T Consensus 248 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 --------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1112223345788999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.15 Aligned_cols=259 Identities=17% Similarity=0.220 Sum_probs=208.4
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||+|+||.||+|+. .+++.||+|++.... ..+.+.+|+.+++.+ +|+|++++++++..+...++||||+ +
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 89 (298)
T 1csn_A 13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 89 (298)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-C
Confidence 3457899999999999996 578999999986443 235688999999999 8999999999999999999999999 9
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc-----EEEEeccCCccCCCCC
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ-----ARLADFGLSKTFPIEG 690 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~-----vkI~DFGla~~~~~~~ 690 (846)
++|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+++......
T Consensus 90 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 90 PSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 999999986543 4899999999999999999999 899999999999999987776 9999999998764332
Q ss_pred cc-----cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHH--HHHhcCCcccc
Q 003114 691 VS-----HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVD--FMLAQGDIKNI 763 (846)
Q Consensus 691 ~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~--~~~~~~~~~~~ 763 (846)
.. .......||+.|+|||.+.+..++.++|||||||+++||++|+.||...........+.. .........+.
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 245 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH
Confidence 21 123456799999999999999999999999999999999999999987543222211111 11111111111
Q ss_pred cCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 764 VDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 764 ~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
.......+.+++.+|++.+|++||++++|++.|++++...
T Consensus 246 ---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 246 ---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp ---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 0122357889999999999999999999999999987543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=346.25 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=208.3
Q ss_pred hhhhhcCcCceEEEEEEEEc-----CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeec--CCeeeEe
Q 003114 538 DFETILGEGSFGKVYHGYLD-----DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNE--GNQIGLI 609 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~LV 609 (846)
.+.+.||+|+||.||++.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 34578999999999998753 67889999998653 3446778999999999999999999999977 4678999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||+++|+|.+++.... +++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 ~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp ECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999997654 899999999999999999999 889999999999999999999999999999876433
Q ss_pred Ccc-cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc-----------cHHHHHHHHHhc
Q 003114 690 GVS-HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK-----------HISQWVDFMLAQ 757 (846)
Q Consensus 690 ~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~-----------~l~~~~~~~~~~ 757 (846)
... .......+|..|+|||.+.+..++.++|||||||+++||++|+.||....... .... .......
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 266 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-LTELLER 266 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH-HHHHHHT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH-HHHHHhc
Confidence 221 22334568889999999999899999999999999999999999997543210 0011 1111111
Q ss_pred CCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 758 GDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 758 ~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
......+......+.+++.+|++.+|++|||++|+++.|+++.+.-
T Consensus 267 ---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 267 ---------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 1111223334567899999999999999999999999999876544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=343.23 Aligned_cols=248 Identities=16% Similarity=0.235 Sum_probs=203.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 8 ~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 86 (321)
T 1tki_A 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence 34578999999999999975 68899999997543 34467889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC--CCcEEEEeccCCccCCCCCcccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND--QFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~--~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++..... ..
T Consensus 87 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~---~~ 159 (321)
T 1tki_A 87 DIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DN 159 (321)
T ss_dssp BHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---CE
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC---Cc
Confidence 9999997654 24899999999999999999999 889999999999999987 789999999999876432 22
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....||+.|+|||.+.+..++.++||||+||++|||++|++||........+.. ...... . .++.. ..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~~~~-~--~~~~~----~~ 228 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNAEY-T--FDEEA----FK 228 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHTCC-C--CCHHH----HT
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH----HHcCCC-C--CChhh----hc
Confidence 3345689999999999988899999999999999999999999987654332222 222111 0 00000 01
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.....+.+++.+|+..+|++|||+.|+++.
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 123468899999999999999999999873
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=336.21 Aligned_cols=258 Identities=19% Similarity=0.312 Sum_probs=200.6
Q ss_pred hhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||+|+||.||+|+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 84 (288)
T 1ob3_A 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-
T ss_pred hhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-
Confidence 4568999999999999998899999999975532 2346788999999999999999999999999999999999975
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++..... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 85 ~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 158 (288)
T 1ob3_A 85 DLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYT 158 (288)
T ss_dssp EHHHHHHTSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred CHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--ccccc
Confidence 99999876543 4899999999999999999999 889999999999999999999999999999765321 12223
Q ss_pred cccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--cc-----cccCCCC
Q 003114 697 GVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--IK-----NIVDPKL 768 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--~~-----~~~d~~L 768 (846)
...||+.|+|||.+.+ ..++.++||||+||+++||++|++||........+....+....... .. ...++..
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 4568999999999875 45899999999999999999999999877655544444332211100 00 0011111
Q ss_pred CC-------CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 769 HG-------DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 769 ~~-------~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.. .........+.+++.+|++.+|++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 10 011123457789999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=338.99 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=205.9
Q ss_pred hhhhhhcCcCceEEEEEEEE-----cCCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecC--CeeeE
Q 003114 537 NDFETILGEGSFGKVYHGYL-----DDNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG--NQIGL 608 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~L 608 (846)
..+.+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++... ...++
T Consensus 23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 44567899999999999984 368899999997543 33457789999999999999999999999776 67899
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
||||+++|+|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 103 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp EEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 9999999999999965543 3899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCcc-cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------ccccHHHHHHHHHh
Q 003114 689 EGVS-HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTE-----------EHKHISQWVDFMLA 756 (846)
Q Consensus 689 ~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~-----------~~~~l~~~~~~~~~ 756 (846)
.... .......||..|+|||.+.+..++.++||||+||+++||++|+.|+.... ............ .
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 257 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL-K 257 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH-H
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH-h
Confidence 3221 23344568889999999999899999999999999999999999864321 111111212211 1
Q ss_pred cCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 757 QGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 757 ~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
.+. ....+......+.+++.+|++.+|++|||++|+++.|++++
T Consensus 258 ~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 258 EGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111 11122234457889999999999999999999999999876
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=333.82 Aligned_cols=256 Identities=26% Similarity=0.417 Sum_probs=203.6
Q ss_pred hhhcCcCceEEEEEEEEc-CC---cEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCee-eEeeecc
Q 003114 540 ETILGEGSFGKVYHGYLD-DN---TEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQI-GLIYEYM 613 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g---~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~-~LV~Ey~ 613 (846)
.+.||+|+||.||+|+.. ++ ..||+|++..... ...+.+.+|+.+++.++||||+++++++...+.. ++|+||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 468999999999999853 22 3699999976543 4557789999999999999999999999766654 9999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc--
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV-- 691 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~-- 691 (846)
.+|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 106 ~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 106 CHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred cCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 9999999998744 34899999999999999999999 88999999999999999999999999999986533211
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
........+++.|+|||.+.+..++.++|||||||+++||++|+.|+........+...+. .+.. ..
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~----~~~~---------~~ 248 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA----QGRR---------LP 248 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH----TTCC---------CC
T ss_pred cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh----cCCC---------CC
Confidence 1222345678999999999999999999999999999999996555433333333322221 1110 01
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
.+......+.+++.+|++.+|++|||++|+++.|++++...
T Consensus 249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 11223457889999999999999999999999999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=345.74 Aligned_cols=248 Identities=20% Similarity=0.347 Sum_probs=194.7
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhccc--ccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHH--KNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H--pnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||++...+++.||||++... .....+.+.+|+.+++.++| +||+++++++..++..++||| +
T Consensus 12 ~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~ 90 (343)
T 3dbq_A 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C 90 (343)
T ss_dssp EEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred EEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-C
Confidence 345789999999999999988999999998654 33445778999999999976 999999999999999999999 5
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
.+++|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++.........
T Consensus 91 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 91 GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 6889999998754 3899999999999999999999 88999999999999997 5789999999998765433333
Q ss_pred ccccccCCCcccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCccc
Q 003114 694 LSTGVAGTFGYLDPEYCQT-----------FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKN 762 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~-----------~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 762 (846)
......||+.|+|||++.+ ..++.++|||||||+++||++|+.||...... ... .....
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~-~~~~~------- 234 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISK-LHAII------- 234 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHH-HHHHH-------
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHH-HHHHh-------
Confidence 3445679999999999865 67899999999999999999999999754322 111 11111
Q ss_pred ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 763 IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 763 ~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
++......+......+.+++.+|++.+|++|||+.|+++.
T Consensus 235 --~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 --DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111112222233568899999999999999999999865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=349.24 Aligned_cols=244 Identities=24% Similarity=0.330 Sum_probs=197.5
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|+.. +++.||+|++++. .....+.+.+|..+++.+ +||||+++++++...+..++||||
T Consensus 26 ~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~ 105 (353)
T 3txo_A 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEF 105 (353)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeC
Confidence 44578999999999999975 6899999999753 223345678899999988 799999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 106 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~--~ 178 (353)
T 3txo_A 106 VNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN--G 178 (353)
T ss_dssp CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccC--C
Confidence 999999999987543 899999999999999999999 889999999999999999999999999999854221 2
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
......+||+.|+|||++.+..++.++||||+||++|||++|++||........... .... .. .+
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~----i~~~-~~----------~~ 243 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILND-EV----------VY 243 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHC-CC----------CC
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH----HHcC-CC----------CC
Confidence 233456899999999999988999999999999999999999999987654433222 2221 11 11
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNM------NRVVM 803 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm------~eVl~ 803 (846)
+......+.+++.+|++.+|++||++ +|+++
T Consensus 244 p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 244 PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11233467899999999999999998 66654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=352.26 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=202.8
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
+.+.+.||+|+||.||+|... +|+.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 92 (444)
T 3soa_A 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV 92 (444)
T ss_dssp EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeC
Confidence 345678999999999999864 78999999997553 334567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC---CCCcEEEEeccCCccCCCCC
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN---DQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld---~~~~vkI~DFGla~~~~~~~ 690 (846)
++|+|.+.+..... +++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||+++.....
T Consensus 93 ~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~- 166 (444)
T 3soa_A 93 TGGELFEDIVAREY--YSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE- 166 (444)
T ss_dssp BCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT-
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC-
Confidence 99999999987643 899999999999999999999 88999999999999998 5678999999999865432
Q ss_pred cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
........||+.|+|||++.+..++.++||||+||++|||++|++||........... . ..+... ...+.+
T Consensus 167 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~----i-~~~~~~-~~~~~~-- 237 (444)
T 3soa_A 167 -QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----I-KAGAYD-FPSPEW-- 237 (444)
T ss_dssp -CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----H-HHTCCC-CCTTTT--
T ss_pred -CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHH----H-HhCCCC-CCcccc--
Confidence 2223456799999999999998999999999999999999999999987654333222 1 112111 111111
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
......+.+++.+|++.+|++|||+.|+++
T Consensus 238 ---~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 238 ---DTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 122356889999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.54 Aligned_cols=263 Identities=25% Similarity=0.381 Sum_probs=210.3
Q ss_pred hhhhhcCcCceEEEEEEEE-----cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEee--cCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYL-----DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN--EGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~~LV~ 610 (846)
.+.+.||+|+||.||+|++ .+++.||||++........+.+.+|+.++++++||||+++++++. +....++||
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 105 (327)
T 3lxl_A 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVM 105 (327)
T ss_dssp EEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEE
T ss_pred hhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEE
Confidence 4457899999999999984 368899999998877777788999999999999999999999886 556789999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+++++|.+++..... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 106 e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 181 (327)
T 3lxl_A 106 EYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181 (327)
T ss_dssp ECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred eecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence 99999999999986433 4899999999999999999999 8899999999999999999999999999998764332
Q ss_pred cc-cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc-----------cHHHHHHHHHhcC
Q 003114 691 VS-HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK-----------HISQWVDFMLAQG 758 (846)
Q Consensus 691 ~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~-----------~l~~~~~~~~~~~ 758 (846)
.. .......||..|+|||.+.+..++.++|||||||+++||++|+.||....... ....... ....
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~- 259 (327)
T 3lxl_A 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE-LLEE- 259 (327)
T ss_dssp SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH-HHHT-
T ss_pred ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH-Hhhc-
Confidence 21 22334568889999999999889999999999999999999999986543211 1111111 1111
Q ss_pred CcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 003114 759 DIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETA 814 (846)
Q Consensus 759 ~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~ 814 (846)
......+......+.+++.+|++.+|++|||++|+++.|+++......
T Consensus 260 --------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 260 --------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred --------ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 111122334456789999999999999999999999999998765544
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=348.58 Aligned_cols=249 Identities=18% Similarity=0.283 Sum_probs=205.7
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.+.||+|+||.||+|... +++.||+|++..........+.+|+.+++.++||||+++++++.++...++||||+++|
T Consensus 54 ~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg 133 (387)
T 1kob_A 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133 (387)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCC
Confidence 44578999999999999975 68899999998776666678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC--CCcEEEEeccCCccCCCCCcccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND--QFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~--~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+++..... ..
T Consensus 134 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~---~~ 206 (387)
T 1kob_A 134 ELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EI 206 (387)
T ss_dssp BHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---SC
T ss_pred cHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCC---cc
Confidence 9999997654 24899999999999999999999 889999999999999974 578999999999876432 22
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........+.. ..... . ..++.. ..
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~----i~~~~-~--~~~~~~----~~ 275 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRCD-W--EFDEDA----FS 275 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHCC-C--CCCSST----TT
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHH----HHhCC-C--CCCccc----cc
Confidence 2345799999999999999999999999999999999999999987654332222 21111 1 111111 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.....+.+++.+|++.+|++|||+.|+++.
T Consensus 276 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 276 SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 234568899999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.15 Aligned_cols=257 Identities=26% Similarity=0.389 Sum_probs=205.6
Q ss_pred hhhhhcCcCceEEEEEEEEcC----CcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLDD----NTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|+..+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++.++ ..++||||
T Consensus 15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~ 93 (281)
T 3cc6_A 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMEL 93 (281)
T ss_dssp EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEEC
T ss_pred EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEec
Confidence 345789999999999998643 335999999765 334567789999999999999999999998754 56899999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 94 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 168 (281)
T 3cc6_A 94 YPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-Y 168 (281)
T ss_dssp CTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred CCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccccc-c
Confidence 99999999997654 34899999999999999999999 8999999999999999999999999999998654321 1
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.......+++.|+|||.+.+..++.++|||||||+++||++ |+.||........... ...+... .
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-----~~~~~~~---------~ 234 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-----LEKGDRL---------P 234 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-----HHHTCCC---------C
T ss_pred cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-----HhcCCCC---------C
Confidence 22234557889999999998899999999999999999998 9999976554432221 1111110 0
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETA 814 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~ 814 (846)
.+......+.+++.+|++.+|++||++.|+++.|+++.+.+..
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 1112335688999999999999999999999999999887654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=371.31 Aligned_cols=253 Identities=28% Similarity=0.466 Sum_probs=209.4
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||.||+|.+.++..||||+++.... ..+++.+|+.+|++++||||+++++++.+ +..++||||+++|+
T Consensus 270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gs 347 (535)
T 2h8h_A 270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 347 (535)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred hhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence 45678999999999999998888999999986543 34679999999999999999999999876 67899999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.++++......+++.+++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++..... .......
T Consensus 348 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~ 423 (535)
T 2h8h_A 348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQG 423 (535)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-HHHTTCS
T ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC-ceecccC
Confidence 999998654445899999999999999999999 889999999999999999999999999999865321 1112233
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..++..|+|||.+....++.++|||||||++|||++ |+.||......+.+ ..+ ..+. ....+...
T Consensus 424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~----~~i-~~~~---------~~~~~~~~ 489 (535)
T 2h8h_A 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL----DQV-ERGY---------RMPCPPEC 489 (535)
T ss_dssp TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH----HHH-HTTC---------CCCCCTTC
T ss_pred CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHH-HcCC---------CCCCCCCC
Confidence 457789999999998899999999999999999999 99999865433222 222 1211 01112234
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
...+.+|+.+||+.+|++|||+++|++.|+++..
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 4578899999999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=344.92 Aligned_cols=249 Identities=23% Similarity=0.355 Sum_probs=203.2
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
+.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 110 (362)
T 2bdw_A 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 110 (362)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 445678999999999999975 6899999999754 3344567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC---CcEEEEeccCCccCCCCC
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ---FQARLADFGLSKTFPIEG 690 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~---~~vkI~DFGla~~~~~~~ 690 (846)
++|+|.+.+.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 111 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 111 TGGELFEDIVARE--FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp CSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 9999999997654 4899999999999999999999 8899999999999999865 45999999999876422
Q ss_pred cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
.......||+.|+|||++.+..++.++|||||||++|||++|++||.......... ... .+.... ..+.
T Consensus 185 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----~i~-~~~~~~-~~~~--- 253 (362)
T 2bdw_A 185 --EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA----QIK-AGAYDY-PSPE--- 253 (362)
T ss_dssp --CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHH-HTCCCC-CTTG---
T ss_pred --cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHH-hCCCCC-Cccc---
Confidence 22334679999999999999899999999999999999999999998655432222 111 111110 0000
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.......+.+++.+|++.+|++||++.|+++.
T Consensus 254 --~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 254 --WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11234568899999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=335.28 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=193.3
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--------------------------hhhHHHHHHHHHHHhccc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--------------------------QGYEQFEAEVILLRTVHH 590 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--------------------------~~~~~~~~Ei~~l~~l~H 590 (846)
.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++|
T Consensus 16 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 95 (298)
T 2zv2_A 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDH 95 (298)
T ss_dssp EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCC
T ss_pred EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCC
Confidence 34578999999999999974 688999999865421 123568899999999999
Q ss_pred ccceeEeeEeec--CCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEE
Q 003114 591 KNLTTLYGYCNE--GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANIL 668 (846)
Q Consensus 591 pnIv~l~g~~~~--~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NIL 668 (846)
|||+++++++.. ++..++||||+++++|.+++... .+++.++..++.|++.||+||| +.+|+||||||+|||
T Consensus 96 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 96 PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLL 169 (298)
T ss_dssp TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEE
Confidence 999999999976 67899999999999999876542 4899999999999999999999 889999999999999
Q ss_pred ECCCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCccccc
Q 003114 669 LNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFR---LTEKSDVYSFGVVLLEIITSRPAIANTEEHK 745 (846)
Q Consensus 669 ld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~ 745 (846)
++.++.+||+|||+++..... ........||+.|+|||.+.+.. .+.++|||||||++|||++|+.||......
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~- 246 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM- 246 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred ECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH-
Confidence 999999999999999876432 12234467999999999987665 478999999999999999999999765432
Q ss_pred cHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 746 HISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 746 ~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+..... ...... + ........+.+++.+|++.+|++||++.|+++
T Consensus 247 ---~~~~~~~-~~~~~~---~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 247 ---CLHSKIK-SQALEF---P-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ---HHHHHHH-HCCCCC---C-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---HHHHHHh-cccCCC---C-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 2222222 111110 0 01123356889999999999999999999865
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=341.35 Aligned_cols=259 Identities=25% Similarity=0.426 Sum_probs=203.7
Q ss_pred hhhcCcCceEEEEEEEEcC-----CcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 540 ETILGEGSFGKVYHGYLDD-----NTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.||+|+||.||+|.... +..||+|++.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 4689999999999998643 2459999997653 334567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc-c
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV-S 692 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~-~ 692 (846)
++|+|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 129 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 204 (333)
T 1mqb_A 129 ENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204 (333)
T ss_dssp TTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred CCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccc
Confidence 9999999998653 34899999999999999999999 88999999999999999999999999999987643221 1
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.......+|+.|+|||.+.+..++.++|||||||+++||++ |+.||........ .......... .
T Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~----~~~~~~~~~~----------~ 270 (333)
T 1mqb_A 205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV----MKAINDGFRL----------P 270 (333)
T ss_dssp ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHHTTCCC----------C
T ss_pred cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH----HHHHHCCCcC----------C
Confidence 12223456788999999998899999999999999999999 9999976543322 2222211111 1
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhhh
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARK 816 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~~ 816 (846)
.+......+.+++.+|++.+|++||++.|+++.|++++......+
T Consensus 271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~ 315 (333)
T 1mqb_A 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 315 (333)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhh
Confidence 122344578899999999999999999999999999886554433
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=349.47 Aligned_cols=268 Identities=20% Similarity=0.269 Sum_probs=212.7
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCC--eeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN--QIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||||+
T Consensus 12 ~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~ 91 (396)
T 4eut_A 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91 (396)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCC
T ss_pred EEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecC
Confidence 34578999999999999976 58999999997543 233567789999999999999999999987654 789999999
Q ss_pred cCCChhhhhhcCCC-CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE----CCCCcEEEEeccCCccCCC
Q 003114 614 ANGSLEEYLSDSNA-DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL----NDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 614 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl----d~~~~vkI~DFGla~~~~~ 688 (846)
++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++....
T Consensus 92 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp TTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred CCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 99999999986542 33899999999999999999999 8899999999999999 7888899999999987532
Q ss_pred CCcccccccccCCCcccCcccccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCc
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQT--------FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDI 760 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~--------~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 760 (846)
. .......||+.|+|||.+.. ..++.++|||||||++|||++|+.||..........+.+.........
T Consensus 169 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~ 245 (396)
T 4eut_A 169 D---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (396)
T ss_dssp G---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred C---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence 2 22334679999999998865 567889999999999999999999997544333333333333332211
Q ss_pred cc---cc-----------CCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 761 KN---IV-----------DPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 761 ~~---~~-----------d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
.. .. +..............+.+++.+|++.||++||+++|+++.+++++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 10 00 00111123456677889999999999999999999999999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=335.24 Aligned_cols=256 Identities=28% Similarity=0.477 Sum_probs=202.4
Q ss_pred hhhhhcCcCceEEEEEEEEcC----CcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEe-ecCCeeeEeee
Q 003114 538 DFETILGEGSFGKVYHGYLDD----NTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYC-NEGNQIGLIYE 611 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~-~~~~~~~LV~E 611 (846)
.+.+.||+|+||.||+|+..+ ...||+|.+.... ....+.+.+|+.++++++||||+++++++ ..++..++|||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 107 (298)
T 3f66_A 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 107 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence 345789999999999998642 2358999997643 34557789999999999999999999986 45668899999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 108 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 108 YMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp CCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred CCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 999999999997644 34889999999999999999999 88999999999999999999999999999986643221
Q ss_pred --ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 692 --SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 692 --~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
........+|+.|+|||.+.+..++.++||||+|++++||++ |.+||............ . .+.. ..
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----~-~~~~--~~---- 252 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----L-QGRR--LL---- 252 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH----H-TTCC--CC----
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH----h-cCCC--CC----
Confidence 122234567889999999999999999999999999999999 56677655443322221 1 1110 00
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
.+......+.+++.+|++.+|++||+++|+++.|++++..
T Consensus 253 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 253 ---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1112335688999999999999999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=338.01 Aligned_cols=241 Identities=24% Similarity=0.371 Sum_probs=201.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 9 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~ 88 (318)
T 1fot_A 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 88 (318)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCC
Confidence 34578999999999999975 78999999997532 223456788999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----- 158 (318)
T 1fot_A 89 EGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 158 (318)
T ss_dssp CSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC-----
Confidence 99999999987543 899999999999999999999 89999999999999999999999999999986532
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
......||+.|+|||.+.+..++.++||||+||++|||++|+.||......... ...... .. . ++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~i~~~-~~------~----~p 223 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY----EKILNA-EL------R----FP 223 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHC-CC------C----CC
T ss_pred ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHHhC-CC------C----CC
Confidence 223467999999999999999999999999999999999999999765543322 222221 11 1 11
Q ss_pred hHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRP-----NMNRVVM 803 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~ 803 (846)
......+.+++.+|+..+|++|| +++|+++
T Consensus 224 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 12234688999999999999999 8888874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=358.14 Aligned_cols=250 Identities=24% Similarity=0.297 Sum_probs=201.4
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.||+|+||+||+|+.. +++.||+|++.+.. ....+.+.+|..++..++||||++++++|.+++..++||||+++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 468999999999999986 57889999996532 12234488999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 159 g~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~ 233 (437)
T 4aw2_A 159 GDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQS 233 (437)
T ss_dssp CBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-CEEC
T ss_pred CcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC-Cccc
Confidence 99999998743 24899999999999999999999 8999999999999999999999999999998664322 2233
Q ss_pred ccccCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 696 TGVAGTFGYLDPEYCQ-----TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
...+||+.|+|||++. ...++.++|||||||++|||++|++||......+.....+..... -.. +...
T Consensus 234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~-----p~~~- 306 (437)
T 4aw2_A 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER-FQF-----PTQV- 306 (437)
T ss_dssp CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-CCC-----CSSC-
T ss_pred ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc-ccC-----Cccc-
Confidence 4468999999999987 557899999999999999999999999876544433333221111 011 1111
Q ss_pred CCChHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTP--RPNMNRVVME 804 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~--RPsm~eVl~~ 804 (846)
......+.+++.+|+..+|++ ||+++|+++.
T Consensus 307 ---~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 307 ---TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ---CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ---ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 112346789999999888888 9999998764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=343.10 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=210.9
Q ss_pred hhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
.+.+.||+|+||.||+|+.. .++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 107 (322)
T 1p4o_A 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 107 (322)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEE
Confidence 44678999999999999864 36789999997653 334567889999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCC--------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccC
Q 003114 611 EYMANGSLEEYLSDSN--------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGL 682 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGl 682 (846)
||+++|+|.+++.... ...+++..+++++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 108 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~Dfg~ 184 (322)
T 1p4o_A 108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 184 (322)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEECcCcc
Confidence 9999999999997532 134789999999999999999999 88999999999999999999999999999
Q ss_pred CccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcc
Q 003114 683 SKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIK 761 (846)
Q Consensus 683 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~ 761 (846)
++...............+|+.|+|||.+.+..++.++|||||||+++||++ |+.||........ ..... .+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----~~~~~-~~~~~ 259 (322)
T 1p4o_A 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----LRFVM-EGGLL 259 (322)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH----HHHHH-TTCCC
T ss_pred ccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH----HHHHH-cCCcC
Confidence 986543322223334457889999999999899999999999999999999 8999976543322 22222 22111
Q ss_pred cccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 003114 762 NIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETA 814 (846)
Q Consensus 762 ~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~ 814 (846)
.........+.+++.+|++.+|++||++.|+++.|++++.....
T Consensus 260 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~ 303 (322)
T 1p4o_A 260 ---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303 (322)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCc
Confidence 11223345688999999999999999999999999988764443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=337.40 Aligned_cols=255 Identities=28% Similarity=0.419 Sum_probs=195.9
Q ss_pred hhhhcCcCceEEEEEEEEc----CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCC-----eee
Q 003114 539 FETILGEGSFGKVYHGYLD----DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN-----QIG 607 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-----~~~ 607 (846)
+.+.||+|+||.||+|+.. .+..||+|++... .....+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEE
T ss_pred eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccE
Confidence 3568999999999999864 3457999998754 3344567899999999999999999999987654 359
Q ss_pred EeeecccCCChhhhhhcC----CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCC
Q 003114 608 LIYEYMANGSLEEYLSDS----NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLS 683 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla 683 (846)
+||||+++|+|.+++... ....+++..++.++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~~ 194 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLS 194 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECSCSCC
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEeecCcc
Confidence 999999999999998532 2345899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCccc
Q 003114 684 KTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKN 762 (846)
Q Consensus 684 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 762 (846)
+...............+++.|+|||.+.+..++.++|||||||+++||++ |+.||........... ... +...
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~-~~~~- 268 (313)
T 3brb_A 195 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY----LLH-GHRL- 268 (313)
T ss_dssp ----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH----HHT-TCCC-
T ss_pred eecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH----HHc-CCCC-
Confidence 87643332233334567889999999999999999999999999999999 8999987654432222 111 1110
Q ss_pred ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 763 IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 763 ~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
..+......+.+++.+|++.+|++||++.++++.|++++.
T Consensus 269 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 269 --------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp --------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1122334578899999999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.13 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=197.9
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||.||+|+.. ++.||+|++... ...+.+.+|+.++++++||||+++++++.+ ..++||||+++|+
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~ 85 (307)
T 2eva_A 11 EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGS 85 (307)
T ss_dssp EEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCB
T ss_pred eeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCC
Confidence 34578999999999999985 788999999654 345778999999999999999999998874 4789999999999
Q ss_pred hhhhhhcCCC-CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc-EEEEeccCCccCCCCCccccc
Q 003114 618 LEEYLSDSNA-DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ-ARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 618 L~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~-vkI~DFGla~~~~~~~~~~~~ 695 (846)
|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++...... .
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~ 160 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----M 160 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----c
Confidence 9999986543 24788999999999999999999433389999999999999988876 799999999764321 2
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....||+.|+|||.+.+..++.++|||||||+++||++|+.||........ ....... .+... .+ ...
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~-~~~~~-----~~----~~~ 228 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVH-NGTRP-----PL----IKN 228 (307)
T ss_dssp ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHH-TTCCC-----CC----BTT
T ss_pred ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHh-cCCCC-----Cc----ccc
Confidence 234689999999999999999999999999999999999999976443221 1111111 11111 11 112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
....+.+++.+|++.+|++|||++|+++.|+.+...-
T Consensus 229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 3356889999999999999999999999999986544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=349.07 Aligned_cols=248 Identities=19% Similarity=0.319 Sum_probs=195.6
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcc--cccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVH--HKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~--HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|...+++.||||++... .....+.+.+|+.+++.++ ||||+++++++..++..++||| +
T Consensus 59 ~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~ 137 (390)
T 2zmd_A 59 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C 137 (390)
T ss_dssp EEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-C
T ss_pred EEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-c
Confidence 345789999999999999888999999998654 3445678899999999996 5999999999999999999999 5
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
.+++|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++.+.......
T Consensus 138 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 138 GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp CSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 6889999998765 4889999999999999999999 89999999999999996 5789999999998764433333
Q ss_pred ccccccCCCcccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCccc
Q 003114 694 LSTGVAGTFGYLDPEYCQT-----------FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKN 762 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~-----------~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 762 (846)
......||+.|+|||++.+ ..++.++|||||||++|||++|++||....... ........
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~~~~~------ 282 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIID------ 282 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHC------
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH---HHHHHHhC------
Confidence 3445679999999999865 368999999999999999999999997543221 11111221
Q ss_pred ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 763 IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 763 ~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+......+......+.+++.+||+.+|++||++.|+++.
T Consensus 283 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 283 ---PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111111122223468899999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=348.25 Aligned_cols=244 Identities=20% Similarity=0.305 Sum_probs=196.1
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|+.. +++.||+|++++. .....+.+.+|..++.++ +||||+++++++..++..++||||
T Consensus 55 ~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~ 134 (396)
T 4dc2_A 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 134 (396)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEc
Confidence 34578999999999999976 5788999999754 223345678899999887 899999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.... ..
T Consensus 135 ~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~~ 207 (396)
T 4dc2_A 135 VNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PG 207 (396)
T ss_dssp CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TT
T ss_pred CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc--CC
Confidence 999999999987543 899999999999999999999 88999999999999999999999999999985322 12
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc----ccHHHHHHHHHhcCCcccccCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEH----KHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~----~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
......+||+.|+|||++.+..++.++|||||||++|||++|++||...... ......+...+..+..
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-------- 279 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-------- 279 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--------
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--------
Confidence 3345578999999999999999999999999999999999999999643211 1111222222222211
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCH
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
.++......+.+++.+||+.+|++||++
T Consensus 280 --~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 --RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1112233467899999999999999996
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=349.42 Aligned_cols=264 Identities=16% Similarity=0.251 Sum_probs=203.9
Q ss_pred hhhhhcCcC--ceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEG--SFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G--~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+| +||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 28 ~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 107 (389)
T 3gni_B 28 ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 107 (389)
T ss_dssp EEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEc
Confidence 445789999 99999999986 78999999997542 34456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc-
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV- 691 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~- 691 (846)
+++|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.+........
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~ 184 (389)
T 3gni_B 108 MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184 (389)
T ss_dssp CTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEE
T ss_pred cCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccc
Confidence 99999999998875556999999999999999999999 88999999999999999999999999998865422111
Q ss_pred ----ccccccccCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc----C---
Q 003114 692 ----SHLSTGVAGTFGYLDPEYCQT--FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ----G--- 758 (846)
Q Consensus 692 ----~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~----~--- 758 (846)
........||+.|+|||.+.+ ..++.++|||||||+++||++|+.||........+.......... .
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (389)
T 3gni_B 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264 (389)
T ss_dssp CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------------
T ss_pred ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccc
Confidence 112233478999999999987 579999999999999999999999998765444332222111000 0
Q ss_pred --C-------------cccccC---CC------CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 759 --D-------------IKNIVD---PK------LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 759 --~-------------~~~~~d---~~------L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
. ..+... +. ............+.+++.+||+.+|++|||++|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 000000 00 0000112233568899999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=349.29 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=195.7
Q ss_pred hhhhcCcCceEEEEEEEEc--CC--cEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeec-CCeeeEeeec
Q 003114 539 FETILGEGSFGKVYHGYLD--DN--TEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE-GNQIGLIYEY 612 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~--~g--~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~LV~Ey 612 (846)
+.+.||+|+||.||+|++. ++ ..||+|.+... .....+++.+|+.++++++||||+++++++.. ++..++||||
T Consensus 93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence 4568999999999999863 22 36899998754 33456789999999999999999999998754 5678999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.+++..... .+++..++.++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 173 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 173 MKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp CTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCCCHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 999999999976543 4889999999999999999999 889999999999999999999999999999865332211
Q ss_pred --cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 693 --HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 693 --~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
.......+|+.|+|||.+.+..++.++|||||||++|||+| |.+||......+.... ...+.. ..
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~-----~~~~~~--~~----- 316 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-----LLQGRR--LL----- 316 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH-----HHTTCC--CC-----
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH-----HHcCCC--CC-----
Confidence 12234567889999999999999999999999999999999 6788876554332211 111110 01
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
.+......+.+++.+||+.+|++||+++|+++.|++++..
T Consensus 317 --~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 317 --QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1122345788999999999999999999999999998743
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=337.01 Aligned_cols=261 Identities=23% Similarity=0.385 Sum_probs=194.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~- 86 (317)
T 2pmi_A 8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD- 86 (317)
T ss_dssp -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-
T ss_pred eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-
Confidence 34578999999999999965 68999999997543 2334678899999999999999999999999999999999998
Q ss_pred CChhhhhhcCC----CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 616 GSLEEYLSDSN----ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 616 gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+|.+++.... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-- 161 (317)
T 2pmi_A 87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-- 161 (317)
T ss_dssp CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC--
T ss_pred CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC--
Confidence 69999886532 235889999999999999999999 889999999999999999999999999999875322
Q ss_pred ccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--ccc-----c
Q 003114 692 SHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--IKN-----I 763 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--~~~-----~ 763 (846)
........||+.|+|||.+.+ ..++.++|||||||+++||++|++||........+............ ... .
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 122334578999999999876 46899999999999999999999999877655544444332211100 000 0
Q ss_pred cCCCCCC------------CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 764 VDPKLHG------------DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 764 ~d~~L~~------------~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
..+.... .........+.+++.+|++.+|++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000000 0001123468899999999999999999998763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=339.43 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=192.4
Q ss_pred hhhhhhcCcCceEEEEEEEE----cCCcEEEEEEeCCCC----chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeE
Q 003114 537 NDFETILGEGSFGKVYHGYL----DDNTEVAVKMLSPSS----RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~L 608 (846)
..+.+.||+|+||.||+++. .+++.||+|+++... ......+.+|+.+++.++||||+++++++..++..++
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 98 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL 98 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence 34457899999999999997 478999999997642 2334567889999999999999999999999999999
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
||||+++|+|.+++..... +++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 99 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 99 ILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEeCCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 9999999999999986543 889999999999999999999 88999999999999999999999999999975422
Q ss_pred CCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
. ........||+.|+|||.+.+..++.++|||||||++|||++|+.||........+.. .... .. .
T Consensus 174 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~----i~~~-~~------~- 239 (327)
T 3a62_A 174 D--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK----ILKC-KL------N- 239 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHT-CC------C-
T ss_pred C--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhC-CC------C-
Confidence 2 1223446799999999999998999999999999999999999999986654332222 2211 10 1
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRP-----NMNRVVM 803 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~ 803 (846)
.+......+.+++.+|++.+|++|| ++.|+++
T Consensus 240 ---~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 ---LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1122335688999999999999999 6667655
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=340.87 Aligned_cols=262 Identities=23% Similarity=0.379 Sum_probs=193.9
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEee-----cCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN-----EGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~-----~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|+. +++.||||++....... ...+.|+..+..++||||+++++.+. .....++||||
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred heeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence 3457899999999999987 68999999996443221 12234444455689999999998543 33467899999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCC---------CeeecCCCCCCEEECCCCcEEEEeccCC
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKP---------PRVHRDIKPANILLNDQFQARLADFGLS 683 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~---------~IiHrDlKp~NILld~~~~vkI~DFGla 683 (846)
+++|+|.+++.... .++..+.+++.|+++||.||| +. +|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 94 YPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp CTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred CCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence 99999999997654 588999999999999999999 66 9999999999999999999999999999
Q ss_pred ccCCCCCc------ccccccccCCCcccCcccccc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCccc-cc----
Q 003114 684 KTFPIEGV------SHLSTGVAGTFGYLDPEYCQT-------FRLTEKSDVYSFGVVLLEIITSRPAIANTEE-HK---- 745 (846)
Q Consensus 684 ~~~~~~~~------~~~~~~~~gt~~Y~APE~~~~-------~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~-~~---- 745 (846)
+.+..... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+..... ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 87643211 122234569999999999876 4567899999999999999999766543221 10
Q ss_pred ---------cHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 746 ---------HISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 746 ---------~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
....+ ............+...+. ........+.+++.+||+.+|++|||++|+++.|++++.
T Consensus 248 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 248 FQTEVGNHPTFEDM-QVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp THHHHCSSCCHHHH-HHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcccCCCchHHHH-HhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 11111 111111111111111111 123456679999999999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=344.32 Aligned_cols=262 Identities=16% Similarity=0.194 Sum_probs=207.3
Q ss_pred hhhhhcCcCceEEEEEEEEcC---------CcEEEEEEeCCCCchhhHHHHHHHHHHHhccccccee-------------
Q 003114 538 DFETILGEGSFGKVYHGYLDD---------NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTT------------- 595 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~---------g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~------------- 595 (846)
.+.+.||+|+||.||+|+... ++.||+|++... +.+.+|+.++++++||||++
T Consensus 45 ~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 119 (352)
T 2jii_A 45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI 119 (352)
T ss_dssp EEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred EEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence 445789999999999999763 789999998754 46889999999999999998
Q ss_pred --EeeEeec-CCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC
Q 003114 596 --LYGYCNE-GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ 672 (846)
Q Consensus 596 --l~g~~~~-~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~ 672 (846)
+++++.. +...++||||+ +++|.+++.......+++..++.++.|++.||.||| +.+|+||||||+|||++.+
T Consensus 120 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 120 PTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPE 195 (352)
T ss_dssp CCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETT
T ss_pred cchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCC
Confidence 5667665 78899999999 999999998764456999999999999999999999 8899999999999999999
Q ss_pred C--cEEEEeccCCccCCCCCc-----ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-cc
Q 003114 673 F--QARLADFGLSKTFPIEGV-----SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTE-EH 744 (846)
Q Consensus 673 ~--~vkI~DFGla~~~~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~-~~ 744 (846)
+ .+||+|||+++.+..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 275 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence 8 999999999987643211 112234579999999999999999999999999999999999999998654 23
Q ss_pred ccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 003114 745 KHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMET 813 (846)
Q Consensus 745 ~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~ 813 (846)
..+.......... .....+.... .......+.+++.+|++.+|++||+++||++.|++++....
T Consensus 276 ~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 276 EDIMKQKQKFVDK--PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp HHHHHHHHHHHHS--CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHhccCC--hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 3333333222211 1222221111 01123578899999999999999999999999999875543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.36 Aligned_cols=250 Identities=27% Similarity=0.421 Sum_probs=199.5
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecC-CeeeEeeecccCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG-NQIGLIYEYMANG 616 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-~~~~LV~Ey~~~g 616 (846)
.+.+.||+|+||.||+|... ++.||+|++.... ..+.+.+|+.++++++||||+++++++.+. +..++||||++++
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~ 100 (278)
T 1byg_A 24 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100 (278)
T ss_dssp EEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred eEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence 44578999999999999874 8899999997543 346789999999999999999999987554 5789999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...... ..
T Consensus 101 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~ 172 (278)
T 1byg_A 101 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QD 172 (278)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc-----cc
Confidence 9999998765445889999999999999999999 889999999999999999999999999998754321 22
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
...+++.|+|||.+.+..++.++||||||++++||++ |+.||........... ...+. ....+..
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-----~~~~~---------~~~~~~~ 238 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGY---------KMDAPDG 238 (278)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-----HTTTC---------CCCCCTT
T ss_pred CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HhcCC---------CCCCccc
Confidence 3457889999999999899999999999999999998 9999986554332211 11111 1111223
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
....+.+++.+|++.+|++||++.|+++.|+++...+
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 239 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 3457889999999999999999999999999986543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=337.52 Aligned_cols=269 Identities=24% Similarity=0.367 Sum_probs=209.7
Q ss_pred HHHHHHhhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHh--cccccceeEeeEeecCC----
Q 003114 531 EITKITNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRT--VHHKNLTTLYGYCNEGN---- 604 (846)
Q Consensus 531 el~~~t~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~g~~~~~~---- 604 (846)
+.......+.+.||+|+||.||+|+. +++.||+|++... ..+.+.+|.+++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 33444556678999999999999998 5899999999643 33567788888887 78999999999998775
Q ss_pred eeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccC-----CCCeeecCCCCCCEEECCCCcEEEEe
Q 003114 605 QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC-----KPPRVHRDIKPANILLNDQFQARLAD 679 (846)
Q Consensus 605 ~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~IiHrDlKp~NILld~~~~vkI~D 679 (846)
..++||||+++|+|.+++... .+++.+++.++.|++.||.|||... +.+|+||||||+|||++.++.+||+|
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred eeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 799999999999999999764 3899999999999999999999321 56899999999999999999999999
Q ss_pred ccCCccCCCCCcc--cccccccCCCcccCccccccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCc
Q 003114 680 FGLSKTFPIEGVS--HLSTGVAGTFGYLDPEYCQTF------RLTEKSDVYSFGVVLLEIITS----------RPAIANT 741 (846)
Q Consensus 680 FGla~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~------~~s~ksDVwS~Gvvl~ELltG----------~~p~~~~ 741 (846)
||+++........ .......||+.|+|||.+.+. .++.++|||||||++|||+|| +.||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 9999865432211 123445799999999998765 234789999999999999999 7788654
Q ss_pred cc-cccHHHHHHHHHhcCCcccccCCCCCCC-CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 742 EE-HKHISQWVDFMLAQGDIKNIVDPKLHGD-IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 742 ~~-~~~l~~~~~~~~~~~~~~~~~d~~L~~~-~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
.. ......+...... .. ..+.+... ...+....+.+++.+|++.+|++|||+.||++.|+++.+.
T Consensus 271 ~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCE-QK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp SCSSCCHHHHHHHHTT-SC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcCcccHHHHHHHHHH-HH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 32 2233333332221 11 11111111 1235667899999999999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=331.08 Aligned_cols=258 Identities=19% Similarity=0.306 Sum_probs=198.3
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 85 (292)
T 3o0g_A 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC
Confidence 4578999999999999975 68899999997543 33446788999999999999999999999999999999999975
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
+|.+.+.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 86 -~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 158 (292)
T 3o0g_A 86 -DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCY 158 (292)
T ss_dssp -EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--CSCC
T ss_pred -CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--cccc
Confidence 6666665433 24899999999999999999999 889999999999999999999999999999865322 2233
Q ss_pred ccccCCCcccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCC-CccccccHHHHHHHHHhcCC--ccccc---C---
Q 003114 696 TGVAGTFGYLDPEYCQTFR-LTEKSDVYSFGVVLLEIITSRPAIA-NTEEHKHISQWVDFMLAQGD--IKNIV---D--- 765 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~-~s~ksDVwS~Gvvl~ELltG~~p~~-~~~~~~~l~~~~~~~~~~~~--~~~~~---d--- 765 (846)
....||+.|+|||.+.+.. ++.++||||+||+++||++|+.|+. .......+............ ..... +
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 4457899999999987765 8999999999999999999887754 43333333333332211100 00000 0
Q ss_pred ------CCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 ------PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 ------~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..............+.+++.+|++.+|++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000111233457789999999999999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=343.80 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=195.2
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.+.||+|+||.||+++.. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 100 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence 344678999999999999976 789999999975432 236788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc--EEEEeccCCccCCCCCccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ--ARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~--vkI~DFGla~~~~~~~~~~ 693 (846)
|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+++.... ..
T Consensus 101 ~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~---~~ 172 (361)
T 3uc3_A 101 GELYERICNAGR--FSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HS 172 (361)
T ss_dssp CBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc---cC
Confidence 999999976543 899999999999999999999 899999999999999987765 99999999974321 12
Q ss_pred ccccccCCCcccCccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEK-SDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~k-sDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
......||+.|+|||.+.+..++.+ +||||+||++|||++|+.||..................... . + ..
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~------~--~~ 243 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-S------I--PD 243 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC-C------C--CT
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC-C------C--CC
Confidence 2334579999999999988877665 89999999999999999999877665555555444432211 0 0 00
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.......+.+++.+|++.+|++|||+.|+++.
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11123467899999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=332.49 Aligned_cols=255 Identities=24% Similarity=0.409 Sum_probs=205.9
Q ss_pred hcCcCceEEEEEEEEc---CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 542 ILGEGSFGKVYHGYLD---DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.||+|+||.||+|... .++.||||++.... ....+++.+|+.+++.++||||+++++++ ..+..++||||++++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 8999999999999652 46789999997553 33457799999999999999999999999 567789999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc-ccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS-HLS 695 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~-~~~ 695 (846)
+|.+++..... +++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++........ ...
T Consensus 103 ~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 177 (291)
T 1xbb_A 103 PLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 177 (291)
T ss_dssp EHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CHHHHHHhCcC--CCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCccccc
Confidence 99999987543 899999999999999999999 889999999999999999999999999999876433221 122
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
....+++.|+|||.+.+..++.++||||||++++||++ |+.||........ .. ....+... ..+.
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~-~~~~~~~~---------~~~~ 243 (291)
T 1xbb_A 178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV----TA-MLEKGERM---------GCPA 243 (291)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----HH-HHHTTCCC---------CCCT
T ss_pred ccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH----HH-HHHcCCCC---------CCCC
Confidence 23456789999999998889999999999999999999 9999986553321 11 12222111 1122
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhhh
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARK 816 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~~ 816 (846)
.....+.+++.+|++.+|++||++.||++.|+++........
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 285 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence 344578899999999999999999999999999987776654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=340.32 Aligned_cols=244 Identities=20% Similarity=0.309 Sum_probs=197.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|..++.++ +||||+++++++...+..++||||
T Consensus 12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~ 91 (345)
T 3a8x_A 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 91 (345)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence 34578999999999999975 6889999999754 233456688899999988 899999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 92 ~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~--~ 164 (345)
T 3a8x_A 92 VNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--G 164 (345)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT--T
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC--C
Confidence 99999999998654 3899999999999999999999 889999999999999999999999999999864221 2
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccc----cHHHHHHHHHhcCCcccccCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK----HISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~----~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
......+||+.|+|||.+.+..++.++||||+||++|||++|++||....... .........+..+...
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------- 237 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------- 237 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-------
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-------
Confidence 23445689999999999999999999999999999999999999997532110 1111122222222111
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCH
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
++......+.+++.+|++.+|++||++
T Consensus 238 ---~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 ---IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 112233468899999999999999996
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=342.02 Aligned_cols=251 Identities=17% Similarity=0.174 Sum_probs=203.5
Q ss_pred hhhhhcCcCceEEEEEEE------EcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc---cccceeEeeEeecCCeeeE
Q 003114 538 DFETILGEGSFGKVYHGY------LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH---HKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~------~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~L 608 (846)
.+.+.||+|+||.||+|. ..+++.||+|++..... .++..|+.+++.++ |+||+++++++..++..++
T Consensus 68 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l 144 (365)
T 3e7e_A 68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144 (365)
T ss_dssp EEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred EEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence 345689999999999994 45788999999986543 45677777777775 9999999999999999999
Q ss_pred eeecccCCChhhhhhcC---CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-----------CCc
Q 003114 609 IYEYMANGSLEEYLSDS---NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-----------QFQ 674 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-----------~~~ 674 (846)
||||+++|+|.+++... ....+++..++.++.|++.||+||| +.+|+||||||+|||++. ++.
T Consensus 145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccccCC
Confidence 99999999999999752 2345999999999999999999999 899999999999999998 899
Q ss_pred EEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHH
Q 003114 675 ARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFM 754 (846)
Q Consensus 675 vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~ 754 (846)
+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------- 292 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--------- 292 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---------
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---------
Confidence 99999999976543333444456789999999999999999999999999999999999999986433211
Q ss_pred HhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHHhhhhhh
Q 003114 755 LAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPR-PNMNRVVMELKECLAMET 813 (846)
Q Consensus 755 ~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~R-Psm~eVl~~L~~~l~~e~ 813 (846)
...+..+... .....+.+++..|++.+|.+| |+++++.+.|++++....
T Consensus 293 -------~~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 293 -------CKPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp -------EEECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -------eeechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 0111111111 123456788999999999988 689999999999886543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=366.95 Aligned_cols=252 Identities=21% Similarity=0.399 Sum_probs=203.3
Q ss_pred hcCcCceEEEEEEEEc---CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 542 ILGEGSFGKVYHGYLD---DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.||+|+||.||+|.+. ++..||||+++... ....+++.+|+.++++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999874 56679999998653 3456789999999999999999999999976 56899999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc-cccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS-HLST 696 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~-~~~~ 696 (846)
|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++........ ....
T Consensus 422 L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 422 LHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp HHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 999997653 34899999999999999999999 889999999999999999999999999999876432211 1122
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
...+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.. . .+..+.. ...+..
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~----~-~i~~~~~---------~~~p~~ 563 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM----A-FIEQGKR---------MECPPE 563 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH----H-HHHTTCC---------CCCCTT
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH----H-HHHcCCC---------CCCCCc
Confidence 2345789999999999999999999999999999998 99999876543321 1 1222211 112233
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
....+.+++.+||+.+|++||++.+|++.|+++....
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 4567899999999999999999999999999977544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=334.46 Aligned_cols=261 Identities=23% Similarity=0.338 Sum_probs=203.4
Q ss_pred HhhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC-----chhhHHHHHHHHHHHhcc---cccceeEeeEeecCC--
Q 003114 536 TNDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS-----RQGYEQFEAEVILLRTVH---HKNLTTLYGYCNEGN-- 604 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-----~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~-- 604 (846)
.+.+.+.||+|+||+||+|+. .+++.||+|++.... ......+.+|+.+++.++ ||||+++++++....
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~ 89 (308)
T 3g33_A 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD 89 (308)
T ss_dssp CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence 345567899999999999996 478999999986322 112346677887777775 999999999987654
Q ss_pred ---eeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEecc
Q 003114 605 ---QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFG 681 (846)
Q Consensus 605 ---~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFG 681 (846)
..++||||+. |+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 90 REIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp SEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 5899999997 69999998877666999999999999999999999 8899999999999999999999999999
Q ss_pred CCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCc-
Q 003114 682 LSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDI- 760 (846)
Q Consensus 682 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~- 760 (846)
+++..... .......||+.|+|||.+.+..++.++|||||||+++||++|++||........+.............
T Consensus 166 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (308)
T 3g33_A 166 LARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242 (308)
T ss_dssp CTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 99865322 22344678999999999999999999999999999999999999998877655555544332111100
Q ss_pred -cc-------ccCCCCCC---CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 761 -KN-------IVDPKLHG---DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 761 -~~-------~~d~~L~~---~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.. .+.+.... ....+....+.+++.+|++.+|++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp SCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00 00000000 001123357889999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=343.07 Aligned_cols=262 Identities=19% Similarity=0.230 Sum_probs=197.4
Q ss_pred hhhhhhcCcCceEEEEEEEEc----CCcEEEEEEeCCCCch-----------hhHHHHHHHHHHHhcccccceeEeeEee
Q 003114 537 NDFETILGEGSFGKVYHGYLD----DNTEVAVKMLSPSSRQ-----------GYEQFEAEVILLRTVHHKNLTTLYGYCN 601 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~-----------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~ 601 (846)
..+.+.||+|+||.||+|+.. .+..+|+|+....... ....+.+|+..++.++||||+++++++.
T Consensus 39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~ 118 (345)
T 2v62_A 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL 118 (345)
T ss_dssp EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence 344578999999999999975 5788999998765322 1223567888899999999999999987
Q ss_pred c----CCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC--cE
Q 003114 602 E----GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF--QA 675 (846)
Q Consensus 602 ~----~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~--~v 675 (846)
. ....++||||+ +++|.+++.... .+++.+++.++.|++.||+||| +.+|+||||||+|||++.++ .+
T Consensus 119 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 119 TEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTSE
T ss_pred cccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCcE
Confidence 7 78899999999 999999998765 4899999999999999999999 88999999999999998877 99
Q ss_pred EEEeccCCccCCCCCc-----ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHH
Q 003114 676 RLADFGLSKTFPIEGV-----SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQW 750 (846)
Q Consensus 676 kI~DFGla~~~~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~ 750 (846)
||+|||+++.+..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||............
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 9999999987632211 11124457999999999999989999999999999999999999999653322222222
Q ss_pred HHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 751 VDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 751 ~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
........ +...+..... .......+.+++.+|++.+|++||++++|++.|+++
T Consensus 273 ~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 273 AKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 22111111 1111110000 012334788999999999999999999999999774
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=333.48 Aligned_cols=266 Identities=22% Similarity=0.325 Sum_probs=200.5
Q ss_pred hhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 537 NDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
..+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 113 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence 34567899999999999997 47899999999753 334556788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 613 MANGSLEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 613 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
+++++|.+++... ....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~- 189 (310)
T 2wqm_A 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 189 (310)
T ss_dssp CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC-
Confidence 9999999999752 2345899999999999999999999 889999999999999999999999999999765322
Q ss_pred cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
........|++.|+|||.+.+..++.++||||||++++||++|+.||..... ....+..... ........
T Consensus 190 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~-~~~~~~~~------ 259 (310)
T 2wqm_A 190 -TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIE-QCDYPPLP------ 259 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C--CHHHHHHHHH-TTCSCCCC------
T ss_pred -CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch--hHHHHHHHhh-cccCCCCc------
Confidence 1222345689999999999999999999999999999999999999975432 1222222222 22111111
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhhhcC
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARKEG 818 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~~~~ 818 (846)
.......+.+++.+|++.+|++||++++|++.|+++........+.
T Consensus 260 --~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~~ 305 (310)
T 2wqm_A 260 --SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEH 305 (310)
T ss_dssp --TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-----
T ss_pred --ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhhh
Confidence 1123346889999999999999999999999999988777665543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=341.37 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=194.7
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCC----eeeEe
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN----QIGLI 609 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~LV 609 (846)
.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv 94 (311)
T 3ork_A 15 ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV 94 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEE
Confidence 3457899999999999996 578999999997642 334567889999999999999999999986644 34999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||+++++|.++++.... +++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 95 ~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 95 MEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred EecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 999999999999986543 899999999999999999999 889999999999999999999999999999866432
Q ss_pred Ccc-cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 690 GVS-HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 690 ~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... ...........
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~----~~~~~~~~~~~---- 241 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ----HVREDPIPPSA---- 241 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHCCCCCHHH----
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HhcCCCCCccc----
Confidence 211 222345689999999999999999999999999999999999999987654332222 22221111000
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHH-HHHHHHhh
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRV-VMELKECL 809 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eV-l~~L~~~l 809 (846)
........+.+++.+|++.+|++||+..++ .+.+.+..
T Consensus 242 ---~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 242 ---RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ---HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 011123468899999999999999966554 45555543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=341.52 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=186.5
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 56 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 133 (349)
T 2w4o_A 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG 133 (349)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence 34578999999999999986 57889999997543 2356889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC---CCcEEEEeccCCccCCCCCccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND---QFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~---~~~vkI~DFGla~~~~~~~~~~ 693 (846)
+|.+++..... +++.++..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++..... .
T Consensus 134 ~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~---~ 205 (349)
T 2w4o_A 134 ELFDRIVEKGY--YSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---V 205 (349)
T ss_dssp BHHHHHTTCSS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc---c
Confidence 99999986543 899999999999999999999 889999999999999975 889999999999865321 2
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........+. .... .... ....+ ..
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~i~-~~~~-~~~~~-----~~ 275 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF---RRIL-NCEY-YFISP-----WW 275 (349)
T ss_dssp -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH---HHHH-TTCC-CCCTT-----TT
T ss_pred ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH---HHHH-hCCC-ccCCc-----hh
Confidence 2334678999999999999899999999999999999999999997654332221 1121 1111 01111 11
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+....+.+++.+|++.+|++|||+.|+++
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 223457889999999999999999999876
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=343.87 Aligned_cols=243 Identities=23% Similarity=0.341 Sum_probs=199.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||
T Consensus 20 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~ 99 (345)
T 1xjd_A 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY 99 (345)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence 34578999999999999985 68899999997532 22345677889999877 999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 100 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~ 172 (345)
T 1xjd_A 100 LNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--D 172 (345)
T ss_dssp CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--T
T ss_pred CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC--C
Confidence 999999999986543 899999999999999999999 889999999999999999999999999999864322 1
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
......+||+.|+|||.+.+..++.++||||+||++|||++|++||......... ..... +. +..
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~-~~------~~~---- 237 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF----HSIRM-DN------PFY---- 237 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHH-CC------CCC----
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHHh-CC------CCC----
Confidence 2234568999999999999999999999999999999999999999865543322 22221 11 111
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMN-RVV 802 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~-eVl 802 (846)
+......+.+++.+|++.+|++||++. ||.
T Consensus 238 p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 112334678999999999999999997 654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=340.77 Aligned_cols=251 Identities=18% Similarity=0.302 Sum_probs=201.3
Q ss_pred HhhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-----chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEe
Q 003114 536 TNDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-----RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV 609 (846)
.+.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3456688999999999999975 68999999985321 12356789999999999999999999999999999999
Q ss_pred eecccCCChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc---EEEEeccCCc
Q 003114 610 YEYMANGSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ---ARLADFGLSK 684 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~---vkI~DFGla~ 684 (846)
|||+++|+|.+.+.... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +||+|||+++
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 99999999998886532 334899999999999999999999 889999999999999986654 9999999998
Q ss_pred cCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 003114 685 TFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIV 764 (846)
Q Consensus 685 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~ 764 (846)
..... ........||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ........ +... .
T Consensus 182 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~i~~-~~~~--~ 251 (351)
T 3c0i_A 182 QLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIK-GKYK--M 251 (351)
T ss_dssp ECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-----HHHHHHHH-TCCC--C
T ss_pred EecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-----HHHHHHHc-CCCC--C
Confidence 76432 2223456799999999999998999999999999999999999999986432 11122221 1110 0
Q ss_pred CCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 765 DPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 765 d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
++... ......+.+++.+|++.+|++|||+.|+++
T Consensus 252 ~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 NPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Ccccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 112346889999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=338.11 Aligned_cols=260 Identities=25% Similarity=0.422 Sum_probs=208.4
Q ss_pred hhhhhcCcCceEEEEEEEE-----cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCC--eeeEee
Q 003114 538 DFETILGEGSFGKVYHGYL-----DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN--QIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~~LV~ 610 (846)
.+.+.||+|+||.||+++. .+++.||+|++........+.+.+|+.++++++||||+++++++...+ ..++||
T Consensus 44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 123 (326)
T 2w1i_A 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 123 (326)
T ss_dssp EEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEE
T ss_pred eeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEE
Confidence 4457899999999999984 368899999998877777788999999999999999999999986644 789999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+++++|.+++..... .+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 124 e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 124 EYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp CCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred ECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 99999999999987543 4899999999999999999999 8899999999999999999999999999998764332
Q ss_pred cc-cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc-----------ccHHHHHHHHHhcC
Q 003114 691 VS-HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEH-----------KHISQWVDFMLAQG 758 (846)
Q Consensus 691 ~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~-----------~~l~~~~~~~~~~~ 758 (846)
.. .......++..|+|||.+.+..++.++|||||||+++||+||+.|+...... .............+
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence 21 1223345778899999999888999999999999999999999988643210 01111111111111
Q ss_pred CcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 759 DIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 759 ~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
. ....+......+.+++.+|++.+|++||++.||++.|+++..
T Consensus 280 ~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 280 G---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 111122344678899999999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=337.49 Aligned_cols=245 Identities=23% Similarity=0.230 Sum_probs=192.1
Q ss_pred HHHhhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEe
Q 003114 534 KITNDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 534 ~~t~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV 609 (846)
.......+.||+|+||+||+|+.. +++.||||++.... .....+...|+..+.++ +||||++++++|.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 334455678999999999999986 79999999986543 23334455566555555 899999999999999999999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||+ +++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999 779999887654 34999999999999999999999 889999999999999999999999999999865322
Q ss_pred CcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
.......||+.|+|||++.+ .++.++|||||||+++||++|+.|+....... .+..+.....+
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--------~~~~~~~~~~~----- 273 (311)
T 3p1a_A 211 ---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ--------QLRQGYLPPEF----- 273 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH--------HHTTTCCCHHH-----
T ss_pred ---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH--------HHhccCCCccc-----
Confidence 22334569999999998876 78999999999999999999977665432211 11111111111
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.......+.+++.+|++.+|++|||++|+++
T Consensus 274 ---~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 ---TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1122357889999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=340.92 Aligned_cols=243 Identities=24% Similarity=0.362 Sum_probs=198.8
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 12 ~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 91 (336)
T 3h4j_B 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA 91 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC
Confidence 3457899999999999997 578999999986432 222357889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
+|+|.+++..... +++.++..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||++...... .
T Consensus 92 -~g~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~---~ 162 (336)
T 3h4j_B 92 -GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---N 162 (336)
T ss_dssp -CEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS---B
T ss_pred -CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC---c
Confidence 7899998876543 899999999999999999999 889999999999999999999999999999865322 2
Q ss_pred ccccccCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
......||+.|+|||.+.+..+ +.++||||+||++|||++|+.||......... ..+ ... ....
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------------~~i-~~~-~~~~ 227 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------------KKV-NSC-VYVM 227 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------------CCC-CSS-CCCC
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------------HHH-HcC-CCCC
Confidence 3344679999999999988775 78999999999999999999999764322110 000 000 0111
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+......+.+++.+|++.+|++|||++|+++.
T Consensus 228 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 22234568899999999999999999999764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=338.51 Aligned_cols=247 Identities=21% Similarity=0.313 Sum_probs=193.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCC-----------
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN----------- 604 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----------- 604 (846)
.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~ 88 (332)
T 3qd2_B 9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEI 88 (332)
T ss_dssp EEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-
T ss_pred ceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhh
Confidence 34578999999999999986 79999999997543 335578999999999999999999999885543
Q ss_pred ----------------------------------------------eeeEeeecccCCChhhhhhcCCC-CccChHHHHH
Q 003114 605 ----------------------------------------------QIGLIYEYMANGSLEEYLSDSNA-DVLSWEGRLR 637 (846)
Q Consensus 605 ----------------------------------------------~~~LV~Ey~~~gsL~~~l~~~~~-~~l~~~~~~~ 637 (846)
..++||||+++|+|.+++..... ...++..++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 168 (332)
T 3qd2_B 89 WLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH 168 (332)
T ss_dssp -------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHH
T ss_pred hhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHH
Confidence 37999999999999999987542 3356667899
Q ss_pred HHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc----------cccccccCCCcccCc
Q 003114 638 IATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS----------HLSTGVAGTFGYLDP 707 (846)
Q Consensus 638 i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~----------~~~~~~~gt~~Y~AP 707 (846)
++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++........ .......||+.|+||
T Consensus 169 i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 169 IFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 9999999999999 889999999999999999999999999999876433211 122345799999999
Q ss_pred cccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhc
Q 003114 708 EYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGC 787 (846)
Q Consensus 708 E~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~C 787 (846)
|.+.+..++.++|||||||+++||++|..|+... ...... ........ ........+.+++.+|
T Consensus 246 E~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------~~~~~~-~~~~~~~~---------~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------VRIITD-VRNLKFPL---------LFTQKYPQEHMMVQDM 309 (332)
T ss_dssp HHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------HHHHHH-HHTTCCCH---------HHHHHCHHHHHHHHHH
T ss_pred HHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------HHHHHH-hhccCCCc---------ccccCChhHHHHHHHH
Confidence 9999999999999999999999999997764211 111111 11111110 0122334678999999
Q ss_pred cCCCCCCCCCHHHHHH
Q 003114 788 VSHSSTPRPNMNRVVM 803 (846)
Q Consensus 788 l~~~P~~RPsm~eVl~ 803 (846)
++.+|++||+++|+++
T Consensus 310 l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 310 LSPSPTERPEATDIIE 325 (332)
T ss_dssp HCSSGGGSCCHHHHHH
T ss_pred ccCCCCcCCCHHHHhh
Confidence 9999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=340.99 Aligned_cols=240 Identities=22% Similarity=0.285 Sum_probs=200.9
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 45 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 124 (350)
T 1rdq_E 45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 3468999999999999975 68999999996532 2234678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 125 gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----- 194 (350)
T 1rdq_E 125 GGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----- 194 (350)
T ss_dssp TCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----
T ss_pred CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-----
Confidence 9999999987543 899999999999999999999 899999999999999999999999999999865321
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....||+.|+|||.+.+..++.++|||||||+++||++|++||......... ..... +.. . ++.
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~-~~~------~----~p~ 259 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVS-GKV------R----FPS 259 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHH-CCC------C----CCT
T ss_pred cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH----HHHHc-CCC------C----CCC
Confidence 23467999999999999999999999999999999999999999865433322 22222 211 1 112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPN-----MNRVVM 803 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPs-----m~eVl~ 803 (846)
.....+.+++.+|++.+|++||+ ++||++
T Consensus 260 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 23356889999999999999998 777765
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=339.95 Aligned_cols=246 Identities=22% Similarity=0.340 Sum_probs=179.8
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
+.||+|+||.||+|... +++.||||++... ....+.+|+.+++.+. ||||+++++++.++...++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 57999999999999975 6899999999643 3466788999999997 99999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC---cEEEEeccCCccCCCCCccccc
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF---QARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~---~vkI~DFGla~~~~~~~~~~~~ 695 (846)
.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++..... ....
T Consensus 94 ~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~ 166 (325)
T 3kn6_A 94 FERIKKKK--HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPL 166 (325)
T ss_dssp HHHHHHCS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CCcc
Confidence 99998764 4899999999999999999999 88999999999999997665 8999999999865322 2223
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc---ccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEH---KHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~---~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
....||+.|+|||.+.+..++.++||||+||+++||++|+.||...... ....+..... ..+... .....
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-~~~~~~------~~~~~ 239 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-KKGDFS------FEGEA 239 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH-TTTCCC------CCSHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH-HcCCCC------CCccc
Confidence 3456899999999999999999999999999999999999999765421 1222222222 221110 00000
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.......+.+++.+|++.+|++|||++|+++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0123457889999999999999999998864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=338.62 Aligned_cols=253 Identities=26% Similarity=0.313 Sum_probs=197.2
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC-----CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS-----SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
..+.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 107 (345)
T 3hko_A 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107 (345)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEE
Confidence 344688999999999999974 6889999998643 3345578999999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCC--------------------------------------CCccChHHHHHHHHHHHHHHHHHhcc
Q 003114 611 EYMANGSLEEYLSDSN--------------------------------------ADVLSWEGRLRIATEAAQGLEYLHLG 652 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~ 652 (846)
||+++|+|.+++.... ...+++..+..++.|++.||+|||
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-- 185 (345)
T 3hko_A 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH-- 185 (345)
T ss_dssp ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH--
Confidence 9999999999985211 112467778899999999999999
Q ss_pred CCCCeeecCCCCCCEEECCCC--cEEEEeccCCccCCCCC--cccccccccCCCcccCcccccc--CCCCchhhHHHHHH
Q 003114 653 CKPPRVHRDIKPANILLNDQF--QARLADFGLSKTFPIEG--VSHLSTGVAGTFGYLDPEYCQT--FRLTEKSDVYSFGV 726 (846)
Q Consensus 653 ~~~~IiHrDlKp~NILld~~~--~vkI~DFGla~~~~~~~--~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~Gv 726 (846)
+.+|+||||||+|||++.++ .+||+|||+++.+.... .........||+.|+|||.+.+ ..++.++|||||||
T Consensus 186 -~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 186 -NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp -HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred -HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 88999999999999998776 89999999998653221 1122345679999999999865 67899999999999
Q ss_pred HHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 727 VLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 727 vl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+++||++|+.||........+... ...... ...+. .......+.+++.+|++.+|++||++.|+++
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~----~~~~~~--~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQV----LNKKLC--FENPN-----YNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHH----HHCCCC--TTSGG-----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHCCCCCCCCChHHHHHHH----Hhcccc--cCCcc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999999999876654433322 211110 00000 1122357889999999999999999999976
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=334.45 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=203.5
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCch------hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEe
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQ------GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV 609 (846)
+.+.+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (321)
T 2a2a_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLI 93 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 455688999999999999975 6899999998754321 356789999999999999999999999999999999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC----cEEEEeccCCcc
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF----QARLADFGLSKT 685 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~----~vkI~DFGla~~ 685 (846)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||++++++ .+||+|||+++.
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 94 LELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp ECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 99999999999998654 4899999999999999999999 88999999999999999887 799999999987
Q ss_pred CCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 003114 686 FPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765 (846)
Q Consensus 686 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 765 (846)
.... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||........+.. ... ... ..+
T Consensus 169 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----i~~-~~~--~~~ 238 (321)
T 2a2a_A 169 IEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITS-VSY--DFD 238 (321)
T ss_dssp CCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHT-TCC--CCC
T ss_pred cCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHh-ccc--ccC
Confidence 6432 122345689999999999988999999999999999999999999986554332222 111 110 001
Q ss_pred CCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 ~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+... ......+.+++.+|++.+|++|||+.|+++
T Consensus 239 ~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 239 EEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 112346889999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=341.41 Aligned_cols=239 Identities=23% Similarity=0.335 Sum_probs=197.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++..+ +||||+++++++...+..++||||
T Consensus 23 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~ 102 (353)
T 2i0e_A 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 102 (353)
T ss_dssp EEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeC
Confidence 44578999999999999986 47889999997542 23345678899999887 899999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 103 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~ 175 (353)
T 2i0e_A 103 VNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--G 175 (353)
T ss_dssp CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--T
T ss_pred CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC--C
Confidence 999999999986543 899999999999999999999 889999999999999999999999999999864221 2
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
......+||+.|+|||++.+..++.++|||||||++|||++|++||......... ...... .. .+
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~-~~----------~~ 240 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF----QSIMEH-NV----------AY 240 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHC-CC----------CC
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH----HHHHhC-CC----------CC
Confidence 2344568999999999999999999999999999999999999999865543322 222221 11 11
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
+......+.+++.+|++.+|++||+.
T Consensus 241 p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 241 PKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 12233578899999999999999964
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=336.89 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=204.0
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcE--EEEEEeCCC-CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTE--VAVKMLSPS-SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~--VAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|+.. ++.. ||+|.+... .....+.+.+|+.+++++ +||||+++++++...+..++||||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 107 (327)
T 1fvr_A 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 107 (327)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEec
Confidence 44678999999999999964 5654 499988753 334456789999999999 999999999999999999999999
Q ss_pred ccCCChhhhhhcCC--------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEE
Q 003114 613 MANGSLEEYLSDSN--------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLA 678 (846)
Q Consensus 613 ~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~ 678 (846)
+++|+|.+++.... ...+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEEC
T ss_pred CCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeEEEc
Confidence 99999999997653 235899999999999999999999 8999999999999999999999999
Q ss_pred eccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhc
Q 003114 679 DFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQ 757 (846)
Q Consensus 679 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~ 757 (846)
|||+++.... ........+++.|+|||.+.+..++.++|||||||+++||++ |+.||....... .... +..
T Consensus 185 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----~~~~-~~~ 256 (327)
T 1fvr_A 185 DFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEK-LPQ 256 (327)
T ss_dssp CTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHH-GGG
T ss_pred ccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH----HHHH-hhc
Confidence 9999874321 122233457889999999998889999999999999999998 999997654322 1111 111
Q ss_pred CCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 758 GDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 758 ~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
+. ....+......+.+++.+|++.+|++||+++|+++.|++++...
T Consensus 257 ~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 257 GY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp TC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 11 11112233457889999999999999999999999999987543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.18 Aligned_cols=247 Identities=21% Similarity=0.343 Sum_probs=202.8
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
..+.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (277)
T 3f3z_A 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90 (277)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence 344678999999999999975 5778999999776555667899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE---CCCCcEEEEeccCCccCCCCCcc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl---d~~~~vkI~DFGla~~~~~~~~~ 692 (846)
++|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++......
T Consensus 91 ~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~--- 162 (277)
T 3f3z_A 91 GELFERVVHKRV--FRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--- 162 (277)
T ss_dssp CBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT---
T ss_pred CcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc---
Confidence 999999876543 899999999999999999999 8899999999999999 78899999999999865432
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
.......||+.|+|||.+.+. ++.++||||||++++||++|+.||...........+ ..+..... ...
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~-~~~----- 230 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI-----REGTFTFP-EKD----- 230 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHCCCCCC-HHH-----
T ss_pred cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH-----HhCCCCCC-chh-----
Confidence 223445799999999988764 899999999999999999999999876543322221 11111000 000
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.......+.+++.+|++.+|++||++.|+++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0012357889999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=326.24 Aligned_cols=248 Identities=24% Similarity=0.397 Sum_probs=202.7
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (276)
T 2yex_A 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 89 (276)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCC
Confidence 44578999999999999975 78999999986443 33457789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++............
T Consensus 90 ~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 90 GELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp EEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 99999997643 3899999999999999999999 889999999999999999999999999999865433333334
Q ss_pred ccccCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccccc-cHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 696 TGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRPAIANTEEHK-HISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~-s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
....|++.|+|||.+.+..+ +.++||||||++++||++|+.||....... ....|.. .... .. ..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~---~~------~~ 231 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----KKTY---LN------PW 231 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT----TCTT---ST------TG
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh----cccc---cC------ch
Confidence 45678999999999987665 789999999999999999999998755432 2222211 1100 00 01
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
......+.+++.+|++.+|++|||++|+++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 232 KKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 123456789999999999999999998875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=349.23 Aligned_cols=247 Identities=21% Similarity=0.299 Sum_probs=200.8
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+++..++||||+++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 153 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 468999999999999976 58899999986421 12234578999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.++++.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 154 g~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~ 226 (410)
T 3v8s_A 154 GDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRC 226 (410)
T ss_dssp EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EEEC
T ss_pred CcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-cccc
Confidence 9999999764 3889999999999999999999 8899999999999999999999999999998764332 1223
Q ss_pred ccccCCCcccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 696 TGVAGTFGYLDPEYCQTFR----LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~----~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
...+||+.|+|||++.+.. ++.++|||||||++|||++|++||...........+....... .. +.
T Consensus 227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-~~-----p~---- 296 (410)
T 3v8s_A 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-TF-----PD---- 296 (410)
T ss_dssp CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-CC-----CT----
T ss_pred cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc-cC-----CC----
Confidence 4568999999999987765 7899999999999999999999998765444333332211110 00 00
Q ss_pred CChHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTP--RPNMNRVVME 804 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~--RPsm~eVl~~ 804 (846)
.......+.+++.+|+..+|++ ||+++||++.
T Consensus 297 -~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 -DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0112346789999999999988 9999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=368.43 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=201.3
Q ss_pred hhcCcCceEEEEEEEEc---CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD---DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||.||+|.+. .++.||||+++... ....+++.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 46999999999999753 46789999997643 2345789999999999999999999999965 558899999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc-ccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV-SHL 694 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~-~~~ 694 (846)
|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+..... ...
T Consensus 454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99999997654 3899999999999999999999 88999999999999999999999999999987643221 122
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. . .+..+.. ...+
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~----~-~i~~~~~---------~~~p 594 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT----A-MLEKGER---------MGCP 594 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----H-HHHTTCC---------CCCC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----H-HHHcCCC---------CCCC
Confidence 233457889999999999999999999999999999998 99999876543221 1 1222211 1112
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
......+.+++.+||+.+|++||++.+|++.|+++..
T Consensus 595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2345678999999999999999999999999998763
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=346.03 Aligned_cols=246 Identities=19% Similarity=0.279 Sum_probs=189.1
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHH-hcccccceeEeeEeec----CCeeeEeeeccc
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLR-TVHHKNLTTLYGYCNE----GNQIGLIYEYMA 614 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~-~l~HpnIv~l~g~~~~----~~~~~LV~Ey~~ 614 (846)
+.||+|+||.||+++.. +++.||||++... ..+.+|+.++. ..+||||+++++++.. ....++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 57999999999999975 6889999999632 45678888874 4589999999998865 567899999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC---CCcEEEEeccCCccCCCCCc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND---QFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~---~~~vkI~DFGla~~~~~~~~ 691 (846)
+|+|.+++.......+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~-- 217 (400)
T 1nxk_A 143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-- 217 (400)
T ss_dssp SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCCC--
Confidence 999999998866556999999999999999999999 889999999999999997 789999999999865322
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.............. .+..+... .-.+.
T Consensus 218 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~-~i~~~~~~-~~~~~---- 290 (400)
T 1nxk_A 218 -NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-RIRMGQYE-FPNPE---- 290 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH-HHHHTCCC-CCTTT----
T ss_pred -CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH-HHHcCccc-CCCcc----
Confidence 223456789999999999999999999999999999999999999976543221100111 11111111 00011
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.......+.+++.+||+.+|++|||+.|+++.
T Consensus 291 -~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 291 -WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11233568899999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=329.86 Aligned_cols=246 Identities=24% Similarity=0.405 Sum_probs=203.2
Q ss_pred HhhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeec------------
Q 003114 536 TNDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE------------ 602 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~------------ 602 (846)
.....+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 3445678999999999999986 78999999997553 457789999999999999999998754
Q ss_pred ----CCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEE
Q 003114 603 ----GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLA 678 (846)
Q Consensus 603 ----~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~ 678 (846)
....++||||+++|+|.+++.......+++..++.++.|++.||.||| +.+|+||||||+||++++++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEEC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEEC
Confidence 456899999999999999998765556999999999999999999999 8899999999999999999999999
Q ss_pred eccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcC
Q 003114 679 DFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG 758 (846)
Q Consensus 679 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~ 758 (846)
|||++....... ......|++.|+|||.+.+..++.++||||||++++||++|..|+.... .+... ...+
T Consensus 165 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------~~~~~-~~~~ 234 (284)
T 2a19_B 165 DFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------KFFTD-LRDG 234 (284)
T ss_dssp CCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH------HHHHH-HHTT
T ss_pred cchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH------HHHHH-hhcc
Confidence 999998764321 2234568999999999999899999999999999999999998874221 11111 1122
Q ss_pred CcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 759 DIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 759 ~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
... . .....+.+++.+|++.+|++||++.|+++.|+.+..
T Consensus 235 ~~~--------~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 235 IIS--------D----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp CCC--------T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred ccc--------c----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 111 1 122457899999999999999999999999988653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=332.38 Aligned_cols=258 Identities=19% Similarity=0.240 Sum_probs=198.3
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 37 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 2h34_A 37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI 116 (309)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEec
Confidence 34578999999999999975 78899999997542 223467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....... ..
T Consensus 117 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~ 190 (309)
T 2h34_A 117 NGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK-LT 190 (309)
T ss_dssp CCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc-cc
Confidence 9999999998654 3899999999999999999999 8899999999999999999999999999997653321 12
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCc-ccccCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDI-KNIVDPKLHGDI 772 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~-~~~~d~~L~~~~ 772 (846)
......|++.|+|||.+.+..++.++||||||++++||++|+.||...... ........... ....
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~-------- 257 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-----VMGAHINQAIPRPSTV-------- 257 (309)
T ss_dssp ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-----HHHHHHHSCCCCGGGT--------
T ss_pred cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-----HHHHHhccCCCCcccc--------
Confidence 223456899999999999889999999999999999999999999865432 11122222111 1111
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhhhhhh
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRP-NMNRVVMELKECLAMETA 814 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RP-sm~eVl~~L~~~l~~e~~ 814 (846)
.......+.+++.+|++.+|++|| +++++++.|++++.....
T Consensus 258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 112234688999999999999999 999999999987755443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=338.72 Aligned_cols=261 Identities=26% Similarity=0.389 Sum_probs=205.7
Q ss_pred hhhhhhcCcCceEEEEEEEE------cCCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEe
Q 003114 537 NDFETILGEGSFGKVYHGYL------DDNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV 609 (846)
..+.+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++++++||||+++++++......++|
T Consensus 32 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (327)
T 2yfx_A 32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 111 (327)
T ss_dssp CEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEE
Confidence 44567899999999999984 35778999999754 334556789999999999999999999999999999999
Q ss_pred eecccCCChhhhhhcCCC-----CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC---CCcEEEEecc
Q 003114 610 YEYMANGSLEEYLSDSNA-----DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND---QFQARLADFG 681 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~---~~~vkI~DFG 681 (846)
|||+++|+|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||+|||++. +..+||+|||
T Consensus 112 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEECccc
Confidence 999999999999987542 34889999999999999999999 889999999999999984 4569999999
Q ss_pred CCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCc
Q 003114 682 LSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDI 760 (846)
Q Consensus 682 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~ 760 (846)
+++...............|++.|+|||.+.+..++.++|||||||+++||+| |+.||....... ..........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~~~~- 263 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEFVTSGGR- 263 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHHHHTTCC-
T ss_pred cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH----HHHHHhcCCC-
Confidence 9875533322223334567899999999998899999999999999999998 999997654322 1222221111
Q ss_pred ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 003114 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETA 814 (846)
Q Consensus 761 ~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~ 814 (846)
. .........+.+++.+|++.+|++||++.|+++.|+.+......
T Consensus 264 ~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 264 M---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred C---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 0 11122345788999999999999999999999999987754433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.56 Aligned_cols=255 Identities=23% Similarity=0.302 Sum_probs=201.7
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-----cccceeEeeEeecCCeeeEeee
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-----HKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-----HpnIv~l~g~~~~~~~~~LV~E 611 (846)
.+.+.||+|+||.||+|+. .+++.||||++... ....+.+..|+.+++.++ ||||+++++++...+..++|||
T Consensus 38 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e 116 (360)
T 3llt_A 38 LVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116 (360)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEEC
T ss_pred EEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEc
Confidence 3457899999999999997 47889999999753 334466788999999986 9999999999999999999999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC--------------------
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-------------------- 671 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-------------------- 671 (846)
|+ +++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 117 ~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 117 PL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp CC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred CC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence 99 999999998877666999999999999999999999 899999999999999975
Q ss_pred -----CCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccccc
Q 003114 672 -----QFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKH 746 (846)
Q Consensus 672 -----~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~ 746 (846)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 267 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH 267 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHH
Confidence 78999999999986432 22346789999999999999999999999999999999999999987654443
Q ss_pred HHHHHHHHHhcC-----------CcccccC-CCC----CCCC-Ch---------------HHHHHHHHHHHhccCCCCCC
Q 003114 747 ISQWVDFMLAQG-----------DIKNIVD-PKL----HGDI-DV---------------NSAWKAVEIAMGCVSHSSTP 794 (846)
Q Consensus 747 l~~~~~~~~~~~-----------~~~~~~d-~~L----~~~~-~~---------------~~~~~l~~L~~~Cl~~~P~~ 794 (846)
+...... .... .....++ ..+ .... .. .....+.+++.+|++.+|++
T Consensus 268 ~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 346 (360)
T 3llt_A 268 LAMMESI-IQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTL 346 (360)
T ss_dssp HHHHHHH-TCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHh-cCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhh
Confidence 3322211 0000 0000000 000 0000 00 01145779999999999999
Q ss_pred CCCHHHHHH
Q 003114 795 RPNMNRVVM 803 (846)
Q Consensus 795 RPsm~eVl~ 803 (846)
|||++|+++
T Consensus 347 Rpta~elL~ 355 (360)
T 3llt_A 347 RPSPAELLK 355 (360)
T ss_dssp SCCHHHHTT
T ss_pred CCCHHHHhc
Confidence 999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.22 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=202.1
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 89 (284)
T 3kk8_A 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89 (284)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred hhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCC
Confidence 4578999999999999975 6899999998654 334457788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc---EEEEeccCCccCCCCCcc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ---ARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~---vkI~DFGla~~~~~~~~~ 692 (846)
++|.+.+..... +++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||+|||++......
T Consensus 90 ~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~--- 161 (284)
T 3kk8_A 90 GELFEDIVAREF--YSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--- 161 (284)
T ss_dssp CBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS---
T ss_pred CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC---
Confidence 999998876543 899999999999999999999 889999999999999986655 999999999765322
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
.......||+.|+|||.+.+..++.++||||+|++++||++|+.||........... .. .+... ...+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~-~~~~~-~~~~~----- 230 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IK-AGAYD-YPSPE----- 230 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH-HTCCC-CCTTT-----
T ss_pred ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH----HH-hcccc-CCchh-----
Confidence 223346799999999999999999999999999999999999999977654332222 11 11111 00111
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.......+.+++.+|++.+|++|||+.|+++.
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 231 WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11223468899999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.09 Aligned_cols=251 Identities=21% Similarity=0.328 Sum_probs=194.1
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+++..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 57999999999999954 7899999999776555567889999999885 799999999999999999999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc---EEEEeccCCccCCCCCc----
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ---ARLADFGLSKTFPIEGV---- 691 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~---vkI~DFGla~~~~~~~~---- 691 (846)
.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+++.......
T Consensus 99 ~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 173 (316)
T 2ac3_A 99 LSHIHKRR--HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173 (316)
T ss_dssp HHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------
T ss_pred HHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccc
Confidence 99998754 3899999999999999999999 889999999999999998776 99999999976532211
Q ss_pred -ccccccccCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccccc-----------HHHHHHHH
Q 003114 692 -SHLSTGVAGTFGYLDPEYCQT-----FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKH-----------ISQWVDFM 754 (846)
Q Consensus 692 -~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~-----------l~~~~~~~ 754 (846)
........||+.|+|||.+.. ..++.++|||||||+++||++|+.||........ .......
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 252 (316)
T 2ac3_A 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES- 252 (316)
T ss_dssp --------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH-
T ss_pred cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH-
Confidence 111223469999999999875 4588999999999999999999999976532110 1111111
Q ss_pred HhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 755 LAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 755 ~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+..+.... -++. .......+.+++.+|++.+|++|||+.|+++
T Consensus 253 i~~~~~~~-~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 253 IQEGKYEF-PDKD-----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHCCCCC-CHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhccCccc-Cchh-----cccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11211100 0000 0012346889999999999999999999876
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=332.24 Aligned_cols=259 Identities=22% Similarity=0.308 Sum_probs=198.2
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 7 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (311)
T 4agu_A 7 KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH 86 (311)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCC
Confidence 4578999999999999975 589999999865533 3356788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++..... +++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 87 ~~l~~~~~~~~~--~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 159 (311)
T 4agu_A 87 TVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDYY 159 (311)
T ss_dssp EHHHHHHHTSSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred chHHHHHhhhcC--CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--cccc
Confidence 999998876543 899999999999999999999 889999999999999999999999999999865322 2223
Q ss_pred ccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHH----------hcC-Ccc--
Q 003114 696 TGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFML----------AQG-DIK-- 761 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~----------~~~-~~~-- 761 (846)
....||..|+|||.+.+ ..++.++||||+||+++||++|++||........+........ ... ...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 34578999999998876 5689999999999999999999999987665444333222110 000 000
Q ss_pred cccCCCCCCCC---ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 762 NIVDPKLHGDI---DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 762 ~~~d~~L~~~~---~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
...++.-.... .......+.+++.+|++.+|++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00011000000 01234568899999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=343.43 Aligned_cols=246 Identities=21% Similarity=0.303 Sum_probs=200.0
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 18 ~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 97 (384)
T 4fr4_A 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLL 97 (384)
T ss_dssp EEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecC
Confidence 34578999999999999975 68889999986432 233467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|+|.+++..... +++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+... .
T Consensus 98 ~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---~ 169 (384)
T 4fr4_A 98 LGGDLRYHLQQNVH--FKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---T 169 (384)
T ss_dssp TTEEHHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT---C
T ss_pred CCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC---C
Confidence 99999999987543 899999999999999999999 889999999999999999999999999999876422 2
Q ss_pred ccccccCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQT---FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ............ .
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~-~---------- 237 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTFETTV-V---------- 237 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHHHHHCC-C----------
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhhcc-c----------
Confidence 3345679999999999864 458999999999999999999999997544322 222222221111 0
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPN-MNRVVM 803 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPs-m~eVl~ 803 (846)
.++......+.+++.+|++.+|++||+ +++|.+
T Consensus 238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 112223457889999999999999998 666543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=353.10 Aligned_cols=244 Identities=24% Similarity=0.341 Sum_probs=192.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 151 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 230 (446)
T 4ejn_A 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 230 (446)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCC
T ss_pred EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeC
Confidence 34578999999999999975 6899999999743 2334456788999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCC-CCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK-PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
++|+|.+++.... .+++..+..++.|++.||+||| + .+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 231 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~ 303 (446)
T 4ejn_A 231 NGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--G 303 (446)
T ss_dssp SSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC--C
Confidence 9999999997654 3899999999999999999999 6 89999999999999999999999999999864322 2
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
.......||+.|+|||++.+..++.++|||||||+++||++|+.||.......... ...... . . +
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~i~~~~-~------~----~ 368 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEE-I------R----F 368 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCC-C------C----C
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH----HHHhCC-C------C----C
Confidence 23345689999999999999999999999999999999999999997655433222 222111 1 0 1
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRP-----NMNRVVM 803 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~ 803 (846)
+......+.+++.+|++.+|++|| +++|+++
T Consensus 369 p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 112335688999999999999999 9999876
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=326.86 Aligned_cols=242 Identities=27% Similarity=0.411 Sum_probs=198.1
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (279)
T 3fdn_A 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 92 (279)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCC
Confidence 4578999999999999975 57789999986432 2234568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|.+++..... +++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..... ..
T Consensus 93 ~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~----~~ 163 (279)
T 3fdn_A 93 LGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SR 163 (279)
T ss_dssp TEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred CCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc----cc
Confidence 9999999986543 899999999999999999999 89999999999999999999999999999865432 12
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....|++.|+|||.+.+..++.++||||+|++++||++|+.||........... ... .. . ..+.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~-~~------~----~~~~ 228 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR----ISR-VE------F----TFPD 228 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHH-TC------C----CCCT
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH----HHh-CC------C----CCCC
Confidence 2345789999999999998999999999999999999999999986543332221 111 11 0 1112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.....+.+++.+|++.+|++||+++|+++.
T Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 229 FVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred cCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 233467899999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=329.69 Aligned_cols=260 Identities=19% Similarity=0.286 Sum_probs=204.5
Q ss_pred hhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEe-ecCCeeeEeeeccc
Q 003114 537 NDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC-NEGNQIGLIYEYMA 614 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~-~~~~~~~LV~Ey~~ 614 (846)
..+.+.||+|+||.||+|+. .+++.||+|++..... .+++.+|+.+++.++|++++..++++ ..++..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence 34467899999999999996 5789999998754432 24688999999999988877776655 6678889999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE---CCCCcEEEEeccCCccCCCCCc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl---d~~~~vkI~DFGla~~~~~~~~ 691 (846)
+++|.+++..... .+++..+..++.|++.||.||| +.+|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 88 ~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 88 GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 9999999985443 3899999999999999999999 8899999999999999 7889999999999987643322
Q ss_pred c-----cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc---ccHHHHHHHHHhcCCcccc
Q 003114 692 S-----HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEH---KHISQWVDFMLAQGDIKNI 763 (846)
Q Consensus 692 ~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~---~~l~~~~~~~~~~~~~~~~ 763 (846)
. .......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... ..+.......... ... .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~-~ 241 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PIE-V 241 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CHH-H
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-hhh-h
Confidence 1 1223467999999999999999999999999999999999999999864422 2222222211111 000 0
Q ss_pred cCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 003114 764 VDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMET 813 (846)
Q Consensus 764 ~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~ 813 (846)
.. ......+.+++.+|++.+|++||++++|++.|++++....
T Consensus 242 ~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 242 LC--------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HT--------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hh--------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 00 1123478899999999999999999999999999885544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=325.37 Aligned_cols=259 Identities=19% Similarity=0.291 Sum_probs=205.1
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEe-ecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC-NEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~-~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||+|+||.||+|+. .+++.||+|++..... .+++.+|+.+++.++|++++..+.++ ..++..++||||+ +
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 3uzp_A 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-C
Confidence 3457899999999999996 5789999999865433 24688999999999998877766655 6677889999999 9
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE---CCCCcEEEEeccCCccCCCCCcc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl---d~~~~vkI~DFGla~~~~~~~~~ 692 (846)
++|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+|||+ ++++.+||+|||+++........
T Consensus 89 ~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 89 PSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 999999975433 4899999999999999999999 8899999999999999 48889999999999876433221
Q ss_pred -----cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccc---cccHHHHHHHHHhcCCccccc
Q 003114 693 -----HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE---HKHISQWVDFMLAQGDIKNIV 764 (846)
Q Consensus 693 -----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~---~~~l~~~~~~~~~~~~~~~~~ 764 (846)
.......||+.|+|||.+.+..++.++|||||||+++||++|+.||..... ...+.......... ... ..
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~-~~ 242 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PIE-VL 242 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CHH-HH
T ss_pred cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-chH-HH
Confidence 122446799999999999999999999999999999999999999986432 22222222221111 000 00
Q ss_pred CCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 003114 765 DPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMET 813 (846)
Q Consensus 765 d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~ 813 (846)
. ......+.+++.+|++.+|++||++++|++.|+++.....
T Consensus 243 ~--------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 243 C--------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp T--------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred H--------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 0 1123468899999999999999999999999999875443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.75 Aligned_cols=243 Identities=25% Similarity=0.366 Sum_probs=198.1
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 57 ~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 136 (348)
T 1u5q_A 57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 136 (348)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecC
Confidence 3346799999999999996 578999999997543 233467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
. |+|.+++.... ..+++..+..++.|+++||.||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 137 ~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 137 L-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp S-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred C-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 7 68888886543 34899999999999999999999 88999999999999999999999999999986532
Q ss_pred ccccccCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQ---TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
.....||+.|+|||++. ...++.++|||||||+++||++|++||........+.. ..... . +.+.
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~----~~~~~-~-----~~~~- 274 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNE-S-----PALQ- 274 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSC-C-----CCCC-
T ss_pred -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhcC-C-----CCCC-
Confidence 23457999999999884 56789999999999999999999999976554332222 22211 1 1111
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.......+.+++.+|++.+|++|||++|+++.
T Consensus 275 --~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 --SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11223467899999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=333.45 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=199.9
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccCC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++...+..++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 78999999999999976 68999999987542 33456789999999999 5699999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC---CCcEEEEeccCCccCCCCCccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND---QFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~---~~~vkI~DFGla~~~~~~~~~~ 693 (846)
+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+++..... .
T Consensus 115 ~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~---~ 188 (327)
T 3lm5_A 115 EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA---C 188 (327)
T ss_dssp EGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-------
T ss_pred cHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc---c
Confidence 9999997765566999999999999999999999 889999999999999997 789999999999875322 2
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
......||+.|+|||.+.+..++.++|||||||+++||++|+.||.............. .... ......
T Consensus 189 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---~~~~--------~~~~~~ 257 (327)
T 3lm5_A 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ---VNVD--------YSEETF 257 (327)
T ss_dssp -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---TCCC--------CCTTTT
T ss_pred ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh---cccc--------cCchhh
Confidence 22345799999999999999999999999999999999999999987654433222111 1110 011111
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
......+.+++.+|++.+|++|||++|+++.
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 2234568899999999999999999998764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=346.96 Aligned_cols=249 Identities=24% Similarity=0.275 Sum_probs=199.4
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|..++..++||||+++++++.+.+..++||||+++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 468999999999999985 78999999996532 22334588999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 146 g~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~-~~~~ 220 (412)
T 2vd5_A 146 GDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVRS 220 (412)
T ss_dssp CBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-CEEC
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheeccCCC-cccc
Confidence 99999998653 24899999999999999999999 8999999999999999999999999999998764322 1223
Q ss_pred ccccCCCcccCccccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 696 TGVAGTFGYLDPEYCQ-------TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~-------~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
...+||+.|+|||++. ...++.++|||||||++|||++|++||......+....++..... -. -+..
T Consensus 221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-~~-----~p~~ 294 (412)
T 2vd5_A 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH-LS-----LPLV 294 (412)
T ss_dssp SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-CC-----CC--
T ss_pred ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-cC-----CCcc
Confidence 3468999999999987 356899999999999999999999999876544433332221110 00 0111
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCC---CCHHHHHHH
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPR---PNMNRVVME 804 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~R---Psm~eVl~~ 804 (846)
.......+.+++.+|+. +|++| |+++|+++.
T Consensus 295 ----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 295 ----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11223468899999999 99998 588888653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=343.31 Aligned_cols=247 Identities=27% Similarity=0.363 Sum_probs=193.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHH-HHhcccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVIL-LRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~-l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|..+ ++.++||||+++++++...+..++||||
T Consensus 41 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~ 120 (373)
T 2r5t_A 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 120 (373)
T ss_dssp EEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeC
Confidence 44678999999999999976 58889999997543 2233455667666 5778999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 121 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~--~ 193 (373)
T 2r5t_A 121 INGGELFYHLQRERC--FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--N 193 (373)
T ss_dssp CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC--C
T ss_pred CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC--C
Confidence 999999999986543 889999999999999999999 899999999999999999999999999999864222 2
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
......+||+.|+|||++.+..++.++|||||||++|||++|++||......+.... .... .. .+
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~----i~~~-~~------~~---- 258 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN----ILNK-PL------QL---- 258 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH----HHHS-CC------CC----
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHhc-cc------CC----
Confidence 234456899999999999999999999999999999999999999986554332222 2221 11 11
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
+......+.+++.+|++.+|++||++.+.++.+.
T Consensus 259 ~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 259 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 1122346789999999999999999875554443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.09 Aligned_cols=248 Identities=22% Similarity=0.342 Sum_probs=200.2
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc------hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEe
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR------QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV 609 (846)
..+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 86 (283)
T 3bhy_A 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLI 86 (283)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEE
Confidence 455678999999999999986 689999999865421 1357789999999999999999999999999999999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC----cEEEEeccCCcc
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF----QARLADFGLSKT 685 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~----~vkI~DFGla~~ 685 (846)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||++..
T Consensus 87 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 87 LELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999999997654 3899999999999999999999 88999999999999998877 899999999986
Q ss_pred CCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 003114 686 FPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765 (846)
Q Consensus 686 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 765 (846)
.... .......|++.|+|||.+.+..++.++||||||++++||++|+.||........+..+ . ..... .+
T Consensus 162 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~-~~~~~--~~ 231 (283)
T 3bhy_A 162 IEAG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI----S-AVNYD--FD 231 (283)
T ss_dssp CC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----H-TTCCC--CC
T ss_pred ccCC---CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh----H-hcccC--Cc
Confidence 5322 1223456899999999999889999999999999999999999999875543322221 1 11100 00
Q ss_pred CCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 ~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+.. .......+.+++.+|++.+|++||++.|+++
T Consensus 232 ~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 232 EEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred chh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000 0122346889999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=328.28 Aligned_cols=248 Identities=21% Similarity=0.336 Sum_probs=201.0
Q ss_pred HhhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 536 TNDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
...+.+.||+|+||.||+++.. +|+.||+|++........+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence 3445678999999999999975 789999999986655455678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE---CCCCcEEEEeccCCccCCCCCc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl---d~~~~vkI~DFGla~~~~~~~~ 691 (846)
+++|.+++..... +++..+..++.|++.||.||| +.+|+||||||+||++ ++++.+||+|||+++....
T Consensus 90 ~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~--- 161 (304)
T 2jam_A 90 GGELFDRILERGV--YTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--- 161 (304)
T ss_dssp SCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC---
T ss_pred CccHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC---
Confidence 9999999976543 899999999999999999999 8899999999999999 7889999999999975422
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.......|++.|+|||.+.+..++.++||||+||+++||++|+.||........... .. .+... ....
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----i~-~~~~~--~~~~---- 229 (304)
T 2jam_A 162 -GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK----IK-EGYYE--FESP---- 229 (304)
T ss_dssp -BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HH-HCCCC--CCTT----
T ss_pred -CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HH-cCCCC--CCcc----
Confidence 122334689999999999998999999999999999999999999976554322222 11 22110 0111
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
........+.+++.+|++.+|++||+++|+++
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 230 FWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11223457889999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=334.98 Aligned_cols=256 Identities=22% Similarity=0.296 Sum_probs=187.6
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-cccceeEeeEe--------ecCCee
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-HKNLTTLYGYC--------NEGNQI 606 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~--------~~~~~~ 606 (846)
..+.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.+++++. ||||+++++++ ......
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 109 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence 345678999999999999974 78999999997766666778999999999996 99999999998 344568
Q ss_pred eEeeecccCCChhhhhhcC-CCCccChHHHHHHHHHHHHHHHHHhccCCCC--eeecCCCCCCEEECCCCcEEEEeccCC
Q 003114 607 GLIYEYMANGSLEEYLSDS-NADVLSWEGRLRIATEAAQGLEYLHLGCKPP--RVHRDIKPANILLNDQFQARLADFGLS 683 (846)
Q Consensus 607 ~LV~Ey~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--IiHrDlKp~NILld~~~~vkI~DFGla 683 (846)
++||||+. |+|.+++... ....+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 110 LLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred EEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 99999995 7999988652 2335999999999999999999999 777 999999999999999999999999999
Q ss_pred ccCCCCCccc----------ccccccCCCcccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHH
Q 003114 684 KTFPIEGVSH----------LSTGVAGTFGYLDPEYC---QTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQW 750 (846)
Q Consensus 684 ~~~~~~~~~~----------~~~~~~gt~~Y~APE~~---~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~ 750 (846)
+......... ......||+.|+|||.+ .+..++.++|||||||++|||++|+.||........+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--- 262 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV--- 262 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh---
Confidence 8764322111 11134589999999988 5667899999999999999999999999754322111
Q ss_pred HHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 003114 751 VDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMET 813 (846)
Q Consensus 751 ~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~ 813 (846)
. + .............+.+++.+|++.+|++||++.|+++.|+++.....
T Consensus 263 -~-----~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 263 -N-----G--------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred -c-----C--------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 0 0 00000011112347789999999999999999999999999875443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=340.80 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=204.1
Q ss_pred hhhhhhcCcCceEEEEEEEE----cCCcEEEEEEeCCCC----chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeee
Q 003114 537 NDFETILGEGSFGKVYHGYL----DDNTEVAVKMLSPSS----RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIG 607 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 607 (846)
..+.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+.+++.+ +||||+++++++..++..+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 34567899999999999997 478999999997542 23345677899999999 6999999999999999999
Q ss_pred EeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCC
Q 003114 608 LIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP 687 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~ 687 (846)
+||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 136 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999998654 3899999999999999999999 8899999999999999999999999999998653
Q ss_pred CCCcccccccccCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 003114 688 IEGVSHLSTGVAGTFGYLDPEYCQT--FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765 (846)
Q Consensus 688 ~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 765 (846)
.. .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+........
T Consensus 211 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------- 282 (355)
T 1vzo_A 211 AD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------- 282 (355)
T ss_dssp GG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-------
T ss_pred cC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC-------
Confidence 22 1222334579999999999875 3578999999999999999999999986655444555444433321
Q ss_pred CCCCCCCChHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 003114 766 PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRP-----NMNRVVMEL 805 (846)
Q Consensus 766 ~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~~L 805 (846)
+ ..+......+.+++.+|+..+|++|| +++|+++..
T Consensus 283 ~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred C----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1 11222335678999999999999999 888887654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=356.41 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=205.3
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 188 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 267 (576)
T 2acx_A 188 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 267 (576)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence 3468999999999999975 78999999996532 2234567899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|.+++.......+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 268 gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~---~~ 341 (576)
T 2acx_A 268 GGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QT 341 (576)
T ss_dssp SCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT---CC
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC---cc
Confidence 999999998766556999999999999999999999 889999999999999999999999999999876432 22
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....||+.|+|||++.+..++.++|||||||++|||++|++||................... . . .++.
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~------~----~~p~ 410 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-P------E----EYSE 410 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-C------C----CCCT
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-c------c----cCCc
Confidence 334589999999999999899999999999999999999999998765433333333322211 1 1 1112
Q ss_pred HHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRP-----NMNRVVM 803 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~ 803 (846)
.....+.+++.+|++.+|++|| +++||++
T Consensus 411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 2335788999999999999999 6777765
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=329.17 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=196.4
Q ss_pred hhhhhcCcCceEEEEEEEEc--CCc--EEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD--DNT--EVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~--~g~--~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
.+.+.||+|+||.||+|++. +++ .||+|+++.. .....+.+.+|+.++++++||||+++++++..+. .++|+
T Consensus 21 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 99 (291)
T 1u46_A 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVT 99 (291)
T ss_dssp EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEE
T ss_pred eeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeE
Confidence 44578999999999999863 233 6899998754 3345678899999999999999999999998765 88999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 100 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 100 ELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp ECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred ecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 9999999999998653 34899999999999999999999 8899999999999999999999999999998764332
Q ss_pred cc-cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 691 VS-HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 691 ~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
.. .......++..|+|||.+.+..++.++||||||++++||++ |+.||........ .......+...
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~~~~~~~~~------- 244 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKIDKEGERL------- 244 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHHTSCCCC-------
T ss_pred cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH----HHHHHccCCCC-------
Confidence 21 12234567889999999998889999999999999999999 9999986654322 22222221110
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
.........+.+++.+|++.+|++||++.++++.|+++..
T Consensus 245 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 245 --PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred --CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1122334578899999999999999999999999988654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=332.88 Aligned_cols=256 Identities=23% Similarity=0.274 Sum_probs=201.6
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEee----cCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN----EGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~----~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+++. .+++.||+|++........+.+.+|+.+++.++||||+++++++. .....++||||
T Consensus 32 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 111 (317)
T 2buj_A 32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF 111 (317)
T ss_dssp EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEEC
T ss_pred EEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEe
Confidence 4457899999999999997 578999999997766667788999999999999999999999986 34578999999
Q ss_pred ccCCChhhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 613 MANGSLEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 613 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
+++|+|.+++... ....+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp CTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred CCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 9999999999763 2345899999999999999999999 8899999999999999999999999999987642111
Q ss_pred ccc-------ccccccCCCcccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCccc-cccHHHHHHHHHhcCC
Q 003114 691 VSH-------LSTGVAGTFGYLDPEYCQTFR---LTEKSDVYSFGVVLLEIITSRPAIANTEE-HKHISQWVDFMLAQGD 759 (846)
Q Consensus 691 ~~~-------~~~~~~gt~~Y~APE~~~~~~---~s~ksDVwS~Gvvl~ELltG~~p~~~~~~-~~~l~~~~~~~~~~~~ 759 (846)
... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||..... ...+.... ...
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~~~- 263 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV----QNQ- 263 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH----HCC-
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh----hcc-
Confidence 000 012245799999999987543 68999999999999999999999964321 11111111 110
Q ss_pred cccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 760 IKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 760 ~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
. ...........+.+++.+|++.+|++||+++|+++.|+.+.
T Consensus 264 ~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 264 L--------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred C--------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0 00111223457889999999999999999999999998865
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=351.41 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=201.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 19 ~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 98 (476)
T 2y94_A 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV 98 (476)
T ss_dssp EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 34578999999999999976 79999999996542 223467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 99 ~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~---~ 170 (476)
T 2y94_A 99 SGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---E 170 (476)
T ss_dssp SSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT---C
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc---c
Confidence 9999999998654 3899999999999999999999 899999999999999999999999999999876432 2
Q ss_pred ccccccCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
.....+||+.|+|||.+.+..+ +.++||||+||+++||++|+.||......... .... .+... .
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~----~~i~-~~~~~----------~ 235 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF----KKIC-DGIFY----------T 235 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH----HHHH-TTCCC----------C
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH----HHHh-cCCcC----------C
Confidence 2344679999999999988765 68999999999999999999999865433222 2221 11110 1
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+......+.+++.+|++.+|++|||++|+++
T Consensus 236 p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1112346789999999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=325.03 Aligned_cols=246 Identities=24% Similarity=0.393 Sum_probs=196.9
Q ss_pred hhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCChh
Q 003114 541 TILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLE 619 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 619 (846)
.+||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999996 468899999998776666678999999999999999999999999999999999999999999
Q ss_pred hhhhcCC-CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-CCcEEEEeccCCccCCCCCccccccc
Q 003114 620 EYLSDSN-ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-QFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 620 ~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
+++.... ...+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+++..... ......
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 182 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NPCTET 182 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--CCcccc
Confidence 9998653 334678889999999999999999 889999999999999987 899999999999865322 122334
Q ss_pred ccCCCcccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 698 VAGTFGYLDPEYCQTFR--LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~--~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
..|++.|+|||.+.+.. ++.++||||||++++||++|+.||......... ........ ..+.+ +..
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~------~~~~~----~~~ 250 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA--MFKVGMFK------VHPEI----PES 250 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH--HHHHHHHC------CCCCC----CTT
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH--HHhhcccc------ccccc----ccc
Confidence 57899999999987643 889999999999999999999999754322211 11111111 11111 223
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
....+.+++.+|++.+|++||++.|+++
T Consensus 251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 251 MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 3457889999999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=325.25 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=195.6
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
..+.+.||+|+||.||+++.. ++..||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 103 (285)
T 3is5_A 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCE 103 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCC
Confidence 445678999999999999975 68899999987543 3345788999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE---CCCCcEEEEeccCCccCCCC
Q 003114 615 NGSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 615 ~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl---d~~~~vkI~DFGla~~~~~~ 689 (846)
+|+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++.....
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 104 GGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred CCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 999999986532 345899999999999999999999 8899999999999999 45688999999999865322
Q ss_pred CcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
.......||+.|+|||.+. ..++.++|||||||+++||++|+.||........ ......... .....
T Consensus 181 ---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~----~~~~~~~~~-~~~~~---- 247 (285)
T 3is5_A 181 ---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV----QQKATYKEP-NYAVE---- 247 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCC-CCCC-----
T ss_pred ---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH----HhhhccCCc-ccccc----
Confidence 2234457899999999876 4689999999999999999999999986543321 111111111 00000
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 248 ---~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 ---CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0012346789999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=345.56 Aligned_cols=259 Identities=21% Similarity=0.354 Sum_probs=191.1
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcc-cccceeEeeEeecC--CeeeEeee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVH-HKNLTTLYGYCNEG--NQIGLIYE 611 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~--~~~~LV~E 611 (846)
.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.+. ||||+++++++... ...++|||
T Consensus 12 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 91 (388)
T 3oz6_A 12 ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFD 91 (388)
T ss_dssp EEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEE
T ss_pred EEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEec
Confidence 44578999999999999974 7899999998653 3345567889999999997 99999999998654 47899999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC-
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG- 690 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~- 690 (846)
|++ ++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 92 ~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 92 YME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp CCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred ccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 997 6999999764 3889999999999999999999 8899999999999999999999999999998653210
Q ss_pred ------------------cccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHH
Q 003114 691 ------------------VSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWV 751 (846)
Q Consensus 691 ------------------~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~ 751 (846)
.........||+.|+|||++.+ ..++.++||||+||+++||++|++||.+.+....+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 1112334679999999999876 678999999999999999999999998876555444443
Q ss_pred HHHHhcCCcccc---------------------cCCCCCCCC------------ChHHHHHHHHHHHhccCCCCCCCCCH
Q 003114 752 DFMLAQGDIKNI---------------------VDPKLHGDI------------DVNSAWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 752 ~~~~~~~~~~~~---------------------~d~~L~~~~------------~~~~~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
...- ......+ ........+ .......+.+++.+|++.+|++|||+
T Consensus 245 ~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 245 GVID-FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHC-CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HhcC-CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 2111 0000000 000000000 00223468899999999999999999
Q ss_pred HHHHHH
Q 003114 799 NRVVME 804 (846)
Q Consensus 799 ~eVl~~ 804 (846)
+|+++.
T Consensus 324 ~e~l~H 329 (388)
T 3oz6_A 324 NDALKH 329 (388)
T ss_dssp HHHTTS
T ss_pred HHHhCC
Confidence 998865
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.62 Aligned_cols=244 Identities=23% Similarity=0.415 Sum_probs=179.6
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 15 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (278)
T 3cok_A 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCH 94 (278)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCC
Confidence 356899999999999997 478999999996432 1224678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....... ..
T Consensus 95 ~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~ 168 (278)
T 3cok_A 95 NGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--EK 168 (278)
T ss_dssp TEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred CCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--Cc
Confidence 999999998653 34899999999999999999999 8899999999999999999999999999998653221 12
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....||+.|+|||.+.+..++.++||||||++++||++|+.||........+.. ...... ..+.
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~~--~~~~ 233 (278)
T 3cok_A 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK-------------VVLADY--EMPS 233 (278)
T ss_dssp -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CCSSCC--CCCT
T ss_pred ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH-------------Hhhccc--CCcc
Confidence 2345689999999999988899999999999999999999999976543322111 000000 1122
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.....+.+++.+|++.+|++||+++|+++
T Consensus 234 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 234 FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 23457889999999999999999999876
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=335.82 Aligned_cols=259 Identities=20% Similarity=0.331 Sum_probs=200.3
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 108 (331)
T 4aaa_A 29 NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108 (331)
T ss_dssp EEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCc
Confidence 3468999999999999975 58999999986543 23345678999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|.+++..... +++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 109 ~~l~~~~~~~~~--~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 181 (331)
T 4aaa_A 109 TILDDLELFPNG--LDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVY 181 (331)
T ss_dssp EHHHHHHHSTTC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred chHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--cccc
Confidence 999988765443 899999999999999999999 889999999999999999999999999999765322 2223
Q ss_pred ccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHH-----------HhcCCcccc
Q 003114 696 TGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFM-----------LAQGDIKNI 763 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~-----------~~~~~~~~~ 763 (846)
....||+.|+|||.+.+. .++.++||||+||+++||++|++||........+...+... .........
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 345689999999998775 78999999999999999999999998776554444333211 011111111
Q ss_pred cCCCCCCCCC-----hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 764 VDPKLHGDID-----VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 764 ~d~~L~~~~~-----~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
..+.+..... ......+.+++.+|++.+|++|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1122211111 1234678899999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.21 Aligned_cols=243 Identities=26% Similarity=0.429 Sum_probs=195.9
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeec----CCeeeEeee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE----GNQIGLIYE 611 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~LV~E 611 (846)
+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.. ....++|||
T Consensus 30 ~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 109 (290)
T 1t4h_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEE
Confidence 3467999999999999975 6788999998654 34456778999999999999999999998764 466899999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCC--eeecCCCCCCEEEC-CCCcEEEEeccCCccCCC
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP--RVHRDIKPANILLN-DQFQARLADFGLSKTFPI 688 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--IiHrDlKp~NILld-~~~~vkI~DFGla~~~~~ 688 (846)
|+++|+|.+++..... +++..+..++.|++.||.||| +.+ |+||||||+|||++ +++.+||+|||++.....
T Consensus 110 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 110 LMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp CCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred ecCCCCHHHHHHHccC--CCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 9999999999987543 899999999999999999999 777 99999999999998 789999999999975432
Q ss_pred CCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
. ......||+.|+|||.+.+ .++.++||||+||+++||++|+.||........+. .... .+......+
T Consensus 185 ~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~-~~~~~~~~~--- 252 (290)
T 1t4h_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY---RRVT-SGVKPASFD--- 252 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---HHHT-TTCCCGGGG---
T ss_pred c----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH---HHHh-ccCCccccC---
Confidence 1 2234568999999998764 58999999999999999999999997654333222 2111 111111111
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
......+.+++.+|++.+|++|||+.|+++
T Consensus 253 -----~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 253 -----KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 112246889999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=333.86 Aligned_cols=261 Identities=25% Similarity=0.333 Sum_probs=201.4
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCch-----hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQ-----GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
+.+.+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 91 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence 344578999999999999975 6899999998753221 2346789999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+++ +|.+++.... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 92 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~- 165 (346)
T 1ua2_A 92 DFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP- 165 (346)
T ss_dssp ECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-
T ss_pred EcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC-
Confidence 99976 8988887654 34889999999999999999999 889999999999999999999999999999876322
Q ss_pred cccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--cccc---c
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--IKNI---V 764 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--~~~~---~ 764 (846)
........||+.|+|||.+.+. .++.++|||||||+++||++|++||........+............ .... .
T Consensus 166 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 166 -NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp -CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred -cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 2233446789999999998654 5899999999999999999999999877655555444433211110 0000 0
Q ss_pred CC---CCCCCCC-----hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 765 DP---KLHGDID-----VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 765 d~---~L~~~~~-----~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+. .-....+ ......+.+++.+|++.+|++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0000011 1233678999999999999999999998774
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=325.41 Aligned_cols=244 Identities=20% Similarity=0.360 Sum_probs=202.3
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 98 (294)
T 2rku_A 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 98 (294)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCC
Confidence 4578999999999999976 5788999998654 23445678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+++|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 99 ~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~ 171 (294)
T 2rku_A 99 RRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ER 171 (294)
T ss_dssp TCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--CC
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc--cc
Confidence 999999987654 3899999999999999999999 8899999999999999999999999999998653221 22
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....|++.|+|||.+.+..++.++||||||++++||++|+.||......+.... .. .+.. .+ +.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~-~~~~------~~----~~ 236 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR----IK-KNEY------SI----PK 236 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HH-TTCC------CC----CT
T ss_pred cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----Hh-hccC------CC----cc
Confidence 3345789999999999998899999999999999999999999986553322211 11 1110 11 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.....+.+++.+|++.+|++||+++|+++.
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 237 HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 223467899999999999999999998874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=334.59 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=198.2
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeeccc
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.+.||+|+||.||+|... +++.||+|++..... ...+|++++.++ +||||+++++++.+++..++||||++
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 344578999999999999975 688999999975533 245688888887 79999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC----CcEEEEeccCCccCCCCC
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ----FQARLADFGLSKTFPIEG 690 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~----~~vkI~DFGla~~~~~~~ 690 (846)
+|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||+.++ +.+||+|||+++......
T Consensus 100 gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 100 GGELLDKILRQK--FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp SCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 999999997654 3899999999999999999999 8899999999999998533 359999999998754321
Q ss_pred cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
.......||+.|+|||.+.+..++.++|||||||++|||++|++||..... ....++..... .+... +..
T Consensus 175 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~-~~~~~------~~~ 244 (342)
T 2qr7_A 175 --GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIG-SGKFS------LSG 244 (342)
T ss_dssp --CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHH-HCCCC------CCS
T ss_pred --CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHc-cCCcc------cCc
Confidence 223446789999999999888899999999999999999999999976432 22223333222 22211 111
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.........+.+++.+|+..+|++||++.|+++.
T Consensus 245 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1112234578899999999999999999998763
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=323.45 Aligned_cols=243 Identities=25% Similarity=0.368 Sum_probs=201.5
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 17 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 96 (284)
T 2vgo_A 17 DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFA 96 (284)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeC
Confidence 34578999999999999976 67889999986432 222467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|+|.+++..... +++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---- 167 (284)
T 2vgo_A 97 PRGELYKELQKHGR--FDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---- 167 (284)
T ss_dssp TTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS----
T ss_pred CCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc----
Confidence 99999999987543 899999999999999999999 899999999999999999999999999998765321
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
......|++.|+|||.+.+..++.++||||||++++||++|+.||.......... ... ... .. .+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~-~~~------~~----~~ 232 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR----RIV-NVD------LK----FP 232 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHH-TTC------CC----CC
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH----HHh-ccc------cC----CC
Confidence 2234578999999999999899999999999999999999999998655332221 111 111 11 11
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
......+.+++.+|++.+|++||+++|+++.
T Consensus 233 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 233 PFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 2233568899999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=350.41 Aligned_cols=244 Identities=23% Similarity=0.340 Sum_probs=202.0
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 357999999999999985 68999999996532 22346688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 616 GSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 616 gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
|+|.+++.... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+.... .
T Consensus 270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~--~ 344 (543)
T 3c4z_A 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--T 344 (543)
T ss_dssp CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--C
T ss_pred CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC--c
Confidence 99999997654 345899999999999999999999 8899999999999999999999999999998764322 2
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.....+||+.|+|||++.+..++.++|||||||++|||++|++||...........+........ . .++
T Consensus 345 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-~----------~~p 413 (543)
T 3c4z_A 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-V----------TYP 413 (543)
T ss_dssp CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-C----------CCC
T ss_pred ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-c----------CCC
Confidence 23345899999999999999999999999999999999999999987654333444444333221 1 112
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMN 799 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~ 799 (846)
......+.+++.+|++.+|++||++.
T Consensus 414 ~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 414 DKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred cccCHHHHHHHHHhccCCHhHCCCCc
Confidence 22345678999999999999999763
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=334.87 Aligned_cols=237 Identities=22% Similarity=0.349 Sum_probs=197.6
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCc--------hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEe
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSR--------QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV 609 (846)
+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 28 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 107 (335)
T 3dls_A 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLV 107 (335)
T ss_dssp EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEE
Confidence 356899999999999996 4788999999975431 1334678899999999999999999999999999999
Q ss_pred eecccCC-ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 610 YEYMANG-SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 610 ~Ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
|||+.+| +|.+++..... +++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 108 ~e~~~~g~~l~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EECCTTSCBHHHHHHTCCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 9999777 99999987643 899999999999999999999 88999999999999999999999999999987643
Q ss_pred CCcccccccccCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCC
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
. .......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||...... ....
T Consensus 183 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------------~~~~ 240 (335)
T 3dls_A 183 G---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------------VEAA 240 (335)
T ss_dssp T---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------------TTTC
T ss_pred C---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------------Hhhc
Confidence 2 22234579999999999988776 88999999999999999999999753221 0011
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.. .+......+.+++.+|++.+|++|||++|+++.
T Consensus 241 ~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 IH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred cC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 011123468899999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=348.10 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=194.0
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecC------CeeeEe
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG------NQIGLI 609 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~LV 609 (846)
+.+.||+|+||.||+|+.. +++.||||++... .....+++.+|+.+++.++||||+++++++... ...++|
T Consensus 66 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv 145 (464)
T 3ttj_A 66 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145 (464)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEE
Confidence 3578999999999999965 6889999999754 334456788999999999999999999998654 467999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||+++ +|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 146 ~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 216 (464)
T 3ttj_A 146 MELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT- 216 (464)
T ss_dssp EECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC------
T ss_pred EeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC-
Confidence 999976 56666643 2889999999999999999999 88999999999999999999999999999986532
Q ss_pred CcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc-----CCc----
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ-----GDI---- 760 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~-----~~~---- 760 (846)
........||+.|+|||++.+..++.++||||+||+++||++|++||.+.+....+...+...-.. ...
T Consensus 217 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 217 --SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred --CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 223345679999999999999999999999999999999999999998776554444433321100 000
Q ss_pred ---------------ccccCCCCCCCC---ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 761 ---------------KNIVDPKLHGDI---DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 761 ---------------~~~~d~~L~~~~---~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
...+...+.... .......+.+|+.+|++.||++|||++|+++.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 01124568899999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.70 Aligned_cols=258 Identities=21% Similarity=0.336 Sum_probs=193.5
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus 37 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 116 (329)
T 3gbz_A 37 RRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE 116 (329)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC
Confidence 34578999999999999964 788999999975432 234567899999999999999999999999999999999997
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE-----CCCCcEEEEeccCCccCCCC
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL-----NDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl-----d~~~~vkI~DFGla~~~~~~ 689 (846)
|+|.+++..... +++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 117 -~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 117 -NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp -EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred -CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 599999987654 899999999999999999999 8899999999999999 45566999999999865322
Q ss_pred CcccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCc--ccc-cC
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDI--KNI-VD 765 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~--~~~-~d 765 (846)
........||+.|+|||.+.+. .++.++|||||||+++||++|++||........+............. ... ..
T Consensus 191 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 191 --IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 2223345689999999998774 48999999999999999999999998776655555544332111100 000 00
Q ss_pred CCCCCCC------------ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 PKLHGDI------------DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 ~~L~~~~------------~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+.+.... .......+.+++.+|++.+|++|||++|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000 0012356789999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=331.36 Aligned_cols=244 Identities=20% Similarity=0.358 Sum_probs=202.3
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 45 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 124 (335)
T 2owb_A 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124 (335)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCC
Confidence 4578999999999999975 5788999998643 23445678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+++|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 125 ~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~ 197 (335)
T 2owb_A 125 RRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ER 197 (335)
T ss_dssp TCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--CC
T ss_pred CCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc--cc
Confidence 999999987654 3899999999999999999999 8899999999999999999999999999998753222 22
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||........... ... +.. .+ +.
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~-~~~------~~----~~ 262 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR----IKK-NEY------SI----PK 262 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHH-TCC------CC----CT
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH----Hhc-CCC------CC----Cc
Confidence 3345789999999999998999999999999999999999999986543322221 111 111 11 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.....+.+++.+|++.+|++||+++|+++.
T Consensus 263 ~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 263 HINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 223467899999999999999999999863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=324.33 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=198.8
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC----chhhHHHHHHHHHHHhcccccceeEeeEe--ecCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS----RQGYEQFEAEVILLRTVHHKNLTTLYGYC--NEGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~--~~~~~~~LV~ 610 (846)
.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++ .+....++||
T Consensus 8 ~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (305)
T 2wtk_C 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM 87 (305)
T ss_dssp CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEE
T ss_pred eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEe
Confidence 44678999999999999974 68899999997542 23456789999999999999999999998 4556889999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||++++ |.+++.......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 88 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 88 EYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp ECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred hhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999876 888887665566999999999999999999999 8899999999999999999999999999998764333
Q ss_pred cccccccccCCCcccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQTFR--LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
.........|++.|+|||.+.+.. .+.++|||||||+++||++|+.||....... ...... .+.. .+
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~i~-~~~~------~~ 232 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK----LFENIG-KGSY------AI 232 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHH-HCCC------CC
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH----HHHHHh-cCCC------CC
Confidence 333344567999999999987644 4789999999999999999999998654322 222222 1111 11
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+......+.+++.+|++.+|++||+++|+++.
T Consensus 233 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 233 ----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11233567899999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=323.17 Aligned_cols=240 Identities=19% Similarity=0.287 Sum_probs=195.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|+.. +++.||+|++... ......++.+|+..+..+ +||||+++++++.+++..++||||+
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 93 (289)
T 1x8b_A 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYC 93 (289)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEec
Confidence 44578999999999999986 7899999998754 334456788899999999 9999999999999999999999999
Q ss_pred cCCChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-------------------C
Q 003114 614 ANGSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-------------------Q 672 (846)
Q Consensus 614 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-------------------~ 672 (846)
++++|.+++.... ...+++..+..++.|++.||.||| +.+|+||||||+|||++. .
T Consensus 94 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 94 NGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp TTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC--------------------C
T ss_pred CCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 9999999997643 245899999999999999999999 889999999999999984 4
Q ss_pred CcEEEEeccCCccCCCCCcccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHH
Q 003114 673 FQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWV 751 (846)
Q Consensus 673 ~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~ 751 (846)
..+||+|||++...... ....||+.|+|||.+.+. .++.++|||||||+++||++|++++...... .
T Consensus 171 ~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~--- 238 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---H--- 238 (289)
T ss_dssp CCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---H---
T ss_pred eEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---H---
Confidence 48999999999865322 224589999999998765 5678999999999999999999877543211 1
Q ss_pred HHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 752 DFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 752 ~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
....+... .+ +......+.+++.+|++.+|++|||+.|+++
T Consensus 239 --~~~~~~~~-----~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 239 --EIRQGRLP-----RI----PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp --HHHTTCCC-----CC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHcCCCC-----CC----CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11122211 11 1223357889999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=344.22 Aligned_cols=260 Identities=20% Similarity=0.316 Sum_probs=182.5
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeec-----CCeeeEe
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE-----GNQIGLI 609 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-----~~~~~LV 609 (846)
.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+|+.++||||+++++++.. ....++|
T Consensus 56 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 135 (458)
T 3rp9_A 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV 135 (458)
T ss_dssp EECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEE
Confidence 44678999999999999965 7899999999754 33455778999999999999999999999843 3679999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||+ +++|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 136 LEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp ECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred Eecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 9998 579999997654 4899999999999999999999 889999999999999999999999999999876422
Q ss_pred Ccc-------------------------cccccccCCCcccCcccc-ccCCCCchhhHHHHHHHHHHHHh----------
Q 003114 690 GVS-------------------------HLSTGVAGTFGYLDPEYC-QTFRLTEKSDVYSFGVVLLEIIT---------- 733 (846)
Q Consensus 690 ~~~-------------------------~~~~~~~gt~~Y~APE~~-~~~~~s~ksDVwS~Gvvl~ELlt---------- 733 (846)
... ......+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 110 123446789999999976 55679999999999999999999
Q ss_pred -CCCCCCCccc--------------------cccHHHHHHHHHhcCCcc--------------cccCCCCCC---CCChH
Q 003114 734 -SRPAIANTEE--------------------HKHISQWVDFMLAQGDIK--------------NIVDPKLHG---DIDVN 775 (846)
Q Consensus 734 -G~~p~~~~~~--------------------~~~l~~~~~~~~~~~~~~--------------~~~d~~L~~---~~~~~ 775 (846)
|+++|.+... ...+..+.. ........ ..+...... .....
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFN-ILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHH-HHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHH-HcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 6666654321 111111111 00000000 000000000 00112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
....+.+|+.+||..||++|||++|+++.
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 24568899999999999999999998874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=336.70 Aligned_cols=257 Identities=22% Similarity=0.326 Sum_probs=199.4
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||++++
T Consensus 37 ~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 116 (360)
T 3eqc_A 37 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 116 (360)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCC
Confidence 3468999999999999976 7899999999765 3444577899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCC-CeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKP-PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
+|.+++..... +++..+..++.+++.||.||| +. +|+||||||+|||++.++.+||+|||++..... ...
T Consensus 117 ~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~~~ 187 (360)
T 3eqc_A 117 SLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMA 187 (360)
T ss_dssp BHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----HC-
T ss_pred CHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc----ccc
Confidence 99999987543 899999999999999999999 64 899999999999999999999999999875421 122
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHh-----------cCC-----
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLA-----------QGD----- 759 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~-----------~~~----- 759 (846)
....||+.|+|||.+.+..++.++|||||||+++||++|+.||...........+...... .+.
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 3457899999999999999999999999999999999999999765432211100000000 000
Q ss_pred ---------ccc----ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 760 ---------IKN----IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 760 ---------~~~----~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
..+ +................+.+++.+|++.+|++|||++|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000 000000000011123468899999999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=323.32 Aligned_cols=245 Identities=26% Similarity=0.445 Sum_probs=203.3
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++......++||||++++
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 105 (303)
T 3a7i_A 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 105 (303)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred HhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence 3468999999999999964 68899999997543 344678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...... .....
T Consensus 106 ~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 177 (303)
T 3a7i_A 106 SALDLLEPG---PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRN 177 (303)
T ss_dssp EHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--BCCBC
T ss_pred cHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcc--ccccC
Confidence 999999753 4899999999999999999999 889999999999999999999999999999865432 12233
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
...|++.|+|||.+.+..++.++||||||++++||++|+.||......... ... ..+.. +.+.. ..
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~-~~~~~-----~~~~~----~~ 243 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL----FLI-PKNNP-----PTLEG----NY 243 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHH-HHSCC-----CCCCS----SC
T ss_pred ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH----HHh-hcCCC-----CCCcc----cc
Confidence 457899999999999999999999999999999999999999765433221 111 11111 11111 22
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
...+.+++.+|++.+|++|||+.|+++..
T Consensus 244 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 244 SKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 34688999999999999999999998753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.06 Aligned_cols=254 Identities=23% Similarity=0.394 Sum_probs=183.3
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||+|+||.||+|.. .+++.||+|++.... ....+++.+|+.++++++||||+++++++...+..++||||+++
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 97 (303)
T 2vwi_A 18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97 (303)
T ss_dssp EEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTT
T ss_pred hhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccC
Confidence 3457899999999999985 478899999986543 33456788999999999999999999999999999999999999
Q ss_pred CChhhhhhcC------CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 616 GSLEEYLSDS------NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 616 gsL~~~l~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
++|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 174 (303)
T 2vwi_A 98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174 (303)
T ss_dssp CBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred CchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence 9999998741 2335899999999999999999999 889999999999999999999999999998765332
Q ss_pred Cc---ccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCccc---
Q 003114 690 GV---SHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKN--- 762 (846)
Q Consensus 690 ~~---~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~--- 762 (846)
.. ........||+.|+|||.+.+ ..++.++|||||||+++||++|+.||........... ... +....
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~-~~~~~~~~ 249 (303)
T 2vwi_A 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML----TLQ-NDPPSLET 249 (303)
T ss_dssp -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH----HHT-SSCCCTTC
T ss_pred CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH----Hhc-cCCCcccc
Confidence 11 112234568999999998875 5689999999999999999999999987654433221 111 11111
Q ss_pred -ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 763 -IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 763 -~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..++... ......+.+++.+|++.+|++||++.|+++
T Consensus 250 ~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 250 GVQDKEML----KKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -----CCC----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccchhh----hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1111111 123356889999999999999999999976
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=343.66 Aligned_cols=248 Identities=21% Similarity=0.339 Sum_probs=189.8
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--------chhhHHHHHHHHHHHhcccccceeEeeEeecCCeee
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--------RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIG 607 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 607 (846)
+.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.. +..+
T Consensus 137 y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~ 215 (419)
T 3i6u_A 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYY 215 (419)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEE
T ss_pred EEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceE
Confidence 445678999999999999975 68999999986432 1123358899999999999999999999865 5578
Q ss_pred EeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC---CcEEEEeccCCc
Q 003114 608 LIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ---FQARLADFGLSK 684 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~---~~vkI~DFGla~ 684 (846)
+||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.+ ..+||+|||+++
T Consensus 216 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 216 IVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred EEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 9999999999999987654 3899999999999999999999 8899999999999999754 459999999998
Q ss_pred cCCCCCcccccccccCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcc
Q 003114 685 TFPIEGVSHLSTGVAGTFGYLDPEYCQT---FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIK 761 (846)
Q Consensus 685 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~ 761 (846)
.... ........||+.|+|||++.+ ..++.++|||||||+++||++|++||........+...+. .+...
T Consensus 291 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~----~~~~~ 363 (419)
T 3i6u_A 291 ILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT----SGKYN 363 (419)
T ss_dssp SCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH----TTCCC
T ss_pred ecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh----cCCCC
Confidence 7532 223345679999999998853 5688999999999999999999999987654444433221 11111
Q ss_pred cccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 762 NIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 762 ~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
. .+.. .......+.+++.+|++.+|++||+++|+++
T Consensus 364 ~--~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 364 F--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp C--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C--Cchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0 0000 0112356889999999999999999999886
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=325.91 Aligned_cols=248 Identities=20% Similarity=0.345 Sum_probs=196.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.+++.++||||+++++++..++..++||||++++
T Consensus 22 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (302)
T 2j7t_A 22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG 101 (302)
T ss_dssp EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTE
T ss_pred eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCC
Confidence 34568999999999999986 58899999998776666788999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++..... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..... ......
T Consensus 102 ~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 175 (302)
T 2j7t_A 102 AVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TLQKRD 175 (302)
T ss_dssp EHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--HHHC--
T ss_pred cHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccc--cccccc
Confidence 99999876432 3899999999999999999999 88999999999999999999999999998753211 011123
Q ss_pred cccCCCcccCcccc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 697 GVAGTFGYLDPEYC-----QTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 697 ~~~gt~~Y~APE~~-----~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
...|++.|+|||.+ ....++.++|||||||+++||++|+.||........+.. ..... .....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~------- 243 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK----IAKSD-PPTLL------- 243 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSC-CCCCS-------
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH----HhccC-CcccC-------
Confidence 35689999999988 356789999999999999999999999987654332222 11111 11110
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+......+.+++.+|++.+|++|||+.|+++
T Consensus 244 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11223456889999999999999999999876
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=342.51 Aligned_cols=257 Identities=23% Similarity=0.299 Sum_probs=203.5
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhc------ccccceeEeeEeecCCeeeEe
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTV------HHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l------~HpnIv~l~g~~~~~~~~~LV 609 (846)
+.+.+.||+|+||.||+|... +++.||||++.... ...+++.+|+.+++.+ +|+||+++++++...+..++|
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 344578999999999999875 58899999997543 3346677888888877 467999999999999999999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc--EEEEeccCCccCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ--ARLADFGLSKTFP 687 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~--vkI~DFGla~~~~ 687 (846)
|||+. ++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+++...
T Consensus 178 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp ECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 99996 69999998877666999999999999999999999 889999999999999999887 9999999997542
Q ss_pred CCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc--------CC
Q 003114 688 IEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ--------GD 759 (846)
Q Consensus 688 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~--------~~ 759 (846)
. ......||+.|+|||++.+..++.++|||||||+++||++|++||....+...+..++...... ..
T Consensus 254 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~ 328 (429)
T 3kvw_A 254 Q-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR 328 (429)
T ss_dssp C-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT
T ss_pred C-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh
Confidence 2 2234578999999999999999999999999999999999999998877665555544321100 00
Q ss_pred cccccCCCC---------------------------CC---C------CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 760 IKNIVDPKL---------------------------HG---D------IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 760 ~~~~~d~~L---------------------------~~---~------~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
....++..- .. . ........+.+++.+||+.||++|||++|+++
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 000000000 00 0 00011346789999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=330.31 Aligned_cols=246 Identities=24% Similarity=0.382 Sum_probs=198.8
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--------hhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeE
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--------QGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--------~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~L 608 (846)
+.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.+++++ +||||+++++++......++
T Consensus 98 ~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 177 (365)
T 2y7j_A 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177 (365)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEE
T ss_pred cceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEE
Confidence 3478999999999999985 799999999875431 1245678899999999 79999999999999999999
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||++..+..
T Consensus 178 v~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 178 VFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 999999999999998654 3899999999999999999999 88999999999999999999999999999987643
Q ss_pred CCcccccccccCCCcccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCccc
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQT------FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKN 762 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~------~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 762 (846)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........+.. . ..+....
T Consensus 253 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~----i-~~~~~~~ 324 (365)
T 2y7j_A 253 G---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----I-MEGQYQF 324 (365)
T ss_dssp T---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----H-HHTCCCC
T ss_pred C---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH----H-HhCCCCC
Confidence 2 22344679999999998863 3588999999999999999999999976543322221 1 1111100
Q ss_pred ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 763 IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 763 ~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+.+ ......+.+++.+|++.+|++||++.|+++
T Consensus 325 -~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 325 -SSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -CHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000 012346889999999999999999999976
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=327.62 Aligned_cols=252 Identities=18% Similarity=0.290 Sum_probs=196.9
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-cccceeEeeEeec--CCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-HKNLTTLYGYCNE--GNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~--~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|+. .+++.||+|++.... .+.+.+|+.++++++ ||||+++++++.. ....++||||+
T Consensus 39 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 39 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred EEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 3457899999999999986 578999999997543 367899999999997 9999999999987 67789999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC-cEEEEeccCCccCCCCCcc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF-QARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-~vkI~DFGla~~~~~~~~~ 692 (846)
++++|.+++.. +++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++......
T Consensus 116 ~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-- 185 (330)
T 3nsz_A 116 NNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-- 185 (330)
T ss_dssp CCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--
T ss_pred CchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--
Confidence 99999999864 788999999999999999999 88999999999999999766 89999999998654322
Q ss_pred cccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcc-ccccHHHHHHHH--------HhcCCc--
Q 003114 693 HLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTE-EHKHISQWVDFM--------LAQGDI-- 760 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~-~~~~l~~~~~~~--------~~~~~~-- 760 (846)
......|+..|+|||.+.+ ..++.++|||||||+++||++|+.||.... ....+....... ......
T Consensus 186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 2334578999999999877 678999999999999999999999996443 222222221111 000000
Q ss_pred ------------ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 761 ------------KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 761 ------------~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
...................+.+++.+|++.+|++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000001111112223567899999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.31 Aligned_cols=248 Identities=24% Similarity=0.391 Sum_probs=199.4
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEee--cCCeeeEeeecc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCN--EGNQIGLIYEYM 613 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~--~~~~~~LV~Ey~ 613 (846)
+.+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.++++++||||+++++++. .+...++||||+
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 89 (279)
T 2w5a_A 10 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89 (279)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECC
T ss_pred eehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCC
Confidence 4578999999999999975 7899999999754 3345567899999999999999999999874 467899999999
Q ss_pred cCCChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccCCCC-----eeecCCCCCCEEECCCCcEEEEeccCCccC
Q 003114 614 ANGSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGCKPP-----RVHRDIKPANILLNDQFQARLADFGLSKTF 686 (846)
Q Consensus 614 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----IiHrDlKp~NILld~~~~vkI~DFGla~~~ 686 (846)
++++|.+++.... ...+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~ 166 (279)
T 2w5a_A 90 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166 (279)
T ss_dssp TTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred CCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence 9999999997643 334899999999999999999999 666 999999999999999999999999999765
Q ss_pred CCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCC
Q 003114 687 PIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDP 766 (846)
Q Consensus 687 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 766 (846)
... ........|++.|+|||.+.+..++.++||||||++++||++|+.||........ ... +..+....
T Consensus 167 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~-i~~~~~~~---- 235 (279)
T 2w5a_A 167 NHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL----AGK-IREGKFRR---- 235 (279)
T ss_dssp -----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHH-HHHTCCCC----
T ss_pred ccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH----HHH-Hhhccccc----
Confidence 322 1122335689999999999988999999999999999999999999986643221 111 22222111
Q ss_pred CCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 003114 767 KLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805 (846)
Q Consensus 767 ~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L 805 (846)
.+......+.+++.+|++.+|++||+++||++.+
T Consensus 236 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 236 -----IPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred -----CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 1122345788999999999999999999998866
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=337.12 Aligned_cols=255 Identities=21% Similarity=0.303 Sum_probs=196.2
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeec--------------
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE-------------- 602 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-------------- 602 (846)
.+.+.||+|+||.||+|+. .+|+.||+|++..... ...+|+.+++.++||||+++++++..
T Consensus 10 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp EEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred EEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 4457899999999999996 5789999999865432 23479999999999999999999843
Q ss_pred ------------------------CCeeeEeeecccCCChhhhhhc--CCCCccChHHHHHHHHHHHHHHHHHhccCCCC
Q 003114 603 ------------------------GNQIGLIYEYMANGSLEEYLSD--SNADVLSWEGRLRIATEAAQGLEYLHLGCKPP 656 (846)
Q Consensus 603 ------------------------~~~~~LV~Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 656 (846)
....++||||++ |+|.+.+.. .....+++..+..++.|++.||+||| +.+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~g 161 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLG 161 (383)
T ss_dssp ------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTT
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCc
Confidence 344889999998 588877764 22345899999999999999999999 899
Q ss_pred eeecCCCCCCEEEC-CCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhC
Q 003114 657 RVHRDIKPANILLN-DQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITS 734 (846)
Q Consensus 657 IiHrDlKp~NILld-~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG 734 (846)
|+||||||+|||++ .++.+||+|||+++.+... .......||+.|+|||.+.+. .++.++||||+||+++||++|
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 238 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence 99999999999998 6899999999999865332 223345789999999988765 489999999999999999999
Q ss_pred CCCCCCccccccHHHHHHHHHhc---------CCcccccCCCCCC-----CCChHHHHHHHHHHHhccCCCCCCCCCHHH
Q 003114 735 RPAIANTEEHKHISQWVDFMLAQ---------GDIKNIVDPKLHG-----DIDVNSAWKAVEIAMGCVSHSSTPRPNMNR 800 (846)
Q Consensus 735 ~~p~~~~~~~~~l~~~~~~~~~~---------~~~~~~~d~~L~~-----~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~e 800 (846)
++||......+.+...++..... ....+..-+.+.. ..+......+.+++.+|++.+|++|||+.|
T Consensus 239 ~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (383)
T 3eb0_A 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318 (383)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 99999877665555544322110 0011111111111 012223456889999999999999999999
Q ss_pred HHH
Q 003114 801 VVM 803 (846)
Q Consensus 801 Vl~ 803 (846)
+++
T Consensus 319 ~l~ 321 (383)
T 3eb0_A 319 AMA 321 (383)
T ss_dssp HHT
T ss_pred Hhc
Confidence 985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=325.25 Aligned_cols=248 Identities=19% Similarity=0.326 Sum_probs=193.1
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcc--cccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVH--HKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~--HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||++...+++.||+|++... .....+.+.+|+.++++++ |+||+++++++..++..++||| +
T Consensus 31 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~ 109 (313)
T 3cek_A 31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C 109 (313)
T ss_dssp EEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred EEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-c
Confidence 345689999999999999988999999998644 3345678899999999997 4999999999999999999999 5
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
.+++|.+++.... .+++..+..++.|+++||.||| +.+|+||||||+|||+++ +.+||+|||+++.........
T Consensus 110 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 110 GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp CSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence 6889999998754 3899999999999999999999 889999999999999965 799999999998764333222
Q ss_pred ccccccCCCcccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCccc
Q 003114 694 LSTGVAGTFGYLDPEYCQT-----------FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKN 762 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~-----------~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 762 (846)
......|++.|+|||.+.+ ..++.++|||||||+++||++|+.||....... ........
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~------ 254 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIID------ 254 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHHHHHC------
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---HHHHHHHh------
Confidence 3344578999999999865 468899999999999999999999997643221 11111221
Q ss_pred ccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 763 IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 763 ~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+......+......+.+++.+|++.+|++||++.|+++.
T Consensus 255 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 255 ---PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ---TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111122223578899999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=344.64 Aligned_cols=240 Identities=17% Similarity=0.161 Sum_probs=187.1
Q ss_pred hhhcCcCceEEEEEEEE-cCCcEEEEEEeCCC---CchhhHHHHHHH---HHHHhcccccceeEe-------eEeecCC-
Q 003114 540 ETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS---SRQGYEQFEAEV---ILLRTVHHKNLTTLY-------GYCNEGN- 604 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~~~~Ei---~~l~~l~HpnIv~l~-------g~~~~~~- 604 (846)
.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ ..++.++||||++++ +++...+
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 46899999999999996 57999999999733 344567889999 455556899999998 5555443
Q ss_pred ----------------eeeEeeecccCCChhhhhhcCCC-----CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCC
Q 003114 605 ----------------QIGLIYEYMANGSLEEYLSDSNA-----DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIK 663 (846)
Q Consensus 605 ----------------~~~LV~Ey~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlK 663 (846)
..++||||+ +|+|.+++..... ..+++..++.++.|++.||+||| +.+|+|||||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDik 233 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLR 233 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 278999999 6899999976431 23456888999999999999999 8899999999
Q ss_pred CCCEEECCCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccC-----------CCCchhhHHHHHHHHHHHH
Q 003114 664 PANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF-----------RLTEKSDVYSFGVVLLEII 732 (846)
Q Consensus 664 p~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----------~~s~ksDVwS~Gvvl~ELl 732 (846)
|+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||++|||+
T Consensus 234 p~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 234 PVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp GGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred HHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 999999999999999999998532 12334567 999999999887 8999999999999999999
Q ss_pred hCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHHHh
Q 003114 733 TSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM--ELKEC 808 (846)
Q Consensus 733 tG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~--~L~~~ 808 (846)
+|+.||......... ..+.. .. ......+.+++.+|++.+|++||++.|+++ .++++
T Consensus 308 tg~~Pf~~~~~~~~~-------------~~~~~-~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 308 CADLPITKDAALGGS-------------EWIFR-SC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HSSCCC------CCS-------------GGGGS-SC-----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HCCCCCcccccccch-------------hhhhh-hc-----cCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 999999754422211 11111 00 122356889999999999999999999986 34443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=333.70 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=194.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecC------CeeeE
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG------NQIGL 608 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~L 608 (846)
.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++... ...++
T Consensus 28 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 107 (367)
T 1cm8_A 28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 107 (367)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEE
Confidence 34568999999999999974 7899999999653 233456788999999999999999999998765 34699
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
||||+ +++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 108 v~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 108 VMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp EEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 99999 88999999863 3899999999999999999999 88999999999999999999999999999986532
Q ss_pred CCcccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcC---------
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG--------- 758 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~--------- 758 (846)
......||+.|+|||.+.+ ..++.++||||+||+++||++|++||.+.+....+...........
T Consensus 181 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 181 -----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp -----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred -----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 2334678999999998877 6799999999999999999999999987665444443332211000
Q ss_pred --------CcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 759 --------DIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 759 --------~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.........+. .........+.+++.+|+..||++|||++|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000000000 0111234568899999999999999999999873
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.78 Aligned_cols=258 Identities=22% Similarity=0.376 Sum_probs=194.8
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCch-hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQ-GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|+.+++.++||||+++++++..++..++||||++ |
T Consensus 6 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (324)
T 3mtl_A 6 KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 84 (324)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-E
T ss_pred EEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-c
Confidence 4568999999999999976 7899999999754322 22345679999999999999999999999999999999997 5
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++..... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 85 ~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~ 158 (324)
T 3mtl_A 85 DLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKTYD 158 (324)
T ss_dssp EHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--ccccc
Confidence 99998876543 4899999999999999999999 889999999999999999999999999999764322 22233
Q ss_pred cccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--cccccC--------
Q 003114 697 GVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--IKNIVD-------- 765 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--~~~~~d-------- 765 (846)
...||+.|+|||.+.+ ..++.++||||+||+++||++|++||........+....+....... ......
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence 4568999999998876 56899999999999999999999999887655544443332211100 000000
Q ss_pred -CCCCCC----CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 -PKLHGD----IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 -~~L~~~----~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+..... ........+.+++.+|++.+|++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 00112356789999999999999999999876
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=318.91 Aligned_cols=244 Identities=22% Similarity=0.354 Sum_probs=192.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (276)
T 2h6d_A 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93 (276)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEecc
Confidence 34578999999999999986 78999999986432 223457889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++++|.+++..... +++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...... .
T Consensus 94 ~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~---~ 165 (276)
T 2h6d_A 94 SGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---E 165 (276)
T ss_dssp CSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred CCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC---c
Confidence 99999999976543 899999999999999999999 889999999999999999999999999999865322 1
Q ss_pred ccccccCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
......|++.|+|||.+.+..+ +.++||||||++++||++|+.||....... ...... .+.. .+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~-~~~~------~~---- 230 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT----LFKKIR-GGVF------YI---- 230 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHH-HCCC------CC----
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----HHHHhh-cCcc------cC----
Confidence 2234568999999999987765 689999999999999999999997654322 122211 1110 01
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+......+.+++.+|++.+|++|||++|+++.
T Consensus 231 ~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11223468899999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.39 Aligned_cols=246 Identities=25% Similarity=0.392 Sum_probs=198.2
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 32 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (314)
T 3com_A 32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG 109 (314)
T ss_dssp EEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred hhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCC
Confidence 34578999999999999976 58999999997543 3467899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.... ..+++..+..++.+++.||.||| +.+|+||||||+||+++.++.+||+|||++...... .....
T Consensus 110 ~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~ 183 (314)
T 3com_A 110 SVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--MAKRN 183 (314)
T ss_dssp EHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--BSCBC
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--ccccC
Confidence 9999997433 34899999999999999999999 889999999999999999999999999999765322 12233
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
...|++.|+|||.+.+..++.++||||||++++||++|+.||........... . ......... .....
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~-~~~~~~~~~-------~~~~~ 251 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM----I-PTNPPPTFR-------KPELW 251 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----H-HHSCCCCCS-------SGGGS
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH----H-hcCCCcccC-------CcccC
Confidence 45789999999999998999999999999999999999999986543322211 1 111111110 11223
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
...+.+++.+|+..+|++||++.|+++
T Consensus 252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 252 SDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 457889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=334.37 Aligned_cols=267 Identities=21% Similarity=0.275 Sum_probs=196.8
Q ss_pred HHHHHHHhhh--hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCc-----------hhhHHHHHHHHHHHhcccccceeE
Q 003114 530 AEITKITNDF--ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSR-----------QGYEQFEAEVILLRTVHHKNLTTL 596 (846)
Q Consensus 530 ~el~~~t~~f--~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-----------~~~~~~~~Ei~~l~~l~HpnIv~l 596 (846)
.++.....++ .+.||+|+||.||+|...+++.||||++..... ...+.+.+|+.++++++||||+++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 94 (362)
T 3pg1_A 15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL 94 (362)
T ss_dssp HHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred HHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence 3444444444 478999999999999988899999999864321 123678999999999999999999
Q ss_pred eeEee-----cCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC
Q 003114 597 YGYCN-----EGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND 671 (846)
Q Consensus 597 ~g~~~-----~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~ 671 (846)
++++. .....++||||++ |+|.+.+.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLAD 169 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcC
Confidence 99983 3447899999997 68888887554 34899999999999999999999 889999999999999999
Q ss_pred CCcEEEEeccCCccCCCCCcccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHH
Q 003114 672 QFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQW 750 (846)
Q Consensus 672 ~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~ 750 (846)
++.+||+|||+++.... ........||+.|+|||.+.+ ..++.++||||+||+++||++|+.||........+...
T Consensus 170 ~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 246 (362)
T 3pg1_A 170 NNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246 (362)
T ss_dssp TCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999975432 222334578999999998876 67899999999999999999999999876655444443
Q ss_pred HHHHHhcCC----------cccccCCCCCC-------CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 751 VDFMLAQGD----------IKNIVDPKLHG-------DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 751 ~~~~~~~~~----------~~~~~d~~L~~-------~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
+........ ..+.+...+.. .........+.+++.+|++.+|++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 322111000 00000011100 0011223568899999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=344.34 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=197.5
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
+.+.+.||+|+||.||+|+.. ++..||+|++.... ......+.+|+.+++.++||||+++++++......++||||+
T Consensus 39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 118 (494)
T 3lij_A 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118 (494)
T ss_dssp EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 445678999999999999975 78899999987543 334567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC---CcEEEEeccCCccCCCCC
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ---FQARLADFGLSKTFPIEG 690 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~---~~vkI~DFGla~~~~~~~ 690 (846)
++|+|.+.+..... +++..+..++.|++.||.||| +.+|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 119 ~~g~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 119 KGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp CSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 99999998876543 899999999999999999999 8899999999999999764 55999999999876422
Q ss_pred cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
.......||+.|+|||++. ..++.++||||+||++|||++|++||........+.. ... +... ...+.+
T Consensus 193 --~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~-~~~~-~~~~~~-- 261 (494)
T 3lij_A 193 --KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK----VEK-GKYT-FDSPEW-- 261 (494)
T ss_dssp --BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHH-TCCC-CCSGGG--
T ss_pred --ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHh-CCCC-CCchhc--
Confidence 2234467999999999886 4699999999999999999999999987654432222 221 1111 001111
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
......+.+++.+|++.+|++|||+.|+++.
T Consensus 262 ---~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 262 ---KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ---TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1123468899999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=325.60 Aligned_cols=259 Identities=23% Similarity=0.380 Sum_probs=201.5
Q ss_pred hhhhhcCcCceEEEEEEEE--cCCcEEEEEEeCCCC--chhhHHHHHHHHHHHhc---ccccceeEeeEee-----cCCe
Q 003114 538 DFETILGEGSFGKVYHGYL--DDNTEVAVKMLSPSS--RQGYEQFEAEVILLRTV---HHKNLTTLYGYCN-----EGNQ 605 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~--~~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~-----~~~~ 605 (846)
.+.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++. ....
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 93 (326)
T 1blx_A 14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCce
Confidence 3457899999999999997 468899999986432 22234566788777766 8999999999987 5678
Q ss_pred eeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCcc
Q 003114 606 IGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685 (846)
Q Consensus 606 ~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~ 685 (846)
.++||||++ |+|.+++.......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 94 LTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp EEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 999999997 69999998776666999999999999999999999 88999999999999999999999999999986
Q ss_pred CCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--cc-c
Q 003114 686 FPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--IK-N 762 (846)
Q Consensus 686 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--~~-~ 762 (846)
... ........||..|+|||.+.+..++.++|||||||+++||++|++||........+...+........ .. .
T Consensus 170 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 170 YSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 532 22334467899999999999889999999999999999999999999877655544443332211100 00 0
Q ss_pred ------ccCCC---CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 763 ------IVDPK---LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 763 ------~~d~~---L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+... ............+.+++.+|++.+|++||++.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 000111223457889999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=343.52 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=201.2
Q ss_pred HhhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 536 TNDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++......++||||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 102 (486)
T 3mwu_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102 (486)
T ss_dssp HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEc
Confidence 4556789999999999999975 7899999998643 223456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC---CCCcEEEEeccCCccCCCC
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN---DQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld---~~~~vkI~DFGla~~~~~~ 689 (846)
+++|+|.+.+..... +++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||+++.....
T Consensus 103 ~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 103 YTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 999999999876543 899999999999999999999 88999999999999995 4568999999999865322
Q ss_pred CcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
.......||+.|+|||++.+ .++.++||||+||++|||++|++||........+.. .. .+..... .+.
T Consensus 178 ---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~-~~~~~~~-~~~-- 245 (486)
T 3mwu_A 178 ---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR----VE-TGKYAFD-LPQ-- 245 (486)
T ss_dssp -------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH-HTCCCSC-SGG--
T ss_pred ---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HH-hCCCCCC-Ccc--
Confidence 22344579999999999876 599999999999999999999999987654433322 21 1111100 000
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.......+.+++.+|++.+|++|||+.|+++.
T Consensus 246 ---~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 246 ---WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11233568899999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=328.24 Aligned_cols=262 Identities=21% Similarity=0.317 Sum_probs=199.1
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeec--------CCee
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNE--------GNQI 606 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--------~~~~ 606 (846)
.+.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.. .+..
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 99 (351)
T 3mi9_A 20 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 99 (351)
T ss_dssp EEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEE
T ss_pred eEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceE
Confidence 3457899999999999997 478999999986543 2234578899999999999999999999876 4568
Q ss_pred eEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccC
Q 003114 607 GLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF 686 (846)
Q Consensus 607 ~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~ 686 (846)
++||||+++ +|.+.+..... .+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus 100 ~lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 100 YLVFDFCEH-DLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp EEEEECCSE-EHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeccCC-CHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 999999975 78777766543 3899999999999999999999 889999999999999999999999999999876
Q ss_pred CCCC--cccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcC--Ccc
Q 003114 687 PIEG--VSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG--DIK 761 (846)
Q Consensus 687 ~~~~--~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~--~~~ 761 (846)
.... .........||+.|+|||.+.+ ..++.++|||||||+++||++|++||........+........... ...
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 4221 1222344678999999998876 4589999999999999999999999987665544443332211100 000
Q ss_pred cccCCC----C---CC-CCCh-HH------HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 762 NIVDPK----L---HG-DIDV-NS------AWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 762 ~~~d~~----L---~~-~~~~-~~------~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
..-... + .. .... +. ...+.+++.+|++.+|++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000000 0 00 0000 01 2347899999999999999999998763
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=319.07 Aligned_cols=246 Identities=24% Similarity=0.331 Sum_probs=199.5
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---------chhhHHHHHHHHHHHhcc-cccceeEeeEeecCCeee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---------RQGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIG 607 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---------~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~ 607 (846)
+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++++. ||||+++++++..++..+
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 100 (298)
T 1phk_A 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 100 (298)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred eeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEE
Confidence 3578999999999999975 68999999996543 122456789999999995 999999999999999999
Q ss_pred EeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCC
Q 003114 608 LIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP 687 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~ 687 (846)
+||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 101 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 101 LVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 9999999999999998654 3899999999999999999999 8899999999999999999999999999998653
Q ss_pred CCCcccccccccCCCcccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcc
Q 003114 688 IEGVSHLSTGVAGTFGYLDPEYCQ------TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIK 761 (846)
Q Consensus 688 ~~~~~~~~~~~~gt~~Y~APE~~~------~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~ 761 (846)
.. .......|++.|+|||.+. ...++.++||||||++++||++|+.||......... ..... +...
T Consensus 176 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~-~~~~ 247 (298)
T 1phk_A 176 PG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML----RMIMS-GNYQ 247 (298)
T ss_dssp TT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHH-TCCC
T ss_pred CC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH----HHHhc-CCcc
Confidence 22 2233457899999999875 456889999999999999999999999765433222 11111 1111
Q ss_pred cccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 762 NIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 762 ~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
. ...........+.+++.+|++.+|++||++.|+++
T Consensus 248 ~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 248 F------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp C------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0 00111233457889999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=327.53 Aligned_cols=255 Identities=22% Similarity=0.376 Sum_probs=197.5
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||+|+||.||+|+..+ .+|+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~ 113 (319)
T 2y4i_B 36 EIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG 113 (319)
T ss_dssp ECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCS
T ss_pred EEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccC
Confidence 345789999999999999854 59999987542 23345678899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC---cc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG---VS 692 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~---~~ 692 (846)
++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++ ++.+||+|||+++...... ..
T Consensus 114 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~ 188 (319)
T 2y4i_B 114 RTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE 188 (319)
T ss_dssp EEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence 99999998754 34899999999999999999999 88999999999999998 6799999999987543211 11
Q ss_pred cccccccCCCcccCcccccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 003114 693 HLSTGVAGTFGYLDPEYCQT---------FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNI 763 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~---------~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~ 763 (846)
.......|++.|+|||.+.. ..++.++|||||||+++||++|+.||......... .. ...+.....
T Consensus 189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~-~~~~~~~~~ 263 (319)
T 2y4i_B 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII----WQ-MGTGMKPNL 263 (319)
T ss_dssp CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH----HH-HHTTCCCCC
T ss_pred cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HH-hccCCCCCC
Confidence 22234568999999998864 45789999999999999999999999765433222 11 112211111
Q ss_pred cCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 764 VDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 764 ~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
... .....+.+++.+|+..+|++|||+.|++++|+++....
T Consensus 264 ~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 264 SQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 111 12235789999999999999999999999999877543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=340.46 Aligned_cols=255 Identities=20% Similarity=0.283 Sum_probs=195.1
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeec------CCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE------GNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~------~~~~~LV~ 610 (846)
...+.||+|+||.||+|+.. +++.||||++.... ....+|+++++.++||||+++++++.. ....++||
T Consensus 57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 34578999999999999985 68999999986542 223579999999999999999998843 22467999
Q ss_pred ecccCCChhhhhhc--CCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC-CcEEEEeccCCccCC
Q 003114 611 EYMANGSLEEYLSD--SNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ-FQARLADFGLSKTFP 687 (846)
Q Consensus 611 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-~~vkI~DFGla~~~~ 687 (846)
||+++ +|.+.+.. .....+++..+..++.|+++||+||| +.+|+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99975 66666543 22345899999999999999999999 8999999999999999955 678999999998753
Q ss_pred CCCcccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHh---------c
Q 003114 688 IEGVSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLA---------Q 757 (846)
Q Consensus 688 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~---------~ 757 (846)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|++||.+....+.+.++++..-. .
T Consensus 209 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 209 RG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp TT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred cC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 32 122345789999999998764 7999999999999999999999999887666555555542211 0
Q ss_pred CCcccccCCCCCCC-----CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 758 GDIKNIVDPKLHGD-----IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 758 ~~~~~~~d~~L~~~-----~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
....+...+.+... +.......+.+|+.+|++.+|++||++.|+++
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 11111111111110 11223457889999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=341.39 Aligned_cols=259 Identities=21% Similarity=0.309 Sum_probs=205.0
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhccc-ccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH-KNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||+|+||.||+|+. .+++.||||++...... .++..|+++++.++| +++..+..++...+..++||||+ +
T Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g 86 (483)
T 3sv0_A 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (483)
T ss_dssp ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence 3457899999999999996 57899999998654332 468899999999987 55666666777888999999999 9
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE---CCCCcEEEEeccCCccCCCCCcc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl---d~~~~vkI~DFGla~~~~~~~~~ 692 (846)
++|.+++..... .+++..++.|+.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+++.+......
T Consensus 87 ~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 87 PSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 999999985443 4999999999999999999999 8899999999999999 68899999999999876433221
Q ss_pred -----cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHH--HHHhcCCcccccC
Q 003114 693 -----HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVD--FMLAQGDIKNIVD 765 (846)
Q Consensus 693 -----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~--~~~~~~~~~~~~d 765 (846)
.......||..|+|||.+.+..++.++|||||||++|||++|+.||...........+.. .......+..+.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~- 241 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC- 241 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH-
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh-
Confidence 122356799999999999999999999999999999999999999987543322221111 111111111110
Q ss_pred CCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 766 PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 766 ~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
.....++.+++..|++.+|++||++++|++.|++++..+
T Consensus 242 --------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 242 --------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp --------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 112347889999999999999999999999999987644
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=355.87 Aligned_cols=256 Identities=24% Similarity=0.358 Sum_probs=204.7
Q ss_pred hhhhhhcCcCceEEEEEEEEcC----CcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 537 NDFETILGEGSFGKVYHGYLDD----NTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
..+.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E 470 (656)
T 2j0j_A 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIME 470 (656)
T ss_dssp EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEE
Confidence 3445789999999999999742 4579999987643 3345678999999999999999999999854 56899999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+++|+|.+++..... .+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 471 ~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~- 545 (656)
T 2j0j_A 471 LCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST- 545 (656)
T ss_dssp CCTTCBHHHHHHHTTT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred cCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc-
Confidence 9999999999986542 4899999999999999999999 8899999999999999999999999999998763322
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
........+|+.|+|||.+.+..++.++|||||||++|||++ |++||........+.. .......
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~----i~~~~~~---------- 611 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IENGERL---------- 611 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHHTCCC----------
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHcCCCC----------
Confidence 222233457789999999998899999999999999999997 9999986554332221 2111111
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
..+......+.+++.+|++.+|++||++.|+++.|+++++.+
T Consensus 612 ~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 612 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 112233457889999999999999999999999999988654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=346.34 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=203.5
Q ss_pred HhhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 536 TNDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
.+.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 3455678999999999999976 78999999986442 3345778999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE---CCCCcEEEEeccCCccCCC
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL---NDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl---d~~~~vkI~DFGla~~~~~ 688 (846)
|+.+|+|.+.+..... +++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 107 ~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 107 VYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CCCSCBHHHHHHTCSC--CBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred cCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999976543 899999999999999999999 8899999999999999 5678999999999986533
Q ss_pred CCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
. .......||+.|+|||.+.+ .++.++||||+||++|||++|++||........+.. .. .+..... .+.
T Consensus 182 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~-~~~~~~~-~~~- 250 (484)
T 3nyv_A 182 S---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK----VE-KGKYTFE-LPQ- 250 (484)
T ss_dssp C---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH-HCCCCCC-SGG-
T ss_pred c---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HH-cCCCCCC-Ccc-
Confidence 2 22334569999999999876 689999999999999999999999987654433322 21 1211100 000
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.......+.+++.+|++.+|++|||+.|+++.
T Consensus 251 ----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 251 ----WKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 11234568899999999999999999999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=332.58 Aligned_cols=257 Identities=21% Similarity=0.275 Sum_probs=199.5
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc--------cccceeEeeEee----cC
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH--------HKNLTTLYGYCN----EG 603 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~--------HpnIv~l~g~~~----~~ 603 (846)
+.+.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.+++.++ |+||+++++++. .+
T Consensus 39 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~ 117 (397)
T 1wak_A 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNG 117 (397)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTE
T ss_pred EEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCC
Confidence 345678999999999999864 6889999999754 334567889999999986 788999999987 56
Q ss_pred CeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCC-CeeecCCCCCCEEECCCC---------
Q 003114 604 NQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKP-PRVHRDIKPANILLNDQF--------- 673 (846)
Q Consensus 604 ~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~IiHrDlKp~NILld~~~--------- 673 (846)
...++||||+ +++|.+.+.......+++..+..++.|++.||.||| +. +|+||||||+|||++.++
T Consensus 118 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 118 THICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp EEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred ceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 7899999999 667777776655456999999999999999999999 77 999999999999999775
Q ss_pred ----------------------------------------cEEEEeccCCccCCCCCcccccccccCCCcccCccccccC
Q 003114 674 ----------------------------------------QARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF 713 (846)
Q Consensus 674 ----------------------------------------~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~ 713 (846)
.+||+|||+++.... ......||+.|+|||++.+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHHHHTS
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChhhcCC
Confidence 799999999986532 12345789999999999999
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCccccc------cHHHHHHHH-------HhcCC-cccccCCC-----C------
Q 003114 714 RLTEKSDVYSFGVVLLEIITSRPAIANTEEHK------HISQWVDFM-------LAQGD-IKNIVDPK-----L------ 768 (846)
Q Consensus 714 ~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~------~l~~~~~~~-------~~~~~-~~~~~d~~-----L------ 768 (846)
.++.++|||||||++|||++|+.||....... .+....... ...+. ....+... +
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 99999999999999999999999997644221 111111110 00000 00111100 0
Q ss_pred --------CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 769 --------HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 769 --------~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
....+......+.+|+.+|++.+|++|||++|+++
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00224556678899999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=357.31 Aligned_cols=239 Identities=23% Similarity=0.336 Sum_probs=198.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||.||+|+.. +++.||||+++.. .....+.+..|..++..+ +||+|+++++++.+.+..++||||
T Consensus 344 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~ 423 (674)
T 3pfq_A 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 423 (674)
T ss_dssp EEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEEC
T ss_pred EEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeC
Confidence 34578999999999999975 6888999999743 223345678899999887 799999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 424 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~--~ 496 (674)
T 3pfq_A 424 VNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--G 496 (674)
T ss_dssp CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT--T
T ss_pred cCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccC--C
Confidence 999999999987543 899999999999999999999 889999999999999999999999999999864322 2
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
.......||+.|+|||++.+..++.++|||||||++|||++|++||...+..+.... ... +.. .+
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~-~~~----------~~ 561 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IME-HNV----------AY 561 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHS-SCC----------CC
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH----HHh-CCC----------CC
Confidence 234457899999999999999999999999999999999999999987654332222 221 111 11
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNM 798 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm 798 (846)
+......+.+|+.+|++.+|++||++
T Consensus 562 p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 562 PKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp CTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred CccCCHHHHHHHHHHccCCHHHCCCC
Confidence 22334578899999999999999998
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=330.96 Aligned_cols=254 Identities=20% Similarity=0.319 Sum_probs=202.3
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCch-----------------hhHHHHHHHHHHHhcccccceeEeeEe
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQ-----------------GYEQFEAEVILLRTVHHKNLTTLYGYC 600 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-----------------~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 600 (846)
.+.+.||+|+||.||+|.. +++.||+|++...... ..+.+.+|+.++++++||||+++++++
T Consensus 34 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 112 (348)
T 2pml_X 34 RIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112 (348)
T ss_dssp EEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEE
T ss_pred EEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 3457899999999999999 8999999998643211 117899999999999999999999999
Q ss_pred ecCCeeeEeeecccCCChhhh------hhcCCCCccChHHHHHHHHHHHHHHHHHhccCC-CCeeecCCCCCCEEECCCC
Q 003114 601 NEGNQIGLIYEYMANGSLEEY------LSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK-PPRVHRDIKPANILLNDQF 673 (846)
Q Consensus 601 ~~~~~~~LV~Ey~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~IiHrDlKp~NILld~~~ 673 (846)
.+.+..++||||+++|+|.++ +.......+++..+..++.|++.||.||| + .+|+||||||+||+++.++
T Consensus 113 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~~~~~ 189 (348)
T 2pml_X 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILMDKNG 189 (348)
T ss_dssp ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEECTTS
T ss_pred eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEEcCCC
Confidence 999999999999999999999 66544556999999999999999999999 7 8999999999999999999
Q ss_pred cEEEEeccCCccCCCCCcccccccccCCCcccCccccccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCccccccHHHHH
Q 003114 674 QARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF-RLTE-KSDVYSFGVVLLEIITSRPAIANTEEHKHISQWV 751 (846)
Q Consensus 674 ~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~-ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~ 751 (846)
.+||+|||++...... ......|+..|+|||.+.+. .++. ++|||||||+++||++|+.||........+..
T Consensus 190 ~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-- 263 (348)
T 2pml_X 190 RVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN-- 263 (348)
T ss_dssp CEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH--
T ss_pred cEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH--
Confidence 9999999999865322 33446789999999999877 5666 99999999999999999999987654222222
Q ss_pred HHHHhcCCcccccC------CCCC---CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 752 DFMLAQGDIKNIVD------PKLH---GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 752 ~~~~~~~~~~~~~d------~~L~---~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
. +..+......+ +... ..........+.+++.+|++.+|++||++.|+++
T Consensus 264 -~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 264 -N-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -H-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -H-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 12221111100 0000 0001223457889999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.28 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=195.7
Q ss_pred HhhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc--------hhhHHHHHHHHHHHhcccccceeEeeEeecCCee
Q 003114 536 TNDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR--------QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQI 606 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 606 (846)
.+.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++..+. .
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence 4455688999999999999975 688999999875421 22345889999999999999999999987655 8
Q ss_pred eEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc---EEEEeccCC
Q 003114 607 GLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ---ARLADFGLS 683 (846)
Q Consensus 607 ~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~---vkI~DFGla 683 (846)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp EEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 99999999999999987654 4899999999999999999999 889999999999999987654 999999999
Q ss_pred ccCCCCCcccccccccCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCc
Q 003114 684 KTFPIEGVSHLSTGVAGTFGYLDPEYCQ---TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDI 760 (846)
Q Consensus 684 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 760 (846)
+..... .......||+.|+|||.+. ...++.++|||||||+++||++|+.||........+...+. .+..
T Consensus 165 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~~ 237 (322)
T 2ycf_A 165 KILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT----SGKY 237 (322)
T ss_dssp EECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH----HTCC
T ss_pred eecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH----hCcc
Confidence 865321 2223456899999999874 46789999999999999999999999986654444433222 1111
Q ss_pred ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 761 ~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.. .+.. .......+.+++.+|++.+|++||++.|+++
T Consensus 238 ~~--~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 238 NF--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CC--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc--Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00 0000 0112356889999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=321.72 Aligned_cols=258 Identities=17% Similarity=0.272 Sum_probs=204.0
Q ss_pred hhhhhhcCcCceEEEEEEEE--cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhccccc------ceeEeeEeecCCeeeE
Q 003114 537 NDFETILGEGSFGKVYHGYL--DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKN------LTTLYGYCNEGNQIGL 608 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~--~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn------Iv~l~g~~~~~~~~~L 608 (846)
+.+.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.+++.++|++ ++++++++...+..++
T Consensus 16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l 94 (339)
T 1z57_A 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI 94 (339)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence 34567899999999999987 368899999997543 34567889999999998775 9999999999999999
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-----------------
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND----------------- 671 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~----------------- 671 (846)
||||+ +++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 95 v~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 95 VFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99999 899999998876556899999999999999999999 889999999999999987
Q ss_pred --CCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHH
Q 003114 672 --QFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ 749 (846)
Q Consensus 672 --~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~ 749 (846)
++.+||+|||+++.... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||........+..
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp ESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred ccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 67899999999986432 22345789999999999999999999999999999999999999987654443332
Q ss_pred HHHHHH-------hcCCcccccC-CC--CC-------------------CCCChHHHHHHHHHHHhccCCCCCCCCCHHH
Q 003114 750 WVDFML-------AQGDIKNIVD-PK--LH-------------------GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNR 800 (846)
Q Consensus 750 ~~~~~~-------~~~~~~~~~d-~~--L~-------------------~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~e 800 (846)
...... .......... .. +. ..........+.+++.+|++.+|++|||+.|
T Consensus 246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 325 (339)
T 1z57_A 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325 (339)
T ss_dssp HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence 222110 0000000000 00 00 0112344677899999999999999999999
Q ss_pred HHHH
Q 003114 801 VVME 804 (846)
Q Consensus 801 Vl~~ 804 (846)
+++.
T Consensus 326 ll~h 329 (339)
T 1z57_A 326 ALKH 329 (339)
T ss_dssp HTTS
T ss_pred HhcC
Confidence 8753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.54 Aligned_cols=246 Identities=24% Similarity=0.425 Sum_probs=193.6
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeec------CCeeeEee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNE------GNQIGLIY 610 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~------~~~~~LV~ 610 (846)
+.+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|+.+++++ +||||+++++++.. .+..++||
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 106 (326)
T 2x7f_A 28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred EEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence 3578999999999999974 789999999865432 346789999999999 89999999999876 56899999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+++|+|.+++.......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 182 (326)
T 2x7f_A 107 EFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT- 182 (326)
T ss_dssp ECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC------
T ss_pred EcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcC-
Confidence 9999999999998765556899999999999999999999 889999999999999999999999999999865321
Q ss_pred cccccccccCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQ-----TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 765 (846)
........|++.|+|||.+. +..++.++|||||||++|||++|+.||........+.. .. ........
T Consensus 183 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~- 255 (326)
T 2x7f_A 183 -VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IP-RNPAPRLK- 255 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HH-HSCCCCCS-
T ss_pred -ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----hh-cCccccCC-
Confidence 11223456899999999986 56789999999999999999999999976554332221 11 11111111
Q ss_pred CCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 ~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.......+.+++.+|+..+|++||++.|+++
T Consensus 256 -------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 256 -------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1122347889999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=336.55 Aligned_cols=195 Identities=24% Similarity=0.376 Sum_probs=162.6
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecC-----CeeeEe
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG-----NQIGLI 609 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~~LV 609 (846)
.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++... ...++|
T Consensus 29 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 108 (432)
T 3n9x_A 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIV 108 (432)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEE
Confidence 44678999999999999975 6888999999754 334557789999999999999999999998765 579999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||++ |+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 109 ~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 109 LEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 99986 59999998654 3899999999999999999999 889999999999999999999999999999876432
Q ss_pred Ccc--------------------cccccccCCCcccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003114 690 GVS--------------------HLSTGVAGTFGYLDPEYC-QTFRLTEKSDVYSFGVVLLEIITSRPAI 738 (846)
Q Consensus 690 ~~~--------------------~~~~~~~gt~~Y~APE~~-~~~~~s~ksDVwS~Gvvl~ELltG~~p~ 738 (846)
... .......||+.|+|||++ ....++.++||||+||+++||++|..||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 211 123456799999999986 5567999999999999999999854443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=337.92 Aligned_cols=257 Identities=20% Similarity=0.283 Sum_probs=194.3
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCC------eeeEeee
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN------QIGLIYE 611 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------~~~LV~E 611 (846)
.+.+.||+|+||.||+|+...+..||+|++..... ...+|+.+++.++||||+++++++.... ..++|||
T Consensus 43 ~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 44578999999999999998777799998864432 2347999999999999999999985433 3889999
Q ss_pred cccCCChhhhhhc-CCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC-CCCcEEEEeccCCccCCCC
Q 003114 612 YMANGSLEEYLSD-SNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN-DQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 612 y~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld-~~~~vkI~DFGla~~~~~~ 689 (846)
|++++.+...... .....+++..+..++.|++.||+||| +.+|+||||||+|||++ .++.+||+|||+++.....
T Consensus 119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 9987544333321 12345899999999999999999999 88999999999999999 7999999999999875322
Q ss_pred CcccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcC---------C
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG---------D 759 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~---------~ 759 (846)
.......||+.|+|||.+.+. .++.++||||+||+++||++|++||.+......+..+++...... .
T Consensus 196 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 272 (394)
T 4e7w_A 196 ---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272 (394)
T ss_dssp ---CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred ---CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 223345789999999988764 589999999999999999999999998776655555544221100 0
Q ss_pred cccccCCCCCC-----CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 760 IKNIVDPKLHG-----DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 760 ~~~~~d~~L~~-----~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
..+..-+.... .+.......+.+++.+|++.+|++|||+.|+++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000011100 0111234578999999999999999999998864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=335.99 Aligned_cols=250 Identities=10% Similarity=0.020 Sum_probs=179.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc---hhhHHHHHHHHHHHhc--ccccceeEe-------eEeecC-
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR---QGYEQFEAEVILLRTV--HHKNLTTLY-------GYCNEG- 603 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~~~~Ei~~l~~l--~HpnIv~l~-------g~~~~~- 603 (846)
.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.+++.+ +||||++++ +++...
T Consensus 65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~ 144 (371)
T 3q60_A 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETT
T ss_pred eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCC
Confidence 34578999999999999975 789999999987543 3455677885555554 699988755 333222
Q ss_pred ----------------CeeeEeeecccCCChhhhhhcCCCCccChHHH------HHHHHHHHHHHHHHhccCCCCeeecC
Q 003114 604 ----------------NQIGLIYEYMANGSLEEYLSDSNADVLSWEGR------LRIATEAAQGLEYLHLGCKPPRVHRD 661 (846)
Q Consensus 604 ----------------~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~IiHrD 661 (846)
...++||||++ |+|.+++..... .+.+..+ ..++.|++.||+||| +.+|+|||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHrD 219 (371)
T 3q60_A 145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGH 219 (371)
T ss_dssp SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccCc
Confidence 34899999998 899999987532 2466666 788899999999999 88999999
Q ss_pred CCCCCEEECCCCcEEEEeccCCccCCCCCcccccccccCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003114 662 IKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT--FRLTEKSDVYSFGVVLLEIITSRPAIA 739 (846)
Q Consensus 662 lKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~Gvvl~ELltG~~p~~ 739 (846)
|||+|||++.++.+||+|||+++.... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999986531 1113456799999999987 679999999999999999999999997
Q ss_pred CccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 740 NTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 740 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.......- . .............+...........+.+++.+|++.+|++|||+.|+++
T Consensus 295 ~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 295 LVTPGIKG-S-----WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp BCCTTCTT-C-----CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CcCccccc-c-----hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 65322100 0 0000000111111111111234567889999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=320.82 Aligned_cols=247 Identities=23% Similarity=0.302 Sum_probs=183.0
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCc--hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSR--QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
.+.+.||+|+||.||+|+. .+++.||+|++..... ...+.+.++...++.++||||+++++++.+++..++||||++
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 89 (290)
T 3fme_A 10 EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD 89 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS
T ss_pred hhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc
Confidence 3457899999999999997 4789999999976532 223344555566888899999999999999999999999997
Q ss_pred CCChhhhhhcC--CCCccChHHHHHHHHHHHHHHHHHhccCCC-CeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 615 NGSLEEYLSDS--NADVLSWEGRLRIATEAAQGLEYLHLGCKP-PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 615 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+|.+++... ....+++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 -~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 163 (290)
T 3fme_A 90 -TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-- 163 (290)
T ss_dssp -EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred -cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc--
Confidence 5888877642 2345999999999999999999999 76 9999999999999999999999999999865322
Q ss_pred ccccccccCCCcccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYC----QTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~----~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
.......||+.|+|||.+ .+..++.++||||+||+++||++|+.||....... .. .......... ..
T Consensus 164 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~-~~~~~~~~~~-~~---- 234 (290)
T 3fme_A 164 -VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--QQ-LKQVVEEPSP-QL---- 234 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH--HH-HHHHHHSCCC-CC----
T ss_pred -ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH--HH-HHHHhccCCC-Cc----
Confidence 222334689999999996 56678999999999999999999999997533221 11 1112222111 11
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
........+.+++.+|++.+|++|||+.|+++
T Consensus 235 ----~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 ----PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 01123356889999999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=333.11 Aligned_cols=259 Identities=22% Similarity=0.329 Sum_probs=182.1
Q ss_pred hhhcCcCceEEEEEEEEc---CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEe--ecCCeeeEeeeccc
Q 003114 540 ETILGEGSFGKVYHGYLD---DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC--NEGNQIGLIYEYMA 614 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~--~~~~~~~LV~Ey~~ 614 (846)
.++||+|+||.||+|+.. +++.||+|++..... ...+.+|+.+++.++||||+++++++ ..+...++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 357999999999999975 578899999975432 35688999999999999999999999 45778999999996
Q ss_pred CCChhhhhhcCC-------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE----CCCCcEEEEeccCC
Q 003114 615 NGSLEEYLSDSN-------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL----NDQFQARLADFGLS 683 (846)
Q Consensus 615 ~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl----d~~~~vkI~DFGla 683 (846)
|+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 58888875321 224899999999999999999999 8899999999999999 67899999999999
Q ss_pred ccCCCCCc-ccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccc---------ccHHHHHH
Q 003114 684 KTFPIEGV-SHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEH---------KHISQWVD 752 (846)
Q Consensus 684 ~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~---------~~l~~~~~ 752 (846)
+.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|++||....+. ..+...+.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 87642211 1223446789999999998874 5899999999999999999999999765431 22222222
Q ss_pred HHHhcCC--cccccC------------CCCCCCC---------ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 753 FMLAQGD--IKNIVD------------PKLHGDI---------DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 753 ~~~~~~~--~~~~~d------------~~L~~~~---------~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
..-.... ...+.. ....... .......+.+|+.+||+.+|++|||++|+++.
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 2111100 000000 0000000 00012467899999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=320.49 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=192.5
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEee--------------cC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN--------------EG 603 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~--------------~~ 603 (846)
..+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++. +.
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 94 (320)
T 2i6l_A 15 DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94 (320)
T ss_dssp EEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred EEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccccc
Confidence 3468999999999999986 58999999998777777788999999999999999999999873 44
Q ss_pred CeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC-CCCcEEEEeccC
Q 003114 604 NQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN-DQFQARLADFGL 682 (846)
Q Consensus 604 ~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld-~~~~vkI~DFGl 682 (846)
...++||||++ |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||+
T Consensus 95 ~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 95 NSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp SEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 67899999997 6999999753 3889999999999999999999 88999999999999997 677999999999
Q ss_pred CccCCCCCc-ccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHh----
Q 003114 683 SKTFPIEGV-SHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLA---- 756 (846)
Q Consensus 683 a~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~---- 756 (846)
++....... ........++..|+|||.+.. ..++.++|||||||+++||++|+.||........+.........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE 247 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence 986532211 112233457899999998765 67899999999999999999999999876644333332221000
Q ss_pred -----cCCcccccCCCCC-CC-----CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 757 -----QGDIKNIVDPKLH-GD-----IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 757 -----~~~~~~~~d~~L~-~~-----~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
...+......... .. ........+.+++.+|++.+|++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 248 DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000000000000 00 00123457889999999999999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=326.47 Aligned_cols=260 Identities=21% Similarity=0.341 Sum_probs=201.0
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecC-----CeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG-----NQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~~LV~ 610 (846)
.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++... ...++||
T Consensus 30 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~ 109 (364)
T 3qyz_A 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 109 (364)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEE
Confidence 34578999999999999975 68889999997543 33447788999999999999999999998654 4689999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||++ |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 110 e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 110 DLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp ECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred cccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 9997 5999998764 3899999999999999999999 8899999999999999999999999999998654221
Q ss_pred c-ccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--c------
Q 003114 691 V-SHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--I------ 760 (846)
Q Consensus 691 ~-~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--~------ 760 (846)
. ........||+.|+|||.+.+ ..++.++||||+||+++||++|++||........+............ .
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1 112344579999999998654 45899999999999999999999999887766555544332111000 0
Q ss_pred ------ccccCCCCCC--CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 761 ------KNIVDPKLHG--DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 761 ------~~~~d~~L~~--~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.....+.-.. .........+.+++.+|++.+|++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 0001123468899999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=343.08 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=197.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc-------------hhhHHHHHHHHHHHhcccccceeEeeEeecC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR-------------QGYEQFEAEVILLRTVHHKNLTTLYGYCNEG 603 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-------------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~ 603 (846)
.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.++
T Consensus 39 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 118 (504)
T 3q5i_A 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK 118 (504)
T ss_dssp EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred EEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 34578999999999999975 678999999865421 2346788999999999999999999999999
Q ss_pred CeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC---cEEEEec
Q 003114 604 NQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF---QARLADF 680 (846)
Q Consensus 604 ~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~---~vkI~DF 680 (846)
...++||||+++|+|.+.+..... +++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+||
T Consensus 119 ~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 119 KYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred CEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 999999999999999999976543 899999999999999999999 88999999999999998775 6999999
Q ss_pred cCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCc
Q 003114 681 GLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDI 760 (846)
Q Consensus 681 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 760 (846)
|+++..... .......||+.|+|||.+.+ .++.++||||+||++|||++|++||........+.. .. .+..
T Consensus 194 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~-~~~~ 264 (504)
T 3q5i_A 194 GLSSFFSKD---YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK----VE-KGKY 264 (504)
T ss_dssp TTCEECCTT---SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH-HCCC
T ss_pred CCCEEcCCC---CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HH-cCCC
Confidence 999876432 22344679999999999874 689999999999999999999999987654432222 22 1111
Q ss_pred ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 761 ~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.. +... .......+.+++.+|++.+|++|||++|+++.
T Consensus 265 ~~--~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 265 YF--DFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CC--CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC--Cccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 0000 01123468899999999999999999998753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=329.77 Aligned_cols=256 Identities=21% Similarity=0.292 Sum_probs=189.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCC------eeeE
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN------QIGL 608 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------~~~L 608 (846)
.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++...+ ..++
T Consensus 28 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l 107 (371)
T 2xrw_A 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 107 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred eEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence 34568999999999999965 6889999999753 3344567889999999999999999999987654 7899
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
||||++ |+|.+.+.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 108 v~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 108 VMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred EEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 999997 478888863 3889999999999999999999 88999999999999999999999999999986532
Q ss_pred CCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHH---------------
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDF--------------- 753 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~--------------- 753 (846)
........||+.|+|||.+.+..++.++||||+||+++||++|+.||...+....+...+..
T Consensus 180 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 180 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred ---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 12233467899999999999989999999999999999999999999876543332222110
Q ss_pred ---HHhcCC-c-----ccccCCCCCCCC---ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 754 ---MLAQGD-I-----KNIVDPKLHGDI---DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 754 ---~~~~~~-~-----~~~~d~~L~~~~---~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
...... . ...+........ .......+.+++.+|++.+|++|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000 0 000000000000 11224678899999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=316.58 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=190.1
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeec-------------C
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE-------------G 603 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-------------~ 603 (846)
.+.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (303)
T 1zy4_A 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK 87 (303)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred hhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence 34578999999999999974 7899999999643 3445778999999999999999999998754 4
Q ss_pred CeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCC
Q 003114 604 NQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLS 683 (846)
Q Consensus 604 ~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla 683 (846)
...++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred CceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 57899999999999999998644 34788999999999999999999 889999999999999999999999999999
Q ss_pred ccCCCCC------------cccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHH
Q 003114 684 KTFPIEG------------VSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQW 750 (846)
Q Consensus 684 ~~~~~~~------------~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~ 750 (846)
+...... .........|++.|+|||.+.+. .++.++|||||||++|||++ ||....... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~---~~ 237 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV---NI 237 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH---HH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH---HH
Confidence 8653211 01122345689999999998764 68999999999999999998 554322221 11
Q ss_pred HHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 751 VDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 751 ~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..... .. ...+...........+.+++.+|++.+|++|||+.|+++
T Consensus 238 ~~~~~-~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 238 LKKLR-SV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHH-ST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcc-cc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 22111 11 111122233344567889999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=324.77 Aligned_cols=258 Identities=21% Similarity=0.304 Sum_probs=201.4
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-cc-----cceeEeeEeecCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-HK-----NLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-Hp-----nIv~l~g~~~~~~~~~LV~ 610 (846)
.+.+.||+|+||.||+|+.. +++.||||++... .....++..|+.+++.++ |+ +|+++++++...+..++||
T Consensus 57 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 135 (382)
T 2vx3_A 57 EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF 135 (382)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEE
Confidence 34578999999999999975 6889999999754 233566788888888885 44 4999999999999999999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC--CCCcEEEEeccCCccCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN--DQFQARLADFGLSKTFPI 688 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld--~~~~vkI~DFGla~~~~~ 688 (846)
||++ |+|.+++.......+++..+..++.|++.||.|||.. +.+|+||||||+|||++ .++.+||+|||+++....
T Consensus 136 e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 136 EMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp ECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred ecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence 9996 5999999887656699999999999999999999931 46899999999999994 578899999999987532
Q ss_pred CCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcC--------Cc
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG--------DI 760 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~--------~~ 760 (846)
......||+.|+|||++.+..++.++|||||||+++||++|++||........+...+....... ..
T Consensus 214 -----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (382)
T 2vx3_A 214 -----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288 (382)
T ss_dssp -----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred -----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence 22346789999999999999999999999999999999999999987765554444433211000 00
Q ss_pred ----ccccCCC------------C-------------------------CCCCChHHHHHHHHHHHhccCCCCCCCCCHH
Q 003114 761 ----KNIVDPK------------L-------------------------HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMN 799 (846)
Q Consensus 761 ----~~~~d~~------------L-------------------------~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~ 799 (846)
..+-+.. . .......+...+.+|+.+||+.||++|||++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~ 368 (382)
T 2vx3_A 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY 368 (382)
T ss_dssp HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence 0000000 0 0001223345789999999999999999999
Q ss_pred HHHH
Q 003114 800 RVVM 803 (846)
Q Consensus 800 eVl~ 803 (846)
|+++
T Consensus 369 e~L~ 372 (382)
T 2vx3_A 369 YALQ 372 (382)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=332.26 Aligned_cols=253 Identities=22% Similarity=0.354 Sum_probs=182.6
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecC------CeeeE
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG------NQIGL 608 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~L 608 (846)
.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++... ...++
T Consensus 32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l 111 (367)
T 2fst_X 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111 (367)
T ss_dssp EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence 3456899999999999996 47899999999754 334456788999999999999999999998654 56899
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
|+|++ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 112 v~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 112 VTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp EEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred Eeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 99999 78999998753 4899999999999999999999 88999999999999999999999999999986432
Q ss_pred CCcccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCC-
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDP- 766 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~- 766 (846)
......||+.|+|||.+.+ ..++.++||||+||+++||++|++||.+.+....+....+...... .+.+..
T Consensus 185 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~--~~~~~~~ 257 (367)
T 2fst_X 185 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG--AELLKKI 257 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC--HHHHTTC
T ss_pred -----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC--HHHHHHh
Confidence 2334678999999999876 6789999999999999999999999987765544444333211100 000000
Q ss_pred ----------CCC--CCCC-----hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 767 ----------KLH--GDID-----VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 767 ----------~L~--~~~~-----~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.+. .... ......+.+|+.+|+..+|++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 0000 1123467899999999999999999998864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=326.30 Aligned_cols=257 Identities=21% Similarity=0.307 Sum_probs=197.3
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecC-----CeeeEeee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEG-----NQIGLIYE 611 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~~LV~E 611 (846)
+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+++.++||||+++++++... ...++|||
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 94 (353)
T 2b9h_A 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQE 94 (353)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEEC
T ss_pred EeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEe
Confidence 4578999999999999975 68899999997543 33456788999999999999999999987654 67899999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+. ++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 95 ~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 95 LMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp CCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 997 6999998763 3899999999999999999999 88999999999999999999999999999987642211
Q ss_pred cc--------ccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCccc
Q 003114 692 SH--------LSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKN 762 (846)
Q Consensus 692 ~~--------~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 762 (846)
.. ......||+.|+|||.+.. ..++.++|||||||+++||++|++||........+........... ...
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~ 246 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH-SDN 246 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-STT
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc-hhc
Confidence 11 1223578999999998754 6789999999999999999999999987665444333322211110 000
Q ss_pred ccCC-----------CCC--CCC-----ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 763 IVDP-----------KLH--GDI-----DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 763 ~~d~-----------~L~--~~~-----~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.... .+. ... .......+.+++.+|++.+|++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 000 000 0123356789999999999999999999876
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=318.16 Aligned_cols=257 Identities=21% Similarity=0.288 Sum_probs=201.0
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CC-cEEEEEEeCCCCchhhHHHHHHHHHHHhccccc------ceeEeeEeecCCeeeE
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DN-TEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKN------LTTLYGYCNEGNQIGL 608 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g-~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn------Iv~l~g~~~~~~~~~L 608 (846)
+.+.+.||+|+||.||+|... ++ +.||+|++.... ...+.+.+|+.+++.++|++ ++.+.+++...+..++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~l 99 (355)
T 2eu9_A 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI 99 (355)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred EEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEE
Confidence 345678999999999999974 34 689999997543 34567889999999998877 8999999999999999
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE-------------------
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL------------------- 669 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl------------------- 669 (846)
||||+ +++|.+.+.......+++..+..++.|++.||+||| +.+|+||||||+|||+
T Consensus 100 v~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 100 AFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 99999 678888887766556999999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHH
Q 003114 670 NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ 749 (846)
Q Consensus 670 d~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~ 749 (846)
+.++.+||+|||+++.... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||........+..
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250 (355)
T ss_dssp ESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 5678999999999986432 22345789999999999999999999999999999999999999987665443332
Q ss_pred HHHHHH-------hcCC-cccccCCCCC---------------------CCCChHHHHHHHHHHHhccCCCCCCCCCHHH
Q 003114 750 WVDFML-------AQGD-IKNIVDPKLH---------------------GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNR 800 (846)
Q Consensus 750 ~~~~~~-------~~~~-~~~~~d~~L~---------------------~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~e 800 (846)
...... .... .......... ..........+.+++.+|++.+|++|||+.|
T Consensus 251 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 330 (355)
T 2eu9_A 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330 (355)
T ss_dssp HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHH
Confidence 222110 0000 0000000000 0012233557889999999999999999999
Q ss_pred HHH
Q 003114 801 VVM 803 (846)
Q Consensus 801 Vl~ 803 (846)
+++
T Consensus 331 ~l~ 333 (355)
T 2eu9_A 331 ALL 333 (355)
T ss_dssp HTT
T ss_pred Hhc
Confidence 875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=323.81 Aligned_cols=245 Identities=18% Similarity=0.242 Sum_probs=169.8
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeec----CCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE----GNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~LV~Ey~~~ 615 (846)
++||+|+||.||+|+.. +++.||+|++.... ....+....++.++||||+++++++.. +...++||||+++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~g 110 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTT
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCC
Confidence 46999999999999976 68999999996532 222233344667799999999999865 4568999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC---CCcEEEEeccCCccCCCCCcc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND---QFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~---~~~vkI~DFGla~~~~~~~~~ 692 (846)
|+|.+++.......+++.++..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++....
T Consensus 111 g~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~---- 183 (336)
T 3fhr_A 111 GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---- 183 (336)
T ss_dssp EEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc----
Confidence 99999998876667999999999999999999999 889999999999999976 45599999999986532
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
.......||+.|+|||.+.+..++.++|||||||+++||++|+.||................ ..+.. ......
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~------~~~~~~ 256 (336)
T 3fhr_A 184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI-RLGQY------GFPNPE 256 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CCCTTT
T ss_pred cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh-hcccc------ccCchh
Confidence 12234568999999999988889999999999999999999999997654322111111111 00000 000011
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.......+.+++.+|++.+|++|||++|+++
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1223457889999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=323.40 Aligned_cols=260 Identities=20% Similarity=0.260 Sum_probs=186.6
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCC-------eeeEee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN-------QIGLIY 610 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-------~~~LV~ 610 (846)
+.+.||+|+||.||+|+.. +++.||||++.... .......+|+..++.++||||+++++++...+ ..++||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~ 105 (360)
T 3e3p_A 27 VERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVM 105 (360)
T ss_dssp EC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEe
Confidence 3578999999999999975 68999999986542 22345677888889999999999999986533 278999
Q ss_pred ecccCCChhhhhhc--CCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-CCcEEEEeccCCccCC
Q 003114 611 EYMANGSLEEYLSD--SNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-QFQARLADFGLSKTFP 687 (846)
Q Consensus 611 Ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-~~~vkI~DFGla~~~~ 687 (846)
||+++ +|.+.+.. .....+++..+..++.|++.||.|||. ++.+|+||||||+|||++. ++.+||+|||+++...
T Consensus 106 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~ 183 (360)
T 3e3p_A 106 EYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183 (360)
T ss_dssp ECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCC
T ss_pred ecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecC
Confidence 99976 55544432 223458899999999999999999993 3678999999999999996 8999999999998764
Q ss_pred CCCcccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcC--------
Q 003114 688 IEGVSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG-------- 758 (846)
Q Consensus 688 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~-------- 758 (846)
.. .......||+.|+|||.+.+. .++.++|||||||++|||++|++||........+..+++......
T Consensus 184 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3e3p_A 184 PS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260 (360)
T ss_dssp TT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred CC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcc
Confidence 32 223345689999999988654 489999999999999999999999988766555555443211100
Q ss_pred ---CcccccCCC------CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 759 ---DIKNIVDPK------LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 759 ---~~~~~~d~~------L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
......+.. ............+.+++.+|++.+|++|||+.|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000 0011122345688999999999999999999998863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.95 Aligned_cols=248 Identities=26% Similarity=0.384 Sum_probs=199.6
Q ss_pred HhhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 536 TNDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (287)
T 2wei_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102 (287)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEc
Confidence 4455678999999999999976 78999999986432 23456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC---CcEEEEeccCCccCCCC
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ---FQARLADFGLSKTFPIE 689 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~---~~vkI~DFGla~~~~~~ 689 (846)
+++++|.+.+.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.+ +.+||+|||++......
T Consensus 103 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 103 YTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999999987654 3899999999999999999999 8899999999999999754 47999999999865322
Q ss_pred CcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
. ......|++.|+|||.+.+ .++.++||||||++++||++|+.||........+ .... .+...... +.
T Consensus 178 ~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~-~~~~~~~~-~~-- 245 (287)
T 2wei_A 178 T---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL----KRVE-TGKYAFDL-PQ-- 245 (287)
T ss_dssp S---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHH-HCCCCCCS-GG--
T ss_pred C---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH----HHHH-cCCCCCCc-hh--
Confidence 1 2223458899999998876 4899999999999999999999999876543322 2222 22111000 00
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 246 ---~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 246 ---WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ---GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0112346889999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.86 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=195.1
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCee------eEe
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQI------GLI 609 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~------~LV 609 (846)
+.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+.. ++|
T Consensus 46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 125 (371)
T 4exu_A 46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEE
Confidence 4568999999999999975 6899999999764 233457788999999999999999999999877654 999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||+. ++|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 126 ~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~- 196 (371)
T 4exu_A 126 MPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 196 (371)
T ss_dssp EECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred Ecccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence 99997 688888743 3899999999999999999999 88999999999999999999999999999986432
Q ss_pred CcccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCccccc----
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIV---- 764 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~---- 764 (846)
......||+.|+|||.+.+ ..++.++|||||||+++||++|+.||........+........... .+..
T Consensus 197 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~ 270 (371)
T 4exu_A 197 ----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG--TEFVQKLN 270 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC--HHHHTTCS
T ss_pred ----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc--HHHHHHhh
Confidence 2334578999999999877 6789999999999999999999999987665444444332211000 0000
Q ss_pred -----------CCCCCCC---CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 765 -----------DPKLHGD---IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 765 -----------d~~L~~~---~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
....... ........+.+++.+|++.+|++|||+.|+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000 011224578899999999999999999998864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=324.55 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=198.0
Q ss_pred hhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-----------cccceeEeeEeecCC
Q 003114 537 NDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-----------HKNLTTLYGYCNEGN 604 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-----------HpnIv~l~g~~~~~~ 604 (846)
+.+.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++ |+||+++++++...+
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~ 99 (373)
T 1q8y_A 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 99 (373)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence 34567899999999999997 47899999999754 334567888999999886 899999999987544
Q ss_pred ----eeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCC-CeeecCCCCCCEEEC------CCC
Q 003114 605 ----QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKP-PRVHRDIKPANILLN------DQF 673 (846)
Q Consensus 605 ----~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~IiHrDlKp~NILld------~~~ 673 (846)
..++||||+ +++|.+++.......+++..+..++.|++.||+||| +. +|+||||||+|||++ ..+
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 100 PNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp TTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCcc
Confidence 789999999 899999998766566999999999999999999999 76 999999999999994 445
Q ss_pred cEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccc------cccH
Q 003114 674 QARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEE------HKHI 747 (846)
Q Consensus 674 ~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~------~~~l 747 (846)
.+||+|||+++.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...+
T Consensus 176 ~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 176 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 899999999986532 22345789999999999999999999999999999999999999986432 1122
Q ss_pred HHHHHHHH-------hcCCc-ccccCC----------CC---------CCCCChHHHHHHHHHHHhccCCCCCCCCCHHH
Q 003114 748 SQWVDFML-------AQGDI-KNIVDP----------KL---------HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNR 800 (846)
Q Consensus 748 ~~~~~~~~-------~~~~~-~~~~d~----------~L---------~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~e 800 (846)
........ ..+.. ...++. .. ....+......+.+++.+|++.+|++|||++|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 22221110 00000 000000 00 01234556778999999999999999999999
Q ss_pred HHH
Q 003114 801 VVM 803 (846)
Q Consensus 801 Vl~ 803 (846)
+++
T Consensus 331 ll~ 333 (373)
T 1q8y_A 331 LVN 333 (373)
T ss_dssp HHT
T ss_pred Hhh
Confidence 987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=319.60 Aligned_cols=249 Identities=22% Similarity=0.303 Sum_probs=175.3
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHH-HHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVI-LLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|+||.||+|... +++.||||++.... .....++..|+. +++.++||||+++++++..++..++||||+++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (327)
T 3aln_A 26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST 105 (327)
T ss_dssp C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred ehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC
Confidence 3467999999999999985 78999999997653 233445555665 77778999999999999999999999999975
Q ss_pred CChhhhhhc---CCCCccChHHHHHHHHHHHHHHHHHhccCCC-CeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 616 GSLEEYLSD---SNADVLSWEGRLRIATEAAQGLEYLHLGCKP-PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 616 gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
+|.+++.. .....+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 106 -~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 179 (327)
T 3aln_A 106 -SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-- 179 (327)
T ss_dssp -EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred -ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc--
Confidence 88877763 22345899999999999999999999 76 9999999999999999999999999999865322
Q ss_pred ccccccccCCCcccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYC----QTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~----~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
.......||+.|+|||.+ .+..++.++|||||||+++||++|+.||......... . ........+.
T Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~------~~~~~~~~~~ 249 (327)
T 3aln_A 180 -IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---L------TQVVKGDPPQ 249 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------CCCCCSCCCC
T ss_pred -cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---H------HHHhcCCCCC
Confidence 122334689999999998 4567899999999999999999999999754321100 0 0011111111
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+...........+.+++.+|++.+|++||++.|+++
T Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 211112234457889999999999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=320.43 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=194.8
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCe------eeEe
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQ------IGLI 609 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~------~~LV 609 (846)
+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++..... .++|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 107 (353)
T 3coi_A 28 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107 (353)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred EeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEE
Confidence 4568999999999999975 68999999997542 3345678899999999999999999999977654 4999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||+. ++|.+++.. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 108 ~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~- 178 (353)
T 3coi_A 108 MPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 178 (353)
T ss_dssp EECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred ecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCCC-
Confidence 99997 688888753 3899999999999999999999 88999999999999999999999999999976432
Q ss_pred CcccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcC----------
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG---------- 758 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~---------- 758 (846)
......||+.|+|||.+.+ ..++.++|||||||+++||++|+.||........+....+......
T Consensus 179 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 179 ----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred ----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 1234578999999998876 6789999999999999999999999987654443333322110000
Q ss_pred -------CcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 759 -------DIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 759 -------~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.......+.+ ..........+.+++.+|++.+|++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000111 01112345678899999999999999999998763
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=329.76 Aligned_cols=247 Identities=24% Similarity=0.317 Sum_probs=185.8
Q ss_pred hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++..++..++||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 4679999999998777778999999998643 235678899999876 89999999999999999999999995 699
Q ss_pred hhhhhcCCCC-----ccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC-------------CcEEEEec
Q 003114 619 EEYLSDSNAD-----VLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ-------------FQARLADF 680 (846)
Q Consensus 619 ~~~l~~~~~~-----~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-------------~~vkI~DF 680 (846)
.+++...... ..++..++.++.|++.||+||| +.+|+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 9999865421 1234456789999999999999 8899999999999999654 58999999
Q ss_pred cCCccCCCCCcc--cccccccCCCcccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHH
Q 003114 681 GLSKTFPIEGVS--HLSTGVAGTFGYLDPEYCQT-------FRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQW 750 (846)
Q Consensus 681 Gla~~~~~~~~~--~~~~~~~gt~~Y~APE~~~~-------~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~ 750 (846)
|+++........ .......||+.|+|||++.+ ..++.++|||||||+++||+| |+.||....... ..+
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i 250 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNI 250 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHH
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHH
Confidence 999876432211 12234579999999999865 578999999999999999999 999997543221 111
Q ss_pred HHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 751 VDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 751 ~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
. . +... .+.+...........+.+++.+|++.+|++|||+.||++
T Consensus 251 ~----~-~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 251 I----R-GIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H----H-TCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred h----c-CCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 1 1110 011111123445678899999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.91 Aligned_cols=240 Identities=23% Similarity=0.385 Sum_probs=190.2
Q ss_pred HHhhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCc------hhhHHHHHHHHHHHhc----ccccceeEeeEeecC
Q 003114 535 ITNDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSR------QGYEQFEAEVILLRTV----HHKNLTTLYGYCNEG 603 (846)
Q Consensus 535 ~t~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~------~~~~~~~~Ei~~l~~l----~HpnIv~l~g~~~~~ 603 (846)
..+.+.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.++.++ +||||+++++++...
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 3445568999999999999986 4788999999975432 1233456799999988 899999999999999
Q ss_pred CeeeEeeec-ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC-CCCcEEEEecc
Q 003114 604 NQIGLIYEY-MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN-DQFQARLADFG 681 (846)
Q Consensus 604 ~~~~LV~Ey-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld-~~~~vkI~DFG 681 (846)
+..++|+|+ +.+++|.+++..... +++..+..++.|++.||.||| +.+|+||||||+||+++ +++.+||+|||
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred CeEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 999999999 789999999987543 899999999999999999999 88999999999999999 88999999999
Q ss_pred CCccCCCCCcccccccccCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCc
Q 003114 682 LSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLT-EKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDI 760 (846)
Q Consensus 682 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s-~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 760 (846)
+++..... ......|+..|+|||.+.+..+. .++|||||||+++||++|+.||..... . .. ...
T Consensus 186 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~----~~-~~~ 250 (312)
T 2iwi_A 186 SGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------I----LE-AEL 250 (312)
T ss_dssp SCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H----HH-TCC
T ss_pred hhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------H----hh-hcc
Confidence 99876432 22345689999999998877664 589999999999999999999975321 0 11 100
Q ss_pred ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 761 ~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
. ........+.+++.+|++.+|++||+++|+++.
T Consensus 251 ------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 251 ------H----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------C----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------C----CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 112233468899999999999999999999863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=318.54 Aligned_cols=237 Identities=23% Similarity=0.390 Sum_probs=194.4
Q ss_pred hhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCch------hhHHHHHHHHHHHhcc--cccceeEeeEeecCCeee
Q 003114 537 NDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQ------GYEQFEAEVILLRTVH--HKNLTTLYGYCNEGNQIG 607 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~------~~~~~~~Ei~~l~~l~--HpnIv~l~g~~~~~~~~~ 607 (846)
..+.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++++++ |+||+++++++..++..+
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~ 124 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence 34467899999999999986 47899999998654221 2345678999999996 599999999999999999
Q ss_pred EeeecccC-CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC-CCCcEEEEeccCCcc
Q 003114 608 LIYEYMAN-GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN-DQFQARLADFGLSKT 685 (846)
Q Consensus 608 LV~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld-~~~~vkI~DFGla~~ 685 (846)
+|+|++.+ ++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++ +++.+||+|||+++.
T Consensus 125 lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 125 LILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp EEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 99999986 89999998754 3899999999999999999999 88999999999999999 789999999999987
Q ss_pred CCCCCcccccccccCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 003114 686 FPIEGVSHLSTGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIV 764 (846)
Q Consensus 686 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~ 764 (846)
.... ......||+.|+|||.+.+..+ +.++|||||||+++||++|+.||..... ... +.. .
T Consensus 200 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------~~~-~~~--~- 261 (320)
T 3a99_A 200 LKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIR-GQV--F- 261 (320)
T ss_dssp CCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------HHH-CCC--C-
T ss_pred cccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------hhc-ccc--c-
Confidence 6422 2234568999999999887665 6889999999999999999999975321 011 110 0
Q ss_pred CCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 765 DPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 765 d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
. .......+.+++.+|++.+|++||+++|+++
T Consensus 262 ---~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 262 ---F----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---C----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---c----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 1122346889999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=310.58 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=176.6
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCch--hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQ--GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.++..+++.++||||+++++++..++..++||||+ +
T Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 107 (318)
T 2dyl_A 29 NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-G 107 (318)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred ccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-C
Confidence 3468999999999999985 7899999999765322 2233445556788889999999999999999999999999 4
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCC-CeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKP-PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+.+..+.... ...+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||++...... ..
T Consensus 108 ~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~---~~ 180 (318)
T 2dyl_A 108 TCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KA 180 (318)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred CcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC---cc
Confidence 5555554432 334899999999999999999999 64 9999999999999999999999999999765322 12
Q ss_pred cccccCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQ-----TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
.....|++.|+|||.+. ...++.++|||||||+++||++|+.||....... ........... . .+.
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~-~-----~~~ 251 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF---EVLTKVLQEEP-P-----LLP 251 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHHHHHHSCC-C-----CCC
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH---HHHHHHhccCC-C-----CCC
Confidence 23456899999999984 4568899999999999999999999997643222 11222222211 1 110
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
. .......+.+++.+|++.+|++||+++|+++.
T Consensus 252 ~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 252 G--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp S--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred c--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 11223468899999999999999999999873
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=325.13 Aligned_cols=245 Identities=25% Similarity=0.363 Sum_probs=185.2
Q ss_pred hhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
..+.||+|+||+||.....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+....++||||+. |+
T Consensus 28 ~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~ 103 (432)
T 3p23_A 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT 103 (432)
T ss_dssp EEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred cCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence 3468999999997665566899999999976433 3467899999999 89999999999999999999999996 69
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-----CCcEEEEeccCCccCCCCCc-
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-----QFQARLADFGLSKTFPIEGV- 691 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-----~~~vkI~DFGla~~~~~~~~- 691 (846)
|.+++...... +.+..+..++.|++.||.||| +.+|+||||||+|||++. ...+||+|||+++.......
T Consensus 104 L~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 104 LQEYVEQKDFA-HLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp HHHHHHSSSCC-CCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred HHHHHHhcCCC-ccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 99999876532 555667899999999999999 889999999999999953 34688999999987643221
Q ss_pred ccccccccCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQ---TFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
........||+.|+|||++. ...++.++|||||||+++||++ |+.||....... ......... .....
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-----~~~~~~~~~-~~~~~-- 251 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-----ANILLGACS-LDCLH-- 251 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-----HHHHTTCCC-CTTSC--
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-----HHHHhccCC-ccccC--
Confidence 12234467999999999987 4567889999999999999999 899996443221 111111111 11111
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
........+.+++.+|++.+|++|||+.||++
T Consensus 252 ----~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 252 ----PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ----TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11233455789999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=335.87 Aligned_cols=267 Identities=23% Similarity=0.315 Sum_probs=206.2
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeec------CCeeeE
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE------GNQIGL 608 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~------~~~~~L 608 (846)
+.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++.. ++..++
T Consensus 16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~L 95 (676)
T 3qa8_A 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL 95 (676)
T ss_dssp -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEE
Confidence 455688999999999999974 6899999998764 34456778999999999999999999998765 677899
Q ss_pred eeecccCCChhhhhhcCC-CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCc---EEEEeccCCc
Q 003114 609 IYEYMANGSLEEYLSDSN-ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQ---ARLADFGLSK 684 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~---vkI~DFGla~ 684 (846)
||||+++|+|.+++.... ...+++..+..++.+++.||+||| +.+|+||||||+||+++.++. +||+|||+++
T Consensus 96 VmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 96 AMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp EEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 999999999999998754 235899999999999999999999 889999999999999997664 9999999998
Q ss_pred cCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 003114 685 TFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIV 764 (846)
Q Consensus 685 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~ 764 (846)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..|..............
T Consensus 173 ~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~---~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 173 ELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP---VQWHGKVREKSNEHIVV 246 (676)
T ss_dssp BTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH---HHSSTTCC------CCS
T ss_pred ccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch---hhhhhhhhcccchhhhh
Confidence 76432 2234467999999999999999999999999999999999999999764321 12211111111000011
Q ss_pred CCC------------CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHH-----HHHHHHHhhhhh
Q 003114 765 DPK------------LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNR-----VVMELKECLAME 812 (846)
Q Consensus 765 d~~------------L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~e-----Vl~~L~~~l~~e 812 (846)
... ............+.+++.+|+..+|++|||+.| ..+.+++++...
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 100 011234456788999999999999999999988 667777776544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=337.53 Aligned_cols=240 Identities=20% Similarity=0.261 Sum_probs=193.3
Q ss_pred hhhhhhcCcCceEEEEEEEEc--CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCe-----eeE
Q 003114 537 NDFETILGEGSFGKVYHGYLD--DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQ-----IGL 608 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~-----~~L 608 (846)
+.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++...+. .++
T Consensus 82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 445678999999999999975 68999999987543 3445678899999999999999999999977655 799
Q ss_pred eeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 609 IYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
||||+++++|.+++.. .+++.+++.++.|++.||.||| +.+|+||||||+|||++.+ .+||+|||+++....
T Consensus 162 v~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 9999999999988765 4899999999999999999999 8899999999999999986 899999999986532
Q ss_pred CCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
. ....||++|+|||++.+.. +.++|||||||+++||++|.+|+........ .
T Consensus 234 ~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------~------- 285 (681)
T 2pzi_A 234 F------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------P------- 285 (681)
T ss_dssp C------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------------C-------
T ss_pred C------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------------c-------
Confidence 2 3457999999999987654 8999999999999999999998865321100 0
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhhhhh
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRP-NMNRVVMELKECLAME 812 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RP-sm~eVl~~L~~~l~~e 812 (846)
...........+.+++.+|++.+|++|| +++++.+.|.+++...
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 0000112234678999999999999999 5777888887766443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.13 Aligned_cols=230 Identities=13% Similarity=0.150 Sum_probs=181.4
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+..+++++||||+++++++..++..++||||
T Consensus 33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 112 (286)
T 3uqc_A 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW 112 (286)
T ss_dssp EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence 445678999999999999986 58999999997653 23347789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++++|.++++.. ....++.+++.|++.||+||| +.+|+||||||+|||+++++.+||+++|
T Consensus 113 ~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 113 IRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp CCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred cCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 9999999999643 345578899999999999999 8899999999999999999999997543
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC--C
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH--G 770 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~--~ 770 (846)
|++ .++.++|||||||++|||+||+.||........+.. .......... .
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~----------~~~~~~~~~~~~~ 226 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP----------AERDTAGQPIEPA 226 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE----------CCBCTTSCBCCHH
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH----------HHHHhccCCCChh
Confidence 333 368899999999999999999999986543221100 0000000000 0
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMET 813 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~ 813 (846)
.........+.+++.+|++.+|++| |+.|+++.|+++...+.
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0111234568899999999999999 99999999999765443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=297.53 Aligned_cols=221 Identities=19% Similarity=0.308 Sum_probs=176.4
Q ss_pred hhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHH-HhcccccceeEeeEeec----CCeeeEeeeccc
Q 003114 541 TILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILL-RTVHHKNLTTLYGYCNE----GNQIGLIYEYMA 614 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l-~~l~HpnIv~l~g~~~~----~~~~~LV~Ey~~ 614 (846)
+.||+|+||.||+|.. .+++.||+|++... ..+.+|+.++ +..+||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 5799999999999997 47899999999642 4567888887 56699999999999876 678999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC---CCcEEEEeccCCccCCCCCc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND---QFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~---~~~vkI~DFGla~~~~~~~~ 691 (846)
+|+|.+++.......+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---- 171 (299)
T 3m2w_A 99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---- 171 (299)
T ss_dssp SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence 999999998876667999999999999999999999 889999999999999998 7899999999986532
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
+..++.++||||+||+++||++|+.||........ .......+..... .
T Consensus 172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---------~~~~~~~~~~~~~--~ 220 (299)
T 3m2w_A 172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---------SPGMKTRIRMGQY--E 220 (299)
T ss_dssp --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------CCSCCSSCTTCC--S
T ss_pred --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh---------hHHHHHHHhhccc--c
Confidence 13467899999999999999999999975432210 0000011111000 1
Q ss_pred CC----hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 772 ID----VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 772 ~~----~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
.+ ......+.+++.+|++.+|++|||+.|+++.
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11 1234578899999999999999999999873
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=311.94 Aligned_cols=235 Identities=17% Similarity=0.162 Sum_probs=177.2
Q ss_pred hhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCc---hhhHHHHHHHHHHHhccc-cccee----------E--------
Q 003114 540 ETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSR---QGYEQFEAEVILLRTVHH-KNLTT----------L-------- 596 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~---~~~~~~~~Ei~~l~~l~H-pnIv~----------l-------- 596 (846)
.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.+++.++| +|... +
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 46899999999999995 4799999999984322 235789999999999977 22111 1
Q ss_pred ---eeEeec-----CCeeeEeeecccCCChhhhhh-----cCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCC
Q 003114 597 ---YGYCNE-----GNQIGLIYEYMANGSLEEYLS-----DSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIK 663 (846)
Q Consensus 597 ---~g~~~~-----~~~~~LV~Ey~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlK 663 (846)
..++.. ....+++|+++ +++|.++++ ......+++..++.++.|+++||+||| +.+|+|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDiK 238 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLR 238 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcc
Confidence 011111 12356667665 689999985 223445889999999999999999999 8999999999
Q ss_pred CCCEEECCCCcEEEEeccCCccCCCCCcccccccccCCCcccCcccc----------ccCCCCchhhHHHHHHHHHHHHh
Q 003114 664 PANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC----------QTFRLTEKSDVYSFGVVLLEIIT 733 (846)
Q Consensus 664 p~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~----------~~~~~s~ksDVwS~Gvvl~ELlt 733 (846)
|+|||++.++.+||+|||+++.... ......| +.|+|||++ ....++.++|||||||++|||++
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred cceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 9999999999999999999886432 1344567 999999998 55568899999999999999999
Q ss_pred CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 734 SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 734 G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
|+.||........ ...++... . .....+.+++.+|++.+|++||++.|+++
T Consensus 313 g~~Pf~~~~~~~~-------------~~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 313 ADLPNTDDAALGG-------------SEWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp SSCCCCTTGGGSC-------------SGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcchhhh-------------HHHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999976543221 11111110 1 12356889999999999999999888754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=299.25 Aligned_cols=241 Identities=20% Similarity=0.180 Sum_probs=179.0
Q ss_pred HhhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCC--------chhhHHHHHHHHHHHhcc---------cccceeEee
Q 003114 536 TNDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSS--------RQGYEQFEAEVILLRTVH---------HKNLTTLYG 598 (846)
Q Consensus 536 t~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--------~~~~~~~~~Ei~~l~~l~---------HpnIv~l~g 598 (846)
.+.+.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.+++.++ ||||+++.+
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~ 99 (336)
T 2vuw_A 21 KLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS 99 (336)
T ss_dssp HHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred cchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence 345568899999999999998 78999999997542 223477889999999886 555555555
Q ss_pred E-----------------eec-------------CCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHH
Q 003114 599 Y-----------------CNE-------------GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEY 648 (846)
Q Consensus 599 ~-----------------~~~-------------~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y 648 (846)
. +.. ++..++||||+++|++.+.+.. ..+++..+..++.|++.||+|
T Consensus 100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHH
T ss_pred eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHH
Confidence 4 333 6889999999999977776644 348999999999999999999
Q ss_pred HhccCCCCeeecCCCCCCEEECCCC--------------------cEEEEeccCCccCCCCCcccccccccCCCcccCcc
Q 003114 649 LHLGCKPPRVHRDIKPANILLNDQF--------------------QARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE 708 (846)
Q Consensus 649 LH~~~~~~IiHrDlKp~NILld~~~--------------------~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE 708 (846)
||+ +.+|+||||||+|||++.++ .+||+|||+++.... ....||+.|+|||
T Consensus 177 lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 177 AEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED 247 (336)
T ss_dssp HHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred HHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence 993 36899999999999999887 999999999986532 1347999999999
Q ss_pred ccccCCCCchhhHHHHHHH-HHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhc
Q 003114 709 YCQTFRLTEKSDVYSFGVV-LLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGC 787 (846)
Q Consensus 709 ~~~~~~~s~ksDVwS~Gvv-l~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~C 787 (846)
++.+.. +.++||||+|++ .+++++|..||..... ............... ..............+.+++.+|
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW---LHYLTDKMLKQMTFK----TKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH---HHHHHHHHHHTCCCS----SCCCSHHHHHHHHHHHHHHHHG
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcchhh---hhHHHHhhhhhhccC----cccchhhhhhcCHHHHHHHHHH
Confidence 998766 899999998777 7788999999843110 011111111111111 1111111234567889999999
Q ss_pred cCCCCCCCCCHHHHH
Q 003114 788 VSHSSTPRPNMNRVV 802 (846)
Q Consensus 788 l~~~P~~RPsm~eVl 802 (846)
++.+ |++|++
T Consensus 320 L~~d-----sa~e~l 329 (336)
T 2vuw_A 320 LNFS-----SATDLL 329 (336)
T ss_dssp GGSS-----SHHHHH
T ss_pred hccC-----CHHHHH
Confidence 9966 888876
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-27 Score=275.82 Aligned_cols=185 Identities=16% Similarity=0.128 Sum_probs=130.9
Q ss_pred hcCcCceEEEEEEE-EcCCcEEEEEEeCCCC----------chhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEe
Q 003114 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSS----------RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 542 ~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~----------~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV 609 (846)
..+.|++|.+..++ .--|+.+|+|++.... ....+++.+|+++|+++ +|+||+++++++.+++..+||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666654 3358899999996531 22346799999999999 799999999999999999999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||++|++|.++|...+. ++.. +|+.||+.||+|+| +.+||||||||+|||+++++.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999987654 5543 58999999999999 999999999999999999999999999999876432
Q ss_pred CcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPA 737 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p 737 (846)
.......+||++|+|||++.+ .+..++|+||+|+++++|.++..+
T Consensus 393 --~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 --CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred --CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 223345679999999999876 467789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-24 Score=253.47 Aligned_cols=184 Identities=17% Similarity=0.223 Sum_probs=146.3
Q ss_pred hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCc--h------hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSR--Q------GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--~------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
.+.||+|+||.||+|.. .++.+++|+...... . ..+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999954 578899998754321 1 13457899999999999999977777667778899999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+++++|.+++.. +..++.|+++||+||| +.+|+||||||+|||+++ .+||+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999976 4589999999999999 889999999999999999 999999999987643211
Q ss_pred cc-----ccccccCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003114 692 SH-----LSTGVAGTFGYLDPEYCQT--FRLTEKSDVYSFGVVLLEIITSRPAIA 739 (846)
Q Consensus 692 ~~-----~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~Gvvl~ELltG~~p~~ 739 (846)
.. ......||+.|+|||++.. ..|+.+.|+|+..+-.++.+.++.+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 11 1235679999999999986 568888999999999998888877664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=5.1e-21 Score=205.53 Aligned_cols=141 Identities=16% Similarity=0.125 Sum_probs=115.3
Q ss_pred hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCc------------------hhhHHHHHHHHHHHhcccccceeEeeEee
Q 003114 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSR------------------QGYEQFEAEVILLRTVHHKNLTTLYGYCN 601 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~------------------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~ 601 (846)
.+.||+|+||.||+|...+|+.||+|+++.... .....+.+|+.++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 378999999999999997799999999964321 13456889999999999 4 66666554
Q ss_pred cCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEecc
Q 003114 602 EGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFG 681 (846)
Q Consensus 602 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFG 681 (846)
. +..++||||+++|+|.+ +.. .....++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred c-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 3 55699999999999998 432 234579999999999999 89999999999999999 9999999999
Q ss_pred CCccCCCCCcccccccccCCCcccCcccccc
Q 003114 682 LSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712 (846)
Q Consensus 682 la~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 712 (846)
+++.. ..++|||++..
T Consensus 238 ~a~~~---------------~~~~a~e~l~r 253 (282)
T 1zar_A 238 QSVEV---------------GEEGWREILER 253 (282)
T ss_dssp TCEET---------------TSTTHHHHHHH
T ss_pred CCeEC---------------CCCCHHHHHHH
Confidence 99642 34789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=4.8e-17 Score=172.12 Aligned_cols=135 Identities=20% Similarity=0.240 Sum_probs=104.9
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcE--EEEEEeCCCCch------------------------hhHHHHHHHHHHHhcccc
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTE--VAVKMLSPSSRQ------------------------GYEQFEAEVILLRTVHHK 591 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~--VAVK~l~~~~~~------------------------~~~~~~~Ei~~l~~l~Hp 591 (846)
+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+..+..++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 346899999999999998 68889 999997543211 113578899999999988
Q ss_pred cc--eeEeeEeecCCeeeEeeecccC-C----ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCC
Q 003114 592 NL--TTLYGYCNEGNQIGLIYEYMAN-G----SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKP 664 (846)
Q Consensus 592 nI--v~l~g~~~~~~~~~LV~Ey~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp 664 (846)
++ ..++++ +..++||||+.+ | +|.+.... .++..+..++.|++.+|.|||. +.+|+||||||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp 199 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLSE 199 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCST
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCH
Confidence 64 333332 356899999942 4 66665432 3355678999999999999994 46899999999
Q ss_pred CCEEECCCCcEEEEeccCCccC
Q 003114 665 ANILLNDQFQARLADFGLSKTF 686 (846)
Q Consensus 665 ~NILld~~~~vkI~DFGla~~~ 686 (846)
+|||+++ .++|+|||++...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999999754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.60 E-value=5.5e-16 Score=168.72 Aligned_cols=128 Identities=29% Similarity=0.467 Sum_probs=113.4
Q ss_pred ccchhhHHHHHHHHhhcC----CCCCCC--CCCCCCCCCceEEeecCCCCCCCceEEEEcCCCCCcc--cCCccccCCCC
Q 003114 341 ETEQADVDAIMNIKSLYK----RKDWQG--DPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGLTG--GIPPYLSNLTM 412 (846)
Q Consensus 341 ~~~~~d~~al~~~k~~~~----~~~W~~--dpC~~~~~~w~gv~C~~~~~~~~~l~~L~L~~n~l~g--~ip~~~~~L~~ 412 (846)
.|.++|.+||++||..+. ..+|.. ||| .+.|.||.|+.. ....+|+.|+|++|+|+| .+|+.|++|++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C---~~~w~gv~C~~~-~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~ 77 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCC---NRTWLGVLCDTD-TQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTT---TTCSTTEEECCS-SSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCC---cCCCcceEeCCC-CCCceEEEEECCCCCccCCcccChhHhCCCC
Confidence 478899999999999986 457963 455 235999999743 233699999999999999 99999999999
Q ss_pred CCeEeccC-CCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCCccccCC
Q 003114 413 IEHLDLSN-NSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVDLCS 472 (846)
Q Consensus 413 L~~L~Ls~-N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~nlc~ 472 (846)
|++|+|++ |+++|.+|..|+++++|++|+|++|+|+|.+|..+..+++|+.|+++.|...
T Consensus 78 L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 138 (313)
T 1ogq_A 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS 138 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEE
T ss_pred CCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccC
Confidence 99999995 9999999999999999999999999999999999999999999999998654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.4e-15 Score=184.26 Aligned_cols=130 Identities=17% Similarity=0.249 Sum_probs=112.5
Q ss_pred cCCccchhhHHHHHHHHhhcCCCCCCCCC----CCCCCCCc------------eEEeecCCCCCCCceEEEEcCCCCCcc
Q 003114 338 SQSETEQADVDAIMNIKSLYKRKDWQGDP----CAPQAFLW------------NGLGCSYNDNDPPRITSLNLSSRGLTG 401 (846)
Q Consensus 338 ~~~~~~~~d~~al~~~k~~~~~~~W~~dp----C~~~~~~w------------~gv~C~~~~~~~~~l~~L~L~~n~l~g 401 (846)
....+..+|+.||++||+.+...+|+.+. +.|+.|.| .||+|+. ..+|+.|+|++|+|+|
T Consensus 262 ~~~~~~~~d~~ALl~~k~~l~~~~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~----~~~V~~L~Ls~~~L~G 337 (876)
T 4ecn_A 262 KETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN----NGRVTGLSLAGFGAKG 337 (876)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTGGGCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT----TSCEEEEECTTTCCEE
T ss_pred cccccchHHHHHHHHHHHHcCCCCCCcCCCcccccCCccccccccccccccCcCceEecC----CCCEEEEECccCCCCC
Confidence 34556788999999999999856896432 33445689 9999975 3699999999999999
Q ss_pred cCCccccCCCCCCeEec-cCCCCCCC------------------------------------------------------
Q 003114 402 GIPPYLSNLTMIEHLDL-SNNSLTGP------------------------------------------------------ 426 (846)
Q Consensus 402 ~ip~~~~~L~~L~~L~L-s~N~l~g~------------------------------------------------------ 426 (846)
.+|++|++|++|+.|+| ++|.++|.
T Consensus 338 ~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i 417 (876)
T 4ecn_A 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417 (876)
T ss_dssp EECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred cCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence 99999999999999999 88866555
Q ss_pred ----------------------CCchhcccCccccccccCccCCC-----------------CCccccc--ccCCCCCCC
Q 003114 427 ----------------------VPEFLSKLQYLRVLNLTGNMLTG-----------------PLPAGLV--ERSKNGSLS 465 (846)
Q Consensus 427 ----------------------iP~~~~~l~~L~~L~Ls~N~l~g-----------------~iP~~~~--~l~~l~~l~ 465 (846)
||.+|++|++|+.|+|++|+|+| .+|+.++ ++++|+.|+
T Consensus 418 ~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~ 497 (876)
T 4ecn_A 418 KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497 (876)
T ss_dssp CCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred ccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEE
Confidence 89999999999999999999999 4999988 999999999
Q ss_pred CccccC
Q 003114 466 LSVDLC 471 (846)
Q Consensus 466 l~~nlc 471 (846)
|+.|..
T Consensus 498 Ls~N~l 503 (876)
T 4ecn_A 498 LYNCPN 503 (876)
T ss_dssp EESCTT
T ss_pred CcCCCC
Confidence 998854
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.51 E-value=6.4e-15 Score=163.07 Aligned_cols=135 Identities=10% Similarity=0.092 Sum_probs=95.0
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCc--------------hhhHH--------HHHHHHHHHhccccccee
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSR--------------QGYEQ--------FEAEVILLRTVHHKNLTT 595 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--------------~~~~~--------~~~Ei~~l~~l~HpnIv~ 595 (846)
.+...||+|++|.||+|...+|+.||||+++.... ..... ..+|...|.++.+.++..
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v 177 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV 177 (397)
T ss_dssp EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 34568999999999999999999999999764210 00111 123455555554433321
Q ss_pred EeeEeecCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC--
Q 003114 596 LYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF-- 673 (846)
Q Consensus 596 l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-- 673 (846)
..-+.. ...+|||||+++++|.++... .....++.|++.+|.+|| +.+||||||||.|||+++++
T Consensus 178 p~p~~~--~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 178 PEPIAQ--SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCEEEE--ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECS
T ss_pred Ceeeec--cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCc
Confidence 111111 123699999999888765432 234568899999999999 88999999999999998776
Q ss_pred --------cEEEEeccCCcc
Q 003114 674 --------QARLADFGLSKT 685 (846)
Q Consensus 674 --------~vkI~DFGla~~ 685 (846)
.+.|+||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 389999997654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.7e-14 Score=170.57 Aligned_cols=127 Identities=21% Similarity=0.283 Sum_probs=108.0
Q ss_pred cCCccchhhHHHHHHHHhhcCCC-------------CCCCCCCCCCCCCc---eEEeecCCCCCCCceEEEEcCCCCCcc
Q 003114 338 SQSETEQADVDAIMNIKSLYKRK-------------DWQGDPCAPQAFLW---NGLGCSYNDNDPPRITSLNLSSRGLTG 401 (846)
Q Consensus 338 ~~~~~~~~d~~al~~~k~~~~~~-------------~W~~dpC~~~~~~w---~gv~C~~~~~~~~~l~~L~L~~n~l~g 401 (846)
.......+|++||.++++.++.. +|+.+ ...|.| .||+|+.. .+|+.|+|++|+|+|
T Consensus 23 ~~~~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~---~~~c~w~~~~GV~C~~~----~~V~~L~L~~~~l~g 95 (636)
T 4eco_A 23 SRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN---KELDMWGAQPGVSLNSN----GRVTGLSLEGFGASG 95 (636)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS---SCGGGTTCCTTEEECTT----CCEEEEECTTSCCEE
T ss_pred hhhhhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC---CCcccccCCCCeEEcCC----CCEEEEEecCcccCC
Confidence 34456678999999999998733 35421 122479 99999753 699999999999999
Q ss_pred cCCccccCCCCCCeEeccCC------------------------------------------------------------
Q 003114 402 GIPPYLSNLTMIEHLDLSNN------------------------------------------------------------ 421 (846)
Q Consensus 402 ~ip~~~~~L~~L~~L~Ls~N------------------------------------------------------------ 421 (846)
.+|++|++|++|+.|+|++|
T Consensus 96 ~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~ 175 (636)
T 4eco_A 96 RVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSI 175 (636)
T ss_dssp EECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCC
T ss_pred cCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCcccccc
Confidence 99999999999999999998
Q ss_pred ------------------CCCCCCCchhcccCccccccccCccCCCC-----------------Cccccc--ccCCCCCC
Q 003114 422 ------------------SLTGPVPEFLSKLQYLRVLNLTGNMLTGP-----------------LPAGLV--ERSKNGSL 464 (846)
Q Consensus 422 ------------------~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~-----------------iP~~~~--~l~~l~~l 464 (846)
+|+| ||.+|++|++|++|+|++|+|+|. +|+.++ ++++|+.|
T Consensus 176 ~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L 254 (636)
T 4eco_A 176 KKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDV 254 (636)
T ss_dssp CCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred ccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEE
Confidence 4456 899999999999999999999996 999999 99999999
Q ss_pred CCccccCC
Q 003114 465 SLSVDLCS 472 (846)
Q Consensus 465 ~l~~nlc~ 472 (846)
+++.|...
T Consensus 255 ~L~~n~l~ 262 (636)
T 4eco_A 255 EVYNCPNL 262 (636)
T ss_dssp EEECCTTC
T ss_pred EecCCcCC
Confidence 99998643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=3.2e-13 Score=164.87 Aligned_cols=123 Identities=27% Similarity=0.412 Sum_probs=93.0
Q ss_pred CccchhhHHHHHHHHhhcC----CCCCC-CCCCCCCCCCceEEeecCCCCCCCceEEEEcCCCCCccc---CC-------
Q 003114 340 SETEQADVDAIMNIKSLYK----RKDWQ-GDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGLTGG---IP------- 404 (846)
Q Consensus 340 ~~~~~~d~~al~~~k~~~~----~~~W~-~dpC~~~~~~w~gv~C~~~~~~~~~l~~L~L~~n~l~g~---ip------- 404 (846)
....++|++||++||+.+. ..+|+ +..| |.|.||+|+ ..+|+.|+|++++++|. +|
T Consensus 7 ~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~----C~w~gv~C~-----~~~v~~L~L~~~~l~g~~~~l~~~l~~L~ 77 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLPDKNLLPDWSSNKNP----CTFDGVTCR-----DDKVTSIDLSSKPLNVGFSAVSSSLLSLT 77 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCG----GGSTTEEEE-----TTEEEEEECTTSCCCEEHHHHHHHTTTCT
T ss_pred ccCCHHHHHHHHHHHhhCCCcccccCCCCCCCC----cCCcceEEC-----CCcEEEEECCCCCcCCccCccChhHhccC
Confidence 4457889999999999885 56896 3334 389999997 25899999999999887 55
Q ss_pred ----------------ccccCCCCCCeEeccCCCCCCCCCc--hhcccCccccccccCccCCCCCcccc-cccCCCCCCC
Q 003114 405 ----------------PYLSNLTMIEHLDLSNNSLTGPVPE--FLSKLQYLRVLNLTGNMLTGPLPAGL-VERSKNGSLS 465 (846)
Q Consensus 405 ----------------~~~~~L~~L~~L~Ls~N~l~g~iP~--~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~l~~l~~l~ 465 (846)
..|++|++|++|+|++|+++|.+|. .+++|++|++|+|++|+++|.+|..+ .++++|+.|+
T Consensus 78 ~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 157 (768)
T 3rgz_A 78 GLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLD 157 (768)
T ss_dssp TCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEE
T ss_pred cccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEE
Confidence 4566777777788888887777777 77777777777777777777777665 5667777777
Q ss_pred CccccC
Q 003114 466 LSVDLC 471 (846)
Q Consensus 466 l~~nlc 471 (846)
++.|..
T Consensus 158 Ls~n~l 163 (768)
T 3rgz_A 158 LSANSI 163 (768)
T ss_dssp CCSSCC
T ss_pred CCCCcc
Confidence 766543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.32 E-value=1.8e-12 Score=127.90 Aligned_cols=101 Identities=24% Similarity=0.203 Sum_probs=90.5
Q ss_pred CCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccC
Q 003114 371 AFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444 (846)
Q Consensus 371 ~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~ 444 (846)
.|+|+.|.|+... ..+.+++.|+|++|+|++..|..|++|++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 8 ~C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 8 SCSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 4589999999752 3457899999999999998899999999999999999999987777889999999999999
Q ss_pred ccCCCCCcccccccCCCCCCCCccccC
Q 003114 445 NMLTGPLPAGLVERSKNGSLSLSVDLC 471 (846)
Q Consensus 445 N~l~g~iP~~~~~l~~l~~l~l~~nlc 471 (846)
|+|++..|..+..+++|+.|+|++|..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~ 114 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPW 114 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCC
Confidence 999976666799999999999999964
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.27 E-value=4.9e-13 Score=146.38 Aligned_cols=128 Identities=23% Similarity=0.344 Sum_probs=107.3
Q ss_pred CccchhhHHHHHHHHhhcC--CC----CCC-CCCCCCCCCCceEEeecCC-----CCCCCceEEEEcCCCCCcccCCccc
Q 003114 340 SETEQADVDAIMNIKSLYK--RK----DWQ-GDPCAPQAFLWNGLGCSYN-----DNDPPRITSLNLSSRGLTGGIPPYL 407 (846)
Q Consensus 340 ~~~~~~d~~al~~~k~~~~--~~----~W~-~dpC~~~~~~w~gv~C~~~-----~~~~~~l~~L~L~~n~l~g~ip~~~ 407 (846)
.....+|..||++||..+. .. +|. ...|.+..|.|.|+.|... .....+++.|+|++|+|+ .+|+.+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 4456788999999999774 33 452 1233445568999999631 123468999999999999 899999
Q ss_pred cCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCCcccc
Q 003114 408 SNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVDL 470 (846)
Q Consensus 408 ~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~nl 470 (846)
++|++|++|+|++|+|+ .+|..++++++|++|+|++|+|+ .+|..+..+++|+.|++++|.
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~ 161 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEET
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCC
Confidence 99999999999999999 99999999999999999999999 899999999999999999854
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=6.3e-12 Score=126.67 Aligned_cols=105 Identities=28% Similarity=0.244 Sum_probs=93.5
Q ss_pred CCCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCcccccccc
Q 003114 370 QAFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443 (846)
Q Consensus 370 ~~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls 443 (846)
+.|.|..|.|++.. +.+.+++.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 8 C~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls 86 (193)
T 2wfh_A 8 CTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILS 86 (193)
T ss_dssp CEEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CEeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECC
Confidence 35678899998752 45678999999999999 899999999999999999999998888899999999999999
Q ss_pred CccCCCCCcccccccCCCCCCCCccccCCCCC
Q 003114 444 GNMLTGPLPAGLVERSKNGSLSLSVDLCSSYP 475 (846)
Q Consensus 444 ~N~l~g~iP~~~~~l~~l~~l~l~~nlc~~~p 475 (846)
+|+|++..|..|..+++|+.|+|++|.....+
T Consensus 87 ~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~ 118 (193)
T 2wfh_A 87 YNRLRCIPPRTFDGLKSLRLLSLHGNDISVVP 118 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred CCccCEeCHHHhCCCCCCCEEECCCCCCCeeC
Confidence 99999887888999999999999999776533
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.1e-11 Score=128.25 Aligned_cols=102 Identities=21% Similarity=0.165 Sum_probs=90.1
Q ss_pred CceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCcc
Q 003114 373 LWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446 (846)
Q Consensus 373 ~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~ 446 (846)
+|++|.|+... +.+++++.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+
T Consensus 20 s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 20 SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 89999998752 456789999999999999889999999999999999999986666778999999999999999
Q ss_pred CCCCCcccccccCCCCCCCCccccCCCC
Q 003114 447 LTGPLPAGLVERSKNGSLSLSVDLCSSY 474 (846)
Q Consensus 447 l~g~iP~~~~~l~~l~~l~l~~nlc~~~ 474 (846)
|++..|..+..+++|+.|+++.|.....
T Consensus 100 l~~l~~~~~~~l~~L~~L~Ls~N~l~~l 127 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLKELFMCCNKLTEL 127 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCSC
T ss_pred CCccChhHhCcchhhCeEeccCCccccc
Confidence 9976666788999999999999876543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.2e-11 Score=122.30 Aligned_cols=105 Identities=23% Similarity=0.241 Sum_probs=91.7
Q ss_pred CCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccC
Q 003114 371 AFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444 (846)
Q Consensus 371 ~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~ 444 (846)
.|+|.+|.|+... ..+.+++.|+|++|++++..+..|+++++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 6 ~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp EEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 4689999998753 3457899999999999977677789999999999999999977777789999999999999
Q ss_pred ccCCCCCcccccccCCCCCCCCccccCCCCC
Q 003114 445 NMLTGPLPAGLVERSKNGSLSLSVDLCSSYP 475 (846)
Q Consensus 445 N~l~g~iP~~~~~l~~l~~l~l~~nlc~~~p 475 (846)
|+|++..|..+..+++|+.|++++|.....+
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 116 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVP 116 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeC
Confidence 9999777777889999999999999776543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.9e-11 Score=121.05 Aligned_cols=101 Identities=19% Similarity=0.155 Sum_probs=87.7
Q ss_pred CCceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCc
Q 003114 372 FLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445 (846)
Q Consensus 372 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N 445 (846)
|....+.|++.. ..+.+++.|+|++|+|++..|..|++|++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 12 C~~~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 12 CDQTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp ECSSEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ECCcEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 456678898752 35578999999999999988999999999999999999999766667899999999999999
Q ss_pred cCCCCCcccccccCCCCCCCCccccCC
Q 003114 446 MLTGPLPAGLVERSKNGSLSLSVDLCS 472 (846)
Q Consensus 446 ~l~g~iP~~~~~l~~l~~l~l~~nlc~ 472 (846)
+|++..|..+..+++|+.|+|++|...
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 999655556999999999999999654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.1e-11 Score=124.80 Aligned_cols=103 Identities=19% Similarity=0.178 Sum_probs=90.7
Q ss_pred CCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCc-cccCCCCCCeEeccCCCCCCCCCchhcccCcccccccc
Q 003114 371 AFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPP-YLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443 (846)
Q Consensus 371 ~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~-~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls 443 (846)
.|.|..|.|+... ..+.+++.|+|++|+|++..+. .|+++++|+.|+|++|+|++.+|..|.++++|+.|+|+
T Consensus 7 ~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred EECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 4689999999752 3445899999999999976665 49999999999999999999999999999999999999
Q ss_pred CccCCCCCcccccccCCCCCCCCccccCCC
Q 003114 444 GNMLTGPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 444 ~N~l~g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
+|+|++..|..+..+++|+.|++++|....
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 116 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISC 116 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCE
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCe
Confidence 999998888889999999999999987654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.17 E-value=3.6e-11 Score=122.11 Aligned_cols=104 Identities=22% Similarity=0.217 Sum_probs=90.0
Q ss_pred CCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccC
Q 003114 371 AFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444 (846)
Q Consensus 371 ~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~ 444 (846)
.|.|.+|.|+..+ +.+.+++.|+|++|++++..+..|+++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 4689999998753 3456899999999999976666799999999999999999977677789999999999999
Q ss_pred ccCCCCCcccccccCCCCCCCCccccCCCC
Q 003114 445 NMLTGPLPAGLVERSKNGSLSLSVDLCSSY 474 (846)
Q Consensus 445 N~l~g~iP~~~~~l~~l~~l~l~~nlc~~~ 474 (846)
|+|++..+..+..+++|+.|+++.|.....
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 115 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSL 115 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCccc
Confidence 999976666788999999999999866543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.16 E-value=3e-11 Score=132.84 Aligned_cols=99 Identities=22% Similarity=0.179 Sum_probs=84.1
Q ss_pred CCceEEeecCC-C-------CCCCceEEEEcCC-CCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccc
Q 003114 372 FLWNGLGCSYN-D-------NDPPRITSLNLSS-RGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNL 442 (846)
Q Consensus 372 ~~w~gv~C~~~-~-------~~~~~l~~L~L~~-n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~L 442 (846)
|.|..|.|++. . ....+|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|.+|++|+.|+|
T Consensus 8 C~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 8 HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp SSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred ccCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence 68999999975 1 2235699999996 9999888889999999999999999999999999999999999999
Q ss_pred cCccCCCCCcccccccCCCCCCCCccccC
Q 003114 443 TGNMLTGPLPAGLVERSKNGSLSLSVDLC 471 (846)
Q Consensus 443 s~N~l~g~iP~~~~~l~~l~~l~l~~nlc 471 (846)
++|+|++ +|..+.....|+.|+|..|..
T Consensus 88 ~~N~l~~-~~~~~~~~~~L~~l~l~~N~~ 115 (347)
T 2ifg_A 88 SFNALES-LSWKTVQGLSLQELVLSGNPL 115 (347)
T ss_dssp CSSCCSC-CCSTTTCSCCCCEEECCSSCC
T ss_pred CCCccce-eCHHHcccCCceEEEeeCCCc
Confidence 9999995 555444444499999998854
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.15 E-value=6e-11 Score=122.00 Aligned_cols=104 Identities=23% Similarity=0.214 Sum_probs=89.7
Q ss_pred CCCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCcccccccc
Q 003114 370 QAFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443 (846)
Q Consensus 370 ~~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls 443 (846)
+.|.|..|.|+..+ ..+.+++.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 9 C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls 88 (220)
T 2v9t_B 9 CTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLY 88 (220)
T ss_dssp SEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECC
T ss_pred CEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECC
Confidence 35689999998752 345689999999999998777789999999999999999998889999999999999999
Q ss_pred CccCCCCCcccccccCCCCCCCCccccCCC
Q 003114 444 GNMLTGPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 444 ~N~l~g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
+|+|++..+..|..+++|+.|+|++|....
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~ 118 (220)
T 2v9t_B 89 GNKITELPKSLFEGLFSLQLLLLNANKINC 118 (220)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCcCCccCHhHccCCCCCCEEECCCCCCCE
Confidence 999995444457889999999999987654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=3.2e-11 Score=147.14 Aligned_cols=87 Identities=25% Similarity=0.418 Sum_probs=83.6
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
...++.|||++|+|+|.||..|++|++|+.|+|++|+|+|.||..|++|++|+.||||+|+|+|.+|..+..++.|+.|+
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCC
Q 003114 466 LSVDLCS 472 (846)
Q Consensus 466 l~~nlc~ 472 (846)
+++|...
T Consensus 711 ls~N~l~ 717 (768)
T 3rgz_A 711 LSNNNLS 717 (768)
T ss_dssp CCSSEEE
T ss_pred CcCCccc
Confidence 9998654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.10 E-value=1e-10 Score=120.17 Aligned_cols=103 Identities=17% Similarity=0.129 Sum_probs=88.2
Q ss_pred CCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCc-cccCCCCCCeEeccCCCCCCCCCchhcccCcccccccc
Q 003114 371 AFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPP-YLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443 (846)
Q Consensus 371 ~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~-~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls 443 (846)
.|.|..+.|++.. ..+..++.|+|++|+|++..|. .|.++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 10 ~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 10 RCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred EECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 4589999998752 3445788999999999987664 48999999999999999998878889999999999999
Q ss_pred CccCCCCCcccccccCCCCCCCCccccCCC
Q 003114 444 GNMLTGPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 444 ~N~l~g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
+|+|++..|..|..+++|+.|+|++|....
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 119 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITC 119 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCC
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCe
Confidence 999998778889999999999999886654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.08 E-value=5.5e-11 Score=119.52 Aligned_cols=88 Identities=24% Similarity=0.339 Sum_probs=82.9
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
..++|+.|+|++|+|++.+|..|+++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.+|..+..+++|+.|
T Consensus 52 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 131 (192)
T 1w8a_A 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131 (192)
T ss_dssp GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred cCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEE
Confidence 35689999999999999999999999999999999999999889999999999999999999999999999999999999
Q ss_pred CCccccCC
Q 003114 465 SLSVDLCS 472 (846)
Q Consensus 465 ~l~~nlc~ 472 (846)
++++|...
T Consensus 132 ~L~~N~l~ 139 (192)
T 1w8a_A 132 NLASNPFN 139 (192)
T ss_dssp ECTTCCBC
T ss_pred EeCCCCcc
Confidence 99998653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=3.4e-10 Score=119.15 Aligned_cols=137 Identities=17% Similarity=0.089 Sum_probs=107.3
Q ss_pred hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
...++.|+.+.||+.... +..+++|+...........+.+|+.+++.+. |..+.++++++...+..++||||++|.+|
T Consensus 19 ~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 97 (263)
T 3tm0_A 19 VKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLC 97 (263)
T ss_dssp EECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred EeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeeh
Confidence 456788888999999754 6889999987532222346889999999884 66778899999888899999999999999
Q ss_pred hhhhhcCCCCccChHHHHHHHHHHHHHHHHHhcc----------------------------------------------
Q 003114 619 EEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG---------------------------------------------- 652 (846)
Q Consensus 619 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------------- 652 (846)
.+.+.. ......++.+++++|..||.-
T Consensus 98 ~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (263)
T 3tm0_A 98 SEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp HHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred hhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence 876421 123457888999999999951
Q ss_pred ----------CCCCeeecCCCCCCEEECCCCcEEEEeccCCc
Q 003114 653 ----------CKPPRVHRDIKPANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 653 ----------~~~~IiHrDlKp~NILld~~~~vkI~DFGla~ 684 (846)
....++|||+++.||+++++..+.|+||+.+.
T Consensus 171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999877667799998774
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=1.6e-10 Score=131.65 Aligned_cols=107 Identities=16% Similarity=0.123 Sum_probs=90.2
Q ss_pred CCCCCCCCCceE--EeecCCC-----CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCC-CchhcccCc
Q 003114 365 DPCAPQAFLWNG--LGCSYND-----NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPV-PEFLSKLQY 436 (846)
Q Consensus 365 dpC~~~~~~w~g--v~C~~~~-----~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~i-P~~~~~l~~ 436 (846)
||| |..|.|.+ |.|+..+ ..+++++.|+|++|++++..|..|++|++|++|+|++|.+.+.+ |..|.++++
T Consensus 2 ~p~-~~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~ 80 (455)
T 3v47_A 2 DPG-TSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80 (455)
T ss_dssp ------CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTT
T ss_pred CCc-cceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECccccccccc
Confidence 677 45666766 9998752 24578999999999999988999999999999999999998877 467999999
Q ss_pred cccccccCccCCCCCcccccccCCCCCCCCccccCC
Q 003114 437 LRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVDLCS 472 (846)
Q Consensus 437 L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~nlc~ 472 (846)
|++|+|++|++++..|..+..+++|+.|+++.|...
T Consensus 81 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 116 (455)
T 3v47_A 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLD 116 (455)
T ss_dssp CCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCB
T ss_pred CCEEeCCCCccCccChhhccCcccCCEEeCCCCCCC
Confidence 999999999999888999999999999999988654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=1.1e-09 Score=114.45 Aligned_cols=128 Identities=16% Similarity=0.077 Sum_probs=97.6
Q ss_pred CcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccc--eeEeeEeecCCeeeEeeecccCCChhhh
Q 003114 544 GEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNL--TTLYGYCNEGNQIGLIYEYMANGSLEEY 621 (846)
Q Consensus 544 G~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnI--v~l~g~~~~~~~~~LV~Ey~~~gsL~~~ 621 (846)
+.|..+.||+....+|..+++|+.... ....+.+|+.+++.+.+.++ .+++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355669999998777888999998654 23567899999999865554 45888888878899999999998884
Q ss_pred hhcCCCCccChHHHHHHHHHHHHHHHHHhccC------------------------------------------------
Q 003114 622 LSDSNADVLSWEGRLRIATEAAQGLEYLHLGC------------------------------------------------ 653 (846)
Q Consensus 622 l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------------ 653 (846)
... . ....++.++++.|..||...
T Consensus 104 ~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 221 1 12356778888888888421
Q ss_pred -------CCCeeecCCCCCCEEECCCCcEEEEeccCCc
Q 003114 654 -------KPPRVHRDIKPANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 654 -------~~~IiHrDlKp~NILld~~~~vkI~DFGla~ 684 (846)
...++|||++|.||+++++..+.|.|||.+.
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887767899999875
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.00 E-value=2.1e-10 Score=132.46 Aligned_cols=84 Identities=19% Similarity=0.158 Sum_probs=54.2
Q ss_pred CceEEEEcCCCCCcccCCcccc-CCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLS-NLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~-~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
++|+.|+|++|+|++.+|..+. +|++|+.|+|++|+|++. |. +..+++|+.|+|++|+|++ +|..+..+++|+.|+
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~ 220 (487)
T 3oja_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS 220 (487)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEE
T ss_pred CCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEE
Confidence 4666666666666666666654 566666666666666644 22 3346777777777777774 444577777777777
Q ss_pred CccccCCC
Q 003114 466 LSVDLCSS 473 (846)
Q Consensus 466 l~~nlc~~ 473 (846)
+++|....
T Consensus 221 Ls~N~l~~ 228 (487)
T 3oja_A 221 LRNNKLVL 228 (487)
T ss_dssp CTTSCCCE
T ss_pred ecCCcCcc
Confidence 77775544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=3.6e-10 Score=116.17 Aligned_cols=87 Identities=20% Similarity=0.208 Sum_probs=72.7
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
...+|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+..+++|+.|
T Consensus 79 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 158 (220)
T 2v70_A 79 GASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTL 158 (220)
T ss_dssp TCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEE
Confidence 44678888888888887777778888888888888888888888888888888888888888887778888888888888
Q ss_pred CCccccC
Q 003114 465 SLSVDLC 471 (846)
Q Consensus 465 ~l~~nlc 471 (846)
++++|..
T Consensus 159 ~L~~N~l 165 (220)
T 2v70_A 159 NLLANPF 165 (220)
T ss_dssp ECCSCCE
T ss_pred EecCcCC
Confidence 8888753
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=98.99 E-value=6.3e-10 Score=116.52 Aligned_cols=102 Identities=22% Similarity=0.195 Sum_probs=88.9
Q ss_pred CceEEeecCC------CCCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCcc
Q 003114 373 LWNGLGCSYN------DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446 (846)
Q Consensus 373 ~w~gv~C~~~------~~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~ 446 (846)
.|..|.|+.. .+.+++++.|+|++|++++..|..|+++++|+.|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 94 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred CCeEEecCCCCccccCCCCCCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCc
Confidence 3556667654 2456789999999999999888899999999999999999999888899999999999999999
Q ss_pred CCCCCcccccccCCCCCCCCccccCCCC
Q 003114 447 LTGPLPAGLVERSKNGSLSLSVDLCSSY 474 (846)
Q Consensus 447 l~g~iP~~~~~l~~l~~l~l~~nlc~~~ 474 (846)
|++..|..+..+++|+.|++++|.....
T Consensus 95 l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 122 (251)
T 3m19_A 95 LASLPLGVFDHLTQLDKLYLGGNQLKSL 122 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred ccccChhHhcccCCCCEEEcCCCcCCCc
Confidence 9977777889999999999999876543
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=1.5e-09 Score=107.32 Aligned_cols=132 Identities=16% Similarity=0.110 Sum_probs=89.1
Q ss_pred CCCCcEEecCccccccCcccc----ccccccccccccCcceeecCCCCCcceeeecccCCceeEEEEEeeeccCCCCCCC
Q 003114 25 NQSGIKYISDTTFVDAGISKS----VALAYQLESLHQPLWNLRSFPEGKRNCYNVKLAKDVRYLIRASFAHGDYDGKGTV 100 (846)
Q Consensus 25 ~~~~~~~~~d~~~~~~g~~~~----v~~~~~~~~~~~~~~~lr~fp~~~~~cy~l~~~~~~~ylvr~~f~yg~~d~~~~~ 100 (846)
+..|++|.+|..|...|.... +..........+.|+|.|.||. ..||.+|+.++|+|+||.-|.--.|.+ ...
T Consensus 19 d~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~--~~tY~f~v~~~G~Y~VrLhF~ei~~~~-~~~ 95 (174)
T 2jwp_A 19 DVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNED--SFGYDIPIKEEGEYVLVLKFAEVYFAQ-SQQ 95 (174)
T ss_dssp ETTTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCCS--CEEEEEECCSCEEEEEEEEEECCSCCC-SSS
T ss_pred CCCCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCCC--CeEEEEEeCCCeEEEEEEEEeccccCC-CCC
Confidence 457999999998864443321 1101011123457999999996 789999999999999999998776654 456
Q ss_pred CeeeEeecCcee-eEEeeC---CCcceEEEEEEEEe-------------cCCceEEEEeecCCCCcceeeeeeeec
Q 003114 101 PEFDLHLGPNKW-ESVILG---NVSTIIVKEIIHVI-------------SSNSTRVCLVNTGAGTPFISALEFRPL 159 (846)
Q Consensus 101 ~~fd~~~~~~~w-~~v~~~---~~~~~~~~e~~~~~-------------~~~~~~vcl~~~~~~~Pfis~le~~~l 159 (846)
.+||+++++..- ...++. ....+++.|..+.+ .+..+.|.|.....+.||||+||+.+-
T Consensus 96 rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~~a~inaIEI~~~ 171 (174)
T 2jwp_A 96 KVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMKG 171 (174)
T ss_dssp SCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSCSSSEEEEEEESS
T ss_pred eEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCCCcEEEEEEEEeC
Confidence 799999999532 112211 11234556665542 455688888854456899999999974
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=3.6e-10 Score=133.78 Aligned_cols=99 Identities=21% Similarity=0.101 Sum_probs=85.8
Q ss_pred EEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCC
Q 003114 376 GLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG 449 (846)
Q Consensus 376 gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g 449 (846)
.|.|+..+ +.|+.++.|||++|+|++..|.+|.+|++|++|+|++|+|++..|++|.+|++|++|+|++|+|++
T Consensus 35 ~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~ 114 (635)
T 4g8a_A 35 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 114 (635)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred EEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC
Confidence 57898642 566789999999999997777789999999999999999998778889999999999999999996
Q ss_pred CCcccccccCCCCCCCCccccCCCC
Q 003114 450 PLPAGLVERSKNGSLSLSVDLCSSY 474 (846)
Q Consensus 450 ~iP~~~~~l~~l~~l~l~~nlc~~~ 474 (846)
..|..|.++++|+.|+++.|.....
T Consensus 115 l~~~~f~~L~~L~~L~Ls~N~l~~l 139 (635)
T 4g8a_A 115 LALGAFSGLSSLQKLVAVETNLASL 139 (635)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCCS
T ss_pred CCHHHhcCCCCCCEEECCCCcCCCC
Confidence 6666789999999999998866543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=98.96 E-value=2.4e-10 Score=123.99 Aligned_cols=112 Identities=26% Similarity=0.492 Sum_probs=95.1
Q ss_pred CCCCCCCCCCC--CCceEEeecCCC-----------CCCCceEEEEcCC-CCCcccCCccccCCCCCCeEeccCCCCCCC
Q 003114 361 DWQGDPCAPQA--FLWNGLGCSYND-----------NDPPRITSLNLSS-RGLTGGIPPYLSNLTMIEHLDLSNNSLTGP 426 (846)
Q Consensus 361 ~W~~dpC~~~~--~~w~gv~C~~~~-----------~~~~~l~~L~L~~-n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~ 426 (846)
.|.|-.|.... ..-..+..+... ...++|+.|+|++ |+++|.+|..|++|++|++|+|++|+++|.
T Consensus 37 ~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~ 116 (313)
T 1ogq_A 37 TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116 (313)
T ss_dssp CSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE
T ss_pred CCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCc
Confidence 39998886432 234444444321 2236899999995 999999999999999999999999999999
Q ss_pred CCchhcccCccccccccCccCCCCCcccccccCCCCCCCCccccCC
Q 003114 427 VPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVDLCS 472 (846)
Q Consensus 427 iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~nlc~ 472 (846)
+|..|+++++|++|+|++|+|+|.+|..+..+++|+.|+++.|...
T Consensus 117 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 162 (313)
T 1ogq_A 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162 (313)
T ss_dssp CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCE
T ss_pred CCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCccc
Confidence 9999999999999999999999999999999999999999988654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=6e-10 Score=112.07 Aligned_cols=86 Identities=24% Similarity=0.251 Sum_probs=78.5
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
..+|+.|+|++|+|++..+..|.+|++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 53 l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 132 (193)
T 2wfh_A 53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLA 132 (193)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEE
Confidence 45899999999999988888899999999999999999988888999999999999999999965555688999999999
Q ss_pred CccccC
Q 003114 466 LSVDLC 471 (846)
Q Consensus 466 l~~nlc 471 (846)
++.|..
T Consensus 133 L~~N~~ 138 (193)
T 2wfh_A 133 IGANPL 138 (193)
T ss_dssp CCSSCE
T ss_pred eCCCCe
Confidence 999853
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=98.94 E-value=9.9e-10 Score=112.83 Aligned_cols=88 Identities=18% Similarity=0.183 Sum_probs=67.5
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 55 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 134 (220)
T 2v9t_B 55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS 134 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEE
Confidence 45778888888888877777888888888888888888854445567788888888888888877777777888888888
Q ss_pred CccccCCC
Q 003114 466 LSVDLCSS 473 (846)
Q Consensus 466 l~~nlc~~ 473 (846)
|++|....
T Consensus 135 L~~N~l~~ 142 (220)
T 2v9t_B 135 LYDNKLQT 142 (220)
T ss_dssp CCSSCCSC
T ss_pred CCCCcCCE
Confidence 88776554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.92 E-value=7.7e-10 Score=122.49 Aligned_cols=110 Identities=25% Similarity=0.189 Sum_probs=89.1
Q ss_pred CCCCCCCC--CCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCcccc-CCCCCCeEeccCCCCCCCCCchhcc
Q 003114 363 QGDPCAPQ--AFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLS-NLTMIEHLDLSNNSLTGPVPEFLSK 433 (846)
Q Consensus 363 ~~dpC~~~--~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~-~L~~L~~L~Ls~N~l~g~iP~~~~~ 433 (846)
....| |. .|.|..|.|+... ..+..++.|+|++|+|++..+..+. +|++|+.|+|++|+|++..|..|.+
T Consensus 8 ~~~~C-p~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~ 86 (361)
T 2xot_A 8 SVVSC-PANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVP 86 (361)
T ss_dssp CCTTC-CTTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTT
T ss_pred cCCCC-CCCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccC
Confidence 34556 43 4578889998752 4456788999999999987777787 8999999999999999777788999
Q ss_pred cCccccccccCccCCCCCcccccccCCCCCCCCccccCCC
Q 003114 434 LQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 434 l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
+++|+.|+|++|+|++..|..|..+++|+.|+|++|....
T Consensus 87 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 126 (361)
T 2xot_A 87 VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV 126 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccE
Confidence 9999999999999986666678889999999998886543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.91 E-value=1.6e-09 Score=114.70 Aligned_cols=111 Identities=23% Similarity=0.226 Sum_probs=88.8
Q ss_pred CCCCCCCCCCCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccC
Q 003114 362 WQGDPCAPQAFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQ 435 (846)
Q Consensus 362 W~~dpC~~~~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~ 435 (846)
|.|..|. +...|..|.|+... ..+..++.|+|++|+|++..+..|+++++|++|+|++|+|++..+..|.+++
T Consensus 7 ~~~~~C~-c~~~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~ 85 (270)
T 2o6q_A 7 KDGGVCS-CNNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELK 85 (270)
T ss_dssp GGTCSBE-EETTTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCT
T ss_pred CCCCCCE-eCCCCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCC
Confidence 5555552 11246677777542 3456799999999999977677899999999999999999965566679999
Q ss_pred ccccccccCccCCCCCcccccccCCCCCCCCccccCCC
Q 003114 436 YLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 436 ~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
+|++|+|++|++++..+..+..+++|+.|+++.|....
T Consensus 86 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 123 (270)
T 2o6q_A 86 NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS 123 (270)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCC
T ss_pred CCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCe
Confidence 99999999999997666678899999999999886554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.91 E-value=9.2e-10 Score=105.35 Aligned_cols=83 Identities=24% Similarity=0.242 Sum_probs=45.0
Q ss_pred CceEEEEcCCCCCc-ccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 387 PRITSLNLSSRGLT-GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 387 ~~l~~L~L~~n~l~-g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
++++.|+|++|+++ |.+|..+..+++|+.|+|++|+|++. ..++++++|+.|+|++|++++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34555555555555 55555555555555555555555543 4455555555555555555554555555555555555
Q ss_pred CccccC
Q 003114 466 LSVDLC 471 (846)
Q Consensus 466 l~~nlc 471 (846)
+++|..
T Consensus 95 ls~N~i 100 (149)
T 2je0_A 95 LSGNKI 100 (149)
T ss_dssp CTTSCC
T ss_pred CCCCcC
Confidence 555543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=6.5e-10 Score=129.77 Aligned_cols=101 Identities=19% Similarity=0.089 Sum_probs=89.0
Q ss_pred CCceEEeecCCC--------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCcccccccc
Q 003114 372 FLWNGLGCSYND--------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443 (846)
Q Consensus 372 ~~w~gv~C~~~~--------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls 443 (846)
|.|.|+ |+... +.+++++.|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 4 C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls 82 (549)
T 2z81_A 4 CDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82 (549)
T ss_dssp ECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred CCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECC
Confidence 478888 76531 345689999999999998889999999999999999999998888999999999999999
Q ss_pred CccCCCCCcccccccCCCCCCCCccccCCC
Q 003114 444 GNMLTGPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 444 ~N~l~g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
+|+|++..|..+..+++|+.|+++.|....
T Consensus 83 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 112 (549)
T 2z81_A 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQT 112 (549)
T ss_dssp TSCCCSCCHHHHTTCTTCCEEECTTCCCSS
T ss_pred CCccCccCHHHhccCCCCcEEECCCCcccc
Confidence 999998878889999999999999986653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.89 E-value=1.4e-09 Score=124.01 Aligned_cols=101 Identities=23% Similarity=0.171 Sum_probs=90.6
Q ss_pred CceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCcc
Q 003114 373 LWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446 (846)
Q Consensus 373 ~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~ 446 (846)
.|..|.|+..+ +.+++++.|+|++|+|++..|..|++|++|+.|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 46789998752 456789999999999999889999999999999999999999888999999999999999999
Q ss_pred CCCCCcccccccCCCCCCCCccccCCC
Q 003114 447 LTGPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 447 l~g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
|++..+..+..+++|+.|++++|....
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~ 161 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIES 161 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCE
T ss_pred CCccChhhhcccCCCCEEECCCCCcce
Confidence 996666678999999999999987654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.88 E-value=1.1e-09 Score=113.70 Aligned_cols=107 Identities=19% Similarity=0.133 Sum_probs=88.0
Q ss_pred CCCCCCCceE-----EeecCCCC---CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCC-CCCCCCchhcccCcc
Q 003114 367 CAPQAFLWNG-----LGCSYNDN---DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNS-LTGPVPEFLSKLQYL 437 (846)
Q Consensus 367 C~~~~~~w~g-----v~C~~~~~---~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~-l~g~iP~~~~~l~~L 437 (846)
|||..|.+.+ |.|..-.. .+.+++.|+|++|+|++..+..|+++++|+.|+|++|+ +++..|..|.++++|
T Consensus 3 ~cp~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L 82 (239)
T 2xwt_C 3 CSSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKV 82 (239)
T ss_dssp CCSSSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTC
T ss_pred CCCCCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCC
Confidence 4455555444 66975211 45689999999999997777789999999999999997 886666789999999
Q ss_pred ccccccC-ccCCCCCcccccccCCCCCCCCccccCCC
Q 003114 438 RVLNLTG-NMLTGPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 438 ~~L~Ls~-N~l~g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
+.|+|++ |+|++..|..|..+++|+.|+++.|....
T Consensus 83 ~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~ 119 (239)
T 2xwt_C 83 THIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM 119 (239)
T ss_dssp CEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS
T ss_pred cEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc
Confidence 9999999 99996666789999999999999986654
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=98.87 E-value=1e-09 Score=108.42 Aligned_cols=146 Identities=10% Similarity=0.048 Sum_probs=89.6
Q ss_pred EEEEEeeeccCCceeecCCCCCCCccccCCCCC-ceeecccceeccCCCCCCCCcHHHHhhccccCCCCCceEEeccc-C
Q 003114 173 TFIRMDVLSITNQVVRYRDDVYDRSWAPYAYPQ-WQQITTPRTIDEDRYNDYQLPSIVMRSAATPKNKSEPLLIDLVH-E 250 (846)
Q Consensus 173 ~~~r~~~g~~~~~~~rypdD~~dR~W~~~~~~~-~~~~~t~~~~~~~~~~~~~~P~~v~~tA~t~~~~~~~l~~~~~~-~ 250 (846)
...|.|.|+.. . . |..+|.|.++.... ....+.. .........+..|+.|+|||=.... +++|.. .
T Consensus 6 ~~~~INcGg~~--~-~---d~~gr~w~~D~~~~~~g~~~~~-~~~~~~~~~~~~~~~lY~TaR~~~~-----~~tY~f~v 73 (174)
T 2jwp_A 6 VIWAVNAGGES--H-V---DVHGIHYRKDPLEGRVGRASDY-GMKLPILRSNPEDQVLYQTERYNED-----SFGYDIPI 73 (174)
T ss_dssp EEEEEEETSSS--E-E---ETTTEEECSSCSSTTCCCCCCC-CTTSCCSSSCHHHHHTTTCCCCCCS-----CEEEEEEC
T ss_pred EEEEEECCCCC--c-c---CCCCCEEcCCcCcccCCccccc-ccceEecccCCCCchhhhhhccCCC-----CeEEEEEe
Confidence 46799999764 2 2 67899999874311 0011100 0000111124568899999976332 455554 4
Q ss_pred CCCceEEEEEeeehhhccccccceEEEEEECCccccCCCCCC-----cceeeeEEeee------------ecCCccEEEE
Q 003114 251 DSTSKFYMYMHFAELEELQANQSRQFNISFNGNHLYGPVVPS-----YRHTTTAYTTS------------ALTGEKLQFS 313 (846)
Q Consensus 251 ~~~~~~~~~lhFae~~~~~~~~~R~F~i~~n~~~~~~~~~p~-----~~~~~~~~~~~------------~~~~~~~~~~ 313 (846)
+++-.|.|.|||||+.. .+.+.|+|||++||+.+...+... .......|... ...++.++|+
T Consensus 74 ~~~G~Y~VrLhF~ei~~-~~~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~ 152 (174)
T 2jwp_A 74 KEEGEYVLVLKFAEVYF-AQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVE 152 (174)
T ss_dssp CSCEEEEEEEEEECCSC-CCSSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEE
T ss_pred CCCeEEEEEEEEecccc-CCCCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEE
Confidence 66789999999999964 456899999999999875433211 00111111111 1356789999
Q ss_pred EecCCCCCchhHHHHHHHhh
Q 003114 314 IHKTENSTLPPILNAIEFYL 333 (846)
Q Consensus 314 l~~t~~S~lpP~lna~ei~~ 333 (846)
+.|... -.|+|||+|++.
T Consensus 153 f~p~~~--~~a~inaIEI~~ 170 (174)
T 2jwp_A 153 FVKGYY--DNPKVCALFIMK 170 (174)
T ss_dssp EECSSS--CSSSEEEEEEES
T ss_pred EeccCC--CCcEEEEEEEEe
Confidence 997533 349999999874
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.87 E-value=2.3e-09 Score=105.77 Aligned_cols=88 Identities=20% Similarity=0.159 Sum_probs=77.4
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
...+|+.|+|++|+|++..+..|+++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|
T Consensus 50 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 129 (177)
T 2o6r_A 50 KLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKI 129 (177)
T ss_dssp TCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEE
Confidence 34689999999999997666678999999999999999998777888999999999999999996555556889999999
Q ss_pred CCccccCC
Q 003114 465 SLSVDLCS 472 (846)
Q Consensus 465 ~l~~nlc~ 472 (846)
+++.|...
T Consensus 130 ~l~~N~~~ 137 (177)
T 2o6r_A 130 WLHTNPWD 137 (177)
T ss_dssp ECCSSCBC
T ss_pred EecCCCee
Confidence 99998643
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.87 E-value=1.2e-09 Score=104.68 Aligned_cols=87 Identities=25% Similarity=0.259 Sum_probs=78.1
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCC-CcccccccCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGP-LPAGLVERSKNGS 463 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~-iP~~~~~l~~l~~ 463 (846)
..++++.|+|++|+|++. ..++++++|+.|+|++|++++.+|..+.++++|+.|+|++|++++. .|..+..+++|+.
T Consensus 40 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~ 117 (149)
T 2je0_A 40 EFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKS 117 (149)
T ss_dssp TCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCE
T ss_pred hcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCE
Confidence 446899999999999976 8899999999999999999988999999999999999999999963 4588999999999
Q ss_pred CCCccccCCC
Q 003114 464 LSLSVDLCSS 473 (846)
Q Consensus 464 l~l~~nlc~~ 473 (846)
|++++|....
T Consensus 118 L~l~~N~l~~ 127 (149)
T 2je0_A 118 LDLFNCEVTN 127 (149)
T ss_dssp EECTTCGGGG
T ss_pred EeCcCCcccc
Confidence 9999886643
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.87 E-value=2e-09 Score=123.56 Aligned_cols=101 Identities=19% Similarity=0.165 Sum_probs=88.8
Q ss_pred CceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCcc
Q 003114 373 LWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446 (846)
Q Consensus 373 ~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~ 446 (846)
.|..|.|+... +.+.+++.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|.+|++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 56789998752 456789999999999998888999999999999999999999889999999999999999999
Q ss_pred CCCCCcccccccCCCCCCCCccccCCC
Q 003114 447 LTGPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 447 l~g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
|++..+..|..+++|+.|+++.|....
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~ 118 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVI 118 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCE
T ss_pred CCccCcccccCCCCCCEEECCCCcccc
Confidence 996555568899999999999886543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.87 E-value=2.9e-09 Score=109.98 Aligned_cols=87 Identities=28% Similarity=0.268 Sum_probs=59.6
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.++|+.|+|++|+|++..+..|..|++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+
T Consensus 63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 141 (229)
T 3e6j_A 63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEE
T ss_pred ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEE
Confidence 356777777777776444445677777777777777777655566677777777777777777 6777777777777777
Q ss_pred CccccCCC
Q 003114 466 LSVDLCSS 473 (846)
Q Consensus 466 l~~nlc~~ 473 (846)
+++|....
T Consensus 142 L~~N~l~~ 149 (229)
T 3e6j_A 142 LDQNQLKS 149 (229)
T ss_dssp CCSSCCCC
T ss_pred CCCCcCCc
Confidence 77765543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.86 E-value=1.6e-09 Score=119.39 Aligned_cols=103 Identities=21% Similarity=0.167 Sum_probs=87.2
Q ss_pred CCCceEEeecCCC--------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccc
Q 003114 371 AFLWNGLGCSYND--------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNL 442 (846)
Q Consensus 371 ~~~w~gv~C~~~~--------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~L 442 (846)
.|.|.|+ |+... +.+++++.|+|++|++++..+..|.++++|+.|+|++|++++..|..|+++++|++|+|
T Consensus 29 ~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 29 SCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp EECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 3478887 65431 34568999999999999766668999999999999999999888899999999999999
Q ss_pred cCccCCCCCcccccccCCCCCCCCccccCCCC
Q 003114 443 TGNMLTGPLPAGLVERSKNGSLSLSVDLCSSY 474 (846)
Q Consensus 443 s~N~l~g~iP~~~~~l~~l~~l~l~~nlc~~~ 474 (846)
++|+|++..+..+..+++|+.|++++|.....
T Consensus 108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l 139 (353)
T 2z80_A 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTL 139 (353)
T ss_dssp CSSCCSSCCHHHHTTCTTCSEEECTTCCCSSS
T ss_pred CCCcCCcCCHhHhCCCccCCEEECCCCCCccc
Confidence 99999964445589999999999999876543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=98.86 E-value=2.2e-09 Score=117.18 Aligned_cols=85 Identities=21% Similarity=0.278 Sum_probs=49.5
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
++|+.|+|++|++.+.+|..|+++++|+.|+|++|++.+.+|..++++++|+.|+|++|++.|.+|+.+.++++|..+.+
T Consensus 229 ~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l 308 (328)
T 4fcg_A 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV 308 (328)
T ss_dssp TTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEEC
T ss_pred CCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeC
Confidence 35555566665555555555555666666666655555555555555556666666665555556655555555555555
Q ss_pred ccccC
Q 003114 467 SVDLC 471 (846)
Q Consensus 467 ~~nlc 471 (846)
..|..
T Consensus 309 ~~~~~ 313 (328)
T 4fcg_A 309 PPHLQ 313 (328)
T ss_dssp CGGGS
T ss_pred CHHHH
Confidence 54443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.86 E-value=1.2e-09 Score=106.90 Aligned_cols=86 Identities=26% Similarity=0.249 Sum_probs=52.5
Q ss_pred CCCceEEEEcCCCCCc-ccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCC
Q 003114 385 DPPRITSLNLSSRGLT-GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGS 463 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~-g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~ 463 (846)
.+++++.|+|++|+++ |.+|..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++.+|..+..+++|+.
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3445666666666665 56666666666666666666666643 45666666666666666666555555555666666
Q ss_pred CCCccccCC
Q 003114 464 LSLSVDLCS 472 (846)
Q Consensus 464 l~l~~nlc~ 472 (846)
|++++|...
T Consensus 100 L~Ls~N~l~ 108 (168)
T 2ell_A 100 LNLSGNKLK 108 (168)
T ss_dssp EECBSSSCC
T ss_pred EeccCCccC
Confidence 666665443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=98.86 E-value=3.4e-09 Score=110.93 Aligned_cols=89 Identities=20% Similarity=0.205 Sum_probs=70.3
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
..++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..|..+..+++|+.|
T Consensus 105 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 184 (251)
T 3m19_A 105 HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184 (251)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred ccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 34578888888888886666667888888888888888886666678888888888888888887666678888888888
Q ss_pred CCccccCCC
Q 003114 465 SLSVDLCSS 473 (846)
Q Consensus 465 ~l~~nlc~~ 473 (846)
++++|....
T Consensus 185 ~l~~N~~~c 193 (251)
T 3m19_A 185 TLFGNQFDC 193 (251)
T ss_dssp ECCSCCBCT
T ss_pred EeeCCceeC
Confidence 888886543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=3.5e-09 Score=112.83 Aligned_cols=99 Identities=17% Similarity=0.117 Sum_probs=86.1
Q ss_pred eEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCcc-C
Q 003114 375 NGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM-L 447 (846)
Q Consensus 375 ~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~-l 447 (846)
..|.|+..+ +.+++++.|+|++|++++..+..|+++++|++|+|++|++++..|..|.++++|+.|+|++|+ +
T Consensus 14 ~~~~c~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l 93 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (285)
T ss_dssp CEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred eEEEcCcCCcccCCcCCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCc
Confidence 457887642 456789999999999998777889999999999999999998889999999999999999998 7
Q ss_pred CCCCcccccccCCCCCCCCccccCCC
Q 003114 448 TGPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 448 ~g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
++..|..+..+++|+.|+++.|....
T Consensus 94 ~~~~~~~~~~l~~L~~L~l~~n~l~~ 119 (285)
T 1ozn_A 94 RSVDPATFHGLGRLHTLHLDRCGLQE 119 (285)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCC
T ss_pred cccCHHHhcCCcCCCEEECCCCcCCE
Confidence 76668889999999999999886654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=2.5e-09 Score=125.50 Aligned_cols=86 Identities=29% Similarity=0.300 Sum_probs=76.5
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCC-cccccccCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPL-PAGLVERSKNGS 463 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~i-P~~~~~l~~l~~ 463 (846)
...+|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .|++|++|+.|+|++|+|++.+ |..+..+++|+.
T Consensus 461 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~ 537 (567)
T 1dce_A 461 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 537 (567)
T ss_dssp GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCE
T ss_pred ccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCE
Confidence 3458899999999999 889999999999999999999996 78 7999999999999999999876 999999999999
Q ss_pred CCCccccCCC
Q 003114 464 LSLSVDLCSS 473 (846)
Q Consensus 464 l~l~~nlc~~ 473 (846)
|++++|....
T Consensus 538 L~L~~N~l~~ 547 (567)
T 1dce_A 538 LNLQGNSLCQ 547 (567)
T ss_dssp EECTTSGGGG
T ss_pred EEecCCcCCC
Confidence 9999886654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=4.9e-09 Score=114.18 Aligned_cols=101 Identities=23% Similarity=0.229 Sum_probs=88.1
Q ss_pred CCCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCcccccccc
Q 003114 370 QAFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443 (846)
Q Consensus 370 ~~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls 443 (846)
+.|.|..+.|+... ..++.++.|+|++|++++..+..|+++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 29 c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 29 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 35689999998642 345789999999999998777789999999999999999998889999999999999999
Q ss_pred CccCCCCCcccccccCCCCCCCCccccCCC
Q 003114 444 GNMLTGPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 444 ~N~l~g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
+|+|+ .+|..+. ++|+.|+++.|....
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~ 135 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITK 135 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCB
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccc
Confidence 99999 7888776 788999998876543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.83 E-value=3.8e-09 Score=115.19 Aligned_cols=101 Identities=21% Similarity=0.190 Sum_probs=88.8
Q ss_pred CCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccC
Q 003114 371 AFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444 (846)
Q Consensus 371 ~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~ 444 (846)
.|.|..+.|+... ..+++++.|+|++|++++..|..|+++++|+.|+|++|++++..|..|+++++|++|+|++
T Consensus 32 ~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred cccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 4689999998652 3456899999999999988888999999999999999999988899999999999999999
Q ss_pred ccCCCCCcccccccCCCCCCCCccccCCCC
Q 003114 445 NMLTGPLPAGLVERSKNGSLSLSVDLCSSY 474 (846)
Q Consensus 445 N~l~g~iP~~~~~l~~l~~l~l~~nlc~~~ 474 (846)
|+++ .+|..+. ++|+.|+++.|.....
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~ 138 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKV 138 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCC
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCcc
Confidence 9999 7888776 7899999998866543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=2.7e-09 Score=113.12 Aligned_cols=98 Identities=21% Similarity=0.102 Sum_probs=86.7
Q ss_pred EEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCC
Q 003114 376 GLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG 449 (846)
Q Consensus 376 gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g 449 (846)
.+.|.... ..+.+++.|+|++|+|++..+..|+++++|+.|+|++|++++..|..|.++++|+.|+|++|++++
T Consensus 11 ~~~c~~~~l~~ip~~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 90 (276)
T 2z62_A 11 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90 (276)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred eEEecCCCccccCCCCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCc
Confidence 68888642 345679999999999998777799999999999999999998778899999999999999999998
Q ss_pred CCcccccccCCCCCCCCccccCCC
Q 003114 450 PLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 450 ~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
..|..+..+++|+.|+++.|....
T Consensus 91 ~~~~~~~~l~~L~~L~l~~n~l~~ 114 (276)
T 2z62_A 91 LALGAFSGLSSLQKLVAVETNLAS 114 (276)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCC
T ss_pred cChhhhcCCccccEEECCCCCccc
Confidence 878899999999999999886543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.81 E-value=4.9e-09 Score=119.16 Aligned_cols=101 Identities=24% Similarity=0.153 Sum_probs=89.7
Q ss_pred CceEEeecCC------CCCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCcc
Q 003114 373 LWNGLGCSYN------DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM 446 (846)
Q Consensus 373 ~w~gv~C~~~------~~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~ 446 (846)
.|..|.|... .+.+.+++.|+|++|+|++..+..|.+|++|+.|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 4678999875 2456789999999999998888999999999999999999998888999999999999999999
Q ss_pred CCCCCcccccccCCCCCCCCccccCCC
Q 003114 447 LTGPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 447 l~g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
|++..+..+..+++|+.|++++|....
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~ 150 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIES 150 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCE
T ss_pred CCeeCHhHhhccccCceeeCCCCcccc
Confidence 996656679999999999999987654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=4.3e-09 Score=124.37 Aligned_cols=99 Identities=22% Similarity=0.175 Sum_probs=85.4
Q ss_pred eEEeecCC------CCCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCC
Q 003114 375 NGLGCSYN------DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448 (846)
Q Consensus 375 ~gv~C~~~------~~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~ 448 (846)
..|.|+.. .+.+.+++.|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|+++
T Consensus 14 ~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~ 93 (606)
T 3vq2_A 14 ITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93 (606)
T ss_dssp TEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred CceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCccc
Confidence 36888764 245678999999999999888889999999999999999999888888999999999999999999
Q ss_pred CCCcccccccCCCCCCCCccccCCC
Q 003114 449 GPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 449 g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
+..|..|..+++|+.|+++.|....
T Consensus 94 ~~~p~~~~~l~~L~~L~L~~n~l~~ 118 (606)
T 3vq2_A 94 SFSPGSFSGLTSLENLVAVETKLAS 118 (606)
T ss_dssp CCCTTSSTTCTTCCEEECTTSCCCC
T ss_pred ccChhhcCCcccCCEEEccCCcccc
Confidence 8889999999999999998886544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.81 E-value=6.2e-09 Score=105.48 Aligned_cols=84 Identities=24% Similarity=0.209 Sum_probs=41.2
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+..+++|+.|++
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 131 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRL 131 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEEC
Confidence 34555555555555333333455555555555555555433344455555555555555555433333445555555555
Q ss_pred cccc
Q 003114 467 SVDL 470 (846)
Q Consensus 467 ~~nl 470 (846)
+.|.
T Consensus 132 ~~N~ 135 (208)
T 2o6s_A 132 YQNQ 135 (208)
T ss_dssp CSSC
T ss_pred CCCc
Confidence 5443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=3.1e-09 Score=125.64 Aligned_cols=111 Identities=19% Similarity=0.082 Sum_probs=90.4
Q ss_pred CCCCCCCCCCCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccC
Q 003114 362 WQGDPCAPQAFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQ 435 (846)
Q Consensus 362 W~~dpC~~~~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~ 435 (846)
|.+.+|.. ...+.-|.|+..+ +.+..++.|+|++|+|++..|..|+++++|++|+|++|++++..|..|++++
T Consensus 3 ~~~~~C~~-~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~ 81 (606)
T 3t6q_A 3 SSDQKCIE-KEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQH 81 (606)
T ss_dssp ---CCCEE-EETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCT
T ss_pred cccCceec-ccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCcc
Confidence 44455521 1124568898642 4567899999999999988888999999999999999999988899999999
Q ss_pred ccccccccCccCCCCCcccccccCCCCCCCCccccCCC
Q 003114 436 YLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 436 ~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
+|++|+|++|++++..|..+..+++|+.|+++.|....
T Consensus 82 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~ 119 (606)
T 3t6q_A 82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS 119 (606)
T ss_dssp TCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSC
T ss_pred ccCeeeCCCCcccccChhhhcccccccEeeccccCccc
Confidence 99999999999998889999999999999998875543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.79 E-value=2.2e-09 Score=115.58 Aligned_cols=101 Identities=21% Similarity=0.263 Sum_probs=87.6
Q ss_pred CCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCc-cccCCCCCCeEeccCCCCC--CCCCchhcccCcccccc
Q 003114 371 AFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPP-YLSNLTMIEHLDLSNNSLT--GPVPEFLSKLQYLRVLN 441 (846)
Q Consensus 371 ~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~-~~~~L~~L~~L~Ls~N~l~--g~iP~~~~~l~~L~~L~ 441 (846)
.|.|.+|.|+..+ +.+++++.|+|++|+++ .+|. .|.++++|+.|+|++|+++ |.+|..+..+++|+.|+
T Consensus 6 ~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~ 84 (306)
T 2z66_A 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84 (306)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEE
T ss_pred eeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEE
Confidence 4689999999752 45578999999999999 5655 5899999999999999998 44578888999999999
Q ss_pred ccCccCCCCCcccccccCCCCCCCCccccCCC
Q 003114 442 LTGNMLTGPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 442 Ls~N~l~g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
|++|.++ .+|..+..+++|+.|+++.|....
T Consensus 85 Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~ 115 (306)
T 2z66_A 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ 115 (306)
T ss_dssp CCSCSEE-EEEEEEETCTTCCEEECTTSEEES
T ss_pred CCCCccc-cChhhcCCCCCCCEEECCCCcccc
Confidence 9999999 689899999999999999886544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.78 E-value=4.2e-09 Score=102.93 Aligned_cols=86 Identities=28% Similarity=0.254 Sum_probs=70.5
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCC-CcccccccCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGP-LPAGLVERSKNGSL 464 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~-iP~~~~~l~~l~~l 464 (846)
.++|+.|+|++|+|++. ..++.+++|+.|+|++|++++.+|..+.++++|+.|+|++|+|++. .+..+..+++|+.|
T Consensus 48 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L 125 (168)
T 2ell_A 48 FVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSL 125 (168)
T ss_dssp GGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEE
T ss_pred CCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEE
Confidence 35788899999998865 7788889999999999999887888888889999999999998853 22678888888888
Q ss_pred CCccccCCC
Q 003114 465 SLSVDLCSS 473 (846)
Q Consensus 465 ~l~~nlc~~ 473 (846)
++++|....
T Consensus 126 ~l~~N~l~~ 134 (168)
T 2ell_A 126 DLFNCEVTN 134 (168)
T ss_dssp ECCSSGGGT
T ss_pred EeeCCcCcc
Confidence 888886543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=98.78 E-value=6.8e-09 Score=102.06 Aligned_cols=84 Identities=26% Similarity=0.290 Sum_probs=75.1
Q ss_pred eEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCCcc
Q 003114 389 ITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSV 468 (846)
Q Consensus 389 l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~ 468 (846)
.+.|++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 458999999999 6888774 8999999999999998899999999999999999999976666788999999999999
Q ss_pred ccCCCCC
Q 003114 469 DLCSSYP 475 (846)
Q Consensus 469 nlc~~~p 475 (846)
|.....+
T Consensus 88 N~l~~~~ 94 (170)
T 3g39_A 88 NQLKSIP 94 (170)
T ss_dssp SCCCCCC
T ss_pred CccCEeC
Confidence 9876544
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=4.7e-09 Score=124.10 Aligned_cols=86 Identities=22% Similarity=0.177 Sum_probs=70.3
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCccccccc-CCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVER-SKNGS 463 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l-~~l~~ 463 (846)
..++++.|+|++|+|++.+|..|++|++|+.|+|++|+|++..|..|.+|++|+.|||++|+|++..|..+..+ ++|+.
T Consensus 492 ~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~ 571 (635)
T 4g8a_A 492 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 571 (635)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCE
T ss_pred hccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCE
Confidence 34678888888888888888888888888888888888887777888888888888888888888878888777 57888
Q ss_pred CCCcccc
Q 003114 464 LSLSVDL 470 (846)
Q Consensus 464 l~l~~nl 470 (846)
|++++|.
T Consensus 572 L~L~~Np 578 (635)
T 4g8a_A 572 LNLTQND 578 (635)
T ss_dssp EECTTCC
T ss_pred EEeeCCC
Confidence 8888875
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.77 E-value=7.6e-09 Score=102.17 Aligned_cols=83 Identities=25% Similarity=0.253 Sum_probs=74.0
Q ss_pred EEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCCccc
Q 003114 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVD 469 (846)
Q Consensus 390 ~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~n 469 (846)
+.+++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 58999999997 8998875 89999999999999998999999999999999999999755555789999999999999
Q ss_pred cCCCCC
Q 003114 470 LCSSYP 475 (846)
Q Consensus 470 lc~~~p 475 (846)
.....+
T Consensus 92 ~l~~l~ 97 (174)
T 2r9u_A 92 HLKSIP 97 (174)
T ss_dssp CCCCCC
T ss_pred ccceeC
Confidence 776543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.77 E-value=1.1e-08 Score=113.07 Aligned_cols=140 Identities=15% Similarity=0.169 Sum_probs=104.4
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeC--CCC-chhhHHHHHHHHHHHhcc--cccceeEeeEeecC---CeeeEeeec
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLS--PSS-RQGYEQFEAEVILLRTVH--HKNLTTLYGYCNEG---NQIGLIYEY 612 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~--~~~-~~~~~~~~~Ei~~l~~l~--HpnIv~l~g~~~~~---~~~~LV~Ey 612 (846)
+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 358899999999988754 578888775 322 123457888999999997 45578888888776 458899999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccC---------------------------------------
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC--------------------------------------- 653 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------- 653 (846)
++|..+.+... ..++..++..++.++++.|..||...
T Consensus 123 v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 123 VSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred cCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99987754211 22677888899999999999999520
Q ss_pred ----------------CCCeeecCCCCCCEEECCCCc--EEEEeccCCcc
Q 003114 654 ----------------KPPRVHRDIKPANILLNDQFQ--ARLADFGLSKT 685 (846)
Q Consensus 654 ----------------~~~IiHrDlKp~NILld~~~~--vkI~DFGla~~ 685 (846)
...++|||+++.||++++++. +.|.||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997653 68999998864
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.75 E-value=5e-09 Score=103.37 Aligned_cols=83 Identities=18% Similarity=0.121 Sum_probs=67.4
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcc--cccccCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPA--GLVERSKNGSL 464 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~--~~~~l~~l~~l 464 (846)
++++.|+|++|+|++. +.|+.+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|+ .+|. .+..+++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 4788899999988864 67888889999999999988654455588888999999999886 6776 78888888888
Q ss_pred CCccccCC
Q 003114 465 SLSVDLCS 472 (846)
Q Consensus 465 ~l~~nlc~ 472 (846)
++++|...
T Consensus 119 ~l~~N~i~ 126 (176)
T 1a9n_A 119 CILRNPVT 126 (176)
T ss_dssp ECCSSGGG
T ss_pred EecCCCCC
Confidence 88887654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=98.74 E-value=1.2e-08 Score=108.04 Aligned_cols=84 Identities=25% Similarity=0.190 Sum_probs=47.3
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
++|+.|+|++|+|++..+..|+++++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..|..+..+++|+.|++
T Consensus 133 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 212 (272)
T 3rfs_A 133 TNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWL 212 (272)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEc
Confidence 45555555555555444444555555566666655555544555555555666666666555544445555555555555
Q ss_pred cccc
Q 003114 467 SVDL 470 (846)
Q Consensus 467 ~~nl 470 (846)
++|.
T Consensus 213 ~~N~ 216 (272)
T 3rfs_A 213 HDNP 216 (272)
T ss_dssp CSSC
T ss_pred cCCC
Confidence 5553
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=98.74 E-value=1e-08 Score=108.68 Aligned_cols=91 Identities=22% Similarity=0.187 Sum_probs=81.8
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
..++|+.|+|++|++++..|..|+++++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..|..+..+++|+.|
T Consensus 107 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 186 (272)
T 3rfs_A 107 KLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDL 186 (272)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEE
Confidence 45689999999999998777789999999999999999998888888999999999999999998777778999999999
Q ss_pred CCccccCCCCC
Q 003114 465 SLSVDLCSSYP 475 (846)
Q Consensus 465 ~l~~nlc~~~p 475 (846)
+++.|.....+
T Consensus 187 ~L~~N~l~~~~ 197 (272)
T 3rfs_A 187 RLYQNQLKSVP 197 (272)
T ss_dssp ECCSSCCSCCC
T ss_pred ECCCCcCCccC
Confidence 99998766543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.74 E-value=4.7e-09 Score=126.93 Aligned_cols=84 Identities=29% Similarity=0.324 Sum_probs=64.3
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
..+|+.|+|++|+|+ .||..|++|++|+.|+|++|+|+ .||..|++|++|++|+|++|.|+ .||.+|+.+++|+.|+
T Consensus 246 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~ 322 (727)
T 4b8c_D 246 YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLG 322 (727)
T ss_dssp CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEE
T ss_pred CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEe
Confidence 356777778877777 77777777888888888888877 67777777778888888887776 6777777777777777
Q ss_pred CccccCC
Q 003114 466 LSVDLCS 472 (846)
Q Consensus 466 l~~nlc~ 472 (846)
|++|...
T Consensus 323 L~~N~l~ 329 (727)
T 4b8c_D 323 VEGNPLE 329 (727)
T ss_dssp CTTSCCC
T ss_pred CCCCccC
Confidence 7777554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.73 E-value=6.8e-09 Score=114.85 Aligned_cols=90 Identities=26% Similarity=0.163 Sum_probs=70.5
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
...+|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..|..+++|+.|
T Consensus 62 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 34578888888888887666778888888888888888886666778888888888888888887667778888888888
Q ss_pred CCccccCCCC
Q 003114 465 SLSVDLCSSY 474 (846)
Q Consensus 465 ~l~~nlc~~~ 474 (846)
+|++|.....
T Consensus 142 ~L~~N~l~~l 151 (361)
T 2xot_A 142 YLSQNQISRF 151 (361)
T ss_dssp ECCSSCCCSC
T ss_pred ECCCCcCCee
Confidence 8888766543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.71 E-value=9.4e-09 Score=103.38 Aligned_cols=86 Identities=20% Similarity=0.226 Sum_probs=60.7
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.++|+.|+|++|++++..|..|+.|++|+.|+|++|++++..|..++++++|+.|+|++|++.+.+| .+..+++|+.|+
T Consensus 87 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~ 165 (197)
T 4ezg_A 87 LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLN 165 (197)
T ss_dssp CTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEE
T ss_pred CCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEE
Confidence 3467777777777777677777777777777777777777677777777777777777776333565 577777777777
Q ss_pred CccccCC
Q 003114 466 LSVDLCS 472 (846)
Q Consensus 466 l~~nlc~ 472 (846)
++.|...
T Consensus 166 l~~n~i~ 172 (197)
T 4ezg_A 166 IQFDGVH 172 (197)
T ss_dssp CTTBCCC
T ss_pred CCCCCCc
Confidence 7766443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=1.4e-08 Score=121.80 Aligned_cols=103 Identities=24% Similarity=0.258 Sum_probs=82.1
Q ss_pred CCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccC
Q 003114 371 AFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444 (846)
Q Consensus 371 ~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~ 444 (846)
.|.++.|.|+... ..+.+++.|+|++|++++..+..|+++++|++|+|++|++++..|..|++|++|++|+|++
T Consensus 3 ~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 82 (680)
T 1ziw_A 3 TVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82 (680)
T ss_dssp -CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred eeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence 4567788888642 3557899999999999977777899999999999999999988888888888899999988
Q ss_pred ccCCCCCcccccccCCCCCCCCccccCCC
Q 003114 445 NMLTGPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 445 N~l~g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
|+|++..+..|..+++|+.|+++.|....
T Consensus 83 n~l~~l~~~~~~~l~~L~~L~L~~n~l~~ 111 (680)
T 1ziw_A 83 NELSQLSDKTFAFCTNLTELHLMSNSIQK 111 (680)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCCCC
T ss_pred CccCccChhhhccCCCCCEEECCCCccCc
Confidence 88885444468888888888888775443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=98.71 E-value=8.3e-09 Score=113.20 Aligned_cols=84 Identities=20% Similarity=0.160 Sum_probs=77.0
Q ss_pred EEEcCCC-CCcccCCccccCCCCCCeEeccC-CCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCCcc
Q 003114 391 SLNLSSR-GLTGGIPPYLSNLTMIEHLDLSN-NSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSV 468 (846)
Q Consensus 391 ~L~L~~n-~l~g~ip~~~~~L~~L~~L~Ls~-N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~ 468 (846)
.++++++ +|+ .||. |..+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4799998 999 5999 99999999999996 999988889999999999999999999998899999999999999999
Q ss_pred ccCCCCCc
Q 003114 469 DLCSSYPC 476 (846)
Q Consensus 469 nlc~~~pc 476 (846)
|.....|.
T Consensus 90 N~l~~~~~ 97 (347)
T 2ifg_A 90 NALESLSW 97 (347)
T ss_dssp SCCSCCCS
T ss_pred CccceeCH
Confidence 98876543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=98.71 E-value=1.7e-08 Score=108.10 Aligned_cols=87 Identities=31% Similarity=0.296 Sum_probs=56.4
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
..++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+..+++|+.|
T Consensus 75 ~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 153 (290)
T 1p9a_G 75 TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153 (290)
T ss_dssp CCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEE
Confidence 3456666777777666 566666666667777777777665555666666667777777776665444455666666666
Q ss_pred CCccccCC
Q 003114 465 SLSVDLCS 472 (846)
Q Consensus 465 ~l~~nlc~ 472 (846)
+++.|...
T Consensus 154 ~L~~N~l~ 161 (290)
T 1p9a_G 154 SLANNNLT 161 (290)
T ss_dssp ECTTSCCS
T ss_pred ECCCCcCC
Confidence 66666544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=98.70 E-value=2e-08 Score=107.65 Aligned_cols=88 Identities=26% Similarity=0.194 Sum_probs=62.0
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.++++.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 99 l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 178 (290)
T 1p9a_G 99 LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178 (290)
T ss_dssp CTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEE
Confidence 45677777777777766566677777777777777777766666677777777777777777743333456677777777
Q ss_pred CccccCCC
Q 003114 466 LSVDLCSS 473 (846)
Q Consensus 466 l~~nlc~~ 473 (846)
++.|....
T Consensus 179 L~~N~l~~ 186 (290)
T 1p9a_G 179 LQENSLYT 186 (290)
T ss_dssp CCSSCCCC
T ss_pred CCCCcCCc
Confidence 77776554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.69 E-value=1.3e-08 Score=123.05 Aligned_cols=89 Identities=29% Similarity=0.368 Sum_probs=82.5
Q ss_pred CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCC
Q 003114 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGS 463 (846)
Q Consensus 384 ~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~ 463 (846)
.....|+.|+|++|+|. .||..+.+|++|+.|+|++|+|+ .||..|++|++|+.|+|++|+|+ .+|.+|+.+++|+.
T Consensus 221 ~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~ 297 (727)
T 4b8c_D 221 YDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKY 297 (727)
T ss_dssp -CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSE
T ss_pred ccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCE
Confidence 34568999999999999 89999999999999999999999 99999999999999999999999 89999999999999
Q ss_pred CCCccccCCCCC
Q 003114 464 LSLSVDLCSSYP 475 (846)
Q Consensus 464 l~l~~nlc~~~p 475 (846)
|+|+.|.....|
T Consensus 298 L~L~~N~l~~lp 309 (727)
T 4b8c_D 298 FYFFDNMVTTLP 309 (727)
T ss_dssp EECCSSCCCCCC
T ss_pred EECCCCCCCccC
Confidence 999999776544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=1.5e-08 Score=119.03 Aligned_cols=82 Identities=29% Similarity=0.426 Sum_probs=76.4
Q ss_pred ceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCCc
Q 003114 388 RITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLS 467 (846)
Q Consensus 388 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~ 467 (846)
.++.|+|++|+|++ +|. |++|++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .++.+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 58899999999996 786 999999999999999999 899999999999999999999996 88 89999999999999
Q ss_pred cccCCCC
Q 003114 468 VDLCSSY 474 (846)
Q Consensus 468 ~nlc~~~ 474 (846)
+|.....
T Consensus 517 ~N~l~~~ 523 (567)
T 1dce_A 517 NNRLQQS 523 (567)
T ss_dssp SSCCCSS
T ss_pred CCCCCCC
Confidence 9977654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=98.69 E-value=4.5e-09 Score=125.35 Aligned_cols=92 Identities=15% Similarity=0.261 Sum_probs=83.2
Q ss_pred CCCCceEEEEcCCCCCccc-----------------CCcccc--CCCCCCeEeccCCCCCCCCCchhcccCccccccccC
Q 003114 384 NDPPRITSLNLSSRGLTGG-----------------IPPYLS--NLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444 (846)
Q Consensus 384 ~~~~~l~~L~L~~n~l~g~-----------------ip~~~~--~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~ 444 (846)
+...+|+.|+|++|+|+|. +|++++ +|++|++|+|++|++.|.+|..|++|++|+.|+|++
T Consensus 203 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 282 (636)
T 4eco_A 203 MRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVAC 282 (636)
T ss_dssp GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTT
T ss_pred hcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcC
Confidence 4567899999999999996 999999 999999999999999999999999999999999999
Q ss_pred cc-CCC-CCccccccc------CCCCCCCCccccCCCCC
Q 003114 445 NM-LTG-PLPAGLVER------SKNGSLSLSVDLCSSYP 475 (846)
Q Consensus 445 N~-l~g-~iP~~~~~l------~~l~~l~l~~nlc~~~p 475 (846)
|+ |+| .+|..++.+ ++|+.|+++.|.....|
T Consensus 283 n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip 321 (636)
T 4eco_A 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFP 321 (636)
T ss_dssp CTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCC
T ss_pred CCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccC
Confidence 98 999 899999887 89999999988766443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.69 E-value=1.9e-08 Score=118.94 Aligned_cols=87 Identities=20% Similarity=0.143 Sum_probs=69.8
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
++|+.|+|++|+|++..|..|++|++|+.|+|++|.|++..|..|+++++|+.|+|++|+|++..|..|..+++|+.|++
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 56788888888888777778888888888888888888877778888888888888888888544444678888888888
Q ss_pred ccccCCC
Q 003114 467 SVDLCSS 473 (846)
Q Consensus 467 ~~nlc~~ 473 (846)
++|....
T Consensus 155 s~N~l~~ 161 (597)
T 3oja_B 155 SNNNLER 161 (597)
T ss_dssp CSSCCCB
T ss_pred eCCcCCC
Confidence 8876544
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.68 E-value=1.5e-08 Score=118.92 Aligned_cols=96 Identities=23% Similarity=0.217 Sum_probs=84.6
Q ss_pred eEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCC
Q 003114 375 NGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448 (846)
Q Consensus 375 ~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~ 448 (846)
.-+.|+... +.+++++.|+|++|+|++..|..|+++++|++|+|++|+|++..|+.|+++++|++|||++|+|+
T Consensus 34 ~~l~ls~~~L~~ip~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 113 (562)
T 3a79_B 34 SMVDYSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ 113 (562)
T ss_dssp CEEECTTSCCCSCCTTSCTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred cEEEcCCCCCccCCCCCCCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC
Confidence 567887642 34578999999999999888889999999999999999999888999999999999999999999
Q ss_pred CCCcccccccCCCCCCCCccccCCC
Q 003114 449 GPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 449 g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
.+|.. .+++|+.|++++|....
T Consensus 114 -~lp~~--~l~~L~~L~Ls~N~l~~ 135 (562)
T 3a79_B 114 -NISCC--PMASLRHLDLSFNDFDV 135 (562)
T ss_dssp -EECSC--CCTTCSEEECCSSCCSB
T ss_pred -ccCcc--ccccCCEEECCCCCccc
Confidence 78887 89999999999987655
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.68 E-value=7e-09 Score=112.21 Aligned_cols=84 Identities=23% Similarity=0.209 Sum_probs=72.8
Q ss_pred CCceEEEEcCCCCCcccCCccc--cCCCCCCeEeccCCCCCCCCCchhccc-----CccccccccCccCCCCCccccccc
Q 003114 386 PPRITSLNLSSRGLTGGIPPYL--SNLTMIEHLDLSNNSLTGPVPEFLSKL-----QYLRVLNLTGNMLTGPLPAGLVER 458 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~--~~L~~L~~L~Ls~N~l~g~iP~~~~~l-----~~L~~L~Ls~N~l~g~iP~~~~~l 458 (846)
..+|+.|+|++|+++|.+|..+ +.+++|++|+|++|+|++. |..++.+ ++|++|+|++|+|++..|..+..+
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 3578899999999998888886 8899999999999999876 8888887 889999999999988777888899
Q ss_pred CCCCCCCCcccc
Q 003114 459 SKNGSLSLSVDL 470 (846)
Q Consensus 459 ~~l~~l~l~~nl 470 (846)
++|+.|++++|.
T Consensus 173 ~~L~~L~Ls~N~ 184 (312)
T 1wwl_A 173 PALSTLDLSDNP 184 (312)
T ss_dssp SSCCEEECCSCT
T ss_pred CCCCEEECCCCC
Confidence 999999988875
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.65 E-value=1e-08 Score=112.81 Aligned_cols=106 Identities=16% Similarity=0.082 Sum_probs=88.0
Q ss_pred CCCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCC-chhcccCcccc-cc
Q 003114 370 QAFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVP-EFLSKLQYLRV-LN 441 (846)
Q Consensus 370 ~~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP-~~~~~l~~L~~-L~ 441 (846)
|.|+|..|.|++.+ +.+.+++.|+|++|+|+...+..|.+|++|+.|+|++|++.+.+| ..|.+|++|.. +.
T Consensus 7 C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~ 86 (350)
T 4ay9_X 7 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86 (350)
T ss_dssp SEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred cEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence 35789999998752 455789999999999994444579999999999999999988887 46889998765 77
Q ss_pred ccCccCCCCCcccccccCCCCCCCCccccCCCCC
Q 003114 442 LTGNMLTGPLPAGLVERSKNGSLSLSVDLCSSYP 475 (846)
Q Consensus 442 Ls~N~l~g~iP~~~~~l~~l~~l~l~~nlc~~~p 475 (846)
+++|+|++..|..|..+++|+.|+++.|.....+
T Consensus 87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~ 120 (350)
T 4ay9_X 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLP 120 (350)
T ss_dssp EEETTCCEECTTSBCCCTTCCEEEEEEECCSSCC
T ss_pred ccCCcccccCchhhhhccccccccccccccccCC
Confidence 7889999777888999999999999998765533
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=1.7e-08 Score=114.75 Aligned_cols=88 Identities=20% Similarity=0.177 Sum_probs=58.2
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.++|+.|+|++|++++..|..|+++++|+.|+|++|+|++..|..|+++++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 298 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 377 (455)
T 3v47_A 298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELA 377 (455)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEE
Confidence 34666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CccccCCC
Q 003114 466 LSVDLCSS 473 (846)
Q Consensus 466 l~~nlc~~ 473 (846)
+++|....
T Consensus 378 L~~N~l~~ 385 (455)
T 3v47_A 378 LDTNQLKS 385 (455)
T ss_dssp CCSSCCSC
T ss_pred CCCCcccc
Confidence 66665443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.65 E-value=2.4e-08 Score=107.34 Aligned_cols=87 Identities=21% Similarity=0.165 Sum_probs=65.2
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccC-CCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERS-KNGS 463 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~-~l~~ 463 (846)
..++++.|+|++|++++..|..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..+..++ +|+.
T Consensus 173 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~ 252 (306)
T 2z66_A 173 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 252 (306)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCE
T ss_pred hCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCE
Confidence 345777788888887777777777777888888888887766666777777788888888888777777777774 7777
Q ss_pred CCCccccC
Q 003114 464 LSLSVDLC 471 (846)
Q Consensus 464 l~l~~nlc 471 (846)
|++++|..
T Consensus 253 L~L~~N~~ 260 (306)
T 2z66_A 253 LNLTQNDF 260 (306)
T ss_dssp EECTTCCE
T ss_pred EEccCCCe
Confidence 77777753
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=3e-08 Score=105.01 Aligned_cols=87 Identities=18% Similarity=0.209 Sum_probs=68.6
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCC-CCcccccccCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG-PLPAGLVERSKNGSL 464 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g-~iP~~~~~l~~l~~l 464 (846)
.++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..++++++|+.|+|++|++++ .+|..+..+++|+.|
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L 154 (276)
T 2z62_A 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154 (276)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEE
T ss_pred CcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEE
Confidence 4578888888888887777778888888888888888887666678888888888888888876 468888888888888
Q ss_pred CCccccCC
Q 003114 465 SLSVDLCS 472 (846)
Q Consensus 465 ~l~~nlc~ 472 (846)
++++|...
T Consensus 155 ~Ls~N~l~ 162 (276)
T 2z62_A 155 DLSSNKIQ 162 (276)
T ss_dssp ECCSSCCC
T ss_pred ECCCCCCC
Confidence 88877543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.63 E-value=4.1e-08 Score=103.81 Aligned_cols=83 Identities=25% Similarity=0.236 Sum_probs=41.0
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
++|+.|+|++|+|++..+..|+.+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|++
T Consensus 133 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 212 (270)
T 2o6q_A 133 TKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212 (270)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEe
Confidence 44555555555555333333555555555555555555444444555555555555555555333333444555555555
Q ss_pred ccc
Q 003114 467 SVD 469 (846)
Q Consensus 467 ~~n 469 (846)
++|
T Consensus 213 ~~N 215 (270)
T 2o6q_A 213 QEN 215 (270)
T ss_dssp CSS
T ss_pred cCC
Confidence 554
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.63 E-value=1.9e-08 Score=108.40 Aligned_cols=185 Identities=18% Similarity=0.170 Sum_probs=119.4
Q ss_pred hcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-ccc--ceeEeeEeecCC---eeeEeeecccC
Q 003114 542 ILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-HKN--LTTLYGYCNEGN---QIGLIYEYMAN 615 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpn--Iv~l~g~~~~~~---~~~LV~Ey~~~ 615 (846)
.++.|.+..||+.. ..+++|+.... .....+.+|..+++.+. +.. +.+++......+ ..++|||+++|
T Consensus 27 ~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp EEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred ecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 47889999999863 56889986532 34567889999998883 333 334444443333 34789999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhcc-------------------------------------------
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG------------------------------------------- 652 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 652 (846)
.+|.+.... .++..++..++.++++.+..||..
T Consensus 101 ~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 101 VPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp EECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred eECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 888753321 256677778888888888888841
Q ss_pred ------------CCCCeeecCCCCCCEEECC--CCcEEEEeccCCccCCCCCc-cccccc-----------ccCCCcccC
Q 003114 653 ------------CKPPRVHRDIKPANILLND--QFQARLADFGLSKTFPIEGV-SHLSTG-----------VAGTFGYLD 706 (846)
Q Consensus 653 ------------~~~~IiHrDlKp~NILld~--~~~vkI~DFGla~~~~~~~~-~~~~~~-----------~~gt~~Y~A 706 (846)
....++|+|+++.||++++ +..+.|.||+.+..-..... ...... .....+...
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 1245899999999999998 56688999998864321100 000000 000011122
Q ss_pred -ccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003114 707 -PEYCQTFRLTEKSDVYSFGVVLLEIITSRPAI 738 (846)
Q Consensus 707 -PE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~ 738 (846)
|+.... .....+.|+++.+++++.+|++++
T Consensus 257 ~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 257 IPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 222211 122368999999999999998765
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.63 E-value=8.4e-09 Score=126.47 Aligned_cols=92 Identities=21% Similarity=0.262 Sum_probs=81.8
Q ss_pred CCCCceEEEEcCCCCCcc-----------------cCCcccc--CCCCCCeEeccCCCCCCCCCchhcccCccccccccC
Q 003114 384 NDPPRITSLNLSSRGLTG-----------------GIPPYLS--NLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444 (846)
Q Consensus 384 ~~~~~l~~L~L~~n~l~g-----------------~ip~~~~--~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~ 444 (846)
...++|+.|+|++|+|+| .||+.++ +|++|+.|+|++|++.|.+|..|++|++|+.|+|++
T Consensus 445 ~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~ 524 (876)
T 4ecn_A 445 QRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC 524 (876)
T ss_dssp GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTT
T ss_pred hcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcC
Confidence 445789999999999998 4999988 999999999999999999999999999999999999
Q ss_pred cc-CCC-CCcccccccC-------CCCCCCCccccCCCCC
Q 003114 445 NM-LTG-PLPAGLVERS-------KNGSLSLSVDLCSSYP 475 (846)
Q Consensus 445 N~-l~g-~iP~~~~~l~-------~l~~l~l~~nlc~~~p 475 (846)
|+ |+| .+|..++.++ +|+.|+++.|.....|
T Consensus 525 N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip 564 (876)
T 4ecn_A 525 NRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFP 564 (876)
T ss_dssp CTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCC
T ss_pred CCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccC
Confidence 98 998 8999888776 8999999988766443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=4.6e-08 Score=104.09 Aligned_cols=87 Identities=25% Similarity=0.183 Sum_probs=56.2
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCC-CCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNS-LTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~-l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
.++|+.|+|++|++++..|..|+++++|+.|+|++|+ +++..|..|.++++|+.|+|++|++++..|..+..+++|+.|
T Consensus 55 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 134 (285)
T 1ozn_A 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134 (285)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEE
Confidence 3466666666666666666666666666666666665 554446666666666666666666666556666666666666
Q ss_pred CCccccCC
Q 003114 465 SLSVDLCS 472 (846)
Q Consensus 465 ~l~~nlc~ 472 (846)
+++.|...
T Consensus 135 ~l~~n~l~ 142 (285)
T 1ozn_A 135 YLQDNALQ 142 (285)
T ss_dssp ECCSSCCC
T ss_pred ECCCCccc
Confidence 66666443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=3.7e-08 Score=107.19 Aligned_cols=88 Identities=28% Similarity=0.338 Sum_probs=81.6
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.++++.|+|++|++++..|..|.++++|+.|+|++|++++..|..+.++++|+.|+|++|+|+ .+|..+..+++|+.|+
T Consensus 191 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~ 269 (330)
T 1xku_A 191 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269 (330)
T ss_dssp CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEE
Confidence 368999999999999988999999999999999999999888889999999999999999999 8999999999999999
Q ss_pred CccccCCCC
Q 003114 466 LSVDLCSSY 474 (846)
Q Consensus 466 l~~nlc~~~ 474 (846)
+++|.....
T Consensus 270 l~~N~i~~~ 278 (330)
T 1xku_A 270 LHNNNISAI 278 (330)
T ss_dssp CCSSCCCCC
T ss_pred CCCCcCCcc
Confidence 999876553
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.58 E-value=4.1e-08 Score=120.92 Aligned_cols=84 Identities=18% Similarity=0.089 Sum_probs=41.5
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCC-CchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPV-PEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~i-P~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
+++++.|+|++|.|++..|..|++|++|++|+|++|.+.+.| |..|++|++|++|+|++|+|++..|..|.++++|+.|
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 102 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence 445556666666655555545555555555544444444344 3444444444444444444444444444444444444
Q ss_pred CCccc
Q 003114 465 SLSVD 469 (846)
Q Consensus 465 ~l~~n 469 (846)
+|+.|
T Consensus 103 ~Ls~n 107 (844)
T 3j0a_A 103 RLYFC 107 (844)
T ss_dssp ECTTC
T ss_pred eCcCC
Confidence 44444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.58 E-value=3.5e-08 Score=112.04 Aligned_cols=87 Identities=18% Similarity=0.120 Sum_probs=79.3
Q ss_pred CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCC
Q 003114 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGS 463 (846)
Q Consensus 384 ~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~ 463 (846)
....+|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+..+++|+.
T Consensus 204 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 283 (440)
T 3zyj_A 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLER 283 (440)
T ss_dssp TTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCE
T ss_pred CCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCE
Confidence 34568999999999999988999999999999999999999988999999999999999999999776777889999999
Q ss_pred CCCcccc
Q 003114 464 LSLSVDL 470 (846)
Q Consensus 464 l~l~~nl 470 (846)
|++++|.
T Consensus 284 L~L~~Np 290 (440)
T 3zyj_A 284 IHLHHNP 290 (440)
T ss_dssp EECCSSC
T ss_pred EEcCCCC
Confidence 9999985
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.58 E-value=3.7e-08 Score=112.24 Aligned_cols=87 Identities=17% Similarity=0.080 Sum_probs=78.6
Q ss_pred CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCC
Q 003114 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGS 463 (846)
Q Consensus 384 ~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~ 463 (846)
...++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+..+++|+.
T Consensus 215 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 294 (452)
T 3zyi_A 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVE 294 (452)
T ss_dssp TTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCE
T ss_pred cccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCE
Confidence 34568999999999999988999999999999999999999988999999999999999999999766677888999999
Q ss_pred CCCcccc
Q 003114 464 LSLSVDL 470 (846)
Q Consensus 464 l~l~~nl 470 (846)
|++++|.
T Consensus 295 L~L~~Np 301 (452)
T 3zyi_A 295 LHLHHNP 301 (452)
T ss_dssp EECCSSC
T ss_pred EEccCCC
Confidence 9999885
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.57 E-value=3.8e-08 Score=98.85 Aligned_cols=85 Identities=20% Similarity=0.202 Sum_probs=74.4
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
..++|+.|+|++|++++..|..++.+++|+.|+|++|++.+.+| .+..+++|+.|+|++|++++ +| .+..+++|+.|
T Consensus 110 ~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L 186 (197)
T 4ezg_A 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQL 186 (197)
T ss_dssp TCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEE
T ss_pred CCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEE
Confidence 34689999999999999999999999999999999999444777 69999999999999999995 55 88999999999
Q ss_pred CCccccCC
Q 003114 465 SLSVDLCS 472 (846)
Q Consensus 465 ~l~~nlc~ 472 (846)
++++|..+
T Consensus 187 ~l~~N~i~ 194 (197)
T 4ezg_A 187 YAFSQTIG 194 (197)
T ss_dssp EECBC---
T ss_pred EeeCcccC
Confidence 99998654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.56 E-value=3.1e-08 Score=97.66 Aligned_cols=86 Identities=19% Similarity=0.087 Sum_probs=74.8
Q ss_pred CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCc--hhcccCccccccccCccCCCCCccc----ccc
Q 003114 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPE--FLSKLQYLRVLNLTGNMLTGPLPAG----LVE 457 (846)
Q Consensus 384 ~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~--~~~~l~~L~~L~Ls~N~l~g~iP~~----~~~ 457 (846)
...++++.|+|++|+|++..|..++.+++|+.|+|++|+|+ .+|. .+.++++|+.|+|++|.++ .+|.. +..
T Consensus 61 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~ 138 (176)
T 1a9n_A 61 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYK 138 (176)
T ss_dssp CCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHH
T ss_pred ccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHH
Confidence 44568999999999999654445699999999999999996 6887 8999999999999999998 67875 889
Q ss_pred cCCCCCCCCccccC
Q 003114 458 RSKNGSLSLSVDLC 471 (846)
Q Consensus 458 l~~l~~l~l~~nlc 471 (846)
+++|+.|+++.|..
T Consensus 139 l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 139 VPQVRVLDFQKVKL 152 (176)
T ss_dssp CTTCSEETTEECCH
T ss_pred CCccceeCCCcCCH
Confidence 99999999987743
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=5.2e-08 Score=115.05 Aligned_cols=88 Identities=22% Similarity=0.231 Sum_probs=67.8
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCC-CCcccccccCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG-PLPAGLVERSKNGS 463 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g-~iP~~~~~l~~l~~ 463 (846)
...+|+.|+|++|++++..|..|++|++|++|+|++|++++..|..|+++++|++|+|++|++++ .+|..+.++++|+.
T Consensus 78 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~ 157 (606)
T 3vq2_A 78 GLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVH 157 (606)
T ss_dssp TCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCE
T ss_pred chhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCE
Confidence 44677888888888887777778888888888888888876666778888888888888888875 67888888888888
Q ss_pred CCCccccCC
Q 003114 464 LSLSVDLCS 472 (846)
Q Consensus 464 l~l~~nlc~ 472 (846)
|+++.|...
T Consensus 158 L~Ls~n~l~ 166 (606)
T 3vq2_A 158 VDLSYNYIQ 166 (606)
T ss_dssp EECCSSCCC
T ss_pred EEccCCcce
Confidence 888777544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.55 E-value=5.2e-08 Score=113.96 Aligned_cols=98 Identities=22% Similarity=0.111 Sum_probs=76.7
Q ss_pred EEeecCC------CCCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCC
Q 003114 376 GLGCSYN------DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG 449 (846)
Q Consensus 376 gv~C~~~------~~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g 449 (846)
-+.|+.. ...+.+++.|+|++|++++..+..|.++++|+.|+|++|++++..|..|+++++|++|+|++|++++
T Consensus 11 ~~~c~~~~l~~ip~~l~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~ 90 (570)
T 2z63_A 11 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90 (570)
T ss_dssp EEECCSSCCSSCCSSSCSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred EEEeCCCCccccCCCccccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCc
Confidence 3666643 1345678888888888887777788888888888888888887777788888888888888888887
Q ss_pred CCcccccccCCCCCCCCccccCCC
Q 003114 450 PLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 450 ~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
..|..|..+++|+.|+++.|....
T Consensus 91 ~~~~~~~~l~~L~~L~L~~n~l~~ 114 (570)
T 2z63_A 91 LALGAFSGLSSLQKLVAVETNLAS 114 (570)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCC
T ss_pred cCHhhhcCcccccccccccccccc
Confidence 667778888888888888775543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.55 E-value=4.1e-08 Score=106.94 Aligned_cols=87 Identities=23% Similarity=0.206 Sum_probs=80.4
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
.+++.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|+ .+|..+..+++|+.|++
T Consensus 193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 271 (332)
T 2ft3_A 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271 (332)
T ss_dssp SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEEC
Confidence 58999999999999888889999999999999999999888889999999999999999999 89999999999999999
Q ss_pred ccccCCCC
Q 003114 467 SVDLCSSY 474 (846)
Q Consensus 467 ~~nlc~~~ 474 (846)
++|.....
T Consensus 272 ~~N~l~~~ 279 (332)
T 2ft3_A 272 HTNNITKV 279 (332)
T ss_dssp CSSCCCBC
T ss_pred CCCCCCcc
Confidence 99876553
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.55 E-value=6.9e-08 Score=114.12 Aligned_cols=90 Identities=17% Similarity=0.152 Sum_probs=76.9
Q ss_pred CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCC
Q 003114 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGS 463 (846)
Q Consensus 384 ~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~ 463 (846)
...++|+.|+|++|.|++..|..|++|++|++|+|++|+|++..|..|+++++|+.|+|++|+|++..|..+..+++|+.
T Consensus 96 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 175 (597)
T 3oja_B 96 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 175 (597)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCE
T ss_pred cCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcE
Confidence 34568999999999999877888899999999999999999655566789999999999999999888888999999999
Q ss_pred CCCccccCCC
Q 003114 464 LSLSVDLCSS 473 (846)
Q Consensus 464 l~l~~nlc~~ 473 (846)
|+++.|....
T Consensus 176 L~L~~N~l~~ 185 (597)
T 3oja_B 176 LQLSSNRLTH 185 (597)
T ss_dssp EECTTSCCSB
T ss_pred EECcCCCCCC
Confidence 9998886654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=4.3e-08 Score=114.23 Aligned_cols=86 Identities=23% Similarity=0.237 Sum_probs=73.2
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCC-CCcccccccCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG-PLPAGLVERSKNGS 463 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g-~iP~~~~~l~~l~~ 463 (846)
..++++.|+|++|++++..|..|++|++|++|+|++|++++..|..|+++++|++|+|++|++++ .+|..+.++++|+.
T Consensus 48 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~ 127 (549)
T 2z81_A 48 ACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127 (549)
T ss_dssp SCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCE
T ss_pred cCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccE
Confidence 44688899999999998888889999999999999999988777778899999999999999886 46778888888888
Q ss_pred CCCcccc
Q 003114 464 LSLSVDL 470 (846)
Q Consensus 464 l~l~~nl 470 (846)
|+++.|.
T Consensus 128 L~L~~n~ 134 (549)
T 2z81_A 128 LRIGNVE 134 (549)
T ss_dssp EEEEESS
T ss_pred EECCCCc
Confidence 8888875
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.53 E-value=4.1e-08 Score=113.70 Aligned_cols=83 Identities=20% Similarity=0.157 Sum_probs=51.9
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
++++.|+|++|++++..|..|.+|++|++|+|++|+|++..|..|+++++|++|||++|+|+ .+|.. .+++|+.|++
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 46666666666666555556666666666666666666555666666666666666666666 45555 5566666666
Q ss_pred ccccCC
Q 003114 467 SVDLCS 472 (846)
Q Consensus 467 ~~nlc~ 472 (846)
+.|...
T Consensus 98 ~~N~l~ 103 (520)
T 2z7x_B 98 SFNAFD 103 (520)
T ss_dssp CSSCCS
T ss_pred cCCccc
Confidence 665443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.53 E-value=2e-08 Score=108.66 Aligned_cols=87 Identities=20% Similarity=0.190 Sum_probs=72.5
Q ss_pred CCCceEEEEcCCCCCcccCCccccCC-----CCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCC--Ccccc--
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNL-----TMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGP--LPAGL-- 455 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L-----~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~--iP~~~-- 455 (846)
..++|+.|+|++|+|++. |..++++ ++|++|+|++|+|++..|..|+++++|+.|+|++|+++|. +|..+
T Consensus 119 ~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 197 (312)
T 1wwl_A 119 TGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197 (312)
T ss_dssp CSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCT
T ss_pred cCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHh
Confidence 456889999999999977 8888887 8999999999999988888899999999999999998876 34555
Q ss_pred cccCCCCCCCCccccCC
Q 003114 456 VERSKNGSLSLSVDLCS 472 (846)
Q Consensus 456 ~~l~~l~~l~l~~nlc~ 472 (846)
..+++|+.|++++|...
T Consensus 198 ~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 198 LKFPTLQVLALRNAGME 214 (312)
T ss_dssp TSCTTCCEEECTTSCCC
T ss_pred ccCCCCCEEECCCCcCc
Confidence 78888999998887543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.51 E-value=5e-08 Score=105.28 Aligned_cols=83 Identities=22% Similarity=0.134 Sum_probs=57.8
Q ss_pred ceEEEEcCCCCCcccCCccc--cCCCCCCeEeccCCCCCCCCC----chhcccCccccccccCccCCCCCcccccccCCC
Q 003114 388 RITSLNLSSRGLTGGIPPYL--SNLTMIEHLDLSNNSLTGPVP----EFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKN 461 (846)
Q Consensus 388 ~l~~L~L~~n~l~g~ip~~~--~~L~~L~~L~Ls~N~l~g~iP----~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l 461 (846)
+++.|+|++|++++.+|..+ +++++|+.|+|++|++++.+| ..+..+++|+.|+|++|++++..|..+..+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 46677777777777777766 777777777777777776555 334556777777777777776666677777777
Q ss_pred CCCCCcccc
Q 003114 462 GSLSLSVDL 470 (846)
Q Consensus 462 ~~l~l~~nl 470 (846)
+.|++++|.
T Consensus 172 ~~L~Ls~N~ 180 (310)
T 4glp_A 172 TSLDLSDNP 180 (310)
T ss_dssp CEEECCSCT
T ss_pred CEEECCCCC
Confidence 777777664
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.51 E-value=6.4e-08 Score=110.89 Aligned_cols=86 Identities=20% Similarity=0.156 Sum_probs=61.0
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.++|+.|+|++|++++..|..|++|++|++|+|++|+|++..+..|.++++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 55 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 55 FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 45677777777777766677777777777777777777754445567777777777777777766666777777777777
Q ss_pred CccccC
Q 003114 466 LSVDLC 471 (846)
Q Consensus 466 l~~nlc 471 (846)
++.|..
T Consensus 135 l~~n~l 140 (477)
T 2id5_A 135 VGDNDL 140 (477)
T ss_dssp ECCTTC
T ss_pred CCCCcc
Confidence 776644
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.50 E-value=5.2e-08 Score=112.84 Aligned_cols=84 Identities=21% Similarity=0.146 Sum_probs=72.1
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCC-CCcccccccCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG-PLPAGLVERSKNGSL 464 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g-~iP~~~~~l~~l~~l 464 (846)
..+|+.|+|++|+|++..|..|++|++|++|+|++|+|+ .+|.. .+++|++|+|++|+|++ .+|..++.+++|+.|
T Consensus 44 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L 120 (520)
T 2z7x_B 44 LSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120 (520)
T ss_dssp CTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEE
T ss_pred cccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEE
Confidence 457889999999999888888999999999999999998 67876 88899999999999987 578889999999999
Q ss_pred CCccccCC
Q 003114 465 SLSVDLCS 472 (846)
Q Consensus 465 ~l~~nlc~ 472 (846)
+++.|...
T Consensus 121 ~L~~n~l~ 128 (520)
T 2z7x_B 121 GLSTTHLE 128 (520)
T ss_dssp EEEESSCC
T ss_pred EecCcccc
Confidence 88887553
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.49 E-value=1.3e-07 Score=105.49 Aligned_cols=89 Identities=17% Similarity=0.155 Sum_probs=70.5
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
...+|+.|+|++|++++..|..|+++++|++|+|++|+|+...+..|+++++|+.|+|++|++++..|..+..+++|+.|
T Consensus 91 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 170 (390)
T 3o6n_A 91 YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 170 (390)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEE
T ss_pred CCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEE
Confidence 45678888888888887777778888888888888888884333446888888888888888887777778888888888
Q ss_pred CCccccCCC
Q 003114 465 SLSVDLCSS 473 (846)
Q Consensus 465 ~l~~nlc~~ 473 (846)
+++.|....
T Consensus 171 ~l~~n~l~~ 179 (390)
T 3o6n_A 171 QLSSNRLTH 179 (390)
T ss_dssp ECCSSCCSB
T ss_pred ECCCCcCCc
Confidence 888876543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.49 E-value=4.9e-08 Score=114.31 Aligned_cols=93 Identities=25% Similarity=0.332 Sum_probs=48.6
Q ss_pred CCCCCCCCCCCceEE-eecCCCCCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCcccccc
Q 003114 363 QGDPCAPQAFLWNGL-GCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLN 441 (846)
Q Consensus 363 ~~dpC~~~~~~w~gv-~C~~~~~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~ 441 (846)
+++||.-....|.|+ .|... +++.|+|++|+|++ ||..+. ++|+.|+|++|+|+ .|| ..+++|+.|+
T Consensus 39 ~~~~~~~~~~~~~~l~~C~~~-----~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~ 106 (571)
T 3cvr_A 39 QALPGENRNEAVSLLKECLIN-----QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLD 106 (571)
T ss_dssp TCCTTCCHHHHHHHHHHHHHT-----TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEE
T ss_pred cCCccccccchhhhccccccC-----CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEE
Confidence 356663222258888 67542 45556666666654 555442 45555555555555 455 3345555555
Q ss_pred ccCccCCCCCcccccccCCCCCCCCccccC
Q 003114 442 LTGNMLTGPLPAGLVERSKNGSLSLSVDLC 471 (846)
Q Consensus 442 Ls~N~l~g~iP~~~~~l~~l~~l~l~~nlc 471 (846)
|++|+|++ +|. +.+ +|+.|++++|..
T Consensus 107 Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l 132 (571)
T 3cvr_A 107 ACDNRLST-LPE-LPA--SLKHLDVDNNQL 132 (571)
T ss_dssp CCSSCCSC-CCC-CCT--TCCEEECCSSCC
T ss_pred ccCCCCCC-cch-hhc--CCCEEECCCCcC
Confidence 55555554 444 333 455555555443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.48 E-value=7.1e-08 Score=112.77 Aligned_cols=85 Identities=20% Similarity=0.258 Sum_probs=55.5
Q ss_pred CCceEEEEcCCCCCc-ccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 386 PPRITSLNLSSRGLT-GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~-g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
.++++.|+|++|.++ +.+|..+..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..|..+..+++|+.|
T Consensus 444 l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 523 (570)
T 2z63_A 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKI 523 (570)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEE
Confidence 346666666666665 4566666666666666666666666666666666666666666666666555566666666666
Q ss_pred CCcccc
Q 003114 465 SLSVDL 470 (846)
Q Consensus 465 ~l~~nl 470 (846)
++++|.
T Consensus 524 ~l~~N~ 529 (570)
T 2z63_A 524 WLHTNP 529 (570)
T ss_dssp ECCSSC
T ss_pred EecCCc
Confidence 666664
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.48 E-value=8.7e-08 Score=105.31 Aligned_cols=85 Identities=28% Similarity=0.286 Sum_probs=75.7
Q ss_pred CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcc--cccccCCC
Q 003114 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPA--GLVERSKN 461 (846)
Q Consensus 384 ~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~--~~~~l~~l 461 (846)
...++|+.|+|++|++++..|..|+++++|++|+|++|+|++..+..|+++++|++|+|++|+++ .+|. .+..+++|
T Consensus 73 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L 151 (353)
T 2z80_A 73 QRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKL 151 (353)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTC
T ss_pred ccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCC
Confidence 34578999999999999888889999999999999999999655555999999999999999999 5665 78899999
Q ss_pred CCCCCccc
Q 003114 462 GSLSLSVD 469 (846)
Q Consensus 462 ~~l~l~~n 469 (846)
+.|+++.|
T Consensus 152 ~~L~l~~n 159 (353)
T 2z80_A 152 QILRVGNM 159 (353)
T ss_dssp CEEEEEES
T ss_pred cEEECCCC
Confidence 99999987
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=9.1e-08 Score=112.98 Aligned_cols=89 Identities=19% Similarity=0.041 Sum_probs=65.0
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
...+|+.|+|++|++++..|..|++|++|++|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|+.|
T Consensus 55 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L 134 (606)
T 3t6q_A 55 RLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESL 134 (606)
T ss_dssp TCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEE
T ss_pred cCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEE
Confidence 34567777777777777777777777777777777777777777777777777777777777776556667777777777
Q ss_pred CCccccCCC
Q 003114 465 SLSVDLCSS 473 (846)
Q Consensus 465 ~l~~nlc~~ 473 (846)
+++.|....
T Consensus 135 ~L~~n~l~~ 143 (606)
T 3t6q_A 135 YLGSNHISS 143 (606)
T ss_dssp ECCSSCCCC
T ss_pred ECCCCcccc
Confidence 777765543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.46 E-value=1.7e-07 Score=104.47 Aligned_cols=85 Identities=24% Similarity=0.253 Sum_probs=54.4
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCccc-ccccCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAG-LVERSKNGSLS 465 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~-~~~l~~l~~l~ 465 (846)
++|+.|+|++|++++..+..|+++++|++|+|++|++++..|..|+++++|+.|+|++|+|+ .+|.. +..+++|+.|+
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEE
Confidence 45666666666666555556666666666666666666666666666666666666666666 34443 45666666666
Q ss_pred CccccCC
Q 003114 466 LSVDLCS 472 (846)
Q Consensus 466 l~~nlc~ 472 (846)
++.|...
T Consensus 148 L~~n~l~ 154 (390)
T 3o6n_A 148 MSNNNLE 154 (390)
T ss_dssp CCSSCCC
T ss_pred CCCCccC
Confidence 6666443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.45 E-value=1.2e-07 Score=116.66 Aligned_cols=86 Identities=21% Similarity=0.202 Sum_probs=52.5
Q ss_pred CCceEEEEcCCCCCcccCCcc--ccCCCCCCeEeccCCCCCCCCC-chhcccCccccccccCccCCCCCccccccc--CC
Q 003114 386 PPRITSLNLSSRGLTGGIPPY--LSNLTMIEHLDLSNNSLTGPVP-EFLSKLQYLRVLNLTGNMLTGPLPAGLVER--SK 460 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~--~~~L~~L~~L~Ls~N~l~g~iP-~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l--~~ 460 (846)
..+|+.|+|++|+|++.+|.. |++|++|++|+|++|++++..| ..|++|++|+.|+|++|++++..|..+..+ ++
T Consensus 96 l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~ 175 (844)
T 3j0a_A 96 LFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175 (844)
T ss_dssp CSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCS
T ss_pred CcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCc
Confidence 345666666666666655554 6666666666666666665443 456666666666666666666666666655 56
Q ss_pred CCCCCCccccC
Q 003114 461 NGSLSLSVDLC 471 (846)
Q Consensus 461 l~~l~l~~nlc 471 (846)
|+.|+++.|..
T Consensus 176 L~~L~L~~n~l 186 (844)
T 3j0a_A 176 LSFFSLAANSL 186 (844)
T ss_dssp SCCCEECCSBS
T ss_pred cceEECCCCcc
Confidence 66666665543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.45 E-value=1.1e-07 Score=111.29 Aligned_cols=87 Identities=22% Similarity=0.120 Sum_probs=76.8
Q ss_pred CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCC-CCcccccccCCCC
Q 003114 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG-PLPAGLVERSKNG 462 (846)
Q Consensus 384 ~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g-~iP~~~~~l~~l~ 462 (846)
...++|+.|+|++|+|++..|..|++|++|++|+|++|+|+ .+|.. .+++|++|+|++|+|++ ++|..+.++++|+
T Consensus 73 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~ 149 (562)
T 3a79_B 73 SFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLT 149 (562)
T ss_dssp TTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCC
T ss_pred ccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCccc
Confidence 34568999999999999888999999999999999999999 78876 89999999999999997 5678999999999
Q ss_pred CCCCccccCCC
Q 003114 463 SLSLSVDLCSS 473 (846)
Q Consensus 463 ~l~l~~nlc~~ 473 (846)
.|+++.|....
T Consensus 150 ~L~L~~n~l~~ 160 (562)
T 3a79_B 150 FLGLSAAKFRQ 160 (562)
T ss_dssp EEEEECSBCCT
T ss_pred EEecCCCcccc
Confidence 99999886543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.43 E-value=1.5e-07 Score=101.52 Aligned_cols=80 Identities=30% Similarity=0.359 Sum_probs=50.7
Q ss_pred CceEEEEcCCCCCcccCCccccCC---CCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNL---TMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGS 463 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L---~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~ 463 (846)
++|+.|+|++|+|++.+|+.++.+ ++|++|+|++|+|+ .+|..+. ++|+.|||++|+|++ +|. +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~-~~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNR-APQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCS-CCC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCC-Cch-hhhCCCccE
Confidence 456667777777776666666665 46777777777776 5666553 567777777777764 233 455566666
Q ss_pred CCCccccC
Q 003114 464 LSLSVDLC 471 (846)
Q Consensus 464 l~l~~nlc 471 (846)
|++++|..
T Consensus 299 L~L~~N~l 306 (310)
T 4glp_A 299 LTLDGNPF 306 (310)
T ss_dssp EECSSTTT
T ss_pred EECcCCCC
Confidence 66666644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2.6e-07 Score=110.67 Aligned_cols=87 Identities=23% Similarity=0.171 Sum_probs=54.9
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCccccc--ccCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLV--ERSKNGS 463 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~--~l~~l~~ 463 (846)
..+|+.|+|++|++++..|..|++|++|++|+|++|++++..|..++++++|+.|+|++|++++..|..+. .+++|+.
T Consensus 96 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~ 175 (680)
T 1ziw_A 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKK 175 (680)
T ss_dssp CTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESE
T ss_pred CCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccE
Confidence 34666666666666655555666666666666666666666666666666666666666666655555443 3456666
Q ss_pred CCCccccCC
Q 003114 464 LSLSVDLCS 472 (846)
Q Consensus 464 l~l~~nlc~ 472 (846)
|+++.|...
T Consensus 176 L~L~~n~l~ 184 (680)
T 1ziw_A 176 LELSSNQIK 184 (680)
T ss_dssp EECTTCCCC
T ss_pred EECCCCccc
Confidence 666666443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.40 E-value=9.2e-08 Score=98.98 Aligned_cols=83 Identities=23% Similarity=0.313 Sum_probs=66.5
Q ss_pred CCCceEEEEcCCCC-CcccCCccccCCCCCCeEeccC-CCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCC
Q 003114 385 DPPRITSLNLSSRG-LTGGIPPYLSNLTMIEHLDLSN-NSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNG 462 (846)
Q Consensus 385 ~~~~l~~L~L~~n~-l~g~ip~~~~~L~~L~~L~Ls~-N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~ 462 (846)
..++|+.|+|++|+ +++..+..|.++++|+.|+|++ |+|++..|..|.++++|+.|+|++|+|++ +|. +..+++|+
T Consensus 53 ~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~ 130 (239)
T 2xwt_C 53 NLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTD 130 (239)
T ss_dssp TCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCC
T ss_pred CCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccc
Confidence 34678888888886 7755555788888888888888 88886666778888888888888888885 776 77777777
Q ss_pred ---CCCCccc
Q 003114 463 ---SLSLSVD 469 (846)
Q Consensus 463 ---~l~l~~n 469 (846)
.|+++.|
T Consensus 131 ~L~~L~l~~N 140 (239)
T 2xwt_C 131 IFFILEITDN 140 (239)
T ss_dssp SEEEEEEESC
T ss_pred cccEEECCCC
Confidence 8888877
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.35 E-value=2.5e-07 Score=97.53 Aligned_cols=82 Identities=29% Similarity=0.391 Sum_probs=72.6
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
.+++.|+|++|+|++ + +.++.+++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++. ..+..+++|+.|++
T Consensus 106 ~~L~~L~L~~N~l~~-~-~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l 179 (263)
T 1xeu_A 106 ACLSRLFLDNNELRD-T-DSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDL 179 (263)
T ss_dssp SSCCEEECCSSCCSB-S-GGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEE
T ss_pred CcccEEEccCCccCC-C-hhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeC
Confidence 689999999999996 4 469999999999999999996 45 699999999999999999975 77889999999999
Q ss_pred ccccCCCC
Q 003114 467 SVDLCSSY 474 (846)
Q Consensus 467 ~~nlc~~~ 474 (846)
++|.+...
T Consensus 180 ~~N~~~~~ 187 (263)
T 1xeu_A 180 TGQKCVNE 187 (263)
T ss_dssp EEEEEECC
T ss_pred CCCcccCC
Confidence 99987654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.34 E-value=1.4e-08 Score=102.09 Aligned_cols=83 Identities=19% Similarity=0.216 Sum_probs=71.9
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.++++.|+|++|+|++ +| .+.++++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +| .+..+++|+.|+
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 121 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence 4578999999999996 77 8999999999999999998 788888888999999999999996 66 688899999999
Q ss_pred CccccCCC
Q 003114 466 LSVDLCSS 473 (846)
Q Consensus 466 l~~nlc~~ 473 (846)
++.|....
T Consensus 122 l~~N~i~~ 129 (198)
T 1ds9_A 122 MSNNKITN 129 (198)
T ss_dssp ESEEECCC
T ss_pred CCCCcCCc
Confidence 98886553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.34 E-value=2.7e-07 Score=98.78 Aligned_cols=82 Identities=32% Similarity=0.419 Sum_probs=59.2
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.++|+.|+|++|++++. +.++.+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++ +|. +..+++|+.|+
T Consensus 133 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~-l~~l~~L~~L~ 206 (291)
T 1h6t_A 133 LPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLE 206 (291)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEE
T ss_pred CCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Chh-hccCCCCCEEE
Confidence 35677778887777754 567777778888888887775444 7777778888888887774 553 77777777777
Q ss_pred CccccCCC
Q 003114 466 LSVDLCSS 473 (846)
Q Consensus 466 l~~nlc~~ 473 (846)
++.|.+..
T Consensus 207 l~~n~i~~ 214 (291)
T 1h6t_A 207 LFSQECLN 214 (291)
T ss_dssp EEEEEEEC
T ss_pred CcCCcccC
Confidence 77776644
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.31 E-value=3.9e-07 Score=99.59 Aligned_cols=81 Identities=28% Similarity=0.322 Sum_probs=55.5
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.++++.|+|++|++++. +.+..+++|+.|+|++|++++..|..++++++|+.|+|++|++++..| +..+++|+.|+
T Consensus 264 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 339 (347)
T 4fmz_A 264 LTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSAD 339 (347)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEES
T ss_pred CCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceee
Confidence 45677777777777753 356777777777777777776666777777777777777777775544 66677777777
Q ss_pred Ccccc
Q 003114 466 LSVDL 470 (846)
Q Consensus 466 l~~nl 470 (846)
+++|.
T Consensus 340 l~~N~ 344 (347)
T 4fmz_A 340 FANQV 344 (347)
T ss_dssp SSCC-
T ss_pred hhhhc
Confidence 76664
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.31 E-value=7e-07 Score=95.55 Aligned_cols=83 Identities=33% Similarity=0.397 Sum_probs=68.7
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
..++|+.|+|++|++++. +.+..+++|+.|+|++|++++. ..++.+++|+.|+|++|+|++..| +..+++|+.|
T Consensus 110 ~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L 183 (291)
T 1h6t_A 110 DLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 183 (291)
T ss_dssp TCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred cCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEE
Confidence 456889999999999863 5788999999999999999864 568899999999999999986544 8888999999
Q ss_pred CCccccCCC
Q 003114 465 SLSVDLCSS 473 (846)
Q Consensus 465 ~l~~nlc~~ 473 (846)
++++|....
T Consensus 184 ~L~~N~i~~ 192 (291)
T 1h6t_A 184 YLSKNHISD 192 (291)
T ss_dssp ECCSSCCCB
T ss_pred ECCCCcCCC
Confidence 998886543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.30 E-value=2e-08 Score=100.96 Aligned_cols=82 Identities=27% Similarity=0.354 Sum_probs=74.2
Q ss_pred ceEEEEcCCCCCcccCCc------cccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCC
Q 003114 388 RITSLNLSSRGLTGGIPP------YLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKN 461 (846)
Q Consensus 388 ~l~~L~L~~n~l~g~ip~------~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l 461 (846)
+++.++|+.+.|+|.+|. .|+++++|+.|+|++|+|++ +| .+.++++|+.|+|++|+|+ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 566778888888888887 99999999999999999996 88 8999999999999999999 799988889999
Q ss_pred CCCCCccccCC
Q 003114 462 GSLSLSVDLCS 472 (846)
Q Consensus 462 ~~l~l~~nlc~ 472 (846)
+.|++++|...
T Consensus 96 ~~L~L~~N~l~ 106 (198)
T 1ds9_A 96 EELWISYNQIA 106 (198)
T ss_dssp SEEEEEEEECC
T ss_pred CEEECcCCcCC
Confidence 99999988654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.29 E-value=2.7e-07 Score=97.13 Aligned_cols=79 Identities=28% Similarity=0.258 Sum_probs=66.1
Q ss_pred CCceEEEEcCCCCCcc--cCCccccCCCCCCeEeccCCCCCCCCCchhcccC--ccccccccCccCCCCCcc-------c
Q 003114 386 PPRITSLNLSSRGLTG--GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQ--YLRVLNLTGNMLTGPLPA-------G 454 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g--~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~--~L~~L~Ls~N~l~g~iP~-------~ 454 (846)
.++|+.|+|++|+|++ .+|..+..|++|+.|+|++|+|++. ..+..++ +|+.|+|++|.+++.+|. .
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~i 246 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAI 246 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHH
Confidence 4689999999999998 6778889999999999999999965 4466666 899999999999988874 3
Q ss_pred ccccCCCCCCCC
Q 003114 455 LVERSKNGSLSL 466 (846)
Q Consensus 455 ~~~l~~l~~l~l 466 (846)
+..+++|+.|+-
T Consensus 247 l~~~P~L~~LDg 258 (267)
T 3rw6_A 247 RERFPKLLRLDG 258 (267)
T ss_dssp HHHCTTCCEESS
T ss_pred HHHCcccCeECC
Confidence 667888887763
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.29 E-value=4.3e-07 Score=107.29 Aligned_cols=84 Identities=30% Similarity=0.394 Sum_probs=67.8
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
..++|+.|+|++|+|++. +.|+.|++|+.|+|++|+|++..| +..|++|+.|+|++|+|++ +| .+..+++|+.|
T Consensus 129 ~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L 202 (605)
T 1m9s_A 129 HLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVL 202 (605)
T ss_dssp GCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEE
T ss_pred CCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEE
Confidence 346788888888888864 678888888888888888887666 8888888888888888885 44 58888888888
Q ss_pred CCccccCCCC
Q 003114 465 SLSVDLCSSY 474 (846)
Q Consensus 465 ~l~~nlc~~~ 474 (846)
+|+.|.|...
T Consensus 203 ~L~~N~l~~~ 212 (605)
T 1m9s_A 203 ELFSQECLNK 212 (605)
T ss_dssp ECCSEEEECC
T ss_pred EccCCcCcCC
Confidence 8888877654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.28 E-value=4.2e-07 Score=98.39 Aligned_cols=80 Identities=18% Similarity=0.088 Sum_probs=43.6
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
++++.|+|++|+|++. | ....+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|++
T Consensus 169 ~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l 244 (317)
T 3o53_A 169 DTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDL 244 (317)
T ss_dssp TTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEEC
T ss_pred CcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEc
Confidence 3555555555555533 2 22335556666666666553 3334555566666666666665 45555555555666655
Q ss_pred cccc
Q 003114 467 SVDL 470 (846)
Q Consensus 467 ~~nl 470 (846)
++|.
T Consensus 245 ~~N~ 248 (317)
T 3o53_A 245 RGNG 248 (317)
T ss_dssp TTCC
T ss_pred cCCC
Confidence 5553
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.25 E-value=3.4e-07 Score=105.46 Aligned_cols=96 Identities=20% Similarity=0.086 Sum_probs=82.5
Q ss_pred CceEEeecCCCCCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhc-ccCccccccccCccCCCCC
Q 003114 373 LWNGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLS-KLQYLRVLNLTGNMLTGPL 451 (846)
Q Consensus 373 ~w~gv~C~~~~~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~-~l~~L~~L~Ls~N~l~g~i 451 (846)
.+.++.|. ..++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++.+|..+. ++++|+.|+|++|+|++.
T Consensus 110 ~l~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~- 184 (487)
T 3oja_A 110 NISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV- 184 (487)
T ss_dssp CCCCEEEC----CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-
T ss_pred cCCCCCcc----ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-
Confidence 45566664 346899999999999999999999999999999999999999998886 899999999999999965
Q ss_pred cccccccCCCCCCCCccccCCCC
Q 003114 452 PAGLVERSKNGSLSLSVDLCSSY 474 (846)
Q Consensus 452 P~~~~~l~~l~~l~l~~nlc~~~ 474 (846)
|. +..+++|+.|++++|.....
T Consensus 185 ~~-~~~l~~L~~L~Ls~N~l~~~ 206 (487)
T 3oja_A 185 KG-QVVFAKLKTLDLSSNKLAFM 206 (487)
T ss_dssp EC-CCCCTTCCEEECCSSCCCEE
T ss_pred cc-cccCCCCCEEECCCCCCCCC
Confidence 33 44699999999999977653
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.23 E-value=1e-06 Score=94.94 Aligned_cols=79 Identities=20% Similarity=0.261 Sum_probs=38.8
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
++|+.|+|++|++++..+ ++++++|+.|+|++|++++ +|. +.++++|+.|+|++|++++. |. +..+++|+.|++
T Consensus 129 ~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~L 202 (308)
T 1h6u_A 129 SNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDI-SP-LASLPNLIEVHL 202 (308)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEEC
T ss_pred CCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcC-hh-hcCCCCCCEEEc
Confidence 445555555555553222 5555555555555555553 222 55555555555555555532 22 445555555555
Q ss_pred ccccC
Q 003114 467 SVDLC 471 (846)
Q Consensus 467 ~~nlc 471 (846)
++|..
T Consensus 203 ~~N~l 207 (308)
T 1h6u_A 203 KNNQI 207 (308)
T ss_dssp TTSCC
T ss_pred cCCcc
Confidence 55443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.23 E-value=1.1e-06 Score=103.68 Aligned_cols=84 Identities=33% Similarity=0.429 Sum_probs=74.0
Q ss_pred CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCC
Q 003114 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGS 463 (846)
Q Consensus 384 ~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~ 463 (846)
...++|+.|+|++|+|++ + +.+..|++|+.|+|++|+|++. ..|+.|++|+.|+|++|+|++..| +..+++|+.
T Consensus 106 ~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~ 179 (605)
T 1m9s_A 106 KDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN 179 (605)
T ss_dssp TTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred ccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCE
Confidence 345689999999999996 3 5699999999999999999965 679999999999999999997766 899999999
Q ss_pred CCCccccCCC
Q 003114 464 LSLSVDLCSS 473 (846)
Q Consensus 464 l~l~~nlc~~ 473 (846)
|+|+.|....
T Consensus 180 L~Ls~N~i~~ 189 (605)
T 1m9s_A 180 LYLSKNHISD 189 (605)
T ss_dssp EECCSSCCCB
T ss_pred EECcCCCCCC
Confidence 9999986654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.20 E-value=1.3e-06 Score=92.03 Aligned_cols=80 Identities=24% Similarity=0.293 Sum_probs=54.9
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.++|+.|+|++|+|++. |+ +++|++|+.|+|++|+|++ +|.. .. ++|+.|+|++|+|++ +| .+..+++|+.|+
T Consensus 62 l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 62 FTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILS 134 (263)
T ss_dssp CTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEE
Confidence 45677777777777753 33 7777777777777777774 4442 22 777777777777774 33 477777777777
Q ss_pred CccccCC
Q 003114 466 LSVDLCS 472 (846)
Q Consensus 466 l~~nlc~ 472 (846)
+++|...
T Consensus 135 Ls~N~i~ 141 (263)
T 1xeu_A 135 IRNNKLK 141 (263)
T ss_dssp CTTSCCC
T ss_pred CCCCcCC
Confidence 7777554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.20 E-value=7.4e-07 Score=96.44 Aligned_cols=85 Identities=19% Similarity=0.158 Sum_probs=68.3
Q ss_pred CCceEEEEcCCCCCcccCCccc-cCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYL-SNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~-~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
.++|+.|+|++|++++..|..+ ..+++|+.|+|++|+|++. |. ...+++|+.|+|++|+|+ .+|..+..+++|+.|
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L 219 (317)
T 3o53_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219 (317)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEE
T ss_pred cCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCC-cchhhhcccCcccEE
Confidence 3578899999999988777776 4788999999999998854 43 445888999999999998 466668889999999
Q ss_pred CCccccCCC
Q 003114 465 SLSVDLCSS 473 (846)
Q Consensus 465 ~l~~nlc~~ 473 (846)
++++|....
T Consensus 220 ~L~~N~l~~ 228 (317)
T 3o53_A 220 SLRNNKLVL 228 (317)
T ss_dssp ECTTSCCCE
T ss_pred ECcCCcccc
Confidence 998886654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.20 E-value=1.4e-06 Score=93.85 Aligned_cols=83 Identities=27% Similarity=0.344 Sum_probs=63.6
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
..++|+.|+|++|++++ +|+ +..+++|+.|+|++|++++. |. ++++++|+.|+|++|++++ +|. +..+++|+.|
T Consensus 105 ~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L 178 (308)
T 1h6u_A 105 GLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTL 178 (308)
T ss_dssp TCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEE
T ss_pred CCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcC-cc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEE
Confidence 34678888888888885 443 88888888888888888854 33 8888888888888888885 444 7788888888
Q ss_pred CCccccCCC
Q 003114 465 SLSVDLCSS 473 (846)
Q Consensus 465 ~l~~nlc~~ 473 (846)
+++.|....
T Consensus 179 ~l~~n~l~~ 187 (308)
T 1h6u_A 179 KADDNKISD 187 (308)
T ss_dssp ECCSSCCCC
T ss_pred ECCCCccCc
Confidence 888776544
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.15 E-value=1.3e-06 Score=102.12 Aligned_cols=78 Identities=23% Similarity=0.343 Sum_probs=64.0
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCcc-------ccccccCccCCCCCccccccc
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYL-------RVLNLTGNMLTGPLPAGLVER 458 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L-------~~L~Ls~N~l~g~iP~~~~~l 458 (846)
.++|+.|+|++|+|++ +|. |+ ++|+.|+|++|+|+ .+|. |.. +| +.|+|++|+|+ .||..++.+
T Consensus 159 l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l 229 (571)
T 3cvr_A 159 PTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSL 229 (571)
T ss_dssp CTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGS
T ss_pred CCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcC
Confidence 4588999999999986 777 66 89999999999998 7887 655 67 99999999998 689988889
Q ss_pred CCCCCCCCccccCC
Q 003114 459 SKNGSLSLSVDLCS 472 (846)
Q Consensus 459 ~~l~~l~l~~nlc~ 472 (846)
++|+.|++++|...
T Consensus 230 ~~L~~L~L~~N~l~ 243 (571)
T 3cvr_A 230 DPTCTIILEDNPLS 243 (571)
T ss_dssp CTTEEEECCSSSCC
T ss_pred CCCCEEEeeCCcCC
Confidence 99999999888654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.13 E-value=2.2e-06 Score=97.76 Aligned_cols=80 Identities=25% Similarity=0.376 Sum_probs=67.8
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
+++++.|+|++|++++ +| +|+++++|++|+|++|++++ +|..+ .+|+.|+|++|++++ +| .+..+++|+.|+
T Consensus 130 ~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~ 201 (454)
T 1jl5_A 130 PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIY 201 (454)
T ss_dssp CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEE
Confidence 3589999999999996 88 69999999999999999995 77644 588999999999996 77 688999999999
Q ss_pred CccccCCC
Q 003114 466 LSVDLCSS 473 (846)
Q Consensus 466 l~~nlc~~ 473 (846)
++.|....
T Consensus 202 l~~N~l~~ 209 (454)
T 1jl5_A 202 ADNNSLKK 209 (454)
T ss_dssp CCSSCCSS
T ss_pred CCCCcCCc
Confidence 98887654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.12 E-value=2.1e-06 Score=93.67 Aligned_cols=86 Identities=20% Similarity=0.263 Sum_probs=72.5
Q ss_pred CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCC
Q 003114 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGS 463 (846)
Q Consensus 384 ~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~ 463 (846)
...++++.|+|++|++++ + +.+..+++|+.|+|++|++++ +| .+..+++|+.|+|++|++++..|..+..+++|+.
T Consensus 240 ~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 315 (347)
T 4fmz_A 240 ANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT 315 (347)
T ss_dssp TTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSE
T ss_pred hcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCE
Confidence 345688999999999986 3 568899999999999999986 44 5889999999999999999888888999999999
Q ss_pred CCCccccCCC
Q 003114 464 LSLSVDLCSS 473 (846)
Q Consensus 464 l~l~~nlc~~ 473 (846)
|++++|....
T Consensus 316 L~L~~n~l~~ 325 (347)
T 4fmz_A 316 LFLSQNHITD 325 (347)
T ss_dssp EECCSSSCCC
T ss_pred EEccCCcccc
Confidence 9999886544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.11 E-value=2.7e-07 Score=102.67 Aligned_cols=87 Identities=20% Similarity=0.150 Sum_probs=68.9
Q ss_pred CCceEEEEcCCCCCc----ccCCccccCCCCCCeEeccCCCCCCC----CCchhc--ccCccccccccCccCCC----CC
Q 003114 386 PPRITSLNLSSRGLT----GGIPPYLSNLTMIEHLDLSNNSLTGP----VPEFLS--KLQYLRVLNLTGNMLTG----PL 451 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~----g~ip~~~~~L~~L~~L~Ls~N~l~g~----iP~~~~--~l~~L~~L~Ls~N~l~g----~i 451 (846)
.++|+.|+|++|+|+ +.+|..+..+++|+.|+|++|+|++. +|..+. ++++|+.|+|++|+|++ .+
T Consensus 215 ~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l 294 (386)
T 2ca6_A 215 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTL 294 (386)
T ss_dssp CTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHH
T ss_pred CCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHH
Confidence 357888888888886 67888888888888888888888866 666663 38888888888888886 47
Q ss_pred cccc-cccCCCCCCCCccccCC
Q 003114 452 PAGL-VERSKNGSLSLSVDLCS 472 (846)
Q Consensus 452 P~~~-~~l~~l~~l~l~~nlc~ 472 (846)
|..+ .++++|+.|++++|...
T Consensus 295 ~~~l~~~l~~L~~L~l~~N~l~ 316 (386)
T 2ca6_A 295 KTVIDEKMPDLLFLELNGNRFS 316 (386)
T ss_dssp HHHHHHHCTTCCEEECTTSBSC
T ss_pred HHHHHhcCCCceEEEccCCcCC
Confidence 8777 55788888888887654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.11 E-value=1.8e-06 Score=98.68 Aligned_cols=82 Identities=22% Similarity=0.264 Sum_probs=60.2
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.++|+.|+|++|++++..| ++.+++|+.|+|++|++++. ..+.++++|+.|+|++|+++|..| +..+++|+.|+
T Consensus 308 l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 381 (466)
T 1o6v_A 308 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 381 (466)
T ss_dssp CTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEE
T ss_pred CCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEe
Confidence 4567777777777776555 67777788888888877754 357777888888888888877666 77777777777
Q ss_pred CccccCCC
Q 003114 466 LSVDLCSS 473 (846)
Q Consensus 466 l~~nlc~~ 473 (846)
+++|....
T Consensus 382 l~~n~~~~ 389 (466)
T 1o6v_A 382 LNDQAWTN 389 (466)
T ss_dssp CCCEEEEC
T ss_pred ccCCcccC
Confidence 77775544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.11 E-value=2.2e-07 Score=100.93 Aligned_cols=82 Identities=22% Similarity=0.235 Sum_probs=56.8
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCC-CCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGP-VPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~-iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.+++.|+|++|.+++.++. +.++++|+.|+|++|++++. +|..+.++++|+.|+|++|++++.+|..+..+++|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 5667777777777765544 45677777777777777655 666677777777777777777766677777777777777
Q ss_pred Cccc
Q 003114 466 LSVD 469 (846)
Q Consensus 466 l~~n 469 (846)
+++|
T Consensus 149 L~~~ 152 (336)
T 2ast_B 149 LSGC 152 (336)
T ss_dssp CTTC
T ss_pred CCCC
Confidence 7665
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.08 E-value=3.6e-06 Score=99.59 Aligned_cols=78 Identities=29% Similarity=0.356 Sum_probs=63.5
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+..+++|+.|+
T Consensus 220 ~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~ 290 (622)
T 3g06_A 220 PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVN 290 (622)
T ss_dssp CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEE
T ss_pred CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEE
Confidence 3578888888888885 66 55688888888888888 5776 6678888888888888 7888888888888888
Q ss_pred CccccCC
Q 003114 466 LSVDLCS 472 (846)
Q Consensus 466 l~~nlc~ 472 (846)
+++|...
T Consensus 291 L~~N~l~ 297 (622)
T 3g06_A 291 LEGNPLS 297 (622)
T ss_dssp CCSCCCC
T ss_pred ecCCCCC
Confidence 8887654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=1.3e-05 Score=86.23 Aligned_cols=134 Identities=23% Similarity=0.219 Sum_probs=91.3
Q ss_pred hcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccc---cceeEeeEee-cCCeeeEeeecccCCC
Q 003114 542 ILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHK---NLTTLYGYCN-EGNQIGLIYEYMANGS 617 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~Hp---nIv~l~g~~~-~~~~~~LV~Ey~~~gs 617 (846)
.++.|....||+. +..+++|+-. .......+.+|..+|+.+.+. .+.+.+.++. ..+..++|||+++|..
T Consensus 26 ~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred ecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 4788888899987 5778888853 233456789999999999653 2455666653 4556789999999988
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhcc---------------------------------------------
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG--------------------------------------------- 652 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------- 652 (846)
|.+..-. .++..++..++.++++.|..||..
T Consensus 100 l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 100 LGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp CHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred Cchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 7663211 123344444455555555554421
Q ss_pred ------------CCCCeeecCCCCCCEEECC---CCc-EEEEeccCCcc
Q 003114 653 ------------CKPPRVHRDIKPANILLND---QFQ-ARLADFGLSKT 685 (846)
Q Consensus 653 ------------~~~~IiHrDlKp~NILld~---~~~-vkI~DFGla~~ 685 (846)
....++|+|+++.||++++ ++. +.|.||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2345799999999999987 455 58999998753
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.07 E-value=3.5e-06 Score=96.13 Aligned_cols=80 Identities=30% Similarity=0.199 Sum_probs=54.8
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccC-------ccccccccCccCCCCCccccccc
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQ-------YLRVLNLTGNMLTGPLPAGLVER 458 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~-------~L~~L~Ls~N~l~g~iP~~~~~l 458 (846)
.++++.|+|++|+|++ +| ++.+++|+.|+|++|+|+|..+..+.+|+ +|+.|++++|++.|.+| +..+
T Consensus 211 l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l 285 (457)
T 3bz5_A 211 NIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGC 285 (457)
T ss_dssp CTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTC
T ss_pred CCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--cccc
Confidence 3567777777777776 55 77777777777777777766555555555 55677777777777666 3566
Q ss_pred CCCCCCCCcccc
Q 003114 459 SKNGSLSLSVDL 470 (846)
Q Consensus 459 ~~l~~l~l~~nl 470 (846)
++|+.|+++.|.
T Consensus 286 ~~L~~L~Ls~n~ 297 (457)
T 3bz5_A 286 RKIKELDVTHNT 297 (457)
T ss_dssp TTCCCCCCTTCT
T ss_pred ccCCEEECCCCc
Confidence 777777777664
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.07 E-value=7.2e-07 Score=98.41 Aligned_cols=88 Identities=31% Similarity=0.292 Sum_probs=64.9
Q ss_pred CCceEEEEcCCCCCcccCC----ccccCCC-CCCeEeccCCCCCCCCCchhccc-----CccccccccCccCCCCCcccc
Q 003114 386 PPRITSLNLSSRGLTGGIP----PYLSNLT-MIEHLDLSNNSLTGPVPEFLSKL-----QYLRVLNLTGNMLTGPLPAGL 455 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip----~~~~~L~-~L~~L~Ls~N~l~g~iP~~~~~l-----~~L~~L~Ls~N~l~g~iP~~~ 455 (846)
+.+++.|+|++|+|++..+ ..|.+++ +|+.|+|++|+|++..+..|..+ ++|+.|+|++|+|++..+..+
T Consensus 21 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l 100 (362)
T 3goz_A 21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL 100 (362)
T ss_dssp CTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred CCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHH
Confidence 3457888888888876655 5677777 78888888888887777777775 788888888888887666655
Q ss_pred ccc-----CCCCCCCCccccCCC
Q 003114 456 VER-----SKNGSLSLSVDLCSS 473 (846)
Q Consensus 456 ~~l-----~~l~~l~l~~nlc~~ 473 (846)
+.. ++|+.|+++.|..+.
T Consensus 101 ~~~l~~~~~~L~~L~Ls~N~l~~ 123 (362)
T 3goz_A 101 VKTLAAIPFTITVLDLGWNDFSS 123 (362)
T ss_dssp HHHHHTSCTTCCEEECCSSCGGG
T ss_pred HHHHHhCCCCccEEECcCCcCCc
Confidence 544 678888887776543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.05 E-value=4.2e-06 Score=95.47 Aligned_cols=80 Identities=20% Similarity=0.241 Sum_probs=55.9
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
..++++.|+|++|+|++ +| ++.+++|+.|+|++|+|++. .++++++|+.|+|++|+|++ +| +..+++|+.|
T Consensus 168 ~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L 238 (457)
T 3bz5_A 168 PQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYF 238 (457)
T ss_dssp TCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEE
T ss_pred cCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEE
Confidence 34567777777777775 44 67777777777777777754 26777777777777777775 55 6677777777
Q ss_pred CCccccCCC
Q 003114 465 SLSVDLCSS 473 (846)
Q Consensus 465 ~l~~nlc~~ 473 (846)
+++.|....
T Consensus 239 ~l~~N~l~~ 247 (457)
T 3bz5_A 239 DCSVNPLTE 247 (457)
T ss_dssp ECCSSCCSC
T ss_pred EeeCCcCCC
Confidence 777765544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.05 E-value=5.3e-07 Score=97.94 Aligned_cols=84 Identities=27% Similarity=0.301 Sum_probs=70.2
Q ss_pred CCceEEEEcCCCCCccc-CCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCc-cCCCC-CcccccccCCCC
Q 003114 386 PPRITSLNLSSRGLTGG-IPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN-MLTGP-LPAGLVERSKNG 462 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~-ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N-~l~g~-iP~~~~~l~~l~ 462 (846)
.++|+.|+|++|.+++. +|..+..+++|++|+|++|++++.+|..++++++|+.|+|++| .+++. +|..+..+++|+
T Consensus 92 ~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~ 171 (336)
T 2ast_B 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171 (336)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence 46788889998888876 8888888889999999988888888888888888999999888 67763 677788888888
Q ss_pred CCCCccc
Q 003114 463 SLSLSVD 469 (846)
Q Consensus 463 ~l~l~~n 469 (846)
.|+++.|
T Consensus 172 ~L~l~~~ 178 (336)
T 2ast_B 172 ELNLSWC 178 (336)
T ss_dssp EEECCCC
T ss_pred EEcCCCC
Confidence 8888766
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=1.9e-05 Score=82.85 Aligned_cols=133 Identities=17% Similarity=0.131 Sum_probs=95.2
Q ss_pred cCcCceE-EEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEeeecccCCChh
Q 003114 543 LGEGSFG-KVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLIYEYMANGSLE 619 (846)
Q Consensus 543 LG~G~fG-~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 619 (846)
+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +-.+-++++++.+++..++|||++++.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445555 68987764 5677899986532 3456788999998874 333667888888889999999999998877
Q ss_pred hhhhcCCCCccChHHHHHHHHHHHHHHHHHhcc-----------------------------------------------
Q 003114 620 EYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG----------------------------------------------- 652 (846)
Q Consensus 620 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------------- 652 (846)
+..... ......++.+++..|..||..
T Consensus 109 ~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 109 QVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred ccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 765432 123345566666666666631
Q ss_pred --------CCCCeeecCCCCCCEEECCCCcEEEEeccCCc
Q 003114 653 --------CKPPRVHRDIKPANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 653 --------~~~~IiHrDlKp~NILld~~~~vkI~DFGla~ 684 (846)
....++|+|+++.||++++++.+-|.||+.+.
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01237999999999999988777899999875
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.03 E-value=4.3e-06 Score=95.48 Aligned_cols=78 Identities=27% Similarity=0.365 Sum_probs=41.0
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
++|+.|+|++|++++..+ +..+++|+.|+|++|++++..| ++++++|+.|+|++|++++..| +..+++|+.|++
T Consensus 265 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l 338 (466)
T 1o6v_A 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEEC
T ss_pred CCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeEC
Confidence 455555555555554322 5555555555555555554322 5555555555555555554433 445555555555
Q ss_pred cccc
Q 003114 467 SVDL 470 (846)
Q Consensus 467 ~~nl 470 (846)
++|.
T Consensus 339 ~~n~ 342 (466)
T 1o6v_A 339 YNNK 342 (466)
T ss_dssp CSSC
T ss_pred CCCc
Confidence 5543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.00 E-value=4.3e-06 Score=95.28 Aligned_cols=79 Identities=28% Similarity=0.371 Sum_probs=55.4
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCC--CCccccccc-----
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG--PLPAGLVER----- 458 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g--~iP~~~~~l----- 458 (846)
+.+++.|+|++|++++ +|.. +++|+.|+|++|+++ .+|. .+++|+.|+|++|+++| .+|.++..+
T Consensus 316 ~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~ 387 (454)
T 1jl5_A 316 PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSH 387 (454)
T ss_dssp CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-
T ss_pred cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhccc
Confidence 4588999999999996 7765 588999999999998 5787 47889999999999998 889888888
Q ss_pred --------CCCCCCCCccccCC
Q 003114 459 --------SKNGSLSLSVDLCS 472 (846)
Q Consensus 459 --------~~l~~l~l~~nlc~ 472 (846)
++|+.|++++|...
T Consensus 388 ~~~i~~~~~~L~~L~ls~N~l~ 409 (454)
T 1jl5_A 388 LAEVPELPQNLKQLHVETNPLR 409 (454)
T ss_dssp ----------------------
T ss_pred ccccccccCcCCEEECCCCcCC
Confidence 77888888887654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.00 E-value=9.4e-07 Score=98.27 Aligned_cols=85 Identities=19% Similarity=0.198 Sum_probs=59.6
Q ss_pred CceEEEEcCCCCCcccCC----ccccCCCCCCeEeccCC---CCCCCCCchh-------cccCccccccccCccCCC---
Q 003114 387 PRITSLNLSSRGLTGGIP----PYLSNLTMIEHLDLSNN---SLTGPVPEFL-------SKLQYLRVLNLTGNMLTG--- 449 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip----~~~~~L~~L~~L~Ls~N---~l~g~iP~~~-------~~l~~L~~L~Ls~N~l~g--- 449 (846)
++|+.|+|++|+|++..+ ..|..+++|+.|+|++| +++|.+|..+ .++++|+.|+|++|+|++
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 357778888887776533 34667777888877774 4556666655 577778888888888776
Q ss_pred -CCcccccccCCCCCCCCccccC
Q 003114 450 -PLPAGLVERSKNGSLSLSVDLC 471 (846)
Q Consensus 450 -~iP~~~~~l~~l~~l~l~~nlc 471 (846)
.+|..+..+++|+.|+|+.|..
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l 134 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGL 134 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCC
T ss_pred HHHHHHHHhCCCCCEEECcCCCC
Confidence 4677777777777777776643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=1.7e-05 Score=86.93 Aligned_cols=80 Identities=6% Similarity=0.023 Sum_probs=56.1
Q ss_pred hhc-CcCceEEEEEEEEc-------CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccc---cceeEeeEeecC---
Q 003114 541 TIL-GEGSFGKVYHGYLD-------DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHK---NLTTLYGYCNEG--- 603 (846)
Q Consensus 541 ~~L-G~G~fG~Vykg~~~-------~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~Hp---nIv~l~g~~~~~--- 603 (846)
+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+++.+... .+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 356 88889999998764 26678888865432 11125678899999888532 466778777655
Q ss_pred CeeeEeeecccCCChhh
Q 003114 604 NQIGLIYEYMANGSLEE 620 (846)
Q Consensus 604 ~~~~LV~Ey~~~gsL~~ 620 (846)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=97.88 E-value=1.8e-06 Score=90.87 Aligned_cols=79 Identities=24% Similarity=0.265 Sum_probs=61.3
Q ss_pred EEcCCCCCc---ccCCccccCCCCCCeEeccCCCCCC--CCCchhcccCccccccccCccCCCCCcccccccC--CCCCC
Q 003114 392 LNLSSRGLT---GGIPPYLSNLTMIEHLDLSNNSLTG--PVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERS--KNGSL 464 (846)
Q Consensus 392 L~L~~n~l~---g~ip~~~~~L~~L~~L~Ls~N~l~g--~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~--~l~~l 464 (846)
++++.|... +.++-...+|++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL 225 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence 556666433 2233333678999999999999998 6778889999999999999999965 4455555 88999
Q ss_pred CCccccCC
Q 003114 465 SLSVDLCS 472 (846)
Q Consensus 465 ~l~~nlc~ 472 (846)
+|++|.+.
T Consensus 226 ~L~~Npl~ 233 (267)
T 3rw6_A 226 WLDGNSLC 233 (267)
T ss_dssp ECTTSTTG
T ss_pred EccCCcCc
Confidence 99998653
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=97.79 E-value=4.5e-06 Score=92.00 Aligned_cols=83 Identities=25% Similarity=0.211 Sum_probs=74.8
Q ss_pred EEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCC----chhcccC-ccccccccCccCCCCCccccccc-----CC
Q 003114 391 SLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVP----EFLSKLQ-YLRVLNLTGNMLTGPLPAGLVER-----SK 460 (846)
Q Consensus 391 ~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP----~~~~~l~-~L~~L~Ls~N~l~g~iP~~~~~l-----~~ 460 (846)
.++|+.|+++|.+|..+...++|+.|+|++|+|++..+ ..|.+++ +|+.|+|++|+|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 47899999999999999999999999999999997777 7888999 89999999999998888888886 99
Q ss_pred CCCCCCccccCCC
Q 003114 461 NGSLSLSVDLCSS 473 (846)
Q Consensus 461 l~~l~l~~nlc~~ 473 (846)
|+.|+++.|....
T Consensus 82 L~~L~Ls~n~l~~ 94 (362)
T 3goz_A 82 VTSLNLSGNFLSY 94 (362)
T ss_dssp CCEEECCSSCGGG
T ss_pred ccEEECcCCcCCh
Confidence 9999999986653
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=97.75 E-value=1.1e-05 Score=95.50 Aligned_cols=73 Identities=29% Similarity=0.311 Sum_probs=65.6
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNG 462 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~ 462 (846)
..++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..|.++++|+.|+|++|.|+|.+|..+..++...
T Consensus 239 ~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~~~~ 311 (622)
T 3g06_A 239 LPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAP 311 (622)
T ss_dssp CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHHHST
T ss_pred CCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhccccc
Confidence 3468999999999999 6887 7899999999999999 8999999999999999999999999999888776543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.70 E-value=3.1e-06 Score=95.99 Aligned_cols=85 Identities=26% Similarity=0.244 Sum_probs=65.1
Q ss_pred CceEEEEcCCCCCccc----CCccccCCCCCCeEeccCCCCCCCCCchhcc-----cCccccccccCccCCC----CCcc
Q 003114 387 PRITSLNLSSRGLTGG----IPPYLSNLTMIEHLDLSNNSLTGPVPEFLSK-----LQYLRVLNLTGNMLTG----PLPA 453 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~----ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~-----l~~L~~L~Ls~N~l~g----~iP~ 453 (846)
++++.|+|++|++++. ++..+..+++|+.|+|++|++++..+..+.. +++|+.|+|++|++++ .+|.
T Consensus 313 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 392 (461)
T 1z7x_W 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 392 (461)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred ccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHH
Confidence 4788888888888865 5666777888888888888887655555543 5688888888888886 7788
Q ss_pred cccccCCCCCCCCccccC
Q 003114 454 GLVERSKNGSLSLSVDLC 471 (846)
Q Consensus 454 ~~~~l~~l~~l~l~~nlc 471 (846)
.+..+++|+.|++++|..
T Consensus 393 ~l~~~~~L~~L~l~~N~i 410 (461)
T 1z7x_W 393 TLLANHSLRELDLSNNCL 410 (461)
T ss_dssp HHHHCCCCCEEECCSSSC
T ss_pred HHHhCCCccEEECCCCCC
Confidence 888888888888887744
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=97.64 E-value=1.7e-05 Score=86.88 Aligned_cols=84 Identities=15% Similarity=0.107 Sum_probs=70.2
Q ss_pred CCCceEEEEcCCCCCcccCCc-cccCCCCCCe-EeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPP-YLSNLTMIEH-LDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNG 462 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~-~~~~L~~L~~-L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~ 462 (846)
..++|+.|+|++|++.+.+|. .|.+|++|+. +.+++|+|++..|+.|.+|++|+.|++++|+|++..+..+....++.
T Consensus 52 ~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~ 131 (350)
T 4ay9_X 52 GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKV 131 (350)
T ss_dssp TCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCE
T ss_pred CCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhh
Confidence 456899999999999888886 5899999875 67788999988889999999999999999999976666666666666
Q ss_pred CCCCcc
Q 003114 463 SLSLSV 468 (846)
Q Consensus 463 ~l~l~~ 468 (846)
.+++..
T Consensus 132 ~l~l~~ 137 (350)
T 4ay9_X 132 LLDIQD 137 (350)
T ss_dssp EEEEES
T ss_pred hhhhcc
Confidence 666654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00016 Score=78.21 Aligned_cols=138 Identities=14% Similarity=0.249 Sum_probs=79.5
Q ss_pred hcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccc--cceeEee------EeecCCeeeEeeecc
Q 003114 542 ILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHK--NLTTLYG------YCNEGNQIGLIYEYM 613 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~Hp--nIv~l~g------~~~~~~~~~LV~Ey~ 613 (846)
.|+.|..+.||+....++ .+++|+.... ...+..|..+++.+... .+.+++. +....+..+++|||+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 356677889999987655 4889998752 13344556666655322 2233332 112456788999999
Q ss_pred cCCChh--------------hhhhcCC-----C-------CccChHHHH-------------------------------
Q 003114 614 ANGSLE--------------EYLSDSN-----A-------DVLSWEGRL------------------------------- 636 (846)
Q Consensus 614 ~~gsL~--------------~~l~~~~-----~-------~~l~~~~~~------------------------------- 636 (846)
+|..+. ..++... . ..-.|....
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 0111110 0 001222110
Q ss_pred HHHHHHHHHHHHHhc----------cCCCCeeecCCCCCCEEECCCCcEEEEeccCCc
Q 003114 637 RIATEAAQGLEYLHL----------GCKPPRVHRDIKPANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 637 ~i~~~ia~gL~yLH~----------~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~ 684 (846)
.+...+..++.+|+. .....++|||+++.||+++.++.+.|.||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123345566652 125789999999999999888899999999774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00018 Score=80.04 Aligned_cols=74 Identities=15% Similarity=0.229 Sum_probs=48.8
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc-------hhhHHHHHHHHHHHhccc--ccce-eEeeEeecCCeeeEe
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR-------QGYEQFEAEVILLRTVHH--KNLT-TLYGYCNEGNQIGLI 609 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-------~~~~~~~~Ei~~l~~l~H--pnIv-~l~g~~~~~~~~~LV 609 (846)
+.||.|.++.||++... +++.+++|...+... ...+.+..|.++++.+.. +..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999764 568899998754321 123456778888888743 4444 44443 23456899
Q ss_pred eecccCC
Q 003114 610 YEYMANG 616 (846)
Q Consensus 610 ~Ey~~~g 616 (846)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.52 E-value=8.8e-06 Score=90.18 Aligned_cols=86 Identities=27% Similarity=0.223 Sum_probs=63.6
Q ss_pred CceEEEEcCCCCCcc----cCCccccCCCCCCeEeccCCCCCCC----CCchhcccCccccccccCccCCCC----Cccc
Q 003114 387 PRITSLNLSSRGLTG----GIPPYLSNLTMIEHLDLSNNSLTGP----VPEFLSKLQYLRVLNLTGNMLTGP----LPAG 454 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g----~ip~~~~~L~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~Ls~N~l~g~----iP~~ 454 (846)
++|+.|+|++|+|+. .++..+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+.. ++..
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 368888888888874 3555567788888888888888742 456677778888888888888742 3445
Q ss_pred ccccCCCCCCCCccccCC
Q 003114 455 LVERSKNGSLSLSVDLCS 472 (846)
Q Consensus 455 ~~~l~~l~~l~l~~nlc~ 472 (846)
+...++|+.|+|+.|..+
T Consensus 235 L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 235 AREHPSLELLHLYFNELS 252 (372)
T ss_dssp HHHCSSCCEEECTTSSCC
T ss_pred HHhCCCCCEEeccCCCCC
Confidence 556788888888887554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.48 E-value=8.7e-06 Score=92.31 Aligned_cols=83 Identities=19% Similarity=0.199 Sum_probs=42.9
Q ss_pred CceEEEEcCCCCCccc----CCccccCCCCCCeEeccCCCCCCCCCchhccc-----CccccccccCccCCCC----Ccc
Q 003114 387 PRITSLNLSSRGLTGG----IPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKL-----QYLRVLNLTGNMLTGP----LPA 453 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~----ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l-----~~L~~L~Ls~N~l~g~----iP~ 453 (846)
++++.|+|++|++++. ++..+.++++|+.|+|++|.+++..+..+... ++|+.|+|++|++++. +|.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 3555555555555543 45555555555555555555544333333322 4555555555555543 344
Q ss_pred cccccCCCCCCCCccc
Q 003114 454 GLVERSKNGSLSLSVD 469 (846)
Q Consensus 454 ~~~~l~~l~~l~l~~n 469 (846)
.+..+++|+.|+++.|
T Consensus 336 ~l~~~~~L~~L~Ls~n 351 (461)
T 1z7x_W 336 VLAQNRFLLELQISNN 351 (461)
T ss_dssp HHHHCSSCCEEECCSS
T ss_pred HHhhCCCccEEEccCC
Confidence 4445555555555554
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00048 Score=73.04 Aligned_cols=74 Identities=20% Similarity=0.182 Sum_probs=54.5
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccc---cceeEeeEeecCCeeeEeeecccCCC
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHK---NLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~Hp---nIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
+.+|.|..+.||+.++.+|+.+++|+-..........+..|+..|+.+.-. -+.+++++. .-++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 358999999999999999999999987655444445688999999888422 234444442 2378999998764
Q ss_pred h
Q 003114 618 L 618 (846)
Q Consensus 618 L 618 (846)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.21 E-value=4e-05 Score=84.85 Aligned_cols=82 Identities=27% Similarity=0.205 Sum_probs=38.5
Q ss_pred ceEEEEcCCCCCcccCCccc-----cCCCCCCeEeccCCCCCC----CCCchhcccCccccccccCccCCCC----Cccc
Q 003114 388 RITSLNLSSRGLTGGIPPYL-----SNLTMIEHLDLSNNSLTG----PVPEFLSKLQYLRVLNLTGNMLTGP----LPAG 454 (846)
Q Consensus 388 ~l~~L~L~~n~l~g~ip~~~-----~~L~~L~~L~Ls~N~l~g----~iP~~~~~l~~L~~L~Ls~N~l~g~----iP~~ 454 (846)
+++.|+|++|+|+..-...| ...++|+.|+|++|+|+. .++..+..+++|+.|||++|+|+.. ++..
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~ 206 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQ 206 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence 34555555555543322222 123455555555555542 1333344455555555555555421 2333
Q ss_pred ccccCCCCCCCCccc
Q 003114 455 LVERSKNGSLSLSVD 469 (846)
Q Consensus 455 ~~~l~~l~~l~l~~n 469 (846)
+...++|+.|+|+.|
T Consensus 207 L~~~~~L~~L~Ls~N 221 (372)
T 3un9_A 207 LDRNRQLQELNVAYN 221 (372)
T ss_dssp GGGCSCCCEEECCSS
T ss_pred HhcCCCcCeEECCCC
Confidence 444455555555544
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.16 E-value=6e-05 Score=74.75 Aligned_cols=84 Identities=19% Similarity=0.304 Sum_probs=50.8
Q ss_pred CceEEEEcCCC-CCccc----CCccccCCCCCCeEeccCCCCCCC----CCchhcccCccccccccCccCCCC----Ccc
Q 003114 387 PRITSLNLSSR-GLTGG----IPPYLSNLTMIEHLDLSNNSLTGP----VPEFLSKLQYLRVLNLTGNMLTGP----LPA 453 (846)
Q Consensus 387 ~~l~~L~L~~n-~l~g~----ip~~~~~L~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~Ls~N~l~g~----iP~ 453 (846)
+.|+.|+|++| +|... +...+...++|+.|+|++|+|... +...+...++|+.|+|++|+|+.. +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 35667777777 66532 344455667777777777776532 334455556677777777777632 344
Q ss_pred cccccCCCCCCCC--cccc
Q 003114 454 GLVERSKNGSLSL--SVDL 470 (846)
Q Consensus 454 ~~~~l~~l~~l~l--~~nl 470 (846)
.+...++|+.|+| +.|.
T Consensus 116 ~L~~n~~L~~L~L~~~~N~ 134 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQP 134 (185)
T ss_dssp GGGGCSSCCEEECCCCSSC
T ss_pred HHHhCCCceEEEecCCCCC
Confidence 5556666777777 4443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0015 Score=70.28 Aligned_cols=135 Identities=21% Similarity=0.191 Sum_probs=89.6
Q ss_pred hcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhccc---ccceeEeeEeecCCeeeEeeecccCCCh
Q 003114 542 ILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH---KNLTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~H---pnIv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
.|+.|....+|+... ++..+++|+.... ....+..|...|+.+.. ..+.+++.++...+..++||||+++..+
T Consensus 43 ~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 43 KLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 588999999999876 4678889987533 24668899999988842 4577888888877889999999998765
Q ss_pred hh-----------hhhcCCC-C-------------------ccChHHHH---HHHH----------------HHHHH-HH
Q 003114 619 EE-----------YLSDSNA-D-------------------VLSWEGRL---RIAT----------------EAAQG-LE 647 (846)
Q Consensus 619 ~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~~----------------~ia~g-L~ 647 (846)
.. .|+.... . .-+|.... ++.. .++.. ..
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 21 1222111 0 01343221 1111 11111 12
Q ss_pred HHh-ccCCCCeeecCCCCCCEEECCCCcEEEEecc
Q 003114 648 YLH-LGCKPPRVHRDIKPANILLNDQFQARLADFG 681 (846)
Q Consensus 648 yLH-~~~~~~IiHrDlKp~NILld~~~~vkI~DFG 681 (846)
.|. ....+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 332 12356799999999999999887 8888874
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.09 E-value=5.2e-05 Score=75.19 Aligned_cols=85 Identities=12% Similarity=0.131 Sum_probs=68.0
Q ss_pred CceEEEEcCCCCCccc----CCccccCCCCCCeEeccCCCCCCC----CCchhcccCccccccc--cCccCCCC----Cc
Q 003114 387 PRITSLNLSSRGLTGG----IPPYLSNLTMIEHLDLSNNSLTGP----VPEFLSKLQYLRVLNL--TGNMLTGP----LP 452 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~----ip~~~~~L~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~L--s~N~l~g~----iP 452 (846)
..|+.|+|++|+|... +...+...++|++|+|++|+|+.. +...+...++|+.|+| ++|.|+.. +.
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~ 144 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 144 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHH
Confidence 4799999999999743 455567778999999999999854 5677888899999999 88999854 33
Q ss_pred ccccccCCCCCCCCccccC
Q 003114 453 AGLVERSKNGSLSLSVDLC 471 (846)
Q Consensus 453 ~~~~~l~~l~~l~l~~nlc 471 (846)
..+...++|+.|+++.|..
T Consensus 145 ~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 145 NMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp HHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCCCcCEEeccCCCC
Confidence 4555668899999987744
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0024 Score=71.64 Aligned_cols=77 Identities=10% Similarity=0.073 Sum_probs=47.4
Q ss_pred CCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccccc--CCCcccCccccccC---CCCchhhHHHHHHHH
Q 003114 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVA--GTFGYLDPEYCQTF---RLTEKSDVYSFGVVL 728 (846)
Q Consensus 654 ~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~--gt~~Y~APE~~~~~---~~s~ksDVwS~Gvvl 728 (846)
...++|||+++.||++++++ +++.||+.+..-+. ........ -...|.+|+..... ......++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p---~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM---GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECH---HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCch---HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 67899999999999999876 99999998864211 00000000 01235666654321 112235566777778
Q ss_pred HHHHhC
Q 003114 729 LEIITS 734 (846)
Q Consensus 729 ~ELltG 734 (846)
|+.+++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877765
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=96.87 E-value=9.2e-05 Score=86.69 Aligned_cols=87 Identities=16% Similarity=0.141 Sum_probs=64.4
Q ss_pred CceEEEEcCCC--CCcccCCccccC-CCCCCeEeccCCCCCC-CCCchhcccCccccccccCccCCCC-CcccccccCCC
Q 003114 387 PRITSLNLSSR--GLTGGIPPYLSN-LTMIEHLDLSNNSLTG-PVPEFLSKLQYLRVLNLTGNMLTGP-LPAGLVERSKN 461 (846)
Q Consensus 387 ~~l~~L~L~~n--~l~g~ip~~~~~-L~~L~~L~Ls~N~l~g-~iP~~~~~l~~L~~L~Ls~N~l~g~-iP~~~~~l~~l 461 (846)
++|+.|+|+.+ .+++..+..++. +++|+.|+|++|++++ .+|..+.++++|+.|+|++|.|++. ++..+..+++|
T Consensus 436 ~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L 515 (592)
T 3ogk_B 436 KKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSL 515 (592)
T ss_dssp TTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSC
T ss_pred CCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCcc
Confidence 46888888743 377666666654 7888888888888876 4566667888899999999888755 34445678888
Q ss_pred CCCCCccccCCC
Q 003114 462 GSLSLSVDLCSS 473 (846)
Q Consensus 462 ~~l~l~~nlc~~ 473 (846)
+.|++++|....
T Consensus 516 ~~L~ls~n~it~ 527 (592)
T 3ogk_B 516 RYLWVQGYRASM 527 (592)
T ss_dssp CEEEEESCBCCT
T ss_pred CeeECcCCcCCH
Confidence 888888876543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=96.83 E-value=9.8e-05 Score=86.47 Aligned_cols=81 Identities=9% Similarity=0.065 Sum_probs=65.3
Q ss_pred CceEEEEcCCCCCccc----CCccccCCCCCCeEeccCCCCC----CCCCchhcccCccccccccCccCCCCCccccccc
Q 003114 387 PRITSLNLSSRGLTGG----IPPYLSNLTMIEHLDLSNNSLT----GPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVER 458 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~----ip~~~~~L~~L~~L~Ls~N~l~----g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l 458 (846)
++|+.|+|++|.+++. ++..+.++++|+.|+|++|.++ +.++..+.++++|+.|+|++|.+++ +|..+..+
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhh
Confidence 5788999999988766 5556678889999999999987 3455566788899999999998885 78888888
Q ss_pred CCCCCCCCcc
Q 003114 459 SKNGSLSLSV 468 (846)
Q Consensus 459 ~~l~~l~l~~ 468 (846)
++|+.|+++.
T Consensus 243 ~~L~~L~l~~ 252 (592)
T 3ogk_B 243 ANLEEFCGGS 252 (592)
T ss_dssp TTCCEEEECB
T ss_pred hHHHhhcccc
Confidence 8888888764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=96.68 E-value=0.00068 Score=73.31 Aligned_cols=83 Identities=17% Similarity=0.108 Sum_probs=62.7
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccc-cccccCccCCCCCcccccccCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLR-VLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~-~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.+|+.|+|++|+++..-+..|.+|++|+.|+|++| ++..-+..|.+|++|+ .|+|.+ +++..-+..|.++++|+.++
T Consensus 226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 37888899988888433446888989999999887 7744457788888898 888888 67633346788888888888
Q ss_pred CccccC
Q 003114 466 LSVDLC 471 (846)
Q Consensus 466 l~~nlc 471 (846)
++.|..
T Consensus 304 l~~n~i 309 (329)
T 3sb4_A 304 ATGDKI 309 (329)
T ss_dssp ECSSCC
T ss_pred eCCCcc
Confidence 866543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0021 Score=59.72 Aligned_cols=56 Identities=30% Similarity=0.408 Sum_probs=44.2
Q ss_pred EEEcCCCCCc-ccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCC
Q 003114 391 SLNLSSRGLT-GGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448 (846)
Q Consensus 391 ~L~L~~n~l~-g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~ 448 (846)
.++.++++|+ ..+|..|. ++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 6777888886 46775432 46889999999999655677889999999999999875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0034 Score=70.62 Aligned_cols=72 Identities=18% Similarity=0.353 Sum_probs=49.6
Q ss_pred hhcCcCceEEEEEEEEcC--------CcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccc-eeEeeEeecCCeeeEeee
Q 003114 541 TILGEGSFGKVYHGYLDD--------NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNL-TTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~LV~E 611 (846)
+.|+.|....+|+....+ +..+++|+...... ...+..|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 357888889999998753 57899999854211 1445578888888864444 456666543 38999
Q ss_pred cccCCCh
Q 003114 612 YMANGSL 618 (846)
Q Consensus 612 y~~~gsL 618 (846)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0045 Score=65.87 Aligned_cols=70 Identities=9% Similarity=0.149 Sum_probs=44.5
Q ss_pred hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccce-eEeeEeecCCeeeEeeecc-cCCCh
Q 003114 541 TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLT-TLYGYCNEGNQIGLIYEYM-ANGSL 618 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~LV~Ey~-~~gsL 618 (846)
+.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++. ++++++. +.-++|+||+ ++.+|
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCccC
Confidence 45788999999998 56888988654222 12346788888877544444 4555433 3347899999 55444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.59 E-value=0.008 Score=64.38 Aligned_cols=140 Identities=12% Similarity=0.135 Sum_probs=79.0
Q ss_pred hcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccc--eeEeeE------eecCCeeeEeeecc
Q 003114 542 ILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNL--TTLYGY------CNEGNQIGLIYEYM 613 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnI--v~l~g~------~~~~~~~~LV~Ey~ 613 (846)
.|+.|....+|+....++ .+++|+..... ....+..|+.+++.+...++ .+++.. ....+..+++++|+
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 466788889999987666 68899887531 22356677877777743232 223321 11235678999999
Q ss_pred cCCChhh--------------hhhcC----CCC------ccChHHHHH------------HHHHHHHHHHHHhc----cC
Q 003114 614 ANGSLEE--------------YLSDS----NAD------VLSWEGRLR------------IATEAAQGLEYLHL----GC 653 (846)
Q Consensus 614 ~~gsL~~--------------~l~~~----~~~------~l~~~~~~~------------i~~~ia~gL~yLH~----~~ 653 (846)
+|..+.. .++.. ... ...|..... +...+...++.++. ..
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8865421 01111 000 012322110 01113344455542 12
Q ss_pred CCCeeecCCCCCCEEECCCCcEEEEeccCCc
Q 003114 654 KPPRVHRDIKPANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 654 ~~~IiHrDlKp~NILld~~~~vkI~DFGla~ 684 (846)
...++|+|+++.|||++++..+.|.||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 4569999999999999987666899998775
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.54 E-value=0.011 Score=63.67 Aligned_cols=139 Identities=15% Similarity=0.113 Sum_probs=72.8
Q ss_pred hcCcCceEE-EEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhccccc--ceeEeeEeecCCeeeEeeecccCCCh
Q 003114 542 ILGEGSFGK-VYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKN--LTTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 542 ~LG~G~fG~-Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
.|+.|.... +|+....++..+++|....... ..+..|+.+++.+.... +.+++.+....+ +++||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 355555544 6676654467777776544321 33456777777764323 445666644433 689999977666
Q ss_pred hhhhhcCC---------------------C---CccChHHHH-------H-------------HHHHHHHHHHHHh---c
Q 003114 619 EEYLSDSN---------------------A---DVLSWEGRL-------R-------------IATEAAQGLEYLH---L 651 (846)
Q Consensus 619 ~~~l~~~~---------------------~---~~l~~~~~~-------~-------------i~~~ia~gL~yLH---~ 651 (846)
.+.+.... . ..++..... . ....+...+..+. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 54432110 0 001111000 0 0001111222221 1
Q ss_pred cCCCCeeecCCCCCCEEECCC----CcEEEEeccCCcc
Q 003114 652 GCKPPRVHRDIKPANILLNDQ----FQARLADFGLSKT 685 (846)
Q Consensus 652 ~~~~~IiHrDlKp~NILld~~----~~vkI~DFGla~~ 685 (846)
.....++|||+.+.||+++.+ ..+.|.||+.+..
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 125679999999999999875 6899999998864
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.00017 Score=84.37 Aligned_cols=82 Identities=18% Similarity=0.106 Sum_probs=52.5
Q ss_pred CceEEEEcCCCCCcccCCccccC-CCCCCeEeccCCCCCCCCCchh-cccCccccccccCccCCCCCcc-cccccCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSN-LTMIEHLDLSNNSLTGPVPEFL-SKLQYLRVLNLTGNMLTGPLPA-GLVERSKNGS 463 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~-L~~L~~L~Ls~N~l~g~iP~~~-~~l~~L~~L~Ls~N~l~g~iP~-~~~~l~~l~~ 463 (846)
++|+.|+|++ ++++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+.
T Consensus 432 ~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~ 510 (594)
T 2p1m_B 432 KDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRS 510 (594)
T ss_dssp TTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSE
T ss_pred CCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCE
Confidence 3677777765 666655555655 7777777777777765544444 5577777777777777544333 2334677777
Q ss_pred CCCccc
Q 003114 464 LSLSVD 469 (846)
Q Consensus 464 l~l~~n 469 (846)
|++++|
T Consensus 511 L~l~~~ 516 (594)
T 2p1m_B 511 LWMSSC 516 (594)
T ss_dssp EEEESS
T ss_pred EeeeCC
Confidence 777655
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.31 E-value=0.00039 Score=81.29 Aligned_cols=82 Identities=15% Similarity=0.112 Sum_probs=46.0
Q ss_pred ceEEEEcCCCCCcccCCcccc-CCCCCCeEeccCC-CCCCC-CCchhcccCccccccccCccCCCCCccccc----ccCC
Q 003114 388 RITSLNLSSRGLTGGIPPYLS-NLTMIEHLDLSNN-SLTGP-VPEFLSKLQYLRVLNLTGNMLTGPLPAGLV----ERSK 460 (846)
Q Consensus 388 ~l~~L~L~~n~l~g~ip~~~~-~L~~L~~L~Ls~N-~l~g~-iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~----~l~~ 460 (846)
+|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+.++++|+.|+|++|.+++..+..+. .+++
T Consensus 106 ~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~ 185 (594)
T 2p1m_B 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTS 185 (594)
T ss_dssp TCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCC
T ss_pred CCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCc
Confidence 566666666666665555554 4666666666666 34321 344444566666666666666554444333 3345
Q ss_pred CCCCCCccc
Q 003114 461 NGSLSLSVD 469 (846)
Q Consensus 461 l~~l~l~~n 469 (846)
|+.|+++.|
T Consensus 186 L~~L~l~~~ 194 (594)
T 2p1m_B 186 LVSLNISCL 194 (594)
T ss_dssp CCEEECTTC
T ss_pred CcEEEeccc
Confidence 666665544
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.27 E-value=0.004 Score=57.77 Aligned_cols=56 Identities=23% Similarity=0.279 Sum_probs=43.4
Q ss_pred CCCCCc--eEEeecCCC--------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCC
Q 003114 369 PQAFLW--NGLGCSYND--------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLT 424 (846)
Q Consensus 369 ~~~~~w--~gv~C~~~~--------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~ 424 (846)
|..|.. .-|.|+..+ +.+.+++.|+|++|+|+..-+..|..|++|+.|+|++|.+.
T Consensus 3 P~~C~C~~~~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 3 PAPCSCAGTLVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp CTTCEEETTEEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCCEEcCCEEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 444444 458888753 34568999999999999544556899999999999999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.26 E-value=0.016 Score=62.17 Aligned_cols=139 Identities=15% Similarity=0.192 Sum_probs=80.1
Q ss_pred cCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhccccc--ceeEeeE-----eecCCeeeEeeecccC
Q 003114 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKN--LTTLYGY-----CNEGNQIGLIYEYMAN 615 (846)
Q Consensus 543 LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~-----~~~~~~~~LV~Ey~~~ 615 (846)
++ |....||+....+|+.+++|+...... ....+..|..+++.+.... +.+++.. ...++..++++|+++|
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 55 777899998877787899999874321 2356677888888775322 3334432 1124456789999987
Q ss_pred CChhh-----------h---hhc----CC---CCccChHHH----------------------HHHHHHHHHHHHHHhc-
Q 003114 616 GSLEE-----------Y---LSD----SN---ADVLSWEGR----------------------LRIATEAAQGLEYLHL- 651 (846)
Q Consensus 616 gsL~~-----------~---l~~----~~---~~~l~~~~~----------------------~~i~~~ia~gL~yLH~- 651 (846)
..+.. . ++. .. ....++... ...+..++..++-+..
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 54321 0 111 00 011221110 0111122222222211
Q ss_pred cCCCCeeecCCCCCCEEECCCCcEEEEeccCCcc
Q 003114 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685 (846)
Q Consensus 652 ~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~ 685 (846)
.....++|||+++.||+++ + .+.|.||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1245689999999999999 4 899999987753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.12 E-value=0.0089 Score=65.56 Aligned_cols=72 Identities=17% Similarity=0.199 Sum_probs=44.6
Q ss_pred hcCcCceEEEEEEEEcC---------CcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccce-eEeeEeecCCeeeEeee
Q 003114 542 ILGEGSFGKVYHGYLDD---------NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLT-TLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~~---------g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~LV~E 611 (846)
.|+.|....+|+....+ +..+++|+...... .......|..+++.+...+++ ++++... -++|||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEEE
Confidence 46778888999998754 26788888765322 122346788888888644544 5555442 268999
Q ss_pred cccCCCh
Q 003114 612 YMANGSL 618 (846)
Q Consensus 612 y~~~gsL 618 (846)
|++|..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.06 E-value=0.019 Score=65.11 Aligned_cols=73 Identities=18% Similarity=0.255 Sum_probs=47.9
Q ss_pred hhcCcCceEEEEEEEEcC-CcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccc-eeEeeEeecCCeeeEeeecccCCCh
Q 003114 541 TILGEGSFGKVYHGYLDD-NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNL-TTLYGYCNEGNQIGLIYEYMANGSL 618 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~LV~Ey~~~gsL 618 (846)
+.|+.|-...+|+....+ +..+++|+....... .-...+|..+++.+...++ .++++.+.. .+|+||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 357888889999998865 578889987543221 1223688888888865555 456666632 359999987544
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=96.02 E-value=0.0031 Score=68.08 Aligned_cols=78 Identities=17% Similarity=0.052 Sum_probs=65.0
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCC-eEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIE-HLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~-~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
..+|+.|+|++| ++..-+..|.+|++|+ .|+|.+ +++..-+.+|.+|++|+.|+|++|+++..-+..|.++++|+.+
T Consensus 249 ~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 249 KKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred CCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence 358999999998 7744445699999999 999999 8885556899999999999999999994445578888888876
Q ss_pred C
Q 003114 465 S 465 (846)
Q Consensus 465 ~ 465 (846)
+
T Consensus 327 y 327 (329)
T 3sb4_A 327 Y 327 (329)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.97 E-value=0.012 Score=65.07 Aligned_cols=138 Identities=20% Similarity=0.287 Sum_probs=80.9
Q ss_pred hcCcCceEEEEEEEEc--------CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccc-eeEeeEeecCCeeeEeeec
Q 003114 542 ILGEGSFGKVYHGYLD--------DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNL-TTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnI-v~l~g~~~~~~~~~LV~Ey 612 (846)
.|..|-...+|+.... ++..+++|+..... .......+|..+++.+...++ .++++++.+ .+|+||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 4666778889998874 24789999864322 234566789999988854333 456666654 299999
Q ss_pred ccCCChhhh-----------------hhcCC---CCcc--ChHHHHHHHHHHHH-------------------HHHHHh-
Q 003114 613 MANGSLEEY-----------------LSDSN---ADVL--SWEGRLRIATEAAQ-------------------GLEYLH- 650 (846)
Q Consensus 613 ~~~gsL~~~-----------------l~~~~---~~~l--~~~~~~~i~~~ia~-------------------gL~yLH- 650 (846)
++|.+|..- |+... .+.. -|.+..++..++.. .+..|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 987654311 11111 1111 23444444433321 223332
Q ss_pred ---c-cCCCCeeecCCCCCCEEECCC----CcEEEEeccCCc
Q 003114 651 ---L-GCKPPRVHRDIKPANILLNDQ----FQARLADFGLSK 684 (846)
Q Consensus 651 ---~-~~~~~IiHrDlKp~NILld~~----~~vkI~DFGla~ 684 (846)
. .....++|+|+.+.||+++++ +.+.++||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 1 124569999999999999876 789999998875
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.93 E-value=0.0012 Score=64.70 Aligned_cols=83 Identities=16% Similarity=0.081 Sum_probs=61.8
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCC-CCCCCCchhccc----CccccccccCcc-CCCCCcccccccC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNS-LTGPVPEFLSKL----QYLRVLNLTGNM-LTGPLPAGLVERS 459 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~-l~g~iP~~~~~l----~~L~~L~Ls~N~-l~g~iP~~~~~l~ 459 (846)
..+|+.|||+++.++..--..+..+++|+.|+|+++. |+..-=..++.+ ++|+.|+|+++. +|..==..+..++
T Consensus 60 ~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~ 139 (176)
T 3e4g_A 60 KYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR 139 (176)
T ss_dssp CCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred CceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence 3579999999999886555568899999999999996 764322345554 479999999975 7632223466788
Q ss_pred CCCCCCCcc
Q 003114 460 KNGSLSLSV 468 (846)
Q Consensus 460 ~l~~l~l~~ 468 (846)
+|+.|+++.
T Consensus 140 ~L~~L~L~~ 148 (176)
T 3e4g_A 140 NLKYLFLSD 148 (176)
T ss_dssp TCCEEEEES
T ss_pred CCCEEECCC
Confidence 888888874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.65 E-value=0.055 Score=54.39 Aligned_cols=167 Identities=16% Similarity=0.069 Sum_probs=91.5
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.++|+..+. ++++.+++.++.|.+.+|.-+-. +..-..+=+.|..|++..+|.+...+ +.+.
T Consensus 34 SL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred cHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence 89999987654 59999999999999999877621 11111223346889999999988764 1110
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC-CccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIA-NTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~-~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
.....+.|||... ...+.+.=|||+|+++|.-+--..|-+ ...-...+...+..+-.........|......-..+
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~ 174 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGL 174 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHHTTCCC----------------
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHHHhccccccccccccccccccc
Confidence 1122356888764 356789999999999999886544432 222333444545444333221122233222000000
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
.-+ .. ...+..|++.++|++.=+.-+.
T Consensus 175 ~d~------~~--~~~~~~~~sl~~Vi~~C~~hl~ 201 (229)
T 2yle_A 175 GDE------DE--KRKISAIRSYRDVMKLCAAHLP 201 (229)
T ss_dssp ----------C--CSCCCCCCSHHHHHHHHHTTSS
T ss_pred ccc------cc--cccccCcCCHHHHHHHHHhhcc
Confidence 000 00 3467899999999887766554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=95.53 E-value=0.0021 Score=70.64 Aligned_cols=61 Identities=13% Similarity=0.195 Sum_probs=39.5
Q ss_pred CCCCCCeEeccCCCCCCCCCchhc---ccCccccccccCccCCCC----CcccccccCCCCCCCCccc
Q 003114 409 NLTMIEHLDLSNNSLTGPVPEFLS---KLQYLRVLNLTGNMLTGP----LPAGLVERSKNGSLSLSVD 469 (846)
Q Consensus 409 ~L~~L~~L~Ls~N~l~g~iP~~~~---~l~~L~~L~Ls~N~l~g~----iP~~~~~l~~l~~l~l~~n 469 (846)
.+++|+.|+|++|.+.+..+..+. .+++|+.|+|+.|+|++. ++..+..+++|+.|+++.|
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n 317 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSB
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCC
Confidence 467777777777777654443343 466777777777777653 4445556677777777655
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=95.50 E-value=0.0017 Score=71.33 Aligned_cols=65 Identities=20% Similarity=0.303 Sum_probs=54.2
Q ss_pred CCCceEEEEcCCCCCcccCCcccc---CCCCCCeEeccCCCCCCC----CCchhcccCccccccccCccCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLS---NLTMIEHLDLSNNSLTGP----VPEFLSKLQYLRVLNLTGNMLTG 449 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~---~L~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~Ls~N~l~g 449 (846)
..++|+.|+|.+|.+.+..+..+. .+++|+.|+|+.|+|++. ++..+.++++|+.|+|++|.|+.
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 457999999999999876655544 588999999999999863 56666788999999999999873
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.12 E-value=0.053 Score=58.74 Aligned_cols=68 Identities=12% Similarity=0.123 Sum_probs=43.7
Q ss_pred CcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhccc---ccceeEeeE------eecCCeeeEeeeccc
Q 003114 544 GEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH---KNLTTLYGY------CNEGNQIGLIYEYMA 614 (846)
Q Consensus 544 G~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~H---pnIv~l~g~------~~~~~~~~LV~Ey~~ 614 (846)
|.|....||+....+| .+++|+...... ..|+.+++.+.. |.+.+.+.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444678999988777 899998765432 355666665532 223444432 233567899999999
Q ss_pred CCCh
Q 003114 615 NGSL 618 (846)
Q Consensus 615 ~gsL 618 (846)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8755
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=93.08 E-value=0.014 Score=58.15 Aligned_cols=82 Identities=20% Similarity=0.257 Sum_probs=52.6
Q ss_pred CceEEEEcCCC-CCcc----cCCccccCCCCCCeEeccCCCCCC----CCCchhcccCccccccccCccCCCC----Ccc
Q 003114 387 PRITSLNLSSR-GLTG----GIPPYLSNLTMIEHLDLSNNSLTG----PVPEFLSKLQYLRVLNLTGNMLTGP----LPA 453 (846)
Q Consensus 387 ~~l~~L~L~~n-~l~g----~ip~~~~~L~~L~~L~Ls~N~l~g----~iP~~~~~l~~L~~L~Ls~N~l~g~----iP~ 453 (846)
+.|+.|+|++| +|.. .|-..+..=+.|+.|+|++|+|.. .|-+.+..-+.|+.|+|++|+|+.. |-+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 36778888875 6652 244456666788888888888862 2344555567788888888888632 122
Q ss_pred cccccCCCCCCCCcc
Q 003114 454 GLVERSKNGSLSLSV 468 (846)
Q Consensus 454 ~~~~l~~l~~l~l~~ 468 (846)
.+.....|+.|+|++
T Consensus 121 aL~~N~tL~~L~L~n 135 (197)
T 1pgv_A 121 STLVTQSIVEFKADN 135 (197)
T ss_dssp HTTTTCCCSEEECCC
T ss_pred HHhhCCceeEEECCC
Confidence 344455677777764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.52 E-value=0.42 Score=53.35 Aligned_cols=72 Identities=11% Similarity=0.195 Sum_probs=47.8
Q ss_pred hcCcCceEEEEEEEEcC--------CcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccce-eEeeEeecCCeeeEeeec
Q 003114 542 ILGEGSFGKVYHGYLDD--------NTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLT-TLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~LV~Ey 612 (846)
.+..|-...+|+....+ +..+++|+...... ......+|..+++.+...+++ ++++.+. -++|+||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 46678888999998763 57899998654332 223346788888888544443 4454432 2789999
Q ss_pred ccCCCh
Q 003114 613 MANGSL 618 (846)
Q Consensus 613 ~~~gsL 618 (846)
++|..|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=91.42 E-value=0.15 Score=56.63 Aligned_cols=77 Identities=13% Similarity=0.176 Sum_probs=53.7
Q ss_pred ceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCC-chhcccCccccccccCccCCCCC-cccccccCCCCCCC
Q 003114 388 RITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVP-EFLSKLQYLRVLNLTGNMLTGPL-PAGLVERSKNGSLS 465 (846)
Q Consensus 388 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP-~~~~~l~~L~~L~Ls~N~l~g~i-P~~~~~l~~l~~l~ 465 (846)
+|+.|.|.+ +++..-+..|.+|++|+.|+|++|+++ .|| ..|. +.+|+.+.|.+| ++ .| ...|.++++|+.+.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~-~~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~ 232 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFV-YAGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIE 232 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTT-TCCCSEEECCTT-CC-EECTTTTTTCTTCCCEE
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEe-ecccCEEEeCCc-hh-eehhhHhhCCCCCCEEe
Confidence 577788875 666444456888888888888888888 444 4444 578888888744 65 34 34566777888887
Q ss_pred Cccc
Q 003114 466 LSVD 469 (846)
Q Consensus 466 l~~n 469 (846)
+..|
T Consensus 233 l~~~ 236 (401)
T 4fdw_A 233 IPEN 236 (401)
T ss_dssp CCTT
T ss_pred cCCC
Confidence 7655
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=91.13 E-value=0.11 Score=57.60 Aligned_cols=16 Identities=19% Similarity=0.391 Sum_probs=9.4
Q ss_pred eeecCC---CCCcceeeec
Q 003114 61 NLRSFP---EGKRNCYNVK 76 (846)
Q Consensus 61 ~lr~fp---~~~~~cy~l~ 76 (846)
||-.++ .-.|.||.+-
T Consensus 22 ~~~~~~~~~~~~~~~y~~g 40 (401)
T 4fdw_A 22 SLEDFSIEQLPAKTIYALG 40 (401)
T ss_dssp CEEEEEEEECCSCCEEETT
T ss_pred eEEEEEeecCCceeEEecC
Confidence 555454 2257788874
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=90.24 E-value=0.038 Score=54.93 Aligned_cols=83 Identities=12% Similarity=0.131 Sum_probs=59.1
Q ss_pred CceEEEEcCCCCCccc----CCccccCCCCCCeEeccCCCCCCC----CCchhcccCccccccccCcc---CCC----CC
Q 003114 387 PRITSLNLSSRGLTGG----IPPYLSNLTMIEHLDLSNNSLTGP----VPEFLSKLQYLRVLNLTGNM---LTG----PL 451 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~----ip~~~~~L~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~Ls~N~---l~g----~i 451 (846)
..|+.|+|++|+|... |...+..=+.|+.|+|++|+|... |-+.+..-+.|+.|+|++|. +.. .|
T Consensus 70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~i 149 (197)
T 1pgv_A 70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 149 (197)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHH
Confidence 4799999999999833 333455668999999999999843 33445556789999999763 331 13
Q ss_pred cccccccCCCCCCCCccc
Q 003114 452 PAGLVERSKNGSLSLSVD 469 (846)
Q Consensus 452 P~~~~~l~~l~~l~l~~n 469 (846)
-+.+...+.|..|+++.|
T Consensus 150 a~aL~~N~tL~~L~l~~~ 167 (197)
T 1pgv_A 150 MMAIEENESLLRVGISFA 167 (197)
T ss_dssp HHHHHHCSSCCEEECCCC
T ss_pred HHHHHhCCCcCeEeccCC
Confidence 345666777888877654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.13 E-value=1.2 Score=49.20 Aligned_cols=30 Identities=33% Similarity=0.421 Sum_probs=25.0
Q ss_pred CeeecCCCCCCEEE------CCCCcEEEEeccCCcc
Q 003114 656 PRVHRDIKPANILL------NDQFQARLADFGLSKT 685 (846)
Q Consensus 656 ~IiHrDlKp~NILl------d~~~~vkI~DFGla~~ 685 (846)
.++|+|+.+.|||+ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999988753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=84.26 E-value=0.62 Score=51.13 Aligned_cols=79 Identities=11% Similarity=0.017 Sum_probs=52.6
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCc-ccccccCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLP-AGLVERSKNGSLS 465 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP-~~~~~l~~l~~l~ 465 (846)
.+|+.+.|.++ ++..-...|.++++|+.++|.++ ++-.=..+|.+|++|+.++|..| ++ .|+ .+|.++.+|+.+.
T Consensus 297 ~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~ 372 (394)
T 4fs7_A 297 SSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVE 372 (394)
T ss_dssp TTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEE
T ss_pred ccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEE
Confidence 46777777654 55233345888888888888644 66333467888888888888766 55 443 4577777887777
Q ss_pred Cccc
Q 003114 466 LSVD 469 (846)
Q Consensus 466 l~~n 469 (846)
+..+
T Consensus 373 lp~~ 376 (394)
T 4fs7_A 373 LPKR 376 (394)
T ss_dssp EEGG
T ss_pred ECCC
Confidence 6544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=83.99 E-value=0.99 Score=49.02 Aligned_cols=79 Identities=11% Similarity=0.135 Sum_probs=54.7
Q ss_pred ceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCc-ccccccCCCCCCCC
Q 003114 388 RITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLP-AGLVERSKNGSLSL 466 (846)
Q Consensus 388 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP-~~~~~l~~l~~l~l 466 (846)
.++.+.+..+ ++..-...|.++++|+.+.|.+|.++-.-+..|.++.+|+.++|..| ++ .|+ .+|.++.+|+.+.+
T Consensus 264 ~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 264 ALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISY 340 (379)
T ss_dssp TCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCC
T ss_pred hhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEE
Confidence 5667777543 55233345888888888888888887444567888888888888754 55 454 35777788888877
Q ss_pred ccc
Q 003114 467 SVD 469 (846)
Q Consensus 467 ~~n 469 (846)
..+
T Consensus 341 p~~ 343 (379)
T 4h09_A 341 PKS 343 (379)
T ss_dssp CTT
T ss_pred CCc
Confidence 544
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=80.08 E-value=0.25 Score=47.99 Aligned_cols=68 Identities=12% Similarity=0.104 Sum_probs=45.9
Q ss_pred cCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCcc-CCCCCccccccc----CCCCCCCCccc
Q 003114 402 GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNM-LTGPLPAGLVER----SKNGSLSLSVD 469 (846)
Q Consensus 402 ~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~-l~g~iP~~~~~l----~~l~~l~l~~n 469 (846)
.+|.....--+|+.|||+++.++..==..+.+|++|+.|+|+++. ++..-=..+..+ ++|+.|+++.+
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C 124 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISC 124 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESC
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCC
Confidence 345443233479999999999875433557899999999999985 663222234443 36888888753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 846 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 8e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 7e-67
Identities = 71/274 (25%), Positives = 121/274 (44%), Gaps = 21/274 (7%)
Query: 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTL 596
+G GSFG VY G +VAVKML+ + + Q + F+ EV +LR H N+
Sbjct: 12 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP 656
GY Q+ ++ ++ SL +L + IA + AQG++YLH
Sbjct: 70 MGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKS 124
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFR-- 714
+HRD+K NI L++ ++ DFGL+ SH ++G+ ++ PE +
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 715 -LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773
+ +SDVY+FG+VL E++T + +N I V + + P L +
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------RGYLSPDLS-KVR 235
Query: 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807
N + C+ RP +++ ++
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 7e-62
Identities = 70/294 (23%), Positives = 120/294 (40%), Gaps = 29/294 (9%)
Query: 543 LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE 602
+G+G FG+V+ G EVAVK+ S + EAE+ + H+N+ N+
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNK 68
Query: 603 GN----QIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC----- 653
N Q+ L+ +Y +GSL +YL+ ++ EG +++A A GL +LH+
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG--VSHLSTGVAGTFGYLDPEYCQ 711
KP HRD+K NIL+ +AD GL+ + GT Y+ PE
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 712 T------FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKH------ISQWVDFMLAQGD 759
F +++D+Y+ G+V EI E+++ S + +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 760 IKNIVDPKLHGDIDVNSAWKAV-EIAMGCVSHSSTPRPNMNRVVMELKECLAME 812
+ + P + A + + +I C + R R+ L + E
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 3e-61
Identities = 74/273 (27%), Positives = 126/273 (46%), Gaps = 21/273 (7%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLT 594
+ + LG G FG+V+ GY + +T+VAVK L S + F AE L++ + H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK 654
LY + I +I EYM NGSL ++L + L+ L +A + A+G+ ++ +
Sbjct: 72 RLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFR 714
+HRD++ ANIL++D ++ADFGL++ + G + PE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 715 LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774
T KSDV+SFG++L EI+T + + Q ++ +V P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE------RGYRMVRPD------- 233
Query: 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807
N + ++ C RP + + L++
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-59
Identities = 64/275 (23%), Positives = 119/275 (43%), Gaps = 21/275 (7%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLT 594
++ + +G G FG V+ GY + +VA+K + + E F E ++ + H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK 654
LYG C E I L++E+M +G L +Y + + + E L + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYL---EE 119
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFR 714
+HRD+ N L+ + +++DFG+++ + STG + PE R
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 715 LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774
+ KSDV+SFGV++ E+ + + + + + + P+L
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------TGFRLYKPRLAST--- 229
Query: 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809
+I C RP +R++ +L E
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 6e-58
Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 21/273 (7%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLT 594
D + LG G FG V +G +VA+KM+ S ++F E ++ + H+ L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 595 TLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK 654
LYG C + I +I EYMANG L YL + + L + + + +EYL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---S 118
Query: 655 PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFR 714
+HRD+ N L+NDQ +++DFGLS+ + S G + PE +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 715 LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774
+ KSD+++FGV++ EI + + ++ + + P L +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA------QGLRLYRPHLASE--- 228
Query: 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807
K I C + RP ++ + +
Sbjct: 229 ----KVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (499), Expect = 2e-57
Identities = 67/273 (24%), Positives = 114/273 (41%), Gaps = 19/273 (6%)
Query: 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTL 596
+ LG G +G+VY G + VAVK L + + E+F E +++ + H NL L
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQL 78
Query: 597 YGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP 656
G C +I E+M G+L +YL + N +S L +AT+ + +EYL K
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKN 135
Query: 657 RVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLT 716
+HRD+ N L+ + ++ADFGLS+ G + PE + +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 717 EKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776
KSDV++FGV+L EI T + + + +++ +
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------VYELLEKDYRMERPEGC 241
Query: 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809
K E+ C + + RP+ + +
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-57
Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 12/226 (5%)
Query: 536 TNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGY-EQFEAEVILLRTVHHK 591
+DFE I LG G+ G V+ +A K++ + Q E+ +L +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHL 651
+ YG +I + E+M GSL++ L + + + +++ +GL YL
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR- 121
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQ 711
K +HRD+KP+NIL+N + + +L DFG+S ++ GT Y+ PE Q
Sbjct: 122 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 176
Query: 712 TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ 757
+ +SD++S G+ L+E+ R I + + + +
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (495), Expect = 9e-57
Identities = 69/304 (22%), Positives = 125/304 (41%), Gaps = 40/304 (13%)
Query: 527 FTYAEITKITNDF-----------ETILGEGSFGKVYHGYLDDNTE----VAVKMLSPS- 570
FT+ + + +F E ++G G FG+V G+L + VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 571 SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVL 630
+ + F +E ++ H N+ L G + + +I E+M NGSL+ + N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-LRQNDGQF 125
Query: 631 SWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690
+ + + A G++YL VHRD+ NIL+N +++DFGLS+ +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 691 VSHLST---GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT--SRPAIANTEEHK 745
T G + PE Q + T SDV+S+G+V+ E+++ RP T +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-- 240
Query: 746 HISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805
D+ N ++ ++ ++ + C RP ++V L
Sbjct: 241 -------------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 806 KECL 809
+ +
Sbjct: 288 DKMI 291
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-56
Identities = 67/272 (24%), Positives = 114/272 (41%), Gaps = 19/272 (6%)
Query: 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYG 598
E LG+G FG+V+ G + T VA+K L P + E F E +++ + H+ L LY
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 599 YCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRV 658
I ++ EYM+ GSL ++L L + +A + A G+ Y+ + V
Sbjct: 80 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 135
Query: 659 HRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEK 718
HRD++ ANIL+ + ++ADFGL++ + G + PE R T K
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 719 SDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAW 778
SDV+SFG++L E+ T ++ ++ + V+
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNR-------------EVLDQVERGYRMPCPPECPE 241
Query: 779 KAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810
++ C RP + L++
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (493), Expect = 2e-56
Identities = 77/304 (25%), Positives = 120/304 (39%), Gaps = 47/304 (15%)
Query: 537 NDFETI--LGEGSFGKVYHGYL------DDNTEVAVKMLSPSSRQGYE-QFEAEVILLRT 587
N+ E + +GEG+FG+V+ + T VAVKML + + F+ E L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 588 VHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL----------------------SDS 625
+ N+ L G C G + L++EYMA G L E+L S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 626 NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685
LS +L IA + A G+ YL + VHRD+ N L+ + ++ADFGLS+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 686 FPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK 745
A ++ PE R T +SDV+++GVVL EI + H+
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 746 HISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMEL 805
+ I + D + N + + C S RP+ + L
Sbjct: 250 EV------------IYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
Query: 806 KECL 809
+
Sbjct: 297 QRMC 300
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 4e-56
Identities = 56/285 (19%), Positives = 114/285 (40%), Gaps = 23/285 (8%)
Query: 540 ETILGEGSFGKVYHGYL---DDNTEVAVKMLSPSSRQG-YEQFEAEVILLRTVHHKNLTT 595
+ LG G+FG V G +VA+K+L + + E+ E ++ + + +
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKP 655
L G C + + L+ E G L ++L + + + + + G++YL +
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE---EK 128
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTF-PIEGVSHLSTGVAGTFGYLDPEYCQTFR 714
VHRD+ N+LL ++ A+++DFGLSK + + + PE +
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 715 LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774
+ +SDV+S+GV + E ++ + + + I+ + +
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---------IEQGKRMECPPECP- 238
Query: 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARKEGH 819
+ + C + RP+ V ++ C ++ EGH
Sbjct: 239 ---PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 1e-55
Identities = 64/272 (23%), Positives = 114/272 (41%), Gaps = 28/272 (10%)
Query: 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTT 595
F+ +G GSF VY G + EVA L ++ ++F+ E +L+ + H N+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 596 LYGYC----NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHL 651
Y I L+ E M +G+L+ YL V+ + + +GL++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT 130
Query: 652 GCKPPRVHRDIKPANILLNDQ-FQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
PP +HRD+K NI + ++ D GL+ + + V GT ++ PE
Sbjct: 131 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEMY 185
Query: 711 QTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770
+ + E DVY+FG+ +LE+ TS + + I + +
Sbjct: 186 EE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------------YRRVTSGVKPA 232
Query: 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVV 802
D + + EI GC+ + R ++ ++
Sbjct: 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 1e-55
Identities = 65/286 (22%), Positives = 122/286 (42%), Gaps = 24/286 (8%)
Query: 538 DFETILGEGSFGKVYHGYLDDNTE-----VAVKMLSPSSRQGY-EQFEAEVILLRTVHHK 591
+ ++G G FG+VY G L ++ VA+K L + F E ++ H
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHL 651
N+ L G ++ + +I EYM NG+L+++L + + S + + A G++YL
Sbjct: 70 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA- 127
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG-VSHLSTGVAGTFGYLDPEYC 710
VHRD+ NIL+N +++DFGLS+ + ++ ++G + PE
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 711 QTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770
+ T SDV+SFG+V+ E++T + L+ ++ ++
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGE-------------RPYWELSNHEVMKAINDGFRL 232
Query: 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARK 816
++ ++ M C RP +V L + + + K
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-55
Identities = 71/331 (21%), Positives = 122/331 (36%), Gaps = 49/331 (14%)
Query: 507 IYWRHKRLRKDGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYL------DDNT 560
+Y +L D E + R + F LG G+FGKV D
Sbjct: 5 VYIDPTQLPYDHKWEFPRNRLS----------FGKTLGAGAFGKVVEATAYGLIKSDAAM 54
Query: 561 EVAVKMLSPSSRQGY-EQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEYMANGSL 618
VAVKML PS+ E +E+ +L + +H N+ L G C G +I EY G L
Sbjct: 55 TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 114
Query: 619 EEYL----------------SDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDI 662
+L + + L E L + + A+G+ +L +HRD+
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDL 171
Query: 663 KPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVY 722
NILL ++ DFGL++ + + ++ PE T +SDV+
Sbjct: 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 723 SFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVE 782
S+G+ L E+ + + M ++ ++ + +
Sbjct: 232 SYGIFLWELFSLGSS------------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD 279
Query: 783 IAMGCVSHSSTPRPNMNRVVMELKECLAMET 813
I C RP ++V +++ ++ T
Sbjct: 280 IMKTCWDADPLKRPTFKQIVQLIEKQISEST 310
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 8e-55
Identities = 66/279 (23%), Positives = 115/279 (41%), Gaps = 27/279 (9%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLT 594
+ + + +G+G FG V G +VAVK + + + F AE ++ + H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 595 TLYGYC-NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC 653
L G E + ++ EYMA GSL +YL VL + L+ + + + +EYL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF 713
VHRD+ N+L+++ A+++DFGL+K S + PE +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREK 175
Query: 714 RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773
+ + KSDV+SFG++L EI + K + ++
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---------VEKGYKMDAPDGCP 226
Query: 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812
E+ C + RP+ ++ +L+ E
Sbjct: 227 ----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 9e-54
Identities = 71/334 (21%), Positives = 125/334 (37%), Gaps = 55/334 (16%)
Query: 513 RLRKDGSLETKKRRFTYAEITKITND-----------FETILGEGSFGKVYHGYL----- 556
+L+ + + Y + + D F +LG G+FGKV +
Sbjct: 4 QLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISK 63
Query: 557 -DDNTEVAVKMLSPSSRQGY-EQFEAEV-ILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613
+ +VAVKML + E +E+ ++ + H+N+ L G C I LI+EY
Sbjct: 64 TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYC 123
Query: 614 ANGSLEEYL---------------------SDSNADVLSWEGRLRIATEAAQGLEYLHLG 652
G L YL + + +VL++E L A + A+G+E+L
Sbjct: 124 CYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE-- 181
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
VHRD+ N+L+ ++ DFGL++ + + ++ PE
Sbjct: 182 -FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 240
Query: 713 FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772
T KSDV+S+G++L EI + + + ++ D
Sbjct: 241 GIYTIKSDVWSYGILLWEIFSLG------------VNPYPGIPVDANFYKLIQNGFKMDQ 288
Query: 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806
+ + I C + S RP+ + L
Sbjct: 289 PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 2e-53
Identities = 69/288 (23%), Positives = 125/288 (43%), Gaps = 25/288 (8%)
Query: 531 EITKITNDFETILGEGSFGKVYHGYLDDN----TEVAVKMLSPSSRQG-YEQFEAEVILL 585
+ + F ++G G FG VYHG L DN AVK L+ + G QF E I++
Sbjct: 23 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82
Query: 586 RTVHHKNLTTLYGYCNEG-NQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ 644
+ H N+ +L G C ++ YM +G L ++ + + + + + + A+
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAK 141
Query: 645 GLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS--HLSTGVAGTF 702
G+ VHRD+ N +L+++F ++ADFGL++ + H TG
Sbjct: 142 GM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
Query: 703 GYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKN 762
++ E QT + T KSDV+SFGV+L E++T I+ ++ +
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGRR 252
Query: 763 IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810
++ P+ E+ + C + RP+ + +V + +
Sbjct: 253 LLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-53
Identities = 61/276 (22%), Positives = 110/276 (39%), Gaps = 27/276 (9%)
Query: 538 DFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKN 592
D+E + +G GS+G+ D + K L S + +EV LLR + H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 593 LTTLYGYCNE--GNQIGLIYEYMANGSLEEYLSDSNAD--VLSWEGRLRIATEAAQGLEY 648
+ Y + + ++ EY G L ++ + L E LR+ T+ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 649 LHL--GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
H +HRD+KPAN+ L+ + +L DFGL++ + + + GT Y+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYMS 182
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDP 766
PE EKSD++S G +L E+ P + + + I+
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK----------IREGKFR 232
Query: 767 KLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVV 802
++ + EI ++ RP++ ++
Sbjct: 233 RIPYRYSD----ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 6e-53
Identities = 59/270 (21%), Positives = 109/270 (40%), Gaps = 22/270 (8%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGY-EQFEAEVILLRTVHHKN 592
D++ + LGEG++G+V VAVK++ E + E+ + + ++H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG 652
+ YG+ EGN L EY + G L + + + R + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH-- 120
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
HRDIKP N+LL+++ +++DFGL+ F L + GT Y+ PE +
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 713 FRL-TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771
E DV+S G+VL ++ + + + K + +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------------YSDWKEKKTYLN 227
Query: 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRV 801
+ + + + + R + +
Sbjct: 228 PWKKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-51
Identities = 59/273 (21%), Positives = 113/273 (41%), Gaps = 29/273 (10%)
Query: 543 LGEGSFGKVYHGYLDD---NTEVAVKMLSPSSRQGY--EQFEAEVILLRTVHHKNLTTLY 597
LG G+FG V GY VAVK+L + ++ AE +++ + + + +
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 598 GYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPR 657
G C + + L+ E G L +YL + + + + + + + G++YL +
Sbjct: 75 GICEAESWM-LVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE---ESNF 128
Query: 658 VHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL-STGVAGTFGYLDPEYCQTFRLT 716
VHRD+ N+LL Q A+++DFGLSK + + T + PE ++ +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 717 EKSDVYSFGVVLLEIIT--SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774
KSDV+SFGV++ E + +P ++ +++
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------------EVTAMLEKGERMGCPA 233
Query: 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKE 807
+ ++ C ++ RP V + L+
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 3e-51
Identities = 68/294 (23%), Positives = 126/294 (42%), Gaps = 40/294 (13%)
Query: 537 NDFE--TILGEGSFGKVYHGYLDDN---TEVAVKMLSP-SSRQGYEQFEAEV-ILLRTVH 589
ND + ++GEG+FG+V + + + A+K + +S+ + F E+ +L + H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 590 HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL--------------SDSNADVLSWEGR 635
H N+ L G C + L EY +G+L ++L ++S A LS +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 636 LRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695
L A + A+G++YL + +HRD+ NIL+ + + A++ADFGLS+ V
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE---VYVKK 183
Query: 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFML 755
T ++ E T SDV+S+GV+L EI++
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------- 233
Query: 756 AQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809
++ + + +N + ++ C RP+ ++++ L L
Sbjct: 234 ---ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-51
Identities = 68/282 (24%), Positives = 104/282 (36%), Gaps = 27/282 (9%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNT----EVAVKMLSP---SSRQGYEQFEAEVILLRT 587
D + LG+GSFG V G D + VAVK L P S + + F EV + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 588 VHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLE 647
+ H+NL LYG + ++ E GSL + L R A + A+G+
Sbjct: 68 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMG 125
Query: 648 YLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH-LSTGVAGTFGYLD 706
YL +HRD+ N+LL + ++ DFGL + P + + F +
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDP 766
PE +T + SD + FGV L E+ T I + I
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------------LHKIDKE 230
Query: 767 KLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808
+ + + C +H RP + L E
Sbjct: 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-51
Identities = 58/250 (23%), Positives = 102/250 (40%), Gaps = 22/250 (8%)
Query: 529 YAEITKITN---DFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEV 582
Y +T+ N +E I LG+G+FGKVY + + A K++ S + E + E+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 583 ILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEA 642
+L + H N+ L N + ++ E+ A G+++ + + L+ + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQT 119
Query: 643 AQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF 702
L YLH +HRD+K NIL +LADFG+S GT
Sbjct: 120 LDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTP 174
Query: 703 GYLDPEYCQTFRL-----TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ 757
++ PE K+DV+S G+ L+E+ P + + +A+
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL-----LKIAK 229
Query: 758 GDIKNIVDPK 767
+ + P
Sbjct: 230 SEPPTLAQPS 239
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 9e-51
Identities = 63/280 (22%), Positives = 112/280 (40%), Gaps = 26/280 (9%)
Query: 538 DFETI--LGEGSFGKVYHGYLDDNTE-----VAVKMLSPS-SRQGYEQFEAEVILLRTVH 589
+F+ I LG G+FG VY G E VA+K L + S + ++ E ++ +V
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 590 HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL 649
+ ++ L G C LI + M G L +Y + D + + L + A+G+ YL
Sbjct: 70 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 650 HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY 709
VHRD+ N+L+ ++ DFGL+K E + + G ++ E
Sbjct: 128 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 710 CQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769
T +SDV+S+GV + E++T + +I +I++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------EISSILEKGER 231
Query: 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809
I + C + RP +++E +
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-50
Identities = 65/283 (22%), Positives = 105/283 (37%), Gaps = 24/283 (8%)
Query: 538 DFETILGEGSFGKVYHGYLDDNTE----VAVKMLSPSSRQGY-EQFEAEVILLRTVHHKN 592
+ +GEG FG V+ G VA+K + E+F E + +R H +
Sbjct: 10 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG 652
+ L G E N + +I E G L + L + A + + L YL
Sbjct: 70 IVKLIGVITE-NPVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLE-- 125
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
VHRDI N+L++ +L DFGLS+ + + ++ ++ PE
Sbjct: 126 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINF 183
Query: 713 FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772
R T SDV+ FGV + EI+ Q V G I+N + +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHG---------VKPFQGVKNNDVIGRIENGERLPMPPNC 234
Query: 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETAR 815
+ C ++ + RP + +L L E A+
Sbjct: 235 PP----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 2e-50
Identities = 72/272 (26%), Positives = 112/272 (41%), Gaps = 30/272 (11%)
Query: 537 NDFETI--LGEGSFGKVYHGYL-DDNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHH 590
DFE LG+G FG VY +A+K+L + Q EV + + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
N+ LYGY ++ ++ LI EY G++ L + + TE A L Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 123
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
+HRDIKP N+LL + ++ADFG S P S T + GT YL PE
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMI 176
Query: 711 QTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770
+ EK D++S GV+ E + +P E + + + + + V
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQETYKRISRVEFTFPDFVTE---- 229
Query: 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVV 802
A ++ + H+ + RP + V+
Sbjct: 230 --------GARDLISRLLKHNPSQRPMLREVL 253
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (447), Expect = 5e-50
Identities = 60/273 (21%), Positives = 101/273 (36%), Gaps = 33/273 (12%)
Query: 539 FETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQG---YEQFEAEVILLRTVHHKN 592
F + +G GSFG VY + ++ VA+K +S S +Q ++ EV L+ + H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG 652
G + L+ EY + + L + A QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLH-- 132
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
+HRD+K NILL++ +L DFG + + GT ++ PE
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVILA 185
Query: 713 F---RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769
+ K DV+S G+ +E+ +P + N + + +AQ + +
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHIAQNESPALQSGHWS 240
Query: 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVV 802
C+ RP ++
Sbjct: 241 EY--------FRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-49
Identities = 63/291 (21%), Positives = 121/291 (41%), Gaps = 31/291 (10%)
Query: 512 KRLRKDGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPS 570
++LR S+ K+++T E +G+G+ G VY + EVA++ ++
Sbjct: 7 EKLRSIVSVGDPKKKYTRFEK----------IGQGASGTVYTAMDVATGQEVAIRQMNLQ 56
Query: 571 SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVL 630
+ E E++++R + N+ G+++ ++ EY+A GSL + ++++ D
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-- 114
Query: 631 SWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690
+ E Q LE+LH +HRDIK NILL +L DFG E
Sbjct: 115 -EGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 691 VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQW 750
+ + GT ++ PE K D++S G++ +E+I P N + +
Sbjct: 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL- 227
Query: 751 VDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRV 801
I P+L +++ ++ + C+ R + +
Sbjct: 228 ---------IATNGTPELQNPEKLSAIFR--DFLNRCLDMDVEKRGSAKEL 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 71/297 (23%), Positives = 124/297 (41%), Gaps = 40/297 (13%)
Query: 539 FETILGEGSFGKVYHGYL--------DDNTEVAVKMLSP-SSRQGYEQFEAEV-ILLRTV 588
LGEG+FG+V + T+VAVKML ++ + +E+ ++
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 589 HHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL--------------SDSNADVLSWEG 634
HKN+ L G C + + +I EY + G+L EYL S + + LS +
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 635 RLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694
+ A + A+G+EYL +HRD+ N+L+ + ++ADFGL++
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFM 754
+T ++ PE T +SDV+SFGV+L EI T + +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--------- 244
Query: 755 LAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811
++ ++ D N + + C + RP ++V +L +A+
Sbjct: 245 ----ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-47
Identities = 66/287 (22%), Positives = 119/287 (41%), Gaps = 31/287 (10%)
Query: 538 DFETILGEGSFGKVYHGYL------DDNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHH 590
LG+GSFG VY G + T VA+K ++ + S + +F E +++ +
Sbjct: 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYL--------SDSNADVLSWEGRLRIATEA 642
++ L G ++G +I E M G L+ YL ++ S +++A E
Sbjct: 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142
Query: 643 AQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTF 702
A G+ YL VHRD+ N ++ + F ++ DFG+++
Sbjct: 143 ADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 703 GYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKN 762
++ PE + T SDV+SFGVVL EI T ++ + ++
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------------LRF 247
Query: 763 IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809
+++ L D N E+ C ++ RP+ ++ +KE +
Sbjct: 248 VMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 6e-47
Identities = 49/203 (24%), Positives = 80/203 (39%), Gaps = 9/203 (4%)
Query: 538 DFETILGEGSFGKVYHGY-LDDNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNL 593
F ILGEGSF V L + E A+K+L E ++ + H
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 594 TTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGC 653
LY + ++ Y NG L +Y+ + A+ + L
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDET---CTRFYTAEIVSALEYLH 125
Query: 654 KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTF 713
+HRD+KP NILLN+ ++ DFG +K E + GT Y+ PE
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 714 RLTEKSDVYSFGVVLLEIITSRP 736
+ SD+++ G ++ +++ P
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLP 208
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 69/294 (23%), Positives = 113/294 (38%), Gaps = 38/294 (12%)
Query: 539 FETILGEGSFGKVYHGY------LDDNTEVAVKMLSPSSRQGYEQ--FEAEVILLRTVHH 590
LG G+FG+V VAVKML + + IL+ HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 591 KNLTTLYGYCNE-GNQIGLIYEYMANGSLEEYL--------------SDSNADVLSWEGR 635
N+ L G C + G + +I E+ G+L YL D D L+ E
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 636 LRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695
+ + + A+G+E+L +HRD+ NILL+++ ++ DFGL++ +
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFML 755
++ PE T +SDV+SFGV+L EI + + I + L
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKIDEEFCRRL 250
Query: 756 AQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809
+G D + + + + C + RP + +V L L
Sbjct: 251 KEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 163 bits (413), Expect = 7e-45
Identities = 47/207 (22%), Positives = 94/207 (45%), Gaps = 12/207 (5%)
Query: 535 ITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHK 591
+ + ++ LG G+FG V+ A K + E E+ + + H
Sbjct: 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 83
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHL 651
L L+ + N++ +IYE+M+ G L E ++D + + +S + + + +GL ++H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 652 GCKPPRVHRDIKPANILLNDQF--QARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY 709
VH D+KP NI+ + + +L DFGL+ + ++TG A + PE
Sbjct: 143 NNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEV 196
Query: 710 CQTFRLTEKSDVYSFGVVLLEIITSRP 736
+ + +D++S GV+ +++
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLS 223
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 160 bits (405), Expect = 1e-44
Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 16/230 (6%)
Query: 533 TKITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPS---SRQGYEQFEAEVILLR 586
+ +++ +E LG G +V+ L + +VAVK+L Y +F E
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 587 TVHHKNLTTLYGYC----NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEA 642
++H + +Y G ++ EY+ +L + + ++ + + + +A
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADA 120
Query: 643 AQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG-VAGT 701
Q L + + +HRD+KPANI+++ ++ DFG+++ G S T V GT
Sbjct: 121 CQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 702 FGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWV 751
YL PE + + +SDVYS G VL E++T P Q V
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 158 bits (400), Expect = 4e-43
Identities = 42/221 (19%), Positives = 97/221 (43%), Gaps = 12/221 (5%)
Query: 534 KITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH 590
+ + ++ + LG G+FG V+ K ++ + E+ ++ +HH
Sbjct: 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 85
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
L L+ + ++ LI E+++ G L + ++ + +S + +A +GL+++H
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMH 144
Query: 651 LGCKPPRVHRDIKPANILL--NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPE 708
+ VH DIKP NI+ ++ DFGL+ + + ++T T + PE
Sbjct: 145 ---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPE 198
Query: 709 YCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ 749
+ +D+++ GV+ +++ A ++ + +
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN 239
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 7e-43
Identities = 48/225 (21%), Positives = 94/225 (41%), Gaps = 9/225 (4%)
Query: 529 YAEITKITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQ-FEAEVIL 584
+ + I + ++ LG G+F +V VA+K ++ + +G E E E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 585 LRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ 644
L + H N+ L G + LI + ++ G L + + + + R+ +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLD 118
Query: 645 GLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGY 704
++YLH R + L++ + ++DFGLSK +E + + GT GY
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGY 175
Query: 705 LDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ 749
+ PE ++ D +S GV+ ++ P + + K Q
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ 220
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 4e-41
Identities = 35/197 (17%), Positives = 79/197 (40%), Gaps = 11/197 (5%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCN 601
LG G FG V+ K + + E+ +L H+N+ L+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 602 EGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRD 661
++ +I+E+++ + E + +++A L+ + + + L++LH H D
Sbjct: 72 SMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127
Query: 662 IKPANILL--NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKS 719
I+P NI+ ++ +FG ++ + Y PE Q ++ +
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 720 DVYSFGVVLLEIITSRP 736
D++S G ++ +++
Sbjct: 185 DMWSLGTLVYVLLSGIN 201
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 6e-41
Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 14/207 (6%)
Query: 537 NDFETI--LGEGSFGKVYHG-YLDDNTEVAVKMLSPSSRQGYEQFEA----EVILLRTVH 589
DF LG+GSFGKV+ + N A+K L + E + +L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 590 HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYL 649
H LT ++ + + EY+ G L ++ + A E GL++L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL 119
Query: 650 HLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY 709
V+RD+K NILL+ ++ADFG+ K + GT Y+ PE
Sbjct: 120 ---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEI 174
Query: 710 CQTFRLTEKSDVYSFGVVLLEIITSRP 736
+ D +SFGV+L E++ +
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 150 bits (379), Expect = 1e-40
Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 16/206 (7%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHH 590
DF+ + LG GSFG+V+ + A+K+L + E E ++L V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
+ ++G + QI +I +Y+ G L L S AA+ L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALE 118
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
++RD+KP NILL+ ++ DFG +K P ++ + GT Y+ PE
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVV 173
Query: 711 QTFRLTEKSDVYSFGVVLLEIITSRP 736
T + D +SFG+++ E++
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 148 bits (375), Expect = 1e-40
Identities = 58/225 (25%), Positives = 91/225 (40%), Gaps = 25/225 (11%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSS---------RQGYEQFEAEVILLRTVH-H 590
ILG G V E AVK++ + ++ E EV +LR V H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
N+ L L+++ M G L +YL++ LS + +I + + LH
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALH 127
Query: 651 LGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYC 710
K VHRD+KP NILL+D +L DFG S V GT YL PE
Sbjct: 128 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLREVCGTPSYLAPEII 181
Query: 711 QTFRL------TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ 749
+ ++ D++S GV++ ++ P + ++ +
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 226
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 150 bits (380), Expect = 2e-40
Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPS---SRQGYEQFEAEVI---LLRT 587
NDF +G G FG+VY D A+K L +QG E I L+ T
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 588 VHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLE 647
+ + + +++ I + M G L +LS A E GLE
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAEIILGLE 121
Query: 648 YLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDP 707
++H V+RD+KPANILL++ R++D GL+ F GT GY+ P
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAP 174
Query: 708 EYCQTFR-LTEKSDVYSFGVVLLEIITSR 735
E Q +D +S G +L +++
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 9e-40
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 14/215 (6%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQG-----YEQFEAEVILLRTVHHKNLTT 595
LGEG F VY + N VA+K + R E+ LL+ + H N+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 596 LYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKP 655
L + I L++++M N+ VL+ QGLEYLH +
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 656 PRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRL 715
+HRD+KP N+LL++ +LADFGL+K+F ++ T T Y PE R+
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARM 177
Query: 716 -TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ 749
D+++ G +L E++ P + + +++
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 212
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 5e-39
Identities = 59/271 (21%), Positives = 107/271 (39%), Gaps = 19/271 (7%)
Query: 534 KITNDFETI--LGEGSFGKVYHGY--LDDNTEVAVKMLSPSSRQG--YEQFEAEVILLR- 586
+ +E + +GEG++GKV+ + VA+K + + + EV +LR
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 587 --TVHHKNLTTLYGYCNEGNQIGLIYEYM----ANGSLEEYLSDSNADVLSWEGRLRIAT 640
T H N+ L+ C + + L YL + E +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 641 EAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAG 700
+ +GL++LH VHRD+KP NIL+ Q +LADFGL++ + + T V
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVV 177
Query: 701 TFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDI 760
T Y PE D++S G + E+ +P + + + + +D + G+
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHS 791
D L + + + +E + +
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDEL 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-38
Identities = 51/231 (22%), Positives = 99/231 (42%), Gaps = 18/231 (7%)
Query: 535 ITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGY-EQFEAEVILLRTVHH 590
+ + + +GEG++G V Y + VA+K +SP Q Y ++ E+ +L H
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADV-----LSWEGRLRIATEAAQG 645
+N+ + + Y+ + + + LS + + +G
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYL----VTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 646 LEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF-PIEGVSHLSTGVAGTFGY 704
L+Y+H +HRD+KP+N+LLN ++ DFGL++ P + T T Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 705 LDPEY-CQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFM 754
PE + T+ D++S G +L E++++RP ++ + +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 229
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (359), Expect = 3e-38
Identities = 51/287 (17%), Positives = 96/287 (33%), Gaps = 24/287 (8%)
Query: 534 KITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH 590
++ N + +G GSFG +Y G + EVA+K+ ++ Q E + + +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQG 61
Query: 591 KNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
+C ++ + SLE L + + S + L +A + +EY+H
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 651 LGCKPPRVHRDIKPANILLNDQ---FQARLADFGLSKTFPIEGVS-----HLSTGVAGTF 702
+HRD+KP N L+ + DFGL+K + + + GT
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 703 GYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKN 762
Y + + D+ S G VL+ + + K
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW-----QGLKAATKRQKYERISEKK 232
Query: 763 IVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809
+ P S + C S +P+ + + +
Sbjct: 233 MSTPIEVLCKGYPSEFA--TYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-38
Identities = 48/281 (17%), Positives = 91/281 (32%), Gaps = 32/281 (11%)
Query: 534 KITNDFETI---LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEV-ILLRTV 588
I +D++ LG G GKV + + A+KML + EV + R
Sbjct: 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRAS 62
Query: 589 HHKNLTTLYGYC----NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQ 644
++ + + ++ E + G L + D + I +
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 645 GLEYLHLGCKPPRVHRDIKPANILLNDQFQ---ARLADFGLSKTFPIEGVSHLSTGVAGT 701
++YLH HRD+KP N+L + +L DFG +K T
Sbjct: 123 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYT 176
Query: 702 FGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVD-FMLAQGDI 760
Y+ PE + + D++S GV++ ++ P + + Q +
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236
Query: 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRV 801
N ++ + + + T R +
Sbjct: 237 PNPEWSEVSEE--------VKMLIRNLLKTEPTQRMTITEF 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-37
Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 14/210 (6%)
Query: 534 KIT-NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPS---SRQGYEQFEAEVILLR 586
K+T NDF+ + LG+G+FGKV A+K+L ++ E +L+
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 587 TVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGL 646
H LT L +++ + EY G L +LS V + E R A+ +
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEE---RARFYGAEIV 115
Query: 647 EYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
L V+RDIK N++L+ ++ DFGL K +G GT YL
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLA 173
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
PE + D + GVV+ E++ R
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 5e-37
Identities = 48/217 (22%), Positives = 95/217 (43%), Gaps = 10/217 (4%)
Query: 538 DFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKN 592
+F+ + +GEG++G VY VA+K + + E+ LL+ ++H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG 652
+ L + N++ L++E++ + L++++ S + + QGL +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC--- 118
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
+HRD+KP N+L+N + +LADFGL++ F V + V +
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILLGC 177
Query: 713 FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ 749
+ D++S G + E++T R E + +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 7e-37
Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 19/213 (8%)
Query: 542 ILGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGY------EQFEAEVILLRTVH--HKN 592
+LG G FG VY G + DN VA+K + + + EV+LL+ V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG 652
+ L + + LI E L E + + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHC--- 126
Query: 653 CKPPRVHRDIKPANILLN-DQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQ 711
+HRDIK NIL++ ++ + +L DFG + T GT Y PE+ +
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIR 182
Query: 712 TFRL-TEKSDVYSFGVVLLEIITSRPAIANTEE 743
R + V+S G++L +++ + EE
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (347), Expect = 7e-37
Identities = 41/217 (18%), Positives = 87/217 (40%), Gaps = 10/217 (4%)
Query: 537 NDFETI--LGEGSFGKVYHGYLDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKN 592
+ + +GEG++G VY + A+K + E+ +L+ + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 593 LTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG 652
+ LY + ++ L++E++ + L + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCH-- 117
Query: 653 CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
+HRD+KP N+L+N + + ++ADFGL++ F I + + + +
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGS 175
Query: 713 FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ 749
+ + D++S G + E++ P E + +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 138 bits (347), Expect = 9e-37
Identities = 47/279 (16%), Positives = 92/279 (32%), Gaps = 26/279 (9%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYC 600
+GEGSFG ++ G L +N +VA+K R Q E + + + +Y +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 601 NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHR 660
EG L+ + + G E L D S + A + ++ +H + V+R
Sbjct: 71 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 125
Query: 661 DIKPANILLNDQFQ-----ARLADFGLSKTFPIEGVS-----HLSTGVAGTFGYLDPEYC 710
DIKP N L+ + DFG+ K + ++GT Y+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 711 QTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770
+ + D+ + G V + + + I
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSL-------PWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809
++ + + + + P+ + + + L
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 6e-35
Identities = 50/222 (22%), Positives = 83/222 (37%), Gaps = 18/222 (8%)
Query: 542 ILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYC 600
++G GSFG VY L D VA+K + R E+ ++R + H N+ L +
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFF 82
Query: 601 NEGNQ------IGLIYEYMANGSLEEYLSDSNAD-VLSWEGRLRIATEAAQGLEYLHLGC 653
+ + L+ +Y+ S A L + + L Y+H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--- 139
Query: 654 KPPRVHRDIKPANILLN-DQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQT 712
HRDIKP N+LL+ D +L DFG +K + + +
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGA 197
Query: 713 FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFM 754
T DV+S G VL E++ +P + + + +
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 6e-35
Identities = 49/234 (20%), Positives = 94/234 (40%), Gaps = 21/234 (8%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQG--YEQFEAEVILLRTVHHK 591
+ +E + +G+G+FG+V+ +VA+K + + + E+ +L+ + H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 592 NLTTLYGYCNEG--------NQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAA 643
N+ L C I L++++ + + LS R+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQ 124
Query: 644 QGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS--TGVAGT 701
L L+ + +HRD+K AN+L+ +LADFGL++ F + S + T T
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 702 FGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFM 754
Y PE R D++ G ++ E+ T P + E ++
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 7e-35
Identities = 51/228 (22%), Positives = 96/228 (42%), Gaps = 21/228 (9%)
Query: 535 ITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQG------YEQFEAEVILL 585
+ + ++T LG G F V + A K + + E E EV +L
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 586 RTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQG 645
+ + H N+ TL+ + LI E +A G L ++L++ + L+ E + G
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNG 125
Query: 646 LEYLHLGCKPPRVHRDIKPANILLNDQ----FQARLADFGLSKTFPIEGVSHLSTGVAGT 701
+ YLH H D+KP NI+L D+ + ++ DFGL+ + + GT
Sbjct: 126 VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGT 179
Query: 702 FGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ 749
++ PE L ++D++S GV+ +++ + + ++
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 227
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (337), Expect = 8e-35
Identities = 54/245 (22%), Positives = 98/245 (40%), Gaps = 16/245 (6%)
Query: 512 KRLRKDGSLETKKRRFTYAEITKITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLS 568
K + K+ T ++ T + F+ I LG GSFG+V + A+K+L
Sbjct: 16 KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 569 PS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDS 625
+ E E +L+ V+ L L + + + ++ EY+A G + +L
Sbjct: 76 KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 626 NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685
S A + EYLH ++RD+KP N+L++ Q ++ DFG +K
Sbjct: 136 GR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 686 FPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHK 745
+ + GT L PE + + D ++ GV++ E+ P + +
Sbjct: 191 VK-----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
Query: 746 HISQW 750
+
Sbjct: 246 IYEKI 250
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-33
Identities = 45/224 (20%), Positives = 89/224 (39%), Gaps = 18/224 (8%)
Query: 524 KRRFTYAEITKITNDFE------TILGEGSFGKVYHGY-LDDNTEVAVKMLSPS--SRQG 574
+ F E+TK + +G G++G V +VA+K L S
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 575 YEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDS--NADVLSW 632
++ E+ LL+ + H+N+ L + ++ + L
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE 120
Query: 633 EGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692
+ + + +GL Y+H +HRD+KP N+ +N+ + ++ DFGL++ S
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----S 173
Query: 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
++ V + R T+ D++S G ++ E+IT +
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 7e-33
Identities = 43/205 (20%), Positives = 86/205 (41%), Gaps = 11/205 (5%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHK 591
+E + +GEG++G V+ + + VA+K + E+ LL+ + HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHL 651
N+ L+ + ++ L++E+ + + S + + + Q L+ L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGF 116
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQ 711
+HRD+KP N+L+N + +LA+FGL++ F I S V +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFG 175
Query: 712 TFRLTEKSDVYSFGVVLLEIITSRP 736
+ D++S G + E+ +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (309), Expect = 2e-31
Identities = 46/237 (19%), Positives = 103/237 (43%), Gaps = 22/237 (9%)
Query: 537 NDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEV-ILLRTVHHKN 592
+D++ + LG G + +V+ + +N +V VK+L P + ++ + E+ IL N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 593 LTTLYGYCNE--GNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLH 650
+ TL + L++E++ N ++ L+ E + L+Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH 146
Query: 651 LGCKPPRVHRDIKPANILL-NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEY 709
+HRD+KP N+++ ++ + RL D+GL++ + + + PE
Sbjct: 147 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASRYFKGPEL 200
Query: 710 CQTFRL-TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765
+++ D++S G +L +I + + ++ + +L D+ + +D
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 7e-31
Identities = 49/226 (21%), Positives = 97/226 (42%), Gaps = 22/226 (9%)
Query: 535 ITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVH 589
+ ++ + +G G+ G V Y + VA+K LS ++ ++ E++L++ V+
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 590 HKNLTTLYGYC------NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAA 643
HKN+ +L E + L+ E M + + E + +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQML 129
Query: 644 QGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFG 703
G+++LH +HRD+KP+NI++ ++ DFGL++T G S + T T
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRY 183
Query: 704 YLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQ 749
Y PE E D++S G ++ E++ + + ++
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 9e-30
Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 19/213 (8%)
Query: 537 NDFETI--LGEGSFGKVYHGYL----DDNTEVAVKMLSPSS----RQGYEQFEAEVILLR 586
+FE + LG G++GKV+ D A+K+L ++ + E E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 587 TV-HHKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQG 645
+ L TL+ ++ LI +Y+ G L +LS + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEI 138
Query: 646 LEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYL 705
+ L K ++RDIK NILL+ L DFGLSK F + + + GT Y+
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIEYM 197
Query: 706 DPEYCQTFR--LTEKSDVYSFGVVLLEIITSRP 736
P+ + + D +S GV++ E++T
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-28
Identities = 45/224 (20%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 527 FTYAEITK----ITNDFETI--LGEGSFGKVYHGY-LDDNTEVAVKMLSPS--SRQGYEQ 577
F E+ K + ++ + +G G++G V + VAVK LS S ++
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 578 FEAEVILLRTVHHKNLTTLYGYCNEGNQIG-----LIYEYMANGSLEEYLSDSNADVLSW 632
E+ LL+ + H+N+ L + + ++ L + L+
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTD 120
Query: 633 EGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692
+ + + +GL+Y+H +HRD+KP+N+ +N+ + ++ DFGL++ E
Sbjct: 121 DHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
+++T + + D++S G ++ E++T R
Sbjct: 178 YVAT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (255), Expect = 4e-24
Identities = 45/210 (21%), Positives = 77/210 (36%), Gaps = 19/210 (9%)
Query: 543 LGEGSFGKVYHGY-LDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLT------- 594
LG G F V+ + +NT VA+K++ E E E+ LL+ V+ + T
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 595 ----TLYGYCNEGNQIGLIYEYMANGSLEEYLSD---SNADVLSWEGRLRIATEAAQGLE 647
L + N G+ + E L+ + +I+ + GL+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 648 YLHLGCKPPRVHRDIKPANILLN-DQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLD 706
Y+H + +H DIKP N+L+ L ++ T T Y
Sbjct: 140 YMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 707 PEYCQTFRLTEKSDVYSFGVVLLEIITSRP 736
PE +D++S ++ E+IT
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDF 227
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.4 bits (226), Expect = 1e-21
Identities = 27/155 (17%), Positives = 48/155 (30%), Gaps = 19/155 (12%)
Query: 542 ILGEGSFGKVYHGYLDDNTEVAVKMLSPSSR----------QGYEQFEAEVILLRTVHHK 591
++GEG V++ Y + E VK G F I +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 592 NLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHL 651
L L G + +Y + N L E + + E + + + +
Sbjct: 67 ALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120
Query: 652 GCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF 686
VH D+ N+L+++ + DF S
Sbjct: 121 --HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEV 152
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.6 bits (171), Expect = 1e-13
Identities = 26/129 (20%), Positives = 44/129 (34%), Gaps = 3/129 (2%)
Query: 327 NAIEFYLVQDFSQSETEQADVDAIMNIKSLYKRKDWQGDPCAPQAFLWNGLGCSYNDNDP 386
N + + F+ D+ M + +
Sbjct: 184 NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN- 445
+ L+L + + G +P L+ L + L++S N+L G +P+ LQ V N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302
Query: 446 MLTG-PLPA 453
L G PLPA
Sbjct: 303 CLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 4e-09
Identities = 31/110 (28%), Positives = 45/110 (40%), Gaps = 13/110 (11%)
Query: 346 DVDAIMNIKSLYKR----KDWQ--GDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGL 399
D A++ IK W D C W G+ C D R+ +L+LS L
Sbjct: 7 DKQALLQIKKDLGNPTTLSSWLPTTDCCNRT---WLGVLCD-TDTQTYRVNNLDLSGLNL 62
Query: 400 TGG--IPPYLSNLTMIEHLDLSNN-SLTGPVPEFLSKLQYLRVLNLTGNM 446
IP L+NL + L + +L GP+P ++KL L L +T
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.8 bits (125), Expect = 7e-08
Identities = 17/44 (38%), Positives = 28/44 (63%)
Query: 411 TMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAG 454
+ LDL NN + G +P+ L++L++L LN++ N L G +P G
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.4 bits (145), Expect = 4e-10
Identities = 17/79 (21%), Positives = 34/79 (43%), Gaps = 4/79 (5%)
Query: 374 WNGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSK 433
N L ++ +T L L ++ P +S+LT ++ L +NN ++ L+
Sbjct: 294 ENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLAN 349
Query: 434 LQYLRVLNLTGNMLTGPLP 452
L + L+ N ++ P
Sbjct: 350 LTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 55.0 bits (131), Expect = 2e-08
Identities = 13/59 (22%), Positives = 25/59 (42%), Gaps = 4/59 (6%)
Query: 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
++ L ++ ++ L+NLT I L +N ++ P L+ L + L L
Sbjct: 329 TKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 1e-04
Identities = 12/70 (17%), Positives = 22/70 (31%), Gaps = 4/70 (5%)
Query: 383 DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNL 442
D L +T + ++L + L + + + L L +N
Sbjct: 18 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINF 73
Query: 443 TGNMLTGPLP 452
+ N LT P
Sbjct: 74 SNNQLTDITP 83
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 21/79 (26%), Positives = 33/79 (41%), Gaps = 4/79 (5%)
Query: 374 WNGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSK 433
N + + L+L+ L L++LT + LDL+NN ++ P LS
Sbjct: 206 NNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSG 261
Query: 434 LQYLRVLNLTGNMLTGPLP 452
L L L L N ++ P
Sbjct: 262 LTKLTELKLGANQISNISP 280
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 5e-04
Identities = 19/59 (32%), Positives = 28/59 (47%), Gaps = 8/59 (13%)
Query: 385 DPPRITSLNLSSRGLTG--GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLN 441
D ++T+L G+ G+ YL+NLT ++ SNN LT P L L L +
Sbjct: 42 DLDQVTTLQADRLGIKSIDGVE-YLNNLT---QINFSNNQLTDITP--LKNLTKLVDIL 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 1e-07
Identities = 18/94 (19%), Positives = 32/94 (34%), Gaps = 6/94 (6%)
Query: 389 ITSLNLSSRGLT-GGIPPYLSNLTMIEHLDLSNNSLTG----PVPEFLSKLQYLRVLNLT 443
I SL++ L+ L L + + L + LT + L L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 444 GNMLTGPLPAGLVERSKNGSLSL-SVDLCSSYPC 476
N L +++ + S + + L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 17/92 (18%), Positives = 27/92 (29%), Gaps = 9/92 (9%)
Query: 379 CSYNDNDPPRITSLNLSSRGLTG----GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSK- 433
C + L L+ ++ + L + LDLSNN L L +
Sbjct: 361 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 420
Query: 434 ----LQYLRVLNLTGNMLTGPLPAGLVERSKN 461
L L L + + L K+
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKD 452
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 12/69 (17%), Positives = 22/69 (31%), Gaps = 9/69 (13%)
Query: 387 PRITSLNLSSRGLTG----GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKL-----QYL 437
+ + L GLT I L + L+L +N L + + +
Sbjct: 27 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKI 86
Query: 438 RVLNLTGNM 446
+ L+L
Sbjct: 87 QKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 6e-04
Identities = 14/75 (18%), Positives = 26/75 (34%), Gaps = 4/75 (5%)
Query: 398 GLTGGIPPYLSNLTMIEHLDLSNNSLTG----PVPEFLSKLQYLRVLNLTGNMLTGPLPA 453
G+ +++ L L++ ++ + L LR L+L+ N L
Sbjct: 356 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 415
Query: 454 GLVERSKNGSLSLSV 468
LVE + L
Sbjct: 416 QLVESVRQPGCLLEQ 430
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 13/63 (20%), Positives = 24/63 (38%), Gaps = 9/63 (14%)
Query: 387 PRITSLNLSSRGLTGGIPPYLS-----NLTMIEHLDLSNNSLTGPVPEFLSKLQ----YL 437
+ L+LS+ L L ++E L L + + + + L L+ L
Sbjct: 397 HSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
Query: 438 RVL 440
RV+
Sbjct: 457 RVI 459
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 51.2 bits (121), Expect = 2e-07
Identities = 20/82 (24%), Positives = 30/82 (36%), Gaps = 6/82 (7%)
Query: 374 WNGLGCSYN------DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPV 427
+ CS + PP L+L + +T NL + L L NN ++
Sbjct: 12 LRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 428 PEFLSKLQYLRVLNLTGNMLTG 449
P + L L L L+ N L
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKE 93
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 49.3 bits (116), Expect = 8e-07
Identities = 34/176 (19%), Positives = 55/176 (31%), Gaps = 13/176 (7%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG 449
+ S GL +P L LDL NN +T L+ L L L N ++
Sbjct: 13 RVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 450 PLPAGLVERSKNGSLSLSVDLCSSYP------CKENNKKKNNFVFPVIASFASLLVVTLA 503
P K L LS + P +E +N + F L + +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV- 128
Query: 504 ISAIYWRHKRLRKDGSLETKKRRFTYAEITKITNDFETILGEGSFGKVYHGYLDDN 559
+ L+ G + +I + T + +G + +LD N
Sbjct: 129 ---VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGN 181
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.2 bits (118), Expect = 5e-07
Identities = 22/96 (22%), Positives = 33/96 (34%), Gaps = 10/96 (10%)
Query: 362 WQGDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNN 421
P + + PP + LN+S+ L +P L E L S N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL---ERLIASFN 314
Query: 422 SLTGPVPEFLSKLQYLRVLNLTGNMLTG--PLPAGL 455
L VPE L+ L ++ N L +P +
Sbjct: 315 HLAE-VPELPQNLKQL---HVEYNPLREFPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.6 bits (106), Expect = 1e-05
Identities = 18/70 (25%), Positives = 27/70 (38%), Gaps = 10/70 (14%)
Query: 377 LGCSYN-----DNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFL 431
L S N PPR+ L S L +P NL + L + N L P+
Sbjct: 289 LNVSNNKLIELPALPPRLERLIASFNHLAE-VPELPQNL---KQLHVEYNPLRE-FPDIP 343
Query: 432 SKLQYLRVLN 441
++ LR+ +
Sbjct: 344 ESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 19/54 (35%), Positives = 26/54 (48%), Gaps = 5/54 (9%)
Query: 389 ITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNL 442
L L++ GL+ +P +L E L S NSLT +PE L+ L V N
Sbjct: 40 AHELELNNLGLSS-LPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNN 88
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 3e-06
Identities = 19/68 (27%), Positives = 22/68 (32%), Gaps = 5/68 (7%)
Query: 379 CSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLR 438
C + +N R LT +PP L T L LS N L L L
Sbjct: 4 CEVSKVA--SHLEVNCDKRNLTA-LPPDLPKDT--TILHLSENLLYTFSLATLMPYTRLT 58
Query: 439 VLNLTGNM 446
LNL
Sbjct: 59 QLNLDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 9e-04
Identities = 21/97 (21%), Positives = 31/97 (31%), Gaps = 3/97 (3%)
Query: 351 MNIKSLYKRKDWQGDPCAPQAFLWNGLGCSYNDNDPPR--ITSLNLSSRGLTGGIPPYLS 408
+ SL N L P + L+L++ LT L+
Sbjct: 110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN 169
Query: 409 NLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGN 445
L ++ L L NSL +P+ L L GN
Sbjct: 170 GLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 1e-05
Identities = 23/101 (22%), Positives = 42/101 (41%), Gaps = 8/101 (7%)
Query: 373 LWNGL---GCSYNDNDPPRITSLNLS----SRGLTGGIPPYLSNLTMIEHLDLSNNSLTG 425
LW L G + + + R+ S + R + ++H+DLSN+ +
Sbjct: 1 LWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60
Query: 426 -PVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465
+ LS+ L+ L+L G L+ P+ L + S L+
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 9e-05
Identities = 7/36 (19%), Positives = 12/36 (33%)
Query: 407 LSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNL 442
+ LD+S + L L+ LR +
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 11/66 (16%), Positives = 15/66 (22%), Gaps = 8/66 (12%)
Query: 386 PPRI-----TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVL 440
RI +T IP L L L S L +
Sbjct: 2 HHRICHCSNRVFLCQESKVTE-IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKI 58
Query: 441 NLTGNM 446
++ N
Sbjct: 59 EISQND 64
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (98), Expect = 1e-04
Identities = 9/74 (12%), Positives = 22/74 (29%), Gaps = 14/74 (18%)
Query: 366 PCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG 425
PC C + + + +GL +P + + + + L N ++
Sbjct: 1 PCPGA--------CVCYNEPK---VTTSCPQQGLQA-VPVGIPAAS--QRIFLHGNRISH 46
Query: 426 PVPEFLSKLQYLRV 439
+ L +
Sbjct: 47 VPAASFRACRNLTI 60
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.7 bits (92), Expect = 2e-04
Identities = 13/39 (33%), Positives = 17/39 (43%), Gaps = 1/39 (2%)
Query: 412 MIEHLDLSNNSLTG-PVPEFLSKLQYLRVLNLTGNMLTG 449
++ L L NN L + L L +LNL GN L
Sbjct: 66 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 3e-04
Identities = 14/39 (35%), Positives = 22/39 (56%), Gaps = 2/39 (5%)
Query: 392 LNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEF 430
L+L+ + LT + +L L ++ HLDLS+N L P
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPAL 39
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 16/106 (15%), Positives = 28/106 (26%), Gaps = 6/106 (5%)
Query: 349 AIMNIKSLYKRKDWQGDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGLTG-GIPPYL 407
+ + L + S+ + + LS+RG
Sbjct: 210 GLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSK 269
Query: 408 SNLTMIEHLDLSNNSLTGPVPEFL-----SKLQYLRVLNLTGNMLT 448
++ L L N + L K+ L L L GN +
Sbjct: 270 LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 0.001
Identities = 9/67 (13%), Positives = 23/67 (34%), Gaps = 8/67 (11%)
Query: 389 ITSLNLSSRGLTG----GIPPYLSNLTMIEHLDLSNNSLTGP----VPEFLSKLQYLRVL 440
I +L +T + L ++ + LS N++ + E ++ + L +
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 441 NLTGNML 447
+
Sbjct: 65 EFSDIFT 71
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 14/69 (20%), Positives = 28/69 (40%), Gaps = 4/69 (5%)
Query: 381 YNDNDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVL 440
++D+ NL + +T + + L I+ + +N+ + + L + L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKL 73
Query: 441 NLTGNMLTG 449
L GN LT
Sbjct: 74 FLNGNKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 13/41 (31%), Positives = 21/41 (51%), Gaps = 2/41 (4%)
Query: 404 PPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
L+ LT +++L LS N ++ L+ L+ L VL L
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 12/42 (28%), Positives = 21/42 (50%), Gaps = 3/42 (7%)
Query: 402 GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443
I P L++L + + L NN ++ P L+ L ++ LT
Sbjct: 187 DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 6e-04
Identities = 6/43 (13%), Positives = 14/43 (32%), Gaps = 1/43 (2%)
Query: 405 PYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNML 447
+N LDL + + + L ++ + N +
Sbjct: 12 AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI 53
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 8e-04
Identities = 15/108 (13%), Positives = 33/108 (30%), Gaps = 3/108 (2%)
Query: 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443
+ R L+L + I + L + +D S+N + + L+ L+ L +
Sbjct: 15 TNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVN 71
Query: 444 GNMLTGPLPAGLVERSKNGSLSLSVDLCSSYPCKENNKKKNNFVFPVI 491
N + L L+ + + + + I
Sbjct: 72 NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 119
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.001
Identities = 20/76 (26%), Positives = 28/76 (36%), Gaps = 2/76 (2%)
Query: 387 PRITSLNLSSRGLTG--GIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444
P + SLNLS+ L + + ++ L+LS N L K L L L G
Sbjct: 65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDG 124
Query: 445 NMLTGPLPAGLVERSK 460
N L+ S
Sbjct: 125 NSLSDTFRDQSTYISA 140
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.002
Identities = 25/112 (22%), Positives = 41/112 (36%), Gaps = 8/112 (7%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTG--PVPEFLSKLQYLRVLNLTGNML 447
LN S + N+ + L+LSNN L + + K L++LNL+GN L
Sbjct: 45 VVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNEL 103
Query: 448 TGPLPAGLVERSKNGSLSLSVDLCSSYPCKENNKKKNNFVFPVIASFASLLV 499
E K L L + + ++ ++ + F LL
Sbjct: 104 K-----SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLR 150
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.002
Identities = 18/106 (16%), Positives = 27/106 (25%), Gaps = 10/106 (9%)
Query: 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLS-NNSLTGPVPEFLSKLQYLRVLNLTGNMLT 448
+ L + G +L + L + L L L LR L + + L
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 449 GPL--------PAGLVERSKNGSLSLSVDLCSSYPCKENNKKKNNF 486
+ S N SLS +E N
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.7 bits (86), Expect = 0.003
Identities = 18/60 (30%), Positives = 27/60 (45%), Gaps = 8/60 (13%)
Query: 388 RITSLNLSSRGLTGGIPP------YLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLN 441
+ + L G IPP LS L +HL LS N++ LS ++ LR+L+
Sbjct: 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE--KISSLSGMENLRILS 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 14/37 (37%), Positives = 21/37 (56%), Gaps = 2/37 (5%)
Query: 404 PPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVL 440
L+NLT +E LD+S+N ++ L+KL L L
Sbjct: 165 LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 846 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.23 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.04 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 98.98 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.93 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.91 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 98.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.7 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.68 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.66 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.59 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.57 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.57 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.44 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.43 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.36 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.27 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.19 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.08 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.02 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.0 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 97.96 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.95 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 97.94 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.9 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.73 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.72 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.66 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 97.59 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.49 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.35 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 97.28 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.01 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.6 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.42 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.27 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.02 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 95.87 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.85 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 95.65 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 95.21 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.15 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 94.98 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 90.82 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 89.94 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=412.28 Aligned_cols=257 Identities=28% Similarity=0.482 Sum_probs=203.3
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||+|+||+||+|++++ .||||+++.. +....+.|.+|+.++++++|||||++++++.+ +..++||||+++
T Consensus 11 ~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~ 87 (276)
T d1uwha_ 11 TVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG 87 (276)
T ss_dssp CCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCE
T ss_pred EEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCC
Confidence 345789999999999998753 6999998754 34556789999999999999999999999865 568999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.+++..... .+++..++.++.|+++||+||| +++|+||||||+|||++.++.+||+|||+|+...........
T Consensus 88 g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 88 SSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp EEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred CCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 999999976543 4899999999999999999999 889999999999999999999999999999876544334444
Q ss_pred ccccCCCcccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 696 TGVAGTFGYLDPEYCQTF---RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~---~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
....||+.|+|||++.+. .++.++|||||||++|||+||+.||.+......+...+ ..+... +.+ ...
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~----~~~~~~----p~~-~~~ 234 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV----GRGYLS----PDL-SKV 234 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH----HHTSCC----CCG-GGS
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH----hcCCCC----Ccc-hhc
Confidence 567899999999998643 58999999999999999999999998765443333222 222111 111 011
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
..+....+.+++.+||+.+|++||||+||++.|+.+..
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 22344578899999999999999999999999988653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.4e-48 Score=415.38 Aligned_cols=269 Identities=23% Similarity=0.418 Sum_probs=208.3
Q ss_pred ccCHHHHHHHHhhh-----------hhhcCcCceEEEEEEEEc-CC---cEEEEEEeCCC-CchhhHHHHHHHHHHHhcc
Q 003114 526 RFTYAEITKITNDF-----------ETILGEGSFGKVYHGYLD-DN---TEVAVKMLSPS-SRQGYEQFEAEVILLRTVH 589 (846)
Q Consensus 526 ~~~~~el~~~t~~f-----------~~~LG~G~fG~Vykg~~~-~g---~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~ 589 (846)
.++|+++.+++.+| .+.||+|+||+||+|++. ++ ..||||++... .....++|.+|+++|++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 34566666666665 357999999999999975 23 35899998754 4445678999999999999
Q ss_pred cccceeEeeEeecCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE
Q 003114 590 HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL 669 (846)
Q Consensus 590 HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl 669 (846)
|||||+++|+|..++..++|||||++|+|.+++..... .++|.++++++.|+++||+||| +++|+||||||+|||+
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILV 161 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEE
Confidence 99999999999999999999999999999998876543 4899999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeccCCccCCCCCccc---ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccc
Q 003114 670 NDQFQARLADFGLSKTFPIEGVSH---LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHK 745 (846)
Q Consensus 670 d~~~~vkI~DFGla~~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~ 745 (846)
+.++.+||+|||+++.+....... ......||+.|+|||.+.+..++.++|||||||++|||+| |++||.+....+
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~ 241 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999998764332211 1223457999999999999999999999999999999998 899998655432
Q ss_pred cHHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 746 HISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 746 ~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
.+........ ...+.+....+.+|+.+||+.+|++||||+||++.|+++++..
T Consensus 242 ----~~~~i~~~~~----------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 242 ----VINAIEQDYR----------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp ----HHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ----HHHHHHcCCC----------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 2222222111 1122344567889999999999999999999999999987643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=406.81 Aligned_cols=253 Identities=26% Similarity=0.457 Sum_probs=199.8
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||+||+|++.+++.||||+++... ...+++.+|++++++++|||||+++|+|..++..++||||+++|+
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 3457899999999999999888999999997643 334789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++.... ..+++..+++++.|+|+||+||| +.+|+||||||+|||+++++.+||+|||+++...... ......
T Consensus 87 L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~~~ 161 (263)
T d1sm2a_ 87 LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTG 161 (263)
T ss_dssp HHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred HHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCC-ceeecc
Confidence 999987654 34899999999999999999999 8999999999999999999999999999998764322 222334
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITS-RPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG-~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..||+.|+|||++.+..++.++|||||||++|||+|+ ++|+....... + ......... ... +...
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~-~---~~~i~~~~~---~~~-------p~~~ 227 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-V---VEDISTGFR---LYK-------PRLA 227 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH-H---HHHHHHTCC---CCC-------CTTS
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH-H---HHHHHhcCC---CCC-------cccc
Confidence 5789999999999999999999999999999999995 55555433222 2 222221111 111 1223
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
..++.+++.+||+.+|++||||+||+++|+++++
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 4578899999999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=406.76 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=207.9
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||+||+|++++++.||||+++.... ..+++.+|+.++++++|||||+++|++.+ +..++||||+++|+
T Consensus 16 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~ 93 (272)
T d1qpca_ 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGS 93 (272)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCB
T ss_pred EEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCc
Confidence 44578999999999999999889999999976543 34679999999999999999999998865 56789999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++.......+++..+++|+.||++||.||| +.+|+||||||+|||+++++.+||+|||+|+.+... .......
T Consensus 94 L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~~~~~~ 169 (272)
T d1qpca_ 94 LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREG 169 (272)
T ss_dssp HHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEECCTT
T ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC-ccccccc
Confidence 999887665556999999999999999999999 889999999999999999999999999999876432 2233445
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNSA 777 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~ 777 (846)
..||+.|+|||++.+..++.++|||||||++|||+||+.|+........+. .... .+. .+ ..+....
T Consensus 170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~---~~i~-~~~-----~~----~~p~~~~ 236 (272)
T d1qpca_ 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---QNLE-RGY-----RM----VRPDNCP 236 (272)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHH-TTC-----CC----CCCTTCC
T ss_pred cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH---HHHH-hcC-----CC----CCcccCh
Confidence 678999999999999999999999999999999999655443332222222 2221 111 11 1122334
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 778 WKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 778 ~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
..+.+|+.+||+.+|++||||+||++.|+++..
T Consensus 237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 578899999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-47 Score=408.48 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=213.1
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
..+.+.||+|+||+||+|++. +++.||||+++.... ..+++.+|+.+|++++|||||+++++|.+++..++||||+++
T Consensus 19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 97 (287)
T d1opja_ 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 97 (287)
T ss_dssp EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccC
Confidence 344678999999999999986 588999999975533 457899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.+++.......+++..++.++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++..... .....
T Consensus 98 g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~~~~ 173 (287)
T d1opja_ 98 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 173 (287)
T ss_dssp CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-SSEEE
T ss_pred cchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCC-Cceee
Confidence 99999998776667999999999999999999999 889999999999999999999999999999876432 22333
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
....|++.|+|||++.+..++.++|||||||++|||++|+.|+........+.+.+ ..+. ....+..
T Consensus 174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i----~~~~---------~~~~~~~ 240 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDY---------RMERPEG 240 (287)
T ss_dssp TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----HTTC---------CCCCCTT
T ss_pred ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH----hcCC---------CCCCCcc
Confidence 44568999999999999999999999999999999999776664433333232222 1211 1112233
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
....+.+|+.+||+.+|++||||+||++.|+.+.+
T Consensus 241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 44578999999999999999999999999988753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=399.62 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=202.5
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 87 (271)
T d1nvra_ 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 87 (271)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCC
Confidence 34578999999999999975 78999999997543 33456789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
|+|.+++.... .+++.++..++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+|+...........
T Consensus 88 g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 88 GELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp EEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 99999997654 4999999999999999999999 889999999999999999999999999999877544444445
Q ss_pred ccccCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCCh
Q 003114 696 TGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDV 774 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~-s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~ 774 (846)
...+||+.|+|||++.+..+ +.++||||+||++|||+||++||....+...... ......... ....
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~---~~~~~~~~~---------~~~~ 230 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYL---------NPWK 230 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH---HHHTTCTTS---------TTGG
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH---HHhcCCCCC---------Cccc
Confidence 56789999999999988776 5789999999999999999999976554332211 111111100 0111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 775 NSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 775 ~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.....+.+++.+|++.+|++|||++|+++
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 231 KIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22356789999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=399.17 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=201.8
Q ss_pred hhhhcCcCceEEEEEEEEcCC-----cEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 539 FETILGEGSFGKVYHGYLDDN-----TEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~~g-----~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.++||+|+||+||+|.++.. ..||||++.... ....++|.+|+.++++++|||||+++|++.+.+..++||||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 457899999999999997532 469999997543 34456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc-
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV- 691 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~- 691 (846)
+.+|++.+++..... .++|.++++++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 91 ~~~~~l~~~~~~~~~-~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 91 MENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp CTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred cccCcchhhhhcccc-cccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 999999998876543 4999999999999999999999 89999999999999999999999999999987643221
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+........+. ... .++ ....
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~---~~i-~~~---------~~~~ 233 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM---KAI-NDG---------FRLP 233 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHH-HTT---------CCCC
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHH---HHH-hcc---------CCCC
Confidence 223344568999999999999999999999999999999999755554332222222 222 221 1112
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
.+.+....+.+|+.+||+.+|++||||+||+++|+++++..
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 23344567899999999999999999999999999988653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=398.93 Aligned_cols=257 Identities=21% Similarity=0.400 Sum_probs=209.5
Q ss_pred hcCcCceEEEEEEEEc---CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 542 ILGEGSFGKVYHGYLD---DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.||+|+||+||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++|+|.. +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 3999999999999864 45679999997653 4456789999999999999999999999875 56889999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc-cccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS-HLST 696 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~-~~~~ 696 (846)
|.+++..... .+++..+.+++.|+++||+||| +++|+||||||+|||++.++.+||+|||+++.+...... ....
T Consensus 95 L~~~l~~~~~-~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 170 (285)
T d1u59a_ 95 LHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170 (285)
T ss_dssp HHHHHTTCTT-TSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred HHHHhhcccc-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccccccccccc
Confidence 9999865443 4899999999999999999999 889999999999999999999999999999877543322 2233
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
...||+.|+|||++.+..++.++|||||||++|||+| |+.||......+. .. .+..+... ..+..
T Consensus 171 ~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~----~~-~i~~~~~~---------~~p~~ 236 (285)
T d1u59a_ 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV----MA-FIEQGKRM---------ECPPE 236 (285)
T ss_dssp SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH----HH-HHHTTCCC---------CCCTT
T ss_pred ccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH----HH-HHHcCCCC---------CCCCc
Confidence 4568999999999999999999999999999999998 8999986553321 12 12222211 12233
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhhhhc
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETARKE 817 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~~~~ 817 (846)
....+.+|+.+||+.+|++||||.+|++.|+.+...-....+
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~ 278 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccc
Confidence 446788999999999999999999999999987654444333
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=394.19 Aligned_cols=251 Identities=27% Similarity=0.445 Sum_probs=210.8
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.+.||+|+||+||+|++++++.||||+++.... ..+++.+|+.++++++||||++++|+|.+++..++||||+++|+
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 35678999999999999999899999999976543 34689999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
|.+++..... .+++..+++++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++...... ......
T Consensus 86 l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 160 (258)
T d1k2pa_ 86 LLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVG 160 (258)
T ss_dssp HHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCCCC
T ss_pred HHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC-ceeecc
Confidence 9999776543 3889999999999999999999 8899999999999999999999999999998764432 223334
Q ss_pred ccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 698 VAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
..||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+.. .. +..+. .... +...
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~----~~-i~~~~--~~~~-------p~~~ 226 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA----EH-IAQGL--RLYR-------PHLA 226 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH----HH-HHTTC--CCCC-------CTTC
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH----HH-HHhCC--CCCC-------cccc
Confidence 678999999999999999999999999999999998 89999876543322 22 22221 1111 2233
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
...+.+++.+||+.+|++|||++||++.|.++
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 45788999999999999999999999998653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=396.86 Aligned_cols=249 Identities=24% Similarity=0.421 Sum_probs=202.2
Q ss_pred hhcCcCceEEEEEEEEcC---CcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 541 TILGEGSFGKVYHGYLDD---NTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.||+|+||+||+|.+.+ ++.||||+++.. +....+++.+|+.+|++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998643 467999999754 33445789999999999999999999999965 457899999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc-cc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS-HL 694 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~-~~ 694 (846)
|+|.+++..... +++..+++++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++.+...... ..
T Consensus 92 g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhccC--CCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999999987554 999999999999999999999 889999999999999999999999999999876433222 22
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.....||+.|+|||.+.+..++.++|||||||++|||+| |++||.+....+ ... .+..+.. ...+
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~----~~~-~i~~~~~---------~~~p 232 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTA-MLEKGER---------MGCP 232 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHH-HHHTTCC---------CCCC
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH----HHH-HHHcCCC---------CCCC
Confidence 334578999999999999999999999999999999998 899998654332 122 2222211 1112
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
......+.+|+.+||+.+|++||||+||.+.|+...
T Consensus 233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 234457889999999999999999999999998864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=396.69 Aligned_cols=246 Identities=22% Similarity=0.367 Sum_probs=206.4
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||+++|
T Consensus 23 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg 102 (293)
T d1yhwa1 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (293)
T ss_dssp CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred EEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCC
Confidence 3456799999999999996 479999999997665555678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+... .....
T Consensus 103 ~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~~~~~ 174 (293)
T d1yhwa1 103 SLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRS 174 (293)
T ss_dssp BHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TCCBC
T ss_pred cHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccc--ccccc
Confidence 999988764 3899999999999999999999 889999999999999999999999999999876432 22334
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
...||+.|+|||++.+..++.++||||+||++|||+||++||.+......+.. ....+... + ..+...
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~~~~~------~--~~~~~~ 242 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL----IATNGTPE------L--QNPEKL 242 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHHCSCC------C--SSGGGS
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH----HHhCCCCC------C--CCcccC
Confidence 56799999999999999999999999999999999999999986554333322 22222111 1 111223
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
...+.+++.+|++.+|++|||++|+++
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 457889999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-46 Score=405.34 Aligned_cols=254 Identities=27% Similarity=0.426 Sum_probs=207.9
Q ss_pred hhhhhhcCcCceEEEEEEEEcC-C-----cEEEEEEeCCC-CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeE
Q 003114 537 NDFETILGEGSFGKVYHGYLDD-N-----TEVAVKMLSPS-SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~-g-----~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~L 608 (846)
..+.+.||+|+||+||+|++.. + ..||+|++... .......+.+|+.++.++ +|||||++++++.+.+..++
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence 3456889999999999999643 2 36999998654 334456789999999998 89999999999999999999
Q ss_pred eeecccCCChhhhhhcCCC---------------------CccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCE
Q 003114 609 IYEYMANGSLEEYLSDSNA---------------------DVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANI 667 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NI 667 (846)
|||||++|+|.++++.... ..+++..++.++.|+++||+||| +++|+||||||+||
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNV 195 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGE
T ss_pred EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchhcc
Confidence 9999999999999976532 34899999999999999999999 88999999999999
Q ss_pred EECCCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccccc
Q 003114 668 LLNDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKH 746 (846)
Q Consensus 668 Lld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~ 746 (846)
|++.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+| |++||.+......
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~ 275 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987654443334445678999999999999999999999999999999998 8999987655444
Q ss_pred HHHHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 003114 747 ISQWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELK 806 (846)
Q Consensus 747 l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~ 806 (846)
+.+.+. .+. ....+......+.+|+.+||+.+|++||||+||+++|.
T Consensus 276 ~~~~~~----~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 276 FYKLIQ----NGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHH----TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHh----cCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 443322 211 11122334457899999999999999999999999995
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=392.44 Aligned_cols=243 Identities=27% Similarity=0.417 Sum_probs=204.1
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.+.+.||+|+||+||+|+.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 345678999999999999985 68899999986432 23356788999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 88 APLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred cCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 999999999987543 899999999999999999999 899999999999999999999999999999865322
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........+.. .. .+.. . .
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~----i~-~~~~------~----~ 223 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR----IS-RVEF------T----F 223 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HH-TTCC------C----C
T ss_pred -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHH----HH-cCCC------C----C
Confidence 23346799999999999999999999999999999999999999976554332222 11 1111 1 1
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+......+.+++.+|++.+|++|||++|+++
T Consensus 224 p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1223356789999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=395.80 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=203.5
Q ss_pred hhhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 537 NDFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
..+.+.||+|+||+||+|++++++.||||+++.... ..+.|.+|+.++++++|||||+++++|.+ +..++||||+++|
T Consensus 19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g 96 (285)
T d1fmka3 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 96 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCC
Confidence 456678999999999999999888999999975543 34789999999999999999999999965 5678999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.......++|.+++.++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++..... ......
T Consensus 97 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-~~~~~~ 172 (285)
T d1fmka3 97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQ 172 (285)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred chhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCC-Cceeec
Confidence 9999988765556999999999999999999999 889999999999999999999999999999876432 222334
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChHH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVNS 776 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~~ 776 (846)
...||+.|+|||++.+..++.++|||||||++|||++|..|+........+...+ .. +. ....+...
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i---~~-~~---------~~~~~~~~ 239 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---ER-GY---------RMPCPPEC 239 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---HT-TC---------CCCCCTTS
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH---Hh-cC---------CCCCCccc
Confidence 4678999999999999999999999999999999999765554433322222222 11 11 11122234
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 777 AWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 777 ~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
..++.+++.+||+.+|++||+|++|+++|++...
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 4578899999999999999999999999988663
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=395.35 Aligned_cols=248 Identities=21% Similarity=0.339 Sum_probs=206.3
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
++.+.||+|+||+||+|+.. +++.||||++........+.+.+|+++|++++|||||++++++.+++..++||||+++|
T Consensus 15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g 94 (288)
T d2jfla1 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence 34567999999999999975 78999999998777777788999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.... ..+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|+.... ......
T Consensus 95 ~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~~~ 168 (288)
T d2jfla1 95 AVDAVMLELE-RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRD 168 (288)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHHHHT
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCC--Cccccc
Confidence 9999987543 34999999999999999999999 88999999999999999999999999999976421 112234
Q ss_pred cccCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 697 GVAGTFGYLDPEYCQ-----TFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
...||+.|+|||++. ...++.++|||||||++|||+||++||......+.+.... .. ..... .
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~----~~-~~~~~-------~ 236 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA----KS-EPPTL-------A 236 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH----HS-CCCCC-------S
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH----cC-CCCCC-------C
Confidence 567999999999884 4568999999999999999999999998766554443322 11 11111 1
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.+......+.+++.+||+.+|++|||++|+++
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11233457889999999999999999999865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=390.78 Aligned_cols=244 Identities=25% Similarity=0.432 Sum_probs=197.2
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeec----CCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE----GNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~LV~ 610 (846)
.|++.||+|+||+||+|+.. +++.||+|++... .....+.+.+|+++|++++|||||++++++.. +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45567999999999999975 6889999998654 33455678999999999999999999999854 45689999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCC--eeecCCCCCCEEEC-CCCcEEEEeccCCccCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPP--RVHRDIKPANILLN-DQFQARLADFGLSKTFP 687 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--IiHrDlKp~NILld-~~~~vkI~DFGla~~~~ 687 (846)
||+++|+|.+++..... +++..+..++.|+++||+||| +.+ |+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhcccc--ccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999987543 899999999999999999999 666 99999999999996 57899999999998542
Q ss_pred CCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCC
Q 003114 688 IEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPK 767 (846)
Q Consensus 688 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 767 (846)
. .......||+.|+|||++.+ +++.++|||||||++|||++|+.||........+.+ . +..+.....++
T Consensus 167 ~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~---~-i~~~~~~~~~~-- 235 (270)
T d1t4ha_ 167 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---R-VTSGVKPASFD-- 235 (270)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---H-HTTTCCCGGGG--
T ss_pred C----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH---H-HHcCCCCcccC--
Confidence 2 22345679999999998875 699999999999999999999999976543332222 1 22221111111
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.....++.+++.+|++.+|++|||++|+++
T Consensus 236 ------~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 ------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 112345789999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=394.26 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=202.9
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeec
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
+.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 455689999999999999974 78999999986432 23346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.+++...+. +++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|+.+......
T Consensus 90 ~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 90 AKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 999999999887654 899999999999999999999 899999999999999999999999999999877544444
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||........... .. .+.. . +
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~----i~-~~~~------~----~ 229 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----II-KLEY------D----F 229 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH-TTCC------C----C
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHH----HH-cCCC------C----C
Confidence 444557899999999999999999999999999999999999999986554332222 11 1111 1 1
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+......+.+|+.+|++.+|++|||++|+.+
T Consensus 230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1223346789999999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=390.98 Aligned_cols=250 Identities=24% Similarity=0.387 Sum_probs=191.2
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeec--CCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNE--GNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~LV~Ey 612 (846)
++.+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|++++++++|||||++++++.+ ++..++||||
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy 86 (269)
T d2java1 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 86 (269)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEEC
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEec
Confidence 44578999999999999975 78999999997653 3445678999999999999999999998854 4568999999
Q ss_pred ccCCChhhhhhcCC--CCccChHHHHHHHHHHHHHHHHHhccC--CCCeeecCCCCCCEEECCCCcEEEEeccCCccCCC
Q 003114 613 MANGSLEEYLSDSN--ADVLSWEGRLRIATEAAQGLEYLHLGC--KPPRVHRDIKPANILLNDQFQARLADFGLSKTFPI 688 (846)
Q Consensus 613 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~ 688 (846)
+++|+|.+++.... ...+++..++.++.|++.||+|||+.. ..+|+||||||+|||+++++.+||+|||+++.+..
T Consensus 87 ~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 166 (269)
T d2java1 87 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166 (269)
T ss_dssp CTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred CCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence 99999999986532 345999999999999999999999422 24599999999999999999999999999987643
Q ss_pred CCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 689 EGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 689 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
. ........||+.|+|||++.+..++.++|||||||++|||+||++||......+.. .. +..+.... +
T Consensus 167 ~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~----~~-i~~~~~~~-----~ 234 (269)
T d2java1 167 D--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA----GK-IREGKFRR-----I 234 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HH-HHHTCCCC-----C
T ss_pred C--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHH----HH-HHcCCCCC-----C
Confidence 2 22334568999999999999999999999999999999999999999865543322 22 22222211 1
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+.....++.+++.+||+.+|++|||++|+++
T Consensus 235 ----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 ----PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1223346889999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=386.58 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=199.6
Q ss_pred hhhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeec-CCeeeEeeecccCC
Q 003114 538 DFETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE-GNQIGLIYEYMANG 616 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~LV~Ey~~~g 616 (846)
.+.+.||+|+||.||+|++ .|+.||||+++... ..+++.+|++++++++||||++++|+|.+ .+..++||||+++|
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 3457899999999999998 47899999997543 34779999999999999999999999855 46689999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
+|.+++.......++|..+++++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.... ...
T Consensus 87 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----~~~ 158 (262)
T d1byga_ 87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQD 158 (262)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC-----CCc
Confidence 9999998765556899999999999999999999 88999999999999999999999999999986432 223
Q ss_pred cccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCChH
Q 003114 697 GVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDIDVN 775 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~~~ 775 (846)
...++..|+|||++.+..++.++|||||||++|||+| |++||....... +..++ ..+. ....+..
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-~~~~i----~~~~---------~~~~~~~ 224 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRV----EKGY---------KMDAPDG 224 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-HHHHH----TTTC---------CCCCCTT
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-HHHHH----HcCC---------CCCCCcc
Confidence 3467899999999999999999999999999999998 688877654333 32222 1211 1122223
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 776 SAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 776 ~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
....+.+|+.+||+.+|++||||.||+++|+++..-
T Consensus 225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 345788999999999999999999999999987643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=390.37 Aligned_cols=256 Identities=28% Similarity=0.472 Sum_probs=206.1
Q ss_pred hhhhhcCcCceEEEEEEEEcCC----cEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeec-CCeeeEeee
Q 003114 538 DFETILGEGSFGKVYHGYLDDN----TEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE-GNQIGLIYE 611 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~g----~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~LV~E 611 (846)
+|.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|++++++++||||++++|++.+ +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4567899999999999997432 35899999754 44556789999999999999999999999865 568999999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
||++|+|.+++..... .+++..+++++.|+++||.||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EeecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999999886543 4788899999999999999999 89999999999999999999999999999987643322
Q ss_pred --ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 692 --SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 692 --~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
........||+.|+|||.+.+..++.++|||||||++|||+||+.||........+.. ... .+.. ...
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~---~i~-~g~~--~~~---- 255 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLL-QGRR--LLQ---- 255 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH---HHH-TTCC--CCC----
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH---HHH-cCCC--CCC----
Confidence 2223346789999999999999999999999999999999998877765433222222 222 2211 111
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
+......+.+|+.+||+.+|++||+|+||+++|++++.
T Consensus 256 ---p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 256 ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12234578899999999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=399.99 Aligned_cols=257 Identities=21% Similarity=0.321 Sum_probs=199.8
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
+.+.||+|+||+||+|+.. +|+.||+|+++.. .....+++.+|+.+|++++|||||+++++|.++++.++||||+++|
T Consensus 10 ~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg 89 (322)
T d1s9ja_ 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89 (322)
T ss_dssp EEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 3478999999999999974 7899999999754 3344567899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCC-CCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCK-PPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
+|.+++..... +++..+..++.|++.||.||| + .+|+||||||+|||+++++.+||+|||+|+.+.. ...
T Consensus 90 ~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~----~~~ 160 (322)
T d1s9ja_ 90 SLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMA 160 (322)
T ss_dssp EHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----HTC
T ss_pred cHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC----Ccc
Confidence 99999987553 899999999999999999999 5 4899999999999999999999999999986532 223
Q ss_pred ccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcC-----------C--ccc
Q 003114 696 TGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG-----------D--IKN 762 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~-----------~--~~~ 762 (846)
...+||+.|+|||++.+..++.++||||+||+++||++|+.||...+.......+........ . ...
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence 456899999999999999999999999999999999999999976543221111000000000 0 000
Q ss_pred ccCCCC---------------CCCC-ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 763 IVDPKL---------------HGDI-DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 763 ~~d~~L---------------~~~~-~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
..+... .... ......++.+++.+|++.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000000 0000 00123467899999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-44 Score=391.25 Aligned_cols=254 Identities=29% Similarity=0.454 Sum_probs=208.9
Q ss_pred hhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 539 FETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSSR-QGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
+.+.||+|+||+||+|++. +++.||||+++.... ...+++.+|+.++++++||||++++++|...+..++|||
T Consensus 17 ~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEE
Confidence 3578999999999999964 357899999976543 345679999999999999999999999999999999999
Q ss_pred cccCCChhhhhhcCC----------------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEE
Q 003114 612 YMANGSLEEYLSDSN----------------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILL 669 (846)
Q Consensus 612 y~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILl 669 (846)
|+++|+|.+++.... ...+++..++.|+.|++.||+||| +.+|+||||||+|||+
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~NILl 173 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLV 173 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcccceEE
Confidence 999999999996432 224889999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCccccccHH
Q 003114 670 NDQFQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSR-PAIANTEEHKHIS 748 (846)
Q Consensus 670 d~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~-~p~~~~~~~~~l~ 748 (846)
+.++.+||+|||+++...............|++.|+|||.+.+..++.++|||||||++|||++|. +||......+.+
T Consensus 174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~- 252 (301)
T d1lufa_ 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI- 252 (301)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-
T ss_pred CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHH-
Confidence 999999999999998764443344445577899999999999999999999999999999999995 677765443322
Q ss_pred HHHHHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhh
Q 003114 749 QWVDFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECL 809 (846)
Q Consensus 749 ~~~~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l 809 (846)
.. +.++.... .+...+..+.+|+.+||+.+|++||||.||+++|+++.
T Consensus 253 ---~~-v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 253 ---YY-VRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ---HH-HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---HH-HHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22 22222211 12233457889999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=384.36 Aligned_cols=258 Identities=25% Similarity=0.369 Sum_probs=200.7
Q ss_pred hhhhhhcCcCceEEEEEEEEcC----CcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 537 NDFETILGEGSFGKVYHGYLDD----NTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
.++.+.||+|+||.||+|++.. +..||||.++... ....+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E 87 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIME 87 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEE
Confidence 3456789999999999998742 3568999987553 3445679999999999999999999999964 67899999
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+++|+|.+++..... .+++..++.++.|+++||.||| +.+|+||||||+||++++++.+||+|||+++..... .
T Consensus 88 ~~~~g~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~-~ 162 (273)
T d1mp8a_ 88 LCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-T 162 (273)
T ss_dssp CCTTEEHHHHHHHTTT-TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred eccCCcHHhhhhccCC-CCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC-c
Confidence 9999999998776543 4899999999999999999999 899999999999999999999999999999875332 2
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
........||+.|+|||.+.+..++.++|||||||++|||+| |++||......+.... +..+...
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~-----i~~~~~~--------- 228 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-----IENGERL--------- 228 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----HHTTCCC---------
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH-----HHcCCCC---------
Confidence 223344678999999999999999999999999999999998 8999987665443322 1222111
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhhh
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMETA 814 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~~ 814 (846)
..+......+.+|+.+||+.+|++|||++||++.|+++++.+.+
T Consensus 229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k~ 272 (273)
T d1mp8a_ 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhC
Confidence 11223345788999999999999999999999999998876544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-44 Score=390.75 Aligned_cols=249 Identities=22% Similarity=0.356 Sum_probs=189.3
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
+++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..++|||||+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 455688999999999999975 68999999997543 2234568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC---CCCcEEEEeccCCccCCCCCc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN---DQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld---~~~~vkI~DFGla~~~~~~~~ 691 (846)
+|+|.+++...+ .+++.++..++.|++.||+||| +.+|+||||||+|||+. +++.+||+|||+++....
T Consensus 91 gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~--- 162 (307)
T d1a06a_ 91 GGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--- 162 (307)
T ss_dssp SCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred CCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccC---
Confidence 999999998654 3999999999999999999999 89999999999999994 578999999999986532
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
........||+.|+|||++.+..++.++||||+||++|||++|++||.+........ .... +... .+. .
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~----~i~~-~~~~--~~~----~ 231 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILK-AEYE--FDS----P 231 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHT-TCCC--CCT----T
T ss_pred CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHH----HHhc-cCCC--CCC----c
Confidence 223345679999999999999999999999999999999999999998655433221 1221 1110 111 1
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
...+....+.+++.+|++.+|++|||++|+++.
T Consensus 232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 112233568899999999999999999999873
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=386.85 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=201.0
Q ss_pred hhhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhc-ccccceeEeeEeec-CCeee
Q 003114 537 NDFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTV-HHKNLTTLYGYCNE-GNQIG 607 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~-~~~~~ 607 (846)
..+.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|...+.++ +|+||+.+++++.+ +...+
T Consensus 15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~ 94 (299)
T d1ywna1 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 94 (299)
T ss_dssp EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence 345678999999999999863 24679999997543 34456677888877776 78999999998765 45689
Q ss_pred EeeecccCCChhhhhhcCC--------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC
Q 003114 608 LIYEYMANGSLEEYLSDSN--------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF 673 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~ 673 (846)
+|||||++|+|.++++... ...+++.+++.++.|+++||+||| +++|+||||||+|||+++++
T Consensus 95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECCCC
Confidence 9999999999999997543 234889999999999999999999 89999999999999999999
Q ss_pred cEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCccccccHHHHHH
Q 003114 674 QARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITS-RPAIANTEEHKHISQWVD 752 (846)
Q Consensus 674 ~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG-~~p~~~~~~~~~l~~~~~ 752 (846)
.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+|| ++||........+...
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~-- 249 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-- 249 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH--
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH--
Confidence 9999999999876544444445567899999999999999999999999999999999997 5678765544333222
Q ss_pred HHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 753 FMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 753 ~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
+..+.... .+.....++.+++.+||+.+|++|||++||+++|+++++..
T Consensus 250 --~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 250 --LKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp --HHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HhcCCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 22222111 12223456889999999999999999999999999998653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.5e-44 Score=393.31 Aligned_cols=250 Identities=20% Similarity=0.311 Sum_probs=207.7
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+.+.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++|||||++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 455688999999999999974 7899999999877666677899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC--CCCcEEEEeccCCccCCCCCccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN--DQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld--~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
|+|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+|||++ .++.+||+|||+++.+... .
T Consensus 108 g~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~---~ 180 (350)
T d1koaa2 108 GELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---Q 180 (350)
T ss_dssp CBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT---S
T ss_pred CCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc---c
Confidence 999999965443 3999999999999999999999 89999999999999996 4678999999999876432 2
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+.+.. ...... . .+. ...
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~----i~~~~~-~--~~~----~~~ 249 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDW-N--MDD----SAF 249 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCC-C--SCC----GGG
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCC-C--CCc----ccc
Confidence 33446799999999999999999999999999999999999999986654333322 221110 0 011 011
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
......+.+++.+|++.||++|||++|+++.
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1233568899999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=388.34 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=202.5
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCc----EEEEEEeCCC-CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNT----EVAVKMLSPS-SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 611 (846)
.+.+.||+|+||+||+|++. +|+ +||+|+++.. +....+++.+|+.++++++|||||+++|+|.++ ..++++|
T Consensus 12 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e 90 (317)
T d1xkka_ 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ 90 (317)
T ss_dssp EEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred EEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEE
Confidence 34578999999999999974 443 5899998754 344567899999999999999999999999875 5678889
Q ss_pred cccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc
Q 003114 612 YMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 612 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~ 691 (846)
|+.+|+|.+.+..... .+++..+++++.|||.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 91 ~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 91 LMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp CCTTCBHHHHHHHTSS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred eccCCccccccccccc-CCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 9999999998876543 4899999999999999999999 88999999999999999999999999999997755444
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHG 770 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~ 770 (846)
........||+.|+|||.+.+..++.++|||||||++|||+| |++||....... +...+ ..+. ..
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-~~~~i----~~~~---------~~ 232 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSIL----EKGE---------RL 232 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-HHHHH----HHTC---------CC
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-HHHHH----HcCC---------CC
Confidence 444445678999999999999999999999999999999998 789988665433 22222 1211 01
Q ss_pred CCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 771 DIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 771 ~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
..+......+.+|+.+||+.+|++|||++||++.|+.+..
T Consensus 233 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1223344678899999999999999999999999988754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-44 Score=388.29 Aligned_cols=241 Identities=23% Similarity=0.331 Sum_probs=199.0
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
..+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++|||||+
T Consensus 19 ~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 98 (309)
T d1u5ra_ 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (309)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecC
Confidence 3467999999999999964 78899999997543 2344678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|+|..++.... .+++.++..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 99 ~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------ 167 (309)
T d1u5ra_ 99 GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167 (309)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred CCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC------
Confidence 999987766544 4999999999999999999999 89999999999999999999999999999986532
Q ss_pred cccccCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQT---FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~---~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+.. ... +.......
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~----i~~-~~~~~~~~------ 236 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQ-NESPALQS------ 236 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHH-SCCCCCSC------
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHh-CCCCCCCC------
Confidence 234579999999999864 4589999999999999999999999976554332222 221 11111111
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
......+.+++.+||+.+|++|||++|+++
T Consensus 237 --~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 --GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 122346889999999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-43 Score=391.52 Aligned_cols=250 Identities=18% Similarity=0.293 Sum_probs=208.0
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
+++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++|||||++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 345678999999999999974 7999999999877666667889999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC--CCCcEEEEeccCCccCCCCCccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN--DQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld--~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
|+|.+.+..... .+++.++..++.||+.||+||| +.+|+||||||+|||++ .++.+||+|||+|+.+... .
T Consensus 111 g~L~~~~~~~~~-~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~---~ 183 (352)
T d1koba_ 111 GELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---E 183 (352)
T ss_dssp CBHHHHTTCTTC-CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---S
T ss_pred ChHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCC---C
Confidence 999998765542 4999999999999999999999 89999999999999998 6789999999999876432 2
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
......||+.|+|||++.+..++.++||||+||++|||+||++||.+......+.. ... +... ..+.. .
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~-~~~~--~~~~~----~ 252 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKR-CDWE--FDEDA----F 252 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHH-CCCC--CCSST----T
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHh-CCCC--CCccc----c
Confidence 33446799999999999999999999999999999999999999987654433322 211 1111 11111 1
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
......+.+|+.+||+.+|++|||++|+++.
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2233467899999999999999999999763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=385.22 Aligned_cols=257 Identities=28% Similarity=0.448 Sum_probs=207.9
Q ss_pred hhhhhcCcCceEEEEEEEEcC--------CcEEEEEEeCCCCc-hhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeee
Q 003114 538 DFETILGEGSFGKVYHGYLDD--------NTEVAVKMLSPSSR-QGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIG 607 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~ 607 (846)
.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||+++++|.+++..+
T Consensus 16 ~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~ 95 (299)
T d1fgka_ 16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 95 (299)
T ss_dssp EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEE
Confidence 345789999999999998532 34799999976543 4457788899988888 8999999999999999999
Q ss_pred EeeecccCCChhhhhhcCC--------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC
Q 003114 608 LIYEYMANGSLEEYLSDSN--------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF 673 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~ 673 (846)
+||||+++|+|.+++.... ...+++.++++++.|++.||+||| +.+|+||||||+|||++.++
T Consensus 96 ~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~~~~ 172 (299)
T d1fgka_ 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDN 172 (299)
T ss_dssp EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTC
T ss_pred EEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeecCCC
Confidence 9999999999999997653 235899999999999999999999 89999999999999999999
Q ss_pred cEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHH
Q 003114 674 QARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVD 752 (846)
Q Consensus 674 ~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~ 752 (846)
.+||+|||+++...............|++.|+|||.+.+..++.++|||||||++|||++ |++||....... +.+
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-~~~--- 248 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-LFK--- 248 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHH---
T ss_pred CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-HHH---
Confidence 999999999987755444444555779999999999999999999999999999999998 688887655432 212
Q ss_pred HHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 753 FMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 753 ~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
.+..+... ..+......+.+|+.+||+.+|++|||+.||++.|+++++.
T Consensus 249 -~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 249 -LLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp -HHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 22222111 11222345788999999999999999999999999998765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-44 Score=386.21 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=214.3
Q ss_pred hhhhhhcCcCceEEEEEEEE------cCCcEEEEEEeCCCCc-hhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeE
Q 003114 537 NDFETILGEGSFGKVYHGYL------DDNTEVAVKMLSPSSR-QGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~L 608 (846)
..+.+.||+|+||.||+|++ .+++.||||+++.... ....++.+|+.+++++ +|||||+++++|.+++..++
T Consensus 25 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~l 104 (311)
T d1t46a_ 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEE
Confidence 44567899999999999986 3456899999986543 3456789999999999 69999999999999999999
Q ss_pred eeecccCCChhhhhhcCC----------------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC
Q 003114 609 IYEYMANGSLEEYLSDSN----------------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ 672 (846)
Q Consensus 609 V~Ey~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~ 672 (846)
|||||++|+|.++++... ...+++..+.+++.||++||+||| +++|+||||||+|||++.+
T Consensus 105 vmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHG 181 (311)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETT
T ss_pred EEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccccc
Confidence 999999999999997543 225889999999999999999999 8999999999999999999
Q ss_pred CcEEEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHH
Q 003114 673 FQARLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWV 751 (846)
Q Consensus 673 ~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~ 751 (846)
+.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+| |++|+........+.+++
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i 261 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999997755444445556789999999999999999999999999999999999 566665555444444433
Q ss_pred HHHHhcCCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 752 DFMLAQGDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 752 ~~~~~~~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
.. +. ....+......+.+|+.+||+.+|++||||+||+++|++++..
T Consensus 262 ~~----~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 262 KE----GF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HH----TC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hc----CC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 22 11 1111223345789999999999999999999999999998653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-44 Score=382.81 Aligned_cols=248 Identities=22% Similarity=0.330 Sum_probs=203.5
Q ss_pred hhhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC------chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEe
Q 003114 537 NDFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS------RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLI 609 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV 609 (846)
+++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..++|
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 91 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 345678999999999999974 78999999986432 12356799999999999999999999999999999999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC----cEEEEeccCCcc
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF----QARLADFGLSKT 685 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~----~vkI~DFGla~~ 685 (846)
||||++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus 92 ~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 92 LELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEcCCCccccchhccccc--cchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 999999999999987653 999999999999999999999 89999999999999998776 599999999987
Q ss_pred CCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 003114 686 FPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765 (846)
Q Consensus 686 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 765 (846)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+.+..+ . .+...
T Consensus 167 ~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i----~-~~~~~---- 234 (293)
T d1jksa_ 167 IDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----S-AVNYE---- 234 (293)
T ss_dssp CTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----H-TTCCC----
T ss_pred cCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH----H-hcCCC----
Confidence 6432 2334567899999999999999999999999999999999999999876544332221 1 11110
Q ss_pred CCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 ~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
............+.+++.+||+.+|++|||++|+++
T Consensus 235 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 --FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000122346789999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-44 Score=380.77 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=196.2
Q ss_pred hhhhhcCcCceEEEEEEEEcC--C--cEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLDD--N--TEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~~--g--~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
++.+.||+|+||.||+|++.. + ..||||++... .....++|.+|+.++++++||||++++|+|.+ +..++||
T Consensus 11 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~ 89 (273)
T d1u46a_ 11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVT 89 (273)
T ss_dssp EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheee
Confidence 345679999999999998642 2 36899998754 33445789999999999999999999999976 4678999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+++|+|.+.+..... .+++..+++++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 90 e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 90 ELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp ECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 99999999998876543 4999999999999999999999 8899999999999999999999999999999764433
Q ss_pred cc-cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccccccHHHHHHHHHhcCCcccccCCCC
Q 003114 691 VS-HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIIT-SRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKL 768 (846)
Q Consensus 691 ~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L 768 (846)
.. .......|+..|+|||.+.+..++.++|||||||++|||+| |++||.+....+.+ ......+...
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~----~~i~~~~~~~------- 234 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEGERL------- 234 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHTSCCCC-------
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH----HHHHhCCCCC-------
Confidence 22 22334568889999999999999999999999999999998 89999765544322 2222222111
Q ss_pred CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHh
Q 003114 769 HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKEC 808 (846)
Q Consensus 769 ~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~ 808 (846)
.........+.+|+.+||+.+|++||||.||.+.|++.
T Consensus 235 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 --PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11223345788999999999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=381.90 Aligned_cols=265 Identities=25% Similarity=0.370 Sum_probs=201.2
Q ss_pred hhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCC----eeeEeeeccc
Q 003114 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN----QIGLIYEYMA 614 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~LV~Ey~~ 614 (846)
+.+.||+|+||.||+|++ +|+.||||+++.... .....+.|+..+..++||||++++++|...+ ..++|||||+
T Consensus 7 l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ 84 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEeccc
Confidence 457899999999999997 688999999964432 1222345666667889999999999997543 6899999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhcc-----CCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLG-----CKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
+|+|.++++.. .++|.++++++.|+|.||.|||+. .+++|+||||||+||||++++.+||+|||+++.....
T Consensus 85 ~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~ 161 (303)
T d1vjya_ 85 HGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp TCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence 99999999865 389999999999999999999942 1479999999999999999999999999999876433
Q ss_pred Ccc--cccccccCCCcccCccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCCcccc-----------ccHHHH
Q 003114 690 GVS--HLSTGVAGTFGYLDPEYCQTFR------LTEKSDVYSFGVVLLEIITSRPAIANTEEH-----------KHISQW 750 (846)
Q Consensus 690 ~~~--~~~~~~~gt~~Y~APE~~~~~~------~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~-----------~~l~~~ 750 (846)
... .......||+.|+|||++.+.. ++.++|||||||++|||+||.+|+...... .....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~- 240 (303)
T d1vjya_ 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE- 240 (303)
T ss_dssp TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH-
T ss_pred CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH-
Confidence 221 1234567999999999987642 677999999999999999999887532211 11112
Q ss_pred HHHHHhcCCcccccCCCCCCCC-ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhhh
Q 003114 751 VDFMLAQGDIKNIVDPKLHGDI-DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAMET 813 (846)
Q Consensus 751 ~~~~~~~~~~~~~~d~~L~~~~-~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e~ 813 (846)
.......+ ..+|.+.... ..+....+.+|+.+||+.+|++||||.||++.|+++..-+.
T Consensus 241 ~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 241 MRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 22222111 1222222111 23456678999999999999999999999999998875543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=382.93 Aligned_cols=253 Identities=28% Similarity=0.469 Sum_probs=202.6
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCc--EEEEEEeCCC-CchhhHHHHHHHHHHHhc-ccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNT--EVAVKMLSPS-SRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~--~VAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||+||+|++. +|. .||||++... .....+.+.+|+++|+++ +|||||+++++|.+++..++||||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 34678999999999999975 444 4788887644 344566899999999998 799999999999999999999999
Q ss_pred ccCCChhhhhhcC--------------CCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEE
Q 003114 613 MANGSLEEYLSDS--------------NADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLA 678 (846)
Q Consensus 613 ~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~ 678 (846)
+++|+|.++++.. ....+++.++.+++.|+|.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCceEEc
Confidence 9999999999754 2346999999999999999999999 8899999999999999999999999
Q ss_pred eccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCccccccHHHHHHHHHhc
Q 003114 679 DFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSR-PAIANTEEHKHISQWVDFMLAQ 757 (846)
Q Consensus 679 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~-~p~~~~~~~~~l~~~~~~~~~~ 757 (846)
|||+++.... ........||..|+|||.+.+..++.++|||||||++|||++|. +||......+ .... +.+
T Consensus 170 DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~----~~~~-i~~ 241 (309)
T d1fvra_ 170 DFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEK-LPQ 241 (309)
T ss_dssp CTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHH-GGG
T ss_pred cccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH----HHHH-HHh
Confidence 9999986432 22223456899999999999999999999999999999999975 5675543222 2222 222
Q ss_pred CCcccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 758 GDIKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 758 ~~~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
+. ....+......+.+|+.+||+.+|++||||+||++.|+++++
T Consensus 242 ~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 242 GY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp TC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 21 111223345678899999999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.9e-43 Score=374.68 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=200.9
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC---chhhHHHHHHHHHHHhcccccceeEeeEeecCC----eeeEe
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS---RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN----QIGLI 609 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~LV 609 (846)
.+.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 10 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lv 89 (277)
T d1o6ya_ 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV 89 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEE
Confidence 4567899999999999996 479999999997543 334567899999999999999999999886543 48899
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||+++|+|.+++...+. +++.++..++.|+++||+||| +.+|+||||||+|||++.++..+|+|||.++.....
T Consensus 90 mE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 90 MEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EECCCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 999999999999877654 899999999999999999999 899999999999999999999999999998765322
Q ss_pred C-cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcc-cccCCC
Q 003114 690 G-VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIK-NIVDPK 767 (846)
Q Consensus 690 ~-~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~-~~~d~~ 767 (846)
. .........||+.|+|||++.+..++.++||||+||++|||+||++||......+.+ ......+... ....
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~-- 238 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA----YQHVREDPIPPSARH-- 238 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHCCCCCGGGTS--
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH----HHHHhcCCCCCchhc--
Confidence 2 222334567999999999999999999999999999999999999999865543322 2223332211 1111
Q ss_pred CCCCCChHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHhh
Q 003114 768 LHGDIDVNSAWKAVEIAMGCVSHSSTPRP-NMNRVVMELKECL 809 (846)
Q Consensus 768 L~~~~~~~~~~~l~~L~~~Cl~~~P~~RP-sm~eVl~~L~~~l 809 (846)
.+....+.+++.+|++.+|++|| |++++.+.|.++.
T Consensus 239 ------~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 239 ------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ------SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 12235788999999999999999 8999999988764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=382.39 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=211.0
Q ss_pred hhhhhcCcCceEEEEEEEEc------CCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD------DNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
.+.+.||+|+||+||+|.+. +++.||||+++... ......+.+|+.++++++||||++++++|..++..++||
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence 34578999999999999863 35789999997543 344567899999999999999999999999999999999
Q ss_pred ecccCCChhhhhhcCC--------CCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccC
Q 003114 611 EYMANGSLEEYLSDSN--------ADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGL 682 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGl 682 (846)
||+++|+|.+++.... ...+++..+.+++.|+|+||.||| +.+|+||||||+|||+++++.+||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEeeccc
Confidence 9999999999986532 234789999999999999999999 88999999999999999999999999999
Q ss_pred CccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCccccccHHHHHHHHHhcCCcc
Q 003114 683 SKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITS-RPAIANTEEHKHISQWVDFMLAQGDIK 761 (846)
Q Consensus 683 a~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG-~~p~~~~~~~~~l~~~~~~~~~~~~~~ 761 (846)
++...............||+.|+|||.+.+..++.++|||||||++|||+|| ++||......+ +...... +...
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~----~~~~i~~-~~~~ 254 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ----VLRFVME-GGLL 254 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH----HHHHHHT-TCCC
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHh-CCCC
Confidence 9876444333344455789999999999999999999999999999999998 57776554332 2332222 2211
Q ss_pred cccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhhh
Q 003114 762 NIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAME 812 (846)
Q Consensus 762 ~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~e 812 (846)
. .+......+.+++.+||+.+|++||||+||+++|++.++..
T Consensus 255 ~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 255 D---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred C---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1 11223457899999999999999999999999998876533
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-42 Score=377.87 Aligned_cols=242 Identities=24% Similarity=0.376 Sum_probs=203.1
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
++.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 7 ~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 86 (316)
T d1fota_ 7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 86 (316)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeec
Confidence 34578999999999999974 6899999999643 2233567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|+|..++..... +++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 87 ~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~----- 156 (316)
T d1fota_ 87 EGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 156 (316)
T ss_dssp CSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred CCcccccccccccc--ccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc-----
Confidence 99999999987654 788889999999999999999 99999999999999999999999999999987632
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.....+||+.|+|||++.+..++.++||||+||++|||+||+.||........... ... +.. . .+
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----i~~-~~~------~----~p 221 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK----ILN-AEL------R----FP 221 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHH-CCC------C----CC
T ss_pred ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH----HHc-CCC------C----CC
Confidence 23356899999999999999999999999999999999999999987654333222 222 111 1 11
Q ss_pred hHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRP-----NMNRVVME 804 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~~ 804 (846)
......+.+++.+|+..+|++|| |++|+++.
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 12234678999999999999996 89998763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-43 Score=382.65 Aligned_cols=244 Identities=25% Similarity=0.349 Sum_probs=203.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
++.+.||+|+||.||+|+.. +|+.||+|++.+. .....+.+.+|+.+|++++||||+++++++.+++..++|||||
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~ 87 (337)
T d1o6la_ 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceecc
Confidence 44678999999999999974 7999999999753 2234567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
++|+|.+++..... +++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 88 ~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~--~~ 160 (337)
T d1o6la_ 88 NGGELFFHLSRERV--FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GA 160 (337)
T ss_dssp TTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--TC
T ss_pred CCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccC--Cc
Confidence 99999999987654 889999999999999999999 899999999999999999999999999999865322 22
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
.....+||+.|+|||++.+..++.++||||+||++|||++|++||...+..... +... .+.+ . ++
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~----~~i~-~~~~------~----~p 225 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELIL-MEEI------R----FP 225 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHH-HCCC------C----CC
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH----HHHh-cCCC------C----CC
Confidence 344578999999999999999999999999999999999999999876543322 2222 2211 1 11
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPN-----MNRVVM 803 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPs-----m~eVl~ 803 (846)
......+.+++.+|++.+|++||+ ++|+++
T Consensus 226 ~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 222346789999999999999995 677765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.9e-42 Score=367.55 Aligned_cols=247 Identities=24% Similarity=0.331 Sum_probs=202.0
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCc---------hhhHHHHHHHHHHHhcc-cccceeEeeEeecCCee
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSR---------QGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQI 606 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~---------~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~ 606 (846)
++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+.++++++ ||||+++++++.+++..
T Consensus 6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 85 (277)
T d1phka_ 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 85 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcce
Confidence 3467899999999999997 4789999999865421 12345789999999997 99999999999999999
Q ss_pred eEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccC
Q 003114 607 GLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTF 686 (846)
Q Consensus 607 ~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~ 686 (846)
++||||+++|+|.++++.... +++.++..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~ivmE~~~~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 86 FLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEcCCCchHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 999999999999999987553 999999999999999999999 889999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCcccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCc
Q 003114 687 PIEGVSHLSTGVAGTFGYLDPEYCQT------FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDI 760 (846)
Q Consensus 687 ~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 760 (846)
... .......||+.|+|||.+.+ ..++.++||||+||+++||++|+.||........... .. .+..
T Consensus 161 ~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~----i~-~~~~ 232 (277)
T d1phka_ 161 DPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IM-SGNY 232 (277)
T ss_dssp CTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH-HTCC
T ss_pred cCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH----HH-hCCC
Confidence 432 23345679999999998853 3578899999999999999999999987654332222 12 2211
Q ss_pred ccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 761 KNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 761 ~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
. ...........++.+++.+|++.+|++|||++||++
T Consensus 233 ~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 233 Q------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp C------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred C------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 111111233457889999999999999999999865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=372.46 Aligned_cols=256 Identities=23% Similarity=0.320 Sum_probs=198.7
Q ss_pred hhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCch-----hhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeeccc
Q 003114 541 TILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQ-----GYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 614 (846)
++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.++++++|||||++++++..++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 57999999999999974 6899999998654321 23568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
++++..+..... .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 84 ~~~~~~~~~~~~--~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~~ 156 (299)
T d1ua2a_ 84 TDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRA 156 (299)
T ss_dssp EEHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCC
T ss_pred chHHhhhhhccc--CCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCC--ccc
Confidence 888777665443 4899999999999999999999 899999999999999999999999999999875432 222
Q ss_pred cccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--cccccC---C-C
Q 003114 695 STGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--IKNIVD---P-K 767 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--~~~~~d---~-~ 767 (846)
.....||+.|+|||.+... .++.++||||+||++|||+||++||....+.+.+....+....... ...... . .
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 3346799999999988654 5799999999999999999999999877666555554433211110 000000 0 0
Q ss_pred CC--CCCC-----hHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 768 LH--GDID-----VNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 768 L~--~~~~-----~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.. ...+ ......+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 0011 112356889999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=379.25 Aligned_cols=245 Identities=19% Similarity=0.259 Sum_probs=194.8
Q ss_pred hhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhc-ccccceeEeeEeec----CCeeeEeeeccc
Q 003114 541 TILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTV-HHKNLTTLYGYCNE----GNQIGLIYEYMA 614 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~----~~~~~LV~Ey~~ 614 (846)
++||+|+||.||+|+. .+++.||||+++.. +.+.+|+.++.++ +|||||++++++.+ +...++|||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 5699999999999997 57899999999643 4677899886654 89999999998864 467899999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC---CCcEEEEeccCCccCCCCCc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND---QFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~---~~~vkI~DFGla~~~~~~~~ 691 (846)
+|+|.+++...+...+++.++..++.|++.||+||| +.+|+||||||+|||+++ ++.+||+|||+++.....
T Consensus 93 gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~-- 167 (335)
T d2ozaa1 93 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-- 167 (335)
T ss_dssp SEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC--
T ss_pred CCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccCC--
Confidence 999999998766667999999999999999999999 899999999999999985 567999999999876432
Q ss_pred ccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCC
Q 003114 692 SHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGD 771 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~ 771 (846)
.......||+.|+|||++.+..++.++||||+||++|||+||++||.+............ ....+ ...+...
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~-~i~~~------~~~~~~~ 239 (335)
T d2ozaa1 168 -NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-RIRMG------QYEFPNP 239 (335)
T ss_dssp -CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCSC------SSSCCTT
T ss_pred -CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH-HHhcC------CCCCCCc
Confidence 233456799999999999999999999999999999999999999975543322211110 00000 0001000
Q ss_pred CChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 772 IDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 772 ~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
........+.+++.+|++.+|++|||+.|+++
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11223457889999999999999999999976
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-42 Score=372.15 Aligned_cols=246 Identities=15% Similarity=0.238 Sum_probs=202.6
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.+.||+|+||+||+|... +++.||||+++.... ....+.+|+++|+.++||||+++++++.+++..++|||||++|
T Consensus 8 ~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 45578999999999999975 688999999976543 3456889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC--CCcEEEEeccCCccCCCCCcccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND--QFQARLADFGLSKTFPIEGVSHL 694 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~--~~~vkI~DFGla~~~~~~~~~~~ 694 (846)
+|.+++...+. .+++.++..++.|++.||+||| +.+|+||||||+|||++. ...+||+|||+++..... ..
T Consensus 87 ~L~~~i~~~~~-~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~---~~ 159 (321)
T d1tkia_ 87 DIFERINTSAF-ELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DN 159 (321)
T ss_dssp BHHHHHTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---CE
T ss_pred cHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC---Cc
Confidence 99999986542 3899999999999999999999 899999999999999984 458999999999875322 22
Q ss_pred cccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcC-CcccccCCCCCCCCC
Q 003114 695 STGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQG-DIKNIVDPKLHGDID 773 (846)
Q Consensus 695 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~-~~~~~~d~~L~~~~~ 773 (846)
.....||+.|+|||...+..++.++||||+||++|||++|++||........+.. ..... .......+
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~------- 228 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNAEYTFDEEAFK------- 228 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHTCCCCCHHHHT-------
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCChhhcc-------
Confidence 3345689999999999999999999999999999999999999987654433222 22111 11111001
Q ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.....+.+++.+|+..||++|||++|+++
T Consensus 229 -~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 -EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12346789999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.7e-42 Score=375.85 Aligned_cols=241 Identities=22% Similarity=0.289 Sum_probs=201.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC---CchhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS---SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 613 (846)
++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.+|+.++||||+++++++......++||||+
T Consensus 44 ~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~ 123 (350)
T d1rdqe_ 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccc
Confidence 33468999999999999975 7999999998643 2233467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSH 693 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~ 693 (846)
.+|+|.+++...+. +++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 124 ~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~----- 193 (350)
T d1rdqe_ 124 AGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----- 193 (350)
T ss_dssp TTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-----
T ss_pred cccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-----
Confidence 99999999987653 899999999999999999999 89999999999999999999999999999987632
Q ss_pred ccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCCC
Q 003114 694 LSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDID 773 (846)
Q Consensus 694 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~~ 773 (846)
......||+.|+|||++.+..++.++|||||||++|||+||++||.+......+.. .. .+... .+
T Consensus 194 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----i~-~~~~~----------~p 258 (350)
T d1rdqe_ 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IV-SGKVR----------FP 258 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH-HCCCC----------CC
T ss_pred ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHH----Hh-cCCCC----------CC
Confidence 22346799999999999999999999999999999999999999986543332222 22 11111 11
Q ss_pred hHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 003114 774 VNSAWKAVEIAMGCVSHSSTPRP-----NMNRVVM 803 (846)
Q Consensus 774 ~~~~~~l~~L~~~Cl~~~P~~RP-----sm~eVl~ 803 (846)
......+.+++.+|++.||++|+ |++|+++
T Consensus 259 ~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 12334688999999999999994 8888875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-42 Score=371.97 Aligned_cols=244 Identities=23% Similarity=0.342 Sum_probs=199.6
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHHHHHHHHH-hcccccceeEeeEeecCCeeeEeeec
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFEAEVILLR-TVHHKNLTTLYGYCNEGNQIGLIYEY 612 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~~Ei~~l~-~l~HpnIv~l~g~~~~~~~~~LV~Ey 612 (846)
.+.+.||+|+||+||+|+.. +++.||||++++.. ....+.+..|..++. .++||||+++++++.+++..++||||
T Consensus 5 ~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy 84 (320)
T d1xjda_ 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY 84 (320)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEee
Confidence 45678999999999999975 78999999996432 223345666666654 68999999999999999999999999
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcc
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~ 692 (846)
+++|+|.++++.... +++.++..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++..... .
T Consensus 85 ~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--~ 157 (320)
T d1xjda_ 85 LNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--D 157 (320)
T ss_dssp CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--T
T ss_pred cCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccc--c
Confidence 999999999987654 889999999999999999999 889999999999999999999999999999865332 2
Q ss_pred cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCCCCC
Q 003114 693 HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLHGDI 772 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~~~~ 772 (846)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||.+......... . ..+. +..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~----i-~~~~------~~~---- 222 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----I-RMDN------PFY---- 222 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----H-HHCC------CCC----
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH----H-HcCC------CCC----
Confidence 333456799999999999999999999999999999999999999986554332221 1 1221 111
Q ss_pred ChHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 003114 773 DVNSAWKAVEIAMGCVSHSSTPRPNMN-RVVM 803 (846)
Q Consensus 773 ~~~~~~~l~~L~~~Cl~~~P~~RPsm~-eVl~ 803 (846)
+......+.+|+.+|++.+|++||++. |+++
T Consensus 223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 112234688999999999999999996 6753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-41 Score=376.35 Aligned_cols=245 Identities=23% Similarity=0.316 Sum_probs=194.6
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC---chhhHHHH---HHHHHHHhcccccceeEeeEeecCCeeeEee
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS---RQGYEQFE---AEVILLRTVHHKNLTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~~~---~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 610 (846)
.+.+.||+|+||.||+|+.. +|+.||||++.+.. ......+. +|+.+++.++|||||++++++.+++..++||
T Consensus 7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm 86 (364)
T d1omwa3 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 86 (364)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence 34578999999999999975 68999999986431 11122233 4467777788999999999999999999999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 87 E~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 87 DLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp CCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EecCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 99999999999987643 889999999999999999999 899999999999999999999999999999876432
Q ss_pred cccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccCCCCC
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVDPKLH 769 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~L~ 769 (846)
......||+.|+|||++.. ..++.++||||+||++|||+||+.||........ ....+ ..... ...
T Consensus 161 ---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~-~~~~~------~~~-- 227 (364)
T d1omwa3 161 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDR-MTLTM------AVE-- 227 (364)
T ss_dssp ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHHH-HSSSC------CCC--
T ss_pred ---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH-hcccC------CCC--
Confidence 2344679999999999864 5689999999999999999999999986543321 11111 11111 011
Q ss_pred CCCChHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 003114 770 GDIDVNSAWKAVEIAMGCVSHSSTPRPN-----MNRVVM 803 (846)
Q Consensus 770 ~~~~~~~~~~l~~L~~~Cl~~~P~~RPs-----m~eVl~ 803 (846)
.+......+.+++.+||+.+|++||| ++|+++
T Consensus 228 --~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 228 --LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11123346889999999999999999 577764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=363.13 Aligned_cols=259 Identities=21% Similarity=0.330 Sum_probs=200.2
Q ss_pred hhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCC
Q 003114 540 ETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANG 616 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 616 (846)
.+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|+.++++++||||+++++++.++++.++||||+.+
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~- 85 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ- 85 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-
Confidence 46899999999999997 578999999996543 22356789999999999999999999999999999999999965
Q ss_pred ChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCcccccc
Q 003114 617 SLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLST 696 (846)
Q Consensus 617 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~ 696 (846)
++.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 86 ~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--~~~~~ 160 (298)
T d1gz8a_ 86 DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYT 160 (298)
T ss_dssp EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--SBCTT
T ss_pred chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCC--cccce
Confidence 5555555554556999999999999999999999 899999999999999999999999999999865322 23344
Q ss_pred cccCCCcccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCc--ccc-cCCCCCCCC
Q 003114 697 GVAGTFGYLDPEYCQTFR-LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDI--KNI-VDPKLHGDI 772 (846)
Q Consensus 697 ~~~gt~~Y~APE~~~~~~-~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~--~~~-~d~~L~~~~ 772 (846)
...||+.|+|||.+.... ++.++||||+||++|||++|+.||...+....+............. ... ..+......
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccc
Confidence 567999999999876655 5889999999999999999999998766554444433322111100 000 000000000
Q ss_pred ------C-----hHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 773 ------D-----VNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 773 ------~-----~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
. ......+.+++.+|++.+|++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 1123567899999999999999999998764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.1e-41 Score=358.72 Aligned_cols=257 Identities=19% Similarity=0.303 Sum_probs=199.3
Q ss_pred hhhcCcCceEEEEEEEEcCCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccCCC
Q 003114 540 ETILGEGSFGKVYHGYLDDNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMANGS 617 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 617 (846)
.+.||+|+||+||+|+.++|+.||||++.... ....+.+.+|+.+|++++||||+++++++..++..++++|++.++.
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 46799999999999999999999999997653 2235789999999999999999999999999999999999998877
Q ss_pred hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccccc
Q 003114 618 LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLSTG 697 (846)
Q Consensus 618 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~ 697 (846)
+..+..... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.+...... ......
T Consensus 87 ~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~ 159 (286)
T d1ob3a_ 87 KKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTH 159 (286)
T ss_dssp HHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred HHHHHhhcC--CcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC--ccccce
Confidence 776665443 4999999999999999999999 889999999999999999999999999999875332 222334
Q ss_pred ccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--c---ccc--cCCCCC
Q 003114 698 VAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--I---KNI--VDPKLH 769 (846)
Q Consensus 698 ~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--~---~~~--~d~~L~ 769 (846)
..|++.|+|||.+.+. .++.++||||+||+++||++|+.||....+.+.+.+.......... . ... .+....
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence 5689999999988654 5789999999999999999999999877655555443332211100 0 000 000000
Q ss_pred -------CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 770 -------GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 770 -------~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..........+.+++.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011122356789999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=359.62 Aligned_cols=259 Identities=22% Similarity=0.329 Sum_probs=196.9
Q ss_pred hhhhhcCcCceEEEEEEEEc-C-CcEEEEEEeCCCC--chhhHHHHHHHHHHHhc---ccccceeEeeEee-----cCCe
Q 003114 538 DFETILGEGSFGKVYHGYLD-D-NTEVAVKMLSPSS--RQGYEQFEAEVILLRTV---HHKNLTTLYGYCN-----EGNQ 605 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~-g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~-----~~~~ 605 (846)
++.+.||+|+||+||+|+.. + ++.||||+++... ......+.+|+.+++.+ +||||++++++|. ....
T Consensus 10 ~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~ 89 (305)
T d1blxa_ 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89 (305)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCce
Confidence 34568999999999999973 4 6679999986432 22234566788777766 7999999999884 3457
Q ss_pred eeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCcc
Q 003114 606 IGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKT 685 (846)
Q Consensus 606 ~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~ 685 (846)
.+++|||++++.+...... ....+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.
T Consensus 90 ~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 90 LTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 8999999988766544433 3345899999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 003114 686 FPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765 (846)
Q Consensus 686 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 765 (846)
.. .........||+.|+|||++.+..++.++||||+||++|||++|++||......+.+.................+
T Consensus 166 ~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 166 YS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 42 233445678999999999999999999999999999999999999999877665555554443221111000000
Q ss_pred --------CCCC----CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 --------PKLH----GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 --------~~L~----~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.... ..........+.+|+.+|++.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 0011123356789999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=358.90 Aligned_cols=236 Identities=24% Similarity=0.383 Sum_probs=192.8
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCc------hhhHHHHHHHHHHHhcc--cccceeEeeEeecCCeeeE
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSR------QGYEQFEAEVILLRTVH--HKNLTTLYGYCNEGNQIGL 608 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~------~~~~~~~~Ei~~l~~l~--HpnIv~l~g~~~~~~~~~L 608 (846)
.+.+.||+|+||+||+|+.. +|+.||||++..... ....++.+|+.++++++ ||||+++++++.+++..++
T Consensus 7 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~l 86 (273)
T d1xwsa_ 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 86 (273)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEE
Confidence 45678999999999999974 789999999864321 12244678999999986 8999999999999999999
Q ss_pred eeecccC-CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-CCcEEEEeccCCccC
Q 003114 609 IYEYMAN-GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-QFQARLADFGLSKTF 686 (846)
Q Consensus 609 V~Ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-~~~vkI~DFGla~~~ 686 (846)
||||+.+ +++.+++..... +++.++..++.|+++||+||| +.+|+||||||+|||++. ++.+||+|||+++..
T Consensus 87 v~e~~~~~~~l~~~~~~~~~--l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 87 ILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeccCcchHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999976 578888876543 899999999999999999999 899999999999999985 579999999999865
Q ss_pred CCCCcccccccccCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 003114 687 PIEGVSHLSTGVAGTFGYLDPEYCQTFRL-TEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765 (846)
Q Consensus 687 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 765 (846)
.. .......||+.|+|||++.+..+ +.++||||+||++|||+||+.||..... .. .+.. .+.
T Consensus 162 ~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----------i~-~~~~--~~~ 224 (273)
T d1xwsa_ 162 KD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------II-RGQV--FFR 224 (273)
T ss_dssp CS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------HH-HCCC--CCS
T ss_pred cc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----------Hh-hccc--CCC
Confidence 32 22345679999999999987765 5779999999999999999999975321 11 1110 111
Q ss_pred CCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 ~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
.....++.+++.+|++.+|++|||++|+++
T Consensus 225 --------~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 225 --------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 122346889999999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-39 Score=357.18 Aligned_cols=260 Identities=21% Similarity=0.272 Sum_probs=195.0
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeEeeEeec------CCeeeEeee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE------GNQIGLIYE 611 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~------~~~~~LV~E 611 (846)
..++||+|+||+||+|+.. +|+.||||++..... ...+|+.+|++++||||+++++++.. ..+.++|||
T Consensus 24 ~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred eeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 3467999999999999975 689999999975432 23579999999999999999999843 335789999
Q ss_pred cccCCChhhhhhc-CCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC-cEEEEeccCCccCCCC
Q 003114 612 YMANGSLEEYLSD-SNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF-QARLADFGLSKTFPIE 689 (846)
Q Consensus 612 y~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~-~vkI~DFGla~~~~~~ 689 (846)
|++++.+..+... .....+++.++..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++.....
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 9987644443322 22345999999999999999999999 99999999999999999765 8999999999876332
Q ss_pred CcccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHh-------c--CC
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLA-------Q--GD 759 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~-------~--~~ 759 (846)
.......||..|+|||.+.+ ..++.++||||+||+++||++|++||......+.+..+++.... . ..
T Consensus 177 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 177 ---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp ---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred ---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 22334579999999998764 57899999999999999999999999877655555444332110 0 00
Q ss_pred cccccCCCCC-----CCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHh
Q 003114 760 IKNIVDPKLH-----GDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME--LKEC 808 (846)
Q Consensus 760 ~~~~~d~~L~-----~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~--L~~~ 808 (846)
.....-+... ..........+.+|+.+|++.||++|||+.|+++. ++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0000001110 01112234568899999999999999999999863 4443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.9e-39 Score=345.55 Aligned_cols=258 Identities=18% Similarity=0.227 Sum_probs=205.5
Q ss_pred hhhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCCchhhHHHHHHHHHHHhccc-ccceeEeeEeecCCeeeEeeecccC
Q 003114 538 DFETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHH-KNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
.+.+.||+|+||+||+|+.. +|+.||||++..... ..++.+|++.++.+.| +|++.+++++..+...++||||+ +
T Consensus 8 ~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~ 84 (293)
T d1csna_ 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 84 (293)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence 45678999999999999965 689999999865432 2457889999999965 89999999999999999999999 6
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECC-----CCcEEEEeccCCccCCCCC
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLND-----QFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~-----~~~vkI~DFGla~~~~~~~ 690 (846)
++|.+++..... .+++.++..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+|+.+....
T Consensus 85 ~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 85 PSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 899999876543 4899999999999999999999 999999999999999974 5789999999998764322
Q ss_pred cc-----cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHH--HHHhcCCcccc
Q 003114 691 VS-----HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVD--FMLAQGDIKNI 763 (846)
Q Consensus 691 ~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~--~~~~~~~~~~~ 763 (846)
.. .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.............+ .........+
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~- 239 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE- 239 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH-
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH-
Confidence 11 123346799999999999999999999999999999999999999986554333222211 1111111111
Q ss_pred cCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhhh
Q 003114 764 VDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLAM 811 (846)
Q Consensus 764 ~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~~ 811 (846)
+.. ..+.++.+++..|+..+|++||+++.+.+.|++++.-
T Consensus 240 ----l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 240 ----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp ----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----hcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 111 1234688999999999999999999999999887643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-39 Score=348.49 Aligned_cols=260 Identities=20% Similarity=0.272 Sum_probs=193.5
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeec--------CCeee
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE--------GNQIG 607 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--------~~~~~ 607 (846)
+.+.||+|+||+||+|+.. +|+.||||++... .....+++.+|+.+|++++||||+++++.+.. ....+
T Consensus 14 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~ 93 (318)
T d3blha1 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 93 (318)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEE
Confidence 4468999999999999974 7999999998644 23345678899999999999999999998754 34689
Q ss_pred EeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCC
Q 003114 608 LIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP 687 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~ 687 (846)
+||||++++.+........ .++...+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 94 iv~e~~~~~~~~~~~~~~~--~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 94 LVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp EEEECCCEEHHHHHTCTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEeccCCCccchhhhccc--ccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 9999998877765544433 4888999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCcc--cccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCC--ccc
Q 003114 688 IEGVS--HLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGD--IKN 762 (846)
Q Consensus 688 ~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~--~~~ 762 (846)
..... .......||+.|+|||.+.+. .++.++||||+||+++||++|++||....+...+....+....... ...
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 32221 222335799999999998765 6899999999999999999999999876654444433332211100 000
Q ss_pred ccCCCCC--------CCCChH-------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 763 IVDPKLH--------GDIDVN-------SAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 763 ~~d~~L~--------~~~~~~-------~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
....... ...... ....+++|+.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0000000 000111 1234678999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-39 Score=346.16 Aligned_cols=258 Identities=19% Similarity=0.253 Sum_probs=197.2
Q ss_pred hhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccceeE-eeEeecCCeeeEeeeccc
Q 003114 537 NDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLTTL-YGYCNEGNQIGLIYEYMA 614 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l-~g~~~~~~~~~LV~Ey~~ 614 (846)
+.+.+.||+|+||.||+|+. .+|+.||||++..... .+++..|+++++.++|+|++.. .++..+++..++||||+
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 34567899999999999997 4689999999875433 3568899999999987765554 55567788899999999
Q ss_pred CCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEEC---CCCcEEEEeccCCccCCCCCc
Q 003114 615 NGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLN---DQFQARLADFGLSKTFPIEGV 691 (846)
Q Consensus 615 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld---~~~~vkI~DFGla~~~~~~~~ 691 (846)
+++|.+.+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++ .+..+||+|||+|+.+.....
T Consensus 86 ~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 86 GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 567777665443 34899999999999999999999 89999999999999986 456799999999997643222
Q ss_pred c-----cccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHh--cCCccccc
Q 003114 692 S-----HLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLA--QGDIKNIV 764 (846)
Q Consensus 692 ~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~--~~~~~~~~ 764 (846)
. .......||+.|+|||.+.+..++.++|||||||+++||+||+.||.................. ......
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 239 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV-- 239 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH--
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH--
Confidence 1 2234567999999999999999999999999999999999999999865533322222111110 000011
Q ss_pred CCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHhhh
Q 003114 765 DPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVMELKECLA 810 (846)
Q Consensus 765 d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~L~~~l~ 810 (846)
+. ...+.++.+++..|++.+|++||++.++.+.|+.+..
T Consensus 240 ---~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 240 ---LC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ---HT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ---hc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 11 1223468899999999999999999999999988764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=348.82 Aligned_cols=258 Identities=21% Similarity=0.313 Sum_probs=194.6
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeecCC------eeeEe
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN------QIGLI 609 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------~~~LV 609 (846)
..+.||+|+||+||+|+.. +|+.||||+++.. +....+.+.+|+.+|+.++|||||+++++|...+ +.++|
T Consensus 22 ~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 101 (346)
T d1cm8a_ 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 101 (346)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEE
Confidence 3467999999999999974 6999999999754 3344567889999999999999999999987654 57999
Q ss_pred eecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCC
Q 003114 610 YEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIE 689 (846)
Q Consensus 610 ~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~ 689 (846)
|||+ +.+|..+++.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++|||+++....
T Consensus 102 ~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~- 173 (346)
T d1cm8a_ 102 MPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 173 (346)
T ss_dssp EECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred Eecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccCC-
Confidence 9999 56788777653 3999999999999999999999 89999999999999999999999999999986532
Q ss_pred CcccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhc-------CC--
Q 003114 690 GVSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQ-------GD-- 759 (846)
Q Consensus 690 ~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~-------~~-- 759 (846)
......||+.|+|||.+.+. .++.++||||+||+++||++|++||........+.......... ..
T Consensus 174 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 174 ----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp ----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred ----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 23456799999999988764 57899999999999999999999998776544443333221100 00
Q ss_pred --------cccccCCCCCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HHHhh
Q 003114 760 --------IKNIVDPKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME--LKECL 809 (846)
Q Consensus 760 --------~~~~~d~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~--L~~~l 809 (846)
..+.....+. .........+.+|+.+|+..||++|||++|+++. ++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000000000 0111223467899999999999999999999875 55543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-39 Score=349.14 Aligned_cols=250 Identities=23% Similarity=0.294 Sum_probs=203.4
Q ss_pred hhhhhhcCcCceEEEEEEEEc----CCcEEEEEEeCCCC----chhhHHHHHHHHHHHhccc-ccceeEeeEeecCCeee
Q 003114 537 NDFETILGEGSFGKVYHGYLD----DNTEVAVKMLSPSS----RQGYEQFEAEVILLRTVHH-KNLTTLYGYCNEGNQIG 607 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~----~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~ 607 (846)
+++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 455689999999999999852 47899999987532 2345678899999999976 89999999999999999
Q ss_pred EeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCC
Q 003114 608 LIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFP 687 (846)
Q Consensus 608 LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~ 687 (846)
+||||+.+|+|.+++..... ++......++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 99999999999999987654 678889999999999999999 8999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCcccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 003114 688 IEGVSHLSTGVAGTFGYLDPEYCQTF--RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD 765 (846)
Q Consensus 688 ~~~~~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 765 (846)
... ........|++.|+|||.+... .++.++||||+||++|||++|+.||.............+.......
T Consensus 181 ~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~------ 253 (322)
T d1vzoa_ 181 ADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------ 253 (322)
T ss_dssp GGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC------
T ss_pred ccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC------
Confidence 322 2233446799999999988654 4788999999999999999999999877666655555444332211
Q ss_pred CCCCCCCChHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 003114 766 PKLHGDIDVNSAWKAVEIAMGCVSHSSTPRPN-----MNRVVM 803 (846)
Q Consensus 766 ~~L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPs-----m~eVl~ 803 (846)
..+......+.+++.+|++.+|++||| ++|+++
T Consensus 254 -----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 -----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 112233457889999999999999995 677764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-39 Score=351.34 Aligned_cols=258 Identities=21% Similarity=0.335 Sum_probs=193.3
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC-chhhHHHHHHHHHHHhcccccceeEeeEeecCC----eeeEeeec
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS-RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGN----QIGLIYEY 612 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----~~~LV~Ey 612 (846)
..+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|+.+|+.++||||+++++++.... ..+++++|
T Consensus 12 ~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~ 91 (345)
T d1pmea_ 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH 91 (345)
T ss_dssp EEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe
Confidence 347899999999999986 489999999997653 344567899999999999999999999986543 23444566
Q ss_pred ccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCc-
Q 003114 613 MANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGV- 691 (846)
Q Consensus 613 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~- 691 (846)
+.+|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 92 ~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 92 LMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp CCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred ecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence 7799999999764 3899999999999999999999 89999999999999999999999999999986533222
Q ss_pred ccccccccCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCccc--------
Q 003114 692 SHLSTGVAGTFGYLDPEYCQT-FRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKN-------- 762 (846)
Q Consensus 692 ~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~-------- 762 (846)
........||+.|+|||.+.. ..++.++||||+||+++||++|++||................... ....
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 244 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP-SQEDLNCIINLK 244 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC-CHHHHHTCCCHH
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC-Chhhhhhhhhhh
Confidence 122345679999999998854 467899999999999999999999998765433332222211100 0000
Q ss_pred -----ccCCCCCCCCCh-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 763 -----IVDPKLHGDIDV-----NSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 763 -----~~d~~L~~~~~~-----~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
...+... ..+. ....++.+++.+|++.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 245 ARNYLLSLPHKN-KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHTSCCCC-CCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccCCccC-CCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 0000 112357899999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-38 Score=337.73 Aligned_cols=258 Identities=19% Similarity=0.265 Sum_probs=199.5
Q ss_pred hhhhcCcCceEEEEEEEEc-CCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeecCCeeeEeeecccC
Q 003114 539 FETILGEGSFGKVYHGYLD-DNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNEGNQIGLIYEYMAN 615 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 615 (846)
..+.||+|+||+||+|+.. +++.||||+++... ....+++.+|+.+++.++||||+++++++......++|+|++.+
T Consensus 6 ~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~ 85 (292)
T d1unla_ 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred eeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccc
Confidence 3468999999999999974 78899999986442 34467889999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCCccccc
Q 003114 616 GSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEGVSHLS 695 (846)
Q Consensus 616 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~ 695 (846)
++|..++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.++...... ...
T Consensus 86 ~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~--~~~ 158 (292)
T d1unla_ 86 DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCY 158 (292)
T ss_dssp EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--SCC
T ss_pred ccccccccccc--ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCC--ccc
Confidence 99988887654 3889999999999999999999 8999999999999999999999999999998764322 223
Q ss_pred ccccCCCcccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcc------cccC---
Q 003114 696 TGVAGTFGYLDPEYCQTFR-LTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIK------NIVD--- 765 (846)
Q Consensus 696 ~~~~gt~~Y~APE~~~~~~-~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~------~~~d--- 765 (846)
....++..|+|||.+.... ++.++||||+||+++||++|+.||...........-+.......... ...+
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 3446788999999887655 68999999999999999999998754433222222121111111000 0000
Q ss_pred -CCC-----CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 -PKL-----HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 -~~L-----~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
+.. ...........+.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00111223356789999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.8e-38 Score=342.06 Aligned_cols=252 Identities=18% Similarity=0.313 Sum_probs=192.6
Q ss_pred hhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-cccceeEeeEeec--CCeeeEeeecc
Q 003114 538 DFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-HKNLTTLYGYCNE--GNQIGLIYEYM 613 (846)
Q Consensus 538 ~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~--~~~~~LV~Ey~ 613 (846)
.+.+.||+|+||+||+|+. .+|+.||||+++... .+++.+|+.+|+.++ ||||+++++++.. ....++||||+
T Consensus 38 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 4457899999999999997 478999999997543 367889999999995 9999999999864 45689999999
Q ss_pred cCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCC-CcEEEEeccCCccCCCCCcc
Q 003114 614 ANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQ-FQARLADFGLSKTFPIEGVS 692 (846)
Q Consensus 614 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~-~~vkI~DFGla~~~~~~~~~ 692 (846)
.+++|..+.+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.+ ..+||+|||+++.....
T Consensus 115 ~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~--- 183 (328)
T d3bqca1 115 NNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--- 183 (328)
T ss_dssp CSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT---
T ss_pred CCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCC---
Confidence 9999987653 3899999999999999999999 8999999999999999865 46999999999865432
Q ss_pred cccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccccc-HHHHHHH--------HHhcCCcc-
Q 003114 693 HLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKH-ISQWVDF--------MLAQGDIK- 761 (846)
Q Consensus 693 ~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~-l~~~~~~--------~~~~~~~~- 761 (846)
.......||+.|+|||.+.+. .++.++||||+||+++||++|+.||........ ....... ........
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 223456789999999987765 479999999999999999999999976543221 1111110 00000000
Q ss_pred -----cccCCC--------CCCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 762 -----NIVDPK--------LHGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 762 -----~~~d~~--------L~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
...... ...........++.+|+.+|++.+|++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 000111223356789999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=344.37 Aligned_cols=254 Identities=20% Similarity=0.279 Sum_probs=187.5
Q ss_pred hhhcCcCceEEEEEEEEc-CCcEEEEEEeCCC--CchhhHHHHHHHHHHHhcccccceeEeeEeec------CCeeeEee
Q 003114 540 ETILGEGSFGKVYHGYLD-DNTEVAVKMLSPS--SRQGYEQFEAEVILLRTVHHKNLTTLYGYCNE------GNQIGLIY 610 (846)
Q Consensus 540 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~------~~~~~LV~ 610 (846)
.+.||+|+||+||+|+.. +|+.||||++... +....+.+.+|+.++++++||||+++++++.. ..+.++||
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence 468999999999999975 6999999999754 33445678899999999999999999999853 46899999
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
||+.++.+. .+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++|||+++....
T Consensus 102 Ey~~~~l~~-~~~~----~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~-- 171 (355)
T d2b1pa1 102 ELMDANLCQ-VIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 171 (355)
T ss_dssp ECCSEEHHH-HHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eccchHHHH-hhhc----CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcccc--
Confidence 999765444 4432 3889999999999999999999 89999999999999999999999999999886532
Q ss_pred cccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHH---------------
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFML--------------- 755 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~--------------- 755 (846)
........||+.|+|||.+.+..++.++||||+||+++||++|++||...+....+........
T Consensus 172 -~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 172 -SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred -ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 2333456789999999999999999999999999999999999999987654443333222111
Q ss_pred ---hcC-Cc-----ccccCCCCCCCC---ChHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 003114 756 ---AQG-DI-----KNIVDPKLHGDI---DVNSAWKAVEIAMGCVSHSSTPRPNMNRVVME 804 (846)
Q Consensus 756 ---~~~-~~-----~~~~d~~L~~~~---~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~~ 804 (846)
... .. ............ .......+.+|+.+|+..||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00 000100111101 12234578899999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-37 Score=340.30 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=192.4
Q ss_pred hhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCC--chhhHHHHHHHHHHHhcccccceeEeeEeec-----CCeeeEee
Q 003114 539 FETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSS--RQGYEQFEAEVILLRTVHHKNLTTLYGYCNE-----GNQIGLIY 610 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-----~~~~~LV~ 610 (846)
..+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|+.+|+.++||||+++++++.. ....++++
T Consensus 22 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~ 101 (348)
T d2gfsa1 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101 (348)
T ss_dssp EEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEE
Confidence 346899999999999996 479999999997543 3345678899999999999999999999853 33456777
Q ss_pred ecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEeccCCccCCCCC
Q 003114 611 EYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADFGLSKTFPIEG 690 (846)
Q Consensus 611 Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~~~~~~~ 690 (846)
+|+.+|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++|||++....
T Consensus 102 ~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~--- 172 (348)
T d2gfsa1 102 THLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--- 172 (348)
T ss_dssp EECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCT---
T ss_pred EeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccC---
Confidence 888899999999654 3999999999999999999999 8999999999999999999999999999997542
Q ss_pred cccccccccCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccccccHHHHHHHHHhcCCcccccC----
Q 003114 691 VSHLSTGVAGTFGYLDPEYCQTF-RLTEKSDVYSFGVVLLEIITSRPAIANTEEHKHISQWVDFMLAQGDIKNIVD---- 765 (846)
Q Consensus 691 ~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d---- 765 (846)
.......|++.|+|||...+. .++.++||||+||+++||++|++||.+.+................ .+...
T Consensus 173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~ 248 (348)
T d2gfsa1 173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG--AELLKKISS 248 (348)
T ss_dssp --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC--HHHHTTCCC
T ss_pred --cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC--hHHhhhccc
Confidence 233456789999999987665 468999999999999999999999987664443333322211100 00000
Q ss_pred -------CCCC--CCCC-----hHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 003114 766 -------PKLH--GDID-----VNSAWKAVEIAMGCVSHSSTPRPNMNRVVM 803 (846)
Q Consensus 766 -------~~L~--~~~~-----~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl~ 803 (846)
..+. .... ......+.+|+.+|++.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000 0000 112345789999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.8e-33 Score=308.08 Aligned_cols=265 Identities=23% Similarity=0.293 Sum_probs=190.6
Q ss_pred hhhhhhcCcCceEEEEEEEE-cCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-----------cccceeEeeEeec--
Q 003114 537 NDFETILGEGSFGKVYHGYL-DDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-----------HKNLTTLYGYCNE-- 602 (846)
Q Consensus 537 ~~f~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-----------HpnIv~l~g~~~~-- 602 (846)
+.+.+.||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|+.+++.++ |+||+++++++..
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 34567899999999999997 4799999999976532 3467788998888775 5789999988754
Q ss_pred CCeeeEeeecccCCC-hhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCC------cE
Q 003114 603 GNQIGLIYEYMANGS-LEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQF------QA 675 (846)
Q Consensus 603 ~~~~~LV~Ey~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~------~v 675 (846)
.....++++++..+. ............+++..+..++.|++.||+|||+ ..+|+||||||+|||++.++ .+
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccccee
Confidence 345666666665443 3333344445568899999999999999999993 37899999999999998654 49
Q ss_pred EEEeccCCccCCCCCcccccccccCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc------ccHHH
Q 003114 676 RLADFGLSKTFPIEGVSHLSTGVAGTFGYLDPEYCQTFRLTEKSDVYSFGVVLLEIITSRPAIANTEEH------KHISQ 749 (846)
Q Consensus 676 kI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvvl~ELltG~~p~~~~~~~------~~l~~ 749 (846)
+++|||.+..... ......||+.|+|||.+....++.++||||+||+++||++|+.||...... ..+..
T Consensus 172 kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 172 KIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 9999999976432 224467999999999999999999999999999999999999999754321 11222
Q ss_pred HHHHH-------HhcC-CcccccCC-----CC--------------CCCCChHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 003114 750 WVDFM-------LAQG-DIKNIVDP-----KL--------------HGDIDVNSAWKAVEIAMGCVSHSSTPRPNMNRVV 802 (846)
Q Consensus 750 ~~~~~-------~~~~-~~~~~~d~-----~L--------------~~~~~~~~~~~l~~L~~~Cl~~~P~~RPsm~eVl 802 (846)
.+... .... ......+. .+ ...........+.+|+.+|++.||++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 21111 0000 00000000 00 1122345667889999999999999999999998
Q ss_pred HH--HHHhh
Q 003114 803 ME--LKECL 809 (846)
Q Consensus 803 ~~--L~~~l 809 (846)
+. +++..
T Consensus 327 ~Hp~f~~~~ 335 (362)
T d1q8ya_ 327 NHPWLKDTL 335 (362)
T ss_dssp TCGGGTTCT
T ss_pred cCcccCCCC
Confidence 74 55444
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=4.3e-21 Score=191.43 Aligned_cols=162 Identities=17% Similarity=0.220 Sum_probs=119.6
Q ss_pred hhhhcCcCceEEEEEEEEcCCcEEEEEEeCCCCc------------------hhhHHHHHHHHHHHhcccccceeEeeEe
Q 003114 539 FETILGEGSFGKVYHGYLDDNTEVAVKMLSPSSR------------------QGYEQFEAEVILLRTVHHKNLTTLYGYC 600 (846)
Q Consensus 539 f~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~------------------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 600 (846)
+.+.||+|+||+||+|+..+|++||||+++.... ........|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4578999999999999998999999998753210 0122345688889999999999888664
Q ss_pred ecCCeeeEeeecccCCChhhhhhcCCCCccChHHHHHHHHHHHHHHHHHhccCCCCeeecCCCCCCEEECCCCcEEEEec
Q 003114 601 NEGNQIGLIYEYMANGSLEEYLSDSNADVLSWEGRLRIATEAAQGLEYLHLGCKPPRVHRDIKPANILLNDQFQARLADF 680 (846)
Q Consensus 601 ~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~IiHrDlKp~NILld~~~~vkI~DF 680 (846)
. .+++|||+++..+.+ ++......++.|++++++||| +.+|+||||||+|||++++ .++|+||
T Consensus 84 ~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 84 G----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp T----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred C----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence 3 379999998765433 444556789999999999999 8999999999999999976 4899999
Q ss_pred cCCccCCCCCcccccccccCCCcccCc------cccccCCCCchhhHHHHHHHH
Q 003114 681 GLSKTFPIEGVSHLSTGVAGTFGYLDP------EYCQTFRLTEKSDVYSFGVVL 728 (846)
Q Consensus 681 Gla~~~~~~~~~~~~~~~~gt~~Y~AP------E~~~~~~~s~ksDVwS~Gvvl 728 (846)
|+|......... .|... |. ..++++.++|+||..--+
T Consensus 147 G~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 999765322111 11111 11 134678889999975443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.72 E-value=1.4e-18 Score=186.26 Aligned_cols=128 Identities=29% Similarity=0.469 Sum_probs=113.8
Q ss_pred ccchhhHHHHHHHHhhcC----CCCCC--CCCCCCCCCCceEEeecCCCCCCCceEEEEcCCCCCcc--cCCccccCCCC
Q 003114 341 ETEQADVDAIMNIKSLYK----RKDWQ--GDPCAPQAFLWNGLGCSYNDNDPPRITSLNLSSRGLTG--GIPPYLSNLTM 412 (846)
Q Consensus 341 ~~~~~d~~al~~~k~~~~----~~~W~--~dpC~~~~~~w~gv~C~~~~~~~~~l~~L~L~~n~l~g--~ip~~~~~L~~ 412 (846)
-|.++|++||++||+.+. ..+|. +||| .+.|.||+|+.. +...+|+.|+|++|+++| .||++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C---~~~w~gv~C~~~-~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~ 77 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCC---NRTWLGVLCDTD-TQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTT---TTCSTTEEECCS-SSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCC---CCcCCCeEEeCC-CCcEEEEEEECCCCCCCCCCCCChHHhcCcc
Confidence 488999999999999886 56894 4666 246999999853 456699999999999998 58999999999
Q ss_pred CCeEeccC-CCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCCccccCC
Q 003114 413 IEHLDLSN-NSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVDLCS 472 (846)
Q Consensus 413 L~~L~Ls~-N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~nlc~ 472 (846)
|++|+|++ |+++|.||.+|++|++|++|+|++|+|+|..|..+..+.+|+.++++.|...
T Consensus 78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~ 138 (313)
T d1ogqa_ 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS 138 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEE
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccccccc
Confidence 99999996 8999999999999999999999999999999999999999999999887543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.23 E-value=4.2e-12 Score=125.36 Aligned_cols=104 Identities=19% Similarity=0.172 Sum_probs=91.8
Q ss_pred CCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCc-cccCCCCCCeEeccCCCCCCCCCchhcccCcccccccc
Q 003114 371 AFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPP-YLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443 (846)
Q Consensus 371 ~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~-~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls 443 (846)
.|.|..|.|++.+ +.+.+++.|+|++|+|++.++. .|+++++|+.|+|++|++++..+..|..+++|+.|+|+
T Consensus 7 ~C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred EEcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 3479999998752 4567899999999999986654 68999999999999999999999999999999999999
Q ss_pred CccCCCCCcccccccCCCCCCCCccccCCCC
Q 003114 444 GNMLTGPLPAGLVERSKNGSLSLSVDLCSSY 474 (846)
Q Consensus 444 ~N~l~g~iP~~~~~l~~l~~l~l~~nlc~~~ 474 (846)
+|+|++..|..|.++++|+.|+|++|.....
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i 117 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCV 117 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEE
T ss_pred cccccccCHHHHhCCCcccccccCCcccccc
Confidence 9999976677899999999999999977653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.04 E-value=1.4e-10 Score=110.32 Aligned_cols=98 Identities=22% Similarity=0.184 Sum_probs=83.4
Q ss_pred CceEEeecCCC--------CCCCceEEEEcCCCC-CcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCcccccccc
Q 003114 373 LWNGLGCSYND--------NDPPRITSLNLSSRG-LTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLT 443 (846)
Q Consensus 373 ~w~gv~C~~~~--------~~~~~l~~L~L~~n~-l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls 443 (846)
.+.+|+|+..+ ....+++.|+|++|+ |+..-+..|.+|++|+.|+|++|+|+..-|..|..+++|+.|+|+
T Consensus 9 ~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 57889999753 233688999998764 885555679999999999999999997778999999999999999
Q ss_pred CccCCCCCcccccccCCCCCCCCccccC
Q 003114 444 GNMLTGPLPAGLVERSKNGSLSLSVDLC 471 (846)
Q Consensus 444 ~N~l~g~iP~~~~~l~~l~~l~l~~nlc 471 (846)
+|+|+ .+|.......+|+.|+|++|..
T Consensus 89 ~N~l~-~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 89 FNALE-SLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp SSCCS-CCCSTTTCSCCCCEEECCSSCC
T ss_pred CCCCc-ccChhhhccccccccccCCCcc
Confidence 99999 7888777777899999999854
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=98.98 E-value=9.1e-11 Score=124.45 Aligned_cols=88 Identities=23% Similarity=0.339 Sum_probs=79.7
Q ss_pred CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCC
Q 003114 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGS 463 (846)
Q Consensus 384 ~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~ 463 (846)
....+++.|++++|+++|.+| .++.+++|+.|+|++|+|+|.+|+.|++|++|++|||++|+|+|.+|+ ++++++|+.
T Consensus 218 ~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~ 295 (313)
T d1ogqa_ 218 GSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDV 295 (313)
T ss_dssp CTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCG
T ss_pred ccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCH
Confidence 345689999999999998765 699999999999999999999999999999999999999999999995 688999999
Q ss_pred CCCcccc--CCC
Q 003114 464 LSLSVDL--CSS 473 (846)
Q Consensus 464 l~l~~nl--c~~ 473 (846)
+++++|. |+.
T Consensus 296 l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 296 SAYANNKCLCGS 307 (313)
T ss_dssp GGTCSSSEEEST
T ss_pred HHhCCCccccCC
Confidence 9999985 554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.93 E-value=5.9e-10 Score=101.59 Aligned_cols=82 Identities=30% Similarity=0.328 Sum_probs=55.1
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCc--ccccccCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLP--AGLVERSKNGS 463 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP--~~~~~l~~l~~ 463 (846)
..+++.|+|++|+|+ .+|+.|+.+++|+.|+|++|+|+ .+|+ ++++++|+.|++++|+|+. +| ..+..+++|+.
T Consensus 19 l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N~i~~-~~~~~~l~~~~~L~~ 94 (124)
T d1dcea3 19 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQ-SAAIQPLVSCPRLVL 94 (124)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCCS-SSTTGGGGGCTTCCE
T ss_pred CCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCc-cccccccCeEECCCCccCC-CCCchhhcCCCCCCE
Confidence 346677777777776 56666777777777777777776 3443 6777777777777777763 33 35666777777
Q ss_pred CCCccccC
Q 003114 464 LSLSVDLC 471 (846)
Q Consensus 464 l~l~~nlc 471 (846)
|++++|.+
T Consensus 95 L~l~~N~i 102 (124)
T d1dcea3 95 LNLQGNSL 102 (124)
T ss_dssp EECTTSGG
T ss_pred EECCCCcC
Confidence 77776654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.91 E-value=7.1e-10 Score=101.04 Aligned_cols=81 Identities=30% Similarity=0.411 Sum_probs=72.4
Q ss_pred EEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCCccc
Q 003114 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSVD 469 (846)
Q Consensus 390 ~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~n 469 (846)
+.|+|++|+|+ .++ .+.+|++|++|+|++|+|+ .+|+.++.+++|+.|+|++|+|+ .+| ++..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 36999999999 666 5999999999999999999 78989999999999999999999 566 5999999999999999
Q ss_pred cCCCCC
Q 003114 470 LCSSYP 475 (846)
Q Consensus 470 lc~~~p 475 (846)
.....+
T Consensus 76 ~i~~~~ 81 (124)
T d1dcea3 76 RLQQSA 81 (124)
T ss_dssp CCCSSS
T ss_pred ccCCCC
Confidence 876543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=98.90 E-value=3.4e-10 Score=111.36 Aligned_cols=87 Identities=24% Similarity=0.340 Sum_probs=80.5
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
..++|+.|+|++|++++..+..|..+++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..|..+++|+.|
T Consensus 52 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l 131 (192)
T d1w8aa_ 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131 (192)
T ss_dssp GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred CCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccc
Confidence 35689999999999999999999999999999999999998888899999999999999999997777789999999999
Q ss_pred CCccccC
Q 003114 465 SLSVDLC 471 (846)
Q Consensus 465 ~l~~nlc 471 (846)
+|++|.-
T Consensus 132 ~L~~N~~ 138 (192)
T d1w8aa_ 132 NLASNPF 138 (192)
T ss_dssp ECTTCCB
T ss_pred ccccccc
Confidence 9998854
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.70 E-value=6.5e-09 Score=107.33 Aligned_cols=95 Identities=25% Similarity=0.221 Sum_probs=81.6
Q ss_pred EEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCC
Q 003114 376 GLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTG 449 (846)
Q Consensus 376 gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g 449 (846)
-|.|++.+ +.+++++.|+|++|+|++..+..|.+|++|+.|+|++|+|+ .+|. ++.+++|+.|+|++|+|+
T Consensus 14 ~v~C~~~~L~~iP~~lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~- 90 (266)
T d1p9ag_ 14 EVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ- 90 (266)
T ss_dssp EEECTTSCCSSCCSCCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCS-
T ss_pred EEEccCCCCCeeCcCcCcCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccccccccc-
Confidence 48887642 45678999999999999766678999999999999999998 5664 689999999999999999
Q ss_pred CCcccccccCCCCCCCCccccCCC
Q 003114 450 PLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 450 ~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
.+|..+..+++|+.|+++.|....
T Consensus 91 ~~~~~~~~l~~L~~L~l~~~~~~~ 114 (266)
T d1p9ag_ 91 SLPLLGQTLPALTVLDVSFNRLTS 114 (266)
T ss_dssp SCCCCTTTCTTCCEEECCSSCCCC
T ss_pred ccccccccccccccccccccccce
Confidence 568889999999999999876544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.68 E-value=5.5e-09 Score=99.68 Aligned_cols=83 Identities=18% Similarity=0.187 Sum_probs=64.0
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCccc-ccccCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAG-LVERSKNGSL 464 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~-~~~l~~l~~l 464 (846)
+.+++.|+|++|+|+ .||..+..+++|+.|+|++|+|+ .++ .|..+++|+.|+|++|+|+ .+|.. +..+++|+.|
T Consensus 17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTEL 92 (162)
T ss_dssp TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEE
T ss_pred cCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhccccccc-CCCccccccccccccc
Confidence 457788888888888 56766778888888888888888 554 4788888888888888888 45444 4568888888
Q ss_pred CCccccCC
Q 003114 465 SLSVDLCS 472 (846)
Q Consensus 465 ~l~~nlc~ 472 (846)
++++|...
T Consensus 93 ~L~~N~i~ 100 (162)
T d1a9na_ 93 ILTNNSLV 100 (162)
T ss_dssp ECCSCCCC
T ss_pred eecccccc
Confidence 88887654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.66 E-value=1.8e-08 Score=105.83 Aligned_cols=99 Identities=23% Similarity=0.242 Sum_probs=81.5
Q ss_pred CCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccC
Q 003114 371 AFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTG 444 (846)
Q Consensus 371 ~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~ 444 (846)
.|.|++|.|++.+ +.++.++.|+|++|+|+...+.+|.+|++|+.|++++|.++...|..|.++++|+.|+|++
T Consensus 9 ~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 9 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 4689999998742 3467899999999999954445799999999999999999987789999999999999999
Q ss_pred ccCCCCCcccccccCCCCCCCCccccCC
Q 003114 445 NMLTGPLPAGLVERSKNGSLSLSVDLCS 472 (846)
Q Consensus 445 N~l~g~iP~~~~~l~~l~~l~l~~nlc~ 472 (846)
|+|+ .+|..+. ..+..|.+..|...
T Consensus 89 n~l~-~l~~~~~--~~l~~L~~~~n~l~ 113 (305)
T d1xkua_ 89 NQLK-ELPEKMP--KTLQELRVHENEIT 113 (305)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCC
T ss_pred CccC-cCccchh--hhhhhhhccccchh
Confidence 9999 6776543 45666666665443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.59 E-value=1.3e-08 Score=96.89 Aligned_cols=84 Identities=18% Similarity=0.139 Sum_probs=72.6
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcc--cccccCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPA--GLVERSKNGS 463 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~--~~~~l~~l~~ 463 (846)
..+++.|+|++|+|+ .++ .|..|++|+.|+|++|+|+...|..+..+++|+.|+|++|+|+ .+++ .+..+++|+.
T Consensus 40 l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~ 116 (162)
T d1a9na_ 40 LDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTY 116 (162)
T ss_dssp TTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCE
T ss_pred cccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccch
Confidence 458999999999999 564 5999999999999999999655566788999999999999998 5553 6888999999
Q ss_pred CCCccccCC
Q 003114 464 LSLSVDLCS 472 (846)
Q Consensus 464 l~l~~nlc~ 472 (846)
|++++|.+.
T Consensus 117 L~l~~N~i~ 125 (162)
T d1a9na_ 117 LCILRNPVT 125 (162)
T ss_dssp EECCSSGGG
T ss_pred hhcCCCccc
Confidence 999998664
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.57 E-value=1.6e-08 Score=105.15 Aligned_cols=85 Identities=20% Similarity=0.149 Sum_probs=72.2
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
..+++.|+|++|+|++..+..|.++++|+.|+|++|++++..|..|.++++|+.||+++|++++..|..+..+++|+.|+
T Consensus 152 ~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~ 231 (284)
T d1ozna_ 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR 231 (284)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEE
T ss_pred ccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEE
Confidence 35788888888888877777888888888888888888888888888888888888888888877778888888888888
Q ss_pred Ccccc
Q 003114 466 LSVDL 470 (846)
Q Consensus 466 l~~nl 470 (846)
+++|.
T Consensus 232 l~~N~ 236 (284)
T d1ozna_ 232 LNDNP 236 (284)
T ss_dssp CCSSC
T ss_pred ecCCC
Confidence 88874
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.57 E-value=2.9e-08 Score=102.33 Aligned_cols=86 Identities=26% Similarity=0.249 Sum_probs=79.3
Q ss_pred CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCC
Q 003114 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGS 463 (846)
Q Consensus 384 ~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~ 463 (846)
....++..|++++|.+++..+..+..+++|+.|++++|+|++..|..|..+++|+.|+|++|+|+ .+|+++..+++|+.
T Consensus 121 ~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~ 199 (266)
T d1p9ag_ 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPF 199 (266)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSE
T ss_pred ccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCE
Confidence 34568899999999999776777899999999999999999888889999999999999999999 89999999999999
Q ss_pred CCCcccc
Q 003114 464 LSLSVDL 470 (846)
Q Consensus 464 l~l~~nl 470 (846)
|+|++|.
T Consensus 200 L~L~~Np 206 (266)
T d1p9ag_ 200 AFLHGNP 206 (266)
T ss_dssp EECCSCC
T ss_pred EEecCCC
Confidence 9999995
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.44 E-value=8e-08 Score=100.69 Aligned_cols=88 Identities=28% Similarity=0.325 Sum_probs=73.2
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
..++++.|+|++|.+++.++..|.+++.++.|++++|.+++..|..+.++++|++|+|++|+|+ .+|+++..+++|+.|
T Consensus 169 ~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L 247 (305)
T d1xkua_ 169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 247 (305)
T ss_dssp CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEE
T ss_pred cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEE
Confidence 4567888888888888888888888888888888888888777888888888888888888888 678888888888888
Q ss_pred CCccccCCC
Q 003114 465 SLSVDLCSS 473 (846)
Q Consensus 465 ~l~~nlc~~ 473 (846)
++++|....
T Consensus 248 ~Ls~N~i~~ 256 (305)
T d1xkua_ 248 YLHNNNISA 256 (305)
T ss_dssp ECCSSCCCC
T ss_pred ECCCCccCc
Confidence 888876544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=7.9e-08 Score=99.81 Aligned_cols=91 Identities=19% Similarity=0.147 Sum_probs=82.7
Q ss_pred CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCC
Q 003114 384 NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGS 463 (846)
Q Consensus 384 ~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~ 463 (846)
.....++.+++++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|..+++|+.
T Consensus 126 ~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~ 205 (284)
T d1ozna_ 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205 (284)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred chhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccc
Confidence 44568999999999999766778999999999999999999888899999999999999999999988999999999999
Q ss_pred CCCccccCCCC
Q 003114 464 LSLSVDLCSSY 474 (846)
Q Consensus 464 l~l~~nlc~~~ 474 (846)
|+++.|.....
T Consensus 206 L~l~~N~i~~~ 216 (284)
T d1ozna_ 206 LYLFANNLSAL 216 (284)
T ss_dssp EECCSSCCSCC
T ss_pred ccccccccccc
Confidence 99999876553
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.36 E-value=1.1e-07 Score=102.37 Aligned_cols=79 Identities=23% Similarity=0.273 Sum_probs=69.1
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
...+++.|+|++|++++.. .+..+++|+.|+|++|+|++ +| .|++|++|+.|+|++|+|++..| +.++++|+.|
T Consensus 305 ~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L 378 (384)
T d2omza2 305 NLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQL 378 (384)
T ss_dssp GCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEE
T ss_pred hhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEe
Confidence 3467899999999999753 38999999999999999994 66 59999999999999999996554 8899999999
Q ss_pred CCccc
Q 003114 465 SLSVD 469 (846)
Q Consensus 465 ~l~~n 469 (846)
++++|
T Consensus 379 ~L~~N 383 (384)
T d2omza2 379 GLNDQ 383 (384)
T ss_dssp ECCCE
T ss_pred eCCCC
Confidence 99987
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.28 E-value=1.7e-07 Score=94.45 Aligned_cols=104 Identities=15% Similarity=0.103 Sum_probs=85.7
Q ss_pred CCCCceEEeecCCC------CCCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCC-chhcccCccccccc
Q 003114 370 QAFLWNGLGCSYND------NDPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVP-EFLSKLQYLRVLNL 442 (846)
Q Consensus 370 ~~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP-~~~~~l~~L~~L~L 442 (846)
|.|+...|.|++.+ +.+.+++.|+|++|+|+...+..|.+|++|++|+|++|.+...+| ..|.++++|+.|++
T Consensus 6 C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~ 85 (242)
T d1xwdc1 6 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85 (242)
T ss_dssp EEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred CCCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence 35678899998642 344689999999999995445579999999999999999987665 57899999999997
Q ss_pred c-CccCCCCCcccccccCCCCCCCCccccCCC
Q 003114 443 T-GNMLTGPLPAGLVERSKNGSLSLSVDLCSS 473 (846)
Q Consensus 443 s-~N~l~g~iP~~~~~l~~l~~l~l~~nlc~~ 473 (846)
. .|++....|..+..+++|+.++++.|....
T Consensus 86 ~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~ 117 (242)
T d1xwdc1 86 EKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117 (242)
T ss_dssp ECCTTCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred cccccccccccccccccccccccccchhhhcc
Confidence 6 478887777889999999999999886543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.27 E-value=3.3e-07 Score=86.32 Aligned_cols=85 Identities=20% Similarity=0.134 Sum_probs=74.1
Q ss_pred EEEEcCCCCCcccCCccccCCCCCCeEeccCC-CCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCCcc
Q 003114 390 TSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNN-SLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLSV 468 (846)
Q Consensus 390 ~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N-~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~~ 468 (846)
+.++.++++++ .+|..+..+++|+.|+|++| .|+..-+..|.+|++|+.|+|++|+|+..-|..|..+++|+.|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 35899999998 78889999999999999866 48855567899999999999999999966678899999999999999
Q ss_pred ccCCCCC
Q 003114 469 DLCSSYP 475 (846)
Q Consensus 469 nlc~~~p 475 (846)
|.....+
T Consensus 90 N~l~~l~ 96 (156)
T d2ifga3 90 NALESLS 96 (156)
T ss_dssp SCCSCCC
T ss_pred CCCcccC
Confidence 9876544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.19 E-value=5.4e-07 Score=90.02 Aligned_cols=77 Identities=18% Similarity=0.274 Sum_probs=64.8
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCC
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSL 464 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l 464 (846)
...+++.|++++|.+++.. .+++|++|+.|+|++|++++ +|. ++++++|+.|+|++|+|+ .+| .+.++++|+.|
T Consensus 149 ~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt-~i~-~l~~l~~L~~L 222 (227)
T d1h6ua2 149 GLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQIS-DVS-PLANTSNLFIV 222 (227)
T ss_dssp GCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCC-BCG-GGTTCTTCCEE
T ss_pred cccccccccccccccccch--hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCC-CCc-ccccCCCCCEE
Confidence 3457899999999998433 38999999999999999995 554 899999999999999999 465 38889999988
Q ss_pred CCc
Q 003114 465 SLS 467 (846)
Q Consensus 465 ~l~ 467 (846)
+++
T Consensus 223 ~ls 225 (227)
T d1h6ua2 223 TLT 225 (227)
T ss_dssp EEE
T ss_pred Eee
Confidence 876
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.08 E-value=7e-08 Score=94.93 Aligned_cols=83 Identities=19% Similarity=0.216 Sum_probs=67.5
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
..+|+.|+|++|+|+ .++ .|..|++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .++ .+..+++|+.|+
T Consensus 47 L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~ 121 (198)
T d1m9la_ 47 LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEE
T ss_pred ccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccc
Confidence 457889999999998 565 5888999999999999988 67876777778999999999988 343 577888888898
Q ss_pred CccccCCC
Q 003114 466 LSVDLCSS 473 (846)
Q Consensus 466 l~~nlc~~ 473 (846)
+++|.+..
T Consensus 122 L~~N~i~~ 129 (198)
T d1m9la_ 122 MSNNKITN 129 (198)
T ss_dssp ESEEECCC
T ss_pred cccchhcc
Confidence 88886653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.02 E-value=2.4e-06 Score=83.49 Aligned_cols=77 Identities=30% Similarity=0.379 Sum_probs=35.5
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
++|+.|+|++|+|++. ++ +++|++|+.|++++|.+. .+|. +.++++|+.|++++|.+... ..+..+++|+.|++
T Consensus 62 ~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l 135 (199)
T d2omxa2 62 NNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLEL 135 (199)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEEC
T ss_pred CCcCcCccccccccCc-cc-ccCCcccccccccccccc-cccc-cccccccccccccccccccc--cccchhhhhHHhhh
Confidence 3445555555555432 21 445555555555555544 2332 44555555555555544421 12444445555555
Q ss_pred ccc
Q 003114 467 SVD 469 (846)
Q Consensus 467 ~~n 469 (846)
+.|
T Consensus 136 ~~n 138 (199)
T d2omxa2 136 SSN 138 (199)
T ss_dssp CSS
T ss_pred hhh
Confidence 444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.00 E-value=2.9e-06 Score=83.68 Aligned_cols=78 Identities=26% Similarity=0.272 Sum_probs=47.3
Q ss_pred ceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCCc
Q 003114 388 RITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSLS 467 (846)
Q Consensus 388 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l~ 467 (846)
.++.|++++|++++ ++ .+..|++|+.|+|++|+|++ +|. +++|++|+.|+|++|+|+ .+| .+..+++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~~-~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-ccc-cccCcccccccccccccc-ccc-cccccccccccccc
Confidence 45666666666663 32 35666666666666666664 332 566666666666666666 344 46666666666666
Q ss_pred cccC
Q 003114 468 VDLC 471 (846)
Q Consensus 468 ~nlc 471 (846)
.|..
T Consensus 121 ~~~~ 124 (210)
T d1h6ta2 121 HNGI 124 (210)
T ss_dssp TSCC
T ss_pred cccc
Confidence 5543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.97 E-value=1.9e-05 Score=79.94 Aligned_cols=130 Identities=18% Similarity=0.136 Sum_probs=90.2
Q ss_pred ceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcc-cccceeEeeEeecCCeeeEeeecccCCChhhhhhcC
Q 003114 547 SFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVH-HKNLTTLYGYCNEGNQIGLIYEYMANGSLEEYLSDS 625 (846)
Q Consensus 547 ~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~ 625 (846)
+.+.||+... ++..+.+|+...........+.+|...++.+. +--+-+++.+...++..++||+++++.++.+.....
T Consensus 26 s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~ 104 (263)
T d1j7la_ 26 SPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE 104 (263)
T ss_dssp SSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred CCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence 3468998764 55667888887655444556788888887774 333566778888888999999999998876544221
Q ss_pred CCCccChHHHHHHHHHHHHHHHHHhcc-----------------------------------------------------
Q 003114 626 NADVLSWEGRLRIATEAAQGLEYLHLG----------------------------------------------------- 652 (846)
Q Consensus 626 ~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------------------- 652 (846)
.....++.++++.+..||..
T Consensus 105 -------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (263)
T d1j7la_ 105 -------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE 177 (263)
T ss_dssp -------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred -------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence 11233445555555555521
Q ss_pred ---CCCCeeecCCCCCCEEECCCCcEEEEeccCCc
Q 003114 653 ---CKPPRVHRDIKPANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 653 ---~~~~IiHrDlKp~NILld~~~~vkI~DFGla~ 684 (846)
....++|+|+.|.||+++++..+-|.||+.+.
T Consensus 178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01237899999999999987767799999875
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=97.96 E-value=3.2e-06 Score=90.45 Aligned_cols=81 Identities=21% Similarity=0.315 Sum_probs=68.8
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
.+|+.|+|++++|+ .+ +.+..|++|++|+|++|+|++ +|. |++|++|++|+|++|++++ ++ .+..+++|+.|++
T Consensus 44 ~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~i~~-i~-~l~~l~~L~~L~~ 117 (384)
T d2omza2 44 DQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTL 117 (384)
T ss_dssp TTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCCC-Ccc-ccCCccccccccccccccc-cc-ccccccccccccc
Confidence 47999999999998 45 468999999999999999995 554 9999999999999999995 44 3889999999998
Q ss_pred ccccCCC
Q 003114 467 SVDLCSS 473 (846)
Q Consensus 467 ~~nlc~~ 473 (846)
+.|....
T Consensus 118 ~~~~~~~ 124 (384)
T d2omza2 118 FNNQITD 124 (384)
T ss_dssp CSSCCCC
T ss_pred ccccccc
Confidence 8775543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.95 E-value=2.9e-06 Score=83.63 Aligned_cols=76 Identities=29% Similarity=0.382 Sum_probs=58.1
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
.+.++.+++++|++++ +..++.+++|+.|++++|++++ +++ ++++++|+.|+|++|+|+ .+| ++..+++|+.|+
T Consensus 133 l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~ 206 (210)
T d1h6ta2 133 LPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLE 206 (210)
T ss_dssp CTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEE
T ss_pred cccccccccccccccc--cccccccccccccccccccccc-ccc-ccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEE
Confidence 3567888888888874 3457778888888888888885 443 788888888888888887 566 577888888887
Q ss_pred Cc
Q 003114 466 LS 467 (846)
Q Consensus 466 l~ 467 (846)
++
T Consensus 207 Ls 208 (210)
T d1h6ta2 207 LF 208 (210)
T ss_dssp EE
T ss_pred cc
Confidence 65
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=97.94 E-value=1.4e-07 Score=92.74 Aligned_cols=83 Identities=23% Similarity=0.191 Sum_probs=71.9
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCc--ccccccCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLP--AGLVERSKNGS 463 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP--~~~~~l~~l~~ 463 (846)
..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+. ++ .+.++++|+.|+|++|+|+ .++ ..+..+++|+.
T Consensus 69 l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~ 144 (198)
T d1m9la_ 69 MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLED 144 (198)
T ss_dssp HTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSE
T ss_pred CccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccccccchhc-cccccccccCCCccce
Confidence 358999999999998 788777778899999999999994 54 4899999999999999998 455 46889999999
Q ss_pred CCCccccCC
Q 003114 464 LSLSVDLCS 472 (846)
Q Consensus 464 l~l~~nlc~ 472 (846)
|++++|.+.
T Consensus 145 L~L~~N~l~ 153 (198)
T d1m9la_ 145 LLLAGNPLY 153 (198)
T ss_dssp EEECSSHHH
T ss_pred eecCCCccc
Confidence 999998653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.90 E-value=6.3e-06 Score=80.39 Aligned_cols=79 Identities=22% Similarity=0.287 Sum_probs=64.4
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
.+++.|+|++|+++ .++ .+..|++|++|+|++|+|++. +. +++|++|+.|++++|.+. .+| .+..++.|+.|++
T Consensus 40 ~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCc-cc-ccCCcccccccccccccc-ccc-ccccccccccccc
Confidence 47889999999988 454 588899999999999999864 43 889999999999999988 455 4788888988888
Q ss_pred ccccC
Q 003114 467 SVDLC 471 (846)
Q Consensus 467 ~~nlc 471 (846)
+.|.-
T Consensus 114 ~~~~~ 118 (199)
T d2omxa2 114 FNNQI 118 (199)
T ss_dssp CSSCC
T ss_pred ccccc
Confidence 76543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.73 E-value=3.7e-06 Score=79.39 Aligned_cols=64 Identities=28% Similarity=0.302 Sum_probs=32.3
Q ss_pred ccCCCCCCeEeccCCCCCCC--CCchhcccCccccccccCccCCCCCcc-cccccCCCCCCCCccccC
Q 003114 407 LSNLTMIEHLDLSNNSLTGP--VPEFLSKLQYLRVLNLTGNMLTGPLPA-GLVERSKNGSLSLSVDLC 471 (846)
Q Consensus 407 ~~~L~~L~~L~Ls~N~l~g~--iP~~~~~l~~L~~L~Ls~N~l~g~iP~-~~~~l~~l~~l~l~~nlc 471 (846)
+.++++|+.|+|++|+|+.. ++..+..+++|+.|||++|+|+ .+++ ......+|+.|++++|.+
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl 127 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSL 127 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTT
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCc
Confidence 34555566666666665532 2334455555666666666655 3332 222333455555555544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.72 E-value=1.5e-05 Score=83.64 Aligned_cols=77 Identities=27% Similarity=0.386 Sum_probs=49.6
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLS 465 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~ 465 (846)
+++|+.|+|++|+|+ .+|..+ .+|+.|++++|+++ .+++ + .+.|++|+|++|+++ .+|. ++.+++|+.|+
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~ 126 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIID 126 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h--ccccccccccccccc-cccc-hhhhccceeec
Confidence 456777777777777 666543 45666777777766 4443 1 135777777777777 5664 46677777777
Q ss_pred CccccCC
Q 003114 466 LSVDLCS 472 (846)
Q Consensus 466 l~~nlc~ 472 (846)
++.|...
T Consensus 127 l~~~~~~ 133 (353)
T d1jl5a_ 127 VDNNSLK 133 (353)
T ss_dssp CCSSCCS
T ss_pred ccccccc
Confidence 7665443
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.66 E-value=9.5e-05 Score=74.14 Aligned_cols=129 Identities=14% Similarity=0.069 Sum_probs=84.7
Q ss_pred cCcCce-EEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhccccc--ceeEeeEeecCCeeeEeeecccCCChh
Q 003114 543 LGEGSF-GKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKN--LTTLYGYCNEGNQIGLIYEYMANGSLE 619 (846)
Q Consensus 543 LG~G~f-G~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~l~g~~~~~~~~~LV~Ey~~~gsL~ 619 (846)
+..|.. +.||+...+++..+++|.-..... ..+..|...++.+.... +.+++.+..+++..++||++++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 344543 679999988888899998765432 35677888887774333 456777778888899999999876553
Q ss_pred hhhhcCCCCccChHHHHHHHHHHHHHHHHHh-------------------------------------------------
Q 003114 620 EYLSDSNADVLSWEGRLRIATEAAQGLEYLH------------------------------------------------- 650 (846)
Q Consensus 620 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH------------------------------------------------- 650 (846)
+... . ....+.++++.|.-||
T Consensus 95 ~~~~-------~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 95 SSHL-------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TSCC-------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccc-------c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 3110 0 0111122222222222
Q ss_pred --cc----CCCCeeecCCCCCCEEECCCCcEEEEeccCCc
Q 003114 651 --LG----CKPPRVHRDIKPANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 651 --~~----~~~~IiHrDlKp~NILld~~~~vkI~DFGla~ 684 (846)
.. ....++|+|+.|.||+++++..+-|.||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 12338999999999999988777899998775
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=97.59 E-value=2.9e-05 Score=76.99 Aligned_cols=78 Identities=27% Similarity=0.356 Sum_probs=66.4
Q ss_pred CceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccccccCCCCCCCC
Q 003114 387 PRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGLVERSKNGSLSL 466 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~l~~l~~l~l 466 (846)
.+|+.|+|++|+|+ .++ .+..|++|+.|+|++|++++..| +..+++|+.|++++|.++ .++ ++..+++|+.+.+
T Consensus 41 ~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l 114 (227)
T d1h6ua2 41 DGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDL 114 (227)
T ss_dssp HTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEEC
T ss_pred CCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-ccccccccccccc
Confidence 47899999999999 564 69999999999999999996544 899999999999999998 555 5788888888888
Q ss_pred cccc
Q 003114 467 SVDL 470 (846)
Q Consensus 467 ~~nl 470 (846)
+.+.
T Consensus 115 ~~~~ 118 (227)
T d1h6ua2 115 TSTQ 118 (227)
T ss_dssp TTSC
T ss_pred cccc
Confidence 7653
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.49 E-value=3.9e-05 Score=80.36 Aligned_cols=62 Identities=34% Similarity=0.425 Sum_probs=49.4
Q ss_pred CCCceEEEEcCCCCCcccCCccccCCCCCCeEeccCCCCCCCCCchhcccCccccccccCccCCCCCcccc
Q 003114 385 DPPRITSLNLSSRGLTGGIPPYLSNLTMIEHLDLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPAGL 455 (846)
Q Consensus 385 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~ 455 (846)
.+++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|...
T Consensus 282 ~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~ 343 (353)
T d1jl5a_ 282 LPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP 343 (353)
T ss_dssp CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC
T ss_pred cCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccc
Confidence 4568999999999998 77754 567888999999998 68863 467888999999988 677643
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.35 E-value=1.4e-05 Score=75.26 Aligned_cols=80 Identities=28% Similarity=0.182 Sum_probs=62.2
Q ss_pred CCceEEEEcCCCCCccc--CCccccCCCCCCeEeccCCCCCCCCCc-hhcccCccccccccCccCCCCCccc-------c
Q 003114 386 PPRITSLNLSSRGLTGG--IPPYLSNLTMIEHLDLSNNSLTGPVPE-FLSKLQYLRVLNLTGNMLTGPLPAG-------L 455 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~--ip~~~~~L~~L~~L~Ls~N~l~g~iP~-~~~~l~~L~~L~Ls~N~l~g~iP~~-------~ 455 (846)
.+.++.|+|++|+|+.. ++..+..|++|+.|+|++|+|+ .+++ .+....+|+.|+|++|.+++..... +
T Consensus 64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~ 142 (162)
T d1koha1 64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR 142 (162)
T ss_dssp CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHH
T ss_pred CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHHHHH
Confidence 46899999999999953 3455888999999999999999 4554 3444567999999999998765532 4
Q ss_pred cccCCCCCCCC
Q 003114 456 VERSKNGSLSL 466 (846)
Q Consensus 456 ~~l~~l~~l~l 466 (846)
..+++|+.||-
T Consensus 143 ~~~P~L~~LDg 153 (162)
T d1koha1 143 ERFPKLLRLDG 153 (162)
T ss_dssp TTSTTCCEETT
T ss_pred HHCCCCCEECc
Confidence 46788887763
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.28 E-value=8.6e-05 Score=73.92 Aligned_cols=80 Identities=21% Similarity=0.180 Sum_probs=61.7
Q ss_pred CCceEEEEcCCCCCcccCCccccCCCCCCeE-eccCCCCCCCCCchhcccCccccccccCccCCCCCcc-cccccCCCCC
Q 003114 386 PPRITSLNLSSRGLTGGIPPYLSNLTMIEHL-DLSNNSLTGPVPEFLSKLQYLRVLNLTGNMLTGPLPA-GLVERSKNGS 463 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L-~Ls~N~l~g~iP~~~~~l~~L~~L~Ls~N~l~g~iP~-~~~~l~~l~~ 463 (846)
+..++.|++++|+++ .++....+.++++.+ ++++|+|+..-+..|.++++|+.|+|++|+|+ .+|. .|.++++|+.
T Consensus 152 ~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~ 229 (242)
T d1xwdc1 152 SFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRA 229 (242)
T ss_dssp BSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCCEEES
T ss_pred cccceeeeccccccc-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcCCccccc
Confidence 457889999999999 566655556665554 67888898433456899999999999999999 5554 6788888887
Q ss_pred CCCc
Q 003114 464 LSLS 467 (846)
Q Consensus 464 l~l~ 467 (846)
+++.
T Consensus 230 l~~~ 233 (242)
T d1xwdc1 230 RSTY 233 (242)
T ss_dssp SSEE
T ss_pred CcCC
Confidence 7764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.01 E-value=0.0012 Score=70.67 Aligned_cols=74 Identities=15% Similarity=0.209 Sum_probs=46.8
Q ss_pred hcCcCceEEEEEEEEc-CCcEEEEEEeCCC-------CchhhHHHHHHHHHHHhcc-c-cc-ceeEeeEeecCCeeeEee
Q 003114 542 ILGEGSFGKVYHGYLD-DNTEVAVKMLSPS-------SRQGYEQFEAEVILLRTVH-H-KN-LTTLYGYCNEGNQIGLIY 610 (846)
Q Consensus 542 ~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-------~~~~~~~~~~Ei~~l~~l~-H-pn-Iv~l~g~~~~~~~~~LV~ 610 (846)
.||.|....||+.... +++.++||.-.+. -+....+...|.+.|+.+. + |. +.+++.+ +++..++||
T Consensus 33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvm 110 (392)
T d2pula1 33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM 110 (392)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEE
Confidence 5899999999999865 4678999975431 1112344566887777663 2 33 4445544 344567899
Q ss_pred ecccCCC
Q 003114 611 EYMANGS 617 (846)
Q Consensus 611 Ey~~~gs 617 (846)
|++++..
T Consensus 111 E~L~~~~ 117 (392)
T d2pula1 111 EDLSHLK 117 (392)
T ss_dssp CCCTTSE
T ss_pred eccCCcc
Confidence 9997643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.61 E-value=0.00011 Score=79.67 Aligned_cols=84 Identities=27% Similarity=0.264 Sum_probs=45.9
Q ss_pred ceEEEEcCCCCCc----ccCCccccCCCCCCeEeccCCCCCCC----CCchhc-ccCccccccccCccCCCC----Cccc
Q 003114 388 RITSLNLSSRGLT----GGIPPYLSNLTMIEHLDLSNNSLTGP----VPEFLS-KLQYLRVLNLTGNMLTGP----LPAG 454 (846)
Q Consensus 388 ~l~~L~L~~n~l~----g~ip~~~~~L~~L~~L~Ls~N~l~g~----iP~~~~-~l~~L~~L~Ls~N~l~g~----iP~~ 454 (846)
+++.|+|++|+|+ ..|+..+..+++|+.|||++|+|+.. +...+. ...+|+.|+|++|+++.. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccch
Confidence 4456666666665 23344456666677777766666411 111221 123566677776666532 3444
Q ss_pred ccccCCCCCCCCccccC
Q 003114 455 LVERSKNGSLSLSVDLC 471 (846)
Q Consensus 455 ~~~l~~l~~l~l~~nlc 471 (846)
+..+++|+.|++++|..
T Consensus 108 l~~~~~L~~L~L~~N~i 124 (460)
T d1z7xw1 108 LRTLPTLQELHLSDNLL 124 (460)
T ss_dssp TTSCTTCCEEECCSSBC
T ss_pred hhccccccccccccccc
Confidence 55566666666666543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.60 E-value=0.0034 Score=65.23 Aligned_cols=134 Identities=15% Similarity=0.176 Sum_probs=78.1
Q ss_pred EEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccc--eeEee-----EeecCCeeeEeeecccCCChhh-
Q 003114 549 GKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNL--TTLYG-----YCNEGNQIGLIYEYMANGSLEE- 620 (846)
Q Consensus 549 G~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnI--v~l~g-----~~~~~~~~~LV~Ey~~~gsL~~- 620 (846)
-.||+...++|+.+++|+.++.. ...+++..|...+..+...++ +..+. .+..++..+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 37999999999999999987652 234678889988888754332 11111 2234566788899987643211
Q ss_pred ----h---------hhc----CC---CCccCh-------------------HHH---HHHHHHHHHHHHHH-hccCCCCe
Q 003114 621 ----Y---------LSD----SN---ADVLSW-------------------EGR---LRIATEAAQGLEYL-HLGCKPPR 657 (846)
Q Consensus 621 ----~---------l~~----~~---~~~l~~-------------------~~~---~~i~~~ia~gL~yL-H~~~~~~I 657 (846)
+ ++. .. ....++ ..+ ...+..+...+.-. ......++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 010 00 011111 111 12222333222222 12234568
Q ss_pred eecCCCCCCEEECCCCcEEEEeccCCcc
Q 003114 658 VHRDIKPANILLNDQFQARLADFGLSKT 685 (846)
Q Consensus 658 iHrDlKp~NILld~~~~vkI~DFGla~~ 685 (846)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45889998763
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.42 E-value=0.00015 Score=78.42 Aligned_cols=83 Identities=20% Similarity=0.130 Sum_probs=48.7
Q ss_pred CceEEEEcCCCCCccc----CCcccc-CCCCCCeEeccCCCCCC----CCCchhcccCccccccccCccCCCCCccccc-
Q 003114 387 PRITSLNLSSRGLTGG----IPPYLS-NLTMIEHLDLSNNSLTG----PVPEFLSKLQYLRVLNLTGNMLTGPLPAGLV- 456 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~----ip~~~~-~L~~L~~L~Ls~N~l~g----~iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~~- 456 (846)
.+|+.|+|++|+|+.. ++..+. ..+.|+.|+|++|+|+. .+++.+..+++|++|||++|+|+..-...+.
T Consensus 340 ~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~ 419 (460)
T d1z7xw1 340 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419 (460)
T ss_dssp SSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHH
T ss_pred cchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHH
Confidence 3577777777777642 333443 35667777777777763 2455566667777777777777643222222
Q ss_pred ----ccCCCCCCCCccc
Q 003114 457 ----ERSKNGSLSLSVD 469 (846)
Q Consensus 457 ----~l~~l~~l~l~~n 469 (846)
+..+|+.|++..|
T Consensus 420 ~l~~~~~~L~~l~l~~~ 436 (460)
T d1z7xw1 420 SVRQPGCLLEQLVLYDI 436 (460)
T ss_dssp HHTSTTCCCCEEECTTC
T ss_pred HHHhCCCccCEEECCCC
Confidence 2224555655544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.27 E-value=0.00065 Score=69.43 Aligned_cols=82 Identities=26% Similarity=0.250 Sum_probs=47.6
Q ss_pred CceEEEEcCCC--CCccc-CCccccCCCCCCeEeccCC-CCCCCCCchhcccCccccccccC-ccCCCCCcccccccCCC
Q 003114 387 PRITSLNLSSR--GLTGG-IPPYLSNLTMIEHLDLSNN-SLTGPVPEFLSKLQYLRVLNLTG-NMLTGPLPAGLVERSKN 461 (846)
Q Consensus 387 ~~l~~L~L~~n--~l~g~-ip~~~~~L~~L~~L~Ls~N-~l~g~iP~~~~~l~~L~~L~Ls~-N~l~g~iP~~~~~l~~l 461 (846)
++++.|+|++. +++.. +..-+.++++|++|+|++| .+++..+..++++++|++|+|++ +++++.....++++++|
T Consensus 148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence 35666666653 33322 2222345666777777664 36655666666666777777766 45655555556666666
Q ss_pred CCCCCcc
Q 003114 462 GSLSLSV 468 (846)
Q Consensus 462 ~~l~l~~ 468 (846)
+.|++++
T Consensus 228 ~~L~l~~ 234 (284)
T d2astb2 228 KTLQVFG 234 (284)
T ss_dssp CEEECTT
T ss_pred CEEeeeC
Confidence 6666654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.02 E-value=0.0015 Score=66.56 Aligned_cols=59 Identities=24% Similarity=0.304 Sum_probs=53.1
Q ss_pred CceEEEEcCCC-CCcccCCccccCCCCCCeEeccC-CCCCCCCCchhcccCccccccccCc
Q 003114 387 PRITSLNLSSR-GLTGGIPPYLSNLTMIEHLDLSN-NSLTGPVPEFLSKLQYLRVLNLTGN 445 (846)
Q Consensus 387 ~~l~~L~L~~n-~l~g~ip~~~~~L~~L~~L~Ls~-N~l~g~iP~~~~~l~~L~~L~Ls~N 445 (846)
++|+.|+|++| .+++.....++++++|++|+|++ ++++......++++++|+.|+++++
T Consensus 175 ~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 57999999986 68988889999999999999999 5788777788999999999999987
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=95.87 E-value=0.00055 Score=71.82 Aligned_cols=84 Identities=20% Similarity=0.229 Sum_probs=53.7
Q ss_pred CceEEEEcCCCCCccc-----CCccccCCCCCCeEeccCCCCCCC----CCchhcccCccccccccCccCCCCCcccc--
Q 003114 387 PRITSLNLSSRGLTGG-----IPPYLSNLTMIEHLDLSNNSLTGP----VPEFLSKLQYLRVLNLTGNMLTGPLPAGL-- 455 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~-----ip~~~~~L~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~Ls~N~l~g~iP~~~-- 455 (846)
..++.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|+.|+|++|+|++.-...+
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 3577788888877632 344567777888888888877532 44556677778888888887764322222
Q ss_pred --c--ccCCCCCCCCcccc
Q 003114 456 --V--ERSKNGSLSLSVDL 470 (846)
Q Consensus 456 --~--~l~~l~~l~l~~nl 470 (846)
. ....|+.|++++|.
T Consensus 266 ~l~~~~~~~L~~L~ls~N~ 284 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNE 284 (344)
T ss_dssp HHHTCSSCCCCEEECCSSC
T ss_pred HhhhccCCCCCEEECCCCc
Confidence 2 12456777777664
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.85 E-value=0.012 Score=62.63 Aligned_cols=72 Identities=18% Similarity=0.341 Sum_probs=49.7
Q ss_pred hhcCcCceEEEEEEEEcCC--------cEEEEEEeCCCCchhhHHHHHHHHHHHhcccccce-eEeeEeecCCeeeEeee
Q 003114 541 TILGEGSFGKVYHGYLDDN--------TEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLT-TLYGYCNEGNQIGLIYE 611 (846)
Q Consensus 541 ~~LG~G~fG~Vykg~~~~g--------~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~l~g~~~~~~~~~LV~E 611 (846)
+.|+.|-.-.+|+....++ +.|.+++...... .....+|..+++.+.-.+++ ++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 3578888889999987543 4577777663322 34566888888888644554 66777654 68999
Q ss_pred cccCCCh
Q 003114 612 YMANGSL 618 (846)
Q Consensus 612 y~~~gsL 618 (846)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=95.65 E-value=0.0011 Score=62.00 Aligned_cols=84 Identities=19% Similarity=0.247 Sum_probs=60.0
Q ss_pred CCceEEEEcCCC-CCccc----CCccccCCCCCCeEeccCCCCCC----CCCchhcccCccccccccCccCCCC----Cc
Q 003114 386 PPRITSLNLSSR-GLTGG----IPPYLSNLTMIEHLDLSNNSLTG----PVPEFLSKLQYLRVLNLTGNMLTGP----LP 452 (846)
Q Consensus 386 ~~~l~~L~L~~n-~l~g~----ip~~~~~L~~L~~L~Ls~N~l~g----~iP~~~~~l~~L~~L~Ls~N~l~g~----iP 452 (846)
.++|+.|+|+++ .++.. +-..+...+.|+.|+|++|.+.. .+-..+...+.|+.|+|++|.|+.. +-
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 357999999874 46532 33457778889999999999863 2334566678899999999998742 12
Q ss_pred ccccccCCCCCCCCccc
Q 003114 453 AGLVERSKNGSLSLSVD 469 (846)
Q Consensus 453 ~~~~~l~~l~~l~l~~n 469 (846)
..+...+.|+.|+++.|
T Consensus 94 ~aL~~n~sL~~L~l~~n 110 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQ 110 (167)
T ss_dssp HHTTTTCCCSEEECCCC
T ss_pred HHHHhCCcCCEEECCCC
Confidence 23555677888888766
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=95.21 E-value=0.0012 Score=69.03 Aligned_cols=86 Identities=21% Similarity=0.224 Sum_probs=66.7
Q ss_pred CCceEEEEcCCCCCcc----cCCccccCCCCCCeEeccCCCCCCC-----CCchhcccCccccccccCccCCCC----Cc
Q 003114 386 PPRITSLNLSSRGLTG----GIPPYLSNLTMIEHLDLSNNSLTGP-----VPEFLSKLQYLRVLNLTGNMLTGP----LP 452 (846)
Q Consensus 386 ~~~l~~L~L~~n~l~g----~ip~~~~~L~~L~~L~Ls~N~l~g~-----iP~~~~~l~~L~~L~Ls~N~l~g~----iP 452 (846)
.+.++.|++++|.++- .+...+..++.|+.|+|++|+++.. +...+..+++|+.|+|++|+|+.. +.
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 3478899999998873 3444567889999999999998742 345577889999999999998632 44
Q ss_pred ccccccCCCCCCCCccccC
Q 003114 453 AGLVERSKNGSLSLSVDLC 471 (846)
Q Consensus 453 ~~~~~l~~l~~l~l~~nlc 471 (846)
..+...++|+.|++++|..
T Consensus 237 ~~l~~~~~L~~L~Ls~n~i 255 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCLL 255 (344)
T ss_dssp HHGGGCTTCCEEECTTCCC
T ss_pred ccccccccchhhhhhcCcc
Confidence 5677888999999987744
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.15 E-value=0.045 Score=55.72 Aligned_cols=155 Identities=10% Similarity=0.049 Sum_probs=80.5
Q ss_pred cCHHHHHHHHhhhh-------hhcCcCceEEEEEEEEcCCcEEEEEEeCCCCchhhHHHHHHHHHHHhcccccce--eEe
Q 003114 527 FTYAEITKITNDFE-------TILGEGSFGKVYHGYLDDNTEVAVKMLSPSSRQGYEQFEAEVILLRTVHHKNLT--TLY 597 (846)
Q Consensus 527 ~~~~el~~~t~~f~-------~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~~~~Ei~~l~~l~HpnIv--~l~ 597 (846)
.+.+|+......+. +.|..|---+.|+...++|+ +++|+..... ..+++..|++++..+...++. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 44556666555442 22455666778998887664 8889886532 224556677777777533221 111
Q ss_pred e------EeecCCeeeEeeecccCCChhhh--------------hhc----CC-C----C----------------ccCh
Q 003114 598 G------YCNEGNQIGLIYEYMANGSLEEY--------------LSD----SN-A----D----------------VLSW 632 (846)
Q Consensus 598 g------~~~~~~~~~LV~Ey~~~gsL~~~--------------l~~----~~-~----~----------------~l~~ 632 (846)
. +.........++.++.+...... ++. .. . . ....
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 11223445556666654322110 000 00 0 0 0001
Q ss_pred HHHHHHHHHHHHHHHHHh-ccCCCCeeecCCCCCCEEECCCCcEEEEeccCCc
Q 003114 633 EGRLRIATEAAQGLEYLH-LGCKPPRVHRDIKPANILLNDQFQARLADFGLSK 684 (846)
Q Consensus 633 ~~~~~i~~~ia~gL~yLH-~~~~~~IiHrDlKp~NILld~~~~vkI~DFGla~ 684 (846)
......+......+.-.+ .....++||+|+.+.||+++++...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111222333333333333 2346679999999999999998877899999885
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=94.98 E-value=0.0021 Score=60.00 Aligned_cols=83 Identities=11% Similarity=0.098 Sum_probs=59.8
Q ss_pred CceEEEEcCCCCCccc----CCccccCCCCCCeEeccCCCCCCC----CCchhcccCccccccccCccCCCC-------C
Q 003114 387 PRITSLNLSSRGLTGG----IPPYLSNLTMIEHLDLSNNSLTGP----VPEFLSKLQYLRVLNLTGNMLTGP-------L 451 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~----ip~~~~~L~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~Ls~N~l~g~-------i 451 (846)
..|+.|+|++|++... +...+...+.|+.|+|++|.|+.. +-..+...++|+.|+|++|.+... +
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l 123 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 123 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHH
Confidence 4789999999999733 333466778999999999999853 233566678899999999987621 2
Q ss_pred cccccccCCCCCCCCccc
Q 003114 452 PAGLVERSKNGSLSLSVD 469 (846)
Q Consensus 452 P~~~~~l~~l~~l~l~~n 469 (846)
...+...+.|..|+++.+
T Consensus 124 ~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 124 MMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHHHHCSSCCEEECCCC
T ss_pred HHHHHhCCCccEeeCcCC
Confidence 334445667777766543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=90.82 E-value=0.029 Score=51.64 Aligned_cols=82 Identities=20% Similarity=0.322 Sum_probs=56.2
Q ss_pred CCceEEEEcCC-CCCccc----CCccccCCCCCCeEeccCCCCCCC----CCchhcccCccccccccCccCCCC----Cc
Q 003114 386 PPRITSLNLSS-RGLTGG----IPPYLSNLTMIEHLDLSNNSLTGP----VPEFLSKLQYLRVLNLTGNMLTGP----LP 452 (846)
Q Consensus 386 ~~~l~~L~L~~-n~l~g~----ip~~~~~L~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~L~Ls~N~l~g~----iP 452 (846)
.+.|+.|+|++ +.++.. +-..+...++|+.|+|++|.++.. +-..+...++|+.|++++|.++.. +-
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 35888999987 456522 233466788999999999988743 233556678899999999988633 22
Q ss_pred ccccccCCCCCCCCc
Q 003114 453 AGLVERSKNGSLSLS 467 (846)
Q Consensus 453 ~~~~~l~~l~~l~l~ 467 (846)
..+...++|+.++|+
T Consensus 96 ~~l~~~~~L~~l~L~ 110 (166)
T d1io0a_ 96 EALQSNTSLIELRID 110 (166)
T ss_dssp HGGGGCSSCCEEECC
T ss_pred HHHHhCccccEEeec
Confidence 345566677764443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=89.94 E-value=0.019 Score=53.01 Aligned_cols=83 Identities=11% Similarity=0.131 Sum_probs=60.7
Q ss_pred CceEEEEcCCCCCccc----CCccccCCCCCCeEeccCCCCCCC----CCchhcccCcccc--ccccCccCCC----CCc
Q 003114 387 PRITSLNLSSRGLTGG----IPPYLSNLTMIEHLDLSNNSLTGP----VPEFLSKLQYLRV--LNLTGNMLTG----PLP 452 (846)
Q Consensus 387 ~~l~~L~L~~n~l~g~----ip~~~~~L~~L~~L~Ls~N~l~g~----iP~~~~~l~~L~~--L~Ls~N~l~g----~iP 452 (846)
++|+.|+|++|+++.. +-..+...+.|+.|++++|.++.. +-..+...++|+. |++++|.+.. .+.
T Consensus 46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La 125 (166)
T d1io0a_ 46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 125 (166)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHH
Confidence 4789999999998754 333466789999999999999743 3356677788886 5556788753 244
Q ss_pred ccccccCCCCCCCCccc
Q 003114 453 AGLVERSKNGSLSLSVD 469 (846)
Q Consensus 453 ~~~~~l~~l~~l~l~~n 469 (846)
..+...++|+.|+++.+
T Consensus 126 ~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 126 NMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHHHCSSCCEEECCCS
T ss_pred HHHHhCCCcCEEeCcCC
Confidence 45667888888887644
|